data_1vvd_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1vvd _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.415 ' O ' HG21 ' A' ' 1' ' ' VAL . 16.6 m . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.101 0.477 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.42 166.58 20.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.132 -0.98 . . . . 0.0 110.471 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.506 ' N ' ' O ' ' A' ' 21' ' ' TYR . 0.9 OUTLIER -135.23 83.63 2.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.418 -0.801 . . . . 0.0 109.805 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.84 172.27 0.11 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.05 -1.031 . . . . 0.0 110.229 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 p -52.45 144.02 25.13 Favored Pre-proline 0 C--N 1.301 -1.525 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.071 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.648 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 54.6 Cg_endo -72.35 151.88 54.54 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 123.798 1.42 . . . . 0.0 110.644 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.64 171.49 18.11 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 O-C-N 123.884 1.465 . . . . 0.0 109.722 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.04 177.82 2.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.069 -1.02 . . . . 0.0 109.675 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.461 HD13 ' SG ' ' A' ' 56' ' ' CYS . 0.3 OUTLIER -140.93 -170.47 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 122.155 0.979 . . . . 0.0 111.543 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 48.4 t -37.87 95.66 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.998 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.5 OUTLIER 42.33 27.24 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.304 -0.873 . . . . 0.0 110.41 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -126.93 -176.34 14.44 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.524 ' HG3' ' CB ' ' A' ' 30' ' ' SER . 0.5 OUTLIER -138.24 177.64 7.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.258 -1.142 . . . . 0.0 110.578 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.648 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 10.8 p80 -130.19 132.76 46.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.504 -0.748 . . . . 0.0 110.209 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -154.11 80.04 1.12 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.203 -0.936 . . . . 0.0 110.568 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.99 -117.36 0.24 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.97 27.02 1.83 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -1.156 . . . . 0.0 110.392 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.621 ' CG ' ' CZ ' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -163.37 -179.29 6.44 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.18 -0.95 . . . . 0.0 109.998 179.593 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -135.23 19.25 3.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -0.95 . . . . 0.0 110.302 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.05 49.31 0.85 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 110.433 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.621 ' CZ ' ' CG ' ' A' ' 18' ' ' GLU . 13.1 m-85 -50.42 165.69 0.09 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.066 -1.021 . . . . 0.0 109.443 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.496 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 10.1 p -131.78 -70.25 0.58 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.016 -1.053 . . . . 0.0 110.837 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -159.56 137.46 10.15 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.332 -0.855 . . . . 0.0 109.663 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 79.35 13.92 82.15 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.591 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -96.65 171.81 8.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.518 -0.99 . . . . 0.0 109.828 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 39.5 t -146.76 154.91 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.121 -0.987 . . . . 0.0 110.796 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.515 ' N ' HG11 ' A' ' 26' ' ' VAL . 20.9 t -133.19 117.09 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.613 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.405 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -72.43 102.5 3.2 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 118.45 -1.3 . . . . 0.0 108.032 177.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.639 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 2.3 m-30 -68.04 174.5 3.76 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.422 -0.799 . . . . 0.0 109.959 -178.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.524 ' CB ' ' HG3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -135.36 148.17 49.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.913 . . . . 0.0 109.606 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.404 ' O ' ' C ' ' A' ' 32' ' ' ASN . 57.7 m -118.62 147.95 43.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.168 -0.958 . . . . 0.0 110.311 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 31' ' ' CYS . 1.8 t-20 -44.27 150.95 0.27 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.217 -0.927 . . . . 0.0 109.944 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 88.2 p -55.35 99.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 0.0 110.31 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 134.68 -20.09 3.92 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -98.76 131.59 44.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.252 -1.146 . . . . 0.0 110.288 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.623 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -79.57 144.24 34.05 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.336 -0.852 . . . . 0.0 111.123 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.522 ' HA ' ' O ' ' A' ' 55' ' ' THR . 0.6 OUTLIER -91.99 102.09 14.64 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.475 -0.766 . . . . 0.0 109.205 178.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.579 ' CG2' ' CG ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -90.9 142.68 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.077 -1.015 . . . . 0.0 109.734 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 132.35 -158.94 23.2 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.493 ' O ' ' C ' ' A' ' 41' ' ' SER . 0.3 OUTLIER -98.31 49.34 0.99 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.842 -1.387 . . . . 0.0 109.65 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.493 ' C ' ' O ' ' A' ' 40' ' ' ASN . 0.4 OUTLIER 27.89 57.29 0.1 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.331 179.654 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 27' ' ' VAL . . . 155.63 117.23 0.57 Allowed Glycine 0 N--CA 1.488 2.166 0 C-N-CA 119.465 -1.35 . . . . 0.0 110.023 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.639 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 2.0 t -62.71 -178.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.991 -1.3 . . . . 0.0 108.013 178.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.46 ' HA ' HG21 ' A' ' 26' ' ' VAL . 4.3 tp -144.45 95.11 2.66 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.014 -1.074 . . . . 0.0 110.508 178.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.574 ' SG ' ' CD2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -80.92 110.3 16.31 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.379 178.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.0 t -126.57 111.04 13.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.592 -0.692 . . . . 0.0 110.643 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.07 22.5 38.17 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.463 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 81.01 19.86 66.43 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -140.64 113.64 8.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.099 -1.236 . . . . 0.0 110.526 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.574 ' CD2' ' SG ' ' A' ' 45' ' ' CYS . 87.8 m95 -62.58 138.11 58.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.317 -0.864 . . . . 0.0 109.73 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 52' ' ' ASP . 3.5 m -141.84 171.61 13.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.102 -0.999 . . . . 0.0 111.417 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.467 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER 37.29 67.65 1.82 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.912 -0.493 . . . . 0.0 111.593 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.467 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.0 Cg_endo -90.66 144.03 3.65 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 O-C-N 124.327 1.698 . . . . 0.0 109.592 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.518 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 45.9 Cg_endo -74.68 171.26 18.55 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.618 1.325 . . . . 0.0 110.35 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.542 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 15.7 p -114.18 169.16 9.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.163 -0.961 . . . . 0.0 111.468 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.461 ' SG ' HD13 ' A' ' 9' ' ' ILE . 37.8 m -126.73 79.32 1.86 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -114.82 -170.8 1.81 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 120.161 -0.615 . . . . 0.0 110.135 -178.746 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -107.92 112.87 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.192 -0.943 . . . . 0.0 108.504 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.66 ' CG1' ' HA ' ' A' ' 105' ' ' PRO . 6.0 m -95.92 83.14 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.051 -1.031 . . . . 0.0 111.612 -178.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.2 mtmt -120.31 96.36 5.11 Favored 'General case' 0 C--N 1.289 -2.059 0 O-C-N 120.417 -1.427 . . . . 0.0 108.657 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.48 ' SG ' ' HB2' ' A' ' 79' ' ' TYR . 4.5 p -68.06 162.52 59.03 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.412 -0.805 . . . . 0.0 111.659 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 61' ' ' CYS . 42.9 Cg_endo -70.47 -89.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.832 0 O-C-N 124.696 1.892 . . . . 0.0 110.286 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.416 ' CD2' ' O ' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -160.51 130.54 3.45 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.593 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 50.9 Cg_endo -77.32 70.85 6.61 Favored 'Trans proline' 0 C--N 1.294 -2.322 0 O-C-N 123.787 1.414 . . . . 0.0 109.818 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.545 ' O ' ' CD2' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -93.45 -175.78 3.91 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.121 -0.987 . . . . 0.0 109.512 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.545 ' CD1' ' HG2' ' A' ' 114' ' ' PRO . 0.4 OUTLIER 177.88 167.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.059 -1.026 . . . . 0.0 110.573 178.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.552 ' O ' ' CB ' ' A' ' 68' ' ' ASN . 2.9 m -64.19 73.15 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.568 -0.708 . . . . 0.0 111.323 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 67' ' ' SER . 0.5 OUTLIER 75.2 -16.72 0.55 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.432 -0.793 . . . . 0.0 111.933 179.093 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.573 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -86.32 35.52 3.3 Favored Glycine 0 N--CA 1.491 2.354 0 O-C-N 120.733 -1.23 . . . . 0.0 110.425 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.573 ' O ' ' O ' ' A' ' 69' ' ' GLY . 2.2 p90 -43.15 -173.49 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 122.712 1.244 . . . . 0.0 112.526 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.536 ' C ' ' CD2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -113.31 161.49 17.18 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.272 178.795 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.8 t -146.97 22.07 1.23 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.173 -0.954 . . . . 0.0 109.917 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.39 -51.37 2.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 0.0 110.898 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -153.44 88.67 0.13 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.592 ' CE2' ' OH ' ' A' ' 79' ' ' TYR . 1.8 t80 -126.3 117.27 22.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -1.133 . . . . 0.0 110.177 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.62 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 28.2 tttt -113.79 148.06 37.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.201 -0.937 . . . . 0.0 109.656 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.462 ' C ' ' O ' ' A' ' 76' ' ' LYS . 1.3 ttm-85 -42.0 -27.41 0.12 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.968 -1.082 . . . . 0.0 109.873 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 76' ' ' LYS . 40.5 m -140.94 147.12 38.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.525 -0.734 . . . . 0.0 110.283 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.672 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -144.03 178.92 7.53 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.218 -0.926 . . . . 0.0 109.583 179.553 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.57 ' O ' ' O ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -170.43 137.85 1.47 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.067 -1.021 . . . . 0.0 110.315 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.62 ' O ' ' CB ' ' A' ' 82' ' ' ASN . 6.6 t80 25.49 105.44 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 120.988 0.423 . . . . 0.0 111.982 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.62 ' CB ' ' O ' ' A' ' 81' ' ' TYR . 10.6 m-20 96.4 -134.86 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 123.373 0.669 . . . . 0.0 109.699 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.463 ' C ' HG21 ' A' ' 102' ' ' THR . 14.2 m-20 52.91 67.65 0.96 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.735 -1.228 . . . . 0.0 108.93 -178.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.521 ' N ' HG21 ' A' ' 102' ' ' THR . 8.1 p30 -69.69 113.04 6.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.556 -0.715 . . . . 0.0 110.969 -178.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.592 HG12 ' CH2' ' A' ' 109' ' ' TRP . 30.0 m -94.16 117.58 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.115 -0.991 . . . . 0.0 110.102 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -79.61 131.8 36.09 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.019 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 54.6 m-85 -92.37 116.5 29.03 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.962 -1.087 . . . . 0.0 112.154 -178.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -88.38 94.82 9.97 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.389 179.143 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.535 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 1.7 t -48.17 119.26 2.83 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.036 -1.04 . . . . 0.0 110.466 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.51 ' CG ' ' O ' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -57.17 125.05 20.95 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.227 -0.921 . . . . 0.0 109.96 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.48 ' HB2' ' O ' ' A' ' 90' ' ' LYS . 2.3 m-85 62.44 -174.5 0.14 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.171 -0.956 . . . . 0.0 111.351 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.46 54.73 0.9 Allowed Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.543 ' CB ' ' SG ' ' A' ' 116' ' ' CYS . 5.5 m-85 -106.34 158.08 17.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.325 -1.103 . . . . 0.0 109.448 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.54 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 9.6 mtmm -99.9 141.6 32.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.073 -1.017 . . . . 0.0 109.655 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.532 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 1.2 mt -87.2 94.11 9.57 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.581 -1.325 . . . . 0.0 110.057 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.548 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -69.61 101.14 1.57 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.233 -0.917 . . . . 0.0 109.127 179.38 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.13 -96.75 0.21 Allowed Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.202 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.576 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 3.3 m -150.19 116.59 5.75 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.165 -1.197 . . . . 0.0 110.577 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.403 ' HB3' HD11 ' A' ' 95' ' ' LEU . 42.8 p -77.17 10.3 2.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.235 -0.915 . . . . 0.0 111.293 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 77.0 p -154.42 99.4 2.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.849 -1.157 . . . . 0.0 110.48 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.482 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 3.5 m -111.57 -174.43 2.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.367 -0.833 . . . . 0.0 110.056 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' A' ' 82' ' ' ASN . 5.8 m -155.88 144.19 20.03 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.481 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.616 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 42.7 t -65.07 86.15 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.672 -0.642 . . . . 0.0 109.386 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.456 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -62.56 176.57 0.49 Allowed Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.194 -0.941 . . . . 0.0 112.731 -178.148 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.66 ' HA ' ' CG1' ' A' ' 59' ' ' VAL . 46.5 Cg_endo -80.37 12.5 2.52 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 124.848 1.973 . . . . 0.0 111.777 -178.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -118.46 18.22 11.04 Favored Glycine 0 C--N 1.294 -1.757 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 107' ' ' ASN . 1.2 m120 65.22 66.99 0.53 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.696 -0.885 . . . . 0.0 109.796 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -168.59 -172.84 1.75 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.227 -0.989 . . . . 0.0 111.497 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.616 ' CZ3' ' N ' ' A' ' 103' ' ' CYS . 41.2 m95 -123.3 95.68 4.69 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.571 0.7 . . . . 0.0 110.132 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.49 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -108.33 146.09 32.87 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.537 -0.727 . . . . 0.0 110.249 -179.537 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.576 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 44.3 Cg_endo -72.65 173.37 54.31 Favored 'Cis proline' 0 C--N 1.315 -1.235 0 C-N-CA 121.697 -2.21 . . . . 0.0 110.534 -0.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.3 mm-40 -36.93 131.05 0.76 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.657 -0.652 . . . . 0.0 111.551 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.545 ' CD2' ' O ' ' A' ' 65' ' ' THR . 0.2 OUTLIER -43.93 154.5 0.37 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.482 -0.761 . . . . 0.0 109.749 179.003 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.545 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 41.4 Cg_endo -83.59 171.67 10.77 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 O-C-N 124.092 1.575 . . . . 0.0 111.433 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.548 ' HB3' ' CB ' ' A' ' 96' ' ' SER . 3.3 ttpt -129.82 109.65 11.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.366 -0.834 . . . . 0.0 110.2 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.543 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.0 OUTLIER -69.12 108.54 3.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.153 -0.967 . . . . 0.0 109.257 179.715 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.54 ' CG2' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -118.95 -174.54 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.635 0.731 . . . . 0.0 110.195 -179.274 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.428 ' HD3' ' OH ' ' A' ' 93' ' ' TYR . 26.4 mtm180 . . . . . 0 C--N 1.292 -1.9 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.221 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 53.8 t . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.247 0.546 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.434 ' HA ' HG23 ' A' ' 22' ' ' THR . 0.1 OUTLIER -136.17 100.2 4.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.329 -0.857 . . . . 0.0 110.387 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.559 ' O ' ' N ' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -69.72 88.22 0.52 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.213 -0.929 . . . . 0.0 109.779 179.566 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.469 ' O ' ' C ' ' A' ' 5' ' ' SER . 1.1 pt20 -85.43 -174.02 4.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.04 -1.037 . . . . 0.0 110.064 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.469 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.3 OUTLIER -38.3 127.39 1.07 Allowed Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 120.306 -0.557 . . . . 0.0 109.569 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.617 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 45.6 Cg_endo -66.31 154.76 72.96 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.902 1.475 . . . . 0.0 111.509 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -75.49 171.52 18.07 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.115 1.587 . . . . 0.0 110.487 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.69 176.0 3.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 110.014 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.526 HG22 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -141.57 -170.28 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-O 122.143 0.973 . . . . 0.0 111.463 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.8 OUTLIER -40.78 95.26 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.26 -179.468 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.49 ' N ' ' O ' ' A' ' 9' ' ' ILE . 2.4 m-20 43.08 41.39 2.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 110.352 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' A' ' 30' ' ' SER . . . -146.11 158.23 27.62 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.509 ' HG3' ' CB ' ' A' ' 30' ' ' SER . 4.5 ptt180 -113.82 -179.85 3.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.233 -1.157 . . . . 0.0 110.325 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.617 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 11.5 p80 -128.98 133.42 47.78 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.629 -0.669 . . . . 0.0 110.049 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -136.62 96.36 3.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.052 -1.03 . . . . 0.0 110.877 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.22 179.59 30.99 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.401 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 5.1 t80 -105.91 46.16 0.94 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.078 -1.248 . . . . 0.0 110.245 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.602 ' CG ' ' CZ ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -175.82 -159.7 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.924 . . . . 0.0 110.392 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.5 -27.41 1.05 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.434 -0.791 . . . . 0.0 110.81 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.416 ' C ' ' OE2' ' A' ' 18' ' ' GLU . 25.8 m-85 -109.74 101.98 10.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.02 -1.05 . . . . 0.0 110.849 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.629 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 2.5 m-85 -102.4 44.9 0.99 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.57 -0.706 . . . . 0.0 109.604 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.491 ' O ' ' O ' ' A' ' 23' ' ' ASP . 24.9 p -53.98 99.8 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.1 0.952 . . . . 0.0 111.718 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 9.8 t70 50.15 165.28 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 121.794 0.807 . . . . 0.0 111.905 178.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.501 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 46.32 26.15 2.24 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.629 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 35.5 m -109.6 154.88 22.15 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.387 -1.066 . . . . 0.0 110.263 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 50.5 t -139.14 153.91 25.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.411 -0.915 . . . . 0.0 110.608 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.584 HG22 ' CH2' ' A' ' 50' ' ' TRP . 28.7 t -141.55 117.39 6.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.384 -0.927 . . . . 0.0 111.245 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.412 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -69.34 102.97 1.86 Allowed 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 118.469 -1.292 . . . . 0.0 107.669 178.256 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.638 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 2.5 m-30 -67.89 177.99 1.93 Allowed 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.749 -0.781 . . . . 0.0 109.979 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.509 ' CB ' ' HG3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -140.77 151.2 44.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 109.708 179.727 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.418 ' O ' ' C ' ' A' ' 32' ' ' ASN . 87.6 m -122.67 149.66 43.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.159 -0.963 . . . . 0.0 110.693 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.418 ' C ' ' O ' ' A' ' 31' ' ' CYS . 5.4 p-10 -42.48 145.55 0.41 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.46 -0.775 . . . . 0.0 110.175 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.4 129.17 31.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.187 -0.946 . . . . 0.0 110.486 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.87 -27.79 15.17 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 -89.39 162.81 15.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.103 -1.233 . . . . 0.0 110.349 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.595 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.9 OUTLIER -103.29 147.33 27.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.406 -0.809 . . . . 0.0 110.964 -179.158 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.52 ' HA ' ' O ' ' A' ' 55' ' ' THR . 6.3 tt -100.99 96.35 7.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.307 -0.871 . . . . 0.0 109.688 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.573 ' CD1' ' N ' ' A' ' 38' ' ' ILE . 0.3 OUTLIER -93.13 139.64 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 109.09 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 150.91 -126.97 2.23 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.506 ' O ' ' C ' ' A' ' 41' ' ' SER . 4.6 m120 -135.16 50.15 2.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -1.164 . . . . 0.0 109.54 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.506 ' C ' ' O ' ' A' ' 40' ' ' ASN . 2.1 p 25.46 54.84 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.345 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 28' ' ' THR . . . 150.86 113.42 0.6 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.638 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 1.9 t -64.65 -177.99 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.161 -1.2 . . . . 0.0 107.821 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.47 ' HA ' ' O ' ' A' ' 25' ' ' SER . 2.3 tp -146.65 97.89 2.98 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.286 -0.966 . . . . 0.0 110.702 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.595 ' SG ' ' CD2' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -75.08 114.1 13.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.081 -1.012 . . . . 0.0 109.165 178.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 85.1 p -129.73 92.74 3.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.57 -0.706 . . . . 0.0 110.219 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.99 39.42 2.68 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.04 11.92 53.11 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -133.3 120.16 20.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -1.183 . . . . 0.0 110.316 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.595 ' CD2' ' SG ' ' A' ' 45' ' ' CYS . 73.7 m95 -62.93 137.97 58.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.284 -0.885 . . . . 0.0 109.829 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.2 m -136.63 163.99 29.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.153 -0.967 . . . . 0.0 111.032 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.485 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 3.8 m-20 53.45 66.13 4.94 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.615 -0.678 . . . . 0.0 111.198 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.485 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.7 Cg_endo -90.37 135.85 2.23 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 O-C-N 124.288 1.678 . . . . 0.0 109.643 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.575 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 42.3 Cg_endo -71.54 178.61 5.46 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.591 1.311 . . . . 0.0 110.378 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.52 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 5.3 p -121.99 163.13 19.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.372 -0.83 . . . . 0.0 112.028 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 10' ' ' SER . 86.9 m -116.57 85.59 2.34 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -120.32 -141.23 0.34 Allowed 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.45 0.643 . . . . 0.0 110.405 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.488 ' CD1' ' N ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -136.32 127.13 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.297 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.63 ' HB ' ' HA ' ' A' ' 105' ' ' PRO . 34.0 m -123.08 49.28 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.031 -1.043 . . . . 0.0 111.61 -178.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 15.0 mtmt -55.99 -179.17 0.02 OUTLIER 'General case' 0 C--N 1.28 -2.431 0 C-N-CA 117.988 -1.485 . . . . 0.0 107.978 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.55 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -145.38 163.39 32.33 Favored Pre-proline 0 C--N 1.297 -1.705 0 C-N-CA 118.707 -1.197 . . . . 0.0 112.297 -179.048 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 42.8 Cg_endo -83.66 -71.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.748 1.92 . . . . 0.0 109.639 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.551 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 162.02 129.46 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.579 ' HG3' ' CZ2' ' A' ' 109' ' ' TRP . 49.7 Cg_endo -77.12 69.43 7.07 Favored 'Trans proline' 0 C--N 1.299 -2.065 0 O-C-N 123.721 1.38 . . . . 0.0 110.178 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.544 ' O ' ' CD2' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -99.38 139.31 35.22 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.562 ' CD1' ' HG2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -131.71 159.29 43.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 C-N-CA 118.594 -1.243 . . . . 0.0 111.057 -178.712 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 0.1 OUTLIER -58.66 111.85 1.41 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.752 -0.592 . . . . 0.0 111.239 -179.339 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 51.32 25.04 2.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.298 -0.876 . . . . 0.0 109.756 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.433 ' HA3' HG12 ' A' ' 66' ' ' ILE . . . -132.45 -177.41 14.9 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.531 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 37.1 p90 -178.54 -172.59 0.29 Allowed 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.541 -0.976 . . . . 0.0 109.388 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.594 ' O ' ' CD2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -126.44 151.49 47.67 Favored 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.709 178.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.2 t -113.65 -6.72 13.35 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.943 -1.098 . . . . 0.0 109.927 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.93 -80.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.378 -0.826 . . . . 0.0 110.259 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -169.79 93.03 0.1 Allowed Glycine 0 N--CA 1.488 2.162 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.167 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.604 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -86.22 174.95 8.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.359 -1.083 . . . . 0.0 109.171 179.219 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.566 ' N ' ' CG ' ' A' ' 75' ' ' PHE . 4.7 tttt -159.68 159.5 33.05 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.317 -0.864 . . . . 0.0 110.256 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.67 -39.63 17.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.898 . . . . 0.0 109.867 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.58 136.66 18.49 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.507 -0.746 . . . . 0.0 110.099 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.604 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 43.6 m-85 -99.29 -162.17 0.93 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.916 . . . . 0.0 109.774 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.53 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 85.6 p -146.59 -104.45 0.1 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -0.895 . . . . 0.0 109.083 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.604 ' CE2' ' ND2' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -111.91 145.14 40.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.818 -1.177 . . . . 0.0 107.904 178.718 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.604 ' ND2' ' CE2' ' A' ' 81' ' ' TYR . 1.6 m120 61.32 -99.43 0.09 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.375 -0.828 . . . . 0.0 110.153 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.469 ' C ' ' O ' ' A' ' 82' ' ' ASN . 10.3 m-20 41.14 79.48 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.995 -1.066 . . . . 0.0 109.238 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.588 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 21.5 t-20 -75.39 143.85 42.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.389 -0.819 . . . . 0.0 112.286 -177.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.593 ' CG2' ' CZ3' ' A' ' 109' ' ' TRP . 4.5 m -132.37 115.07 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.437 -0.789 . . . . 0.0 109.44 177.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.553 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 2.7 t70 -75.54 134.64 40.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.315 -0.866 . . . . 0.0 108.992 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.569 ' CE1' HD11 ' A' ' 71' ' ' LEU . 45.0 m-85 -94.63 142.47 27.4 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 118.682 -1.207 . . . . 0.0 112.253 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -120.12 98.71 6.2 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.581 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.491 ' HB2' HD13 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -46.92 129.49 11.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.133 -0.979 . . . . 0.0 110.457 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.435 ' O ' ' O ' ' A' ' 89' ' ' CYS . 6.8 mmtp -44.37 -92.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.29 -0.881 . . . . 0.0 110.173 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.556 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 1.9 t80 -152.73 158.81 42.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.211 -0.931 . . . . 0.0 110.049 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.588 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 45.31 25.85 1.32 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.588 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 18.0 m-85 -141.45 147.39 37.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.401 -1.058 . . . . 0.0 110.395 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.1 ptmm? -117.83 129.96 55.98 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.294 -0.879 . . . . 0.0 109.897 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.525 ' CD2' ' HB3' ' A' ' 87' ' ' PHE . 1.2 mt -57.12 103.0 0.1 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.186 -0.946 . . . . 0.0 110.8 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.539 ' CB ' HG23 ' A' ' 117' ' ' VAL . 3.0 t -85.96 91.36 8.35 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.22 -0.925 . . . . 0.0 109.053 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 152.2 -91.27 0.13 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.557 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -149.41 118.85 6.89 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.159 -1.2 . . . . 0.0 110.83 -179.432 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.435 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -80.88 13.71 2.54 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.25 -0.906 . . . . 0.0 110.918 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 60.2 p -152.91 113.41 4.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.123 -0.985 . . . . 0.0 109.72 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.479 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 13.0 m -124.6 -177.36 3.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 110.971 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -153.49 128.2 9.43 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.685 0.755 . . . . 0.0 110.21 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.587 ' N ' ' O ' ' A' ' 82' ' ' ASN . 4.7 t -66.09 81.5 0.08 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.447 ' HB3' ' HD2' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -64.38 173.75 1.41 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.342 -0.849 . . . . 0.0 110.988 -179.152 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.63 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 41.7 Cg_endo -73.18 120.49 6.6 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 O-C-N 124.586 1.835 . . . . 0.0 110.859 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.557 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 131.51 -6.06 5.57 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 1.6 m-20 81.0 93.61 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.916 -0.755 . . . . 0.0 111.361 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.527 ' CG2' ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 175.02 -168.34 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.475 -0.766 . . . . 0.0 111.198 179.024 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.593 ' CZ3' ' CG2' ' A' ' 85' ' ' VAL . 36.9 m95 -142.14 94.08 2.62 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.579 -0.7 . . . . 0.0 110.03 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.488 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 14.7 mmtt -103.61 147.17 33.82 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.367 -0.833 . . . . 0.0 110.086 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.557 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.1 Cg_endo -71.98 175.27 43.53 Favored 'Cis proline' 0 N--CA 1.49 1.28 0 C-N-CA 121.956 -2.102 . . . . 0.0 110.956 0.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 113' ' ' LEU . 12.7 pt-20 -37.68 122.39 0.95 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.684 -0.635 . . . . 0.0 110.986 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.549 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.9 OUTLIER -41.24 141.14 1.1 Allowed Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.517 -0.739 . . . . 0.0 110.174 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.562 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 40.4 Cg_endo -69.8 159.42 53.43 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 124.206 1.635 . . . . 0.0 110.851 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 117' ' ' VAL . 3.2 ttpm? -119.43 101.34 7.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.919 . . . . 0.0 110.281 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.534 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 4.6 t -61.77 82.3 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.052 -1.03 . . . . 0.0 108.894 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.539 HG23 ' CB ' ' A' ' 96' ' ' SER . 4.5 m -96.48 -171.61 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-O 121.942 0.877 . . . . 0.0 111.37 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.418 ' HG2' ' CE1' ' A' ' 93' ' ' TYR . 9.0 mtm180 . . . . . 0 C--N 1.293 -1.877 0 C-N-CA 119.152 -1.019 . . . . 0.0 110.446 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.55 ' CG2' ' HA3' ' A' ' 48' ' ' GLY . 4.7 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.227 0.537 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -141.51 176.67 8.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.197 -0.939 . . . . 0.0 110.388 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.524 ' O ' ' N ' ' A' ' 21' ' ' TYR . 1.1 m -130.13 87.74 2.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.406 -0.809 . . . . 0.0 110.37 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -70.86 175.4 5.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.815 -1.178 . . . . 0.0 109.926 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -44.09 141.41 2.47 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.31 -0.868 . . . . 0.0 109.977 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.614 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 53.2 Cg_endo -70.71 156.38 60.98 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 124.015 1.534 . . . . 0.0 110.845 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -75.23 174.92 11.97 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.955 1.503 . . . . 0.0 110.093 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.38 -179.92 1.81 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.186 -0.946 . . . . 0.0 110.389 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.55 HG22 ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -145.11 -170.23 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 122.206 1.003 . . . . 0.0 111.45 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.2 OUTLIER -45.1 92.75 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.387 -179.597 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.506 ' N ' ' O ' ' A' ' 9' ' ' ILE . 27.6 m-20 42.62 53.19 4.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.271 -0.893 . . . . 0.0 110.205 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.14 163.66 32.01 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 30' ' ' SER . 10.1 ptp180 -114.92 -178.38 3.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -1.148 . . . . 0.0 110.438 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.614 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 18.1 p80 -136.67 124.21 22.22 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.67 -0.644 . . . . 0.0 110.107 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -133.74 96.12 3.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 110.53 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.25 16.72 58.84 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.438 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 5.7 m-85 53.36 56.46 7.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.356 -1.084 . . . . 0.0 110.162 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.473 ' CD ' ' CE2' ' A' ' 21' ' ' TYR . 0.3 OUTLIER 179.93 -165.25 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.341 -0.849 . . . . 0.0 110.096 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -138.48 -39.98 0.51 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 109.815 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -110.64 136.03 50.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.406 -0.809 . . . . 0.0 109.721 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.617 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.4 OUTLIER -122.27 -7.01 8.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.921 . . . . 0.0 110.605 -179.541 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.523 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 38.2 p 46.06 -95.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.6 -0.687 . . . . 0.0 111.824 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.413 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 1.0 OUTLIER -153.95 151.21 29.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.772 -1.205 . . . . 0.0 110.637 -178.732 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.57 29.92 54.35 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.617 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -121.79 169.7 10.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.356 -1.084 . . . . 0.0 110.552 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 24.2 t -142.52 156.29 18.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.888 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.564 HG13 ' CD1' ' A' ' 29' ' ' TYR . 11.9 t -131.19 124.75 56.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.433 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.85 101.91 8.81 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 118.541 -1.264 . . . . 0.0 107.613 177.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.678 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 1.8 m-30 -68.29 122.11 17.67 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.644 -0.823 . . . . 0.0 110.024 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -86.61 144.69 27.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -0.975 . . . . 0.0 109.574 179.423 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 37' ' ' LEU . 33.9 m -102.48 171.43 7.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.152 -0.968 . . . . 0.0 110.563 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -72.03 163.87 27.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -0.894 . . . . 0.0 110.096 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.48 99.84 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 0.0 110.693 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.99 19.29 9.16 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.46 ' CE1' HG13 ' A' ' 58' ' ' ILE . 6.9 m-85 -117.17 124.47 49.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.049 -1.265 . . . . 0.0 110.185 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.554 ' OG ' ' CG2' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -74.88 140.5 43.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.35 -0.844 . . . . 0.0 111.261 -179.549 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 55' ' ' THR . 2.7 tp -92.63 106.95 18.84 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.515 -0.741 . . . . 0.0 109.35 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.568 ' HB ' ' OG1' ' A' ' 55' ' ' THR . 0.2 OUTLIER -98.43 155.91 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.151 -0.968 . . . . 0.0 109.394 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.67 175.87 38.44 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.476 ' O ' ' HG3' ' A' ' 54' ' ' PRO . 2.5 m120 -50.82 143.69 9.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -1.152 . . . . 0.0 109.873 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 76.2 p -80.09 51.94 1.45 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -0.95 . . . . 0.0 110.161 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 27' ' ' VAL . . . 161.23 122.87 0.64 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.678 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 1.4 t -65.62 177.45 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.108 -1.231 . . . . 0.0 108.423 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.5 ' C ' ' CD2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -141.34 93.4 2.57 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.416 179.308 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.609 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -81.51 110.65 17.1 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.935 -1.106 . . . . 0.0 109.122 178.695 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.33 97.15 3.22 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.568 -0.708 . . . . 0.0 110.034 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.413 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 108.8 39.58 1.7 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.55 ' HA3' ' CG2' ' A' ' 1' ' ' VAL . . . 60.84 27.7 67.18 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 48' ' ' GLY . 2.7 mt-10 -154.1 132.46 11.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.193 -1.181 . . . . 0.0 110.396 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.609 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 84.8 m95 -82.34 142.85 31.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.882 . . . . 0.0 109.546 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.7 166.1 25.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.902 -1.124 . . . . 0.0 111.499 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.507 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.4 OUTLIER 44.96 65.98 5.72 Favored Pre-proline 0 N--CA 1.496 1.829 0 CA-C-O 121.146 0.498 . . . . 0.0 111.554 179.439 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.507 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.9 Cg_endo -91.33 130.89 1.35 Allowed 'Trans proline' 0 C--N 1.299 -2.04 0 O-C-N 124.342 1.706 . . . . 0.0 109.713 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.479 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.3 Cg_endo -77.47 158.94 32.64 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 123.752 1.396 . . . . 0.0 110.183 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.568 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 38.8 p -99.43 164.18 12.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.246 -0.909 . . . . 0.0 111.184 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 10' ' ' SER . 13.9 m -129.15 74.44 1.58 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.542 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -110.32 -175.43 2.73 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.563 0.697 . . . . 0.0 110.711 -178.025 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.46 HG13 ' CE1' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -96.26 128.77 47.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 80' ' ' SER . 30.7 m -118.55 41.64 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.065 -1.022 . . . . 0.0 111.229 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.552 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 0.9 OUTLIER -52.75 179.42 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.323 0 C-N-CA 118.369 -1.333 . . . . 0.0 108.293 179.665 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.48 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -141.73 169.64 10.8 Favored Pre-proline 0 C--N 1.298 -1.643 0 C-N-CA 118.272 -1.371 . . . . 0.0 113.654 -178.015 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.437 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 46.6 Cg_endo -90.27 -75.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.393 2.062 . . . . 0.0 110.688 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.437 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 170.26 125.31 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.689 -0.632 . . . . 0.0 109.453 -179.125 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.598 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 55.3 Cg_endo -77.94 65.73 8.26 Favored 'Trans proline' 0 C--N 1.299 -2.065 0 O-C-N 123.74 1.389 . . . . 0.0 110.171 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.544 ' N ' HD22 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -83.89 -179.1 7.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.38 -0.825 . . . . 0.0 109.629 179.504 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.537 HD13 ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -179.56 169.49 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.045 -1.035 . . . . 0.0 110.628 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.523 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -74.21 105.76 5.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.572 -0.705 . . . . 0.0 111.037 -179.621 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.499 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 33.0 m120 38.47 38.35 0.23 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.587 -0.696 . . . . 0.0 111.129 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.533 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -144.58 27.85 1.93 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.533 ' O ' ' O ' ' A' ' 69' ' ' GLY . 12.4 p90 -43.64 -175.58 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.653 1.216 . . . . 0.0 112.501 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.575 ' O ' ' CD2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -112.72 157.52 21.2 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.579 179.234 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.7 t -138.69 23.12 2.68 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.932 -1.105 . . . . 0.0 109.806 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -100.93 -79.03 0.51 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.389 -0.819 . . . . 0.0 111.024 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -131.26 78.41 0.37 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -102.46 169.96 8.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.406 -1.055 . . . . 0.0 109.65 179.525 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.603 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 4.8 tttm -169.39 159.09 8.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.307 -0.871 . . . . 0.0 110.234 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.49 -40.08 11.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.365 -0.834 . . . . 0.0 110.091 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.504 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 0.3 OUTLIER -141.59 172.31 12.86 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.477 -0.765 . . . . 0.0 110.049 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.597 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 6.5 m-85 -141.63 -156.18 0.66 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.328 -0.857 . . . . 0.0 109.949 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.56 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 5.4 m -150.72 -111.32 0.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.953 -1.092 . . . . 0.0 110.929 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.619 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -110.32 18.48 19.83 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.691 -1.256 . . . . 0.0 110.509 -179.145 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.508 ' OD1' ' N ' ' A' ' 82' ' ' ASN . 17.7 p-10 -158.02 -114.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.797 -1.189 . . . . 0.0 110.357 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.415 ' C ' HG21 ' A' ' 102' ' ' THR . 5.9 t0 49.85 73.55 0.25 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.738 -1.226 . . . . 0.0 109.2 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 9.4 p30 -69.35 120.69 15.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.306 -0.871 . . . . 0.0 110.252 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.574 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 16.1 m -101.34 120.28 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.06 -1.025 . . . . 0.0 110.511 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.417 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -83.22 125.98 32.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.235 -0.915 . . . . 0.0 108.534 179.112 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.598 ' CG ' ' HG3' ' A' ' 114' ' ' PRO . 72.8 m-85 -86.97 139.21 30.82 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 122.185 0.993 . . . . 0.0 111.827 -178.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -114.43 91.56 3.67 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.809 -179.383 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.485 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.5 OUTLIER -43.35 127.24 4.52 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.259 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 3.3 mmtt -35.58 -77.19 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.682 -178.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.571 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.3 OUTLIER -167.42 135.5 2.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.364 -0.835 . . . . 0.0 110.168 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.583 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 60.27 47.77 89.43 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.583 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 24.3 m-85 -154.28 157.4 38.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.512 -0.993 . . . . 0.0 109.764 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.534 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 36.6 mtpt -118.38 122.26 42.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 110.063 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.535 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 10.1 mt -60.26 104.61 0.33 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.153 -0.967 . . . . 0.0 110.429 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.484 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 12.7 t -92.66 101.98 14.4 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.357 -0.839 . . . . 0.0 109.842 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 98' ' ' SER . . . 146.76 -56.28 0.51 Allowed Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.78 -1.2 . . . . 0.0 110.224 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.552 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 58.8 p 179.49 99.06 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.285 -1.126 . . . . 0.0 110.913 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 53.1 m -65.36 -18.39 65.28 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.121 -0.987 . . . . 0.0 110.372 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.6 p -137.08 101.17 4.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.158 -0.964 . . . . 0.0 109.626 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 85' ' ' VAL . 3.2 m -113.29 168.22 9.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.361 -0.837 . . . . 0.0 111.059 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -139.74 142.29 36.82 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.58 0.705 . . . . 0.0 110.083 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.599 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -73.25 94.77 2.03 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.555 -0.716 . . . . 0.0 110.663 -179.511 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.536 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -69.4 -175.41 0.27 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.375 -0.828 . . . . 0.0 110.959 -179.739 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.556 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 43.2 Cg_endo -81.42 128.52 6.24 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.343 1.707 . . . . 0.0 110.753 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 123.56 -7.65 8.96 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.558 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 1.3 m120 80.92 96.01 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.642 0.734 . . . . 0.0 111.111 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.477 ' CG2' ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 176.25 -159.2 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.485 -0.76 . . . . 0.0 110.654 179.341 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.599 ' CE2' ' SG ' ' A' ' 103' ' ' CYS . 22.6 m95 -145.84 89.95 1.94 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.39 -0.819 . . . . 0.0 110.172 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.452 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 13.6 mttm -100.62 142.77 25.27 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.562 -0.711 . . . . 0.0 110.531 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.552 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.4 Cg_endo -74.19 172.47 61.74 Favored 'Cis proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.68 -2.217 . . . . 0.0 110.266 -0.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.44 ' O ' ' OG ' ' A' ' 98' ' ' SER . 1.3 mp0 -37.6 127.41 1.13 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.466 -0.771 . . . . 0.0 111.439 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.551 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.2 OUTLIER -40.74 150.39 0.29 Allowed Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.492 -0.755 . . . . 0.0 110.192 179.116 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.598 ' HG3' ' CG ' ' A' ' 87' ' ' PHE . 39.6 Cg_endo -76.01 165.95 28.87 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 O-C-N 124.177 1.619 . . . . 0.0 110.937 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.528 ' O ' HG23 ' A' ' 117' ' ' VAL . 12.5 ttpt -129.84 101.8 6.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.268 -0.895 . . . . 0.0 110.034 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.529 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.2 t -55.59 91.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.098 -1.001 . . . . 0.0 109.377 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.534 ' CG2' ' O ' ' A' ' 94' ' ' LYS . 1.5 m -104.8 -177.79 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 121.714 0.768 . . . . 0.0 110.641 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.504 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 5.0 ptt-85 . . . . . 0 C--N 1.295 -1.776 0 C-N-CA 119.014 -1.075 . . . . 0.0 110.549 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 54.4 t . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.318 0.58 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.75 170.3 10.24 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.242 -0.911 . . . . 0.0 110.419 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.558 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.2 m -125.44 142.14 51.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.411 -0.806 . . . . 0.0 109.531 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -113.0 175.86 5.26 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.015 -1.053 . . . . 0.0 109.807 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.57 140.87 56.55 Favored Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 121.298 -0.876 . . . . 0.0 109.734 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.626 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 49.2 Cg_endo -71.49 153.25 60.6 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 O-C-N 124.023 1.538 . . . . 0.0 110.717 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.61 173.01 14.59 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.863 1.454 . . . . 0.0 110.009 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.61 176.44 3.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.917 . . . . 0.0 109.935 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.584 HG22 ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -143.43 -169.61 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 122.194 0.997 . . . . 0.0 111.336 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 11' ' ' ASN . 0.3 OUTLIER -46.61 93.56 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.683 -179.312 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.46 ' N ' ' O ' ' A' ' 9' ' ' ILE . 4.2 m-80 42.08 53.15 4.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.195 -0.941 . . . . 0.0 110.427 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.05 152.59 24.01 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -98.14 -167.76 1.56 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -1.147 . . . . 0.0 110.686 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.626 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 20.7 p80 -153.19 113.04 3.9 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.537 0.684 . . . . 0.0 110.191 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.414 ' O ' ' C ' ' A' ' 16' ' ' GLY . 0.9 OUTLIER -138.78 63.57 1.51 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.101 -0.999 . . . . 0.0 110.098 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 17' ' ' TYR . . . -44.01 -77.11 0.1 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.441 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 9.8 t80 -178.01 36.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -1.113 . . . . 0.0 110.197 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.566 ' OE2' ' CG ' ' A' ' 21' ' ' TYR . 2.0 pt-20 178.5 -161.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.89 . . . . 0.0 110.011 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -117.37 -36.84 3.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.227 -0.92 . . . . 0.0 110.286 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.535 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 21.9 p90 -129.99 123.55 30.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.152 -0.967 . . . . 0.0 110.471 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.621 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 14.0 m-85 -92.08 -167.79 1.85 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.451 -0.78 . . . . 0.0 110.27 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.558 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 0.6 OUTLIER -141.84 -64.66 0.43 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.915 -1.116 . . . . 0.0 110.964 -179.483 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 7.8 t0 -169.07 144.37 3.23 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.466 -0.771 . . . . 0.0 109.492 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.449 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 68.47 13.79 65.91 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -178.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.621 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 16.2 m -88.94 177.71 6.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.527 -0.984 . . . . 0.0 110.094 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.548 ' CG1' ' HA3' ' A' ' 42' ' ' GLY . 24.4 t -154.15 155.54 6.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.498 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.572 HG13 ' CD1' ' A' ' 29' ' ' TYR . 16.1 t -136.22 114.8 15.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 119.416 -0.914 . . . . 0.0 111.684 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.409 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -71.66 104.56 3.39 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.431 -1.308 . . . . 0.0 107.626 177.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.617 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 2.1 m-30 -67.79 130.48 43.13 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.135 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 13' ' ' ARG . 1.0 OUTLIER -82.24 160.33 23.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 109.808 179.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.457 ' SG ' HD11 ' A' ' 37' ' ' LEU . 12.4 m -130.45 162.87 28.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.154 -0.966 . . . . 0.0 110.107 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.445 ' O ' ' HB2' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -64.13 152.57 40.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 110.088 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.12 108.72 0.27 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 110.418 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 109.44 -6.76 31.95 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 3.2 m-30 -95.18 128.88 42.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.208 -1.172 . . . . 0.0 110.279 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.587 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -81.94 145.93 30.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.189 -0.945 . . . . 0.0 110.96 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.53 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 4.5 tp -94.73 98.4 10.75 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.445 -0.784 . . . . 0.0 108.932 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.573 ' CD1' ' N ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -91.28 160.51 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.252 -0.905 . . . . 0.0 109.476 -179.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.467 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 95.53 -179.33 35.88 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -53.78 142.13 24.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.162 -1.199 . . . . 0.0 109.714 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.6 p -73.62 53.8 0.44 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.935 . . . . 0.0 110.256 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.548 ' HA3' ' CG1' ' A' ' 26' ' ' VAL . . . 148.24 122.9 1.3 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.617 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 1.6 t -54.87 -179.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.162 -1.199 . . . . 0.0 107.926 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.483 ' HA ' HG21 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -143.42 96.75 2.96 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.237 178.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.596 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -81.36 104.86 12.1 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.112 178.604 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.7 p -129.49 102.78 6.54 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.478 -0.764 . . . . 0.0 110.229 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.64 26.13 8.78 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.57 21.66 78.73 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -141.26 110.49 6.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -1.203 . . . . 0.0 110.365 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.596 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 88.2 m95 -64.27 136.6 57.33 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.239 -0.913 . . . . 0.0 109.894 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.423 ' O ' ' HB3' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -143.97 158.79 43.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 110.837 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.488 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 20.7 t0 60.32 66.31 1.96 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.753 -0.592 . . . . 0.0 111.242 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 48.7 Cg_endo -90.71 131.13 1.57 Allowed 'Trans proline' 0 C--N 1.301 -1.973 0 O-C-N 124.342 1.707 . . . . 0.0 109.682 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.548 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.9 Cg_endo -77.0 170.53 19.6 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 O-C-N 123.809 1.426 . . . . 0.0 110.035 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.495 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 12.3 p -113.16 147.87 36.54 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.066 -1.021 . . . . 0.0 111.824 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.408 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 42.2 m -114.11 78.68 1.17 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -114.07 -156.81 0.61 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.324 0.583 . . . . 0.0 110.324 -178.564 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.27 139.7 31.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.636 ' HB ' ' HA ' ' A' ' 105' ' ' PRO . 34.1 m -130.31 52.67 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 120.889 -1.132 . . . . 0.0 111.525 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 2.9 mptt -81.55 171.01 15.18 Favored 'General case' 0 C--N 1.282 -2.353 0 C-N-CA 118.349 -1.34 . . . . 0.0 107.567 178.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.481 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 60.3 m -140.81 164.74 34.35 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 120.302 -1.499 . . . . 0.0 113.031 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 40.1 Cg_endo -69.55 -86.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 124.886 1.993 . . . . 0.0 110.569 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.463 ' CD2' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -176.02 136.72 0.48 Allowed Pre-proline 0 C--N 1.301 -1.53 0 O-C-N 121.517 -0.739 . . . . 0.0 109.531 -179.616 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.6 ' HG3' ' CZ2' ' A' ' 109' ' ' TRP . 57.6 Cg_endo -86.21 69.9 4.54 Favored 'Trans proline' 0 C--N 1.297 -2.14 0 O-C-N 123.756 1.398 . . . . 0.0 109.599 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.572 ' C ' ' CG2' ' A' ' 66' ' ' ILE . 3.2 p -84.77 -43.74 13.96 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 122.506 1.146 . . . . 0.0 109.78 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.597 HG23 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER 56.22 160.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.828 -178.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.508 ' N ' HG13 ' A' ' 66' ' ' ILE . 8.1 t -63.7 98.18 0.18 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.479 -0.763 . . . . 0.0 111.345 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.441 ' O ' ' SG ' ' A' ' 116' ' ' CYS . 3.6 m-20 44.72 52.21 7.94 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.4 -0.813 . . . . 0.0 111.255 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.593 ' O ' ' CD2' ' A' ' 70' ' ' TYR . . . -135.32 -39.47 0.17 Allowed Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.308 -1.425 . . . . 0.0 109.635 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.593 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 16.2 p90 41.36 -177.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 122.807 1.289 . . . . 0.0 112.222 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.603 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -130.69 153.13 49.3 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.138 -179.047 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.1 t -112.51 -9.47 13.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.65 -1.281 . . . . 0.0 110.781 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.484 ' HB2' ' HB2' ' A' ' 86' ' ' ASP . 11.0 t -55.8 -70.31 0.12 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.175 -0.953 . . . . 0.0 110.269 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.42 101.58 0.15 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.568 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -98.71 145.24 27.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.312 -1.11 . . . . 0.0 110.005 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.44 ' CG ' ' N ' ' A' ' 77' ' ' ARG . 10.4 tttm -126.16 165.74 18.34 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.438 -0.789 . . . . 0.0 109.419 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.44 ' N ' ' CG ' ' A' ' 76' ' ' LYS . 8.6 mtp180 -56.09 -56.0 26.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.062 -1.024 . . . . 0.0 110.023 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.6 171.28 8.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.467 -0.77 . . . . 0.0 109.948 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.572 ' CD1' ' CZ2' ' A' ' 109' ' ' TRP . 27.1 m-85 -145.03 -179.88 6.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 0.0 110.219 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.539 ' O ' ' HB3' ' A' ' 103' ' ' CYS . 1.5 m -158.49 176.07 12.89 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.156 -0.965 . . . . 0.0 110.981 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.529 ' H ' ' CG2' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -38.57 -24.94 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.83 -0.544 . . . . 0.0 111.546 -178.776 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.537 ' HA ' HG23 ' A' ' 102' ' ' THR . 43.8 t-20 -116.67 -122.48 0.29 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.779 -1.201 . . . . 0.0 110.094 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 51.98 71.08 0.49 Allowed 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.761 -1.212 . . . . 0.0 108.979 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.518 ' N ' HG21 ' A' ' 102' ' ' THR . 9.3 p30 -72.18 152.32 42.33 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.894 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.597 ' CG2' ' CZ3' ' A' ' 109' ' ' TRP . 0.3 OUTLIER -133.04 121.12 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.337 -0.852 . . . . 0.0 110.261 179.557 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.547 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 3.3 t0 -81.76 122.01 27.13 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.246 -0.909 . . . . 0.0 109.033 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.597 ' CE1' HG23 ' A' ' 66' ' ' ILE . 28.3 m-85 -80.48 132.52 35.71 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.275 1.035 . . . . 0.0 112.531 -177.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 4.2 tmtt? -116.41 87.59 2.72 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.046 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.483 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -36.5 131.21 0.68 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.434 -0.791 . . . . 0.0 111.315 -179.349 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' A' ' 89' ' ' CYS . 0.3 OUTLIER -39.01 -93.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.542 -0.724 . . . . 0.0 110.966 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.569 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 77.3 t80 -152.95 120.27 5.89 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.101 -0.999 . . . . 0.0 110.311 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.578 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 72.06 54.74 7.75 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.578 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 63.0 m-85 -159.42 150.76 20.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.482 -1.011 . . . . 0.0 109.925 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 117' ' ' VAL . 7.9 mtmt -104.89 140.53 38.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.237 -0.914 . . . . 0.0 110.252 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.551 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 7.1 mt -80.8 99.79 8.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.89 -1.131 . . . . 0.0 110.267 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.463 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 3.7 t -82.39 93.73 7.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.185 -0.947 . . . . 0.0 109.962 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' A' ' 114' ' ' PRO . . . 154.15 -97.2 0.17 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.593 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 15.3 t -150.79 122.03 7.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.191 -1.182 . . . . 0.0 110.276 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.414 ' O ' ' CD2' ' A' ' 87' ' ' PHE . 79.4 p -58.51 -58.94 6.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.246 -0.909 . . . . 0.0 110.426 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 51.5 p -91.75 138.67 31.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.407 -0.808 . . . . 0.0 110.197 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 70.7 m -144.58 169.93 17.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.393 -0.817 . . . . 0.0 109.974 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.537 HG23 ' HA ' ' A' ' 82' ' ' ASN . 1.8 m -147.88 134.44 19.8 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.32 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.539 ' HB3' ' O ' ' A' ' 80' ' ' SER . 1.8 t -54.77 87.47 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.51 -0.744 . . . . 0.0 109.502 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -53.05 170.8 0.24 Allowed Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.033 -1.042 . . . . 0.0 112.417 -178.711 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.636 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 51.5 Cg_endo -81.88 15.58 1.92 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 125.012 2.059 . . . . 0.0 111.37 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.555 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -114.59 13.32 20.64 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.555 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 11.1 t30 77.69 62.33 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.892 -0.769 . . . . 0.0 110.351 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.514 ' CG2' ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -177.68 178.0 1.05 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 118.818 -1.153 . . . . 0.0 111.891 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.6 ' CZ2' ' HG3' ' A' ' 64' ' ' PRO . 25.2 m95 -104.2 89.65 3.33 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.233 0.54 . . . . 0.0 110.746 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.486 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 3.8 mmtm -98.01 154.63 37.68 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.222 -0.924 . . . . 0.0 109.502 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.593 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 51.5 Cg_endo -71.71 -174.43 11.48 Favored 'Cis proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.258 -1.976 . . . . 0.0 111.054 -0.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -36.87 120.69 0.73 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.347 0.594 . . . . 0.0 110.762 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.594 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 4.2 tp -54.01 138.97 54.64 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.339 -0.851 . . . . 0.0 110.096 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.57 ' HG3' ' CD2' ' A' ' 87' ' ' PHE . 40.6 Cg_endo -70.17 158.81 55.25 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 O-C-N 124.051 1.553 . . . . 0.0 110.565 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 117' ' ' VAL . 61.5 tttt -126.7 94.05 3.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.665 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.523 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.6 t -45.16 96.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.222 -0.924 . . . . 0.0 109.113 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 115' ' ' LYS . 0.7 OUTLIER -109.93 -173.24 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 121.83 0.824 . . . . 0.0 110.59 -179.262 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.421 ' CG ' ' CE1' ' A' ' 93' ' ' TYR . 11.7 mtp180 . . . . . 0 C--N 1.293 -1.887 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.555 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.169 0.509 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.04 178.46 6.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 110.51 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.591 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 9.2 t -141.26 132.79 26.97 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.457 ' O ' ' C ' ' A' ' 5' ' ' SER . 5.3 mt-30 -115.13 179.27 4.0 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.141 -0.974 . . . . 0.0 110.041 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.2 OUTLIER -40.22 141.04 0.88 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.701 -0.624 . . . . 0.0 109.986 -179.888 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.617 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 50.6 Cg_endo -70.3 154.87 65.24 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 123.993 1.523 . . . . 0.0 111.028 -178.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -75.01 173.57 14.28 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.049 1.552 . . . . 0.0 109.957 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.47 178.42 2.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.222 -0.924 . . . . 0.0 110.16 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.514 ' O ' ' N ' ' A' ' 11' ' ' ASN . 0.3 OUTLIER -144.13 -170.09 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.208 1.004 . . . . 0.0 111.196 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 11' ' ' ASN . 21.7 m -44.1 92.56 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.455 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 9' ' ' ILE . 2.3 m-80 43.59 54.04 5.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 110.243 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.447 ' O ' HG13 ' A' ' 9' ' ' ILE . . . -157.71 146.98 14.36 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.525 ' HG2' ' CB ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -97.48 -176.9 3.63 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.331 -1.099 . . . . 0.0 110.335 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.617 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 19.3 p80 -140.15 158.89 43.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.64 -0.662 . . . . 0.0 110.334 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.481 ' O ' ' ND1' ' A' ' 14' ' ' HIS . 10.8 m120 -47.71 162.77 0.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.924 . . . . 0.0 110.246 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -156.6 26.12 0.52 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -87.13 14.44 7.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.105 -1.232 . . . . 0.0 110.222 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.548 ' HG3' ' CE2' ' A' ' 21' ' ' TYR . 8.8 pm0 -135.05 -150.31 0.38 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.933 . . . . 0.0 109.994 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -163.63 -36.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 110.209 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.575 ' O ' ' CD2' ' A' ' 20' ' ' PHE . 16.3 p90 -135.41 81.53 1.9 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.965 . . . . 0.0 109.97 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.592 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 1.6 m-85 -59.27 -23.88 62.75 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.556 -0.715 . . . . 0.0 110.872 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.558 ' N ' ' HB3' ' A' ' 3' ' ' CYS . 91.2 m 58.89 -95.53 0.06 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.377 -0.827 . . . . 0.0 111.424 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 4.3 t0 -147.56 150.28 34.17 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.987 -1.071 . . . . 0.0 110.331 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 77.1 18.9 78.0 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.592 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -103.4 160.2 14.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.571 -0.958 . . . . 0.0 110.563 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 39.4 t -141.07 156.92 22.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.418 -0.801 . . . . 0.0 110.522 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.578 HG13 ' CE1' ' A' ' 29' ' ' TYR . 20.0 t -138.03 122.54 22.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 119.186 -1.006 . . . . 0.0 111.691 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.468 ' CG2' ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -76.34 103.55 6.42 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.837 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.643 ' CE1' HG23 ' A' ' 43' ' ' VAL . 2.6 m-30 -68.67 125.6 27.07 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.414 -178.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.525 ' CB ' ' HG2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -92.91 147.16 23.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.155 -0.965 . . . . 0.0 109.621 179.269 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 37' ' ' LEU . 34.0 m -106.63 159.83 15.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.115 -0.991 . . . . 0.0 110.681 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.461 ' O ' ' N ' ' A' ' 34' ' ' GLY . 5.0 t30 -52.06 160.76 0.69 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.361 -0.837 . . . . 0.0 110.007 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.23 79.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 110.537 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 32' ' ' ASN . . . 145.08 -10.42 1.8 Allowed Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.706 -1.235 . . . . 0.0 110.206 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -97.04 137.66 35.78 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.049 -1.265 . . . . 0.0 110.478 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.546 ' OG ' ' CG2' ' A' ' 59' ' ' VAL . 0.5 OUTLIER -82.68 145.41 29.64 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.394 -0.816 . . . . 0.0 110.914 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.462 ' HB2' ' SG ' ' A' ' 31' ' ' CYS . 9.5 tp -98.41 106.42 18.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.473 -0.767 . . . . 0.0 109.687 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.561 ' CD1' ' N ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -101.31 163.31 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.923 . . . . 0.0 109.069 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.19 176.96 44.84 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -55.69 133.1 50.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.236 -1.155 . . . . 0.0 109.846 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.468 ' O ' ' CG2' ' A' ' 28' ' ' THR . 81.2 p -76.88 54.01 0.97 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -0.949 . . . . 0.0 110.158 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 27' ' ' VAL . . . 167.38 109.56 0.22 Allowed Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.695 -1.241 . . . . 0.0 110.131 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.643 HG23 ' CE1' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -58.59 177.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.032 -1.275 . . . . 0.0 108.16 178.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.84 99.79 3.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.158 -0.964 . . . . 0.0 110.259 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.613 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 3.1 t -84.63 111.86 19.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.144 -0.972 . . . . 0.0 109.31 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.6 t -124.84 82.67 2.07 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.166 -0.959 . . . . 0.0 110.395 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.16 45.06 1.92 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.451 ' HA2' ' HB2' ' A' ' 3' ' ' CYS . . . 62.75 15.2 54.1 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -126.28 97.43 5.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.223 -1.163 . . . . 0.0 110.338 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.613 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 87.7 m95 -66.59 137.46 56.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -0.95 . . . . 0.0 109.822 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.31 162.88 34.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.149 -0.969 . . . . 0.0 111.189 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.529 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 33.3 m-20 56.41 65.13 4.32 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.852 -0.53 . . . . 0.0 111.445 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.3 Cg_endo -92.33 134.96 1.39 Allowed 'Trans proline' 0 C--N 1.299 -2.042 0 O-C-N 124.379 1.726 . . . . 0.0 109.521 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.488 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 47.4 Cg_endo -78.19 174.23 12.76 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 123.607 1.319 . . . . 0.0 109.758 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.517 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 17.1 p -113.15 144.97 41.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.045 -1.034 . . . . 0.0 112.219 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 11.0 m -113.63 77.13 1.03 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 36' ' ' SER . 4.5 mm-40 -111.77 -171.53 1.86 Allowed 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.531 0.682 . . . . 0.0 110.945 -177.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.415 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -101.58 128.25 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.301 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.627 ' CG1' ' HA ' ' A' ' 105' ' ' PRO . 20.6 m -118.65 52.31 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.058 -1.026 . . . . 0.0 111.039 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.465 ' N ' ' OD1' ' A' ' 107' ' ' ASN . 1.6 mttp -83.97 110.42 18.41 Favored 'General case' 0 C--N 1.283 -2.318 0 C-N-CA 118.5 -1.28 . . . . 0.0 109.367 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.545 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 84.4 m -78.05 166.55 42.55 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.189 -0.945 . . . . 0.0 111.274 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 38.0 Cg_endo -71.89 -76.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.278 1.672 . . . . 0.0 110.47 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.4 ' CG ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 175.39 136.33 0.17 Allowed Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.652 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.611 ' HG3' ' CZ2' ' A' ' 109' ' ' TRP . 58.8 Cg_endo -84.95 87.75 1.0 Allowed 'Trans proline' 0 C--N 1.297 -2.178 0 O-C-N 123.733 1.386 . . . . 0.0 109.721 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.571 ' C ' ' CG2' ' A' ' 66' ' ' ILE . 2.6 p -112.29 -43.23 3.56 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 122.394 1.092 . . . . 0.0 110.144 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.656 ' CG2' ' CE1' ' A' ' 87' ' ' PHE . 0.1 OUTLIER 51.95 166.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.242 -179.16 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.484 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 12.9 t -65.15 97.43 0.25 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.521 -0.737 . . . . 0.0 111.265 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 6.2 m-80 45.95 55.64 6.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.448 -0.783 . . . . 0.0 111.905 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.57 ' O ' ' CG ' ' A' ' 70' ' ' TYR . . . -135.34 -42.31 0.12 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.607 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 18.7 p90 43.67 -179.31 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 122.891 1.329 . . . . 0.0 112.074 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.584 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -125.24 153.54 43.01 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.15 -179.856 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.466 ' HB3' ' HG3' ' A' ' 88' ' ' LYS . 0.3 OUTLIER -111.58 7.84 20.72 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.01 -1.056 . . . . 0.0 110.267 -178.486 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.85 -70.68 0.52 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.283 -0.886 . . . . 0.0 110.331 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -175.95 100.04 0.14 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.595 ' CD1' ' OH ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -94.01 110.03 21.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.402 -1.058 . . . . 0.0 109.498 179.533 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.512 ' N ' ' OH ' ' A' ' 79' ' ' TYR . 9.4 mttp -86.08 151.96 23.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.913 . . . . 0.0 110.247 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.3 mtt180 -48.45 -32.91 8.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.283 -0.885 . . . . 0.0 110.085 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.4 p -141.38 159.05 43.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.399 -0.813 . . . . 0.0 110.307 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.595 ' OH ' ' CD1' ' A' ' 75' ' ' PHE . 79.5 m-85 -132.23 -171.26 2.59 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.281 -0.887 . . . . 0.0 110.05 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.554 ' O ' ' SG ' ' A' ' 103' ' ' CYS . 78.8 p -147.18 -103.67 0.09 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.873 -1.142 . . . . 0.0 111.495 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.612 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -114.29 22.35 13.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 119.77 -1.831 . . . . 0.0 110.96 -178.396 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.598 ' HA ' HG23 ' A' ' 102' ' ' THR . 50.3 t30 -165.55 -110.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.869 -1.144 . . . . 0.0 110.72 178.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 82' ' ' ASN . 0.1 OUTLIER 46.99 79.03 0.06 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.686 -1.259 . . . . 0.0 108.923 -179.032 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.531 ' N ' HG21 ' A' ' 102' ' ' THR . 2.1 p-10 -71.91 142.12 49.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.347 -0.846 . . . . 0.0 110.885 -178.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.584 HG21 ' CZ3' ' A' ' 109' ' ' TRP . 5.4 m -129.42 117.55 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.909 . . . . 0.0 110.455 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.539 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 3.1 t0 -76.64 128.52 34.85 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.376 -0.828 . . . . 0.0 108.897 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.656 ' CE1' ' CG2' ' A' ' 66' ' ' ILE . 34.2 m-85 -88.09 142.59 27.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.033 -1.042 . . . . 0.0 112.629 -177.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.607 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -121.4 84.78 2.29 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.128 -179.434 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.472 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.8 OUTLIER -35.2 126.46 0.58 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.761 -0.587 . . . . 0.0 110.853 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.9 OUTLIER -34.18 -78.52 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.625 -0.672 . . . . 0.0 110.843 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.464 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -168.78 143.45 3.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.312 -0.868 . . . . 0.0 110.395 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 51.51 45.26 53.83 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.577 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 10.8 m-85 -148.22 154.78 40.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.406 -1.055 . . . . 0.0 110.217 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.524 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 35.9 mtpt -109.94 131.12 55.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 109.967 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.533 HD22 ' CD1' ' A' ' 66' ' ' ILE . 2.0 mt -73.12 93.12 1.77 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.904 . . . . 0.0 110.246 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.455 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -74.39 98.54 3.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.928 . . . . 0.0 109.766 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 147.32 -97.94 0.19 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.588 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -149.87 128.52 12.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.234 -1.156 . . . . 0.0 110.211 -179.655 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 87' ' ' PHE . 24.9 p -72.36 -45.44 59.84 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.125 -0.985 . . . . 0.0 110.59 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.6 p -102.89 116.3 32.29 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.115 -0.991 . . . . 0.0 110.248 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 16.4 m -120.83 178.96 4.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.421 -0.799 . . . . 0.0 110.297 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.598 HG23 ' HA ' ' A' ' 82' ' ' ASN . 0.5 OUTLIER -152.58 134.24 14.61 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.571 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.554 ' SG ' ' O ' ' A' ' 80' ' ' SER . 12.9 t -62.03 78.48 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.542 0.687 . . . . 0.0 109.547 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 102' ' ' THR . 0.1 OUTLIER -56.43 176.9 0.19 Allowed Pre-proline 0 N--CA 1.498 1.935 0 CA-C-O 121.506 0.67 . . . . 0.0 112.753 -178.485 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.627 ' HA ' ' CG1' ' A' ' 59' ' ' VAL . 47.2 Cg_endo -79.08 25.45 0.57 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 124.779 1.936 . . . . 0.0 112.079 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.509 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -122.86 18.86 7.96 Favored Glycine 0 N--CA 1.482 1.757 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.509 ' HB2' ' O ' ' A' ' 106' ' ' GLY . 16.3 m-80 62.63 53.05 2.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.894 -0.768 . . . . 0.0 110.066 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.507 ' HA ' ' CD ' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -163.64 179.27 7.3 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.288 -0.883 . . . . 0.0 111.166 179.881 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.611 ' CZ2' ' HG3' ' A' ' 64' ' ' PRO . 45.4 m95 -110.03 90.74 3.4 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.561 -0.712 . . . . 0.0 110.243 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.514 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 1.0 OUTLIER -100.33 154.91 36.94 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.322 -0.861 . . . . 0.0 109.596 179.84 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.588 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.3 Cg_endo -69.48 -179.92 19.96 Favored 'Cis proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.33 -1.946 . . . . 0.0 111.414 0.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.472 ' C ' ' O ' ' A' ' 111' ' ' PRO . 9.5 mt-10 -34.44 121.8 0.5 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.416 0.627 . . . . 0.0 111.097 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.574 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 3.0 tp -49.13 141.7 10.82 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.39 -0.819 . . . . 0.0 110.127 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.544 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 41.5 Cg_endo -70.26 158.5 56.1 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 124.073 1.564 . . . . 0.0 110.416 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 117' ' ' VAL . 11.5 ttpt -124.11 107.17 10.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 110.37 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.491 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.6 t -63.01 78.28 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.17 -0.957 . . . . 0.0 109.168 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 94' ' ' LYS . 2.5 m -92.92 -173.83 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.903 0.859 . . . . 0.0 111.264 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.442 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.6 OUTLIER . . . . . 0 C--N 1.296 -1.758 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.239 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.404 HG13 ' HA3' ' A' ' 48' ' ' GLY . 59.1 t . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.162 0.505 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -93.53 164.79 13.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.248 -0.907 . . . . 0.0 110.285 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.553 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -131.37 83.74 2.12 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.165 -0.959 . . . . 0.0 110.343 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.423 ' O ' ' C ' ' A' ' 5' ' ' SER . 4.3 pm0 -63.52 179.57 0.45 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.12 -0.988 . . . . 0.0 109.928 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.3 p -44.99 144.52 1.93 Allowed Pre-proline 0 C--N 1.297 -1.684 0 C-N-CA 119.715 -0.794 . . . . 0.0 109.443 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.612 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 45.9 Cg_endo -70.16 159.86 51.63 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 124.028 1.541 . . . . 0.0 111.004 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.72 171.17 18.73 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.004 1.528 . . . . 0.0 110.216 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 77.4 p -73.58 179.18 4.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 0.0 110.17 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.54 ' CG2' ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -145.14 -169.51 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 122.232 1.015 . . . . 0.0 111.78 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 3.6 t -50.27 100.23 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.2 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 10' ' ' SER . 5.5 m-20 36.72 55.49 1.16 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.658 -0.651 . . . . 0.0 111.335 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.406 ' HA3' HD13 ' A' ' 9' ' ' ILE . . . -150.28 -163.34 11.13 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.532 ' CG ' ' HB3' ' A' ' 30' ' ' SER . 0.0 OUTLIER -148.2 174.9 11.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.206 -1.173 . . . . 0.0 110.362 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.612 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 23.2 p80 -140.74 -155.32 0.58 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.551 -0.718 . . . . 0.0 110.023 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 0.1 OUTLIER 70.35 106.8 0.06 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.332 -0.855 . . . . 0.0 110.434 179.621 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.495 ' O ' ' CD2' ' A' ' 17' ' ' TYR . . . -166.35 46.89 0.27 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.495 ' CD2' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER 179.18 -33.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -1.175 . . . . 0.0 110.571 -179.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.45 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 8.8 pt-20 -179.71 -168.69 0.12 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.094 -1.004 . . . . 0.0 110.761 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -114.35 -41.69 3.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.461 -0.774 . . . . 0.0 109.635 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -95.64 130.13 42.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.395 -0.815 . . . . 0.0 109.733 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.62 ' CD1' ' CB ' ' A' ' 25' ' ' SER . 0.4 OUTLIER -122.45 -6.48 8.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.144 -0.973 . . . . 0.0 110.626 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.553 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 72.6 p 46.69 -95.75 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.501 -0.75 . . . . 0.0 112.1 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 0.8 OUTLIER -154.62 144.86 21.97 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.887 -1.133 . . . . 0.0 110.577 -178.527 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.22 31.96 29.92 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.62 ' CB ' ' CD1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -122.13 172.25 8.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.438 -1.037 . . . . 0.0 110.267 -179.742 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.575 HG11 ' N ' ' A' ' 27' ' ' VAL . 48.6 t -142.99 152.87 16.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.265 -0.897 . . . . 0.0 110.826 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.584 HG13 ' CD1' ' A' ' 29' ' ' TYR . 11.9 t -129.81 122.11 53.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 C-N-CA 119.831 -0.747 . . . . 0.0 111.413 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.42 102.3 5.12 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 118.723 -1.191 . . . . 0.0 107.882 178.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.631 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 2.1 m-30 -68.34 120.65 14.81 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.263 -178.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.532 ' HB3' ' CG ' ' A' ' 13' ' ' ARG . 4.9 t -73.18 -177.65 2.59 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.945 -1.097 . . . . 0.0 109.2 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 30' ' ' SER . 71.0 m -151.56 163.89 38.06 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.344 -0.848 . . . . 0.0 109.975 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.34 145.58 26.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.182 -0.949 . . . . 0.0 109.701 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 33' ' ' SER . 1.6 p -52.64 110.9 0.56 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 110.499 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.04 -20.43 26.33 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -79.27 132.17 36.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.182 -1.187 . . . . 0.0 110.354 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.604 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -80.84 138.86 36.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.16 -0.962 . . . . 0.0 110.579 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.531 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 0.8 OUTLIER -85.87 98.03 10.54 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.431 -0.793 . . . . 0.0 109.358 179.09 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.575 ' HB ' ' OG1' ' A' ' 55' ' ' THR . 0.7 OUTLIER -89.17 148.86 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -0.884 . . . . 0.0 109.065 179.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.89 -150.43 16.91 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.05 137.43 32.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.358 -1.083 . . . . 0.0 110.371 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 54.8 p -76.69 55.29 1.04 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.933 . . . . 0.0 109.444 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.455 ' HA3' ' CG1' ' A' ' 26' ' ' VAL . . . 153.93 121.17 0.8 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.631 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 1.7 t -69.27 -178.29 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.173 -1.193 . . . . 0.0 108.263 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.412 ' HA ' ' O ' ' A' ' 25' ' ' SER . 2.3 tp -143.92 97.54 3.08 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.923 -1.11 . . . . 0.0 110.714 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.594 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 1.0 OUTLIER -86.04 114.7 23.13 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.081 -1.047 . . . . 0.0 109.132 178.569 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.07 91.91 3.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.501 -0.749 . . . . 0.0 110.225 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.526 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 78.49 63.49 2.12 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.404 ' HA3' HG13 ' A' ' 1' ' ' VAL . . . 46.7 53.15 10.35 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -157.31 73.37 0.73 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.346 -1.091 . . . . 0.0 110.569 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.594 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 76.1 m95 -55.7 137.73 48.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.087 -1.008 . . . . 0.0 109.354 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -146.87 163.8 34.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.001 -1.062 . . . . 0.0 111.342 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.513 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 1.5 m-20 62.11 65.77 1.56 Allowed Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.826 -0.546 . . . . 0.0 111.377 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.513 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 46.5 Cg_endo -91.47 129.23 1.2 Allowed 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 121.802 1.668 . . . . 0.0 110.17 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.563 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 49.7 Cg_endo -80.21 168.21 18.83 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.904 1.476 . . . . 0.0 110.086 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.575 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 65.7 p -107.83 148.01 30.12 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.979 -1.076 . . . . 0.0 111.347 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 10' ' ' SER . 88.9 m -109.25 77.91 1.1 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -113.81 -167.68 1.24 Allowed 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.394 0.616 . . . . 0.0 110.487 -178.305 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -104.69 134.69 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.604 ' CG1' ' CB ' ' A' ' 36' ' ' SER . 19.8 m -122.7 43.75 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.063 -1.023 . . . . 0.0 111.099 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -82.93 96.69 8.37 Favored 'General case' 0 C--N 1.286 -2.179 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.956 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 107' ' ' ASN . 29.2 m -69.69 162.09 69.97 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.397 -0.814 . . . . 0.0 111.423 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 44.3 Cg_endo -72.88 -90.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.559 1.82 . . . . 0.0 110.578 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.401 ' CD2' ' HE1' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -161.69 132.77 3.79 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.613 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 55.7 Cg_endo -78.7 65.71 8.67 Favored 'Trans proline' 0 C--N 1.295 -2.267 0 O-C-N 123.665 1.35 . . . . 0.0 109.454 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.534 ' N ' HD22 ' A' ' 113' ' ' LEU . 0.2 OUTLIER -82.98 176.03 9.58 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.579 -0.701 . . . . 0.0 110.287 -179.652 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.549 ' CD1' ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -176.7 163.39 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.227 -0.92 . . . . 0.0 110.625 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.441 ' N ' HG13 ' A' ' 66' ' ' ILE . 1.8 m -75.9 107.61 8.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.509 -0.744 . . . . 0.0 110.831 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 8.6 m-20 43.37 37.89 1.53 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.457 -0.777 . . . . 0.0 110.432 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -145.1 26.72 1.88 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.551 ' O ' ' N ' ' A' ' 88' ' ' LYS . 23.4 p90 -43.91 -178.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.409 1.1 . . . . 0.0 111.833 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.565 ' O ' ' CD2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -109.63 156.29 20.4 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 121.913 0.864 . . . . 0.0 110.858 179.083 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.08 11.77 4.25 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.778 -1.201 . . . . 0.0 110.033 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.22 -79.68 0.23 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.347 -0.845 . . . . 0.0 110.917 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -141.42 84.08 0.21 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.537 ' C ' ' CD1' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -98.95 160.92 13.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.467 -1.019 . . . . 0.0 109.911 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.584 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 24.4 ttmt -153.44 156.81 38.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.264 -0.897 . . . . 0.0 110.531 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 26.5 mtp85 -53.37 -30.16 38.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.897 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.418 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -141.77 171.56 13.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.484 -0.76 . . . . 0.0 110.21 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.584 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 31.2 m-85 -144.08 177.66 8.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.214 -0.929 . . . . 0.0 110.408 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.529 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 7.7 p -162.85 92.36 0.77 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.177 -0.952 . . . . 0.0 110.238 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.562 ' CB ' HG23 ' A' ' 59' ' ' VAL . 13.3 t80 56.83 136.31 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.092 -1.005 . . . . 0.0 110.247 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.556 ' O ' ' N ' ' A' ' 103' ' ' CYS . 14.4 t-20 63.57 -125.05 0.55 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.849 -1.157 . . . . 0.0 110.521 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.45 ' HB3' ' HB3' ' A' ' 103' ' ' CYS . 0.5 OUTLIER 54.13 71.2 0.53 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.617 -1.302 . . . . 0.0 109.014 -178.526 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 5.4 t30 -73.53 136.69 44.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.515 -0.741 . . . . 0.0 111.332 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.557 HG12 ' CH2' ' A' ' 109' ' ' TRP . 12.5 m -124.0 117.21 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.246 -0.909 . . . . 0.0 109.877 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 48.6 t0 -78.4 136.04 37.56 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.564 ' CD2' ' HG3' ' A' ' 114' ' ' PRO . 60.6 m-85 -94.24 129.68 40.78 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.99 -1.069 . . . . 0.0 112.158 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 70' ' ' TYR . 9.1 tptt -99.52 90.05 4.37 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.631 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.47 ' HB2' HD13 ' A' ' 95' ' ' LEU . 0.3 OUTLIER -44.35 128.77 6.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.004 -1.06 . . . . 0.0 109.861 -179.668 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 2.9 mmtt -38.93 -78.0 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.595 -0.691 . . . . 0.0 110.472 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.589 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -168.27 141.53 3.14 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.358 -0.839 . . . . 0.0 110.366 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.582 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 49.79 53.78 20.47 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.589 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 11.6 m-85 -158.28 151.23 22.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.469 -1.019 . . . . 0.0 109.624 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.471 ' O ' ' O ' ' A' ' 115' ' ' LYS . 13.1 mtmm -109.18 134.64 51.47 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.113 -0.992 . . . . 0.0 110.161 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.543 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 1.8 mt -72.13 103.51 3.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.259 -0.9 . . . . 0.0 110.571 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.49 ' HB3' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -84.87 112.83 20.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.151 -0.968 . . . . 0.0 109.751 179.379 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 132.08 -77.74 0.38 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.52 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -167.73 112.05 0.67 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.358 -1.084 . . . . 0.0 110.44 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 43.9 t -69.97 -7.07 37.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.211 -0.931 . . . . 0.0 110.306 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.0 p -139.65 98.8 3.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.182 -0.949 . . . . 0.0 110.04 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.539 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 7.0 m -106.47 -174.69 2.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.192 -0.943 . . . . 0.0 110.565 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 19.8 m -157.93 134.9 9.97 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.251 -0.98 . . . . 0.0 111.301 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.602 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 1.8 t -62.2 87.4 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.466 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -78.57 177.05 3.06 Favored Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.133 -0.98 . . . . 0.0 110.859 -179.387 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.56 ' CG ' HG22 ' A' ' 38' ' ' ILE . 41.9 Cg_endo -73.55 138.28 26.6 Favored 'Trans proline' 0 C--N 1.302 -1.91 0 O-C-N 124.436 1.756 . . . . 0.0 110.499 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.554 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 116.92 -10.05 15.72 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.554 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 1.4 m-20 81.12 77.72 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.943 -0.74 . . . . 0.0 110.065 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.484 HG22 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -173.73 -175.05 1.03 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.626 -0.83 . . . . 0.0 110.969 -179.697 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.613 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 38.9 m95 -124.35 89.03 3.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.546 -0.721 . . . . 0.0 109.723 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.517 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -101.86 136.05 19.6 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.491 -0.755 . . . . 0.0 110.652 -179.109 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.539 ' HD2' ' HA ' ' A' ' 101' ' ' SER . 40.9 Cg_endo -68.52 163.73 77.28 Favored 'Cis proline' 0 N--CA 1.489 1.224 0 C-N-CA 122.101 -2.041 . . . . 0.0 111.029 -0.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 111' ' ' PRO . 28.5 tt0 -40.06 155.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.457 0.646 . . . . 0.0 110.689 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -62.99 146.29 95.78 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.494 -0.754 . . . . 0.0 110.043 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.564 ' HG3' ' CD2' ' A' ' 87' ' ' PHE . 41.1 Cg_endo -72.45 175.4 10.15 Favored 'Trans proline' 0 C--N 1.299 -2.057 0 O-C-N 124.365 1.718 . . . . 0.0 111.136 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 96' ' ' SER . 6.4 tttp -133.79 114.39 13.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.493 -0.755 . . . . 0.0 109.907 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.52 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 3.5 t -72.96 71.19 1.06 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.082 -1.011 . . . . 0.0 109.505 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.49 HG23 ' HB3' ' A' ' 96' ' ' SER . 5.9 m -86.91 -170.37 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-O 122.057 0.932 . . . . 0.0 110.924 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.469 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.294 -1.844 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.281 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.521 ' CG2' ' HA3' ' A' ' 48' ' ' GLY . 9.1 m . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.301 0.572 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.77 178.96 6.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.296 -0.878 . . . . 0.0 110.512 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.524 ' O ' ' N ' ' A' ' 21' ' ' TYR . 1.2 m -117.99 136.38 53.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.493 -0.754 . . . . 0.0 110.131 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 5' ' ' SER . 5.7 pt20 -110.61 172.94 6.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.046 -1.034 . . . . 0.0 109.647 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.461 ' HB2' ' HA ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -46.65 132.86 8.21 Favored Pre-proline 0 C--N 1.298 -1.637 0 C-N-CA 119.369 -0.933 . . . . 0.0 109.36 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.592 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 43.8 Cg_endo -69.81 166.03 29.03 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.939 1.494 . . . . 0.0 110.325 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.02 166.47 27.81 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 O-C-N 123.942 1.496 . . . . 0.0 110.306 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.74 175.37 9.45 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.376 -0.827 . . . . 0.0 109.949 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 11' ' ' ASN . 0.3 OUTLIER -141.44 -170.33 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-O 122.227 1.013 . . . . 0.0 111.331 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 1.3 m -46.44 91.54 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.92 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.506 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER 42.03 51.09 4.33 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.147 -0.97 . . . . 0.0 110.376 179.643 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -150.53 151.79 23.76 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -111.15 -179.05 3.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.34 -1.094 . . . . 0.0 110.265 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.614 ' CD2' ' N ' ' A' ' 14' ' ' HIS . 8.4 m170 -66.06 -139.42 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.279 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -85.28 -97.76 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.935 . . . . 0.0 110.212 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.32 -71.2 0.69 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -164.61 84.75 0.42 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -1.173 . . . . 0.0 110.254 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.441 ' N ' ' CD ' ' A' ' 18' ' ' GLU . 5.9 mp0 -109.49 -54.01 2.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.84 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.461 ' HA ' ' HB2' ' A' ' 5' ' ' SER . 2.1 m-20 59.04 18.38 6.28 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.5 -0.75 . . . . 0.0 110.232 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.563 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 0.2 OUTLIER -163.27 149.13 11.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 110.618 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.575 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 9.0 m-85 -163.98 174.75 11.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.509 -0.744 . . . . 0.0 109.649 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.482 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 22.6 p -136.03 -69.83 0.48 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.779 -1.201 . . . . 0.0 111.099 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -161.49 145.4 12.88 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.514 -0.742 . . . . 0.0 109.384 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.17 12.31 57.59 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.38 -1.888 . . . . 0.0 108.38 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.575 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -82.63 174.3 11.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.507 -0.996 . . . . 0.0 109.816 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 28.2 t -153.85 156.65 5.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.856 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.548 ' HB ' HG22 ' A' ' 43' ' ' VAL . 4.0 t -137.16 114.22 12.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 C-N-CA 119.631 -0.827 . . . . 0.0 111.546 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.527 ' CG2' ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -70.45 102.76 2.27 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 118.543 -1.263 . . . . 0.0 108.015 178.366 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.614 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 1.0 OUTLIER -68.22 97.49 0.72 Allowed 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.205 -0.998 . . . . 0.0 109.592 -178.589 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.493 ' OG ' ' O ' ' A' ' 14' ' ' HIS . 0.1 OUTLIER -70.08 139.43 52.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.78 -1.2 . . . . 0.0 109.8 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 56' ' ' CYS . 12.4 m -108.27 153.11 23.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.372 -0.83 . . . . 0.0 109.679 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 31' ' ' CYS . 0.7 OUTLIER -44.05 140.92 1.87 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.163 -0.961 . . . . 0.0 109.841 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 83.2 p -52.42 98.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 110.084 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 134.33 -1.74 4.13 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' A' ' 56' ' ' CYS . 0.6 OUTLIER -106.15 161.03 14.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.067 -1.255 . . . . 0.0 110.421 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.616 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.7 OUTLIER -102.58 129.99 49.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.359 -0.838 . . . . 0.0 110.963 -179.405 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.533 ' HA ' ' O ' ' A' ' 55' ' ' THR . 4.6 tp -89.05 120.67 30.67 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.329 -0.857 . . . . 0.0 109.294 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.571 ' O ' ' N ' ' A' ' 55' ' ' THR . 0.2 OUTLIER -118.37 141.74 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.138 -0.976 . . . . 0.0 109.881 -179.501 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.506 ' O ' ' CB ' ' A' ' 40' ' ' ASN . . . 101.58 44.22 2.0 Favored Glycine 0 N--CA 1.488 2.154 0 C-N-CA 119.393 -1.384 . . . . 0.0 109.687 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 3.1 t30 72.11 169.45 0.32 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.491 -1.005 . . . . 0.0 109.775 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.527 ' O ' ' CG2' ' A' ' 28' ' ' THR . 0.8 OUTLIER -112.36 63.15 0.63 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 110.457 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 27' ' ' VAL . . . 160.12 113.89 0.34 Allowed Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.635 -1.269 . . . . 0.0 110.306 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.614 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 1.1 t -60.84 -179.06 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.05 -1.265 . . . . 0.0 108.066 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 25' ' ' SER . 0.8 OUTLIER -143.78 102.55 3.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.994 -1.066 . . . . 0.0 110.533 178.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.589 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.6 OUTLIER -85.48 113.84 22.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.317 -0.864 . . . . 0.0 109.276 178.654 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 87.7 p -129.64 137.52 50.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 0.0 110.531 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.01 9.12 45.93 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.521 ' HA3' ' CG2' ' A' ' 1' ' ' VAL . . . 93.36 29.08 10.54 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -146.08 135.18 22.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.366 -1.079 . . . . 0.0 110.097 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.589 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 89.1 m95 -80.71 138.36 36.34 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.217 -0.927 . . . . 0.0 109.909 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -141.81 165.46 27.4 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.119 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.535 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 1.3 t70 43.11 64.87 5.99 Favored Pre-proline 0 N--CA 1.491 1.614 0 CA-C-O 121.141 0.496 . . . . 0.0 111.819 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.535 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 47.0 Cg_endo -91.8 125.56 0.86 Allowed 'Trans proline' 0 C--N 1.3 -1.996 0 O-C-N 124.341 1.706 . . . . 0.0 109.261 178.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.517 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 45.1 Cg_endo -70.79 -178.44 2.74 Favored 'Trans proline' 0 C--N 1.297 -2.15 0 O-C-N 123.808 1.425 . . . . 0.0 110.759 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.571 ' N ' ' O ' ' A' ' 38' ' ' ILE . 6.0 p -119.82 -169.09 1.71 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.851 0.834 . . . . 0.0 111.255 -178.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.479 ' O ' ' CD2' ' A' ' 35' ' ' TYR . 96.4 m -151.92 86.65 1.32 Allowed 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -111.11 -139.5 0.38 Allowed 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.055 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.528 ' CD1' ' N ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -142.82 74.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 179.391 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.627 HG22 ' HB3' ' A' ' 81' ' ' TYR . 4.6 m -68.72 126.49 28.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 122.55 1.167 . . . . 0.0 110.679 -177.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 107' ' ' ASN . 24.6 mtpt -147.22 93.67 2.28 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.48 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 27.4 m -69.1 162.78 62.84 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.513 -0.742 . . . . 0.0 111.732 -177.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 46.1 Cg_endo -72.82 -90.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.612 1.848 . . . . 0.0 110.615 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.444 ' HB3' ' CG2' ' A' ' 65' ' ' THR . 0.0 OUTLIER -164.98 129.34 1.81 Allowed Pre-proline 0 C--N 1.302 -1.462 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.616 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 54.7 Cg_endo -77.33 65.68 7.94 Favored 'Trans proline' 0 C--N 1.298 -2.114 0 O-C-N 123.608 1.32 . . . . 0.0 109.617 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.528 ' O ' ' CD2' ' A' ' 113' ' ' LEU . 0.8 OUTLIER -83.95 178.81 7.72 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.266 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.564 ' CD1' ' HG2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -175.02 158.39 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.077 179.388 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.478 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 0.7 OUTLIER -64.35 101.82 0.47 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.496 -0.753 . . . . 0.0 110.5 -179.57 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.469 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 45.0 m-20 39.66 50.74 2.26 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.438 -0.789 . . . . 0.0 110.607 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.518 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -158.54 32.07 0.48 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.554 ' CD2' ' O ' ' A' ' 71' ' ' LEU . 4.9 p90 -45.17 -172.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.798 1.285 . . . . 0.0 112.684 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.568 HD22 ' CD2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -109.96 167.91 9.82 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.601 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 72' ' ' SER . 0.3 OUTLIER -144.97 24.91 1.45 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.044 -1.035 . . . . 0.0 110.155 -179.611 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.3 t -104.24 -89.02 0.41 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.032 -1.042 . . . . 0.0 110.824 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -118.92 72.86 0.31 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 2.9 t80 -98.2 164.82 12.16 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.446 -1.032 . . . . 0.0 110.19 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.63 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 2.4 tttp -168.93 159.13 9.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.367 -0.833 . . . . 0.0 109.95 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -52.6 -27.79 18.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.128 -0.983 . . . . 0.0 109.981 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.462 ' C ' ' CG ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -141.31 173.87 11.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.366 -0.834 . . . . 0.0 110.556 -179.723 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.575 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 43.3 m-85 -148.82 -168.15 3.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.519 -0.738 . . . . 0.0 109.486 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.546 ' CA ' HG21 ' A' ' 59' ' ' VAL . 88.1 p -141.47 -102.12 0.14 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.741 -1.225 . . . . 0.0 111.355 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.627 ' HB3' HG22 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -119.27 19.36 12.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.608 -1.307 . . . . 0.0 111.24 -178.696 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' A' ' 103' ' ' CYS . 29.0 t-20 -159.86 -101.59 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.875 -1.14 . . . . 0.0 110.118 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 82' ' ' ASN . 2.9 m-20 44.94 72.79 0.18 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.87 -1.144 . . . . 0.0 109.277 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.516 ' N ' HG21 ' A' ' 102' ' ' THR . 8.7 p30 -68.74 113.91 6.63 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.386 -0.821 . . . . 0.0 110.172 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.529 ' N ' ' O ' ' A' ' 101' ' ' SER . 33.1 m -99.28 121.88 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.249 -0.907 . . . . 0.0 111.073 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.522 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 28.8 t70 -83.27 134.6 34.93 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.547 ' CE1' HD11 ' A' ' 71' ' ' LEU . 29.3 m-85 -91.46 132.82 35.98 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.825 -1.172 . . . . 0.0 112.046 -178.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.2 OUTLIER -111.2 92.0 3.87 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.181 -179.39 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.453 ' SG ' ' HG ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -44.49 128.37 6.37 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.043 -1.036 . . . . 0.0 109.907 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 2.4 mmmp? -41.19 -85.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.32 -0.862 . . . . 0.0 110.375 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.581 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -159.09 142.2 14.52 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.273 -0.892 . . . . 0.0 110.418 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.594 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 54.7 54.94 29.95 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.594 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 18.2 m-85 -160.27 167.41 27.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.469 -1.018 . . . . 0.0 109.729 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.481 ' N ' ' O ' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -132.22 114.37 14.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.24 -0.913 . . . . 0.0 109.911 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.524 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 10.2 mt -46.39 107.49 0.11 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.11 -0.994 . . . . 0.0 110.479 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.477 ' CB ' HG23 ' A' ' 117' ' ' VAL . 1.2 t -90.1 97.04 10.96 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.432 -0.792 . . . . 0.0 109.685 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.62 -40.33 1.38 Allowed Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.404 -1.379 . . . . 0.0 110.546 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.549 ' O ' ' HB3' ' A' ' 114' ' ' PRO . 0.0 OUTLIER 177.58 -164.45 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.889 -1.359 . . . . 0.0 111.524 -179.191 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.529 ' N ' ' OG ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -149.21 -53.42 0.17 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.713 -0.617 . . . . 0.0 110.2 -179.833 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 91.1 p -110.48 105.51 14.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.23 -0.919 . . . . 0.0 110.644 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.529 ' O ' ' N ' ' A' ' 85' ' ' VAL . 50.6 m -113.73 164.27 13.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.329 -0.857 . . . . 0.0 110.118 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.516 HG21 ' N ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -133.39 143.39 48.9 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.345 -0.847 . . . . 0.0 110.885 -179.687 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.628 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -72.95 98.27 2.45 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.33 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.553 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -67.98 176.27 1.41 Allowed Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.182 -0.949 . . . . 0.0 112.333 -178.52 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.614 ' CA ' HG13 ' A' ' 59' ' ' VAL . 41.0 Cg_endo -70.03 -33.36 15.72 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 124.689 1.889 . . . . 0.0 111.728 -177.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.56 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -75.5 4.64 41.42 Favored Glycine 0 N--CA 1.486 2.001 0 C-N-CA 119.267 -1.444 . . . . 0.0 110.799 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 0.9 OUTLIER 78.13 89.4 0.07 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.445 -1.033 . . . . 0.0 110.929 179.245 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 103' ' ' CYS . 0.0 OUTLIER -178.45 -161.7 0.05 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.857 . . . . 0.0 110.906 179.354 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.628 ' CZ3' ' N ' ' A' ' 103' ' ' CYS . 22.7 m95 -142.71 97.94 3.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 111.305 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.472 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 2.5 mtpp -106.75 145.83 31.85 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.411 -0.806 . . . . 0.0 109.512 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.507 ' HG2' ' HB2' ' A' ' 98' ' ' SER . 47.3 Cg_endo -72.91 178.62 31.27 Favored 'Cis proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.088 -2.047 . . . . 0.0 111.089 -0.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.447 ' O ' ' C ' ' A' ' 113' ' ' LEU . 5.3 tt0 -40.74 121.16 1.42 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.606 -0.684 . . . . 0.0 110.352 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.555 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.6 OUTLIER -40.91 138.56 1.31 Allowed Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.416 -0.802 . . . . 0.0 110.001 179.701 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.564 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 42.8 Cg_endo -75.04 160.69 39.75 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 O-C-N 124.176 1.619 . . . . 0.0 111.758 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.519 ' O ' HG23 ' A' ' 117' ' ' VAL . 5.6 ttpp -125.67 99.89 6.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.469 -0.769 . . . . 0.0 110.813 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.546 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.8 t -53.29 100.88 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.93 . . . . 0.0 109.468 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 115' ' ' LYS . 2.0 m -118.92 179.18 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.664 0.745 . . . . 0.0 110.624 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.504 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.293 -1.858 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.371 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.507 HG11 ' N ' ' A' ' 2' ' ' LYS . 53.8 t . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.213 0.53 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.507 ' N ' HG11 ' A' ' 1' ' ' VAL . 9.1 mptt -81.13 170.32 16.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.256 -0.902 . . . . 0.0 110.319 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 21' ' ' TYR . 1.2 m -125.39 90.58 3.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 109.713 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.513 ' CG ' ' N ' ' A' ' 5' ' ' SER . 37.6 tt0 -72.88 173.58 8.99 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.021 -1.049 . . . . 0.0 109.895 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.513 ' N ' ' CG ' ' A' ' 4' ' ' GLN . 0.7 OUTLIER -44.09 134.76 4.12 Favored Pre-proline 0 C--N 1.297 -1.706 0 O-C-N 121.501 -0.749 . . . . 0.0 109.642 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.641 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 51.6 Cg_endo -71.36 150.5 58.59 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.939 1.494 . . . . 0.0 110.525 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.34 172.23 15.36 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 O-C-N 124.007 1.53 . . . . 0.0 109.932 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.53 177.71 2.81 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.248 -0.907 . . . . 0.0 109.509 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.504 HG22 ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -139.09 -170.41 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 122.172 0.987 . . . . 0.0 111.297 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 5.5 t -47.37 98.25 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.616 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.2 m120 44.35 47.85 8.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 0.0 110.415 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.458 ' O ' HG13 ' A' ' 9' ' ' ILE . . . -159.6 156.64 27.81 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.42 -169.71 1.51 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.117 -1.225 . . . . 0.0 111.071 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.641 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 13.8 p80 -137.85 126.0 22.97 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.353 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -100.37 -175.33 2.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.308 -0.87 . . . . 0.0 110.263 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . 154.22 -36.6 0.7 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.472 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER 67.44 35.88 4.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.395 -1.061 . . . . 0.0 110.482 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.577 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -142.48 -159.61 0.99 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.292 -0.88 . . . . 0.0 109.817 179.599 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 4' ' ' GLN . 1.5 m-20 -147.47 -35.2 0.24 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.171 -0.956 . . . . 0.0 110.59 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -121.03 79.05 1.46 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.191 -0.943 . . . . 0.0 110.14 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.603 ' CE2' ' CG2' ' A' ' 27' ' ' VAL . 0.9 OUTLIER -57.57 -24.7 57.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.07 -1.019 . . . . 0.0 110.339 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.445 ' C ' ' HB2' ' A' ' 3' ' ' CYS . 0.2 OUTLIER 66.43 -79.08 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.464 -0.772 . . . . 0.0 112.32 178.561 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.51 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER -168.3 160.84 11.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.891 -1.13 . . . . 0.0 109.865 -178.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 59.39 17.07 38.09 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.506 ' CB ' ' CD1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -92.89 160.11 15.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.566 -0.961 . . . . 0.0 109.725 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.631 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 57.4 t -133.75 150.23 31.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 118.977 -1.089 . . . . 0.0 110.907 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.603 ' CG2' ' CE2' ' A' ' 21' ' ' TYR . 45.6 t -138.13 112.02 8.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.46 -0.775 . . . . 0.0 110.977 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.99 104.14 2.46 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.035 -1.466 . . . . 0.0 107.653 178.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.644 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 1.9 m-30 -67.62 130.67 43.75 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.956 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.71 152.64 23.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.122 -0.986 . . . . 0.0 109.906 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.521 ' SG ' ' CD1' ' A' ' 37' ' ' LEU . 98.1 m -129.71 143.81 50.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.154 -0.966 . . . . 0.0 110.354 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -55.17 127.95 31.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.267 -0.896 . . . . 0.0 110.285 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 71.1 p -44.88 139.73 2.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.298 -0.876 . . . . 0.0 110.332 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.5 -21.81 37.91 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.471 ' CZ ' HG22 ' A' ' 58' ' ' ILE . 8.4 m-85 -108.94 141.22 41.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.12 -1.223 . . . . 0.0 110.3 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.59 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -79.03 136.36 37.16 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.349 -0.844 . . . . 0.0 110.995 -179.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.545 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 3.8 tt -92.54 94.23 8.95 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.59 ' CG2' ' CG ' ' A' ' 105' ' ' PRO . 0.9 OUTLIER -76.68 145.16 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.43 -0.793 . . . . 0.0 109.207 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 126.94 -160.26 21.2 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.514 ' O ' ' C ' ' A' ' 41' ' ' SER . 4.2 m-20 -115.8 52.01 0.92 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.113 -1.228 . . . . 0.0 109.798 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.514 ' C ' ' O ' ' A' ' 40' ' ' ASN . 18.3 p 24.88 67.78 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.715 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.87 116.08 0.42 Allowed Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.383 -1.389 . . . . 0.0 110.609 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.644 ' CG2' ' CE1' ' A' ' 29' ' ' TYR . 1.4 t -84.72 126.88 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.7 tp -97.29 106.88 19.29 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 120.201 -1.562 . . . . 0.0 111.423 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.592 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.8 OUTLIER -87.56 114.72 24.43 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.449 -0.901 . . . . 0.0 108.92 178.034 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.467 ' HA ' ' OD2' ' A' ' 23' ' ' ASP . 0.3 OUTLIER -132.43 128.67 38.0 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.404 -179.686 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.51 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 80.02 -5.48 62.38 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.461 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 109.79 6.76 28.24 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -126.54 116.49 21.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -1.18 . . . . 0.0 110.517 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.592 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 82.7 m95 -64.85 141.42 58.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.224 -0.922 . . . . 0.0 109.542 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 52' ' ' ASP . 2.4 t -140.98 -177.77 5.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.015 -1.053 . . . . 0.0 111.105 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.53 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER 36.26 65.4 2.14 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.746 -0.596 . . . . 0.0 111.207 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.53 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.8 Cg_endo -91.58 138.15 2.09 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 124.403 1.738 . . . . 0.0 109.666 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.536 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 51.3 Cg_endo -80.56 175.88 9.68 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.489 1.257 . . . . 0.0 110.321 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.581 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 20.0 p -130.12 138.58 50.75 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.171 -0.956 . . . . 0.0 111.0 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 14.2 m -97.52 76.48 2.54 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.459 ' HG3' HG12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -119.08 144.83 46.37 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.428 0.632 . . . . 0.0 110.219 -178.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.471 HG22 ' CZ ' ' A' ' 35' ' ' TYR . 1.7 pt -69.46 120.54 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.632 ' CG1' ' HA ' ' A' ' 105' ' ' PRO . 12.1 m -99.5 51.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.151 -0.968 . . . . 0.0 112.094 -178.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.0 mtpp -87.61 99.35 11.99 Favored 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 118.626 -1.229 . . . . 0.0 108.434 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.466 ' SG ' ' O ' ' A' ' 108' ' ' THR . 59.6 m -69.25 162.62 64.62 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.397 -0.814 . . . . 0.0 111.502 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 47.9 Cg_endo -72.0 -91.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.464 1.771 . . . . 0.0 110.587 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.453 ' HB3' ' CG2' ' A' ' 65' ' ' THR . 0.0 OUTLIER -158.27 132.27 5.04 Favored Pre-proline 0 C--N 1.302 -1.47 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.607 ' HD3' ' CZ2' ' A' ' 109' ' ' TRP . 55.5 Cg_endo -77.77 67.89 7.83 Favored 'Trans proline' 0 C--N 1.293 -2.344 0 O-C-N 123.757 1.398 . . . . 0.0 109.528 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.534 ' N ' HD22 ' A' ' 113' ' ' LEU . 1.5 p -88.97 174.98 7.61 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.553 ' CD1' ' HG2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -170.35 159.87 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 118.405 -1.318 . . . . 0.0 110.675 179.182 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 1.5 m -61.33 95.84 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.644 -0.66 . . . . 0.0 110.395 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.469 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 8.6 m-20 44.57 45.07 7.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.426 -0.796 . . . . 0.0 110.597 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.527 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -151.85 33.4 0.88 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.528 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 3.7 p90 -45.89 -171.39 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 122.743 1.258 . . . . 0.0 112.628 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.585 HD11 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -113.85 162.93 15.73 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.194 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.7 t -149.88 28.93 0.75 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.993 -1.067 . . . . 0.0 109.944 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.64 -16.98 7.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 111.235 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -154.08 -87.86 0.06 OUTLIER Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.169 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.616 ' CD2' ' N ' ' A' ' 76' ' ' LYS . 58.5 t80 58.6 170.24 0.06 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.626 -0.926 . . . . 0.0 110.577 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.616 ' N ' ' CD2' ' A' ' 75' ' ' PHE . 4.1 tptt 174.83 134.3 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.403 -0.811 . . . . 0.0 109.842 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 76' ' ' LYS . 2.3 mtt-85 -40.1 -45.16 1.93 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.262 -0.899 . . . . 0.0 110.4 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.432 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 3.6 t -132.86 125.42 29.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.438 -0.789 . . . . 0.0 110.198 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.599 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 14.9 m-85 -101.49 -173.98 2.49 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.146 -0.971 . . . . 0.0 110.506 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -170.41 106.9 0.31 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.148 -0.97 . . . . 0.0 110.971 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.648 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 5.1 t80 35.04 32.51 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.107 -0.996 . . . . 0.0 112.118 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.567 ' N ' ' O ' ' A' ' 103' ' ' CYS . 15.5 t30 -177.37 -140.25 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.221 -1.549 . . . . 0.0 111.149 178.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.418 ' C ' HG21 ' A' ' 102' ' ' THR . 1.6 m-20 56.3 73.19 0.45 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.114 -0.991 . . . . 0.0 108.948 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.512 ' N ' HG21 ' A' ' 102' ' ' THR . 7.0 t30 -69.57 112.53 6.13 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.458 -0.776 . . . . 0.0 110.31 -179.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.597 HG12 ' CH2' ' A' ' 109' ' ' TRP . 23.1 m -95.03 120.55 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 111.053 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 4.4 t0 -80.77 131.23 35.4 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.585 ' CE1' HD11 ' A' ' 71' ' ' LEU . 46.4 m-85 -91.14 136.9 32.77 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.881 -1.137 . . . . 0.0 111.945 -178.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -115.65 102.5 9.81 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.964 -179.587 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.517 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -49.44 131.31 20.66 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.098 -1.001 . . . . 0.0 110.081 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -39.96 -69.19 0.14 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.477 -0.764 . . . . 0.0 110.347 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.585 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 39.3 t80 -172.86 141.6 1.04 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -0.817 . . . . 0.0 110.21 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 50.99 56.92 12.14 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.585 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 13.2 m-85 -155.29 172.24 18.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.341 -1.093 . . . . 0.0 110.23 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.47 ' O ' HG21 ' A' ' 117' ' ' VAL . 0.7 OUTLIER -133.01 106.98 7.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.294 -0.879 . . . . 0.0 109.86 179.735 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.542 ' CD2' ' HB3' ' A' ' 87' ' ' PHE . 1.1 mt -46.83 99.38 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.194 -0.941 . . . . 0.0 110.675 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.469 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -78.99 101.4 7.76 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.358 -0.839 . . . . 0.0 109.441 179.226 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.86 -89.2 0.19 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.57 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.4 OUTLIER -154.35 116.94 4.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -1.173 . . . . 0.0 110.612 -179.404 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.48 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 2.0 m -83.42 29.83 0.49 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.308 -0.87 . . . . 0.0 110.832 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 65.4 p -170.5 102.56 0.26 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.16 -0.962 . . . . 0.0 109.531 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 85' ' ' VAL . 9.2 m -125.37 172.63 9.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.181 -0.949 . . . . 0.0 111.092 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.512 HG21 ' N ' ' A' ' 84' ' ' ASN . 19.9 m -143.52 142.47 31.14 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.458 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.567 ' O ' ' N ' ' A' ' 82' ' ' ASN . 6.8 t -54.57 100.51 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.399 -0.813 . . . . 0.0 109.124 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.444 ' OG ' ' HE3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -72.99 173.0 6.58 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 120.783 -1.198 . . . . 0.0 111.462 -178.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.632 ' HA ' ' CG1' ' A' ' 59' ' ' VAL . 47.2 Cg_endo -80.08 25.65 0.6 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.559 1.821 . . . . 0.0 112.451 -178.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -126.57 16.94 6.54 Favored Glycine 0 N--CA 1.484 1.851 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.472 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 0.9 OUTLIER 68.86 51.98 0.55 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.628 -0.925 . . . . 0.0 109.969 -179.86 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.466 ' O ' ' SG ' ' A' ' 61' ' ' CYS . 0.1 OUTLIER -160.78 -169.5 2.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.906 . . . . 0.0 111.109 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.607 ' CZ2' ' HD3' ' A' ' 64' ' ' PRO . 36.4 m95 -117.48 99.95 7.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.382 -0.823 . . . . 0.0 110.336 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.452 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 2.8 mtmt -105.56 140.19 20.93 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.537 -0.727 . . . . 0.0 110.071 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.57 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 47.3 Cg_endo -73.54 171.71 64.79 Favored 'Cis proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.809 -2.163 . . . . 0.0 110.434 -0.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.0 OUTLIER -40.8 128.53 2.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.372 -0.83 . . . . 0.0 111.074 -179.419 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.553 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.2 OUTLIER -41.46 147.58 0.47 Allowed Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.511 -0.743 . . . . 0.0 110.541 179.461 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.553 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 41.4 Cg_endo -75.53 169.91 21.36 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.342 1.707 . . . . 0.0 111.05 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.486 ' O ' HG23 ' A' ' 117' ' ' VAL . 30.7 ttmt -128.79 110.62 12.32 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.24 -0.912 . . . . 0.0 110.503 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.554 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 3.2 t -65.95 93.55 0.2 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.012 -1.055 . . . . 0.0 109.351 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 115' ' ' LYS . 2.3 m -113.21 -174.54 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 121.859 0.838 . . . . 0.0 111.176 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.507 ' HG2' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.792 0 CA-C-O 117.951 -1.024 . . . . 0.0 110.348 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.408 ' CG2' ' N ' ' A' ' 2' ' ' LYS . 7.0 p . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.248 0.547 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.408 ' N ' ' CG2' ' A' ' 1' ' ' VAL . 10.5 ptmt -159.84 -177.74 6.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 110.385 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.526 ' O ' ' HB2' ' A' ' 21' ' ' TYR . 1.1 m -133.54 81.16 1.91 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.606 -0.684 . . . . 0.0 109.818 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.562 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 58.4 mt-30 -63.46 178.57 0.54 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.827 -1.171 . . . . 0.0 110.456 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.8 p -46.35 143.83 3.58 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.45 -0.782 . . . . 0.0 109.896 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.618 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 48.7 Cg_endo -73.97 151.63 45.25 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.076 1.566 . . . . 0.0 111.204 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.61 171.31 18.03 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.789 1.415 . . . . 0.0 109.956 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.2 p -69.65 175.86 3.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.118 -0.989 . . . . 0.0 110.001 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.605 ' CG2' ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -142.25 -170.16 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 122.239 1.019 . . . . 0.0 111.296 179.757 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 3.2 t -51.48 99.47 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.852 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 10' ' ' SER . 1.3 m120 41.66 57.58 3.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.236 -0.915 . . . . 0.0 110.656 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -163.82 148.72 15.25 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.455 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -98.12 -176.85 3.54 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.298 -1.119 . . . . 0.0 110.12 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.618 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 23.8 p80 -143.92 138.65 28.69 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.697 -0.627 . . . . 0.0 109.814 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -166.93 -141.13 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.102 -0.999 . . . . 0.0 110.432 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.72 36.93 1.21 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 53.44 47.21 24.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.394 -1.063 . . . . 0.0 110.235 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.639 ' CB ' ' CE2' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -110.44 -159.74 0.69 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.248 -0.908 . . . . 0.0 109.913 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.421 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 0.4 OUTLIER 174.73 -28.05 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.342 -0.849 . . . . 0.0 110.458 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.572 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 3.2 p90 -165.45 55.01 0.11 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.143 -0.973 . . . . 0.0 110.722 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.639 ' CE2' ' CB ' ' A' ' 18' ' ' GLU . 19.5 m-85 -43.51 159.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.148 -0.97 . . . . 0.0 110.255 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.465 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -125.35 -59.98 1.36 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.933 -1.104 . . . . 0.0 110.58 -179.218 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.413 ' OD1' ' HA ' ' A' ' 46' ' ' SER . 3.6 t0 -166.37 140.62 4.26 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.472 -0.768 . . . . 0.0 109.618 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 74.36 17.27 79.71 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.575 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 3.1 m -97.54 168.04 10.61 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.474 -1.015 . . . . 0.0 109.936 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.646 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 74.5 t -137.27 158.43 35.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.032 -1.067 . . . . 0.0 111.1 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.59 HG13 ' CE1' ' A' ' 29' ' ' TYR . 39.0 t -143.67 107.61 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.426 -0.796 . . . . 0.0 110.957 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.81 105.65 2.41 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 117.974 -1.491 . . . . 0.0 107.722 178.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.64 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 2.0 m-30 -67.78 119.53 12.63 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.613 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -69.64 152.0 45.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.169 -0.957 . . . . 0.0 109.958 -179.86 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 78.6 m -121.81 163.92 18.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 110.424 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 33' ' ' SER . 3.3 m-20 -58.79 138.99 56.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.308 -0.87 . . . . 0.0 110.059 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 32' ' ' ASN . 1.5 m -43.2 104.9 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 110.22 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.51 -32.63 5.14 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -72.66 130.29 40.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.288 -1.125 . . . . 0.0 110.423 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.601 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -78.55 149.39 33.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.328 -0.858 . . . . 0.0 110.897 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.533 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 2.5 tp -95.09 113.45 25.14 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.414 -0.804 . . . . 0.0 108.858 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.591 ' CG2' ' CG ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -108.7 150.5 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.921 . . . . 0.0 109.298 -179.653 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 125.61 -139.41 11.51 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.35 -1.405 . . . . 0.0 109.697 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.504 ' O ' ' C ' ' A' ' 41' ' ' SER . 0.6 OUTLIER -110.0 51.43 0.76 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.196 -1.179 . . . . 0.0 109.989 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.504 ' C ' ' O ' ' A' ' 40' ' ' ASN . 13.5 p 22.68 50.64 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.345 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.453 ' HA3' ' CG1' ' A' ' 26' ' ' VAL . . . 152.37 131.58 1.71 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.331 -1.414 . . . . 0.0 110.408 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.646 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 1.2 t -81.67 121.38 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 178.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.449 ' HA ' ' O ' ' A' ' 25' ' ' SER . 11.6 tp -95.13 103.48 15.33 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 120.277 -1.514 . . . . 0.0 111.385 -178.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.6 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.7 OUTLIER -80.99 121.43 26.04 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.061 178.491 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.413 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 4.7 m -135.14 123.95 23.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.438 -0.789 . . . . 0.0 110.863 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.4 16.08 80.06 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.47 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 87.03 25.9 32.96 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -141.33 103.43 4.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.169 -1.195 . . . . 0.0 110.318 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.6 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 77.9 m95 -56.25 137.31 52.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.913 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 52' ' ' ASP . 10.1 m -140.73 179.45 6.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.93 . . . . 0.0 111.009 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.521 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER 39.25 65.36 3.44 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.666 -0.646 . . . . 0.0 111.177 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 46.3 Cg_endo -90.14 127.64 1.48 Allowed 'Trans proline' 0 C--N 1.298 -2.122 0 O-C-N 124.356 1.714 . . . . 0.0 109.689 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.527 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 50.8 Cg_endo -76.62 176.78 9.66 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 O-C-N 123.821 1.432 . . . . 0.0 110.746 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.529 ' OG1' ' CG1' ' A' ' 38' ' ' ILE . 9.6 p -119.98 153.37 36.08 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.476 -0.765 . . . . 0.0 111.125 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 10' ' ' SER . 94.6 m -114.11 78.84 1.18 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -115.09 -178.24 3.32 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.3 0.572 . . . . 0.0 110.366 -178.511 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -95.6 130.1 44.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.305 -0.872 . . . . 0.0 109.299 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.601 ' CG1' ' CB ' ' A' ' 36' ' ' SER . 23.4 m -117.3 49.91 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 110.787 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 1.1 mttm -64.83 -163.27 0.02 OUTLIER 'General case' 0 C--N 1.281 -2.393 0 C-N-CA 118.797 -1.161 . . . . 0.0 109.167 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -151.0 154.56 34.36 Favored Pre-proline 0 C--N 1.291 -1.94 0 C-N-CA 119.167 -1.013 . . . . 0.0 112.179 -179.219 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.561 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 43.2 Cg_endo -81.03 -59.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.54 1.81 . . . . 0.0 108.539 177.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.561 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.2 OUTLIER 157.45 127.2 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.588 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.597 ' HB3' ' CE2' ' A' ' 109' ' ' TRP . 55.7 Cg_endo -79.91 67.14 8.7 Favored 'Trans proline' 0 C--N 1.296 -2.213 0 O-C-N 123.767 1.404 . . . . 0.0 109.771 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.537 ' O ' ' CD2' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -92.96 177.04 6.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.334 -0.854 . . . . 0.0 109.363 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.574 HG23 ' CE1' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -174.82 162.87 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 119.155 -1.018 . . . . 0.0 110.303 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 68' ' ' ASN . 3.0 t -67.32 108.08 2.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.514 -0.741 . . . . 0.0 111.054 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.49 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 31.2 m-80 38.69 34.93 0.09 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.593 -0.692 . . . . 0.0 110.853 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.551 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -145.92 35.98 1.35 Allowed Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.359 -1.4 . . . . 0.0 110.001 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.551 ' O ' ' O ' ' A' ' 69' ' ' GLY . 5.1 p90 -48.28 -163.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 123.169 1.461 . . . . 0.0 112.287 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.534 ' CD2' ' HB2' ' A' ' 64' ' ' PRO . 1.9 pp -117.66 124.6 48.95 Favored 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 114.341 -1.3 . . . . 0.0 110.11 -178.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.483 ' HB3' ' HB2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -92.61 9.99 32.36 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.479 -0.763 . . . . 0.0 109.534 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.28 -71.73 0.43 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.382 -0.824 . . . . 0.0 110.652 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -172.55 98.5 0.13 Allowed Glycine 0 N--CA 1.489 2.197 0 C-N-CA 119.781 -1.2 . . . . 0.0 110.121 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.608 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -98.78 174.9 6.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.427 -1.043 . . . . 0.0 109.576 179.529 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.561 ' N ' ' CG ' ' A' ' 75' ' ' PHE . 3.3 ttmt -166.54 168.39 14.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.339 -0.85 . . . . 0.0 109.873 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.55 -31.03 61.8 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.754 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.462 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 0.5 OUTLIER -155.26 163.3 40.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.14 -0.975 . . . . 0.0 110.447 -179.868 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.608 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 10.2 m-85 -133.83 -164.97 1.57 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.262 -0.899 . . . . 0.0 110.401 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 40.9 p -143.22 -149.25 0.26 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.394 -0.817 . . . . 0.0 109.383 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.574 ' N ' ' CG2' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -70.67 144.74 50.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.632 -1.293 . . . . 0.0 108.508 179.052 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 103' ' ' CYS . 34.8 t-20 65.45 -111.85 0.23 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.328 -0.857 . . . . 0.0 110.704 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 1.0 OUTLIER 46.43 84.42 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.617 -1.302 . . . . 0.0 108.207 -178.31 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.577 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.0 OUTLIER -85.5 135.01 34.01 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.464 -0.772 . . . . 0.0 112.143 -177.595 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.607 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 6.3 m -119.94 118.95 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.312 -0.867 . . . . 0.0 109.435 177.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.489 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 20.0 t0 -73.61 134.56 43.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.092 -1.005 . . . . 0.0 109.16 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.576 ' CE2' HD13 ' A' ' 113' ' ' LEU . 28.2 m-85 -94.25 129.35 40.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.071 -1.018 . . . . 0.0 111.144 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -106.67 96.11 6.21 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.806 -179.124 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.435 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -47.56 133.63 13.03 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.904 -1.122 . . . . 0.0 109.217 179.199 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -40.43 -85.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.272 -0.892 . . . . 0.0 110.269 -179.596 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.472 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 1.0 OUTLIER -163.65 135.01 4.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.458 -0.776 . . . . 0.0 109.922 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.72 48.94 62.58 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.081 -1.607 . . . . 0.0 109.081 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.536 ' CB ' ' SG ' ' A' ' 116' ' ' CYS . 36.2 m-85 -153.04 170.01 21.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.442 -1.034 . . . . 0.0 110.131 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.537 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 1.0 OUTLIER -131.17 107.46 9.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.271 -0.893 . . . . 0.0 109.656 179.432 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.543 ' CD2' HD12 ' A' ' 66' ' ' ILE . 43.0 mt -46.87 102.76 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.187 -0.945 . . . . 0.0 110.623 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.428 ' HB2' HG22 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -81.15 98.13 7.91 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.39 -0.819 . . . . 0.0 109.29 179.067 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.87 -86.3 0.17 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.562 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -160.4 124.51 3.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.157 -1.202 . . . . 0.0 110.734 -179.489 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.46 ' OG ' ' N ' ' A' ' 100' ' ' SER . 13.3 p -70.03 -55.99 8.11 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.101 -0.999 . . . . 0.0 110.574 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.46 ' N ' ' OG ' ' A' ' 99' ' ' SER . 54.7 p -94.75 121.5 36.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.286 -0.884 . . . . 0.0 110.127 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 29.6 m -121.42 -174.64 2.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.892 . . . . 0.0 110.119 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -157.28 128.5 6.79 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.324 -0.86 . . . . 0.0 110.735 179.658 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.555 ' N ' ' O ' ' A' ' 82' ' ' ASN . 46.9 t -65.52 91.93 0.13 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.746 -0.596 . . . . 0.0 109.613 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.465 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -71.58 -179.89 0.84 Allowed Pre-proline 0 C--N 1.298 -1.644 0 O-C-N 121.403 -0.811 . . . . 0.0 110.863 -179.339 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.591 ' CG ' ' CG2' ' A' ' 38' ' ' ILE . 42.7 Cg_endo -80.55 121.61 4.27 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 O-C-N 124.467 1.772 . . . . 0.0 110.424 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.577 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 132.21 -3.6 5.19 Favored Glycine 0 N--CA 1.481 1.638 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.577 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 1.0 OUTLIER 80.71 88.08 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.777 -0.837 . . . . 0.0 111.264 179.431 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.544 ' CG2' ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 176.66 -164.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 111.523 179.15 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.607 ' CZ3' HG23 ' A' ' 85' ' ' VAL . 28.6 m95 -139.68 90.02 2.37 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.412 0.625 . . . . 0.0 110.13 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.478 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 1.5 mmtp -99.3 141.25 22.51 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.408 -0.808 . . . . 0.0 110.15 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.562 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.0 Cg_endo -72.0 173.33 52.56 Favored 'Cis proline' 0 C--N 1.312 -1.348 0 C-N-CA 122.034 -2.069 . . . . 0.0 110.811 -0.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 111' ' ' PRO . 10.2 pt-20 -40.81 137.83 1.13 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.398 -0.814 . . . . 0.0 110.801 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.576 HD13 ' CE2' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -53.09 144.55 27.75 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.416 -0.802 . . . . 0.0 110.342 179.639 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.542 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . 43.4 Cg_endo -72.22 163.62 38.13 Favored 'Trans proline' 0 C--N 1.302 -1.885 0 O-C-N 124.224 1.644 . . . . 0.0 111.12 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.541 ' O ' HG23 ' A' ' 117' ' ' VAL . 9.4 tttt -127.84 115.39 18.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.456 -0.778 . . . . 0.0 109.848 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.536 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 0.8 OUTLIER -66.29 100.94 0.67 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.034 -1.041 . . . . 0.0 109.651 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 115' ' ' LYS . 0.7 OUTLIER -118.22 -177.19 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 121.625 0.726 . . . . 0.0 110.931 -179.538 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.7 mtp-105 . . . . . 0 C--N 1.295 -1.797 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.53 179.937 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 121.24 0.543 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -135.13 103.89 5.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 110.332 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.612 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 37.3 t -68.98 155.87 39.58 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.669 -0.644 . . . . 0.0 110.486 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.423 ' O ' ' C ' ' A' ' 5' ' ' SER . 69.6 mt-30 -140.08 -177.09 4.84 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.356 -0.84 . . . . 0.0 109.644 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.2 OUTLIER -42.05 133.02 2.51 Favored Pre-proline 0 C--N 1.297 -1.683 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.123 -179.666 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.583 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 51.8 Cg_endo -70.14 157.41 59.74 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.12 1.589 . . . . 0.0 111.112 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -75.66 172.23 16.71 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.969 1.51 . . . . 0.0 110.109 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.46 175.26 4.9 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.208 -0.932 . . . . 0.0 109.94 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.469 HG22 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -139.58 -170.36 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 122.241 1.02 . . . . 0.0 111.412 179.648 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 11' ' ' ASN . 39.2 m -45.38 97.26 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.484 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 9' ' ' ILE . 2.5 m-20 43.14 47.26 5.26 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.294 -0.879 . . . . 0.0 110.511 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -152.4 155.67 26.26 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.459 ' N ' ' O ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -104.58 -166.42 1.24 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.347 -1.09 . . . . 0.0 110.659 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.583 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 14.6 p80 -151.74 121.79 7.14 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.104 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -119.32 123.11 43.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.202 -0.936 . . . . 0.0 110.33 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.71 -5.44 6.42 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.422 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 0.5 OUTLIER 55.49 55.99 6.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -1.149 . . . . 0.0 110.075 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.54 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 2.6 pp20? -178.59 -162.67 0.06 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.3 -0.875 . . . . 0.0 110.223 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.414 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 1.1 t0 -136.4 -42.62 0.62 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.358 -0.839 . . . . 0.0 109.844 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.431 ' CD1' ' C ' ' A' ' 20' ' ' PHE . 21.2 p90 -111.53 140.65 45.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.332 -0.855 . . . . 0.0 109.844 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.629 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.5 OUTLIER -122.65 -12.06 8.16 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.28 -0.888 . . . . 0.0 110.432 -179.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.488 ' N ' ' HB3' ' A' ' 3' ' ' CYS . 82.8 m 52.61 -99.15 0.08 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.458 -0.776 . . . . 0.0 111.173 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -151.63 157.45 42.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.19 -0.943 . . . . 0.0 109.995 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.59 16.0 80.31 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.629 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 30.4 m -99.34 173.99 6.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.434 -1.039 . . . . 0.0 110.316 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.521 HG11 ' N ' ' A' ' 27' ' ' VAL . 28.2 t -151.66 154.75 7.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.318 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.582 HG13 ' CD1' ' A' ' 29' ' ' TYR . 17.4 t -136.52 114.32 14.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 119.349 -0.941 . . . . 0.0 111.459 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.46 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -69.29 104.09 2.14 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 118.397 -1.321 . . . . 0.0 107.77 178.12 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.619 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 2.1 m-30 -68.09 144.87 54.88 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.431 -0.793 . . . . 0.0 110.287 -178.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -100.08 153.16 19.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.389 -0.819 . . . . 0.0 109.591 179.214 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.446 ' SG ' HD13 ' A' ' 37' ' ' LEU . 57.1 m -125.0 160.46 28.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.149 -0.969 . . . . 0.0 110.515 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -49.55 157.61 0.52 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.445 -0.785 . . . . 0.0 110.102 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.29 99.71 0.74 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.221 -0.924 . . . . 0.0 110.261 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.25 10.44 5.6 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 -107.99 166.35 10.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -1.15 . . . . 0.0 110.295 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.564 ' CB ' HG23 ' A' ' 59' ' ' VAL . 4.8 p -108.27 133.57 52.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.433 -0.792 . . . . 0.0 110.649 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' A' ' 55' ' ' THR . 0.6 OUTLIER -95.1 109.82 21.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -0.955 . . . . 0.0 109.697 179.178 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.573 HG22 ' CB ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -105.19 140.09 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.252 -0.905 . . . . 0.0 108.962 179.556 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.95 -156.81 24.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.488 ' O ' ' C ' ' A' ' 41' ' ' SER . 4.7 m-20 -99.5 51.19 0.93 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -1.153 . . . . 0.0 109.848 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.488 ' C ' ' O ' ' A' ' 40' ' ' ASN . 59.2 p 27.22 57.41 0.08 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.803 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 27' ' ' VAL . . . 144.06 114.88 0.99 Allowed Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.158 -1.496 . . . . 0.0 110.73 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.619 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -55.06 -177.65 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.081 -1.247 . . . . 0.0 107.636 178.426 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.487 ' HA ' ' O ' ' A' ' 25' ' ' SER . 5.0 tp -145.87 93.02 2.28 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.313 -0.867 . . . . 0.0 110.106 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.6 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.8 OUTLIER -74.19 118.9 17.67 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.173 -0.955 . . . . 0.0 109.455 179.379 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.2 t -129.73 76.12 1.7 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.114 -0.991 . . . . 0.0 110.804 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.74 53.43 0.71 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 58.13 26.17 58.15 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -145.75 119.12 8.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -1.181 . . . . 0.0 109.917 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.612 ' CE2' ' SG ' ' A' ' 3' ' ' CYS . 91.7 m95 -81.68 133.36 35.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.881 . . . . 0.0 110.358 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.31 165.28 26.14 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.196 -0.94 . . . . 0.0 110.72 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.542 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 1.1 t0 55.1 64.54 5.67 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.559 -0.713 . . . . 0.0 111.0 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.542 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.5 Cg_endo -91.8 136.14 1.71 Allowed 'Trans proline' 0 C--N 1.3 -2.007 0 O-C-N 124.347 1.709 . . . . 0.0 109.491 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.552 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 43.4 Cg_endo -75.09 175.26 11.48 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 O-C-N 123.58 1.305 . . . . 0.0 110.397 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.49 ' OG1' ' CG1' ' A' ' 38' ' ' ILE . 6.3 p -121.98 145.39 48.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.32 -0.863 . . . . 0.0 111.656 -178.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 77.4 m -105.93 83.01 1.85 Allowed 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.467 ' OE1' HG13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -110.46 -145.54 0.4 Allowed 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.735 -0.603 . . . . 0.0 110.193 -178.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.479 ' CD1' ' N ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -137.05 100.15 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.158 -0.963 . . . . 0.0 108.909 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.638 ' HB ' ' HA ' ' A' ' 105' ' ' PRO . 31.8 m -102.09 64.28 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.255 -0.903 . . . . 0.0 112.213 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 2.0 mptp? -66.97 176.51 2.05 Favored 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 117.541 -1.663 . . . . 0.0 107.306 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.53 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 1.1 m -130.63 166.59 26.02 Favored Pre-proline 0 N--CA 1.494 1.73 0 C-N-CA 117.996 -1.482 . . . . 0.0 113.904 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.588 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 44.5 Cg_endo -88.88 -76.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 125.01 2.058 . . . . 0.0 110.735 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.588 ' CD2' ' O ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER 169.9 124.12 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.263 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.616 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 48.1 Cg_endo -76.09 71.1 5.8 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 123.58 1.305 . . . . 0.0 109.661 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.451 ' C ' ' CG2' ' A' ' 66' ' ' ILE . 1.1 p -89.39 -174.62 4.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.394 -0.816 . . . . 0.0 109.826 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.537 ' CD1' ' HG2' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -179.95 167.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.181 179.248 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.492 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 31.8 t -72.31 95.45 1.72 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.566 -0.709 . . . . 0.0 110.827 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 80.0 m-20 46.58 43.62 12.61 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.358 -0.839 . . . . 0.0 110.894 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.519 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -151.61 32.81 0.91 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.577 ' O ' ' N ' ' A' ' 88' ' ' LYS . 1.9 p90 -44.9 -174.99 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 122.697 1.237 . . . . 0.0 112.522 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.538 ' C ' ' CD2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -108.0 168.16 9.48 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.442 179.4 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.8 14.91 0.84 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.943 -1.098 . . . . 0.0 110.009 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.467 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -95.21 -55.46 3.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.312 -0.867 . . . . 0.0 110.557 -179.708 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.425 ' O ' HG13 ' A' ' 85' ' ' VAL . . . -153.09 88.8 0.13 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.615 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -109.44 162.79 14.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.288 -1.125 . . . . 0.0 109.717 179.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.615 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -159.51 155.53 26.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.134 -0.979 . . . . 0.0 110.458 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.0 mtp180 -56.62 -40.08 74.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.224 -0.922 . . . . 0.0 110.027 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.2 t -136.89 127.36 26.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.425 -0.797 . . . . 0.0 110.11 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.585 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 14.5 m-85 -102.35 -146.96 0.37 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.138 -0.977 . . . . 0.0 110.217 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 60.0 p -160.03 -119.85 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.371 -0.83 . . . . 0.0 109.773 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.582 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.2 OUTLIER -109.13 35.39 3.28 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.829 -1.169 . . . . 0.0 110.536 -179.784 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.542 ' N ' ' ND2' ' A' ' 82' ' ' ASN . 0.1 OUTLIER -169.76 -109.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.159 -0.963 . . . . 0.0 110.296 179.425 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.449 ' OD2' ' ND2' ' A' ' 82' ' ' ASN . 8.1 m-20 42.99 75.47 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.96 -1.088 . . . . 0.0 109.761 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.533 ' N ' HG21 ' A' ' 102' ' ' THR . 9.4 p30 -69.53 120.37 15.21 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.259 -0.9 . . . . 0.0 110.206 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.578 HG22 ' CE1' ' A' ' 87' ' ' PHE . 33.8 m -108.14 118.35 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.86 -1.15 . . . . 0.0 111.029 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.538 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 9.0 t0 -76.91 134.49 38.94 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.583 ' CZ ' HD11 ' A' ' 113' ' ' LEU . 48.8 m-85 -93.87 127.4 39.61 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.009 -1.057 . . . . 0.0 112.42 -177.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.577 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -102.69 110.08 21.9 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.091 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.453 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -56.64 132.5 51.99 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.004 -1.06 . . . . 0.0 109.855 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 89' ' ' CYS . 0.3 OUTLIER -39.93 -69.95 0.12 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.483 -0.761 . . . . 0.0 110.33 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.537 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.3 OUTLIER -171.77 136.86 0.96 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.324 -0.86 . . . . 0.0 110.277 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.584 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 50.6 58.77 8.65 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.116 -1.593 . . . . 0.0 109.116 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 9.9 m-85 -160.66 152.48 19.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.432 -1.04 . . . . 0.0 110.162 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -105.74 142.55 35.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -0.846 . . . . 0.0 109.596 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.52 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 0.7 OUTLIER -84.05 93.66 8.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.08 -1.013 . . . . 0.0 110.423 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.464 ' HB3' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -70.4 102.45 2.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.267 -0.895 . . . . 0.0 109.671 179.554 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.52 -93.1 0.19 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.564 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.2 OUTLIER -152.47 118.74 5.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.158 -1.201 . . . . 0.0 110.491 -179.523 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.16 5.07 1.8 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.285 -0.884 . . . . 0.0 111.641 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.512 ' OG ' ' HA ' ' A' ' 86' ' ' ASP . 0.6 OUTLIER -161.87 119.77 2.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.702 -1.249 . . . . 0.0 109.896 179.409 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.469 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 3.1 m -129.63 168.2 16.81 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.408 -0.808 . . . . 0.0 110.482 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.533 HG21 ' N ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -130.71 140.67 50.36 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.298 179.764 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.559 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -72.56 84.98 1.15 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.761 -0.587 . . . . 0.0 110.564 -179.53 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.452 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -62.7 174.22 0.86 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.285 -0.885 . . . . 0.0 111.197 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.638 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 40.8 Cg_endo -72.68 125.45 10.57 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 O-C-N 124.551 1.816 . . . . 0.0 110.626 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.574 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 129.77 -11.54 5.97 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.574 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 0.6 OUTLIER 82.5 90.25 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 122.014 -0.698 . . . . 0.0 110.366 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.437 ' OG1' ' C ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -179.86 -166.35 0.08 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.492 -0.755 . . . . 0.0 110.407 179.777 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.616 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 38.8 m95 -141.66 92.7 2.48 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.46 -0.775 . . . . 0.0 110.379 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.47 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 6.2 mttt -104.5 139.86 20.52 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.57 -0.706 . . . . 0.0 109.69 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.564 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 46.3 Cg_endo -71.63 166.59 78.21 Favored 'Cis proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.033 -2.069 . . . . 0.0 111.207 -0.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 111' ' ' PRO . 2.9 tt0 -38.31 133.94 0.91 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.684 -0.635 . . . . 0.0 110.976 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.593 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.9 OUTLIER -45.67 148.24 1.35 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.902 . . . . 0.0 109.684 179.412 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.537 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 42.2 Cg_endo -74.35 170.92 19.13 Favored 'Trans proline' 0 C--N 1.299 -2.067 0 O-C-N 124.253 1.659 . . . . 0.0 110.851 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.459 ' O ' HG23 ' A' ' 117' ' ' VAL . 35.7 tttt -128.93 111.44 13.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.161 -0.962 . . . . 0.0 110.449 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.544 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 3.8 t -67.29 81.79 0.14 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.797 0.808 . . . . 0.0 109.83 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.464 HG23 ' HB3' ' A' ' 96' ' ' SER . 1.4 m -97.4 -169.29 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.904 0.859 . . . . 0.0 110.717 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.458 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.293 -1.876 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.505 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.496 HG22 ' N ' ' A' ' 48' ' ' GLY . 3.4 m . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.285 0.564 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.8 mttm -94.4 169.86 9.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.218 -0.926 . . . . 0.0 110.549 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.617 ' CB ' ' N ' ' A' ' 22' ' ' THR . 0.7 OUTLIER -129.14 146.68 51.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.302 -0.874 . . . . 0.0 110.401 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 19' ' ' ASP . 0.5 OUTLIER -128.92 177.42 7.12 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.506 -0.746 . . . . 0.0 109.578 179.496 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.02 136.45 14.2 Favored Pre-proline 0 C--N 1.298 -1.656 0 O-C-N 121.26 -0.9 . . . . 0.0 109.706 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.612 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 48.5 Cg_endo -69.37 163.51 37.67 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.052 1.554 . . . . 0.0 111.08 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.95 170.25 20.21 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.896 1.472 . . . . 0.0 109.618 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.482 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -87.17 105.47 17.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.106 -0.996 . . . . 0.0 109.973 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.536 HG12 ' CD2' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -47.34 -179.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-O 121.861 0.839 . . . . 0.0 111.059 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 11' ' ' ASN . 0.4 OUTLIER -103.55 69.28 0.98 Allowed 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.975 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.529 ' CB ' ' O ' ' A' ' 10' ' ' SER . 3.1 p30 164.4 -24.23 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.595 -0.69 . . . . 0.0 109.786 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.462 ' CA ' HD13 ' A' ' 9' ' ' ILE . . . -145.91 -160.61 8.76 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -126.77 -175.7 3.48 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.476 -1.014 . . . . 0.0 109.358 179.89 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.612 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 10.2 p80 -137.23 160.89 37.72 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.308 -0.87 . . . . 0.0 110.768 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.449 ' OD1' HG12 ' A' ' 27' ' ' VAL . 26.7 p-10 -38.54 146.81 0.06 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.541 -0.724 . . . . 0.0 110.985 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -137.83 18.34 3.38 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.76 -26.46 9.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.296 -1.12 . . . . 0.0 110.258 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -81.64 -147.53 0.07 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.939 . . . . 0.0 109.827 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 20' ' ' PHE . 3.7 p30 178.53 -34.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.597 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.508 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 9.5 m-85 -124.58 133.78 53.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -0.929 . . . . 0.0 109.9 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.648 ' CD2' ' HB3' ' A' ' 25' ' ' SER . 2.8 m-85 -127.82 -9.87 5.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.068 -1.02 . . . . 0.0 111.132 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.617 ' N ' ' CB ' ' A' ' 3' ' ' CYS . 69.6 p 37.82 -98.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.507 -0.745 . . . . 0.0 111.424 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.486 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 23.0 t0 -150.65 138.88 20.27 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.991 -1.068 . . . . 0.0 110.488 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.43 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 91.09 22.7 31.84 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.648 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 50.8 m -118.27 163.82 16.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.306 -1.114 . . . . 0.0 110.073 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.554 ' CG1' ' HA3' ' A' ' 42' ' ' GLY . 19.6 t -139.58 149.85 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.029 -1.044 . . . . 0.0 112.289 -178.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.563 HG13 ' CD1' ' A' ' 29' ' ' TYR . 18.1 t -122.26 114.13 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-O 121.356 0.598 . . . . 0.0 112.007 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.522 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -71.51 105.63 3.68 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.437 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.662 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 2.8 m-30 -67.82 136.1 53.61 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.729 -178.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 13' ' ' ARG . 6.3 m -73.46 -173.64 1.46 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.99 -1.069 . . . . 0.0 109.301 179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.451 ' SG ' ' HB3' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -154.74 137.12 14.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.974 -1.079 . . . . 0.0 110.803 -179.642 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -44.84 159.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.342 -0.849 . . . . 0.0 109.775 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.99 97.63 0.69 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.215 -0.928 . . . . 0.0 110.401 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 129.22 -20.85 5.26 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.511 ' CD2' ' O ' ' A' ' 56' ' ' CYS . 2.5 m-30 -92.33 139.31 30.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.197 -1.178 . . . . 0.0 110.627 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.588 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -91.03 144.4 25.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.294 -0.879 . . . . 0.0 110.73 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.542 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 2.4 tp -91.36 113.75 26.09 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.415 -0.803 . . . . 0.0 109.798 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.564 ' CD1' ' N ' ' A' ' 38' ' ' ILE . 0.3 OUTLIER -107.21 149.89 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.223 -0.923 . . . . 0.0 109.748 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 129.32 -153.39 19.86 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.507 ' O ' ' C ' ' A' ' 41' ' ' SER . 1.2 t30 -92.4 50.72 1.65 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.079 -1.248 . . . . 0.0 109.765 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.507 ' C ' ' O ' ' A' ' 40' ' ' ASN . 13.7 p 26.44 43.03 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.708 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.554 ' HA3' ' CG1' ' A' ' 26' ' ' VAL . . . 152.7 123.21 0.97 Allowed Glycine 0 N--CA 1.49 2.27 0 C-N-CA 119.229 -1.463 . . . . 0.0 110.694 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.662 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 1.6 t -58.15 -178.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.459 HD13 HG21 ' A' ' 26' ' ' VAL . 10.8 tp -147.81 97.99 2.89 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.722 -1.191 . . . . 0.0 110.684 178.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.481 ' HB2' ' CD2' ' A' ' 50' ' ' TRP . 14.6 t -78.39 115.54 18.18 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.41 179.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.437 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 4.7 m -124.48 81.82 1.98 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.551 -0.718 . . . . 0.0 110.272 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.486 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 93.64 56.85 1.39 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.496 ' N ' HG22 ' A' ' 1' ' ' VAL . . . 51.67 23.15 9.55 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -126.04 82.04 2.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.284 -1.127 . . . . 0.0 110.681 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.528 ' HH2' ' CD2' ' A' ' 21' ' ' TYR . 67.0 m95 -54.33 128.52 31.84 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.15 -0.969 . . . . 0.0 109.148 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.407 ' O ' ' CB ' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -148.07 157.06 43.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.935 -1.103 . . . . 0.0 111.474 -179.328 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.502 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 4.8 t0 66.66 65.79 0.73 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.796 -0.565 . . . . 0.0 111.348 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.502 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.9 Cg_endo -91.45 141.49 2.75 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 O-C-N 124.37 1.721 . . . . 0.0 109.986 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.541 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 51.8 Cg_endo -80.11 -179.31 5.15 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 O-C-N 123.891 1.469 . . . . 0.0 110.308 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.535 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 8.6 p -117.91 -172.28 2.22 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.971 0.891 . . . . 0.0 111.104 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.516 ' CB ' ' HB2' ' A' ' 11' ' ' ASN . 0.8 OUTLIER -147.8 79.62 1.48 Allowed 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.778 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -113.42 -152.27 0.5 Allowed 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.004 -178.605 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.76 128.53 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.608 HG22 ' HB3' ' A' ' 81' ' ' TYR . 26.0 m -120.39 48.17 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.896 -1.127 . . . . 0.0 112.346 -178.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -60.94 164.07 5.25 Favored 'General case' 0 C--N 1.278 -2.519 0 C-N-CA 117.581 -1.648 . . . . 0.0 107.558 178.788 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.52 ' SG ' ' HB2' ' A' ' 79' ' ' TYR . 35.5 m -131.98 161.33 63.31 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 120.603 -1.311 . . . . 0.0 111.749 -178.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 43.5 Cg_endo -75.79 -84.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.832 0 O-C-N 124.565 1.824 . . . . 0.0 110.251 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -179.84 128.43 0.24 Allowed Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 121.552 -0.717 . . . . 0.0 109.167 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.622 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 54.2 Cg_endo -77.97 67.14 8.13 Favored 'Trans proline' 0 C--N 1.298 -2.081 0 O-C-N 123.773 1.407 . . . . 0.0 109.744 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.421 ' C ' HG23 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -87.11 175.27 8.17 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.383 -0.823 . . . . 0.0 110.199 -179.691 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.568 HG22 ' CD1' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -170.21 165.49 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 110.211 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.449 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 17.5 m -74.6 106.14 6.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.451 -0.781 . . . . 0.0 110.724 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 5.1 m120 41.54 41.13 1.53 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.344 -0.848 . . . . 0.0 110.718 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.539 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -150.61 32.52 1.0 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.55 ' O ' ' N ' ' A' ' 88' ' ' LYS . 5.5 p90 -44.13 -173.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 122.826 1.298 . . . . 0.0 112.657 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.587 HD22 ' CD2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -111.04 162.23 15.08 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.392 179.42 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.06 20.03 1.42 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.961 -1.087 . . . . 0.0 110.103 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.3 t -103.03 -67.82 0.86 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.254 -0.904 . . . . 0.0 110.693 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -137.85 82.9 0.26 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.631 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 2.5 t80 -110.3 163.86 13.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.358 -1.083 . . . . 0.0 110.238 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.631 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 19.7 tttm -164.17 153.3 13.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.883 . . . . 0.0 110.007 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -51.72 -28.33 14.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 0.0 109.822 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.5 m -144.54 158.18 43.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.417 -0.802 . . . . 0.0 110.436 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.569 ' OH ' ' CE2' ' A' ' 75' ' ' PHE . 10.9 m-85 -131.27 -149.55 0.39 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.401 -0.812 . . . . 0.0 109.572 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.518 ' CA ' HG21 ' A' ' 59' ' ' VAL . 94.8 p -157.46 -108.84 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.73 -1.231 . . . . 0.0 110.984 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.608 ' HB3' HG22 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -108.16 23.36 14.6 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.286 -1.509 . . . . 0.0 110.467 -179.525 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.536 ' HA ' HG23 ' A' ' 102' ' ' THR . 47.6 t30 -171.31 -97.01 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.152 -0.968 . . . . 0.0 110.424 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 82' ' ' ASN . 5.0 m-20 42.05 72.48 0.17 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 109.546 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 101' ' ' SER . 0.4 OUTLIER -68.62 137.5 54.28 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.345 -179.065 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.579 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 16.0 m -117.79 120.19 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.143 -0.973 . . . . 0.0 110.552 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.436 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -78.07 128.12 33.35 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.57 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.613 ' CD2' ' CD ' ' A' ' 114' ' ' PRO . 32.6 m-85 -89.17 125.14 34.93 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.031 -1.043 . . . . 0.0 112.087 -178.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -100.11 93.05 5.52 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.922 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.452 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -44.3 133.81 5.29 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.014 -1.054 . . . . 0.0 109.923 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -39.5 -72.47 0.06 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.515 -0.741 . . . . 0.0 110.345 -179.672 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.454 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 5.5 t80 -175.92 144.68 0.62 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.299 -0.876 . . . . 0.0 110.018 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.548 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 52.55 31.91 37.69 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.548 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 13.9 m-85 -141.67 146.96 36.75 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.514 -0.992 . . . . 0.0 110.097 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 117' ' ' VAL . 19.0 mttt -104.0 155.6 18.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.355 -0.84 . . . . 0.0 109.27 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.542 ' CD2' ' HB3' ' A' ' 87' ' ' PHE . 0.8 OUTLIER -91.93 100.86 13.45 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.736 -1.227 . . . . 0.0 110.5 -179.587 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.45 ' HB3' HG23 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -78.62 100.78 7.14 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.442 -0.786 . . . . 0.0 109.559 179.486 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.2 -81.02 0.22 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.561 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -167.16 114.8 0.8 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.228 -1.16 . . . . 0.0 110.774 -179.32 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -61.49 -48.5 80.79 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.203 -0.935 . . . . 0.0 110.74 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.2 p -101.24 130.63 47.39 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.191 -0.943 . . . . 0.0 109.87 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 11.6 m -140.89 158.71 43.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.156 -0.965 . . . . 0.0 110.743 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.536 HG23 ' HA ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -134.88 140.31 45.69 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.515 -0.741 . . . . 0.0 109.652 179.625 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.609 ' O ' ' CB ' ' A' ' 104' ' ' SER . 0.7 OUTLIER -59.08 -59.18 5.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.241 -0.912 . . . . 0.0 111.057 -178.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.609 ' CB ' ' O ' ' A' ' 103' ' ' CYS . 0.2 OUTLIER 82.92 161.93 0.12 Allowed Pre-proline 0 C--N 1.292 -1.934 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -178.76 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.58 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 38.3 Cg_endo -67.1 120.28 7.35 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.767 1.404 . . . . 0.0 111.2 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 130.99 -9.09 5.72 Favored Glycine 0 N--CA 1.481 1.665 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.627 ' O ' ' CG2' ' A' ' 108' ' ' THR . 0.1 OUTLIER 77.66 105.34 0.07 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.592 -0.946 . . . . 0.0 111.103 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.627 ' CG2' ' O ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER 171.67 -148.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.426 -0.796 . . . . 0.0 110.711 179.345 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.622 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 22.3 m95 -163.32 66.31 0.18 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.345 -0.847 . . . . 0.0 109.617 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.468 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.2 OUTLIER -83.81 140.27 40.6 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.508 -0.745 . . . . 0.0 110.238 -179.625 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.561 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 44.8 Cg_endo -72.48 165.44 83.13 Favored 'Cis proline' 0 C--N 1.313 -1.336 0 C-N-CA 121.901 -2.125 . . . . 0.0 110.682 -0.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.5 pm0 -37.5 140.75 0.2 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.675 -0.641 . . . . 0.0 110.888 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.556 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 1.2 mm? -50.68 146.3 9.92 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.361 -0.837 . . . . 0.0 109.696 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.613 ' CD ' ' CD2' ' A' ' 87' ' ' PHE . 37.6 Cg_endo -71.02 168.51 22.98 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 124.181 1.621 . . . . 0.0 111.268 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.463 ' O ' HG23 ' A' ' 117' ' ' VAL . 5.0 ttpt -128.12 111.97 14.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.342 -0.849 . . . . 0.0 110.355 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.54 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.1 t -68.0 100.14 0.94 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 109.33 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -113.78 -178.58 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.483 0.659 . . . . 0.0 110.367 -179.487 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.52 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 6.5 ptt180 . . . . . 0 C--N 1.295 -1.784 0 C-N-CA 118.871 -1.131 . . . . 0.0 110.51 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.6 m . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.327 0.584 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.426 ' C ' ' HA2' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -112.97 166.61 11.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.324 -0.86 . . . . 0.0 109.971 179.828 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.464 ' O ' ' O ' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -96.68 83.23 3.42 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.054 -1.029 . . . . 0.0 109.784 179.81 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 19' ' ' ASP . 0.6 OUTLIER -47.53 173.12 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.89 -1.131 . . . . 0.0 109.601 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.473 ' N ' ' O ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -42.84 135.59 2.78 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.256 -0.902 . . . . 0.0 109.974 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.625 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 51.6 Cg_endo -70.75 151.35 63.34 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.855 1.45 . . . . 0.0 110.754 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.61 170.46 20.18 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 123.938 1.494 . . . . 0.0 110.469 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.71 174.64 4.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.339 -0.851 . . . . 0.0 109.961 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.577 HG12 ' CD2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -144.84 -170.0 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 122.198 0.999 . . . . 0.0 111.401 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' A' ' 56' ' ' CYS . 7.1 m -40.32 99.34 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.998 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 32' ' ' ASN . 1.6 m-80 40.91 28.13 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.374 -0.828 . . . . 0.0 110.565 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -132.13 157.23 22.37 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.465 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -112.35 -165.85 1.03 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.47 -1.018 . . . . 0.0 110.586 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.625 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 10.3 p80 -148.76 122.84 9.47 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.105 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -113.53 -167.0 1.14 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.172 -0.955 . . . . 0.0 110.446 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 145.49 -15.31 1.83 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 61.13 59.13 2.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.424 -1.045 . . . . 0.0 110.408 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.539 ' OE1' ' CD2' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -174.17 -174.63 0.92 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.176 -0.953 . . . . 0.0 110.449 179.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.488 ' O ' ' HA ' ' A' ' 4' ' ' GLN . 7.8 t70 -131.73 -41.57 1.05 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.405 -0.809 . . . . 0.0 109.71 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 m-30 -106.43 143.55 34.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.446 -0.784 . . . . 0.0 110.04 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.639 ' CD1' ' CB ' ' A' ' 25' ' ' SER . 0.4 OUTLIER -127.17 -8.22 5.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.262 -0.899 . . . . 0.0 110.691 -179.743 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.512 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 30.2 p 50.89 -93.39 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.721 -0.612 . . . . 0.0 112.37 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 33.6 t0 -158.34 143.31 16.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.02 -1.05 . . . . 0.0 110.404 -178.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.539 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 87.3 20.68 51.63 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.639 ' CB ' ' CD1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -115.7 166.6 11.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.371 -1.076 . . . . 0.0 110.489 -179.723 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.527 HG11 ' N ' ' A' ' 27' ' ' VAL . 20.8 t -142.19 156.55 19.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.433 -0.792 . . . . 0.0 110.649 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.576 HG13 ' CD1' ' A' ' 29' ' ' TYR . 10.8 t -130.71 111.6 20.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.224 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.472 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -66.67 103.61 1.12 Allowed 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 118.56 -1.256 . . . . 0.0 108.327 178.607 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.631 ' CE1' HG23 ' A' ' 43' ' ' VAL . 1.7 m-30 -68.73 121.79 17.21 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.595 -0.691 . . . . 0.0 110.384 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -69.87 158.85 34.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -0.985 . . . . 0.0 109.415 179.23 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.9 154.2 46.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.951 -1.093 . . . . 0.0 110.704 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 11' ' ' ASN . 3.8 t-20 -64.45 152.75 40.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.402 -0.811 . . . . 0.0 110.01 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.71 120.69 15.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.2 -0.937 . . . . 0.0 110.278 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.16 -5.67 30.36 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.588 ' CD2' ' O ' ' A' ' 56' ' ' CYS . 0.8 OUTLIER -116.06 146.91 41.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.189 -1.183 . . . . 0.0 110.518 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.557 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -89.05 142.01 28.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.395 -0.816 . . . . 0.0 111.205 -179.693 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' A' ' 55' ' ' THR . 0.7 OUTLIER -94.54 104.55 16.5 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.46 -0.775 . . . . 0.0 109.079 178.802 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.578 ' HB ' ' OG1' ' A' ' 55' ' ' THR . 0.8 OUTLIER -94.96 141.89 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.305 -0.872 . . . . 0.0 109.677 -179.361 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.48 -160.29 23.05 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.519 ' O ' ' C ' ' A' ' 41' ' ' SER . 0.7 OUTLIER -99.54 50.4 0.93 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.1 -1.235 . . . . 0.0 109.974 179.824 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.519 ' C ' ' O ' ' A' ' 40' ' ' ASN . 0.3 OUTLIER 22.06 63.52 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.864 179.585 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 28' ' ' THR . . . 146.34 120.75 1.29 Allowed Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.416 -1.373 . . . . 0.0 110.184 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.631 HG23 ' CE1' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -68.43 179.65 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.452 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 25.3 tp -136.24 104.69 5.73 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.602 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.509 ' HB2' ' CH2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -75.32 103.83 5.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.394 -0.816 . . . . 0.0 109.236 179.379 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.48 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 12.2 t -132.59 103.62 6.24 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.31 -0.869 . . . . 0.0 110.304 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.88 41.36 5.97 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.426 ' HA2' ' C ' ' A' ' 2' ' ' LYS . . . 60.33 18.1 48.76 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.12 153.94 49.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -1.128 . . . . 0.0 110.147 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.509 ' CH2' ' HB2' ' A' ' 45' ' ' CYS . 83.0 m95 -105.46 130.82 53.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.749 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 11.8 t -136.87 156.16 48.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.972 . . . . 0.0 111.173 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.535 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.1 OUTLIER 65.2 64.96 0.98 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.819 -0.551 . . . . 0.0 111.436 179.477 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.535 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.0 Cg_endo -91.93 137.86 1.91 Allowed 'Trans proline' 0 C--N 1.3 -2.02 0 O-C-N 124.39 1.732 . . . . 0.0 109.695 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.573 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 47.8 Cg_endo -81.75 164.19 18.33 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.728 1.383 . . . . 0.0 110.453 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.578 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 33.9 p -107.37 -174.97 2.66 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.226 -0.921 . . . . 0.0 111.185 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.588 ' O ' ' CD2' ' A' ' 35' ' ' TYR . 1.0 OUTLIER -140.71 76.14 1.54 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.336 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.525 ' HG3' ' CG1' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -115.82 174.05 6.23 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.129 -178.729 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.28 124.26 42.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.278 -0.889 . . . . 0.0 108.683 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.636 ' HB ' ' HA ' ' A' ' 105' ' ' PRO . 29.5 m -112.37 48.43 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.098 -1.001 . . . . 0.0 111.752 -178.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 11.4 mttm -55.48 170.49 0.24 Allowed 'General case' 0 C--N 1.28 -2.448 0 C-N-CA 117.624 -1.63 . . . . 0.0 108.043 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.535 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -131.53 168.36 17.79 Favored Pre-proline 0 N--CA 1.491 1.602 0 C-N-CA 118.532 -1.267 . . . . 0.0 112.999 -178.1 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.502 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 47.2 Cg_endo -89.98 -73.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 124.896 1.998 . . . . 0.0 110.421 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.502 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 164.24 126.12 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.285 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.622 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 55.5 Cg_endo -80.53 60.63 7.93 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 123.544 1.286 . . . . 0.0 110.211 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.542 ' N ' HD22 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -76.17 170.64 15.93 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.535 -0.728 . . . . 0.0 109.478 179.444 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.557 ' CD1' ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -168.05 164.88 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.015 -1.053 . . . . 0.0 110.525 -179.6 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.424 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 2.5 t -70.22 98.81 1.41 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.514 -0.741 . . . . 0.0 110.675 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 51.0 m-80 43.19 48.98 5.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.368 -0.832 . . . . 0.0 110.841 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.552 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -160.18 38.74 0.45 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.553 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 53.1 p90 -49.23 -151.89 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 122.886 1.327 . . . . 0.0 113.134 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.609 HD21 ' CZ ' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -144.72 122.04 11.59 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.765 -176.445 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.9 t -98.88 14.0 30.5 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.342 -0.848 . . . . 0.0 110.127 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.511 ' OG ' ' N ' ' A' ' 86' ' ' ASP . 1.3 p -74.82 -101.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.312 -0.867 . . . . 0.0 110.712 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -120.28 74.92 0.32 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.587 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 1.9 t80 -91.53 161.5 14.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.495 -1.003 . . . . 0.0 110.396 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.587 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 23.8 tttt -162.35 156.15 21.02 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.451 -0.78 . . . . 0.0 109.862 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -47.14 -32.65 4.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -0.883 . . . . 0.0 110.146 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.524 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 3.3 t -144.04 167.82 21.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.385 -0.822 . . . . 0.0 110.366 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.628 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 9.3 m-85 -138.02 -149.87 0.32 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.292 -0.88 . . . . 0.0 109.844 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.524 ' C ' ' CG2' ' A' ' 59' ' ' VAL . 2.7 p -156.33 -100.41 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.597 -1.315 . . . . 0.0 111.877 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.586 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -123.04 14.2 9.82 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.733 -1.229 . . . . 0.0 110.311 -178.466 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.513 ' HA ' HG23 ' A' ' 102' ' ' THR . 8.0 p30 -155.74 -108.3 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.02 -1.05 . . . . 0.0 110.398 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.449 ' C ' HG21 ' A' ' 102' ' ' THR . 5.3 t0 46.22 71.99 0.26 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.817 -1.177 . . . . 0.0 109.539 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.523 ' N ' HG21 ' A' ' 102' ' ' THR . 14.0 p-10 -68.65 106.47 2.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.314 -0.866 . . . . 0.0 109.491 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.562 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 35.8 m -92.03 121.48 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.11 -0.993 . . . . 0.0 111.523 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.529 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.6 OUTLIER -82.66 135.36 35.05 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.25 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.609 ' CZ ' HD21 ' A' ' 71' ' ' LEU . 38.3 m-85 -90.94 144.39 25.73 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.805 -1.184 . . . . 0.0 112.252 -177.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -116.1 91.95 3.75 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.669 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.469 ' HB2' HD13 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -44.76 132.52 6.49 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.068 -1.02 . . . . 0.0 110.054 -179.741 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -40.82 -74.17 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.41 -0.806 . . . . 0.0 110.639 -179.683 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.576 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 31.5 t80 -169.62 144.11 2.86 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.225 -0.922 . . . . 0.0 110.674 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.578 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 46.38 41.11 11.63 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.586 ' CE1' ' HB3' ' A' ' 118' ' ' ARG . 12.2 m-85 -145.93 147.5 31.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.517 -0.99 . . . . 0.0 109.947 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 117' ' ' VAL . 6.7 ttpt -102.57 152.48 21.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.196 -0.94 . . . . 0.0 109.959 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.529 HD22 ' CD1' ' A' ' 66' ' ' ILE . 0.6 OUTLIER -92.99 89.44 6.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.056 -1.027 . . . . 0.0 110.446 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.531 ' HB2' ' CG2' ' A' ' 117' ' ' VAL . 18.6 t -70.55 108.1 4.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.9 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 138.69 -65.34 0.54 Allowed Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.844 -1.17 . . . . 0.0 110.236 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.549 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.1 OUTLIER 174.84 114.43 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.277 -1.131 . . . . 0.0 110.705 -179.383 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.417 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 0.9 OUTLIER -80.86 20.92 0.72 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.106 -0.996 . . . . 0.0 111.258 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 100' ' ' SER . 16.4 p -161.28 103.84 1.26 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.957 -1.09 . . . . 0.0 109.905 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.498 ' O ' ' N ' ' A' ' 85' ' ' VAL . 70.2 m -123.13 171.13 9.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.933 . . . . 0.0 110.611 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.523 HG21 ' N ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -136.78 145.39 44.5 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.223 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.501 ' SG ' ' HB2' ' A' ' 79' ' ' TYR . 7.0 t -74.96 88.76 2.37 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.466 -0.772 . . . . 0.0 109.912 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.453 ' OG ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -66.03 174.5 1.62 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.258 -0.901 . . . . 0.0 111.327 -179.44 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.636 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 41.7 Cg_endo -74.16 126.94 10.86 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.401 1.738 . . . . 0.0 110.73 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 120.48 -6.64 11.57 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.553 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 0.5 OUTLIER 82.13 96.06 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 O-C-N 122.107 -0.643 . . . . 0.0 110.699 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -178.51 -162.34 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.356 -0.84 . . . . 0.0 111.175 179.516 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.622 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 31.1 m95 -150.34 87.51 1.46 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.59 -0.694 . . . . 0.0 110.11 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.457 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 58.4 mttt -98.85 140.27 21.64 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.475 -0.765 . . . . 0.0 110.098 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.549 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 47.7 Cg_endo -72.7 174.55 48.53 Favored 'Cis proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.992 -2.087 . . . . 0.0 110.686 -0.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 112' ' ' GLU . 0.0 OUTLIER -43.82 135.27 4.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.402 -0.811 . . . . 0.0 110.988 -179.558 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.542 HD22 ' N ' ' A' ' 65' ' ' THR . 0.1 OUTLIER -45.76 146.8 1.78 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.445 -0.785 . . . . 0.0 110.287 179.426 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.557 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 42.7 Cg_endo -76.53 169.57 21.6 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 O-C-N 124.341 1.706 . . . . 0.0 111.182 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 96' ' ' SER . 2.6 ttpt -130.16 109.71 11.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.24 -0.912 . . . . 0.0 110.208 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.527 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.0 t -63.9 80.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -0.913 . . . . 0.0 109.341 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 94' ' ' LYS . 0.3 OUTLIER -88.54 -176.82 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.749 0.785 . . . . 0.0 110.645 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.586 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--N 1.295 -1.792 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.504 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.302 0.572 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.81 176.84 5.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.934 . . . . 0.0 110.313 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.541 ' HB3' ' N ' ' A' ' 22' ' ' THR . 2.8 t -136.63 95.55 3.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.344 -0.848 . . . . 0.0 110.828 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 5' ' ' SER . 0.0 OUTLIER -74.33 176.45 6.7 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 118.766 -1.174 . . . . 0.0 108.972 178.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -46.76 145.46 3.08 Favored Pre-proline 0 C--N 1.293 -1.861 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.278 179.794 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.62 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 48.8 Cg_endo -71.01 153.91 63.0 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.835 1.44 . . . . 0.0 110.78 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -74.84 171.61 17.93 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 O-C-N 123.911 1.48 . . . . 0.0 109.787 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.64 177.09 3.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.14 -0.975 . . . . 0.0 109.758 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.558 HG22 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -142.54 -170.57 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 122.178 0.989 . . . . 0.0 111.642 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 14.2 t -40.85 93.28 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.698 -179.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 9' ' ' ILE . 3.5 m-80 42.17 44.16 3.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 110.25 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -140.82 178.05 20.39 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.522 ' CB ' ' HB3' ' A' ' 30' ' ' SER . 0.0 OUTLIER -125.0 -168.27 1.8 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.178 -1.189 . . . . 0.0 110.578 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.62 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 13.9 p80 -156.46 123.94 5.43 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.958 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -147.5 128.11 14.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.166 -0.959 . . . . 0.0 110.53 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.49 -115.73 2.14 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -166.84 37.27 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -1.131 . . . . 0.0 110.052 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.572 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 1.4 pp20? -150.04 -155.61 0.64 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 0.0 110.09 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -140.7 -42.44 0.4 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.367 -0.833 . . . . 0.0 110.068 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.402 ' C ' ' OE1' ' A' ' 18' ' ' GLU . 17.6 m-85 -119.52 100.98 7.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 109.526 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.623 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.8 OUTLIER -77.53 -11.04 59.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.44 -0.787 . . . . 0.0 111.395 -179.226 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.541 ' N ' ' HB3' ' A' ' 3' ' ' CYS . 56.4 p 46.71 -95.78 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.209 -0.932 . . . . 0.0 111.636 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.445 ' N ' ' OG1' ' A' ' 22' ' ' THR . 1.3 t70 -152.77 146.92 25.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.842 -1.161 . . . . 0.0 110.948 -178.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 82.45 23.88 55.38 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.623 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.9 OUTLIER -116.9 169.84 9.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.395 -1.061 . . . . 0.0 110.207 -179.799 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.539 ' CG1' ' O ' ' A' ' 43' ' ' VAL . 23.7 t -139.26 156.15 26.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 119.29 -0.964 . . . . 0.0 111.033 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.572 HG13 ' CD1' ' A' ' 29' ' ' TYR . 24.0 t -133.25 124.25 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 119.846 -0.741 . . . . 0.0 111.066 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.519 ' CG2' ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -73.86 100.9 3.61 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 118.347 -1.341 . . . . 0.0 108.432 178.412 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.649 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 2.1 m-30 -68.56 127.93 34.8 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.144 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.522 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 12.5 t -80.12 -170.43 2.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.026 -1.046 . . . . 0.0 109.687 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.457 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 67.4 m -150.83 160.94 43.54 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.147 -0.971 . . . . 0.0 110.161 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.508 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 14.8 t-20 -48.43 171.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.0 110.059 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.68 107.45 5.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 110.181 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.79 11.46 40.4 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.508 ' CG ' ' HB3' ' A' ' 32' ' ' ASN . 2.9 m-30 -106.84 128.33 54.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -1.136 . . . . 0.0 110.238 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.619 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.5 OUTLIER -74.23 138.99 44.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.306 -0.871 . . . . 0.0 110.808 -179.885 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.53 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 2.8 tp -91.24 104.51 17.05 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.445 -0.784 . . . . 0.0 109.421 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.552 HG22 ' CG ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -97.48 154.04 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.279 -0.888 . . . . 0.0 109.37 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.478 ' O ' ' CB ' ' A' ' 40' ' ' ASN . . . 94.56 39.54 4.68 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.7 OUTLIER 68.52 174.5 0.28 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.353 -1.087 . . . . 0.0 110.116 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.519 ' O ' ' CG2' ' A' ' 28' ' ' THR . 0.3 OUTLIER -119.79 71.5 0.89 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 110.318 -179.859 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 27' ' ' VAL . . . 163.36 119.35 0.48 Allowed Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.75 -1.215 . . . . 0.0 110.173 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.649 ' CG2' ' CE1' ' A' ' 29' ' ' TYR . 2.0 t -76.31 -175.23 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.147 -1.208 . . . . 0.0 108.506 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.426 ' HA ' ' O ' ' A' ' 25' ' ' SER . 0.9 OUTLIER -144.05 102.28 3.86 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.215 178.902 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.54 ' HB2' ' CD2' ' A' ' 50' ' ' TRP . 13.5 t -83.96 124.61 31.2 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.362 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.428 ' C ' ' OD2' ' A' ' 23' ' ' ASP . 84.5 p -132.22 80.22 1.9 Allowed 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.283 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.444 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 92.8 46.75 3.33 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.59 23.22 62.6 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 50' ' ' TRP . 3.3 mt-10 -126.4 68.78 1.22 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.206 -1.173 . . . . 0.0 110.374 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.569 ' CH2' HG22 ' A' ' 27' ' ' VAL . 72.7 m95 -43.58 135.63 3.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.485 -0.759 . . . . 0.0 109.632 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.2 t -146.73 169.87 18.16 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.962 -1.086 . . . . 0.0 111.069 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.538 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER 59.52 65.02 2.72 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.671 -0.643 . . . . 0.0 110.981 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.538 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.0 Cg_endo -91.22 127.95 1.18 Allowed 'Trans proline' 0 C--N 1.301 -1.928 0 O-C-N 124.393 1.733 . . . . 0.0 110.305 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.523 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 51.4 Cg_endo -77.09 173.18 14.84 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 O-C-N 123.897 1.472 . . . . 0.0 110.096 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.539 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 21.0 p -107.09 164.6 12.01 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.92 . . . . 0.0 111.272 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 10' ' ' SER . 97.3 m -128.37 76.11 1.68 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 177.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -111.82 -158.93 0.66 Allowed 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.28 0.562 . . . . 0.0 110.162 -178.831 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.413 HD12 HG22 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -111.21 147.13 15.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.619 ' CG1' ' CB ' ' A' ' 36' ' ' SER . 33.7 m -132.49 49.25 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 O-C-N 121.044 -1.035 . . . . 0.0 111.267 -178.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 5.3 mttm -64.19 -169.5 0.03 OUTLIER 'General case' 0 C--N 1.281 -2.404 0 C-N-CA 118.225 -1.39 . . . . 0.0 107.9 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -144.52 170.75 7.69 Favored Pre-proline 0 C--N 1.293 -1.848 0 C-N-CA 118.347 -1.341 . . . . 0.0 113.22 -178.824 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.557 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 45.1 Cg_endo -92.47 -70.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.421 2.081 . . . . 0.0 109.139 178.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.557 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 159.34 129.44 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 122.04 -0.413 . . . . 0.0 110.068 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.576 ' HG3' ' CZ2' ' A' ' 109' ' ' TRP . 55.3 Cg_endo -85.18 94.31 0.66 Allowed 'Trans proline' 0 C--N 1.299 -2.044 0 O-C-N 123.802 1.422 . . . . 0.0 109.346 178.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.574 ' C ' ' CG2' ' A' ' 66' ' ' ILE . 3.5 p -111.57 -43.15 3.7 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 122.342 1.068 . . . . 0.0 110.452 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.668 ' CG2' ' CE1' ' A' ' 87' ' ' PHE . 0.1 OUTLIER 53.27 170.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.017 -178.71 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.506 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -68.37 101.66 1.26 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.472 -0.767 . . . . 0.0 111.331 -179.088 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.435 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 60.7 m-20 42.36 51.95 4.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.507 -0.746 . . . . 0.0 111.684 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.594 ' O ' ' CD1' ' A' ' 70' ' ' TYR . . . -133.05 -38.49 0.23 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.607 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 2.0 p90 38.2 -171.58 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 122.965 1.364 . . . . 0.0 112.645 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.597 HD13 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -139.17 159.76 41.39 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.724 -178.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.59 27.73 3.04 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.755 -1.215 . . . . 0.0 110.152 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.74 -78.65 0.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.193 -0.942 . . . . 0.0 111.111 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -135.4 82.15 0.29 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.624 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -108.93 170.65 7.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.5 -1.0 . . . . 0.0 109.934 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.624 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 10.5 ttmt -171.23 170.1 6.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.353 -0.842 . . . . 0.0 109.974 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.402 ' N ' ' CG ' ' A' ' 76' ' ' LYS . 29.3 mtm180 -60.67 -37.39 81.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.971 -1.081 . . . . 0.0 110.517 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.4 m -134.09 159.0 42.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.286 -0.883 . . . . 0.0 110.322 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.623 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 3.7 m-85 -133.72 -146.44 0.27 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.312 -0.868 . . . . 0.0 110.058 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.535 ' CA ' HG21 ' A' ' 59' ' ' VAL . 21.6 p -160.02 -128.52 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.907 -1.121 . . . . 0.0 110.94 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.609 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -93.8 14.24 19.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.375 -1.453 . . . . 0.0 110.603 -179.292 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.508 ' O ' ' N ' ' A' ' 103' ' ' CYS . 50.6 t30 -160.73 -104.05 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.743 -1.223 . . . . 0.0 110.706 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 82' ' ' ASN . 0.7 OUTLIER 45.68 79.48 0.05 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.877 -1.14 . . . . 0.0 108.801 -178.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.569 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 30.2 p-10 -69.36 150.29 47.48 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.415 -0.803 . . . . 0.0 110.853 -178.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.508 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 17.0 m -133.5 118.67 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.419 -0.8 . . . . 0.0 110.049 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.521 ' O ' ' HB2' ' A' ' 71' ' ' LEU . 8.8 t0 -82.55 127.46 33.36 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.206 -0.934 . . . . 0.0 108.613 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.668 ' CE1' ' CG2' ' A' ' 66' ' ' ILE . 53.5 m-85 -84.26 136.96 33.72 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.369 1.081 . . . . 0.0 113.339 -177.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.607 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -111.8 85.62 2.18 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.149 179.792 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.469 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -37.3 130.06 0.93 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.52 -0.737 . . . . 0.0 111.198 -179.029 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.8 OUTLIER -41.35 -88.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.489 -0.757 . . . . 0.0 110.697 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.557 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 3.8 t80 -152.68 144.93 23.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.227 -0.92 . . . . 0.0 110.543 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.549 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 46.87 53.85 9.89 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.574 ' CD1' ' HB3' ' A' ' 118' ' ' ARG . 9.3 m-85 -151.28 167.87 26.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.253 -1.145 . . . . 0.0 110.27 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 117' ' ' VAL . 1.9 ttpt -132.23 112.23 12.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.361 -0.837 . . . . 0.0 109.812 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.544 HD21 ' CD1' ' A' ' 66' ' ' ILE . 6.2 mt -47.65 109.56 0.23 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.261 -0.899 . . . . 0.0 110.348 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -90.61 99.32 12.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.392 -0.817 . . . . 0.0 109.88 179.614 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 141.09 -76.62 0.31 Allowed Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.119 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.59 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 1.2 m -163.4 117.35 1.59 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.372 -1.075 . . . . 0.0 110.594 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.8 p -76.63 6.27 6.18 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.276 -0.89 . . . . 0.0 110.967 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 59.8 p -147.42 113.11 5.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.114 -0.991 . . . . 0.0 109.761 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.454 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 13.1 m -128.25 168.9 14.83 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.242 -0.912 . . . . 0.0 110.776 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.5 OUTLIER -136.44 146.66 46.61 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.51 -0.744 . . . . 0.0 110.461 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 80' ' ' SER . 41.9 t -76.41 84.91 3.15 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.611 -0.681 . . . . 0.0 110.439 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.5 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -65.59 -179.12 0.32 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 110.279 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.552 ' CG ' HG22 ' A' ' 38' ' ' ILE . 46.1 Cg_endo -76.47 131.27 12.48 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 O-C-N 124.23 1.647 . . . . 0.0 110.878 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 121.91 -11.33 9.43 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.553 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 1.0 OUTLIER 82.8 92.9 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 O-C-N 122.015 -0.697 . . . . 0.0 110.956 179.668 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.47 HG22 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -179.1 -160.02 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.556 -0.715 . . . . 0.0 110.725 179.437 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.591 ' HB3' ' CD1' ' A' ' 113' ' ' LEU . 24.0 m95 -148.9 87.92 1.58 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.513 -0.742 . . . . 0.0 110.538 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.491 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -95.2 154.68 39.46 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.382 -0.824 . . . . 0.0 109.777 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.59 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 48.5 Cg_endo -71.65 -177.51 17.41 Favored 'Cis proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.163 -2.016 . . . . 0.0 110.514 -0.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.474 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.9 OUTLIER -37.54 111.74 0.17 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.802 -0.561 . . . . 0.0 110.236 -179.759 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.591 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 3.9 tp -37.61 141.86 0.45 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.66 -0.65 . . . . 0.0 110.446 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.527 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 40.6 Cg_endo -69.89 161.79 44.6 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 124.11 1.584 . . . . 0.0 110.47 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.527 ' O ' HG23 ' A' ' 117' ' ' VAL . 0.8 OUTLIER -125.1 100.21 6.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 110.497 179.704 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.547 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.9 t -56.19 91.84 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.019 -1.051 . . . . 0.0 109.272 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 115' ' ' LYS . 3.7 m -110.95 179.11 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.628 0.728 . . . . 0.0 110.941 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.574 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.688 0 C-N-CA 118.997 -1.081 . . . . 0.0 110.239 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.503 HG11 ' N ' ' A' ' 2' ' ' LYS . 69.2 t . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 121.231 0.539 . . . . 0.0 110.275 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.503 ' N ' HG11 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -119.87 179.69 4.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.901 . . . . 0.0 110.294 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.53 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.3 m -131.61 137.28 48.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.546 -0.721 . . . . 0.0 110.008 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.487 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 3.8 mt-30 -114.2 168.49 9.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.767 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -45.21 131.89 5.72 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.112 -0.992 . . . . 0.0 109.446 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.61 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 45.6 Cg_endo -66.99 153.16 78.8 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 124.011 1.532 . . . . 0.0 112.209 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.64 175.29 11.49 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 124.097 1.578 . . . . 0.0 110.304 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.44 173.63 5.7 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.276 -0.89 . . . . 0.0 110.254 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.432 HG22 ' CE2' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -143.46 -172.96 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-O 122.038 0.923 . . . . 0.0 111.085 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.3 OUTLIER -39.73 100.51 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.215 -179.214 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.415 ' C ' ' O ' ' A' ' 10' ' ' SER . 1.2 m120 39.21 45.59 1.14 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.434 -0.791 . . . . 0.0 111.09 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.438 ' HA3' ' CB ' ' A' ' 56' ' ' CYS . . . -158.21 161.45 31.62 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.8 OUTLIER -119.41 -175.22 2.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -1.146 . . . . 0.0 110.713 -179.613 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.61 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 7.5 p80 -126.91 163.3 23.95 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.196 0.522 . . . . 0.0 110.063 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.491 ' ND2' ' OG ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -170.5 -159.07 0.17 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.093 -1.004 . . . . 0.0 110.322 -179.819 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.44 -126.36 2.37 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.535 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 11.4 p90 -149.19 33.87 0.73 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -1.129 . . . . 0.0 110.068 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.479 ' HG3' ' CZ ' ' A' ' 21' ' ' TYR . 0.9 OUTLIER -147.1 -177.43 5.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.933 . . . . 0.0 109.912 179.854 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -124.03 -41.33 2.22 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.207 -0.933 . . . . 0.0 110.253 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.621 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 21.0 p90 -128.34 98.81 5.19 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.11 -0.994 . . . . 0.0 110.516 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.592 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 11.6 m-85 -61.95 -165.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.984 -1.073 . . . . 0.0 110.054 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.53 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 0.3 OUTLIER -151.42 -65.57 0.18 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.026 -1.046 . . . . 0.0 110.778 -179.731 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -167.15 147.33 5.47 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.444 -0.785 . . . . 0.0 109.658 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 65.61 14.58 60.53 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.592 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -94.54 172.41 8.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.387 -1.067 . . . . 0.0 109.938 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 24.4 t -148.75 154.71 9.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.224 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.533 ' HB ' HG22 ' A' ' 43' ' ' VAL . 24.4 t -134.04 113.81 18.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.596 -0.69 . . . . 0.0 110.922 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.48 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -69.39 104.08 2.18 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 118.052 -1.459 . . . . 0.0 107.597 178.187 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.634 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 1.3 m-30 -67.4 111.87 4.3 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.366 -178.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.491 ' OG ' ' ND2' ' A' ' 15' ' ' ASN . 0.7 OUTLIER -70.69 154.98 41.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.114 -0.991 . . . . 0.0 110.278 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.413 ' SG ' HD11 ' A' ' 37' ' ' LEU . 19.7 m -123.97 157.27 34.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.319 -0.863 . . . . 0.0 109.662 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.52 168.51 1.57 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.107 -0.996 . . . . 0.0 110.241 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.21 100.61 0.81 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.26 -0.9 . . . . 0.0 110.124 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.92 -6.99 11.0 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.564 ' CG ' HG21 ' A' ' 58' ' ' ILE . 27.7 m-85 -96.61 133.63 40.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -1.136 . . . . 0.0 110.2 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.58 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -89.25 144.34 26.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 0.0 110.797 -179.783 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.506 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 1.9 tp -92.09 98.15 11.37 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.376 -0.827 . . . . 0.0 109.237 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.581 ' CG2' ' CG ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -87.99 144.02 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.31 -0.869 . . . . 0.0 109.051 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.59 -174.6 22.87 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.475 ' ND2' ' OD1' ' A' ' 52' ' ' ASP . 2.4 m-80 -55.33 145.93 20.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.343 -1.092 . . . . 0.0 110.092 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.474 ' HA ' HD22 ' A' ' 37' ' ' LEU . 87.4 p -80.52 49.53 1.17 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.173 -0.954 . . . . 0.0 110.076 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.497 ' O ' ' O ' ' A' ' 43' ' ' VAL . . . 152.19 109.83 0.43 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.634 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -46.49 172.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.244 -1.151 . . . . 0.0 108.244 179.276 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.405 ' HA ' ' O ' ' A' ' 25' ' ' SER . 0.4 OUTLIER -138.26 97.08 3.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.046 -1.034 . . . . 0.0 110.183 179.01 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.603 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.2 OUTLIER -76.48 107.78 9.0 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.091 -1.005 . . . . 0.0 109.266 178.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.66 107.05 8.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.545 -0.722 . . . . 0.0 110.238 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.03 5.08 55.15 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.495 ' HA3' ' CG1' ' A' ' 1' ' ' VAL . . . 94.49 15.79 45.54 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -141.42 113.73 8.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.348 -1.09 . . . . 0.0 110.261 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.603 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 96.3 m95 -58.34 134.75 56.86 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.189 -0.944 . . . . 0.0 109.975 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.7 t -135.3 149.84 49.87 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.184 -0.948 . . . . 0.0 110.95 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.511 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 1.1 t70 62.81 65.47 1.41 Allowed Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.716 -0.615 . . . . 0.0 111.372 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.511 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.6 Cg_endo -91.58 124.44 0.82 Allowed 'Trans proline' 0 C--N 1.3 -2.021 0 O-C-N 124.337 1.704 . . . . 0.0 109.841 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.494 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.0 Cg_endo -71.67 175.14 9.99 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 O-C-N 123.88 1.463 . . . . 0.0 109.979 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.563 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 23.6 p -118.37 141.81 48.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.194 -0.941 . . . . 0.0 111.187 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 10' ' ' SER . 35.1 m -103.58 76.06 1.37 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.479 ' OE1' ' CB ' ' A' ' 55' ' ' THR . 0.0 OUTLIER -113.46 147.24 38.21 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.406 0.622 . . . . 0.0 110.214 -178.73 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.564 HG21 ' CG ' ' A' ' 35' ' ' TYR . 1.7 pt -70.74 112.55 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.435 -0.79 . . . . 0.0 109.161 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.605 ' CG1' ' HA ' ' A' ' 105' ' ' PRO . 18.8 m -99.54 53.01 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.309 -0.869 . . . . 0.0 111.751 -178.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 23.2 mtpp -71.62 -174.12 1.07 Allowed 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 118.065 -1.454 . . . . 0.0 107.2 177.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.511 ' SG ' ' HB2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -143.42 163.61 35.88 Favored Pre-proline 0 C--N 1.29 -2.018 0 C-N-CA 118.014 -1.474 . . . . 0.0 111.98 -178.499 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.528 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 41.3 Cg_endo -80.57 -68.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.866 0 O-C-N 124.787 1.941 . . . . 0.0 109.609 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.528 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 161.13 135.06 0.01 OUTLIER Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.613 ' HG3' ' CZ2' ' A' ' 109' ' ' TRP . 56.9 Cg_endo -82.95 66.76 7.9 Favored 'Trans proline' 0 C--N 1.289 -2.555 0 O-C-N 123.952 1.501 . . . . 0.0 109.47 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.582 ' C ' ' CG2' ' A' ' 66' ' ' ILE . 3.1 p -81.88 -41.92 20.29 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 122.43 1.109 . . . . 0.0 110.455 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.582 ' CG2' ' C ' ' A' ' 65' ' ' THR . 0.1 OUTLIER 54.54 162.15 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.53 -179.037 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.431 ' N ' HG13 ' A' ' 66' ' ' ILE . 12.8 t -65.95 101.1 0.63 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.573 -0.705 . . . . 0.0 111.78 -178.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 2.2 m-20 41.68 31.91 0.22 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.499 -0.751 . . . . 0.0 111.743 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.559 ' C ' ' CD1' ' A' ' 70' ' ' TYR . . . -124.11 -27.0 1.43 Allowed Glycine 0 N--CA 1.491 2.358 0 C-N-CA 118.732 -1.699 . . . . 0.0 109.938 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.559 ' CD1' ' C ' ' A' ' 69' ' ' GLY . 37.9 p90 33.4 -160.59 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 122.762 1.268 . . . . 0.0 112.016 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.618 ' HB3' ' CD1' ' A' ' 87' ' ' PHE . 0.7 OUTLIER -135.56 149.08 49.33 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 114.154 -1.384 . . . . 0.0 109.691 -176.889 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' A' ' 72' ' ' SER . 0.1 OUTLIER -116.03 24.38 11.49 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.866 -1.146 . . . . 0.0 109.883 -179.662 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.51 ' OG ' ' CB ' ' A' ' 86' ' ' ASP . 8.5 m -101.62 -99.87 0.27 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.065 -1.022 . . . . 0.0 111.836 -178.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -109.81 -73.96 0.77 Allowed Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.739 -1.22 . . . . 0.0 111.144 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.5 OUTLIER 60.62 174.54 0.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.409 -1.053 . . . . 0.0 109.609 -178.768 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.627 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 28.6 ttmt 179.65 159.07 0.71 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.302 -0.874 . . . . 0.0 109.641 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.511 ' N ' ' HG2' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -43.01 -31.17 0.49 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.292 -0.88 . . . . 0.0 110.635 -179.843 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.446 ' C ' ' CG ' ' A' ' 79' ' ' TYR . 2.8 p -154.43 169.93 22.58 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.132 -0.98 . . . . 0.0 111.161 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.656 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -150.62 -168.53 3.13 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.443 -0.786 . . . . 0.0 108.897 179.762 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 82' ' ' ASN . 0.1 OUTLIER -170.75 120.52 0.56 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.667 -1.27 . . . . 0.0 111.424 179.783 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.668 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 4.1 t80 38.37 22.85 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.995 -1.066 . . . . 0.0 112.074 178.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.524 ' N ' ' O ' ' A' ' 80' ' ' SER . 26.2 p30 -178.49 -134.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.025 -1.672 . . . . 0.0 110.882 178.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.515 ' CB ' ' HB3' ' A' ' 79' ' ' TYR . 0.4 OUTLIER 57.27 72.14 0.53 Allowed 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.006 -1.059 . . . . 0.0 108.519 -178.46 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.51 ' HB3' HG22 ' A' ' 102' ' ' THR . 6.8 p30 -68.44 143.23 55.11 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.453 -0.78 . . . . 0.0 110.331 -178.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.598 HG21 ' CZ3' ' A' ' 109' ' ' TRP . 3.6 m -134.47 121.36 36.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.228 -0.92 . . . . 0.0 110.221 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.548 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 1.1 t70 -69.95 141.96 52.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.09 -1.006 . . . . 0.0 108.479 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.618 ' CD1' ' HB3' ' A' ' 71' ' ' LEU . 7.1 m-85 -104.89 143.38 33.23 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.672 -1.267 . . . . 0.0 112.5 -178.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 69' ' ' GLY . 3.7 tptt -116.4 -173.34 2.35 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.163 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.49 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.5 OUTLIER -132.11 127.96 37.12 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.241 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.49 ' C ' ' O ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -33.57 -70.72 0.07 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.404 0.621 . . . . 0.0 110.733 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.518 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -177.25 145.42 0.45 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.371 -0.831 . . . . 0.0 109.927 179.708 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.442 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 51.86 43.13 54.46 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.573 ' CE1' ' HB3' ' A' ' 118' ' ' ARG . 11.6 m-85 -146.61 162.7 37.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.34 -1.094 . . . . 0.0 110.32 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.482 ' O ' HG21 ' A' ' 117' ' ' VAL . 23.1 tptt -127.5 113.26 15.92 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.391 -0.818 . . . . 0.0 109.877 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.542 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 2.1 mt -46.49 112.62 0.52 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.107 -0.995 . . . . 0.0 109.868 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.48 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 1.1 t -95.92 103.64 15.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 110.205 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.16 -98.29 0.24 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.594 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -141.63 135.51 30.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -1.133 . . . . 0.0 110.614 -179.502 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 100' ' ' SER . 37.3 p -78.69 -64.91 1.07 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 110.11 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.52 ' N ' ' OG ' ' A' ' 99' ' ' SER . 15.8 p -74.86 140.28 43.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.087 -1.008 . . . . 0.0 110.065 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.583 ' HB2' ' CE2' ' A' ' 87' ' ' PHE . 3.8 m -151.16 148.35 28.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -0.934 . . . . 0.0 110.659 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.51 HG22 ' HB3' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -125.48 145.25 50.17 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.564 -0.71 . . . . 0.0 109.769 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.583 ' O ' ' CA ' ' A' ' 81' ' ' TYR . 7.6 t -69.4 78.93 0.39 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.104 -0.998 . . . . 0.0 109.946 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.44 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.4 OUTLIER -47.3 171.15 0.08 OUTLIER Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.286 -0.884 . . . . 0.0 112.197 -179.397 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.605 ' HA ' ' CG1' ' A' ' 59' ' ' VAL . 47.9 Cg_endo -78.08 21.84 0.65 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 124.731 1.911 . . . . 0.0 112.569 -178.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -114.69 7.61 22.14 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.526 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 0.8 OUTLIER 76.91 61.83 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.835 -0.803 . . . . 0.0 109.572 -179.761 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 103' ' ' CYS . 0.0 OUTLIER -171.41 -170.62 0.84 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.277 -179.426 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.613 ' CZ2' ' HG3' ' A' ' 64' ' ' PRO . 19.4 m95 -118.22 86.45 2.53 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.631 -0.668 . . . . 0.0 110.133 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.477 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 2.7 mmmt -92.1 152.33 42.59 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.407 -0.808 . . . . 0.0 110.014 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.594 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 48.8 Cg_endo -72.23 -178.68 21.17 Favored 'Cis proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.071 -2.054 . . . . 0.0 111.025 -0.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 111' ' ' PRO . 3.4 mt-10 -37.11 118.5 0.61 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.334 0.588 . . . . 0.0 110.758 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.58 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 2.9 tp -47.39 141.65 6.55 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.365 -0.834 . . . . 0.0 110.562 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.542 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . 41.1 Cg_endo -71.37 159.91 50.24 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.119 1.589 . . . . 0.0 110.289 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 117' ' ' VAL . 13.9 tttt -124.3 108.5 12.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 0.0 110.545 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.545 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 5.2 t -58.47 84.38 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.29 -0.881 . . . . 0.0 108.85 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' A' ' 115' ' ' LYS . 4.0 m -103.45 -176.95 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.771 0.796 . . . . 0.0 111.113 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.573 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.765 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.309 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.401 ' O ' ' CG1' ' A' ' 1' ' ' VAL . 8.1 p . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -129.99 166.89 19.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.935 . . . . 0.0 110.149 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -111.85 91.8 3.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.173 -0.954 . . . . 0.0 110.735 -179.629 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.476 ' O ' ' C ' ' A' ' 5' ' ' SER . 39.0 mt-30 -91.64 -177.17 4.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -0.943 . . . . 0.0 109.426 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.476 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.5 OUTLIER -36.9 131.76 0.7 Allowed Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.799 -0.563 . . . . 0.0 110.134 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.612 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 48.5 Cg_endo -68.87 157.35 62.19 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.998 1.525 . . . . 0.0 111.084 -178.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -75.58 170.74 19.61 Favored 'Trans proline' 0 C--N 1.302 -1.921 0 O-C-N 123.926 1.487 . . . . 0.0 109.608 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.6 p -70.33 175.49 4.64 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.145 -0.972 . . . . 0.0 109.874 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.565 HG22 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -140.33 -169.53 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -0.91 . . . . 0.0 110.804 179.556 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.2 OUTLIER -39.76 92.14 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.606 -179.262 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' A' ' 9' ' ' ILE . 3.9 m-80 42.08 41.26 1.94 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.276 -0.89 . . . . 0.0 110.113 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.438 ' O ' HG13 ' A' ' 9' ' ' ILE . . . -140.73 145.96 17.0 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -92.63 -166.81 1.61 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.268 -1.137 . . . . 0.0 110.605 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.612 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 14.9 p80 -153.9 126.14 7.94 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.157 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -145.62 112.31 5.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 110.311 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.439 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -111.05 19.43 25.13 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.468 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 0.3 OUTLIER 67.07 35.76 4.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.389 -1.065 . . . . 0.0 110.222 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.558 ' OE1' ' CE1' ' A' ' 21' ' ' TYR . 5.9 pt-20 176.88 -175.22 0.12 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 110.436 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -128.43 -3.8 5.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.377 -0.827 . . . . 0.0 110.056 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.588 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 0.9 OUTLIER -109.55 150.8 27.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 110.257 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.598 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 1.9 m-85 -167.43 42.31 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.54 -0.725 . . . . 0.0 109.746 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.482 ' O ' ' O ' ' A' ' 23' ' ' ASP . 21.1 p -52.79 99.15 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 122.042 0.925 . . . . 0.0 111.729 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 22' ' ' THR . 26.7 t70 50.54 163.45 0.0 OUTLIER 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 121.742 0.782 . . . . 0.0 112.037 178.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 48.32 26.83 5.15 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.598 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 16.7 m -106.47 174.56 5.84 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.289 -1.124 . . . . 0.0 110.302 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 24.6 t -155.56 154.25 6.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.821 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.585 ' CG2' ' CH2' ' A' ' 50' ' ' TRP . 39.2 t -143.81 124.17 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.837 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -74.55 104.52 5.28 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 118.483 -1.287 . . . . 0.0 107.534 177.538 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.644 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 2.2 m-30 -68.36 127.1 31.72 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.287 -0.883 . . . . 0.0 110.395 -178.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -84.8 156.4 21.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.817 . . . . 0.0 110.08 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.437 ' O ' ' C ' ' A' ' 32' ' ' ASN . 75.6 m -124.86 154.35 41.17 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -0.885 . . . . 0.0 110.155 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.484 ' O ' ' N ' ' A' ' 34' ' ' GLY . 7.8 m-20 -41.92 143.37 0.56 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.322 -0.861 . . . . 0.0 110.202 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 95.8 p -52.56 88.63 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.91 . . . . 0.0 110.503 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 32' ' ' ASN . . . 127.69 10.95 3.42 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.2 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.441 ' CD2' ' O ' ' A' ' 56' ' ' CYS . 1.7 m-30 -106.64 153.8 21.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.08 -1.247 . . . . 0.0 110.442 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.604 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.6 OUTLIER -90.04 137.42 32.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.458 -0.776 . . . . 0.0 110.582 -179.473 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.491 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 0.9 OUTLIER -98.92 98.54 9.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.189 -0.945 . . . . 0.0 109.484 178.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.569 ' CD1' ' N ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -95.86 141.86 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.902 . . . . 0.0 109.397 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.99 -120.21 3.88 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -125.01 137.14 54.24 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.362 -1.081 . . . . 0.0 109.93 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.467 ' O ' HG22 ' A' ' 28' ' ' THR . 73.0 p -71.86 55.86 0.29 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.229 -0.919 . . . . 0.0 109.77 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.437 ' HA2' ' C ' ' A' ' 27' ' ' VAL . . . 154.74 117.6 0.61 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.644 ' CG2' ' CE1' ' A' ' 29' ' ' TYR . 2.1 t -67.73 179.65 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.188 -1.183 . . . . 0.0 108.177 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.72 104.04 4.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.955 -1.091 . . . . 0.0 110.638 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.599 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -81.93 111.05 17.76 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.161 -1.016 . . . . 0.0 109.262 178.675 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.58 103.2 7.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.584 -0.697 . . . . 0.0 110.488 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.61 36.21 8.08 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.47 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 64.89 31.38 80.75 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -147.78 105.42 3.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.176 -1.191 . . . . 0.0 110.549 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.599 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 77.6 m95 -58.5 140.06 54.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.155 -0.965 . . . . 0.0 109.514 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.2 m -143.51 170.64 15.43 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.952 -1.092 . . . . 0.0 111.059 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.517 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 20.0 t0 53.01 65.7 5.61 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.539 -0.726 . . . . 0.0 110.889 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.8 Cg_endo -91.23 139.15 2.4 Favored 'Trans proline' 0 C--N 1.3 -1.977 0 C-N-CA 121.9 1.733 . . . . 0.0 110.329 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.423 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 47.8 Cg_endo -83.52 -175.68 2.42 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.826 1.435 . . . . 0.0 110.052 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.522 ' N ' ' O ' ' A' ' 38' ' ' ILE . 7.4 p -124.63 143.65 50.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.38 -0.825 . . . . 0.0 111.569 -178.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 10' ' ' SER . 90.1 m -107.58 80.43 1.4 Allowed 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -110.63 -150.43 0.46 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.712 -0.618 . . . . 0.0 110.162 -178.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.423 ' CD1' ' N ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -127.82 120.01 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.256 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.604 ' CG1' ' CB ' ' A' ' 36' ' ' SER . 26.9 m -115.13 52.66 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.018 -1.051 . . . . 0.0 111.824 -178.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.513 ' N ' ' OD1' ' A' ' 107' ' ' ASN . 9.0 mtpt -71.45 129.73 39.53 Favored 'General case' 0 C--N 1.283 -2.312 0 C-N-CA 118.262 -1.375 . . . . 0.0 108.232 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.482 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 5.8 m -95.01 172.2 5.72 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.928 -1.107 . . . . 0.0 112.371 -178.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 43.6 Cg_endo -84.94 -66.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.721 1.906 . . . . 0.0 110.287 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.456 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 167.98 129.29 0.04 OUTLIER Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -179.232 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.616 ' N ' ' NE1' ' A' ' 109' ' ' TRP . 45.9 Cg_endo -74.0 65.23 5.11 Favored 'Trans proline' 0 C--N 1.296 -2.187 0 O-C-N 123.61 1.321 . . . . 0.0 109.868 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.538 ' O ' ' CD2' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -85.49 170.39 12.7 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.739 -0.601 . . . . 0.0 110.446 -179.576 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.6 HG23 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -169.31 164.09 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.126 -0.984 . . . . 0.0 110.277 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.554 ' O ' ' CB ' ' A' ' 68' ' ' ASN . 73.2 m -66.47 75.27 0.1 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.535 -0.728 . . . . 0.0 111.978 -178.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.554 ' CB ' ' O ' ' A' ' 67' ' ' SER . 1.5 t-20 76.31 -24.72 0.21 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.285 -0.885 . . . . 0.0 112.473 178.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.55 ' CA ' ' HA ' ' A' ' 89' ' ' CYS . . . -86.32 38.6 3.08 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.522 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 11.9 p90 -41.61 159.75 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 123.032 1.396 . . . . 0.0 112.839 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.614 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -43.11 -81.39 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 113.922 -1.49 . . . . 0.0 109.699 178.269 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.57 ' CB ' ' O ' ' A' ' 71' ' ' LEU . 0.3 OUTLIER 79.05 13.89 1.17 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.606 -0.684 . . . . 0.0 110.427 179.668 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.443 ' HB3' ' HB2' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -156.73 53.27 0.52 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.124 -0.985 . . . . 0.0 110.507 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.444 ' O ' HG13 ' A' ' 85' ' ' VAL . . . 122.38 113.09 2.17 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.61 ' CE2' ' OH ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -172.25 160.44 5.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -1.14 . . . . 0.0 110.18 -179.823 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.511 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -152.29 169.46 22.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.455 -0.778 . . . . 0.0 109.949 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -58.92 -32.94 70.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.096 -1.003 . . . . 0.0 109.784 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.51 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -142.18 167.66 21.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.465 -0.772 . . . . 0.0 110.328 179.867 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.623 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 3.2 m-85 -141.83 -151.29 0.35 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.237 -0.915 . . . . 0.0 110.121 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.555 ' C ' ' CG2' ' A' ' 59' ' ' VAL . 85.2 p -160.54 -99.24 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.041 -1.037 . . . . 0.0 111.239 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.62 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -120.66 23.52 10.74 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.487 -1.383 . . . . 0.0 110.931 -178.281 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.543 ' N ' ' O ' ' A' ' 103' ' ' CYS . 17.5 t-20 -165.02 -109.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.769 -1.207 . . . . 0.0 110.541 178.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 48.52 75.71 0.14 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.706 -1.246 . . . . 0.0 109.114 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 24.4 t30 -69.79 125.89 28.07 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.51 -0.744 . . . . 0.0 110.942 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.594 HG12 ' CH2' ' A' ' 109' ' ' TRP . 13.3 m -108.53 125.08 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.214 -0.929 . . . . 0.0 109.418 178.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -80.82 123.93 28.66 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.989 -1.07 . . . . 0.0 108.882 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.614 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 9.7 m-85 -87.96 124.07 33.34 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.459 1.123 . . . . 0.0 112.302 -178.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.491 ' HB2' ' OG ' ' A' ' 72' ' ' SER . 0.0 OUTLIER -106.88 96.72 6.64 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.594 -178.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.55 ' HA ' ' CA ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -46.65 137.46 6.87 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.002 -1.061 . . . . 0.0 109.719 179.494 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.439 ' HD3' ' ND2' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -64.42 57.08 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.255 -0.903 . . . . 0.0 111.351 -179.377 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.581 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER 58.68 137.65 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.353 -0.842 . . . . 0.0 112.689 178.465 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.624 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 57.0 55.47 30.13 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 178.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.624 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 34.3 m-85 -162.05 165.05 27.79 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.312 -1.11 . . . . 0.0 110.396 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.542 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 1.2 ttmm -123.2 104.03 8.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.296 -0.878 . . . . 0.0 109.629 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.527 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 4.6 mt -46.66 93.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.965 . . . . 0.0 110.451 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -71.7 84.91 0.9 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.337 -0.852 . . . . 0.0 109.671 179.514 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 157.86 -88.75 0.11 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.578 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.2 OUTLIER -160.92 128.36 4.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.153 -1.204 . . . . 0.0 110.716 -179.547 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 0.4 OUTLIER -69.38 -76.91 0.09 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.289 -0.882 . . . . 0.0 110.612 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 40.4 p -74.55 106.02 5.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.284 -0.885 . . . . 0.0 110.725 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.49 ' O ' ' N ' ' A' ' 85' ' ' VAL . 58.3 m -113.66 164.38 13.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.354 -0.841 . . . . 0.0 110.068 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -136.2 142.01 44.06 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.274 -0.891 . . . . 0.0 111.066 -179.721 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.621 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 0.5 OUTLIER -71.93 87.02 1.01 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.246 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.489 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -62.28 178.39 0.33 Allowed Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.202 -0.936 . . . . 0.0 112.619 -178.225 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.603 ' HA ' ' CG1' ' A' ' 59' ' ' VAL . 44.3 Cg_endo -79.02 42.84 1.36 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 124.813 1.954 . . . . 0.0 112.207 -178.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -140.64 16.76 2.86 Favored Glycine 0 C--N 1.292 -1.884 0 N-CA-C 108.2 -1.96 . . . . 0.0 108.2 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.513 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 22.3 m-80 62.98 57.0 1.72 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.666 -0.903 . . . . 0.0 109.725 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 103' ' ' CYS . 0.2 OUTLIER -160.37 -159.5 0.7 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.309 -0.869 . . . . 0.0 110.452 -179.585 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.621 ' CZ3' ' N ' ' A' ' 103' ' ' CYS . 37.0 m95 -136.6 91.28 2.64 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.372 -0.83 . . . . 0.0 110.442 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.512 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 15.2 mmtt -100.4 148.99 35.68 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.562 -0.711 . . . . 0.0 110.078 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.578 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 47.2 Cg_endo -71.01 174.36 45.2 Favored 'Cis proline' 0 C--N 1.312 -1.342 0 C-N-CA 121.999 -2.084 . . . . 0.0 111.014 -0.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -33.17 131.14 0.2 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.458 0.647 . . . . 0.0 111.838 -179.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.565 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.9 OUTLIER -53.38 137.59 50.18 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.56 -0.712 . . . . 0.0 109.812 179.298 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.58 ' CG ' ' CD2' ' A' ' 87' ' ' PHE . 40.4 Cg_endo -69.19 147.69 67.09 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 O-C-N 124.139 1.599 . . . . 0.0 111.066 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.552 ' O ' HG21 ' A' ' 117' ' ' VAL . 3.6 ttpp -115.9 92.47 3.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.43 -0.794 . . . . 0.0 110.301 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.587 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.1 t -47.67 105.97 0.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.919 . . . . 0.0 110.088 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.552 HG21 ' O ' ' A' ' 115' ' ' LYS . 0.7 OUTLIER -122.55 177.08 4.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.427 -0.796 . . . . 0.0 110.511 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 21.3 ptt85 . . . . . 0 C--N 1.297 -1.674 0 C-N-CA 118.805 -1.158 . . . . 0.0 110.384 179.64 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 51.6 t . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.293 0.568 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.4 ptpt -137.57 178.3 7.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 0.0 110.456 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.546 ' O ' ' N ' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -161.27 93.12 0.93 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.607 -0.683 . . . . 0.0 109.514 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 9.5 mt-30 -72.84 176.96 5.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.072 -1.017 . . . . 0.0 110.428 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.9 140.93 29.13 Favored Pre-proline 0 C--N 1.301 -1.532 0 O-C-N 121.569 -0.707 . . . . 0.0 109.95 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.624 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 53.4 Cg_endo -70.91 153.21 63.76 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 124.019 1.536 . . . . 0.0 110.861 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -74.98 170.63 19.99 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.959 1.505 . . . . 0.0 109.947 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 92.4 p -69.51 178.25 2.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.174 -0.954 . . . . 0.0 110.191 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.485 ' O ' ' N ' ' A' ' 11' ' ' ASN . 0.2 OUTLIER -142.39 -170.17 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 122.125 0.964 . . . . 0.0 111.273 179.81 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 54.7 m -38.22 93.61 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.068 -179.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER 43.92 30.47 0.4 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.243 -0.911 . . . . 0.0 110.502 179.689 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.64 162.31 25.15 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.134 -1.587 . . . . 0.0 109.134 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 30' ' ' SER . 5.2 ptt180 -118.45 -173.0 2.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.079 -1.248 . . . . 0.0 110.778 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.624 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 11.9 p80 -131.95 153.53 50.21 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.306 0.574 . . . . 0.0 110.66 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -170.63 -156.57 0.13 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.283 -0.885 . . . . 0.0 110.072 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.441 ' C ' ' CD2' ' A' ' 17' ' ' TYR . . . 124.27 24.98 1.71 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.441 ' CD2' ' C ' ' A' ' 16' ' ' GLY . 24.5 m-85 58.66 65.86 1.17 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.175 -1.191 . . . . 0.0 110.284 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 19' ' ' ASP . 1.6 pp20? -141.21 -174.37 4.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.91 . . . . 0.0 109.874 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.449 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 31.9 m-20 -158.3 -33.38 0.07 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.11 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.577 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 5.6 p90 -160.74 70.7 0.4 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.851 -1.156 . . . . 0.0 110.782 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.604 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 30.5 m-85 -46.95 175.4 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.469 -0.77 . . . . 0.0 110.318 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.517 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 21.2 m -132.64 -54.57 0.95 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.058 -1.026 . . . . 0.0 110.738 -179.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -171.95 148.12 2.25 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.394 -0.816 . . . . 0.0 109.44 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 65.88 11.83 55.5 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 -178.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.604 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 66.2 m -86.5 175.0 8.59 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.407 -1.055 . . . . 0.0 110.167 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 26.1 t -151.34 154.75 7.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.514 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.547 ' HB ' HG21 ' A' ' 43' ' ' VAL . 24.5 t -135.02 117.47 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.147 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.459 HG21 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -70.28 104.22 2.6 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.302 -1.359 . . . . 0.0 107.746 178.132 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.643 ' CE1' HG22 ' A' ' 43' ' ' VAL . 2.2 m-30 -68.25 133.18 48.4 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.325 -178.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -92.87 153.55 18.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.309 -0.869 . . . . 0.0 109.973 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 57.2 m -119.49 154.41 33.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 110.025 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.459 ' O ' ' HB2' ' A' ' 35' ' ' TYR . 1.6 t-20 -46.81 140.28 4.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.935 . . . . 0.0 110.141 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -45.2 108.68 0.13 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.141 -0.975 . . . . 0.0 110.45 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.81 9.84 27.72 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 2.7 m-30 -108.5 146.76 32.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.104 -1.233 . . . . 0.0 110.327 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.535 ' HB2' ' CG2' ' A' ' 59' ' ' VAL . 48.2 t -89.33 137.71 32.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.395 -0.816 . . . . 0.0 110.878 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.473 ' HA ' ' O ' ' A' ' 55' ' ' THR . 4.3 tp -94.12 110.04 21.78 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 177.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.555 ' CG2' ' CG ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -107.56 147.46 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.069 -1.019 . . . . 0.0 109.839 -179.225 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.9 -163.55 12.96 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -65.08 130.81 44.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.219 -1.165 . . . . 0.0 109.773 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.459 ' O ' HG21 ' A' ' 28' ' ' THR . 89.9 p -74.11 53.37 0.49 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.209 -0.932 . . . . 0.0 110.22 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 43' ' ' VAL . . . 150.62 105.59 0.32 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.643 HG22 ' CE1' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -48.09 177.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.222 -1.164 . . . . 0.0 108.601 179.377 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 25' ' ' SER . 2.5 tp -139.5 105.68 5.24 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.361 -0.837 . . . . 0.0 109.829 178.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.619 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 1.0 OUTLIER -86.05 106.87 17.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.093 -1.004 . . . . 0.0 109.969 179.58 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.7 m -124.38 104.0 8.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.492 -0.755 . . . . 0.0 109.856 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.77 53.97 3.82 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 48.49 46.94 29.5 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -156.83 99.14 1.83 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -1.153 . . . . 0.0 110.897 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.619 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 90.8 m95 -68.18 137.97 55.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.2 -0.938 . . . . 0.0 109.063 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.8 p -140.24 169.77 17.06 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.833 -1.167 . . . . 0.0 111.519 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.511 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.5 OUTLIER 51.8 65.86 5.88 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.734 -0.604 . . . . 0.0 111.457 179.627 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.511 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 46.7 Cg_endo -90.65 130.39 1.54 Allowed 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 121.874 1.716 . . . . 0.0 110.057 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.541 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 53.5 Cg_endo -77.76 176.37 10.1 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.811 1.427 . . . . 0.0 110.705 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.519 ' OG1' ' CG1' ' A' ' 38' ' ' ILE . 12.2 p -108.97 156.46 19.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.464 -0.772 . . . . 0.0 110.776 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 10' ' ' SER . 22.2 m -122.67 80.14 1.71 Allowed 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.507 ' O ' ' N ' ' A' ' 36' ' ' SER . 5.8 mm100 -109.98 -145.07 0.39 Allowed 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.428 0.632 . . . . 0.0 110.609 -178.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.469 ' CD1' ' N ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -137.32 114.16 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.598 HG22 ' N ' ' A' ' 81' ' ' TYR . 19.6 m -111.87 60.66 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.161 -0.962 . . . . 0.0 112.182 -178.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 8.5 mttt -69.73 159.35 33.69 Favored 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 117.852 -1.539 . . . . 0.0 107.245 178.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.492 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -118.95 168.82 9.03 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 120.391 -1.443 . . . . 0.0 114.304 -176.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -89.9 -81.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.739 2.293 . . . . 0.0 110.972 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 177.37 125.62 0.18 Allowed Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 121.711 -0.618 . . . . 0.0 109.521 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.597 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 49.0 Cg_endo -75.86 67.32 6.65 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 123.714 1.376 . . . . 0.0 109.673 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.416 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -81.7 175.32 10.56 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.57 -0.707 . . . . 0.0 110.471 -179.451 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.548 ' CD1' ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -172.46 163.48 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.295 -0.878 . . . . 0.0 110.341 179.665 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.46 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 96.4 p -72.86 100.13 2.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.522 -0.736 . . . . 0.0 110.645 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.469 ' O ' ' SG ' ' A' ' 116' ' ' CYS . 7.4 m-20 44.51 45.17 7.6 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.362 -0.837 . . . . 0.0 110.573 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.514 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -152.71 31.02 0.83 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.533 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 6.9 p90 -44.68 -176.08 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 122.663 1.22 . . . . 0.0 112.644 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.565 HD11 ' CE2' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -110.49 162.99 14.14 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.558 179.22 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.468 ' HB2' ' HD3' ' A' ' 88' ' ' LYS . 2.5 t -144.49 14.89 1.61 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.003 -1.061 . . . . 0.0 110.178 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.67 -69.79 0.74 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.216 -0.927 . . . . 0.0 110.909 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.418 ' O ' HG11 ' A' ' 85' ' ' VAL . . . -136.82 81.47 0.28 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.594 ' CE2' ' OH ' ' A' ' 79' ' ' TYR . 1.9 t80 -105.94 160.02 15.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.43 -1.041 . . . . 0.0 109.977 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.481 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 25.3 tttt -158.4 148.14 19.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.897 . . . . 0.0 110.446 -179.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' A' ' 76' ' ' LYS . 2.2 mtp85 -44.71 -34.58 2.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.177 -0.952 . . . . 0.0 109.702 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.438 ' O ' ' HD3' ' A' ' 76' ' ' LYS . 0.5 OUTLIER -143.63 153.48 42.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.406 -0.808 . . . . 0.0 109.917 179.725 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.594 ' OH ' ' CE2' ' A' ' 75' ' ' PHE . 8.3 m-85 -125.41 -148.12 0.38 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.161 -0.962 . . . . 0.0 110.462 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.52 ' C ' HG22 ' A' ' 59' ' ' VAL . 81.6 p -158.62 -124.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.3 -0.875 . . . . 0.0 110.3 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.631 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -99.93 29.9 3.98 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.037 -1.039 . . . . 0.0 111.068 -178.295 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.486 ' HA ' HG23 ' A' ' 102' ' ' THR . 48.7 t30 -173.93 -114.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.93 -1.107 . . . . 0.0 110.462 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 49.43 75.39 0.16 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.696 -1.252 . . . . 0.0 109.244 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.546 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 10.3 p30 -69.27 125.46 26.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.381 -0.824 . . . . 0.0 110.826 -179.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.58 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 26.4 m -107.2 118.03 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.166 -0.959 . . . . 0.0 110.235 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.547 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -78.77 137.7 37.86 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.738 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.604 ' CZ ' HD11 ' A' ' 113' ' ' LEU . 70.0 m-85 -95.58 137.83 34.1 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.872 -1.142 . . . . 0.0 112.52 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.468 ' HD3' ' HB2' ' A' ' 72' ' ' SER . 0.7 OUTLIER -111.1 93.84 4.69 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.744 -179.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.428 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -44.15 131.97 5.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.053 -1.029 . . . . 0.0 110.302 -179.663 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 11.6 mmtt -42.27 -78.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.295 -0.878 . . . . 0.0 110.258 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.573 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -162.3 136.78 6.73 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.321 -0.862 . . . . 0.0 110.492 -179.892 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.592 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 52.98 66.08 2.94 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.592 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 14.6 m-85 -162.49 172.43 15.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.42 -1.047 . . . . 0.0 110.096 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.52 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 4.4 mtmt -131.2 107.65 9.15 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.321 -0.862 . . . . 0.0 109.957 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.517 ' CD2' ' HB3' ' A' ' 87' ' ' PHE . 1.1 mt -49.54 93.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.099 -1.001 . . . . 0.0 110.425 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.473 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -77.44 109.33 11.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -0.937 . . . . 0.0 110.184 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 135.03 -85.13 0.26 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.544 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.2 OUTLIER -158.77 112.46 2.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.293 -1.122 . . . . 0.0 110.546 -179.61 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.4 t -72.82 -0.1 12.47 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.279 -0.888 . . . . 0.0 110.326 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.5 p -141.5 117.92 10.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.143 -0.973 . . . . 0.0 109.547 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.496 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 40.1 m -134.33 151.42 51.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.149 -0.969 . . . . 0.0 111.122 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -120.36 151.95 38.55 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.61 0.719 . . . . 0.0 110.049 179.608 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.594 ' SG ' ' CZ2' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -83.8 77.96 9.79 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.683 -0.635 . . . . 0.0 110.554 -179.348 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.458 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.5 OUTLIER -48.37 175.78 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.348 -0.845 . . . . 0.0 111.675 -179.641 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.572 ' HA ' ' CG1' ' A' ' 59' ' ' VAL . 47.3 Cg_endo -77.53 43.18 1.28 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.656 1.872 . . . . 0.0 111.968 -178.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -139.57 12.04 3.21 Favored Glycine 0 C--N 1.292 -1.903 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.529 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 2.0 m120 64.2 63.83 0.76 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.718 -0.872 . . . . 0.0 109.836 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.474 HG21 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -159.8 -160.52 0.82 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.319 -0.863 . . . . 0.0 111.035 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.597 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 26.4 m95 -137.43 82.0 1.9 Allowed 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.64 0.733 . . . . 0.0 110.293 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.505 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.8 OUTLIER -99.27 136.5 20.45 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.72 -0.612 . . . . 0.0 110.161 -179.819 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.544 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 42.7 Cg_endo -69.53 164.94 77.26 Favored 'Cis proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.084 -2.048 . . . . 0.0 111.001 -0.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -41.24 149.39 0.1 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.563 -0.711 . . . . 0.0 110.555 -179.303 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.604 HD11 ' CZ ' ' A' ' 87' ' ' PHE . 1.1 mm? -57.19 145.64 65.25 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.422 -0.798 . . . . 0.0 109.982 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.548 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 37.4 Cg_endo -69.0 169.47 17.87 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 O-C-N 124.31 1.689 . . . . 0.0 110.951 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.507 ' HG2' ' CG1' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -128.34 106.32 8.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 0.0 110.528 -179.549 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.545 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.4 t -63.31 87.13 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.184 -0.947 . . . . 0.0 108.912 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.52 ' CG2' ' O ' ' A' ' 94' ' ' LYS . 2.3 m -103.3 177.58 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.612 0.72 . . . . 0.0 111.007 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.58 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.709 0 C-N-CA 118.971 -1.092 . . . . 0.0 110.327 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.0 p . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.2 0.524 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.75 177.54 7.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.393 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.576 ' CB ' ' N ' ' A' ' 22' ' ' THR . 1.4 t -159.4 104.13 1.63 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.434 -0.791 . . . . 0.0 110.486 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.424 ' C ' ' O ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -81.25 176.58 9.63 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.73 -1.232 . . . . 0.0 109.325 179.023 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 19' ' ' ASP . 0.1 OUTLIER -54.57 146.68 33.37 Favored Pre-proline 0 C--N 1.294 -1.812 0 O-C-N 121.379 -0.825 . . . . 0.0 109.666 179.882 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.636 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 51.7 Cg_endo -70.11 154.2 66.56 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.93 1.489 . . . . 0.0 111.404 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -76.21 172.88 15.44 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.014 1.534 . . . . 0.0 110.281 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 m -69.7 179.47 2.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.161 -0.962 . . . . 0.0 110.007 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.57 HG22 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -145.24 -170.16 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 122.335 1.064 . . . . 0.0 111.905 -179.786 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.481 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 14.1 t -46.17 105.75 0.07 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.313 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 10' ' ' SER . 6.6 m120 40.96 26.43 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.352 -0.842 . . . . 0.0 110.763 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -141.38 169.86 24.92 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 30' ' ' SER . 2.5 ptt180 -133.91 -178.55 5.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -1.142 . . . . 0.0 110.332 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.636 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 7.0 p80 -120.22 156.23 31.58 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.545 -0.722 . . . . 0.0 110.095 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -173.84 50.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.141 -0.974 . . . . 0.0 110.587 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 17' ' ' TYR . . . -53.92 -78.76 0.1 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.467 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER 174.98 35.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.355 -1.085 . . . . 0.0 110.248 179.515 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.457 ' OE2' ' HB3' ' A' ' 17' ' ' TYR . 0.6 OUTLIER 176.81 -178.38 0.16 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 110.428 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 5' ' ' SER . 8.1 t70 -117.49 -43.62 2.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.428 -0.795 . . . . 0.0 109.955 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 3' ' ' CYS . 14.2 m-85 -84.31 130.3 34.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.334 -0.854 . . . . 0.0 109.859 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.596 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.5 OUTLIER -132.42 -6.02 3.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.344 -0.847 . . . . 0.0 110.889 -179.39 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.576 ' N ' ' CB ' ' A' ' 3' ' ' CYS . 66.7 p 45.91 -96.71 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.516 -0.74 . . . . 0.0 111.841 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -150.13 150.89 32.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.843 -1.161 . . . . 0.0 110.661 -178.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 79.42 15.49 79.81 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.596 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 20.5 m -97.25 172.77 7.59 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.459 -1.024 . . . . 0.0 110.281 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.556 HG11 ' N ' ' A' ' 27' ' ' VAL . 33.4 t -151.49 151.94 11.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.382 -0.824 . . . . 0.0 110.066 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.556 ' N ' HG11 ' A' ' 26' ' ' VAL . 34.6 t -134.66 119.89 30.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.223 -0.923 . . . . 0.0 111.583 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.464 HG21 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -72.3 103.6 3.45 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.399 -1.321 . . . . 0.0 107.489 177.736 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.594 ' CZ ' HG22 ' A' ' 43' ' ' VAL . 2.2 m-30 -67.55 121.4 15.77 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.338 -0.851 . . . . 0.0 110.074 -178.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -74.76 150.3 39.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.206 -0.934 . . . . 0.0 109.617 179.352 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.461 ' SG ' HD11 ' A' ' 37' ' ' LEU . 60.3 m -118.2 159.51 23.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.176 -0.952 . . . . 0.0 110.306 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 33' ' ' SER . 4.4 t-20 -53.72 134.89 41.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 110.236 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 32' ' ' ASN . 0.5 OUTLIER -44.39 102.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.245 -0.909 . . . . 0.0 110.305 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.73 -11.31 12.17 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -93.84 139.74 30.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.236 -1.155 . . . . 0.0 110.062 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.619 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -84.62 142.05 30.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.172 -0.955 . . . . 0.0 110.879 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.475 HD11 ' O ' ' A' ' 29' ' ' TYR . 3.2 tp -92.81 97.04 10.51 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.458 -0.776 . . . . 0.0 109.231 179.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.571 ' HB ' ' OG1' ' A' ' 55' ' ' THR . 0.2 OUTLIER -88.42 157.0 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.409 -0.807 . . . . 0.0 109.05 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 91.07 178.22 43.31 Favored Glycine 0 N--CA 1.488 2.11 0 C-N-CA 119.417 -1.373 . . . . 0.0 109.988 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.476 ' O ' ' HG3' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -54.71 124.65 17.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.311 -1.111 . . . . 0.0 109.85 179.729 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.464 ' O ' HG21 ' A' ' 28' ' ' THR . 0.1 OUTLIER -72.45 55.14 0.34 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.206 -0.934 . . . . 0.0 109.956 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.515 ' O ' ' O ' ' A' ' 43' ' ' VAL . . . 161.39 96.98 0.11 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.594 HG22 ' CZ ' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -45.3 173.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.365 -1.079 . . . . 0.0 108.345 179.336 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.455 ' HB3' ' OD2' ' A' ' 52' ' ' ASP . 7.3 tp -134.08 103.37 5.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.984 -1.073 . . . . 0.0 110.371 178.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.537 ' HB2' ' CE2' ' A' ' 50' ' ' TRP . 0.6 OUTLIER -77.23 115.28 16.88 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.367 -0.833 . . . . 0.0 109.45 179.168 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.86 101.74 5.37 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.113 -0.992 . . . . 0.0 110.171 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.96 41.15 19.18 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.41 30.76 78.75 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.79 102.09 4.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -1.142 . . . . 0.0 110.552 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.537 ' CE2' ' HB2' ' A' ' 45' ' ' CYS . 89.7 m95 -73.59 123.0 23.14 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.127 -0.983 . . . . 0.0 109.551 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.418 ' O ' ' CG ' ' A' ' 52' ' ' ASP . 22.4 m -129.22 -176.38 3.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.062 -1.024 . . . . 0.0 111.399 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.521 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 1.6 p30 37.56 65.64 2.56 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.851 -0.53 . . . . 0.0 111.191 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.1 Cg_endo -91.09 131.73 1.48 Allowed 'Trans proline' 0 C--N 1.301 -1.946 0 C-N-CA 121.95 1.767 . . . . 0.0 110.03 178.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.541 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 53.8 Cg_endo -76.27 172.67 15.82 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.596 1.314 . . . . 0.0 110.205 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.571 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 37.9 p -114.22 143.16 45.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.08 -1.013 . . . . 0.0 111.291 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 10' ' ' SER . 69.4 m -107.57 78.89 1.24 Allowed 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -113.84 -159.33 0.69 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.481 0.658 . . . . 0.0 110.56 -178.299 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.454 ' CG2' ' HD2' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -110.49 142.8 21.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.426 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.624 ' CG1' ' HA ' ' A' ' 105' ' ' PRO . 21.3 m -133.44 44.96 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.988 -1.07 . . . . 0.0 110.992 -178.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.478 ' N ' ' OD1' ' A' ' 107' ' ' ASN . 2.9 mttp -81.34 102.45 10.45 Favored 'General case' 0 C--N 1.281 -2.377 0 C-N-CA 118.858 -1.137 . . . . 0.0 109.343 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.51 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 53.2 m -72.94 164.0 64.11 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.372 -0.83 . . . . 0.0 111.298 -178.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 42.5 Cg_endo -69.54 -89.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 124.306 1.687 . . . . 0.0 110.666 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.463 ' HB3' ' CG2' ' A' ' 65' ' ' THR . 0.0 OUTLIER -159.68 133.36 4.97 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.776 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.601 ' HG3' ' CZ2' ' A' ' 109' ' ' TRP . 56.7 Cg_endo -77.93 65.86 8.24 Favored 'Trans proline' 0 C--N 1.296 -2.22 0 O-C-N 123.604 1.318 . . . . 0.0 109.671 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.543 ' N ' HD22 ' A' ' 113' ' ' LEU . 0.7 OUTLIER -87.27 -175.37 5.26 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.533 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.538 HG22 HD11 ' A' ' 66' ' ' ILE . 0.2 OUTLIER 179.7 169.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 C-N-CA 118.756 -1.178 . . . . 0.0 110.721 179.438 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.511 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 4.0 t -69.71 90.89 0.59 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.46 -0.775 . . . . 0.0 110.915 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 1.9 m-80 51.17 34.72 11.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.336 -0.852 . . . . 0.0 110.902 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.55 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -139.15 30.07 2.48 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.57 ' O ' ' N ' ' A' ' 88' ' ' LYS . 4.7 p90 -43.12 -174.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 122.707 1.241 . . . . 0.0 112.789 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.551 HD11 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -113.73 158.0 21.49 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.056 179.088 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.8 19.44 2.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.094 -1.004 . . . . 0.0 110.086 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.8 t -99.25 -85.14 0.4 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.918 . . . . 0.0 110.844 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -98.62 -86.24 1.86 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.59 ' CE2' ' OH ' ' A' ' 79' ' ' TYR . 17.5 t80 57.3 106.84 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.418 -1.048 . . . . 0.0 110.207 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.61 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -114.96 123.35 48.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.253 -0.905 . . . . 0.0 108.918 179.309 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.526 ' C ' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -28.79 -39.54 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.353 0.597 . . . . 0.0 111.204 -179.073 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -123.52 105.81 10.07 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.379 -0.825 . . . . 0.0 109.739 179.192 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.61 ' CE1' ' O ' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -91.73 175.23 6.97 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.128 -0.982 . . . . 0.0 109.849 -179.517 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.539 ' CA ' HG22 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -170.27 107.09 0.33 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.149 -0.97 . . . . 0.0 111.128 179.821 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.633 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 10.2 t80 46.77 18.44 0.07 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.091 -1.006 . . . . 0.0 111.809 178.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.543 ' N ' ' O ' ' A' ' 103' ' ' CYS . 28.5 p30 -172.49 -128.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.186 -1.571 . . . . 0.0 110.841 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.459 ' OD2' ' HA ' ' A' ' 79' ' ' TYR . 11.0 m-20 52.78 72.51 0.41 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.858 -1.151 . . . . 0.0 108.831 -178.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.487 ' HA ' ' O ' ' A' ' 101' ' ' SER . 15.5 p30 -68.5 138.41 55.18 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.473 -0.767 . . . . 0.0 110.169 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.591 HG21 ' CZ3' ' A' ' 109' ' ' TRP . 5.2 m -124.54 119.49 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.181 -0.949 . . . . 0.0 110.746 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.537 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 5.2 t0 -81.39 132.56 35.33 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.551 ' CE1' HD11 ' A' ' 71' ' ' LEU . 69.6 m-85 -92.01 120.94 33.12 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 122.326 1.06 . . . . 0.0 112.464 -177.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -92.7 90.68 7.17 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.763 179.594 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.464 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -44.07 131.02 6.02 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.157 -0.965 . . . . 0.0 109.774 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -37.65 -70.9 0.09 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.647 -0.658 . . . . 0.0 110.74 -179.434 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.574 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 49.1 t80 -175.11 145.65 0.81 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.276 -0.89 . . . . 0.0 110.366 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.58 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 46.18 42.21 12.27 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 12.1 m-85 -145.37 150.7 37.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.526 -0.985 . . . . 0.0 109.934 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.531 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 6.8 mtmp? -107.42 138.96 42.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.291 -0.881 . . . . 0.0 109.903 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.527 ' CD2' ' HB3' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -78.49 100.17 6.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.025 -1.047 . . . . 0.0 110.725 -179.545 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.463 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -78.49 105.91 10.08 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.423 -0.798 . . . . 0.0 109.436 179.273 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 138.62 -88.61 0.2 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.563 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -158.07 112.94 2.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.296 -1.12 . . . . 0.0 110.549 -179.614 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 82.8 p -65.0 -22.11 66.95 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.191 -0.943 . . . . 0.0 110.765 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.6 p -125.65 126.26 44.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.813 -1.179 . . . . 0.0 109.877 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 4.5 m -135.11 172.57 12.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 0.0 110.429 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.51 HG23 ' HA ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -148.03 140.46 24.42 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.506 -0.746 . . . . 0.0 110.456 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.574 ' O ' ' CA ' ' A' ' 81' ' ' TYR . 7.8 t -59.97 88.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.43 -0.794 . . . . 0.0 109.43 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.47 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.2 OUTLIER -61.53 173.23 0.82 Allowed Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.037 -1.039 . . . . 0.0 111.768 -178.844 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.624 ' HA ' ' CG1' ' A' ' 59' ' ' VAL . 50.5 Cg_endo -75.37 13.91 1.03 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 124.554 1.818 . . . . 0.0 111.937 -178.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -112.35 23.14 16.42 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 106' ' ' GLY . 39.5 m-80 60.47 48.53 7.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.808 -0.819 . . . . 0.0 110.636 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.459 ' HA ' ' HD2' ' A' ' 62' ' ' PRO . 0.6 OUTLIER -160.98 -179.39 7.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.03 -1.044 . . . . 0.0 111.387 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.601 ' CZ2' ' HG3' ' A' ' 64' ' ' PRO . 42.2 m95 -104.15 99.01 8.74 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.556 0.693 . . . . 0.0 110.845 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.467 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 8.8 mttt -110.19 141.01 22.96 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.503 -0.748 . . . . 0.0 109.59 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.563 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.4 Cg_endo -71.04 168.68 71.45 Favored 'Cis proline' 0 C--N 1.313 -1.312 0 C-N-CA 122.109 -2.038 . . . . 0.0 110.981 -0.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 111' ' ' PRO . 4.3 tt0 -38.97 130.79 1.46 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.502 -0.749 . . . . 0.0 111.106 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.543 HD22 ' N ' ' A' ' 65' ' ' THR . 0.2 OUTLIER -42.32 146.88 0.63 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.47 -0.769 . . . . 0.0 110.117 179.178 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.532 ' CG ' ' CG ' ' A' ' 87' ' ' PHE . 41.9 Cg_endo -74.14 173.51 14.0 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 O-C-N 124.382 1.727 . . . . 0.0 110.658 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.525 ' O ' HG23 ' A' ' 117' ' ' VAL . 24.6 ttmt -135.12 111.67 9.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 110.565 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.535 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.8 t -66.15 100.19 0.58 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.344 -0.847 . . . . 0.0 108.809 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -110.57 -177.63 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-O 121.798 0.809 . . . . 0.0 110.825 -179.12 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.296 -1.75 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.472 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.224 0.535 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.6 172.76 6.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.158 -0.964 . . . . 0.0 110.601 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.542 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -124.76 83.73 2.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.441 -0.787 . . . . 0.0 109.829 179.853 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.512 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 3.0 mt-30 -60.11 174.54 0.5 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.291 -0.88 . . . . 0.0 110.417 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 19' ' ' ASP . 1.0 OUTLIER -47.09 144.48 4.0 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.423 -0.798 . . . . 0.0 110.204 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.624 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 53.3 Cg_endo -71.52 157.72 55.53 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.988 1.52 . . . . 0.0 110.871 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -76.72 171.96 17.06 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.992 1.522 . . . . 0.0 110.286 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.61 175.96 6.64 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.221 -0.924 . . . . 0.0 109.895 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.563 HG12 ' CD2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -141.14 -170.57 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 122.281 1.039 . . . . 0.0 111.587 179.581 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 12' ' ' GLY . 0.4 OUTLIER -44.93 105.13 0.05 Allowed 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.157 -178.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.453 ' C ' ' O ' ' A' ' 10' ' ' SER . 0.9 OUTLIER 39.05 27.95 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.315 -0.866 . . . . 0.0 110.583 179.604 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -135.99 160.42 24.61 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -123.2 178.22 5.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -1.131 . . . . 0.0 110.321 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.624 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 11.3 p80 -123.31 135.98 54.46 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.572 -0.705 . . . . 0.0 110.355 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -137.43 64.68 1.52 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.413 -0.804 . . . . 0.0 110.077 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -59.09 -173.59 0.55 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.404 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -94.06 31.61 1.63 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.322 -1.105 . . . . 0.0 110.229 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.568 ' OE2' ' CD1' ' A' ' 21' ' ' TYR . 6.7 pt-20 179.09 -171.81 0.14 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 110.371 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 5' ' ' SER . 29.4 t0 -92.03 -52.54 4.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 110.014 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.573 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 52.0 p90 -104.03 -155.17 0.52 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.177 -0.952 . . . . 0.0 109.983 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.61 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 1.8 m-85 -170.0 -31.62 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.157 -0.964 . . . . 0.0 110.883 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.548 ' CB ' ' O ' ' A' ' 21' ' ' TYR . 3.0 m 78.42 -83.03 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.659 -0.65 . . . . 0.0 111.904 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 47' ' ' GLY . 2.1 t70 -161.93 157.13 23.33 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.745 -1.222 . . . . 0.0 110.14 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.29 14.86 60.25 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.61 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 20.1 m -94.01 176.77 6.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.476 -1.014 . . . . 0.0 110.179 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 25.2 t -154.29 158.29 3.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 119.549 -0.861 . . . . 0.0 110.379 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.584 HG13 ' CD1' ' A' ' 29' ' ' TYR . 10.0 t -141.82 113.31 3.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 118.933 -1.107 . . . . 0.0 111.915 -179.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.467 HG21 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -69.8 105.21 2.69 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.127 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.623 ' CE1' HG23 ' A' ' 43' ' ' VAL . 3.1 m-30 -67.73 -176.44 0.65 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 110.21 -178.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.464 ' O ' ' CA ' ' A' ' 12' ' ' GLY . 0.6 OUTLIER -142.25 146.94 35.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.434 -0.791 . . . . 0.0 109.626 179.455 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 35.2 m -123.3 137.19 54.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 110.245 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 31' ' ' CYS . 2.5 m-20 -44.04 148.2 0.43 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 110.141 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -47.98 131.06 15.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.0 110.138 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.05 -12.7 52.55 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.466 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 1.9 m-30 -110.17 125.94 53.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.266 -1.138 . . . . 0.0 110.42 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.545 ' OG ' ' CG2' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -79.86 144.85 33.09 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.322 -0.861 . . . . 0.0 110.977 -179.689 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.499 ' HA ' ' O ' ' A' ' 55' ' ' THR . 2.3 tp -95.48 105.11 17.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.347 -0.845 . . . . 0.0 109.935 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.587 ' HB ' ' OG1' ' A' ' 55' ' ' THR . 0.6 OUTLIER -97.2 149.56 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.247 -0.908 . . . . 0.0 109.466 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 130.89 -158.71 22.74 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.487 ' O ' ' C ' ' A' ' 41' ' ' SER . 8.5 t-20 -97.89 51.7 1.05 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.107 -1.231 . . . . 0.0 109.897 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.487 ' C ' ' O ' ' A' ' 40' ' ' ASN . 79.5 p 28.65 45.45 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.499 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 27' ' ' VAL . . . 157.33 126.04 0.89 Allowed Glycine 0 N--CA 1.49 2.299 0 C-N-CA 119.378 -1.392 . . . . 0.0 110.44 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.623 HG23 ' CE1' ' A' ' 29' ' ' TYR . 1.7 t -65.01 178.27 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.182 -1.187 . . . . 0.0 107.864 178.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.55 ' C ' ' CD2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -140.41 94.31 2.72 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.057 178.452 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.587 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -81.88 107.75 14.85 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.114 178.566 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.465 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -132.37 121.13 23.0 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.317 -179.479 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.539 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 90.96 8.88 64.5 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.04 27.86 19.84 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -154.22 125.57 7.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.223 -1.163 . . . . 0.0 110.19 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.587 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 92.2 m95 -72.06 137.32 47.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.713 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.93 166.49 25.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.127 -0.983 . . . . 0.0 111.077 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.52 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 87.8 m-20 48.34 65.37 7.16 Favored Pre-proline 0 N--CA 1.492 1.629 0 CA-C-O 121.216 0.532 . . . . 0.0 111.204 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.4 Cg_endo -91.02 151.41 3.87 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 O-C-N 124.433 1.754 . . . . 0.0 110.045 179.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.557 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 48.8 Cg_endo -78.72 175.95 10.42 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 123.852 1.448 . . . . 0.0 110.41 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.587 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 17.7 p -119.03 177.55 4.82 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.28 -0.887 . . . . 0.0 110.876 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 10' ' ' SER . 65.4 m -132.93 71.8 1.48 Allowed 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -113.72 171.95 7.27 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.144 -178.713 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -87.66 144.13 9.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 119.349 -0.94 . . . . 0.0 108.577 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.56 HG22 ' HB3' ' A' ' 81' ' ' TYR . 34.1 m -130.42 44.9 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.549 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 2.6 mmtt -53.91 179.79 0.02 OUTLIER 'General case' 0 C--N 1.278 -2.507 0 C-N-CA 118.035 -1.466 . . . . 0.0 108.381 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -145.36 165.28 22.25 Favored Pre-proline 0 N--CA 1.492 1.667 0 C-N-CA 118.402 -1.319 . . . . 0.0 112.887 -178.587 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.426 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 45.4 Cg_endo -88.2 -78.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.877 1.988 . . . . 0.0 110.401 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.426 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 170.93 129.26 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.653 -0.654 . . . . 0.0 109.352 -179.365 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.618 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 52.8 Cg_endo -80.97 65.83 8.89 Favored 'Trans proline' 0 C--N 1.298 -2.091 0 O-C-N 123.723 1.38 . . . . 0.0 110.074 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.549 ' N ' HD22 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -84.19 169.0 15.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.468 -0.77 . . . . 0.0 109.9 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.557 ' CD1' ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -169.17 161.78 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.035 -1.041 . . . . 0.0 110.638 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.492 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 0.6 OUTLIER -66.28 105.84 1.53 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.544 -0.723 . . . . 0.0 111.025 -179.18 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.459 ' O ' ' CG ' ' A' ' 90' ' ' LYS . 7.4 m-80 38.74 38.64 0.28 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.532 -0.73 . . . . 0.0 110.803 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -147.38 32.67 1.36 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.555 ' CD2' ' O ' ' A' ' 71' ' ' LEU . 3.6 p90 -46.46 -170.77 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 122.72 1.248 . . . . 0.0 112.515 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.567 HD11 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -114.07 168.48 9.78 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.007 179.554 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.3 t -149.67 15.87 0.87 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.848 -1.158 . . . . 0.0 110.644 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.448 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 41.9 t -92.49 -77.1 0.44 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.921 . . . . 0.0 110.515 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -130.87 77.98 0.38 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.62 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -103.85 163.74 12.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.354 -1.086 . . . . 0.0 109.548 179.538 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.62 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 17.0 ttmm -165.2 158.89 16.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 109.941 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.466 ' N ' ' HG2' ' A' ' 76' ' ' LYS . 26.2 mtt180 -54.1 -25.21 20.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.072 -1.017 . . . . 0.0 109.861 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.468 ' O ' ' HD2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -145.14 160.41 41.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.452 -0.78 . . . . 0.0 110.203 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.591 ' OH ' ' CE2' ' A' ' 75' ' ' PHE . 16.2 m-85 -135.75 -150.14 0.36 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.308 -0.87 . . . . 0.0 109.818 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.522 ' CA ' HG21 ' A' ' 59' ' ' VAL . 83.3 p -162.5 -104.96 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.807 -1.183 . . . . 0.0 111.388 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.594 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -114.47 15.87 17.8 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.481 -1.387 . . . . 0.0 110.431 -178.741 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.481 ' O ' HG21 ' A' ' 102' ' ' THR . 7.7 p30 -160.51 -107.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.925 -1.109 . . . . 0.0 110.443 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.454 ' C ' HG21 ' A' ' 102' ' ' THR . 0.3 OUTLIER 46.34 74.24 0.15 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.806 -1.184 . . . . 0.0 108.734 -179.1 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.511 ' HA ' ' CG2' ' A' ' 102' ' ' THR . 20.8 t-20 -68.52 122.64 18.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.468 -0.77 . . . . 0.0 110.338 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.592 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 23.4 m -104.96 120.04 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 0.0 110.608 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.464 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 62.8 t0 -83.72 127.77 34.03 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.567 ' CE1' HD11 ' A' ' 71' ' ' LEU . 35.1 m-85 -85.15 122.52 29.46 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.412 1.101 . . . . 0.0 111.876 -178.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -101.26 88.55 3.51 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.94 -179.778 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.481 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -42.52 129.24 4.03 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.31 -0.869 . . . . 0.0 109.814 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.459 ' CG ' ' O ' ' A' ' 68' ' ' ASN . 2.1 mmmt -38.48 -89.67 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.551 -0.718 . . . . 0.0 110.841 -179.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.573 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 1.9 t80 -153.37 131.13 11.59 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.102 -0.999 . . . . 0.0 110.341 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.584 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 60.11 52.66 51.41 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 26.4 m-85 -158.08 145.79 18.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.54 -0.976 . . . . 0.0 109.764 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -103.29 153.18 20.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.529 179.735 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.538 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 2.7 mt -91.32 97.55 11.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.754 -1.216 . . . . 0.0 110.086 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.471 ' HB2' HG22 ' A' ' 117' ' ' VAL . 16.8 t -80.65 107.83 13.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 110.241 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 98' ' ' SER . . . 129.85 -32.42 3.16 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.635 -1.269 . . . . 0.0 110.561 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.485 ' O ' ' HB3' ' A' ' 114' ' ' PRO . 12.7 p 177.18 -168.48 0.06 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.999 -1.295 . . . . 0.0 111.154 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.3 p -160.24 -35.09 0.05 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.247 0.546 . . . . 0.0 109.836 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 82.7 p -130.59 82.82 2.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 0.0 109.556 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.497 ' O ' ' N ' ' A' ' 85' ' ' VAL . 7.1 m -91.0 176.15 6.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.396 -0.815 . . . . 0.0 110.993 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.511 ' CG2' ' HA ' ' A' ' 84' ' ' ASN . 1.6 m -151.06 142.98 23.91 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.601 -0.687 . . . . 0.0 110.317 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.5 ' SG ' ' HB2' ' A' ' 79' ' ' TYR . 8.2 t -75.23 78.02 2.35 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.494 -0.754 . . . . 0.0 109.635 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.508 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -64.43 177.29 0.58 Allowed Pre-proline 0 C--N 1.299 -1.595 0 O-C-N 121.324 -0.86 . . . . 0.0 110.465 -179.664 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.54 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 42.0 Cg_endo -69.8 131.73 21.8 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 124.332 1.701 . . . . 0.0 110.142 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 121.9 -10.91 9.5 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 108.679 -1.769 . . . . 0.0 108.679 -179.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.549 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 10.4 m-20 79.64 92.25 0.05 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.893 -0.769 . . . . 0.0 110.807 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 103' ' ' CYS . 0.0 OUTLIER -177.51 -162.56 0.07 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.581 179.597 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.618 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 20.5 m95 -147.88 82.78 1.51 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.389 0.614 . . . . 0.0 109.897 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 101' ' ' SER . 9.2 mmtt -91.81 146.51 33.13 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.393 -0.817 . . . . 0.0 109.972 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.466 ' HD2' ' HA ' ' A' ' 101' ' ' SER . 46.7 Cg_endo -75.42 176.35 43.98 Favored 'Cis proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.654 -2.228 . . . . 0.0 110.481 -0.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.2 OUTLIER -37.17 124.63 0.95 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.685 -0.634 . . . . 0.0 110.741 -179.524 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.553 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.5 OUTLIER -42.57 137.36 2.36 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.873 . . . . 0.0 109.859 179.811 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.557 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 49.0 Cg_endo -74.67 165.1 32.32 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 O-C-N 124.258 1.662 . . . . 0.0 111.614 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 117' ' ' VAL . 12.6 ttmt -126.71 105.19 8.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.538 -0.726 . . . . 0.0 109.924 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.531 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.6 t -55.38 86.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.16 -0.963 . . . . 0.0 109.846 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.53 ' N ' ' O ' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -98.62 -172.16 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 121.822 0.82 . . . . 0.0 110.528 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.2 mtm180 . . . . . 0 C--N 1.294 -1.83 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.497 -179.991 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.366 0.603 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.51 177.39 6.38 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.385 -0.822 . . . . 0.0 110.305 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.538 ' HB2' ' CA ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -125.41 75.35 1.46 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.421 -0.799 . . . . 0.0 110.106 -179.889 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.444 ' O ' ' C ' ' A' ' 5' ' ' SER . 3.0 mp0 -54.17 172.02 0.1 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.041 -1.037 . . . . 0.0 109.725 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.2 p -42.41 144.82 0.89 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 109.94 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.609 ' HG2' ' CG ' ' A' ' 14' ' ' HIS . 53.9 Cg_endo -70.62 160.45 49.43 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.046 1.551 . . . . 0.0 110.79 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -76.26 170.21 20.46 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 O-C-N 124.014 1.534 . . . . 0.0 109.945 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.55 176.18 6.38 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.141 -0.975 . . . . 0.0 110.27 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.5 HG22 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -144.26 -170.33 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 122.24 1.019 . . . . 0.0 111.746 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.3 OUTLIER -50.27 105.19 0.09 Allowed 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.287 -178.91 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 10' ' ' SER . 65.0 m-20 37.27 47.12 0.65 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.516 -0.74 . . . . 0.0 111.274 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.53 152.85 24.3 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 30' ' ' SER . 1.6 ptt180 -113.04 -172.5 2.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.104 -1.233 . . . . 0.0 111.192 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.621 ' CG ' ' O ' ' A' ' 14' ' ' HIS . 20.3 p80 -143.99 111.6 6.04 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.294 0.568 . . . . 0.0 109.469 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 14' ' ' HIS . 2.6 t-20 -177.87 174.22 1.46 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.601 -1.312 . . . . 0.0 110.87 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 17' ' ' TYR . . . 145.62 -39.74 1.14 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.8 OUTLIER 178.17 46.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.513 -0.992 . . . . 0.0 109.568 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.58 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . 0.9 OUTLIER -134.19 -94.16 0.3 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.225 -0.922 . . . . 0.0 110.491 -179.495 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 9.2 m-20 66.26 6.45 4.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.279 -0.888 . . . . 0.0 110.387 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -170.42 116.48 0.5 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 110.621 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.594 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 18.3 m-85 -132.83 173.47 11.35 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.364 -0.835 . . . . 0.0 109.294 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.538 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 1.9 p -130.59 -68.9 0.67 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.779 -1.2 . . . . 0.0 110.75 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.417 ' C ' ' OD1' ' A' ' 23' ' ' ASP . 14.7 t0 -162.04 132.4 4.85 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.392 -0.818 . . . . 0.0 109.684 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.54 16.19 71.64 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.618 -1.793 . . . . 0.0 108.618 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.594 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.5 OUTLIER -97.73 -179.25 4.38 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.46 -1.023 . . . . 0.0 110.506 -179.808 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 11.8 t -149.58 162.26 4.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.041 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.574 HG13 ' CD1' ' A' ' 29' ' ' TYR . 16.4 t -143.07 118.56 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 119.698 -0.801 . . . . 0.0 111.681 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.464 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 0.1 OUTLIER -75.3 102.41 5.05 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 118.636 -1.225 . . . . 0.0 107.884 177.831 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.616 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 2.3 m-30 -67.94 127.55 33.25 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.441 -0.787 . . . . 0.0 109.915 -178.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -82.14 142.34 32.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.059 -1.026 . . . . 0.0 109.728 179.404 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.452 ' SG ' HD11 ' A' ' 37' ' ' LEU . 64.3 m -112.56 142.87 44.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.17 -0.956 . . . . 0.0 110.075 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -46.59 167.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 110.141 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 p -64.72 138.81 58.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.108 -0.995 . . . . 0.0 110.425 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.37 6.11 89.5 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.572 ' CD2' ' O ' ' A' ' 56' ' ' CYS . 1.0 OUTLIER -111.63 120.88 43.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.172 -1.193 . . . . 0.0 110.274 -179.881 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.564 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -79.79 130.45 35.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.394 -0.816 . . . . 0.0 110.942 -179.663 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.454 HD11 ' O ' ' A' ' 29' ' ' TYR . 1.9 tp -81.05 100.15 8.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.377 -0.827 . . . . 0.0 109.131 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.577 ' HB ' ' OG1' ' A' ' 55' ' ' THR . 1.0 OUTLIER -89.12 151.05 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.495 -179.716 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.7 -176.66 26.37 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.413 ' OD1' ' O ' ' A' ' 40' ' ' ASN . 12.0 p30 -59.21 143.12 49.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -1.168 . . . . 0.0 109.72 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.433 ' O ' ' CG2' ' A' ' 28' ' ' THR . 0.4 OUTLIER -76.09 53.27 0.78 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.158 -0.964 . . . . 0.0 110.125 -179.908 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 27' ' ' VAL . . . 160.56 131.07 1.18 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.616 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 2.2 t -69.58 -175.28 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.113 -1.228 . . . . 0.0 108.364 178.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.403 ' HA ' HG21 ' A' ' 26' ' ' VAL . 6.1 tp -143.84 98.54 3.25 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.479 178.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.598 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.8 OUTLIER -84.3 112.47 20.34 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.231 178.895 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 t -124.77 145.94 49.47 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.332 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 54.28 32.09 50.9 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.451 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 69.19 40.01 82.42 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 1.5 mt-10 -151.42 128.04 10.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.298 -1.119 . . . . 0.0 110.502 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.598 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 74.8 m95 -81.95 134.36 35.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.25 -0.907 . . . . 0.0 110.107 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 25.9 t -151.29 163.38 39.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.115 -0.991 . . . . 0.0 110.742 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.525 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 2.4 m-20 64.3 65.5 1.1 Allowed Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.633 -0.667 . . . . 0.0 110.944 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.525 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 52.1 Cg_endo -91.77 132.92 1.34 Allowed 'Trans proline' 0 C--N 1.299 -2.053 0 C-N-CA 121.89 1.727 . . . . 0.0 110.173 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.459 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.2 Cg_endo -76.61 172.05 16.92 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.689 1.363 . . . . 0.0 109.488 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.577 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 52.8 p -109.86 148.91 30.67 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.812 -1.18 . . . . 0.0 111.919 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.572 ' O ' ' CD2' ' A' ' 35' ' ' TYR . 86.5 m -111.44 77.62 1.05 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 36' ' ' SER . 1.0 OUTLIER -115.25 -163.72 0.9 Allowed 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.547 0.689 . . . . 0.0 110.502 -178.115 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -107.7 137.62 38.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.376 -0.828 . . . . 0.0 108.888 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.62 HG22 ' CB ' ' A' ' 81' ' ' TYR . 30.2 m -123.08 41.1 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.034 -1.041 . . . . 0.0 111.229 -178.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -75.49 98.63 3.99 Favored 'General case' 0 C--N 1.284 -2.267 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.443 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 107' ' ' ASN . 64.0 m -70.01 161.96 71.93 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.438 -0.789 . . . . 0.0 111.842 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 44.7 Cg_endo -72.57 -88.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.546 1.814 . . . . 0.0 111.008 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.451 ' CD2' ' HE1' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -172.49 132.12 0.68 Allowed Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.527 -0.733 . . . . 0.0 109.225 -179.321 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.612 ' HG3' ' CZ2' ' A' ' 109' ' ' TRP . 58.2 Cg_endo -85.35 69.85 5.3 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 O-C-N 123.398 1.21 . . . . 0.0 109.886 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.582 ' C ' ' CG2' ' A' ' 66' ' ' ILE . 3.2 p -87.19 -40.6 14.44 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.464 1.126 . . . . 0.0 109.999 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.603 HG23 ' CD1' ' A' ' 87' ' ' PHE . 0.1 OUTLIER 52.59 160.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.355 -178.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.479 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 0.5 OUTLIER -58.64 91.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.474 -0.766 . . . . 0.0 111.576 -178.826 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 47.94 60.27 3.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.378 -0.826 . . . . 0.0 111.471 178.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.576 ' O ' ' CG ' ' A' ' 70' ' ' TYR . . . -143.58 -36.98 0.07 OUTLIER Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.17 -1.491 . . . . 0.0 110.226 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.588 ' CE1' ' HB3' ' A' ' 88' ' ' LYS . 40.2 p90 42.44 -175.34 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 122.097 0.951 . . . . 0.0 110.932 -178.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.681 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -122.75 -32.13 3.59 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.694 -178.549 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.581 ' N ' HD21 ' A' ' 71' ' ' LEU . 0.5 OUTLIER 57.09 15.15 2.27 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.635 -1.291 . . . . 0.0 110.78 177.587 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.2 m -119.49 10.02 11.71 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.524 -178.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 133.91 87.38 0.29 Allowed Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.358 -1.401 . . . . 0.0 110.047 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.585 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -127.36 150.82 49.44 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.31 -1.112 . . . . 0.0 109.55 179.429 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.45 ' O ' ' OH ' ' A' ' 79' ' ' TYR . 2.0 tttp -135.39 170.41 15.99 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.423 -0.798 . . . . 0.0 109.723 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 30.0 mtt85 -67.45 -26.08 66.21 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.307 -0.871 . . . . 0.0 109.855 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.94 150.87 36.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 110.481 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.585 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 13.8 m-85 -128.82 -170.62 2.3 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.292 -0.88 . . . . 0.0 110.332 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 1.2 t -169.83 90.33 0.19 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.227 -0.921 . . . . 0.0 110.136 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.62 ' CB ' HG22 ' A' ' 59' ' ' VAL . 6.6 t80 55.72 134.2 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.158 -0.964 . . . . 0.0 110.042 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.557 ' N ' ' O ' ' A' ' 103' ' ' CYS . 22.7 t30 71.66 -129.82 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.822 -1.174 . . . . 0.0 110.578 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.498 ' HB3' ' HB3' ' A' ' 103' ' ' CYS . 5.1 t0 51.62 74.54 0.25 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.653 -1.279 . . . . 0.0 108.921 -178.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 21.3 t-20 -75.69 141.84 42.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.437 -0.79 . . . . 0.0 111.608 -178.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.616 HG21 ' CZ3' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -125.9 146.88 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.4 -0.812 . . . . 0.0 109.679 178.834 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.548 ' O ' ' CA ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -109.57 108.29 18.69 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.027 -1.046 . . . . 0.0 108.95 179.473 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.681 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 35.5 m-85 -66.84 134.93 53.09 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.382 1.087 . . . . 0.0 113.715 -177.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.588 ' HB3' ' CE1' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -123.3 84.37 2.26 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.664 -179.816 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.484 ' C ' ' O ' ' A' ' 88' ' ' LYS . 0.1 OUTLIER -32.75 133.7 0.12 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.762 -0.586 . . . . 0.0 111.489 -179.518 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -40.51 -87.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.496 -0.753 . . . . 0.0 110.331 179.584 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -161.94 143.37 10.98 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.173 -0.955 . . . . 0.0 110.03 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.572 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 59.05 24.95 59.07 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.572 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 18.1 m-85 -138.99 144.56 38.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.566 -0.961 . . . . 0.0 109.901 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.468 ' O ' HG21 ' A' ' 117' ' ' VAL . 9.6 ttpt -105.36 153.65 21.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.261 -0.899 . . . . 0.0 109.493 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.589 ' CD2' ' CD1' ' A' ' 66' ' ' ILE . 3.4 mt -88.57 114.14 24.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.708 -1.245 . . . . 0.0 110.445 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.454 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 1.3 t -89.21 97.48 11.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.334 -0.854 . . . . 0.0 109.721 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.26 -111.38 0.64 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.59 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 5.7 t -129.51 127.22 40.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.27 -1.135 . . . . 0.0 110.557 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.429 ' O ' ' CD2' ' A' ' 87' ' ' PHE . 0.8 OUTLIER -74.07 -44.38 54.33 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.388 -0.82 . . . . 0.0 110.37 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.2 p -101.21 123.39 45.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.122 -0.986 . . . . 0.0 110.154 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.485 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 57.9 m -129.99 -168.14 1.92 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 110.298 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 14.6 m -162.72 134.14 5.08 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.252 -0.979 . . . . 0.0 111.134 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.603 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 1.6 t -57.41 95.42 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.677 -0.64 . . . . 0.0 109.48 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.12 173.94 6.77 Favored Pre-proline 0 C--N 1.299 -1.587 0 O-C-N 120.974 -1.079 . . . . 0.0 110.789 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.551 ' CG ' HG22 ' A' ' 38' ' ' ILE . 43.9 Cg_endo -76.26 132.16 13.53 Favored 'Trans proline' 0 C--N 1.299 -2.051 0 O-C-N 124.467 1.772 . . . . 0.0 110.703 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.548 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 121.69 -4.04 10.9 Favored Glycine 0 N--CA 1.482 1.748 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 8.2 m-80 80.25 81.28 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.91 -0.759 . . . . 0.0 110.499 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.515 ' CG2' ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 177.48 -177.26 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.222 -0.924 . . . . 0.0 111.467 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.616 ' CZ3' HG21 ' A' ' 85' ' ' VAL . 44.6 m95 -124.54 101.77 7.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.624 -0.673 . . . . 0.0 110.515 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.471 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 4.6 mttt -102.59 148.91 36.19 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.25 -0.906 . . . . 0.0 109.871 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.59 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 52.3 Cg_endo -73.28 -175.19 14.18 Favored 'Cis proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.144 -2.023 . . . . 0.0 111.007 -0.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.7 mt-10 -38.37 123.84 1.21 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.339 0.59 . . . . 0.0 110.437 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.586 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 2.9 tp -53.9 143.11 42.72 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 110.448 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.574 ' HG3' ' CD2' ' A' ' 87' ' ' PHE . 41.2 Cg_endo -72.1 155.66 56.6 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.024 1.539 . . . . 0.0 110.594 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.492 ' O ' HG23 ' A' ' 117' ' ' VAL . 0.4 OUTLIER -120.91 110.87 16.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.327 -0.858 . . . . 0.0 110.508 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.521 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.3 t -60.48 96.91 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.186 -0.946 . . . . 0.0 109.342 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -107.04 -175.35 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 121.798 0.809 . . . . 0.0 111.019 -179.447 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.296 -1.735 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.176 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 62.7 t . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.192 0.52 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.54 149.82 52.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.194 -0.941 . . . . 0.0 110.275 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.514 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.6 m -80.64 138.74 36.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.422 -0.799 . . . . 0.0 110.611 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.446 ' O ' ' C ' ' A' ' 5' ' ' SER . 21.0 mt-30 -119.5 174.28 6.48 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.439 -0.788 . . . . 0.0 109.286 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 19' ' ' ASP . 1.1 p -42.64 133.76 2.83 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 0.0 109.776 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.624 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 51.7 Cg_endo -70.2 155.76 63.76 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.944 1.497 . . . . 0.0 111.357 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -76.73 170.67 19.43 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.041 1.548 . . . . 0.0 110.04 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.13 176.2 4.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.168 -0.958 . . . . 0.0 109.689 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.562 HG12 ' CD2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -142.52 -170.32 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 122.178 0.99 . . . . 0.0 111.81 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 13.2 t -37.69 94.37 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.204 -179.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 9' ' ' ILE . 11.8 m-20 42.9 25.45 0.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.068 -1.02 . . . . 0.0 110.648 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -121.01 -166.56 13.03 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.528 ' HG3' ' CB ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -151.71 178.8 8.99 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.193 -1.181 . . . . 0.0 110.145 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.624 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 9.2 p80 -135.6 141.33 45.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.403 -0.811 . . . . 0.0 110.462 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -171.22 65.54 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.895 . . . . 0.0 110.267 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.41 ' O ' ' CD2' ' A' ' 17' ' ' TYR . . . -60.23 -81.59 0.08 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -177.38 29.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -1.156 . . . . 0.0 110.298 179.876 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -165.59 -165.92 0.9 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.921 . . . . 0.0 110.212 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 20' ' ' PHE . 25.1 p-10 -123.27 -41.82 2.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.896 . . . . 0.0 109.947 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.506 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 2.0 m-85 -96.14 149.74 21.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.387 -0.821 . . . . 0.0 110.338 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.668 ' CD2' ' HB3' ' A' ' 25' ' ' SER . 1.6 m-85 -130.91 -2.41 4.1 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.217 -0.927 . . . . 0.0 110.833 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.514 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 15.6 p 42.8 -99.3 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.353 -0.842 . . . . 0.0 111.264 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.497 ' OD1' ' HA ' ' A' ' 46' ' ' SER . 3.6 t0 -156.82 137.53 13.26 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.059 -1.026 . . . . 0.0 110.179 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 86.87 23.75 40.75 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.668 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 58.2 m -116.61 154.41 30.55 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -1.079 . . . . 0.0 109.563 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.56 ' CG1' ' O ' ' A' ' 43' ' ' VAL . 38.1 t -126.1 149.33 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.884 -1.135 . . . . 0.0 112.556 -177.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.593 HG21 ' CE2' ' A' ' 21' ' ' TYR . 45.8 t -121.44 120.77 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.587 -0.696 . . . . 0.0 111.32 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.472 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -73.81 103.12 4.24 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 177.443 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.649 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 2.0 m-30 -67.63 121.11 15.18 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.244 -177.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.528 ' CB ' ' HG3' ' A' ' 13' ' ' ARG . 2.3 m -70.81 -163.89 0.08 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.979 -1.075 . . . . 0.0 108.966 179.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.461 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 5.5 t -164.38 160.47 20.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.896 -1.127 . . . . 0.0 110.702 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 34' ' ' GLY . 9.7 t-20 -55.56 144.3 26.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.343 -0.848 . . . . 0.0 109.679 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.54 79.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.255 -0.903 . . . . 0.0 110.428 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 32' ' ' ASN . . . 153.7 -28.9 0.75 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.427 ' CD1' ' O ' ' A' ' 56' ' ' CYS . 6.4 m-85 -87.25 134.97 33.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.155 -1.203 . . . . 0.0 110.184 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.61 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 1.2 t -80.28 142.49 34.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.278 -0.889 . . . . 0.0 110.527 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.559 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 2.1 tp -93.81 111.18 22.83 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.375 -0.828 . . . . 0.0 109.21 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.584 ' CG2' ' CG ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -103.53 156.9 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.137 -0.977 . . . . 0.0 109.62 -179.661 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.23 -146.53 16.48 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.535 ' O ' ' C ' ' A' ' 41' ' ' SER . 0.7 OUTLIER -106.16 54.97 0.68 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.107 -1.231 . . . . 0.0 110.021 179.829 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.535 ' C ' ' O ' ' A' ' 40' ' ' ASN . 7.3 p 14.44 56.62 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.167 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 40' ' ' ASN . . . 155.58 118.83 0.63 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.649 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 1.9 t -70.42 -178.77 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.084 -1.244 . . . . 0.0 108.005 178.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.2 tp -144.15 97.52 3.06 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.715 -1.241 . . . . 0.0 110.531 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.583 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.9 OUTLIER -83.92 111.98 19.74 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.304 178.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.497 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 0.4 OUTLIER -123.2 93.22 3.88 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.299 -179.681 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.28 61.52 1.64 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 49.55 27.06 8.08 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -136.47 108.85 7.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.207 -1.172 . . . . 0.0 110.442 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.583 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 70.8 m95 -74.76 135.29 41.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 109.711 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -144.14 157.62 44.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.085 -1.009 . . . . 0.0 111.092 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.541 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 4.4 t70 63.56 64.41 1.38 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.691 -0.631 . . . . 0.0 110.965 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 53.3 Cg_endo -92.14 133.44 1.28 Allowed 'Trans proline' 0 C--N 1.298 -2.098 0 O-C-N 124.406 1.74 . . . . 0.0 109.674 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.534 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 49.4 Cg_endo -75.93 176.81 9.54 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 O-C-N 123.688 1.362 . . . . 0.0 109.819 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.499 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 6.7 p -111.09 -175.75 2.78 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.995 0.902 . . . . 0.0 111.271 -178.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 10' ' ' SER . 0.8 OUTLIER -144.64 75.08 1.44 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.109 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.522 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.3 OUTLIER -112.85 -158.86 0.66 Allowed 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.913 -178.908 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.463 HG21 ' HE3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -113.78 130.42 67.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 108.603 179.415 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.61 ' CG1' ' CB ' ' A' ' 36' ' ' SER . 19.2 m -118.49 46.43 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.994 -1.067 . . . . 0.0 112.067 -178.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 1.6 mttt -58.13 -175.11 0.02 OUTLIER 'General case' 0 C--N 1.281 -2.384 0 C-N-CA 117.763 -1.575 . . . . 0.0 107.541 178.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.523 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 1.2 m -141.54 167.38 17.21 Favored Pre-proline 0 C--N 1.293 -1.857 0 C-N-CA 117.811 -1.555 . . . . 0.0 113.814 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.553 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 48.9 Cg_endo -90.08 -69.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 125.026 2.066 . . . . 0.0 110.368 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.553 ' CD2' ' O ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER 165.4 124.24 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.299 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.623 ' HB3' ' CE2' ' A' ' 109' ' ' TRP . 45.9 Cg_endo -76.47 80.22 2.8 Favored 'Trans proline' 0 C--N 1.301 -1.953 0 O-C-N 123.467 1.246 . . . . 0.0 109.329 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.433 ' C ' HG23 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -102.91 173.79 6.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.872 . . . . 0.0 109.791 -179.33 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.571 ' CG2' ' HA ' ' A' ' 70' ' ' TYR . 0.2 OUTLIER -169.99 166.35 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.334 -0.947 . . . . 0.0 110.305 179.558 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.472 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 16.4 t -75.73 107.04 7.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.488 -0.757 . . . . 0.0 110.652 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.529 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 3.3 m-80 38.89 55.87 2.0 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.567 -0.708 . . . . 0.0 110.643 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -168.66 32.04 0.18 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.571 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 16.9 p90 -45.25 -174.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 123.463 1.601 . . . . 0.0 112.862 -179.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 2.8 pp -100.89 126.79 47.54 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 113.308 -1.769 . . . . 0.0 109.887 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.483 ' HB3' ' HB2' ' A' ' 88' ' ' LYS . 0.2 OUTLIER -96.35 2.48 52.78 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.28 -0.888 . . . . 0.0 109.515 179.767 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.7 t -73.09 -73.91 0.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.38 -0.825 . . . . 0.0 110.572 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.9 97.62 0.12 Allowed Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.626 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.582 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -94.17 145.13 24.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.358 -1.083 . . . . 0.0 109.18 179.053 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.486 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -132.38 160.72 35.53 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.158 -0.964 . . . . 0.0 110.242 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -52.45 -33.99 46.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.225 -0.922 . . . . 0.0 110.394 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.406 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -142.02 165.62 26.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.333 -0.855 . . . . 0.0 110.361 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.582 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 22.3 m-85 -138.06 -138.63 0.14 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.373 -0.83 . . . . 0.0 109.956 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 21.2 p -170.05 -132.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 0.0 109.629 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.646 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 1.6 t80 -101.87 38.23 1.68 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.002 -1.061 . . . . 0.0 109.459 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.571 ' N ' ' O ' ' A' ' 103' ' ' CYS . 9.4 p30 -169.36 -114.37 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.73 -1.231 . . . . 0.0 110.498 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 82' ' ' ASN . 81.5 m-20 44.83 77.19 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.78 -1.2 . . . . 0.0 109.374 -179.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.55 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 5.6 p-10 -75.11 113.5 12.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.285 -0.885 . . . . 0.0 110.93 -178.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.602 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 15.7 m -101.56 120.86 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.773 -1.204 . . . . 0.0 110.364 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.539 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 25.8 t0 -76.65 126.3 30.75 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.169 -0.957 . . . . 0.0 109.161 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.611 ' CE2' HD11 ' A' ' 113' ' ' LEU . 23.4 m-85 -86.97 126.02 34.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.052 -1.03 . . . . 0.0 111.357 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -104.31 110.94 23.37 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.53 -179.377 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.441 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -58.56 133.11 55.55 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.038 -1.039 . . . . 0.0 109.551 179.314 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -42.63 -67.49 0.27 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.12 -179.644 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.521 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.3 OUTLIER -176.66 137.16 0.26 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.413 -0.804 . . . . 0.0 110.345 179.935 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.597 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 54.03 58.22 13.55 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.597 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 12.7 m-85 -162.21 155.84 20.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.534 -0.98 . . . . 0.0 109.819 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.467 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -110.2 124.18 51.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.142 -0.973 . . . . 0.0 110.323 -179.856 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.515 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 1.7 mt -63.7 87.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.373 -0.83 . . . . 0.0 110.033 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.476 ' HB3' HG23 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -69.47 104.81 2.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 110.07 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 141.58 -81.53 0.24 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.56 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -169.72 124.73 0.81 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.257 -1.143 . . . . 0.0 110.534 -179.827 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 73.8 p -68.56 -72.19 0.19 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.349 -0.845 . . . . 0.0 110.867 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 58.6 p -78.19 118.33 20.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.153 -0.967 . . . . 0.0 110.329 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 85' ' ' VAL . 59.9 m -125.25 158.47 34.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.55 -0.719 . . . . 0.0 110.611 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -135.08 142.26 46.25 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.395 179.694 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.585 ' SG ' ' CZ2' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -67.9 105.41 1.98 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.614 -0.679 . . . . 0.0 110.278 -179.769 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.532 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -76.88 -175.15 0.47 Allowed Pre-proline 0 C--N 1.295 -1.779 0 O-C-N 121.231 -0.918 . . . . 0.0 111.315 -179.411 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.603 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 41.4 Cg_endo -87.78 126.42 2.14 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 124.4 1.737 . . . . 0.0 110.597 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 117.53 2.86 17.15 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.649 ' O ' ' CG2' ' A' ' 108' ' ' THR . 0.0 OUTLIER 79.16 105.61 0.07 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.649 -0.912 . . . . 0.0 110.426 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.649 ' CG2' ' O ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER 166.03 -163.39 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.867 0.841 . . . . 0.0 111.271 179.443 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.623 ' CE2' ' HB3' ' A' ' 64' ' ' PRO . 32.8 m95 -144.91 88.02 1.87 Allowed 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.698 0.761 . . . . 0.0 109.651 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.504 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 14.4 mmmt -98.54 137.08 20.62 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.764 -0.585 . . . . 0.0 110.186 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.56 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 42.8 Cg_endo -69.69 166.25 74.34 Favored 'Cis proline' 0 N--CA 1.49 1.298 0 C-N-CA 122.056 -2.06 . . . . 0.0 110.983 -0.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -38.52 153.23 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.578 -0.702 . . . . 0.0 111.081 -179.168 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.611 HD11 ' CE2' ' A' ' 87' ' ' PHE . 1.2 mm? -64.68 141.61 98.32 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.43 -0.793 . . . . 0.0 109.716 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.59 ' CD ' ' CD2' ' A' ' 87' ' ' PHE . 42.5 Cg_endo -72.1 165.12 33.56 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 O-C-N 124.189 1.626 . . . . 0.0 110.548 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -129.28 107.44 9.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.339 -0.851 . . . . 0.0 109.918 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 68' ' ' ASN . 3.0 t -61.17 83.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.276 -0.89 . . . . 0.0 109.466 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 115' ' ' LYS . 3.3 m -101.86 -169.68 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-O 121.945 0.879 . . . . 0.0 110.89 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.47 ' HG2' ' CE1' ' A' ' 93' ' ' TYR . 6.7 mtm-85 . . . . . 0 C--N 1.291 -1.953 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.211 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.504 HG21 ' N ' ' A' ' 2' ' ' LYS . 5.8 p . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.27 0.557 . . . . 0.0 110.241 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.504 ' N ' HG21 ' A' ' 1' ' ' VAL . 3.1 mtpp -119.78 174.73 6.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.412 -179.722 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.553 ' O ' ' N ' ' A' ' 21' ' ' TYR . 1.1 m -113.54 89.75 3.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.35 -0.844 . . . . 0.0 110.56 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.41 ' O ' ' C ' ' A' ' 5' ' ' SER . 18.7 mt-30 -69.68 172.11 7.99 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.021 -1.05 . . . . 0.0 109.844 179.6 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 19' ' ' ASP . 1.1 p -42.12 141.95 1.28 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 110.138 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.61 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 51.1 Cg_endo -71.8 154.89 58.8 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.029 1.542 . . . . 0.0 111.019 -179.494 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -74.74 172.48 16.17 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.868 1.457 . . . . 0.0 110.005 179.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.7 p -70.98 174.91 5.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.107 -0.996 . . . . 0.0 110.017 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.569 HG22 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -142.8 -170.3 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 122.156 0.979 . . . . 0.0 111.543 179.719 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.523 ' O ' ' CB ' ' A' ' 56' ' ' CYS . 1.2 m -43.54 90.83 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.673 -179.302 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.8 OUTLIER 43.7 53.08 6.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.114 -0.991 . . . . 0.0 110.581 179.827 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.31 147.22 16.15 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.483 ' O ' ' N ' ' A' ' 30' ' ' SER . 1.3 mtp180 -92.98 -167.99 1.85 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.246 -1.149 . . . . 0.0 110.647 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.61 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 17.6 p80 -156.33 -159.19 0.86 Allowed 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.283 0.564 . . . . 0.0 110.543 -179.501 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 13.5 t-20 72.89 141.36 0.06 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.514 -0.741 . . . . 0.0 110.572 179.625 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.54 -57.92 0.19 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -163.63 29.27 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -1.134 . . . . 0.0 110.111 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.72 -178.26 7.19 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.194 -0.941 . . . . 0.0 110.444 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 5' ' ' SER . 24.0 m-20 -124.06 -44.15 2.06 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.417 -0.802 . . . . 0.0 109.976 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -94.92 139.94 30.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 109.94 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.6 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.3 OUTLIER -128.43 -4.67 5.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.254 -0.904 . . . . 0.0 110.625 -179.633 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.517 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 32.2 p 45.86 -97.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.92 . . . . 0.0 111.91 179.768 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.524 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -153.2 158.57 41.93 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.91 -1.119 . . . . 0.0 110.594 -178.51 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.53 25.65 75.36 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 179.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.6 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -114.43 171.21 7.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.416 -1.049 . . . . 0.0 110.2 -179.763 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 40.6 t -143.08 153.93 16.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.518 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.579 HG13 ' CD1' ' A' ' 29' ' ' TYR . 18.8 t -132.86 123.7 49.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.62 -179.262 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -76.31 103.04 6.13 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.937 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.618 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 2.4 m-30 -68.12 127.27 32.29 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.412 -0.805 . . . . 0.0 110.349 -178.13 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -71.53 158.21 36.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.561 179.451 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.451 ' SG ' HD11 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -133.6 156.82 47.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.113 -0.992 . . . . 0.0 110.337 -179.808 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.36 129.24 37.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.269 -0.894 . . . . 0.0 110.067 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 t -46.57 122.71 4.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 0.0 110.592 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.25 -40.85 1.89 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.423 ' CE1' HG13 ' A' ' 58' ' ' ILE . 7.9 m-85 -90.86 155.45 18.75 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -1.155 . . . . 0.0 110.786 -179.504 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.62 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -91.45 141.45 28.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.404 -0.81 . . . . 0.0 110.205 179.541 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.502 ' HA ' ' O ' ' A' ' 55' ' ' THR . 0.6 OUTLIER -92.9 97.4 10.72 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.275 -0.89 . . . . 0.0 109.531 179.207 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.556 ' CD1' ' N ' ' A' ' 38' ' ' ILE . 0.5 OUTLIER -85.81 142.79 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.421 -0.799 . . . . 0.0 108.985 179.847 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.57 -154.11 21.94 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 42' ' ' GLY . 15.6 p-10 -110.73 51.86 0.75 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.168 -1.195 . . . . 0.0 110.541 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.502 ' C ' ' O ' ' A' ' 40' ' ' ASN . 75.4 p 28.0 38.6 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.904 179.657 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 40' ' ' ASN . . . 169.09 125.99 0.82 Allowed Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.452 -1.356 . . . . 0.0 110.125 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.618 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 2.0 t -71.94 -178.1 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -1.113 . . . . 0.0 108.092 179.026 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 25' ' ' SER . 2.5 tp -144.59 99.48 3.36 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.251 -0.979 . . . . 0.0 110.225 179.05 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.587 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -87.15 110.17 19.95 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.055 -1.058 . . . . 0.0 109.438 178.686 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.7 p -128.64 123.19 32.59 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.032 -179.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.524 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 76.24 35.85 41.76 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.876 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.19 40.88 97.05 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 1.8 mt-10 -157.95 128.94 6.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.379 -1.071 . . . . 0.0 110.292 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.587 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 84.2 m95 -82.46 138.53 34.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.792 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -143.73 157.89 44.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.163 -0.961 . . . . 0.0 111.011 -179.574 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.507 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER 63.2 65.46 1.31 Allowed Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.631 -0.668 . . . . 0.0 111.0 179.606 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.507 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.5 Cg_endo -90.64 140.95 3.12 Favored 'Trans proline' 0 C--N 1.301 -1.967 0 C-N-CA 121.851 1.701 . . . . 0.0 109.972 179.158 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.52 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 46.9 Cg_endo -78.71 175.56 10.87 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.729 1.383 . . . . 0.0 110.233 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.528 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 11.1 p -124.38 158.82 31.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.207 -0.933 . . . . 0.0 111.438 -178.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.523 ' CB ' ' O ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -116.06 78.37 1.18 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.177 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.455 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -117.2 -158.51 0.7 Allowed 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.875 -178.922 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.484 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -116.06 142.71 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.92 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.64 ' CG1' ' HA ' ' A' ' 105' ' ' PRO . 12.7 m -127.88 43.05 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.825 -1.172 . . . . 0.0 111.559 -178.663 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -80.91 95.23 6.68 Favored 'General case' 0 C--N 1.281 -2.384 0 C-N-CA 119.071 -1.052 . . . . 0.0 108.593 179.014 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.467 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 32.3 m -69.28 162.33 66.81 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.356 -0.84 . . . . 0.0 111.153 -178.481 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 49.6 Cg_endo -72.97 -92.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 124.471 1.774 . . . . 0.0 110.349 -179.521 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.465 ' C ' ' CD1' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -155.82 137.45 9.65 Favored Pre-proline 0 C--N 1.299 -1.611 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.62 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.632 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 52.2 Cg_endo -77.82 62.61 7.91 Favored 'Trans proline' 0 C--N 1.294 -2.336 0 O-C-N 123.525 1.277 . . . . 0.0 109.072 -179.161 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.469 ' O ' HD22 ' A' ' 113' ' ' LEU . 0.8 OUTLIER -75.66 166.82 22.98 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.098 -179.634 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.587 ' CD1' ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -165.87 164.74 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 C-N-CA 118.75 -1.18 . . . . 0.0 110.716 179.81 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.432 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -71.06 95.49 1.21 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.483 -0.761 . . . . 0.0 110.482 -179.534 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.452 ' O ' ' SG ' ' A' ' 116' ' ' CYS . 3.8 m-20 45.67 51.41 10.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 110.593 179.572 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.555 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -162.12 38.9 0.38 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.771 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.557 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 50.2 p90 -49.54 -152.53 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.898 1.333 . . . . 0.0 112.958 -179.393 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.572 HD21 ' CZ ' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -141.07 120.56 13.2 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.031 -176.383 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.2 t -100.78 17.9 20.82 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.615 -0.678 . . . . 0.0 109.414 -179.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.9 t -77.98 -79.2 0.12 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.582 -0.699 . . . . 0.0 111.255 -179.166 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.49 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -122.76 -66.16 0.22 Allowed Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.632 -178.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.565 ' HB2' ' CD1' ' A' ' 71' ' ' LEU . 52.1 t80 58.71 167.0 0.05 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.571 -0.958 . . . . 0.0 110.255 -179.144 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.583 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 17.7 tttm -178.14 145.3 0.36 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.408 -0.807 . . . . 0.0 109.748 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -41.79 -32.43 0.4 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.17 -0.956 . . . . 0.0 110.244 -179.824 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.9 m -147.33 166.97 25.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.481 -0.762 . . . . 0.0 110.297 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.583 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 8.7 m-85 -140.5 -172.15 3.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.244 -0.91 . . . . 0.0 110.031 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.553 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 6.6 t -170.24 109.63 0.38 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.935 -1.103 . . . . 0.0 111.161 179.734 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.617 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 14.1 t80 32.75 32.64 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.307 -0.871 . . . . 0.0 111.663 179.164 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.545 ' N ' ' O ' ' A' ' 103' ' ' CYS . 49.9 t30 -176.63 -134.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.642 -1.286 . . . . 0.0 110.522 179.342 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 50.65 69.66 0.61 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.056 -1.027 . . . . 0.0 109.019 -178.695 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.554 ' N ' HG21 ' A' ' 102' ' ' THR . 16.2 p30 -69.75 131.88 45.24 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.486 -0.759 . . . . 0.0 110.09 -179.204 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.591 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 16.2 m -119.27 122.25 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.054 -1.029 . . . . 0.0 111.018 -179.723 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -79.73 138.76 37.4 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.481 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.572 ' CZ ' HD21 ' A' ' 71' ' ' LEU . 72.5 m-85 -93.59 146.6 23.69 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.918 -1.114 . . . . 0.0 112.215 -178.07 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -118.82 89.93 3.23 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.65 -179.765 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.447 ' HB2' HD13 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -42.08 131.16 3.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 0.0 110.249 -179.653 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 89' ' ' CYS . 0.1 OUTLIER -38.99 -66.06 0.31 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.527 -0.733 . . . . 0.0 110.624 -179.535 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.585 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER 176.69 141.74 0.07 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.401 -0.812 . . . . 0.0 110.025 179.978 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.583 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 53.35 46.2 64.36 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.946 -1.661 . . . . 0.0 108.946 -179.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.585 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 16.3 m-85 -155.59 152.13 28.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.556 -0.967 . . . . 0.0 109.64 -179.48 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.498 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -112.63 128.18 56.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 110.191 -179.998 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.485 HD22 ' HB2' ' A' ' 114' ' ' PRO . 0.7 OUTLIER -64.39 97.05 0.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -0.91 . . . . 0.0 110.422 -179.879 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.442 ' HB3' HG23 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -78.67 101.1 7.32 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.315 -0.866 . . . . 0.0 109.54 179.469 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.22 -85.37 0.18 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.553 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 2.4 m -158.41 111.69 2.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.329 -1.101 . . . . 0.0 110.641 -179.353 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.8 t -71.65 -5.56 34.57 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.246 -0.909 . . . . 0.0 110.666 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.3 p -138.46 120.02 15.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.115 -0.99 . . . . 0.0 110.185 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 20.9 m -133.65 172.11 13.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.347 -0.845 . . . . 0.0 110.745 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.554 HG21 ' N ' ' A' ' 84' ' ' ASN . 17.1 m -147.51 136.24 21.96 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.385 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.575 ' O ' ' CA ' ' A' ' 81' ' ' TYR . 4.8 t -48.95 96.2 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.145 179.577 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.478 ' CB ' ' HG3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -64.63 174.22 1.32 Allowed Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.082 -1.011 . . . . 0.0 111.902 -178.935 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.64 ' HA ' ' CG1' ' A' ' 59' ' ' VAL . 49.7 Cg_endo -82.04 16.47 1.74 Allowed 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 124.613 1.849 . . . . 0.0 111.559 -178.585 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -119.53 25.81 7.54 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 179.307 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 58' ' ' ILE . 1.9 m-80 61.24 51.63 4.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.746 -0.855 . . . . 0.0 109.932 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.457 ' O ' ' SG ' ' A' ' 61' ' ' CYS . 0.5 OUTLIER -161.91 -176.72 5.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 0.0 110.977 -179.849 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.632 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 51.0 m95 -109.06 102.03 11.05 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.483 -0.76 . . . . 0.0 110.553 -179.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.478 ' HG3' ' CB ' ' A' ' 104' ' ' SER . 0.3 OUTLIER -107.06 140.53 21.5 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.45 -0.781 . . . . 0.0 110.209 -179.746 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.553 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.1 Cg_endo -73.18 172.44 60.46 Favored 'Cis proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.964 -2.098 . . . . 0.0 110.363 -0.355 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.9 OUTLIER -40.25 137.07 1.1 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.393 -0.817 . . . . 0.0 110.966 -179.278 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.529 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -47.83 146.57 3.86 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.448 -0.782 . . . . 0.0 110.162 179.547 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.587 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 39.3 Cg_endo -72.9 167.68 26.67 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 124.38 1.726 . . . . 0.0 111.063 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.49 ' O ' HG23 ' A' ' 117' ' ' VAL . 3.3 ttpt -127.32 109.68 12.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.386 -0.821 . . . . 0.0 110.801 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.531 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.9 t -66.35 90.16 0.15 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.1 -1.0 . . . . 0.0 109.172 179.225 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.498 ' CG2' ' O ' ' A' ' 94' ' ' LYS . 1.7 m -105.69 -176.26 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 121.73 0.776 . . . . 0.0 110.925 -179.386 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.476 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.762 0 C-N-CA 118.927 -1.109 . . . . 0.0 110.616 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.415 ' O ' HG21 ' A' ' 1' ' ' VAL . 16.6 m . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.101 0.477 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.42 166.58 20.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.132 -0.98 . . . . 0.0 110.471 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.506 ' N ' ' O ' ' A' ' 21' ' ' TYR . 0.9 OUTLIER -135.23 83.63 2.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.418 -0.801 . . . . 0.0 109.805 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.84 172.27 0.11 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.05 -1.031 . . . . 0.0 110.229 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 p -52.45 144.02 25.13 Favored Pre-proline 0 C--N 1.301 -1.525 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.071 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.648 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 54.6 Cg_endo -72.35 151.88 54.54 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 123.798 1.42 . . . . 0.0 110.644 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.64 171.49 18.11 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 O-C-N 123.884 1.465 . . . . 0.0 109.722 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.04 177.82 2.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.069 -1.02 . . . . 0.0 109.675 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.461 HD13 ' SG ' ' A' ' 56' ' ' CYS . 0.3 OUTLIER -140.93 -170.47 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 122.155 0.979 . . . . 0.0 111.543 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 48.4 t -37.87 95.66 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.998 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.5 OUTLIER 42.33 27.24 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.304 -0.873 . . . . 0.0 110.41 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -126.93 -176.34 14.44 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.524 ' HG3' ' CB ' ' A' ' 30' ' ' SER . 0.5 OUTLIER -138.24 177.64 7.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.258 -1.142 . . . . 0.0 110.578 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.648 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 10.8 p80 -130.19 132.76 46.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.504 -0.748 . . . . 0.0 110.209 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -154.11 80.04 1.12 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.203 -0.936 . . . . 0.0 110.568 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.99 -117.36 0.24 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.97 27.02 1.83 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -1.156 . . . . 0.0 110.392 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.621 ' CG ' ' CZ ' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -163.37 -179.29 6.44 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.18 -0.95 . . . . 0.0 109.998 179.593 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -135.23 19.25 3.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -0.95 . . . . 0.0 110.302 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.05 49.31 0.85 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 110.433 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.621 ' CZ ' ' CG ' ' A' ' 18' ' ' GLU . 13.1 m-85 -50.42 165.69 0.09 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.066 -1.021 . . . . 0.0 109.443 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.496 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 10.1 p -131.78 -70.25 0.58 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.016 -1.053 . . . . 0.0 110.837 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -159.56 137.46 10.15 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.332 -0.855 . . . . 0.0 109.663 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 79.35 13.92 82.15 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.591 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -96.65 171.81 8.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.518 -0.99 . . . . 0.0 109.828 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 39.5 t -146.76 154.91 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.121 -0.987 . . . . 0.0 110.796 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.515 ' N ' HG11 ' A' ' 26' ' ' VAL . 20.9 t -133.19 117.09 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.613 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.405 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -72.43 102.5 3.2 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 118.45 -1.3 . . . . 0.0 108.032 177.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.639 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 2.3 m-30 -68.04 174.5 3.76 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.422 -0.799 . . . . 0.0 109.959 -178.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.524 ' CB ' ' HG3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -135.36 148.17 49.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.913 . . . . 0.0 109.606 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.404 ' O ' ' C ' ' A' ' 32' ' ' ASN . 57.7 m -118.62 147.95 43.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.168 -0.958 . . . . 0.0 110.311 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 31' ' ' CYS . 1.8 t-20 -44.27 150.95 0.27 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.217 -0.927 . . . . 0.0 109.944 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 88.2 p -55.35 99.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 0.0 110.31 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 134.68 -20.09 3.92 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -98.76 131.59 44.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.252 -1.146 . . . . 0.0 110.288 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.623 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -79.57 144.24 34.05 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.336 -0.852 . . . . 0.0 111.123 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.522 ' HA ' ' O ' ' A' ' 55' ' ' THR . 0.6 OUTLIER -91.99 102.09 14.64 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.475 -0.766 . . . . 0.0 109.205 178.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.579 ' CG2' ' CG ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -90.9 142.68 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.077 -1.015 . . . . 0.0 109.734 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 132.35 -158.94 23.2 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.493 ' O ' ' C ' ' A' ' 41' ' ' SER . 0.3 OUTLIER -98.31 49.34 0.99 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.842 -1.387 . . . . 0.0 109.65 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.493 ' C ' ' O ' ' A' ' 40' ' ' ASN . 0.4 OUTLIER 27.89 57.29 0.1 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.331 179.654 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 27' ' ' VAL . . . 155.63 117.23 0.57 Allowed Glycine 0 N--CA 1.488 2.166 0 C-N-CA 119.465 -1.35 . . . . 0.0 110.023 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.639 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 2.0 t -62.71 -178.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.991 -1.3 . . . . 0.0 108.013 178.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.46 ' HA ' HG21 ' A' ' 26' ' ' VAL . 4.3 tp -144.45 95.11 2.66 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.014 -1.074 . . . . 0.0 110.508 178.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.574 ' SG ' ' CD2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -80.92 110.3 16.31 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.379 178.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.0 t -126.57 111.04 13.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.592 -0.692 . . . . 0.0 110.643 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.07 22.5 38.17 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.463 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 81.01 19.86 66.43 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -140.64 113.64 8.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.099 -1.236 . . . . 0.0 110.526 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.574 ' CD2' ' SG ' ' A' ' 45' ' ' CYS . 87.8 m95 -62.58 138.11 58.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.317 -0.864 . . . . 0.0 109.73 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 52' ' ' ASP . 3.5 m -141.84 171.61 13.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.102 -0.999 . . . . 0.0 111.417 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.467 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER 37.29 67.65 1.82 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.912 -0.493 . . . . 0.0 111.593 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.467 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.0 Cg_endo -90.66 144.03 3.65 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 O-C-N 124.327 1.698 . . . . 0.0 109.592 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.518 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 45.9 Cg_endo -74.68 171.26 18.55 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.618 1.325 . . . . 0.0 110.35 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.542 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 15.7 p -114.18 169.16 9.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.163 -0.961 . . . . 0.0 111.468 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.461 ' SG ' HD13 ' A' ' 9' ' ' ILE . 37.8 m -126.73 79.32 1.86 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -114.82 -170.8 1.81 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 120.161 -0.615 . . . . 0.0 110.135 -178.746 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -107.92 112.87 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.192 -0.943 . . . . 0.0 108.504 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.66 ' CG1' ' HA ' ' A' ' 105' ' ' PRO . 6.0 m -95.92 83.14 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.051 -1.031 . . . . 0.0 111.612 -178.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.2 mtmt -120.31 96.36 5.11 Favored 'General case' 0 C--N 1.289 -2.059 0 O-C-N 120.417 -1.427 . . . . 0.0 108.657 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.48 ' SG ' ' HB2' ' A' ' 79' ' ' TYR . 4.5 p -68.06 162.52 59.03 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.412 -0.805 . . . . 0.0 111.659 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 61' ' ' CYS . 42.9 Cg_endo -70.47 -89.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.832 0 O-C-N 124.696 1.892 . . . . 0.0 110.286 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.416 ' CD2' ' O ' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -160.51 130.54 3.45 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.593 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 50.9 Cg_endo -77.32 70.85 6.61 Favored 'Trans proline' 0 C--N 1.294 -2.322 0 O-C-N 123.787 1.414 . . . . 0.0 109.818 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.545 ' O ' ' CD2' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -93.45 -175.78 3.91 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.121 -0.987 . . . . 0.0 109.512 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.545 ' CD1' ' HG2' ' A' ' 114' ' ' PRO . 0.4 OUTLIER 177.88 167.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.059 -1.026 . . . . 0.0 110.573 178.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.552 ' O ' ' CB ' ' A' ' 68' ' ' ASN . 2.9 m -64.19 73.15 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.568 -0.708 . . . . 0.0 111.323 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 67' ' ' SER . 0.5 OUTLIER 75.2 -16.72 0.55 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.432 -0.793 . . . . 0.0 111.933 179.093 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.573 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -86.32 35.52 3.3 Favored Glycine 0 N--CA 1.491 2.354 0 O-C-N 120.733 -1.23 . . . . 0.0 110.425 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.573 ' O ' ' O ' ' A' ' 69' ' ' GLY . 2.2 p90 -43.15 -173.49 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 122.712 1.244 . . . . 0.0 112.526 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.536 ' C ' ' CD2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -113.31 161.49 17.18 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.272 178.795 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.8 t -146.97 22.07 1.23 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.173 -0.954 . . . . 0.0 109.917 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.39 -51.37 2.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 0.0 110.898 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -153.44 88.67 0.13 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.592 ' CE2' ' OH ' ' A' ' 79' ' ' TYR . 1.8 t80 -126.3 117.27 22.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -1.133 . . . . 0.0 110.177 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.62 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 28.2 tttt -113.79 148.06 37.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.201 -0.937 . . . . 0.0 109.656 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.462 ' C ' ' O ' ' A' ' 76' ' ' LYS . 1.3 ttm-85 -42.0 -27.41 0.12 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.968 -1.082 . . . . 0.0 109.873 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 76' ' ' LYS . 40.5 m -140.94 147.12 38.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.525 -0.734 . . . . 0.0 110.283 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.672 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -144.03 178.92 7.53 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.218 -0.926 . . . . 0.0 109.583 179.553 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.57 ' O ' ' O ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -170.43 137.85 1.47 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.067 -1.021 . . . . 0.0 110.315 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.62 ' O ' ' CB ' ' A' ' 82' ' ' ASN . 6.6 t80 25.49 105.44 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 120.988 0.423 . . . . 0.0 111.982 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.62 ' CB ' ' O ' ' A' ' 81' ' ' TYR . 10.6 m-20 96.4 -134.86 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 123.373 0.669 . . . . 0.0 109.699 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.463 ' C ' HG21 ' A' ' 102' ' ' THR . 14.2 m-20 52.91 67.65 0.96 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.735 -1.228 . . . . 0.0 108.93 -178.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.521 ' N ' HG21 ' A' ' 102' ' ' THR . 8.1 p30 -69.69 113.04 6.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.556 -0.715 . . . . 0.0 110.969 -178.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.592 HG12 ' CH2' ' A' ' 109' ' ' TRP . 30.0 m -94.16 117.58 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.115 -0.991 . . . . 0.0 110.102 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -79.61 131.8 36.09 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.019 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 54.6 m-85 -92.37 116.5 29.03 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.962 -1.087 . . . . 0.0 112.154 -178.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -88.38 94.82 9.97 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.389 179.143 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.535 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 1.7 t -48.17 119.26 2.83 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.036 -1.04 . . . . 0.0 110.466 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.51 ' CG ' ' O ' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -57.17 125.05 20.95 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.227 -0.921 . . . . 0.0 109.96 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.48 ' HB2' ' O ' ' A' ' 90' ' ' LYS . 2.3 m-85 62.44 -174.5 0.14 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.171 -0.956 . . . . 0.0 111.351 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.46 54.73 0.9 Allowed Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.543 ' CB ' ' SG ' ' A' ' 116' ' ' CYS . 5.5 m-85 -106.34 158.08 17.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.325 -1.103 . . . . 0.0 109.448 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.54 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 9.6 mtmm -99.9 141.6 32.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.073 -1.017 . . . . 0.0 109.655 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.532 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 1.2 mt -87.2 94.11 9.57 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.581 -1.325 . . . . 0.0 110.057 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.548 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -69.61 101.14 1.57 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.233 -0.917 . . . . 0.0 109.127 179.38 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.13 -96.75 0.21 Allowed Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.202 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.576 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 3.3 m -150.19 116.59 5.75 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.165 -1.197 . . . . 0.0 110.577 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.403 ' HB3' HD11 ' A' ' 95' ' ' LEU . 42.8 p -77.17 10.3 2.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.235 -0.915 . . . . 0.0 111.293 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 77.0 p -154.42 99.4 2.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.849 -1.157 . . . . 0.0 110.48 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.482 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 3.5 m -111.57 -174.43 2.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.367 -0.833 . . . . 0.0 110.056 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' A' ' 82' ' ' ASN . 5.8 m -155.88 144.19 20.03 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.481 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.616 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 42.7 t -65.07 86.15 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.672 -0.642 . . . . 0.0 109.386 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.456 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -62.56 176.57 0.49 Allowed Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.194 -0.941 . . . . 0.0 112.731 -178.148 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.66 ' HA ' ' CG1' ' A' ' 59' ' ' VAL . 46.5 Cg_endo -80.37 12.5 2.52 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 124.848 1.973 . . . . 0.0 111.777 -178.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -118.46 18.22 11.04 Favored Glycine 0 C--N 1.294 -1.757 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 107' ' ' ASN . 1.2 m120 65.22 66.99 0.53 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.696 -0.885 . . . . 0.0 109.796 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -168.59 -172.84 1.75 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.227 -0.989 . . . . 0.0 111.497 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.616 ' CZ3' ' N ' ' A' ' 103' ' ' CYS . 41.2 m95 -123.3 95.68 4.69 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.571 0.7 . . . . 0.0 110.132 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.49 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -108.33 146.09 32.87 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.537 -0.727 . . . . 0.0 110.249 -179.537 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.576 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 44.3 Cg_endo -72.65 173.37 54.31 Favored 'Cis proline' 0 C--N 1.315 -1.235 0 C-N-CA 121.697 -2.21 . . . . 0.0 110.534 -0.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.3 mm-40 -36.93 131.05 0.76 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.657 -0.652 . . . . 0.0 111.551 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.545 ' CD2' ' O ' ' A' ' 65' ' ' THR . 0.2 OUTLIER -43.93 154.5 0.37 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.482 -0.761 . . . . 0.0 109.749 179.003 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.545 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 41.4 Cg_endo -83.59 171.67 10.77 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 O-C-N 124.092 1.575 . . . . 0.0 111.433 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.548 ' HB3' ' CB ' ' A' ' 96' ' ' SER . 3.3 ttpt -129.82 109.65 11.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.366 -0.834 . . . . 0.0 110.2 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.543 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.0 OUTLIER -69.12 108.54 3.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.153 -0.967 . . . . 0.0 109.257 179.715 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.54 ' CG2' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -118.95 -174.54 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.635 0.731 . . . . 0.0 110.195 -179.274 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.428 ' HD3' ' OH ' ' A' ' 93' ' ' TYR . 26.4 mtm180 . . . . . 0 C--N 1.292 -1.9 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.221 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 53.8 t . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.247 0.546 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.434 ' HA ' HG23 ' A' ' 22' ' ' THR . 0.1 OUTLIER -136.17 100.2 4.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.329 -0.857 . . . . 0.0 110.387 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.559 ' O ' ' N ' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -69.72 88.22 0.52 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.213 -0.929 . . . . 0.0 109.779 179.566 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.469 ' O ' ' C ' ' A' ' 5' ' ' SER . 1.1 pt20 -85.43 -174.02 4.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.04 -1.037 . . . . 0.0 110.064 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.469 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.3 OUTLIER -38.3 127.39 1.07 Allowed Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 120.306 -0.557 . . . . 0.0 109.569 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.617 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 45.6 Cg_endo -66.31 154.76 72.96 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.902 1.475 . . . . 0.0 111.509 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -75.49 171.52 18.07 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.115 1.587 . . . . 0.0 110.487 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.69 176.0 3.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 110.014 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.526 HG22 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -141.57 -170.28 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-O 122.143 0.973 . . . . 0.0 111.463 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.8 OUTLIER -40.78 95.26 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.26 -179.468 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.49 ' N ' ' O ' ' A' ' 9' ' ' ILE . 2.4 m-20 43.08 41.39 2.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 110.352 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' A' ' 30' ' ' SER . . . -146.11 158.23 27.62 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.509 ' HG3' ' CB ' ' A' ' 30' ' ' SER . 4.5 ptt180 -113.82 -179.85 3.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.233 -1.157 . . . . 0.0 110.325 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.617 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 11.5 p80 -128.98 133.42 47.78 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.629 -0.669 . . . . 0.0 110.049 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -136.62 96.36 3.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.052 -1.03 . . . . 0.0 110.877 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.22 179.59 30.99 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.401 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 5.1 t80 -105.91 46.16 0.94 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.078 -1.248 . . . . 0.0 110.245 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.602 ' CG ' ' CZ ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -175.82 -159.7 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.924 . . . . 0.0 110.392 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.5 -27.41 1.05 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.434 -0.791 . . . . 0.0 110.81 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.416 ' C ' ' OE2' ' A' ' 18' ' ' GLU . 25.8 m-85 -109.74 101.98 10.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.02 -1.05 . . . . 0.0 110.849 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.629 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 2.5 m-85 -102.4 44.9 0.99 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.57 -0.706 . . . . 0.0 109.604 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.491 ' O ' ' O ' ' A' ' 23' ' ' ASP . 24.9 p -53.98 99.8 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.1 0.952 . . . . 0.0 111.718 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 9.8 t70 50.15 165.28 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 121.794 0.807 . . . . 0.0 111.905 178.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.501 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 46.32 26.15 2.24 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.629 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 35.5 m -109.6 154.88 22.15 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.387 -1.066 . . . . 0.0 110.263 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 50.5 t -139.14 153.91 25.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.411 -0.915 . . . . 0.0 110.608 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.584 HG22 ' CH2' ' A' ' 50' ' ' TRP . 28.7 t -141.55 117.39 6.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.384 -0.927 . . . . 0.0 111.245 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.412 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -69.34 102.97 1.86 Allowed 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 118.469 -1.292 . . . . 0.0 107.669 178.256 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.638 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 2.5 m-30 -67.89 177.99 1.93 Allowed 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.749 -0.781 . . . . 0.0 109.979 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.509 ' CB ' ' HG3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -140.77 151.2 44.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 109.708 179.727 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.418 ' O ' ' C ' ' A' ' 32' ' ' ASN . 87.6 m -122.67 149.66 43.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.159 -0.963 . . . . 0.0 110.693 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.418 ' C ' ' O ' ' A' ' 31' ' ' CYS . 5.4 p-10 -42.48 145.55 0.41 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.46 -0.775 . . . . 0.0 110.175 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.4 129.17 31.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.187 -0.946 . . . . 0.0 110.486 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.87 -27.79 15.17 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 -89.39 162.81 15.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.103 -1.233 . . . . 0.0 110.349 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.595 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.9 OUTLIER -103.29 147.33 27.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.406 -0.809 . . . . 0.0 110.964 -179.158 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.52 ' HA ' ' O ' ' A' ' 55' ' ' THR . 6.3 tt -100.99 96.35 7.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.307 -0.871 . . . . 0.0 109.688 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.573 ' CD1' ' N ' ' A' ' 38' ' ' ILE . 0.3 OUTLIER -93.13 139.64 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 109.09 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 150.91 -126.97 2.23 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.506 ' O ' ' C ' ' A' ' 41' ' ' SER . 4.6 m120 -135.16 50.15 2.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -1.164 . . . . 0.0 109.54 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.506 ' C ' ' O ' ' A' ' 40' ' ' ASN . 2.1 p 25.46 54.84 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.345 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 28' ' ' THR . . . 150.86 113.42 0.6 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.638 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 1.9 t -64.65 -177.99 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.161 -1.2 . . . . 0.0 107.821 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.47 ' HA ' ' O ' ' A' ' 25' ' ' SER . 2.3 tp -146.65 97.89 2.98 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.286 -0.966 . . . . 0.0 110.702 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.595 ' SG ' ' CD2' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -75.08 114.1 13.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.081 -1.012 . . . . 0.0 109.165 178.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 85.1 p -129.73 92.74 3.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.57 -0.706 . . . . 0.0 110.219 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.99 39.42 2.68 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.04 11.92 53.11 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -133.3 120.16 20.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -1.183 . . . . 0.0 110.316 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.595 ' CD2' ' SG ' ' A' ' 45' ' ' CYS . 73.7 m95 -62.93 137.97 58.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.284 -0.885 . . . . 0.0 109.829 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.2 m -136.63 163.99 29.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.153 -0.967 . . . . 0.0 111.032 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.485 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 3.8 m-20 53.45 66.13 4.94 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.615 -0.678 . . . . 0.0 111.198 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.485 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.7 Cg_endo -90.37 135.85 2.23 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 O-C-N 124.288 1.678 . . . . 0.0 109.643 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.575 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 42.3 Cg_endo -71.54 178.61 5.46 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.591 1.311 . . . . 0.0 110.378 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.52 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 5.3 p -121.99 163.13 19.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.372 -0.83 . . . . 0.0 112.028 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 10' ' ' SER . 86.9 m -116.57 85.59 2.34 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -120.32 -141.23 0.34 Allowed 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.45 0.643 . . . . 0.0 110.405 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.488 ' CD1' ' N ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -136.32 127.13 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.297 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.63 ' HB ' ' HA ' ' A' ' 105' ' ' PRO . 34.0 m -123.08 49.28 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.031 -1.043 . . . . 0.0 111.61 -178.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 15.0 mtmt -55.99 -179.17 0.02 OUTLIER 'General case' 0 C--N 1.28 -2.431 0 C-N-CA 117.988 -1.485 . . . . 0.0 107.978 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.55 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -145.38 163.39 32.33 Favored Pre-proline 0 C--N 1.297 -1.705 0 C-N-CA 118.707 -1.197 . . . . 0.0 112.297 -179.048 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 42.8 Cg_endo -83.66 -71.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.748 1.92 . . . . 0.0 109.639 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.551 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 162.02 129.46 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.579 ' HG3' ' CZ2' ' A' ' 109' ' ' TRP . 49.7 Cg_endo -77.12 69.43 7.07 Favored 'Trans proline' 0 C--N 1.299 -2.065 0 O-C-N 123.721 1.38 . . . . 0.0 110.178 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.544 ' O ' ' CD2' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -99.38 139.31 35.22 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.562 ' CD1' ' HG2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -131.71 159.29 43.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 C-N-CA 118.594 -1.243 . . . . 0.0 111.057 -178.712 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 0.1 OUTLIER -58.66 111.85 1.41 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.752 -0.592 . . . . 0.0 111.239 -179.339 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 51.32 25.04 2.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.298 -0.876 . . . . 0.0 109.756 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.433 ' HA3' HG12 ' A' ' 66' ' ' ILE . . . -132.45 -177.41 14.9 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.531 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 37.1 p90 -178.54 -172.59 0.29 Allowed 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.541 -0.976 . . . . 0.0 109.388 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.594 ' O ' ' CD2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -126.44 151.49 47.67 Favored 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.709 178.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.2 t -113.65 -6.72 13.35 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.943 -1.098 . . . . 0.0 109.927 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.93 -80.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.378 -0.826 . . . . 0.0 110.259 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -169.79 93.03 0.1 Allowed Glycine 0 N--CA 1.488 2.162 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.167 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.604 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -86.22 174.95 8.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.359 -1.083 . . . . 0.0 109.171 179.219 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.566 ' N ' ' CG ' ' A' ' 75' ' ' PHE . 4.7 tttt -159.68 159.5 33.05 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.317 -0.864 . . . . 0.0 110.256 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.67 -39.63 17.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.898 . . . . 0.0 109.867 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.58 136.66 18.49 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.507 -0.746 . . . . 0.0 110.099 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.604 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 43.6 m-85 -99.29 -162.17 0.93 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.916 . . . . 0.0 109.774 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.53 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 85.6 p -146.59 -104.45 0.1 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -0.895 . . . . 0.0 109.083 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.604 ' CE2' ' ND2' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -111.91 145.14 40.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.818 -1.177 . . . . 0.0 107.904 178.718 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.604 ' ND2' ' CE2' ' A' ' 81' ' ' TYR . 1.6 m120 61.32 -99.43 0.09 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.375 -0.828 . . . . 0.0 110.153 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.469 ' C ' ' O ' ' A' ' 82' ' ' ASN . 10.3 m-20 41.14 79.48 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.995 -1.066 . . . . 0.0 109.238 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.588 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 21.5 t-20 -75.39 143.85 42.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.389 -0.819 . . . . 0.0 112.286 -177.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.593 ' CG2' ' CZ3' ' A' ' 109' ' ' TRP . 4.5 m -132.37 115.07 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.437 -0.789 . . . . 0.0 109.44 177.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.553 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 2.7 t70 -75.54 134.64 40.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.315 -0.866 . . . . 0.0 108.992 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.569 ' CE1' HD11 ' A' ' 71' ' ' LEU . 45.0 m-85 -94.63 142.47 27.4 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 118.682 -1.207 . . . . 0.0 112.253 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -120.12 98.71 6.2 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.581 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.491 ' HB2' HD13 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -46.92 129.49 11.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.133 -0.979 . . . . 0.0 110.457 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.435 ' O ' ' O ' ' A' ' 89' ' ' CYS . 6.8 mmtp -44.37 -92.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.29 -0.881 . . . . 0.0 110.173 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.556 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 1.9 t80 -152.73 158.81 42.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.211 -0.931 . . . . 0.0 110.049 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.588 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 45.31 25.85 1.32 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.588 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 18.0 m-85 -141.45 147.39 37.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.401 -1.058 . . . . 0.0 110.395 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.1 ptmm? -117.83 129.96 55.98 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.294 -0.879 . . . . 0.0 109.897 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.525 ' CD2' ' HB3' ' A' ' 87' ' ' PHE . 1.2 mt -57.12 103.0 0.1 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.186 -0.946 . . . . 0.0 110.8 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.539 ' CB ' HG23 ' A' ' 117' ' ' VAL . 3.0 t -85.96 91.36 8.35 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.22 -0.925 . . . . 0.0 109.053 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 152.2 -91.27 0.13 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.557 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -149.41 118.85 6.89 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.159 -1.2 . . . . 0.0 110.83 -179.432 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.435 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -80.88 13.71 2.54 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.25 -0.906 . . . . 0.0 110.918 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 60.2 p -152.91 113.41 4.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.123 -0.985 . . . . 0.0 109.72 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.479 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 13.0 m -124.6 -177.36 3.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 110.971 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -153.49 128.2 9.43 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.685 0.755 . . . . 0.0 110.21 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.587 ' N ' ' O ' ' A' ' 82' ' ' ASN . 4.7 t -66.09 81.5 0.08 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.447 ' HB3' ' HD2' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -64.38 173.75 1.41 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.342 -0.849 . . . . 0.0 110.988 -179.152 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.63 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 41.7 Cg_endo -73.18 120.49 6.6 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 O-C-N 124.586 1.835 . . . . 0.0 110.859 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.557 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 131.51 -6.06 5.57 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 1.6 m-20 81.0 93.61 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.916 -0.755 . . . . 0.0 111.361 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.527 ' CG2' ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 175.02 -168.34 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.475 -0.766 . . . . 0.0 111.198 179.024 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.593 ' CZ3' ' CG2' ' A' ' 85' ' ' VAL . 36.9 m95 -142.14 94.08 2.62 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.579 -0.7 . . . . 0.0 110.03 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.488 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 14.7 mmtt -103.61 147.17 33.82 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.367 -0.833 . . . . 0.0 110.086 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.557 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.1 Cg_endo -71.98 175.27 43.53 Favored 'Cis proline' 0 N--CA 1.49 1.28 0 C-N-CA 121.956 -2.102 . . . . 0.0 110.956 0.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 113' ' ' LEU . 12.7 pt-20 -37.68 122.39 0.95 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.684 -0.635 . . . . 0.0 110.986 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.549 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.9 OUTLIER -41.24 141.14 1.1 Allowed Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.517 -0.739 . . . . 0.0 110.174 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.562 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 40.4 Cg_endo -69.8 159.42 53.43 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 124.206 1.635 . . . . 0.0 110.851 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 117' ' ' VAL . 3.2 ttpm? -119.43 101.34 7.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.919 . . . . 0.0 110.281 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.534 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 4.6 t -61.77 82.3 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.052 -1.03 . . . . 0.0 108.894 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.539 HG23 ' CB ' ' A' ' 96' ' ' SER . 4.5 m -96.48 -171.61 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-O 121.942 0.877 . . . . 0.0 111.37 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.418 ' HG2' ' CE1' ' A' ' 93' ' ' TYR . 9.0 mtm180 . . . . . 0 C--N 1.293 -1.877 0 C-N-CA 119.152 -1.019 . . . . 0.0 110.446 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.55 ' CG2' ' HA3' ' A' ' 48' ' ' GLY . 4.7 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.227 0.537 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -141.51 176.67 8.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.197 -0.939 . . . . 0.0 110.388 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.524 ' O ' ' N ' ' A' ' 21' ' ' TYR . 1.1 m -130.13 87.74 2.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.406 -0.809 . . . . 0.0 110.37 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -70.86 175.4 5.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.815 -1.178 . . . . 0.0 109.926 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -44.09 141.41 2.47 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.31 -0.868 . . . . 0.0 109.977 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.614 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 53.2 Cg_endo -70.71 156.38 60.98 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 124.015 1.534 . . . . 0.0 110.845 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -75.23 174.92 11.97 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.955 1.503 . . . . 0.0 110.093 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.38 -179.92 1.81 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.186 -0.946 . . . . 0.0 110.389 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.55 HG22 ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -145.11 -170.23 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 122.206 1.003 . . . . 0.0 111.45 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.2 OUTLIER -45.1 92.75 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.387 -179.597 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.506 ' N ' ' O ' ' A' ' 9' ' ' ILE . 27.6 m-20 42.62 53.19 4.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.271 -0.893 . . . . 0.0 110.205 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.14 163.66 32.01 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 30' ' ' SER . 10.1 ptp180 -114.92 -178.38 3.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -1.148 . . . . 0.0 110.438 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.614 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 18.1 p80 -136.67 124.21 22.22 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.67 -0.644 . . . . 0.0 110.107 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -133.74 96.12 3.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 110.53 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.25 16.72 58.84 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.438 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 5.7 m-85 53.36 56.46 7.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.356 -1.084 . . . . 0.0 110.162 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.473 ' CD ' ' CE2' ' A' ' 21' ' ' TYR . 0.3 OUTLIER 179.93 -165.25 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.341 -0.849 . . . . 0.0 110.096 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -138.48 -39.98 0.51 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 109.815 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -110.64 136.03 50.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.406 -0.809 . . . . 0.0 109.721 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.617 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.4 OUTLIER -122.27 -7.01 8.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.921 . . . . 0.0 110.605 -179.541 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.523 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 38.2 p 46.06 -95.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.6 -0.687 . . . . 0.0 111.824 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.413 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 1.0 OUTLIER -153.95 151.21 29.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.772 -1.205 . . . . 0.0 110.637 -178.732 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.57 29.92 54.35 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.617 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -121.79 169.7 10.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.356 -1.084 . . . . 0.0 110.552 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 24.2 t -142.52 156.29 18.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.888 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.564 HG13 ' CD1' ' A' ' 29' ' ' TYR . 11.9 t -131.19 124.75 56.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.433 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.85 101.91 8.81 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 118.541 -1.264 . . . . 0.0 107.613 177.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.678 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 1.8 m-30 -68.29 122.11 17.67 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.644 -0.823 . . . . 0.0 110.024 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -86.61 144.69 27.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -0.975 . . . . 0.0 109.574 179.423 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 37' ' ' LEU . 33.9 m -102.48 171.43 7.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.152 -0.968 . . . . 0.0 110.563 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -72.03 163.87 27.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -0.894 . . . . 0.0 110.096 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.48 99.84 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 0.0 110.693 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.99 19.29 9.16 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.46 ' CE1' HG13 ' A' ' 58' ' ' ILE . 6.9 m-85 -117.17 124.47 49.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.049 -1.265 . . . . 0.0 110.185 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.554 ' OG ' ' CG2' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -74.88 140.5 43.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.35 -0.844 . . . . 0.0 111.261 -179.549 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 55' ' ' THR . 2.7 tp -92.63 106.95 18.84 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.515 -0.741 . . . . 0.0 109.35 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.568 ' HB ' ' OG1' ' A' ' 55' ' ' THR . 0.2 OUTLIER -98.43 155.91 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.151 -0.968 . . . . 0.0 109.394 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.67 175.87 38.44 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.476 ' O ' ' HG3' ' A' ' 54' ' ' PRO . 2.5 m120 -50.82 143.69 9.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -1.152 . . . . 0.0 109.873 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 76.2 p -80.09 51.94 1.45 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -0.95 . . . . 0.0 110.161 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 27' ' ' VAL . . . 161.23 122.87 0.64 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.678 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 1.4 t -65.62 177.45 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.108 -1.231 . . . . 0.0 108.423 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.5 ' C ' ' CD2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -141.34 93.4 2.57 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.416 179.308 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.609 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -81.51 110.65 17.1 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.935 -1.106 . . . . 0.0 109.122 178.695 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.33 97.15 3.22 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.568 -0.708 . . . . 0.0 110.034 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.413 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 108.8 39.58 1.7 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.55 ' HA3' ' CG2' ' A' ' 1' ' ' VAL . . . 60.84 27.7 67.18 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 48' ' ' GLY . 2.7 mt-10 -154.1 132.46 11.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.193 -1.181 . . . . 0.0 110.396 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.609 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 84.8 m95 -82.34 142.85 31.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.882 . . . . 0.0 109.546 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.7 166.1 25.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.902 -1.124 . . . . 0.0 111.499 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.507 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.4 OUTLIER 44.96 65.98 5.72 Favored Pre-proline 0 N--CA 1.496 1.829 0 CA-C-O 121.146 0.498 . . . . 0.0 111.554 179.439 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.507 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.9 Cg_endo -91.33 130.89 1.35 Allowed 'Trans proline' 0 C--N 1.299 -2.04 0 O-C-N 124.342 1.706 . . . . 0.0 109.713 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.479 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.3 Cg_endo -77.47 158.94 32.64 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 123.752 1.396 . . . . 0.0 110.183 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.568 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 38.8 p -99.43 164.18 12.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.246 -0.909 . . . . 0.0 111.184 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 10' ' ' SER . 13.9 m -129.15 74.44 1.58 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.542 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -110.32 -175.43 2.73 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.563 0.697 . . . . 0.0 110.711 -178.025 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.46 HG13 ' CE1' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -96.26 128.77 47.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 80' ' ' SER . 30.7 m -118.55 41.64 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.065 -1.022 . . . . 0.0 111.229 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.552 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 0.9 OUTLIER -52.75 179.42 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.323 0 C-N-CA 118.369 -1.333 . . . . 0.0 108.293 179.665 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.48 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -141.73 169.64 10.8 Favored Pre-proline 0 C--N 1.298 -1.643 0 C-N-CA 118.272 -1.371 . . . . 0.0 113.654 -178.015 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.437 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 46.6 Cg_endo -90.27 -75.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.393 2.062 . . . . 0.0 110.688 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.437 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 170.26 125.31 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.689 -0.632 . . . . 0.0 109.453 -179.125 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.598 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 55.3 Cg_endo -77.94 65.73 8.26 Favored 'Trans proline' 0 C--N 1.299 -2.065 0 O-C-N 123.74 1.389 . . . . 0.0 110.171 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.544 ' N ' HD22 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -83.89 -179.1 7.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.38 -0.825 . . . . 0.0 109.629 179.504 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.537 HD13 ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -179.56 169.49 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.045 -1.035 . . . . 0.0 110.628 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.523 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -74.21 105.76 5.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.572 -0.705 . . . . 0.0 111.037 -179.621 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.499 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 33.0 m120 38.47 38.35 0.23 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.587 -0.696 . . . . 0.0 111.129 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.533 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -144.58 27.85 1.93 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.533 ' O ' ' O ' ' A' ' 69' ' ' GLY . 12.4 p90 -43.64 -175.58 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.653 1.216 . . . . 0.0 112.501 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.575 ' O ' ' CD2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -112.72 157.52 21.2 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.579 179.234 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.7 t -138.69 23.12 2.68 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.932 -1.105 . . . . 0.0 109.806 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -100.93 -79.03 0.51 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.389 -0.819 . . . . 0.0 111.024 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -131.26 78.41 0.37 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -102.46 169.96 8.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.406 -1.055 . . . . 0.0 109.65 179.525 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.603 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 4.8 tttm -169.39 159.09 8.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.307 -0.871 . . . . 0.0 110.234 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.49 -40.08 11.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.365 -0.834 . . . . 0.0 110.091 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.504 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 0.3 OUTLIER -141.59 172.31 12.86 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.477 -0.765 . . . . 0.0 110.049 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.597 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 6.5 m-85 -141.63 -156.18 0.66 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.328 -0.857 . . . . 0.0 109.949 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.56 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 5.4 m -150.72 -111.32 0.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.953 -1.092 . . . . 0.0 110.929 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.619 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -110.32 18.48 19.83 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.691 -1.256 . . . . 0.0 110.509 -179.145 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.508 ' OD1' ' N ' ' A' ' 82' ' ' ASN . 17.7 p-10 -158.02 -114.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.797 -1.189 . . . . 0.0 110.357 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.415 ' C ' HG21 ' A' ' 102' ' ' THR . 5.9 t0 49.85 73.55 0.25 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.738 -1.226 . . . . 0.0 109.2 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 9.4 p30 -69.35 120.69 15.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.306 -0.871 . . . . 0.0 110.252 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.574 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 16.1 m -101.34 120.28 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.06 -1.025 . . . . 0.0 110.511 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.417 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -83.22 125.98 32.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.235 -0.915 . . . . 0.0 108.534 179.112 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.598 ' CG ' ' HG3' ' A' ' 114' ' ' PRO . 72.8 m-85 -86.97 139.21 30.82 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 122.185 0.993 . . . . 0.0 111.827 -178.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -114.43 91.56 3.67 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.809 -179.383 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.485 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.5 OUTLIER -43.35 127.24 4.52 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.259 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 3.3 mmtt -35.58 -77.19 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.682 -178.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.571 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.3 OUTLIER -167.42 135.5 2.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.364 -0.835 . . . . 0.0 110.168 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.583 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 60.27 47.77 89.43 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.583 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 24.3 m-85 -154.28 157.4 38.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.512 -0.993 . . . . 0.0 109.764 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.534 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 36.6 mtpt -118.38 122.26 42.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 110.063 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.535 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 10.1 mt -60.26 104.61 0.33 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.153 -0.967 . . . . 0.0 110.429 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.484 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 12.7 t -92.66 101.98 14.4 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.357 -0.839 . . . . 0.0 109.842 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 98' ' ' SER . . . 146.76 -56.28 0.51 Allowed Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.78 -1.2 . . . . 0.0 110.224 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.552 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 58.8 p 179.49 99.06 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.285 -1.126 . . . . 0.0 110.913 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 53.1 m -65.36 -18.39 65.28 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.121 -0.987 . . . . 0.0 110.372 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.6 p -137.08 101.17 4.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.158 -0.964 . . . . 0.0 109.626 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 85' ' ' VAL . 3.2 m -113.29 168.22 9.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.361 -0.837 . . . . 0.0 111.059 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -139.74 142.29 36.82 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.58 0.705 . . . . 0.0 110.083 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.599 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -73.25 94.77 2.03 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.555 -0.716 . . . . 0.0 110.663 -179.511 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.536 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -69.4 -175.41 0.27 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.375 -0.828 . . . . 0.0 110.959 -179.739 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.556 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 43.2 Cg_endo -81.42 128.52 6.24 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.343 1.707 . . . . 0.0 110.753 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 123.56 -7.65 8.96 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.558 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 1.3 m120 80.92 96.01 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.642 0.734 . . . . 0.0 111.111 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.477 ' CG2' ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 176.25 -159.2 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.485 -0.76 . . . . 0.0 110.654 179.341 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.599 ' CE2' ' SG ' ' A' ' 103' ' ' CYS . 22.6 m95 -145.84 89.95 1.94 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.39 -0.819 . . . . 0.0 110.172 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.452 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 13.6 mttm -100.62 142.77 25.27 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.562 -0.711 . . . . 0.0 110.531 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.552 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.4 Cg_endo -74.19 172.47 61.74 Favored 'Cis proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.68 -2.217 . . . . 0.0 110.266 -0.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.44 ' O ' ' OG ' ' A' ' 98' ' ' SER . 1.3 mp0 -37.6 127.41 1.13 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.466 -0.771 . . . . 0.0 111.439 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.551 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.2 OUTLIER -40.74 150.39 0.29 Allowed Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.492 -0.755 . . . . 0.0 110.192 179.116 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.598 ' HG3' ' CG ' ' A' ' 87' ' ' PHE . 39.6 Cg_endo -76.01 165.95 28.87 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 O-C-N 124.177 1.619 . . . . 0.0 110.937 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.528 ' O ' HG23 ' A' ' 117' ' ' VAL . 12.5 ttpt -129.84 101.8 6.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.268 -0.895 . . . . 0.0 110.034 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.529 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.2 t -55.59 91.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.098 -1.001 . . . . 0.0 109.377 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.534 ' CG2' ' O ' ' A' ' 94' ' ' LYS . 1.5 m -104.8 -177.79 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 121.714 0.768 . . . . 0.0 110.641 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.504 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 5.0 ptt-85 . . . . . 0 C--N 1.295 -1.776 0 C-N-CA 119.014 -1.075 . . . . 0.0 110.549 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 54.4 t . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.318 0.58 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.75 170.3 10.24 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.242 -0.911 . . . . 0.0 110.419 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.558 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.2 m -125.44 142.14 51.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.411 -0.806 . . . . 0.0 109.531 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -113.0 175.86 5.26 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.015 -1.053 . . . . 0.0 109.807 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.57 140.87 56.55 Favored Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 121.298 -0.876 . . . . 0.0 109.734 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.626 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 49.2 Cg_endo -71.49 153.25 60.6 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 O-C-N 124.023 1.538 . . . . 0.0 110.717 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.61 173.01 14.59 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.863 1.454 . . . . 0.0 110.009 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.61 176.44 3.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.917 . . . . 0.0 109.935 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.584 HG22 ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -143.43 -169.61 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 122.194 0.997 . . . . 0.0 111.336 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 11' ' ' ASN . 0.3 OUTLIER -46.61 93.56 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.683 -179.312 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.46 ' N ' ' O ' ' A' ' 9' ' ' ILE . 4.2 m-80 42.08 53.15 4.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.195 -0.941 . . . . 0.0 110.427 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.05 152.59 24.01 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -98.14 -167.76 1.56 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -1.147 . . . . 0.0 110.686 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.626 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 20.7 p80 -153.19 113.04 3.9 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.537 0.684 . . . . 0.0 110.191 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.414 ' O ' ' C ' ' A' ' 16' ' ' GLY . 0.9 OUTLIER -138.78 63.57 1.51 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.101 -0.999 . . . . 0.0 110.098 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 17' ' ' TYR . . . -44.01 -77.11 0.1 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.441 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 9.8 t80 -178.01 36.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -1.113 . . . . 0.0 110.197 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.566 ' OE2' ' CG ' ' A' ' 21' ' ' TYR . 2.0 pt-20 178.5 -161.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.89 . . . . 0.0 110.011 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -117.37 -36.84 3.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.227 -0.92 . . . . 0.0 110.286 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.535 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 21.9 p90 -129.99 123.55 30.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.152 -0.967 . . . . 0.0 110.471 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.621 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 14.0 m-85 -92.08 -167.79 1.85 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.451 -0.78 . . . . 0.0 110.27 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.558 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 0.6 OUTLIER -141.84 -64.66 0.43 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.915 -1.116 . . . . 0.0 110.964 -179.483 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 7.8 t0 -169.07 144.37 3.23 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.466 -0.771 . . . . 0.0 109.492 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.449 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 68.47 13.79 65.91 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -178.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.621 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 16.2 m -88.94 177.71 6.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.527 -0.984 . . . . 0.0 110.094 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.548 ' CG1' ' HA3' ' A' ' 42' ' ' GLY . 24.4 t -154.15 155.54 6.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.498 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.572 HG13 ' CD1' ' A' ' 29' ' ' TYR . 16.1 t -136.22 114.8 15.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 119.416 -0.914 . . . . 0.0 111.684 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.409 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -71.66 104.56 3.39 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.431 -1.308 . . . . 0.0 107.626 177.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.617 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 2.1 m-30 -67.79 130.48 43.13 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.135 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 13' ' ' ARG . 1.0 OUTLIER -82.24 160.33 23.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 109.808 179.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.457 ' SG ' HD11 ' A' ' 37' ' ' LEU . 12.4 m -130.45 162.87 28.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.154 -0.966 . . . . 0.0 110.107 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.445 ' O ' ' HB2' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -64.13 152.57 40.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 110.088 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.12 108.72 0.27 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 110.418 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 109.44 -6.76 31.95 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 3.2 m-30 -95.18 128.88 42.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.208 -1.172 . . . . 0.0 110.279 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.587 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -81.94 145.93 30.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.189 -0.945 . . . . 0.0 110.96 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.53 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 4.5 tp -94.73 98.4 10.75 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.445 -0.784 . . . . 0.0 108.932 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.573 ' CD1' ' N ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -91.28 160.51 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.252 -0.905 . . . . 0.0 109.476 -179.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.467 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 95.53 -179.33 35.88 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -53.78 142.13 24.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.162 -1.199 . . . . 0.0 109.714 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.6 p -73.62 53.8 0.44 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.935 . . . . 0.0 110.256 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.548 ' HA3' ' CG1' ' A' ' 26' ' ' VAL . . . 148.24 122.9 1.3 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.617 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 1.6 t -54.87 -179.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.162 -1.199 . . . . 0.0 107.926 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.483 ' HA ' HG21 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -143.42 96.75 2.96 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.237 178.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.596 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -81.36 104.86 12.1 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.112 178.604 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.7 p -129.49 102.78 6.54 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.478 -0.764 . . . . 0.0 110.229 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.64 26.13 8.78 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.57 21.66 78.73 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -141.26 110.49 6.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -1.203 . . . . 0.0 110.365 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.596 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 88.2 m95 -64.27 136.6 57.33 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.239 -0.913 . . . . 0.0 109.894 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.423 ' O ' ' HB3' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -143.97 158.79 43.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 110.837 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.488 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 20.7 t0 60.32 66.31 1.96 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.753 -0.592 . . . . 0.0 111.242 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 48.7 Cg_endo -90.71 131.13 1.57 Allowed 'Trans proline' 0 C--N 1.301 -1.973 0 O-C-N 124.342 1.707 . . . . 0.0 109.682 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.548 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.9 Cg_endo -77.0 170.53 19.6 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 O-C-N 123.809 1.426 . . . . 0.0 110.035 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.495 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 12.3 p -113.16 147.87 36.54 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.066 -1.021 . . . . 0.0 111.824 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.408 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 42.2 m -114.11 78.68 1.17 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -114.07 -156.81 0.61 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.324 0.583 . . . . 0.0 110.324 -178.564 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.27 139.7 31.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.636 ' HB ' ' HA ' ' A' ' 105' ' ' PRO . 34.1 m -130.31 52.67 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 120.889 -1.132 . . . . 0.0 111.525 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 2.9 mptt -81.55 171.01 15.18 Favored 'General case' 0 C--N 1.282 -2.353 0 C-N-CA 118.349 -1.34 . . . . 0.0 107.567 178.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.481 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 60.3 m -140.81 164.74 34.35 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 120.302 -1.499 . . . . 0.0 113.031 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 40.1 Cg_endo -69.55 -86.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 124.886 1.993 . . . . 0.0 110.569 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.463 ' CD2' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -176.02 136.72 0.48 Allowed Pre-proline 0 C--N 1.301 -1.53 0 O-C-N 121.517 -0.739 . . . . 0.0 109.531 -179.616 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.6 ' HG3' ' CZ2' ' A' ' 109' ' ' TRP . 57.6 Cg_endo -86.21 69.9 4.54 Favored 'Trans proline' 0 C--N 1.297 -2.14 0 O-C-N 123.756 1.398 . . . . 0.0 109.599 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.572 ' C ' ' CG2' ' A' ' 66' ' ' ILE . 3.2 p -84.77 -43.74 13.96 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 122.506 1.146 . . . . 0.0 109.78 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.597 HG23 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER 56.22 160.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.828 -178.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.508 ' N ' HG13 ' A' ' 66' ' ' ILE . 8.1 t -63.7 98.18 0.18 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.479 -0.763 . . . . 0.0 111.345 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.441 ' O ' ' SG ' ' A' ' 116' ' ' CYS . 3.6 m-20 44.72 52.21 7.94 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.4 -0.813 . . . . 0.0 111.255 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.593 ' O ' ' CD2' ' A' ' 70' ' ' TYR . . . -135.32 -39.47 0.17 Allowed Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.308 -1.425 . . . . 0.0 109.635 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.593 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 16.2 p90 41.36 -177.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 122.807 1.289 . . . . 0.0 112.222 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.603 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -130.69 153.13 49.3 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.138 -179.047 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.1 t -112.51 -9.47 13.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.65 -1.281 . . . . 0.0 110.781 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.484 ' HB2' ' HB2' ' A' ' 86' ' ' ASP . 11.0 t -55.8 -70.31 0.12 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.175 -0.953 . . . . 0.0 110.269 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.42 101.58 0.15 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.568 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -98.71 145.24 27.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.312 -1.11 . . . . 0.0 110.005 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.44 ' CG ' ' N ' ' A' ' 77' ' ' ARG . 10.4 tttm -126.16 165.74 18.34 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.438 -0.789 . . . . 0.0 109.419 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.44 ' N ' ' CG ' ' A' ' 76' ' ' LYS . 8.6 mtp180 -56.09 -56.0 26.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.062 -1.024 . . . . 0.0 110.023 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.6 171.28 8.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.467 -0.77 . . . . 0.0 109.948 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.572 ' CD1' ' CZ2' ' A' ' 109' ' ' TRP . 27.1 m-85 -145.03 -179.88 6.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 0.0 110.219 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.539 ' O ' ' HB3' ' A' ' 103' ' ' CYS . 1.5 m -158.49 176.07 12.89 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.156 -0.965 . . . . 0.0 110.981 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.529 ' H ' ' CG2' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -38.57 -24.94 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.83 -0.544 . . . . 0.0 111.546 -178.776 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.537 ' HA ' HG23 ' A' ' 102' ' ' THR . 43.8 t-20 -116.67 -122.48 0.29 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.779 -1.201 . . . . 0.0 110.094 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 51.98 71.08 0.49 Allowed 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.761 -1.212 . . . . 0.0 108.979 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.518 ' N ' HG21 ' A' ' 102' ' ' THR . 9.3 p30 -72.18 152.32 42.33 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.894 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.597 ' CG2' ' CZ3' ' A' ' 109' ' ' TRP . 0.3 OUTLIER -133.04 121.12 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.337 -0.852 . . . . 0.0 110.261 179.557 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.547 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 3.3 t0 -81.76 122.01 27.13 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.246 -0.909 . . . . 0.0 109.033 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.597 ' CE1' HG23 ' A' ' 66' ' ' ILE . 28.3 m-85 -80.48 132.52 35.71 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.275 1.035 . . . . 0.0 112.531 -177.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 4.2 tmtt? -116.41 87.59 2.72 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.046 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.483 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -36.5 131.21 0.68 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.434 -0.791 . . . . 0.0 111.315 -179.349 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' A' ' 89' ' ' CYS . 0.3 OUTLIER -39.01 -93.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.542 -0.724 . . . . 0.0 110.966 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.569 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 77.3 t80 -152.95 120.27 5.89 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.101 -0.999 . . . . 0.0 110.311 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.578 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 72.06 54.74 7.75 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.578 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 63.0 m-85 -159.42 150.76 20.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.482 -1.011 . . . . 0.0 109.925 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 117' ' ' VAL . 7.9 mtmt -104.89 140.53 38.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.237 -0.914 . . . . 0.0 110.252 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.551 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 7.1 mt -80.8 99.79 8.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.89 -1.131 . . . . 0.0 110.267 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.463 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 3.7 t -82.39 93.73 7.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.185 -0.947 . . . . 0.0 109.962 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' A' ' 114' ' ' PRO . . . 154.15 -97.2 0.17 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.593 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 15.3 t -150.79 122.03 7.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.191 -1.182 . . . . 0.0 110.276 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.414 ' O ' ' CD2' ' A' ' 87' ' ' PHE . 79.4 p -58.51 -58.94 6.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.246 -0.909 . . . . 0.0 110.426 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 51.5 p -91.75 138.67 31.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.407 -0.808 . . . . 0.0 110.197 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 70.7 m -144.58 169.93 17.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.393 -0.817 . . . . 0.0 109.974 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.537 HG23 ' HA ' ' A' ' 82' ' ' ASN . 1.8 m -147.88 134.44 19.8 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.32 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.539 ' HB3' ' O ' ' A' ' 80' ' ' SER . 1.8 t -54.77 87.47 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.51 -0.744 . . . . 0.0 109.502 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -53.05 170.8 0.24 Allowed Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.033 -1.042 . . . . 0.0 112.417 -178.711 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.636 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 51.5 Cg_endo -81.88 15.58 1.92 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 125.012 2.059 . . . . 0.0 111.37 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.555 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -114.59 13.32 20.64 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.555 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 11.1 t30 77.69 62.33 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.892 -0.769 . . . . 0.0 110.351 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.514 ' CG2' ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -177.68 178.0 1.05 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 118.818 -1.153 . . . . 0.0 111.891 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.6 ' CZ2' ' HG3' ' A' ' 64' ' ' PRO . 25.2 m95 -104.2 89.65 3.33 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.233 0.54 . . . . 0.0 110.746 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.486 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 3.8 mmtm -98.01 154.63 37.68 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.222 -0.924 . . . . 0.0 109.502 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.593 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 51.5 Cg_endo -71.71 -174.43 11.48 Favored 'Cis proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.258 -1.976 . . . . 0.0 111.054 -0.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -36.87 120.69 0.73 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.347 0.594 . . . . 0.0 110.762 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.594 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 4.2 tp -54.01 138.97 54.64 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.339 -0.851 . . . . 0.0 110.096 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.57 ' HG3' ' CD2' ' A' ' 87' ' ' PHE . 40.6 Cg_endo -70.17 158.81 55.25 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 O-C-N 124.051 1.553 . . . . 0.0 110.565 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 117' ' ' VAL . 61.5 tttt -126.7 94.05 3.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.665 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.523 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.6 t -45.16 96.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.222 -0.924 . . . . 0.0 109.113 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 115' ' ' LYS . 0.7 OUTLIER -109.93 -173.24 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 121.83 0.824 . . . . 0.0 110.59 -179.262 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.421 ' CG ' ' CE1' ' A' ' 93' ' ' TYR . 11.7 mtp180 . . . . . 0 C--N 1.293 -1.887 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.555 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.169 0.509 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.04 178.46 6.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 110.51 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.591 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 9.2 t -141.26 132.79 26.97 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.457 ' O ' ' C ' ' A' ' 5' ' ' SER . 5.3 mt-30 -115.13 179.27 4.0 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.141 -0.974 . . . . 0.0 110.041 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.2 OUTLIER -40.22 141.04 0.88 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.701 -0.624 . . . . 0.0 109.986 -179.888 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.617 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 50.6 Cg_endo -70.3 154.87 65.24 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 123.993 1.523 . . . . 0.0 111.028 -178.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -75.01 173.57 14.28 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.049 1.552 . . . . 0.0 109.957 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.47 178.42 2.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.222 -0.924 . . . . 0.0 110.16 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.514 ' O ' ' N ' ' A' ' 11' ' ' ASN . 0.3 OUTLIER -144.13 -170.09 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.208 1.004 . . . . 0.0 111.196 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 11' ' ' ASN . 21.7 m -44.1 92.56 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.455 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 9' ' ' ILE . 2.3 m-80 43.59 54.04 5.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 110.243 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.447 ' O ' HG13 ' A' ' 9' ' ' ILE . . . -157.71 146.98 14.36 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.525 ' HG2' ' CB ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -97.48 -176.9 3.63 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.331 -1.099 . . . . 0.0 110.335 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.617 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 19.3 p80 -140.15 158.89 43.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.64 -0.662 . . . . 0.0 110.334 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.481 ' O ' ' ND1' ' A' ' 14' ' ' HIS . 10.8 m120 -47.71 162.77 0.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.924 . . . . 0.0 110.246 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -156.6 26.12 0.52 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -87.13 14.44 7.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.105 -1.232 . . . . 0.0 110.222 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.548 ' HG3' ' CE2' ' A' ' 21' ' ' TYR . 8.8 pm0 -135.05 -150.31 0.38 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.933 . . . . 0.0 109.994 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -163.63 -36.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 110.209 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.575 ' O ' ' CD2' ' A' ' 20' ' ' PHE . 16.3 p90 -135.41 81.53 1.9 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.965 . . . . 0.0 109.97 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.592 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 1.6 m-85 -59.27 -23.88 62.75 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.556 -0.715 . . . . 0.0 110.872 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.558 ' N ' ' HB3' ' A' ' 3' ' ' CYS . 91.2 m 58.89 -95.53 0.06 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.377 -0.827 . . . . 0.0 111.424 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 4.3 t0 -147.56 150.28 34.17 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.987 -1.071 . . . . 0.0 110.331 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 77.1 18.9 78.0 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.592 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -103.4 160.2 14.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.571 -0.958 . . . . 0.0 110.563 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 39.4 t -141.07 156.92 22.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.418 -0.801 . . . . 0.0 110.522 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.578 HG13 ' CE1' ' A' ' 29' ' ' TYR . 20.0 t -138.03 122.54 22.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 119.186 -1.006 . . . . 0.0 111.691 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.468 ' CG2' ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -76.34 103.55 6.42 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.837 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.643 ' CE1' HG23 ' A' ' 43' ' ' VAL . 2.6 m-30 -68.67 125.6 27.07 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.414 -178.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.525 ' CB ' ' HG2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -92.91 147.16 23.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.155 -0.965 . . . . 0.0 109.621 179.269 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 37' ' ' LEU . 34.0 m -106.63 159.83 15.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.115 -0.991 . . . . 0.0 110.681 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.461 ' O ' ' N ' ' A' ' 34' ' ' GLY . 5.0 t30 -52.06 160.76 0.69 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.361 -0.837 . . . . 0.0 110.007 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.23 79.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 110.537 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 32' ' ' ASN . . . 145.08 -10.42 1.8 Allowed Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.706 -1.235 . . . . 0.0 110.206 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -97.04 137.66 35.78 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.049 -1.265 . . . . 0.0 110.478 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.546 ' OG ' ' CG2' ' A' ' 59' ' ' VAL . 0.5 OUTLIER -82.68 145.41 29.64 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.394 -0.816 . . . . 0.0 110.914 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.462 ' HB2' ' SG ' ' A' ' 31' ' ' CYS . 9.5 tp -98.41 106.42 18.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.473 -0.767 . . . . 0.0 109.687 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.561 ' CD1' ' N ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -101.31 163.31 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.923 . . . . 0.0 109.069 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.19 176.96 44.84 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -55.69 133.1 50.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.236 -1.155 . . . . 0.0 109.846 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.468 ' O ' ' CG2' ' A' ' 28' ' ' THR . 81.2 p -76.88 54.01 0.97 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -0.949 . . . . 0.0 110.158 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 27' ' ' VAL . . . 167.38 109.56 0.22 Allowed Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.695 -1.241 . . . . 0.0 110.131 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.643 HG23 ' CE1' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -58.59 177.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.032 -1.275 . . . . 0.0 108.16 178.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.84 99.79 3.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.158 -0.964 . . . . 0.0 110.259 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.613 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 3.1 t -84.63 111.86 19.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.144 -0.972 . . . . 0.0 109.31 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.6 t -124.84 82.67 2.07 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.166 -0.959 . . . . 0.0 110.395 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.16 45.06 1.92 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.451 ' HA2' ' HB2' ' A' ' 3' ' ' CYS . . . 62.75 15.2 54.1 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -126.28 97.43 5.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.223 -1.163 . . . . 0.0 110.338 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.613 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 87.7 m95 -66.59 137.46 56.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -0.95 . . . . 0.0 109.822 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.31 162.88 34.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.149 -0.969 . . . . 0.0 111.189 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.529 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 33.3 m-20 56.41 65.13 4.32 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.852 -0.53 . . . . 0.0 111.445 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.3 Cg_endo -92.33 134.96 1.39 Allowed 'Trans proline' 0 C--N 1.299 -2.042 0 O-C-N 124.379 1.726 . . . . 0.0 109.521 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.488 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 47.4 Cg_endo -78.19 174.23 12.76 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 123.607 1.319 . . . . 0.0 109.758 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.517 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 17.1 p -113.15 144.97 41.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.045 -1.034 . . . . 0.0 112.219 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 11.0 m -113.63 77.13 1.03 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 36' ' ' SER . 4.5 mm-40 -111.77 -171.53 1.86 Allowed 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.531 0.682 . . . . 0.0 110.945 -177.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.415 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -101.58 128.25 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.301 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.627 ' CG1' ' HA ' ' A' ' 105' ' ' PRO . 20.6 m -118.65 52.31 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.058 -1.026 . . . . 0.0 111.039 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.465 ' N ' ' OD1' ' A' ' 107' ' ' ASN . 1.6 mttp -83.97 110.42 18.41 Favored 'General case' 0 C--N 1.283 -2.318 0 C-N-CA 118.5 -1.28 . . . . 0.0 109.367 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.545 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 84.4 m -78.05 166.55 42.55 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.189 -0.945 . . . . 0.0 111.274 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 38.0 Cg_endo -71.89 -76.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.278 1.672 . . . . 0.0 110.47 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.4 ' CG ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 175.39 136.33 0.17 Allowed Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.652 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.611 ' HG3' ' CZ2' ' A' ' 109' ' ' TRP . 58.8 Cg_endo -84.95 87.75 1.0 Allowed 'Trans proline' 0 C--N 1.297 -2.178 0 O-C-N 123.733 1.386 . . . . 0.0 109.721 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.571 ' C ' ' CG2' ' A' ' 66' ' ' ILE . 2.6 p -112.29 -43.23 3.56 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 122.394 1.092 . . . . 0.0 110.144 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.656 ' CG2' ' CE1' ' A' ' 87' ' ' PHE . 0.1 OUTLIER 51.95 166.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.242 -179.16 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.484 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 12.9 t -65.15 97.43 0.25 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.521 -0.737 . . . . 0.0 111.265 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 6.2 m-80 45.95 55.64 6.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.448 -0.783 . . . . 0.0 111.905 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.57 ' O ' ' CG ' ' A' ' 70' ' ' TYR . . . -135.34 -42.31 0.12 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.607 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 18.7 p90 43.67 -179.31 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 122.891 1.329 . . . . 0.0 112.074 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.584 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -125.24 153.54 43.01 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.15 -179.856 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.466 ' HB3' ' HG3' ' A' ' 88' ' ' LYS . 0.3 OUTLIER -111.58 7.84 20.72 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.01 -1.056 . . . . 0.0 110.267 -178.486 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.85 -70.68 0.52 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.283 -0.886 . . . . 0.0 110.331 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -175.95 100.04 0.14 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.595 ' CD1' ' OH ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -94.01 110.03 21.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.402 -1.058 . . . . 0.0 109.498 179.533 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.512 ' N ' ' OH ' ' A' ' 79' ' ' TYR . 9.4 mttp -86.08 151.96 23.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.913 . . . . 0.0 110.247 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.3 mtt180 -48.45 -32.91 8.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.283 -0.885 . . . . 0.0 110.085 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.4 p -141.38 159.05 43.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.399 -0.813 . . . . 0.0 110.307 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.595 ' OH ' ' CD1' ' A' ' 75' ' ' PHE . 79.5 m-85 -132.23 -171.26 2.59 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.281 -0.887 . . . . 0.0 110.05 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.554 ' O ' ' SG ' ' A' ' 103' ' ' CYS . 78.8 p -147.18 -103.67 0.09 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.873 -1.142 . . . . 0.0 111.495 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.612 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -114.29 22.35 13.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 119.77 -1.831 . . . . 0.0 110.96 -178.396 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.598 ' HA ' HG23 ' A' ' 102' ' ' THR . 50.3 t30 -165.55 -110.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.869 -1.144 . . . . 0.0 110.72 178.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 82' ' ' ASN . 0.1 OUTLIER 46.99 79.03 0.06 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.686 -1.259 . . . . 0.0 108.923 -179.032 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.531 ' N ' HG21 ' A' ' 102' ' ' THR . 2.1 p-10 -71.91 142.12 49.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.347 -0.846 . . . . 0.0 110.885 -178.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.584 HG21 ' CZ3' ' A' ' 109' ' ' TRP . 5.4 m -129.42 117.55 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.909 . . . . 0.0 110.455 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.539 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 3.1 t0 -76.64 128.52 34.85 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.376 -0.828 . . . . 0.0 108.897 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.656 ' CE1' ' CG2' ' A' ' 66' ' ' ILE . 34.2 m-85 -88.09 142.59 27.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.033 -1.042 . . . . 0.0 112.629 -177.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.607 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -121.4 84.78 2.29 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.128 -179.434 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.472 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.8 OUTLIER -35.2 126.46 0.58 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.761 -0.587 . . . . 0.0 110.853 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.9 OUTLIER -34.18 -78.52 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.625 -0.672 . . . . 0.0 110.843 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.464 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -168.78 143.45 3.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.312 -0.868 . . . . 0.0 110.395 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 51.51 45.26 53.83 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.577 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 10.8 m-85 -148.22 154.78 40.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.406 -1.055 . . . . 0.0 110.217 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.524 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 35.9 mtpt -109.94 131.12 55.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 109.967 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.533 HD22 ' CD1' ' A' ' 66' ' ' ILE . 2.0 mt -73.12 93.12 1.77 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.904 . . . . 0.0 110.246 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.455 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -74.39 98.54 3.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.928 . . . . 0.0 109.766 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 147.32 -97.94 0.19 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.588 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -149.87 128.52 12.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.234 -1.156 . . . . 0.0 110.211 -179.655 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 87' ' ' PHE . 24.9 p -72.36 -45.44 59.84 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.125 -0.985 . . . . 0.0 110.59 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.6 p -102.89 116.3 32.29 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.115 -0.991 . . . . 0.0 110.248 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 16.4 m -120.83 178.96 4.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.421 -0.799 . . . . 0.0 110.297 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.598 HG23 ' HA ' ' A' ' 82' ' ' ASN . 0.5 OUTLIER -152.58 134.24 14.61 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.571 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.554 ' SG ' ' O ' ' A' ' 80' ' ' SER . 12.9 t -62.03 78.48 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.542 0.687 . . . . 0.0 109.547 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 102' ' ' THR . 0.1 OUTLIER -56.43 176.9 0.19 Allowed Pre-proline 0 N--CA 1.498 1.935 0 CA-C-O 121.506 0.67 . . . . 0.0 112.753 -178.485 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.627 ' HA ' ' CG1' ' A' ' 59' ' ' VAL . 47.2 Cg_endo -79.08 25.45 0.57 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 124.779 1.936 . . . . 0.0 112.079 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.509 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -122.86 18.86 7.96 Favored Glycine 0 N--CA 1.482 1.757 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.509 ' HB2' ' O ' ' A' ' 106' ' ' GLY . 16.3 m-80 62.63 53.05 2.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.894 -0.768 . . . . 0.0 110.066 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.507 ' HA ' ' CD ' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -163.64 179.27 7.3 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.288 -0.883 . . . . 0.0 111.166 179.881 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.611 ' CZ2' ' HG3' ' A' ' 64' ' ' PRO . 45.4 m95 -110.03 90.74 3.4 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.561 -0.712 . . . . 0.0 110.243 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.514 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 1.0 OUTLIER -100.33 154.91 36.94 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.322 -0.861 . . . . 0.0 109.596 179.84 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.588 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.3 Cg_endo -69.48 -179.92 19.96 Favored 'Cis proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.33 -1.946 . . . . 0.0 111.414 0.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.472 ' C ' ' O ' ' A' ' 111' ' ' PRO . 9.5 mt-10 -34.44 121.8 0.5 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.416 0.627 . . . . 0.0 111.097 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.574 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 3.0 tp -49.13 141.7 10.82 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.39 -0.819 . . . . 0.0 110.127 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.544 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 41.5 Cg_endo -70.26 158.5 56.1 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 124.073 1.564 . . . . 0.0 110.416 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 117' ' ' VAL . 11.5 ttpt -124.11 107.17 10.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 110.37 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.491 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.6 t -63.01 78.28 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.17 -0.957 . . . . 0.0 109.168 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 94' ' ' LYS . 2.5 m -92.92 -173.83 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.903 0.859 . . . . 0.0 111.264 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.442 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.6 OUTLIER . . . . . 0 C--N 1.296 -1.758 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.239 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.404 HG13 ' HA3' ' A' ' 48' ' ' GLY . 59.1 t . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.162 0.505 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -93.53 164.79 13.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.248 -0.907 . . . . 0.0 110.285 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.553 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -131.37 83.74 2.12 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.165 -0.959 . . . . 0.0 110.343 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.423 ' O ' ' C ' ' A' ' 5' ' ' SER . 4.3 pm0 -63.52 179.57 0.45 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.12 -0.988 . . . . 0.0 109.928 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.3 p -44.99 144.52 1.93 Allowed Pre-proline 0 C--N 1.297 -1.684 0 C-N-CA 119.715 -0.794 . . . . 0.0 109.443 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.612 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 45.9 Cg_endo -70.16 159.86 51.63 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 124.028 1.541 . . . . 0.0 111.004 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.72 171.17 18.73 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.004 1.528 . . . . 0.0 110.216 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 77.4 p -73.58 179.18 4.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 0.0 110.17 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.54 ' CG2' ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -145.14 -169.51 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 122.232 1.015 . . . . 0.0 111.78 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 3.6 t -50.27 100.23 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.2 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 10' ' ' SER . 5.5 m-20 36.72 55.49 1.16 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.658 -0.651 . . . . 0.0 111.335 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.406 ' HA3' HD13 ' A' ' 9' ' ' ILE . . . -150.28 -163.34 11.13 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.532 ' CG ' ' HB3' ' A' ' 30' ' ' SER . 0.0 OUTLIER -148.2 174.9 11.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.206 -1.173 . . . . 0.0 110.362 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.612 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 23.2 p80 -140.74 -155.32 0.58 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.551 -0.718 . . . . 0.0 110.023 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 0.1 OUTLIER 70.35 106.8 0.06 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.332 -0.855 . . . . 0.0 110.434 179.621 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.495 ' O ' ' CD2' ' A' ' 17' ' ' TYR . . . -166.35 46.89 0.27 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.495 ' CD2' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER 179.18 -33.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -1.175 . . . . 0.0 110.571 -179.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.45 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 8.8 pt-20 -179.71 -168.69 0.12 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.094 -1.004 . . . . 0.0 110.761 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -114.35 -41.69 3.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.461 -0.774 . . . . 0.0 109.635 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -95.64 130.13 42.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.395 -0.815 . . . . 0.0 109.733 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.62 ' CD1' ' CB ' ' A' ' 25' ' ' SER . 0.4 OUTLIER -122.45 -6.48 8.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.144 -0.973 . . . . 0.0 110.626 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.553 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 72.6 p 46.69 -95.75 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.501 -0.75 . . . . 0.0 112.1 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 0.8 OUTLIER -154.62 144.86 21.97 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.887 -1.133 . . . . 0.0 110.577 -178.527 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.22 31.96 29.92 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.62 ' CB ' ' CD1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -122.13 172.25 8.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.438 -1.037 . . . . 0.0 110.267 -179.742 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.575 HG11 ' N ' ' A' ' 27' ' ' VAL . 48.6 t -142.99 152.87 16.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.265 -0.897 . . . . 0.0 110.826 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.584 HG13 ' CD1' ' A' ' 29' ' ' TYR . 11.9 t -129.81 122.11 53.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 C-N-CA 119.831 -0.747 . . . . 0.0 111.413 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.42 102.3 5.12 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 118.723 -1.191 . . . . 0.0 107.882 178.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.631 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 2.1 m-30 -68.34 120.65 14.81 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.263 -178.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.532 ' HB3' ' CG ' ' A' ' 13' ' ' ARG . 4.9 t -73.18 -177.65 2.59 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.945 -1.097 . . . . 0.0 109.2 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 30' ' ' SER . 71.0 m -151.56 163.89 38.06 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.344 -0.848 . . . . 0.0 109.975 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.34 145.58 26.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.182 -0.949 . . . . 0.0 109.701 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 33' ' ' SER . 1.6 p -52.64 110.9 0.56 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 110.499 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.04 -20.43 26.33 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -79.27 132.17 36.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.182 -1.187 . . . . 0.0 110.354 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.604 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -80.84 138.86 36.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.16 -0.962 . . . . 0.0 110.579 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.531 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 0.8 OUTLIER -85.87 98.03 10.54 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.431 -0.793 . . . . 0.0 109.358 179.09 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.575 ' HB ' ' OG1' ' A' ' 55' ' ' THR . 0.7 OUTLIER -89.17 148.86 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -0.884 . . . . 0.0 109.065 179.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.89 -150.43 16.91 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.05 137.43 32.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.358 -1.083 . . . . 0.0 110.371 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 54.8 p -76.69 55.29 1.04 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.933 . . . . 0.0 109.444 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.455 ' HA3' ' CG1' ' A' ' 26' ' ' VAL . . . 153.93 121.17 0.8 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.631 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 1.7 t -69.27 -178.29 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.173 -1.193 . . . . 0.0 108.263 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.412 ' HA ' ' O ' ' A' ' 25' ' ' SER . 2.3 tp -143.92 97.54 3.08 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.923 -1.11 . . . . 0.0 110.714 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.594 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 1.0 OUTLIER -86.04 114.7 23.13 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.081 -1.047 . . . . 0.0 109.132 178.569 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.07 91.91 3.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.501 -0.749 . . . . 0.0 110.225 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.526 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 78.49 63.49 2.12 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.404 ' HA3' HG13 ' A' ' 1' ' ' VAL . . . 46.7 53.15 10.35 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -157.31 73.37 0.73 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.346 -1.091 . . . . 0.0 110.569 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.594 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 76.1 m95 -55.7 137.73 48.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.087 -1.008 . . . . 0.0 109.354 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -146.87 163.8 34.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.001 -1.062 . . . . 0.0 111.342 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.513 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 1.5 m-20 62.11 65.77 1.56 Allowed Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.826 -0.546 . . . . 0.0 111.377 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.513 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 46.5 Cg_endo -91.47 129.23 1.2 Allowed 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 121.802 1.668 . . . . 0.0 110.17 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.563 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 49.7 Cg_endo -80.21 168.21 18.83 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.904 1.476 . . . . 0.0 110.086 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.575 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 65.7 p -107.83 148.01 30.12 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.979 -1.076 . . . . 0.0 111.347 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 10' ' ' SER . 88.9 m -109.25 77.91 1.1 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -113.81 -167.68 1.24 Allowed 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.394 0.616 . . . . 0.0 110.487 -178.305 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -104.69 134.69 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.604 ' CG1' ' CB ' ' A' ' 36' ' ' SER . 19.8 m -122.7 43.75 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.063 -1.023 . . . . 0.0 111.099 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -82.93 96.69 8.37 Favored 'General case' 0 C--N 1.286 -2.179 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.956 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 107' ' ' ASN . 29.2 m -69.69 162.09 69.97 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.397 -0.814 . . . . 0.0 111.423 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 44.3 Cg_endo -72.88 -90.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.559 1.82 . . . . 0.0 110.578 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.401 ' CD2' ' HE1' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -161.69 132.77 3.79 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.613 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 55.7 Cg_endo -78.7 65.71 8.67 Favored 'Trans proline' 0 C--N 1.295 -2.267 0 O-C-N 123.665 1.35 . . . . 0.0 109.454 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.534 ' N ' HD22 ' A' ' 113' ' ' LEU . 0.2 OUTLIER -82.98 176.03 9.58 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.579 -0.701 . . . . 0.0 110.287 -179.652 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.549 ' CD1' ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -176.7 163.39 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.227 -0.92 . . . . 0.0 110.625 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.441 ' N ' HG13 ' A' ' 66' ' ' ILE . 1.8 m -75.9 107.61 8.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.509 -0.744 . . . . 0.0 110.831 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 8.6 m-20 43.37 37.89 1.53 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.457 -0.777 . . . . 0.0 110.432 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -145.1 26.72 1.88 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.551 ' O ' ' N ' ' A' ' 88' ' ' LYS . 23.4 p90 -43.91 -178.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.409 1.1 . . . . 0.0 111.833 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.565 ' O ' ' CD2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -109.63 156.29 20.4 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 121.913 0.864 . . . . 0.0 110.858 179.083 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.08 11.77 4.25 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.778 -1.201 . . . . 0.0 110.033 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.22 -79.68 0.23 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.347 -0.845 . . . . 0.0 110.917 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -141.42 84.08 0.21 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.537 ' C ' ' CD1' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -98.95 160.92 13.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.467 -1.019 . . . . 0.0 109.911 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.584 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 24.4 ttmt -153.44 156.81 38.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.264 -0.897 . . . . 0.0 110.531 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 26.5 mtp85 -53.37 -30.16 38.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.897 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.418 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -141.77 171.56 13.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.484 -0.76 . . . . 0.0 110.21 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.584 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 31.2 m-85 -144.08 177.66 8.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.214 -0.929 . . . . 0.0 110.408 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.529 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 7.7 p -162.85 92.36 0.77 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.177 -0.952 . . . . 0.0 110.238 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.562 ' CB ' HG23 ' A' ' 59' ' ' VAL . 13.3 t80 56.83 136.31 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.092 -1.005 . . . . 0.0 110.247 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.556 ' O ' ' N ' ' A' ' 103' ' ' CYS . 14.4 t-20 63.57 -125.05 0.55 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.849 -1.157 . . . . 0.0 110.521 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.45 ' HB3' ' HB3' ' A' ' 103' ' ' CYS . 0.5 OUTLIER 54.13 71.2 0.53 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.617 -1.302 . . . . 0.0 109.014 -178.526 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 5.4 t30 -73.53 136.69 44.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.515 -0.741 . . . . 0.0 111.332 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.557 HG12 ' CH2' ' A' ' 109' ' ' TRP . 12.5 m -124.0 117.21 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.246 -0.909 . . . . 0.0 109.877 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 48.6 t0 -78.4 136.04 37.56 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.564 ' CD2' ' HG3' ' A' ' 114' ' ' PRO . 60.6 m-85 -94.24 129.68 40.78 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.99 -1.069 . . . . 0.0 112.158 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 70' ' ' TYR . 9.1 tptt -99.52 90.05 4.37 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.631 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.47 ' HB2' HD13 ' A' ' 95' ' ' LEU . 0.3 OUTLIER -44.35 128.77 6.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.004 -1.06 . . . . 0.0 109.861 -179.668 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 2.9 mmtt -38.93 -78.0 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.595 -0.691 . . . . 0.0 110.472 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.589 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -168.27 141.53 3.14 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.358 -0.839 . . . . 0.0 110.366 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.582 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 49.79 53.78 20.47 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.589 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 11.6 m-85 -158.28 151.23 22.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.469 -1.019 . . . . 0.0 109.624 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.471 ' O ' ' O ' ' A' ' 115' ' ' LYS . 13.1 mtmm -109.18 134.64 51.47 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.113 -0.992 . . . . 0.0 110.161 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.543 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 1.8 mt -72.13 103.51 3.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.259 -0.9 . . . . 0.0 110.571 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.49 ' HB3' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -84.87 112.83 20.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.151 -0.968 . . . . 0.0 109.751 179.379 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 132.08 -77.74 0.38 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.52 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -167.73 112.05 0.67 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.358 -1.084 . . . . 0.0 110.44 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 43.9 t -69.97 -7.07 37.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.211 -0.931 . . . . 0.0 110.306 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.0 p -139.65 98.8 3.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.182 -0.949 . . . . 0.0 110.04 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.539 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 7.0 m -106.47 -174.69 2.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.192 -0.943 . . . . 0.0 110.565 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 19.8 m -157.93 134.9 9.97 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.251 -0.98 . . . . 0.0 111.301 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.602 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 1.8 t -62.2 87.4 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.466 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -78.57 177.05 3.06 Favored Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.133 -0.98 . . . . 0.0 110.859 -179.387 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.56 ' CG ' HG22 ' A' ' 38' ' ' ILE . 41.9 Cg_endo -73.55 138.28 26.6 Favored 'Trans proline' 0 C--N 1.302 -1.91 0 O-C-N 124.436 1.756 . . . . 0.0 110.499 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.554 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 116.92 -10.05 15.72 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.554 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 1.4 m-20 81.12 77.72 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.943 -0.74 . . . . 0.0 110.065 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.484 HG22 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -173.73 -175.05 1.03 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.626 -0.83 . . . . 0.0 110.969 -179.697 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.613 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 38.9 m95 -124.35 89.03 3.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.546 -0.721 . . . . 0.0 109.723 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.517 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -101.86 136.05 19.6 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.491 -0.755 . . . . 0.0 110.652 -179.109 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.539 ' HD2' ' HA ' ' A' ' 101' ' ' SER . 40.9 Cg_endo -68.52 163.73 77.28 Favored 'Cis proline' 0 N--CA 1.489 1.224 0 C-N-CA 122.101 -2.041 . . . . 0.0 111.029 -0.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 111' ' ' PRO . 28.5 tt0 -40.06 155.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.457 0.646 . . . . 0.0 110.689 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -62.99 146.29 95.78 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.494 -0.754 . . . . 0.0 110.043 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.564 ' HG3' ' CD2' ' A' ' 87' ' ' PHE . 41.1 Cg_endo -72.45 175.4 10.15 Favored 'Trans proline' 0 C--N 1.299 -2.057 0 O-C-N 124.365 1.718 . . . . 0.0 111.136 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 96' ' ' SER . 6.4 tttp -133.79 114.39 13.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.493 -0.755 . . . . 0.0 109.907 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.52 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 3.5 t -72.96 71.19 1.06 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.082 -1.011 . . . . 0.0 109.505 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.49 HG23 ' HB3' ' A' ' 96' ' ' SER . 5.9 m -86.91 -170.37 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-O 122.057 0.932 . . . . 0.0 110.924 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.469 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.294 -1.844 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.281 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.521 ' CG2' ' HA3' ' A' ' 48' ' ' GLY . 9.1 m . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.301 0.572 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.77 178.96 6.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.296 -0.878 . . . . 0.0 110.512 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.524 ' O ' ' N ' ' A' ' 21' ' ' TYR . 1.2 m -117.99 136.38 53.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.493 -0.754 . . . . 0.0 110.131 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 5' ' ' SER . 5.7 pt20 -110.61 172.94 6.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.046 -1.034 . . . . 0.0 109.647 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.461 ' HB2' ' HA ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -46.65 132.86 8.21 Favored Pre-proline 0 C--N 1.298 -1.637 0 C-N-CA 119.369 -0.933 . . . . 0.0 109.36 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.592 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 43.8 Cg_endo -69.81 166.03 29.03 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.939 1.494 . . . . 0.0 110.325 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.02 166.47 27.81 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 O-C-N 123.942 1.496 . . . . 0.0 110.306 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.74 175.37 9.45 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.376 -0.827 . . . . 0.0 109.949 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 11' ' ' ASN . 0.3 OUTLIER -141.44 -170.33 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-O 122.227 1.013 . . . . 0.0 111.331 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 1.3 m -46.44 91.54 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.92 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.506 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER 42.03 51.09 4.33 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.147 -0.97 . . . . 0.0 110.376 179.643 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -150.53 151.79 23.76 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -111.15 -179.05 3.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.34 -1.094 . . . . 0.0 110.265 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.614 ' CD2' ' N ' ' A' ' 14' ' ' HIS . 8.4 m170 -66.06 -139.42 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.279 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -85.28 -97.76 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.935 . . . . 0.0 110.212 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.32 -71.2 0.69 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -164.61 84.75 0.42 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -1.173 . . . . 0.0 110.254 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.441 ' N ' ' CD ' ' A' ' 18' ' ' GLU . 5.9 mp0 -109.49 -54.01 2.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.84 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.461 ' HA ' ' HB2' ' A' ' 5' ' ' SER . 2.1 m-20 59.04 18.38 6.28 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.5 -0.75 . . . . 0.0 110.232 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.563 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 0.2 OUTLIER -163.27 149.13 11.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 110.618 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.575 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 9.0 m-85 -163.98 174.75 11.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.509 -0.744 . . . . 0.0 109.649 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.482 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 22.6 p -136.03 -69.83 0.48 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.779 -1.201 . . . . 0.0 111.099 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -161.49 145.4 12.88 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.514 -0.742 . . . . 0.0 109.384 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.17 12.31 57.59 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.38 -1.888 . . . . 0.0 108.38 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.575 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -82.63 174.3 11.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.507 -0.996 . . . . 0.0 109.816 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 28.2 t -153.85 156.65 5.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.856 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.548 ' HB ' HG22 ' A' ' 43' ' ' VAL . 4.0 t -137.16 114.22 12.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 C-N-CA 119.631 -0.827 . . . . 0.0 111.546 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.527 ' CG2' ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -70.45 102.76 2.27 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 118.543 -1.263 . . . . 0.0 108.015 178.366 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.614 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 1.0 OUTLIER -68.22 97.49 0.72 Allowed 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.205 -0.998 . . . . 0.0 109.592 -178.589 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.493 ' OG ' ' O ' ' A' ' 14' ' ' HIS . 0.1 OUTLIER -70.08 139.43 52.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.78 -1.2 . . . . 0.0 109.8 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 56' ' ' CYS . 12.4 m -108.27 153.11 23.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.372 -0.83 . . . . 0.0 109.679 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 31' ' ' CYS . 0.7 OUTLIER -44.05 140.92 1.87 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.163 -0.961 . . . . 0.0 109.841 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 83.2 p -52.42 98.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 110.084 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 134.33 -1.74 4.13 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' A' ' 56' ' ' CYS . 0.6 OUTLIER -106.15 161.03 14.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.067 -1.255 . . . . 0.0 110.421 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.616 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.7 OUTLIER -102.58 129.99 49.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.359 -0.838 . . . . 0.0 110.963 -179.405 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.533 ' HA ' ' O ' ' A' ' 55' ' ' THR . 4.6 tp -89.05 120.67 30.67 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.329 -0.857 . . . . 0.0 109.294 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.571 ' O ' ' N ' ' A' ' 55' ' ' THR . 0.2 OUTLIER -118.37 141.74 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.138 -0.976 . . . . 0.0 109.881 -179.501 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.506 ' O ' ' CB ' ' A' ' 40' ' ' ASN . . . 101.58 44.22 2.0 Favored Glycine 0 N--CA 1.488 2.154 0 C-N-CA 119.393 -1.384 . . . . 0.0 109.687 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 3.1 t30 72.11 169.45 0.32 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.491 -1.005 . . . . 0.0 109.775 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.527 ' O ' ' CG2' ' A' ' 28' ' ' THR . 0.8 OUTLIER -112.36 63.15 0.63 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 110.457 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 27' ' ' VAL . . . 160.12 113.89 0.34 Allowed Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.635 -1.269 . . . . 0.0 110.306 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.614 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 1.1 t -60.84 -179.06 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.05 -1.265 . . . . 0.0 108.066 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 25' ' ' SER . 0.8 OUTLIER -143.78 102.55 3.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.994 -1.066 . . . . 0.0 110.533 178.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.589 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.6 OUTLIER -85.48 113.84 22.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.317 -0.864 . . . . 0.0 109.276 178.654 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 87.7 p -129.64 137.52 50.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 0.0 110.531 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.01 9.12 45.93 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.521 ' HA3' ' CG2' ' A' ' 1' ' ' VAL . . . 93.36 29.08 10.54 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -146.08 135.18 22.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.366 -1.079 . . . . 0.0 110.097 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.589 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 89.1 m95 -80.71 138.36 36.34 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.217 -0.927 . . . . 0.0 109.909 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -141.81 165.46 27.4 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.119 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.535 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 1.3 t70 43.11 64.87 5.99 Favored Pre-proline 0 N--CA 1.491 1.614 0 CA-C-O 121.141 0.496 . . . . 0.0 111.819 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.535 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 47.0 Cg_endo -91.8 125.56 0.86 Allowed 'Trans proline' 0 C--N 1.3 -1.996 0 O-C-N 124.341 1.706 . . . . 0.0 109.261 178.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.517 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 45.1 Cg_endo -70.79 -178.44 2.74 Favored 'Trans proline' 0 C--N 1.297 -2.15 0 O-C-N 123.808 1.425 . . . . 0.0 110.759 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.571 ' N ' ' O ' ' A' ' 38' ' ' ILE . 6.0 p -119.82 -169.09 1.71 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.851 0.834 . . . . 0.0 111.255 -178.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.479 ' O ' ' CD2' ' A' ' 35' ' ' TYR . 96.4 m -151.92 86.65 1.32 Allowed 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -111.11 -139.5 0.38 Allowed 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.055 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.528 ' CD1' ' N ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -142.82 74.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 179.391 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.627 HG22 ' HB3' ' A' ' 81' ' ' TYR . 4.6 m -68.72 126.49 28.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 122.55 1.167 . . . . 0.0 110.679 -177.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 107' ' ' ASN . 24.6 mtpt -147.22 93.67 2.28 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.48 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 27.4 m -69.1 162.78 62.84 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.513 -0.742 . . . . 0.0 111.732 -177.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 46.1 Cg_endo -72.82 -90.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.612 1.848 . . . . 0.0 110.615 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.444 ' HB3' ' CG2' ' A' ' 65' ' ' THR . 0.0 OUTLIER -164.98 129.34 1.81 Allowed Pre-proline 0 C--N 1.302 -1.462 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.616 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 54.7 Cg_endo -77.33 65.68 7.94 Favored 'Trans proline' 0 C--N 1.298 -2.114 0 O-C-N 123.608 1.32 . . . . 0.0 109.617 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.528 ' O ' ' CD2' ' A' ' 113' ' ' LEU . 0.8 OUTLIER -83.95 178.81 7.72 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.266 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.564 ' CD1' ' HG2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -175.02 158.39 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.077 179.388 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.478 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 0.7 OUTLIER -64.35 101.82 0.47 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.496 -0.753 . . . . 0.0 110.5 -179.57 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.469 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 45.0 m-20 39.66 50.74 2.26 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.438 -0.789 . . . . 0.0 110.607 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.518 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -158.54 32.07 0.48 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.554 ' CD2' ' O ' ' A' ' 71' ' ' LEU . 4.9 p90 -45.17 -172.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.798 1.285 . . . . 0.0 112.684 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.568 HD22 ' CD2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -109.96 167.91 9.82 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.601 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 72' ' ' SER . 0.3 OUTLIER -144.97 24.91 1.45 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.044 -1.035 . . . . 0.0 110.155 -179.611 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.3 t -104.24 -89.02 0.41 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.032 -1.042 . . . . 0.0 110.824 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -118.92 72.86 0.31 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 2.9 t80 -98.2 164.82 12.16 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.446 -1.032 . . . . 0.0 110.19 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.63 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 2.4 tttp -168.93 159.13 9.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.367 -0.833 . . . . 0.0 109.95 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -52.6 -27.79 18.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.128 -0.983 . . . . 0.0 109.981 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.462 ' C ' ' CG ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -141.31 173.87 11.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.366 -0.834 . . . . 0.0 110.556 -179.723 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.575 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 43.3 m-85 -148.82 -168.15 3.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.519 -0.738 . . . . 0.0 109.486 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.546 ' CA ' HG21 ' A' ' 59' ' ' VAL . 88.1 p -141.47 -102.12 0.14 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.741 -1.225 . . . . 0.0 111.355 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.627 ' HB3' HG22 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -119.27 19.36 12.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.608 -1.307 . . . . 0.0 111.24 -178.696 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' A' ' 103' ' ' CYS . 29.0 t-20 -159.86 -101.59 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.875 -1.14 . . . . 0.0 110.118 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 82' ' ' ASN . 2.9 m-20 44.94 72.79 0.18 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.87 -1.144 . . . . 0.0 109.277 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.516 ' N ' HG21 ' A' ' 102' ' ' THR . 8.7 p30 -68.74 113.91 6.63 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.386 -0.821 . . . . 0.0 110.172 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.529 ' N ' ' O ' ' A' ' 101' ' ' SER . 33.1 m -99.28 121.88 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.249 -0.907 . . . . 0.0 111.073 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.522 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 28.8 t70 -83.27 134.6 34.93 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.547 ' CE1' HD11 ' A' ' 71' ' ' LEU . 29.3 m-85 -91.46 132.82 35.98 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.825 -1.172 . . . . 0.0 112.046 -178.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.2 OUTLIER -111.2 92.0 3.87 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.181 -179.39 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.453 ' SG ' ' HG ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -44.49 128.37 6.37 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.043 -1.036 . . . . 0.0 109.907 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 2.4 mmmp? -41.19 -85.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.32 -0.862 . . . . 0.0 110.375 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.581 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -159.09 142.2 14.52 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.273 -0.892 . . . . 0.0 110.418 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.594 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 54.7 54.94 29.95 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.594 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 18.2 m-85 -160.27 167.41 27.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.469 -1.018 . . . . 0.0 109.729 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.481 ' N ' ' O ' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -132.22 114.37 14.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.24 -0.913 . . . . 0.0 109.911 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.524 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 10.2 mt -46.39 107.49 0.11 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.11 -0.994 . . . . 0.0 110.479 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.477 ' CB ' HG23 ' A' ' 117' ' ' VAL . 1.2 t -90.1 97.04 10.96 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.432 -0.792 . . . . 0.0 109.685 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.62 -40.33 1.38 Allowed Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.404 -1.379 . . . . 0.0 110.546 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.549 ' O ' ' HB3' ' A' ' 114' ' ' PRO . 0.0 OUTLIER 177.58 -164.45 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.889 -1.359 . . . . 0.0 111.524 -179.191 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.529 ' N ' ' OG ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -149.21 -53.42 0.17 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.713 -0.617 . . . . 0.0 110.2 -179.833 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 91.1 p -110.48 105.51 14.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.23 -0.919 . . . . 0.0 110.644 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.529 ' O ' ' N ' ' A' ' 85' ' ' VAL . 50.6 m -113.73 164.27 13.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.329 -0.857 . . . . 0.0 110.118 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.516 HG21 ' N ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -133.39 143.39 48.9 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.345 -0.847 . . . . 0.0 110.885 -179.687 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.628 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -72.95 98.27 2.45 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.33 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.553 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -67.98 176.27 1.41 Allowed Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.182 -0.949 . . . . 0.0 112.333 -178.52 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.614 ' CA ' HG13 ' A' ' 59' ' ' VAL . 41.0 Cg_endo -70.03 -33.36 15.72 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 124.689 1.889 . . . . 0.0 111.728 -177.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.56 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -75.5 4.64 41.42 Favored Glycine 0 N--CA 1.486 2.001 0 C-N-CA 119.267 -1.444 . . . . 0.0 110.799 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 0.9 OUTLIER 78.13 89.4 0.07 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.445 -1.033 . . . . 0.0 110.929 179.245 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 103' ' ' CYS . 0.0 OUTLIER -178.45 -161.7 0.05 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.857 . . . . 0.0 110.906 179.354 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.628 ' CZ3' ' N ' ' A' ' 103' ' ' CYS . 22.7 m95 -142.71 97.94 3.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 111.305 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.472 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 2.5 mtpp -106.75 145.83 31.85 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.411 -0.806 . . . . 0.0 109.512 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.507 ' HG2' ' HB2' ' A' ' 98' ' ' SER . 47.3 Cg_endo -72.91 178.62 31.27 Favored 'Cis proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.088 -2.047 . . . . 0.0 111.089 -0.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.447 ' O ' ' C ' ' A' ' 113' ' ' LEU . 5.3 tt0 -40.74 121.16 1.42 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.606 -0.684 . . . . 0.0 110.352 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.555 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.6 OUTLIER -40.91 138.56 1.31 Allowed Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.416 -0.802 . . . . 0.0 110.001 179.701 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.564 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 42.8 Cg_endo -75.04 160.69 39.75 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 O-C-N 124.176 1.619 . . . . 0.0 111.758 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.519 ' O ' HG23 ' A' ' 117' ' ' VAL . 5.6 ttpp -125.67 99.89 6.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.469 -0.769 . . . . 0.0 110.813 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.546 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.8 t -53.29 100.88 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.93 . . . . 0.0 109.468 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 115' ' ' LYS . 2.0 m -118.92 179.18 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.664 0.745 . . . . 0.0 110.624 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.504 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.293 -1.858 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.371 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.507 HG11 ' N ' ' A' ' 2' ' ' LYS . 53.8 t . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.213 0.53 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.507 ' N ' HG11 ' A' ' 1' ' ' VAL . 9.1 mptt -81.13 170.32 16.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.256 -0.902 . . . . 0.0 110.319 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 21' ' ' TYR . 1.2 m -125.39 90.58 3.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 109.713 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.513 ' CG ' ' N ' ' A' ' 5' ' ' SER . 37.6 tt0 -72.88 173.58 8.99 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.021 -1.049 . . . . 0.0 109.895 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.513 ' N ' ' CG ' ' A' ' 4' ' ' GLN . 0.7 OUTLIER -44.09 134.76 4.12 Favored Pre-proline 0 C--N 1.297 -1.706 0 O-C-N 121.501 -0.749 . . . . 0.0 109.642 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.641 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 51.6 Cg_endo -71.36 150.5 58.59 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.939 1.494 . . . . 0.0 110.525 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.34 172.23 15.36 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 O-C-N 124.007 1.53 . . . . 0.0 109.932 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.53 177.71 2.81 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.248 -0.907 . . . . 0.0 109.509 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.504 HG22 ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -139.09 -170.41 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 122.172 0.987 . . . . 0.0 111.297 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 5.5 t -47.37 98.25 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.616 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.2 m120 44.35 47.85 8.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 0.0 110.415 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.458 ' O ' HG13 ' A' ' 9' ' ' ILE . . . -159.6 156.64 27.81 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.42 -169.71 1.51 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.117 -1.225 . . . . 0.0 111.071 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.641 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 13.8 p80 -137.85 126.0 22.97 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.353 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -100.37 -175.33 2.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.308 -0.87 . . . . 0.0 110.263 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . 154.22 -36.6 0.7 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.472 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER 67.44 35.88 4.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.395 -1.061 . . . . 0.0 110.482 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.577 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -142.48 -159.61 0.99 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.292 -0.88 . . . . 0.0 109.817 179.599 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 4' ' ' GLN . 1.5 m-20 -147.47 -35.2 0.24 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.171 -0.956 . . . . 0.0 110.59 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -121.03 79.05 1.46 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.191 -0.943 . . . . 0.0 110.14 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.603 ' CE2' ' CG2' ' A' ' 27' ' ' VAL . 0.9 OUTLIER -57.57 -24.7 57.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.07 -1.019 . . . . 0.0 110.339 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.445 ' C ' ' HB2' ' A' ' 3' ' ' CYS . 0.2 OUTLIER 66.43 -79.08 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.464 -0.772 . . . . 0.0 112.32 178.561 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.51 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER -168.3 160.84 11.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.891 -1.13 . . . . 0.0 109.865 -178.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 59.39 17.07 38.09 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.506 ' CB ' ' CD1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -92.89 160.11 15.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.566 -0.961 . . . . 0.0 109.725 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.631 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 57.4 t -133.75 150.23 31.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 118.977 -1.089 . . . . 0.0 110.907 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.603 ' CG2' ' CE2' ' A' ' 21' ' ' TYR . 45.6 t -138.13 112.02 8.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.46 -0.775 . . . . 0.0 110.977 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.99 104.14 2.46 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.035 -1.466 . . . . 0.0 107.653 178.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.644 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 1.9 m-30 -67.62 130.67 43.75 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.956 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.71 152.64 23.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.122 -0.986 . . . . 0.0 109.906 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.521 ' SG ' ' CD1' ' A' ' 37' ' ' LEU . 98.1 m -129.71 143.81 50.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.154 -0.966 . . . . 0.0 110.354 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -55.17 127.95 31.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.267 -0.896 . . . . 0.0 110.285 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 71.1 p -44.88 139.73 2.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.298 -0.876 . . . . 0.0 110.332 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.5 -21.81 37.91 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.471 ' CZ ' HG22 ' A' ' 58' ' ' ILE . 8.4 m-85 -108.94 141.22 41.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.12 -1.223 . . . . 0.0 110.3 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.59 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -79.03 136.36 37.16 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.349 -0.844 . . . . 0.0 110.995 -179.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.545 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 3.8 tt -92.54 94.23 8.95 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.59 ' CG2' ' CG ' ' A' ' 105' ' ' PRO . 0.9 OUTLIER -76.68 145.16 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.43 -0.793 . . . . 0.0 109.207 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 126.94 -160.26 21.2 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.514 ' O ' ' C ' ' A' ' 41' ' ' SER . 4.2 m-20 -115.8 52.01 0.92 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.113 -1.228 . . . . 0.0 109.798 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.514 ' C ' ' O ' ' A' ' 40' ' ' ASN . 18.3 p 24.88 67.78 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.715 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.87 116.08 0.42 Allowed Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.383 -1.389 . . . . 0.0 110.609 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.644 ' CG2' ' CE1' ' A' ' 29' ' ' TYR . 1.4 t -84.72 126.88 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.7 tp -97.29 106.88 19.29 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 120.201 -1.562 . . . . 0.0 111.423 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.592 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.8 OUTLIER -87.56 114.72 24.43 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.449 -0.901 . . . . 0.0 108.92 178.034 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.467 ' HA ' ' OD2' ' A' ' 23' ' ' ASP . 0.3 OUTLIER -132.43 128.67 38.0 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.404 -179.686 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.51 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 80.02 -5.48 62.38 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.461 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 109.79 6.76 28.24 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -126.54 116.49 21.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -1.18 . . . . 0.0 110.517 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.592 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 82.7 m95 -64.85 141.42 58.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.224 -0.922 . . . . 0.0 109.542 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 52' ' ' ASP . 2.4 t -140.98 -177.77 5.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.015 -1.053 . . . . 0.0 111.105 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.53 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER 36.26 65.4 2.14 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.746 -0.596 . . . . 0.0 111.207 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.53 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.8 Cg_endo -91.58 138.15 2.09 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 124.403 1.738 . . . . 0.0 109.666 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.536 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 51.3 Cg_endo -80.56 175.88 9.68 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.489 1.257 . . . . 0.0 110.321 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.581 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 20.0 p -130.12 138.58 50.75 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.171 -0.956 . . . . 0.0 111.0 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 14.2 m -97.52 76.48 2.54 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.459 ' HG3' HG12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -119.08 144.83 46.37 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.428 0.632 . . . . 0.0 110.219 -178.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.471 HG22 ' CZ ' ' A' ' 35' ' ' TYR . 1.7 pt -69.46 120.54 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.632 ' CG1' ' HA ' ' A' ' 105' ' ' PRO . 12.1 m -99.5 51.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.151 -0.968 . . . . 0.0 112.094 -178.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.0 mtpp -87.61 99.35 11.99 Favored 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 118.626 -1.229 . . . . 0.0 108.434 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.466 ' SG ' ' O ' ' A' ' 108' ' ' THR . 59.6 m -69.25 162.62 64.62 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.397 -0.814 . . . . 0.0 111.502 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 47.9 Cg_endo -72.0 -91.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.464 1.771 . . . . 0.0 110.587 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.453 ' HB3' ' CG2' ' A' ' 65' ' ' THR . 0.0 OUTLIER -158.27 132.27 5.04 Favored Pre-proline 0 C--N 1.302 -1.47 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.607 ' HD3' ' CZ2' ' A' ' 109' ' ' TRP . 55.5 Cg_endo -77.77 67.89 7.83 Favored 'Trans proline' 0 C--N 1.293 -2.344 0 O-C-N 123.757 1.398 . . . . 0.0 109.528 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.534 ' N ' HD22 ' A' ' 113' ' ' LEU . 1.5 p -88.97 174.98 7.61 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.553 ' CD1' ' HG2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -170.35 159.87 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 118.405 -1.318 . . . . 0.0 110.675 179.182 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 1.5 m -61.33 95.84 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.644 -0.66 . . . . 0.0 110.395 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.469 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 8.6 m-20 44.57 45.07 7.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.426 -0.796 . . . . 0.0 110.597 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.527 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -151.85 33.4 0.88 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.528 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 3.7 p90 -45.89 -171.39 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 122.743 1.258 . . . . 0.0 112.628 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.585 HD11 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -113.85 162.93 15.73 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.194 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.7 t -149.88 28.93 0.75 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.993 -1.067 . . . . 0.0 109.944 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.64 -16.98 7.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 111.235 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -154.08 -87.86 0.06 OUTLIER Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.169 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.616 ' CD2' ' N ' ' A' ' 76' ' ' LYS . 58.5 t80 58.6 170.24 0.06 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.626 -0.926 . . . . 0.0 110.577 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.616 ' N ' ' CD2' ' A' ' 75' ' ' PHE . 4.1 tptt 174.83 134.3 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.403 -0.811 . . . . 0.0 109.842 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 76' ' ' LYS . 2.3 mtt-85 -40.1 -45.16 1.93 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.262 -0.899 . . . . 0.0 110.4 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.432 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 3.6 t -132.86 125.42 29.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.438 -0.789 . . . . 0.0 110.198 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.599 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 14.9 m-85 -101.49 -173.98 2.49 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.146 -0.971 . . . . 0.0 110.506 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -170.41 106.9 0.31 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.148 -0.97 . . . . 0.0 110.971 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.648 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 5.1 t80 35.04 32.51 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.107 -0.996 . . . . 0.0 112.118 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.567 ' N ' ' O ' ' A' ' 103' ' ' CYS . 15.5 t30 -177.37 -140.25 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.221 -1.549 . . . . 0.0 111.149 178.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.418 ' C ' HG21 ' A' ' 102' ' ' THR . 1.6 m-20 56.3 73.19 0.45 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.114 -0.991 . . . . 0.0 108.948 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.512 ' N ' HG21 ' A' ' 102' ' ' THR . 7.0 t30 -69.57 112.53 6.13 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.458 -0.776 . . . . 0.0 110.31 -179.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.597 HG12 ' CH2' ' A' ' 109' ' ' TRP . 23.1 m -95.03 120.55 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 111.053 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 4.4 t0 -80.77 131.23 35.4 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.585 ' CE1' HD11 ' A' ' 71' ' ' LEU . 46.4 m-85 -91.14 136.9 32.77 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.881 -1.137 . . . . 0.0 111.945 -178.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -115.65 102.5 9.81 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.964 -179.587 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.517 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -49.44 131.31 20.66 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.098 -1.001 . . . . 0.0 110.081 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -39.96 -69.19 0.14 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.477 -0.764 . . . . 0.0 110.347 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.585 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 39.3 t80 -172.86 141.6 1.04 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -0.817 . . . . 0.0 110.21 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 50.99 56.92 12.14 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.585 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 13.2 m-85 -155.29 172.24 18.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.341 -1.093 . . . . 0.0 110.23 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.47 ' O ' HG21 ' A' ' 117' ' ' VAL . 0.7 OUTLIER -133.01 106.98 7.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.294 -0.879 . . . . 0.0 109.86 179.735 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.542 ' CD2' ' HB3' ' A' ' 87' ' ' PHE . 1.1 mt -46.83 99.38 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.194 -0.941 . . . . 0.0 110.675 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.469 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -78.99 101.4 7.76 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.358 -0.839 . . . . 0.0 109.441 179.226 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.86 -89.2 0.19 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.57 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.4 OUTLIER -154.35 116.94 4.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -1.173 . . . . 0.0 110.612 -179.404 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.48 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 2.0 m -83.42 29.83 0.49 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.308 -0.87 . . . . 0.0 110.832 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 65.4 p -170.5 102.56 0.26 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.16 -0.962 . . . . 0.0 109.531 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 85' ' ' VAL . 9.2 m -125.37 172.63 9.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.181 -0.949 . . . . 0.0 111.092 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.512 HG21 ' N ' ' A' ' 84' ' ' ASN . 19.9 m -143.52 142.47 31.14 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.458 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.567 ' O ' ' N ' ' A' ' 82' ' ' ASN . 6.8 t -54.57 100.51 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.399 -0.813 . . . . 0.0 109.124 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.444 ' OG ' ' HE3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -72.99 173.0 6.58 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 120.783 -1.198 . . . . 0.0 111.462 -178.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.632 ' HA ' ' CG1' ' A' ' 59' ' ' VAL . 47.2 Cg_endo -80.08 25.65 0.6 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.559 1.821 . . . . 0.0 112.451 -178.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -126.57 16.94 6.54 Favored Glycine 0 N--CA 1.484 1.851 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.472 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 0.9 OUTLIER 68.86 51.98 0.55 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.628 -0.925 . . . . 0.0 109.969 -179.86 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.466 ' O ' ' SG ' ' A' ' 61' ' ' CYS . 0.1 OUTLIER -160.78 -169.5 2.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.906 . . . . 0.0 111.109 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.607 ' CZ2' ' HD3' ' A' ' 64' ' ' PRO . 36.4 m95 -117.48 99.95 7.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.382 -0.823 . . . . 0.0 110.336 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.452 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 2.8 mtmt -105.56 140.19 20.93 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.537 -0.727 . . . . 0.0 110.071 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.57 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 47.3 Cg_endo -73.54 171.71 64.79 Favored 'Cis proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.809 -2.163 . . . . 0.0 110.434 -0.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.0 OUTLIER -40.8 128.53 2.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.372 -0.83 . . . . 0.0 111.074 -179.419 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.553 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.2 OUTLIER -41.46 147.58 0.47 Allowed Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.511 -0.743 . . . . 0.0 110.541 179.461 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.553 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 41.4 Cg_endo -75.53 169.91 21.36 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.342 1.707 . . . . 0.0 111.05 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.486 ' O ' HG23 ' A' ' 117' ' ' VAL . 30.7 ttmt -128.79 110.62 12.32 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.24 -0.912 . . . . 0.0 110.503 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.554 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 3.2 t -65.95 93.55 0.2 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.012 -1.055 . . . . 0.0 109.351 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 115' ' ' LYS . 2.3 m -113.21 -174.54 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 121.859 0.838 . . . . 0.0 111.176 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.507 ' HG2' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.792 0 CA-C-O 117.951 -1.024 . . . . 0.0 110.348 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.408 ' CG2' ' N ' ' A' ' 2' ' ' LYS . 7.0 p . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.248 0.547 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.408 ' N ' ' CG2' ' A' ' 1' ' ' VAL . 10.5 ptmt -159.84 -177.74 6.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 110.385 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.526 ' O ' ' HB2' ' A' ' 21' ' ' TYR . 1.1 m -133.54 81.16 1.91 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.606 -0.684 . . . . 0.0 109.818 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.562 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 58.4 mt-30 -63.46 178.57 0.54 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.827 -1.171 . . . . 0.0 110.456 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.8 p -46.35 143.83 3.58 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.45 -0.782 . . . . 0.0 109.896 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.618 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 48.7 Cg_endo -73.97 151.63 45.25 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.076 1.566 . . . . 0.0 111.204 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.61 171.31 18.03 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.789 1.415 . . . . 0.0 109.956 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.2 p -69.65 175.86 3.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.118 -0.989 . . . . 0.0 110.001 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.605 ' CG2' ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -142.25 -170.16 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 122.239 1.019 . . . . 0.0 111.296 179.757 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 3.2 t -51.48 99.47 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.852 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 10' ' ' SER . 1.3 m120 41.66 57.58 3.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.236 -0.915 . . . . 0.0 110.656 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -163.82 148.72 15.25 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.455 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -98.12 -176.85 3.54 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.298 -1.119 . . . . 0.0 110.12 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.618 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 23.8 p80 -143.92 138.65 28.69 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.697 -0.627 . . . . 0.0 109.814 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -166.93 -141.13 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.102 -0.999 . . . . 0.0 110.432 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.72 36.93 1.21 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 53.44 47.21 24.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.394 -1.063 . . . . 0.0 110.235 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.639 ' CB ' ' CE2' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -110.44 -159.74 0.69 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.248 -0.908 . . . . 0.0 109.913 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.421 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 0.4 OUTLIER 174.73 -28.05 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.342 -0.849 . . . . 0.0 110.458 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.572 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 3.2 p90 -165.45 55.01 0.11 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.143 -0.973 . . . . 0.0 110.722 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.639 ' CE2' ' CB ' ' A' ' 18' ' ' GLU . 19.5 m-85 -43.51 159.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.148 -0.97 . . . . 0.0 110.255 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.465 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -125.35 -59.98 1.36 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.933 -1.104 . . . . 0.0 110.58 -179.218 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.413 ' OD1' ' HA ' ' A' ' 46' ' ' SER . 3.6 t0 -166.37 140.62 4.26 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.472 -0.768 . . . . 0.0 109.618 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 74.36 17.27 79.71 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.575 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 3.1 m -97.54 168.04 10.61 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.474 -1.015 . . . . 0.0 109.936 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.646 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 74.5 t -137.27 158.43 35.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.032 -1.067 . . . . 0.0 111.1 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.59 HG13 ' CE1' ' A' ' 29' ' ' TYR . 39.0 t -143.67 107.61 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.426 -0.796 . . . . 0.0 110.957 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.81 105.65 2.41 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 117.974 -1.491 . . . . 0.0 107.722 178.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.64 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 2.0 m-30 -67.78 119.53 12.63 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.613 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -69.64 152.0 45.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.169 -0.957 . . . . 0.0 109.958 -179.86 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 78.6 m -121.81 163.92 18.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 110.424 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 33' ' ' SER . 3.3 m-20 -58.79 138.99 56.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.308 -0.87 . . . . 0.0 110.059 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 32' ' ' ASN . 1.5 m -43.2 104.9 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 110.22 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.51 -32.63 5.14 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -72.66 130.29 40.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.288 -1.125 . . . . 0.0 110.423 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.601 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -78.55 149.39 33.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.328 -0.858 . . . . 0.0 110.897 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.533 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 2.5 tp -95.09 113.45 25.14 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.414 -0.804 . . . . 0.0 108.858 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.591 ' CG2' ' CG ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -108.7 150.5 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.921 . . . . 0.0 109.298 -179.653 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 125.61 -139.41 11.51 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.35 -1.405 . . . . 0.0 109.697 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.504 ' O ' ' C ' ' A' ' 41' ' ' SER . 0.6 OUTLIER -110.0 51.43 0.76 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.196 -1.179 . . . . 0.0 109.989 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.504 ' C ' ' O ' ' A' ' 40' ' ' ASN . 13.5 p 22.68 50.64 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.345 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.453 ' HA3' ' CG1' ' A' ' 26' ' ' VAL . . . 152.37 131.58 1.71 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.331 -1.414 . . . . 0.0 110.408 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.646 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 1.2 t -81.67 121.38 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 178.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.449 ' HA ' ' O ' ' A' ' 25' ' ' SER . 11.6 tp -95.13 103.48 15.33 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 120.277 -1.514 . . . . 0.0 111.385 -178.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.6 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.7 OUTLIER -80.99 121.43 26.04 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.061 178.491 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.413 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 4.7 m -135.14 123.95 23.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.438 -0.789 . . . . 0.0 110.863 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.4 16.08 80.06 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.47 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 87.03 25.9 32.96 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -141.33 103.43 4.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.169 -1.195 . . . . 0.0 110.318 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.6 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 77.9 m95 -56.25 137.31 52.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.913 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 52' ' ' ASP . 10.1 m -140.73 179.45 6.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.93 . . . . 0.0 111.009 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.521 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER 39.25 65.36 3.44 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.666 -0.646 . . . . 0.0 111.177 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 46.3 Cg_endo -90.14 127.64 1.48 Allowed 'Trans proline' 0 C--N 1.298 -2.122 0 O-C-N 124.356 1.714 . . . . 0.0 109.689 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.527 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 50.8 Cg_endo -76.62 176.78 9.66 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 O-C-N 123.821 1.432 . . . . 0.0 110.746 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.529 ' OG1' ' CG1' ' A' ' 38' ' ' ILE . 9.6 p -119.98 153.37 36.08 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.476 -0.765 . . . . 0.0 111.125 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 10' ' ' SER . 94.6 m -114.11 78.84 1.18 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -115.09 -178.24 3.32 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.3 0.572 . . . . 0.0 110.366 -178.511 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -95.6 130.1 44.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.305 -0.872 . . . . 0.0 109.299 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.601 ' CG1' ' CB ' ' A' ' 36' ' ' SER . 23.4 m -117.3 49.91 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 110.787 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 1.1 mttm -64.83 -163.27 0.02 OUTLIER 'General case' 0 C--N 1.281 -2.393 0 C-N-CA 118.797 -1.161 . . . . 0.0 109.167 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -151.0 154.56 34.36 Favored Pre-proline 0 C--N 1.291 -1.94 0 C-N-CA 119.167 -1.013 . . . . 0.0 112.179 -179.219 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.561 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 43.2 Cg_endo -81.03 -59.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.54 1.81 . . . . 0.0 108.539 177.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.561 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.2 OUTLIER 157.45 127.2 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.588 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.597 ' HB3' ' CE2' ' A' ' 109' ' ' TRP . 55.7 Cg_endo -79.91 67.14 8.7 Favored 'Trans proline' 0 C--N 1.296 -2.213 0 O-C-N 123.767 1.404 . . . . 0.0 109.771 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.537 ' O ' ' CD2' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -92.96 177.04 6.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.334 -0.854 . . . . 0.0 109.363 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.574 HG23 ' CE1' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -174.82 162.87 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 119.155 -1.018 . . . . 0.0 110.303 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 68' ' ' ASN . 3.0 t -67.32 108.08 2.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.514 -0.741 . . . . 0.0 111.054 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.49 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 31.2 m-80 38.69 34.93 0.09 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.593 -0.692 . . . . 0.0 110.853 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.551 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -145.92 35.98 1.35 Allowed Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.359 -1.4 . . . . 0.0 110.001 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.551 ' O ' ' O ' ' A' ' 69' ' ' GLY . 5.1 p90 -48.28 -163.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 123.169 1.461 . . . . 0.0 112.287 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.534 ' CD2' ' HB2' ' A' ' 64' ' ' PRO . 1.9 pp -117.66 124.6 48.95 Favored 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 114.341 -1.3 . . . . 0.0 110.11 -178.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.483 ' HB3' ' HB2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -92.61 9.99 32.36 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.479 -0.763 . . . . 0.0 109.534 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.28 -71.73 0.43 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.382 -0.824 . . . . 0.0 110.652 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -172.55 98.5 0.13 Allowed Glycine 0 N--CA 1.489 2.197 0 C-N-CA 119.781 -1.2 . . . . 0.0 110.121 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.608 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -98.78 174.9 6.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.427 -1.043 . . . . 0.0 109.576 179.529 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.561 ' N ' ' CG ' ' A' ' 75' ' ' PHE . 3.3 ttmt -166.54 168.39 14.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.339 -0.85 . . . . 0.0 109.873 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.55 -31.03 61.8 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.754 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.462 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 0.5 OUTLIER -155.26 163.3 40.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.14 -0.975 . . . . 0.0 110.447 -179.868 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.608 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 10.2 m-85 -133.83 -164.97 1.57 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.262 -0.899 . . . . 0.0 110.401 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 40.9 p -143.22 -149.25 0.26 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.394 -0.817 . . . . 0.0 109.383 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.574 ' N ' ' CG2' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -70.67 144.74 50.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.632 -1.293 . . . . 0.0 108.508 179.052 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 103' ' ' CYS . 34.8 t-20 65.45 -111.85 0.23 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.328 -0.857 . . . . 0.0 110.704 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 1.0 OUTLIER 46.43 84.42 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.617 -1.302 . . . . 0.0 108.207 -178.31 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.577 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.0 OUTLIER -85.5 135.01 34.01 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.464 -0.772 . . . . 0.0 112.143 -177.595 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.607 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 6.3 m -119.94 118.95 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.312 -0.867 . . . . 0.0 109.435 177.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.489 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 20.0 t0 -73.61 134.56 43.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.092 -1.005 . . . . 0.0 109.16 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.576 ' CE2' HD13 ' A' ' 113' ' ' LEU . 28.2 m-85 -94.25 129.35 40.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.071 -1.018 . . . . 0.0 111.144 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -106.67 96.11 6.21 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.806 -179.124 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.435 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -47.56 133.63 13.03 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.904 -1.122 . . . . 0.0 109.217 179.199 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -40.43 -85.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.272 -0.892 . . . . 0.0 110.269 -179.596 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.472 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 1.0 OUTLIER -163.65 135.01 4.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.458 -0.776 . . . . 0.0 109.922 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.72 48.94 62.58 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.081 -1.607 . . . . 0.0 109.081 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.536 ' CB ' ' SG ' ' A' ' 116' ' ' CYS . 36.2 m-85 -153.04 170.01 21.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.442 -1.034 . . . . 0.0 110.131 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.537 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 1.0 OUTLIER -131.17 107.46 9.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.271 -0.893 . . . . 0.0 109.656 179.432 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.543 ' CD2' HD12 ' A' ' 66' ' ' ILE . 43.0 mt -46.87 102.76 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.187 -0.945 . . . . 0.0 110.623 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.428 ' HB2' HG22 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -81.15 98.13 7.91 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.39 -0.819 . . . . 0.0 109.29 179.067 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.87 -86.3 0.17 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.562 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -160.4 124.51 3.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.157 -1.202 . . . . 0.0 110.734 -179.489 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.46 ' OG ' ' N ' ' A' ' 100' ' ' SER . 13.3 p -70.03 -55.99 8.11 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.101 -0.999 . . . . 0.0 110.574 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.46 ' N ' ' OG ' ' A' ' 99' ' ' SER . 54.7 p -94.75 121.5 36.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.286 -0.884 . . . . 0.0 110.127 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 29.6 m -121.42 -174.64 2.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.892 . . . . 0.0 110.119 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -157.28 128.5 6.79 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.324 -0.86 . . . . 0.0 110.735 179.658 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.555 ' N ' ' O ' ' A' ' 82' ' ' ASN . 46.9 t -65.52 91.93 0.13 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.746 -0.596 . . . . 0.0 109.613 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.465 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -71.58 -179.89 0.84 Allowed Pre-proline 0 C--N 1.298 -1.644 0 O-C-N 121.403 -0.811 . . . . 0.0 110.863 -179.339 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.591 ' CG ' ' CG2' ' A' ' 38' ' ' ILE . 42.7 Cg_endo -80.55 121.61 4.27 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 O-C-N 124.467 1.772 . . . . 0.0 110.424 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.577 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 132.21 -3.6 5.19 Favored Glycine 0 N--CA 1.481 1.638 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.577 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 1.0 OUTLIER 80.71 88.08 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.777 -0.837 . . . . 0.0 111.264 179.431 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.544 ' CG2' ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 176.66 -164.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 111.523 179.15 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.607 ' CZ3' HG23 ' A' ' 85' ' ' VAL . 28.6 m95 -139.68 90.02 2.37 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.412 0.625 . . . . 0.0 110.13 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.478 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 1.5 mmtp -99.3 141.25 22.51 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.408 -0.808 . . . . 0.0 110.15 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.562 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.0 Cg_endo -72.0 173.33 52.56 Favored 'Cis proline' 0 C--N 1.312 -1.348 0 C-N-CA 122.034 -2.069 . . . . 0.0 110.811 -0.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 111' ' ' PRO . 10.2 pt-20 -40.81 137.83 1.13 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.398 -0.814 . . . . 0.0 110.801 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.576 HD13 ' CE2' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -53.09 144.55 27.75 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.416 -0.802 . . . . 0.0 110.342 179.639 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.542 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . 43.4 Cg_endo -72.22 163.62 38.13 Favored 'Trans proline' 0 C--N 1.302 -1.885 0 O-C-N 124.224 1.644 . . . . 0.0 111.12 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.541 ' O ' HG23 ' A' ' 117' ' ' VAL . 9.4 tttt -127.84 115.39 18.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.456 -0.778 . . . . 0.0 109.848 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.536 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 0.8 OUTLIER -66.29 100.94 0.67 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.034 -1.041 . . . . 0.0 109.651 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 115' ' ' LYS . 0.7 OUTLIER -118.22 -177.19 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 121.625 0.726 . . . . 0.0 110.931 -179.538 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.7 mtp-105 . . . . . 0 C--N 1.295 -1.797 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.53 179.937 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 121.24 0.543 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -135.13 103.89 5.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 110.332 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.612 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 37.3 t -68.98 155.87 39.58 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.669 -0.644 . . . . 0.0 110.486 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.423 ' O ' ' C ' ' A' ' 5' ' ' SER . 69.6 mt-30 -140.08 -177.09 4.84 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.356 -0.84 . . . . 0.0 109.644 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.2 OUTLIER -42.05 133.02 2.51 Favored Pre-proline 0 C--N 1.297 -1.683 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.123 -179.666 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.583 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 51.8 Cg_endo -70.14 157.41 59.74 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.12 1.589 . . . . 0.0 111.112 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -75.66 172.23 16.71 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.969 1.51 . . . . 0.0 110.109 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.46 175.26 4.9 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.208 -0.932 . . . . 0.0 109.94 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.469 HG22 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -139.58 -170.36 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 122.241 1.02 . . . . 0.0 111.412 179.648 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 11' ' ' ASN . 39.2 m -45.38 97.26 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.484 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 9' ' ' ILE . 2.5 m-20 43.14 47.26 5.26 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.294 -0.879 . . . . 0.0 110.511 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -152.4 155.67 26.26 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.459 ' N ' ' O ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -104.58 -166.42 1.24 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.347 -1.09 . . . . 0.0 110.659 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.583 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 14.6 p80 -151.74 121.79 7.14 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.104 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -119.32 123.11 43.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.202 -0.936 . . . . 0.0 110.33 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.71 -5.44 6.42 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.422 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 0.5 OUTLIER 55.49 55.99 6.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -1.149 . . . . 0.0 110.075 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.54 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 2.6 pp20? -178.59 -162.67 0.06 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.3 -0.875 . . . . 0.0 110.223 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.414 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 1.1 t0 -136.4 -42.62 0.62 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.358 -0.839 . . . . 0.0 109.844 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.431 ' CD1' ' C ' ' A' ' 20' ' ' PHE . 21.2 p90 -111.53 140.65 45.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.332 -0.855 . . . . 0.0 109.844 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.629 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.5 OUTLIER -122.65 -12.06 8.16 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.28 -0.888 . . . . 0.0 110.432 -179.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.488 ' N ' ' HB3' ' A' ' 3' ' ' CYS . 82.8 m 52.61 -99.15 0.08 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.458 -0.776 . . . . 0.0 111.173 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -151.63 157.45 42.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.19 -0.943 . . . . 0.0 109.995 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.59 16.0 80.31 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.629 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 30.4 m -99.34 173.99 6.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.434 -1.039 . . . . 0.0 110.316 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.521 HG11 ' N ' ' A' ' 27' ' ' VAL . 28.2 t -151.66 154.75 7.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.318 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.582 HG13 ' CD1' ' A' ' 29' ' ' TYR . 17.4 t -136.52 114.32 14.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 119.349 -0.941 . . . . 0.0 111.459 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.46 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -69.29 104.09 2.14 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 118.397 -1.321 . . . . 0.0 107.77 178.12 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.619 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 2.1 m-30 -68.09 144.87 54.88 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.431 -0.793 . . . . 0.0 110.287 -178.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -100.08 153.16 19.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.389 -0.819 . . . . 0.0 109.591 179.214 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.446 ' SG ' HD13 ' A' ' 37' ' ' LEU . 57.1 m -125.0 160.46 28.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.149 -0.969 . . . . 0.0 110.515 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -49.55 157.61 0.52 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.445 -0.785 . . . . 0.0 110.102 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.29 99.71 0.74 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.221 -0.924 . . . . 0.0 110.261 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.25 10.44 5.6 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 -107.99 166.35 10.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -1.15 . . . . 0.0 110.295 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.564 ' CB ' HG23 ' A' ' 59' ' ' VAL . 4.8 p -108.27 133.57 52.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.433 -0.792 . . . . 0.0 110.649 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' A' ' 55' ' ' THR . 0.6 OUTLIER -95.1 109.82 21.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -0.955 . . . . 0.0 109.697 179.178 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.573 HG22 ' CB ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -105.19 140.09 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.252 -0.905 . . . . 0.0 108.962 179.556 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.95 -156.81 24.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.488 ' O ' ' C ' ' A' ' 41' ' ' SER . 4.7 m-20 -99.5 51.19 0.93 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -1.153 . . . . 0.0 109.848 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.488 ' C ' ' O ' ' A' ' 40' ' ' ASN . 59.2 p 27.22 57.41 0.08 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.803 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 27' ' ' VAL . . . 144.06 114.88 0.99 Allowed Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.158 -1.496 . . . . 0.0 110.73 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.619 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -55.06 -177.65 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.081 -1.247 . . . . 0.0 107.636 178.426 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.487 ' HA ' ' O ' ' A' ' 25' ' ' SER . 5.0 tp -145.87 93.02 2.28 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.313 -0.867 . . . . 0.0 110.106 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.6 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.8 OUTLIER -74.19 118.9 17.67 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.173 -0.955 . . . . 0.0 109.455 179.379 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.2 t -129.73 76.12 1.7 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.114 -0.991 . . . . 0.0 110.804 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.74 53.43 0.71 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 58.13 26.17 58.15 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -145.75 119.12 8.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -1.181 . . . . 0.0 109.917 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.612 ' CE2' ' SG ' ' A' ' 3' ' ' CYS . 91.7 m95 -81.68 133.36 35.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.881 . . . . 0.0 110.358 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.31 165.28 26.14 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.196 -0.94 . . . . 0.0 110.72 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.542 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 1.1 t0 55.1 64.54 5.67 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.559 -0.713 . . . . 0.0 111.0 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.542 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.5 Cg_endo -91.8 136.14 1.71 Allowed 'Trans proline' 0 C--N 1.3 -2.007 0 O-C-N 124.347 1.709 . . . . 0.0 109.491 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.552 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 43.4 Cg_endo -75.09 175.26 11.48 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 O-C-N 123.58 1.305 . . . . 0.0 110.397 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.49 ' OG1' ' CG1' ' A' ' 38' ' ' ILE . 6.3 p -121.98 145.39 48.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.32 -0.863 . . . . 0.0 111.656 -178.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 77.4 m -105.93 83.01 1.85 Allowed 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.467 ' OE1' HG13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -110.46 -145.54 0.4 Allowed 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.735 -0.603 . . . . 0.0 110.193 -178.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.479 ' CD1' ' N ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -137.05 100.15 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.158 -0.963 . . . . 0.0 108.909 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.638 ' HB ' ' HA ' ' A' ' 105' ' ' PRO . 31.8 m -102.09 64.28 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.255 -0.903 . . . . 0.0 112.213 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 2.0 mptp? -66.97 176.51 2.05 Favored 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 117.541 -1.663 . . . . 0.0 107.306 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.53 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 1.1 m -130.63 166.59 26.02 Favored Pre-proline 0 N--CA 1.494 1.73 0 C-N-CA 117.996 -1.482 . . . . 0.0 113.904 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.588 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 44.5 Cg_endo -88.88 -76.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 125.01 2.058 . . . . 0.0 110.735 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.588 ' CD2' ' O ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER 169.9 124.12 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.263 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.616 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 48.1 Cg_endo -76.09 71.1 5.8 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 123.58 1.305 . . . . 0.0 109.661 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.451 ' C ' ' CG2' ' A' ' 66' ' ' ILE . 1.1 p -89.39 -174.62 4.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.394 -0.816 . . . . 0.0 109.826 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.537 ' CD1' ' HG2' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -179.95 167.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.181 179.248 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.492 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 31.8 t -72.31 95.45 1.72 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.566 -0.709 . . . . 0.0 110.827 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 80.0 m-20 46.58 43.62 12.61 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.358 -0.839 . . . . 0.0 110.894 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.519 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -151.61 32.81 0.91 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.577 ' O ' ' N ' ' A' ' 88' ' ' LYS . 1.9 p90 -44.9 -174.99 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 122.697 1.237 . . . . 0.0 112.522 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.538 ' C ' ' CD2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -108.0 168.16 9.48 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.442 179.4 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.8 14.91 0.84 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.943 -1.098 . . . . 0.0 110.009 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.467 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -95.21 -55.46 3.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.312 -0.867 . . . . 0.0 110.557 -179.708 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.425 ' O ' HG13 ' A' ' 85' ' ' VAL . . . -153.09 88.8 0.13 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.615 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -109.44 162.79 14.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.288 -1.125 . . . . 0.0 109.717 179.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.615 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -159.51 155.53 26.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.134 -0.979 . . . . 0.0 110.458 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.0 mtp180 -56.62 -40.08 74.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.224 -0.922 . . . . 0.0 110.027 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.2 t -136.89 127.36 26.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.425 -0.797 . . . . 0.0 110.11 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.585 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 14.5 m-85 -102.35 -146.96 0.37 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.138 -0.977 . . . . 0.0 110.217 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 60.0 p -160.03 -119.85 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.371 -0.83 . . . . 0.0 109.773 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.582 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.2 OUTLIER -109.13 35.39 3.28 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.829 -1.169 . . . . 0.0 110.536 -179.784 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.542 ' N ' ' ND2' ' A' ' 82' ' ' ASN . 0.1 OUTLIER -169.76 -109.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.159 -0.963 . . . . 0.0 110.296 179.425 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.449 ' OD2' ' ND2' ' A' ' 82' ' ' ASN . 8.1 m-20 42.99 75.47 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.96 -1.088 . . . . 0.0 109.761 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.533 ' N ' HG21 ' A' ' 102' ' ' THR . 9.4 p30 -69.53 120.37 15.21 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.259 -0.9 . . . . 0.0 110.206 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.578 HG22 ' CE1' ' A' ' 87' ' ' PHE . 33.8 m -108.14 118.35 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.86 -1.15 . . . . 0.0 111.029 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.538 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 9.0 t0 -76.91 134.49 38.94 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.583 ' CZ ' HD11 ' A' ' 113' ' ' LEU . 48.8 m-85 -93.87 127.4 39.61 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.009 -1.057 . . . . 0.0 112.42 -177.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.577 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -102.69 110.08 21.9 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.091 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.453 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -56.64 132.5 51.99 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.004 -1.06 . . . . 0.0 109.855 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 89' ' ' CYS . 0.3 OUTLIER -39.93 -69.95 0.12 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.483 -0.761 . . . . 0.0 110.33 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.537 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.3 OUTLIER -171.77 136.86 0.96 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.324 -0.86 . . . . 0.0 110.277 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.584 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 50.6 58.77 8.65 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.116 -1.593 . . . . 0.0 109.116 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 9.9 m-85 -160.66 152.48 19.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.432 -1.04 . . . . 0.0 110.162 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -105.74 142.55 35.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -0.846 . . . . 0.0 109.596 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.52 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 0.7 OUTLIER -84.05 93.66 8.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.08 -1.013 . . . . 0.0 110.423 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.464 ' HB3' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -70.4 102.45 2.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.267 -0.895 . . . . 0.0 109.671 179.554 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.52 -93.1 0.19 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.564 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.2 OUTLIER -152.47 118.74 5.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.158 -1.201 . . . . 0.0 110.491 -179.523 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.16 5.07 1.8 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.285 -0.884 . . . . 0.0 111.641 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.512 ' OG ' ' HA ' ' A' ' 86' ' ' ASP . 0.6 OUTLIER -161.87 119.77 2.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.702 -1.249 . . . . 0.0 109.896 179.409 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.469 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 3.1 m -129.63 168.2 16.81 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.408 -0.808 . . . . 0.0 110.482 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.533 HG21 ' N ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -130.71 140.67 50.36 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.298 179.764 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.559 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -72.56 84.98 1.15 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.761 -0.587 . . . . 0.0 110.564 -179.53 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.452 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -62.7 174.22 0.86 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.285 -0.885 . . . . 0.0 111.197 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.638 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 40.8 Cg_endo -72.68 125.45 10.57 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 O-C-N 124.551 1.816 . . . . 0.0 110.626 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.574 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 129.77 -11.54 5.97 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.574 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 0.6 OUTLIER 82.5 90.25 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 122.014 -0.698 . . . . 0.0 110.366 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.437 ' OG1' ' C ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -179.86 -166.35 0.08 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.492 -0.755 . . . . 0.0 110.407 179.777 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.616 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 38.8 m95 -141.66 92.7 2.48 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.46 -0.775 . . . . 0.0 110.379 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.47 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 6.2 mttt -104.5 139.86 20.52 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.57 -0.706 . . . . 0.0 109.69 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.564 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 46.3 Cg_endo -71.63 166.59 78.21 Favored 'Cis proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.033 -2.069 . . . . 0.0 111.207 -0.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 111' ' ' PRO . 2.9 tt0 -38.31 133.94 0.91 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.684 -0.635 . . . . 0.0 110.976 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.593 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.9 OUTLIER -45.67 148.24 1.35 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.902 . . . . 0.0 109.684 179.412 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.537 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 42.2 Cg_endo -74.35 170.92 19.13 Favored 'Trans proline' 0 C--N 1.299 -2.067 0 O-C-N 124.253 1.659 . . . . 0.0 110.851 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.459 ' O ' HG23 ' A' ' 117' ' ' VAL . 35.7 tttt -128.93 111.44 13.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.161 -0.962 . . . . 0.0 110.449 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.544 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 3.8 t -67.29 81.79 0.14 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.797 0.808 . . . . 0.0 109.83 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.464 HG23 ' HB3' ' A' ' 96' ' ' SER . 1.4 m -97.4 -169.29 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.904 0.859 . . . . 0.0 110.717 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.458 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.293 -1.876 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.505 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.496 HG22 ' N ' ' A' ' 48' ' ' GLY . 3.4 m . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.285 0.564 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.8 mttm -94.4 169.86 9.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.218 -0.926 . . . . 0.0 110.549 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.617 ' CB ' ' N ' ' A' ' 22' ' ' THR . 0.7 OUTLIER -129.14 146.68 51.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.302 -0.874 . . . . 0.0 110.401 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 19' ' ' ASP . 0.5 OUTLIER -128.92 177.42 7.12 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.506 -0.746 . . . . 0.0 109.578 179.496 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.02 136.45 14.2 Favored Pre-proline 0 C--N 1.298 -1.656 0 O-C-N 121.26 -0.9 . . . . 0.0 109.706 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.612 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 48.5 Cg_endo -69.37 163.51 37.67 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.052 1.554 . . . . 0.0 111.08 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.95 170.25 20.21 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.896 1.472 . . . . 0.0 109.618 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.482 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -87.17 105.47 17.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.106 -0.996 . . . . 0.0 109.973 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.536 HG12 ' CD2' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -47.34 -179.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-O 121.861 0.839 . . . . 0.0 111.059 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 11' ' ' ASN . 0.4 OUTLIER -103.55 69.28 0.98 Allowed 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.975 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.529 ' CB ' ' O ' ' A' ' 10' ' ' SER . 3.1 p30 164.4 -24.23 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.595 -0.69 . . . . 0.0 109.786 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.462 ' CA ' HD13 ' A' ' 9' ' ' ILE . . . -145.91 -160.61 8.76 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -126.77 -175.7 3.48 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.476 -1.014 . . . . 0.0 109.358 179.89 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.612 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 10.2 p80 -137.23 160.89 37.72 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.308 -0.87 . . . . 0.0 110.768 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.449 ' OD1' HG12 ' A' ' 27' ' ' VAL . 26.7 p-10 -38.54 146.81 0.06 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.541 -0.724 . . . . 0.0 110.985 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -137.83 18.34 3.38 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.76 -26.46 9.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.296 -1.12 . . . . 0.0 110.258 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -81.64 -147.53 0.07 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.939 . . . . 0.0 109.827 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 20' ' ' PHE . 3.7 p30 178.53 -34.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.597 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.508 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 9.5 m-85 -124.58 133.78 53.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -0.929 . . . . 0.0 109.9 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.648 ' CD2' ' HB3' ' A' ' 25' ' ' SER . 2.8 m-85 -127.82 -9.87 5.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.068 -1.02 . . . . 0.0 111.132 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.617 ' N ' ' CB ' ' A' ' 3' ' ' CYS . 69.6 p 37.82 -98.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.507 -0.745 . . . . 0.0 111.424 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.486 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 23.0 t0 -150.65 138.88 20.27 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.991 -1.068 . . . . 0.0 110.488 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.43 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 91.09 22.7 31.84 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.648 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 50.8 m -118.27 163.82 16.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.306 -1.114 . . . . 0.0 110.073 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.554 ' CG1' ' HA3' ' A' ' 42' ' ' GLY . 19.6 t -139.58 149.85 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.029 -1.044 . . . . 0.0 112.289 -178.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.563 HG13 ' CD1' ' A' ' 29' ' ' TYR . 18.1 t -122.26 114.13 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-O 121.356 0.598 . . . . 0.0 112.007 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.522 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -71.51 105.63 3.68 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.437 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.662 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 2.8 m-30 -67.82 136.1 53.61 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.729 -178.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 13' ' ' ARG . 6.3 m -73.46 -173.64 1.46 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.99 -1.069 . . . . 0.0 109.301 179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.451 ' SG ' ' HB3' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -154.74 137.12 14.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.974 -1.079 . . . . 0.0 110.803 -179.642 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -44.84 159.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.342 -0.849 . . . . 0.0 109.775 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.99 97.63 0.69 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.215 -0.928 . . . . 0.0 110.401 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 129.22 -20.85 5.26 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.511 ' CD2' ' O ' ' A' ' 56' ' ' CYS . 2.5 m-30 -92.33 139.31 30.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.197 -1.178 . . . . 0.0 110.627 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.588 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -91.03 144.4 25.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.294 -0.879 . . . . 0.0 110.73 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.542 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 2.4 tp -91.36 113.75 26.09 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.415 -0.803 . . . . 0.0 109.798 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.564 ' CD1' ' N ' ' A' ' 38' ' ' ILE . 0.3 OUTLIER -107.21 149.89 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.223 -0.923 . . . . 0.0 109.748 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 129.32 -153.39 19.86 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.507 ' O ' ' C ' ' A' ' 41' ' ' SER . 1.2 t30 -92.4 50.72 1.65 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.079 -1.248 . . . . 0.0 109.765 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.507 ' C ' ' O ' ' A' ' 40' ' ' ASN . 13.7 p 26.44 43.03 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.708 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.554 ' HA3' ' CG1' ' A' ' 26' ' ' VAL . . . 152.7 123.21 0.97 Allowed Glycine 0 N--CA 1.49 2.27 0 C-N-CA 119.229 -1.463 . . . . 0.0 110.694 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.662 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 1.6 t -58.15 -178.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.459 HD13 HG21 ' A' ' 26' ' ' VAL . 10.8 tp -147.81 97.99 2.89 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.722 -1.191 . . . . 0.0 110.684 178.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.481 ' HB2' ' CD2' ' A' ' 50' ' ' TRP . 14.6 t -78.39 115.54 18.18 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.41 179.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.437 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 4.7 m -124.48 81.82 1.98 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.551 -0.718 . . . . 0.0 110.272 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.486 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 93.64 56.85 1.39 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.496 ' N ' HG22 ' A' ' 1' ' ' VAL . . . 51.67 23.15 9.55 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -126.04 82.04 2.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.284 -1.127 . . . . 0.0 110.681 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.528 ' HH2' ' CD2' ' A' ' 21' ' ' TYR . 67.0 m95 -54.33 128.52 31.84 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.15 -0.969 . . . . 0.0 109.148 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.407 ' O ' ' CB ' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -148.07 157.06 43.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.935 -1.103 . . . . 0.0 111.474 -179.328 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.502 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 4.8 t0 66.66 65.79 0.73 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.796 -0.565 . . . . 0.0 111.348 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.502 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.9 Cg_endo -91.45 141.49 2.75 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 O-C-N 124.37 1.721 . . . . 0.0 109.986 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.541 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 51.8 Cg_endo -80.11 -179.31 5.15 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 O-C-N 123.891 1.469 . . . . 0.0 110.308 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.535 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 8.6 p -117.91 -172.28 2.22 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.971 0.891 . . . . 0.0 111.104 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.516 ' CB ' ' HB2' ' A' ' 11' ' ' ASN . 0.8 OUTLIER -147.8 79.62 1.48 Allowed 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.778 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -113.42 -152.27 0.5 Allowed 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.004 -178.605 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.76 128.53 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.608 HG22 ' HB3' ' A' ' 81' ' ' TYR . 26.0 m -120.39 48.17 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.896 -1.127 . . . . 0.0 112.346 -178.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -60.94 164.07 5.25 Favored 'General case' 0 C--N 1.278 -2.519 0 C-N-CA 117.581 -1.648 . . . . 0.0 107.558 178.788 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.52 ' SG ' ' HB2' ' A' ' 79' ' ' TYR . 35.5 m -131.98 161.33 63.31 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 120.603 -1.311 . . . . 0.0 111.749 -178.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 43.5 Cg_endo -75.79 -84.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.832 0 O-C-N 124.565 1.824 . . . . 0.0 110.251 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -179.84 128.43 0.24 Allowed Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 121.552 -0.717 . . . . 0.0 109.167 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.622 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 54.2 Cg_endo -77.97 67.14 8.13 Favored 'Trans proline' 0 C--N 1.298 -2.081 0 O-C-N 123.773 1.407 . . . . 0.0 109.744 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.421 ' C ' HG23 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -87.11 175.27 8.17 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.383 -0.823 . . . . 0.0 110.199 -179.691 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.568 HG22 ' CD1' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -170.21 165.49 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 110.211 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.449 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 17.5 m -74.6 106.14 6.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.451 -0.781 . . . . 0.0 110.724 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 5.1 m120 41.54 41.13 1.53 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.344 -0.848 . . . . 0.0 110.718 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.539 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -150.61 32.52 1.0 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.55 ' O ' ' N ' ' A' ' 88' ' ' LYS . 5.5 p90 -44.13 -173.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 122.826 1.298 . . . . 0.0 112.657 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.587 HD22 ' CD2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -111.04 162.23 15.08 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.392 179.42 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.06 20.03 1.42 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.961 -1.087 . . . . 0.0 110.103 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.3 t -103.03 -67.82 0.86 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.254 -0.904 . . . . 0.0 110.693 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -137.85 82.9 0.26 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.631 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 2.5 t80 -110.3 163.86 13.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.358 -1.083 . . . . 0.0 110.238 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.631 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 19.7 tttm -164.17 153.3 13.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.883 . . . . 0.0 110.007 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -51.72 -28.33 14.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 0.0 109.822 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.5 m -144.54 158.18 43.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.417 -0.802 . . . . 0.0 110.436 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.569 ' OH ' ' CE2' ' A' ' 75' ' ' PHE . 10.9 m-85 -131.27 -149.55 0.39 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.401 -0.812 . . . . 0.0 109.572 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.518 ' CA ' HG21 ' A' ' 59' ' ' VAL . 94.8 p -157.46 -108.84 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.73 -1.231 . . . . 0.0 110.984 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.608 ' HB3' HG22 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -108.16 23.36 14.6 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.286 -1.509 . . . . 0.0 110.467 -179.525 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.536 ' HA ' HG23 ' A' ' 102' ' ' THR . 47.6 t30 -171.31 -97.01 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.152 -0.968 . . . . 0.0 110.424 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 82' ' ' ASN . 5.0 m-20 42.05 72.48 0.17 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 109.546 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 101' ' ' SER . 0.4 OUTLIER -68.62 137.5 54.28 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.345 -179.065 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.579 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 16.0 m -117.79 120.19 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.143 -0.973 . . . . 0.0 110.552 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.436 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -78.07 128.12 33.35 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.57 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.613 ' CD2' ' CD ' ' A' ' 114' ' ' PRO . 32.6 m-85 -89.17 125.14 34.93 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.031 -1.043 . . . . 0.0 112.087 -178.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -100.11 93.05 5.52 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.922 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.452 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -44.3 133.81 5.29 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.014 -1.054 . . . . 0.0 109.923 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -39.5 -72.47 0.06 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.515 -0.741 . . . . 0.0 110.345 -179.672 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.454 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 5.5 t80 -175.92 144.68 0.62 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.299 -0.876 . . . . 0.0 110.018 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.548 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 52.55 31.91 37.69 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.548 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 13.9 m-85 -141.67 146.96 36.75 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.514 -0.992 . . . . 0.0 110.097 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 117' ' ' VAL . 19.0 mttt -104.0 155.6 18.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.355 -0.84 . . . . 0.0 109.27 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.542 ' CD2' ' HB3' ' A' ' 87' ' ' PHE . 0.8 OUTLIER -91.93 100.86 13.45 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.736 -1.227 . . . . 0.0 110.5 -179.587 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.45 ' HB3' HG23 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -78.62 100.78 7.14 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.442 -0.786 . . . . 0.0 109.559 179.486 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.2 -81.02 0.22 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.561 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -167.16 114.8 0.8 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.228 -1.16 . . . . 0.0 110.774 -179.32 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -61.49 -48.5 80.79 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.203 -0.935 . . . . 0.0 110.74 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.2 p -101.24 130.63 47.39 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.191 -0.943 . . . . 0.0 109.87 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 11.6 m -140.89 158.71 43.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.156 -0.965 . . . . 0.0 110.743 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.536 HG23 ' HA ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -134.88 140.31 45.69 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.515 -0.741 . . . . 0.0 109.652 179.625 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.609 ' O ' ' CB ' ' A' ' 104' ' ' SER . 0.7 OUTLIER -59.08 -59.18 5.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.241 -0.912 . . . . 0.0 111.057 -178.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.609 ' CB ' ' O ' ' A' ' 103' ' ' CYS . 0.2 OUTLIER 82.92 161.93 0.12 Allowed Pre-proline 0 C--N 1.292 -1.934 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -178.76 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.58 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 38.3 Cg_endo -67.1 120.28 7.35 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.767 1.404 . . . . 0.0 111.2 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 130.99 -9.09 5.72 Favored Glycine 0 N--CA 1.481 1.665 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.627 ' O ' ' CG2' ' A' ' 108' ' ' THR . 0.1 OUTLIER 77.66 105.34 0.07 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.592 -0.946 . . . . 0.0 111.103 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.627 ' CG2' ' O ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER 171.67 -148.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.426 -0.796 . . . . 0.0 110.711 179.345 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.622 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 22.3 m95 -163.32 66.31 0.18 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.345 -0.847 . . . . 0.0 109.617 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.468 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.2 OUTLIER -83.81 140.27 40.6 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.508 -0.745 . . . . 0.0 110.238 -179.625 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.561 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 44.8 Cg_endo -72.48 165.44 83.13 Favored 'Cis proline' 0 C--N 1.313 -1.336 0 C-N-CA 121.901 -2.125 . . . . 0.0 110.682 -0.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.5 pm0 -37.5 140.75 0.2 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.675 -0.641 . . . . 0.0 110.888 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.556 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 1.2 mm? -50.68 146.3 9.92 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.361 -0.837 . . . . 0.0 109.696 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.613 ' CD ' ' CD2' ' A' ' 87' ' ' PHE . 37.6 Cg_endo -71.02 168.51 22.98 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 124.181 1.621 . . . . 0.0 111.268 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.463 ' O ' HG23 ' A' ' 117' ' ' VAL . 5.0 ttpt -128.12 111.97 14.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.342 -0.849 . . . . 0.0 110.355 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.54 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.1 t -68.0 100.14 0.94 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 109.33 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -113.78 -178.58 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.483 0.659 . . . . 0.0 110.367 -179.487 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.52 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 6.5 ptt180 . . . . . 0 C--N 1.295 -1.784 0 C-N-CA 118.871 -1.131 . . . . 0.0 110.51 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.6 m . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.327 0.584 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.426 ' C ' ' HA2' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -112.97 166.61 11.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.324 -0.86 . . . . 0.0 109.971 179.828 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.464 ' O ' ' O ' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -96.68 83.23 3.42 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.054 -1.029 . . . . 0.0 109.784 179.81 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 19' ' ' ASP . 0.6 OUTLIER -47.53 173.12 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.89 -1.131 . . . . 0.0 109.601 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.473 ' N ' ' O ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -42.84 135.59 2.78 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.256 -0.902 . . . . 0.0 109.974 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.625 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 51.6 Cg_endo -70.75 151.35 63.34 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.855 1.45 . . . . 0.0 110.754 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.61 170.46 20.18 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 123.938 1.494 . . . . 0.0 110.469 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.71 174.64 4.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.339 -0.851 . . . . 0.0 109.961 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.577 HG12 ' CD2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -144.84 -170.0 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 122.198 0.999 . . . . 0.0 111.401 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' A' ' 56' ' ' CYS . 7.1 m -40.32 99.34 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.998 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 32' ' ' ASN . 1.6 m-80 40.91 28.13 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.374 -0.828 . . . . 0.0 110.565 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -132.13 157.23 22.37 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.465 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -112.35 -165.85 1.03 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.47 -1.018 . . . . 0.0 110.586 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.625 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 10.3 p80 -148.76 122.84 9.47 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.105 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -113.53 -167.0 1.14 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.172 -0.955 . . . . 0.0 110.446 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 145.49 -15.31 1.83 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 61.13 59.13 2.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.424 -1.045 . . . . 0.0 110.408 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.539 ' OE1' ' CD2' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -174.17 -174.63 0.92 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.176 -0.953 . . . . 0.0 110.449 179.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.488 ' O ' ' HA ' ' A' ' 4' ' ' GLN . 7.8 t70 -131.73 -41.57 1.05 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.405 -0.809 . . . . 0.0 109.71 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 m-30 -106.43 143.55 34.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.446 -0.784 . . . . 0.0 110.04 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.639 ' CD1' ' CB ' ' A' ' 25' ' ' SER . 0.4 OUTLIER -127.17 -8.22 5.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.262 -0.899 . . . . 0.0 110.691 -179.743 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.512 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 30.2 p 50.89 -93.39 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.721 -0.612 . . . . 0.0 112.37 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 33.6 t0 -158.34 143.31 16.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.02 -1.05 . . . . 0.0 110.404 -178.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.539 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 87.3 20.68 51.63 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.639 ' CB ' ' CD1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -115.7 166.6 11.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.371 -1.076 . . . . 0.0 110.489 -179.723 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.527 HG11 ' N ' ' A' ' 27' ' ' VAL . 20.8 t -142.19 156.55 19.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.433 -0.792 . . . . 0.0 110.649 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.576 HG13 ' CD1' ' A' ' 29' ' ' TYR . 10.8 t -130.71 111.6 20.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.224 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.472 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -66.67 103.61 1.12 Allowed 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 118.56 -1.256 . . . . 0.0 108.327 178.607 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.631 ' CE1' HG23 ' A' ' 43' ' ' VAL . 1.7 m-30 -68.73 121.79 17.21 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.595 -0.691 . . . . 0.0 110.384 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -69.87 158.85 34.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -0.985 . . . . 0.0 109.415 179.23 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.9 154.2 46.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.951 -1.093 . . . . 0.0 110.704 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 11' ' ' ASN . 3.8 t-20 -64.45 152.75 40.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.402 -0.811 . . . . 0.0 110.01 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.71 120.69 15.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.2 -0.937 . . . . 0.0 110.278 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.16 -5.67 30.36 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.588 ' CD2' ' O ' ' A' ' 56' ' ' CYS . 0.8 OUTLIER -116.06 146.91 41.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.189 -1.183 . . . . 0.0 110.518 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.557 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -89.05 142.01 28.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.395 -0.816 . . . . 0.0 111.205 -179.693 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' A' ' 55' ' ' THR . 0.7 OUTLIER -94.54 104.55 16.5 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.46 -0.775 . . . . 0.0 109.079 178.802 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.578 ' HB ' ' OG1' ' A' ' 55' ' ' THR . 0.8 OUTLIER -94.96 141.89 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.305 -0.872 . . . . 0.0 109.677 -179.361 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.48 -160.29 23.05 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.519 ' O ' ' C ' ' A' ' 41' ' ' SER . 0.7 OUTLIER -99.54 50.4 0.93 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.1 -1.235 . . . . 0.0 109.974 179.824 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.519 ' C ' ' O ' ' A' ' 40' ' ' ASN . 0.3 OUTLIER 22.06 63.52 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.864 179.585 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 28' ' ' THR . . . 146.34 120.75 1.29 Allowed Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.416 -1.373 . . . . 0.0 110.184 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.631 HG23 ' CE1' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -68.43 179.65 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.452 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 25.3 tp -136.24 104.69 5.73 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.602 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.509 ' HB2' ' CH2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -75.32 103.83 5.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.394 -0.816 . . . . 0.0 109.236 179.379 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.48 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 12.2 t -132.59 103.62 6.24 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.31 -0.869 . . . . 0.0 110.304 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.88 41.36 5.97 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.426 ' HA2' ' C ' ' A' ' 2' ' ' LYS . . . 60.33 18.1 48.76 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.12 153.94 49.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -1.128 . . . . 0.0 110.147 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.509 ' CH2' ' HB2' ' A' ' 45' ' ' CYS . 83.0 m95 -105.46 130.82 53.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.749 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 11.8 t -136.87 156.16 48.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.972 . . . . 0.0 111.173 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.535 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.1 OUTLIER 65.2 64.96 0.98 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.819 -0.551 . . . . 0.0 111.436 179.477 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.535 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.0 Cg_endo -91.93 137.86 1.91 Allowed 'Trans proline' 0 C--N 1.3 -2.02 0 O-C-N 124.39 1.732 . . . . 0.0 109.695 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.573 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 47.8 Cg_endo -81.75 164.19 18.33 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.728 1.383 . . . . 0.0 110.453 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.578 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 33.9 p -107.37 -174.97 2.66 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.226 -0.921 . . . . 0.0 111.185 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.588 ' O ' ' CD2' ' A' ' 35' ' ' TYR . 1.0 OUTLIER -140.71 76.14 1.54 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.336 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.525 ' HG3' ' CG1' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -115.82 174.05 6.23 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.129 -178.729 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.28 124.26 42.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.278 -0.889 . . . . 0.0 108.683 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.636 ' HB ' ' HA ' ' A' ' 105' ' ' PRO . 29.5 m -112.37 48.43 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.098 -1.001 . . . . 0.0 111.752 -178.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 11.4 mttm -55.48 170.49 0.24 Allowed 'General case' 0 C--N 1.28 -2.448 0 C-N-CA 117.624 -1.63 . . . . 0.0 108.043 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.535 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -131.53 168.36 17.79 Favored Pre-proline 0 N--CA 1.491 1.602 0 C-N-CA 118.532 -1.267 . . . . 0.0 112.999 -178.1 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.502 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 47.2 Cg_endo -89.98 -73.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 124.896 1.998 . . . . 0.0 110.421 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.502 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 164.24 126.12 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.285 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.622 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 55.5 Cg_endo -80.53 60.63 7.93 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 123.544 1.286 . . . . 0.0 110.211 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.542 ' N ' HD22 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -76.17 170.64 15.93 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.535 -0.728 . . . . 0.0 109.478 179.444 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.557 ' CD1' ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -168.05 164.88 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.015 -1.053 . . . . 0.0 110.525 -179.6 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.424 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 2.5 t -70.22 98.81 1.41 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.514 -0.741 . . . . 0.0 110.675 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 51.0 m-80 43.19 48.98 5.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.368 -0.832 . . . . 0.0 110.841 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.552 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -160.18 38.74 0.45 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.553 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 53.1 p90 -49.23 -151.89 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 122.886 1.327 . . . . 0.0 113.134 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.609 HD21 ' CZ ' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -144.72 122.04 11.59 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.765 -176.445 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.9 t -98.88 14.0 30.5 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.342 -0.848 . . . . 0.0 110.127 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.511 ' OG ' ' N ' ' A' ' 86' ' ' ASP . 1.3 p -74.82 -101.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.312 -0.867 . . . . 0.0 110.712 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -120.28 74.92 0.32 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.587 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 1.9 t80 -91.53 161.5 14.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.495 -1.003 . . . . 0.0 110.396 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.587 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 23.8 tttt -162.35 156.15 21.02 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.451 -0.78 . . . . 0.0 109.862 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -47.14 -32.65 4.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -0.883 . . . . 0.0 110.146 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.524 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 3.3 t -144.04 167.82 21.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.385 -0.822 . . . . 0.0 110.366 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.628 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 9.3 m-85 -138.02 -149.87 0.32 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.292 -0.88 . . . . 0.0 109.844 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.524 ' C ' ' CG2' ' A' ' 59' ' ' VAL . 2.7 p -156.33 -100.41 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.597 -1.315 . . . . 0.0 111.877 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.586 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -123.04 14.2 9.82 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.733 -1.229 . . . . 0.0 110.311 -178.466 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.513 ' HA ' HG23 ' A' ' 102' ' ' THR . 8.0 p30 -155.74 -108.3 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.02 -1.05 . . . . 0.0 110.398 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.449 ' C ' HG21 ' A' ' 102' ' ' THR . 5.3 t0 46.22 71.99 0.26 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.817 -1.177 . . . . 0.0 109.539 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.523 ' N ' HG21 ' A' ' 102' ' ' THR . 14.0 p-10 -68.65 106.47 2.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.314 -0.866 . . . . 0.0 109.491 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.562 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 35.8 m -92.03 121.48 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.11 -0.993 . . . . 0.0 111.523 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.529 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.6 OUTLIER -82.66 135.36 35.05 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.25 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.609 ' CZ ' HD21 ' A' ' 71' ' ' LEU . 38.3 m-85 -90.94 144.39 25.73 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.805 -1.184 . . . . 0.0 112.252 -177.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -116.1 91.95 3.75 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.669 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.469 ' HB2' HD13 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -44.76 132.52 6.49 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.068 -1.02 . . . . 0.0 110.054 -179.741 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -40.82 -74.17 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.41 -0.806 . . . . 0.0 110.639 -179.683 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.576 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 31.5 t80 -169.62 144.11 2.86 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.225 -0.922 . . . . 0.0 110.674 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.578 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 46.38 41.11 11.63 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.586 ' CE1' ' HB3' ' A' ' 118' ' ' ARG . 12.2 m-85 -145.93 147.5 31.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.517 -0.99 . . . . 0.0 109.947 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 117' ' ' VAL . 6.7 ttpt -102.57 152.48 21.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.196 -0.94 . . . . 0.0 109.959 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.529 HD22 ' CD1' ' A' ' 66' ' ' ILE . 0.6 OUTLIER -92.99 89.44 6.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.056 -1.027 . . . . 0.0 110.446 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.531 ' HB2' ' CG2' ' A' ' 117' ' ' VAL . 18.6 t -70.55 108.1 4.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.9 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 138.69 -65.34 0.54 Allowed Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.844 -1.17 . . . . 0.0 110.236 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.549 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.1 OUTLIER 174.84 114.43 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.277 -1.131 . . . . 0.0 110.705 -179.383 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.417 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 0.9 OUTLIER -80.86 20.92 0.72 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.106 -0.996 . . . . 0.0 111.258 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 100' ' ' SER . 16.4 p -161.28 103.84 1.26 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.957 -1.09 . . . . 0.0 109.905 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.498 ' O ' ' N ' ' A' ' 85' ' ' VAL . 70.2 m -123.13 171.13 9.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.933 . . . . 0.0 110.611 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.523 HG21 ' N ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -136.78 145.39 44.5 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.223 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.501 ' SG ' ' HB2' ' A' ' 79' ' ' TYR . 7.0 t -74.96 88.76 2.37 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.466 -0.772 . . . . 0.0 109.912 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.453 ' OG ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -66.03 174.5 1.62 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.258 -0.901 . . . . 0.0 111.327 -179.44 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.636 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 41.7 Cg_endo -74.16 126.94 10.86 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.401 1.738 . . . . 0.0 110.73 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 120.48 -6.64 11.57 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.553 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 0.5 OUTLIER 82.13 96.06 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 O-C-N 122.107 -0.643 . . . . 0.0 110.699 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -178.51 -162.34 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.356 -0.84 . . . . 0.0 111.175 179.516 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.622 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 31.1 m95 -150.34 87.51 1.46 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.59 -0.694 . . . . 0.0 110.11 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.457 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 58.4 mttt -98.85 140.27 21.64 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.475 -0.765 . . . . 0.0 110.098 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.549 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 47.7 Cg_endo -72.7 174.55 48.53 Favored 'Cis proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.992 -2.087 . . . . 0.0 110.686 -0.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 112' ' ' GLU . 0.0 OUTLIER -43.82 135.27 4.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.402 -0.811 . . . . 0.0 110.988 -179.558 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.542 HD22 ' N ' ' A' ' 65' ' ' THR . 0.1 OUTLIER -45.76 146.8 1.78 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.445 -0.785 . . . . 0.0 110.287 179.426 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.557 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 42.7 Cg_endo -76.53 169.57 21.6 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 O-C-N 124.341 1.706 . . . . 0.0 111.182 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 96' ' ' SER . 2.6 ttpt -130.16 109.71 11.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.24 -0.912 . . . . 0.0 110.208 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.527 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.0 t -63.9 80.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -0.913 . . . . 0.0 109.341 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 94' ' ' LYS . 0.3 OUTLIER -88.54 -176.82 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.749 0.785 . . . . 0.0 110.645 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.586 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--N 1.295 -1.792 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.504 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.302 0.572 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.81 176.84 5.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.934 . . . . 0.0 110.313 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.541 ' HB3' ' N ' ' A' ' 22' ' ' THR . 2.8 t -136.63 95.55 3.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.344 -0.848 . . . . 0.0 110.828 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 5' ' ' SER . 0.0 OUTLIER -74.33 176.45 6.7 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 118.766 -1.174 . . . . 0.0 108.972 178.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -46.76 145.46 3.08 Favored Pre-proline 0 C--N 1.293 -1.861 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.278 179.794 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.62 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 48.8 Cg_endo -71.01 153.91 63.0 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.835 1.44 . . . . 0.0 110.78 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -74.84 171.61 17.93 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 O-C-N 123.911 1.48 . . . . 0.0 109.787 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.64 177.09 3.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.14 -0.975 . . . . 0.0 109.758 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.558 HG22 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -142.54 -170.57 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 122.178 0.989 . . . . 0.0 111.642 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 14.2 t -40.85 93.28 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.698 -179.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 9' ' ' ILE . 3.5 m-80 42.17 44.16 3.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 110.25 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -140.82 178.05 20.39 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.522 ' CB ' ' HB3' ' A' ' 30' ' ' SER . 0.0 OUTLIER -125.0 -168.27 1.8 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.178 -1.189 . . . . 0.0 110.578 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.62 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 13.9 p80 -156.46 123.94 5.43 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.958 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -147.5 128.11 14.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.166 -0.959 . . . . 0.0 110.53 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.49 -115.73 2.14 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -166.84 37.27 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -1.131 . . . . 0.0 110.052 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.572 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 1.4 pp20? -150.04 -155.61 0.64 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 0.0 110.09 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -140.7 -42.44 0.4 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.367 -0.833 . . . . 0.0 110.068 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.402 ' C ' ' OE1' ' A' ' 18' ' ' GLU . 17.6 m-85 -119.52 100.98 7.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 109.526 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.623 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.8 OUTLIER -77.53 -11.04 59.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.44 -0.787 . . . . 0.0 111.395 -179.226 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.541 ' N ' ' HB3' ' A' ' 3' ' ' CYS . 56.4 p 46.71 -95.78 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.209 -0.932 . . . . 0.0 111.636 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.445 ' N ' ' OG1' ' A' ' 22' ' ' THR . 1.3 t70 -152.77 146.92 25.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.842 -1.161 . . . . 0.0 110.948 -178.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 82.45 23.88 55.38 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.623 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.9 OUTLIER -116.9 169.84 9.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.395 -1.061 . . . . 0.0 110.207 -179.799 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.539 ' CG1' ' O ' ' A' ' 43' ' ' VAL . 23.7 t -139.26 156.15 26.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 119.29 -0.964 . . . . 0.0 111.033 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.572 HG13 ' CD1' ' A' ' 29' ' ' TYR . 24.0 t -133.25 124.25 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 119.846 -0.741 . . . . 0.0 111.066 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.519 ' CG2' ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -73.86 100.9 3.61 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 118.347 -1.341 . . . . 0.0 108.432 178.412 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.649 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 2.1 m-30 -68.56 127.93 34.8 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.144 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.522 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 12.5 t -80.12 -170.43 2.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.026 -1.046 . . . . 0.0 109.687 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.457 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 67.4 m -150.83 160.94 43.54 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.147 -0.971 . . . . 0.0 110.161 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.508 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 14.8 t-20 -48.43 171.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.0 110.059 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.68 107.45 5.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 110.181 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.79 11.46 40.4 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.508 ' CG ' ' HB3' ' A' ' 32' ' ' ASN . 2.9 m-30 -106.84 128.33 54.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -1.136 . . . . 0.0 110.238 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.619 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.5 OUTLIER -74.23 138.99 44.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.306 -0.871 . . . . 0.0 110.808 -179.885 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.53 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 2.8 tp -91.24 104.51 17.05 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.445 -0.784 . . . . 0.0 109.421 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.552 HG22 ' CG ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -97.48 154.04 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.279 -0.888 . . . . 0.0 109.37 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.478 ' O ' ' CB ' ' A' ' 40' ' ' ASN . . . 94.56 39.54 4.68 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.7 OUTLIER 68.52 174.5 0.28 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.353 -1.087 . . . . 0.0 110.116 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.519 ' O ' ' CG2' ' A' ' 28' ' ' THR . 0.3 OUTLIER -119.79 71.5 0.89 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 110.318 -179.859 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 27' ' ' VAL . . . 163.36 119.35 0.48 Allowed Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.75 -1.215 . . . . 0.0 110.173 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.649 ' CG2' ' CE1' ' A' ' 29' ' ' TYR . 2.0 t -76.31 -175.23 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.147 -1.208 . . . . 0.0 108.506 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.426 ' HA ' ' O ' ' A' ' 25' ' ' SER . 0.9 OUTLIER -144.05 102.28 3.86 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.215 178.902 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.54 ' HB2' ' CD2' ' A' ' 50' ' ' TRP . 13.5 t -83.96 124.61 31.2 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.362 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.428 ' C ' ' OD2' ' A' ' 23' ' ' ASP . 84.5 p -132.22 80.22 1.9 Allowed 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.283 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.444 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 92.8 46.75 3.33 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.59 23.22 62.6 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 50' ' ' TRP . 3.3 mt-10 -126.4 68.78 1.22 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.206 -1.173 . . . . 0.0 110.374 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.569 ' CH2' HG22 ' A' ' 27' ' ' VAL . 72.7 m95 -43.58 135.63 3.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.485 -0.759 . . . . 0.0 109.632 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.2 t -146.73 169.87 18.16 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.962 -1.086 . . . . 0.0 111.069 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.538 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER 59.52 65.02 2.72 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.671 -0.643 . . . . 0.0 110.981 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.538 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.0 Cg_endo -91.22 127.95 1.18 Allowed 'Trans proline' 0 C--N 1.301 -1.928 0 O-C-N 124.393 1.733 . . . . 0.0 110.305 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.523 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 51.4 Cg_endo -77.09 173.18 14.84 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 O-C-N 123.897 1.472 . . . . 0.0 110.096 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.539 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 21.0 p -107.09 164.6 12.01 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.92 . . . . 0.0 111.272 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 10' ' ' SER . 97.3 m -128.37 76.11 1.68 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 177.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -111.82 -158.93 0.66 Allowed 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.28 0.562 . . . . 0.0 110.162 -178.831 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.413 HD12 HG22 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -111.21 147.13 15.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.619 ' CG1' ' CB ' ' A' ' 36' ' ' SER . 33.7 m -132.49 49.25 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 O-C-N 121.044 -1.035 . . . . 0.0 111.267 -178.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 5.3 mttm -64.19 -169.5 0.03 OUTLIER 'General case' 0 C--N 1.281 -2.404 0 C-N-CA 118.225 -1.39 . . . . 0.0 107.9 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -144.52 170.75 7.69 Favored Pre-proline 0 C--N 1.293 -1.848 0 C-N-CA 118.347 -1.341 . . . . 0.0 113.22 -178.824 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.557 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 45.1 Cg_endo -92.47 -70.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.421 2.081 . . . . 0.0 109.139 178.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.557 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 159.34 129.44 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 122.04 -0.413 . . . . 0.0 110.068 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.576 ' HG3' ' CZ2' ' A' ' 109' ' ' TRP . 55.3 Cg_endo -85.18 94.31 0.66 Allowed 'Trans proline' 0 C--N 1.299 -2.044 0 O-C-N 123.802 1.422 . . . . 0.0 109.346 178.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.574 ' C ' ' CG2' ' A' ' 66' ' ' ILE . 3.5 p -111.57 -43.15 3.7 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 122.342 1.068 . . . . 0.0 110.452 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.668 ' CG2' ' CE1' ' A' ' 87' ' ' PHE . 0.1 OUTLIER 53.27 170.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.017 -178.71 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.506 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -68.37 101.66 1.26 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.472 -0.767 . . . . 0.0 111.331 -179.088 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.435 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 60.7 m-20 42.36 51.95 4.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.507 -0.746 . . . . 0.0 111.684 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.594 ' O ' ' CD1' ' A' ' 70' ' ' TYR . . . -133.05 -38.49 0.23 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.607 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 2.0 p90 38.2 -171.58 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 122.965 1.364 . . . . 0.0 112.645 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.597 HD13 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -139.17 159.76 41.39 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.724 -178.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.59 27.73 3.04 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.755 -1.215 . . . . 0.0 110.152 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.74 -78.65 0.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.193 -0.942 . . . . 0.0 111.111 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -135.4 82.15 0.29 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.624 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -108.93 170.65 7.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.5 -1.0 . . . . 0.0 109.934 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.624 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 10.5 ttmt -171.23 170.1 6.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.353 -0.842 . . . . 0.0 109.974 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.402 ' N ' ' CG ' ' A' ' 76' ' ' LYS . 29.3 mtm180 -60.67 -37.39 81.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.971 -1.081 . . . . 0.0 110.517 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.4 m -134.09 159.0 42.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.286 -0.883 . . . . 0.0 110.322 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.623 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 3.7 m-85 -133.72 -146.44 0.27 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.312 -0.868 . . . . 0.0 110.058 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.535 ' CA ' HG21 ' A' ' 59' ' ' VAL . 21.6 p -160.02 -128.52 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.907 -1.121 . . . . 0.0 110.94 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.609 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -93.8 14.24 19.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.375 -1.453 . . . . 0.0 110.603 -179.292 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.508 ' O ' ' N ' ' A' ' 103' ' ' CYS . 50.6 t30 -160.73 -104.05 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.743 -1.223 . . . . 0.0 110.706 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 82' ' ' ASN . 0.7 OUTLIER 45.68 79.48 0.05 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.877 -1.14 . . . . 0.0 108.801 -178.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.569 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 30.2 p-10 -69.36 150.29 47.48 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.415 -0.803 . . . . 0.0 110.853 -178.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.508 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 17.0 m -133.5 118.67 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.419 -0.8 . . . . 0.0 110.049 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.521 ' O ' ' HB2' ' A' ' 71' ' ' LEU . 8.8 t0 -82.55 127.46 33.36 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.206 -0.934 . . . . 0.0 108.613 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.668 ' CE1' ' CG2' ' A' ' 66' ' ' ILE . 53.5 m-85 -84.26 136.96 33.72 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.369 1.081 . . . . 0.0 113.339 -177.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.607 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -111.8 85.62 2.18 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.149 179.792 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.469 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -37.3 130.06 0.93 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.52 -0.737 . . . . 0.0 111.198 -179.029 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.8 OUTLIER -41.35 -88.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.489 -0.757 . . . . 0.0 110.697 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.557 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 3.8 t80 -152.68 144.93 23.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.227 -0.92 . . . . 0.0 110.543 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.549 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 46.87 53.85 9.89 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.574 ' CD1' ' HB3' ' A' ' 118' ' ' ARG . 9.3 m-85 -151.28 167.87 26.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.253 -1.145 . . . . 0.0 110.27 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 117' ' ' VAL . 1.9 ttpt -132.23 112.23 12.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.361 -0.837 . . . . 0.0 109.812 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.544 HD21 ' CD1' ' A' ' 66' ' ' ILE . 6.2 mt -47.65 109.56 0.23 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.261 -0.899 . . . . 0.0 110.348 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -90.61 99.32 12.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.392 -0.817 . . . . 0.0 109.88 179.614 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 141.09 -76.62 0.31 Allowed Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.119 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.59 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 1.2 m -163.4 117.35 1.59 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.372 -1.075 . . . . 0.0 110.594 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.8 p -76.63 6.27 6.18 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.276 -0.89 . . . . 0.0 110.967 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 59.8 p -147.42 113.11 5.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.114 -0.991 . . . . 0.0 109.761 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.454 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 13.1 m -128.25 168.9 14.83 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.242 -0.912 . . . . 0.0 110.776 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.5 OUTLIER -136.44 146.66 46.61 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.51 -0.744 . . . . 0.0 110.461 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 80' ' ' SER . 41.9 t -76.41 84.91 3.15 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.611 -0.681 . . . . 0.0 110.439 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.5 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -65.59 -179.12 0.32 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 110.279 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.552 ' CG ' HG22 ' A' ' 38' ' ' ILE . 46.1 Cg_endo -76.47 131.27 12.48 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 O-C-N 124.23 1.647 . . . . 0.0 110.878 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 121.91 -11.33 9.43 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.553 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 1.0 OUTLIER 82.8 92.9 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 O-C-N 122.015 -0.697 . . . . 0.0 110.956 179.668 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.47 HG22 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -179.1 -160.02 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.556 -0.715 . . . . 0.0 110.725 179.437 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.591 ' HB3' ' CD1' ' A' ' 113' ' ' LEU . 24.0 m95 -148.9 87.92 1.58 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.513 -0.742 . . . . 0.0 110.538 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.491 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -95.2 154.68 39.46 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.382 -0.824 . . . . 0.0 109.777 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.59 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 48.5 Cg_endo -71.65 -177.51 17.41 Favored 'Cis proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.163 -2.016 . . . . 0.0 110.514 -0.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.474 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.9 OUTLIER -37.54 111.74 0.17 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.802 -0.561 . . . . 0.0 110.236 -179.759 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.591 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 3.9 tp -37.61 141.86 0.45 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.66 -0.65 . . . . 0.0 110.446 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.527 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 40.6 Cg_endo -69.89 161.79 44.6 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 124.11 1.584 . . . . 0.0 110.47 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.527 ' O ' HG23 ' A' ' 117' ' ' VAL . 0.8 OUTLIER -125.1 100.21 6.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 110.497 179.704 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.547 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.9 t -56.19 91.84 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.019 -1.051 . . . . 0.0 109.272 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 115' ' ' LYS . 3.7 m -110.95 179.11 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.628 0.728 . . . . 0.0 110.941 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.574 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.688 0 C-N-CA 118.997 -1.081 . . . . 0.0 110.239 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.503 HG11 ' N ' ' A' ' 2' ' ' LYS . 69.2 t . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 121.231 0.539 . . . . 0.0 110.275 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.503 ' N ' HG11 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -119.87 179.69 4.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.901 . . . . 0.0 110.294 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.53 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.3 m -131.61 137.28 48.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.546 -0.721 . . . . 0.0 110.008 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.487 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 3.8 mt-30 -114.2 168.49 9.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.767 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -45.21 131.89 5.72 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.112 -0.992 . . . . 0.0 109.446 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.61 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 45.6 Cg_endo -66.99 153.16 78.8 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 124.011 1.532 . . . . 0.0 112.209 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.64 175.29 11.49 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 124.097 1.578 . . . . 0.0 110.304 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.44 173.63 5.7 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.276 -0.89 . . . . 0.0 110.254 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.432 HG22 ' CE2' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -143.46 -172.96 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-O 122.038 0.923 . . . . 0.0 111.085 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.3 OUTLIER -39.73 100.51 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.215 -179.214 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.415 ' C ' ' O ' ' A' ' 10' ' ' SER . 1.2 m120 39.21 45.59 1.14 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.434 -0.791 . . . . 0.0 111.09 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.438 ' HA3' ' CB ' ' A' ' 56' ' ' CYS . . . -158.21 161.45 31.62 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.8 OUTLIER -119.41 -175.22 2.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -1.146 . . . . 0.0 110.713 -179.613 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.61 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 7.5 p80 -126.91 163.3 23.95 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.196 0.522 . . . . 0.0 110.063 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.491 ' ND2' ' OG ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -170.5 -159.07 0.17 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.093 -1.004 . . . . 0.0 110.322 -179.819 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.44 -126.36 2.37 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.535 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 11.4 p90 -149.19 33.87 0.73 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -1.129 . . . . 0.0 110.068 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.479 ' HG3' ' CZ ' ' A' ' 21' ' ' TYR . 0.9 OUTLIER -147.1 -177.43 5.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.933 . . . . 0.0 109.912 179.854 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -124.03 -41.33 2.22 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.207 -0.933 . . . . 0.0 110.253 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.621 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 21.0 p90 -128.34 98.81 5.19 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.11 -0.994 . . . . 0.0 110.516 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.592 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 11.6 m-85 -61.95 -165.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.984 -1.073 . . . . 0.0 110.054 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.53 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 0.3 OUTLIER -151.42 -65.57 0.18 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.026 -1.046 . . . . 0.0 110.778 -179.731 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -167.15 147.33 5.47 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.444 -0.785 . . . . 0.0 109.658 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 65.61 14.58 60.53 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.592 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -94.54 172.41 8.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.387 -1.067 . . . . 0.0 109.938 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 24.4 t -148.75 154.71 9.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.224 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.533 ' HB ' HG22 ' A' ' 43' ' ' VAL . 24.4 t -134.04 113.81 18.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.596 -0.69 . . . . 0.0 110.922 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.48 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -69.39 104.08 2.18 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 118.052 -1.459 . . . . 0.0 107.597 178.187 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.634 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 1.3 m-30 -67.4 111.87 4.3 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.366 -178.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.491 ' OG ' ' ND2' ' A' ' 15' ' ' ASN . 0.7 OUTLIER -70.69 154.98 41.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.114 -0.991 . . . . 0.0 110.278 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.413 ' SG ' HD11 ' A' ' 37' ' ' LEU . 19.7 m -123.97 157.27 34.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.319 -0.863 . . . . 0.0 109.662 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.52 168.51 1.57 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.107 -0.996 . . . . 0.0 110.241 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.21 100.61 0.81 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.26 -0.9 . . . . 0.0 110.124 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.92 -6.99 11.0 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.564 ' CG ' HG21 ' A' ' 58' ' ' ILE . 27.7 m-85 -96.61 133.63 40.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -1.136 . . . . 0.0 110.2 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.58 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -89.25 144.34 26.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 0.0 110.797 -179.783 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.506 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 1.9 tp -92.09 98.15 11.37 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.376 -0.827 . . . . 0.0 109.237 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.581 ' CG2' ' CG ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -87.99 144.02 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.31 -0.869 . . . . 0.0 109.051 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.59 -174.6 22.87 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.475 ' ND2' ' OD1' ' A' ' 52' ' ' ASP . 2.4 m-80 -55.33 145.93 20.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.343 -1.092 . . . . 0.0 110.092 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.474 ' HA ' HD22 ' A' ' 37' ' ' LEU . 87.4 p -80.52 49.53 1.17 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.173 -0.954 . . . . 0.0 110.076 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.497 ' O ' ' O ' ' A' ' 43' ' ' VAL . . . 152.19 109.83 0.43 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.634 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -46.49 172.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.244 -1.151 . . . . 0.0 108.244 179.276 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.405 ' HA ' ' O ' ' A' ' 25' ' ' SER . 0.4 OUTLIER -138.26 97.08 3.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.046 -1.034 . . . . 0.0 110.183 179.01 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.603 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.2 OUTLIER -76.48 107.78 9.0 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.091 -1.005 . . . . 0.0 109.266 178.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.66 107.05 8.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.545 -0.722 . . . . 0.0 110.238 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.03 5.08 55.15 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.495 ' HA3' ' CG1' ' A' ' 1' ' ' VAL . . . 94.49 15.79 45.54 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -141.42 113.73 8.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.348 -1.09 . . . . 0.0 110.261 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.603 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 96.3 m95 -58.34 134.75 56.86 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.189 -0.944 . . . . 0.0 109.975 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.7 t -135.3 149.84 49.87 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.184 -0.948 . . . . 0.0 110.95 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.511 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 1.1 t70 62.81 65.47 1.41 Allowed Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.716 -0.615 . . . . 0.0 111.372 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.511 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.6 Cg_endo -91.58 124.44 0.82 Allowed 'Trans proline' 0 C--N 1.3 -2.021 0 O-C-N 124.337 1.704 . . . . 0.0 109.841 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.494 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.0 Cg_endo -71.67 175.14 9.99 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 O-C-N 123.88 1.463 . . . . 0.0 109.979 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.563 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 23.6 p -118.37 141.81 48.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.194 -0.941 . . . . 0.0 111.187 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 10' ' ' SER . 35.1 m -103.58 76.06 1.37 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.479 ' OE1' ' CB ' ' A' ' 55' ' ' THR . 0.0 OUTLIER -113.46 147.24 38.21 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.406 0.622 . . . . 0.0 110.214 -178.73 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.564 HG21 ' CG ' ' A' ' 35' ' ' TYR . 1.7 pt -70.74 112.55 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.435 -0.79 . . . . 0.0 109.161 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.605 ' CG1' ' HA ' ' A' ' 105' ' ' PRO . 18.8 m -99.54 53.01 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.309 -0.869 . . . . 0.0 111.751 -178.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 23.2 mtpp -71.62 -174.12 1.07 Allowed 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 118.065 -1.454 . . . . 0.0 107.2 177.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.511 ' SG ' ' HB2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -143.42 163.61 35.88 Favored Pre-proline 0 C--N 1.29 -2.018 0 C-N-CA 118.014 -1.474 . . . . 0.0 111.98 -178.499 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.528 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 41.3 Cg_endo -80.57 -68.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.866 0 O-C-N 124.787 1.941 . . . . 0.0 109.609 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.528 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 161.13 135.06 0.01 OUTLIER Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.613 ' HG3' ' CZ2' ' A' ' 109' ' ' TRP . 56.9 Cg_endo -82.95 66.76 7.9 Favored 'Trans proline' 0 C--N 1.289 -2.555 0 O-C-N 123.952 1.501 . . . . 0.0 109.47 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.582 ' C ' ' CG2' ' A' ' 66' ' ' ILE . 3.1 p -81.88 -41.92 20.29 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 122.43 1.109 . . . . 0.0 110.455 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.582 ' CG2' ' C ' ' A' ' 65' ' ' THR . 0.1 OUTLIER 54.54 162.15 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.53 -179.037 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.431 ' N ' HG13 ' A' ' 66' ' ' ILE . 12.8 t -65.95 101.1 0.63 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.573 -0.705 . . . . 0.0 111.78 -178.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 2.2 m-20 41.68 31.91 0.22 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.499 -0.751 . . . . 0.0 111.743 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.559 ' C ' ' CD1' ' A' ' 70' ' ' TYR . . . -124.11 -27.0 1.43 Allowed Glycine 0 N--CA 1.491 2.358 0 C-N-CA 118.732 -1.699 . . . . 0.0 109.938 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.559 ' CD1' ' C ' ' A' ' 69' ' ' GLY . 37.9 p90 33.4 -160.59 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 122.762 1.268 . . . . 0.0 112.016 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.618 ' HB3' ' CD1' ' A' ' 87' ' ' PHE . 0.7 OUTLIER -135.56 149.08 49.33 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 114.154 -1.384 . . . . 0.0 109.691 -176.889 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' A' ' 72' ' ' SER . 0.1 OUTLIER -116.03 24.38 11.49 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.866 -1.146 . . . . 0.0 109.883 -179.662 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.51 ' OG ' ' CB ' ' A' ' 86' ' ' ASP . 8.5 m -101.62 -99.87 0.27 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.065 -1.022 . . . . 0.0 111.836 -178.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -109.81 -73.96 0.77 Allowed Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.739 -1.22 . . . . 0.0 111.144 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.5 OUTLIER 60.62 174.54 0.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.409 -1.053 . . . . 0.0 109.609 -178.768 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.627 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 28.6 ttmt 179.65 159.07 0.71 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.302 -0.874 . . . . 0.0 109.641 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.511 ' N ' ' HG2' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -43.01 -31.17 0.49 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.292 -0.88 . . . . 0.0 110.635 -179.843 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.446 ' C ' ' CG ' ' A' ' 79' ' ' TYR . 2.8 p -154.43 169.93 22.58 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.132 -0.98 . . . . 0.0 111.161 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.656 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -150.62 -168.53 3.13 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.443 -0.786 . . . . 0.0 108.897 179.762 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 82' ' ' ASN . 0.1 OUTLIER -170.75 120.52 0.56 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.667 -1.27 . . . . 0.0 111.424 179.783 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.668 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 4.1 t80 38.37 22.85 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.995 -1.066 . . . . 0.0 112.074 178.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.524 ' N ' ' O ' ' A' ' 80' ' ' SER . 26.2 p30 -178.49 -134.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.025 -1.672 . . . . 0.0 110.882 178.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.515 ' CB ' ' HB3' ' A' ' 79' ' ' TYR . 0.4 OUTLIER 57.27 72.14 0.53 Allowed 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.006 -1.059 . . . . 0.0 108.519 -178.46 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.51 ' HB3' HG22 ' A' ' 102' ' ' THR . 6.8 p30 -68.44 143.23 55.11 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.453 -0.78 . . . . 0.0 110.331 -178.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.598 HG21 ' CZ3' ' A' ' 109' ' ' TRP . 3.6 m -134.47 121.36 36.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.228 -0.92 . . . . 0.0 110.221 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.548 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 1.1 t70 -69.95 141.96 52.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.09 -1.006 . . . . 0.0 108.479 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.618 ' CD1' ' HB3' ' A' ' 71' ' ' LEU . 7.1 m-85 -104.89 143.38 33.23 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.672 -1.267 . . . . 0.0 112.5 -178.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 69' ' ' GLY . 3.7 tptt -116.4 -173.34 2.35 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.163 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.49 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.5 OUTLIER -132.11 127.96 37.12 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.241 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.49 ' C ' ' O ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -33.57 -70.72 0.07 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.404 0.621 . . . . 0.0 110.733 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.518 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -177.25 145.42 0.45 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.371 -0.831 . . . . 0.0 109.927 179.708 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.442 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 51.86 43.13 54.46 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.573 ' CE1' ' HB3' ' A' ' 118' ' ' ARG . 11.6 m-85 -146.61 162.7 37.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.34 -1.094 . . . . 0.0 110.32 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.482 ' O ' HG21 ' A' ' 117' ' ' VAL . 23.1 tptt -127.5 113.26 15.92 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.391 -0.818 . . . . 0.0 109.877 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.542 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 2.1 mt -46.49 112.62 0.52 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.107 -0.995 . . . . 0.0 109.868 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.48 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 1.1 t -95.92 103.64 15.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 110.205 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.16 -98.29 0.24 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.594 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -141.63 135.51 30.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -1.133 . . . . 0.0 110.614 -179.502 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 100' ' ' SER . 37.3 p -78.69 -64.91 1.07 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 110.11 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.52 ' N ' ' OG ' ' A' ' 99' ' ' SER . 15.8 p -74.86 140.28 43.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.087 -1.008 . . . . 0.0 110.065 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.583 ' HB2' ' CE2' ' A' ' 87' ' ' PHE . 3.8 m -151.16 148.35 28.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -0.934 . . . . 0.0 110.659 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.51 HG22 ' HB3' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -125.48 145.25 50.17 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.564 -0.71 . . . . 0.0 109.769 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.583 ' O ' ' CA ' ' A' ' 81' ' ' TYR . 7.6 t -69.4 78.93 0.39 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.104 -0.998 . . . . 0.0 109.946 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.44 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.4 OUTLIER -47.3 171.15 0.08 OUTLIER Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.286 -0.884 . . . . 0.0 112.197 -179.397 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.605 ' HA ' ' CG1' ' A' ' 59' ' ' VAL . 47.9 Cg_endo -78.08 21.84 0.65 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 124.731 1.911 . . . . 0.0 112.569 -178.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -114.69 7.61 22.14 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.526 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 0.8 OUTLIER 76.91 61.83 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.835 -0.803 . . . . 0.0 109.572 -179.761 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 103' ' ' CYS . 0.0 OUTLIER -171.41 -170.62 0.84 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.277 -179.426 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.613 ' CZ2' ' HG3' ' A' ' 64' ' ' PRO . 19.4 m95 -118.22 86.45 2.53 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.631 -0.668 . . . . 0.0 110.133 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.477 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 2.7 mmmt -92.1 152.33 42.59 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.407 -0.808 . . . . 0.0 110.014 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.594 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 48.8 Cg_endo -72.23 -178.68 21.17 Favored 'Cis proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.071 -2.054 . . . . 0.0 111.025 -0.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 111' ' ' PRO . 3.4 mt-10 -37.11 118.5 0.61 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.334 0.588 . . . . 0.0 110.758 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.58 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 2.9 tp -47.39 141.65 6.55 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.365 -0.834 . . . . 0.0 110.562 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.542 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . 41.1 Cg_endo -71.37 159.91 50.24 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.119 1.589 . . . . 0.0 110.289 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 117' ' ' VAL . 13.9 tttt -124.3 108.5 12.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 0.0 110.545 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.545 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 5.2 t -58.47 84.38 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.29 -0.881 . . . . 0.0 108.85 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' A' ' 115' ' ' LYS . 4.0 m -103.45 -176.95 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.771 0.796 . . . . 0.0 111.113 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.573 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.765 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.309 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.401 ' O ' ' CG1' ' A' ' 1' ' ' VAL . 8.1 p . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -129.99 166.89 19.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.935 . . . . 0.0 110.149 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -111.85 91.8 3.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.173 -0.954 . . . . 0.0 110.735 -179.629 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.476 ' O ' ' C ' ' A' ' 5' ' ' SER . 39.0 mt-30 -91.64 -177.17 4.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -0.943 . . . . 0.0 109.426 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.476 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.5 OUTLIER -36.9 131.76 0.7 Allowed Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.799 -0.563 . . . . 0.0 110.134 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.612 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 48.5 Cg_endo -68.87 157.35 62.19 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.998 1.525 . . . . 0.0 111.084 -178.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -75.58 170.74 19.61 Favored 'Trans proline' 0 C--N 1.302 -1.921 0 O-C-N 123.926 1.487 . . . . 0.0 109.608 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.6 p -70.33 175.49 4.64 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.145 -0.972 . . . . 0.0 109.874 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.565 HG22 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -140.33 -169.53 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -0.91 . . . . 0.0 110.804 179.556 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.2 OUTLIER -39.76 92.14 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.606 -179.262 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' A' ' 9' ' ' ILE . 3.9 m-80 42.08 41.26 1.94 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.276 -0.89 . . . . 0.0 110.113 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.438 ' O ' HG13 ' A' ' 9' ' ' ILE . . . -140.73 145.96 17.0 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -92.63 -166.81 1.61 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.268 -1.137 . . . . 0.0 110.605 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.612 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 14.9 p80 -153.9 126.14 7.94 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.157 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -145.62 112.31 5.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 110.311 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.439 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -111.05 19.43 25.13 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.468 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 0.3 OUTLIER 67.07 35.76 4.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.389 -1.065 . . . . 0.0 110.222 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.558 ' OE1' ' CE1' ' A' ' 21' ' ' TYR . 5.9 pt-20 176.88 -175.22 0.12 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 110.436 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -128.43 -3.8 5.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.377 -0.827 . . . . 0.0 110.056 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.588 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 0.9 OUTLIER -109.55 150.8 27.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 110.257 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.598 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 1.9 m-85 -167.43 42.31 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.54 -0.725 . . . . 0.0 109.746 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.482 ' O ' ' O ' ' A' ' 23' ' ' ASP . 21.1 p -52.79 99.15 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 122.042 0.925 . . . . 0.0 111.729 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 22' ' ' THR . 26.7 t70 50.54 163.45 0.0 OUTLIER 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 121.742 0.782 . . . . 0.0 112.037 178.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 48.32 26.83 5.15 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.598 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 16.7 m -106.47 174.56 5.84 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.289 -1.124 . . . . 0.0 110.302 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 24.6 t -155.56 154.25 6.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.821 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.585 ' CG2' ' CH2' ' A' ' 50' ' ' TRP . 39.2 t -143.81 124.17 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.837 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -74.55 104.52 5.28 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 118.483 -1.287 . . . . 0.0 107.534 177.538 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.644 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 2.2 m-30 -68.36 127.1 31.72 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.287 -0.883 . . . . 0.0 110.395 -178.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -84.8 156.4 21.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.817 . . . . 0.0 110.08 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.437 ' O ' ' C ' ' A' ' 32' ' ' ASN . 75.6 m -124.86 154.35 41.17 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -0.885 . . . . 0.0 110.155 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.484 ' O ' ' N ' ' A' ' 34' ' ' GLY . 7.8 m-20 -41.92 143.37 0.56 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.322 -0.861 . . . . 0.0 110.202 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 95.8 p -52.56 88.63 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.91 . . . . 0.0 110.503 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 32' ' ' ASN . . . 127.69 10.95 3.42 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.2 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.441 ' CD2' ' O ' ' A' ' 56' ' ' CYS . 1.7 m-30 -106.64 153.8 21.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.08 -1.247 . . . . 0.0 110.442 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.604 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.6 OUTLIER -90.04 137.42 32.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.458 -0.776 . . . . 0.0 110.582 -179.473 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.491 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 0.9 OUTLIER -98.92 98.54 9.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.189 -0.945 . . . . 0.0 109.484 178.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.569 ' CD1' ' N ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -95.86 141.86 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.902 . . . . 0.0 109.397 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.99 -120.21 3.88 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -125.01 137.14 54.24 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.362 -1.081 . . . . 0.0 109.93 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.467 ' O ' HG22 ' A' ' 28' ' ' THR . 73.0 p -71.86 55.86 0.29 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.229 -0.919 . . . . 0.0 109.77 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.437 ' HA2' ' C ' ' A' ' 27' ' ' VAL . . . 154.74 117.6 0.61 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.644 ' CG2' ' CE1' ' A' ' 29' ' ' TYR . 2.1 t -67.73 179.65 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.188 -1.183 . . . . 0.0 108.177 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.72 104.04 4.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.955 -1.091 . . . . 0.0 110.638 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.599 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -81.93 111.05 17.76 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.161 -1.016 . . . . 0.0 109.262 178.675 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.58 103.2 7.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.584 -0.697 . . . . 0.0 110.488 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.61 36.21 8.08 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.47 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 64.89 31.38 80.75 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -147.78 105.42 3.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.176 -1.191 . . . . 0.0 110.549 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.599 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 77.6 m95 -58.5 140.06 54.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.155 -0.965 . . . . 0.0 109.514 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.2 m -143.51 170.64 15.43 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.952 -1.092 . . . . 0.0 111.059 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.517 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 20.0 t0 53.01 65.7 5.61 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.539 -0.726 . . . . 0.0 110.889 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.8 Cg_endo -91.23 139.15 2.4 Favored 'Trans proline' 0 C--N 1.3 -1.977 0 C-N-CA 121.9 1.733 . . . . 0.0 110.329 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.423 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 47.8 Cg_endo -83.52 -175.68 2.42 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.826 1.435 . . . . 0.0 110.052 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.522 ' N ' ' O ' ' A' ' 38' ' ' ILE . 7.4 p -124.63 143.65 50.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.38 -0.825 . . . . 0.0 111.569 -178.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 10' ' ' SER . 90.1 m -107.58 80.43 1.4 Allowed 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -110.63 -150.43 0.46 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.712 -0.618 . . . . 0.0 110.162 -178.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.423 ' CD1' ' N ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -127.82 120.01 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.256 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.604 ' CG1' ' CB ' ' A' ' 36' ' ' SER . 26.9 m -115.13 52.66 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.018 -1.051 . . . . 0.0 111.824 -178.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.513 ' N ' ' OD1' ' A' ' 107' ' ' ASN . 9.0 mtpt -71.45 129.73 39.53 Favored 'General case' 0 C--N 1.283 -2.312 0 C-N-CA 118.262 -1.375 . . . . 0.0 108.232 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.482 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 5.8 m -95.01 172.2 5.72 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.928 -1.107 . . . . 0.0 112.371 -178.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 43.6 Cg_endo -84.94 -66.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.721 1.906 . . . . 0.0 110.287 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.456 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 167.98 129.29 0.04 OUTLIER Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -179.232 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.616 ' N ' ' NE1' ' A' ' 109' ' ' TRP . 45.9 Cg_endo -74.0 65.23 5.11 Favored 'Trans proline' 0 C--N 1.296 -2.187 0 O-C-N 123.61 1.321 . . . . 0.0 109.868 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.538 ' O ' ' CD2' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -85.49 170.39 12.7 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.739 -0.601 . . . . 0.0 110.446 -179.576 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.6 HG23 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -169.31 164.09 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.126 -0.984 . . . . 0.0 110.277 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.554 ' O ' ' CB ' ' A' ' 68' ' ' ASN . 73.2 m -66.47 75.27 0.1 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.535 -0.728 . . . . 0.0 111.978 -178.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.554 ' CB ' ' O ' ' A' ' 67' ' ' SER . 1.5 t-20 76.31 -24.72 0.21 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.285 -0.885 . . . . 0.0 112.473 178.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.55 ' CA ' ' HA ' ' A' ' 89' ' ' CYS . . . -86.32 38.6 3.08 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.522 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 11.9 p90 -41.61 159.75 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 123.032 1.396 . . . . 0.0 112.839 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.614 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -43.11 -81.39 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 113.922 -1.49 . . . . 0.0 109.699 178.269 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.57 ' CB ' ' O ' ' A' ' 71' ' ' LEU . 0.3 OUTLIER 79.05 13.89 1.17 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.606 -0.684 . . . . 0.0 110.427 179.668 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.443 ' HB3' ' HB2' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -156.73 53.27 0.52 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.124 -0.985 . . . . 0.0 110.507 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.444 ' O ' HG13 ' A' ' 85' ' ' VAL . . . 122.38 113.09 2.17 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.61 ' CE2' ' OH ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -172.25 160.44 5.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -1.14 . . . . 0.0 110.18 -179.823 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.511 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -152.29 169.46 22.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.455 -0.778 . . . . 0.0 109.949 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -58.92 -32.94 70.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.096 -1.003 . . . . 0.0 109.784 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.51 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -142.18 167.66 21.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.465 -0.772 . . . . 0.0 110.328 179.867 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.623 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 3.2 m-85 -141.83 -151.29 0.35 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.237 -0.915 . . . . 0.0 110.121 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.555 ' C ' ' CG2' ' A' ' 59' ' ' VAL . 85.2 p -160.54 -99.24 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.041 -1.037 . . . . 0.0 111.239 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.62 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -120.66 23.52 10.74 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.487 -1.383 . . . . 0.0 110.931 -178.281 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.543 ' N ' ' O ' ' A' ' 103' ' ' CYS . 17.5 t-20 -165.02 -109.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.769 -1.207 . . . . 0.0 110.541 178.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 48.52 75.71 0.14 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.706 -1.246 . . . . 0.0 109.114 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 24.4 t30 -69.79 125.89 28.07 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.51 -0.744 . . . . 0.0 110.942 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.594 HG12 ' CH2' ' A' ' 109' ' ' TRP . 13.3 m -108.53 125.08 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.214 -0.929 . . . . 0.0 109.418 178.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -80.82 123.93 28.66 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.989 -1.07 . . . . 0.0 108.882 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.614 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 9.7 m-85 -87.96 124.07 33.34 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.459 1.123 . . . . 0.0 112.302 -178.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.491 ' HB2' ' OG ' ' A' ' 72' ' ' SER . 0.0 OUTLIER -106.88 96.72 6.64 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.594 -178.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.55 ' HA ' ' CA ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -46.65 137.46 6.87 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.002 -1.061 . . . . 0.0 109.719 179.494 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.439 ' HD3' ' ND2' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -64.42 57.08 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.255 -0.903 . . . . 0.0 111.351 -179.377 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.581 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER 58.68 137.65 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.353 -0.842 . . . . 0.0 112.689 178.465 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.624 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 57.0 55.47 30.13 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 178.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.624 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 34.3 m-85 -162.05 165.05 27.79 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.312 -1.11 . . . . 0.0 110.396 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.542 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 1.2 ttmm -123.2 104.03 8.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.296 -0.878 . . . . 0.0 109.629 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.527 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 4.6 mt -46.66 93.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.965 . . . . 0.0 110.451 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -71.7 84.91 0.9 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.337 -0.852 . . . . 0.0 109.671 179.514 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 157.86 -88.75 0.11 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.578 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.2 OUTLIER -160.92 128.36 4.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.153 -1.204 . . . . 0.0 110.716 -179.547 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 0.4 OUTLIER -69.38 -76.91 0.09 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.289 -0.882 . . . . 0.0 110.612 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 40.4 p -74.55 106.02 5.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.284 -0.885 . . . . 0.0 110.725 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.49 ' O ' ' N ' ' A' ' 85' ' ' VAL . 58.3 m -113.66 164.38 13.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.354 -0.841 . . . . 0.0 110.068 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -136.2 142.01 44.06 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.274 -0.891 . . . . 0.0 111.066 -179.721 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.621 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 0.5 OUTLIER -71.93 87.02 1.01 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.246 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.489 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -62.28 178.39 0.33 Allowed Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.202 -0.936 . . . . 0.0 112.619 -178.225 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.603 ' HA ' ' CG1' ' A' ' 59' ' ' VAL . 44.3 Cg_endo -79.02 42.84 1.36 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 124.813 1.954 . . . . 0.0 112.207 -178.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -140.64 16.76 2.86 Favored Glycine 0 C--N 1.292 -1.884 0 N-CA-C 108.2 -1.96 . . . . 0.0 108.2 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.513 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 22.3 m-80 62.98 57.0 1.72 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.666 -0.903 . . . . 0.0 109.725 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 103' ' ' CYS . 0.2 OUTLIER -160.37 -159.5 0.7 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.309 -0.869 . . . . 0.0 110.452 -179.585 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.621 ' CZ3' ' N ' ' A' ' 103' ' ' CYS . 37.0 m95 -136.6 91.28 2.64 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.372 -0.83 . . . . 0.0 110.442 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.512 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 15.2 mmtt -100.4 148.99 35.68 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.562 -0.711 . . . . 0.0 110.078 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.578 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 47.2 Cg_endo -71.01 174.36 45.2 Favored 'Cis proline' 0 C--N 1.312 -1.342 0 C-N-CA 121.999 -2.084 . . . . 0.0 111.014 -0.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -33.17 131.14 0.2 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.458 0.647 . . . . 0.0 111.838 -179.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.565 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.9 OUTLIER -53.38 137.59 50.18 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.56 -0.712 . . . . 0.0 109.812 179.298 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.58 ' CG ' ' CD2' ' A' ' 87' ' ' PHE . 40.4 Cg_endo -69.19 147.69 67.09 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 O-C-N 124.139 1.599 . . . . 0.0 111.066 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.552 ' O ' HG21 ' A' ' 117' ' ' VAL . 3.6 ttpp -115.9 92.47 3.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.43 -0.794 . . . . 0.0 110.301 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.587 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.1 t -47.67 105.97 0.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.919 . . . . 0.0 110.088 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.552 HG21 ' O ' ' A' ' 115' ' ' LYS . 0.7 OUTLIER -122.55 177.08 4.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.427 -0.796 . . . . 0.0 110.511 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 21.3 ptt85 . . . . . 0 C--N 1.297 -1.674 0 C-N-CA 118.805 -1.158 . . . . 0.0 110.384 179.64 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 51.6 t . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.293 0.568 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.4 ptpt -137.57 178.3 7.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 0.0 110.456 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.546 ' O ' ' N ' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -161.27 93.12 0.93 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.607 -0.683 . . . . 0.0 109.514 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 9.5 mt-30 -72.84 176.96 5.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.072 -1.017 . . . . 0.0 110.428 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.9 140.93 29.13 Favored Pre-proline 0 C--N 1.301 -1.532 0 O-C-N 121.569 -0.707 . . . . 0.0 109.95 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.624 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 53.4 Cg_endo -70.91 153.21 63.76 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 124.019 1.536 . . . . 0.0 110.861 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -74.98 170.63 19.99 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.959 1.505 . . . . 0.0 109.947 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 92.4 p -69.51 178.25 2.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.174 -0.954 . . . . 0.0 110.191 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.485 ' O ' ' N ' ' A' ' 11' ' ' ASN . 0.2 OUTLIER -142.39 -170.17 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 122.125 0.964 . . . . 0.0 111.273 179.81 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 54.7 m -38.22 93.61 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.068 -179.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER 43.92 30.47 0.4 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.243 -0.911 . . . . 0.0 110.502 179.689 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.64 162.31 25.15 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.134 -1.587 . . . . 0.0 109.134 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 30' ' ' SER . 5.2 ptt180 -118.45 -173.0 2.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.079 -1.248 . . . . 0.0 110.778 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.624 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 11.9 p80 -131.95 153.53 50.21 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.306 0.574 . . . . 0.0 110.66 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -170.63 -156.57 0.13 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.283 -0.885 . . . . 0.0 110.072 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.441 ' C ' ' CD2' ' A' ' 17' ' ' TYR . . . 124.27 24.98 1.71 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.441 ' CD2' ' C ' ' A' ' 16' ' ' GLY . 24.5 m-85 58.66 65.86 1.17 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.175 -1.191 . . . . 0.0 110.284 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 19' ' ' ASP . 1.6 pp20? -141.21 -174.37 4.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.91 . . . . 0.0 109.874 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.449 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 31.9 m-20 -158.3 -33.38 0.07 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.11 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.577 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 5.6 p90 -160.74 70.7 0.4 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.851 -1.156 . . . . 0.0 110.782 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.604 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 30.5 m-85 -46.95 175.4 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.469 -0.77 . . . . 0.0 110.318 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.517 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 21.2 m -132.64 -54.57 0.95 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.058 -1.026 . . . . 0.0 110.738 -179.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -171.95 148.12 2.25 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.394 -0.816 . . . . 0.0 109.44 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 65.88 11.83 55.5 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 -178.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.604 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 66.2 m -86.5 175.0 8.59 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.407 -1.055 . . . . 0.0 110.167 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 26.1 t -151.34 154.75 7.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.514 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.547 ' HB ' HG21 ' A' ' 43' ' ' VAL . 24.5 t -135.02 117.47 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.147 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.459 HG21 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -70.28 104.22 2.6 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.302 -1.359 . . . . 0.0 107.746 178.132 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.643 ' CE1' HG22 ' A' ' 43' ' ' VAL . 2.2 m-30 -68.25 133.18 48.4 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.325 -178.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -92.87 153.55 18.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.309 -0.869 . . . . 0.0 109.973 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 57.2 m -119.49 154.41 33.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 110.025 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.459 ' O ' ' HB2' ' A' ' 35' ' ' TYR . 1.6 t-20 -46.81 140.28 4.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.935 . . . . 0.0 110.141 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -45.2 108.68 0.13 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.141 -0.975 . . . . 0.0 110.45 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.81 9.84 27.72 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 2.7 m-30 -108.5 146.76 32.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.104 -1.233 . . . . 0.0 110.327 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.535 ' HB2' ' CG2' ' A' ' 59' ' ' VAL . 48.2 t -89.33 137.71 32.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.395 -0.816 . . . . 0.0 110.878 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.473 ' HA ' ' O ' ' A' ' 55' ' ' THR . 4.3 tp -94.12 110.04 21.78 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 177.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.555 ' CG2' ' CG ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -107.56 147.46 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.069 -1.019 . . . . 0.0 109.839 -179.225 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.9 -163.55 12.96 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -65.08 130.81 44.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.219 -1.165 . . . . 0.0 109.773 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.459 ' O ' HG21 ' A' ' 28' ' ' THR . 89.9 p -74.11 53.37 0.49 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.209 -0.932 . . . . 0.0 110.22 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 43' ' ' VAL . . . 150.62 105.59 0.32 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.643 HG22 ' CE1' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -48.09 177.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.222 -1.164 . . . . 0.0 108.601 179.377 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 25' ' ' SER . 2.5 tp -139.5 105.68 5.24 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.361 -0.837 . . . . 0.0 109.829 178.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.619 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 1.0 OUTLIER -86.05 106.87 17.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.093 -1.004 . . . . 0.0 109.969 179.58 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.7 m -124.38 104.0 8.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.492 -0.755 . . . . 0.0 109.856 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.77 53.97 3.82 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 48.49 46.94 29.5 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -156.83 99.14 1.83 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -1.153 . . . . 0.0 110.897 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.619 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 90.8 m95 -68.18 137.97 55.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.2 -0.938 . . . . 0.0 109.063 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.8 p -140.24 169.77 17.06 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.833 -1.167 . . . . 0.0 111.519 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.511 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.5 OUTLIER 51.8 65.86 5.88 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.734 -0.604 . . . . 0.0 111.457 179.627 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.511 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 46.7 Cg_endo -90.65 130.39 1.54 Allowed 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 121.874 1.716 . . . . 0.0 110.057 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.541 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 53.5 Cg_endo -77.76 176.37 10.1 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.811 1.427 . . . . 0.0 110.705 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.519 ' OG1' ' CG1' ' A' ' 38' ' ' ILE . 12.2 p -108.97 156.46 19.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.464 -0.772 . . . . 0.0 110.776 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 10' ' ' SER . 22.2 m -122.67 80.14 1.71 Allowed 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.507 ' O ' ' N ' ' A' ' 36' ' ' SER . 5.8 mm100 -109.98 -145.07 0.39 Allowed 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.428 0.632 . . . . 0.0 110.609 -178.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.469 ' CD1' ' N ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -137.32 114.16 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.598 HG22 ' N ' ' A' ' 81' ' ' TYR . 19.6 m -111.87 60.66 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.161 -0.962 . . . . 0.0 112.182 -178.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 8.5 mttt -69.73 159.35 33.69 Favored 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 117.852 -1.539 . . . . 0.0 107.245 178.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.492 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -118.95 168.82 9.03 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 120.391 -1.443 . . . . 0.0 114.304 -176.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -89.9 -81.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.739 2.293 . . . . 0.0 110.972 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 177.37 125.62 0.18 Allowed Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 121.711 -0.618 . . . . 0.0 109.521 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.597 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 49.0 Cg_endo -75.86 67.32 6.65 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 123.714 1.376 . . . . 0.0 109.673 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.416 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -81.7 175.32 10.56 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.57 -0.707 . . . . 0.0 110.471 -179.451 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.548 ' CD1' ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -172.46 163.48 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.295 -0.878 . . . . 0.0 110.341 179.665 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.46 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 96.4 p -72.86 100.13 2.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.522 -0.736 . . . . 0.0 110.645 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.469 ' O ' ' SG ' ' A' ' 116' ' ' CYS . 7.4 m-20 44.51 45.17 7.6 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.362 -0.837 . . . . 0.0 110.573 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.514 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -152.71 31.02 0.83 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.533 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 6.9 p90 -44.68 -176.08 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 122.663 1.22 . . . . 0.0 112.644 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.565 HD11 ' CE2' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -110.49 162.99 14.14 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.558 179.22 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.468 ' HB2' ' HD3' ' A' ' 88' ' ' LYS . 2.5 t -144.49 14.89 1.61 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.003 -1.061 . . . . 0.0 110.178 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.67 -69.79 0.74 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.216 -0.927 . . . . 0.0 110.909 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.418 ' O ' HG11 ' A' ' 85' ' ' VAL . . . -136.82 81.47 0.28 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.594 ' CE2' ' OH ' ' A' ' 79' ' ' TYR . 1.9 t80 -105.94 160.02 15.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.43 -1.041 . . . . 0.0 109.977 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.481 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 25.3 tttt -158.4 148.14 19.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.897 . . . . 0.0 110.446 -179.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' A' ' 76' ' ' LYS . 2.2 mtp85 -44.71 -34.58 2.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.177 -0.952 . . . . 0.0 109.702 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.438 ' O ' ' HD3' ' A' ' 76' ' ' LYS . 0.5 OUTLIER -143.63 153.48 42.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.406 -0.808 . . . . 0.0 109.917 179.725 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.594 ' OH ' ' CE2' ' A' ' 75' ' ' PHE . 8.3 m-85 -125.41 -148.12 0.38 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.161 -0.962 . . . . 0.0 110.462 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.52 ' C ' HG22 ' A' ' 59' ' ' VAL . 81.6 p -158.62 -124.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.3 -0.875 . . . . 0.0 110.3 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.631 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -99.93 29.9 3.98 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.037 -1.039 . . . . 0.0 111.068 -178.295 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.486 ' HA ' HG23 ' A' ' 102' ' ' THR . 48.7 t30 -173.93 -114.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.93 -1.107 . . . . 0.0 110.462 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 49.43 75.39 0.16 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.696 -1.252 . . . . 0.0 109.244 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.546 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 10.3 p30 -69.27 125.46 26.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.381 -0.824 . . . . 0.0 110.826 -179.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.58 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 26.4 m -107.2 118.03 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.166 -0.959 . . . . 0.0 110.235 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.547 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -78.77 137.7 37.86 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.738 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.604 ' CZ ' HD11 ' A' ' 113' ' ' LEU . 70.0 m-85 -95.58 137.83 34.1 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.872 -1.142 . . . . 0.0 112.52 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.468 ' HD3' ' HB2' ' A' ' 72' ' ' SER . 0.7 OUTLIER -111.1 93.84 4.69 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.744 -179.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.428 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -44.15 131.97 5.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.053 -1.029 . . . . 0.0 110.302 -179.663 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 11.6 mmtt -42.27 -78.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.295 -0.878 . . . . 0.0 110.258 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.573 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -162.3 136.78 6.73 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.321 -0.862 . . . . 0.0 110.492 -179.892 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.592 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 52.98 66.08 2.94 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.592 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 14.6 m-85 -162.49 172.43 15.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.42 -1.047 . . . . 0.0 110.096 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.52 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 4.4 mtmt -131.2 107.65 9.15 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.321 -0.862 . . . . 0.0 109.957 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.517 ' CD2' ' HB3' ' A' ' 87' ' ' PHE . 1.1 mt -49.54 93.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.099 -1.001 . . . . 0.0 110.425 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.473 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -77.44 109.33 11.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -0.937 . . . . 0.0 110.184 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 135.03 -85.13 0.26 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.544 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.2 OUTLIER -158.77 112.46 2.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.293 -1.122 . . . . 0.0 110.546 -179.61 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.4 t -72.82 -0.1 12.47 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.279 -0.888 . . . . 0.0 110.326 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.5 p -141.5 117.92 10.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.143 -0.973 . . . . 0.0 109.547 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.496 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 40.1 m -134.33 151.42 51.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.149 -0.969 . . . . 0.0 111.122 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -120.36 151.95 38.55 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.61 0.719 . . . . 0.0 110.049 179.608 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.594 ' SG ' ' CZ2' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -83.8 77.96 9.79 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.683 -0.635 . . . . 0.0 110.554 -179.348 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.458 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.5 OUTLIER -48.37 175.78 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.348 -0.845 . . . . 0.0 111.675 -179.641 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.572 ' HA ' ' CG1' ' A' ' 59' ' ' VAL . 47.3 Cg_endo -77.53 43.18 1.28 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.656 1.872 . . . . 0.0 111.968 -178.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -139.57 12.04 3.21 Favored Glycine 0 C--N 1.292 -1.903 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.529 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 2.0 m120 64.2 63.83 0.76 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.718 -0.872 . . . . 0.0 109.836 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.474 HG21 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -159.8 -160.52 0.82 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.319 -0.863 . . . . 0.0 111.035 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.597 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 26.4 m95 -137.43 82.0 1.9 Allowed 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.64 0.733 . . . . 0.0 110.293 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.505 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.8 OUTLIER -99.27 136.5 20.45 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.72 -0.612 . . . . 0.0 110.161 -179.819 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.544 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 42.7 Cg_endo -69.53 164.94 77.26 Favored 'Cis proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.084 -2.048 . . . . 0.0 111.001 -0.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -41.24 149.39 0.1 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.563 -0.711 . . . . 0.0 110.555 -179.303 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.604 HD11 ' CZ ' ' A' ' 87' ' ' PHE . 1.1 mm? -57.19 145.64 65.25 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.422 -0.798 . . . . 0.0 109.982 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.548 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 37.4 Cg_endo -69.0 169.47 17.87 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 O-C-N 124.31 1.689 . . . . 0.0 110.951 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.507 ' HG2' ' CG1' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -128.34 106.32 8.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 0.0 110.528 -179.549 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.545 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.4 t -63.31 87.13 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.184 -0.947 . . . . 0.0 108.912 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.52 ' CG2' ' O ' ' A' ' 94' ' ' LYS . 2.3 m -103.3 177.58 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.612 0.72 . . . . 0.0 111.007 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.58 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.709 0 C-N-CA 118.971 -1.092 . . . . 0.0 110.327 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.0 p . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.2 0.524 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.75 177.54 7.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.393 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.576 ' CB ' ' N ' ' A' ' 22' ' ' THR . 1.4 t -159.4 104.13 1.63 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.434 -0.791 . . . . 0.0 110.486 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.424 ' C ' ' O ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -81.25 176.58 9.63 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.73 -1.232 . . . . 0.0 109.325 179.023 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 19' ' ' ASP . 0.1 OUTLIER -54.57 146.68 33.37 Favored Pre-proline 0 C--N 1.294 -1.812 0 O-C-N 121.379 -0.825 . . . . 0.0 109.666 179.882 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.636 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 51.7 Cg_endo -70.11 154.2 66.56 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.93 1.489 . . . . 0.0 111.404 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -76.21 172.88 15.44 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.014 1.534 . . . . 0.0 110.281 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 m -69.7 179.47 2.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.161 -0.962 . . . . 0.0 110.007 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.57 HG22 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -145.24 -170.16 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 122.335 1.064 . . . . 0.0 111.905 -179.786 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.481 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 14.1 t -46.17 105.75 0.07 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.313 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 10' ' ' SER . 6.6 m120 40.96 26.43 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.352 -0.842 . . . . 0.0 110.763 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -141.38 169.86 24.92 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 30' ' ' SER . 2.5 ptt180 -133.91 -178.55 5.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -1.142 . . . . 0.0 110.332 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.636 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 7.0 p80 -120.22 156.23 31.58 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.545 -0.722 . . . . 0.0 110.095 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -173.84 50.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.141 -0.974 . . . . 0.0 110.587 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 17' ' ' TYR . . . -53.92 -78.76 0.1 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.467 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER 174.98 35.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.355 -1.085 . . . . 0.0 110.248 179.515 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.457 ' OE2' ' HB3' ' A' ' 17' ' ' TYR . 0.6 OUTLIER 176.81 -178.38 0.16 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 110.428 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 5' ' ' SER . 8.1 t70 -117.49 -43.62 2.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.428 -0.795 . . . . 0.0 109.955 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 3' ' ' CYS . 14.2 m-85 -84.31 130.3 34.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.334 -0.854 . . . . 0.0 109.859 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.596 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.5 OUTLIER -132.42 -6.02 3.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.344 -0.847 . . . . 0.0 110.889 -179.39 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.576 ' N ' ' CB ' ' A' ' 3' ' ' CYS . 66.7 p 45.91 -96.71 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.516 -0.74 . . . . 0.0 111.841 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -150.13 150.89 32.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.843 -1.161 . . . . 0.0 110.661 -178.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 79.42 15.49 79.81 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.596 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 20.5 m -97.25 172.77 7.59 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.459 -1.024 . . . . 0.0 110.281 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.556 HG11 ' N ' ' A' ' 27' ' ' VAL . 33.4 t -151.49 151.94 11.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.382 -0.824 . . . . 0.0 110.066 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.556 ' N ' HG11 ' A' ' 26' ' ' VAL . 34.6 t -134.66 119.89 30.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.223 -0.923 . . . . 0.0 111.583 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.464 HG21 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -72.3 103.6 3.45 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.399 -1.321 . . . . 0.0 107.489 177.736 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.594 ' CZ ' HG22 ' A' ' 43' ' ' VAL . 2.2 m-30 -67.55 121.4 15.77 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.338 -0.851 . . . . 0.0 110.074 -178.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -74.76 150.3 39.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.206 -0.934 . . . . 0.0 109.617 179.352 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.461 ' SG ' HD11 ' A' ' 37' ' ' LEU . 60.3 m -118.2 159.51 23.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.176 -0.952 . . . . 0.0 110.306 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 33' ' ' SER . 4.4 t-20 -53.72 134.89 41.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 110.236 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 32' ' ' ASN . 0.5 OUTLIER -44.39 102.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.245 -0.909 . . . . 0.0 110.305 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.73 -11.31 12.17 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -93.84 139.74 30.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.236 -1.155 . . . . 0.0 110.062 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.619 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -84.62 142.05 30.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.172 -0.955 . . . . 0.0 110.879 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.475 HD11 ' O ' ' A' ' 29' ' ' TYR . 3.2 tp -92.81 97.04 10.51 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.458 -0.776 . . . . 0.0 109.231 179.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.571 ' HB ' ' OG1' ' A' ' 55' ' ' THR . 0.2 OUTLIER -88.42 157.0 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.409 -0.807 . . . . 0.0 109.05 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 91.07 178.22 43.31 Favored Glycine 0 N--CA 1.488 2.11 0 C-N-CA 119.417 -1.373 . . . . 0.0 109.988 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.476 ' O ' ' HG3' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -54.71 124.65 17.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.311 -1.111 . . . . 0.0 109.85 179.729 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.464 ' O ' HG21 ' A' ' 28' ' ' THR . 0.1 OUTLIER -72.45 55.14 0.34 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.206 -0.934 . . . . 0.0 109.956 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.515 ' O ' ' O ' ' A' ' 43' ' ' VAL . . . 161.39 96.98 0.11 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.594 HG22 ' CZ ' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -45.3 173.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.365 -1.079 . . . . 0.0 108.345 179.336 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.455 ' HB3' ' OD2' ' A' ' 52' ' ' ASP . 7.3 tp -134.08 103.37 5.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.984 -1.073 . . . . 0.0 110.371 178.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.537 ' HB2' ' CE2' ' A' ' 50' ' ' TRP . 0.6 OUTLIER -77.23 115.28 16.88 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.367 -0.833 . . . . 0.0 109.45 179.168 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.86 101.74 5.37 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.113 -0.992 . . . . 0.0 110.171 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.96 41.15 19.18 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.41 30.76 78.75 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.79 102.09 4.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -1.142 . . . . 0.0 110.552 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.537 ' CE2' ' HB2' ' A' ' 45' ' ' CYS . 89.7 m95 -73.59 123.0 23.14 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.127 -0.983 . . . . 0.0 109.551 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.418 ' O ' ' CG ' ' A' ' 52' ' ' ASP . 22.4 m -129.22 -176.38 3.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.062 -1.024 . . . . 0.0 111.399 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.521 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 1.6 p30 37.56 65.64 2.56 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.851 -0.53 . . . . 0.0 111.191 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.1 Cg_endo -91.09 131.73 1.48 Allowed 'Trans proline' 0 C--N 1.301 -1.946 0 C-N-CA 121.95 1.767 . . . . 0.0 110.03 178.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.541 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 53.8 Cg_endo -76.27 172.67 15.82 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.596 1.314 . . . . 0.0 110.205 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.571 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 37.9 p -114.22 143.16 45.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.08 -1.013 . . . . 0.0 111.291 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 10' ' ' SER . 69.4 m -107.57 78.89 1.24 Allowed 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -113.84 -159.33 0.69 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.481 0.658 . . . . 0.0 110.56 -178.299 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.454 ' CG2' ' HD2' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -110.49 142.8 21.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.426 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.624 ' CG1' ' HA ' ' A' ' 105' ' ' PRO . 21.3 m -133.44 44.96 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.988 -1.07 . . . . 0.0 110.992 -178.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.478 ' N ' ' OD1' ' A' ' 107' ' ' ASN . 2.9 mttp -81.34 102.45 10.45 Favored 'General case' 0 C--N 1.281 -2.377 0 C-N-CA 118.858 -1.137 . . . . 0.0 109.343 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.51 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 53.2 m -72.94 164.0 64.11 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.372 -0.83 . . . . 0.0 111.298 -178.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 42.5 Cg_endo -69.54 -89.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 124.306 1.687 . . . . 0.0 110.666 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.463 ' HB3' ' CG2' ' A' ' 65' ' ' THR . 0.0 OUTLIER -159.68 133.36 4.97 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.776 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.601 ' HG3' ' CZ2' ' A' ' 109' ' ' TRP . 56.7 Cg_endo -77.93 65.86 8.24 Favored 'Trans proline' 0 C--N 1.296 -2.22 0 O-C-N 123.604 1.318 . . . . 0.0 109.671 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.543 ' N ' HD22 ' A' ' 113' ' ' LEU . 0.7 OUTLIER -87.27 -175.37 5.26 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.533 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.538 HG22 HD11 ' A' ' 66' ' ' ILE . 0.2 OUTLIER 179.7 169.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 C-N-CA 118.756 -1.178 . . . . 0.0 110.721 179.438 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.511 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 4.0 t -69.71 90.89 0.59 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.46 -0.775 . . . . 0.0 110.915 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 1.9 m-80 51.17 34.72 11.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.336 -0.852 . . . . 0.0 110.902 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.55 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -139.15 30.07 2.48 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.57 ' O ' ' N ' ' A' ' 88' ' ' LYS . 4.7 p90 -43.12 -174.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 122.707 1.241 . . . . 0.0 112.789 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.551 HD11 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -113.73 158.0 21.49 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.056 179.088 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.8 19.44 2.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.094 -1.004 . . . . 0.0 110.086 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.8 t -99.25 -85.14 0.4 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.918 . . . . 0.0 110.844 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -98.62 -86.24 1.86 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.59 ' CE2' ' OH ' ' A' ' 79' ' ' TYR . 17.5 t80 57.3 106.84 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.418 -1.048 . . . . 0.0 110.207 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.61 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -114.96 123.35 48.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.253 -0.905 . . . . 0.0 108.918 179.309 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.526 ' C ' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -28.79 -39.54 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.353 0.597 . . . . 0.0 111.204 -179.073 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -123.52 105.81 10.07 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.379 -0.825 . . . . 0.0 109.739 179.192 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.61 ' CE1' ' O ' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -91.73 175.23 6.97 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.128 -0.982 . . . . 0.0 109.849 -179.517 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.539 ' CA ' HG22 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -170.27 107.09 0.33 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.149 -0.97 . . . . 0.0 111.128 179.821 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.633 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 10.2 t80 46.77 18.44 0.07 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.091 -1.006 . . . . 0.0 111.809 178.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.543 ' N ' ' O ' ' A' ' 103' ' ' CYS . 28.5 p30 -172.49 -128.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.186 -1.571 . . . . 0.0 110.841 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.459 ' OD2' ' HA ' ' A' ' 79' ' ' TYR . 11.0 m-20 52.78 72.51 0.41 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.858 -1.151 . . . . 0.0 108.831 -178.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.487 ' HA ' ' O ' ' A' ' 101' ' ' SER . 15.5 p30 -68.5 138.41 55.18 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.473 -0.767 . . . . 0.0 110.169 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.591 HG21 ' CZ3' ' A' ' 109' ' ' TRP . 5.2 m -124.54 119.49 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.181 -0.949 . . . . 0.0 110.746 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.537 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 5.2 t0 -81.39 132.56 35.33 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.551 ' CE1' HD11 ' A' ' 71' ' ' LEU . 69.6 m-85 -92.01 120.94 33.12 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 122.326 1.06 . . . . 0.0 112.464 -177.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -92.7 90.68 7.17 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.763 179.594 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.464 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -44.07 131.02 6.02 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.157 -0.965 . . . . 0.0 109.774 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -37.65 -70.9 0.09 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.647 -0.658 . . . . 0.0 110.74 -179.434 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.574 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 49.1 t80 -175.11 145.65 0.81 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.276 -0.89 . . . . 0.0 110.366 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.58 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 46.18 42.21 12.27 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 12.1 m-85 -145.37 150.7 37.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.526 -0.985 . . . . 0.0 109.934 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.531 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 6.8 mtmp? -107.42 138.96 42.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.291 -0.881 . . . . 0.0 109.903 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.527 ' CD2' ' HB3' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -78.49 100.17 6.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.025 -1.047 . . . . 0.0 110.725 -179.545 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.463 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -78.49 105.91 10.08 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.423 -0.798 . . . . 0.0 109.436 179.273 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 138.62 -88.61 0.2 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.563 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -158.07 112.94 2.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.296 -1.12 . . . . 0.0 110.549 -179.614 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 82.8 p -65.0 -22.11 66.95 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.191 -0.943 . . . . 0.0 110.765 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.6 p -125.65 126.26 44.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.813 -1.179 . . . . 0.0 109.877 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 4.5 m -135.11 172.57 12.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 0.0 110.429 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.51 HG23 ' HA ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -148.03 140.46 24.42 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.506 -0.746 . . . . 0.0 110.456 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.574 ' O ' ' CA ' ' A' ' 81' ' ' TYR . 7.8 t -59.97 88.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.43 -0.794 . . . . 0.0 109.43 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.47 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.2 OUTLIER -61.53 173.23 0.82 Allowed Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.037 -1.039 . . . . 0.0 111.768 -178.844 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.624 ' HA ' ' CG1' ' A' ' 59' ' ' VAL . 50.5 Cg_endo -75.37 13.91 1.03 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 124.554 1.818 . . . . 0.0 111.937 -178.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -112.35 23.14 16.42 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 106' ' ' GLY . 39.5 m-80 60.47 48.53 7.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.808 -0.819 . . . . 0.0 110.636 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.459 ' HA ' ' HD2' ' A' ' 62' ' ' PRO . 0.6 OUTLIER -160.98 -179.39 7.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.03 -1.044 . . . . 0.0 111.387 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.601 ' CZ2' ' HG3' ' A' ' 64' ' ' PRO . 42.2 m95 -104.15 99.01 8.74 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.556 0.693 . . . . 0.0 110.845 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.467 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 8.8 mttt -110.19 141.01 22.96 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.503 -0.748 . . . . 0.0 109.59 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.563 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.4 Cg_endo -71.04 168.68 71.45 Favored 'Cis proline' 0 C--N 1.313 -1.312 0 C-N-CA 122.109 -2.038 . . . . 0.0 110.981 -0.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 111' ' ' PRO . 4.3 tt0 -38.97 130.79 1.46 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.502 -0.749 . . . . 0.0 111.106 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.543 HD22 ' N ' ' A' ' 65' ' ' THR . 0.2 OUTLIER -42.32 146.88 0.63 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.47 -0.769 . . . . 0.0 110.117 179.178 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.532 ' CG ' ' CG ' ' A' ' 87' ' ' PHE . 41.9 Cg_endo -74.14 173.51 14.0 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 O-C-N 124.382 1.727 . . . . 0.0 110.658 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.525 ' O ' HG23 ' A' ' 117' ' ' VAL . 24.6 ttmt -135.12 111.67 9.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 110.565 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.535 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.8 t -66.15 100.19 0.58 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.344 -0.847 . . . . 0.0 108.809 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -110.57 -177.63 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-O 121.798 0.809 . . . . 0.0 110.825 -179.12 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.296 -1.75 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.472 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.224 0.535 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.6 172.76 6.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.158 -0.964 . . . . 0.0 110.601 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.542 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -124.76 83.73 2.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.441 -0.787 . . . . 0.0 109.829 179.853 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.512 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 3.0 mt-30 -60.11 174.54 0.5 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.291 -0.88 . . . . 0.0 110.417 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 19' ' ' ASP . 1.0 OUTLIER -47.09 144.48 4.0 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.423 -0.798 . . . . 0.0 110.204 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.624 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 53.3 Cg_endo -71.52 157.72 55.53 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.988 1.52 . . . . 0.0 110.871 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -76.72 171.96 17.06 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.992 1.522 . . . . 0.0 110.286 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.61 175.96 6.64 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.221 -0.924 . . . . 0.0 109.895 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.563 HG12 ' CD2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -141.14 -170.57 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 122.281 1.039 . . . . 0.0 111.587 179.581 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 12' ' ' GLY . 0.4 OUTLIER -44.93 105.13 0.05 Allowed 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.157 -178.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.453 ' C ' ' O ' ' A' ' 10' ' ' SER . 0.9 OUTLIER 39.05 27.95 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.315 -0.866 . . . . 0.0 110.583 179.604 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -135.99 160.42 24.61 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -123.2 178.22 5.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -1.131 . . . . 0.0 110.321 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.624 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 11.3 p80 -123.31 135.98 54.46 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.572 -0.705 . . . . 0.0 110.355 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -137.43 64.68 1.52 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.413 -0.804 . . . . 0.0 110.077 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -59.09 -173.59 0.55 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.404 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -94.06 31.61 1.63 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.322 -1.105 . . . . 0.0 110.229 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.568 ' OE2' ' CD1' ' A' ' 21' ' ' TYR . 6.7 pt-20 179.09 -171.81 0.14 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 110.371 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 5' ' ' SER . 29.4 t0 -92.03 -52.54 4.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 110.014 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.573 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 52.0 p90 -104.03 -155.17 0.52 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.177 -0.952 . . . . 0.0 109.983 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.61 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 1.8 m-85 -170.0 -31.62 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.157 -0.964 . . . . 0.0 110.883 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.548 ' CB ' ' O ' ' A' ' 21' ' ' TYR . 3.0 m 78.42 -83.03 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.659 -0.65 . . . . 0.0 111.904 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 47' ' ' GLY . 2.1 t70 -161.93 157.13 23.33 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.745 -1.222 . . . . 0.0 110.14 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.29 14.86 60.25 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.61 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 20.1 m -94.01 176.77 6.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.476 -1.014 . . . . 0.0 110.179 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 25.2 t -154.29 158.29 3.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 119.549 -0.861 . . . . 0.0 110.379 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.584 HG13 ' CD1' ' A' ' 29' ' ' TYR . 10.0 t -141.82 113.31 3.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 118.933 -1.107 . . . . 0.0 111.915 -179.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.467 HG21 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -69.8 105.21 2.69 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.127 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.623 ' CE1' HG23 ' A' ' 43' ' ' VAL . 3.1 m-30 -67.73 -176.44 0.65 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 110.21 -178.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.464 ' O ' ' CA ' ' A' ' 12' ' ' GLY . 0.6 OUTLIER -142.25 146.94 35.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.434 -0.791 . . . . 0.0 109.626 179.455 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 35.2 m -123.3 137.19 54.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 110.245 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 31' ' ' CYS . 2.5 m-20 -44.04 148.2 0.43 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 110.141 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -47.98 131.06 15.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.0 110.138 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.05 -12.7 52.55 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.466 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 1.9 m-30 -110.17 125.94 53.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.266 -1.138 . . . . 0.0 110.42 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.545 ' OG ' ' CG2' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -79.86 144.85 33.09 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.322 -0.861 . . . . 0.0 110.977 -179.689 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.499 ' HA ' ' O ' ' A' ' 55' ' ' THR . 2.3 tp -95.48 105.11 17.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.347 -0.845 . . . . 0.0 109.935 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.587 ' HB ' ' OG1' ' A' ' 55' ' ' THR . 0.6 OUTLIER -97.2 149.56 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.247 -0.908 . . . . 0.0 109.466 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 130.89 -158.71 22.74 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.487 ' O ' ' C ' ' A' ' 41' ' ' SER . 8.5 t-20 -97.89 51.7 1.05 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.107 -1.231 . . . . 0.0 109.897 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.487 ' C ' ' O ' ' A' ' 40' ' ' ASN . 79.5 p 28.65 45.45 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.499 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 27' ' ' VAL . . . 157.33 126.04 0.89 Allowed Glycine 0 N--CA 1.49 2.299 0 C-N-CA 119.378 -1.392 . . . . 0.0 110.44 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.623 HG23 ' CE1' ' A' ' 29' ' ' TYR . 1.7 t -65.01 178.27 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.182 -1.187 . . . . 0.0 107.864 178.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.55 ' C ' ' CD2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -140.41 94.31 2.72 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.057 178.452 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.587 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -81.88 107.75 14.85 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.114 178.566 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.465 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -132.37 121.13 23.0 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.317 -179.479 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.539 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 90.96 8.88 64.5 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.04 27.86 19.84 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -154.22 125.57 7.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.223 -1.163 . . . . 0.0 110.19 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.587 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 92.2 m95 -72.06 137.32 47.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.713 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.93 166.49 25.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.127 -0.983 . . . . 0.0 111.077 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.52 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 87.8 m-20 48.34 65.37 7.16 Favored Pre-proline 0 N--CA 1.492 1.629 0 CA-C-O 121.216 0.532 . . . . 0.0 111.204 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.4 Cg_endo -91.02 151.41 3.87 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 O-C-N 124.433 1.754 . . . . 0.0 110.045 179.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.557 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 48.8 Cg_endo -78.72 175.95 10.42 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 123.852 1.448 . . . . 0.0 110.41 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.587 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 17.7 p -119.03 177.55 4.82 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.28 -0.887 . . . . 0.0 110.876 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 10' ' ' SER . 65.4 m -132.93 71.8 1.48 Allowed 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -113.72 171.95 7.27 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.144 -178.713 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -87.66 144.13 9.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 119.349 -0.94 . . . . 0.0 108.577 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.56 HG22 ' HB3' ' A' ' 81' ' ' TYR . 34.1 m -130.42 44.9 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.549 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 2.6 mmtt -53.91 179.79 0.02 OUTLIER 'General case' 0 C--N 1.278 -2.507 0 C-N-CA 118.035 -1.466 . . . . 0.0 108.381 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -145.36 165.28 22.25 Favored Pre-proline 0 N--CA 1.492 1.667 0 C-N-CA 118.402 -1.319 . . . . 0.0 112.887 -178.587 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.426 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 45.4 Cg_endo -88.2 -78.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.877 1.988 . . . . 0.0 110.401 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.426 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 170.93 129.26 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.653 -0.654 . . . . 0.0 109.352 -179.365 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.618 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 52.8 Cg_endo -80.97 65.83 8.89 Favored 'Trans proline' 0 C--N 1.298 -2.091 0 O-C-N 123.723 1.38 . . . . 0.0 110.074 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.549 ' N ' HD22 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -84.19 169.0 15.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.468 -0.77 . . . . 0.0 109.9 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.557 ' CD1' ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -169.17 161.78 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.035 -1.041 . . . . 0.0 110.638 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.492 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 0.6 OUTLIER -66.28 105.84 1.53 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.544 -0.723 . . . . 0.0 111.025 -179.18 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.459 ' O ' ' CG ' ' A' ' 90' ' ' LYS . 7.4 m-80 38.74 38.64 0.28 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.532 -0.73 . . . . 0.0 110.803 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -147.38 32.67 1.36 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.555 ' CD2' ' O ' ' A' ' 71' ' ' LEU . 3.6 p90 -46.46 -170.77 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 122.72 1.248 . . . . 0.0 112.515 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.567 HD11 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -114.07 168.48 9.78 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.007 179.554 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.3 t -149.67 15.87 0.87 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.848 -1.158 . . . . 0.0 110.644 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.448 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 41.9 t -92.49 -77.1 0.44 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.921 . . . . 0.0 110.515 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -130.87 77.98 0.38 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.62 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -103.85 163.74 12.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.354 -1.086 . . . . 0.0 109.548 179.538 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.62 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 17.0 ttmm -165.2 158.89 16.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 109.941 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.466 ' N ' ' HG2' ' A' ' 76' ' ' LYS . 26.2 mtt180 -54.1 -25.21 20.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.072 -1.017 . . . . 0.0 109.861 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.468 ' O ' ' HD2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -145.14 160.41 41.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.452 -0.78 . . . . 0.0 110.203 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.591 ' OH ' ' CE2' ' A' ' 75' ' ' PHE . 16.2 m-85 -135.75 -150.14 0.36 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.308 -0.87 . . . . 0.0 109.818 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.522 ' CA ' HG21 ' A' ' 59' ' ' VAL . 83.3 p -162.5 -104.96 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.807 -1.183 . . . . 0.0 111.388 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.594 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -114.47 15.87 17.8 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.481 -1.387 . . . . 0.0 110.431 -178.741 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.481 ' O ' HG21 ' A' ' 102' ' ' THR . 7.7 p30 -160.51 -107.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.925 -1.109 . . . . 0.0 110.443 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.454 ' C ' HG21 ' A' ' 102' ' ' THR . 0.3 OUTLIER 46.34 74.24 0.15 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.806 -1.184 . . . . 0.0 108.734 -179.1 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.511 ' HA ' ' CG2' ' A' ' 102' ' ' THR . 20.8 t-20 -68.52 122.64 18.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.468 -0.77 . . . . 0.0 110.338 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.592 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 23.4 m -104.96 120.04 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 0.0 110.608 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.464 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 62.8 t0 -83.72 127.77 34.03 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.567 ' CE1' HD11 ' A' ' 71' ' ' LEU . 35.1 m-85 -85.15 122.52 29.46 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.412 1.101 . . . . 0.0 111.876 -178.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -101.26 88.55 3.51 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.94 -179.778 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.481 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -42.52 129.24 4.03 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.31 -0.869 . . . . 0.0 109.814 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.459 ' CG ' ' O ' ' A' ' 68' ' ' ASN . 2.1 mmmt -38.48 -89.67 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.551 -0.718 . . . . 0.0 110.841 -179.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.573 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 1.9 t80 -153.37 131.13 11.59 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.102 -0.999 . . . . 0.0 110.341 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.584 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 60.11 52.66 51.41 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 26.4 m-85 -158.08 145.79 18.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.54 -0.976 . . . . 0.0 109.764 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -103.29 153.18 20.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.529 179.735 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.538 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 2.7 mt -91.32 97.55 11.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.754 -1.216 . . . . 0.0 110.086 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.471 ' HB2' HG22 ' A' ' 117' ' ' VAL . 16.8 t -80.65 107.83 13.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 110.241 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 98' ' ' SER . . . 129.85 -32.42 3.16 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.635 -1.269 . . . . 0.0 110.561 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.485 ' O ' ' HB3' ' A' ' 114' ' ' PRO . 12.7 p 177.18 -168.48 0.06 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.999 -1.295 . . . . 0.0 111.154 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.3 p -160.24 -35.09 0.05 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.247 0.546 . . . . 0.0 109.836 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 82.7 p -130.59 82.82 2.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 0.0 109.556 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.497 ' O ' ' N ' ' A' ' 85' ' ' VAL . 7.1 m -91.0 176.15 6.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.396 -0.815 . . . . 0.0 110.993 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.511 ' CG2' ' HA ' ' A' ' 84' ' ' ASN . 1.6 m -151.06 142.98 23.91 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.601 -0.687 . . . . 0.0 110.317 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.5 ' SG ' ' HB2' ' A' ' 79' ' ' TYR . 8.2 t -75.23 78.02 2.35 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.494 -0.754 . . . . 0.0 109.635 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.508 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -64.43 177.29 0.58 Allowed Pre-proline 0 C--N 1.299 -1.595 0 O-C-N 121.324 -0.86 . . . . 0.0 110.465 -179.664 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.54 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 42.0 Cg_endo -69.8 131.73 21.8 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 124.332 1.701 . . . . 0.0 110.142 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 121.9 -10.91 9.5 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 108.679 -1.769 . . . . 0.0 108.679 -179.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.549 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 10.4 m-20 79.64 92.25 0.05 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.893 -0.769 . . . . 0.0 110.807 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 103' ' ' CYS . 0.0 OUTLIER -177.51 -162.56 0.07 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.581 179.597 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.618 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 20.5 m95 -147.88 82.78 1.51 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.389 0.614 . . . . 0.0 109.897 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 101' ' ' SER . 9.2 mmtt -91.81 146.51 33.13 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.393 -0.817 . . . . 0.0 109.972 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.466 ' HD2' ' HA ' ' A' ' 101' ' ' SER . 46.7 Cg_endo -75.42 176.35 43.98 Favored 'Cis proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.654 -2.228 . . . . 0.0 110.481 -0.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.2 OUTLIER -37.17 124.63 0.95 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.685 -0.634 . . . . 0.0 110.741 -179.524 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.553 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.5 OUTLIER -42.57 137.36 2.36 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.873 . . . . 0.0 109.859 179.811 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.557 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 49.0 Cg_endo -74.67 165.1 32.32 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 O-C-N 124.258 1.662 . . . . 0.0 111.614 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 117' ' ' VAL . 12.6 ttmt -126.71 105.19 8.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.538 -0.726 . . . . 0.0 109.924 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.531 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.6 t -55.38 86.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.16 -0.963 . . . . 0.0 109.846 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.53 ' N ' ' O ' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -98.62 -172.16 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 121.822 0.82 . . . . 0.0 110.528 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.2 mtm180 . . . . . 0 C--N 1.294 -1.83 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.497 -179.991 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.366 0.603 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.51 177.39 6.38 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.385 -0.822 . . . . 0.0 110.305 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.538 ' HB2' ' CA ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -125.41 75.35 1.46 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.421 -0.799 . . . . 0.0 110.106 -179.889 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.444 ' O ' ' C ' ' A' ' 5' ' ' SER . 3.0 mp0 -54.17 172.02 0.1 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.041 -1.037 . . . . 0.0 109.725 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.2 p -42.41 144.82 0.89 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 109.94 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.609 ' HG2' ' CG ' ' A' ' 14' ' ' HIS . 53.9 Cg_endo -70.62 160.45 49.43 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.046 1.551 . . . . 0.0 110.79 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -76.26 170.21 20.46 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 O-C-N 124.014 1.534 . . . . 0.0 109.945 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.55 176.18 6.38 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.141 -0.975 . . . . 0.0 110.27 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.5 HG22 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -144.26 -170.33 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 122.24 1.019 . . . . 0.0 111.746 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.3 OUTLIER -50.27 105.19 0.09 Allowed 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.287 -178.91 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 10' ' ' SER . 65.0 m-20 37.27 47.12 0.65 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.516 -0.74 . . . . 0.0 111.274 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.53 152.85 24.3 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 30' ' ' SER . 1.6 ptt180 -113.04 -172.5 2.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.104 -1.233 . . . . 0.0 111.192 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.621 ' CG ' ' O ' ' A' ' 14' ' ' HIS . 20.3 p80 -143.99 111.6 6.04 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.294 0.568 . . . . 0.0 109.469 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 14' ' ' HIS . 2.6 t-20 -177.87 174.22 1.46 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.601 -1.312 . . . . 0.0 110.87 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 17' ' ' TYR . . . 145.62 -39.74 1.14 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.8 OUTLIER 178.17 46.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.513 -0.992 . . . . 0.0 109.568 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.58 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . 0.9 OUTLIER -134.19 -94.16 0.3 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.225 -0.922 . . . . 0.0 110.491 -179.495 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 9.2 m-20 66.26 6.45 4.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.279 -0.888 . . . . 0.0 110.387 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -170.42 116.48 0.5 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 110.621 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.594 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 18.3 m-85 -132.83 173.47 11.35 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.364 -0.835 . . . . 0.0 109.294 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.538 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 1.9 p -130.59 -68.9 0.67 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.779 -1.2 . . . . 0.0 110.75 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.417 ' C ' ' OD1' ' A' ' 23' ' ' ASP . 14.7 t0 -162.04 132.4 4.85 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.392 -0.818 . . . . 0.0 109.684 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.54 16.19 71.64 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.618 -1.793 . . . . 0.0 108.618 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.594 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.5 OUTLIER -97.73 -179.25 4.38 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.46 -1.023 . . . . 0.0 110.506 -179.808 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 11.8 t -149.58 162.26 4.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.041 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.574 HG13 ' CD1' ' A' ' 29' ' ' TYR . 16.4 t -143.07 118.56 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 119.698 -0.801 . . . . 0.0 111.681 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.464 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 0.1 OUTLIER -75.3 102.41 5.05 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 118.636 -1.225 . . . . 0.0 107.884 177.831 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.616 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 2.3 m-30 -67.94 127.55 33.25 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.441 -0.787 . . . . 0.0 109.915 -178.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -82.14 142.34 32.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.059 -1.026 . . . . 0.0 109.728 179.404 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.452 ' SG ' HD11 ' A' ' 37' ' ' LEU . 64.3 m -112.56 142.87 44.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.17 -0.956 . . . . 0.0 110.075 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -46.59 167.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 110.141 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 p -64.72 138.81 58.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.108 -0.995 . . . . 0.0 110.425 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.37 6.11 89.5 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.572 ' CD2' ' O ' ' A' ' 56' ' ' CYS . 1.0 OUTLIER -111.63 120.88 43.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.172 -1.193 . . . . 0.0 110.274 -179.881 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.564 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -79.79 130.45 35.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.394 -0.816 . . . . 0.0 110.942 -179.663 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.454 HD11 ' O ' ' A' ' 29' ' ' TYR . 1.9 tp -81.05 100.15 8.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.377 -0.827 . . . . 0.0 109.131 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.577 ' HB ' ' OG1' ' A' ' 55' ' ' THR . 1.0 OUTLIER -89.12 151.05 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.495 -179.716 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.7 -176.66 26.37 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.413 ' OD1' ' O ' ' A' ' 40' ' ' ASN . 12.0 p30 -59.21 143.12 49.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -1.168 . . . . 0.0 109.72 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.433 ' O ' ' CG2' ' A' ' 28' ' ' THR . 0.4 OUTLIER -76.09 53.27 0.78 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.158 -0.964 . . . . 0.0 110.125 -179.908 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 27' ' ' VAL . . . 160.56 131.07 1.18 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.616 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 2.2 t -69.58 -175.28 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.113 -1.228 . . . . 0.0 108.364 178.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.403 ' HA ' HG21 ' A' ' 26' ' ' VAL . 6.1 tp -143.84 98.54 3.25 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.479 178.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.598 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.8 OUTLIER -84.3 112.47 20.34 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.231 178.895 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 t -124.77 145.94 49.47 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.332 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 54.28 32.09 50.9 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.451 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 69.19 40.01 82.42 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 1.5 mt-10 -151.42 128.04 10.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.298 -1.119 . . . . 0.0 110.502 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.598 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 74.8 m95 -81.95 134.36 35.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.25 -0.907 . . . . 0.0 110.107 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 25.9 t -151.29 163.38 39.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.115 -0.991 . . . . 0.0 110.742 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.525 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 2.4 m-20 64.3 65.5 1.1 Allowed Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.633 -0.667 . . . . 0.0 110.944 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.525 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 52.1 Cg_endo -91.77 132.92 1.34 Allowed 'Trans proline' 0 C--N 1.299 -2.053 0 C-N-CA 121.89 1.727 . . . . 0.0 110.173 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.459 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.2 Cg_endo -76.61 172.05 16.92 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.689 1.363 . . . . 0.0 109.488 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.577 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 52.8 p -109.86 148.91 30.67 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.812 -1.18 . . . . 0.0 111.919 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.572 ' O ' ' CD2' ' A' ' 35' ' ' TYR . 86.5 m -111.44 77.62 1.05 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 36' ' ' SER . 1.0 OUTLIER -115.25 -163.72 0.9 Allowed 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.547 0.689 . . . . 0.0 110.502 -178.115 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -107.7 137.62 38.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.376 -0.828 . . . . 0.0 108.888 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.62 HG22 ' CB ' ' A' ' 81' ' ' TYR . 30.2 m -123.08 41.1 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.034 -1.041 . . . . 0.0 111.229 -178.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -75.49 98.63 3.99 Favored 'General case' 0 C--N 1.284 -2.267 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.443 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 107' ' ' ASN . 64.0 m -70.01 161.96 71.93 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.438 -0.789 . . . . 0.0 111.842 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 44.7 Cg_endo -72.57 -88.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.546 1.814 . . . . 0.0 111.008 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.451 ' CD2' ' HE1' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -172.49 132.12 0.68 Allowed Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.527 -0.733 . . . . 0.0 109.225 -179.321 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.612 ' HG3' ' CZ2' ' A' ' 109' ' ' TRP . 58.2 Cg_endo -85.35 69.85 5.3 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 O-C-N 123.398 1.21 . . . . 0.0 109.886 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.582 ' C ' ' CG2' ' A' ' 66' ' ' ILE . 3.2 p -87.19 -40.6 14.44 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.464 1.126 . . . . 0.0 109.999 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.603 HG23 ' CD1' ' A' ' 87' ' ' PHE . 0.1 OUTLIER 52.59 160.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.355 -178.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.479 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 0.5 OUTLIER -58.64 91.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.474 -0.766 . . . . 0.0 111.576 -178.826 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 47.94 60.27 3.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.378 -0.826 . . . . 0.0 111.471 178.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.576 ' O ' ' CG ' ' A' ' 70' ' ' TYR . . . -143.58 -36.98 0.07 OUTLIER Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.17 -1.491 . . . . 0.0 110.226 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.588 ' CE1' ' HB3' ' A' ' 88' ' ' LYS . 40.2 p90 42.44 -175.34 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 122.097 0.951 . . . . 0.0 110.932 -178.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.681 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -122.75 -32.13 3.59 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.694 -178.549 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.581 ' N ' HD21 ' A' ' 71' ' ' LEU . 0.5 OUTLIER 57.09 15.15 2.27 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.635 -1.291 . . . . 0.0 110.78 177.587 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.2 m -119.49 10.02 11.71 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.524 -178.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 133.91 87.38 0.29 Allowed Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.358 -1.401 . . . . 0.0 110.047 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.585 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -127.36 150.82 49.44 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.31 -1.112 . . . . 0.0 109.55 179.429 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.45 ' O ' ' OH ' ' A' ' 79' ' ' TYR . 2.0 tttp -135.39 170.41 15.99 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.423 -0.798 . . . . 0.0 109.723 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 30.0 mtt85 -67.45 -26.08 66.21 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.307 -0.871 . . . . 0.0 109.855 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.94 150.87 36.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 110.481 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.585 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 13.8 m-85 -128.82 -170.62 2.3 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.292 -0.88 . . . . 0.0 110.332 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 1.2 t -169.83 90.33 0.19 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.227 -0.921 . . . . 0.0 110.136 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.62 ' CB ' HG22 ' A' ' 59' ' ' VAL . 6.6 t80 55.72 134.2 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.158 -0.964 . . . . 0.0 110.042 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.557 ' N ' ' O ' ' A' ' 103' ' ' CYS . 22.7 t30 71.66 -129.82 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.822 -1.174 . . . . 0.0 110.578 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.498 ' HB3' ' HB3' ' A' ' 103' ' ' CYS . 5.1 t0 51.62 74.54 0.25 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.653 -1.279 . . . . 0.0 108.921 -178.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 21.3 t-20 -75.69 141.84 42.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.437 -0.79 . . . . 0.0 111.608 -178.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.616 HG21 ' CZ3' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -125.9 146.88 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.4 -0.812 . . . . 0.0 109.679 178.834 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.548 ' O ' ' CA ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -109.57 108.29 18.69 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.027 -1.046 . . . . 0.0 108.95 179.473 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.681 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 35.5 m-85 -66.84 134.93 53.09 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.382 1.087 . . . . 0.0 113.715 -177.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.588 ' HB3' ' CE1' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -123.3 84.37 2.26 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.664 -179.816 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.484 ' C ' ' O ' ' A' ' 88' ' ' LYS . 0.1 OUTLIER -32.75 133.7 0.12 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.762 -0.586 . . . . 0.0 111.489 -179.518 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -40.51 -87.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.496 -0.753 . . . . 0.0 110.331 179.584 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -161.94 143.37 10.98 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.173 -0.955 . . . . 0.0 110.03 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.572 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 59.05 24.95 59.07 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.572 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 18.1 m-85 -138.99 144.56 38.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.566 -0.961 . . . . 0.0 109.901 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.468 ' O ' HG21 ' A' ' 117' ' ' VAL . 9.6 ttpt -105.36 153.65 21.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.261 -0.899 . . . . 0.0 109.493 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.589 ' CD2' ' CD1' ' A' ' 66' ' ' ILE . 3.4 mt -88.57 114.14 24.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.708 -1.245 . . . . 0.0 110.445 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.454 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 1.3 t -89.21 97.48 11.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.334 -0.854 . . . . 0.0 109.721 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.26 -111.38 0.64 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.59 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 5.7 t -129.51 127.22 40.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.27 -1.135 . . . . 0.0 110.557 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.429 ' O ' ' CD2' ' A' ' 87' ' ' PHE . 0.8 OUTLIER -74.07 -44.38 54.33 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.388 -0.82 . . . . 0.0 110.37 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.2 p -101.21 123.39 45.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.122 -0.986 . . . . 0.0 110.154 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.485 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 57.9 m -129.99 -168.14 1.92 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 110.298 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 14.6 m -162.72 134.14 5.08 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.252 -0.979 . . . . 0.0 111.134 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.603 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 1.6 t -57.41 95.42 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.677 -0.64 . . . . 0.0 109.48 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.12 173.94 6.77 Favored Pre-proline 0 C--N 1.299 -1.587 0 O-C-N 120.974 -1.079 . . . . 0.0 110.789 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.551 ' CG ' HG22 ' A' ' 38' ' ' ILE . 43.9 Cg_endo -76.26 132.16 13.53 Favored 'Trans proline' 0 C--N 1.299 -2.051 0 O-C-N 124.467 1.772 . . . . 0.0 110.703 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.548 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 121.69 -4.04 10.9 Favored Glycine 0 N--CA 1.482 1.748 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 8.2 m-80 80.25 81.28 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.91 -0.759 . . . . 0.0 110.499 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.515 ' CG2' ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 177.48 -177.26 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.222 -0.924 . . . . 0.0 111.467 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.616 ' CZ3' HG21 ' A' ' 85' ' ' VAL . 44.6 m95 -124.54 101.77 7.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.624 -0.673 . . . . 0.0 110.515 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.471 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 4.6 mttt -102.59 148.91 36.19 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.25 -0.906 . . . . 0.0 109.871 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.59 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 52.3 Cg_endo -73.28 -175.19 14.18 Favored 'Cis proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.144 -2.023 . . . . 0.0 111.007 -0.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.7 mt-10 -38.37 123.84 1.21 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.339 0.59 . . . . 0.0 110.437 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.586 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 2.9 tp -53.9 143.11 42.72 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 110.448 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.574 ' HG3' ' CD2' ' A' ' 87' ' ' PHE . 41.2 Cg_endo -72.1 155.66 56.6 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.024 1.539 . . . . 0.0 110.594 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.492 ' O ' HG23 ' A' ' 117' ' ' VAL . 0.4 OUTLIER -120.91 110.87 16.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.327 -0.858 . . . . 0.0 110.508 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.521 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.3 t -60.48 96.91 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.186 -0.946 . . . . 0.0 109.342 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -107.04 -175.35 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 121.798 0.809 . . . . 0.0 111.019 -179.447 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.296 -1.735 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.176 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 62.7 t . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.192 0.52 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.54 149.82 52.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.194 -0.941 . . . . 0.0 110.275 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.514 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.6 m -80.64 138.74 36.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.422 -0.799 . . . . 0.0 110.611 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.446 ' O ' ' C ' ' A' ' 5' ' ' SER . 21.0 mt-30 -119.5 174.28 6.48 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.439 -0.788 . . . . 0.0 109.286 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 19' ' ' ASP . 1.1 p -42.64 133.76 2.83 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 0.0 109.776 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.624 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 51.7 Cg_endo -70.2 155.76 63.76 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.944 1.497 . . . . 0.0 111.357 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -76.73 170.67 19.43 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.041 1.548 . . . . 0.0 110.04 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.13 176.2 4.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.168 -0.958 . . . . 0.0 109.689 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.562 HG12 ' CD2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -142.52 -170.32 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 122.178 0.99 . . . . 0.0 111.81 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 13.2 t -37.69 94.37 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.204 -179.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 9' ' ' ILE . 11.8 m-20 42.9 25.45 0.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.068 -1.02 . . . . 0.0 110.648 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -121.01 -166.56 13.03 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.528 ' HG3' ' CB ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -151.71 178.8 8.99 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.193 -1.181 . . . . 0.0 110.145 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.624 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 9.2 p80 -135.6 141.33 45.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.403 -0.811 . . . . 0.0 110.462 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -171.22 65.54 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.895 . . . . 0.0 110.267 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.41 ' O ' ' CD2' ' A' ' 17' ' ' TYR . . . -60.23 -81.59 0.08 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -177.38 29.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -1.156 . . . . 0.0 110.298 179.876 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -165.59 -165.92 0.9 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.921 . . . . 0.0 110.212 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 20' ' ' PHE . 25.1 p-10 -123.27 -41.82 2.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.896 . . . . 0.0 109.947 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.506 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 2.0 m-85 -96.14 149.74 21.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.387 -0.821 . . . . 0.0 110.338 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.668 ' CD2' ' HB3' ' A' ' 25' ' ' SER . 1.6 m-85 -130.91 -2.41 4.1 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.217 -0.927 . . . . 0.0 110.833 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.514 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 15.6 p 42.8 -99.3 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.353 -0.842 . . . . 0.0 111.264 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.497 ' OD1' ' HA ' ' A' ' 46' ' ' SER . 3.6 t0 -156.82 137.53 13.26 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.059 -1.026 . . . . 0.0 110.179 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 86.87 23.75 40.75 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.668 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 58.2 m -116.61 154.41 30.55 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -1.079 . . . . 0.0 109.563 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.56 ' CG1' ' O ' ' A' ' 43' ' ' VAL . 38.1 t -126.1 149.33 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.884 -1.135 . . . . 0.0 112.556 -177.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.593 HG21 ' CE2' ' A' ' 21' ' ' TYR . 45.8 t -121.44 120.77 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.587 -0.696 . . . . 0.0 111.32 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.472 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -73.81 103.12 4.24 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 177.443 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.649 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 2.0 m-30 -67.63 121.11 15.18 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.244 -177.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.528 ' CB ' ' HG3' ' A' ' 13' ' ' ARG . 2.3 m -70.81 -163.89 0.08 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.979 -1.075 . . . . 0.0 108.966 179.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.461 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 5.5 t -164.38 160.47 20.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.896 -1.127 . . . . 0.0 110.702 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 34' ' ' GLY . 9.7 t-20 -55.56 144.3 26.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.343 -0.848 . . . . 0.0 109.679 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.54 79.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.255 -0.903 . . . . 0.0 110.428 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 32' ' ' ASN . . . 153.7 -28.9 0.75 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.427 ' CD1' ' O ' ' A' ' 56' ' ' CYS . 6.4 m-85 -87.25 134.97 33.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.155 -1.203 . . . . 0.0 110.184 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.61 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 1.2 t -80.28 142.49 34.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.278 -0.889 . . . . 0.0 110.527 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.559 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 2.1 tp -93.81 111.18 22.83 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.375 -0.828 . . . . 0.0 109.21 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.584 ' CG2' ' CG ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -103.53 156.9 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.137 -0.977 . . . . 0.0 109.62 -179.661 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.23 -146.53 16.48 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.535 ' O ' ' C ' ' A' ' 41' ' ' SER . 0.7 OUTLIER -106.16 54.97 0.68 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.107 -1.231 . . . . 0.0 110.021 179.829 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.535 ' C ' ' O ' ' A' ' 40' ' ' ASN . 7.3 p 14.44 56.62 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.167 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 40' ' ' ASN . . . 155.58 118.83 0.63 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.649 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 1.9 t -70.42 -178.77 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.084 -1.244 . . . . 0.0 108.005 178.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.2 tp -144.15 97.52 3.06 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.715 -1.241 . . . . 0.0 110.531 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.583 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.9 OUTLIER -83.92 111.98 19.74 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.304 178.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.497 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 0.4 OUTLIER -123.2 93.22 3.88 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.299 -179.681 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.28 61.52 1.64 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 49.55 27.06 8.08 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -136.47 108.85 7.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.207 -1.172 . . . . 0.0 110.442 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.583 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 70.8 m95 -74.76 135.29 41.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 109.711 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -144.14 157.62 44.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.085 -1.009 . . . . 0.0 111.092 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.541 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 4.4 t70 63.56 64.41 1.38 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.691 -0.631 . . . . 0.0 110.965 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 53.3 Cg_endo -92.14 133.44 1.28 Allowed 'Trans proline' 0 C--N 1.298 -2.098 0 O-C-N 124.406 1.74 . . . . 0.0 109.674 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.534 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 49.4 Cg_endo -75.93 176.81 9.54 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 O-C-N 123.688 1.362 . . . . 0.0 109.819 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.499 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 6.7 p -111.09 -175.75 2.78 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.995 0.902 . . . . 0.0 111.271 -178.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 10' ' ' SER . 0.8 OUTLIER -144.64 75.08 1.44 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.109 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.522 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.3 OUTLIER -112.85 -158.86 0.66 Allowed 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.913 -178.908 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.463 HG21 ' HE3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -113.78 130.42 67.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 108.603 179.415 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.61 ' CG1' ' CB ' ' A' ' 36' ' ' SER . 19.2 m -118.49 46.43 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.994 -1.067 . . . . 0.0 112.067 -178.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 1.6 mttt -58.13 -175.11 0.02 OUTLIER 'General case' 0 C--N 1.281 -2.384 0 C-N-CA 117.763 -1.575 . . . . 0.0 107.541 178.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.523 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 1.2 m -141.54 167.38 17.21 Favored Pre-proline 0 C--N 1.293 -1.857 0 C-N-CA 117.811 -1.555 . . . . 0.0 113.814 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.553 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 48.9 Cg_endo -90.08 -69.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 125.026 2.066 . . . . 0.0 110.368 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.553 ' CD2' ' O ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER 165.4 124.24 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.299 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.623 ' HB3' ' CE2' ' A' ' 109' ' ' TRP . 45.9 Cg_endo -76.47 80.22 2.8 Favored 'Trans proline' 0 C--N 1.301 -1.953 0 O-C-N 123.467 1.246 . . . . 0.0 109.329 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.433 ' C ' HG23 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -102.91 173.79 6.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.872 . . . . 0.0 109.791 -179.33 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.571 ' CG2' ' HA ' ' A' ' 70' ' ' TYR . 0.2 OUTLIER -169.99 166.35 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.334 -0.947 . . . . 0.0 110.305 179.558 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.472 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 16.4 t -75.73 107.04 7.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.488 -0.757 . . . . 0.0 110.652 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.529 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 3.3 m-80 38.89 55.87 2.0 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.567 -0.708 . . . . 0.0 110.643 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -168.66 32.04 0.18 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.571 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 16.9 p90 -45.25 -174.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 123.463 1.601 . . . . 0.0 112.862 -179.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 2.8 pp -100.89 126.79 47.54 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 113.308 -1.769 . . . . 0.0 109.887 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.483 ' HB3' ' HB2' ' A' ' 88' ' ' LYS . 0.2 OUTLIER -96.35 2.48 52.78 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.28 -0.888 . . . . 0.0 109.515 179.767 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.7 t -73.09 -73.91 0.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.38 -0.825 . . . . 0.0 110.572 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.9 97.62 0.12 Allowed Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.626 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.582 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -94.17 145.13 24.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.358 -1.083 . . . . 0.0 109.18 179.053 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.486 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -132.38 160.72 35.53 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.158 -0.964 . . . . 0.0 110.242 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -52.45 -33.99 46.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.225 -0.922 . . . . 0.0 110.394 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.406 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -142.02 165.62 26.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.333 -0.855 . . . . 0.0 110.361 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.582 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 22.3 m-85 -138.06 -138.63 0.14 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.373 -0.83 . . . . 0.0 109.956 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 21.2 p -170.05 -132.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 0.0 109.629 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.646 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 1.6 t80 -101.87 38.23 1.68 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.002 -1.061 . . . . 0.0 109.459 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.571 ' N ' ' O ' ' A' ' 103' ' ' CYS . 9.4 p30 -169.36 -114.37 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.73 -1.231 . . . . 0.0 110.498 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 82' ' ' ASN . 81.5 m-20 44.83 77.19 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.78 -1.2 . . . . 0.0 109.374 -179.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.55 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 5.6 p-10 -75.11 113.5 12.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.285 -0.885 . . . . 0.0 110.93 -178.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.602 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 15.7 m -101.56 120.86 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.773 -1.204 . . . . 0.0 110.364 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.539 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 25.8 t0 -76.65 126.3 30.75 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.169 -0.957 . . . . 0.0 109.161 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.611 ' CE2' HD11 ' A' ' 113' ' ' LEU . 23.4 m-85 -86.97 126.02 34.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.052 -1.03 . . . . 0.0 111.357 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -104.31 110.94 23.37 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.53 -179.377 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.441 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -58.56 133.11 55.55 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.038 -1.039 . . . . 0.0 109.551 179.314 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -42.63 -67.49 0.27 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.12 -179.644 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.521 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.3 OUTLIER -176.66 137.16 0.26 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.413 -0.804 . . . . 0.0 110.345 179.935 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.597 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 54.03 58.22 13.55 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.597 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 12.7 m-85 -162.21 155.84 20.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.534 -0.98 . . . . 0.0 109.819 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.467 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -110.2 124.18 51.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.142 -0.973 . . . . 0.0 110.323 -179.856 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.515 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 1.7 mt -63.7 87.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.373 -0.83 . . . . 0.0 110.033 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.476 ' HB3' HG23 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -69.47 104.81 2.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 110.07 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 141.58 -81.53 0.24 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.56 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -169.72 124.73 0.81 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.257 -1.143 . . . . 0.0 110.534 -179.827 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 73.8 p -68.56 -72.19 0.19 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.349 -0.845 . . . . 0.0 110.867 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 58.6 p -78.19 118.33 20.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.153 -0.967 . . . . 0.0 110.329 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 85' ' ' VAL . 59.9 m -125.25 158.47 34.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.55 -0.719 . . . . 0.0 110.611 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -135.08 142.26 46.25 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.395 179.694 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.585 ' SG ' ' CZ2' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -67.9 105.41 1.98 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.614 -0.679 . . . . 0.0 110.278 -179.769 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.532 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -76.88 -175.15 0.47 Allowed Pre-proline 0 C--N 1.295 -1.779 0 O-C-N 121.231 -0.918 . . . . 0.0 111.315 -179.411 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.603 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 41.4 Cg_endo -87.78 126.42 2.14 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 124.4 1.737 . . . . 0.0 110.597 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 117.53 2.86 17.15 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.649 ' O ' ' CG2' ' A' ' 108' ' ' THR . 0.0 OUTLIER 79.16 105.61 0.07 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.649 -0.912 . . . . 0.0 110.426 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.649 ' CG2' ' O ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER 166.03 -163.39 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.867 0.841 . . . . 0.0 111.271 179.443 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.623 ' CE2' ' HB3' ' A' ' 64' ' ' PRO . 32.8 m95 -144.91 88.02 1.87 Allowed 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.698 0.761 . . . . 0.0 109.651 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.504 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 14.4 mmmt -98.54 137.08 20.62 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.764 -0.585 . . . . 0.0 110.186 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.56 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 42.8 Cg_endo -69.69 166.25 74.34 Favored 'Cis proline' 0 N--CA 1.49 1.298 0 C-N-CA 122.056 -2.06 . . . . 0.0 110.983 -0.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -38.52 153.23 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.578 -0.702 . . . . 0.0 111.081 -179.168 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.611 HD11 ' CE2' ' A' ' 87' ' ' PHE . 1.2 mm? -64.68 141.61 98.32 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.43 -0.793 . . . . 0.0 109.716 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.59 ' CD ' ' CD2' ' A' ' 87' ' ' PHE . 42.5 Cg_endo -72.1 165.12 33.56 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 O-C-N 124.189 1.626 . . . . 0.0 110.548 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -129.28 107.44 9.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.339 -0.851 . . . . 0.0 109.918 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 68' ' ' ASN . 3.0 t -61.17 83.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.276 -0.89 . . . . 0.0 109.466 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 115' ' ' LYS . 3.3 m -101.86 -169.68 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-O 121.945 0.879 . . . . 0.0 110.89 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.47 ' HG2' ' CE1' ' A' ' 93' ' ' TYR . 6.7 mtm-85 . . . . . 0 C--N 1.291 -1.953 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.211 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.504 HG21 ' N ' ' A' ' 2' ' ' LYS . 5.8 p . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.27 0.557 . . . . 0.0 110.241 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.504 ' N ' HG21 ' A' ' 1' ' ' VAL . 3.1 mtpp -119.78 174.73 6.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.412 -179.722 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.553 ' O ' ' N ' ' A' ' 21' ' ' TYR . 1.1 m -113.54 89.75 3.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.35 -0.844 . . . . 0.0 110.56 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.41 ' O ' ' C ' ' A' ' 5' ' ' SER . 18.7 mt-30 -69.68 172.11 7.99 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.021 -1.05 . . . . 0.0 109.844 179.6 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 19' ' ' ASP . 1.1 p -42.12 141.95 1.28 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 110.138 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.61 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 51.1 Cg_endo -71.8 154.89 58.8 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.029 1.542 . . . . 0.0 111.019 -179.494 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -74.74 172.48 16.17 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.868 1.457 . . . . 0.0 110.005 179.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.7 p -70.98 174.91 5.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.107 -0.996 . . . . 0.0 110.017 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.569 HG22 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -142.8 -170.3 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 122.156 0.979 . . . . 0.0 111.543 179.719 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.523 ' O ' ' CB ' ' A' ' 56' ' ' CYS . 1.2 m -43.54 90.83 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.673 -179.302 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.8 OUTLIER 43.7 53.08 6.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.114 -0.991 . . . . 0.0 110.581 179.827 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.31 147.22 16.15 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.483 ' O ' ' N ' ' A' ' 30' ' ' SER . 1.3 mtp180 -92.98 -167.99 1.85 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.246 -1.149 . . . . 0.0 110.647 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.61 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 17.6 p80 -156.33 -159.19 0.86 Allowed 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.283 0.564 . . . . 0.0 110.543 -179.501 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 13.5 t-20 72.89 141.36 0.06 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.514 -0.741 . . . . 0.0 110.572 179.625 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.54 -57.92 0.19 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -163.63 29.27 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -1.134 . . . . 0.0 110.111 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.72 -178.26 7.19 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.194 -0.941 . . . . 0.0 110.444 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 5' ' ' SER . 24.0 m-20 -124.06 -44.15 2.06 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.417 -0.802 . . . . 0.0 109.976 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -94.92 139.94 30.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 109.94 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.6 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.3 OUTLIER -128.43 -4.67 5.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.254 -0.904 . . . . 0.0 110.625 -179.633 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.517 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 32.2 p 45.86 -97.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.92 . . . . 0.0 111.91 179.768 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.524 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -153.2 158.57 41.93 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.91 -1.119 . . . . 0.0 110.594 -178.51 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.53 25.65 75.36 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 179.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.6 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -114.43 171.21 7.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.416 -1.049 . . . . 0.0 110.2 -179.763 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 40.6 t -143.08 153.93 16.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.518 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.579 HG13 ' CD1' ' A' ' 29' ' ' TYR . 18.8 t -132.86 123.7 49.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.62 -179.262 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -76.31 103.04 6.13 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.937 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.618 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 2.4 m-30 -68.12 127.27 32.29 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.412 -0.805 . . . . 0.0 110.349 -178.13 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -71.53 158.21 36.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.561 179.451 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.451 ' SG ' HD11 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -133.6 156.82 47.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.113 -0.992 . . . . 0.0 110.337 -179.808 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.36 129.24 37.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.269 -0.894 . . . . 0.0 110.067 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 t -46.57 122.71 4.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 0.0 110.592 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.25 -40.85 1.89 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.423 ' CE1' HG13 ' A' ' 58' ' ' ILE . 7.9 m-85 -90.86 155.45 18.75 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -1.155 . . . . 0.0 110.786 -179.504 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.62 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -91.45 141.45 28.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.404 -0.81 . . . . 0.0 110.205 179.541 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.502 ' HA ' ' O ' ' A' ' 55' ' ' THR . 0.6 OUTLIER -92.9 97.4 10.72 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.275 -0.89 . . . . 0.0 109.531 179.207 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.556 ' CD1' ' N ' ' A' ' 38' ' ' ILE . 0.5 OUTLIER -85.81 142.79 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.421 -0.799 . . . . 0.0 108.985 179.847 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.57 -154.11 21.94 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 42' ' ' GLY . 15.6 p-10 -110.73 51.86 0.75 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.168 -1.195 . . . . 0.0 110.541 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.502 ' C ' ' O ' ' A' ' 40' ' ' ASN . 75.4 p 28.0 38.6 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.904 179.657 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 40' ' ' ASN . . . 169.09 125.99 0.82 Allowed Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.452 -1.356 . . . . 0.0 110.125 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.618 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 2.0 t -71.94 -178.1 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -1.113 . . . . 0.0 108.092 179.026 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 25' ' ' SER . 2.5 tp -144.59 99.48 3.36 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.251 -0.979 . . . . 0.0 110.225 179.05 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.587 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -87.15 110.17 19.95 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.055 -1.058 . . . . 0.0 109.438 178.686 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.7 p -128.64 123.19 32.59 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.032 -179.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.524 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 76.24 35.85 41.76 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.876 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.19 40.88 97.05 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 1.8 mt-10 -157.95 128.94 6.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.379 -1.071 . . . . 0.0 110.292 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.587 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 84.2 m95 -82.46 138.53 34.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.792 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -143.73 157.89 44.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.163 -0.961 . . . . 0.0 111.011 -179.574 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.507 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER 63.2 65.46 1.31 Allowed Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.631 -0.668 . . . . 0.0 111.0 179.606 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.507 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.5 Cg_endo -90.64 140.95 3.12 Favored 'Trans proline' 0 C--N 1.301 -1.967 0 C-N-CA 121.851 1.701 . . . . 0.0 109.972 179.158 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.52 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 46.9 Cg_endo -78.71 175.56 10.87 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.729 1.383 . . . . 0.0 110.233 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.528 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 11.1 p -124.38 158.82 31.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.207 -0.933 . . . . 0.0 111.438 -178.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.523 ' CB ' ' O ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -116.06 78.37 1.18 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.177 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.455 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -117.2 -158.51 0.7 Allowed 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.875 -178.922 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.484 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -116.06 142.71 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.92 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.64 ' CG1' ' HA ' ' A' ' 105' ' ' PRO . 12.7 m -127.88 43.05 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.825 -1.172 . . . . 0.0 111.559 -178.663 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -80.91 95.23 6.68 Favored 'General case' 0 C--N 1.281 -2.384 0 C-N-CA 119.071 -1.052 . . . . 0.0 108.593 179.014 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.467 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 32.3 m -69.28 162.33 66.81 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.356 -0.84 . . . . 0.0 111.153 -178.481 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 49.6 Cg_endo -72.97 -92.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 124.471 1.774 . . . . 0.0 110.349 -179.521 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.465 ' C ' ' CD1' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -155.82 137.45 9.65 Favored Pre-proline 0 C--N 1.299 -1.611 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.62 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.632 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 52.2 Cg_endo -77.82 62.61 7.91 Favored 'Trans proline' 0 C--N 1.294 -2.336 0 O-C-N 123.525 1.277 . . . . 0.0 109.072 -179.161 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.469 ' O ' HD22 ' A' ' 113' ' ' LEU . 0.8 OUTLIER -75.66 166.82 22.98 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.098 -179.634 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.587 ' CD1' ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -165.87 164.74 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 C-N-CA 118.75 -1.18 . . . . 0.0 110.716 179.81 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.432 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -71.06 95.49 1.21 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.483 -0.761 . . . . 0.0 110.482 -179.534 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.452 ' O ' ' SG ' ' A' ' 116' ' ' CYS . 3.8 m-20 45.67 51.41 10.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 110.593 179.572 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.555 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -162.12 38.9 0.38 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.771 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.557 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 50.2 p90 -49.54 -152.53 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.898 1.333 . . . . 0.0 112.958 -179.393 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.572 HD21 ' CZ ' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -141.07 120.56 13.2 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.031 -176.383 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.2 t -100.78 17.9 20.82 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.615 -0.678 . . . . 0.0 109.414 -179.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.9 t -77.98 -79.2 0.12 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.582 -0.699 . . . . 0.0 111.255 -179.166 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.49 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -122.76 -66.16 0.22 Allowed Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.632 -178.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.565 ' HB2' ' CD1' ' A' ' 71' ' ' LEU . 52.1 t80 58.71 167.0 0.05 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.571 -0.958 . . . . 0.0 110.255 -179.144 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.583 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 17.7 tttm -178.14 145.3 0.36 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.408 -0.807 . . . . 0.0 109.748 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -41.79 -32.43 0.4 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.17 -0.956 . . . . 0.0 110.244 -179.824 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.9 m -147.33 166.97 25.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.481 -0.762 . . . . 0.0 110.297 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.583 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 8.7 m-85 -140.5 -172.15 3.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.244 -0.91 . . . . 0.0 110.031 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.553 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 6.6 t -170.24 109.63 0.38 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.935 -1.103 . . . . 0.0 111.161 179.734 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.617 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 14.1 t80 32.75 32.64 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.307 -0.871 . . . . 0.0 111.663 179.164 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.545 ' N ' ' O ' ' A' ' 103' ' ' CYS . 49.9 t30 -176.63 -134.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.642 -1.286 . . . . 0.0 110.522 179.342 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 50.65 69.66 0.61 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.056 -1.027 . . . . 0.0 109.019 -178.695 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.554 ' N ' HG21 ' A' ' 102' ' ' THR . 16.2 p30 -69.75 131.88 45.24 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.486 -0.759 . . . . 0.0 110.09 -179.204 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.591 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 16.2 m -119.27 122.25 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.054 -1.029 . . . . 0.0 111.018 -179.723 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -79.73 138.76 37.4 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.481 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.572 ' CZ ' HD21 ' A' ' 71' ' ' LEU . 72.5 m-85 -93.59 146.6 23.69 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.918 -1.114 . . . . 0.0 112.215 -178.07 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -118.82 89.93 3.23 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.65 -179.765 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.447 ' HB2' HD13 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -42.08 131.16 3.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 0.0 110.249 -179.653 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 89' ' ' CYS . 0.1 OUTLIER -38.99 -66.06 0.31 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.527 -0.733 . . . . 0.0 110.624 -179.535 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.585 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER 176.69 141.74 0.07 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.401 -0.812 . . . . 0.0 110.025 179.978 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.583 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 53.35 46.2 64.36 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.946 -1.661 . . . . 0.0 108.946 -179.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.585 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 16.3 m-85 -155.59 152.13 28.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.556 -0.967 . . . . 0.0 109.64 -179.48 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.498 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -112.63 128.18 56.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 110.191 -179.998 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.485 HD22 ' HB2' ' A' ' 114' ' ' PRO . 0.7 OUTLIER -64.39 97.05 0.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -0.91 . . . . 0.0 110.422 -179.879 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.442 ' HB3' HG23 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -78.67 101.1 7.32 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.315 -0.866 . . . . 0.0 109.54 179.469 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.22 -85.37 0.18 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.553 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 2.4 m -158.41 111.69 2.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.329 -1.101 . . . . 0.0 110.641 -179.353 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.8 t -71.65 -5.56 34.57 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.246 -0.909 . . . . 0.0 110.666 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.3 p -138.46 120.02 15.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.115 -0.99 . . . . 0.0 110.185 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 20.9 m -133.65 172.11 13.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.347 -0.845 . . . . 0.0 110.745 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.554 HG21 ' N ' ' A' ' 84' ' ' ASN . 17.1 m -147.51 136.24 21.96 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.385 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.575 ' O ' ' CA ' ' A' ' 81' ' ' TYR . 4.8 t -48.95 96.2 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.145 179.577 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.478 ' CB ' ' HG3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -64.63 174.22 1.32 Allowed Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.082 -1.011 . . . . 0.0 111.902 -178.935 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.64 ' HA ' ' CG1' ' A' ' 59' ' ' VAL . 49.7 Cg_endo -82.04 16.47 1.74 Allowed 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 124.613 1.849 . . . . 0.0 111.559 -178.585 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -119.53 25.81 7.54 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 179.307 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 58' ' ' ILE . 1.9 m-80 61.24 51.63 4.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.746 -0.855 . . . . 0.0 109.932 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.457 ' O ' ' SG ' ' A' ' 61' ' ' CYS . 0.5 OUTLIER -161.91 -176.72 5.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 0.0 110.977 -179.849 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.632 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 51.0 m95 -109.06 102.03 11.05 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.483 -0.76 . . . . 0.0 110.553 -179.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.478 ' HG3' ' CB ' ' A' ' 104' ' ' SER . 0.3 OUTLIER -107.06 140.53 21.5 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.45 -0.781 . . . . 0.0 110.209 -179.746 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.553 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.1 Cg_endo -73.18 172.44 60.46 Favored 'Cis proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.964 -2.098 . . . . 0.0 110.363 -0.355 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.9 OUTLIER -40.25 137.07 1.1 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.393 -0.817 . . . . 0.0 110.966 -179.278 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.529 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -47.83 146.57 3.86 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.448 -0.782 . . . . 0.0 110.162 179.547 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.587 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 39.3 Cg_endo -72.9 167.68 26.67 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 124.38 1.726 . . . . 0.0 111.063 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.49 ' O ' HG23 ' A' ' 117' ' ' VAL . 3.3 ttpt -127.32 109.68 12.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.386 -0.821 . . . . 0.0 110.801 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.531 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.9 t -66.35 90.16 0.15 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.1 -1.0 . . . . 0.0 109.172 179.225 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.498 ' CG2' ' O ' ' A' ' 94' ' ' LYS . 1.7 m -105.69 -176.26 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 121.73 0.776 . . . . 0.0 110.925 -179.386 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.476 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.762 0 C-N-CA 118.927 -1.109 . . . . 0.0 110.616 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.436 ' H3 ' HG22 ' A' ' 1' ' ' VAL . 16.6 m . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.101 0.477 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.42 166.58 20.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.132 -0.98 . . . . 0.0 110.471 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.506 ' N ' ' O ' ' A' ' 21' ' ' TYR . 0.9 OUTLIER -135.23 83.63 2.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.418 -0.801 . . . . 0.0 109.805 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -54.84 172.27 0.11 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.05 -1.031 . . . . 0.0 110.229 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 p -52.45 144.02 25.13 Favored Pre-proline 0 C--N 1.301 -1.525 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.071 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.654 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 54.6 Cg_endo -72.35 151.88 54.54 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 123.798 1.42 . . . . 0.0 110.644 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.64 171.49 18.11 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 O-C-N 123.884 1.465 . . . . 0.0 109.722 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.04 177.82 2.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.069 -1.02 . . . . 0.0 109.675 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.615 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -140.93 -170.47 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 122.155 0.979 . . . . 0.0 111.543 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 48.4 t -37.87 95.66 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.998 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.5 OUTLIER 42.33 27.24 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.304 -0.873 . . . . 0.0 110.41 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -126.93 -176.34 14.44 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.53 ' HG3' ' CB ' ' A' ' 30' ' ' SER . 0.5 OUTLIER -138.24 177.64 7.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.258 -1.142 . . . . 0.0 110.578 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.654 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 10.8 p80 -130.19 132.76 46.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.504 -0.748 . . . . 0.0 110.209 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -154.11 80.04 1.12 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.203 -0.936 . . . . 0.0 110.568 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.99 -117.36 0.24 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.97 27.02 1.83 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -1.156 . . . . 0.0 110.392 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.621 ' CG ' ' CZ ' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -163.37 -179.29 6.44 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.18 -0.95 . . . . 0.0 109.998 179.593 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -135.23 19.25 3.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -0.95 . . . . 0.0 110.302 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.05 49.31 0.85 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 110.433 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.621 ' CZ ' ' CG ' ' A' ' 18' ' ' GLU . 13.1 m-85 -50.42 165.69 0.09 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.066 -1.021 . . . . 0.0 109.443 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.503 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 10.1 p -131.78 -70.25 0.58 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.016 -1.053 . . . . 0.0 110.837 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.423 ' OD1' ' HA ' ' A' ' 46' ' ' SER . 4.9 t0 -159.56 137.46 10.15 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.332 -0.855 . . . . 0.0 109.663 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 79.35 13.92 82.15 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.614 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -96.65 171.81 8.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.518 -0.99 . . . . 0.0 109.828 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.834 HG13 ' O ' ' A' ' 43' ' ' VAL . 39.5 t -146.76 154.91 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.121 -0.987 . . . . 0.0 110.796 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.642 ' O ' HG23 ' A' ' 43' ' ' VAL . 20.9 t -133.19 117.09 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.613 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.683 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -72.43 102.5 3.2 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 118.45 -1.3 . . . . 0.0 108.032 177.98 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.663 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.3 m-30 -68.04 174.5 3.76 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.422 -0.799 . . . . 0.0 109.959 -178.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.53 ' CB ' ' HG3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -135.36 148.17 49.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.913 . . . . 0.0 109.606 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.404 ' O ' ' C ' ' A' ' 32' ' ' ASN . 57.7 m -118.62 147.95 43.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.168 -0.958 . . . . 0.0 110.311 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 31' ' ' CYS . 1.8 t-20 -44.27 150.95 0.27 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.217 -0.927 . . . . 0.0 109.944 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 88.2 p -55.35 99.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 0.0 110.31 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 134.68 -20.09 3.92 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -98.76 131.59 44.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.252 -1.146 . . . . 0.0 110.288 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.721 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -79.57 144.24 34.05 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.336 -0.852 . . . . 0.0 111.123 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.625 HD21 ' HA ' ' A' ' 41' ' ' SER . 0.6 OUTLIER -91.99 102.09 14.64 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.475 -0.766 . . . . 0.0 109.205 178.666 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.79 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -90.9 142.68 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.077 -1.015 . . . . 0.0 109.734 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 132.35 -158.94 23.2 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.493 ' O ' ' C ' ' A' ' 41' ' ' SER . 0.3 OUTLIER -98.31 49.34 0.99 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.842 -1.387 . . . . 0.0 109.65 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.683 ' O ' HG23 ' A' ' 28' ' ' THR . 0.4 OUTLIER 27.89 57.29 0.1 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.331 179.654 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.581 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 155.63 117.23 0.57 Allowed Glycine 0 N--CA 1.488 2.166 0 C-N-CA 119.465 -1.35 . . . . 0.0 110.023 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.834 ' O ' HG13 ' A' ' 26' ' ' VAL . 2.0 t -62.71 -178.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.991 -1.3 . . . . 0.0 108.013 178.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.555 ' H ' HG12 ' A' ' 43' ' ' VAL . 4.3 tp -144.45 95.11 2.66 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.014 -1.074 . . . . 0.0 110.508 178.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.574 ' SG ' ' CD2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -80.92 110.3 16.31 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.379 178.942 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.423 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 8.0 t -126.57 111.04 13.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.592 -0.692 . . . . 0.0 110.643 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.07 22.5 38.17 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.454 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 81.01 19.86 66.43 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -140.64 113.64 8.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.099 -1.236 . . . . 0.0 110.526 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.574 ' CD2' ' SG ' ' A' ' 45' ' ' CYS . 87.8 m95 -62.58 138.11 58.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.317 -0.864 . . . . 0.0 109.73 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 52' ' ' ASP . 3.5 m -141.84 171.61 13.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.102 -0.999 . . . . 0.0 111.417 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.465 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER 37.29 67.65 1.82 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.912 -0.493 . . . . 0.0 111.593 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.465 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.0 Cg_endo -90.66 144.03 3.65 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 O-C-N 124.327 1.698 . . . . 0.0 109.592 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.518 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 45.9 Cg_endo -74.68 171.26 18.55 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.618 1.325 . . . . 0.0 110.35 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.582 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 15.7 p -114.18 169.16 9.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.163 -0.961 . . . . 0.0 111.468 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 10' ' ' SER . 37.8 m -126.73 79.32 1.86 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -114.82 -170.8 1.81 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 120.161 -0.615 . . . . 0.0 110.135 -178.746 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.606 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -107.92 112.87 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.192 -0.943 . . . . 0.0 108.504 179.221 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.84 HG23 ' O ' ' A' ' 59' ' ' VAL . 6.0 m -95.92 83.14 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.051 -1.031 . . . . 0.0 111.612 -178.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.2 mtmt -120.31 96.36 5.11 Favored 'General case' 0 C--N 1.289 -2.059 0 O-C-N 120.417 -1.427 . . . . 0.0 108.657 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 79' ' ' TYR . 4.5 p -68.06 162.52 59.03 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.412 -0.805 . . . . 0.0 111.659 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.515 ' HD2' ' HA ' ' A' ' 108' ' ' THR . 42.9 Cg_endo -70.47 -89.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.832 0 O-C-N 124.696 1.892 . . . . 0.0 110.286 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.421 ' O ' HG23 ' A' ' 65' ' ' THR . 0.2 OUTLIER -160.51 130.54 3.45 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.612 ' HG3' HG11 ' A' ' 85' ' ' VAL . 50.9 Cg_endo -77.32 70.85 6.61 Favored 'Trans proline' 0 C--N 1.294 -2.322 0 O-C-N 123.787 1.414 . . . . 0.0 109.818 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.669 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.5 OUTLIER -93.45 -175.78 3.91 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.121 -0.987 . . . . 0.0 109.512 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.669 HG22 ' C ' ' A' ' 65' ' ' THR . 0.4 OUTLIER 177.88 167.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.059 -1.026 . . . . 0.0 110.573 178.839 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.552 ' O ' ' CB ' ' A' ' 68' ' ' ASN . 2.9 m -64.19 73.15 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.568 -0.708 . . . . 0.0 111.323 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 67' ' ' SER . 0.5 OUTLIER 75.2 -16.72 0.55 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.432 -0.793 . . . . 0.0 111.933 179.093 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.604 ' HA2' ' HA ' ' A' ' 89' ' ' CYS . . . -86.32 35.52 3.3 Favored Glycine 0 N--CA 1.491 2.354 0 O-C-N 120.733 -1.23 . . . . 0.0 110.425 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.573 ' O ' ' O ' ' A' ' 69' ' ' GLY . 2.2 p90 -43.15 -173.49 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 122.712 1.244 . . . . 0.0 112.526 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.724 HD13 ' H ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -113.31 161.49 17.18 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.272 178.795 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.8 t -146.97 22.07 1.23 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.173 -0.954 . . . . 0.0 109.917 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.39 -51.37 2.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 0.0 110.898 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.616 ' O ' HG12 ' A' ' 85' ' ' VAL . . . -153.44 88.67 0.13 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.58 ' CE2' ' OH ' ' A' ' 79' ' ' TYR . 1.8 t80 -126.3 117.27 22.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -1.133 . . . . 0.0 110.177 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.62 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 28.2 tttt -113.79 148.06 37.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.201 -0.937 . . . . 0.0 109.656 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.462 ' C ' ' O ' ' A' ' 76' ' ' LYS . 1.3 ttm-85 -42.0 -27.41 0.12 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.968 -1.082 . . . . 0.0 109.873 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 76' ' ' LYS . 40.5 m -140.94 147.12 38.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.525 -0.734 . . . . 0.0 110.283 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.672 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -144.03 178.92 7.53 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.218 -0.926 . . . . 0.0 109.583 179.553 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.57 ' O ' ' O ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -170.43 137.85 1.47 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.067 -1.021 . . . . 0.0 110.315 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.833 ' CB ' HG21 ' A' ' 59' ' ' VAL . 6.6 t80 25.49 105.44 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 120.988 0.423 . . . . 0.0 111.982 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.789 ' O ' HG22 ' A' ' 102' ' ' THR . 10.6 m-20 96.4 -134.86 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 123.373 0.669 . . . . 0.0 109.699 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 52.91 67.65 0.96 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.735 -1.228 . . . . 0.0 108.93 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.645 ' N ' HG23 ' A' ' 102' ' ' THR . 8.1 p30 -69.69 113.04 6.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.556 -0.715 . . . . 0.0 110.969 -178.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.616 HG12 ' O ' ' A' ' 74' ' ' GLY . 30.0 m -94.16 117.58 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.115 -0.991 . . . . 0.0 110.102 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -79.61 131.8 36.09 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.019 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.612 ' CE1' HD12 ' A' ' 71' ' ' LEU . 54.6 m-85 -92.37 116.5 29.03 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.962 -1.087 . . . . 0.0 112.154 -178.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -88.38 94.82 9.97 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.389 179.143 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.604 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 1.7 t -48.17 119.26 2.83 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.036 -1.04 . . . . 0.0 110.466 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.51 ' CG ' ' O ' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -57.17 125.05 20.95 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.227 -0.921 . . . . 0.0 109.96 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.489 ' HB2' ' O ' ' A' ' 90' ' ' LYS . 2.3 m-85 62.44 -174.5 0.14 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.171 -0.956 . . . . 0.0 111.351 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.46 54.73 0.9 Allowed Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.543 ' CB ' ' SG ' ' A' ' 116' ' ' CYS . 5.5 m-85 -106.34 158.08 17.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.325 -1.103 . . . . 0.0 109.448 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.593 ' O ' HG22 ' A' ' 117' ' ' VAL . 9.6 mtmm -99.9 141.6 32.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.073 -1.017 . . . . 0.0 109.655 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.54 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 1.2 mt -87.2 94.11 9.57 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.581 -1.325 . . . . 0.0 110.057 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.565 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -69.61 101.14 1.57 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.233 -0.917 . . . . 0.0 109.127 179.38 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.13 -96.75 0.21 Allowed Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.202 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.596 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 3.3 m -150.19 116.59 5.75 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.165 -1.197 . . . . 0.0 110.577 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.411 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 42.8 p -77.17 10.3 2.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.235 -0.915 . . . . 0.0 111.293 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 77.0 p -154.42 99.4 2.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.849 -1.157 . . . . 0.0 110.48 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 3.5 m -111.57 -174.43 2.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.367 -0.833 . . . . 0.0 110.056 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.789 HG22 ' O ' ' A' ' 82' ' ' ASN . 5.8 m -155.88 144.19 20.03 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.481 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.616 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 42.7 t -65.07 86.15 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.672 -0.642 . . . . 0.0 109.386 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.456 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -62.56 176.57 0.49 Allowed Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.194 -0.941 . . . . 0.0 112.731 -178.148 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.79 ' CB ' HD12 ' A' ' 38' ' ' ILE . 46.5 Cg_endo -80.37 12.5 2.52 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 124.848 1.973 . . . . 0.0 111.777 -178.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -118.46 18.22 11.04 Favored Glycine 0 C--N 1.294 -1.757 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.718 ' O ' HG23 ' A' ' 108' ' ' THR . 1.2 m120 65.22 66.99 0.53 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.696 -0.885 . . . . 0.0 109.796 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.718 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -168.59 -172.84 1.75 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.227 -0.989 . . . . 0.0 111.497 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.616 ' CZ3' ' N ' ' A' ' 103' ' ' CYS . 41.2 m95 -123.3 95.68 4.69 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.571 0.7 . . . . 0.0 110.132 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.552 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -108.33 146.09 32.87 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.537 -0.727 . . . . 0.0 110.249 -179.537 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.596 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 44.3 Cg_endo -72.65 173.37 54.31 Favored 'Cis proline' 0 C--N 1.315 -1.235 0 C-N-CA 121.697 -2.21 . . . . 0.0 110.534 -0.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.3 mm-40 -36.93 131.05 0.76 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.657 -0.652 . . . . 0.0 111.551 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.57 HD23 ' O ' ' A' ' 65' ' ' THR . 0.2 OUTLIER -43.93 154.5 0.37 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.482 -0.761 . . . . 0.0 109.749 179.003 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.574 ' O ' HD12 ' A' ' 66' ' ' ILE . 41.4 Cg_endo -83.59 171.67 10.77 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 O-C-N 124.092 1.575 . . . . 0.0 111.433 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.565 ' HB3' ' CB ' ' A' ' 96' ' ' SER . 3.3 ttpt -129.82 109.65 11.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.366 -0.834 . . . . 0.0 110.2 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.543 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.0 OUTLIER -69.12 108.54 3.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.153 -0.967 . . . . 0.0 109.257 179.715 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -118.95 -174.54 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.635 0.731 . . . . 0.0 110.195 -179.274 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.409 ' HG2' ' CZ ' ' A' ' 93' ' ' TYR . 26.4 mtm180 . . . . . 0 C--N 1.292 -1.9 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.221 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 53.8 t . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.247 0.546 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.624 ' HA ' HG22 ' A' ' 22' ' ' THR . 0.1 OUTLIER -136.17 100.2 4.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.329 -0.857 . . . . 0.0 110.387 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.559 ' O ' ' N ' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -69.72 88.22 0.52 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.213 -0.929 . . . . 0.0 109.779 179.566 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.469 ' O ' ' C ' ' A' ' 5' ' ' SER . 1.1 pt20 -85.43 -174.02 4.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.04 -1.037 . . . . 0.0 110.064 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.469 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.3 OUTLIER -38.3 127.39 1.07 Allowed Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 120.306 -0.557 . . . . 0.0 109.569 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.652 ' HG3' HG11 ' A' ' 27' ' ' VAL . 45.6 Cg_endo -66.31 154.76 72.96 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.902 1.475 . . . . 0.0 111.509 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -75.49 171.52 18.07 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.115 1.587 . . . . 0.0 110.487 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.69 176.0 3.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 110.014 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.639 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -141.57 -170.28 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-O 122.143 0.973 . . . . 0.0 111.463 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.8 OUTLIER -40.78 95.26 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.26 -179.468 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.49 ' N ' ' O ' ' A' ' 9' ' ' ILE . 2.4 m-20 43.08 41.39 2.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 110.352 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' A' ' 30' ' ' SER . . . -146.11 158.23 27.62 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.521 ' HG3' ' CB ' ' A' ' 30' ' ' SER . 4.5 ptt180 -113.82 -179.85 3.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.233 -1.157 . . . . 0.0 110.325 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.623 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 11.5 p80 -128.98 133.42 47.78 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.629 -0.669 . . . . 0.0 110.049 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -136.62 96.36 3.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.052 -1.03 . . . . 0.0 110.877 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.22 179.59 30.99 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -105.91 46.16 0.94 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.078 -1.248 . . . . 0.0 110.245 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.602 ' CG ' ' CZ ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -175.82 -159.7 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.924 . . . . 0.0 110.392 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.5 -27.41 1.05 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.434 -0.791 . . . . 0.0 110.81 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.416 ' C ' ' OE2' ' A' ' 18' ' ' GLU . 25.8 m-85 -109.74 101.98 10.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.02 -1.05 . . . . 0.0 110.849 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.634 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 2.5 m-85 -102.4 44.9 0.99 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.57 -0.706 . . . . 0.0 109.604 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.624 HG22 ' HA ' ' A' ' 2' ' ' LYS . 24.9 p -53.98 99.8 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.1 0.952 . . . . 0.0 111.718 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.533 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 9.8 t70 50.15 165.28 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 121.794 0.807 . . . . 0.0 111.905 178.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.501 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 46.32 26.15 2.24 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.634 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 35.5 m -109.6 154.88 22.15 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.387 -1.066 . . . . 0.0 110.263 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.877 HG13 ' O ' ' A' ' 43' ' ' VAL . 50.5 t -139.14 153.91 25.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.411 -0.915 . . . . 0.0 110.608 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 1.004 ' O ' HG23 ' A' ' 43' ' ' VAL . 28.7 t -141.55 117.39 6.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.384 -0.927 . . . . 0.0 111.245 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.617 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -69.34 102.97 1.86 Allowed 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 118.469 -1.292 . . . . 0.0 107.669 178.256 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 1.039 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.5 m-30 -67.89 177.99 1.93 Allowed 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.749 -0.781 . . . . 0.0 109.979 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.521 ' CB ' ' HG3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -140.77 151.2 44.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 109.708 179.727 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.418 ' O ' ' C ' ' A' ' 32' ' ' ASN . 87.6 m -122.67 149.66 43.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.159 -0.963 . . . . 0.0 110.693 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.418 ' C ' ' O ' ' A' ' 31' ' ' CYS . 5.4 p-10 -42.48 145.55 0.41 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.46 -0.775 . . . . 0.0 110.175 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.4 129.17 31.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.187 -0.946 . . . . 0.0 110.486 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.87 -27.79 15.17 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 -89.39 162.81 15.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.103 -1.233 . . . . 0.0 110.349 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.848 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.9 OUTLIER -103.29 147.33 27.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.406 -0.809 . . . . 0.0 110.964 -179.158 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.663 HD23 ' O ' ' A' ' 37' ' ' LEU . 6.3 tt -100.99 96.35 7.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.307 -0.871 . . . . 0.0 109.688 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.842 HD11 ' HB2' ' A' ' 36' ' ' SER . 0.3 OUTLIER -93.13 139.64 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 109.09 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 150.91 -126.97 2.23 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.506 ' O ' ' C ' ' A' ' 41' ' ' SER . 4.6 m120 -135.16 50.15 2.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -1.164 . . . . 0.0 109.54 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.617 ' O ' HG23 ' A' ' 28' ' ' THR . 2.1 p 25.46 54.84 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.345 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.501 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 150.86 113.42 0.6 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.039 HG21 ' CE1' ' A' ' 29' ' ' TYR . 1.9 t -64.65 -177.99 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.161 -1.2 . . . . 0.0 107.821 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.531 ' HA ' ' O ' ' A' ' 25' ' ' SER . 2.3 tp -146.65 97.89 2.98 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.286 -0.966 . . . . 0.0 110.702 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.595 ' SG ' ' CD2' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -75.08 114.1 13.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.081 -1.012 . . . . 0.0 109.165 178.857 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 85.1 p -129.73 92.74 3.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.57 -0.706 . . . . 0.0 110.219 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.99 39.42 2.68 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.04 11.92 53.11 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -133.3 120.16 20.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -1.183 . . . . 0.0 110.316 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.616 ' CH2' HG23 ' A' ' 27' ' ' VAL . 73.7 m95 -62.93 137.97 58.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.284 -0.885 . . . . 0.0 109.829 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.2 m -136.63 163.99 29.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.153 -0.967 . . . . 0.0 111.032 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.481 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 3.8 m-20 53.45 66.13 4.94 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.615 -0.678 . . . . 0.0 111.198 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.481 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.7 Cg_endo -90.37 135.85 2.23 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 O-C-N 124.288 1.678 . . . . 0.0 109.643 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.574 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 42.3 Cg_endo -71.54 178.61 5.46 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.591 1.311 . . . . 0.0 110.378 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 5.3 p -121.99 163.13 19.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.372 -0.83 . . . . 0.0 112.028 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 10' ' ' SER . 86.9 m -116.57 85.59 2.34 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -120.32 -141.23 0.34 Allowed 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.45 0.643 . . . . 0.0 110.405 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.714 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -136.32 127.13 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.297 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.848 HG13 ' CB ' ' A' ' 36' ' ' SER . 34.0 m -123.08 49.28 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.031 -1.043 . . . . 0.0 111.61 -178.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 15.0 mtmt -55.99 -179.17 0.02 OUTLIER 'General case' 0 C--N 1.28 -2.431 0 C-N-CA 117.988 -1.485 . . . . 0.0 107.978 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.554 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -145.38 163.39 32.33 Favored Pre-proline 0 C--N 1.297 -1.705 0 C-N-CA 118.707 -1.197 . . . . 0.0 112.297 -179.048 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 42.8 Cg_endo -83.66 -71.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.748 1.92 . . . . 0.0 109.639 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.551 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 162.02 129.46 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.57 ' N ' ' NE1' ' A' ' 109' ' ' TRP . 49.7 Cg_endo -77.12 69.43 7.07 Favored 'Trans proline' 0 C--N 1.299 -2.065 0 O-C-N 123.721 1.38 . . . . 0.0 110.178 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.883 ' O ' HD23 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -99.38 139.31 35.22 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.884 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -131.71 159.29 43.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 C-N-CA 118.594 -1.243 . . . . 0.0 111.057 -178.712 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.472 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 0.1 OUTLIER -58.66 111.85 1.41 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.752 -0.592 . . . . 0.0 111.239 -179.339 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.408 ' O ' ' HG3' ' A' ' 90' ' ' LYS . 1.2 m-20 51.32 25.04 2.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.298 -0.876 . . . . 0.0 109.756 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.55 ' C ' HG23 ' A' ' 66' ' ' ILE . . . -132.45 -177.41 14.9 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.59 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 37.1 p90 -178.54 -172.59 0.29 Allowed 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.541 -0.976 . . . . 0.0 109.388 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.764 HD22 ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -126.44 151.49 47.67 Favored 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.709 178.962 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.2 t -113.65 -6.72 13.35 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.943 -1.098 . . . . 0.0 109.927 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.93 -80.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.378 -0.826 . . . . 0.0 110.259 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -169.79 93.03 0.1 Allowed Glycine 0 N--CA 1.488 2.162 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.167 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.598 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -86.22 174.95 8.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.359 -1.083 . . . . 0.0 109.171 179.219 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.566 ' N ' ' CG ' ' A' ' 75' ' ' PHE . 4.7 tttt -159.68 159.5 33.05 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.317 -0.864 . . . . 0.0 110.256 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.67 -39.63 17.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.898 . . . . 0.0 109.867 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.58 136.66 18.49 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.507 -0.746 . . . . 0.0 110.099 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.598 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 43.6 m-85 -99.29 -162.17 0.93 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.916 . . . . 0.0 109.774 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.627 ' CA ' HG23 ' A' ' 59' ' ' VAL . 85.6 p -146.59 -104.45 0.1 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -0.895 . . . . 0.0 109.083 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.609 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -111.91 145.14 40.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.818 -1.177 . . . . 0.0 107.904 178.718 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.897 ' C ' HG22 ' A' ' 102' ' ' THR . 1.6 m120 61.32 -99.43 0.09 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.375 -0.828 . . . . 0.0 110.153 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.476 ' HB2' ' HB3' ' A' ' 103' ' ' CYS . 10.3 m-20 41.14 79.48 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.995 -1.066 . . . . 0.0 109.238 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.765 ' CA ' HG23 ' A' ' 102' ' ' THR . 21.5 t-20 -75.39 143.85 42.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.389 -0.819 . . . . 0.0 112.286 -177.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.84 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 4.5 m -132.37 115.07 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.437 -0.789 . . . . 0.0 109.44 177.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.553 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 2.7 t70 -75.54 134.64 40.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.315 -0.866 . . . . 0.0 108.992 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.68 ' CE1' HD12 ' A' ' 71' ' ' LEU . 45.0 m-85 -94.63 142.47 27.4 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 118.682 -1.207 . . . . 0.0 112.253 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.564 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -120.12 98.71 6.2 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.581 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.686 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -46.92 129.49 11.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.133 -0.979 . . . . 0.0 110.457 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.435 ' O ' ' O ' ' A' ' 89' ' ' CYS . 6.8 mmtp -44.37 -92.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.29 -0.881 . . . . 0.0 110.173 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.556 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 1.9 t80 -152.73 158.81 42.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.211 -0.931 . . . . 0.0 110.049 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.588 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 45.31 25.85 1.32 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.588 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 18.0 m-85 -141.45 147.39 37.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.401 -1.058 . . . . 0.0 110.395 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.1 ptmm? -117.83 129.96 55.98 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.294 -0.879 . . . . 0.0 109.897 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.686 HD11 ' H ' ' A' ' 89' ' ' CYS . 1.2 mt -57.12 103.0 0.1 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.186 -0.946 . . . . 0.0 110.8 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.697 ' HB2' HG21 ' A' ' 117' ' ' VAL . 3.0 t -85.96 91.36 8.35 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.22 -0.925 . . . . 0.0 109.053 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 152.2 -91.27 0.13 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.575 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -149.41 118.85 6.89 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.159 -1.2 . . . . 0.0 110.83 -179.432 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.541 ' HB3' HD13 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -80.88 13.71 2.54 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.25 -0.906 . . . . 0.0 110.918 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 60.2 p -152.91 113.41 4.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.123 -0.985 . . . . 0.0 109.72 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.517 ' HG ' ' HE2' ' A' ' 87' ' ' PHE . 13.0 m -124.6 -177.36 3.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 110.971 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.897 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -153.49 128.2 9.43 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.685 0.755 . . . . 0.0 110.21 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.587 ' N ' ' O ' ' A' ' 82' ' ' ASN . 4.7 t -66.09 81.5 0.08 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.476 ' HA ' ' H ' ' A' ' 82' ' ' ASN . 0.4 OUTLIER -64.38 173.75 1.41 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.342 -0.849 . . . . 0.0 110.988 -179.152 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.799 ' HG3' HG23 ' A' ' 38' ' ' ILE . 41.7 Cg_endo -73.18 120.49 6.6 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 O-C-N 124.586 1.835 . . . . 0.0 110.859 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.557 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 131.51 -6.06 5.57 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.824 ' O ' HG23 ' A' ' 108' ' ' THR . 1.6 m-20 81.0 93.61 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.916 -0.755 . . . . 0.0 111.361 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.824 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 175.02 -168.34 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.475 -0.766 . . . . 0.0 111.198 179.024 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.84 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 36.9 m95 -142.14 94.08 2.62 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.579 -0.7 . . . . 0.0 110.03 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.562 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 14.7 mmtt -103.61 147.17 33.82 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.367 -0.833 . . . . 0.0 110.086 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.575 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.1 Cg_endo -71.98 175.27 43.53 Favored 'Cis proline' 0 N--CA 1.49 1.28 0 C-N-CA 121.956 -2.102 . . . . 0.0 110.956 0.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 113' ' ' LEU . 12.7 pt-20 -37.68 122.39 0.95 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.684 -0.635 . . . . 0.0 110.986 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.883 HD23 ' O ' ' A' ' 65' ' ' THR . 0.9 OUTLIER -41.24 141.14 1.1 Allowed Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.517 -0.739 . . . . 0.0 110.174 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.884 ' HG2' HD12 ' A' ' 66' ' ' ILE . 40.4 Cg_endo -69.8 159.42 53.43 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 124.206 1.635 . . . . 0.0 110.851 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.565 ' HG2' HG13 ' A' ' 117' ' ' VAL . 3.2 ttpm? -119.43 101.34 7.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.919 . . . . 0.0 110.281 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.534 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 4.6 t -61.77 82.3 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.052 -1.03 . . . . 0.0 108.894 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.697 HG21 ' HB2' ' A' ' 96' ' ' SER . 4.5 m -96.48 -171.61 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-O 121.942 0.877 . . . . 0.0 111.37 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.413 ' HG2' ' CE1' ' A' ' 93' ' ' TYR . 9.0 mtm180 . . . . . 0 C--N 1.293 -1.877 0 C-N-CA 119.152 -1.019 . . . . 0.0 110.446 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.642 HG22 ' HA3' ' A' ' 48' ' ' GLY . 4.7 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.227 0.537 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -141.51 176.67 8.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.197 -0.939 . . . . 0.0 110.388 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.536 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.1 m -130.13 87.74 2.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.406 -0.809 . . . . 0.0 110.37 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -70.86 175.4 5.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.815 -1.178 . . . . 0.0 109.926 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -44.09 141.41 2.47 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.31 -0.868 . . . . 0.0 109.977 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.744 ' HG3' HG11 ' A' ' 27' ' ' VAL . 53.2 Cg_endo -70.71 156.38 60.98 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 124.015 1.534 . . . . 0.0 110.845 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -75.23 174.92 11.97 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.955 1.503 . . . . 0.0 110.093 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.38 -179.92 1.81 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.186 -0.946 . . . . 0.0 110.389 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.679 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -145.11 -170.23 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 122.206 1.003 . . . . 0.0 111.45 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.2 OUTLIER -45.1 92.75 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.387 -179.597 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.506 ' N ' ' O ' ' A' ' 9' ' ' ILE . 27.6 m-20 42.62 53.19 4.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.271 -0.893 . . . . 0.0 110.205 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.14 163.66 32.01 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 30' ' ' SER . 10.1 ptp180 -114.92 -178.38 3.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -1.148 . . . . 0.0 110.438 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.62 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 18.1 p80 -136.67 124.21 22.22 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.67 -0.644 . . . . 0.0 110.107 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -133.74 96.12 3.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 110.53 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.25 16.72 58.84 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.426 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 5.7 m-85 53.36 56.46 7.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.356 -1.084 . . . . 0.0 110.162 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.473 ' CD ' ' CE2' ' A' ' 21' ' ' TYR . 0.3 OUTLIER 179.93 -165.25 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.341 -0.849 . . . . 0.0 110.096 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -138.48 -39.98 0.51 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 109.815 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -110.64 136.03 50.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.406 -0.809 . . . . 0.0 109.721 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.645 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.4 OUTLIER -122.27 -7.01 8.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.921 . . . . 0.0 110.605 -179.541 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.536 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 38.2 p 46.06 -95.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.6 -0.687 . . . . 0.0 111.824 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.413 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 1.0 OUTLIER -153.95 151.21 29.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.772 -1.205 . . . . 0.0 110.637 -178.732 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.57 29.92 54.35 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.645 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -121.79 169.7 10.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.356 -1.084 . . . . 0.0 110.552 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.788 HG13 ' O ' ' A' ' 43' ' ' VAL . 24.2 t -142.52 156.29 18.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.888 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.744 HG11 ' HG3' ' A' ' 6' ' ' PRO . 11.9 t -131.19 124.75 56.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.433 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.85 101.91 8.81 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 118.541 -1.264 . . . . 0.0 107.613 177.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.69 ' O ' HD13 ' A' ' 37' ' ' LEU . 1.8 m-30 -68.29 122.11 17.67 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.644 -0.823 . . . . 0.0 110.024 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -86.61 144.69 27.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -0.975 . . . . 0.0 109.574 179.423 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.498 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 33.9 m -102.48 171.43 7.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.152 -0.968 . . . . 0.0 110.563 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -72.03 163.87 27.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -0.894 . . . . 0.0 110.096 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.48 99.84 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 0.0 110.693 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.99 19.29 9.16 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.498 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 6.9 m-85 -117.17 124.47 49.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.049 -1.265 . . . . 0.0 110.185 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.632 ' OG ' HG21 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -74.88 140.5 43.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.35 -0.844 . . . . 0.0 111.261 -179.549 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.69 HD13 ' O ' ' A' ' 29' ' ' TYR . 2.7 tp -92.63 106.95 18.84 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.515 -0.741 . . . . 0.0 109.35 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.746 HD12 ' HB3' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -98.43 155.91 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.151 -0.968 . . . . 0.0 109.394 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.67 175.87 38.44 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.462 ' O ' ' HG3' ' A' ' 54' ' ' PRO . 2.5 m120 -50.82 143.69 9.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -1.152 . . . . 0.0 109.873 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 76.2 p -80.09 51.94 1.45 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -0.95 . . . . 0.0 110.161 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.554 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 161.23 122.87 0.64 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.788 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.4 t -65.62 177.45 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.108 -1.231 . . . . 0.0 108.423 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.534 ' C ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -141.34 93.4 2.57 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.416 179.308 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.617 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -81.51 110.65 17.1 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.935 -1.106 . . . . 0.0 109.122 178.695 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.33 97.15 3.22 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.568 -0.708 . . . . 0.0 110.034 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.413 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 108.8 39.58 1.7 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.642 ' HA3' HG22 ' A' ' 1' ' ' VAL . . . 60.84 27.7 67.18 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 48' ' ' GLY . 2.7 mt-10 -154.1 132.46 11.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.193 -1.181 . . . . 0.0 110.396 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.617 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 84.8 m95 -82.34 142.85 31.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.882 . . . . 0.0 109.546 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.7 166.1 25.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.902 -1.124 . . . . 0.0 111.499 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.502 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.4 OUTLIER 44.96 65.98 5.72 Favored Pre-proline 0 N--CA 1.496 1.829 0 CA-C-O 121.146 0.498 . . . . 0.0 111.554 179.439 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.502 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.9 Cg_endo -91.33 130.89 1.35 Allowed 'Trans proline' 0 C--N 1.299 -2.04 0 O-C-N 124.342 1.706 . . . . 0.0 109.713 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.479 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.3 Cg_endo -77.47 158.94 32.64 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 123.752 1.396 . . . . 0.0 110.183 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.611 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 38.8 p -99.43 164.18 12.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.246 -0.909 . . . . 0.0 111.184 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 10' ' ' SER . 13.9 m -129.15 74.44 1.58 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.542 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -110.32 -175.43 2.73 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.563 0.697 . . . . 0.0 110.711 -178.025 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.595 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -96.26 128.77 47.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.647 HG23 ' CA ' ' A' ' 80' ' ' SER . 30.7 m -118.55 41.64 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.065 -1.022 . . . . 0.0 111.229 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 0.9 OUTLIER -52.75 179.42 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.323 0 C-N-CA 118.369 -1.333 . . . . 0.0 108.293 179.665 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.473 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -141.73 169.64 10.8 Favored Pre-proline 0 C--N 1.298 -1.643 0 C-N-CA 118.272 -1.371 . . . . 0.0 113.654 -178.015 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.437 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 46.6 Cg_endo -90.27 -75.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.393 2.062 . . . . 0.0 110.688 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.437 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 170.26 125.31 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.689 -0.632 . . . . 0.0 109.453 -179.125 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.662 ' HA ' HD21 ' A' ' 113' ' ' LEU . 55.3 Cg_endo -77.94 65.73 8.26 Favored 'Trans proline' 0 C--N 1.299 -2.065 0 O-C-N 123.74 1.389 . . . . 0.0 110.171 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.699 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -83.89 -179.1 7.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.38 -0.825 . . . . 0.0 109.629 179.504 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.742 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -179.56 169.49 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.045 -1.035 . . . . 0.0 110.628 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.523 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -74.21 105.76 5.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.572 -0.705 . . . . 0.0 111.037 -179.621 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 33.0 m120 38.47 38.35 0.23 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.587 -0.696 . . . . 0.0 111.129 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.708 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -144.58 27.85 1.93 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.533 ' O ' ' O ' ' A' ' 69' ' ' GLY . 12.4 p90 -43.64 -175.58 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.653 1.216 . . . . 0.0 112.501 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.825 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -112.72 157.52 21.2 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.579 179.234 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.7 t -138.69 23.12 2.68 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.932 -1.105 . . . . 0.0 109.806 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -100.93 -79.03 0.51 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.389 -0.819 . . . . 0.0 111.024 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -131.26 78.41 0.37 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -102.46 169.96 8.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.406 -1.055 . . . . 0.0 109.65 179.525 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.603 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 4.8 tttm -169.39 159.09 8.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.307 -0.871 . . . . 0.0 110.234 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.49 -40.08 11.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.365 -0.834 . . . . 0.0 110.091 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.504 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 0.3 OUTLIER -141.59 172.31 12.86 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.477 -0.765 . . . . 0.0 110.049 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.597 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 6.5 m-85 -141.63 -156.18 0.66 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.328 -0.857 . . . . 0.0 109.949 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.647 ' CA ' HG23 ' A' ' 59' ' ' VAL . 5.4 m -150.72 -111.32 0.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.953 -1.092 . . . . 0.0 110.929 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.619 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -110.32 18.48 19.83 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.691 -1.256 . . . . 0.0 110.509 -179.145 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.659 ' C ' HG22 ' A' ' 102' ' ' THR . 17.7 p-10 -158.02 -114.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.797 -1.189 . . . . 0.0 110.357 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.9 t0 49.85 73.55 0.25 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.738 -1.226 . . . . 0.0 109.2 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.866 ' CA ' HG23 ' A' ' 102' ' ' THR . 9.4 p30 -69.35 120.69 15.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.306 -0.871 . . . . 0.0 110.252 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.577 HG11 ' HG3' ' A' ' 64' ' ' PRO . 16.1 m -101.34 120.28 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.06 -1.025 . . . . 0.0 110.511 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.417 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -83.22 125.98 32.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.235 -0.915 . . . . 0.0 108.534 179.112 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.825 ' CE1' HD12 ' A' ' 71' ' ' LEU . 72.8 m-85 -86.97 139.21 30.82 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 122.185 0.993 . . . . 0.0 111.827 -178.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -114.43 91.56 3.67 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.809 -179.383 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.531 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -43.35 127.24 4.52 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.259 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 3.3 mmtt -35.58 -77.19 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.682 -178.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.571 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.3 OUTLIER -167.42 135.5 2.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.364 -0.835 . . . . 0.0 110.168 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.583 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 60.27 47.77 89.43 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.583 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 24.3 m-85 -154.28 157.4 38.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.512 -0.993 . . . . 0.0 109.764 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.562 ' O ' HG22 ' A' ' 117' ' ' VAL . 36.6 mtpt -118.38 122.26 42.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 110.063 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.674 HD23 HD11 ' A' ' 66' ' ' ILE . 10.1 mt -60.26 104.61 0.33 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.153 -0.967 . . . . 0.0 110.429 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.624 ' HB2' HG21 ' A' ' 117' ' ' VAL . 12.7 t -92.66 101.98 14.4 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.357 -0.839 . . . . 0.0 109.842 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 98' ' ' SER . . . 146.76 -56.28 0.51 Allowed Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.78 -1.2 . . . . 0.0 110.224 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.563 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 58.8 p 179.49 99.06 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.285 -1.126 . . . . 0.0 110.913 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 53.1 m -65.36 -18.39 65.28 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.121 -0.987 . . . . 0.0 110.372 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.6 p -137.08 101.17 4.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.158 -0.964 . . . . 0.0 109.626 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 85' ' ' VAL . 3.2 m -113.29 168.22 9.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.361 -0.837 . . . . 0.0 111.059 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.866 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -139.74 142.29 36.82 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.58 0.705 . . . . 0.0 110.083 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.599 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -73.25 94.77 2.03 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.555 -0.716 . . . . 0.0 110.663 -179.511 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.536 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -69.4 -175.41 0.27 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.375 -0.828 . . . . 0.0 110.959 -179.739 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.746 ' HB3' HD12 ' A' ' 38' ' ' ILE . 43.2 Cg_endo -81.42 128.52 6.24 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.343 1.707 . . . . 0.0 110.753 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 123.56 -7.65 8.96 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.746 ' O ' HG23 ' A' ' 108' ' ' THR . 3.0 m-20 80.92 96.01 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.642 0.734 . . . . 0.0 111.111 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.746 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 176.25 -159.2 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.485 -0.76 . . . . 0.0 110.654 179.341 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.744 ' HB3' HD13 ' A' ' 113' ' ' LEU . 22.6 m95 -145.84 89.95 1.94 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.39 -0.819 . . . . 0.0 110.172 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.517 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 13.6 mttm -100.62 142.77 25.27 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.562 -0.711 . . . . 0.0 110.531 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.563 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.4 Cg_endo -74.19 172.47 61.74 Favored 'Cis proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.68 -2.217 . . . . 0.0 110.266 -0.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.3 mp0 -37.6 127.41 1.13 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.466 -0.771 . . . . 0.0 111.439 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.744 HD13 ' HB3' ' A' ' 109' ' ' TRP . 0.2 OUTLIER -40.74 150.39 0.29 Allowed Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.492 -0.755 . . . . 0.0 110.192 179.116 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.742 ' HG2' HD12 ' A' ' 66' ' ' ILE . 39.6 Cg_endo -76.01 165.95 28.87 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 O-C-N 124.177 1.619 . . . . 0.0 110.937 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.539 ' O ' HG22 ' A' ' 117' ' ' VAL . 12.5 ttpt -129.84 101.8 6.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.268 -0.895 . . . . 0.0 110.034 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.529 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.2 t -55.59 91.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.098 -1.001 . . . . 0.0 109.377 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.624 HG21 ' HB2' ' A' ' 96' ' ' SER . 1.5 m -104.8 -177.79 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 121.714 0.768 . . . . 0.0 110.641 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.517 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 5.0 ptt-85 . . . . . 0 C--N 1.295 -1.776 0 C-N-CA 119.014 -1.075 . . . . 0.0 110.549 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 54.4 t . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.318 0.58 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.75 170.3 10.24 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.242 -0.911 . . . . 0.0 110.419 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.579 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.2 m -125.44 142.14 51.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.411 -0.806 . . . . 0.0 109.531 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 4.6 mp0 -113.0 175.86 5.26 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.015 -1.053 . . . . 0.0 109.807 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.57 140.87 56.55 Favored Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 121.298 -0.876 . . . . 0.0 109.734 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.815 ' HG3' HG11 ' A' ' 27' ' ' VAL . 49.2 Cg_endo -71.49 153.25 60.6 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 O-C-N 124.023 1.538 . . . . 0.0 110.717 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.61 173.01 14.59 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.863 1.454 . . . . 0.0 110.009 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.61 176.44 3.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.917 . . . . 0.0 109.935 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.68 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -143.43 -169.61 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 122.194 0.997 . . . . 0.0 111.336 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 11' ' ' ASN . 0.3 OUTLIER -46.61 93.56 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.683 -179.312 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.46 ' N ' ' O ' ' A' ' 9' ' ' ILE . 4.2 m-80 42.08 53.15 4.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.195 -0.941 . . . . 0.0 110.427 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.05 152.59 24.01 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.461 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -98.14 -167.76 1.56 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -1.147 . . . . 0.0 110.686 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.636 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 20.7 p80 -153.19 113.04 3.9 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.537 0.684 . . . . 0.0 110.191 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.414 ' O ' ' C ' ' A' ' 16' ' ' GLY . 0.9 OUTLIER -138.78 63.57 1.51 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.101 -0.999 . . . . 0.0 110.098 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 17' ' ' TYR . . . -44.01 -77.11 0.1 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.431 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 9.8 t80 -178.01 36.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -1.113 . . . . 0.0 110.197 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.566 ' OE2' ' CG ' ' A' ' 21' ' ' TYR . 2.0 pt-20 178.5 -161.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.89 . . . . 0.0 110.011 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -117.37 -36.84 3.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.227 -0.92 . . . . 0.0 110.286 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.535 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 21.9 p90 -129.99 123.55 30.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.152 -0.967 . . . . 0.0 110.471 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.637 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 14.0 m-85 -92.08 -167.79 1.85 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.451 -0.78 . . . . 0.0 110.27 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.579 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 0.6 OUTLIER -141.84 -64.66 0.43 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.915 -1.116 . . . . 0.0 110.964 -179.483 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 7.8 t0 -169.07 144.37 3.23 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.466 -0.771 . . . . 0.0 109.492 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.449 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 68.47 13.79 65.91 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.637 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 16.2 m -88.94 177.71 6.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.527 -0.984 . . . . 0.0 110.094 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 43' ' ' VAL . 24.4 t -154.15 155.54 6.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.498 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.815 HG11 ' HG3' ' A' ' 6' ' ' PRO . 16.1 t -136.22 114.8 15.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 119.416 -0.914 . . . . 0.0 111.684 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.464 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -71.66 104.56 3.39 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.431 -1.308 . . . . 0.0 107.626 177.784 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.887 ' O ' HD13 ' A' ' 37' ' ' LEU . 2.1 m-30 -67.79 130.48 43.13 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.135 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 13' ' ' ARG . 1.0 OUTLIER -82.24 160.33 23.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 109.808 179.665 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 12.4 m -130.45 162.87 28.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.154 -0.966 . . . . 0.0 110.107 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -64.13 152.57 40.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 110.088 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.12 108.72 0.27 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 110.418 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 109.44 -6.76 31.95 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 3.2 m-30 -95.18 128.88 42.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.208 -1.172 . . . . 0.0 110.279 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.587 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -81.94 145.93 30.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.189 -0.945 . . . . 0.0 110.96 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.887 HD13 ' O ' ' A' ' 29' ' ' TYR . 4.5 tp -94.73 98.4 10.75 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.445 -0.784 . . . . 0.0 108.932 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.823 HD12 ' HB2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -91.28 160.51 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.252 -0.905 . . . . 0.0 109.476 -179.67 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 95.53 -179.33 35.88 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -53.78 142.13 24.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.162 -1.199 . . . . 0.0 109.714 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.464 ' O ' HG23 ' A' ' 28' ' ' THR . 9.6 p -73.62 53.8 0.44 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.935 . . . . 0.0 110.256 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.616 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 148.24 122.9 1.3 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.676 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.6 t -54.87 -179.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.162 -1.199 . . . . 0.0 107.926 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.492 ' H ' HG12 ' A' ' 43' ' ' VAL . 0.3 OUTLIER -143.42 96.75 2.96 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.237 178.907 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.596 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -81.36 104.86 12.1 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.112 178.604 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.7 p -129.49 102.78 6.54 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.478 -0.764 . . . . 0.0 110.229 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.64 26.13 8.78 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.57 21.66 78.73 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -141.26 110.49 6.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -1.203 . . . . 0.0 110.365 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.596 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 88.2 m95 -64.27 136.6 57.33 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.239 -0.913 . . . . 0.0 109.894 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.429 ' O ' ' HB3' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -143.97 158.79 43.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 110.837 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.488 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 20.7 t0 60.32 66.31 1.96 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.753 -0.592 . . . . 0.0 111.242 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 48.7 Cg_endo -90.71 131.13 1.57 Allowed 'Trans proline' 0 C--N 1.301 -1.973 0 O-C-N 124.342 1.707 . . . . 0.0 109.682 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.548 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.9 Cg_endo -77.0 170.53 19.6 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 O-C-N 123.809 1.426 . . . . 0.0 110.035 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.539 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 12.3 p -113.16 147.87 36.54 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.066 -1.021 . . . . 0.0 111.824 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 36' ' ' SER . 42.2 m -114.11 78.68 1.17 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -114.07 -156.81 0.61 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.324 0.583 . . . . 0.0 110.324 -178.564 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.657 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -109.27 139.7 31.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.341 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.711 ' HB ' ' HA ' ' A' ' 105' ' ' PRO . 34.1 m -130.31 52.67 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 120.889 -1.132 . . . . 0.0 111.525 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 2.9 mptt -81.55 171.01 15.18 Favored 'General case' 0 C--N 1.282 -2.353 0 C-N-CA 118.349 -1.34 . . . . 0.0 107.567 178.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.465 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 60.3 m -140.81 164.74 34.35 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 120.302 -1.499 . . . . 0.0 113.031 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 40.1 Cg_endo -69.55 -86.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 124.886 1.993 . . . . 0.0 110.569 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.582 ' CE1' ' HE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -176.02 136.72 0.48 Allowed Pre-proline 0 C--N 1.301 -1.53 0 O-C-N 121.517 -0.739 . . . . 0.0 109.531 -179.616 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.599 ' HG3' ' CZ2' ' A' ' 109' ' ' TRP . 57.6 Cg_endo -86.21 69.9 4.54 Favored 'Trans proline' 0 C--N 1.297 -2.14 0 O-C-N 123.756 1.398 . . . . 0.0 109.599 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.698 ' O ' HG23 ' A' ' 66' ' ' ILE . 3.2 p -84.77 -43.74 13.96 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 122.506 1.146 . . . . 0.0 109.78 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.698 HG23 ' O ' ' A' ' 65' ' ' THR . 0.0 OUTLIER 56.22 160.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.828 -178.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.517 ' N ' HG13 ' A' ' 66' ' ' ILE . 8.1 t -63.7 98.18 0.18 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.479 -0.763 . . . . 0.0 111.345 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.451 ' C ' ' HG3' ' A' ' 90' ' ' LYS . 3.6 m-20 44.72 52.21 7.94 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.4 -0.813 . . . . 0.0 111.255 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.593 ' O ' ' CD2' ' A' ' 70' ' ' TYR . . . -135.32 -39.47 0.17 Allowed Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.308 -1.425 . . . . 0.0 109.635 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 16.2 p90 41.36 -177.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 122.807 1.289 . . . . 0.0 112.222 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.893 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -130.69 153.13 49.3 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.138 -179.047 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.1 t -112.51 -9.47 13.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.65 -1.281 . . . . 0.0 110.781 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.512 ' HB2' ' HB2' ' A' ' 86' ' ' ASP . 11.0 t -55.8 -70.31 0.12 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.175 -0.953 . . . . 0.0 110.269 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.42 101.58 0.15 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.582 ' HE2' ' CE1' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -98.71 145.24 27.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.312 -1.11 . . . . 0.0 110.005 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.444 ' HG2' ' N ' ' A' ' 77' ' ' ARG . 10.4 tttm -126.16 165.74 18.34 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.438 -0.789 . . . . 0.0 109.419 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.444 ' N ' ' HG2' ' A' ' 76' ' ' LYS . 8.6 mtp180 -56.09 -56.0 26.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.062 -1.024 . . . . 0.0 110.023 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.6 171.28 8.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.467 -0.77 . . . . 0.0 109.948 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.572 ' CD1' ' CZ2' ' A' ' 109' ' ' TRP . 27.1 m-85 -145.03 -179.88 6.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 0.0 110.219 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.534 ' O ' ' HB3' ' A' ' 103' ' ' CYS . 1.5 m -158.49 176.07 12.89 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.156 -0.965 . . . . 0.0 110.981 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.598 ' H ' ' CG2' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -38.57 -24.94 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.83 -0.544 . . . . 0.0 111.546 -178.776 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.688 ' O ' HG22 ' A' ' 102' ' ' THR . 43.8 t-20 -116.67 -122.48 0.29 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.779 -1.201 . . . . 0.0 110.094 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 51.98 71.08 0.49 Allowed 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.761 -1.212 . . . . 0.0 108.979 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.567 ' N ' HG23 ' A' ' 102' ' ' THR . 3.3 p-10 -72.18 152.32 42.33 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.894 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.795 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 0.3 OUTLIER -133.04 121.12 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.337 -0.852 . . . . 0.0 110.261 179.557 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.547 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 3.3 t0 -81.76 122.01 27.13 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.246 -0.909 . . . . 0.0 109.033 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.893 ' CE1' HD12 ' A' ' 71' ' ' LEU . 28.3 m-85 -80.48 132.52 35.71 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.275 1.035 . . . . 0.0 112.531 -177.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.598 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 4.2 tmtt? -116.41 87.59 2.72 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.046 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.558 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -36.5 131.21 0.68 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.434 -0.791 . . . . 0.0 111.315 -179.349 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.451 ' HG3' ' C ' ' A' ' 68' ' ' ASN . 0.3 OUTLIER -39.01 -93.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.542 -0.724 . . . . 0.0 110.966 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.569 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 77.3 t80 -152.95 120.27 5.89 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.101 -0.999 . . . . 0.0 110.311 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.578 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 72.06 54.74 7.75 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.578 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 63.0 m-85 -159.42 150.76 20.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.482 -1.011 . . . . 0.0 109.925 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.553 ' O ' HG22 ' A' ' 117' ' ' VAL . 7.9 mtmt -104.89 140.53 38.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.237 -0.914 . . . . 0.0 110.252 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.56 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 7.1 mt -80.8 99.79 8.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.89 -1.131 . . . . 0.0 110.267 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 3.7 t -82.39 93.73 7.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.185 -0.947 . . . . 0.0 109.962 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 114' ' ' PRO . . . 154.15 -97.2 0.17 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.615 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 15.3 t -150.79 122.03 7.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.191 -1.182 . . . . 0.0 110.276 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.414 ' O ' ' CD2' ' A' ' 87' ' ' PHE . 79.4 p -58.51 -58.94 6.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.246 -0.909 . . . . 0.0 110.426 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 51.5 p -91.75 138.67 31.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.407 -0.808 . . . . 0.0 110.197 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.547 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 70.7 m -144.58 169.93 17.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.393 -0.817 . . . . 0.0 109.974 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.688 HG22 ' O ' ' A' ' 82' ' ' ASN . 1.8 m -147.88 134.44 19.8 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.32 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 108' ' ' THR . 1.8 t -54.77 87.47 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.51 -0.744 . . . . 0.0 109.502 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -53.05 170.8 0.24 Allowed Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.033 -1.042 . . . . 0.0 112.417 -178.711 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.823 ' HB2' HD12 ' A' ' 38' ' ' ILE . 51.5 Cg_endo -81.88 15.58 1.92 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 125.012 2.059 . . . . 0.0 111.37 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.555 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -114.59 13.32 20.64 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.862 ' O ' HG23 ' A' ' 108' ' ' THR . 11.1 t30 77.69 62.33 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.892 -0.769 . . . . 0.0 110.351 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.862 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -177.68 178.0 1.05 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 118.818 -1.153 . . . . 0.0 111.891 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.795 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 25.2 m95 -104.2 89.65 3.33 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.233 0.54 . . . . 0.0 110.746 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.544 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 3.8 mmtm -98.01 154.63 37.68 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.222 -0.924 . . . . 0.0 109.502 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.615 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 51.5 Cg_endo -71.71 -174.43 11.48 Favored 'Cis proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.258 -1.976 . . . . 0.0 111.054 -0.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -36.87 120.69 0.73 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.347 0.594 . . . . 0.0 110.762 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.676 HD13 ' HB3' ' A' ' 109' ' ' TRP . 4.2 tp -54.01 138.97 54.64 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.339 -0.851 . . . . 0.0 110.096 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.585 ' HG3' ' CD2' ' A' ' 87' ' ' PHE . 40.6 Cg_endo -70.17 158.81 55.25 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 O-C-N 124.051 1.553 . . . . 0.0 110.565 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.641 ' HG2' HG13 ' A' ' 117' ' ' VAL . 61.5 tttt -126.7 94.05 3.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.665 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.554 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 1.6 t -45.16 96.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.222 -0.924 . . . . 0.0 109.113 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.641 HG13 ' HG2' ' A' ' 115' ' ' LYS . 0.7 OUTLIER -109.93 -173.24 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 121.83 0.824 . . . . 0.0 110.59 -179.262 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.421 ' CG ' ' CE1' ' A' ' 93' ' ' TYR . 11.7 mtp180 . . . . . 0 C--N 1.293 -1.887 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.555 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.169 0.509 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.04 178.46 6.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 110.51 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.591 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 9.2 t -141.26 132.79 26.97 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.457 ' O ' ' C ' ' A' ' 5' ' ' SER . 5.3 mt-30 -115.13 179.27 4.0 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.141 -0.974 . . . . 0.0 110.041 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.2 OUTLIER -40.22 141.04 0.88 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.701 -0.624 . . . . 0.0 109.986 -179.888 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.759 ' HG3' HG11 ' A' ' 27' ' ' VAL . 50.6 Cg_endo -70.3 154.87 65.24 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 123.993 1.523 . . . . 0.0 111.028 -178.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -75.01 173.57 14.28 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.049 1.552 . . . . 0.0 109.957 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.47 178.42 2.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.222 -0.924 . . . . 0.0 110.16 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.656 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -144.13 -170.09 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.208 1.004 . . . . 0.0 111.196 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 11' ' ' ASN . 21.7 m -44.1 92.56 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.455 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 9' ' ' ILE . 2.3 m-80 43.59 54.04 5.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 110.243 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.456 ' O ' HG13 ' A' ' 9' ' ' ILE . . . -157.71 146.98 14.36 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.55 ' HG2' ' CB ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -97.48 -176.9 3.63 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.331 -1.099 . . . . 0.0 110.335 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.626 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 19.3 p80 -140.15 158.89 43.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.64 -0.662 . . . . 0.0 110.334 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.559 ' HB2' HG13 ' A' ' 27' ' ' VAL . 10.8 m120 -47.71 162.77 0.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.924 . . . . 0.0 110.246 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -156.6 26.12 0.52 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -87.13 14.44 7.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.105 -1.232 . . . . 0.0 110.222 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.548 ' HG3' ' CE2' ' A' ' 21' ' ' TYR . 8.8 pm0 -135.05 -150.31 0.38 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.933 . . . . 0.0 109.994 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 4' ' ' GLN . 2.9 t70 -163.63 -36.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 110.209 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.575 ' O ' ' CD2' ' A' ' 20' ' ' PHE . 16.3 p90 -135.41 81.53 1.9 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.965 . . . . 0.0 109.97 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.614 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 1.6 m-85 -59.27 -23.88 62.75 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.556 -0.715 . . . . 0.0 110.872 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.563 ' N ' ' HB3' ' A' ' 3' ' ' CYS . 91.2 m 58.89 -95.53 0.06 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.377 -0.827 . . . . 0.0 111.424 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 4.3 t0 -147.56 150.28 34.17 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.987 -1.071 . . . . 0.0 110.331 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 77.1 18.9 78.0 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.614 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -103.4 160.2 14.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.571 -0.958 . . . . 0.0 110.563 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.789 HG13 ' O ' ' A' ' 43' ' ' VAL . 39.4 t -141.07 156.92 22.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.418 -0.801 . . . . 0.0 110.522 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.759 HG11 ' HG3' ' A' ' 6' ' ' PRO . 20.0 t -138.03 122.54 22.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 119.186 -1.006 . . . . 0.0 111.691 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.77 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -76.34 103.55 6.42 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.837 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.73 ' O ' HD13 ' A' ' 37' ' ' LEU . 2.6 m-30 -68.67 125.6 27.07 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.414 -178.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.55 ' CB ' ' HG2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -92.91 147.16 23.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.155 -0.965 . . . . 0.0 109.621 179.269 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 37' ' ' LEU . 34.0 m -106.63 159.83 15.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.115 -0.991 . . . . 0.0 110.681 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.461 ' O ' ' N ' ' A' ' 34' ' ' GLY . 5.0 t30 -52.06 160.76 0.69 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.361 -0.837 . . . . 0.0 110.007 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.23 79.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 110.537 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 32' ' ' ASN . . . 145.08 -10.42 1.8 Allowed Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.706 -1.235 . . . . 0.0 110.206 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -97.04 137.66 35.78 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.049 -1.265 . . . . 0.0 110.478 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.721 ' HB2' HG13 ' A' ' 59' ' ' VAL . 0.5 OUTLIER -82.68 145.41 29.64 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.394 -0.816 . . . . 0.0 110.914 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.73 HD13 ' O ' ' A' ' 29' ' ' TYR . 9.5 tp -98.41 106.42 18.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.473 -0.767 . . . . 0.0 109.687 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.784 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -101.31 163.31 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.923 . . . . 0.0 109.069 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.19 176.96 44.84 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -55.69 133.1 50.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.236 -1.155 . . . . 0.0 109.846 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.77 ' O ' HG23 ' A' ' 28' ' ' THR . 81.2 p -76.88 54.01 0.97 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -0.949 . . . . 0.0 110.158 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.539 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 167.38 109.56 0.22 Allowed Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.695 -1.241 . . . . 0.0 110.131 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.789 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -58.59 177.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.032 -1.275 . . . . 0.0 108.16 178.914 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.84 99.79 3.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.158 -0.964 . . . . 0.0 110.259 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.624 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 3.1 t -84.63 111.86 19.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.144 -0.972 . . . . 0.0 109.31 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.6 t -124.84 82.67 2.07 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.166 -0.959 . . . . 0.0 110.395 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.16 45.06 1.92 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.445 ' HA2' ' HB2' ' A' ' 3' ' ' CYS . . . 62.75 15.2 54.1 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -126.28 97.43 5.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.223 -1.163 . . . . 0.0 110.338 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.624 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 87.7 m95 -66.59 137.46 56.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -0.95 . . . . 0.0 109.822 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.31 162.88 34.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.149 -0.969 . . . . 0.0 111.189 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.524 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 33.3 m-20 56.41 65.13 4.32 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.852 -0.53 . . . . 0.0 111.445 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.3 Cg_endo -92.33 134.96 1.39 Allowed 'Trans proline' 0 C--N 1.299 -2.042 0 O-C-N 124.379 1.726 . . . . 0.0 109.521 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.512 ' HG2' ' HB2' ' A' ' 29' ' ' TYR . 47.4 Cg_endo -78.19 174.23 12.76 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 123.607 1.319 . . . . 0.0 109.758 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.556 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 17.1 p -113.15 144.97 41.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.045 -1.034 . . . . 0.0 112.219 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 11.0 m -113.63 77.13 1.03 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 36' ' ' SER . 4.5 mm-40 -111.77 -171.53 1.86 Allowed 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.531 0.682 . . . . 0.0 110.945 -177.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.594 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -101.58 128.25 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.301 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.721 HG13 ' HB2' ' A' ' 36' ' ' SER . 20.6 m -118.65 52.31 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.058 -1.026 . . . . 0.0 111.039 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.465 ' N ' ' OD1' ' A' ' 107' ' ' ASN . 1.6 mttp -83.97 110.42 18.41 Favored 'General case' 0 C--N 1.283 -2.318 0 C-N-CA 118.5 -1.28 . . . . 0.0 109.367 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.555 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 84.4 m -78.05 166.55 42.55 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.189 -0.945 . . . . 0.0 111.274 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.555 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 38.0 Cg_endo -71.89 -76.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.278 1.672 . . . . 0.0 110.47 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.4 ' CG ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 175.39 136.33 0.17 Allowed Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.652 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.608 ' HG3' ' CZ2' ' A' ' 109' ' ' TRP . 58.8 Cg_endo -84.95 87.75 1.0 Allowed 'Trans proline' 0 C--N 1.297 -2.178 0 O-C-N 123.733 1.386 . . . . 0.0 109.721 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.695 ' O ' HG23 ' A' ' 66' ' ' ILE . 2.6 p -112.29 -43.23 3.56 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 122.394 1.092 . . . . 0.0 110.144 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.698 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER 51.95 166.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.242 -179.16 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.507 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 12.9 t -65.15 97.43 0.25 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.521 -0.737 . . . . 0.0 111.265 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 6.2 m-80 45.95 55.64 6.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.448 -0.783 . . . . 0.0 111.905 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.57 ' O ' ' CG ' ' A' ' 70' ' ' TYR . . . -135.34 -42.31 0.12 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.629 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 18.7 p90 43.67 -179.31 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 122.891 1.329 . . . . 0.0 112.074 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.845 HD13 ' N ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -125.24 153.54 43.01 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.15 -179.856 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.484 ' HB3' ' HG3' ' A' ' 88' ' ' LYS . 0.3 OUTLIER -111.58 7.84 20.72 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.01 -1.056 . . . . 0.0 110.267 -178.486 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.85 -70.68 0.52 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.283 -0.886 . . . . 0.0 110.331 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -175.95 100.04 0.14 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.594 ' CD2' ' O ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -94.01 110.03 21.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.402 -1.058 . . . . 0.0 109.498 179.533 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.512 ' N ' ' OH ' ' A' ' 79' ' ' TYR . 9.4 mttp -86.08 151.96 23.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.913 . . . . 0.0 110.247 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.3 mtt180 -48.45 -32.91 8.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.283 -0.885 . . . . 0.0 110.085 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.4 p -141.38 159.05 43.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.399 -0.813 . . . . 0.0 110.307 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.584 ' OH ' ' CD1' ' A' ' 75' ' ' PHE . 79.5 m-85 -132.23 -171.26 2.59 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.281 -0.887 . . . . 0.0 110.05 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.67 ' C ' HG23 ' A' ' 59' ' ' VAL . 78.8 p -147.18 -103.67 0.09 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.873 -1.142 . . . . 0.0 111.495 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.612 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -114.29 22.35 13.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 119.77 -1.831 . . . . 0.0 110.96 -178.396 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.683 ' C ' HG22 ' A' ' 102' ' ' THR . 50.3 t30 -165.55 -110.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.869 -1.144 . . . . 0.0 110.72 178.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 82' ' ' ASN . 0.1 OUTLIER 46.99 79.03 0.06 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.686 -1.259 . . . . 0.0 108.923 -179.032 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.736 ' CA ' HG23 ' A' ' 102' ' ' THR . 2.1 p-10 -71.91 142.12 49.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.347 -0.846 . . . . 0.0 110.885 -178.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.778 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 5.4 m -129.42 117.55 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.909 . . . . 0.0 110.455 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.539 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 3.1 t0 -76.64 128.52 34.85 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.376 -0.828 . . . . 0.0 108.897 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.656 ' CD1' HG21 ' A' ' 66' ' ' ILE . 34.2 m-85 -88.09 142.59 27.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.033 -1.042 . . . . 0.0 112.629 -177.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -121.4 84.78 2.29 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.128 -179.434 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.683 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.8 OUTLIER -35.2 126.46 0.58 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.761 -0.587 . . . . 0.0 110.853 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.9 OUTLIER -34.18 -78.52 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.625 -0.672 . . . . 0.0 110.843 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.464 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -168.78 143.45 3.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.312 -0.868 . . . . 0.0 110.395 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 51.51 45.26 53.83 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.577 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 10.8 m-85 -148.22 154.78 40.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.406 -1.055 . . . . 0.0 110.217 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.705 ' O ' HG22 ' A' ' 117' ' ' VAL . 35.9 mtpt -109.94 131.12 55.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 109.967 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.683 HD11 ' H ' ' A' ' 89' ' ' CYS . 2.0 mt -73.12 93.12 1.77 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.904 . . . . 0.0 110.246 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.468 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -74.39 98.54 3.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.928 . . . . 0.0 109.766 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 147.32 -97.94 0.19 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.608 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -149.87 128.52 12.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.234 -1.156 . . . . 0.0 110.211 -179.655 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 87' ' ' PHE . 24.9 p -72.36 -45.44 59.84 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.125 -0.985 . . . . 0.0 110.59 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.6 p -102.89 116.3 32.29 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.115 -0.991 . . . . 0.0 110.248 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 16.4 m -120.83 178.96 4.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.421 -0.799 . . . . 0.0 110.297 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.736 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.5 OUTLIER -152.58 134.24 14.61 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.571 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.554 ' SG ' ' O ' ' A' ' 80' ' ' SER . 12.9 t -62.03 78.48 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.542 0.687 . . . . 0.0 109.547 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.499 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -56.43 176.9 0.19 Allowed Pre-proline 0 N--CA 1.498 1.935 0 CA-C-O 121.506 0.67 . . . . 0.0 112.753 -178.485 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.784 ' CB ' HD12 ' A' ' 38' ' ' ILE . 47.2 Cg_endo -79.08 25.45 0.57 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 124.779 1.936 . . . . 0.0 112.079 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -122.86 18.86 7.96 Favored Glycine 0 N--CA 1.482 1.757 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.691 ' O ' HG23 ' A' ' 108' ' ' THR . 16.3 m-80 62.63 53.05 2.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.894 -0.768 . . . . 0.0 110.066 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.2 OUTLIER -163.64 179.27 7.3 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.288 -0.883 . . . . 0.0 111.166 179.881 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.778 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 45.4 m95 -110.03 90.74 3.4 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.561 -0.712 . . . . 0.0 110.243 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.581 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 1.0 OUTLIER -100.33 154.91 36.94 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.322 -0.861 . . . . 0.0 109.596 179.84 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.608 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.3 Cg_endo -69.48 -179.92 19.96 Favored 'Cis proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.33 -1.946 . . . . 0.0 111.414 0.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.472 ' C ' ' O ' ' A' ' 111' ' ' PRO . 9.5 mt-10 -34.44 121.8 0.5 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.416 0.627 . . . . 0.0 111.097 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.609 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 3.0 tp -49.13 141.7 10.82 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.39 -0.819 . . . . 0.0 110.127 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.698 ' HG2' HD12 ' A' ' 66' ' ' ILE . 41.5 Cg_endo -70.26 158.5 56.1 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 124.073 1.564 . . . . 0.0 110.416 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.845 ' HG2' HG13 ' A' ' 117' ' ' VAL . 11.5 ttpt -124.11 107.17 10.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 110.37 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 2.6 t -63.01 78.28 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.17 -0.957 . . . . 0.0 109.168 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.845 HG13 ' HG2' ' A' ' 115' ' ' LYS . 2.5 m -92.92 -173.83 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.903 0.859 . . . . 0.0 111.264 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.461 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.6 OUTLIER . . . . . 0 C--N 1.296 -1.758 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.239 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 2' ' ' LYS . 59.1 t . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.162 0.505 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 32.4 mttt -93.53 164.79 13.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.248 -0.907 . . . . 0.0 110.285 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.571 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -131.37 83.74 2.12 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.165 -0.959 . . . . 0.0 110.343 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.423 ' O ' ' C ' ' A' ' 5' ' ' SER . 4.3 pm0 -63.52 179.57 0.45 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.12 -0.988 . . . . 0.0 109.928 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.3 p -44.99 144.52 1.93 Allowed Pre-proline 0 C--N 1.297 -1.684 0 C-N-CA 119.715 -0.794 . . . . 0.0 109.443 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.892 ' HG3' HG11 ' A' ' 27' ' ' VAL . 45.9 Cg_endo -70.16 159.86 51.63 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 124.028 1.541 . . . . 0.0 111.004 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.72 171.17 18.73 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.004 1.528 . . . . 0.0 110.216 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 77.4 p -73.58 179.18 4.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 0.0 110.17 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.639 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -145.14 -169.51 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 122.232 1.015 . . . . 0.0 111.78 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 3.6 t -50.27 100.23 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.2 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 10' ' ' SER . 5.5 m-20 36.72 55.49 1.16 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.658 -0.651 . . . . 0.0 111.335 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.414 ' HA3' ' SG ' ' A' ' 56' ' ' CYS . . . -150.28 -163.34 11.13 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.528 ' CG ' ' HB3' ' A' ' 30' ' ' SER . 0.0 OUTLIER -148.2 174.9 11.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.206 -1.173 . . . . 0.0 110.362 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.621 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 23.2 p80 -140.74 -155.32 0.58 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.551 -0.718 . . . . 0.0 110.023 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 0.1 OUTLIER 70.35 106.8 0.06 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.332 -0.855 . . . . 0.0 110.434 179.621 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.495 ' O ' ' CD2' ' A' ' 17' ' ' TYR . . . -166.35 46.89 0.27 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.495 ' CD2' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER 179.18 -33.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -1.175 . . . . 0.0 110.571 -179.908 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 8.8 pt-20 -179.71 -168.69 0.12 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.094 -1.004 . . . . 0.0 110.761 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -114.35 -41.69 3.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.461 -0.774 . . . . 0.0 109.635 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -95.64 130.13 42.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.395 -0.815 . . . . 0.0 109.733 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.647 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.4 OUTLIER -122.45 -6.48 8.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.144 -0.973 . . . . 0.0 110.626 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.571 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 72.6 p 46.69 -95.75 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.501 -0.75 . . . . 0.0 112.1 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 0.8 OUTLIER -154.62 144.86 21.97 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.887 -1.133 . . . . 0.0 110.577 -178.527 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.22 31.96 29.92 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.647 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -122.13 172.25 8.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.438 -1.037 . . . . 0.0 110.267 -179.742 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.91 HG13 ' O ' ' A' ' 43' ' ' VAL . 48.6 t -142.99 152.87 16.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.265 -0.897 . . . . 0.0 110.826 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.935 ' O ' HG23 ' A' ' 43' ' ' VAL . 11.9 t -129.81 122.11 53.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 C-N-CA 119.831 -0.747 . . . . 0.0 111.413 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.42 102.3 5.12 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 118.723 -1.191 . . . . 0.0 107.882 178.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.952 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.1 m-30 -68.34 120.65 14.81 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.263 -178.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.528 ' HB3' ' CG ' ' A' ' 13' ' ' ARG . 4.9 t -73.18 -177.65 2.59 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.945 -1.097 . . . . 0.0 109.2 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 30' ' ' SER . 71.0 m -151.56 163.89 38.06 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.344 -0.848 . . . . 0.0 109.975 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.34 145.58 26.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.182 -0.949 . . . . 0.0 109.701 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.432 ' O ' ' OG ' ' A' ' 33' ' ' SER . 1.6 p -52.64 110.9 0.56 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 110.499 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.04 -20.43 26.33 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -79.27 132.17 36.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.182 -1.187 . . . . 0.0 110.354 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.702 ' HB3' HD11 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -80.84 138.86 36.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.16 -0.962 . . . . 0.0 110.579 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.565 HD13 ' O ' ' A' ' 29' ' ' TYR . 0.8 OUTLIER -85.87 98.03 10.54 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.431 -0.793 . . . . 0.0 109.358 179.09 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.903 HD12 ' HB3' ' A' ' 105' ' ' PRO . 0.7 OUTLIER -89.17 148.86 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -0.884 . . . . 0.0 109.065 179.784 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.89 -150.43 16.91 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.05 137.43 32.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.358 -1.083 . . . . 0.0 110.371 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.415 ' HA ' HD21 ' A' ' 37' ' ' LEU . 54.8 p -76.69 55.29 1.04 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.933 . . . . 0.0 109.444 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.606 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 153.93 121.17 0.8 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.952 HG21 ' CE1' ' A' ' 29' ' ' TYR . 1.7 t -69.27 -178.29 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.173 -1.193 . . . . 0.0 108.263 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.498 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.3 tp -143.92 97.54 3.08 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.923 -1.11 . . . . 0.0 110.714 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.594 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 1.0 OUTLIER -86.04 114.7 23.13 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.081 -1.047 . . . . 0.0 109.132 178.569 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.07 91.91 3.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.501 -0.749 . . . . 0.0 110.225 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.526 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 78.49 63.49 2.12 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 46.7 53.15 10.35 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -157.31 73.37 0.73 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.346 -1.091 . . . . 0.0 110.569 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.594 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 76.1 m95 -55.7 137.73 48.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.087 -1.008 . . . . 0.0 109.354 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -146.87 163.8 34.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.001 -1.062 . . . . 0.0 111.342 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.51 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 1.5 m-20 62.11 65.77 1.56 Allowed Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.826 -0.546 . . . . 0.0 111.377 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.51 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 46.5 Cg_endo -91.47 129.23 1.2 Allowed 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 121.802 1.668 . . . . 0.0 110.17 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.573 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 49.7 Cg_endo -80.21 168.21 18.83 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.904 1.476 . . . . 0.0 110.086 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.615 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 65.7 p -107.83 148.01 30.12 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.979 -1.076 . . . . 0.0 111.347 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 10' ' ' SER . 88.9 m -109.25 77.91 1.1 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -113.81 -167.68 1.24 Allowed 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.394 0.616 . . . . 0.0 110.487 -178.305 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.654 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -104.69 134.69 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.246 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.634 HG21 ' CB ' ' A' ' 81' ' ' TYR . 19.8 m -122.7 43.75 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.063 -1.023 . . . . 0.0 111.099 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -82.93 96.69 8.37 Favored 'General case' 0 C--N 1.286 -2.179 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.956 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 107' ' ' ASN . 29.2 m -69.69 162.09 69.97 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.397 -0.814 . . . . 0.0 111.423 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.459 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 44.3 Cg_endo -72.88 -90.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.559 1.82 . . . . 0.0 110.578 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.485 ' CE1' ' CZ ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -161.69 132.77 3.79 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.802 ' HA ' HD21 ' A' ' 113' ' ' LEU . 55.7 Cg_endo -78.7 65.71 8.67 Favored 'Trans proline' 0 C--N 1.295 -2.267 0 O-C-N 123.665 1.35 . . . . 0.0 109.454 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.646 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -82.98 176.03 9.58 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.579 -0.701 . . . . 0.0 110.287 -179.652 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.646 HG22 ' C ' ' A' ' 65' ' ' THR . 0.2 OUTLIER -176.7 163.39 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.227 -0.92 . . . . 0.0 110.625 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.46 ' N ' HG13 ' A' ' 66' ' ' ILE . 1.8 m -75.9 107.61 8.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.509 -0.744 . . . . 0.0 110.831 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 8.6 m-20 43.37 37.89 1.53 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.457 -0.777 . . . . 0.0 110.432 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.597 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -145.1 26.72 1.88 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.551 ' O ' ' N ' ' A' ' 88' ' ' LYS . 23.4 p90 -43.91 -178.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.409 1.1 . . . . 0.0 111.833 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.69 HD13 ' H ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -109.63 156.29 20.4 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 121.913 0.864 . . . . 0.0 110.858 179.083 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.08 11.77 4.25 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.778 -1.201 . . . . 0.0 110.033 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.22 -79.68 0.23 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.347 -0.845 . . . . 0.0 110.917 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -141.42 84.08 0.21 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.537 ' C ' ' CD1' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -98.95 160.92 13.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.467 -1.019 . . . . 0.0 109.911 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.584 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 24.4 ttmt -153.44 156.81 38.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.264 -0.897 . . . . 0.0 110.531 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 26.5 mtp85 -53.37 -30.16 38.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.897 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.418 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -141.77 171.56 13.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.484 -0.76 . . . . 0.0 110.21 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.584 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 31.2 m-85 -144.08 177.66 8.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.214 -0.929 . . . . 0.0 110.408 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.575 ' HA ' HG23 ' A' ' 59' ' ' VAL . 7.7 p -162.85 92.36 0.77 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.177 -0.952 . . . . 0.0 110.238 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.634 ' CB ' HG21 ' A' ' 59' ' ' VAL . 13.3 t80 56.83 136.31 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.092 -1.005 . . . . 0.0 110.247 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.733 ' O ' HG22 ' A' ' 102' ' ' THR . 14.4 t-20 63.57 -125.05 0.55 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.849 -1.157 . . . . 0.0 110.521 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.498 ' HB3' ' HB3' ' A' ' 103' ' ' CYS . 0.5 OUTLIER 54.13 71.2 0.53 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.617 -1.302 . . . . 0.0 109.014 -178.526 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.539 ' N ' HG23 ' A' ' 102' ' ' THR . 5.4 t30 -73.53 136.69 44.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.515 -0.741 . . . . 0.0 111.332 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.586 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 12.5 m -124.0 117.21 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.246 -0.909 . . . . 0.0 109.877 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 48.6 t0 -78.4 136.04 37.56 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.682 ' CE1' HD12 ' A' ' 71' ' ' LEU . 60.6 m-85 -94.24 129.68 40.78 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.99 -1.069 . . . . 0.0 112.158 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 70' ' ' TYR . 9.1 tptt -99.52 90.05 4.37 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.631 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.518 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -44.35 128.77 6.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.004 -1.06 . . . . 0.0 109.861 -179.668 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 2.9 mmtt -38.93 -78.0 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.595 -0.691 . . . . 0.0 110.472 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.589 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -168.27 141.53 3.14 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.358 -0.839 . . . . 0.0 110.366 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.582 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 49.79 53.78 20.47 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.589 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 11.6 m-85 -158.28 151.23 22.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.469 -1.019 . . . . 0.0 109.624 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.565 ' O ' HG22 ' A' ' 117' ' ' VAL . 13.1 mtmm -109.18 134.64 51.47 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.113 -0.992 . . . . 0.0 110.161 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' A' ' 114' ' ' PRO . 1.8 mt -72.13 103.51 3.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.259 -0.9 . . . . 0.0 110.571 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.488 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -84.87 112.83 20.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.151 -0.968 . . . . 0.0 109.751 179.379 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 132.08 -77.74 0.38 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.538 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -167.73 112.05 0.67 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.358 -1.084 . . . . 0.0 110.44 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 43.9 t -69.97 -7.07 37.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.211 -0.931 . . . . 0.0 110.306 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.0 p -139.65 98.8 3.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.182 -0.949 . . . . 0.0 110.04 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.604 ' HG ' ' HE2' ' A' ' 87' ' ' PHE . 7.0 m -106.47 -174.69 2.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.192 -0.943 . . . . 0.0 110.565 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.733 HG22 ' O ' ' A' ' 82' ' ' ASN . 19.8 m -157.93 134.9 9.97 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.251 -0.98 . . . . 0.0 111.301 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.602 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 1.8 t -62.2 87.4 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.479 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -78.57 177.05 3.06 Favored Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.133 -0.98 . . . . 0.0 110.859 -179.387 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.903 ' HB3' HD12 ' A' ' 38' ' ' ILE . 41.9 Cg_endo -73.55 138.28 26.6 Favored 'Trans proline' 0 C--N 1.302 -1.91 0 O-C-N 124.436 1.756 . . . . 0.0 110.499 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.554 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 116.92 -10.05 15.72 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.554 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 1.4 m-20 81.12 77.72 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.943 -0.74 . . . . 0.0 110.065 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -173.73 -175.05 1.03 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.626 -0.83 . . . . 0.0 110.969 -179.697 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.606 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 38.9 m95 -124.35 89.03 3.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.546 -0.721 . . . . 0.0 109.723 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.592 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -101.86 136.05 19.6 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.491 -0.755 . . . . 0.0 110.652 -179.109 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.592 ' C ' ' HA ' ' A' ' 110' ' ' LYS . 40.9 Cg_endo -68.52 163.73 77.28 Favored 'Cis proline' 0 N--CA 1.489 1.224 0 C-N-CA 122.101 -2.041 . . . . 0.0 111.029 -0.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 111' ' ' PRO . 28.5 tt0 -40.06 155.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.457 0.646 . . . . 0.0 110.689 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.802 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -62.99 146.29 95.78 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.494 -0.754 . . . . 0.0 110.043 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.576 ' HG3' ' CD2' ' A' ' 87' ' ' PHE . 41.1 Cg_endo -72.45 175.4 10.15 Favored 'Trans proline' 0 C--N 1.299 -2.057 0 O-C-N 124.365 1.718 . . . . 0.0 111.136 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.643 ' HG2' HG13 ' A' ' 117' ' ' VAL . 6.4 tttp -133.79 114.39 13.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.493 -0.755 . . . . 0.0 109.907 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.52 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 3.5 t -72.96 71.19 1.06 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.082 -1.011 . . . . 0.0 109.505 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.643 HG13 ' HG2' ' A' ' 115' ' ' LYS . 5.9 m -86.91 -170.37 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-O 122.057 0.932 . . . . 0.0 110.924 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.477 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.294 -1.844 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.281 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.593 HG23 ' HA3' ' A' ' 48' ' ' GLY . 9.1 m . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.301 0.572 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.77 178.96 6.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.296 -0.878 . . . . 0.0 110.512 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.524 ' O ' ' N ' ' A' ' 21' ' ' TYR . 1.2 m -117.99 136.38 53.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.493 -0.754 . . . . 0.0 110.131 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 5' ' ' SER . 5.7 pt20 -110.61 172.94 6.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.046 -1.034 . . . . 0.0 109.647 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.503 ' HB2' ' HA ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -46.65 132.86 8.21 Favored Pre-proline 0 C--N 1.298 -1.637 0 C-N-CA 119.369 -0.933 . . . . 0.0 109.36 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.592 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 43.8 Cg_endo -69.81 166.03 29.03 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.939 1.494 . . . . 0.0 110.325 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.02 166.47 27.81 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 O-C-N 123.942 1.496 . . . . 0.0 110.306 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.74 175.37 9.45 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.376 -0.827 . . . . 0.0 109.949 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 11' ' ' ASN . 0.3 OUTLIER -141.44 -170.33 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-O 122.227 1.013 . . . . 0.0 111.331 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.5 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 1.3 m -46.44 91.54 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.92 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.506 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER 42.03 51.09 4.33 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.147 -0.97 . . . . 0.0 110.376 179.643 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -150.53 151.79 23.76 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -111.15 -179.05 3.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.34 -1.094 . . . . 0.0 110.265 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.614 ' CD2' ' N ' ' A' ' 14' ' ' HIS . 8.4 m170 -66.06 -139.42 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.279 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -85.28 -97.76 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.935 . . . . 0.0 110.212 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.32 -71.2 0.69 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -164.61 84.75 0.42 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -1.173 . . . . 0.0 110.254 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.441 ' N ' ' CD ' ' A' ' 18' ' ' GLU . 5.9 mp0 -109.49 -54.01 2.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.84 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.503 ' HA ' ' HB2' ' A' ' 5' ' ' SER . 2.1 m-20 59.04 18.38 6.28 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.5 -0.75 . . . . 0.0 110.232 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.563 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 0.2 OUTLIER -163.27 149.13 11.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 110.618 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.6 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 9.0 m-85 -163.98 174.75 11.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.509 -0.744 . . . . 0.0 109.649 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.501 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 22.6 p -136.03 -69.83 0.48 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.779 -1.201 . . . . 0.0 111.099 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -161.49 145.4 12.88 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.514 -0.742 . . . . 0.0 109.384 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.17 12.31 57.59 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.38 -1.888 . . . . 0.0 108.38 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.6 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -82.63 174.3 11.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.507 -0.996 . . . . 0.0 109.816 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.719 HG13 ' O ' ' A' ' 43' ' ' VAL . 28.2 t -153.85 156.65 5.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.856 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.682 ' O ' HG23 ' A' ' 43' ' ' VAL . 4.0 t -137.16 114.22 12.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 C-N-CA 119.631 -0.827 . . . . 0.0 111.546 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.881 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -70.45 102.76 2.27 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 118.543 -1.263 . . . . 0.0 108.015 178.366 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.639 ' O ' HD13 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -68.22 97.49 0.72 Allowed 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.205 -0.998 . . . . 0.0 109.592 -178.589 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.493 ' OG ' ' O ' ' A' ' 14' ' ' HIS . 0.1 OUTLIER -70.08 139.43 52.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.78 -1.2 . . . . 0.0 109.8 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 56' ' ' CYS . 12.4 m -108.27 153.11 23.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.372 -0.83 . . . . 0.0 109.679 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 31' ' ' CYS . 0.7 OUTLIER -44.05 140.92 1.87 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.163 -0.961 . . . . 0.0 109.841 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 83.2 p -52.42 98.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 110.084 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 134.33 -1.74 4.13 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' A' ' 56' ' ' CYS . 0.6 OUTLIER -106.15 161.03 14.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.067 -1.255 . . . . 0.0 110.421 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.98 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.7 OUTLIER -102.58 129.99 49.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.359 -0.838 . . . . 0.0 110.963 -179.405 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.809 HD21 ' HA ' ' A' ' 41' ' ' SER . 4.6 tp -89.05 120.67 30.67 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.329 -0.857 . . . . 0.0 109.294 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.789 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -118.37 141.74 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.138 -0.976 . . . . 0.0 109.881 -179.501 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.506 ' O ' ' CB ' ' A' ' 40' ' ' ASN . . . 101.58 44.22 2.0 Favored Glycine 0 N--CA 1.488 2.154 0 C-N-CA 119.393 -1.384 . . . . 0.0 109.687 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 5.8 t-20 72.11 169.45 0.32 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.491 -1.005 . . . . 0.0 109.775 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.881 ' O ' HG23 ' A' ' 28' ' ' THR . 0.8 OUTLIER -112.36 63.15 0.63 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 110.457 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.541 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 160.12 113.89 0.34 Allowed Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.635 -1.269 . . . . 0.0 110.306 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.719 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.1 t -60.84 -179.06 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.05 -1.265 . . . . 0.0 108.066 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.458 ' HA ' ' O ' ' A' ' 25' ' ' SER . 0.8 OUTLIER -143.78 102.55 3.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.994 -1.066 . . . . 0.0 110.533 178.904 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.591 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.6 OUTLIER -85.48 113.84 22.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.317 -0.864 . . . . 0.0 109.276 178.654 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 87.7 p -129.64 137.52 50.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 0.0 110.531 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.01 9.12 45.93 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.593 ' HA3' HG23 ' A' ' 1' ' ' VAL . . . 93.36 29.08 10.54 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -146.08 135.18 22.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.366 -1.079 . . . . 0.0 110.097 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.591 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 89.1 m95 -80.71 138.36 36.34 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.217 -0.927 . . . . 0.0 109.909 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -141.81 165.46 27.4 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.119 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.529 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 1.3 t70 43.11 64.87 5.99 Favored Pre-proline 0 N--CA 1.491 1.614 0 CA-C-O 121.141 0.496 . . . . 0.0 111.819 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 47.0 Cg_endo -91.8 125.56 0.86 Allowed 'Trans proline' 0 C--N 1.3 -1.996 0 O-C-N 124.341 1.706 . . . . 0.0 109.261 178.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.517 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 45.1 Cg_endo -70.79 -178.44 2.74 Favored 'Trans proline' 0 C--N 1.297 -2.15 0 O-C-N 123.808 1.425 . . . . 0.0 110.759 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.571 ' N ' ' O ' ' A' ' 38' ' ' ILE . 6.0 p -119.82 -169.09 1.71 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.851 0.834 . . . . 0.0 111.255 -178.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 10' ' ' SER . 96.4 m -151.92 86.65 1.32 Allowed 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -111.11 -139.5 0.38 Allowed 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.055 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.781 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -142.82 74.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 179.391 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.98 HG13 ' CB ' ' A' ' 36' ' ' SER . 4.6 m -68.72 126.49 28.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 122.55 1.167 . . . . 0.0 110.679 -177.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 107' ' ' ASN . 24.6 mtpt -147.22 93.67 2.28 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.499 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 27.4 m -69.1 162.78 62.84 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.513 -0.742 . . . . 0.0 111.732 -177.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 46.1 Cg_endo -72.82 -90.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.612 1.848 . . . . 0.0 110.615 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.458 ' HB3' ' CG2' ' A' ' 65' ' ' THR . 0.0 OUTLIER -164.98 129.34 1.81 Allowed Pre-proline 0 C--N 1.302 -1.462 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.615 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 54.7 Cg_endo -77.33 65.68 7.94 Favored 'Trans proline' 0 C--N 1.298 -2.114 0 O-C-N 123.608 1.32 . . . . 0.0 109.617 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.724 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.8 OUTLIER -83.95 178.81 7.72 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.266 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.786 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -175.02 158.39 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.077 179.388 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.501 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 0.7 OUTLIER -64.35 101.82 0.47 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.496 -0.753 . . . . 0.0 110.5 -179.57 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.463 ' O ' ' SG ' ' A' ' 116' ' ' CYS . 45.0 m-20 39.66 50.74 2.26 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.438 -0.789 . . . . 0.0 110.607 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.786 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -158.54 32.07 0.48 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.562 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 4.9 p90 -45.17 -172.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.798 1.285 . . . . 0.0 112.684 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.706 HD13 ' H ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -109.96 167.91 9.82 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.601 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.46 ' O ' ' OG ' ' A' ' 72' ' ' SER . 0.3 OUTLIER -144.97 24.91 1.45 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.044 -1.035 . . . . 0.0 110.155 -179.611 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.3 t -104.24 -89.02 0.41 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.032 -1.042 . . . . 0.0 110.824 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -118.92 72.86 0.31 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 2.9 t80 -98.2 164.82 12.16 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.446 -1.032 . . . . 0.0 110.19 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.63 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 2.4 tttp -168.93 159.13 9.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.367 -0.833 . . . . 0.0 109.95 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -52.6 -27.79 18.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.128 -0.983 . . . . 0.0 109.981 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.462 ' C ' ' CG ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -141.31 173.87 11.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.366 -0.834 . . . . 0.0 110.556 -179.723 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.575 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 43.3 m-85 -148.82 -168.15 3.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.519 -0.738 . . . . 0.0 109.486 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.608 ' CA ' HG23 ' A' ' 59' ' ' VAL . 88.1 p -141.47 -102.12 0.14 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.741 -1.225 . . . . 0.0 111.355 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.686 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -119.27 19.36 12.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.608 -1.307 . . . . 0.0 111.24 -178.696 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.791 ' O ' HG22 ' A' ' 102' ' ' THR . 29.0 t-20 -159.86 -101.59 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.875 -1.14 . . . . 0.0 110.118 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 82' ' ' ASN . 2.9 m-20 44.94 72.79 0.18 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.87 -1.144 . . . . 0.0 109.277 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.887 ' CA ' HG23 ' A' ' 102' ' ' THR . 8.7 p30 -68.74 113.91 6.63 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.386 -0.821 . . . . 0.0 110.172 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.529 ' N ' ' O ' ' A' ' 101' ' ' SER . 33.1 m -99.28 121.88 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.249 -0.907 . . . . 0.0 111.073 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.522 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 28.8 t70 -83.27 134.6 34.93 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.645 ' CE1' HD12 ' A' ' 71' ' ' LEU . 29.3 m-85 -91.46 132.82 35.98 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.825 -1.172 . . . . 0.0 112.046 -178.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.2 OUTLIER -111.2 92.0 3.87 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.181 -179.39 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.477 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -44.49 128.37 6.37 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.043 -1.036 . . . . 0.0 109.907 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 2.4 mmmp? -41.19 -85.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.32 -0.862 . . . . 0.0 110.375 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.581 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -159.09 142.2 14.52 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.273 -0.892 . . . . 0.0 110.418 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.594 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 54.7 54.94 29.95 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.594 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 18.2 m-85 -160.27 167.41 27.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.469 -1.018 . . . . 0.0 109.729 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.481 ' N ' ' O ' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -132.22 114.37 14.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.24 -0.913 . . . . 0.0 109.911 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.753 HD23 HD11 ' A' ' 66' ' ' ILE . 10.2 mt -46.39 107.49 0.11 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.11 -0.994 . . . . 0.0 110.479 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.705 ' HB2' HG21 ' A' ' 117' ' ' VAL . 1.2 t -90.1 97.04 10.96 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.432 -0.792 . . . . 0.0 109.685 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.62 -40.33 1.38 Allowed Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.404 -1.379 . . . . 0.0 110.546 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.581 ' O ' ' HB3' ' A' ' 114' ' ' PRO . 0.0 OUTLIER 177.58 -164.45 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.889 -1.359 . . . . 0.0 111.524 -179.191 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.529 ' N ' ' OG ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -149.21 -53.42 0.17 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.713 -0.617 . . . . 0.0 110.2 -179.833 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 91.1 p -110.48 105.51 14.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.23 -0.919 . . . . 0.0 110.644 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.529 ' O ' ' N ' ' A' ' 85' ' ' VAL . 50.6 m -113.73 164.27 13.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.329 -0.857 . . . . 0.0 110.118 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.887 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -133.39 143.39 48.9 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.345 -0.847 . . . . 0.0 110.885 -179.687 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.628 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -72.95 98.27 2.45 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.33 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.565 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -67.98 176.27 1.41 Allowed Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.182 -0.949 . . . . 0.0 112.333 -178.52 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.789 ' CB ' HD12 ' A' ' 38' ' ' ILE . 41.0 Cg_endo -70.03 -33.36 15.72 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 124.689 1.889 . . . . 0.0 111.728 -177.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.56 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -75.5 4.64 41.42 Favored Glycine 0 N--CA 1.486 2.001 0 C-N-CA 119.267 -1.444 . . . . 0.0 110.799 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.719 ' O ' HG23 ' A' ' 108' ' ' THR . 0.9 OUTLIER 78.13 89.4 0.07 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.445 -1.033 . . . . 0.0 110.929 179.245 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.719 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -178.45 -161.7 0.05 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.857 . . . . 0.0 110.906 179.354 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.727 ' HB3' HD13 ' A' ' 113' ' ' LEU . 22.7 m95 -142.71 97.94 3.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 111.305 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.525 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 2.5 mtpp -106.75 145.83 31.85 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.411 -0.806 . . . . 0.0 109.512 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.536 ' HG2' ' HB2' ' A' ' 98' ' ' SER . 47.3 Cg_endo -72.91 178.62 31.27 Favored 'Cis proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.088 -2.047 . . . . 0.0 111.089 -0.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.447 ' O ' ' C ' ' A' ' 113' ' ' LEU . 5.3 tt0 -40.74 121.16 1.42 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.606 -0.684 . . . . 0.0 110.352 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.727 HD13 ' HB3' ' A' ' 109' ' ' TRP . 0.6 OUTLIER -40.91 138.56 1.31 Allowed Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.416 -0.802 . . . . 0.0 110.001 179.701 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.731 ' HG2' HD12 ' A' ' 66' ' ' ILE . 42.8 Cg_endo -75.04 160.69 39.75 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 O-C-N 124.176 1.619 . . . . 0.0 111.758 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.75 ' HG2' HG13 ' A' ' 117' ' ' VAL . 5.6 ttpp -125.67 99.89 6.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.469 -0.769 . . . . 0.0 110.813 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.546 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.8 t -53.29 100.88 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.93 . . . . 0.0 109.468 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.75 HG13 ' HG2' ' A' ' 115' ' ' LYS . 2.0 m -118.92 179.18 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.664 0.745 . . . . 0.0 110.624 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.5 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.293 -1.858 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.371 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 53.8 t . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.213 0.53 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -81.13 170.32 16.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.256 -0.902 . . . . 0.0 110.319 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 21' ' ' TYR . 1.2 m -125.39 90.58 3.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 109.713 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.517 ' HA ' ' O ' ' A' ' 19' ' ' ASP . 37.6 tt0 -72.88 173.58 8.99 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.021 -1.049 . . . . 0.0 109.895 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.513 ' N ' ' CG ' ' A' ' 4' ' ' GLN . 0.7 OUTLIER -44.09 134.76 4.12 Favored Pre-proline 0 C--N 1.297 -1.706 0 O-C-N 121.501 -0.749 . . . . 0.0 109.642 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.647 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 51.6 Cg_endo -71.36 150.5 58.59 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.939 1.494 . . . . 0.0 110.525 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.34 172.23 15.36 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 O-C-N 124.007 1.53 . . . . 0.0 109.932 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.53 177.71 2.81 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.248 -0.907 . . . . 0.0 109.509 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.682 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -139.09 -170.41 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 122.172 0.987 . . . . 0.0 111.297 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 5.5 t -47.37 98.25 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.616 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.2 m120 44.35 47.85 8.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 0.0 110.415 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.467 ' O ' HG13 ' A' ' 9' ' ' ILE . . . -159.6 156.64 27.81 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.42 -169.71 1.51 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.117 -1.225 . . . . 0.0 111.071 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.657 ' HB2' HG11 ' A' ' 27' ' ' VAL . 13.8 p80 -137.85 126.0 22.97 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.353 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.669 ' O ' HG13 ' A' ' 27' ' ' VAL . 2.1 t30 -100.37 -175.33 2.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.308 -0.87 . . . . 0.0 110.263 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.485 ' HA3' ' OH ' ' A' ' 21' ' ' TYR . . . 154.22 -36.6 0.7 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.472 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER 67.44 35.88 4.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.395 -1.061 . . . . 0.0 110.482 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.595 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -142.48 -159.61 0.99 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.292 -0.88 . . . . 0.0 109.817 179.599 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.517 ' O ' ' HA ' ' A' ' 4' ' ' GLN . 1.5 m-20 -147.47 -35.2 0.24 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.171 -0.956 . . . . 0.0 110.59 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -121.03 79.05 1.46 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.191 -0.943 . . . . 0.0 110.14 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.603 ' CE2' ' CG2' ' A' ' 27' ' ' VAL . 0.9 OUTLIER -57.57 -24.7 57.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.07 -1.019 . . . . 0.0 110.339 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.448 ' C ' ' HB2' ' A' ' 3' ' ' CYS . 0.2 OUTLIER 66.43 -79.08 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.464 -0.772 . . . . 0.0 112.32 178.561 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.529 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER -168.3 160.84 11.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.891 -1.13 . . . . 0.0 109.865 -178.938 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 59.39 17.07 38.09 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.506 ' CB ' ' CD1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -92.89 160.11 15.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.566 -0.961 . . . . 0.0 109.725 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.674 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 57.4 t -133.75 150.23 31.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 118.977 -1.089 . . . . 0.0 110.907 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.861 ' O ' HG23 ' A' ' 43' ' ' VAL . 45.6 t -138.13 112.02 8.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.46 -0.775 . . . . 0.0 110.977 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -69.99 104.14 2.46 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.035 -1.466 . . . . 0.0 107.653 178.211 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 1.122 ' CE1' HG21 ' A' ' 43' ' ' VAL . 1.9 m-30 -67.62 130.67 43.75 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.956 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.71 152.64 23.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.122 -0.986 . . . . 0.0 109.906 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 1.024 ' SG ' HD12 ' A' ' 37' ' ' LEU . 98.1 m -129.71 143.81 50.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.154 -0.966 . . . . 0.0 110.354 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -55.17 127.95 31.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.267 -0.896 . . . . 0.0 110.285 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 71.1 p -44.88 139.73 2.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.298 -0.876 . . . . 0.0 110.332 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.5 -21.81 37.91 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.614 ' CE2' HG23 ' A' ' 58' ' ' ILE . 8.4 m-85 -108.94 141.22 41.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.12 -1.223 . . . . 0.0 110.3 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.792 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -79.03 136.36 37.16 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.349 -0.844 . . . . 0.0 110.995 -179.634 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 1.024 HD12 ' SG ' ' A' ' 31' ' ' CYS . 3.8 tt -92.54 94.23 8.95 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.833 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.9 OUTLIER -76.68 145.16 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.43 -0.793 . . . . 0.0 109.207 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 126.94 -160.26 21.2 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.514 ' O ' ' C ' ' A' ' 41' ' ' SER . 4.2 m-20 -115.8 52.01 0.92 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.113 -1.228 . . . . 0.0 109.798 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.675 ' O ' HG23 ' A' ' 28' ' ' THR . 18.3 p 24.88 67.78 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.715 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.87 116.08 0.42 Allowed Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.383 -1.389 . . . . 0.0 110.609 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.122 HG21 ' CE1' ' A' ' 29' ' ' TYR . 1.4 t -84.72 126.88 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.7 tp -97.29 106.88 19.29 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 120.201 -1.562 . . . . 0.0 111.423 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.602 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.8 OUTLIER -87.56 114.72 24.43 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.449 -0.901 . . . . 0.0 108.92 178.034 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.515 ' HA ' ' OD2' ' A' ' 23' ' ' ASP . 0.3 OUTLIER -132.43 128.67 38.0 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.404 -179.686 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.529 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 80.02 -5.48 62.38 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.449 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 109.79 6.76 28.24 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -126.54 116.49 21.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -1.18 . . . . 0.0 110.517 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.602 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 82.7 m95 -64.85 141.42 58.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.224 -0.922 . . . . 0.0 109.542 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 52' ' ' ASP . 2.4 t -140.98 -177.77 5.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.015 -1.053 . . . . 0.0 111.105 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.526 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER 36.26 65.4 2.14 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.746 -0.596 . . . . 0.0 111.207 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.526 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.8 Cg_endo -91.58 138.15 2.09 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 124.403 1.738 . . . . 0.0 109.666 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.536 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 51.3 Cg_endo -80.56 175.88 9.68 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.489 1.257 . . . . 0.0 110.321 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.618 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 20.0 p -130.12 138.58 50.75 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.171 -0.956 . . . . 0.0 111.0 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 10' ' ' SER . 14.2 m -97.52 76.48 2.54 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.494 ' HG3' HG12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -119.08 144.83 46.37 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.428 0.632 . . . . 0.0 110.219 -178.751 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.614 HG23 ' CE2' ' A' ' 35' ' ' TYR . 1.7 pt -69.46 120.54 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.792 HG13 ' CB ' ' A' ' 36' ' ' SER . 12.1 m -99.5 51.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.151 -0.968 . . . . 0.0 112.094 -178.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.425 ' HD3' HD12 ' A' ' 58' ' ' ILE . 3.0 mtpp -87.61 99.35 11.99 Favored 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 118.626 -1.229 . . . . 0.0 108.434 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.477 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 59.6 m -69.25 162.62 64.62 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.397 -0.814 . . . . 0.0 111.502 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 47.9 Cg_endo -72.0 -91.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.464 1.771 . . . . 0.0 110.587 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.469 ' HB3' ' CG2' ' A' ' 65' ' ' THR . 0.1 OUTLIER -158.27 132.27 5.04 Favored Pre-proline 0 C--N 1.302 -1.47 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.707 ' HA ' HD21 ' A' ' 113' ' ' LEU . 55.5 Cg_endo -77.77 67.89 7.83 Favored 'Trans proline' 0 C--N 1.293 -2.344 0 O-C-N 123.757 1.398 . . . . 0.0 109.528 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.657 ' O ' HD23 ' A' ' 113' ' ' LEU . 1.5 p -88.97 174.98 7.61 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.805 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -170.35 159.87 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 118.405 -1.318 . . . . 0.0 110.675 179.182 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.489 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 1.5 m -61.33 95.84 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.644 -0.66 . . . . 0.0 110.395 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.458 ' O ' ' SG ' ' A' ' 116' ' ' CYS . 8.6 m-20 44.57 45.07 7.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.426 -0.796 . . . . 0.0 110.597 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.805 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -151.85 33.4 0.88 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.567 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 3.7 p90 -45.89 -171.39 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 122.743 1.258 . . . . 0.0 112.628 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.798 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -113.85 162.93 15.73 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.194 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.7 t -149.88 28.93 0.75 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.993 -1.067 . . . . 0.0 109.944 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.64 -16.98 7.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 111.235 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -154.08 -87.86 0.06 OUTLIER Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.169 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.616 ' CD2' ' N ' ' A' ' 76' ' ' LYS . 58.5 t80 58.6 170.24 0.06 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.626 -0.926 . . . . 0.0 110.577 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.616 ' N ' ' CD2' ' A' ' 75' ' ' PHE . 4.1 tptt 174.83 134.3 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.403 -0.811 . . . . 0.0 109.842 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 76' ' ' LYS . 2.3 mtt-85 -40.1 -45.16 1.93 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.262 -0.899 . . . . 0.0 110.4 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.457 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 3.6 t -132.86 125.42 29.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.438 -0.789 . . . . 0.0 110.198 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.599 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 14.9 m-85 -101.49 -173.98 2.49 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.146 -0.971 . . . . 0.0 110.506 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -170.41 106.9 0.31 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.148 -0.97 . . . . 0.0 110.971 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.773 ' CB ' HG21 ' A' ' 59' ' ' VAL . 5.1 t80 35.04 32.51 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.107 -0.996 . . . . 0.0 112.118 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.567 ' N ' ' O ' ' A' ' 103' ' ' CYS . 15.5 t30 -177.37 -140.25 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.221 -1.549 . . . . 0.0 111.149 178.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.41 ' C ' HG23 ' A' ' 102' ' ' THR . 1.6 m-20 56.3 73.19 0.45 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.114 -0.991 . . . . 0.0 108.948 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.542 ' N ' HG23 ' A' ' 102' ' ' THR . 7.0 t30 -69.57 112.53 6.13 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.458 -0.776 . . . . 0.0 110.31 -179.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.606 ' O ' HG23 ' A' ' 85' ' ' VAL . 23.1 m -95.03 120.55 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 111.053 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 4.4 t0 -80.77 131.23 35.4 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.798 ' CE1' HD12 ' A' ' 71' ' ' LEU . 46.4 m-85 -91.14 136.9 32.77 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.881 -1.137 . . . . 0.0 111.945 -178.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -115.65 102.5 9.81 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.964 -179.587 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.517 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -49.44 131.31 20.66 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.098 -1.001 . . . . 0.0 110.081 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -39.96 -69.19 0.14 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.477 -0.764 . . . . 0.0 110.347 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.585 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 39.3 t80 -172.86 141.6 1.04 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -0.817 . . . . 0.0 110.21 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 50.99 56.92 12.14 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.585 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 13.2 m-85 -155.29 172.24 18.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.341 -1.093 . . . . 0.0 110.23 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 117' ' ' VAL . 0.7 OUTLIER -133.01 106.98 7.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.294 -0.879 . . . . 0.0 109.86 179.735 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.578 ' CD2' ' HB3' ' A' ' 87' ' ' PHE . 1.1 mt -46.83 99.38 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.194 -0.941 . . . . 0.0 110.675 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.453 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -78.99 101.4 7.76 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.358 -0.839 . . . . 0.0 109.441 179.226 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.86 -89.2 0.19 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.594 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.4 OUTLIER -154.35 116.94 4.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -1.173 . . . . 0.0 110.612 -179.404 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.536 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 2.0 m -83.42 29.83 0.49 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.308 -0.87 . . . . 0.0 110.832 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 65.4 p -170.5 102.56 0.26 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.16 -0.962 . . . . 0.0 109.531 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 85' ' ' VAL . 9.2 m -125.37 172.63 9.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.181 -0.949 . . . . 0.0 111.092 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.542 HG23 ' N ' ' A' ' 84' ' ' ASN . 19.9 m -143.52 142.47 31.14 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.458 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.567 ' O ' ' N ' ' A' ' 82' ' ' ASN . 6.8 t -54.57 100.51 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.399 -0.813 . . . . 0.0 109.124 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.45 ' OG ' ' HE3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -72.99 173.0 6.58 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 120.783 -1.198 . . . . 0.0 111.462 -178.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.833 ' CB ' HD12 ' A' ' 38' ' ' ILE . 47.2 Cg_endo -80.08 25.65 0.6 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.559 1.821 . . . . 0.0 112.451 -178.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -126.57 16.94 6.54 Favored Glycine 0 N--CA 1.484 1.851 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.595 ' O ' HG23 ' A' ' 108' ' ' THR . 0.9 OUTLIER 68.86 51.98 0.55 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.628 -0.925 . . . . 0.0 109.969 -179.86 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.595 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -160.78 -169.5 2.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.906 . . . . 0.0 111.109 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.688 ' HB3' HD13 ' A' ' 113' ' ' LEU . 36.4 m95 -117.48 99.95 7.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.382 -0.823 . . . . 0.0 110.336 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.52 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 2.8 mtmt -105.56 140.19 20.93 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.537 -0.727 . . . . 0.0 110.071 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.594 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 47.3 Cg_endo -73.54 171.71 64.79 Favored 'Cis proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.809 -2.163 . . . . 0.0 110.434 -0.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.0 OUTLIER -40.8 128.53 2.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.372 -0.83 . . . . 0.0 111.074 -179.419 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.707 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -41.46 147.58 0.47 Allowed Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.511 -0.743 . . . . 0.0 110.541 179.461 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.681 ' HG2' HD12 ' A' ' 66' ' ' ILE . 41.4 Cg_endo -75.53 169.91 21.36 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.342 1.707 . . . . 0.0 111.05 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.832 ' HG2' HG13 ' A' ' 117' ' ' VAL . 30.7 ttmt -128.79 110.62 12.32 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.24 -0.912 . . . . 0.0 110.503 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.554 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 3.2 t -65.95 93.55 0.2 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.012 -1.055 . . . . 0.0 109.351 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.832 HG13 ' HG2' ' A' ' 115' ' ' LYS . 2.3 m -113.21 -174.54 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 121.859 0.838 . . . . 0.0 111.176 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.529 ' HG2' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.792 0 CA-C-O 117.951 -1.024 . . . . 0.0 110.348 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.536 HG22 ' N ' ' A' ' 2' ' ' LYS . 7.0 p . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.248 0.547 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.536 ' N ' HG22 ' A' ' 1' ' ' VAL . 10.5 ptmt -159.84 -177.74 6.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 110.385 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.535 ' O ' ' HB2' ' A' ' 21' ' ' TYR . 1.1 m -133.54 81.16 1.91 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.606 -0.684 . . . . 0.0 109.818 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.631 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 58.4 mt-30 -63.46 178.57 0.54 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.827 -1.171 . . . . 0.0 110.456 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.8 p -46.35 143.83 3.58 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.45 -0.782 . . . . 0.0 109.896 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.889 ' HG3' HG11 ' A' ' 27' ' ' VAL . 48.7 Cg_endo -73.97 151.63 45.25 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.076 1.566 . . . . 0.0 111.204 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.61 171.31 18.03 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.789 1.415 . . . . 0.0 109.956 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.2 p -69.65 175.86 3.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.118 -0.989 . . . . 0.0 110.001 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.744 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -142.25 -170.16 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 122.239 1.019 . . . . 0.0 111.296 179.757 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 3.2 t -51.48 99.47 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.852 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 10' ' ' SER . 1.3 m120 41.66 57.58 3.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.236 -0.915 . . . . 0.0 110.656 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -163.82 148.72 15.25 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.455 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -98.12 -176.85 3.54 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.298 -1.119 . . . . 0.0 110.12 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.623 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 23.8 p80 -143.92 138.65 28.69 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.697 -0.627 . . . . 0.0 109.814 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -166.93 -141.13 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.102 -0.999 . . . . 0.0 110.432 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.72 36.93 1.21 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 53.44 47.21 24.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.394 -1.063 . . . . 0.0 110.235 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.639 ' CB ' ' CE2' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -110.44 -159.74 0.69 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.248 -0.908 . . . . 0.0 109.913 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.421 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 0.4 OUTLIER 174.73 -28.05 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.342 -0.849 . . . . 0.0 110.458 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.631 ' HA ' ' HA ' ' A' ' 4' ' ' GLN . 3.2 p90 -165.45 55.01 0.11 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.143 -0.973 . . . . 0.0 110.722 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.639 ' CE2' ' CB ' ' A' ' 18' ' ' GLU . 19.5 m-85 -43.51 159.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.148 -0.97 . . . . 0.0 110.255 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.471 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -125.35 -59.98 1.36 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.933 -1.104 . . . . 0.0 110.58 -179.218 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.444 ' OD1' ' HA ' ' A' ' 46' ' ' SER . 3.6 t0 -166.37 140.62 4.26 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.472 -0.768 . . . . 0.0 109.618 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 74.36 17.27 79.71 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.584 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 3.1 m -97.54 168.04 10.61 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.474 -1.015 . . . . 0.0 109.936 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.702 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 74.5 t -137.27 158.43 35.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.032 -1.067 . . . . 0.0 111.1 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.896 ' O ' HG23 ' A' ' 43' ' ' VAL . 39.0 t -143.67 107.61 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.426 -0.796 . . . . 0.0 110.957 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.81 105.65 2.41 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 117.974 -1.491 . . . . 0.0 107.722 178.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 1.06 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.0 m-30 -67.78 119.53 12.63 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.613 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -69.64 152.0 45.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.169 -0.957 . . . . 0.0 109.958 -179.86 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.511 ' SG ' HD12 ' A' ' 37' ' ' LEU . 78.6 m -121.81 163.92 18.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 110.424 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 33' ' ' SER . 3.3 m-20 -58.79 138.99 56.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.308 -0.87 . . . . 0.0 110.059 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 32' ' ' ASN . 1.5 m -43.2 104.9 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 110.22 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.51 -32.63 5.14 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -72.66 130.29 40.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.288 -1.125 . . . . 0.0 110.423 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.601 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -78.55 149.39 33.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.328 -0.858 . . . . 0.0 110.897 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.588 ' C ' HD13 ' A' ' 38' ' ' ILE . 2.5 tp -95.09 113.45 25.14 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.414 -0.804 . . . . 0.0 108.858 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.629 ' N ' HD13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -108.7 150.5 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.921 . . . . 0.0 109.298 -179.653 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 125.61 -139.41 11.51 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.35 -1.405 . . . . 0.0 109.697 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.504 ' O ' ' C ' ' A' ' 41' ' ' SER . 0.6 OUTLIER -110.0 51.43 0.76 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.196 -1.179 . . . . 0.0 109.989 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.513 ' HA ' HD21 ' A' ' 37' ' ' LEU . 13.5 p 22.68 50.64 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.345 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.465 ' HA3' ' CG1' ' A' ' 26' ' ' VAL . . . 152.37 131.58 1.71 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.331 -1.414 . . . . 0.0 110.408 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.06 HG21 ' CE1' ' A' ' 29' ' ' TYR . 1.2 t -81.67 121.38 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 178.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.491 ' HA ' ' O ' ' A' ' 25' ' ' SER . 11.6 tp -95.13 103.48 15.33 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 120.277 -1.514 . . . . 0.0 111.385 -178.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.607 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.7 OUTLIER -80.99 121.43 26.04 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.061 178.491 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.444 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 4.7 m -135.14 123.95 23.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.438 -0.789 . . . . 0.0 110.863 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.4 16.08 80.06 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.462 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 87.03 25.9 32.96 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -141.33 103.43 4.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.169 -1.195 . . . . 0.0 110.318 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.607 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 77.9 m95 -56.25 137.31 52.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.913 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 52' ' ' ASP . 10.1 m -140.73 179.45 6.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.93 . . . . 0.0 111.009 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.516 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER 39.25 65.36 3.44 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.666 -0.646 . . . . 0.0 111.177 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.516 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 46.3 Cg_endo -90.14 127.64 1.48 Allowed 'Trans proline' 0 C--N 1.298 -2.122 0 O-C-N 124.356 1.714 . . . . 0.0 109.689 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.527 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 50.8 Cg_endo -76.62 176.78 9.66 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 O-C-N 123.821 1.432 . . . . 0.0 110.746 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.529 ' OG1' ' CG1' ' A' ' 38' ' ' ILE . 9.6 p -119.98 153.37 36.08 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.476 -0.765 . . . . 0.0 111.125 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 10' ' ' SER . 94.6 m -114.11 78.84 1.18 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -115.09 -178.24 3.32 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.3 0.572 . . . . 0.0 110.366 -178.511 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.596 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -95.6 130.1 44.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.305 -0.872 . . . . 0.0 109.299 179.844 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.601 ' CG1' ' CB ' ' A' ' 36' ' ' SER . 23.4 m -117.3 49.91 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 110.787 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 1.1 mttm -64.83 -163.27 0.02 OUTLIER 'General case' 0 C--N 1.281 -2.393 0 C-N-CA 118.797 -1.161 . . . . 0.0 109.167 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.497 ' SG ' ' HD2' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -151.0 154.56 34.36 Favored Pre-proline 0 C--N 1.291 -1.94 0 C-N-CA 119.167 -1.013 . . . . 0.0 112.179 -179.219 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.561 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 43.2 Cg_endo -81.03 -59.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.54 1.81 . . . . 0.0 108.539 177.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.561 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.2 OUTLIER 157.45 127.2 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.588 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.861 ' HG2' HD21 ' A' ' 71' ' ' LEU . 55.7 Cg_endo -79.91 67.14 8.7 Favored 'Trans proline' 0 C--N 1.296 -2.213 0 O-C-N 123.767 1.404 . . . . 0.0 109.771 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.718 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -92.96 177.04 6.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.334 -0.854 . . . . 0.0 109.363 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.876 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -174.82 162.87 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 119.155 -1.018 . . . . 0.0 110.303 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 68' ' ' ASN . 3.0 t -67.32 108.08 2.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.514 -0.741 . . . . 0.0 111.054 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 31.2 m-80 38.69 34.93 0.09 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.593 -0.692 . . . . 0.0 110.853 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.876 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -145.92 35.98 1.35 Allowed Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.359 -1.4 . . . . 0.0 110.001 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.671 ' HA ' HG23 ' A' ' 66' ' ' ILE . 5.1 p90 -48.28 -163.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 123.169 1.461 . . . . 0.0 112.287 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.032 HD11 ' HB2' ' A' ' 75' ' ' PHE . 1.9 pp -117.66 124.6 48.95 Favored 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 114.341 -1.3 . . . . 0.0 110.11 -178.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.512 ' HB3' ' HB2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -92.61 9.99 32.36 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.479 -0.763 . . . . 0.0 109.534 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.28 -71.73 0.43 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.382 -0.824 . . . . 0.0 110.652 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -172.55 98.5 0.13 Allowed Glycine 0 N--CA 1.489 2.197 0 C-N-CA 119.781 -1.2 . . . . 0.0 110.121 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 1.032 ' HB2' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -98.78 174.9 6.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.427 -1.043 . . . . 0.0 109.576 179.529 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.561 ' N ' ' CG ' ' A' ' 75' ' ' PHE . 3.3 ttmt -166.54 168.39 14.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.339 -0.85 . . . . 0.0 109.873 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.55 -31.03 61.8 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.754 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.462 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 0.5 OUTLIER -155.26 163.3 40.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.14 -0.975 . . . . 0.0 110.447 -179.868 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.608 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 10.2 m-85 -133.83 -164.97 1.57 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.262 -0.899 . . . . 0.0 110.401 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.553 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 40.9 p -143.22 -149.25 0.26 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.394 -0.817 . . . . 0.0 109.383 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.596 ' CB ' HG21 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -70.67 144.74 50.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.632 -1.293 . . . . 0.0 108.508 179.052 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.759 ' C ' HG22 ' A' ' 102' ' ' THR . 34.8 t-20 65.45 -111.85 0.23 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.328 -0.857 . . . . 0.0 110.704 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 1.0 OUTLIER 46.43 84.42 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.617 -1.302 . . . . 0.0 108.207 -178.31 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 7.9 p30 -85.5 135.01 34.01 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.464 -0.772 . . . . 0.0 112.143 -177.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.738 ' HB ' HD22 ' A' ' 71' ' ' LEU . 6.3 m -119.94 118.95 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.312 -0.867 . . . . 0.0 109.435 177.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 20.0 t0 -73.61 134.56 43.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.092 -1.005 . . . . 0.0 109.16 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.684 ' CD1' HG21 ' A' ' 66' ' ' ILE . 28.2 m-85 -94.25 129.35 40.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.071 -1.018 . . . . 0.0 111.144 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.571 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -106.67 96.11 6.21 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.806 -179.124 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.435 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -47.56 133.63 13.03 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.904 -1.122 . . . . 0.0 109.217 179.199 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -40.43 -85.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.272 -0.892 . . . . 0.0 110.269 -179.596 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.472 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 1.0 OUTLIER -163.65 135.01 4.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.458 -0.776 . . . . 0.0 109.922 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.72 48.94 62.58 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.081 -1.607 . . . . 0.0 109.081 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.536 ' CB ' ' SG ' ' A' ' 116' ' ' CYS . 36.2 m-85 -153.04 170.01 21.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.442 -1.034 . . . . 0.0 110.131 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.537 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 1.0 OUTLIER -131.17 107.46 9.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.271 -0.893 . . . . 0.0 109.656 179.432 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.776 HD22 ' HB2' ' A' ' 114' ' ' PRO . 43.0 mt -46.87 102.76 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.187 -0.945 . . . . 0.0 110.623 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.473 ' HB2' HG21 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -81.15 98.13 7.91 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.39 -0.819 . . . . 0.0 109.29 179.067 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.87 -86.3 0.17 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.585 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -160.4 124.51 3.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.157 -1.202 . . . . 0.0 110.734 -179.489 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.46 ' OG ' ' N ' ' A' ' 100' ' ' SER . 13.3 p -70.03 -55.99 8.11 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.101 -0.999 . . . . 0.0 110.574 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.46 ' N ' ' OG ' ' A' ' 99' ' ' SER . 54.7 p -94.75 121.5 36.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.286 -0.884 . . . . 0.0 110.127 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 29.6 m -121.42 -174.64 2.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.892 . . . . 0.0 110.119 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.759 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -157.28 128.5 6.79 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.324 -0.86 . . . . 0.0 110.735 179.658 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.555 ' N ' ' O ' ' A' ' 82' ' ' ASN . 46.9 t -65.52 91.93 0.13 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.746 -0.596 . . . . 0.0 109.613 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.465 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -71.58 -179.89 0.84 Allowed Pre-proline 0 C--N 1.298 -1.644 0 O-C-N 121.403 -0.811 . . . . 0.0 110.863 -179.339 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.597 ' HG3' HG23 ' A' ' 38' ' ' ILE . 42.7 Cg_endo -80.55 121.61 4.27 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 O-C-N 124.467 1.772 . . . . 0.0 110.424 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.577 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 132.21 -3.6 5.19 Favored Glycine 0 N--CA 1.481 1.638 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.853 ' O ' HG23 ' A' ' 108' ' ' THR . 1.0 OUTLIER 80.71 88.08 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.777 -0.837 . . . . 0.0 111.264 179.431 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.853 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 176.66 -164.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 111.523 179.15 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.661 ' HB3' HD13 ' A' ' 113' ' ' LEU . 28.6 m95 -139.68 90.02 2.37 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.412 0.625 . . . . 0.0 110.13 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.544 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 1.5 mmtp -99.3 141.25 22.51 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.408 -0.808 . . . . 0.0 110.15 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.585 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.0 Cg_endo -72.0 173.33 52.56 Favored 'Cis proline' 0 C--N 1.312 -1.348 0 C-N-CA 122.034 -2.069 . . . . 0.0 110.811 -0.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 111' ' ' PRO . 10.2 pt-20 -40.81 137.83 1.13 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.398 -0.814 . . . . 0.0 110.801 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.7 HD23 ' O ' ' A' ' 65' ' ' THR . 0.3 OUTLIER -53.09 144.55 27.75 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.416 -0.802 . . . . 0.0 110.342 179.639 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.776 ' HB2' HD22 ' A' ' 95' ' ' LEU . 43.4 Cg_endo -72.22 163.62 38.13 Favored 'Trans proline' 0 C--N 1.302 -1.885 0 O-C-N 124.224 1.644 . . . . 0.0 111.12 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.55 ' O ' HG22 ' A' ' 117' ' ' VAL . 9.4 tttt -127.84 115.39 18.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.456 -0.778 . . . . 0.0 109.848 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.536 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 0.8 OUTLIER -66.29 100.94 0.67 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.034 -1.041 . . . . 0.0 109.651 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.55 HG22 ' O ' ' A' ' 115' ' ' LYS . 0.7 OUTLIER -118.22 -177.19 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 121.625 0.726 . . . . 0.0 110.931 -179.538 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.7 mtp-105 . . . . . 0 C--N 1.295 -1.797 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.53 179.937 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 1' ' ' VAL . 7.7 p . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 121.24 0.543 . . . . 0.0 110.115 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -135.13 103.89 5.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 110.332 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.612 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 37.3 t -68.98 155.87 39.58 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.669 -0.644 . . . . 0.0 110.486 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.423 ' O ' ' C ' ' A' ' 5' ' ' SER . 69.6 mt-30 -140.08 -177.09 4.84 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.356 -0.84 . . . . 0.0 109.644 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.2 OUTLIER -42.05 133.02 2.51 Favored Pre-proline 0 C--N 1.297 -1.683 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.123 -179.666 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.781 ' HG3' HG11 ' A' ' 27' ' ' VAL . 51.8 Cg_endo -70.14 157.41 59.74 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.12 1.589 . . . . 0.0 111.112 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -75.66 172.23 16.71 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.969 1.51 . . . . 0.0 110.109 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.46 175.26 4.9 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.208 -0.932 . . . . 0.0 109.94 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.65 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -139.58 -170.36 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 122.241 1.02 . . . . 0.0 111.412 179.648 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 11' ' ' ASN . 39.2 m -45.38 97.26 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.484 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 9' ' ' ILE . 2.5 m-20 43.14 47.26 5.26 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.294 -0.879 . . . . 0.0 110.511 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -152.4 155.67 26.26 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.466 ' N ' ' O ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -104.58 -166.42 1.24 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.347 -1.09 . . . . 0.0 110.659 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.583 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 14.6 p80 -151.74 121.79 7.14 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.104 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -119.32 123.11 43.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.202 -0.936 . . . . 0.0 110.33 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.71 -5.44 6.42 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.41 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 0.5 OUTLIER 55.49 55.99 6.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -1.149 . . . . 0.0 110.075 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.555 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 2.6 pp20? -178.59 -162.67 0.06 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.3 -0.875 . . . . 0.0 110.223 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.414 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 1.1 t0 -136.4 -42.62 0.62 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.358 -0.839 . . . . 0.0 109.844 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.431 ' CD1' ' C ' ' A' ' 20' ' ' PHE . 21.2 p90 -111.53 140.65 45.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.332 -0.855 . . . . 0.0 109.844 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.644 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.5 OUTLIER -122.65 -12.06 8.16 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.28 -0.888 . . . . 0.0 110.432 -179.825 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.564 HG22 ' N ' ' A' ' 23' ' ' ASP . 82.8 m 52.61 -99.15 0.08 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.458 -0.776 . . . . 0.0 111.173 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.564 ' N ' HG22 ' A' ' 22' ' ' THR . 0.4 OUTLIER -151.63 157.45 42.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.19 -0.943 . . . . 0.0 109.995 -179.248 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.59 16.0 80.31 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.644 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 30.4 m -99.34 173.99 6.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.434 -1.039 . . . . 0.0 110.316 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.797 HG13 ' O ' ' A' ' 43' ' ' VAL . 28.2 t -151.66 154.75 7.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.318 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.781 HG11 ' HG3' ' A' ' 6' ' ' PRO . 17.4 t -136.52 114.32 14.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 119.349 -0.941 . . . . 0.0 111.459 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -69.29 104.09 2.14 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 118.397 -1.321 . . . . 0.0 107.77 178.12 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.65 ' CE2' HG21 ' A' ' 9' ' ' ILE . 2.1 m-30 -68.09 144.87 54.88 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.431 -0.793 . . . . 0.0 110.287 -178.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -100.08 153.16 19.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.389 -0.819 . . . . 0.0 109.591 179.214 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.567 ' SG ' HD12 ' A' ' 37' ' ' LEU . 57.1 m -125.0 160.46 28.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.149 -0.969 . . . . 0.0 110.515 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -49.55 157.61 0.52 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.445 -0.785 . . . . 0.0 110.102 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.29 99.71 0.74 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.221 -0.924 . . . . 0.0 110.261 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.25 10.44 5.6 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 -107.99 166.35 10.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -1.15 . . . . 0.0 110.295 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . 1.008 ' HB3' HG22 ' A' ' 59' ' ' VAL . 4.8 p -108.27 133.57 52.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.433 -0.792 . . . . 0.0 110.649 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.567 HD12 ' SG ' ' A' ' 31' ' ' CYS . 0.6 OUTLIER -95.1 109.82 21.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -0.955 . . . . 0.0 109.697 179.178 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.767 HG23 ' HG3' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -105.19 140.09 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.252 -0.905 . . . . 0.0 108.962 179.556 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.95 -156.81 24.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.488 ' O ' ' C ' ' A' ' 41' ' ' SER . 4.7 m-20 -99.5 51.19 0.93 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -1.153 . . . . 0.0 109.848 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.493 ' O ' HG23 ' A' ' 28' ' ' THR . 59.2 p 27.22 57.41 0.08 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.803 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.619 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 144.06 114.88 0.99 Allowed Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.158 -1.496 . . . . 0.0 110.73 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.797 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -55.06 -177.65 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.081 -1.247 . . . . 0.0 107.636 178.426 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.524 ' HA ' ' O ' ' A' ' 25' ' ' SER . 5.0 tp -145.87 93.02 2.28 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.313 -0.867 . . . . 0.0 110.106 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.609 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.8 OUTLIER -74.19 118.9 17.67 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.173 -0.955 . . . . 0.0 109.455 179.379 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.2 t -129.73 76.12 1.7 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.114 -0.991 . . . . 0.0 110.804 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.74 53.43 0.71 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 58.13 26.17 58.15 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -145.75 119.12 8.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -1.181 . . . . 0.0 109.917 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.612 ' CE2' ' SG ' ' A' ' 3' ' ' CYS . 91.7 m95 -81.68 133.36 35.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.881 . . . . 0.0 110.358 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.31 165.28 26.14 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.196 -0.94 . . . . 0.0 110.72 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.538 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 1.1 t0 55.1 64.54 5.67 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.559 -0.713 . . . . 0.0 111.0 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.538 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.5 Cg_endo -91.8 136.14 1.71 Allowed 'Trans proline' 0 C--N 1.3 -2.007 0 O-C-N 124.347 1.709 . . . . 0.0 109.491 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 43.4 Cg_endo -75.09 175.26 11.48 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 O-C-N 123.58 1.305 . . . . 0.0 110.397 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 6.3 p -121.98 145.39 48.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.32 -0.863 . . . . 0.0 111.656 -178.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.441 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 77.4 m -105.93 83.01 1.85 Allowed 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.493 ' OE1' HG13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -110.46 -145.54 0.4 Allowed 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.735 -0.603 . . . . 0.0 110.193 -178.707 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.605 HD12 ' N ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -137.05 100.15 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.158 -0.963 . . . . 0.0 108.909 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 1.059 HG21 ' HB3' ' A' ' 81' ' ' TYR . 31.8 m -102.09 64.28 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.255 -0.903 . . . . 0.0 112.213 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 2.0 mptp? -66.97 176.51 2.05 Favored 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 117.541 -1.663 . . . . 0.0 107.306 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.529 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 1.1 m -130.63 166.59 26.02 Favored Pre-proline 0 N--CA 1.494 1.73 0 C-N-CA 117.996 -1.482 . . . . 0.0 113.904 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.475 ' O ' ' CG ' ' A' ' 63' ' ' HIS . 44.5 Cg_endo -88.88 -76.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 125.01 2.058 . . . . 0.0 110.735 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.507 ' O ' HG23 ' A' ' 65' ' ' THR . 0.0 OUTLIER 169.9 124.12 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.263 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.613 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 48.1 Cg_endo -76.09 71.1 5.8 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 123.58 1.305 . . . . 0.0 109.661 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.689 ' C ' HG22 ' A' ' 66' ' ' ILE . 1.1 p -89.39 -174.62 4.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.394 -0.816 . . . . 0.0 109.826 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.806 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -179.95 167.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.181 179.248 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.492 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 31.8 t -72.31 95.45 1.72 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.566 -0.709 . . . . 0.0 110.827 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 80.0 m-20 46.58 43.62 12.61 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.358 -0.839 . . . . 0.0 110.894 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.806 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -151.61 32.81 0.91 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.577 ' O ' ' N ' ' A' ' 88' ' ' LYS . 1.9 p90 -44.9 -174.99 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 122.697 1.237 . . . . 0.0 112.522 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.678 HD13 ' H ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -108.0 168.16 9.48 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.442 179.4 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.8 14.91 0.84 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.943 -1.098 . . . . 0.0 110.009 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.488 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -95.21 -55.46 3.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.312 -0.867 . . . . 0.0 110.557 -179.708 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.606 ' O ' HG12 ' A' ' 85' ' ' VAL . . . -153.09 88.8 0.13 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.615 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -109.44 162.79 14.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.288 -1.125 . . . . 0.0 109.717 179.821 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.615 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -159.51 155.53 26.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.134 -0.979 . . . . 0.0 110.458 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.0 mtp180 -56.62 -40.08 74.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.224 -0.922 . . . . 0.0 110.027 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.2 t -136.89 127.36 26.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.425 -0.797 . . . . 0.0 110.11 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.585 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 14.5 m-85 -102.35 -146.96 0.37 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.138 -0.977 . . . . 0.0 110.217 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 60.0 p -160.03 -119.85 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.371 -0.83 . . . . 0.0 109.773 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 1.059 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -109.13 35.39 3.28 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.829 -1.169 . . . . 0.0 110.536 -179.784 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.698 ' C ' HG22 ' A' ' 102' ' ' THR . 0.1 OUTLIER -169.76 -109.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.159 -0.963 . . . . 0.0 110.296 179.425 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.449 ' OD2' ' ND2' ' A' ' 82' ' ' ASN . 8.1 m-20 42.99 75.47 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.96 -1.088 . . . . 0.0 109.761 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.817 ' CA ' HG23 ' A' ' 102' ' ' THR . 9.4 p30 -69.53 120.37 15.21 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.259 -0.9 . . . . 0.0 110.206 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.844 HG23 ' CE1' ' A' ' 87' ' ' PHE . 33.8 m -108.14 118.35 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.86 -1.15 . . . . 0.0 111.029 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.538 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 9.0 t0 -76.91 134.49 38.94 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.844 ' CE1' HG23 ' A' ' 85' ' ' VAL . 48.8 m-85 -93.87 127.4 39.61 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.009 -1.057 . . . . 0.0 112.42 -177.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.577 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -102.69 110.08 21.9 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.091 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.453 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -56.64 132.5 51.99 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.004 -1.06 . . . . 0.0 109.855 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 89' ' ' CYS . 0.3 OUTLIER -39.93 -69.95 0.12 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.483 -0.761 . . . . 0.0 110.33 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.537 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.3 OUTLIER -171.77 136.86 0.96 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.324 -0.86 . . . . 0.0 110.277 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.584 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 50.6 58.77 8.65 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.116 -1.593 . . . . 0.0 109.116 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 9.9 m-85 -160.66 152.48 19.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.432 -1.04 . . . . 0.0 110.162 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -105.74 142.55 35.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -0.846 . . . . 0.0 109.596 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.615 HD23 ' HB2' ' A' ' 114' ' ' PRO . 0.7 OUTLIER -84.05 93.66 8.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.08 -1.013 . . . . 0.0 110.423 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.459 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -70.4 102.45 2.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.267 -0.895 . . . . 0.0 109.671 179.554 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.52 -93.1 0.19 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.586 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.2 OUTLIER -152.47 118.74 5.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.158 -1.201 . . . . 0.0 110.491 -179.523 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.16 5.07 1.8 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.285 -0.884 . . . . 0.0 111.641 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.492 ' OG ' ' HA ' ' A' ' 86' ' ' ASP . 0.6 OUTLIER -161.87 119.77 2.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.702 -1.249 . . . . 0.0 109.896 179.409 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.467 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 3.1 m -129.63 168.2 16.81 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.408 -0.808 . . . . 0.0 110.482 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.817 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -130.71 140.67 50.36 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.298 179.764 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.559 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -72.56 84.98 1.15 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.761 -0.587 . . . . 0.0 110.564 -179.53 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.475 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -62.7 174.22 0.86 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.285 -0.885 . . . . 0.0 111.197 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.82 ' CB ' HG11 ' A' ' 59' ' ' VAL . 40.8 Cg_endo -72.68 125.45 10.57 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 O-C-N 124.551 1.816 . . . . 0.0 110.626 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.574 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 129.77 -11.54 5.97 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.633 ' O ' HG23 ' A' ' 108' ' ' THR . 0.6 OUTLIER 82.5 90.25 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 122.014 -0.698 . . . . 0.0 110.366 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.633 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -179.86 -166.35 0.08 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.492 -0.755 . . . . 0.0 110.407 179.777 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.74 ' HB3' HD11 ' A' ' 113' ' ' LEU . 38.8 m95 -141.66 92.7 2.48 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.46 -0.775 . . . . 0.0 110.379 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.532 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 6.2 mttt -104.5 139.86 20.52 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.57 -0.706 . . . . 0.0 109.69 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.586 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 46.3 Cg_endo -71.63 166.59 78.21 Favored 'Cis proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.033 -2.069 . . . . 0.0 111.207 -0.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 111' ' ' PRO . 2.9 tt0 -38.31 133.94 0.91 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.684 -0.635 . . . . 0.0 110.976 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.777 HD22 ' H ' ' A' ' 113' ' ' LEU . 0.9 OUTLIER -45.67 148.24 1.35 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.902 . . . . 0.0 109.684 179.412 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.736 ' HG2' HD12 ' A' ' 66' ' ' ILE . 42.2 Cg_endo -74.35 170.92 19.13 Favored 'Trans proline' 0 C--N 1.299 -2.067 0 O-C-N 124.253 1.659 . . . . 0.0 110.851 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.67 ' HG2' HG13 ' A' ' 117' ' ' VAL . 35.7 tttt -128.93 111.44 13.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.161 -0.962 . . . . 0.0 110.449 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.544 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 3.8 t -67.29 81.79 0.14 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.797 0.808 . . . . 0.0 109.83 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.67 HG13 ' HG2' ' A' ' 115' ' ' LYS . 1.4 m -97.4 -169.29 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.904 0.859 . . . . 0.0 110.717 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.469 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.293 -1.876 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.505 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.427 HG21 ' C ' ' A' ' 47' ' ' GLY . 3.4 m . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.285 0.564 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.8 mttm -94.4 169.86 9.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.218 -0.926 . . . . 0.0 110.549 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.617 ' CB ' ' N ' ' A' ' 22' ' ' THR . 0.7 OUTLIER -129.14 146.68 51.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.302 -0.874 . . . . 0.0 110.401 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 19' ' ' ASP . 0.5 OUTLIER -128.92 177.42 7.12 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.506 -0.746 . . . . 0.0 109.578 179.496 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.02 136.45 14.2 Favored Pre-proline 0 C--N 1.298 -1.656 0 O-C-N 121.26 -0.9 . . . . 0.0 109.706 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.657 ' HG3' HG11 ' A' ' 27' ' ' VAL . 48.5 Cg_endo -69.37 163.51 37.67 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.052 1.554 . . . . 0.0 111.08 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.95 170.25 20.21 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.896 1.472 . . . . 0.0 109.618 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.482 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -87.17 105.47 17.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.106 -0.996 . . . . 0.0 109.973 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.755 HD12 ' OD1' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -47.34 -179.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-O 121.861 0.839 . . . . 0.0 111.059 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 11' ' ' ASN . 0.4 OUTLIER -103.55 69.28 0.98 Allowed 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.975 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.755 ' OD1' HD12 ' A' ' 9' ' ' ILE . 3.1 p30 164.4 -24.23 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.595 -0.69 . . . . 0.0 109.786 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.402 ' HA3' ' SG ' ' A' ' 56' ' ' CYS . . . -145.91 -160.61 8.76 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -126.77 -175.7 3.48 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.476 -1.014 . . . . 0.0 109.358 179.89 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.612 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 10.2 p80 -137.23 160.89 37.72 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.308 -0.87 . . . . 0.0 110.768 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 14' ' ' HIS . 26.7 p-10 -38.54 146.81 0.06 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.541 -0.724 . . . . 0.0 110.985 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -137.83 18.34 3.38 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.76 -26.46 9.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.296 -1.12 . . . . 0.0 110.258 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -81.64 -147.53 0.07 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.939 . . . . 0.0 109.827 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 20' ' ' PHE . 3.7 p30 178.53 -34.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.597 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.508 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 9.5 m-85 -124.58 133.78 53.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -0.929 . . . . 0.0 109.9 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.67 ' CD2' ' HB3' ' A' ' 25' ' ' SER . 2.8 m-85 -127.82 -9.87 5.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.068 -1.02 . . . . 0.0 111.132 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.617 ' N ' ' CB ' ' A' ' 3' ' ' CYS . 69.6 p 37.82 -98.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.507 -0.745 . . . . 0.0 111.424 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.486 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 23.0 t0 -150.65 138.88 20.27 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.991 -1.068 . . . . 0.0 110.488 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.43 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 91.09 22.7 31.84 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.67 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 50.8 m -118.27 163.82 16.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.306 -1.114 . . . . 0.0 110.073 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.87 HG13 ' O ' ' A' ' 43' ' ' VAL . 19.6 t -139.58 149.85 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.029 -1.044 . . . . 0.0 112.289 -178.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.657 HG11 ' HG3' ' A' ' 6' ' ' PRO . 18.1 t -122.26 114.13 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-O 121.356 0.598 . . . . 0.0 112.007 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.794 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -71.51 105.63 3.68 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.437 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.888 ' O ' HD13 ' A' ' 37' ' ' LEU . 2.8 m-30 -67.82 136.1 53.61 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.729 -178.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 13' ' ' ARG . 6.3 m -73.46 -173.64 1.46 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.99 -1.069 . . . . 0.0 109.301 179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -154.74 137.12 14.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.974 -1.079 . . . . 0.0 110.803 -179.642 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -44.84 159.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.342 -0.849 . . . . 0.0 109.775 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.99 97.63 0.69 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.215 -0.928 . . . . 0.0 110.401 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 129.22 -20.85 5.26 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.511 ' CD2' ' O ' ' A' ' 56' ' ' CYS . 2.5 m-30 -92.33 139.31 30.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.197 -1.178 . . . . 0.0 110.627 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.659 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -91.03 144.4 25.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.294 -0.879 . . . . 0.0 110.73 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.888 HD13 ' O ' ' A' ' 29' ' ' TYR . 2.4 tp -91.36 113.75 26.09 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.415 -0.803 . . . . 0.0 109.798 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.854 HG23 ' HG3' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -107.21 149.89 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.223 -0.923 . . . . 0.0 109.748 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 129.32 -153.39 19.86 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.507 ' O ' ' C ' ' A' ' 41' ' ' SER . 1.2 t30 -92.4 50.72 1.65 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.079 -1.248 . . . . 0.0 109.765 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.794 ' O ' HG23 ' A' ' 28' ' ' THR . 13.7 p 26.44 43.03 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.708 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.713 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 152.7 123.21 0.97 Allowed Glycine 0 N--CA 1.49 2.27 0 C-N-CA 119.229 -1.463 . . . . 0.0 110.694 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.87 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.6 t -58.15 -178.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.563 HD12 HG23 ' A' ' 26' ' ' VAL . 10.8 tp -147.81 97.99 2.89 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.722 -1.191 . . . . 0.0 110.684 178.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.483 ' HB2' ' CD2' ' A' ' 50' ' ' TRP . 14.6 t -78.39 115.54 18.18 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.41 179.124 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.47 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 4.7 m -124.48 81.82 1.98 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.551 -0.718 . . . . 0.0 110.272 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.486 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 93.64 56.85 1.39 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.67 23.15 9.55 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -126.04 82.04 2.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.284 -1.127 . . . . 0.0 110.681 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.538 ' HH2' ' CD2' ' A' ' 21' ' ' TYR . 67.0 m95 -54.33 128.52 31.84 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.15 -0.969 . . . . 0.0 109.148 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.407 ' O ' ' CB ' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -148.07 157.06 43.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.935 -1.103 . . . . 0.0 111.474 -179.328 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.503 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 4.8 t0 66.66 65.79 0.73 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.796 -0.565 . . . . 0.0 111.348 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.503 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.9 Cg_endo -91.45 141.49 2.75 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 O-C-N 124.37 1.721 . . . . 0.0 109.986 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.547 ' HG2' ' HB2' ' A' ' 29' ' ' TYR . 51.8 Cg_endo -80.11 -179.31 5.15 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 O-C-N 123.891 1.469 . . . . 0.0 110.308 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.567 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 8.6 p -117.91 -172.28 2.22 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.971 0.891 . . . . 0.0 111.104 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.511 ' O ' ' CD2' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -147.8 79.62 1.48 Allowed 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.778 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -113.42 -152.27 0.5 Allowed 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.004 -178.605 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.737 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -118.76 128.53 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.169 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.67 HG21 ' HB3' ' A' ' 81' ' ' TYR . 26.0 m -120.39 48.17 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.896 -1.127 . . . . 0.0 112.346 -178.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -60.94 164.07 5.25 Favored 'General case' 0 C--N 1.278 -2.519 0 C-N-CA 117.581 -1.648 . . . . 0.0 107.558 178.788 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 79' ' ' TYR . 35.5 m -131.98 161.33 63.31 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 120.603 -1.311 . . . . 0.0 111.749 -178.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 43.5 Cg_endo -75.79 -84.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.832 0 O-C-N 124.565 1.824 . . . . 0.0 110.251 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -179.84 128.43 0.24 Allowed Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 121.552 -0.717 . . . . 0.0 109.167 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.664 ' CB ' HG21 ' A' ' 85' ' ' VAL . 54.2 Cg_endo -77.97 67.14 8.13 Favored 'Trans proline' 0 C--N 1.298 -2.081 0 O-C-N 123.773 1.407 . . . . 0.0 109.744 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.509 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -87.11 175.27 8.17 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.383 -0.823 . . . . 0.0 110.199 -179.691 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.803 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -170.21 165.49 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 110.211 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.449 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 17.5 m -74.6 106.14 6.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.451 -0.781 . . . . 0.0 110.724 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.435 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 10.1 m-80 41.54 41.13 1.53 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.344 -0.848 . . . . 0.0 110.718 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.803 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -150.61 32.52 1.0 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.573 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 5.5 p90 -44.13 -173.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 122.826 1.298 . . . . 0.0 112.657 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.704 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -111.04 162.23 15.08 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.392 179.42 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.06 20.03 1.42 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.961 -1.087 . . . . 0.0 110.103 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.3 t -103.03 -67.82 0.86 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.254 -0.904 . . . . 0.0 110.693 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.406 ' O ' HG12 ' A' ' 85' ' ' VAL . . . -137.85 82.9 0.26 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.631 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 2.5 t80 -110.3 163.86 13.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.358 -1.083 . . . . 0.0 110.238 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.631 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 19.7 tttm -164.17 153.3 13.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.883 . . . . 0.0 110.007 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -51.72 -28.33 14.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 0.0 109.822 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.5 m -144.54 158.18 43.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.417 -0.802 . . . . 0.0 110.436 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.569 ' OH ' ' CE2' ' A' ' 75' ' ' PHE . 10.9 m-85 -131.27 -149.55 0.39 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.401 -0.812 . . . . 0.0 109.572 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.638 ' CA ' HG23 ' A' ' 59' ' ' VAL . 94.8 p -157.46 -108.84 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.73 -1.231 . . . . 0.0 110.984 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.67 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -108.16 23.36 14.6 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.286 -1.509 . . . . 0.0 110.467 -179.525 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.743 ' O ' HG22 ' A' ' 102' ' ' THR . 47.6 t30 -171.31 -97.01 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.152 -0.968 . . . . 0.0 110.424 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 82' ' ' ASN . 5.0 m-20 42.05 72.48 0.17 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 109.546 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.813 ' CA ' HG23 ' A' ' 102' ' ' THR . 0.4 OUTLIER -68.62 137.5 54.28 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.345 -179.065 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.664 HG21 ' CB ' ' A' ' 64' ' ' PRO . 16.0 m -117.79 120.19 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.143 -0.973 . . . . 0.0 110.552 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -78.07 128.12 33.35 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.57 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.708 ' CD1' HG21 ' A' ' 66' ' ' ILE . 32.6 m-85 -89.17 125.14 34.93 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.031 -1.043 . . . . 0.0 112.087 -178.024 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.565 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -100.11 93.05 5.52 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.922 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.495 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -44.3 133.81 5.29 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.014 -1.054 . . . . 0.0 109.923 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -39.5 -72.47 0.06 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.515 -0.741 . . . . 0.0 110.345 -179.672 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.454 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 5.5 t80 -175.92 144.68 0.62 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.299 -0.876 . . . . 0.0 110.018 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.548 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 52.55 31.91 37.69 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.548 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 13.9 m-85 -141.67 146.96 36.75 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.514 -0.992 . . . . 0.0 110.097 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 116' ' ' CYS . 19.0 mttt -104.0 155.6 18.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.355 -0.84 . . . . 0.0 109.27 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.576 ' CD2' ' HB3' ' A' ' 87' ' ' PHE . 0.8 OUTLIER -91.93 100.86 13.45 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.736 -1.227 . . . . 0.0 110.5 -179.587 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.62 100.78 7.14 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.442 -0.786 . . . . 0.0 109.559 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.2 -81.02 0.22 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.586 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -167.16 114.8 0.8 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.228 -1.16 . . . . 0.0 110.774 -179.32 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -61.49 -48.5 80.79 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.203 -0.935 . . . . 0.0 110.74 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.2 p -101.24 130.63 47.39 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.191 -0.943 . . . . 0.0 109.87 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 11.6 m -140.89 158.71 43.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.156 -0.965 . . . . 0.0 110.743 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.813 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -134.88 140.31 45.69 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.515 -0.741 . . . . 0.0 109.652 179.625 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.609 ' O ' ' CB ' ' A' ' 104' ' ' SER . 0.7 OUTLIER -59.08 -59.18 5.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.241 -0.912 . . . . 0.0 111.057 -178.976 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.609 ' CB ' ' O ' ' A' ' 103' ' ' CYS . 0.2 OUTLIER 82.92 161.93 0.12 Allowed Pre-proline 0 C--N 1.292 -1.934 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -178.76 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.854 ' HG3' HG23 ' A' ' 38' ' ' ILE . 38.3 Cg_endo -67.1 120.28 7.35 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.767 1.404 . . . . 0.0 111.2 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.619 ' O ' ' ND2' ' A' ' 107' ' ' ASN . . . 130.99 -9.09 5.72 Favored Glycine 0 N--CA 1.481 1.665 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.927 ' O ' HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER 77.66 105.34 0.07 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.592 -0.946 . . . . 0.0 111.103 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.927 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER 171.67 -148.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.426 -0.796 . . . . 0.0 110.711 179.345 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.678 ' HB3' HD11 ' A' ' 113' ' ' LEU . 22.3 m95 -163.32 66.31 0.18 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.345 -0.847 . . . . 0.0 109.617 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.527 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.2 OUTLIER -83.81 140.27 40.6 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.508 -0.745 . . . . 0.0 110.238 -179.625 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.586 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 44.8 Cg_endo -72.48 165.44 83.13 Favored 'Cis proline' 0 C--N 1.313 -1.336 0 C-N-CA 121.901 -2.125 . . . . 0.0 110.682 -0.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.5 pm0 -37.5 140.75 0.2 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.675 -0.641 . . . . 0.0 110.888 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.767 HD22 ' H ' ' A' ' 113' ' ' LEU . 1.2 mm? -50.68 146.3 9.92 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.361 -0.837 . . . . 0.0 109.696 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.744 ' HG2' HD12 ' A' ' 66' ' ' ILE . 37.6 Cg_endo -71.02 168.51 22.98 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 124.181 1.621 . . . . 0.0 111.268 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.574 ' HG2' HG13 ' A' ' 117' ' ' VAL . 5.0 ttpt -128.12 111.97 14.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.342 -0.849 . . . . 0.0 110.355 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.54 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.1 t -68.0 100.14 0.94 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 109.33 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.574 HG13 ' HG2' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -113.78 -178.58 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.483 0.659 . . . . 0.0 110.367 -179.487 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.533 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 6.5 ptt180 . . . . . 0 C--N 1.295 -1.784 0 C-N-CA 118.871 -1.131 . . . . 0.0 110.51 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.6 m . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.327 0.584 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.547 ' HG2' HG22 ' A' ' 22' ' ' THR . 0.0 OUTLIER -112.97 166.61 11.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.324 -0.86 . . . . 0.0 109.971 179.828 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.464 ' O ' ' O ' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -96.68 83.23 3.42 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.054 -1.029 . . . . 0.0 109.784 179.81 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.536 ' HA ' ' O ' ' A' ' 19' ' ' ASP . 0.6 OUTLIER -47.53 173.12 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.89 -1.131 . . . . 0.0 109.601 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.473 ' N ' ' O ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -42.84 135.59 2.78 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.256 -0.902 . . . . 0.0 109.974 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.774 ' CG ' HG11 ' A' ' 27' ' ' VAL . 51.6 Cg_endo -70.75 151.35 63.34 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.855 1.45 . . . . 0.0 110.754 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.61 170.46 20.18 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 123.938 1.494 . . . . 0.0 110.469 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.71 174.64 4.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.339 -0.851 . . . . 0.0 109.961 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.615 HD11 ' HB3' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -144.84 -170.0 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 122.198 0.999 . . . . 0.0 111.401 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' A' ' 56' ' ' CYS . 7.1 m -40.32 99.34 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.998 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 32' ' ' ASN . 1.6 m-80 40.91 28.13 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.374 -0.828 . . . . 0.0 110.565 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -132.13 157.23 22.37 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -112.35 -165.85 1.03 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.47 -1.018 . . . . 0.0 110.586 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.643 ' HB2' HG11 ' A' ' 27' ' ' VAL . 10.3 p80 -148.76 122.84 9.47 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.105 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -113.53 -167.0 1.14 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.172 -0.955 . . . . 0.0 110.446 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 145.49 -15.31 1.83 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 61.13 59.13 2.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.424 -1.045 . . . . 0.0 110.408 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.539 ' OE1' ' CD2' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -174.17 -174.63 0.92 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.176 -0.953 . . . . 0.0 110.449 179.932 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.536 ' O ' ' HA ' ' A' ' 4' ' ' GLN . 7.8 t70 -131.73 -41.57 1.05 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.405 -0.809 . . . . 0.0 109.71 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 m-30 -106.43 143.55 34.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.446 -0.784 . . . . 0.0 110.04 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.655 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.4 OUTLIER -127.17 -8.22 5.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.262 -0.899 . . . . 0.0 110.691 -179.743 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.553 ' HG1' ' C ' ' A' ' 21' ' ' TYR . 30.2 p 50.89 -93.39 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.721 -0.612 . . . . 0.0 112.37 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 33.6 t0 -158.34 143.31 16.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.02 -1.05 . . . . 0.0 110.404 -178.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.539 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 87.3 20.68 51.63 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.655 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -115.7 166.6 11.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.371 -1.076 . . . . 0.0 110.489 -179.723 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.8 HG13 ' O ' ' A' ' 43' ' ' VAL . 20.8 t -142.19 156.55 19.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.433 -0.792 . . . . 0.0 110.649 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.774 HG11 ' CG ' ' A' ' 6' ' ' PRO . 10.8 t -130.71 111.6 20.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.224 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.441 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -66.67 103.61 1.12 Allowed 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 118.56 -1.256 . . . . 0.0 108.327 178.607 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.641 ' CE1' HG21 ' A' ' 43' ' ' VAL . 1.7 m-30 -68.73 121.79 17.21 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.595 -0.691 . . . . 0.0 110.384 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -69.87 158.85 34.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -0.985 . . . . 0.0 109.415 179.23 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.9 154.2 46.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.951 -1.093 . . . . 0.0 110.704 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 11' ' ' ASN . 3.8 t-20 -64.45 152.75 40.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.402 -0.811 . . . . 0.0 110.01 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.71 120.69 15.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.2 -0.937 . . . . 0.0 110.278 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.16 -5.67 30.36 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.588 ' CD2' ' O ' ' A' ' 56' ' ' CYS . 0.8 OUTLIER -116.06 146.91 41.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.189 -1.183 . . . . 0.0 110.518 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.732 ' HB3' HD11 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -89.05 142.01 28.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.395 -0.816 . . . . 0.0 111.205 -179.693 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.568 ' C ' HD13 ' A' ' 38' ' ' ILE . 0.7 OUTLIER -94.54 104.55 16.5 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.46 -0.775 . . . . 0.0 109.079 178.802 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.868 HG23 ' HG3' ' A' ' 105' ' ' PRO . 0.8 OUTLIER -94.96 141.89 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.305 -0.872 . . . . 0.0 109.677 -179.361 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.48 -160.29 23.05 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.519 ' O ' ' C ' ' A' ' 41' ' ' SER . 5.9 m-20 -99.54 50.4 0.93 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.1 -1.235 . . . . 0.0 109.974 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.526 ' HA ' HD21 ' A' ' 37' ' ' LEU . 0.3 OUTLIER 22.06 63.52 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.864 179.585 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.473 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 146.34 120.75 1.29 Allowed Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.416 -1.373 . . . . 0.0 110.184 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.8 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -68.43 179.65 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.452 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.413 ' HA ' HG22 ' A' ' 26' ' ' VAL . 25.3 tp -136.24 104.69 5.73 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.602 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.531 ' HB2' ' CH2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -75.32 103.83 5.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.394 -0.816 . . . . 0.0 109.236 179.379 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.504 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 12.2 t -132.59 103.62 6.24 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.31 -0.869 . . . . 0.0 110.304 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.88 41.36 5.97 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.443 ' HA2' ' C ' ' A' ' 2' ' ' LYS . . . 60.33 18.1 48.76 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.12 153.94 49.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -1.128 . . . . 0.0 110.147 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.531 ' CH2' ' HB2' ' A' ' 45' ' ' CYS . 83.0 m95 -105.46 130.82 53.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.749 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 11.8 t -136.87 156.16 48.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.972 . . . . 0.0 111.173 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.531 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.1 OUTLIER 65.2 64.96 0.98 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.819 -0.551 . . . . 0.0 111.436 179.477 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.0 Cg_endo -91.93 137.86 1.91 Allowed 'Trans proline' 0 C--N 1.3 -2.02 0 O-C-N 124.39 1.732 . . . . 0.0 109.695 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.583 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 47.8 Cg_endo -81.75 164.19 18.33 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.728 1.383 . . . . 0.0 110.453 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.608 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 33.9 p -107.37 -174.97 2.66 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.226 -0.921 . . . . 0.0 111.185 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.588 ' O ' ' CD2' ' A' ' 35' ' ' TYR . 1.0 OUTLIER -140.71 76.14 1.54 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.336 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.538 ' HG3' ' CG1' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -115.82 174.05 6.23 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.129 -178.729 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.563 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -90.28 124.26 42.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.278 -0.889 . . . . 0.0 108.683 179.389 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.699 ' HB ' ' HA ' ' A' ' 105' ' ' PRO . 29.5 m -112.37 48.43 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.098 -1.001 . . . . 0.0 111.752 -178.39 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.474 ' O ' ' OD1' ' A' ' 107' ' ' ASN . 11.4 mttm -55.48 170.49 0.24 Allowed 'General case' 0 C--N 1.28 -2.448 0 C-N-CA 117.624 -1.63 . . . . 0.0 108.043 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.534 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -131.53 168.36 17.79 Favored Pre-proline 0 N--CA 1.491 1.602 0 C-N-CA 118.532 -1.267 . . . . 0.0 112.999 -178.1 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.502 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 47.2 Cg_endo -89.98 -73.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 124.896 1.998 . . . . 0.0 110.421 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.502 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 164.24 126.12 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.285 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.903 ' HA ' HD21 ' A' ' 113' ' ' LEU . 55.5 Cg_endo -80.53 60.63 7.93 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 123.544 1.286 . . . . 0.0 110.211 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.601 ' O ' HD23 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -76.17 170.64 15.93 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.535 -0.728 . . . . 0.0 109.478 179.444 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.98 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -168.05 164.88 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.015 -1.053 . . . . 0.0 110.525 -179.6 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.424 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 2.5 t -70.22 98.81 1.41 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.514 -0.741 . . . . 0.0 110.675 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 51.0 m-80 43.19 48.98 5.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.368 -0.832 . . . . 0.0 110.841 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.98 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -160.18 38.74 0.45 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.587 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 53.1 p90 -49.23 -151.89 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 122.886 1.327 . . . . 0.0 113.134 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.009 HD23 ' CE2' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -144.72 122.04 11.59 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.765 -176.445 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.9 t -98.88 14.0 30.5 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.342 -0.848 . . . . 0.0 110.127 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.511 ' OG ' ' N ' ' A' ' 86' ' ' ASP . 1.3 p -74.82 -101.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.312 -0.867 . . . . 0.0 110.712 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -120.28 74.92 0.32 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.615 ' HD2' HD11 ' A' ' 71' ' ' LEU . 1.9 t80 -91.53 161.5 14.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.495 -1.003 . . . . 0.0 110.396 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.587 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 23.8 tttt -162.35 156.15 21.02 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.451 -0.78 . . . . 0.0 109.862 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -47.14 -32.65 4.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -0.883 . . . . 0.0 110.146 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.524 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 3.3 t -144.04 167.82 21.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.385 -0.822 . . . . 0.0 110.366 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.628 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 9.3 m-85 -138.02 -149.87 0.32 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.292 -0.88 . . . . 0.0 109.844 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.649 ' CA ' HG23 ' A' ' 59' ' ' VAL . 2.7 p -156.33 -100.41 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.597 -1.315 . . . . 0.0 111.877 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.628 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -123.04 14.2 9.82 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.733 -1.229 . . . . 0.0 110.311 -178.466 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.774 ' O ' HG22 ' A' ' 102' ' ' THR . 8.0 p30 -155.74 -108.3 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.02 -1.05 . . . . 0.0 110.398 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 82' ' ' ASN . 5.3 t0 46.22 71.99 0.26 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.817 -1.177 . . . . 0.0 109.539 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.894 ' CA ' HG23 ' A' ' 102' ' ' THR . 14.0 p-10 -68.65 106.47 2.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.314 -0.866 . . . . 0.0 109.491 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.586 ' CG2' HD22 ' A' ' 71' ' ' LEU . 35.8 m -92.03 121.48 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.11 -0.993 . . . . 0.0 111.523 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.529 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.6 OUTLIER -82.66 135.36 35.05 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.25 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 1.009 ' CE2' HD23 ' A' ' 71' ' ' LEU . 38.3 m-85 -90.94 144.39 25.73 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.805 -1.184 . . . . 0.0 112.252 -177.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -116.1 91.95 3.75 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.669 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.548 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -44.76 132.52 6.49 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.068 -1.02 . . . . 0.0 110.054 -179.741 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -40.82 -74.17 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.41 -0.806 . . . . 0.0 110.639 -179.683 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.576 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 31.5 t80 -169.62 144.11 2.86 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.225 -0.922 . . . . 0.0 110.674 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.578 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 46.38 41.11 11.63 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.607 ' CE1' ' HB3' ' A' ' 118' ' ' ARG . 12.2 m-85 -145.93 147.5 31.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.517 -0.99 . . . . 0.0 109.947 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 117' ' ' VAL . 6.7 ttpt -102.57 152.48 21.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.196 -0.94 . . . . 0.0 109.959 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.612 HD23 ' HB2' ' A' ' 114' ' ' PRO . 0.6 OUTLIER -92.99 89.44 6.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.056 -1.027 . . . . 0.0 110.446 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.739 ' HB2' HG21 ' A' ' 117' ' ' VAL . 18.6 t -70.55 108.1 4.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.9 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 138.69 -65.34 0.54 Allowed Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.844 -1.17 . . . . 0.0 110.236 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.576 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.1 OUTLIER 174.84 114.43 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.277 -1.131 . . . . 0.0 110.705 -179.383 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.485 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 0.9 OUTLIER -80.86 20.92 0.72 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.106 -0.996 . . . . 0.0 111.258 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.409 ' O ' ' OG ' ' A' ' 100' ' ' SER . 16.4 p -161.28 103.84 1.26 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.957 -1.09 . . . . 0.0 109.905 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.498 ' O ' ' N ' ' A' ' 85' ' ' VAL . 70.2 m -123.13 171.13 9.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.933 . . . . 0.0 110.611 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.894 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -136.78 145.39 44.5 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.223 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 79' ' ' TYR . 7.0 t -74.96 88.76 2.37 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.466 -0.772 . . . . 0.0 109.912 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.452 ' OG ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -66.03 174.5 1.62 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.258 -0.901 . . . . 0.0 111.327 -179.44 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.868 ' HG3' HG23 ' A' ' 38' ' ' ILE . 41.7 Cg_endo -74.16 126.94 10.86 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.401 1.738 . . . . 0.0 110.73 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 120.48 -6.64 11.57 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.577 ' O ' HG23 ' A' ' 108' ' ' THR . 0.5 OUTLIER 82.13 96.06 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 O-C-N 122.107 -0.643 . . . . 0.0 110.699 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -178.51 -162.34 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.356 -0.84 . . . . 0.0 111.175 179.516 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.619 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 31.1 m95 -150.34 87.51 1.46 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.59 -0.694 . . . . 0.0 110.11 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.516 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 58.4 mttt -98.85 140.27 21.64 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.475 -0.765 . . . . 0.0 110.098 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.576 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 47.7 Cg_endo -72.7 174.55 48.53 Favored 'Cis proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.992 -2.087 . . . . 0.0 110.686 -0.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 112' ' ' GLU . 0.0 OUTLIER -43.82 135.27 4.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.402 -0.811 . . . . 0.0 110.988 -179.558 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.903 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -45.76 146.8 1.78 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.445 -0.785 . . . . 0.0 110.287 179.426 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.723 ' HG2' HD12 ' A' ' 66' ' ' ILE . 42.7 Cg_endo -76.53 169.57 21.6 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 O-C-N 124.341 1.706 . . . . 0.0 111.182 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.593 ' HG2' HG13 ' A' ' 117' ' ' VAL . 2.6 ttpt -130.16 109.71 11.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.24 -0.912 . . . . 0.0 110.208 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 2.0 t -63.9 80.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -0.913 . . . . 0.0 109.341 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.739 HG21 ' HB2' ' A' ' 96' ' ' SER . 0.3 OUTLIER -88.54 -176.82 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.749 0.785 . . . . 0.0 110.645 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.607 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--N 1.295 -1.792 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.504 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.401 ' C ' ' HD3' ' A' ' 2' ' ' LYS . 4.8 m . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.302 0.572 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.401 ' HD3' ' C ' ' A' ' 1' ' ' VAL . 0.0 OUTLIER -122.81 176.84 5.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.934 . . . . 0.0 110.313 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.57 ' HB3' ' N ' ' A' ' 22' ' ' THR . 2.8 t -136.63 95.55 3.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.344 -0.848 . . . . 0.0 110.828 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 5' ' ' SER . 0.0 OUTLIER -74.33 176.45 6.7 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 118.766 -1.174 . . . . 0.0 108.972 178.889 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -46.76 145.46 3.08 Favored Pre-proline 0 C--N 1.293 -1.861 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.278 179.794 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.825 ' HG3' HG11 ' A' ' 27' ' ' VAL . 48.8 Cg_endo -71.01 153.91 63.0 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.835 1.44 . . . . 0.0 110.78 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -74.84 171.61 17.93 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 O-C-N 123.911 1.48 . . . . 0.0 109.787 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.64 177.09 3.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.14 -0.975 . . . . 0.0 109.758 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.713 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -142.54 -170.57 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 122.178 0.989 . . . . 0.0 111.642 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 14.2 t -40.85 93.28 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.698 -179.067 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 9' ' ' ILE . 3.5 m-80 42.17 44.16 3.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 110.25 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -140.82 178.05 20.39 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.527 ' CB ' ' HB3' ' A' ' 30' ' ' SER . 0.0 OUTLIER -125.0 -168.27 1.8 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.178 -1.189 . . . . 0.0 110.578 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.625 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 13.9 p80 -156.46 123.94 5.43 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.958 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -147.5 128.11 14.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.166 -0.959 . . . . 0.0 110.53 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.49 -115.73 2.14 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -166.84 37.27 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -1.131 . . . . 0.0 110.052 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.592 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 1.4 pp20? -150.04 -155.61 0.64 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 0.0 110.09 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -140.7 -42.44 0.4 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.367 -0.833 . . . . 0.0 110.068 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.402 ' C ' ' OE1' ' A' ' 18' ' ' GLU . 17.6 m-85 -119.52 100.98 7.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 109.526 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.655 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.8 OUTLIER -77.53 -11.04 59.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.44 -0.787 . . . . 0.0 111.395 -179.226 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.57 ' N ' ' HB3' ' A' ' 3' ' ' CYS . 56.4 p 46.71 -95.78 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.209 -0.932 . . . . 0.0 111.636 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.539 ' H ' ' HG1' ' A' ' 22' ' ' THR . 1.3 t70 -152.77 146.92 25.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.842 -1.161 . . . . 0.0 110.948 -178.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 82.45 23.88 55.38 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.655 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.9 OUTLIER -116.9 169.84 9.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.395 -1.061 . . . . 0.0 110.207 -179.799 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.848 HG13 ' O ' ' A' ' 43' ' ' VAL . 23.7 t -139.26 156.15 26.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 119.29 -0.964 . . . . 0.0 111.033 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.9 ' O ' HG23 ' A' ' 43' ' ' VAL . 24.0 t -133.25 124.25 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 119.846 -0.741 . . . . 0.0 111.066 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.849 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -73.86 100.9 3.61 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 118.347 -1.341 . . . . 0.0 108.432 178.412 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 1.076 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.1 m-30 -68.56 127.93 34.8 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.144 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.527 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 12.5 t -80.12 -170.43 2.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.026 -1.046 . . . . 0.0 109.687 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.623 ' SG ' HD12 ' A' ' 37' ' ' LEU . 67.4 m -150.83 160.94 43.54 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.147 -0.971 . . . . 0.0 110.161 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.523 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 14.8 t-20 -48.43 171.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.0 110.059 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.68 107.45 5.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 110.181 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.79 11.46 40.4 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.523 ' CG ' ' HB3' ' A' ' 32' ' ' ASN . 2.9 m-30 -106.84 128.33 54.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -1.136 . . . . 0.0 110.238 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.624 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.5 OUTLIER -74.23 138.99 44.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.306 -0.871 . . . . 0.0 110.808 -179.885 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.778 HD13 ' O ' ' A' ' 29' ' ' TYR . 2.8 tp -91.24 104.51 17.05 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.445 -0.784 . . . . 0.0 109.421 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.799 HG23 ' HG3' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -97.48 154.04 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.279 -0.888 . . . . 0.0 109.37 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.478 ' O ' ' CB ' ' A' ' 40' ' ' ASN . . . 94.56 39.54 4.68 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.7 OUTLIER 68.52 174.5 0.28 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.353 -1.087 . . . . 0.0 110.116 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.849 ' O ' HG23 ' A' ' 28' ' ' THR . 0.3 OUTLIER -119.79 71.5 0.89 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 110.318 -179.859 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.501 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 163.36 119.35 0.48 Allowed Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.75 -1.215 . . . . 0.0 110.173 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.076 HG21 ' CE1' ' A' ' 29' ' ' TYR . 2.0 t -76.31 -175.23 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.147 -1.208 . . . . 0.0 108.506 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.563 ' H ' HG12 ' A' ' 43' ' ' VAL . 0.9 OUTLIER -144.05 102.28 3.86 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.215 178.902 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.543 ' HB2' ' CD2' ' A' ' 50' ' ' TRP . 13.5 t -83.96 124.61 31.2 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.362 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.428 ' C ' ' OD2' ' A' ' 23' ' ' ASP . 84.5 p -132.22 80.22 1.9 Allowed 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.283 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.444 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 92.8 46.75 3.33 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.59 23.22 62.6 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 50' ' ' TRP . 3.3 mt-10 -126.4 68.78 1.22 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.206 -1.173 . . . . 0.0 110.374 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.594 ' CH2' HG23 ' A' ' 27' ' ' VAL . 72.7 m95 -43.58 135.63 3.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.485 -0.759 . . . . 0.0 109.632 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.2 t -146.73 169.87 18.16 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.962 -1.086 . . . . 0.0 111.069 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.534 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER 59.52 65.02 2.72 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.671 -0.643 . . . . 0.0 110.981 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.534 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.0 Cg_endo -91.22 127.95 1.18 Allowed 'Trans proline' 0 C--N 1.301 -1.928 0 O-C-N 124.393 1.733 . . . . 0.0 110.305 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.523 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 51.4 Cg_endo -77.09 173.18 14.84 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 O-C-N 123.897 1.472 . . . . 0.0 110.096 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.584 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 21.0 p -107.09 164.6 12.01 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.92 . . . . 0.0 111.272 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 10' ' ' SER . 97.3 m -128.37 76.11 1.68 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 177.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -111.82 -158.93 0.66 Allowed 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.28 0.562 . . . . 0.0 110.162 -178.831 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.21 147.13 15.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.624 HG13 ' CB ' ' A' ' 36' ' ' SER . 33.7 m -132.49 49.25 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 O-C-N 121.044 -1.035 . . . . 0.0 111.267 -178.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 5.3 mttm -64.19 -169.5 0.03 OUTLIER 'General case' 0 C--N 1.281 -2.404 0 C-N-CA 118.225 -1.39 . . . . 0.0 107.9 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.545 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -144.52 170.75 7.69 Favored Pre-proline 0 C--N 1.293 -1.848 0 C-N-CA 118.347 -1.341 . . . . 0.0 113.22 -178.824 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.557 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 45.1 Cg_endo -92.47 -70.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.421 2.081 . . . . 0.0 109.139 178.186 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.557 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 159.34 129.44 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 122.04 -0.413 . . . . 0.0 110.068 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.574 ' HG3' ' CZ2' ' A' ' 109' ' ' TRP . 55.3 Cg_endo -85.18 94.31 0.66 Allowed 'Trans proline' 0 C--N 1.299 -2.044 0 O-C-N 123.802 1.422 . . . . 0.0 109.346 178.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.726 ' O ' HG23 ' A' ' 66' ' ' ILE . 3.5 p -111.57 -43.15 3.7 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 122.342 1.068 . . . . 0.0 110.452 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.73 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER 53.27 170.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.017 -178.71 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.506 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -68.37 101.66 1.26 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.472 -0.767 . . . . 0.0 111.331 -179.088 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 60.7 m-20 42.36 51.95 4.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.507 -0.746 . . . . 0.0 111.684 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.594 ' O ' ' CD1' ' A' ' 70' ' ' TYR . . . -133.05 -38.49 0.23 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.631 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 2.0 p90 38.2 -171.58 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 122.965 1.364 . . . . 0.0 112.645 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.661 HD22 ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -139.17 159.76 41.39 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.724 -178.91 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.59 27.73 3.04 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.755 -1.215 . . . . 0.0 110.152 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.74 -78.65 0.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.193 -0.942 . . . . 0.0 111.111 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -135.4 82.15 0.29 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.624 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -108.93 170.65 7.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.5 -1.0 . . . . 0.0 109.934 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.624 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 10.5 ttmt -171.23 170.1 6.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.353 -0.842 . . . . 0.0 109.974 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.402 ' N ' ' CG ' ' A' ' 76' ' ' LYS . 29.3 mtm180 -60.67 -37.39 81.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.971 -1.081 . . . . 0.0 110.517 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.4 m -134.09 159.0 42.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.286 -0.883 . . . . 0.0 110.322 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.623 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 3.7 m-85 -133.72 -146.44 0.27 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.312 -0.868 . . . . 0.0 110.058 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.574 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 21.6 p -160.02 -128.52 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.907 -1.121 . . . . 0.0 110.94 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.609 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -93.8 14.24 19.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.375 -1.453 . . . . 0.0 110.603 -179.292 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.689 ' C ' HG22 ' A' ' 102' ' ' THR . 50.6 t30 -160.73 -104.05 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.743 -1.223 . . . . 0.0 110.706 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 82' ' ' ASN . 0.7 OUTLIER 45.68 79.48 0.05 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.877 -1.14 . . . . 0.0 108.801 -178.973 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.716 ' CA ' HG23 ' A' ' 102' ' ' THR . 30.2 p-10 -69.36 150.29 47.48 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.415 -0.803 . . . . 0.0 110.853 -178.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.507 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 17.0 m -133.5 118.67 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.419 -0.8 . . . . 0.0 110.049 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.541 ' O ' ' HB2' ' A' ' 71' ' ' LEU . 8.8 t0 -82.55 127.46 33.36 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.206 -0.934 . . . . 0.0 108.613 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.698 ' CD1' HG21 ' A' ' 66' ' ' ILE . 53.5 m-85 -84.26 136.96 33.72 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.369 1.081 . . . . 0.0 113.339 -177.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.631 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -111.8 85.62 2.18 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.149 179.792 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.547 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -37.3 130.06 0.93 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.52 -0.737 . . . . 0.0 111.198 -179.029 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.8 OUTLIER -41.35 -88.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.489 -0.757 . . . . 0.0 110.697 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.557 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 3.8 t80 -152.68 144.93 23.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.227 -0.92 . . . . 0.0 110.543 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.549 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 46.87 53.85 9.89 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.569 ' CD1' ' HB3' ' A' ' 118' ' ' ARG . 9.3 m-85 -151.28 167.87 26.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.253 -1.145 . . . . 0.0 110.27 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 117' ' ' VAL . 1.9 ttpt -132.23 112.23 12.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.361 -0.837 . . . . 0.0 109.812 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.567 HD23 ' CD1' ' A' ' 66' ' ' ILE . 6.2 mt -47.65 109.56 0.23 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.261 -0.899 . . . . 0.0 110.348 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.433 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -90.61 99.32 12.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.392 -0.817 . . . . 0.0 109.88 179.614 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 141.09 -76.62 0.31 Allowed Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.119 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.615 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 1.2 m -163.4 117.35 1.59 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.372 -1.075 . . . . 0.0 110.594 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.404 ' HB2' HD13 ' A' ' 95' ' ' LEU . 9.8 p -76.63 6.27 6.18 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.276 -0.89 . . . . 0.0 110.967 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 59.8 p -147.42 113.11 5.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.114 -0.991 . . . . 0.0 109.761 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.442 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 13.1 m -128.25 168.9 14.83 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.242 -0.912 . . . . 0.0 110.776 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.716 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.5 OUTLIER -136.44 146.66 46.61 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.51 -0.744 . . . . 0.0 110.461 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 80' ' ' SER . 41.9 t -76.41 84.91 3.15 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.611 -0.681 . . . . 0.0 110.439 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.516 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -65.59 -179.12 0.32 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 110.279 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.799 ' HG3' HG23 ' A' ' 38' ' ' ILE . 46.1 Cg_endo -76.47 131.27 12.48 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 O-C-N 124.23 1.647 . . . . 0.0 110.878 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 121.91 -11.33 9.43 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.587 ' O ' HG23 ' A' ' 108' ' ' THR . 1.0 OUTLIER 82.8 92.9 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 O-C-N 122.015 -0.697 . . . . 0.0 110.956 179.668 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -179.1 -160.02 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.556 -0.715 . . . . 0.0 110.725 179.437 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.674 ' HB3' HD13 ' A' ' 113' ' ' LEU . 24.0 m95 -148.9 87.92 1.58 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.513 -0.742 . . . . 0.0 110.538 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.548 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -95.2 154.68 39.46 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.382 -0.824 . . . . 0.0 109.777 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.615 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 48.5 Cg_endo -71.65 -177.51 17.41 Favored 'Cis proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.163 -2.016 . . . . 0.0 110.514 -0.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.474 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.9 OUTLIER -37.54 111.74 0.17 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.802 -0.561 . . . . 0.0 110.236 -179.759 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.674 HD13 ' HB3' ' A' ' 109' ' ' TRP . 3.9 tp -37.61 141.86 0.45 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.66 -0.65 . . . . 0.0 110.446 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.73 ' HG2' HD12 ' A' ' 66' ' ' ILE . 40.6 Cg_endo -69.89 161.79 44.6 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 124.11 1.584 . . . . 0.0 110.47 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.517 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.8 OUTLIER -125.1 100.21 6.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 110.497 179.704 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.547 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.9 t -56.19 91.84 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.019 -1.051 . . . . 0.0 109.272 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 3.7 m -110.95 179.11 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.628 0.728 . . . . 0.0 110.941 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.569 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.688 0 C-N-CA 118.997 -1.081 . . . . 0.0 110.239 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.513 ' CG1' ' HA3' ' A' ' 48' ' ' GLY . 69.2 t . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 121.231 0.539 . . . . 0.0 110.275 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.474 ' N ' HG12 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -119.87 179.69 4.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.901 . . . . 0.0 110.294 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.549 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.3 m -131.61 137.28 48.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.546 -0.721 . . . . 0.0 110.008 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.567 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 3.8 mt-30 -114.2 168.49 9.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.767 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -45.21 131.89 5.72 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.112 -0.992 . . . . 0.0 109.446 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.681 ' HG3' HG11 ' A' ' 27' ' ' VAL . 45.6 Cg_endo -66.99 153.16 78.8 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 124.011 1.532 . . . . 0.0 112.209 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.64 175.29 11.49 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 124.097 1.578 . . . . 0.0 110.304 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.44 173.63 5.7 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.276 -0.89 . . . . 0.0 110.254 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.432 HG12 ' CG ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -143.46 -172.96 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-O 122.038 0.923 . . . . 0.0 111.085 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.3 OUTLIER -39.73 100.51 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.215 -179.214 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.415 ' C ' ' O ' ' A' ' 10' ' ' SER . 1.2 m120 39.21 45.59 1.14 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.434 -0.791 . . . . 0.0 111.09 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.452 ' HA3' ' CB ' ' A' ' 56' ' ' CYS . . . -158.21 161.45 31.62 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.435 ' HG3' ' HB2' ' A' ' 30' ' ' SER . 0.8 OUTLIER -119.41 -175.22 2.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -1.146 . . . . 0.0 110.713 -179.613 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.635 ' HB2' HG11 ' A' ' 27' ' ' VAL . 7.5 p80 -126.91 163.3 23.95 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.196 0.522 . . . . 0.0 110.063 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -170.5 -159.07 0.17 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.093 -1.004 . . . . 0.0 110.322 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.44 -126.36 2.37 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.535 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 11.4 p90 -149.19 33.87 0.73 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -1.129 . . . . 0.0 110.068 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.488 ' HG3' ' CZ ' ' A' ' 21' ' ' TYR . 0.9 OUTLIER -147.1 -177.43 5.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.933 . . . . 0.0 109.912 179.854 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -124.03 -41.33 2.22 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.207 -0.933 . . . . 0.0 110.253 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.621 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 21.0 p90 -128.34 98.81 5.19 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.11 -0.994 . . . . 0.0 110.516 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.618 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 11.6 m-85 -61.95 -165.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.984 -1.073 . . . . 0.0 110.054 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.549 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 0.3 OUTLIER -151.42 -65.57 0.18 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.026 -1.046 . . . . 0.0 110.778 -179.731 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -167.15 147.33 5.47 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.444 -0.785 . . . . 0.0 109.658 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 65.61 14.58 60.53 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.618 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -94.54 172.41 8.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.387 -1.067 . . . . 0.0 109.938 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 43' ' ' VAL . 24.4 t -148.75 154.71 9.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.224 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.681 HG11 ' HG3' ' A' ' 6' ' ' PRO . 24.4 t -134.04 113.81 18.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.596 -0.69 . . . . 0.0 110.922 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -69.39 104.08 2.18 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 118.052 -1.459 . . . . 0.0 107.597 178.187 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.653 ' O ' HD13 ' A' ' 37' ' ' LEU . 1.3 m-30 -67.4 111.87 4.3 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.366 -178.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.435 ' HB2' ' HG3' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -70.69 154.98 41.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.114 -0.991 . . . . 0.0 110.278 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.7 m -123.97 157.27 34.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.319 -0.863 . . . . 0.0 109.662 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.52 168.51 1.57 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.107 -0.996 . . . . 0.0 110.241 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.21 100.61 0.81 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.26 -0.9 . . . . 0.0 110.124 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.482 ' O ' HG22 ' A' ' 58' ' ' ILE . . . 120.92 -6.99 11.0 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.693 ' CD2' HG23 ' A' ' 58' ' ' ILE . 27.7 m-85 -96.61 133.63 40.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -1.136 . . . . 0.0 110.2 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.723 ' HB2' HG22 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -89.25 144.34 26.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 0.0 110.797 -179.783 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.653 HD13 ' O ' ' A' ' 29' ' ' TYR . 1.9 tp -92.09 98.15 11.37 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.376 -0.827 . . . . 0.0 109.237 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.929 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -87.99 144.02 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.31 -0.869 . . . . 0.0 109.051 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.59 -174.6 22.87 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.475 ' ND2' ' OD1' ' A' ' 52' ' ' ASP . 2.4 m-80 -55.33 145.93 20.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.343 -1.092 . . . . 0.0 110.092 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.608 ' O ' HG23 ' A' ' 28' ' ' THR . 87.4 p -80.52 49.53 1.17 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.173 -0.954 . . . . 0.0 110.076 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.657 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 152.19 109.83 0.43 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.665 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -46.49 172.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.244 -1.151 . . . . 0.0 108.244 179.276 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 25' ' ' SER . 0.4 OUTLIER -138.26 97.08 3.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.046 -1.034 . . . . 0.0 110.183 179.01 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.608 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.2 OUTLIER -76.48 107.78 9.0 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.091 -1.005 . . . . 0.0 109.266 178.936 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.66 107.05 8.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.545 -0.722 . . . . 0.0 110.238 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.03 5.08 55.15 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.513 ' HA3' ' CG1' ' A' ' 1' ' ' VAL . . . 94.49 15.79 45.54 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -141.42 113.73 8.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.348 -1.09 . . . . 0.0 110.261 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.608 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 96.3 m95 -58.34 134.75 56.86 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.189 -0.944 . . . . 0.0 109.975 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.7 t -135.3 149.84 49.87 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.184 -0.948 . . . . 0.0 110.95 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.51 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 1.1 t70 62.81 65.47 1.41 Allowed Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.716 -0.615 . . . . 0.0 111.372 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.51 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.6 Cg_endo -91.58 124.44 0.82 Allowed 'Trans proline' 0 C--N 1.3 -2.021 0 O-C-N 124.337 1.704 . . . . 0.0 109.841 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.494 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.0 Cg_endo -71.67 175.14 9.99 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 O-C-N 123.88 1.463 . . . . 0.0 109.979 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.601 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 23.6 p -118.37 141.81 48.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.194 -0.941 . . . . 0.0 111.187 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 10' ' ' SER . 35.1 m -103.58 76.06 1.37 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.479 ' OE1' ' CB ' ' A' ' 55' ' ' THR . 0.0 OUTLIER -113.46 147.24 38.21 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.406 0.622 . . . . 0.0 110.214 -178.73 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.693 HG23 ' CD2' ' A' ' 35' ' ' TYR . 1.7 pt -70.74 112.55 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.435 -0.79 . . . . 0.0 109.161 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.894 HG21 ' CB ' ' A' ' 81' ' ' TYR . 18.8 m -99.54 53.01 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.309 -0.869 . . . . 0.0 111.751 -178.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 23.2 mtpp -71.62 -174.12 1.07 Allowed 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 118.065 -1.454 . . . . 0.0 107.2 177.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.516 ' SG ' ' HB2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -143.42 163.61 35.88 Favored Pre-proline 0 C--N 1.29 -2.018 0 C-N-CA 118.014 -1.474 . . . . 0.0 111.98 -178.499 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.528 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 41.3 Cg_endo -80.57 -68.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.866 0 O-C-N 124.787 1.941 . . . . 0.0 109.609 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.528 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 161.13 135.06 0.01 OUTLIER Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.881 ' HG2' HD21 ' A' ' 71' ' ' LEU . 56.9 Cg_endo -82.95 66.76 7.9 Favored 'Trans proline' 0 C--N 1.289 -2.555 0 O-C-N 123.952 1.501 . . . . 0.0 109.47 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.73 ' O ' HG23 ' A' ' 66' ' ' ILE . 3.1 p -81.88 -41.92 20.29 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 122.43 1.109 . . . . 0.0 110.455 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.878 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER 54.54 162.15 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.53 -179.037 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.449 ' N ' HG13 ' A' ' 66' ' ' ILE . 12.8 t -65.95 101.1 0.63 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.573 -0.705 . . . . 0.0 111.78 -178.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 2.2 m-20 41.68 31.91 0.22 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.499 -0.751 . . . . 0.0 111.743 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.559 ' C ' ' CD1' ' A' ' 70' ' ' TYR . . . -124.11 -27.0 1.43 Allowed Glycine 0 N--CA 1.491 2.358 0 C-N-CA 118.732 -1.699 . . . . 0.0 109.938 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.559 ' CD1' ' C ' ' A' ' 69' ' ' GLY . 37.9 p90 33.4 -160.59 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 122.762 1.268 . . . . 0.0 112.016 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.895 HD23 ' HE1' ' A' ' 87' ' ' PHE . 0.7 OUTLIER -135.56 149.08 49.33 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 114.154 -1.384 . . . . 0.0 109.691 -176.889 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' A' ' 72' ' ' SER . 0.1 OUTLIER -116.03 24.38 11.49 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.866 -1.146 . . . . 0.0 109.883 -179.662 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.51 ' OG ' ' CB ' ' A' ' 86' ' ' ASP . 8.5 m -101.62 -99.87 0.27 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.065 -1.022 . . . . 0.0 111.836 -178.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.489 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -109.81 -73.96 0.77 Allowed Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.739 -1.22 . . . . 0.0 111.144 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.5 OUTLIER 60.62 174.54 0.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.409 -1.053 . . . . 0.0 109.609 -178.768 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.627 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 28.6 ttmt 179.65 159.07 0.71 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.302 -0.874 . . . . 0.0 109.641 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.526 ' N ' ' HG2' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -43.01 -31.17 0.49 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.292 -0.88 . . . . 0.0 110.635 -179.843 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.446 ' C ' ' CG ' ' A' ' 79' ' ' TYR . 2.8 p -154.43 169.93 22.58 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.132 -0.98 . . . . 0.0 111.161 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.656 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -150.62 -168.53 3.13 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.443 -0.786 . . . . 0.0 108.897 179.762 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 82' ' ' ASN . 0.1 OUTLIER -170.75 120.52 0.56 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.667 -1.27 . . . . 0.0 111.424 179.783 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.894 ' CB ' HG21 ' A' ' 59' ' ' VAL . 4.1 t80 38.37 22.85 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.995 -1.066 . . . . 0.0 112.074 178.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.672 ' C ' HG22 ' A' ' 102' ' ' THR . 26.2 p30 -178.49 -134.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.025 -1.672 . . . . 0.0 110.882 178.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.524 ' CB ' ' HB3' ' A' ' 79' ' ' TYR . 0.4 OUTLIER 57.27 72.14 0.53 Allowed 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.006 -1.059 . . . . 0.0 108.519 -178.46 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.649 ' CA ' HG23 ' A' ' 102' ' ' THR . 6.8 p30 -68.44 143.23 55.11 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.453 -0.78 . . . . 0.0 110.331 -178.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.746 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 3.6 m -134.47 121.36 36.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.228 -0.92 . . . . 0.0 110.221 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.548 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 1.1 t70 -69.95 141.96 52.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.09 -1.006 . . . . 0.0 108.479 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.895 ' HE1' HD23 ' A' ' 71' ' ' LEU . 7.1 m-85 -104.89 143.38 33.23 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.672 -1.267 . . . . 0.0 112.5 -178.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.509 ' O ' HD21 ' A' ' 95' ' ' LEU . 3.7 tptt -116.4 -173.34 2.35 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.163 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.503 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -132.11 127.96 37.12 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.241 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.49 ' C ' ' O ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -33.57 -70.72 0.07 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.404 0.621 . . . . 0.0 110.733 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.518 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -177.25 145.42 0.45 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.371 -0.831 . . . . 0.0 109.927 179.708 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.442 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 51.86 43.13 54.46 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.572 ' CD1' ' HB3' ' A' ' 118' ' ' ARG . 11.6 m-85 -146.61 162.7 37.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.34 -1.094 . . . . 0.0 110.32 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 117' ' ' VAL . 23.1 tptt -127.5 113.26 15.92 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.391 -0.818 . . . . 0.0 109.877 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.631 HD23 ' HB2' ' A' ' 114' ' ' PRO . 2.1 mt -46.49 112.62 0.52 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.107 -0.995 . . . . 0.0 109.868 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.615 ' HB2' HG21 ' A' ' 117' ' ' VAL . 1.1 t -95.92 103.64 15.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 110.205 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.16 -98.29 0.24 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.618 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -141.63 135.51 30.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -1.133 . . . . 0.0 110.614 -179.502 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 100' ' ' SER . 37.3 p -78.69 -64.91 1.07 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 110.11 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.52 ' N ' ' OG ' ' A' ' 99' ' ' SER . 15.8 p -74.86 140.28 43.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.087 -1.008 . . . . 0.0 110.065 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.595 ' HB2' ' CE2' ' A' ' 87' ' ' PHE . 3.8 m -151.16 148.35 28.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -0.934 . . . . 0.0 110.659 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.672 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -125.48 145.25 50.17 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.564 -0.71 . . . . 0.0 109.769 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.583 ' O ' ' CA ' ' A' ' 81' ' ' TYR . 7.6 t -69.4 78.93 0.39 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.104 -0.998 . . . . 0.0 109.946 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.445 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.4 OUTLIER -47.3 171.15 0.08 OUTLIER Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.286 -0.884 . . . . 0.0 112.197 -179.397 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.929 ' CB ' HD12 ' A' ' 38' ' ' ILE . 47.9 Cg_endo -78.08 21.84 0.65 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 124.731 1.911 . . . . 0.0 112.569 -178.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -114.69 7.61 22.14 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.53 ' O ' HG23 ' A' ' 108' ' ' THR . 0.8 OUTLIER 76.91 61.83 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.835 -0.803 . . . . 0.0 109.572 -179.761 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.571 ' O ' ' HA ' ' A' ' 103' ' ' CYS . 0.0 OUTLIER -171.41 -170.62 0.84 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.277 -179.426 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.746 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 19.4 m95 -118.22 86.45 2.53 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.631 -0.668 . . . . 0.0 110.133 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.543 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 2.7 mmmt -92.1 152.33 42.59 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.407 -0.808 . . . . 0.0 110.014 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.618 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 48.8 Cg_endo -72.23 -178.68 21.17 Favored 'Cis proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.071 -2.054 . . . . 0.0 111.025 -0.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 111' ' ' PRO . 3.4 mt-10 -37.11 118.5 0.61 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.334 0.588 . . . . 0.0 110.758 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.642 HD13 ' HB3' ' A' ' 109' ' ' TRP . 2.9 tp -47.39 141.65 6.55 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.365 -0.834 . . . . 0.0 110.562 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.878 ' HG2' HD12 ' A' ' 66' ' ' ILE . 41.1 Cg_endo -71.37 159.91 50.24 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.119 1.589 . . . . 0.0 110.289 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.565 ' O ' HG22 ' A' ' 117' ' ' VAL . 13.9 tttt -124.3 108.5 12.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 0.0 110.545 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.545 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 5.2 t -58.47 84.38 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.29 -0.881 . . . . 0.0 108.85 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.615 HG21 ' HB2' ' A' ' 96' ' ' SER . 4.0 m -103.45 -176.95 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.771 0.796 . . . . 0.0 111.113 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.572 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.765 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.309 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 1' ' ' VAL . 8.1 p . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -129.99 166.89 19.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.935 . . . . 0.0 110.149 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.542 ' HB3' ' O ' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -111.85 91.8 3.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.173 -0.954 . . . . 0.0 110.735 -179.629 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.476 ' O ' ' C ' ' A' ' 5' ' ' SER . 39.0 mt-30 -91.64 -177.17 4.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -0.943 . . . . 0.0 109.426 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.476 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.5 OUTLIER -36.9 131.76 0.7 Allowed Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.799 -0.563 . . . . 0.0 110.134 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.795 ' HG3' HG11 ' A' ' 27' ' ' VAL . 48.5 Cg_endo -68.87 157.35 62.19 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.998 1.525 . . . . 0.0 111.084 -178.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -75.58 170.74 19.61 Favored 'Trans proline' 0 C--N 1.302 -1.921 0 O-C-N 123.926 1.487 . . . . 0.0 109.608 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.6 p -70.33 175.49 4.64 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.145 -0.972 . . . . 0.0 109.874 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.683 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -140.33 -169.53 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -0.91 . . . . 0.0 110.804 179.556 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.2 OUTLIER -39.76 92.14 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.606 -179.262 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' A' ' 9' ' ' ILE . 3.9 m-80 42.08 41.26 1.94 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.276 -0.89 . . . . 0.0 110.113 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.449 ' O ' HG13 ' A' ' 9' ' ' ILE . . . -140.73 145.96 17.0 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -92.63 -166.81 1.61 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.268 -1.137 . . . . 0.0 110.605 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.612 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 14.9 p80 -153.9 126.14 7.94 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.157 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -145.62 112.31 5.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 110.311 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.439 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -111.05 19.43 25.13 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.457 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 0.3 OUTLIER 67.07 35.76 4.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.389 -1.065 . . . . 0.0 110.222 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.558 ' OE1' ' CE1' ' A' ' 21' ' ' TYR . 5.9 pt-20 176.88 -175.22 0.12 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 110.436 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -128.43 -3.8 5.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.377 -0.827 . . . . 0.0 110.056 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.588 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 0.9 OUTLIER -109.55 150.8 27.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 110.257 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.596 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 1.9 m-85 -167.43 42.31 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.54 -0.725 . . . . 0.0 109.746 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.518 ' HA ' ' HB2' ' A' ' 3' ' ' CYS . 21.1 p -52.79 99.15 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 122.042 0.925 . . . . 0.0 111.729 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.541 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 26.7 t70 50.54 163.45 0.0 OUTLIER 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 121.742 0.782 . . . . 0.0 112.037 178.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 48.32 26.83 5.15 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.629 ' O ' HG23 ' A' ' 26' ' ' VAL . 16.7 m -106.47 174.56 5.84 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.289 -1.124 . . . . 0.0 110.302 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 25' ' ' SER . 24.6 t -155.56 154.25 6.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.821 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.892 ' O ' HG23 ' A' ' 43' ' ' VAL . 39.2 t -143.81 124.17 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.837 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -74.55 104.52 5.28 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 118.483 -1.287 . . . . 0.0 107.534 177.538 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 1.083 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.2 m-30 -68.36 127.1 31.72 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.287 -0.883 . . . . 0.0 110.395 -178.081 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -84.8 156.4 21.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.817 . . . . 0.0 110.08 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.538 ' SG ' HD12 ' A' ' 37' ' ' LEU . 75.6 m -124.86 154.35 41.17 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -0.885 . . . . 0.0 110.155 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.484 ' O ' ' N ' ' A' ' 34' ' ' GLY . 7.8 m-20 -41.92 143.37 0.56 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.322 -0.861 . . . . 0.0 110.202 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 95.8 p -52.56 88.63 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.91 . . . . 0.0 110.503 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 32' ' ' ASN . . . 127.69 10.95 3.42 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.2 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.441 ' CD2' ' O ' ' A' ' 56' ' ' CYS . 1.7 m-30 -106.64 153.8 21.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.08 -1.247 . . . . 0.0 110.442 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.849 ' HB2' HD11 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -90.04 137.42 32.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.458 -0.776 . . . . 0.0 110.582 -179.473 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.558 HD13 ' O ' ' A' ' 29' ' ' TYR . 0.9 OUTLIER -98.92 98.54 9.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.189 -0.945 . . . . 0.0 109.484 178.909 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.849 HD11 ' HB2' ' A' ' 36' ' ' SER . 0.1 OUTLIER -95.86 141.86 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.902 . . . . 0.0 109.397 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.99 -120.21 3.88 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -125.01 137.14 54.24 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.362 -1.081 . . . . 0.0 109.93 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.531 ' O ' HG23 ' A' ' 28' ' ' THR . 73.0 p -71.86 55.86 0.29 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.229 -0.919 . . . . 0.0 109.77 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.445 ' HA2' ' C ' ' A' ' 27' ' ' VAL . . . 154.74 117.6 0.61 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.083 HG21 ' CE1' ' A' ' 29' ' ' TYR . 2.1 t -67.73 179.65 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.188 -1.183 . . . . 0.0 108.177 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.48 ' H ' HG12 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -139.72 104.04 4.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.955 -1.091 . . . . 0.0 110.638 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.599 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -81.93 111.05 17.76 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.161 -1.016 . . . . 0.0 109.262 178.675 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.58 103.2 7.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.584 -0.697 . . . . 0.0 110.488 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.61 36.21 8.08 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.462 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 64.89 31.38 80.75 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -147.78 105.42 3.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.176 -1.191 . . . . 0.0 110.549 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.74 ' CH2' HG23 ' A' ' 27' ' ' VAL . 77.6 m95 -58.5 140.06 54.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.155 -0.965 . . . . 0.0 109.514 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.2 m -143.51 170.64 15.43 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.952 -1.092 . . . . 0.0 111.059 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.516 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 20.0 t0 53.01 65.7 5.61 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.539 -0.726 . . . . 0.0 110.889 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.516 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.8 Cg_endo -91.23 139.15 2.4 Favored 'Trans proline' 0 C--N 1.3 -1.977 0 C-N-CA 121.9 1.733 . . . . 0.0 110.329 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.425 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 47.8 Cg_endo -83.52 -175.68 2.42 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.826 1.435 . . . . 0.0 110.052 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.554 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 7.4 p -124.63 143.65 50.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.38 -0.825 . . . . 0.0 111.569 -178.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 10' ' ' SER . 90.1 m -107.58 80.43 1.4 Allowed 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.464 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.9 OUTLIER -110.63 -150.43 0.46 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.712 -0.618 . . . . 0.0 110.162 -178.447 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.759 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -127.82 120.01 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.256 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.835 HG13 ' CB ' ' A' ' 36' ' ' SER . 26.9 m -115.13 52.66 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.018 -1.051 . . . . 0.0 111.824 -178.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.513 ' N ' ' OD1' ' A' ' 107' ' ' ASN . 9.0 mtpt -71.45 129.73 39.53 Favored 'General case' 0 C--N 1.283 -2.312 0 C-N-CA 118.262 -1.375 . . . . 0.0 108.232 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.5 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 5.8 m -95.01 172.2 5.72 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.928 -1.107 . . . . 0.0 112.371 -178.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 43.6 Cg_endo -84.94 -66.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.721 1.906 . . . . 0.0 110.287 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.456 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 167.98 129.29 0.04 OUTLIER Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -179.232 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.67 ' HG2' HD22 ' A' ' 71' ' ' LEU . 45.9 Cg_endo -74.0 65.23 5.11 Favored 'Trans proline' 0 C--N 1.296 -2.187 0 O-C-N 123.61 1.321 . . . . 0.0 109.868 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.705 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -85.49 170.39 12.7 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.739 -0.601 . . . . 0.0 110.446 -179.576 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.779 HG23 ' HA ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -169.31 164.09 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.126 -0.984 . . . . 0.0 110.277 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.565 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 73.2 m -66.47 75.27 0.1 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.535 -0.728 . . . . 0.0 111.978 -178.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.554 ' CB ' ' O ' ' A' ' 67' ' ' SER . 1.5 t-20 76.31 -24.72 0.21 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.285 -0.885 . . . . 0.0 112.473 178.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.573 ' CA ' ' HA ' ' A' ' 89' ' ' CYS . . . -86.32 38.6 3.08 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.779 ' HA ' HG23 ' A' ' 66' ' ' ILE . 11.9 p90 -41.61 159.75 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 123.032 1.396 . . . . 0.0 112.839 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.066 HD13 ' HB2' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -43.11 -81.39 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 113.922 -1.49 . . . . 0.0 109.699 178.269 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.597 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER 79.05 13.89 1.17 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.606 -0.684 . . . . 0.0 110.427 179.668 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.479 ' HB3' ' HB2' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -156.73 53.27 0.52 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.124 -0.985 . . . . 0.0 110.507 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.747 ' O ' HG12 ' A' ' 85' ' ' VAL . . . 122.38 113.09 2.17 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 1.066 ' HB2' HD13 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -172.25 160.44 5.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -1.14 . . . . 0.0 110.18 -179.823 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.511 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -152.29 169.46 22.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.455 -0.778 . . . . 0.0 109.949 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -58.92 -32.94 70.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.096 -1.003 . . . . 0.0 109.784 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.51 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -142.18 167.66 21.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.465 -0.772 . . . . 0.0 110.328 179.867 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.623 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 3.2 m-85 -141.83 -151.29 0.35 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.237 -0.915 . . . . 0.0 110.121 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.668 ' C ' HG23 ' A' ' 59' ' ' VAL . 85.2 p -160.54 -99.24 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.041 -1.037 . . . . 0.0 111.239 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.675 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -120.66 23.52 10.74 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.487 -1.383 . . . . 0.0 110.931 -178.281 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.693 ' C ' HG22 ' A' ' 102' ' ' THR . 17.5 t-20 -165.02 -109.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.769 -1.207 . . . . 0.0 110.541 178.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 48.52 75.71 0.14 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.706 -1.246 . . . . 0.0 109.114 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.683 ' CA ' HG23 ' A' ' 102' ' ' THR . 1.8 t-20 -69.79 125.89 28.07 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.51 -0.744 . . . . 0.0 110.942 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.747 HG12 ' O ' ' A' ' 74' ' ' GLY . 13.3 m -108.53 125.08 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.214 -0.929 . . . . 0.0 109.418 178.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.577 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -80.82 123.93 28.66 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.989 -1.07 . . . . 0.0 108.882 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.761 ' CD1' HG21 ' A' ' 66' ' ' ILE . 9.7 m-85 -87.96 124.07 33.34 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.459 1.123 . . . . 0.0 112.302 -178.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.511 ' HB2' ' OG ' ' A' ' 72' ' ' SER . 0.0 OUTLIER -106.88 96.72 6.64 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.594 -178.899 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.573 ' HA ' ' CA ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -46.65 137.46 6.87 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.002 -1.061 . . . . 0.0 109.719 179.494 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.457 ' HD3' ' ND2' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -64.42 57.08 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.255 -0.903 . . . . 0.0 111.351 -179.377 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.581 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER 58.68 137.65 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.353 -0.842 . . . . 0.0 112.689 178.465 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.624 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 57.0 55.47 30.13 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 178.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.624 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 34.3 m-85 -162.05 165.05 27.79 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.312 -1.11 . . . . 0.0 110.396 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.542 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 1.2 ttmm -123.2 104.03 8.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.296 -0.878 . . . . 0.0 109.629 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.556 HD23 HD11 ' A' ' 66' ' ' ILE . 4.6 mt -46.66 93.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.965 . . . . 0.0 110.451 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -71.7 84.91 0.9 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.337 -0.852 . . . . 0.0 109.671 179.514 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 157.86 -88.75 0.11 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.598 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.2 OUTLIER -160.92 128.36 4.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.153 -1.204 . . . . 0.0 110.716 -179.547 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.505 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 0.4 OUTLIER -69.38 -76.91 0.09 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.289 -0.882 . . . . 0.0 110.612 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 40.4 p -74.55 106.02 5.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.284 -0.885 . . . . 0.0 110.725 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.496 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 58.3 m -113.66 164.38 13.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.354 -0.841 . . . . 0.0 110.068 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.693 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -136.2 142.01 44.06 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.274 -0.891 . . . . 0.0 111.066 -179.721 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.621 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 0.5 OUTLIER -71.93 87.02 1.01 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.246 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.489 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -62.28 178.39 0.33 Allowed Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.202 -0.936 . . . . 0.0 112.619 -178.225 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.759 ' CB ' HD12 ' A' ' 38' ' ' ILE . 44.3 Cg_endo -79.02 42.84 1.36 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 124.813 1.954 . . . . 0.0 112.207 -178.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -140.64 16.76 2.86 Favored Glycine 0 C--N 1.292 -1.884 0 N-CA-C 108.2 -1.96 . . . . 0.0 108.2 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.583 ' O ' HG23 ' A' ' 108' ' ' THR . 22.3 m-80 62.98 57.0 1.72 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.666 -0.903 . . . . 0.0 109.725 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.583 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.2 OUTLIER -160.37 -159.5 0.7 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.309 -0.869 . . . . 0.0 110.452 -179.585 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.621 ' CZ3' ' N ' ' A' ' 103' ' ' CYS . 37.0 m95 -136.6 91.28 2.64 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.372 -0.83 . . . . 0.0 110.442 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.571 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 15.2 mmtt -100.4 148.99 35.68 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.562 -0.711 . . . . 0.0 110.078 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.598 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 47.2 Cg_endo -71.01 174.36 45.2 Favored 'Cis proline' 0 C--N 1.312 -1.342 0 C-N-CA 121.999 -2.084 . . . . 0.0 111.014 -0.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -33.17 131.14 0.2 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.458 0.647 . . . . 0.0 111.838 -179.0 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.597 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.9 OUTLIER -53.38 137.59 50.18 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.56 -0.712 . . . . 0.0 109.812 179.298 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.688 ' HG2' HD12 ' A' ' 66' ' ' ILE . 40.4 Cg_endo -69.19 147.69 67.09 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 O-C-N 124.139 1.599 . . . . 0.0 111.066 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.574 ' O ' HG22 ' A' ' 117' ' ' VAL . 3.6 ttpp -115.9 92.47 3.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.43 -0.794 . . . . 0.0 110.301 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.587 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.1 t -47.67 105.97 0.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.919 . . . . 0.0 110.088 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 115' ' ' LYS . 0.7 OUTLIER -122.55 177.08 4.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.427 -0.796 . . . . 0.0 110.511 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 21.3 ptt85 . . . . . 0 C--N 1.297 -1.674 0 C-N-CA 118.805 -1.158 . . . . 0.0 110.384 179.64 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 51.6 t . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.293 0.568 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.4 ptpt -137.57 178.3 7.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 0.0 110.456 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.546 ' O ' ' N ' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -161.27 93.12 0.93 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.607 -0.683 . . . . 0.0 109.514 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 9.5 mt-30 -72.84 176.96 5.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.072 -1.017 . . . . 0.0 110.428 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.9 140.93 29.13 Favored Pre-proline 0 C--N 1.301 -1.532 0 O-C-N 121.569 -0.707 . . . . 0.0 109.95 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.833 ' HG2' ' CD2' ' A' ' 14' ' ' HIS . 53.4 Cg_endo -70.91 153.21 63.76 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 124.019 1.536 . . . . 0.0 110.861 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -74.98 170.63 19.99 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.959 1.505 . . . . 0.0 109.947 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 92.4 p -69.51 178.25 2.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.174 -0.954 . . . . 0.0 110.191 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.629 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -142.39 -170.17 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 122.125 0.964 . . . . 0.0 111.273 179.81 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 54.7 m -38.22 93.61 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.068 -179.29 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER 43.92 30.47 0.4 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.243 -0.911 . . . . 0.0 110.502 179.689 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.64 162.31 25.15 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.134 -1.587 . . . . 0.0 109.134 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 30' ' ' SER . 5.2 ptt180 -118.45 -173.0 2.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.079 -1.248 . . . . 0.0 110.778 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.833 ' CD2' ' HG2' ' A' ' 6' ' ' PRO . 47.2 p-80 -131.95 153.53 50.21 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.306 0.574 . . . . 0.0 110.66 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -170.63 -156.57 0.13 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.283 -0.885 . . . . 0.0 110.072 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.441 ' C ' ' CD2' ' A' ' 17' ' ' TYR . . . 124.27 24.98 1.71 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.441 ' CD2' ' C ' ' A' ' 16' ' ' GLY . 24.5 m-85 58.66 65.86 1.17 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.175 -1.191 . . . . 0.0 110.284 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 19' ' ' ASP . 1.6 pp20? -141.21 -174.37 4.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.91 . . . . 0.0 109.874 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.449 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 31.9 m-20 -158.3 -33.38 0.07 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.11 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.577 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 5.6 p90 -160.74 70.7 0.4 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.851 -1.156 . . . . 0.0 110.782 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.616 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 30.5 m-85 -46.95 175.4 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.469 -0.77 . . . . 0.0 110.318 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.526 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 21.2 m -132.64 -54.57 0.95 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.058 -1.026 . . . . 0.0 110.738 -179.389 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.424 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 3.9 t70 -171.95 148.12 2.25 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.394 -0.816 . . . . 0.0 109.44 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 65.88 11.83 55.5 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 -178.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.616 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 66.2 m -86.5 175.0 8.59 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.407 -1.055 . . . . 0.0 110.167 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.717 HG13 ' O ' ' A' ' 43' ' ' VAL . 26.1 t -151.34 154.75 7.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.514 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.684 HG11 ' HB2' ' A' ' 14' ' ' HIS . 24.5 t -135.02 117.47 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.147 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.28 104.22 2.6 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.302 -1.359 . . . . 0.0 107.746 178.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.687 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.2 m-30 -68.25 133.18 48.4 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.325 -178.092 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -92.87 153.55 18.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.309 -0.869 . . . . 0.0 109.973 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 57.2 m -119.49 154.41 33.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 110.025 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' A' ' 35' ' ' TYR . 1.6 t-20 -46.81 140.28 4.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.935 . . . . 0.0 110.141 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -45.2 108.68 0.13 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.141 -0.975 . . . . 0.0 110.45 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.81 9.84 27.72 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.5 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 2.7 m-30 -108.5 146.76 32.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.104 -1.233 . . . . 0.0 110.327 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.888 ' HB2' HG22 ' A' ' 59' ' ' VAL . 48.2 t -89.33 137.71 32.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.395 -0.816 . . . . 0.0 110.878 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.656 HD13 ' O ' ' A' ' 29' ' ' TYR . 4.3 tp -94.12 110.04 21.78 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 177.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.71 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -107.56 147.46 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.069 -1.019 . . . . 0.0 109.839 -179.225 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.9 -163.55 12.96 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -65.08 130.81 44.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.219 -1.165 . . . . 0.0 109.773 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.9 p -74.11 53.37 0.49 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.209 -0.932 . . . . 0.0 110.22 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.654 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 150.62 105.59 0.32 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.717 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -48.09 177.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.222 -1.164 . . . . 0.0 108.601 179.377 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.5 ' HA ' ' O ' ' A' ' 25' ' ' SER . 2.5 tp -139.5 105.68 5.24 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.361 -0.837 . . . . 0.0 109.829 178.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.628 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 1.0 OUTLIER -86.05 106.87 17.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.093 -1.004 . . . . 0.0 109.969 179.58 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.7 m -124.38 104.0 8.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.492 -0.755 . . . . 0.0 109.856 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.77 53.97 3.82 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 48.49 46.94 29.5 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -156.83 99.14 1.83 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -1.153 . . . . 0.0 110.897 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.628 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 90.8 m95 -68.18 137.97 55.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.2 -0.938 . . . . 0.0 109.063 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.8 p -140.24 169.77 17.06 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.833 -1.167 . . . . 0.0 111.519 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.508 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.5 OUTLIER 51.8 65.86 5.88 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.734 -0.604 . . . . 0.0 111.457 179.627 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.508 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 46.7 Cg_endo -90.65 130.39 1.54 Allowed 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 121.874 1.716 . . . . 0.0 110.057 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.541 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 53.5 Cg_endo -77.76 176.37 10.1 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.811 1.427 . . . . 0.0 110.705 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.524 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 12.2 p -108.97 156.46 19.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.464 -0.772 . . . . 0.0 110.776 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 10' ' ' SER . 22.2 m -122.67 80.14 1.71 Allowed 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.507 ' O ' ' N ' ' A' ' 36' ' ' SER . 5.8 mm100 -109.98 -145.07 0.39 Allowed 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.428 0.632 . . . . 0.0 110.609 -178.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.592 HD12 ' N ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -137.32 114.16 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.952 HG21 ' HB3' ' A' ' 81' ' ' TYR . 19.6 m -111.87 60.66 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.161 -0.962 . . . . 0.0 112.182 -178.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 107' ' ' ASN . 8.5 mttt -69.73 159.35 33.69 Favored 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 117.852 -1.539 . . . . 0.0 107.245 178.142 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.488 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -118.95 168.82 9.03 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 120.391 -1.443 . . . . 0.0 114.304 -176.974 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -89.9 -81.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.739 2.293 . . . . 0.0 110.972 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 177.37 125.62 0.18 Allowed Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 121.711 -0.618 . . . . 0.0 109.521 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.595 ' N ' ' NE1' ' A' ' 109' ' ' TRP . 49.0 Cg_endo -75.86 67.32 6.65 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 123.714 1.376 . . . . 0.0 109.673 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.55 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -81.7 175.32 10.56 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.57 -0.707 . . . . 0.0 110.471 -179.451 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.697 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -172.46 163.48 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.295 -0.878 . . . . 0.0 110.341 179.665 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 96.4 p -72.86 100.13 2.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.522 -0.736 . . . . 0.0 110.645 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.469 ' O ' ' SG ' ' A' ' 116' ' ' CYS . 7.4 m-20 44.51 45.17 7.6 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.362 -0.837 . . . . 0.0 110.573 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.697 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -152.71 31.02 0.83 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.572 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 6.9 p90 -44.68 -176.08 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 122.663 1.22 . . . . 0.0 112.644 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.681 HD13 ' H ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -110.49 162.99 14.14 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.558 179.22 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.508 ' HB2' ' HD3' ' A' ' 88' ' ' LYS . 2.5 t -144.49 14.89 1.61 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.003 -1.061 . . . . 0.0 110.178 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.67 -69.79 0.74 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.216 -0.927 . . . . 0.0 110.909 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.452 ' O ' HG12 ' A' ' 85' ' ' VAL . . . -136.82 81.47 0.28 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.594 ' CE2' ' OH ' ' A' ' 79' ' ' TYR . 1.9 t80 -105.94 160.02 15.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.43 -1.041 . . . . 0.0 109.977 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.481 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 25.3 tttt -158.4 148.14 19.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.897 . . . . 0.0 110.446 -179.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' A' ' 76' ' ' LYS . 2.2 mtp85 -44.71 -34.58 2.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.177 -0.952 . . . . 0.0 109.702 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.448 ' O ' ' HD3' ' A' ' 76' ' ' LYS . 0.5 OUTLIER -143.63 153.48 42.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.406 -0.808 . . . . 0.0 109.917 179.725 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.594 ' OH ' ' CE2' ' A' ' 75' ' ' PHE . 8.3 m-85 -125.41 -148.12 0.38 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.161 -0.962 . . . . 0.0 110.462 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.525 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 81.6 p -158.62 -124.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.3 -0.875 . . . . 0.0 110.3 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.952 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -99.93 29.9 3.98 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.037 -1.039 . . . . 0.0 111.068 -178.295 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.67 ' C ' HG22 ' A' ' 102' ' ' THR . 48.7 t30 -173.93 -114.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.93 -1.107 . . . . 0.0 110.462 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 49.43 75.39 0.16 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.696 -1.252 . . . . 0.0 109.244 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.616 ' CA ' HG23 ' A' ' 102' ' ' THR . 10.3 p30 -69.27 125.46 26.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.381 -0.824 . . . . 0.0 110.826 -179.089 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.597 HG23 ' CE1' ' A' ' 87' ' ' PHE . 26.4 m -107.2 118.03 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.166 -0.959 . . . . 0.0 110.235 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.547 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -78.77 137.7 37.86 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.738 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.665 ' CZ ' HD12 ' A' ' 113' ' ' LEU . 70.0 m-85 -95.58 137.83 34.1 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.872 -1.142 . . . . 0.0 112.52 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.508 ' HD3' ' HB2' ' A' ' 72' ' ' SER . 0.7 OUTLIER -111.1 93.84 4.69 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.744 -179.923 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.578 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -44.15 131.97 5.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.053 -1.029 . . . . 0.0 110.302 -179.663 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 11.6 mmtt -42.27 -78.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.295 -0.878 . . . . 0.0 110.258 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.573 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -162.3 136.78 6.73 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.321 -0.862 . . . . 0.0 110.492 -179.892 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.592 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 52.98 66.08 2.94 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.592 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 14.6 m-85 -162.49 172.43 15.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.42 -1.047 . . . . 0.0 110.096 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.592 ' O ' HG22 ' A' ' 117' ' ' VAL . 4.4 mtmt -131.2 107.65 9.15 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.321 -0.862 . . . . 0.0 109.957 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.578 HD11 ' H ' ' A' ' 89' ' ' CYS . 1.1 mt -49.54 93.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.099 -1.001 . . . . 0.0 110.425 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.468 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -77.44 109.33 11.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -0.937 . . . . 0.0 110.184 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 135.03 -85.13 0.26 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.565 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.2 OUTLIER -158.77 112.46 2.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.293 -1.122 . . . . 0.0 110.546 -179.61 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.422 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 28.4 t -72.82 -0.1 12.47 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.279 -0.888 . . . . 0.0 110.326 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.5 p -141.5 117.92 10.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.143 -0.973 . . . . 0.0 109.547 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.49 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 40.1 m -134.33 151.42 51.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.149 -0.969 . . . . 0.0 111.122 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.67 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -120.36 151.95 38.55 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.61 0.719 . . . . 0.0 110.049 179.608 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.594 ' SG ' ' CZ2' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -83.8 77.96 9.79 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.683 -0.635 . . . . 0.0 110.554 -179.348 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.501 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.5 OUTLIER -48.37 175.78 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.348 -0.845 . . . . 0.0 111.675 -179.641 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.71 ' CB ' HD12 ' A' ' 38' ' ' ILE . 47.3 Cg_endo -77.53 43.18 1.28 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.656 1.872 . . . . 0.0 111.968 -178.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -139.57 12.04 3.21 Favored Glycine 0 C--N 1.292 -1.903 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 2.0 m120 64.2 63.83 0.76 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.718 -0.872 . . . . 0.0 109.836 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -159.8 -160.52 0.82 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.319 -0.863 . . . . 0.0 111.035 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.638 ' HB3' HD11 ' A' ' 113' ' ' LEU . 26.4 m95 -137.43 82.0 1.9 Allowed 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.64 0.733 . . . . 0.0 110.293 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.567 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.8 OUTLIER -99.27 136.5 20.45 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.72 -0.612 . . . . 0.0 110.161 -179.819 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.567 ' C ' ' HA ' ' A' ' 110' ' ' LYS . 42.7 Cg_endo -69.53 164.94 77.26 Favored 'Cis proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.084 -2.048 . . . . 0.0 111.001 -0.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -41.24 149.39 0.1 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.563 -0.711 . . . . 0.0 110.555 -179.303 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.733 HD22 ' H ' ' A' ' 113' ' ' LEU . 1.1 mm? -57.19 145.64 65.25 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.422 -0.798 . . . . 0.0 109.982 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.662 ' HG2' HD12 ' A' ' 66' ' ' ILE . 37.4 Cg_endo -69.0 169.47 17.87 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 O-C-N 124.31 1.689 . . . . 0.0 110.951 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.719 ' HG2' HG13 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -128.34 106.32 8.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 0.0 110.528 -179.549 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.545 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.4 t -63.31 87.13 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.184 -0.947 . . . . 0.0 108.912 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.719 HG13 ' HG2' ' A' ' 115' ' ' LYS . 2.3 m -103.3 177.58 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.612 0.72 . . . . 0.0 111.007 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.582 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.709 0 C-N-CA 118.971 -1.092 . . . . 0.0 110.327 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 1' ' ' VAL . 5.0 p . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.2 0.524 . . . . 0.0 110.052 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.75 177.54 7.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.393 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.576 ' CB ' ' N ' ' A' ' 22' ' ' THR . 1.4 t -159.4 104.13 1.63 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.434 -0.791 . . . . 0.0 110.486 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.424 ' C ' ' O ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -81.25 176.58 9.63 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.73 -1.232 . . . . 0.0 109.325 179.023 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 19' ' ' ASP . 0.1 OUTLIER -54.57 146.68 33.37 Favored Pre-proline 0 C--N 1.294 -1.812 0 O-C-N 121.379 -0.825 . . . . 0.0 109.666 179.882 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.84 ' HG2' ' CD2' ' A' ' 14' ' ' HIS . 51.7 Cg_endo -70.11 154.2 66.56 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.93 1.489 . . . . 0.0 111.404 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -76.21 172.88 15.44 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.014 1.534 . . . . 0.0 110.281 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 m -69.7 179.47 2.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.161 -0.962 . . . . 0.0 110.007 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.633 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -145.24 -170.16 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 122.335 1.064 . . . . 0.0 111.905 -179.786 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.496 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 14.1 t -46.17 105.75 0.07 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.313 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 10' ' ' SER . 6.6 m120 40.96 26.43 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.352 -0.842 . . . . 0.0 110.763 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -141.38 169.86 24.92 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 30' ' ' SER . 2.5 ptt180 -133.91 -178.55 5.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -1.142 . . . . 0.0 110.332 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.84 ' CD2' ' HG2' ' A' ' 6' ' ' PRO . 39.6 p-80 -120.22 156.23 31.58 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.545 -0.722 . . . . 0.0 110.095 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -173.84 50.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.141 -0.974 . . . . 0.0 110.587 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 17' ' ' TYR . . . -53.92 -78.76 0.1 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.469 ' HB3' ' OE2' ' A' ' 18' ' ' GLU . 0.2 OUTLIER 174.98 35.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.355 -1.085 . . . . 0.0 110.248 179.515 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.469 ' OE2' ' HB3' ' A' ' 17' ' ' TYR . 0.6 OUTLIER 176.81 -178.38 0.16 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 110.428 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 5' ' ' SER . 8.1 t70 -117.49 -43.62 2.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.428 -0.795 . . . . 0.0 109.955 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 3' ' ' CYS . 14.2 m-85 -84.31 130.3 34.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.334 -0.854 . . . . 0.0 109.859 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.607 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.5 OUTLIER -132.42 -6.02 3.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.344 -0.847 . . . . 0.0 110.889 -179.39 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.576 ' N ' ' CB ' ' A' ' 3' ' ' CYS . 66.7 p 45.91 -96.71 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.516 -0.74 . . . . 0.0 111.841 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.402 ' HB2' ' H ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER -150.13 150.89 32.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.843 -1.161 . . . . 0.0 110.661 -178.442 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 79.42 15.49 79.81 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.607 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 20.5 m -97.25 172.77 7.59 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.459 -1.024 . . . . 0.0 110.281 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.706 HG13 ' O ' ' A' ' 43' ' ' VAL . 33.4 t -151.49 151.94 11.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.382 -0.824 . . . . 0.0 110.066 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.636 HG11 ' HB2' ' A' ' 14' ' ' HIS . 34.6 t -134.66 119.89 30.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.223 -0.923 . . . . 0.0 111.583 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.764 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -72.3 103.6 3.45 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.399 -1.321 . . . . 0.0 107.489 177.736 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.669 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 2.2 m-30 -67.55 121.4 15.77 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.338 -0.851 . . . . 0.0 110.074 -178.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -74.76 150.3 39.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.206 -0.934 . . . . 0.0 109.617 179.352 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.479 ' SG ' HD12 ' A' ' 37' ' ' LEU . 60.3 m -118.2 159.51 23.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.176 -0.952 . . . . 0.0 110.306 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 33' ' ' SER . 4.4 t-20 -53.72 134.89 41.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 110.236 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 32' ' ' ASN . 0.5 OUTLIER -44.39 102.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.245 -0.909 . . . . 0.0 110.305 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.73 -11.31 12.17 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -93.84 139.74 30.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.236 -1.155 . . . . 0.0 110.062 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.634 ' HB3' HD11 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -84.62 142.05 30.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.172 -0.955 . . . . 0.0 110.879 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.693 HD21 ' HA ' ' A' ' 41' ' ' SER . 3.2 tp -92.81 97.04 10.51 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.458 -0.776 . . . . 0.0 109.231 179.018 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.904 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -88.42 157.0 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.409 -0.807 . . . . 0.0 109.05 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 91.07 178.22 43.31 Favored Glycine 0 N--CA 1.488 2.11 0 C-N-CA 119.417 -1.373 . . . . 0.0 109.988 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.459 ' O ' ' HG3' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -54.71 124.65 17.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.311 -1.111 . . . . 0.0 109.85 179.729 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.764 ' O ' HG23 ' A' ' 28' ' ' THR . 0.1 OUTLIER -72.45 55.14 0.34 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.206 -0.934 . . . . 0.0 109.956 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.644 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 161.39 96.98 0.11 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.706 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -45.3 173.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.365 -1.079 . . . . 0.0 108.345 179.336 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.477 ' HB3' ' OD2' ' A' ' 52' ' ' ASP . 7.3 tp -134.08 103.37 5.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.984 -1.073 . . . . 0.0 110.371 178.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.549 ' HB2' ' CE2' ' A' ' 50' ' ' TRP . 0.6 OUTLIER -77.23 115.28 16.88 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.367 -0.833 . . . . 0.0 109.45 179.168 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.86 101.74 5.37 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.113 -0.992 . . . . 0.0 110.171 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.402 ' H ' ' HB2' ' A' ' 23' ' ' ASP . . . 77.96 41.15 19.18 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.41 30.76 78.75 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.79 102.09 4.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -1.142 . . . . 0.0 110.552 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.549 ' CE2' ' HB2' ' A' ' 45' ' ' CYS . 89.7 m95 -73.59 123.0 23.14 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.127 -0.983 . . . . 0.0 109.551 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.418 ' O ' ' CG ' ' A' ' 52' ' ' ASP . 22.4 m -129.22 -176.38 3.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.062 -1.024 . . . . 0.0 111.399 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.52 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 1.6 p30 37.56 65.64 2.56 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.851 -0.53 . . . . 0.0 111.191 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.1 Cg_endo -91.09 131.73 1.48 Allowed 'Trans proline' 0 C--N 1.301 -1.946 0 C-N-CA 121.95 1.767 . . . . 0.0 110.03 178.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.541 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 53.8 Cg_endo -76.27 172.67 15.82 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.596 1.314 . . . . 0.0 110.205 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.615 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 37.9 p -114.22 143.16 45.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.08 -1.013 . . . . 0.0 111.291 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 10' ' ' SER . 69.4 m -107.57 78.89 1.24 Allowed 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -113.84 -159.33 0.69 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.481 0.658 . . . . 0.0 110.56 -178.299 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.635 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -110.49 142.8 21.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.426 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.726 HG21 ' CB ' ' A' ' 81' ' ' TYR . 21.3 m -133.44 44.96 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.988 -1.07 . . . . 0.0 110.992 -178.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.629 ' HD2' HG22 ' A' ' 58' ' ' ILE . 2.9 mttp -81.34 102.45 10.45 Favored 'General case' 0 C--N 1.281 -2.377 0 C-N-CA 118.858 -1.137 . . . . 0.0 109.343 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.512 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 53.2 m -72.94 164.0 64.11 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.372 -0.83 . . . . 0.0 111.298 -178.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.544 ' HD2' ' HA ' ' A' ' 108' ' ' THR . 42.5 Cg_endo -69.54 -89.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 124.306 1.687 . . . . 0.0 110.666 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.477 ' HB3' ' CG2' ' A' ' 65' ' ' THR . 0.2 OUTLIER -159.68 133.36 4.97 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.776 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.694 ' HA ' HD21 ' A' ' 113' ' ' LEU . 56.7 Cg_endo -77.93 65.86 8.24 Favored 'Trans proline' 0 C--N 1.296 -2.22 0 O-C-N 123.604 1.318 . . . . 0.0 109.671 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.716 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.7 OUTLIER -87.27 -175.37 5.26 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.533 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.716 HG22 ' C ' ' A' ' 65' ' ' THR . 0.2 OUTLIER 179.7 169.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 C-N-CA 118.756 -1.178 . . . . 0.0 110.721 179.438 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.511 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 4.0 t -69.71 90.89 0.59 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.46 -0.775 . . . . 0.0 110.915 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 1.9 m-80 51.17 34.72 11.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.336 -0.852 . . . . 0.0 110.902 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.666 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -139.15 30.07 2.48 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.57 ' O ' ' N ' ' A' ' 88' ' ' LYS . 4.7 p90 -43.12 -174.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 122.707 1.241 . . . . 0.0 112.789 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.749 HD22 ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -113.73 158.0 21.49 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.056 179.088 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.8 19.44 2.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.094 -1.004 . . . . 0.0 110.086 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.8 t -99.25 -85.14 0.4 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.918 . . . . 0.0 110.844 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -98.62 -86.24 1.86 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.59 ' CE2' ' OH ' ' A' ' 79' ' ' TYR . 17.5 t80 57.3 106.84 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.418 -1.048 . . . . 0.0 110.207 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.61 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -114.96 123.35 48.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.253 -0.905 . . . . 0.0 108.918 179.309 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.526 ' C ' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -28.79 -39.54 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.353 0.597 . . . . 0.0 111.204 -179.073 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -123.52 105.81 10.07 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.379 -0.825 . . . . 0.0 109.739 179.192 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.61 ' CE1' ' O ' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -91.73 175.23 6.97 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.128 -0.982 . . . . 0.0 109.849 -179.517 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.555 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -170.27 107.09 0.33 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.149 -0.97 . . . . 0.0 111.128 179.821 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.726 ' CB ' HG21 ' A' ' 59' ' ' VAL . 10.2 t80 46.77 18.44 0.07 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.091 -1.006 . . . . 0.0 111.809 178.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.661 ' C ' HG22 ' A' ' 102' ' ' THR . 28.5 p30 -172.49 -128.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.186 -1.571 . . . . 0.0 110.841 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.462 ' OD2' ' HA ' ' A' ' 79' ' ' TYR . 11.0 m-20 52.78 72.51 0.41 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.858 -1.151 . . . . 0.0 108.831 -178.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.761 ' CA ' HG23 ' A' ' 102' ' ' THR . 15.5 p30 -68.5 138.41 55.18 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.473 -0.767 . . . . 0.0 110.169 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.608 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 5.2 m -124.54 119.49 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.181 -0.949 . . . . 0.0 110.746 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.537 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 5.2 t0 -81.39 132.56 35.33 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.655 ' CE1' HD12 ' A' ' 71' ' ' LEU . 69.6 m-85 -92.01 120.94 33.12 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 122.326 1.06 . . . . 0.0 112.464 -177.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -92.7 90.68 7.17 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.763 179.594 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.517 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -44.07 131.02 6.02 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.157 -0.965 . . . . 0.0 109.774 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -37.65 -70.9 0.09 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.647 -0.658 . . . . 0.0 110.74 -179.434 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.574 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 49.1 t80 -175.11 145.65 0.81 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.276 -0.89 . . . . 0.0 110.366 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.58 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 46.18 42.21 12.27 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 12.1 m-85 -145.37 150.7 37.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.526 -0.985 . . . . 0.0 109.934 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.531 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 6.8 mtmp? -107.42 138.96 42.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.291 -0.881 . . . . 0.0 109.903 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.63 HD23 ' HB2' ' A' ' 114' ' ' PRO . 0.5 OUTLIER -78.49 100.17 6.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.025 -1.047 . . . . 0.0 110.725 -179.545 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.454 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -78.49 105.91 10.08 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.423 -0.798 . . . . 0.0 109.436 179.273 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 138.62 -88.61 0.2 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.586 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -158.07 112.94 2.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.296 -1.12 . . . . 0.0 110.549 -179.614 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 82.8 p -65.0 -22.11 66.95 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.191 -0.943 . . . . 0.0 110.765 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.6 p -125.65 126.26 44.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.813 -1.179 . . . . 0.0 109.877 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.535 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 4.5 m -135.11 172.57 12.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 0.0 110.429 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.761 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -148.03 140.46 24.42 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.506 -0.746 . . . . 0.0 110.456 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.574 ' O ' ' CA ' ' A' ' 81' ' ' TYR . 7.8 t -59.97 88.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.43 -0.794 . . . . 0.0 109.43 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.465 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.2 OUTLIER -61.53 173.23 0.82 Allowed Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.037 -1.039 . . . . 0.0 111.768 -178.844 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.904 ' CB ' HD12 ' A' ' 38' ' ' ILE . 50.5 Cg_endo -75.37 13.91 1.03 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 124.554 1.818 . . . . 0.0 111.937 -178.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.486 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -112.35 23.14 16.42 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.699 ' O ' HG23 ' A' ' 108' ' ' THR . 39.5 m-80 60.47 48.53 7.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.808 -0.819 . . . . 0.0 110.636 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.699 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.6 OUTLIER -160.98 -179.39 7.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.03 -1.044 . . . . 0.0 111.387 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.691 ' HB3' HD13 ' A' ' 113' ' ' LEU . 42.2 m95 -104.15 99.01 8.74 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.556 0.693 . . . . 0.0 110.845 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.536 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 8.8 mttt -110.19 141.01 22.96 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.503 -0.748 . . . . 0.0 109.59 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.586 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.4 Cg_endo -71.04 168.68 71.45 Favored 'Cis proline' 0 C--N 1.313 -1.312 0 C-N-CA 122.109 -2.038 . . . . 0.0 110.981 -0.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 111' ' ' PRO . 4.3 tt0 -38.97 130.79 1.46 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.502 -0.749 . . . . 0.0 111.106 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.694 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -42.32 146.88 0.63 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.47 -0.769 . . . . 0.0 110.117 179.178 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.675 ' HG2' HD12 ' A' ' 66' ' ' ILE . 41.9 Cg_endo -74.14 173.51 14.0 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 O-C-N 124.382 1.727 . . . . 0.0 110.658 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.542 ' O ' HG22 ' A' ' 117' ' ' VAL . 24.6 ttmt -135.12 111.67 9.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 110.565 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.535 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.8 t -66.15 100.19 0.58 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.344 -0.847 . . . . 0.0 108.809 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -110.57 -177.63 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-O 121.798 0.809 . . . . 0.0 110.825 -179.12 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.296 -1.75 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.472 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.224 0.535 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.6 172.76 6.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.158 -0.964 . . . . 0.0 110.601 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.565 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -124.76 83.73 2.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.441 -0.787 . . . . 0.0 109.829 179.853 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.562 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 9.3 mt-30 -60.11 174.54 0.5 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.291 -0.88 . . . . 0.0 110.417 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 19' ' ' ASP . 1.0 OUTLIER -47.09 144.48 4.0 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.423 -0.798 . . . . 0.0 110.204 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.67 ' HG3' HG11 ' A' ' 27' ' ' VAL . 53.3 Cg_endo -71.52 157.72 55.53 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.988 1.52 . . . . 0.0 110.871 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -76.72 171.96 17.06 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.992 1.522 . . . . 0.0 110.286 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.61 175.96 6.64 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.221 -0.924 . . . . 0.0 109.895 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.604 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -141.14 -170.57 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 122.281 1.039 . . . . 0.0 111.587 179.581 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.4 OUTLIER -44.93 105.13 0.05 Allowed 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.157 -178.998 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.453 ' C ' ' O ' ' A' ' 10' ' ' SER . 0.9 OUTLIER 39.05 27.95 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.315 -0.866 . . . . 0.0 110.583 179.604 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -135.99 160.42 24.61 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -123.2 178.22 5.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -1.131 . . . . 0.0 110.321 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.638 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 11.3 p80 -123.31 135.98 54.46 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.572 -0.705 . . . . 0.0 110.355 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -137.43 64.68 1.52 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.413 -0.804 . . . . 0.0 110.077 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -59.09 -173.59 0.55 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.06 31.61 1.63 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.322 -1.105 . . . . 0.0 110.229 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.568 ' OE2' ' CD1' ' A' ' 21' ' ' TYR . 6.7 pt-20 179.09 -171.81 0.14 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 110.371 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 5' ' ' SER . 29.4 t0 -92.03 -52.54 4.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 110.014 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.573 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 52.0 p90 -104.03 -155.17 0.52 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.177 -0.952 . . . . 0.0 109.983 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.618 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 1.8 m-85 -170.0 -31.62 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.157 -0.964 . . . . 0.0 110.883 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.565 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 3.0 m 78.42 -83.03 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.659 -0.65 . . . . 0.0 111.904 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 47' ' ' GLY . 2.1 t70 -161.93 157.13 23.33 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.745 -1.222 . . . . 0.0 110.14 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.29 14.86 60.25 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.618 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 20.1 m -94.01 176.77 6.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.476 -1.014 . . . . 0.0 110.179 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.664 HG13 ' O ' ' A' ' 43' ' ' VAL . 25.2 t -154.29 158.29 3.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 119.549 -0.861 . . . . 0.0 110.379 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.67 HG11 ' HG3' ' A' ' 6' ' ' PRO . 10.0 t -141.82 113.31 3.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 118.933 -1.107 . . . . 0.0 111.915 -179.161 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.905 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -69.8 105.21 2.69 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.127 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.645 ' CE1' HG21 ' A' ' 43' ' ' VAL . 3.1 m-30 -67.73 -176.44 0.65 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 110.21 -178.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.464 ' O ' ' CA ' ' A' ' 12' ' ' GLY . 0.6 OUTLIER -142.25 146.94 35.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.434 -0.791 . . . . 0.0 109.626 179.455 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.613 ' SG ' HD12 ' A' ' 37' ' ' LEU . 35.2 m -123.3 137.19 54.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 110.245 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 31' ' ' CYS . 2.5 m-20 -44.04 148.2 0.43 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 110.141 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -47.98 131.06 15.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.0 110.138 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.05 -12.7 52.55 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.513 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 1.9 m-30 -110.17 125.94 53.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.266 -1.138 . . . . 0.0 110.42 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.619 ' HB3' HD11 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -79.86 144.85 33.09 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.322 -0.861 . . . . 0.0 110.977 -179.689 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.656 ' C ' HD13 ' A' ' 38' ' ' ILE . 2.3 tp -95.48 105.11 17.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.347 -0.845 . . . . 0.0 109.935 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.869 HD12 ' HB3' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -97.2 149.56 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.247 -0.908 . . . . 0.0 109.466 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 130.89 -158.71 22.74 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.487 ' O ' ' C ' ' A' ' 41' ' ' SER . 8.5 t-20 -97.89 51.7 1.05 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.107 -1.231 . . . . 0.0 109.897 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.905 ' O ' HG23 ' A' ' 28' ' ' THR . 79.5 p 28.65 45.45 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.499 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.494 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 157.33 126.04 0.89 Allowed Glycine 0 N--CA 1.49 2.299 0 C-N-CA 119.378 -1.392 . . . . 0.0 110.44 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.664 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.7 t -65.01 178.27 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.182 -1.187 . . . . 0.0 107.864 178.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.55 ' C ' ' CD2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -140.41 94.31 2.72 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.057 178.452 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.588 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -81.88 107.75 14.85 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.114 178.566 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.526 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -132.37 121.13 23.0 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.317 -179.479 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.539 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 90.96 8.88 64.5 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.04 27.86 19.84 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -154.22 125.57 7.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.223 -1.163 . . . . 0.0 110.19 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.588 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 92.2 m95 -72.06 137.32 47.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.713 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.93 166.49 25.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.127 -0.983 . . . . 0.0 111.077 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.52 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 87.8 m-20 48.34 65.37 7.16 Favored Pre-proline 0 N--CA 1.492 1.629 0 CA-C-O 121.216 0.532 . . . . 0.0 111.204 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.4 Cg_endo -91.02 151.41 3.87 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 O-C-N 124.433 1.754 . . . . 0.0 110.045 179.096 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.557 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 48.8 Cg_endo -78.72 175.95 10.42 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 123.852 1.448 . . . . 0.0 110.41 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.627 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 17.7 p -119.03 177.55 4.82 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.28 -0.887 . . . . 0.0 110.876 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 10' ' ' SER . 65.4 m -132.93 71.8 1.48 Allowed 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -113.72 171.95 7.27 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.144 -178.713 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -87.66 144.13 9.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 119.349 -0.94 . . . . 0.0 108.577 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.634 HG23 ' CA ' ' A' ' 80' ' ' SER . 34.1 m -130.42 44.9 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.549 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 2.6 mmtt -53.91 179.79 0.02 OUTLIER 'General case' 0 C--N 1.278 -2.507 0 C-N-CA 118.035 -1.466 . . . . 0.0 108.381 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -145.36 165.28 22.25 Favored Pre-proline 0 N--CA 1.492 1.667 0 C-N-CA 118.402 -1.319 . . . . 0.0 112.887 -178.587 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.426 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 45.4 Cg_endo -88.2 -78.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.877 1.988 . . . . 0.0 110.401 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.426 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 170.93 129.26 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.653 -0.654 . . . . 0.0 109.352 -179.365 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.613 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 52.8 Cg_endo -80.97 65.83 8.89 Favored 'Trans proline' 0 C--N 1.298 -2.091 0 O-C-N 123.723 1.38 . . . . 0.0 110.074 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.605 ' O ' HD23 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -84.19 169.0 15.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.468 -0.77 . . . . 0.0 109.9 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.828 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -169.17 161.78 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.035 -1.041 . . . . 0.0 110.638 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.492 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 0.6 OUTLIER -66.28 105.84 1.53 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.544 -0.723 . . . . 0.0 111.025 -179.18 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.459 ' O ' ' CG ' ' A' ' 90' ' ' LYS . 7.4 m-80 38.74 38.64 0.28 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.532 -0.73 . . . . 0.0 110.803 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.828 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -147.38 32.67 1.36 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.584 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 3.6 p90 -46.46 -170.77 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 122.72 1.248 . . . . 0.0 112.515 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.742 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -114.07 168.48 9.78 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.007 179.554 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.3 t -149.67 15.87 0.87 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.848 -1.158 . . . . 0.0 110.644 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.505 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 41.9 t -92.49 -77.1 0.44 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.921 . . . . 0.0 110.515 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -130.87 77.98 0.38 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.62 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -103.85 163.74 12.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.354 -1.086 . . . . 0.0 109.548 179.538 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.62 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 17.0 ttmm -165.2 158.89 16.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 109.941 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.469 ' N ' ' HG2' ' A' ' 76' ' ' LYS . 26.2 mtt180 -54.1 -25.21 20.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.072 -1.017 . . . . 0.0 109.861 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.474 ' O ' ' HD2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -145.14 160.41 41.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.452 -0.78 . . . . 0.0 110.203 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.591 ' OH ' ' CE2' ' A' ' 75' ' ' PHE . 16.2 m-85 -135.75 -150.14 0.36 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.308 -0.87 . . . . 0.0 109.818 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.634 ' CA ' HG23 ' A' ' 59' ' ' VAL . 83.3 p -162.5 -104.96 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.807 -1.183 . . . . 0.0 111.388 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.596 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -114.47 15.87 17.8 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.481 -1.387 . . . . 0.0 110.431 -178.741 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.683 ' O ' HG22 ' A' ' 102' ' ' THR . 7.7 p30 -160.51 -107.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.925 -1.109 . . . . 0.0 110.443 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 82' ' ' ASN . 0.3 OUTLIER 46.34 74.24 0.15 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.806 -1.184 . . . . 0.0 108.734 -179.1 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.952 ' CA ' HG23 ' A' ' 102' ' ' THR . 20.8 t-20 -68.52 122.64 18.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.468 -0.77 . . . . 0.0 110.338 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.533 HG11 ' HG3' ' A' ' 64' ' ' PRO . 23.4 m -104.96 120.04 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 0.0 110.608 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' A' ' 73' ' ' SER . 62.8 t0 -83.72 127.77 34.03 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.742 ' CE1' HD12 ' A' ' 71' ' ' LEU . 35.1 m-85 -85.15 122.52 29.46 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.412 1.101 . . . . 0.0 111.876 -178.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -101.26 88.55 3.51 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.94 -179.778 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.549 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -42.52 129.24 4.03 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.31 -0.869 . . . . 0.0 109.814 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.459 ' CG ' ' O ' ' A' ' 68' ' ' ASN . 2.1 mmmt -38.48 -89.67 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.551 -0.718 . . . . 0.0 110.841 -179.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.573 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 1.9 t80 -153.37 131.13 11.59 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.102 -0.999 . . . . 0.0 110.341 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.584 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 60.11 52.66 51.41 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 26.4 m-85 -158.08 145.79 18.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.54 -0.976 . . . . 0.0 109.764 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.55 ' O ' ' N ' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -103.29 153.18 20.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.529 179.735 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.657 HD23 HD11 ' A' ' 66' ' ' ILE . 2.7 mt -91.32 97.55 11.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.754 -1.216 . . . . 0.0 110.086 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.828 ' HB2' HG21 ' A' ' 117' ' ' VAL . 16.8 t -80.65 107.83 13.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 110.241 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 98' ' ' SER . . . 129.85 -32.42 3.16 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.635 -1.269 . . . . 0.0 110.561 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.513 ' O ' ' HB3' ' A' ' 114' ' ' PRO . 12.7 p 177.18 -168.48 0.06 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.999 -1.295 . . . . 0.0 111.154 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.3 p -160.24 -35.09 0.05 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.247 0.546 . . . . 0.0 109.836 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 82.7 p -130.59 82.82 2.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 0.0 109.556 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.497 ' O ' ' N ' ' A' ' 85' ' ' VAL . 7.1 m -91.0 176.15 6.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.396 -0.815 . . . . 0.0 110.993 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.952 HG23 ' CA ' ' A' ' 84' ' ' ASN . 1.6 m -151.06 142.98 23.91 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.601 -0.687 . . . . 0.0 110.317 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' A' ' 79' ' ' TYR . 8.2 t -75.23 78.02 2.35 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.494 -0.754 . . . . 0.0 109.635 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.514 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -64.43 177.29 0.58 Allowed Pre-proline 0 C--N 1.299 -1.595 0 O-C-N 121.324 -0.86 . . . . 0.0 110.465 -179.664 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.869 ' HB3' HD12 ' A' ' 38' ' ' ILE . 42.0 Cg_endo -69.8 131.73 21.8 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 124.332 1.701 . . . . 0.0 110.142 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 121.9 -10.91 9.5 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 108.679 -1.769 . . . . 0.0 108.679 -179.062 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.591 ' O ' HG23 ' A' ' 108' ' ' THR . 10.4 m-20 79.64 92.25 0.05 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.893 -0.769 . . . . 0.0 110.807 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.591 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -177.51 -162.56 0.07 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.581 179.597 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.613 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 20.5 m95 -147.88 82.78 1.51 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.389 0.614 . . . . 0.0 109.897 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.509 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 9.2 mmtt -91.81 146.51 33.13 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.393 -0.817 . . . . 0.0 109.972 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 110' ' ' LYS . 46.7 Cg_endo -75.42 176.35 43.98 Favored 'Cis proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.654 -2.228 . . . . 0.0 110.481 -0.076 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.2 OUTLIER -37.17 124.63 0.95 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.685 -0.634 . . . . 0.0 110.741 -179.524 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.609 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.5 OUTLIER -42.57 137.36 2.36 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.873 . . . . 0.0 109.859 179.811 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.742 ' HG2' HD12 ' A' ' 66' ' ' ILE . 49.0 Cg_endo -74.67 165.1 32.32 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 O-C-N 124.258 1.662 . . . . 0.0 111.614 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.887 ' HG2' HG13 ' A' ' 117' ' ' VAL . 12.6 ttmt -126.71 105.19 8.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.538 -0.726 . . . . 0.0 109.924 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.531 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.6 t -55.38 86.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.16 -0.963 . . . . 0.0 109.846 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.887 HG13 ' HG2' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -98.62 -172.16 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 121.822 0.82 . . . . 0.0 110.528 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.2 mtm180 . . . . . 0 C--N 1.294 -1.83 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.497 -179.991 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.366 0.603 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.51 177.39 6.38 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.385 -0.822 . . . . 0.0 110.305 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.547 ' HB2' ' CA ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -125.41 75.35 1.46 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.421 -0.799 . . . . 0.0 110.106 -179.889 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.444 ' O ' ' C ' ' A' ' 5' ' ' SER . 3.0 mp0 -54.17 172.02 0.1 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.041 -1.037 . . . . 0.0 109.725 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.2 p -42.41 144.82 0.89 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 109.94 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.858 ' HG3' HG11 ' A' ' 27' ' ' VAL . 53.9 Cg_endo -70.62 160.45 49.43 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.046 1.551 . . . . 0.0 110.79 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -76.26 170.21 20.46 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 O-C-N 124.014 1.534 . . . . 0.0 109.945 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.55 176.18 6.38 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.141 -0.975 . . . . 0.0 110.27 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.499 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -144.26 -170.33 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 122.24 1.019 . . . . 0.0 111.746 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.484 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.3 OUTLIER -50.27 105.19 0.09 Allowed 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.287 -178.91 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 10' ' ' SER . 65.0 m-20 37.27 47.12 0.65 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.516 -0.74 . . . . 0.0 111.274 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.53 152.85 24.3 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 30' ' ' SER . 1.6 ptt180 -113.04 -172.5 2.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.104 -1.233 . . . . 0.0 111.192 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.623 ' CG ' ' HG2' ' A' ' 6' ' ' PRO . 20.3 p80 -143.99 111.6 6.04 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.294 0.568 . . . . 0.0 109.469 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 14' ' ' HIS . 2.6 t-20 -177.87 174.22 1.46 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.601 -1.312 . . . . 0.0 110.87 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 17' ' ' TYR . . . 145.62 -39.74 1.14 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.468 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.8 OUTLIER 178.17 46.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.513 -0.992 . . . . 0.0 109.568 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.644 ' OE2' HG13 ' A' ' 27' ' ' VAL . 0.9 OUTLIER -134.19 -94.16 0.3 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.225 -0.922 . . . . 0.0 110.491 -179.495 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 9.2 m-20 66.26 6.45 4.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.279 -0.888 . . . . 0.0 110.387 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -170.42 116.48 0.5 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 110.621 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.62 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 18.3 m-85 -132.83 173.47 11.35 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.364 -0.835 . . . . 0.0 109.294 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.547 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 1.9 p -130.59 -68.9 0.67 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.779 -1.2 . . . . 0.0 110.75 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.417 ' C ' ' OD1' ' A' ' 23' ' ' ASP . 14.7 t0 -162.04 132.4 4.85 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.392 -0.818 . . . . 0.0 109.684 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.54 16.19 71.64 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.618 -1.793 . . . . 0.0 108.618 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.62 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.5 OUTLIER -97.73 -179.25 4.38 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.46 -1.023 . . . . 0.0 110.506 -179.808 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 43' ' ' VAL . 11.8 t -149.58 162.26 4.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.041 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.858 HG11 ' HG3' ' A' ' 6' ' ' PRO . 16.4 t -143.07 118.56 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 119.698 -0.801 . . . . 0.0 111.681 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.885 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -75.3 102.41 5.05 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 118.636 -1.225 . . . . 0.0 107.884 177.831 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.725 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.3 m-30 -67.94 127.55 33.25 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.441 -0.787 . . . . 0.0 109.915 -178.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -82.14 142.34 32.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.059 -1.026 . . . . 0.0 109.728 179.404 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.54 ' SG ' HD12 ' A' ' 37' ' ' LEU . 64.3 m -112.56 142.87 44.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.17 -0.956 . . . . 0.0 110.075 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.479 ' O ' ' HB2' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -46.59 167.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 110.141 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 p -64.72 138.81 58.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.108 -0.995 . . . . 0.0 110.425 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.37 6.11 89.5 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.572 ' CD2' ' O ' ' A' ' 56' ' ' CYS . 1.0 OUTLIER -111.63 120.88 43.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.172 -1.193 . . . . 0.0 110.274 -179.881 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.639 ' HB3' HD11 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -79.79 130.45 35.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.394 -0.816 . . . . 0.0 110.942 -179.663 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.701 HD13 ' O ' ' A' ' 29' ' ' TYR . 1.9 tp -81.05 100.15 8.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.377 -0.827 . . . . 0.0 109.131 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.831 HD12 ' HB3' ' A' ' 105' ' ' PRO . 1.0 OUTLIER -89.12 151.05 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.495 -179.716 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.7 -176.66 26.37 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.413 ' OD1' ' O ' ' A' ' 40' ' ' ASN . 12.0 p30 -59.21 143.12 49.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -1.168 . . . . 0.0 109.72 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.885 ' O ' HG23 ' A' ' 28' ' ' THR . 0.4 OUTLIER -76.09 53.27 0.78 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.158 -0.964 . . . . 0.0 110.125 -179.908 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.504 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 160.56 131.07 1.18 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 27' ' ' VAL . 2.2 t -69.58 -175.28 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.113 -1.228 . . . . 0.0 108.364 178.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.635 ' H ' HG12 ' A' ' 43' ' ' VAL . 6.1 tp -143.84 98.54 3.25 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.479 178.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.608 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.8 OUTLIER -84.3 112.47 20.34 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.231 178.895 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 t -124.77 145.94 49.47 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.332 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 54.28 32.09 50.9 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.44 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 69.19 40.01 82.42 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 1.5 mt-10 -151.42 128.04 10.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.298 -1.119 . . . . 0.0 110.502 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.608 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 74.8 m95 -81.95 134.36 35.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.25 -0.907 . . . . 0.0 110.107 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 25.9 t -151.29 163.38 39.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.115 -0.991 . . . . 0.0 110.742 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.52 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 2.4 m-20 64.3 65.5 1.1 Allowed Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.633 -0.667 . . . . 0.0 110.944 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 52.1 Cg_endo -91.77 132.92 1.34 Allowed 'Trans proline' 0 C--N 1.299 -2.053 0 C-N-CA 121.89 1.727 . . . . 0.0 110.173 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.459 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.2 Cg_endo -76.61 172.05 16.92 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.689 1.363 . . . . 0.0 109.488 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.611 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 52.8 p -109.86 148.91 30.67 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.812 -1.18 . . . . 0.0 111.919 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.572 ' O ' ' CD2' ' A' ' 35' ' ' TYR . 86.5 m -111.44 77.62 1.05 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 36' ' ' SER . 1.0 OUTLIER -115.25 -163.72 0.9 Allowed 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.547 0.689 . . . . 0.0 110.502 -178.115 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.634 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -107.7 137.62 38.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.376 -0.828 . . . . 0.0 108.888 179.505 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.688 HG23 ' HA ' ' A' ' 80' ' ' SER . 30.2 m -123.08 41.1 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.034 -1.041 . . . . 0.0 111.229 -178.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.443 ' CD ' HG22 ' A' ' 58' ' ' ILE . 7.8 mtpp -75.49 98.63 3.99 Favored 'General case' 0 C--N 1.284 -2.267 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.443 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 107' ' ' ASN . 64.0 m -70.01 161.96 71.93 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.438 -0.789 . . . . 0.0 111.842 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 44.7 Cg_endo -72.57 -88.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.546 1.814 . . . . 0.0 111.008 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.457 ' CD2' ' HE1' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -172.49 132.12 0.68 Allowed Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.527 -0.733 . . . . 0.0 109.225 -179.321 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.628 ' HA ' HD21 ' A' ' 113' ' ' LEU . 58.2 Cg_endo -85.35 69.85 5.3 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 O-C-N 123.398 1.21 . . . . 0.0 109.886 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.711 ' O ' HG23 ' A' ' 66' ' ' ILE . 3.2 p -87.19 -40.6 14.44 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.464 1.126 . . . . 0.0 109.999 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.775 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER 52.59 160.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.355 -178.894 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.479 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 0.5 OUTLIER -58.64 91.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.474 -0.766 . . . . 0.0 111.576 -178.826 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 47.94 60.27 3.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.378 -0.826 . . . . 0.0 111.471 178.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.576 ' O ' ' CG ' ' A' ' 70' ' ' TYR . . . -143.58 -36.98 0.07 OUTLIER Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.17 -1.491 . . . . 0.0 110.226 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.611 ' CE1' ' HB3' ' A' ' 88' ' ' LYS . 40.2 p90 42.44 -175.34 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 122.097 0.951 . . . . 0.0 110.932 -178.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.988 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -122.75 -32.13 3.59 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.694 -178.549 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.833 ' H ' HD22 ' A' ' 71' ' ' LEU . 0.5 OUTLIER 57.09 15.15 2.27 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.635 -1.291 . . . . 0.0 110.78 177.587 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.421 ' HB2' ' H ' ' A' ' 86' ' ' ASP . 66.2 m -119.49 10.02 11.71 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.524 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 133.91 87.38 0.29 Allowed Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.358 -1.401 . . . . 0.0 110.047 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.585 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -127.36 150.82 49.44 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.31 -1.112 . . . . 0.0 109.55 179.429 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.441 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 2.0 tttp -135.39 170.41 15.99 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.423 -0.798 . . . . 0.0 109.723 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 30.0 mtt85 -67.45 -26.08 66.21 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.307 -0.871 . . . . 0.0 109.855 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.94 150.87 36.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 110.481 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.585 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 13.8 m-85 -128.82 -170.62 2.3 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.292 -0.88 . . . . 0.0 110.332 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.688 ' HA ' HG23 ' A' ' 59' ' ' VAL . 1.2 t -169.83 90.33 0.19 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.227 -0.921 . . . . 0.0 110.136 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.571 ' CB ' HG21 ' A' ' 59' ' ' VAL . 6.6 t80 55.72 134.2 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.158 -0.964 . . . . 0.0 110.042 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.75 ' O ' HG22 ' A' ' 102' ' ' THR . 6.7 t-20 71.66 -129.82 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.822 -1.174 . . . . 0.0 110.578 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.551 ' HB3' ' HB3' ' A' ' 103' ' ' CYS . 5.1 t0 51.62 74.54 0.25 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.653 -1.279 . . . . 0.0 108.921 -178.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.549 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 21.3 t-20 -75.69 141.84 42.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.437 -0.79 . . . . 0.0 111.608 -178.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.805 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -125.9 146.88 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.4 -0.812 . . . . 0.0 109.679 178.834 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.554 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -109.57 108.29 18.69 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.027 -1.046 . . . . 0.0 108.95 179.473 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.988 ' CE1' HD12 ' A' ' 71' ' ' LEU . 35.5 m-85 -66.84 134.93 53.09 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.382 1.087 . . . . 0.0 113.715 -177.34 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.611 ' HB3' ' CE1' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -123.3 84.37 2.26 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.664 -179.816 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.773 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -32.75 133.7 0.12 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.762 -0.586 . . . . 0.0 111.489 -179.518 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -40.51 -87.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.496 -0.753 . . . . 0.0 110.331 179.584 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -161.94 143.37 10.98 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.173 -0.955 . . . . 0.0 110.03 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.572 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 59.05 24.95 59.07 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.572 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 18.1 m-85 -138.99 144.56 38.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.566 -0.961 . . . . 0.0 109.901 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 117' ' ' VAL . 9.6 ttpt -105.36 153.65 21.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.261 -0.899 . . . . 0.0 109.493 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.773 HD11 ' H ' ' A' ' 89' ' ' CYS . 3.4 mt -88.57 114.14 24.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.708 -1.245 . . . . 0.0 110.445 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.453 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 1.3 t -89.21 97.48 11.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.334 -0.854 . . . . 0.0 109.721 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.26 -111.38 0.64 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.615 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 5.7 t -129.51 127.22 40.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.27 -1.135 . . . . 0.0 110.557 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.487 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 0.8 OUTLIER -74.07 -44.38 54.33 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.388 -0.82 . . . . 0.0 110.37 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 32.2 p -101.21 123.39 45.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.122 -0.986 . . . . 0.0 110.154 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.535 ' C ' ' HG1' ' A' ' 102' ' ' THR . 57.9 m -129.99 -168.14 1.92 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 110.298 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.75 HG22 ' O ' ' A' ' 82' ' ' ASN . 14.6 m -162.72 134.14 5.08 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.252 -0.979 . . . . 0.0 111.134 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.603 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 1.6 t -57.41 95.42 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.677 -0.64 . . . . 0.0 109.48 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.4 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -83.12 173.94 6.77 Favored Pre-proline 0 C--N 1.299 -1.587 0 O-C-N 120.974 -1.079 . . . . 0.0 110.789 -179.609 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.831 ' HB3' HD12 ' A' ' 38' ' ' ILE . 43.9 Cg_endo -76.26 132.16 13.53 Favored 'Trans proline' 0 C--N 1.299 -2.051 0 O-C-N 124.467 1.772 . . . . 0.0 110.703 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.548 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 121.69 -4.04 10.9 Favored Glycine 0 N--CA 1.482 1.748 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.824 ' O ' HG23 ' A' ' 108' ' ' THR . 7.2 m120 80.25 81.28 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.91 -0.759 . . . . 0.0 110.499 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.824 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 177.48 -177.26 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.222 -0.924 . . . . 0.0 111.467 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.805 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 44.6 m95 -124.54 101.77 7.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.624 -0.673 . . . . 0.0 110.515 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.531 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 4.6 mttt -102.59 148.91 36.19 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.25 -0.906 . . . . 0.0 109.871 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.615 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 52.3 Cg_endo -73.28 -175.19 14.18 Favored 'Cis proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.144 -2.023 . . . . 0.0 111.007 -0.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.7 mt-10 -38.37 123.84 1.21 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.339 0.59 . . . . 0.0 110.437 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.661 HD13 ' HB3' ' A' ' 109' ' ' TRP . 2.9 tp -53.9 143.11 42.72 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 110.448 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.775 ' HG2' HD12 ' A' ' 66' ' ' ILE . 41.2 Cg_endo -72.1 155.66 56.6 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.024 1.539 . . . . 0.0 110.594 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.709 ' HG2' HG13 ' A' ' 117' ' ' VAL . 0.4 OUTLIER -120.91 110.87 16.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.327 -0.858 . . . . 0.0 110.508 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 1.3 t -60.48 96.91 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.186 -0.946 . . . . 0.0 109.342 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.709 HG13 ' HG2' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -107.04 -175.35 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 121.798 0.809 . . . . 0.0 111.019 -179.447 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.296 -1.735 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.176 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 62.7 t . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.192 0.52 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.54 149.82 52.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.194 -0.941 . . . . 0.0 110.275 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.528 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.6 m -80.64 138.74 36.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.422 -0.799 . . . . 0.0 110.611 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.446 ' O ' ' C ' ' A' ' 5' ' ' SER . 21.0 mt-30 -119.5 174.28 6.48 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.439 -0.788 . . . . 0.0 109.286 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 19' ' ' ASP . 1.1 p -42.64 133.76 2.83 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 0.0 109.776 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.736 ' HG3' HG11 ' A' ' 27' ' ' VAL . 51.7 Cg_endo -70.2 155.76 63.76 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.944 1.497 . . . . 0.0 111.357 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -76.73 170.67 19.43 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.041 1.548 . . . . 0.0 110.04 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.13 176.2 4.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.168 -0.958 . . . . 0.0 109.689 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.661 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -142.52 -170.32 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 122.178 0.99 . . . . 0.0 111.81 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.531 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 13.2 t -37.69 94.37 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.204 -179.015 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 9' ' ' ILE . 11.8 m-20 42.9 25.45 0.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.068 -1.02 . . . . 0.0 110.648 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -121.01 -166.56 13.03 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.53 ' HG3' ' CB ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -151.71 178.8 8.99 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.193 -1.181 . . . . 0.0 110.145 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.632 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 9.2 p80 -135.6 141.33 45.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.403 -0.811 . . . . 0.0 110.462 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -171.22 65.54 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.895 . . . . 0.0 110.267 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.41 ' O ' ' CD2' ' A' ' 17' ' ' TYR . . . -60.23 -81.59 0.08 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -177.38 29.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -1.156 . . . . 0.0 110.298 179.876 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.415 ' HG3' ' CE1' ' A' ' 21' ' ' TYR . 0.9 OUTLIER -165.59 -165.92 0.9 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.921 . . . . 0.0 110.212 179.81 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 20' ' ' PHE . 25.1 p-10 -123.27 -41.82 2.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.896 . . . . 0.0 109.947 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.506 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 2.0 m-85 -96.14 149.74 21.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.387 -0.821 . . . . 0.0 110.338 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.688 ' CD2' ' HB3' ' A' ' 25' ' ' SER . 1.6 m-85 -130.91 -2.41 4.1 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.217 -0.927 . . . . 0.0 110.833 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.528 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 15.6 p 42.8 -99.3 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.353 -0.842 . . . . 0.0 111.264 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.534 ' OD1' ' HA ' ' A' ' 46' ' ' SER . 3.6 t0 -156.82 137.53 13.26 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.059 -1.026 . . . . 0.0 110.179 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 86.87 23.75 40.75 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.688 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 58.2 m -116.61 154.41 30.55 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -1.079 . . . . 0.0 109.563 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.909 HG13 ' O ' ' A' ' 43' ' ' VAL . 38.1 t -126.1 149.33 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.884 -1.135 . . . . 0.0 112.556 -177.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.74 ' O ' HG23 ' A' ' 43' ' ' VAL . 45.8 t -121.44 120.77 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.587 -0.696 . . . . 0.0 111.32 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -73.81 103.12 4.24 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 177.443 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 1.026 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.0 m-30 -67.63 121.11 15.18 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.244 -177.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.53 ' CB ' ' HG3' ' A' ' 13' ' ' ARG . 2.3 m -70.81 -163.89 0.08 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.979 -1.075 . . . . 0.0 108.966 179.127 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.53 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 5.5 t -164.38 160.47 20.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.896 -1.127 . . . . 0.0 110.702 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 34' ' ' GLY . 9.7 t-20 -55.56 144.3 26.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.343 -0.848 . . . . 0.0 109.679 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.54 79.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.255 -0.903 . . . . 0.0 110.428 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 32' ' ' ASN . . . 153.7 -28.9 0.75 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.434 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 6.4 m-85 -87.25 134.97 33.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.155 -1.203 . . . . 0.0 110.184 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.733 ' CB ' HG13 ' A' ' 59' ' ' VAL . 1.2 t -80.28 142.49 34.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.278 -0.889 . . . . 0.0 110.527 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.854 HD13 ' O ' ' A' ' 29' ' ' TYR . 2.1 tp -93.81 111.18 22.83 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.375 -0.828 . . . . 0.0 109.21 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.654 ' N ' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -103.53 156.9 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.137 -0.977 . . . . 0.0 109.62 -179.661 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.23 -146.53 16.48 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.535 ' O ' ' C ' ' A' ' 41' ' ' SER . 0.7 OUTLIER -106.16 54.97 0.68 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.107 -1.231 . . . . 0.0 110.021 179.829 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.571 ' O ' HG23 ' A' ' 28' ' ' THR . 7.3 p 14.44 56.62 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.167 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.581 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 155.58 118.83 0.63 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.026 HG21 ' CE1' ' A' ' 29' ' ' TYR . 1.9 t -70.42 -178.77 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.084 -1.244 . . . . 0.0 108.005 178.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.488 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.2 tp -144.15 97.52 3.06 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.715 -1.241 . . . . 0.0 110.531 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.589 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.9 OUTLIER -83.92 111.98 19.74 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.304 178.951 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.534 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 0.4 OUTLIER -123.2 93.22 3.88 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.299 -179.681 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.28 61.52 1.64 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 49.55 27.06 8.08 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -136.47 108.85 7.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.207 -1.172 . . . . 0.0 110.442 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.589 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 70.8 m95 -74.76 135.29 41.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 109.711 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -144.14 157.62 44.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.085 -1.009 . . . . 0.0 111.092 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.534 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 4.4 t70 63.56 64.41 1.38 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.691 -0.631 . . . . 0.0 110.965 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.534 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 53.3 Cg_endo -92.14 133.44 1.28 Allowed 'Trans proline' 0 C--N 1.298 -2.098 0 O-C-N 124.406 1.74 . . . . 0.0 109.674 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.534 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 49.4 Cg_endo -75.93 176.81 9.54 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 O-C-N 123.688 1.362 . . . . 0.0 109.819 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.54 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 6.7 p -111.09 -175.75 2.78 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.995 0.902 . . . . 0.0 111.271 -178.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 10' ' ' SER . 0.8 OUTLIER -144.64 75.08 1.44 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.109 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.522 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.3 OUTLIER -112.85 -158.86 0.66 Allowed 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.913 -178.908 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.637 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -113.78 130.42 67.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 108.603 179.415 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.733 HG13 ' CB ' ' A' ' 36' ' ' SER . 19.2 m -118.49 46.43 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.994 -1.067 . . . . 0.0 112.067 -178.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.499 ' HE3' HG22 ' A' ' 58' ' ' ILE . 1.6 mttt -58.13 -175.11 0.02 OUTLIER 'General case' 0 C--N 1.281 -2.384 0 C-N-CA 117.763 -1.575 . . . . 0.0 107.541 178.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.524 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 1.2 m -141.54 167.38 17.21 Favored Pre-proline 0 C--N 1.293 -1.857 0 C-N-CA 117.811 -1.555 . . . . 0.0 113.814 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.494 ' O ' ' CG ' ' A' ' 63' ' ' HIS . 48.9 Cg_endo -90.08 -69.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 125.026 2.066 . . . . 0.0 110.368 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.494 ' CG ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 165.4 124.24 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.299 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.72 ' HG2' HD21 ' A' ' 71' ' ' LEU . 45.9 Cg_endo -76.47 80.22 2.8 Favored 'Trans proline' 0 C--N 1.301 -1.953 0 O-C-N 123.467 1.246 . . . . 0.0 109.329 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.512 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -102.91 173.79 6.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.872 . . . . 0.0 109.791 -179.33 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.821 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -169.99 166.35 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.334 -0.947 . . . . 0.0 110.305 179.558 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.472 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 16.4 t -75.73 107.04 7.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.488 -0.757 . . . . 0.0 110.652 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.529 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 3.3 m-80 38.89 55.87 2.0 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.567 -0.708 . . . . 0.0 110.643 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.77 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -168.66 32.04 0.18 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.63 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 16.9 p90 -45.25 -174.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 123.463 1.601 . . . . 0.0 112.862 -179.073 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.968 HD11 ' HB2' ' A' ' 75' ' ' PHE . 2.8 pp -100.89 126.79 47.54 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 113.308 -1.769 . . . . 0.0 109.887 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.509 ' HB3' ' HB2' ' A' ' 88' ' ' LYS . 0.2 OUTLIER -96.35 2.48 52.78 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.28 -0.888 . . . . 0.0 109.515 179.767 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.7 t -73.09 -73.91 0.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.38 -0.825 . . . . 0.0 110.572 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.9 97.62 0.12 Allowed Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.626 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.968 ' HB2' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -94.17 145.13 24.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.358 -1.083 . . . . 0.0 109.18 179.053 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.486 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -132.38 160.72 35.53 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.158 -0.964 . . . . 0.0 110.242 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -52.45 -33.99 46.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.225 -0.922 . . . . 0.0 110.394 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.406 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -142.02 165.62 26.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.333 -0.855 . . . . 0.0 110.361 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.582 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 22.3 m-85 -138.06 -138.63 0.14 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.373 -0.83 . . . . 0.0 109.956 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 21.2 p -170.05 -132.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 0.0 109.629 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.646 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 1.6 t80 -101.87 38.23 1.68 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.002 -1.061 . . . . 0.0 109.459 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.676 ' C ' HG22 ' A' ' 102' ' ' THR . 9.4 p30 -169.36 -114.37 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.73 -1.231 . . . . 0.0 110.498 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 82' ' ' ASN . 81.5 m-20 44.83 77.19 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.78 -1.2 . . . . 0.0 109.374 -179.133 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.823 ' CA ' HG23 ' A' ' 102' ' ' THR . 5.6 p-10 -75.11 113.5 12.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.285 -0.885 . . . . 0.0 110.93 -178.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.578 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 15.7 m -101.56 120.86 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.773 -1.204 . . . . 0.0 110.364 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.537 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 25.8 t0 -76.65 126.3 30.75 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.169 -0.957 . . . . 0.0 109.161 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.634 ' CZ ' HD12 ' A' ' 113' ' ' LEU . 23.4 m-85 -86.97 126.02 34.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.052 -1.03 . . . . 0.0 111.357 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -104.31 110.94 23.37 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.53 -179.377 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.441 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -58.56 133.11 55.55 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.038 -1.039 . . . . 0.0 109.551 179.314 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -42.63 -67.49 0.27 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.12 -179.644 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.521 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.3 OUTLIER -176.66 137.16 0.26 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.413 -0.804 . . . . 0.0 110.345 179.935 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.597 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 54.03 58.22 13.55 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.597 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 12.7 m-85 -162.21 155.84 20.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.534 -0.98 . . . . 0.0 109.819 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.609 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -110.2 124.18 51.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.142 -0.973 . . . . 0.0 110.323 -179.856 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.568 HD23 HD11 ' A' ' 66' ' ' ILE . 1.7 mt -63.7 87.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.373 -0.83 . . . . 0.0 110.033 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.453 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -69.47 104.81 2.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 110.07 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 141.58 -81.53 0.24 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.581 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -169.72 124.73 0.81 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.257 -1.143 . . . . 0.0 110.534 -179.827 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 73.8 p -68.56 -72.19 0.19 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.349 -0.845 . . . . 0.0 110.867 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.537 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 58.6 p -78.19 118.33 20.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.153 -0.967 . . . . 0.0 110.329 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 85' ' ' VAL . 59.9 m -125.25 158.47 34.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.55 -0.719 . . . . 0.0 110.611 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.823 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -135.08 142.26 46.25 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.395 179.694 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.585 ' SG ' ' CZ2' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -67.9 105.41 1.98 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.614 -0.679 . . . . 0.0 110.278 -179.769 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.532 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -76.88 -175.15 0.47 Allowed Pre-proline 0 C--N 1.295 -1.779 0 O-C-N 121.231 -0.918 . . . . 0.0 111.315 -179.411 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.644 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 41.4 Cg_endo -87.78 126.42 2.14 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 124.4 1.737 . . . . 0.0 110.597 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 117.53 2.86 17.15 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.88 ' O ' HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER 79.16 105.61 0.07 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.649 -0.912 . . . . 0.0 110.426 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.88 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER 166.03 -163.39 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.867 0.841 . . . . 0.0 111.271 179.443 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.703 ' HB3' HD11 ' A' ' 113' ' ' LEU . 32.8 m95 -144.91 88.02 1.87 Allowed 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.698 0.761 . . . . 0.0 109.651 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.578 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 14.4 mmmt -98.54 137.08 20.62 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.764 -0.585 . . . . 0.0 110.186 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.581 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 42.8 Cg_endo -69.69 166.25 74.34 Favored 'Cis proline' 0 N--CA 1.49 1.298 0 C-N-CA 122.056 -2.06 . . . . 0.0 110.983 -0.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -38.52 153.23 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.578 -0.702 . . . . 0.0 111.081 -179.168 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.703 HD11 ' HB3' ' A' ' 109' ' ' TRP . 1.2 mm? -64.68 141.61 98.32 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.43 -0.793 . . . . 0.0 109.716 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.821 ' HG2' HD12 ' A' ' 66' ' ' ILE . 42.5 Cg_endo -72.1 165.12 33.56 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 O-C-N 124.189 1.626 . . . . 0.0 110.548 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.728 ' HG2' HG13 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -129.28 107.44 9.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.339 -0.851 . . . . 0.0 109.918 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.538 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 3.0 t -61.17 83.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.276 -0.89 . . . . 0.0 109.466 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.728 HG13 ' HG2' ' A' ' 115' ' ' LYS . 3.3 m -101.86 -169.68 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-O 121.945 0.879 . . . . 0.0 110.89 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.467 ' HG2' ' CE1' ' A' ' 93' ' ' TYR . 6.7 mtm-85 . . . . . 0 C--N 1.291 -1.953 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.211 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.8 p . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.27 0.557 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -119.78 174.73 6.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.412 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.553 ' O ' ' N ' ' A' ' 21' ' ' TYR . 1.1 m -113.54 89.75 3.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.35 -0.844 . . . . 0.0 110.56 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.41 ' O ' ' C ' ' A' ' 5' ' ' SER . 62.3 mt-30 -69.68 172.11 7.99 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.021 -1.05 . . . . 0.0 109.844 179.6 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 19' ' ' ASP . 1.1 p -42.12 141.95 1.28 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 110.138 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.82 ' HG3' HG11 ' A' ' 27' ' ' VAL . 51.1 Cg_endo -71.8 154.89 58.8 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.029 1.542 . . . . 0.0 111.019 -179.494 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -74.74 172.48 16.17 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.868 1.457 . . . . 0.0 110.005 179.458 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.7 p -70.98 174.91 5.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.107 -0.996 . . . . 0.0 110.017 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.728 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -142.8 -170.3 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 122.156 0.979 . . . . 0.0 111.543 179.719 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.523 ' O ' ' CB ' ' A' ' 56' ' ' CYS . 1.2 m -43.54 90.83 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.673 -179.302 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.8 OUTLIER 43.7 53.08 6.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.114 -0.991 . . . . 0.0 110.581 179.827 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.31 147.22 16.15 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.483 ' O ' ' N ' ' A' ' 30' ' ' SER . 1.3 mtp180 -92.98 -167.99 1.85 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.246 -1.149 . . . . 0.0 110.647 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.61 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 17.6 p80 -156.33 -159.19 0.86 Allowed 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.283 0.564 . . . . 0.0 110.543 -179.501 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 13.5 t-20 72.89 141.36 0.06 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.514 -0.741 . . . . 0.0 110.572 179.625 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.54 -57.92 0.19 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -163.63 29.27 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -1.134 . . . . 0.0 110.111 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.72 -178.26 7.19 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.194 -0.941 . . . . 0.0 110.444 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 5' ' ' SER . 24.0 m-20 -124.06 -44.15 2.06 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.417 -0.802 . . . . 0.0 109.976 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -94.92 139.94 30.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 109.94 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.628 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.3 OUTLIER -128.43 -4.67 5.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.254 -0.904 . . . . 0.0 110.625 -179.633 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.53 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 32.2 p 45.86 -97.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.92 . . . . 0.0 111.91 179.768 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.524 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -153.2 158.57 41.93 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.91 -1.119 . . . . 0.0 110.594 -178.51 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.53 25.65 75.36 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 179.733 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.628 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -114.43 171.21 7.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.416 -1.049 . . . . 0.0 110.2 -179.763 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.874 HG13 ' O ' ' A' ' 43' ' ' VAL . 40.6 t -143.08 153.93 16.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.518 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.939 ' O ' HG23 ' A' ' 43' ' ' VAL . 18.8 t -132.86 123.7 49.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.62 -179.262 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.796 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -76.31 103.04 6.13 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.937 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 1.014 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.4 m-30 -68.12 127.27 32.29 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.412 -0.805 . . . . 0.0 110.349 -178.13 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -71.53 158.21 36.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.561 179.451 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.419 ' SG ' HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -133.6 156.82 47.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.113 -0.992 . . . . 0.0 110.337 -179.808 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.36 129.24 37.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.269 -0.894 . . . . 0.0 110.067 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 t -46.57 122.71 4.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 0.0 110.592 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.25 -40.85 1.89 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.478 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.444 ' CE1' HG13 ' A' ' 58' ' ' ILE . 7.9 m-85 -90.86 155.45 18.75 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -1.155 . . . . 0.0 110.786 -179.504 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.693 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -91.45 141.45 28.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.404 -0.81 . . . . 0.0 110.205 179.541 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.536 ' HA ' ' O ' ' A' ' 55' ' ' THR . 0.6 OUTLIER -92.9 97.4 10.72 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.275 -0.89 . . . . 0.0 109.531 179.207 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.822 HG23 ' CB ' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -85.81 142.79 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.421 -0.799 . . . . 0.0 108.985 179.847 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.57 -154.11 21.94 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 42' ' ' GLY . 15.6 p-10 -110.73 51.86 0.75 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.168 -1.195 . . . . 0.0 110.541 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.796 ' O ' HG23 ' A' ' 28' ' ' THR . 75.4 p 28.0 38.6 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.904 179.657 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.53 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 169.09 125.99 0.82 Allowed Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.452 -1.356 . . . . 0.0 110.125 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.014 HG21 ' CE1' ' A' ' 29' ' ' TYR . 2.0 t -71.94 -178.1 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -1.113 . . . . 0.0 108.092 179.026 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.516 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.5 tp -144.59 99.48 3.36 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.251 -0.979 . . . . 0.0 110.225 179.05 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.587 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -87.15 110.17 19.95 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.055 -1.058 . . . . 0.0 109.438 178.686 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.7 p -128.64 123.19 32.59 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.032 -179.774 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.524 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 76.24 35.85 41.76 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.876 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.19 40.88 97.05 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 1.8 mt-10 -157.95 128.94 6.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.379 -1.071 . . . . 0.0 110.292 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.604 ' CH2' HG23 ' A' ' 27' ' ' VAL . 84.2 m95 -82.46 138.53 34.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.792 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -143.73 157.89 44.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.163 -0.961 . . . . 0.0 111.011 -179.574 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.504 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER 63.2 65.46 1.31 Allowed Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.631 -0.668 . . . . 0.0 111.0 179.606 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.504 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.5 Cg_endo -90.64 140.95 3.12 Favored 'Trans proline' 0 C--N 1.301 -1.967 0 C-N-CA 121.851 1.701 . . . . 0.0 109.972 179.158 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.525 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 46.9 Cg_endo -78.71 175.56 10.87 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.729 1.383 . . . . 0.0 110.233 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.568 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 11.1 p -124.38 158.82 31.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.207 -0.933 . . . . 0.0 111.438 -178.914 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.523 ' CB ' ' O ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -116.06 78.37 1.18 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.177 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.455 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -117.2 -158.51 0.7 Allowed 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.875 -178.922 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.584 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -116.06 142.71 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.92 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.713 HG21 ' CB ' ' A' ' 81' ' ' TYR . 12.7 m -127.88 43.05 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.825 -1.172 . . . . 0.0 111.559 -178.663 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -80.91 95.23 6.68 Favored 'General case' 0 C--N 1.281 -2.384 0 C-N-CA 119.071 -1.052 . . . . 0.0 108.593 179.014 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.47 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 32.3 m -69.28 162.33 66.81 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.356 -0.84 . . . . 0.0 111.153 -178.481 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.511 ' HD2' ' HA ' ' A' ' 108' ' ' THR . 49.6 Cg_endo -72.97 -92.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 124.471 1.774 . . . . 0.0 110.349 -179.521 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.465 ' C ' ' CD1' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -155.82 137.45 9.65 Favored Pre-proline 0 C--N 1.299 -1.611 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.62 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.931 ' HG2' HD21 ' A' ' 71' ' ' LEU . 52.2 Cg_endo -77.82 62.61 7.91 Favored 'Trans proline' 0 C--N 1.294 -2.336 0 O-C-N 123.525 1.277 . . . . 0.0 109.072 -179.161 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.474 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.8 OUTLIER -75.66 166.82 22.98 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.098 -179.634 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.967 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -165.87 164.74 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 C-N-CA 118.75 -1.18 . . . . 0.0 110.716 179.81 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.432 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -71.06 95.49 1.21 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.483 -0.761 . . . . 0.0 110.482 -179.534 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.452 ' O ' ' SG ' ' A' ' 116' ' ' CYS . 3.8 m-20 45.67 51.41 10.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 110.593 179.572 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.967 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -162.12 38.9 0.38 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.771 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.582 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 50.2 p90 -49.54 -152.53 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.898 1.333 . . . . 0.0 112.958 -179.393 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.026 HD23 ' CE2' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -141.07 120.56 13.2 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.031 -176.383 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.2 t -100.78 17.9 20.82 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.615 -0.678 . . . . 0.0 109.414 -179.851 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.9 t -77.98 -79.2 0.12 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.582 -0.699 . . . . 0.0 111.255 -179.166 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -122.76 -66.16 0.22 Allowed Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.632 -178.954 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.574 ' HB2' ' CD1' ' A' ' 71' ' ' LEU . 52.1 t80 58.71 167.0 0.05 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.571 -0.958 . . . . 0.0 110.255 -179.144 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.583 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 17.7 tttm -178.14 145.3 0.36 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.408 -0.807 . . . . 0.0 109.748 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -41.79 -32.43 0.4 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.17 -0.956 . . . . 0.0 110.244 -179.824 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.9 m -147.33 166.97 25.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.481 -0.762 . . . . 0.0 110.297 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.583 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 8.7 m-85 -140.5 -172.15 3.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.244 -0.91 . . . . 0.0 110.031 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.584 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 6.6 t -170.24 109.63 0.38 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.935 -1.103 . . . . 0.0 111.161 179.734 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.713 ' CB ' HG21 ' A' ' 59' ' ' VAL . 14.1 t80 32.75 32.64 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.307 -0.871 . . . . 0.0 111.663 179.164 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.545 ' HA ' HG22 ' A' ' 102' ' ' THR . 49.9 t30 -176.63 -134.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.642 -1.286 . . . . 0.0 110.522 179.342 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 50.65 69.66 0.61 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.056 -1.027 . . . . 0.0 109.019 -178.695 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.615 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 0.4 OUTLIER -69.75 131.88 45.24 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.486 -0.759 . . . . 0.0 110.09 -179.204 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.593 ' CG2' HD22 ' A' ' 71' ' ' LEU . 16.2 m -119.27 122.25 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.054 -1.029 . . . . 0.0 111.018 -179.723 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -79.73 138.76 37.4 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.481 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 1.026 ' CE2' HD23 ' A' ' 71' ' ' LEU . 72.5 m-85 -93.59 146.6 23.69 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.918 -1.114 . . . . 0.0 112.215 -178.07 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -118.82 89.93 3.23 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.65 -179.765 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.597 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -42.08 131.16 3.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 0.0 110.249 -179.653 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 89' ' ' CYS . 0.1 OUTLIER -38.99 -66.06 0.31 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.527 -0.733 . . . . 0.0 110.624 -179.535 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.585 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER 176.69 141.74 0.07 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.401 -0.812 . . . . 0.0 110.025 179.978 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.583 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 53.35 46.2 64.36 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.946 -1.661 . . . . 0.0 108.946 -179.605 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.585 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 16.3 m-85 -155.59 152.13 28.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.556 -0.967 . . . . 0.0 109.64 -179.48 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.559 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -112.63 128.18 56.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 110.191 -179.998 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.597 HD11 ' H ' ' A' ' 89' ' ' CYS . 0.7 OUTLIER -64.39 97.05 0.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -0.91 . . . . 0.0 110.422 -179.879 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.456 ' HB2' HG21 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -78.67 101.1 7.32 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.315 -0.866 . . . . 0.0 109.54 179.469 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.22 -85.37 0.18 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.739 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.577 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 2.4 m -158.41 111.69 2.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.329 -1.101 . . . . 0.0 110.641 -179.353 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.8 t -71.65 -5.56 34.57 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.246 -0.909 . . . . 0.0 110.666 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.3 p -138.46 120.02 15.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.115 -0.99 . . . . 0.0 110.185 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.541 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 20.9 m -133.65 172.11 13.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.347 -0.845 . . . . 0.0 110.745 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.58 HG23 ' N ' ' A' ' 84' ' ' ASN . 17.1 m -147.51 136.24 21.96 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.385 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.575 ' O ' ' CA ' ' A' ' 81' ' ' TYR . 4.8 t -48.95 96.2 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.145 179.577 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.472 ' CB ' ' HG3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -64.63 174.22 1.32 Allowed Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.082 -1.011 . . . . 0.0 111.902 -178.935 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.822 ' CB ' HG23 ' A' ' 38' ' ' ILE . 49.7 Cg_endo -82.04 16.47 1.74 Allowed 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 124.613 1.849 . . . . 0.0 111.559 -178.585 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -119.53 25.81 7.54 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 179.307 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.687 ' O ' HG23 ' A' ' 108' ' ' THR . 2.4 m120 61.24 51.63 4.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.746 -0.855 . . . . 0.0 109.932 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.687 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.5 OUTLIER -161.91 -176.72 5.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 0.0 110.977 -179.849 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.623 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 51.0 m95 -109.06 102.03 11.05 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.483 -0.76 . . . . 0.0 110.553 -179.727 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.515 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -107.06 140.53 21.5 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.45 -0.781 . . . . 0.0 110.209 -179.746 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.577 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.1 Cg_endo -73.18 172.44 60.46 Favored 'Cis proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.964 -2.098 . . . . 0.0 110.363 -0.355 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.9 OUTLIER -40.25 137.07 1.1 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.393 -0.817 . . . . 0.0 110.966 -179.278 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.646 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -47.83 146.57 3.86 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.448 -0.782 . . . . 0.0 110.162 179.547 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.787 ' HG2' HD12 ' A' ' 66' ' ' ILE . 39.3 Cg_endo -72.9 167.68 26.67 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 124.38 1.726 . . . . 0.0 111.063 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.513 ' O ' HG22 ' A' ' 117' ' ' VAL . 3.3 ttpt -127.32 109.68 12.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.386 -0.821 . . . . 0.0 110.801 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.531 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.9 t -66.35 90.16 0.15 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.1 -1.0 . . . . 0.0 109.172 179.225 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 94' ' ' LYS . 1.7 m -105.69 -176.26 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 121.73 0.776 . . . . 0.0 110.925 -179.386 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.5 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.762 0 C-N-CA 118.927 -1.109 . . . . 0.0 110.616 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.436 ' H3 ' HG22 ' A' ' 1' ' ' VAL . 16.6 m . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.101 0.477 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.42 166.58 20.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.132 -0.98 . . . . 0.0 110.471 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.506 ' N ' ' O ' ' A' ' 21' ' ' TYR . 0.9 OUTLIER -135.23 83.63 2.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.418 -0.801 . . . . 0.0 109.805 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -54.84 172.27 0.11 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.05 -1.031 . . . . 0.0 110.229 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 p -52.45 144.02 25.13 Favored Pre-proline 0 C--N 1.301 -1.525 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.071 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.654 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 54.6 Cg_endo -72.35 151.88 54.54 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 123.798 1.42 . . . . 0.0 110.644 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.64 171.49 18.11 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 O-C-N 123.884 1.465 . . . . 0.0 109.722 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.04 177.82 2.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.069 -1.02 . . . . 0.0 109.675 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.615 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -140.93 -170.47 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 122.155 0.979 . . . . 0.0 111.543 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 48.4 t -37.87 95.66 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.998 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.5 OUTLIER 42.33 27.24 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.304 -0.873 . . . . 0.0 110.41 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -126.93 -176.34 14.44 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.53 ' HG3' ' CB ' ' A' ' 30' ' ' SER . 0.5 OUTLIER -138.24 177.64 7.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.258 -1.142 . . . . 0.0 110.578 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.654 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 10.8 p80 -130.19 132.76 46.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.504 -0.748 . . . . 0.0 110.209 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -154.11 80.04 1.12 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.203 -0.936 . . . . 0.0 110.568 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.99 -117.36 0.24 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.97 27.02 1.83 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -1.156 . . . . 0.0 110.392 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.621 ' CG ' ' CZ ' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -163.37 -179.29 6.44 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.18 -0.95 . . . . 0.0 109.998 179.593 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -135.23 19.25 3.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -0.95 . . . . 0.0 110.302 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.05 49.31 0.85 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 110.433 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.621 ' CZ ' ' CG ' ' A' ' 18' ' ' GLU . 13.1 m-85 -50.42 165.69 0.09 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.066 -1.021 . . . . 0.0 109.443 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.503 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 10.1 p -131.78 -70.25 0.58 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.016 -1.053 . . . . 0.0 110.837 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.423 ' OD1' ' HA ' ' A' ' 46' ' ' SER . 4.9 t0 -159.56 137.46 10.15 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.332 -0.855 . . . . 0.0 109.663 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 79.35 13.92 82.15 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.614 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -96.65 171.81 8.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.518 -0.99 . . . . 0.0 109.828 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.834 HG13 ' O ' ' A' ' 43' ' ' VAL . 39.5 t -146.76 154.91 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.121 -0.987 . . . . 0.0 110.796 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.642 ' O ' HG23 ' A' ' 43' ' ' VAL . 20.9 t -133.19 117.09 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.613 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.683 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -72.43 102.5 3.2 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 118.45 -1.3 . . . . 0.0 108.032 177.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.663 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.3 m-30 -68.04 174.5 3.76 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.422 -0.799 . . . . 0.0 109.959 -178.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.53 ' CB ' ' HG3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -135.36 148.17 49.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.913 . . . . 0.0 109.606 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.404 ' O ' ' C ' ' A' ' 32' ' ' ASN . 57.7 m -118.62 147.95 43.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.168 -0.958 . . . . 0.0 110.311 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 31' ' ' CYS . 1.8 t-20 -44.27 150.95 0.27 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.217 -0.927 . . . . 0.0 109.944 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 88.2 p -55.35 99.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 0.0 110.31 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 134.68 -20.09 3.92 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -98.76 131.59 44.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.252 -1.146 . . . . 0.0 110.288 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.721 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -79.57 144.24 34.05 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.336 -0.852 . . . . 0.0 111.123 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.625 HD21 ' HA ' ' A' ' 41' ' ' SER . 0.6 OUTLIER -91.99 102.09 14.64 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.475 -0.766 . . . . 0.0 109.205 178.666 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.79 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -90.9 142.68 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.077 -1.015 . . . . 0.0 109.734 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 132.35 -158.94 23.2 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.493 ' O ' ' C ' ' A' ' 41' ' ' SER . 0.3 OUTLIER -98.31 49.34 0.99 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.842 -1.387 . . . . 0.0 109.65 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.683 ' O ' HG23 ' A' ' 28' ' ' THR . 0.4 OUTLIER 27.89 57.29 0.1 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.331 179.654 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.581 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 155.63 117.23 0.57 Allowed Glycine 0 N--CA 1.488 2.166 0 C-N-CA 119.465 -1.35 . . . . 0.0 110.023 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.834 ' O ' HG13 ' A' ' 26' ' ' VAL . 2.0 t -62.71 -178.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.991 -1.3 . . . . 0.0 108.013 178.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.555 ' H ' HG12 ' A' ' 43' ' ' VAL . 4.3 tp -144.45 95.11 2.66 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.014 -1.074 . . . . 0.0 110.508 178.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.574 ' SG ' ' CD2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -80.92 110.3 16.31 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.379 178.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.423 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 8.0 t -126.57 111.04 13.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.592 -0.692 . . . . 0.0 110.643 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.07 22.5 38.17 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.454 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 81.01 19.86 66.43 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -140.64 113.64 8.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.099 -1.236 . . . . 0.0 110.526 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.574 ' CD2' ' SG ' ' A' ' 45' ' ' CYS . 87.8 m95 -62.58 138.11 58.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.317 -0.864 . . . . 0.0 109.73 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 52' ' ' ASP . 3.5 m -141.84 171.61 13.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.102 -0.999 . . . . 0.0 111.417 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.465 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER 37.29 67.65 1.82 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.912 -0.493 . . . . 0.0 111.593 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.465 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.0 Cg_endo -90.66 144.03 3.65 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 O-C-N 124.327 1.698 . . . . 0.0 109.592 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.518 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 45.9 Cg_endo -74.68 171.26 18.55 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.618 1.325 . . . . 0.0 110.35 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.582 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 15.7 p -114.18 169.16 9.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.163 -0.961 . . . . 0.0 111.468 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 10' ' ' SER . 37.8 m -126.73 79.32 1.86 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -114.82 -170.8 1.81 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 120.161 -0.615 . . . . 0.0 110.135 -178.746 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.606 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -107.92 112.87 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.192 -0.943 . . . . 0.0 108.504 179.221 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.84 HG23 ' O ' ' A' ' 59' ' ' VAL . 6.0 m -95.92 83.14 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.051 -1.031 . . . . 0.0 111.612 -178.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.2 mtmt -120.31 96.36 5.11 Favored 'General case' 0 C--N 1.289 -2.059 0 O-C-N 120.417 -1.427 . . . . 0.0 108.657 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 79' ' ' TYR . 4.5 p -68.06 162.52 59.03 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.412 -0.805 . . . . 0.0 111.659 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.515 ' HD2' ' HA ' ' A' ' 108' ' ' THR . 42.9 Cg_endo -70.47 -89.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.832 0 O-C-N 124.696 1.892 . . . . 0.0 110.286 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.421 ' O ' HG23 ' A' ' 65' ' ' THR . 0.2 OUTLIER -160.51 130.54 3.45 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.612 ' HG3' HG11 ' A' ' 85' ' ' VAL . 50.9 Cg_endo -77.32 70.85 6.61 Favored 'Trans proline' 0 C--N 1.294 -2.322 0 O-C-N 123.787 1.414 . . . . 0.0 109.818 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.669 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.5 OUTLIER -93.45 -175.78 3.91 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.121 -0.987 . . . . 0.0 109.512 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.669 HG22 ' C ' ' A' ' 65' ' ' THR . 0.4 OUTLIER 177.88 167.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.059 -1.026 . . . . 0.0 110.573 178.839 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.552 ' O ' ' CB ' ' A' ' 68' ' ' ASN . 2.9 m -64.19 73.15 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.568 -0.708 . . . . 0.0 111.323 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 67' ' ' SER . 0.5 OUTLIER 75.2 -16.72 0.55 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.432 -0.793 . . . . 0.0 111.933 179.093 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.604 ' HA2' ' HA ' ' A' ' 89' ' ' CYS . . . -86.32 35.52 3.3 Favored Glycine 0 N--CA 1.491 2.354 0 O-C-N 120.733 -1.23 . . . . 0.0 110.425 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.573 ' O ' ' O ' ' A' ' 69' ' ' GLY . 2.2 p90 -43.15 -173.49 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 122.712 1.244 . . . . 0.0 112.526 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.724 HD13 ' H ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -113.31 161.49 17.18 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.272 178.795 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.8 t -146.97 22.07 1.23 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.173 -0.954 . . . . 0.0 109.917 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.39 -51.37 2.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 0.0 110.898 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.616 ' O ' HG12 ' A' ' 85' ' ' VAL . . . -153.44 88.67 0.13 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.58 ' CE2' ' OH ' ' A' ' 79' ' ' TYR . 1.8 t80 -126.3 117.27 22.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -1.133 . . . . 0.0 110.177 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.62 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 28.2 tttt -113.79 148.06 37.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.201 -0.937 . . . . 0.0 109.656 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.462 ' C ' ' O ' ' A' ' 76' ' ' LYS . 1.3 ttm-85 -42.0 -27.41 0.12 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.968 -1.082 . . . . 0.0 109.873 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 76' ' ' LYS . 40.5 m -140.94 147.12 38.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.525 -0.734 . . . . 0.0 110.283 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.672 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -144.03 178.92 7.53 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.218 -0.926 . . . . 0.0 109.583 179.553 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.57 ' O ' ' O ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -170.43 137.85 1.47 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.067 -1.021 . . . . 0.0 110.315 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.833 ' CB ' HG21 ' A' ' 59' ' ' VAL . 6.6 t80 25.49 105.44 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 120.988 0.423 . . . . 0.0 111.982 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.789 ' O ' HG22 ' A' ' 102' ' ' THR . 10.6 m-20 96.4 -134.86 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 123.373 0.669 . . . . 0.0 109.699 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 52.91 67.65 0.96 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.735 -1.228 . . . . 0.0 108.93 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.645 ' N ' HG23 ' A' ' 102' ' ' THR . 8.1 p30 -69.69 113.04 6.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.556 -0.715 . . . . 0.0 110.969 -178.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.616 HG12 ' O ' ' A' ' 74' ' ' GLY . 30.0 m -94.16 117.58 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.115 -0.991 . . . . 0.0 110.102 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -79.61 131.8 36.09 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.019 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.612 ' CE1' HD12 ' A' ' 71' ' ' LEU . 54.6 m-85 -92.37 116.5 29.03 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.962 -1.087 . . . . 0.0 112.154 -178.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -88.38 94.82 9.97 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.389 179.143 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.604 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 1.7 t -48.17 119.26 2.83 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.036 -1.04 . . . . 0.0 110.466 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.51 ' CG ' ' O ' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -57.17 125.05 20.95 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.227 -0.921 . . . . 0.0 109.96 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.489 ' HB2' ' O ' ' A' ' 90' ' ' LYS . 2.3 m-85 62.44 -174.5 0.14 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.171 -0.956 . . . . 0.0 111.351 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.46 54.73 0.9 Allowed Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.543 ' CB ' ' SG ' ' A' ' 116' ' ' CYS . 5.5 m-85 -106.34 158.08 17.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.325 -1.103 . . . . 0.0 109.448 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.593 ' O ' HG22 ' A' ' 117' ' ' VAL . 9.6 mtmm -99.9 141.6 32.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.073 -1.017 . . . . 0.0 109.655 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.54 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 1.2 mt -87.2 94.11 9.57 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.581 -1.325 . . . . 0.0 110.057 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.565 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -69.61 101.14 1.57 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.233 -0.917 . . . . 0.0 109.127 179.38 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.13 -96.75 0.21 Allowed Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.202 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.596 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 3.3 m -150.19 116.59 5.75 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.165 -1.197 . . . . 0.0 110.577 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.411 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 42.8 p -77.17 10.3 2.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.235 -0.915 . . . . 0.0 111.293 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 77.0 p -154.42 99.4 2.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.849 -1.157 . . . . 0.0 110.48 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 3.5 m -111.57 -174.43 2.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.367 -0.833 . . . . 0.0 110.056 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.789 HG22 ' O ' ' A' ' 82' ' ' ASN . 5.8 m -155.88 144.19 20.03 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.481 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.616 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 42.7 t -65.07 86.15 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.672 -0.642 . . . . 0.0 109.386 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.456 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -62.56 176.57 0.49 Allowed Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.194 -0.941 . . . . 0.0 112.731 -178.148 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.79 ' CB ' HD12 ' A' ' 38' ' ' ILE . 46.5 Cg_endo -80.37 12.5 2.52 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 124.848 1.973 . . . . 0.0 111.777 -178.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -118.46 18.22 11.04 Favored Glycine 0 C--N 1.294 -1.757 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.718 ' O ' HG23 ' A' ' 108' ' ' THR . 1.2 m120 65.22 66.99 0.53 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.696 -0.885 . . . . 0.0 109.796 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.718 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -168.59 -172.84 1.75 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.227 -0.989 . . . . 0.0 111.497 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.616 ' CZ3' ' N ' ' A' ' 103' ' ' CYS . 41.2 m95 -123.3 95.68 4.69 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.571 0.7 . . . . 0.0 110.132 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.552 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -108.33 146.09 32.87 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.537 -0.727 . . . . 0.0 110.249 -179.537 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.596 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 44.3 Cg_endo -72.65 173.37 54.31 Favored 'Cis proline' 0 C--N 1.315 -1.235 0 C-N-CA 121.697 -2.21 . . . . 0.0 110.534 -0.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.3 mm-40 -36.93 131.05 0.76 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.657 -0.652 . . . . 0.0 111.551 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.57 HD23 ' O ' ' A' ' 65' ' ' THR . 0.2 OUTLIER -43.93 154.5 0.37 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.482 -0.761 . . . . 0.0 109.749 179.003 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.574 ' O ' HD12 ' A' ' 66' ' ' ILE . 41.4 Cg_endo -83.59 171.67 10.77 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 O-C-N 124.092 1.575 . . . . 0.0 111.433 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.565 ' HB3' ' CB ' ' A' ' 96' ' ' SER . 3.3 ttpt -129.82 109.65 11.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.366 -0.834 . . . . 0.0 110.2 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.543 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.0 OUTLIER -69.12 108.54 3.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.153 -0.967 . . . . 0.0 109.257 179.715 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -118.95 -174.54 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.635 0.731 . . . . 0.0 110.195 -179.274 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.409 ' HG2' ' CZ ' ' A' ' 93' ' ' TYR . 26.4 mtm180 . . . . . 0 C--N 1.292 -1.9 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.221 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 53.8 t . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.247 0.546 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.624 ' HA ' HG22 ' A' ' 22' ' ' THR . 0.1 OUTLIER -136.17 100.2 4.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.329 -0.857 . . . . 0.0 110.387 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.559 ' O ' ' N ' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -69.72 88.22 0.52 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.213 -0.929 . . . . 0.0 109.779 179.566 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.469 ' O ' ' C ' ' A' ' 5' ' ' SER . 1.1 pt20 -85.43 -174.02 4.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.04 -1.037 . . . . 0.0 110.064 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.469 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.3 OUTLIER -38.3 127.39 1.07 Allowed Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 120.306 -0.557 . . . . 0.0 109.569 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.652 ' HG3' HG11 ' A' ' 27' ' ' VAL . 45.6 Cg_endo -66.31 154.76 72.96 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.902 1.475 . . . . 0.0 111.509 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -75.49 171.52 18.07 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.115 1.587 . . . . 0.0 110.487 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.69 176.0 3.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 110.014 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.639 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -141.57 -170.28 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-O 122.143 0.973 . . . . 0.0 111.463 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.8 OUTLIER -40.78 95.26 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.26 -179.468 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.49 ' N ' ' O ' ' A' ' 9' ' ' ILE . 2.4 m-20 43.08 41.39 2.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 110.352 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' A' ' 30' ' ' SER . . . -146.11 158.23 27.62 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.521 ' HG3' ' CB ' ' A' ' 30' ' ' SER . 4.5 ptt180 -113.82 -179.85 3.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.233 -1.157 . . . . 0.0 110.325 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.623 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 11.5 p80 -128.98 133.42 47.78 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.629 -0.669 . . . . 0.0 110.049 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -136.62 96.36 3.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.052 -1.03 . . . . 0.0 110.877 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.22 179.59 30.99 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -105.91 46.16 0.94 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.078 -1.248 . . . . 0.0 110.245 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.602 ' CG ' ' CZ ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -175.82 -159.7 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.924 . . . . 0.0 110.392 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.5 -27.41 1.05 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.434 -0.791 . . . . 0.0 110.81 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.416 ' C ' ' OE2' ' A' ' 18' ' ' GLU . 25.8 m-85 -109.74 101.98 10.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.02 -1.05 . . . . 0.0 110.849 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.634 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 2.5 m-85 -102.4 44.9 0.99 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.57 -0.706 . . . . 0.0 109.604 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.624 HG22 ' HA ' ' A' ' 2' ' ' LYS . 24.9 p -53.98 99.8 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.1 0.952 . . . . 0.0 111.718 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.533 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 9.8 t70 50.15 165.28 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 121.794 0.807 . . . . 0.0 111.905 178.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.501 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 46.32 26.15 2.24 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.634 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 35.5 m -109.6 154.88 22.15 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.387 -1.066 . . . . 0.0 110.263 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.877 HG13 ' O ' ' A' ' 43' ' ' VAL . 50.5 t -139.14 153.91 25.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.411 -0.915 . . . . 0.0 110.608 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 1.004 ' O ' HG23 ' A' ' 43' ' ' VAL . 28.7 t -141.55 117.39 6.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.384 -0.927 . . . . 0.0 111.245 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.617 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -69.34 102.97 1.86 Allowed 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 118.469 -1.292 . . . . 0.0 107.669 178.256 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 1.039 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.5 m-30 -67.89 177.99 1.93 Allowed 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.749 -0.781 . . . . 0.0 109.979 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.521 ' CB ' ' HG3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -140.77 151.2 44.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 109.708 179.727 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.418 ' O ' ' C ' ' A' ' 32' ' ' ASN . 87.6 m -122.67 149.66 43.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.159 -0.963 . . . . 0.0 110.693 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.418 ' C ' ' O ' ' A' ' 31' ' ' CYS . 5.4 p-10 -42.48 145.55 0.41 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.46 -0.775 . . . . 0.0 110.175 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.4 129.17 31.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.187 -0.946 . . . . 0.0 110.486 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.87 -27.79 15.17 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 -89.39 162.81 15.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.103 -1.233 . . . . 0.0 110.349 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.848 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.9 OUTLIER -103.29 147.33 27.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.406 -0.809 . . . . 0.0 110.964 -179.158 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.663 HD23 ' O ' ' A' ' 37' ' ' LEU . 6.3 tt -100.99 96.35 7.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.307 -0.871 . . . . 0.0 109.688 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.842 HD11 ' HB2' ' A' ' 36' ' ' SER . 0.3 OUTLIER -93.13 139.64 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 109.09 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 150.91 -126.97 2.23 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.506 ' O ' ' C ' ' A' ' 41' ' ' SER . 4.6 m120 -135.16 50.15 2.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -1.164 . . . . 0.0 109.54 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.617 ' O ' HG23 ' A' ' 28' ' ' THR . 2.1 p 25.46 54.84 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.345 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.501 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 150.86 113.42 0.6 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.039 HG21 ' CE1' ' A' ' 29' ' ' TYR . 1.9 t -64.65 -177.99 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.161 -1.2 . . . . 0.0 107.821 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.531 ' HA ' ' O ' ' A' ' 25' ' ' SER . 2.3 tp -146.65 97.89 2.98 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.286 -0.966 . . . . 0.0 110.702 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.595 ' SG ' ' CD2' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -75.08 114.1 13.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.081 -1.012 . . . . 0.0 109.165 178.857 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 85.1 p -129.73 92.74 3.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.57 -0.706 . . . . 0.0 110.219 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.99 39.42 2.68 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.04 11.92 53.11 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -133.3 120.16 20.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -1.183 . . . . 0.0 110.316 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.616 ' CH2' HG23 ' A' ' 27' ' ' VAL . 73.7 m95 -62.93 137.97 58.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.284 -0.885 . . . . 0.0 109.829 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.2 m -136.63 163.99 29.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.153 -0.967 . . . . 0.0 111.032 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.481 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 3.8 m-20 53.45 66.13 4.94 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.615 -0.678 . . . . 0.0 111.198 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.481 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.7 Cg_endo -90.37 135.85 2.23 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 O-C-N 124.288 1.678 . . . . 0.0 109.643 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.574 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 42.3 Cg_endo -71.54 178.61 5.46 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.591 1.311 . . . . 0.0 110.378 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 5.3 p -121.99 163.13 19.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.372 -0.83 . . . . 0.0 112.028 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 10' ' ' SER . 86.9 m -116.57 85.59 2.34 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -120.32 -141.23 0.34 Allowed 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.45 0.643 . . . . 0.0 110.405 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.714 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -136.32 127.13 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.297 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.848 HG13 ' CB ' ' A' ' 36' ' ' SER . 34.0 m -123.08 49.28 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.031 -1.043 . . . . 0.0 111.61 -178.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 15.0 mtmt -55.99 -179.17 0.02 OUTLIER 'General case' 0 C--N 1.28 -2.431 0 C-N-CA 117.988 -1.485 . . . . 0.0 107.978 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.554 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -145.38 163.39 32.33 Favored Pre-proline 0 C--N 1.297 -1.705 0 C-N-CA 118.707 -1.197 . . . . 0.0 112.297 -179.048 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 42.8 Cg_endo -83.66 -71.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.748 1.92 . . . . 0.0 109.639 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.551 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 162.02 129.46 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.57 ' N ' ' NE1' ' A' ' 109' ' ' TRP . 49.7 Cg_endo -77.12 69.43 7.07 Favored 'Trans proline' 0 C--N 1.299 -2.065 0 O-C-N 123.721 1.38 . . . . 0.0 110.178 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.883 ' O ' HD23 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -99.38 139.31 35.22 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.884 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -131.71 159.29 43.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 C-N-CA 118.594 -1.243 . . . . 0.0 111.057 -178.712 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.472 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 0.1 OUTLIER -58.66 111.85 1.41 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.752 -0.592 . . . . 0.0 111.239 -179.339 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.408 ' O ' ' HG3' ' A' ' 90' ' ' LYS . 1.2 m-20 51.32 25.04 2.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.298 -0.876 . . . . 0.0 109.756 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.55 ' C ' HG23 ' A' ' 66' ' ' ILE . . . -132.45 -177.41 14.9 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.59 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 37.1 p90 -178.54 -172.59 0.29 Allowed 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.541 -0.976 . . . . 0.0 109.388 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.764 HD22 ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -126.44 151.49 47.67 Favored 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.709 178.962 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.2 t -113.65 -6.72 13.35 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.943 -1.098 . . . . 0.0 109.927 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.93 -80.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.378 -0.826 . . . . 0.0 110.259 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -169.79 93.03 0.1 Allowed Glycine 0 N--CA 1.488 2.162 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.167 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.598 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -86.22 174.95 8.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.359 -1.083 . . . . 0.0 109.171 179.219 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.566 ' N ' ' CG ' ' A' ' 75' ' ' PHE . 4.7 tttt -159.68 159.5 33.05 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.317 -0.864 . . . . 0.0 110.256 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.67 -39.63 17.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.898 . . . . 0.0 109.867 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.58 136.66 18.49 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.507 -0.746 . . . . 0.0 110.099 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.598 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 43.6 m-85 -99.29 -162.17 0.93 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.916 . . . . 0.0 109.774 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.627 ' CA ' HG23 ' A' ' 59' ' ' VAL . 85.6 p -146.59 -104.45 0.1 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -0.895 . . . . 0.0 109.083 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.609 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -111.91 145.14 40.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.818 -1.177 . . . . 0.0 107.904 178.718 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.897 ' C ' HG22 ' A' ' 102' ' ' THR . 1.6 m120 61.32 -99.43 0.09 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.375 -0.828 . . . . 0.0 110.153 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.476 ' HB2' ' HB3' ' A' ' 103' ' ' CYS . 10.3 m-20 41.14 79.48 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.995 -1.066 . . . . 0.0 109.238 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.765 ' CA ' HG23 ' A' ' 102' ' ' THR . 21.5 t-20 -75.39 143.85 42.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.389 -0.819 . . . . 0.0 112.286 -177.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.84 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 4.5 m -132.37 115.07 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.437 -0.789 . . . . 0.0 109.44 177.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.553 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 2.7 t70 -75.54 134.64 40.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.315 -0.866 . . . . 0.0 108.992 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.68 ' CE1' HD12 ' A' ' 71' ' ' LEU . 45.0 m-85 -94.63 142.47 27.4 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 118.682 -1.207 . . . . 0.0 112.253 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.564 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -120.12 98.71 6.2 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.581 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.686 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -46.92 129.49 11.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.133 -0.979 . . . . 0.0 110.457 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.435 ' O ' ' O ' ' A' ' 89' ' ' CYS . 6.8 mmtp -44.37 -92.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.29 -0.881 . . . . 0.0 110.173 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.556 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 1.9 t80 -152.73 158.81 42.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.211 -0.931 . . . . 0.0 110.049 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.588 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 45.31 25.85 1.32 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.588 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 18.0 m-85 -141.45 147.39 37.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.401 -1.058 . . . . 0.0 110.395 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.1 ptmm? -117.83 129.96 55.98 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.294 -0.879 . . . . 0.0 109.897 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.686 HD11 ' H ' ' A' ' 89' ' ' CYS . 1.2 mt -57.12 103.0 0.1 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.186 -0.946 . . . . 0.0 110.8 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.697 ' HB2' HG21 ' A' ' 117' ' ' VAL . 3.0 t -85.96 91.36 8.35 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.22 -0.925 . . . . 0.0 109.053 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 152.2 -91.27 0.13 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.575 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -149.41 118.85 6.89 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.159 -1.2 . . . . 0.0 110.83 -179.432 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.541 ' HB3' HD13 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -80.88 13.71 2.54 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.25 -0.906 . . . . 0.0 110.918 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 60.2 p -152.91 113.41 4.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.123 -0.985 . . . . 0.0 109.72 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.517 ' HG ' ' HE2' ' A' ' 87' ' ' PHE . 13.0 m -124.6 -177.36 3.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 110.971 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.897 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -153.49 128.2 9.43 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.685 0.755 . . . . 0.0 110.21 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.587 ' N ' ' O ' ' A' ' 82' ' ' ASN . 4.7 t -66.09 81.5 0.08 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.476 ' HA ' ' H ' ' A' ' 82' ' ' ASN . 0.4 OUTLIER -64.38 173.75 1.41 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.342 -0.849 . . . . 0.0 110.988 -179.152 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.799 ' HG3' HG23 ' A' ' 38' ' ' ILE . 41.7 Cg_endo -73.18 120.49 6.6 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 O-C-N 124.586 1.835 . . . . 0.0 110.859 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.557 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 131.51 -6.06 5.57 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.824 ' O ' HG23 ' A' ' 108' ' ' THR . 1.6 m-20 81.0 93.61 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.916 -0.755 . . . . 0.0 111.361 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.824 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 175.02 -168.34 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.475 -0.766 . . . . 0.0 111.198 179.024 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.84 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 36.9 m95 -142.14 94.08 2.62 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.579 -0.7 . . . . 0.0 110.03 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.562 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 14.7 mmtt -103.61 147.17 33.82 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.367 -0.833 . . . . 0.0 110.086 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.575 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.1 Cg_endo -71.98 175.27 43.53 Favored 'Cis proline' 0 N--CA 1.49 1.28 0 C-N-CA 121.956 -2.102 . . . . 0.0 110.956 0.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 113' ' ' LEU . 12.7 pt-20 -37.68 122.39 0.95 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.684 -0.635 . . . . 0.0 110.986 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.883 HD23 ' O ' ' A' ' 65' ' ' THR . 0.9 OUTLIER -41.24 141.14 1.1 Allowed Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.517 -0.739 . . . . 0.0 110.174 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.884 ' HG2' HD12 ' A' ' 66' ' ' ILE . 40.4 Cg_endo -69.8 159.42 53.43 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 124.206 1.635 . . . . 0.0 110.851 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.565 ' HG2' HG13 ' A' ' 117' ' ' VAL . 3.2 ttpm? -119.43 101.34 7.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.919 . . . . 0.0 110.281 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.534 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 4.6 t -61.77 82.3 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.052 -1.03 . . . . 0.0 108.894 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.697 HG21 ' HB2' ' A' ' 96' ' ' SER . 4.5 m -96.48 -171.61 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-O 121.942 0.877 . . . . 0.0 111.37 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.413 ' HG2' ' CE1' ' A' ' 93' ' ' TYR . 9.0 mtm180 . . . . . 0 C--N 1.293 -1.877 0 C-N-CA 119.152 -1.019 . . . . 0.0 110.446 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.642 HG22 ' HA3' ' A' ' 48' ' ' GLY . 4.7 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.227 0.537 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -141.51 176.67 8.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.197 -0.939 . . . . 0.0 110.388 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.536 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.1 m -130.13 87.74 2.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.406 -0.809 . . . . 0.0 110.37 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -70.86 175.4 5.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.815 -1.178 . . . . 0.0 109.926 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -44.09 141.41 2.47 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.31 -0.868 . . . . 0.0 109.977 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.744 ' HG3' HG11 ' A' ' 27' ' ' VAL . 53.2 Cg_endo -70.71 156.38 60.98 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 124.015 1.534 . . . . 0.0 110.845 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -75.23 174.92 11.97 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.955 1.503 . . . . 0.0 110.093 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.38 -179.92 1.81 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.186 -0.946 . . . . 0.0 110.389 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.679 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -145.11 -170.23 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 122.206 1.003 . . . . 0.0 111.45 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.2 OUTLIER -45.1 92.75 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.387 -179.597 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.506 ' N ' ' O ' ' A' ' 9' ' ' ILE . 27.6 m-20 42.62 53.19 4.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.271 -0.893 . . . . 0.0 110.205 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.14 163.66 32.01 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 30' ' ' SER . 10.1 ptp180 -114.92 -178.38 3.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -1.148 . . . . 0.0 110.438 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.62 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 18.1 p80 -136.67 124.21 22.22 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.67 -0.644 . . . . 0.0 110.107 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -133.74 96.12 3.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 110.53 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.25 16.72 58.84 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.426 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 5.7 m-85 53.36 56.46 7.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.356 -1.084 . . . . 0.0 110.162 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.473 ' CD ' ' CE2' ' A' ' 21' ' ' TYR . 0.3 OUTLIER 179.93 -165.25 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.341 -0.849 . . . . 0.0 110.096 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -138.48 -39.98 0.51 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 109.815 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -110.64 136.03 50.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.406 -0.809 . . . . 0.0 109.721 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.645 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.4 OUTLIER -122.27 -7.01 8.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.921 . . . . 0.0 110.605 -179.541 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.536 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 38.2 p 46.06 -95.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.6 -0.687 . . . . 0.0 111.824 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.413 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 1.0 OUTLIER -153.95 151.21 29.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.772 -1.205 . . . . 0.0 110.637 -178.732 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.57 29.92 54.35 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.645 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -121.79 169.7 10.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.356 -1.084 . . . . 0.0 110.552 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.788 HG13 ' O ' ' A' ' 43' ' ' VAL . 24.2 t -142.52 156.29 18.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.888 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.744 HG11 ' HG3' ' A' ' 6' ' ' PRO . 11.9 t -131.19 124.75 56.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.433 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.85 101.91 8.81 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 118.541 -1.264 . . . . 0.0 107.613 177.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.69 ' O ' HD13 ' A' ' 37' ' ' LEU . 1.8 m-30 -68.29 122.11 17.67 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.644 -0.823 . . . . 0.0 110.024 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -86.61 144.69 27.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -0.975 . . . . 0.0 109.574 179.423 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.498 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 33.9 m -102.48 171.43 7.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.152 -0.968 . . . . 0.0 110.563 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -72.03 163.87 27.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -0.894 . . . . 0.0 110.096 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.48 99.84 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 0.0 110.693 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.99 19.29 9.16 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.498 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 6.9 m-85 -117.17 124.47 49.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.049 -1.265 . . . . 0.0 110.185 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.632 ' OG ' HG21 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -74.88 140.5 43.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.35 -0.844 . . . . 0.0 111.261 -179.549 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.69 HD13 ' O ' ' A' ' 29' ' ' TYR . 2.7 tp -92.63 106.95 18.84 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.515 -0.741 . . . . 0.0 109.35 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.746 HD12 ' HB3' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -98.43 155.91 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.151 -0.968 . . . . 0.0 109.394 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.67 175.87 38.44 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.462 ' O ' ' HG3' ' A' ' 54' ' ' PRO . 2.5 m120 -50.82 143.69 9.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -1.152 . . . . 0.0 109.873 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 76.2 p -80.09 51.94 1.45 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -0.95 . . . . 0.0 110.161 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.554 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 161.23 122.87 0.64 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.788 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.4 t -65.62 177.45 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.108 -1.231 . . . . 0.0 108.423 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.534 ' C ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -141.34 93.4 2.57 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.416 179.308 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.617 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -81.51 110.65 17.1 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.935 -1.106 . . . . 0.0 109.122 178.695 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.33 97.15 3.22 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.568 -0.708 . . . . 0.0 110.034 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.413 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 108.8 39.58 1.7 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.642 ' HA3' HG22 ' A' ' 1' ' ' VAL . . . 60.84 27.7 67.18 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 48' ' ' GLY . 2.7 mt-10 -154.1 132.46 11.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.193 -1.181 . . . . 0.0 110.396 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.617 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 84.8 m95 -82.34 142.85 31.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.882 . . . . 0.0 109.546 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.7 166.1 25.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.902 -1.124 . . . . 0.0 111.499 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.502 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.4 OUTLIER 44.96 65.98 5.72 Favored Pre-proline 0 N--CA 1.496 1.829 0 CA-C-O 121.146 0.498 . . . . 0.0 111.554 179.439 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.502 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.9 Cg_endo -91.33 130.89 1.35 Allowed 'Trans proline' 0 C--N 1.299 -2.04 0 O-C-N 124.342 1.706 . . . . 0.0 109.713 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.479 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.3 Cg_endo -77.47 158.94 32.64 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 123.752 1.396 . . . . 0.0 110.183 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.611 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 38.8 p -99.43 164.18 12.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.246 -0.909 . . . . 0.0 111.184 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 10' ' ' SER . 13.9 m -129.15 74.44 1.58 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.542 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -110.32 -175.43 2.73 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.563 0.697 . . . . 0.0 110.711 -178.025 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.595 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -96.26 128.77 47.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.647 HG23 ' CA ' ' A' ' 80' ' ' SER . 30.7 m -118.55 41.64 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.065 -1.022 . . . . 0.0 111.229 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 0.9 OUTLIER -52.75 179.42 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.323 0 C-N-CA 118.369 -1.333 . . . . 0.0 108.293 179.665 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.473 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -141.73 169.64 10.8 Favored Pre-proline 0 C--N 1.298 -1.643 0 C-N-CA 118.272 -1.371 . . . . 0.0 113.654 -178.015 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.437 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 46.6 Cg_endo -90.27 -75.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.393 2.062 . . . . 0.0 110.688 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.437 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 170.26 125.31 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.689 -0.632 . . . . 0.0 109.453 -179.125 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.662 ' HA ' HD21 ' A' ' 113' ' ' LEU . 55.3 Cg_endo -77.94 65.73 8.26 Favored 'Trans proline' 0 C--N 1.299 -2.065 0 O-C-N 123.74 1.389 . . . . 0.0 110.171 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.699 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -83.89 -179.1 7.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.38 -0.825 . . . . 0.0 109.629 179.504 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.742 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -179.56 169.49 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.045 -1.035 . . . . 0.0 110.628 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.523 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -74.21 105.76 5.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.572 -0.705 . . . . 0.0 111.037 -179.621 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 33.0 m120 38.47 38.35 0.23 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.587 -0.696 . . . . 0.0 111.129 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.708 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -144.58 27.85 1.93 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.533 ' O ' ' O ' ' A' ' 69' ' ' GLY . 12.4 p90 -43.64 -175.58 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.653 1.216 . . . . 0.0 112.501 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.825 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -112.72 157.52 21.2 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.579 179.234 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.7 t -138.69 23.12 2.68 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.932 -1.105 . . . . 0.0 109.806 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -100.93 -79.03 0.51 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.389 -0.819 . . . . 0.0 111.024 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -131.26 78.41 0.37 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -102.46 169.96 8.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.406 -1.055 . . . . 0.0 109.65 179.525 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.603 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 4.8 tttm -169.39 159.09 8.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.307 -0.871 . . . . 0.0 110.234 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.49 -40.08 11.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.365 -0.834 . . . . 0.0 110.091 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.504 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 0.3 OUTLIER -141.59 172.31 12.86 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.477 -0.765 . . . . 0.0 110.049 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.597 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 6.5 m-85 -141.63 -156.18 0.66 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.328 -0.857 . . . . 0.0 109.949 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.647 ' CA ' HG23 ' A' ' 59' ' ' VAL . 5.4 m -150.72 -111.32 0.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.953 -1.092 . . . . 0.0 110.929 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.619 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -110.32 18.48 19.83 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.691 -1.256 . . . . 0.0 110.509 -179.145 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.659 ' C ' HG22 ' A' ' 102' ' ' THR . 17.7 p-10 -158.02 -114.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.797 -1.189 . . . . 0.0 110.357 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.9 t0 49.85 73.55 0.25 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.738 -1.226 . . . . 0.0 109.2 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.866 ' CA ' HG23 ' A' ' 102' ' ' THR . 9.4 p30 -69.35 120.69 15.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.306 -0.871 . . . . 0.0 110.252 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.577 HG11 ' HG3' ' A' ' 64' ' ' PRO . 16.1 m -101.34 120.28 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.06 -1.025 . . . . 0.0 110.511 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.417 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -83.22 125.98 32.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.235 -0.915 . . . . 0.0 108.534 179.112 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.825 ' CE1' HD12 ' A' ' 71' ' ' LEU . 72.8 m-85 -86.97 139.21 30.82 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 122.185 0.993 . . . . 0.0 111.827 -178.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -114.43 91.56 3.67 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.809 -179.383 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.531 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -43.35 127.24 4.52 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.259 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 3.3 mmtt -35.58 -77.19 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.682 -178.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.571 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.3 OUTLIER -167.42 135.5 2.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.364 -0.835 . . . . 0.0 110.168 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.583 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 60.27 47.77 89.43 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.583 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 24.3 m-85 -154.28 157.4 38.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.512 -0.993 . . . . 0.0 109.764 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.562 ' O ' HG22 ' A' ' 117' ' ' VAL . 36.6 mtpt -118.38 122.26 42.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 110.063 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.674 HD23 HD11 ' A' ' 66' ' ' ILE . 10.1 mt -60.26 104.61 0.33 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.153 -0.967 . . . . 0.0 110.429 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.624 ' HB2' HG21 ' A' ' 117' ' ' VAL . 12.7 t -92.66 101.98 14.4 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.357 -0.839 . . . . 0.0 109.842 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 98' ' ' SER . . . 146.76 -56.28 0.51 Allowed Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.78 -1.2 . . . . 0.0 110.224 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.563 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 58.8 p 179.49 99.06 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.285 -1.126 . . . . 0.0 110.913 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 53.1 m -65.36 -18.39 65.28 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.121 -0.987 . . . . 0.0 110.372 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.6 p -137.08 101.17 4.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.158 -0.964 . . . . 0.0 109.626 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 85' ' ' VAL . 3.2 m -113.29 168.22 9.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.361 -0.837 . . . . 0.0 111.059 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.866 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -139.74 142.29 36.82 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.58 0.705 . . . . 0.0 110.083 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.599 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -73.25 94.77 2.03 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.555 -0.716 . . . . 0.0 110.663 -179.511 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.536 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -69.4 -175.41 0.27 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.375 -0.828 . . . . 0.0 110.959 -179.739 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.746 ' HB3' HD12 ' A' ' 38' ' ' ILE . 43.2 Cg_endo -81.42 128.52 6.24 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.343 1.707 . . . . 0.0 110.753 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 123.56 -7.65 8.96 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.746 ' O ' HG23 ' A' ' 108' ' ' THR . 3.0 m-20 80.92 96.01 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.642 0.734 . . . . 0.0 111.111 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.746 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 176.25 -159.2 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.485 -0.76 . . . . 0.0 110.654 179.341 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.744 ' HB3' HD13 ' A' ' 113' ' ' LEU . 22.6 m95 -145.84 89.95 1.94 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.39 -0.819 . . . . 0.0 110.172 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.517 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 13.6 mttm -100.62 142.77 25.27 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.562 -0.711 . . . . 0.0 110.531 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.563 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.4 Cg_endo -74.19 172.47 61.74 Favored 'Cis proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.68 -2.217 . . . . 0.0 110.266 -0.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.3 mp0 -37.6 127.41 1.13 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.466 -0.771 . . . . 0.0 111.439 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.744 HD13 ' HB3' ' A' ' 109' ' ' TRP . 0.2 OUTLIER -40.74 150.39 0.29 Allowed Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.492 -0.755 . . . . 0.0 110.192 179.116 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.742 ' HG2' HD12 ' A' ' 66' ' ' ILE . 39.6 Cg_endo -76.01 165.95 28.87 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 O-C-N 124.177 1.619 . . . . 0.0 110.937 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.539 ' O ' HG22 ' A' ' 117' ' ' VAL . 12.5 ttpt -129.84 101.8 6.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.268 -0.895 . . . . 0.0 110.034 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.529 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.2 t -55.59 91.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.098 -1.001 . . . . 0.0 109.377 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.624 HG21 ' HB2' ' A' ' 96' ' ' SER . 1.5 m -104.8 -177.79 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 121.714 0.768 . . . . 0.0 110.641 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.517 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 5.0 ptt-85 . . . . . 0 C--N 1.295 -1.776 0 C-N-CA 119.014 -1.075 . . . . 0.0 110.549 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 54.4 t . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.318 0.58 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.75 170.3 10.24 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.242 -0.911 . . . . 0.0 110.419 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.579 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.2 m -125.44 142.14 51.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.411 -0.806 . . . . 0.0 109.531 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 4.6 mp0 -113.0 175.86 5.26 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.015 -1.053 . . . . 0.0 109.807 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.57 140.87 56.55 Favored Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 121.298 -0.876 . . . . 0.0 109.734 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.815 ' HG3' HG11 ' A' ' 27' ' ' VAL . 49.2 Cg_endo -71.49 153.25 60.6 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 O-C-N 124.023 1.538 . . . . 0.0 110.717 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.61 173.01 14.59 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.863 1.454 . . . . 0.0 110.009 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.61 176.44 3.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.917 . . . . 0.0 109.935 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.68 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -143.43 -169.61 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 122.194 0.997 . . . . 0.0 111.336 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 11' ' ' ASN . 0.3 OUTLIER -46.61 93.56 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.683 -179.312 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.46 ' N ' ' O ' ' A' ' 9' ' ' ILE . 4.2 m-80 42.08 53.15 4.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.195 -0.941 . . . . 0.0 110.427 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.05 152.59 24.01 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.461 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -98.14 -167.76 1.56 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -1.147 . . . . 0.0 110.686 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.636 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 20.7 p80 -153.19 113.04 3.9 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.537 0.684 . . . . 0.0 110.191 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.414 ' O ' ' C ' ' A' ' 16' ' ' GLY . 0.9 OUTLIER -138.78 63.57 1.51 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.101 -0.999 . . . . 0.0 110.098 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 17' ' ' TYR . . . -44.01 -77.11 0.1 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.431 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 9.8 t80 -178.01 36.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -1.113 . . . . 0.0 110.197 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.566 ' OE2' ' CG ' ' A' ' 21' ' ' TYR . 2.0 pt-20 178.5 -161.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.89 . . . . 0.0 110.011 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -117.37 -36.84 3.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.227 -0.92 . . . . 0.0 110.286 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.535 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 21.9 p90 -129.99 123.55 30.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.152 -0.967 . . . . 0.0 110.471 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.637 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 14.0 m-85 -92.08 -167.79 1.85 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.451 -0.78 . . . . 0.0 110.27 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.579 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 0.6 OUTLIER -141.84 -64.66 0.43 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.915 -1.116 . . . . 0.0 110.964 -179.483 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 7.8 t0 -169.07 144.37 3.23 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.466 -0.771 . . . . 0.0 109.492 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.449 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 68.47 13.79 65.91 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.637 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 16.2 m -88.94 177.71 6.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.527 -0.984 . . . . 0.0 110.094 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 43' ' ' VAL . 24.4 t -154.15 155.54 6.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.498 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.815 HG11 ' HG3' ' A' ' 6' ' ' PRO . 16.1 t -136.22 114.8 15.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 119.416 -0.914 . . . . 0.0 111.684 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.464 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -71.66 104.56 3.39 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.431 -1.308 . . . . 0.0 107.626 177.784 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.887 ' O ' HD13 ' A' ' 37' ' ' LEU . 2.1 m-30 -67.79 130.48 43.13 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.135 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 13' ' ' ARG . 1.0 OUTLIER -82.24 160.33 23.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 109.808 179.665 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 12.4 m -130.45 162.87 28.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.154 -0.966 . . . . 0.0 110.107 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -64.13 152.57 40.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 110.088 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.12 108.72 0.27 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 110.418 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 109.44 -6.76 31.95 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 3.2 m-30 -95.18 128.88 42.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.208 -1.172 . . . . 0.0 110.279 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.587 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -81.94 145.93 30.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.189 -0.945 . . . . 0.0 110.96 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.887 HD13 ' O ' ' A' ' 29' ' ' TYR . 4.5 tp -94.73 98.4 10.75 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.445 -0.784 . . . . 0.0 108.932 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.823 HD12 ' HB2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -91.28 160.51 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.252 -0.905 . . . . 0.0 109.476 -179.67 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 95.53 -179.33 35.88 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -53.78 142.13 24.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.162 -1.199 . . . . 0.0 109.714 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.464 ' O ' HG23 ' A' ' 28' ' ' THR . 9.6 p -73.62 53.8 0.44 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.935 . . . . 0.0 110.256 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.616 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 148.24 122.9 1.3 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.676 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.6 t -54.87 -179.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.162 -1.199 . . . . 0.0 107.926 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.492 ' H ' HG12 ' A' ' 43' ' ' VAL . 0.3 OUTLIER -143.42 96.75 2.96 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.237 178.907 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.596 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -81.36 104.86 12.1 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.112 178.604 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.7 p -129.49 102.78 6.54 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.478 -0.764 . . . . 0.0 110.229 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.64 26.13 8.78 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.57 21.66 78.73 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -141.26 110.49 6.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -1.203 . . . . 0.0 110.365 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.596 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 88.2 m95 -64.27 136.6 57.33 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.239 -0.913 . . . . 0.0 109.894 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.429 ' O ' ' HB3' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -143.97 158.79 43.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 110.837 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.488 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 20.7 t0 60.32 66.31 1.96 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.753 -0.592 . . . . 0.0 111.242 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 48.7 Cg_endo -90.71 131.13 1.57 Allowed 'Trans proline' 0 C--N 1.301 -1.973 0 O-C-N 124.342 1.707 . . . . 0.0 109.682 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.548 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.9 Cg_endo -77.0 170.53 19.6 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 O-C-N 123.809 1.426 . . . . 0.0 110.035 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.539 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 12.3 p -113.16 147.87 36.54 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.066 -1.021 . . . . 0.0 111.824 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 36' ' ' SER . 42.2 m -114.11 78.68 1.17 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -114.07 -156.81 0.61 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.324 0.583 . . . . 0.0 110.324 -178.564 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.657 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -109.27 139.7 31.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.341 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.711 ' HB ' ' HA ' ' A' ' 105' ' ' PRO . 34.1 m -130.31 52.67 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 120.889 -1.132 . . . . 0.0 111.525 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 2.9 mptt -81.55 171.01 15.18 Favored 'General case' 0 C--N 1.282 -2.353 0 C-N-CA 118.349 -1.34 . . . . 0.0 107.567 178.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.465 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 60.3 m -140.81 164.74 34.35 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 120.302 -1.499 . . . . 0.0 113.031 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 40.1 Cg_endo -69.55 -86.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 124.886 1.993 . . . . 0.0 110.569 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.582 ' CE1' ' HE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -176.02 136.72 0.48 Allowed Pre-proline 0 C--N 1.301 -1.53 0 O-C-N 121.517 -0.739 . . . . 0.0 109.531 -179.616 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.599 ' HG3' ' CZ2' ' A' ' 109' ' ' TRP . 57.6 Cg_endo -86.21 69.9 4.54 Favored 'Trans proline' 0 C--N 1.297 -2.14 0 O-C-N 123.756 1.398 . . . . 0.0 109.599 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.698 ' O ' HG23 ' A' ' 66' ' ' ILE . 3.2 p -84.77 -43.74 13.96 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 122.506 1.146 . . . . 0.0 109.78 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.698 HG23 ' O ' ' A' ' 65' ' ' THR . 0.0 OUTLIER 56.22 160.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.828 -178.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.517 ' N ' HG13 ' A' ' 66' ' ' ILE . 8.1 t -63.7 98.18 0.18 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.479 -0.763 . . . . 0.0 111.345 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.451 ' C ' ' HG3' ' A' ' 90' ' ' LYS . 3.6 m-20 44.72 52.21 7.94 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.4 -0.813 . . . . 0.0 111.255 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.593 ' O ' ' CD2' ' A' ' 70' ' ' TYR . . . -135.32 -39.47 0.17 Allowed Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.308 -1.425 . . . . 0.0 109.635 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 16.2 p90 41.36 -177.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 122.807 1.289 . . . . 0.0 112.222 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.893 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -130.69 153.13 49.3 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.138 -179.047 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.1 t -112.51 -9.47 13.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.65 -1.281 . . . . 0.0 110.781 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.512 ' HB2' ' HB2' ' A' ' 86' ' ' ASP . 11.0 t -55.8 -70.31 0.12 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.175 -0.953 . . . . 0.0 110.269 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.42 101.58 0.15 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.582 ' HE2' ' CE1' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -98.71 145.24 27.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.312 -1.11 . . . . 0.0 110.005 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.444 ' HG2' ' N ' ' A' ' 77' ' ' ARG . 10.4 tttm -126.16 165.74 18.34 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.438 -0.789 . . . . 0.0 109.419 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.444 ' N ' ' HG2' ' A' ' 76' ' ' LYS . 8.6 mtp180 -56.09 -56.0 26.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.062 -1.024 . . . . 0.0 110.023 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.6 171.28 8.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.467 -0.77 . . . . 0.0 109.948 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.572 ' CD1' ' CZ2' ' A' ' 109' ' ' TRP . 27.1 m-85 -145.03 -179.88 6.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 0.0 110.219 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.534 ' O ' ' HB3' ' A' ' 103' ' ' CYS . 1.5 m -158.49 176.07 12.89 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.156 -0.965 . . . . 0.0 110.981 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.598 ' H ' ' CG2' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -38.57 -24.94 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.83 -0.544 . . . . 0.0 111.546 -178.776 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.688 ' O ' HG22 ' A' ' 102' ' ' THR . 43.8 t-20 -116.67 -122.48 0.29 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.779 -1.201 . . . . 0.0 110.094 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 51.98 71.08 0.49 Allowed 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.761 -1.212 . . . . 0.0 108.979 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.567 ' N ' HG23 ' A' ' 102' ' ' THR . 3.3 p-10 -72.18 152.32 42.33 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.894 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.795 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 0.3 OUTLIER -133.04 121.12 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.337 -0.852 . . . . 0.0 110.261 179.557 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.547 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 3.3 t0 -81.76 122.01 27.13 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.246 -0.909 . . . . 0.0 109.033 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.893 ' CE1' HD12 ' A' ' 71' ' ' LEU . 28.3 m-85 -80.48 132.52 35.71 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.275 1.035 . . . . 0.0 112.531 -177.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.598 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 4.2 tmtt? -116.41 87.59 2.72 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.046 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.558 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -36.5 131.21 0.68 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.434 -0.791 . . . . 0.0 111.315 -179.349 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.451 ' HG3' ' C ' ' A' ' 68' ' ' ASN . 0.3 OUTLIER -39.01 -93.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.542 -0.724 . . . . 0.0 110.966 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.569 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 77.3 t80 -152.95 120.27 5.89 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.101 -0.999 . . . . 0.0 110.311 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.578 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 72.06 54.74 7.75 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.578 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 63.0 m-85 -159.42 150.76 20.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.482 -1.011 . . . . 0.0 109.925 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.553 ' O ' HG22 ' A' ' 117' ' ' VAL . 7.9 mtmt -104.89 140.53 38.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.237 -0.914 . . . . 0.0 110.252 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.56 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 7.1 mt -80.8 99.79 8.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.89 -1.131 . . . . 0.0 110.267 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 3.7 t -82.39 93.73 7.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.185 -0.947 . . . . 0.0 109.962 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 114' ' ' PRO . . . 154.15 -97.2 0.17 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.615 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 15.3 t -150.79 122.03 7.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.191 -1.182 . . . . 0.0 110.276 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.414 ' O ' ' CD2' ' A' ' 87' ' ' PHE . 79.4 p -58.51 -58.94 6.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.246 -0.909 . . . . 0.0 110.426 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 51.5 p -91.75 138.67 31.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.407 -0.808 . . . . 0.0 110.197 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.547 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 70.7 m -144.58 169.93 17.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.393 -0.817 . . . . 0.0 109.974 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.688 HG22 ' O ' ' A' ' 82' ' ' ASN . 1.8 m -147.88 134.44 19.8 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.32 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 108' ' ' THR . 1.8 t -54.77 87.47 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.51 -0.744 . . . . 0.0 109.502 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -53.05 170.8 0.24 Allowed Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.033 -1.042 . . . . 0.0 112.417 -178.711 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.823 ' HB2' HD12 ' A' ' 38' ' ' ILE . 51.5 Cg_endo -81.88 15.58 1.92 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 125.012 2.059 . . . . 0.0 111.37 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.555 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -114.59 13.32 20.64 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.862 ' O ' HG23 ' A' ' 108' ' ' THR . 11.1 t30 77.69 62.33 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.892 -0.769 . . . . 0.0 110.351 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.862 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -177.68 178.0 1.05 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 118.818 -1.153 . . . . 0.0 111.891 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.795 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 25.2 m95 -104.2 89.65 3.33 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.233 0.54 . . . . 0.0 110.746 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.544 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 3.8 mmtm -98.01 154.63 37.68 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.222 -0.924 . . . . 0.0 109.502 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.615 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 51.5 Cg_endo -71.71 -174.43 11.48 Favored 'Cis proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.258 -1.976 . . . . 0.0 111.054 -0.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -36.87 120.69 0.73 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.347 0.594 . . . . 0.0 110.762 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.676 HD13 ' HB3' ' A' ' 109' ' ' TRP . 4.2 tp -54.01 138.97 54.64 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.339 -0.851 . . . . 0.0 110.096 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.585 ' HG3' ' CD2' ' A' ' 87' ' ' PHE . 40.6 Cg_endo -70.17 158.81 55.25 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 O-C-N 124.051 1.553 . . . . 0.0 110.565 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.641 ' HG2' HG13 ' A' ' 117' ' ' VAL . 61.5 tttt -126.7 94.05 3.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.665 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.554 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 1.6 t -45.16 96.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.222 -0.924 . . . . 0.0 109.113 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.641 HG13 ' HG2' ' A' ' 115' ' ' LYS . 0.7 OUTLIER -109.93 -173.24 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 121.83 0.824 . . . . 0.0 110.59 -179.262 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.421 ' CG ' ' CE1' ' A' ' 93' ' ' TYR . 11.7 mtp180 . . . . . 0 C--N 1.293 -1.887 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.555 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.169 0.509 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.04 178.46 6.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 110.51 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.591 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 9.2 t -141.26 132.79 26.97 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.457 ' O ' ' C ' ' A' ' 5' ' ' SER . 5.3 mt-30 -115.13 179.27 4.0 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.141 -0.974 . . . . 0.0 110.041 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.2 OUTLIER -40.22 141.04 0.88 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.701 -0.624 . . . . 0.0 109.986 -179.888 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.759 ' HG3' HG11 ' A' ' 27' ' ' VAL . 50.6 Cg_endo -70.3 154.87 65.24 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 123.993 1.523 . . . . 0.0 111.028 -178.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -75.01 173.57 14.28 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.049 1.552 . . . . 0.0 109.957 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.47 178.42 2.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.222 -0.924 . . . . 0.0 110.16 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.656 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -144.13 -170.09 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.208 1.004 . . . . 0.0 111.196 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 11' ' ' ASN . 21.7 m -44.1 92.56 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.455 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 9' ' ' ILE . 2.3 m-80 43.59 54.04 5.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 110.243 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.456 ' O ' HG13 ' A' ' 9' ' ' ILE . . . -157.71 146.98 14.36 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.55 ' HG2' ' CB ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -97.48 -176.9 3.63 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.331 -1.099 . . . . 0.0 110.335 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.626 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 19.3 p80 -140.15 158.89 43.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.64 -0.662 . . . . 0.0 110.334 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.559 ' HB2' HG13 ' A' ' 27' ' ' VAL . 10.8 m120 -47.71 162.77 0.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.924 . . . . 0.0 110.246 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -156.6 26.12 0.52 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -87.13 14.44 7.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.105 -1.232 . . . . 0.0 110.222 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.548 ' HG3' ' CE2' ' A' ' 21' ' ' TYR . 8.8 pm0 -135.05 -150.31 0.38 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.933 . . . . 0.0 109.994 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 4' ' ' GLN . 2.9 t70 -163.63 -36.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 110.209 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.575 ' O ' ' CD2' ' A' ' 20' ' ' PHE . 16.3 p90 -135.41 81.53 1.9 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.965 . . . . 0.0 109.97 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.614 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 1.6 m-85 -59.27 -23.88 62.75 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.556 -0.715 . . . . 0.0 110.872 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.563 ' N ' ' HB3' ' A' ' 3' ' ' CYS . 91.2 m 58.89 -95.53 0.06 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.377 -0.827 . . . . 0.0 111.424 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 4.3 t0 -147.56 150.28 34.17 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.987 -1.071 . . . . 0.0 110.331 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 77.1 18.9 78.0 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.614 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -103.4 160.2 14.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.571 -0.958 . . . . 0.0 110.563 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.789 HG13 ' O ' ' A' ' 43' ' ' VAL . 39.4 t -141.07 156.92 22.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.418 -0.801 . . . . 0.0 110.522 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.759 HG11 ' HG3' ' A' ' 6' ' ' PRO . 20.0 t -138.03 122.54 22.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 119.186 -1.006 . . . . 0.0 111.691 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.77 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -76.34 103.55 6.42 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.837 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.73 ' O ' HD13 ' A' ' 37' ' ' LEU . 2.6 m-30 -68.67 125.6 27.07 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.414 -178.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.55 ' CB ' ' HG2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -92.91 147.16 23.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.155 -0.965 . . . . 0.0 109.621 179.269 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 37' ' ' LEU . 34.0 m -106.63 159.83 15.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.115 -0.991 . . . . 0.0 110.681 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.461 ' O ' ' N ' ' A' ' 34' ' ' GLY . 5.0 t30 -52.06 160.76 0.69 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.361 -0.837 . . . . 0.0 110.007 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.23 79.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 110.537 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 32' ' ' ASN . . . 145.08 -10.42 1.8 Allowed Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.706 -1.235 . . . . 0.0 110.206 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -97.04 137.66 35.78 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.049 -1.265 . . . . 0.0 110.478 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.721 ' HB2' HG13 ' A' ' 59' ' ' VAL . 0.5 OUTLIER -82.68 145.41 29.64 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.394 -0.816 . . . . 0.0 110.914 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.73 HD13 ' O ' ' A' ' 29' ' ' TYR . 9.5 tp -98.41 106.42 18.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.473 -0.767 . . . . 0.0 109.687 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.784 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -101.31 163.31 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.923 . . . . 0.0 109.069 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.19 176.96 44.84 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -55.69 133.1 50.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.236 -1.155 . . . . 0.0 109.846 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.77 ' O ' HG23 ' A' ' 28' ' ' THR . 81.2 p -76.88 54.01 0.97 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -0.949 . . . . 0.0 110.158 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.539 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 167.38 109.56 0.22 Allowed Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.695 -1.241 . . . . 0.0 110.131 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.789 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -58.59 177.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.032 -1.275 . . . . 0.0 108.16 178.914 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.84 99.79 3.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.158 -0.964 . . . . 0.0 110.259 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.624 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 3.1 t -84.63 111.86 19.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.144 -0.972 . . . . 0.0 109.31 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.6 t -124.84 82.67 2.07 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.166 -0.959 . . . . 0.0 110.395 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.16 45.06 1.92 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.445 ' HA2' ' HB2' ' A' ' 3' ' ' CYS . . . 62.75 15.2 54.1 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -126.28 97.43 5.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.223 -1.163 . . . . 0.0 110.338 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.624 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 87.7 m95 -66.59 137.46 56.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -0.95 . . . . 0.0 109.822 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.31 162.88 34.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.149 -0.969 . . . . 0.0 111.189 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.524 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 33.3 m-20 56.41 65.13 4.32 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.852 -0.53 . . . . 0.0 111.445 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.3 Cg_endo -92.33 134.96 1.39 Allowed 'Trans proline' 0 C--N 1.299 -2.042 0 O-C-N 124.379 1.726 . . . . 0.0 109.521 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.512 ' HG2' ' HB2' ' A' ' 29' ' ' TYR . 47.4 Cg_endo -78.19 174.23 12.76 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 123.607 1.319 . . . . 0.0 109.758 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.556 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 17.1 p -113.15 144.97 41.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.045 -1.034 . . . . 0.0 112.219 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 11.0 m -113.63 77.13 1.03 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 36' ' ' SER . 4.5 mm-40 -111.77 -171.53 1.86 Allowed 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.531 0.682 . . . . 0.0 110.945 -177.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.594 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -101.58 128.25 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.301 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.721 HG13 ' HB2' ' A' ' 36' ' ' SER . 20.6 m -118.65 52.31 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.058 -1.026 . . . . 0.0 111.039 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.465 ' N ' ' OD1' ' A' ' 107' ' ' ASN . 1.6 mttp -83.97 110.42 18.41 Favored 'General case' 0 C--N 1.283 -2.318 0 C-N-CA 118.5 -1.28 . . . . 0.0 109.367 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.555 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 84.4 m -78.05 166.55 42.55 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.189 -0.945 . . . . 0.0 111.274 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.555 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 38.0 Cg_endo -71.89 -76.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.278 1.672 . . . . 0.0 110.47 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.4 ' CG ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 175.39 136.33 0.17 Allowed Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.652 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.608 ' HG3' ' CZ2' ' A' ' 109' ' ' TRP . 58.8 Cg_endo -84.95 87.75 1.0 Allowed 'Trans proline' 0 C--N 1.297 -2.178 0 O-C-N 123.733 1.386 . . . . 0.0 109.721 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.695 ' O ' HG23 ' A' ' 66' ' ' ILE . 2.6 p -112.29 -43.23 3.56 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 122.394 1.092 . . . . 0.0 110.144 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.698 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER 51.95 166.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.242 -179.16 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.507 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 12.9 t -65.15 97.43 0.25 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.521 -0.737 . . . . 0.0 111.265 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 6.2 m-80 45.95 55.64 6.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.448 -0.783 . . . . 0.0 111.905 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.57 ' O ' ' CG ' ' A' ' 70' ' ' TYR . . . -135.34 -42.31 0.12 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.629 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 18.7 p90 43.67 -179.31 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 122.891 1.329 . . . . 0.0 112.074 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.845 HD13 ' N ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -125.24 153.54 43.01 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.15 -179.856 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.484 ' HB3' ' HG3' ' A' ' 88' ' ' LYS . 0.3 OUTLIER -111.58 7.84 20.72 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.01 -1.056 . . . . 0.0 110.267 -178.486 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.85 -70.68 0.52 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.283 -0.886 . . . . 0.0 110.331 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -175.95 100.04 0.14 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.594 ' CD2' ' O ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -94.01 110.03 21.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.402 -1.058 . . . . 0.0 109.498 179.533 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.512 ' N ' ' OH ' ' A' ' 79' ' ' TYR . 9.4 mttp -86.08 151.96 23.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.913 . . . . 0.0 110.247 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.3 mtt180 -48.45 -32.91 8.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.283 -0.885 . . . . 0.0 110.085 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.4 p -141.38 159.05 43.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.399 -0.813 . . . . 0.0 110.307 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.584 ' OH ' ' CD1' ' A' ' 75' ' ' PHE . 79.5 m-85 -132.23 -171.26 2.59 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.281 -0.887 . . . . 0.0 110.05 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.67 ' C ' HG23 ' A' ' 59' ' ' VAL . 78.8 p -147.18 -103.67 0.09 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.873 -1.142 . . . . 0.0 111.495 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.612 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -114.29 22.35 13.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 119.77 -1.831 . . . . 0.0 110.96 -178.396 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.683 ' C ' HG22 ' A' ' 102' ' ' THR . 50.3 t30 -165.55 -110.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.869 -1.144 . . . . 0.0 110.72 178.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 82' ' ' ASN . 0.1 OUTLIER 46.99 79.03 0.06 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.686 -1.259 . . . . 0.0 108.923 -179.032 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.736 ' CA ' HG23 ' A' ' 102' ' ' THR . 2.1 p-10 -71.91 142.12 49.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.347 -0.846 . . . . 0.0 110.885 -178.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.778 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 5.4 m -129.42 117.55 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.909 . . . . 0.0 110.455 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.539 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 3.1 t0 -76.64 128.52 34.85 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.376 -0.828 . . . . 0.0 108.897 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.656 ' CD1' HG21 ' A' ' 66' ' ' ILE . 34.2 m-85 -88.09 142.59 27.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.033 -1.042 . . . . 0.0 112.629 -177.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -121.4 84.78 2.29 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.128 -179.434 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.683 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.8 OUTLIER -35.2 126.46 0.58 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.761 -0.587 . . . . 0.0 110.853 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.9 OUTLIER -34.18 -78.52 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.625 -0.672 . . . . 0.0 110.843 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.464 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -168.78 143.45 3.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.312 -0.868 . . . . 0.0 110.395 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 51.51 45.26 53.83 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.577 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 10.8 m-85 -148.22 154.78 40.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.406 -1.055 . . . . 0.0 110.217 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.705 ' O ' HG22 ' A' ' 117' ' ' VAL . 35.9 mtpt -109.94 131.12 55.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 109.967 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.683 HD11 ' H ' ' A' ' 89' ' ' CYS . 2.0 mt -73.12 93.12 1.77 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.904 . . . . 0.0 110.246 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.468 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -74.39 98.54 3.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.928 . . . . 0.0 109.766 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 147.32 -97.94 0.19 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.608 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -149.87 128.52 12.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.234 -1.156 . . . . 0.0 110.211 -179.655 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 87' ' ' PHE . 24.9 p -72.36 -45.44 59.84 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.125 -0.985 . . . . 0.0 110.59 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.6 p -102.89 116.3 32.29 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.115 -0.991 . . . . 0.0 110.248 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 16.4 m -120.83 178.96 4.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.421 -0.799 . . . . 0.0 110.297 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.736 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.5 OUTLIER -152.58 134.24 14.61 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.571 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.554 ' SG ' ' O ' ' A' ' 80' ' ' SER . 12.9 t -62.03 78.48 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.542 0.687 . . . . 0.0 109.547 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.499 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -56.43 176.9 0.19 Allowed Pre-proline 0 N--CA 1.498 1.935 0 CA-C-O 121.506 0.67 . . . . 0.0 112.753 -178.485 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.784 ' CB ' HD12 ' A' ' 38' ' ' ILE . 47.2 Cg_endo -79.08 25.45 0.57 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 124.779 1.936 . . . . 0.0 112.079 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -122.86 18.86 7.96 Favored Glycine 0 N--CA 1.482 1.757 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.691 ' O ' HG23 ' A' ' 108' ' ' THR . 16.3 m-80 62.63 53.05 2.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.894 -0.768 . . . . 0.0 110.066 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.2 OUTLIER -163.64 179.27 7.3 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.288 -0.883 . . . . 0.0 111.166 179.881 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.778 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 45.4 m95 -110.03 90.74 3.4 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.561 -0.712 . . . . 0.0 110.243 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.581 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 1.0 OUTLIER -100.33 154.91 36.94 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.322 -0.861 . . . . 0.0 109.596 179.84 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.608 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.3 Cg_endo -69.48 -179.92 19.96 Favored 'Cis proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.33 -1.946 . . . . 0.0 111.414 0.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.472 ' C ' ' O ' ' A' ' 111' ' ' PRO . 9.5 mt-10 -34.44 121.8 0.5 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.416 0.627 . . . . 0.0 111.097 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.609 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 3.0 tp -49.13 141.7 10.82 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.39 -0.819 . . . . 0.0 110.127 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.698 ' HG2' HD12 ' A' ' 66' ' ' ILE . 41.5 Cg_endo -70.26 158.5 56.1 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 124.073 1.564 . . . . 0.0 110.416 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.845 ' HG2' HG13 ' A' ' 117' ' ' VAL . 11.5 ttpt -124.11 107.17 10.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 110.37 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 2.6 t -63.01 78.28 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.17 -0.957 . . . . 0.0 109.168 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.845 HG13 ' HG2' ' A' ' 115' ' ' LYS . 2.5 m -92.92 -173.83 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.903 0.859 . . . . 0.0 111.264 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.461 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.6 OUTLIER . . . . . 0 C--N 1.296 -1.758 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.239 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 2' ' ' LYS . 59.1 t . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.162 0.505 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 32.4 mttt -93.53 164.79 13.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.248 -0.907 . . . . 0.0 110.285 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.571 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -131.37 83.74 2.12 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.165 -0.959 . . . . 0.0 110.343 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.423 ' O ' ' C ' ' A' ' 5' ' ' SER . 4.3 pm0 -63.52 179.57 0.45 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.12 -0.988 . . . . 0.0 109.928 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.3 p -44.99 144.52 1.93 Allowed Pre-proline 0 C--N 1.297 -1.684 0 C-N-CA 119.715 -0.794 . . . . 0.0 109.443 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.892 ' HG3' HG11 ' A' ' 27' ' ' VAL . 45.9 Cg_endo -70.16 159.86 51.63 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 124.028 1.541 . . . . 0.0 111.004 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.72 171.17 18.73 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.004 1.528 . . . . 0.0 110.216 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 77.4 p -73.58 179.18 4.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 0.0 110.17 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.639 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -145.14 -169.51 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 122.232 1.015 . . . . 0.0 111.78 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 3.6 t -50.27 100.23 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.2 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 10' ' ' SER . 5.5 m-20 36.72 55.49 1.16 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.658 -0.651 . . . . 0.0 111.335 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.414 ' HA3' ' SG ' ' A' ' 56' ' ' CYS . . . -150.28 -163.34 11.13 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.528 ' CG ' ' HB3' ' A' ' 30' ' ' SER . 0.0 OUTLIER -148.2 174.9 11.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.206 -1.173 . . . . 0.0 110.362 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.621 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 23.2 p80 -140.74 -155.32 0.58 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.551 -0.718 . . . . 0.0 110.023 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 0.1 OUTLIER 70.35 106.8 0.06 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.332 -0.855 . . . . 0.0 110.434 179.621 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.495 ' O ' ' CD2' ' A' ' 17' ' ' TYR . . . -166.35 46.89 0.27 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.495 ' CD2' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER 179.18 -33.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -1.175 . . . . 0.0 110.571 -179.908 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 8.8 pt-20 -179.71 -168.69 0.12 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.094 -1.004 . . . . 0.0 110.761 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -114.35 -41.69 3.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.461 -0.774 . . . . 0.0 109.635 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -95.64 130.13 42.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.395 -0.815 . . . . 0.0 109.733 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.647 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.4 OUTLIER -122.45 -6.48 8.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.144 -0.973 . . . . 0.0 110.626 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.571 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 72.6 p 46.69 -95.75 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.501 -0.75 . . . . 0.0 112.1 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 0.8 OUTLIER -154.62 144.86 21.97 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.887 -1.133 . . . . 0.0 110.577 -178.527 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.22 31.96 29.92 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.647 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -122.13 172.25 8.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.438 -1.037 . . . . 0.0 110.267 -179.742 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.91 HG13 ' O ' ' A' ' 43' ' ' VAL . 48.6 t -142.99 152.87 16.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.265 -0.897 . . . . 0.0 110.826 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.935 ' O ' HG23 ' A' ' 43' ' ' VAL . 11.9 t -129.81 122.11 53.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 C-N-CA 119.831 -0.747 . . . . 0.0 111.413 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.42 102.3 5.12 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 118.723 -1.191 . . . . 0.0 107.882 178.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.952 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.1 m-30 -68.34 120.65 14.81 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.263 -178.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.528 ' HB3' ' CG ' ' A' ' 13' ' ' ARG . 4.9 t -73.18 -177.65 2.59 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.945 -1.097 . . . . 0.0 109.2 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 30' ' ' SER . 71.0 m -151.56 163.89 38.06 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.344 -0.848 . . . . 0.0 109.975 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.34 145.58 26.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.182 -0.949 . . . . 0.0 109.701 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.432 ' O ' ' OG ' ' A' ' 33' ' ' SER . 1.6 p -52.64 110.9 0.56 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 110.499 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.04 -20.43 26.33 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -79.27 132.17 36.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.182 -1.187 . . . . 0.0 110.354 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.702 ' HB3' HD11 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -80.84 138.86 36.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.16 -0.962 . . . . 0.0 110.579 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.565 HD13 ' O ' ' A' ' 29' ' ' TYR . 0.8 OUTLIER -85.87 98.03 10.54 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.431 -0.793 . . . . 0.0 109.358 179.09 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.903 HD12 ' HB3' ' A' ' 105' ' ' PRO . 0.7 OUTLIER -89.17 148.86 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -0.884 . . . . 0.0 109.065 179.784 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.89 -150.43 16.91 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.05 137.43 32.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.358 -1.083 . . . . 0.0 110.371 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.415 ' HA ' HD21 ' A' ' 37' ' ' LEU . 54.8 p -76.69 55.29 1.04 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.933 . . . . 0.0 109.444 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.606 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 153.93 121.17 0.8 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.952 HG21 ' CE1' ' A' ' 29' ' ' TYR . 1.7 t -69.27 -178.29 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.173 -1.193 . . . . 0.0 108.263 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.498 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.3 tp -143.92 97.54 3.08 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.923 -1.11 . . . . 0.0 110.714 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.594 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 1.0 OUTLIER -86.04 114.7 23.13 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.081 -1.047 . . . . 0.0 109.132 178.569 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.07 91.91 3.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.501 -0.749 . . . . 0.0 110.225 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.526 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 78.49 63.49 2.12 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 46.7 53.15 10.35 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -157.31 73.37 0.73 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.346 -1.091 . . . . 0.0 110.569 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.594 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 76.1 m95 -55.7 137.73 48.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.087 -1.008 . . . . 0.0 109.354 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -146.87 163.8 34.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.001 -1.062 . . . . 0.0 111.342 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.51 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 1.5 m-20 62.11 65.77 1.56 Allowed Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.826 -0.546 . . . . 0.0 111.377 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.51 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 46.5 Cg_endo -91.47 129.23 1.2 Allowed 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 121.802 1.668 . . . . 0.0 110.17 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.573 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 49.7 Cg_endo -80.21 168.21 18.83 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.904 1.476 . . . . 0.0 110.086 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.615 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 65.7 p -107.83 148.01 30.12 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.979 -1.076 . . . . 0.0 111.347 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 10' ' ' SER . 88.9 m -109.25 77.91 1.1 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -113.81 -167.68 1.24 Allowed 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.394 0.616 . . . . 0.0 110.487 -178.305 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.654 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -104.69 134.69 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.246 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.634 HG21 ' CB ' ' A' ' 81' ' ' TYR . 19.8 m -122.7 43.75 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.063 -1.023 . . . . 0.0 111.099 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -82.93 96.69 8.37 Favored 'General case' 0 C--N 1.286 -2.179 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.956 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 107' ' ' ASN . 29.2 m -69.69 162.09 69.97 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.397 -0.814 . . . . 0.0 111.423 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.459 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 44.3 Cg_endo -72.88 -90.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.559 1.82 . . . . 0.0 110.578 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.485 ' CE1' ' CZ ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -161.69 132.77 3.79 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.802 ' HA ' HD21 ' A' ' 113' ' ' LEU . 55.7 Cg_endo -78.7 65.71 8.67 Favored 'Trans proline' 0 C--N 1.295 -2.267 0 O-C-N 123.665 1.35 . . . . 0.0 109.454 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.646 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -82.98 176.03 9.58 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.579 -0.701 . . . . 0.0 110.287 -179.652 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.646 HG22 ' C ' ' A' ' 65' ' ' THR . 0.2 OUTLIER -176.7 163.39 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.227 -0.92 . . . . 0.0 110.625 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.46 ' N ' HG13 ' A' ' 66' ' ' ILE . 1.8 m -75.9 107.61 8.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.509 -0.744 . . . . 0.0 110.831 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 8.6 m-20 43.37 37.89 1.53 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.457 -0.777 . . . . 0.0 110.432 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.597 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -145.1 26.72 1.88 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.551 ' O ' ' N ' ' A' ' 88' ' ' LYS . 23.4 p90 -43.91 -178.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.409 1.1 . . . . 0.0 111.833 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.69 HD13 ' H ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -109.63 156.29 20.4 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 121.913 0.864 . . . . 0.0 110.858 179.083 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.08 11.77 4.25 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.778 -1.201 . . . . 0.0 110.033 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.22 -79.68 0.23 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.347 -0.845 . . . . 0.0 110.917 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -141.42 84.08 0.21 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.537 ' C ' ' CD1' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -98.95 160.92 13.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.467 -1.019 . . . . 0.0 109.911 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.584 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 24.4 ttmt -153.44 156.81 38.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.264 -0.897 . . . . 0.0 110.531 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 26.5 mtp85 -53.37 -30.16 38.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.897 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.418 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -141.77 171.56 13.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.484 -0.76 . . . . 0.0 110.21 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.584 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 31.2 m-85 -144.08 177.66 8.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.214 -0.929 . . . . 0.0 110.408 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.575 ' HA ' HG23 ' A' ' 59' ' ' VAL . 7.7 p -162.85 92.36 0.77 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.177 -0.952 . . . . 0.0 110.238 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.634 ' CB ' HG21 ' A' ' 59' ' ' VAL . 13.3 t80 56.83 136.31 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.092 -1.005 . . . . 0.0 110.247 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.733 ' O ' HG22 ' A' ' 102' ' ' THR . 14.4 t-20 63.57 -125.05 0.55 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.849 -1.157 . . . . 0.0 110.521 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.498 ' HB3' ' HB3' ' A' ' 103' ' ' CYS . 0.5 OUTLIER 54.13 71.2 0.53 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.617 -1.302 . . . . 0.0 109.014 -178.526 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.539 ' N ' HG23 ' A' ' 102' ' ' THR . 5.4 t30 -73.53 136.69 44.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.515 -0.741 . . . . 0.0 111.332 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.586 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 12.5 m -124.0 117.21 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.246 -0.909 . . . . 0.0 109.877 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 48.6 t0 -78.4 136.04 37.56 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.682 ' CE1' HD12 ' A' ' 71' ' ' LEU . 60.6 m-85 -94.24 129.68 40.78 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.99 -1.069 . . . . 0.0 112.158 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 70' ' ' TYR . 9.1 tptt -99.52 90.05 4.37 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.631 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.518 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -44.35 128.77 6.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.004 -1.06 . . . . 0.0 109.861 -179.668 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 2.9 mmtt -38.93 -78.0 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.595 -0.691 . . . . 0.0 110.472 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.589 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -168.27 141.53 3.14 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.358 -0.839 . . . . 0.0 110.366 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.582 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 49.79 53.78 20.47 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.589 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 11.6 m-85 -158.28 151.23 22.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.469 -1.019 . . . . 0.0 109.624 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.565 ' O ' HG22 ' A' ' 117' ' ' VAL . 13.1 mtmm -109.18 134.64 51.47 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.113 -0.992 . . . . 0.0 110.161 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' A' ' 114' ' ' PRO . 1.8 mt -72.13 103.51 3.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.259 -0.9 . . . . 0.0 110.571 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.488 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -84.87 112.83 20.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.151 -0.968 . . . . 0.0 109.751 179.379 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 132.08 -77.74 0.38 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.538 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -167.73 112.05 0.67 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.358 -1.084 . . . . 0.0 110.44 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 43.9 t -69.97 -7.07 37.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.211 -0.931 . . . . 0.0 110.306 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.0 p -139.65 98.8 3.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.182 -0.949 . . . . 0.0 110.04 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.604 ' HG ' ' HE2' ' A' ' 87' ' ' PHE . 7.0 m -106.47 -174.69 2.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.192 -0.943 . . . . 0.0 110.565 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.733 HG22 ' O ' ' A' ' 82' ' ' ASN . 19.8 m -157.93 134.9 9.97 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.251 -0.98 . . . . 0.0 111.301 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.602 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 1.8 t -62.2 87.4 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.479 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -78.57 177.05 3.06 Favored Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.133 -0.98 . . . . 0.0 110.859 -179.387 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.903 ' HB3' HD12 ' A' ' 38' ' ' ILE . 41.9 Cg_endo -73.55 138.28 26.6 Favored 'Trans proline' 0 C--N 1.302 -1.91 0 O-C-N 124.436 1.756 . . . . 0.0 110.499 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.554 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 116.92 -10.05 15.72 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.554 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 1.4 m-20 81.12 77.72 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.943 -0.74 . . . . 0.0 110.065 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -173.73 -175.05 1.03 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.626 -0.83 . . . . 0.0 110.969 -179.697 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.606 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 38.9 m95 -124.35 89.03 3.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.546 -0.721 . . . . 0.0 109.723 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.592 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -101.86 136.05 19.6 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.491 -0.755 . . . . 0.0 110.652 -179.109 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.592 ' C ' ' HA ' ' A' ' 110' ' ' LYS . 40.9 Cg_endo -68.52 163.73 77.28 Favored 'Cis proline' 0 N--CA 1.489 1.224 0 C-N-CA 122.101 -2.041 . . . . 0.0 111.029 -0.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 111' ' ' PRO . 28.5 tt0 -40.06 155.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.457 0.646 . . . . 0.0 110.689 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.802 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -62.99 146.29 95.78 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.494 -0.754 . . . . 0.0 110.043 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.576 ' HG3' ' CD2' ' A' ' 87' ' ' PHE . 41.1 Cg_endo -72.45 175.4 10.15 Favored 'Trans proline' 0 C--N 1.299 -2.057 0 O-C-N 124.365 1.718 . . . . 0.0 111.136 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.643 ' HG2' HG13 ' A' ' 117' ' ' VAL . 6.4 tttp -133.79 114.39 13.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.493 -0.755 . . . . 0.0 109.907 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.52 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 3.5 t -72.96 71.19 1.06 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.082 -1.011 . . . . 0.0 109.505 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.643 HG13 ' HG2' ' A' ' 115' ' ' LYS . 5.9 m -86.91 -170.37 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-O 122.057 0.932 . . . . 0.0 110.924 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.477 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.294 -1.844 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.281 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.593 HG23 ' HA3' ' A' ' 48' ' ' GLY . 9.1 m . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.301 0.572 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.77 178.96 6.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.296 -0.878 . . . . 0.0 110.512 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.524 ' O ' ' N ' ' A' ' 21' ' ' TYR . 1.2 m -117.99 136.38 53.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.493 -0.754 . . . . 0.0 110.131 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 5' ' ' SER . 5.7 pt20 -110.61 172.94 6.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.046 -1.034 . . . . 0.0 109.647 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.503 ' HB2' ' HA ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -46.65 132.86 8.21 Favored Pre-proline 0 C--N 1.298 -1.637 0 C-N-CA 119.369 -0.933 . . . . 0.0 109.36 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.592 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 43.8 Cg_endo -69.81 166.03 29.03 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.939 1.494 . . . . 0.0 110.325 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.02 166.47 27.81 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 O-C-N 123.942 1.496 . . . . 0.0 110.306 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.74 175.37 9.45 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.376 -0.827 . . . . 0.0 109.949 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 11' ' ' ASN . 0.3 OUTLIER -141.44 -170.33 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-O 122.227 1.013 . . . . 0.0 111.331 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.5 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 1.3 m -46.44 91.54 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.92 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.506 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER 42.03 51.09 4.33 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.147 -0.97 . . . . 0.0 110.376 179.643 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -150.53 151.79 23.76 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -111.15 -179.05 3.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.34 -1.094 . . . . 0.0 110.265 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.614 ' CD2' ' N ' ' A' ' 14' ' ' HIS . 8.4 m170 -66.06 -139.42 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.279 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -85.28 -97.76 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.935 . . . . 0.0 110.212 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.32 -71.2 0.69 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -164.61 84.75 0.42 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -1.173 . . . . 0.0 110.254 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.441 ' N ' ' CD ' ' A' ' 18' ' ' GLU . 5.9 mp0 -109.49 -54.01 2.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.84 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.503 ' HA ' ' HB2' ' A' ' 5' ' ' SER . 2.1 m-20 59.04 18.38 6.28 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.5 -0.75 . . . . 0.0 110.232 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.563 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 0.2 OUTLIER -163.27 149.13 11.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 110.618 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.6 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 9.0 m-85 -163.98 174.75 11.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.509 -0.744 . . . . 0.0 109.649 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.501 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 22.6 p -136.03 -69.83 0.48 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.779 -1.201 . . . . 0.0 111.099 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -161.49 145.4 12.88 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.514 -0.742 . . . . 0.0 109.384 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.17 12.31 57.59 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.38 -1.888 . . . . 0.0 108.38 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.6 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -82.63 174.3 11.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.507 -0.996 . . . . 0.0 109.816 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.719 HG13 ' O ' ' A' ' 43' ' ' VAL . 28.2 t -153.85 156.65 5.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.856 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.682 ' O ' HG23 ' A' ' 43' ' ' VAL . 4.0 t -137.16 114.22 12.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 C-N-CA 119.631 -0.827 . . . . 0.0 111.546 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.881 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -70.45 102.76 2.27 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 118.543 -1.263 . . . . 0.0 108.015 178.366 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.639 ' O ' HD13 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -68.22 97.49 0.72 Allowed 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.205 -0.998 . . . . 0.0 109.592 -178.589 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.493 ' OG ' ' O ' ' A' ' 14' ' ' HIS . 0.1 OUTLIER -70.08 139.43 52.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.78 -1.2 . . . . 0.0 109.8 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 56' ' ' CYS . 12.4 m -108.27 153.11 23.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.372 -0.83 . . . . 0.0 109.679 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 31' ' ' CYS . 0.7 OUTLIER -44.05 140.92 1.87 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.163 -0.961 . . . . 0.0 109.841 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 83.2 p -52.42 98.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 110.084 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 134.33 -1.74 4.13 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' A' ' 56' ' ' CYS . 0.6 OUTLIER -106.15 161.03 14.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.067 -1.255 . . . . 0.0 110.421 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.98 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.7 OUTLIER -102.58 129.99 49.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.359 -0.838 . . . . 0.0 110.963 -179.405 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.809 HD21 ' HA ' ' A' ' 41' ' ' SER . 4.6 tp -89.05 120.67 30.67 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.329 -0.857 . . . . 0.0 109.294 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.789 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -118.37 141.74 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.138 -0.976 . . . . 0.0 109.881 -179.501 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.506 ' O ' ' CB ' ' A' ' 40' ' ' ASN . . . 101.58 44.22 2.0 Favored Glycine 0 N--CA 1.488 2.154 0 C-N-CA 119.393 -1.384 . . . . 0.0 109.687 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 5.8 t-20 72.11 169.45 0.32 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.491 -1.005 . . . . 0.0 109.775 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.881 ' O ' HG23 ' A' ' 28' ' ' THR . 0.8 OUTLIER -112.36 63.15 0.63 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 110.457 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.541 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 160.12 113.89 0.34 Allowed Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.635 -1.269 . . . . 0.0 110.306 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.719 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.1 t -60.84 -179.06 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.05 -1.265 . . . . 0.0 108.066 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.458 ' HA ' ' O ' ' A' ' 25' ' ' SER . 0.8 OUTLIER -143.78 102.55 3.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.994 -1.066 . . . . 0.0 110.533 178.904 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.591 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.6 OUTLIER -85.48 113.84 22.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.317 -0.864 . . . . 0.0 109.276 178.654 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 87.7 p -129.64 137.52 50.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 0.0 110.531 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.01 9.12 45.93 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.593 ' HA3' HG23 ' A' ' 1' ' ' VAL . . . 93.36 29.08 10.54 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -146.08 135.18 22.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.366 -1.079 . . . . 0.0 110.097 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.591 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 89.1 m95 -80.71 138.36 36.34 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.217 -0.927 . . . . 0.0 109.909 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -141.81 165.46 27.4 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.119 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.529 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 1.3 t70 43.11 64.87 5.99 Favored Pre-proline 0 N--CA 1.491 1.614 0 CA-C-O 121.141 0.496 . . . . 0.0 111.819 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 47.0 Cg_endo -91.8 125.56 0.86 Allowed 'Trans proline' 0 C--N 1.3 -1.996 0 O-C-N 124.341 1.706 . . . . 0.0 109.261 178.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.517 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 45.1 Cg_endo -70.79 -178.44 2.74 Favored 'Trans proline' 0 C--N 1.297 -2.15 0 O-C-N 123.808 1.425 . . . . 0.0 110.759 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.571 ' N ' ' O ' ' A' ' 38' ' ' ILE . 6.0 p -119.82 -169.09 1.71 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.851 0.834 . . . . 0.0 111.255 -178.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 10' ' ' SER . 96.4 m -151.92 86.65 1.32 Allowed 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -111.11 -139.5 0.38 Allowed 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.055 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.781 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -142.82 74.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 179.391 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.98 HG13 ' CB ' ' A' ' 36' ' ' SER . 4.6 m -68.72 126.49 28.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 122.55 1.167 . . . . 0.0 110.679 -177.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 107' ' ' ASN . 24.6 mtpt -147.22 93.67 2.28 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.499 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 27.4 m -69.1 162.78 62.84 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.513 -0.742 . . . . 0.0 111.732 -177.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 46.1 Cg_endo -72.82 -90.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.612 1.848 . . . . 0.0 110.615 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.458 ' HB3' ' CG2' ' A' ' 65' ' ' THR . 0.0 OUTLIER -164.98 129.34 1.81 Allowed Pre-proline 0 C--N 1.302 -1.462 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.615 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 54.7 Cg_endo -77.33 65.68 7.94 Favored 'Trans proline' 0 C--N 1.298 -2.114 0 O-C-N 123.608 1.32 . . . . 0.0 109.617 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.724 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.8 OUTLIER -83.95 178.81 7.72 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.266 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.786 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -175.02 158.39 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.077 179.388 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.501 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 0.7 OUTLIER -64.35 101.82 0.47 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.496 -0.753 . . . . 0.0 110.5 -179.57 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.463 ' O ' ' SG ' ' A' ' 116' ' ' CYS . 45.0 m-20 39.66 50.74 2.26 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.438 -0.789 . . . . 0.0 110.607 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.786 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -158.54 32.07 0.48 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.562 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 4.9 p90 -45.17 -172.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.798 1.285 . . . . 0.0 112.684 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.706 HD13 ' H ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -109.96 167.91 9.82 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.601 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.46 ' O ' ' OG ' ' A' ' 72' ' ' SER . 0.3 OUTLIER -144.97 24.91 1.45 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.044 -1.035 . . . . 0.0 110.155 -179.611 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.3 t -104.24 -89.02 0.41 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.032 -1.042 . . . . 0.0 110.824 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -118.92 72.86 0.31 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 2.9 t80 -98.2 164.82 12.16 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.446 -1.032 . . . . 0.0 110.19 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.63 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 2.4 tttp -168.93 159.13 9.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.367 -0.833 . . . . 0.0 109.95 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -52.6 -27.79 18.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.128 -0.983 . . . . 0.0 109.981 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.462 ' C ' ' CG ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -141.31 173.87 11.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.366 -0.834 . . . . 0.0 110.556 -179.723 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.575 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 43.3 m-85 -148.82 -168.15 3.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.519 -0.738 . . . . 0.0 109.486 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.608 ' CA ' HG23 ' A' ' 59' ' ' VAL . 88.1 p -141.47 -102.12 0.14 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.741 -1.225 . . . . 0.0 111.355 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.686 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -119.27 19.36 12.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.608 -1.307 . . . . 0.0 111.24 -178.696 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.791 ' O ' HG22 ' A' ' 102' ' ' THR . 29.0 t-20 -159.86 -101.59 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.875 -1.14 . . . . 0.0 110.118 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 82' ' ' ASN . 2.9 m-20 44.94 72.79 0.18 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.87 -1.144 . . . . 0.0 109.277 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.887 ' CA ' HG23 ' A' ' 102' ' ' THR . 8.7 p30 -68.74 113.91 6.63 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.386 -0.821 . . . . 0.0 110.172 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.529 ' N ' ' O ' ' A' ' 101' ' ' SER . 33.1 m -99.28 121.88 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.249 -0.907 . . . . 0.0 111.073 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.522 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 28.8 t70 -83.27 134.6 34.93 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.645 ' CE1' HD12 ' A' ' 71' ' ' LEU . 29.3 m-85 -91.46 132.82 35.98 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.825 -1.172 . . . . 0.0 112.046 -178.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.2 OUTLIER -111.2 92.0 3.87 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.181 -179.39 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.477 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -44.49 128.37 6.37 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.043 -1.036 . . . . 0.0 109.907 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 2.4 mmmp? -41.19 -85.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.32 -0.862 . . . . 0.0 110.375 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.581 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -159.09 142.2 14.52 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.273 -0.892 . . . . 0.0 110.418 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.594 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 54.7 54.94 29.95 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.594 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 18.2 m-85 -160.27 167.41 27.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.469 -1.018 . . . . 0.0 109.729 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.481 ' N ' ' O ' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -132.22 114.37 14.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.24 -0.913 . . . . 0.0 109.911 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.753 HD23 HD11 ' A' ' 66' ' ' ILE . 10.2 mt -46.39 107.49 0.11 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.11 -0.994 . . . . 0.0 110.479 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.705 ' HB2' HG21 ' A' ' 117' ' ' VAL . 1.2 t -90.1 97.04 10.96 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.432 -0.792 . . . . 0.0 109.685 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.62 -40.33 1.38 Allowed Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.404 -1.379 . . . . 0.0 110.546 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.581 ' O ' ' HB3' ' A' ' 114' ' ' PRO . 0.0 OUTLIER 177.58 -164.45 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.889 -1.359 . . . . 0.0 111.524 -179.191 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.529 ' N ' ' OG ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -149.21 -53.42 0.17 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.713 -0.617 . . . . 0.0 110.2 -179.833 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 91.1 p -110.48 105.51 14.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.23 -0.919 . . . . 0.0 110.644 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.529 ' O ' ' N ' ' A' ' 85' ' ' VAL . 50.6 m -113.73 164.27 13.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.329 -0.857 . . . . 0.0 110.118 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.887 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -133.39 143.39 48.9 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.345 -0.847 . . . . 0.0 110.885 -179.687 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.628 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -72.95 98.27 2.45 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.33 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.565 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -67.98 176.27 1.41 Allowed Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.182 -0.949 . . . . 0.0 112.333 -178.52 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.789 ' CB ' HD12 ' A' ' 38' ' ' ILE . 41.0 Cg_endo -70.03 -33.36 15.72 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 124.689 1.889 . . . . 0.0 111.728 -177.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.56 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -75.5 4.64 41.42 Favored Glycine 0 N--CA 1.486 2.001 0 C-N-CA 119.267 -1.444 . . . . 0.0 110.799 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.719 ' O ' HG23 ' A' ' 108' ' ' THR . 0.9 OUTLIER 78.13 89.4 0.07 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.445 -1.033 . . . . 0.0 110.929 179.245 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.719 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -178.45 -161.7 0.05 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.857 . . . . 0.0 110.906 179.354 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.727 ' HB3' HD13 ' A' ' 113' ' ' LEU . 22.7 m95 -142.71 97.94 3.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 111.305 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.525 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 2.5 mtpp -106.75 145.83 31.85 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.411 -0.806 . . . . 0.0 109.512 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.536 ' HG2' ' HB2' ' A' ' 98' ' ' SER . 47.3 Cg_endo -72.91 178.62 31.27 Favored 'Cis proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.088 -2.047 . . . . 0.0 111.089 -0.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.447 ' O ' ' C ' ' A' ' 113' ' ' LEU . 5.3 tt0 -40.74 121.16 1.42 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.606 -0.684 . . . . 0.0 110.352 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.727 HD13 ' HB3' ' A' ' 109' ' ' TRP . 0.6 OUTLIER -40.91 138.56 1.31 Allowed Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.416 -0.802 . . . . 0.0 110.001 179.701 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.731 ' HG2' HD12 ' A' ' 66' ' ' ILE . 42.8 Cg_endo -75.04 160.69 39.75 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 O-C-N 124.176 1.619 . . . . 0.0 111.758 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.75 ' HG2' HG13 ' A' ' 117' ' ' VAL . 5.6 ttpp -125.67 99.89 6.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.469 -0.769 . . . . 0.0 110.813 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.546 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.8 t -53.29 100.88 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.93 . . . . 0.0 109.468 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.75 HG13 ' HG2' ' A' ' 115' ' ' LYS . 2.0 m -118.92 179.18 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.664 0.745 . . . . 0.0 110.624 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.5 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.293 -1.858 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.371 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 53.8 t . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.213 0.53 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -81.13 170.32 16.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.256 -0.902 . . . . 0.0 110.319 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 21' ' ' TYR . 1.2 m -125.39 90.58 3.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 109.713 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.517 ' HA ' ' O ' ' A' ' 19' ' ' ASP . 37.6 tt0 -72.88 173.58 8.99 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.021 -1.049 . . . . 0.0 109.895 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.513 ' N ' ' CG ' ' A' ' 4' ' ' GLN . 0.7 OUTLIER -44.09 134.76 4.12 Favored Pre-proline 0 C--N 1.297 -1.706 0 O-C-N 121.501 -0.749 . . . . 0.0 109.642 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.647 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 51.6 Cg_endo -71.36 150.5 58.59 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.939 1.494 . . . . 0.0 110.525 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.34 172.23 15.36 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 O-C-N 124.007 1.53 . . . . 0.0 109.932 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.53 177.71 2.81 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.248 -0.907 . . . . 0.0 109.509 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.682 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -139.09 -170.41 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 122.172 0.987 . . . . 0.0 111.297 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 5.5 t -47.37 98.25 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.616 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.2 m120 44.35 47.85 8.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 0.0 110.415 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.467 ' O ' HG13 ' A' ' 9' ' ' ILE . . . -159.6 156.64 27.81 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.42 -169.71 1.51 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.117 -1.225 . . . . 0.0 111.071 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.657 ' HB2' HG11 ' A' ' 27' ' ' VAL . 13.8 p80 -137.85 126.0 22.97 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.353 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.669 ' O ' HG13 ' A' ' 27' ' ' VAL . 2.1 t30 -100.37 -175.33 2.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.308 -0.87 . . . . 0.0 110.263 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.485 ' HA3' ' OH ' ' A' ' 21' ' ' TYR . . . 154.22 -36.6 0.7 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.472 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER 67.44 35.88 4.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.395 -1.061 . . . . 0.0 110.482 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.595 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -142.48 -159.61 0.99 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.292 -0.88 . . . . 0.0 109.817 179.599 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.517 ' O ' ' HA ' ' A' ' 4' ' ' GLN . 1.5 m-20 -147.47 -35.2 0.24 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.171 -0.956 . . . . 0.0 110.59 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -121.03 79.05 1.46 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.191 -0.943 . . . . 0.0 110.14 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.603 ' CE2' ' CG2' ' A' ' 27' ' ' VAL . 0.9 OUTLIER -57.57 -24.7 57.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.07 -1.019 . . . . 0.0 110.339 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.448 ' C ' ' HB2' ' A' ' 3' ' ' CYS . 0.2 OUTLIER 66.43 -79.08 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.464 -0.772 . . . . 0.0 112.32 178.561 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.529 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER -168.3 160.84 11.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.891 -1.13 . . . . 0.0 109.865 -178.938 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 59.39 17.07 38.09 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.506 ' CB ' ' CD1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -92.89 160.11 15.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.566 -0.961 . . . . 0.0 109.725 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.674 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 57.4 t -133.75 150.23 31.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 118.977 -1.089 . . . . 0.0 110.907 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.861 ' O ' HG23 ' A' ' 43' ' ' VAL . 45.6 t -138.13 112.02 8.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.46 -0.775 . . . . 0.0 110.977 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -69.99 104.14 2.46 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.035 -1.466 . . . . 0.0 107.653 178.211 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 1.122 ' CE1' HG21 ' A' ' 43' ' ' VAL . 1.9 m-30 -67.62 130.67 43.75 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.956 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.71 152.64 23.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.122 -0.986 . . . . 0.0 109.906 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 1.024 ' SG ' HD12 ' A' ' 37' ' ' LEU . 98.1 m -129.71 143.81 50.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.154 -0.966 . . . . 0.0 110.354 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -55.17 127.95 31.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.267 -0.896 . . . . 0.0 110.285 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 71.1 p -44.88 139.73 2.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.298 -0.876 . . . . 0.0 110.332 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.5 -21.81 37.91 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.614 ' CE2' HG23 ' A' ' 58' ' ' ILE . 8.4 m-85 -108.94 141.22 41.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.12 -1.223 . . . . 0.0 110.3 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.792 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -79.03 136.36 37.16 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.349 -0.844 . . . . 0.0 110.995 -179.634 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 1.024 HD12 ' SG ' ' A' ' 31' ' ' CYS . 3.8 tt -92.54 94.23 8.95 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.833 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.9 OUTLIER -76.68 145.16 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.43 -0.793 . . . . 0.0 109.207 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 126.94 -160.26 21.2 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.514 ' O ' ' C ' ' A' ' 41' ' ' SER . 4.2 m-20 -115.8 52.01 0.92 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.113 -1.228 . . . . 0.0 109.798 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.675 ' O ' HG23 ' A' ' 28' ' ' THR . 18.3 p 24.88 67.78 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.715 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.87 116.08 0.42 Allowed Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.383 -1.389 . . . . 0.0 110.609 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.122 HG21 ' CE1' ' A' ' 29' ' ' TYR . 1.4 t -84.72 126.88 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.7 tp -97.29 106.88 19.29 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 120.201 -1.562 . . . . 0.0 111.423 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.602 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.8 OUTLIER -87.56 114.72 24.43 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.449 -0.901 . . . . 0.0 108.92 178.034 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.515 ' HA ' ' OD2' ' A' ' 23' ' ' ASP . 0.3 OUTLIER -132.43 128.67 38.0 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.404 -179.686 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.529 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 80.02 -5.48 62.38 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.449 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 109.79 6.76 28.24 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -126.54 116.49 21.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -1.18 . . . . 0.0 110.517 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.602 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 82.7 m95 -64.85 141.42 58.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.224 -0.922 . . . . 0.0 109.542 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 52' ' ' ASP . 2.4 t -140.98 -177.77 5.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.015 -1.053 . . . . 0.0 111.105 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.526 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER 36.26 65.4 2.14 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.746 -0.596 . . . . 0.0 111.207 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.526 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.8 Cg_endo -91.58 138.15 2.09 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 124.403 1.738 . . . . 0.0 109.666 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.536 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 51.3 Cg_endo -80.56 175.88 9.68 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.489 1.257 . . . . 0.0 110.321 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.618 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 20.0 p -130.12 138.58 50.75 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.171 -0.956 . . . . 0.0 111.0 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 10' ' ' SER . 14.2 m -97.52 76.48 2.54 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.494 ' HG3' HG12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -119.08 144.83 46.37 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.428 0.632 . . . . 0.0 110.219 -178.751 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.614 HG23 ' CE2' ' A' ' 35' ' ' TYR . 1.7 pt -69.46 120.54 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.792 HG13 ' CB ' ' A' ' 36' ' ' SER . 12.1 m -99.5 51.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.151 -0.968 . . . . 0.0 112.094 -178.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.425 ' HD3' HD12 ' A' ' 58' ' ' ILE . 3.0 mtpp -87.61 99.35 11.99 Favored 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 118.626 -1.229 . . . . 0.0 108.434 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.477 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 59.6 m -69.25 162.62 64.62 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.397 -0.814 . . . . 0.0 111.502 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 47.9 Cg_endo -72.0 -91.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.464 1.771 . . . . 0.0 110.587 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.469 ' HB3' ' CG2' ' A' ' 65' ' ' THR . 0.1 OUTLIER -158.27 132.27 5.04 Favored Pre-proline 0 C--N 1.302 -1.47 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.707 ' HA ' HD21 ' A' ' 113' ' ' LEU . 55.5 Cg_endo -77.77 67.89 7.83 Favored 'Trans proline' 0 C--N 1.293 -2.344 0 O-C-N 123.757 1.398 . . . . 0.0 109.528 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.657 ' O ' HD23 ' A' ' 113' ' ' LEU . 1.5 p -88.97 174.98 7.61 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.805 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -170.35 159.87 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 118.405 -1.318 . . . . 0.0 110.675 179.182 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.489 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 1.5 m -61.33 95.84 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.644 -0.66 . . . . 0.0 110.395 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.458 ' O ' ' SG ' ' A' ' 116' ' ' CYS . 8.6 m-20 44.57 45.07 7.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.426 -0.796 . . . . 0.0 110.597 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.805 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -151.85 33.4 0.88 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.567 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 3.7 p90 -45.89 -171.39 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 122.743 1.258 . . . . 0.0 112.628 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.798 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -113.85 162.93 15.73 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.194 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.7 t -149.88 28.93 0.75 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.993 -1.067 . . . . 0.0 109.944 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.64 -16.98 7.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 111.235 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -154.08 -87.86 0.06 OUTLIER Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.169 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.616 ' CD2' ' N ' ' A' ' 76' ' ' LYS . 58.5 t80 58.6 170.24 0.06 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.626 -0.926 . . . . 0.0 110.577 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.616 ' N ' ' CD2' ' A' ' 75' ' ' PHE . 4.1 tptt 174.83 134.3 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.403 -0.811 . . . . 0.0 109.842 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 76' ' ' LYS . 2.3 mtt-85 -40.1 -45.16 1.93 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.262 -0.899 . . . . 0.0 110.4 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.457 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 3.6 t -132.86 125.42 29.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.438 -0.789 . . . . 0.0 110.198 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.599 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 14.9 m-85 -101.49 -173.98 2.49 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.146 -0.971 . . . . 0.0 110.506 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -170.41 106.9 0.31 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.148 -0.97 . . . . 0.0 110.971 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.773 ' CB ' HG21 ' A' ' 59' ' ' VAL . 5.1 t80 35.04 32.51 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.107 -0.996 . . . . 0.0 112.118 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.567 ' N ' ' O ' ' A' ' 103' ' ' CYS . 15.5 t30 -177.37 -140.25 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.221 -1.549 . . . . 0.0 111.149 178.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.41 ' C ' HG23 ' A' ' 102' ' ' THR . 1.6 m-20 56.3 73.19 0.45 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.114 -0.991 . . . . 0.0 108.948 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.542 ' N ' HG23 ' A' ' 102' ' ' THR . 7.0 t30 -69.57 112.53 6.13 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.458 -0.776 . . . . 0.0 110.31 -179.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.606 ' O ' HG23 ' A' ' 85' ' ' VAL . 23.1 m -95.03 120.55 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 111.053 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 4.4 t0 -80.77 131.23 35.4 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.798 ' CE1' HD12 ' A' ' 71' ' ' LEU . 46.4 m-85 -91.14 136.9 32.77 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.881 -1.137 . . . . 0.0 111.945 -178.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -115.65 102.5 9.81 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.964 -179.587 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.517 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -49.44 131.31 20.66 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.098 -1.001 . . . . 0.0 110.081 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -39.96 -69.19 0.14 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.477 -0.764 . . . . 0.0 110.347 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.585 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 39.3 t80 -172.86 141.6 1.04 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -0.817 . . . . 0.0 110.21 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 50.99 56.92 12.14 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.585 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 13.2 m-85 -155.29 172.24 18.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.341 -1.093 . . . . 0.0 110.23 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 117' ' ' VAL . 0.7 OUTLIER -133.01 106.98 7.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.294 -0.879 . . . . 0.0 109.86 179.735 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.578 ' CD2' ' HB3' ' A' ' 87' ' ' PHE . 1.1 mt -46.83 99.38 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.194 -0.941 . . . . 0.0 110.675 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.453 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -78.99 101.4 7.76 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.358 -0.839 . . . . 0.0 109.441 179.226 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.86 -89.2 0.19 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.594 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.4 OUTLIER -154.35 116.94 4.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -1.173 . . . . 0.0 110.612 -179.404 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.536 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 2.0 m -83.42 29.83 0.49 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.308 -0.87 . . . . 0.0 110.832 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 65.4 p -170.5 102.56 0.26 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.16 -0.962 . . . . 0.0 109.531 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 85' ' ' VAL . 9.2 m -125.37 172.63 9.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.181 -0.949 . . . . 0.0 111.092 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.542 HG23 ' N ' ' A' ' 84' ' ' ASN . 19.9 m -143.52 142.47 31.14 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.458 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.567 ' O ' ' N ' ' A' ' 82' ' ' ASN . 6.8 t -54.57 100.51 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.399 -0.813 . . . . 0.0 109.124 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.45 ' OG ' ' HE3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -72.99 173.0 6.58 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 120.783 -1.198 . . . . 0.0 111.462 -178.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.833 ' CB ' HD12 ' A' ' 38' ' ' ILE . 47.2 Cg_endo -80.08 25.65 0.6 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.559 1.821 . . . . 0.0 112.451 -178.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -126.57 16.94 6.54 Favored Glycine 0 N--CA 1.484 1.851 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.595 ' O ' HG23 ' A' ' 108' ' ' THR . 0.9 OUTLIER 68.86 51.98 0.55 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.628 -0.925 . . . . 0.0 109.969 -179.86 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.595 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -160.78 -169.5 2.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.906 . . . . 0.0 111.109 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.688 ' HB3' HD13 ' A' ' 113' ' ' LEU . 36.4 m95 -117.48 99.95 7.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.382 -0.823 . . . . 0.0 110.336 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.52 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 2.8 mtmt -105.56 140.19 20.93 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.537 -0.727 . . . . 0.0 110.071 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.594 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 47.3 Cg_endo -73.54 171.71 64.79 Favored 'Cis proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.809 -2.163 . . . . 0.0 110.434 -0.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.0 OUTLIER -40.8 128.53 2.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.372 -0.83 . . . . 0.0 111.074 -179.419 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.707 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -41.46 147.58 0.47 Allowed Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.511 -0.743 . . . . 0.0 110.541 179.461 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.681 ' HG2' HD12 ' A' ' 66' ' ' ILE . 41.4 Cg_endo -75.53 169.91 21.36 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.342 1.707 . . . . 0.0 111.05 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.832 ' HG2' HG13 ' A' ' 117' ' ' VAL . 30.7 ttmt -128.79 110.62 12.32 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.24 -0.912 . . . . 0.0 110.503 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.554 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 3.2 t -65.95 93.55 0.2 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.012 -1.055 . . . . 0.0 109.351 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.832 HG13 ' HG2' ' A' ' 115' ' ' LYS . 2.3 m -113.21 -174.54 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 121.859 0.838 . . . . 0.0 111.176 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.529 ' HG2' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.792 0 CA-C-O 117.951 -1.024 . . . . 0.0 110.348 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.536 HG22 ' N ' ' A' ' 2' ' ' LYS . 7.0 p . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.248 0.547 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.536 ' N ' HG22 ' A' ' 1' ' ' VAL . 10.5 ptmt -159.84 -177.74 6.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 110.385 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.535 ' O ' ' HB2' ' A' ' 21' ' ' TYR . 1.1 m -133.54 81.16 1.91 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.606 -0.684 . . . . 0.0 109.818 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.631 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 58.4 mt-30 -63.46 178.57 0.54 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.827 -1.171 . . . . 0.0 110.456 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.8 p -46.35 143.83 3.58 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.45 -0.782 . . . . 0.0 109.896 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.889 ' HG3' HG11 ' A' ' 27' ' ' VAL . 48.7 Cg_endo -73.97 151.63 45.25 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.076 1.566 . . . . 0.0 111.204 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.61 171.31 18.03 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.789 1.415 . . . . 0.0 109.956 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.2 p -69.65 175.86 3.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.118 -0.989 . . . . 0.0 110.001 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.744 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -142.25 -170.16 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 122.239 1.019 . . . . 0.0 111.296 179.757 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 3.2 t -51.48 99.47 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.852 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 10' ' ' SER . 1.3 m120 41.66 57.58 3.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.236 -0.915 . . . . 0.0 110.656 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -163.82 148.72 15.25 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.455 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -98.12 -176.85 3.54 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.298 -1.119 . . . . 0.0 110.12 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.623 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 23.8 p80 -143.92 138.65 28.69 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.697 -0.627 . . . . 0.0 109.814 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -166.93 -141.13 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.102 -0.999 . . . . 0.0 110.432 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.72 36.93 1.21 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 53.44 47.21 24.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.394 -1.063 . . . . 0.0 110.235 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.639 ' CB ' ' CE2' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -110.44 -159.74 0.69 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.248 -0.908 . . . . 0.0 109.913 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.421 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 0.4 OUTLIER 174.73 -28.05 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.342 -0.849 . . . . 0.0 110.458 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.631 ' HA ' ' HA ' ' A' ' 4' ' ' GLN . 3.2 p90 -165.45 55.01 0.11 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.143 -0.973 . . . . 0.0 110.722 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.639 ' CE2' ' CB ' ' A' ' 18' ' ' GLU . 19.5 m-85 -43.51 159.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.148 -0.97 . . . . 0.0 110.255 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.471 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -125.35 -59.98 1.36 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.933 -1.104 . . . . 0.0 110.58 -179.218 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.444 ' OD1' ' HA ' ' A' ' 46' ' ' SER . 3.6 t0 -166.37 140.62 4.26 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.472 -0.768 . . . . 0.0 109.618 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 74.36 17.27 79.71 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.584 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 3.1 m -97.54 168.04 10.61 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.474 -1.015 . . . . 0.0 109.936 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.702 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 74.5 t -137.27 158.43 35.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.032 -1.067 . . . . 0.0 111.1 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.896 ' O ' HG23 ' A' ' 43' ' ' VAL . 39.0 t -143.67 107.61 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.426 -0.796 . . . . 0.0 110.957 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.81 105.65 2.41 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 117.974 -1.491 . . . . 0.0 107.722 178.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 1.06 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.0 m-30 -67.78 119.53 12.63 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.613 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -69.64 152.0 45.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.169 -0.957 . . . . 0.0 109.958 -179.86 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.511 ' SG ' HD12 ' A' ' 37' ' ' LEU . 78.6 m -121.81 163.92 18.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 110.424 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 33' ' ' SER . 3.3 m-20 -58.79 138.99 56.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.308 -0.87 . . . . 0.0 110.059 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 32' ' ' ASN . 1.5 m -43.2 104.9 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 110.22 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.51 -32.63 5.14 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -72.66 130.29 40.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.288 -1.125 . . . . 0.0 110.423 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.601 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -78.55 149.39 33.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.328 -0.858 . . . . 0.0 110.897 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.588 ' C ' HD13 ' A' ' 38' ' ' ILE . 2.5 tp -95.09 113.45 25.14 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.414 -0.804 . . . . 0.0 108.858 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.629 ' N ' HD13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -108.7 150.5 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.921 . . . . 0.0 109.298 -179.653 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 125.61 -139.41 11.51 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.35 -1.405 . . . . 0.0 109.697 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.504 ' O ' ' C ' ' A' ' 41' ' ' SER . 0.6 OUTLIER -110.0 51.43 0.76 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.196 -1.179 . . . . 0.0 109.989 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.513 ' HA ' HD21 ' A' ' 37' ' ' LEU . 13.5 p 22.68 50.64 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.345 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.465 ' HA3' ' CG1' ' A' ' 26' ' ' VAL . . . 152.37 131.58 1.71 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.331 -1.414 . . . . 0.0 110.408 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.06 HG21 ' CE1' ' A' ' 29' ' ' TYR . 1.2 t -81.67 121.38 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 178.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.491 ' HA ' ' O ' ' A' ' 25' ' ' SER . 11.6 tp -95.13 103.48 15.33 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 120.277 -1.514 . . . . 0.0 111.385 -178.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.607 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.7 OUTLIER -80.99 121.43 26.04 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.061 178.491 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.444 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 4.7 m -135.14 123.95 23.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.438 -0.789 . . . . 0.0 110.863 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.4 16.08 80.06 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.462 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 87.03 25.9 32.96 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -141.33 103.43 4.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.169 -1.195 . . . . 0.0 110.318 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.607 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 77.9 m95 -56.25 137.31 52.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.913 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 52' ' ' ASP . 10.1 m -140.73 179.45 6.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.93 . . . . 0.0 111.009 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.516 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER 39.25 65.36 3.44 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.666 -0.646 . . . . 0.0 111.177 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.516 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 46.3 Cg_endo -90.14 127.64 1.48 Allowed 'Trans proline' 0 C--N 1.298 -2.122 0 O-C-N 124.356 1.714 . . . . 0.0 109.689 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.527 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 50.8 Cg_endo -76.62 176.78 9.66 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 O-C-N 123.821 1.432 . . . . 0.0 110.746 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.529 ' OG1' ' CG1' ' A' ' 38' ' ' ILE . 9.6 p -119.98 153.37 36.08 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.476 -0.765 . . . . 0.0 111.125 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 10' ' ' SER . 94.6 m -114.11 78.84 1.18 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -115.09 -178.24 3.32 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.3 0.572 . . . . 0.0 110.366 -178.511 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.596 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -95.6 130.1 44.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.305 -0.872 . . . . 0.0 109.299 179.844 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.601 ' CG1' ' CB ' ' A' ' 36' ' ' SER . 23.4 m -117.3 49.91 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 110.787 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 1.1 mttm -64.83 -163.27 0.02 OUTLIER 'General case' 0 C--N 1.281 -2.393 0 C-N-CA 118.797 -1.161 . . . . 0.0 109.167 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.497 ' SG ' ' HD2' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -151.0 154.56 34.36 Favored Pre-proline 0 C--N 1.291 -1.94 0 C-N-CA 119.167 -1.013 . . . . 0.0 112.179 -179.219 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.561 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 43.2 Cg_endo -81.03 -59.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.54 1.81 . . . . 0.0 108.539 177.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.561 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.2 OUTLIER 157.45 127.2 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.588 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.861 ' HG2' HD21 ' A' ' 71' ' ' LEU . 55.7 Cg_endo -79.91 67.14 8.7 Favored 'Trans proline' 0 C--N 1.296 -2.213 0 O-C-N 123.767 1.404 . . . . 0.0 109.771 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.718 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -92.96 177.04 6.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.334 -0.854 . . . . 0.0 109.363 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.876 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -174.82 162.87 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 119.155 -1.018 . . . . 0.0 110.303 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 68' ' ' ASN . 3.0 t -67.32 108.08 2.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.514 -0.741 . . . . 0.0 111.054 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 31.2 m-80 38.69 34.93 0.09 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.593 -0.692 . . . . 0.0 110.853 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.876 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -145.92 35.98 1.35 Allowed Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.359 -1.4 . . . . 0.0 110.001 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.671 ' HA ' HG23 ' A' ' 66' ' ' ILE . 5.1 p90 -48.28 -163.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 123.169 1.461 . . . . 0.0 112.287 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.032 HD11 ' HB2' ' A' ' 75' ' ' PHE . 1.9 pp -117.66 124.6 48.95 Favored 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 114.341 -1.3 . . . . 0.0 110.11 -178.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.512 ' HB3' ' HB2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -92.61 9.99 32.36 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.479 -0.763 . . . . 0.0 109.534 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.28 -71.73 0.43 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.382 -0.824 . . . . 0.0 110.652 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -172.55 98.5 0.13 Allowed Glycine 0 N--CA 1.489 2.197 0 C-N-CA 119.781 -1.2 . . . . 0.0 110.121 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 1.032 ' HB2' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -98.78 174.9 6.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.427 -1.043 . . . . 0.0 109.576 179.529 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.561 ' N ' ' CG ' ' A' ' 75' ' ' PHE . 3.3 ttmt -166.54 168.39 14.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.339 -0.85 . . . . 0.0 109.873 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.55 -31.03 61.8 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.754 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.462 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 0.5 OUTLIER -155.26 163.3 40.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.14 -0.975 . . . . 0.0 110.447 -179.868 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.608 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 10.2 m-85 -133.83 -164.97 1.57 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.262 -0.899 . . . . 0.0 110.401 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.553 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 40.9 p -143.22 -149.25 0.26 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.394 -0.817 . . . . 0.0 109.383 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.596 ' CB ' HG21 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -70.67 144.74 50.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.632 -1.293 . . . . 0.0 108.508 179.052 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.759 ' C ' HG22 ' A' ' 102' ' ' THR . 34.8 t-20 65.45 -111.85 0.23 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.328 -0.857 . . . . 0.0 110.704 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 1.0 OUTLIER 46.43 84.42 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.617 -1.302 . . . . 0.0 108.207 -178.31 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 7.9 p30 -85.5 135.01 34.01 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.464 -0.772 . . . . 0.0 112.143 -177.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.738 ' HB ' HD22 ' A' ' 71' ' ' LEU . 6.3 m -119.94 118.95 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.312 -0.867 . . . . 0.0 109.435 177.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 20.0 t0 -73.61 134.56 43.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.092 -1.005 . . . . 0.0 109.16 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.684 ' CD1' HG21 ' A' ' 66' ' ' ILE . 28.2 m-85 -94.25 129.35 40.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.071 -1.018 . . . . 0.0 111.144 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.571 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -106.67 96.11 6.21 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.806 -179.124 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.435 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -47.56 133.63 13.03 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.904 -1.122 . . . . 0.0 109.217 179.199 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -40.43 -85.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.272 -0.892 . . . . 0.0 110.269 -179.596 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.472 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 1.0 OUTLIER -163.65 135.01 4.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.458 -0.776 . . . . 0.0 109.922 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.72 48.94 62.58 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.081 -1.607 . . . . 0.0 109.081 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.536 ' CB ' ' SG ' ' A' ' 116' ' ' CYS . 36.2 m-85 -153.04 170.01 21.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.442 -1.034 . . . . 0.0 110.131 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.537 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 1.0 OUTLIER -131.17 107.46 9.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.271 -0.893 . . . . 0.0 109.656 179.432 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.776 HD22 ' HB2' ' A' ' 114' ' ' PRO . 43.0 mt -46.87 102.76 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.187 -0.945 . . . . 0.0 110.623 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.473 ' HB2' HG21 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -81.15 98.13 7.91 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.39 -0.819 . . . . 0.0 109.29 179.067 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.87 -86.3 0.17 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.585 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -160.4 124.51 3.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.157 -1.202 . . . . 0.0 110.734 -179.489 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.46 ' OG ' ' N ' ' A' ' 100' ' ' SER . 13.3 p -70.03 -55.99 8.11 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.101 -0.999 . . . . 0.0 110.574 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.46 ' N ' ' OG ' ' A' ' 99' ' ' SER . 54.7 p -94.75 121.5 36.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.286 -0.884 . . . . 0.0 110.127 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 29.6 m -121.42 -174.64 2.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.892 . . . . 0.0 110.119 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.759 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -157.28 128.5 6.79 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.324 -0.86 . . . . 0.0 110.735 179.658 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.555 ' N ' ' O ' ' A' ' 82' ' ' ASN . 46.9 t -65.52 91.93 0.13 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.746 -0.596 . . . . 0.0 109.613 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.465 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -71.58 -179.89 0.84 Allowed Pre-proline 0 C--N 1.298 -1.644 0 O-C-N 121.403 -0.811 . . . . 0.0 110.863 -179.339 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.597 ' HG3' HG23 ' A' ' 38' ' ' ILE . 42.7 Cg_endo -80.55 121.61 4.27 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 O-C-N 124.467 1.772 . . . . 0.0 110.424 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.577 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 132.21 -3.6 5.19 Favored Glycine 0 N--CA 1.481 1.638 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.853 ' O ' HG23 ' A' ' 108' ' ' THR . 1.0 OUTLIER 80.71 88.08 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.777 -0.837 . . . . 0.0 111.264 179.431 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.853 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 176.66 -164.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 111.523 179.15 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.661 ' HB3' HD13 ' A' ' 113' ' ' LEU . 28.6 m95 -139.68 90.02 2.37 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.412 0.625 . . . . 0.0 110.13 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.544 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 1.5 mmtp -99.3 141.25 22.51 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.408 -0.808 . . . . 0.0 110.15 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.585 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.0 Cg_endo -72.0 173.33 52.56 Favored 'Cis proline' 0 C--N 1.312 -1.348 0 C-N-CA 122.034 -2.069 . . . . 0.0 110.811 -0.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 111' ' ' PRO . 10.2 pt-20 -40.81 137.83 1.13 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.398 -0.814 . . . . 0.0 110.801 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.7 HD23 ' O ' ' A' ' 65' ' ' THR . 0.3 OUTLIER -53.09 144.55 27.75 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.416 -0.802 . . . . 0.0 110.342 179.639 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.776 ' HB2' HD22 ' A' ' 95' ' ' LEU . 43.4 Cg_endo -72.22 163.62 38.13 Favored 'Trans proline' 0 C--N 1.302 -1.885 0 O-C-N 124.224 1.644 . . . . 0.0 111.12 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.55 ' O ' HG22 ' A' ' 117' ' ' VAL . 9.4 tttt -127.84 115.39 18.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.456 -0.778 . . . . 0.0 109.848 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.536 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 0.8 OUTLIER -66.29 100.94 0.67 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.034 -1.041 . . . . 0.0 109.651 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.55 HG22 ' O ' ' A' ' 115' ' ' LYS . 0.7 OUTLIER -118.22 -177.19 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 121.625 0.726 . . . . 0.0 110.931 -179.538 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.7 mtp-105 . . . . . 0 C--N 1.295 -1.797 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.53 179.937 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 1' ' ' VAL . 7.7 p . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 121.24 0.543 . . . . 0.0 110.115 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -135.13 103.89 5.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 110.332 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.612 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 37.3 t -68.98 155.87 39.58 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.669 -0.644 . . . . 0.0 110.486 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.423 ' O ' ' C ' ' A' ' 5' ' ' SER . 69.6 mt-30 -140.08 -177.09 4.84 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.356 -0.84 . . . . 0.0 109.644 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.2 OUTLIER -42.05 133.02 2.51 Favored Pre-proline 0 C--N 1.297 -1.683 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.123 -179.666 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.781 ' HG3' HG11 ' A' ' 27' ' ' VAL . 51.8 Cg_endo -70.14 157.41 59.74 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.12 1.589 . . . . 0.0 111.112 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -75.66 172.23 16.71 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.969 1.51 . . . . 0.0 110.109 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.46 175.26 4.9 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.208 -0.932 . . . . 0.0 109.94 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.65 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -139.58 -170.36 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 122.241 1.02 . . . . 0.0 111.412 179.648 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 11' ' ' ASN . 39.2 m -45.38 97.26 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.484 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 9' ' ' ILE . 2.5 m-20 43.14 47.26 5.26 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.294 -0.879 . . . . 0.0 110.511 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -152.4 155.67 26.26 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.466 ' N ' ' O ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -104.58 -166.42 1.24 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.347 -1.09 . . . . 0.0 110.659 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.583 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 14.6 p80 -151.74 121.79 7.14 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.104 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -119.32 123.11 43.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.202 -0.936 . . . . 0.0 110.33 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.71 -5.44 6.42 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.41 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 0.5 OUTLIER 55.49 55.99 6.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -1.149 . . . . 0.0 110.075 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.555 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 2.6 pp20? -178.59 -162.67 0.06 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.3 -0.875 . . . . 0.0 110.223 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.414 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 1.1 t0 -136.4 -42.62 0.62 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.358 -0.839 . . . . 0.0 109.844 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.431 ' CD1' ' C ' ' A' ' 20' ' ' PHE . 21.2 p90 -111.53 140.65 45.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.332 -0.855 . . . . 0.0 109.844 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.644 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.5 OUTLIER -122.65 -12.06 8.16 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.28 -0.888 . . . . 0.0 110.432 -179.825 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.564 HG22 ' N ' ' A' ' 23' ' ' ASP . 82.8 m 52.61 -99.15 0.08 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.458 -0.776 . . . . 0.0 111.173 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.564 ' N ' HG22 ' A' ' 22' ' ' THR . 0.4 OUTLIER -151.63 157.45 42.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.19 -0.943 . . . . 0.0 109.995 -179.248 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.59 16.0 80.31 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.644 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 30.4 m -99.34 173.99 6.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.434 -1.039 . . . . 0.0 110.316 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.797 HG13 ' O ' ' A' ' 43' ' ' VAL . 28.2 t -151.66 154.75 7.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.318 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.781 HG11 ' HG3' ' A' ' 6' ' ' PRO . 17.4 t -136.52 114.32 14.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 119.349 -0.941 . . . . 0.0 111.459 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -69.29 104.09 2.14 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 118.397 -1.321 . . . . 0.0 107.77 178.12 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.65 ' CE2' HG21 ' A' ' 9' ' ' ILE . 2.1 m-30 -68.09 144.87 54.88 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.431 -0.793 . . . . 0.0 110.287 -178.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -100.08 153.16 19.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.389 -0.819 . . . . 0.0 109.591 179.214 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.567 ' SG ' HD12 ' A' ' 37' ' ' LEU . 57.1 m -125.0 160.46 28.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.149 -0.969 . . . . 0.0 110.515 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -49.55 157.61 0.52 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.445 -0.785 . . . . 0.0 110.102 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.29 99.71 0.74 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.221 -0.924 . . . . 0.0 110.261 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.25 10.44 5.6 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 -107.99 166.35 10.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -1.15 . . . . 0.0 110.295 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . 1.008 ' HB3' HG22 ' A' ' 59' ' ' VAL . 4.8 p -108.27 133.57 52.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.433 -0.792 . . . . 0.0 110.649 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.567 HD12 ' SG ' ' A' ' 31' ' ' CYS . 0.6 OUTLIER -95.1 109.82 21.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -0.955 . . . . 0.0 109.697 179.178 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.767 HG23 ' HG3' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -105.19 140.09 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.252 -0.905 . . . . 0.0 108.962 179.556 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.95 -156.81 24.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.488 ' O ' ' C ' ' A' ' 41' ' ' SER . 4.7 m-20 -99.5 51.19 0.93 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -1.153 . . . . 0.0 109.848 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.493 ' O ' HG23 ' A' ' 28' ' ' THR . 59.2 p 27.22 57.41 0.08 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.803 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.619 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 144.06 114.88 0.99 Allowed Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.158 -1.496 . . . . 0.0 110.73 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.797 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -55.06 -177.65 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.081 -1.247 . . . . 0.0 107.636 178.426 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.524 ' HA ' ' O ' ' A' ' 25' ' ' SER . 5.0 tp -145.87 93.02 2.28 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.313 -0.867 . . . . 0.0 110.106 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.609 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.8 OUTLIER -74.19 118.9 17.67 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.173 -0.955 . . . . 0.0 109.455 179.379 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.2 t -129.73 76.12 1.7 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.114 -0.991 . . . . 0.0 110.804 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.74 53.43 0.71 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 58.13 26.17 58.15 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -145.75 119.12 8.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -1.181 . . . . 0.0 109.917 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.612 ' CE2' ' SG ' ' A' ' 3' ' ' CYS . 91.7 m95 -81.68 133.36 35.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.881 . . . . 0.0 110.358 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.31 165.28 26.14 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.196 -0.94 . . . . 0.0 110.72 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.538 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 1.1 t0 55.1 64.54 5.67 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.559 -0.713 . . . . 0.0 111.0 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.538 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.5 Cg_endo -91.8 136.14 1.71 Allowed 'Trans proline' 0 C--N 1.3 -2.007 0 O-C-N 124.347 1.709 . . . . 0.0 109.491 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 43.4 Cg_endo -75.09 175.26 11.48 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 O-C-N 123.58 1.305 . . . . 0.0 110.397 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 6.3 p -121.98 145.39 48.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.32 -0.863 . . . . 0.0 111.656 -178.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.441 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 77.4 m -105.93 83.01 1.85 Allowed 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.493 ' OE1' HG13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -110.46 -145.54 0.4 Allowed 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.735 -0.603 . . . . 0.0 110.193 -178.707 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.605 HD12 ' N ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -137.05 100.15 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.158 -0.963 . . . . 0.0 108.909 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 1.059 HG21 ' HB3' ' A' ' 81' ' ' TYR . 31.8 m -102.09 64.28 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.255 -0.903 . . . . 0.0 112.213 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 2.0 mptp? -66.97 176.51 2.05 Favored 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 117.541 -1.663 . . . . 0.0 107.306 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.529 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 1.1 m -130.63 166.59 26.02 Favored Pre-proline 0 N--CA 1.494 1.73 0 C-N-CA 117.996 -1.482 . . . . 0.0 113.904 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.475 ' O ' ' CG ' ' A' ' 63' ' ' HIS . 44.5 Cg_endo -88.88 -76.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 125.01 2.058 . . . . 0.0 110.735 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.507 ' O ' HG23 ' A' ' 65' ' ' THR . 0.0 OUTLIER 169.9 124.12 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.263 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.613 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 48.1 Cg_endo -76.09 71.1 5.8 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 123.58 1.305 . . . . 0.0 109.661 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.689 ' C ' HG22 ' A' ' 66' ' ' ILE . 1.1 p -89.39 -174.62 4.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.394 -0.816 . . . . 0.0 109.826 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.806 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -179.95 167.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.181 179.248 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.492 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 31.8 t -72.31 95.45 1.72 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.566 -0.709 . . . . 0.0 110.827 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 80.0 m-20 46.58 43.62 12.61 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.358 -0.839 . . . . 0.0 110.894 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.806 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -151.61 32.81 0.91 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.577 ' O ' ' N ' ' A' ' 88' ' ' LYS . 1.9 p90 -44.9 -174.99 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 122.697 1.237 . . . . 0.0 112.522 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.678 HD13 ' H ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -108.0 168.16 9.48 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.442 179.4 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.8 14.91 0.84 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.943 -1.098 . . . . 0.0 110.009 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.488 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -95.21 -55.46 3.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.312 -0.867 . . . . 0.0 110.557 -179.708 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.606 ' O ' HG12 ' A' ' 85' ' ' VAL . . . -153.09 88.8 0.13 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.615 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -109.44 162.79 14.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.288 -1.125 . . . . 0.0 109.717 179.821 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.615 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -159.51 155.53 26.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.134 -0.979 . . . . 0.0 110.458 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.0 mtp180 -56.62 -40.08 74.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.224 -0.922 . . . . 0.0 110.027 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.2 t -136.89 127.36 26.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.425 -0.797 . . . . 0.0 110.11 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.585 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 14.5 m-85 -102.35 -146.96 0.37 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.138 -0.977 . . . . 0.0 110.217 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 60.0 p -160.03 -119.85 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.371 -0.83 . . . . 0.0 109.773 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 1.059 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -109.13 35.39 3.28 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.829 -1.169 . . . . 0.0 110.536 -179.784 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.698 ' C ' HG22 ' A' ' 102' ' ' THR . 0.1 OUTLIER -169.76 -109.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.159 -0.963 . . . . 0.0 110.296 179.425 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.449 ' OD2' ' ND2' ' A' ' 82' ' ' ASN . 8.1 m-20 42.99 75.47 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.96 -1.088 . . . . 0.0 109.761 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.817 ' CA ' HG23 ' A' ' 102' ' ' THR . 9.4 p30 -69.53 120.37 15.21 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.259 -0.9 . . . . 0.0 110.206 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.844 HG23 ' CE1' ' A' ' 87' ' ' PHE . 33.8 m -108.14 118.35 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.86 -1.15 . . . . 0.0 111.029 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.538 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 9.0 t0 -76.91 134.49 38.94 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.844 ' CE1' HG23 ' A' ' 85' ' ' VAL . 48.8 m-85 -93.87 127.4 39.61 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.009 -1.057 . . . . 0.0 112.42 -177.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.577 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -102.69 110.08 21.9 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.091 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.453 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -56.64 132.5 51.99 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.004 -1.06 . . . . 0.0 109.855 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 89' ' ' CYS . 0.3 OUTLIER -39.93 -69.95 0.12 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.483 -0.761 . . . . 0.0 110.33 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.537 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.3 OUTLIER -171.77 136.86 0.96 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.324 -0.86 . . . . 0.0 110.277 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.584 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 50.6 58.77 8.65 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.116 -1.593 . . . . 0.0 109.116 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 9.9 m-85 -160.66 152.48 19.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.432 -1.04 . . . . 0.0 110.162 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -105.74 142.55 35.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -0.846 . . . . 0.0 109.596 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.615 HD23 ' HB2' ' A' ' 114' ' ' PRO . 0.7 OUTLIER -84.05 93.66 8.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.08 -1.013 . . . . 0.0 110.423 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.459 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -70.4 102.45 2.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.267 -0.895 . . . . 0.0 109.671 179.554 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.52 -93.1 0.19 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.586 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.2 OUTLIER -152.47 118.74 5.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.158 -1.201 . . . . 0.0 110.491 -179.523 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.16 5.07 1.8 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.285 -0.884 . . . . 0.0 111.641 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.492 ' OG ' ' HA ' ' A' ' 86' ' ' ASP . 0.6 OUTLIER -161.87 119.77 2.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.702 -1.249 . . . . 0.0 109.896 179.409 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.467 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 3.1 m -129.63 168.2 16.81 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.408 -0.808 . . . . 0.0 110.482 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.817 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -130.71 140.67 50.36 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.298 179.764 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.559 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -72.56 84.98 1.15 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.761 -0.587 . . . . 0.0 110.564 -179.53 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.475 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -62.7 174.22 0.86 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.285 -0.885 . . . . 0.0 111.197 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.82 ' CB ' HG11 ' A' ' 59' ' ' VAL . 40.8 Cg_endo -72.68 125.45 10.57 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 O-C-N 124.551 1.816 . . . . 0.0 110.626 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.574 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 129.77 -11.54 5.97 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.633 ' O ' HG23 ' A' ' 108' ' ' THR . 0.6 OUTLIER 82.5 90.25 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 122.014 -0.698 . . . . 0.0 110.366 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.633 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -179.86 -166.35 0.08 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.492 -0.755 . . . . 0.0 110.407 179.777 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.74 ' HB3' HD11 ' A' ' 113' ' ' LEU . 38.8 m95 -141.66 92.7 2.48 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.46 -0.775 . . . . 0.0 110.379 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.532 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 6.2 mttt -104.5 139.86 20.52 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.57 -0.706 . . . . 0.0 109.69 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.586 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 46.3 Cg_endo -71.63 166.59 78.21 Favored 'Cis proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.033 -2.069 . . . . 0.0 111.207 -0.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 111' ' ' PRO . 2.9 tt0 -38.31 133.94 0.91 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.684 -0.635 . . . . 0.0 110.976 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.777 HD22 ' H ' ' A' ' 113' ' ' LEU . 0.9 OUTLIER -45.67 148.24 1.35 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.902 . . . . 0.0 109.684 179.412 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.736 ' HG2' HD12 ' A' ' 66' ' ' ILE . 42.2 Cg_endo -74.35 170.92 19.13 Favored 'Trans proline' 0 C--N 1.299 -2.067 0 O-C-N 124.253 1.659 . . . . 0.0 110.851 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.67 ' HG2' HG13 ' A' ' 117' ' ' VAL . 35.7 tttt -128.93 111.44 13.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.161 -0.962 . . . . 0.0 110.449 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.544 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 3.8 t -67.29 81.79 0.14 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.797 0.808 . . . . 0.0 109.83 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.67 HG13 ' HG2' ' A' ' 115' ' ' LYS . 1.4 m -97.4 -169.29 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.904 0.859 . . . . 0.0 110.717 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.469 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.293 -1.876 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.505 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.427 HG21 ' C ' ' A' ' 47' ' ' GLY . 3.4 m . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.285 0.564 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.8 mttm -94.4 169.86 9.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.218 -0.926 . . . . 0.0 110.549 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.617 ' CB ' ' N ' ' A' ' 22' ' ' THR . 0.7 OUTLIER -129.14 146.68 51.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.302 -0.874 . . . . 0.0 110.401 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 19' ' ' ASP . 0.5 OUTLIER -128.92 177.42 7.12 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.506 -0.746 . . . . 0.0 109.578 179.496 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.02 136.45 14.2 Favored Pre-proline 0 C--N 1.298 -1.656 0 O-C-N 121.26 -0.9 . . . . 0.0 109.706 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.657 ' HG3' HG11 ' A' ' 27' ' ' VAL . 48.5 Cg_endo -69.37 163.51 37.67 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.052 1.554 . . . . 0.0 111.08 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.95 170.25 20.21 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.896 1.472 . . . . 0.0 109.618 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.482 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -87.17 105.47 17.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.106 -0.996 . . . . 0.0 109.973 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.755 HD12 ' OD1' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -47.34 -179.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-O 121.861 0.839 . . . . 0.0 111.059 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 11' ' ' ASN . 0.4 OUTLIER -103.55 69.28 0.98 Allowed 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.975 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.755 ' OD1' HD12 ' A' ' 9' ' ' ILE . 3.1 p30 164.4 -24.23 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.595 -0.69 . . . . 0.0 109.786 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.402 ' HA3' ' SG ' ' A' ' 56' ' ' CYS . . . -145.91 -160.61 8.76 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -126.77 -175.7 3.48 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.476 -1.014 . . . . 0.0 109.358 179.89 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.612 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 10.2 p80 -137.23 160.89 37.72 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.308 -0.87 . . . . 0.0 110.768 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 14' ' ' HIS . 26.7 p-10 -38.54 146.81 0.06 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.541 -0.724 . . . . 0.0 110.985 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -137.83 18.34 3.38 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.76 -26.46 9.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.296 -1.12 . . . . 0.0 110.258 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -81.64 -147.53 0.07 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.939 . . . . 0.0 109.827 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 20' ' ' PHE . 3.7 p30 178.53 -34.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.597 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.508 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 9.5 m-85 -124.58 133.78 53.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -0.929 . . . . 0.0 109.9 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.67 ' CD2' ' HB3' ' A' ' 25' ' ' SER . 2.8 m-85 -127.82 -9.87 5.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.068 -1.02 . . . . 0.0 111.132 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.617 ' N ' ' CB ' ' A' ' 3' ' ' CYS . 69.6 p 37.82 -98.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.507 -0.745 . . . . 0.0 111.424 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.486 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 23.0 t0 -150.65 138.88 20.27 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.991 -1.068 . . . . 0.0 110.488 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.43 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 91.09 22.7 31.84 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.67 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 50.8 m -118.27 163.82 16.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.306 -1.114 . . . . 0.0 110.073 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.87 HG13 ' O ' ' A' ' 43' ' ' VAL . 19.6 t -139.58 149.85 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.029 -1.044 . . . . 0.0 112.289 -178.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.657 HG11 ' HG3' ' A' ' 6' ' ' PRO . 18.1 t -122.26 114.13 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-O 121.356 0.598 . . . . 0.0 112.007 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.794 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -71.51 105.63 3.68 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.437 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.888 ' O ' HD13 ' A' ' 37' ' ' LEU . 2.8 m-30 -67.82 136.1 53.61 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.729 -178.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 13' ' ' ARG . 6.3 m -73.46 -173.64 1.46 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.99 -1.069 . . . . 0.0 109.301 179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -154.74 137.12 14.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.974 -1.079 . . . . 0.0 110.803 -179.642 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -44.84 159.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.342 -0.849 . . . . 0.0 109.775 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.99 97.63 0.69 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.215 -0.928 . . . . 0.0 110.401 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 129.22 -20.85 5.26 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.511 ' CD2' ' O ' ' A' ' 56' ' ' CYS . 2.5 m-30 -92.33 139.31 30.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.197 -1.178 . . . . 0.0 110.627 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.659 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -91.03 144.4 25.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.294 -0.879 . . . . 0.0 110.73 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.888 HD13 ' O ' ' A' ' 29' ' ' TYR . 2.4 tp -91.36 113.75 26.09 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.415 -0.803 . . . . 0.0 109.798 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.854 HG23 ' HG3' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -107.21 149.89 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.223 -0.923 . . . . 0.0 109.748 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 129.32 -153.39 19.86 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.507 ' O ' ' C ' ' A' ' 41' ' ' SER . 1.2 t30 -92.4 50.72 1.65 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.079 -1.248 . . . . 0.0 109.765 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.794 ' O ' HG23 ' A' ' 28' ' ' THR . 13.7 p 26.44 43.03 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.708 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.713 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 152.7 123.21 0.97 Allowed Glycine 0 N--CA 1.49 2.27 0 C-N-CA 119.229 -1.463 . . . . 0.0 110.694 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.87 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.6 t -58.15 -178.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.563 HD12 HG23 ' A' ' 26' ' ' VAL . 10.8 tp -147.81 97.99 2.89 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.722 -1.191 . . . . 0.0 110.684 178.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.483 ' HB2' ' CD2' ' A' ' 50' ' ' TRP . 14.6 t -78.39 115.54 18.18 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.41 179.124 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.47 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 4.7 m -124.48 81.82 1.98 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.551 -0.718 . . . . 0.0 110.272 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.486 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 93.64 56.85 1.39 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.67 23.15 9.55 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -126.04 82.04 2.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.284 -1.127 . . . . 0.0 110.681 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.538 ' HH2' ' CD2' ' A' ' 21' ' ' TYR . 67.0 m95 -54.33 128.52 31.84 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.15 -0.969 . . . . 0.0 109.148 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.407 ' O ' ' CB ' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -148.07 157.06 43.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.935 -1.103 . . . . 0.0 111.474 -179.328 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.503 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 4.8 t0 66.66 65.79 0.73 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.796 -0.565 . . . . 0.0 111.348 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.503 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.9 Cg_endo -91.45 141.49 2.75 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 O-C-N 124.37 1.721 . . . . 0.0 109.986 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.547 ' HG2' ' HB2' ' A' ' 29' ' ' TYR . 51.8 Cg_endo -80.11 -179.31 5.15 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 O-C-N 123.891 1.469 . . . . 0.0 110.308 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.567 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 8.6 p -117.91 -172.28 2.22 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.971 0.891 . . . . 0.0 111.104 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.511 ' O ' ' CD2' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -147.8 79.62 1.48 Allowed 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.778 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -113.42 -152.27 0.5 Allowed 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.004 -178.605 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.737 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -118.76 128.53 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.169 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.67 HG21 ' HB3' ' A' ' 81' ' ' TYR . 26.0 m -120.39 48.17 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.896 -1.127 . . . . 0.0 112.346 -178.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -60.94 164.07 5.25 Favored 'General case' 0 C--N 1.278 -2.519 0 C-N-CA 117.581 -1.648 . . . . 0.0 107.558 178.788 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 79' ' ' TYR . 35.5 m -131.98 161.33 63.31 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 120.603 -1.311 . . . . 0.0 111.749 -178.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 43.5 Cg_endo -75.79 -84.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.832 0 O-C-N 124.565 1.824 . . . . 0.0 110.251 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -179.84 128.43 0.24 Allowed Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 121.552 -0.717 . . . . 0.0 109.167 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.664 ' CB ' HG21 ' A' ' 85' ' ' VAL . 54.2 Cg_endo -77.97 67.14 8.13 Favored 'Trans proline' 0 C--N 1.298 -2.081 0 O-C-N 123.773 1.407 . . . . 0.0 109.744 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.509 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -87.11 175.27 8.17 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.383 -0.823 . . . . 0.0 110.199 -179.691 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.803 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -170.21 165.49 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 110.211 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.449 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 17.5 m -74.6 106.14 6.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.451 -0.781 . . . . 0.0 110.724 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.435 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 10.1 m-80 41.54 41.13 1.53 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.344 -0.848 . . . . 0.0 110.718 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.803 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -150.61 32.52 1.0 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.573 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 5.5 p90 -44.13 -173.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 122.826 1.298 . . . . 0.0 112.657 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.704 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -111.04 162.23 15.08 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.392 179.42 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.06 20.03 1.42 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.961 -1.087 . . . . 0.0 110.103 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.3 t -103.03 -67.82 0.86 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.254 -0.904 . . . . 0.0 110.693 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.406 ' O ' HG12 ' A' ' 85' ' ' VAL . . . -137.85 82.9 0.26 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.631 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 2.5 t80 -110.3 163.86 13.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.358 -1.083 . . . . 0.0 110.238 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.631 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 19.7 tttm -164.17 153.3 13.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.883 . . . . 0.0 110.007 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -51.72 -28.33 14.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 0.0 109.822 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.5 m -144.54 158.18 43.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.417 -0.802 . . . . 0.0 110.436 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.569 ' OH ' ' CE2' ' A' ' 75' ' ' PHE . 10.9 m-85 -131.27 -149.55 0.39 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.401 -0.812 . . . . 0.0 109.572 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.638 ' CA ' HG23 ' A' ' 59' ' ' VAL . 94.8 p -157.46 -108.84 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.73 -1.231 . . . . 0.0 110.984 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.67 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -108.16 23.36 14.6 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.286 -1.509 . . . . 0.0 110.467 -179.525 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.743 ' O ' HG22 ' A' ' 102' ' ' THR . 47.6 t30 -171.31 -97.01 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.152 -0.968 . . . . 0.0 110.424 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 82' ' ' ASN . 5.0 m-20 42.05 72.48 0.17 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 109.546 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.813 ' CA ' HG23 ' A' ' 102' ' ' THR . 0.4 OUTLIER -68.62 137.5 54.28 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.345 -179.065 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.664 HG21 ' CB ' ' A' ' 64' ' ' PRO . 16.0 m -117.79 120.19 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.143 -0.973 . . . . 0.0 110.552 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -78.07 128.12 33.35 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.57 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.708 ' CD1' HG21 ' A' ' 66' ' ' ILE . 32.6 m-85 -89.17 125.14 34.93 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.031 -1.043 . . . . 0.0 112.087 -178.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.565 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -100.11 93.05 5.52 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.922 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.495 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -44.3 133.81 5.29 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.014 -1.054 . . . . 0.0 109.923 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -39.5 -72.47 0.06 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.515 -0.741 . . . . 0.0 110.345 -179.672 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.454 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 5.5 t80 -175.92 144.68 0.62 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.299 -0.876 . . . . 0.0 110.018 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.548 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 52.55 31.91 37.69 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.548 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 13.9 m-85 -141.67 146.96 36.75 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.514 -0.992 . . . . 0.0 110.097 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 116' ' ' CYS . 19.0 mttt -104.0 155.6 18.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.355 -0.84 . . . . 0.0 109.27 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.576 ' CD2' ' HB3' ' A' ' 87' ' ' PHE . 0.8 OUTLIER -91.93 100.86 13.45 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.736 -1.227 . . . . 0.0 110.5 -179.587 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.62 100.78 7.14 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.442 -0.786 . . . . 0.0 109.559 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.2 -81.02 0.22 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.586 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -167.16 114.8 0.8 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.228 -1.16 . . . . 0.0 110.774 -179.32 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -61.49 -48.5 80.79 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.203 -0.935 . . . . 0.0 110.74 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.2 p -101.24 130.63 47.39 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.191 -0.943 . . . . 0.0 109.87 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 11.6 m -140.89 158.71 43.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.156 -0.965 . . . . 0.0 110.743 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.813 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -134.88 140.31 45.69 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.515 -0.741 . . . . 0.0 109.652 179.625 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.609 ' O ' ' CB ' ' A' ' 104' ' ' SER . 0.7 OUTLIER -59.08 -59.18 5.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.241 -0.912 . . . . 0.0 111.057 -178.976 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.609 ' CB ' ' O ' ' A' ' 103' ' ' CYS . 0.2 OUTLIER 82.92 161.93 0.12 Allowed Pre-proline 0 C--N 1.292 -1.934 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -178.76 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.854 ' HG3' HG23 ' A' ' 38' ' ' ILE . 38.3 Cg_endo -67.1 120.28 7.35 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.767 1.404 . . . . 0.0 111.2 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.619 ' O ' ' ND2' ' A' ' 107' ' ' ASN . . . 130.99 -9.09 5.72 Favored Glycine 0 N--CA 1.481 1.665 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.927 ' O ' HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER 77.66 105.34 0.07 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.592 -0.946 . . . . 0.0 111.103 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.927 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER 171.67 -148.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.426 -0.796 . . . . 0.0 110.711 179.345 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.678 ' HB3' HD11 ' A' ' 113' ' ' LEU . 22.3 m95 -163.32 66.31 0.18 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.345 -0.847 . . . . 0.0 109.617 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.527 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.2 OUTLIER -83.81 140.27 40.6 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.508 -0.745 . . . . 0.0 110.238 -179.625 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.586 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 44.8 Cg_endo -72.48 165.44 83.13 Favored 'Cis proline' 0 C--N 1.313 -1.336 0 C-N-CA 121.901 -2.125 . . . . 0.0 110.682 -0.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.5 pm0 -37.5 140.75 0.2 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.675 -0.641 . . . . 0.0 110.888 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.767 HD22 ' H ' ' A' ' 113' ' ' LEU . 1.2 mm? -50.68 146.3 9.92 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.361 -0.837 . . . . 0.0 109.696 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.744 ' HG2' HD12 ' A' ' 66' ' ' ILE . 37.6 Cg_endo -71.02 168.51 22.98 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 124.181 1.621 . . . . 0.0 111.268 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.574 ' HG2' HG13 ' A' ' 117' ' ' VAL . 5.0 ttpt -128.12 111.97 14.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.342 -0.849 . . . . 0.0 110.355 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.54 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.1 t -68.0 100.14 0.94 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 109.33 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.574 HG13 ' HG2' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -113.78 -178.58 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.483 0.659 . . . . 0.0 110.367 -179.487 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.533 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 6.5 ptt180 . . . . . 0 C--N 1.295 -1.784 0 C-N-CA 118.871 -1.131 . . . . 0.0 110.51 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.6 m . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.327 0.584 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.547 ' HG2' HG22 ' A' ' 22' ' ' THR . 0.0 OUTLIER -112.97 166.61 11.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.324 -0.86 . . . . 0.0 109.971 179.828 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.464 ' O ' ' O ' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -96.68 83.23 3.42 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.054 -1.029 . . . . 0.0 109.784 179.81 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.536 ' HA ' ' O ' ' A' ' 19' ' ' ASP . 0.6 OUTLIER -47.53 173.12 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.89 -1.131 . . . . 0.0 109.601 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.473 ' N ' ' O ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -42.84 135.59 2.78 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.256 -0.902 . . . . 0.0 109.974 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.774 ' CG ' HG11 ' A' ' 27' ' ' VAL . 51.6 Cg_endo -70.75 151.35 63.34 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.855 1.45 . . . . 0.0 110.754 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.61 170.46 20.18 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 123.938 1.494 . . . . 0.0 110.469 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.71 174.64 4.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.339 -0.851 . . . . 0.0 109.961 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.615 HD11 ' HB3' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -144.84 -170.0 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 122.198 0.999 . . . . 0.0 111.401 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' A' ' 56' ' ' CYS . 7.1 m -40.32 99.34 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.998 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 32' ' ' ASN . 1.6 m-80 40.91 28.13 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.374 -0.828 . . . . 0.0 110.565 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -132.13 157.23 22.37 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -112.35 -165.85 1.03 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.47 -1.018 . . . . 0.0 110.586 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.643 ' HB2' HG11 ' A' ' 27' ' ' VAL . 10.3 p80 -148.76 122.84 9.47 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.105 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -113.53 -167.0 1.14 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.172 -0.955 . . . . 0.0 110.446 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 145.49 -15.31 1.83 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 61.13 59.13 2.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.424 -1.045 . . . . 0.0 110.408 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.539 ' OE1' ' CD2' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -174.17 -174.63 0.92 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.176 -0.953 . . . . 0.0 110.449 179.932 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.536 ' O ' ' HA ' ' A' ' 4' ' ' GLN . 7.8 t70 -131.73 -41.57 1.05 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.405 -0.809 . . . . 0.0 109.71 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 m-30 -106.43 143.55 34.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.446 -0.784 . . . . 0.0 110.04 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.655 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.4 OUTLIER -127.17 -8.22 5.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.262 -0.899 . . . . 0.0 110.691 -179.743 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.553 ' HG1' ' C ' ' A' ' 21' ' ' TYR . 30.2 p 50.89 -93.39 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.721 -0.612 . . . . 0.0 112.37 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 33.6 t0 -158.34 143.31 16.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.02 -1.05 . . . . 0.0 110.404 -178.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.539 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 87.3 20.68 51.63 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.655 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -115.7 166.6 11.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.371 -1.076 . . . . 0.0 110.489 -179.723 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.8 HG13 ' O ' ' A' ' 43' ' ' VAL . 20.8 t -142.19 156.55 19.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.433 -0.792 . . . . 0.0 110.649 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.774 HG11 ' CG ' ' A' ' 6' ' ' PRO . 10.8 t -130.71 111.6 20.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.224 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.441 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -66.67 103.61 1.12 Allowed 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 118.56 -1.256 . . . . 0.0 108.327 178.607 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.641 ' CE1' HG21 ' A' ' 43' ' ' VAL . 1.7 m-30 -68.73 121.79 17.21 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.595 -0.691 . . . . 0.0 110.384 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -69.87 158.85 34.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -0.985 . . . . 0.0 109.415 179.23 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.9 154.2 46.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.951 -1.093 . . . . 0.0 110.704 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 11' ' ' ASN . 3.8 t-20 -64.45 152.75 40.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.402 -0.811 . . . . 0.0 110.01 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.71 120.69 15.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.2 -0.937 . . . . 0.0 110.278 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.16 -5.67 30.36 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.588 ' CD2' ' O ' ' A' ' 56' ' ' CYS . 0.8 OUTLIER -116.06 146.91 41.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.189 -1.183 . . . . 0.0 110.518 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.732 ' HB3' HD11 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -89.05 142.01 28.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.395 -0.816 . . . . 0.0 111.205 -179.693 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.568 ' C ' HD13 ' A' ' 38' ' ' ILE . 0.7 OUTLIER -94.54 104.55 16.5 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.46 -0.775 . . . . 0.0 109.079 178.802 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.868 HG23 ' HG3' ' A' ' 105' ' ' PRO . 0.8 OUTLIER -94.96 141.89 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.305 -0.872 . . . . 0.0 109.677 -179.361 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.48 -160.29 23.05 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.519 ' O ' ' C ' ' A' ' 41' ' ' SER . 5.9 m-20 -99.54 50.4 0.93 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.1 -1.235 . . . . 0.0 109.974 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.526 ' HA ' HD21 ' A' ' 37' ' ' LEU . 0.3 OUTLIER 22.06 63.52 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.864 179.585 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.473 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 146.34 120.75 1.29 Allowed Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.416 -1.373 . . . . 0.0 110.184 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.8 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -68.43 179.65 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.452 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.413 ' HA ' HG22 ' A' ' 26' ' ' VAL . 25.3 tp -136.24 104.69 5.73 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.602 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.531 ' HB2' ' CH2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -75.32 103.83 5.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.394 -0.816 . . . . 0.0 109.236 179.379 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.504 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 12.2 t -132.59 103.62 6.24 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.31 -0.869 . . . . 0.0 110.304 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.88 41.36 5.97 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.443 ' HA2' ' C ' ' A' ' 2' ' ' LYS . . . 60.33 18.1 48.76 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.12 153.94 49.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -1.128 . . . . 0.0 110.147 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.531 ' CH2' ' HB2' ' A' ' 45' ' ' CYS . 83.0 m95 -105.46 130.82 53.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.749 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 11.8 t -136.87 156.16 48.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.972 . . . . 0.0 111.173 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.531 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.1 OUTLIER 65.2 64.96 0.98 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.819 -0.551 . . . . 0.0 111.436 179.477 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.0 Cg_endo -91.93 137.86 1.91 Allowed 'Trans proline' 0 C--N 1.3 -2.02 0 O-C-N 124.39 1.732 . . . . 0.0 109.695 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.583 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 47.8 Cg_endo -81.75 164.19 18.33 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.728 1.383 . . . . 0.0 110.453 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.608 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 33.9 p -107.37 -174.97 2.66 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.226 -0.921 . . . . 0.0 111.185 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.588 ' O ' ' CD2' ' A' ' 35' ' ' TYR . 1.0 OUTLIER -140.71 76.14 1.54 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.336 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.538 ' HG3' ' CG1' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -115.82 174.05 6.23 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.129 -178.729 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.563 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -90.28 124.26 42.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.278 -0.889 . . . . 0.0 108.683 179.389 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.699 ' HB ' ' HA ' ' A' ' 105' ' ' PRO . 29.5 m -112.37 48.43 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.098 -1.001 . . . . 0.0 111.752 -178.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.474 ' O ' ' OD1' ' A' ' 107' ' ' ASN . 11.4 mttm -55.48 170.49 0.24 Allowed 'General case' 0 C--N 1.28 -2.448 0 C-N-CA 117.624 -1.63 . . . . 0.0 108.043 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.534 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -131.53 168.36 17.79 Favored Pre-proline 0 N--CA 1.491 1.602 0 C-N-CA 118.532 -1.267 . . . . 0.0 112.999 -178.1 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.502 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 47.2 Cg_endo -89.98 -73.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 124.896 1.998 . . . . 0.0 110.421 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.502 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 164.24 126.12 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.285 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.903 ' HA ' HD21 ' A' ' 113' ' ' LEU . 55.5 Cg_endo -80.53 60.63 7.93 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 123.544 1.286 . . . . 0.0 110.211 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.601 ' O ' HD23 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -76.17 170.64 15.93 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.535 -0.728 . . . . 0.0 109.478 179.444 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.98 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -168.05 164.88 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.015 -1.053 . . . . 0.0 110.525 -179.6 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.424 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 2.5 t -70.22 98.81 1.41 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.514 -0.741 . . . . 0.0 110.675 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 51.0 m-80 43.19 48.98 5.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.368 -0.832 . . . . 0.0 110.841 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.98 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -160.18 38.74 0.45 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.587 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 53.1 p90 -49.23 -151.89 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 122.886 1.327 . . . . 0.0 113.134 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.009 HD23 ' CE2' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -144.72 122.04 11.59 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.765 -176.445 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.9 t -98.88 14.0 30.5 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.342 -0.848 . . . . 0.0 110.127 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.511 ' OG ' ' N ' ' A' ' 86' ' ' ASP . 1.3 p -74.82 -101.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.312 -0.867 . . . . 0.0 110.712 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -120.28 74.92 0.32 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.615 ' HD2' HD11 ' A' ' 71' ' ' LEU . 1.9 t80 -91.53 161.5 14.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.495 -1.003 . . . . 0.0 110.396 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.587 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 23.8 tttt -162.35 156.15 21.02 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.451 -0.78 . . . . 0.0 109.862 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -47.14 -32.65 4.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -0.883 . . . . 0.0 110.146 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.524 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 3.3 t -144.04 167.82 21.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.385 -0.822 . . . . 0.0 110.366 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.628 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 9.3 m-85 -138.02 -149.87 0.32 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.292 -0.88 . . . . 0.0 109.844 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.649 ' CA ' HG23 ' A' ' 59' ' ' VAL . 2.7 p -156.33 -100.41 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.597 -1.315 . . . . 0.0 111.877 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.628 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -123.04 14.2 9.82 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.733 -1.229 . . . . 0.0 110.311 -178.466 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.774 ' O ' HG22 ' A' ' 102' ' ' THR . 8.0 p30 -155.74 -108.3 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.02 -1.05 . . . . 0.0 110.398 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 82' ' ' ASN . 5.3 t0 46.22 71.99 0.26 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.817 -1.177 . . . . 0.0 109.539 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.894 ' CA ' HG23 ' A' ' 102' ' ' THR . 14.0 p-10 -68.65 106.47 2.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.314 -0.866 . . . . 0.0 109.491 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.586 ' CG2' HD22 ' A' ' 71' ' ' LEU . 35.8 m -92.03 121.48 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.11 -0.993 . . . . 0.0 111.523 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.529 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.6 OUTLIER -82.66 135.36 35.05 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.25 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 1.009 ' CE2' HD23 ' A' ' 71' ' ' LEU . 38.3 m-85 -90.94 144.39 25.73 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.805 -1.184 . . . . 0.0 112.252 -177.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -116.1 91.95 3.75 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.669 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.548 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -44.76 132.52 6.49 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.068 -1.02 . . . . 0.0 110.054 -179.741 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -40.82 -74.17 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.41 -0.806 . . . . 0.0 110.639 -179.683 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.576 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 31.5 t80 -169.62 144.11 2.86 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.225 -0.922 . . . . 0.0 110.674 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.578 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 46.38 41.11 11.63 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.607 ' CE1' ' HB3' ' A' ' 118' ' ' ARG . 12.2 m-85 -145.93 147.5 31.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.517 -0.99 . . . . 0.0 109.947 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 117' ' ' VAL . 6.7 ttpt -102.57 152.48 21.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.196 -0.94 . . . . 0.0 109.959 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.612 HD23 ' HB2' ' A' ' 114' ' ' PRO . 0.6 OUTLIER -92.99 89.44 6.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.056 -1.027 . . . . 0.0 110.446 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.739 ' HB2' HG21 ' A' ' 117' ' ' VAL . 18.6 t -70.55 108.1 4.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.9 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 138.69 -65.34 0.54 Allowed Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.844 -1.17 . . . . 0.0 110.236 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.576 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.1 OUTLIER 174.84 114.43 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.277 -1.131 . . . . 0.0 110.705 -179.383 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.485 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 0.9 OUTLIER -80.86 20.92 0.72 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.106 -0.996 . . . . 0.0 111.258 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.409 ' O ' ' OG ' ' A' ' 100' ' ' SER . 16.4 p -161.28 103.84 1.26 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.957 -1.09 . . . . 0.0 109.905 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.498 ' O ' ' N ' ' A' ' 85' ' ' VAL . 70.2 m -123.13 171.13 9.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.933 . . . . 0.0 110.611 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.894 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -136.78 145.39 44.5 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.223 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 79' ' ' TYR . 7.0 t -74.96 88.76 2.37 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.466 -0.772 . . . . 0.0 109.912 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.452 ' OG ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -66.03 174.5 1.62 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.258 -0.901 . . . . 0.0 111.327 -179.44 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.868 ' HG3' HG23 ' A' ' 38' ' ' ILE . 41.7 Cg_endo -74.16 126.94 10.86 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.401 1.738 . . . . 0.0 110.73 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 120.48 -6.64 11.57 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.577 ' O ' HG23 ' A' ' 108' ' ' THR . 0.5 OUTLIER 82.13 96.06 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 O-C-N 122.107 -0.643 . . . . 0.0 110.699 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -178.51 -162.34 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.356 -0.84 . . . . 0.0 111.175 179.516 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.619 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 31.1 m95 -150.34 87.51 1.46 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.59 -0.694 . . . . 0.0 110.11 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.516 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 58.4 mttt -98.85 140.27 21.64 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.475 -0.765 . . . . 0.0 110.098 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.576 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 47.7 Cg_endo -72.7 174.55 48.53 Favored 'Cis proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.992 -2.087 . . . . 0.0 110.686 -0.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 112' ' ' GLU . 0.0 OUTLIER -43.82 135.27 4.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.402 -0.811 . . . . 0.0 110.988 -179.558 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.903 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -45.76 146.8 1.78 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.445 -0.785 . . . . 0.0 110.287 179.426 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.723 ' HG2' HD12 ' A' ' 66' ' ' ILE . 42.7 Cg_endo -76.53 169.57 21.6 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 O-C-N 124.341 1.706 . . . . 0.0 111.182 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.593 ' HG2' HG13 ' A' ' 117' ' ' VAL . 2.6 ttpt -130.16 109.71 11.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.24 -0.912 . . . . 0.0 110.208 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 2.0 t -63.9 80.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -0.913 . . . . 0.0 109.341 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.739 HG21 ' HB2' ' A' ' 96' ' ' SER . 0.3 OUTLIER -88.54 -176.82 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.749 0.785 . . . . 0.0 110.645 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.607 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--N 1.295 -1.792 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.504 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.401 ' C ' ' HD3' ' A' ' 2' ' ' LYS . 4.8 m . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.302 0.572 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.401 ' HD3' ' C ' ' A' ' 1' ' ' VAL . 0.0 OUTLIER -122.81 176.84 5.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.934 . . . . 0.0 110.313 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.57 ' HB3' ' N ' ' A' ' 22' ' ' THR . 2.8 t -136.63 95.55 3.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.344 -0.848 . . . . 0.0 110.828 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 5' ' ' SER . 0.0 OUTLIER -74.33 176.45 6.7 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 118.766 -1.174 . . . . 0.0 108.972 178.889 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -46.76 145.46 3.08 Favored Pre-proline 0 C--N 1.293 -1.861 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.278 179.794 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.825 ' HG3' HG11 ' A' ' 27' ' ' VAL . 48.8 Cg_endo -71.01 153.91 63.0 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.835 1.44 . . . . 0.0 110.78 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -74.84 171.61 17.93 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 O-C-N 123.911 1.48 . . . . 0.0 109.787 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.64 177.09 3.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.14 -0.975 . . . . 0.0 109.758 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.713 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -142.54 -170.57 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 122.178 0.989 . . . . 0.0 111.642 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 14.2 t -40.85 93.28 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.698 -179.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 9' ' ' ILE . 3.5 m-80 42.17 44.16 3.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 110.25 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -140.82 178.05 20.39 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.527 ' CB ' ' HB3' ' A' ' 30' ' ' SER . 0.0 OUTLIER -125.0 -168.27 1.8 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.178 -1.189 . . . . 0.0 110.578 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.625 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 13.9 p80 -156.46 123.94 5.43 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.958 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -147.5 128.11 14.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.166 -0.959 . . . . 0.0 110.53 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.49 -115.73 2.14 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -166.84 37.27 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -1.131 . . . . 0.0 110.052 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.592 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 1.4 pp20? -150.04 -155.61 0.64 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 0.0 110.09 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -140.7 -42.44 0.4 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.367 -0.833 . . . . 0.0 110.068 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.402 ' C ' ' OE1' ' A' ' 18' ' ' GLU . 17.6 m-85 -119.52 100.98 7.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 109.526 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.655 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.8 OUTLIER -77.53 -11.04 59.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.44 -0.787 . . . . 0.0 111.395 -179.226 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.57 ' N ' ' HB3' ' A' ' 3' ' ' CYS . 56.4 p 46.71 -95.78 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.209 -0.932 . . . . 0.0 111.636 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.539 ' H ' ' HG1' ' A' ' 22' ' ' THR . 1.3 t70 -152.77 146.92 25.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.842 -1.161 . . . . 0.0 110.948 -178.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 82.45 23.88 55.38 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.655 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.9 OUTLIER -116.9 169.84 9.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.395 -1.061 . . . . 0.0 110.207 -179.799 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.848 HG13 ' O ' ' A' ' 43' ' ' VAL . 23.7 t -139.26 156.15 26.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 119.29 -0.964 . . . . 0.0 111.033 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.9 ' O ' HG23 ' A' ' 43' ' ' VAL . 24.0 t -133.25 124.25 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 119.846 -0.741 . . . . 0.0 111.066 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.849 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -73.86 100.9 3.61 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 118.347 -1.341 . . . . 0.0 108.432 178.412 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 1.076 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.1 m-30 -68.56 127.93 34.8 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.144 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.527 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 12.5 t -80.12 -170.43 2.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.026 -1.046 . . . . 0.0 109.687 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.623 ' SG ' HD12 ' A' ' 37' ' ' LEU . 67.4 m -150.83 160.94 43.54 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.147 -0.971 . . . . 0.0 110.161 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.523 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 14.8 t-20 -48.43 171.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.0 110.059 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.68 107.45 5.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 110.181 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.79 11.46 40.4 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.523 ' CG ' ' HB3' ' A' ' 32' ' ' ASN . 2.9 m-30 -106.84 128.33 54.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -1.136 . . . . 0.0 110.238 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.624 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.5 OUTLIER -74.23 138.99 44.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.306 -0.871 . . . . 0.0 110.808 -179.885 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.778 HD13 ' O ' ' A' ' 29' ' ' TYR . 2.8 tp -91.24 104.51 17.05 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.445 -0.784 . . . . 0.0 109.421 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.799 HG23 ' HG3' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -97.48 154.04 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.279 -0.888 . . . . 0.0 109.37 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.478 ' O ' ' CB ' ' A' ' 40' ' ' ASN . . . 94.56 39.54 4.68 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.7 OUTLIER 68.52 174.5 0.28 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.353 -1.087 . . . . 0.0 110.116 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.849 ' O ' HG23 ' A' ' 28' ' ' THR . 0.3 OUTLIER -119.79 71.5 0.89 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 110.318 -179.859 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.501 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 163.36 119.35 0.48 Allowed Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.75 -1.215 . . . . 0.0 110.173 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.076 HG21 ' CE1' ' A' ' 29' ' ' TYR . 2.0 t -76.31 -175.23 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.147 -1.208 . . . . 0.0 108.506 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.563 ' H ' HG12 ' A' ' 43' ' ' VAL . 0.9 OUTLIER -144.05 102.28 3.86 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.215 178.902 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.543 ' HB2' ' CD2' ' A' ' 50' ' ' TRP . 13.5 t -83.96 124.61 31.2 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.362 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.428 ' C ' ' OD2' ' A' ' 23' ' ' ASP . 84.5 p -132.22 80.22 1.9 Allowed 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.283 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.444 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 92.8 46.75 3.33 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.59 23.22 62.6 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 50' ' ' TRP . 3.3 mt-10 -126.4 68.78 1.22 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.206 -1.173 . . . . 0.0 110.374 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.594 ' CH2' HG23 ' A' ' 27' ' ' VAL . 72.7 m95 -43.58 135.63 3.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.485 -0.759 . . . . 0.0 109.632 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.2 t -146.73 169.87 18.16 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.962 -1.086 . . . . 0.0 111.069 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.534 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER 59.52 65.02 2.72 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.671 -0.643 . . . . 0.0 110.981 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.534 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.0 Cg_endo -91.22 127.95 1.18 Allowed 'Trans proline' 0 C--N 1.301 -1.928 0 O-C-N 124.393 1.733 . . . . 0.0 110.305 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.523 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 51.4 Cg_endo -77.09 173.18 14.84 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 O-C-N 123.897 1.472 . . . . 0.0 110.096 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.584 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 21.0 p -107.09 164.6 12.01 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.92 . . . . 0.0 111.272 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 10' ' ' SER . 97.3 m -128.37 76.11 1.68 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 177.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -111.82 -158.93 0.66 Allowed 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.28 0.562 . . . . 0.0 110.162 -178.831 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.21 147.13 15.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.624 HG13 ' CB ' ' A' ' 36' ' ' SER . 33.7 m -132.49 49.25 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 O-C-N 121.044 -1.035 . . . . 0.0 111.267 -178.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 5.3 mttm -64.19 -169.5 0.03 OUTLIER 'General case' 0 C--N 1.281 -2.404 0 C-N-CA 118.225 -1.39 . . . . 0.0 107.9 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.545 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -144.52 170.75 7.69 Favored Pre-proline 0 C--N 1.293 -1.848 0 C-N-CA 118.347 -1.341 . . . . 0.0 113.22 -178.824 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.557 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 45.1 Cg_endo -92.47 -70.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.421 2.081 . . . . 0.0 109.139 178.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.557 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 159.34 129.44 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 122.04 -0.413 . . . . 0.0 110.068 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.574 ' HG3' ' CZ2' ' A' ' 109' ' ' TRP . 55.3 Cg_endo -85.18 94.31 0.66 Allowed 'Trans proline' 0 C--N 1.299 -2.044 0 O-C-N 123.802 1.422 . . . . 0.0 109.346 178.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.726 ' O ' HG23 ' A' ' 66' ' ' ILE . 3.5 p -111.57 -43.15 3.7 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 122.342 1.068 . . . . 0.0 110.452 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.73 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER 53.27 170.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.017 -178.71 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.506 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -68.37 101.66 1.26 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.472 -0.767 . . . . 0.0 111.331 -179.088 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 60.7 m-20 42.36 51.95 4.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.507 -0.746 . . . . 0.0 111.684 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.594 ' O ' ' CD1' ' A' ' 70' ' ' TYR . . . -133.05 -38.49 0.23 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.631 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 2.0 p90 38.2 -171.58 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 122.965 1.364 . . . . 0.0 112.645 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.661 HD22 ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -139.17 159.76 41.39 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.724 -178.91 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.59 27.73 3.04 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.755 -1.215 . . . . 0.0 110.152 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.74 -78.65 0.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.193 -0.942 . . . . 0.0 111.111 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -135.4 82.15 0.29 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.624 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -108.93 170.65 7.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.5 -1.0 . . . . 0.0 109.934 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.624 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 10.5 ttmt -171.23 170.1 6.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.353 -0.842 . . . . 0.0 109.974 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.402 ' N ' ' CG ' ' A' ' 76' ' ' LYS . 29.3 mtm180 -60.67 -37.39 81.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.971 -1.081 . . . . 0.0 110.517 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.4 m -134.09 159.0 42.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.286 -0.883 . . . . 0.0 110.322 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.623 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 3.7 m-85 -133.72 -146.44 0.27 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.312 -0.868 . . . . 0.0 110.058 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.574 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 21.6 p -160.02 -128.52 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.907 -1.121 . . . . 0.0 110.94 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.609 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -93.8 14.24 19.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.375 -1.453 . . . . 0.0 110.603 -179.292 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.689 ' C ' HG22 ' A' ' 102' ' ' THR . 50.6 t30 -160.73 -104.05 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.743 -1.223 . . . . 0.0 110.706 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 82' ' ' ASN . 0.7 OUTLIER 45.68 79.48 0.05 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.877 -1.14 . . . . 0.0 108.801 -178.973 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.716 ' CA ' HG23 ' A' ' 102' ' ' THR . 30.2 p-10 -69.36 150.29 47.48 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.415 -0.803 . . . . 0.0 110.853 -178.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.507 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 17.0 m -133.5 118.67 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.419 -0.8 . . . . 0.0 110.049 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.541 ' O ' ' HB2' ' A' ' 71' ' ' LEU . 8.8 t0 -82.55 127.46 33.36 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.206 -0.934 . . . . 0.0 108.613 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.698 ' CD1' HG21 ' A' ' 66' ' ' ILE . 53.5 m-85 -84.26 136.96 33.72 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.369 1.081 . . . . 0.0 113.339 -177.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.631 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -111.8 85.62 2.18 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.149 179.792 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.547 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -37.3 130.06 0.93 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.52 -0.737 . . . . 0.0 111.198 -179.029 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.8 OUTLIER -41.35 -88.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.489 -0.757 . . . . 0.0 110.697 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.557 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 3.8 t80 -152.68 144.93 23.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.227 -0.92 . . . . 0.0 110.543 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.549 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 46.87 53.85 9.89 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.569 ' CD1' ' HB3' ' A' ' 118' ' ' ARG . 9.3 m-85 -151.28 167.87 26.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.253 -1.145 . . . . 0.0 110.27 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 117' ' ' VAL . 1.9 ttpt -132.23 112.23 12.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.361 -0.837 . . . . 0.0 109.812 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.567 HD23 ' CD1' ' A' ' 66' ' ' ILE . 6.2 mt -47.65 109.56 0.23 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.261 -0.899 . . . . 0.0 110.348 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.433 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -90.61 99.32 12.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.392 -0.817 . . . . 0.0 109.88 179.614 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 141.09 -76.62 0.31 Allowed Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.119 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.615 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 1.2 m -163.4 117.35 1.59 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.372 -1.075 . . . . 0.0 110.594 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.404 ' HB2' HD13 ' A' ' 95' ' ' LEU . 9.8 p -76.63 6.27 6.18 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.276 -0.89 . . . . 0.0 110.967 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 59.8 p -147.42 113.11 5.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.114 -0.991 . . . . 0.0 109.761 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.442 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 13.1 m -128.25 168.9 14.83 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.242 -0.912 . . . . 0.0 110.776 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.716 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.5 OUTLIER -136.44 146.66 46.61 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.51 -0.744 . . . . 0.0 110.461 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 80' ' ' SER . 41.9 t -76.41 84.91 3.15 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.611 -0.681 . . . . 0.0 110.439 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.516 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -65.59 -179.12 0.32 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 110.279 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.799 ' HG3' HG23 ' A' ' 38' ' ' ILE . 46.1 Cg_endo -76.47 131.27 12.48 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 O-C-N 124.23 1.647 . . . . 0.0 110.878 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 121.91 -11.33 9.43 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.587 ' O ' HG23 ' A' ' 108' ' ' THR . 1.0 OUTLIER 82.8 92.9 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 O-C-N 122.015 -0.697 . . . . 0.0 110.956 179.668 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -179.1 -160.02 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.556 -0.715 . . . . 0.0 110.725 179.437 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.674 ' HB3' HD13 ' A' ' 113' ' ' LEU . 24.0 m95 -148.9 87.92 1.58 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.513 -0.742 . . . . 0.0 110.538 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.548 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -95.2 154.68 39.46 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.382 -0.824 . . . . 0.0 109.777 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.615 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 48.5 Cg_endo -71.65 -177.51 17.41 Favored 'Cis proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.163 -2.016 . . . . 0.0 110.514 -0.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.474 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.9 OUTLIER -37.54 111.74 0.17 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.802 -0.561 . . . . 0.0 110.236 -179.759 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.674 HD13 ' HB3' ' A' ' 109' ' ' TRP . 3.9 tp -37.61 141.86 0.45 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.66 -0.65 . . . . 0.0 110.446 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.73 ' HG2' HD12 ' A' ' 66' ' ' ILE . 40.6 Cg_endo -69.89 161.79 44.6 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 124.11 1.584 . . . . 0.0 110.47 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.517 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.8 OUTLIER -125.1 100.21 6.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 110.497 179.704 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.547 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.9 t -56.19 91.84 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.019 -1.051 . . . . 0.0 109.272 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 3.7 m -110.95 179.11 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.628 0.728 . . . . 0.0 110.941 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.569 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.688 0 C-N-CA 118.997 -1.081 . . . . 0.0 110.239 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.513 ' CG1' ' HA3' ' A' ' 48' ' ' GLY . 69.2 t . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 121.231 0.539 . . . . 0.0 110.275 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.474 ' N ' HG12 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -119.87 179.69 4.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.901 . . . . 0.0 110.294 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.549 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.3 m -131.61 137.28 48.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.546 -0.721 . . . . 0.0 110.008 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.567 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 3.8 mt-30 -114.2 168.49 9.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.767 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -45.21 131.89 5.72 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.112 -0.992 . . . . 0.0 109.446 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.681 ' HG3' HG11 ' A' ' 27' ' ' VAL . 45.6 Cg_endo -66.99 153.16 78.8 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 124.011 1.532 . . . . 0.0 112.209 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.64 175.29 11.49 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 124.097 1.578 . . . . 0.0 110.304 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.44 173.63 5.7 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.276 -0.89 . . . . 0.0 110.254 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.432 HG12 ' CG ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -143.46 -172.96 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-O 122.038 0.923 . . . . 0.0 111.085 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.3 OUTLIER -39.73 100.51 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.215 -179.214 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.415 ' C ' ' O ' ' A' ' 10' ' ' SER . 1.2 m120 39.21 45.59 1.14 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.434 -0.791 . . . . 0.0 111.09 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.452 ' HA3' ' CB ' ' A' ' 56' ' ' CYS . . . -158.21 161.45 31.62 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.435 ' HG3' ' HB2' ' A' ' 30' ' ' SER . 0.8 OUTLIER -119.41 -175.22 2.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -1.146 . . . . 0.0 110.713 -179.613 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.635 ' HB2' HG11 ' A' ' 27' ' ' VAL . 7.5 p80 -126.91 163.3 23.95 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.196 0.522 . . . . 0.0 110.063 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -170.5 -159.07 0.17 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.093 -1.004 . . . . 0.0 110.322 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.44 -126.36 2.37 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.535 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 11.4 p90 -149.19 33.87 0.73 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -1.129 . . . . 0.0 110.068 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.488 ' HG3' ' CZ ' ' A' ' 21' ' ' TYR . 0.9 OUTLIER -147.1 -177.43 5.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.933 . . . . 0.0 109.912 179.854 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -124.03 -41.33 2.22 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.207 -0.933 . . . . 0.0 110.253 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.621 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 21.0 p90 -128.34 98.81 5.19 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.11 -0.994 . . . . 0.0 110.516 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.618 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 11.6 m-85 -61.95 -165.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.984 -1.073 . . . . 0.0 110.054 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.549 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 0.3 OUTLIER -151.42 -65.57 0.18 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.026 -1.046 . . . . 0.0 110.778 -179.731 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -167.15 147.33 5.47 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.444 -0.785 . . . . 0.0 109.658 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 65.61 14.58 60.53 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.618 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -94.54 172.41 8.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.387 -1.067 . . . . 0.0 109.938 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 43' ' ' VAL . 24.4 t -148.75 154.71 9.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.224 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.681 HG11 ' HG3' ' A' ' 6' ' ' PRO . 24.4 t -134.04 113.81 18.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.596 -0.69 . . . . 0.0 110.922 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -69.39 104.08 2.18 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 118.052 -1.459 . . . . 0.0 107.597 178.187 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.653 ' O ' HD13 ' A' ' 37' ' ' LEU . 1.3 m-30 -67.4 111.87 4.3 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.366 -178.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.435 ' HB2' ' HG3' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -70.69 154.98 41.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.114 -0.991 . . . . 0.0 110.278 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.7 m -123.97 157.27 34.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.319 -0.863 . . . . 0.0 109.662 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.52 168.51 1.57 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.107 -0.996 . . . . 0.0 110.241 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.21 100.61 0.81 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.26 -0.9 . . . . 0.0 110.124 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.482 ' O ' HG22 ' A' ' 58' ' ' ILE . . . 120.92 -6.99 11.0 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.693 ' CD2' HG23 ' A' ' 58' ' ' ILE . 27.7 m-85 -96.61 133.63 40.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -1.136 . . . . 0.0 110.2 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.723 ' HB2' HG22 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -89.25 144.34 26.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 0.0 110.797 -179.783 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.653 HD13 ' O ' ' A' ' 29' ' ' TYR . 1.9 tp -92.09 98.15 11.37 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.376 -0.827 . . . . 0.0 109.237 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.929 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -87.99 144.02 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.31 -0.869 . . . . 0.0 109.051 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.59 -174.6 22.87 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.475 ' ND2' ' OD1' ' A' ' 52' ' ' ASP . 2.4 m-80 -55.33 145.93 20.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.343 -1.092 . . . . 0.0 110.092 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.608 ' O ' HG23 ' A' ' 28' ' ' THR . 87.4 p -80.52 49.53 1.17 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.173 -0.954 . . . . 0.0 110.076 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.657 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 152.19 109.83 0.43 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.665 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -46.49 172.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.244 -1.151 . . . . 0.0 108.244 179.276 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 25' ' ' SER . 0.4 OUTLIER -138.26 97.08 3.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.046 -1.034 . . . . 0.0 110.183 179.01 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.608 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.2 OUTLIER -76.48 107.78 9.0 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.091 -1.005 . . . . 0.0 109.266 178.936 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.66 107.05 8.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.545 -0.722 . . . . 0.0 110.238 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.03 5.08 55.15 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.513 ' HA3' ' CG1' ' A' ' 1' ' ' VAL . . . 94.49 15.79 45.54 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -141.42 113.73 8.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.348 -1.09 . . . . 0.0 110.261 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.608 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 96.3 m95 -58.34 134.75 56.86 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.189 -0.944 . . . . 0.0 109.975 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.7 t -135.3 149.84 49.87 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.184 -0.948 . . . . 0.0 110.95 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.51 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 1.1 t70 62.81 65.47 1.41 Allowed Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.716 -0.615 . . . . 0.0 111.372 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.51 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.6 Cg_endo -91.58 124.44 0.82 Allowed 'Trans proline' 0 C--N 1.3 -2.021 0 O-C-N 124.337 1.704 . . . . 0.0 109.841 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.494 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.0 Cg_endo -71.67 175.14 9.99 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 O-C-N 123.88 1.463 . . . . 0.0 109.979 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.601 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 23.6 p -118.37 141.81 48.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.194 -0.941 . . . . 0.0 111.187 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 10' ' ' SER . 35.1 m -103.58 76.06 1.37 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.479 ' OE1' ' CB ' ' A' ' 55' ' ' THR . 0.0 OUTLIER -113.46 147.24 38.21 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.406 0.622 . . . . 0.0 110.214 -178.73 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.693 HG23 ' CD2' ' A' ' 35' ' ' TYR . 1.7 pt -70.74 112.55 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.435 -0.79 . . . . 0.0 109.161 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.894 HG21 ' CB ' ' A' ' 81' ' ' TYR . 18.8 m -99.54 53.01 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.309 -0.869 . . . . 0.0 111.751 -178.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 23.2 mtpp -71.62 -174.12 1.07 Allowed 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 118.065 -1.454 . . . . 0.0 107.2 177.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.516 ' SG ' ' HB2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -143.42 163.61 35.88 Favored Pre-proline 0 C--N 1.29 -2.018 0 C-N-CA 118.014 -1.474 . . . . 0.0 111.98 -178.499 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.528 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 41.3 Cg_endo -80.57 -68.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.866 0 O-C-N 124.787 1.941 . . . . 0.0 109.609 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.528 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 161.13 135.06 0.01 OUTLIER Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.881 ' HG2' HD21 ' A' ' 71' ' ' LEU . 56.9 Cg_endo -82.95 66.76 7.9 Favored 'Trans proline' 0 C--N 1.289 -2.555 0 O-C-N 123.952 1.501 . . . . 0.0 109.47 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.73 ' O ' HG23 ' A' ' 66' ' ' ILE . 3.1 p -81.88 -41.92 20.29 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 122.43 1.109 . . . . 0.0 110.455 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.878 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER 54.54 162.15 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.53 -179.037 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.449 ' N ' HG13 ' A' ' 66' ' ' ILE . 12.8 t -65.95 101.1 0.63 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.573 -0.705 . . . . 0.0 111.78 -178.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 2.2 m-20 41.68 31.91 0.22 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.499 -0.751 . . . . 0.0 111.743 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.559 ' C ' ' CD1' ' A' ' 70' ' ' TYR . . . -124.11 -27.0 1.43 Allowed Glycine 0 N--CA 1.491 2.358 0 C-N-CA 118.732 -1.699 . . . . 0.0 109.938 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.559 ' CD1' ' C ' ' A' ' 69' ' ' GLY . 37.9 p90 33.4 -160.59 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 122.762 1.268 . . . . 0.0 112.016 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.895 HD23 ' HE1' ' A' ' 87' ' ' PHE . 0.7 OUTLIER -135.56 149.08 49.33 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 114.154 -1.384 . . . . 0.0 109.691 -176.889 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' A' ' 72' ' ' SER . 0.1 OUTLIER -116.03 24.38 11.49 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.866 -1.146 . . . . 0.0 109.883 -179.662 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.51 ' OG ' ' CB ' ' A' ' 86' ' ' ASP . 8.5 m -101.62 -99.87 0.27 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.065 -1.022 . . . . 0.0 111.836 -178.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.489 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -109.81 -73.96 0.77 Allowed Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.739 -1.22 . . . . 0.0 111.144 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.5 OUTLIER 60.62 174.54 0.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.409 -1.053 . . . . 0.0 109.609 -178.768 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.627 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 28.6 ttmt 179.65 159.07 0.71 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.302 -0.874 . . . . 0.0 109.641 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.526 ' N ' ' HG2' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -43.01 -31.17 0.49 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.292 -0.88 . . . . 0.0 110.635 -179.843 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.446 ' C ' ' CG ' ' A' ' 79' ' ' TYR . 2.8 p -154.43 169.93 22.58 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.132 -0.98 . . . . 0.0 111.161 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.656 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -150.62 -168.53 3.13 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.443 -0.786 . . . . 0.0 108.897 179.762 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 82' ' ' ASN . 0.1 OUTLIER -170.75 120.52 0.56 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.667 -1.27 . . . . 0.0 111.424 179.783 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.894 ' CB ' HG21 ' A' ' 59' ' ' VAL . 4.1 t80 38.37 22.85 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.995 -1.066 . . . . 0.0 112.074 178.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.672 ' C ' HG22 ' A' ' 102' ' ' THR . 26.2 p30 -178.49 -134.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.025 -1.672 . . . . 0.0 110.882 178.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.524 ' CB ' ' HB3' ' A' ' 79' ' ' TYR . 0.4 OUTLIER 57.27 72.14 0.53 Allowed 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.006 -1.059 . . . . 0.0 108.519 -178.46 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.649 ' CA ' HG23 ' A' ' 102' ' ' THR . 6.8 p30 -68.44 143.23 55.11 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.453 -0.78 . . . . 0.0 110.331 -178.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.746 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 3.6 m -134.47 121.36 36.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.228 -0.92 . . . . 0.0 110.221 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.548 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 1.1 t70 -69.95 141.96 52.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.09 -1.006 . . . . 0.0 108.479 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.895 ' HE1' HD23 ' A' ' 71' ' ' LEU . 7.1 m-85 -104.89 143.38 33.23 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.672 -1.267 . . . . 0.0 112.5 -178.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.509 ' O ' HD21 ' A' ' 95' ' ' LEU . 3.7 tptt -116.4 -173.34 2.35 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.163 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.503 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -132.11 127.96 37.12 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.241 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.49 ' C ' ' O ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -33.57 -70.72 0.07 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.404 0.621 . . . . 0.0 110.733 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.518 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -177.25 145.42 0.45 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.371 -0.831 . . . . 0.0 109.927 179.708 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.442 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 51.86 43.13 54.46 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.572 ' CD1' ' HB3' ' A' ' 118' ' ' ARG . 11.6 m-85 -146.61 162.7 37.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.34 -1.094 . . . . 0.0 110.32 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 117' ' ' VAL . 23.1 tptt -127.5 113.26 15.92 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.391 -0.818 . . . . 0.0 109.877 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.631 HD23 ' HB2' ' A' ' 114' ' ' PRO . 2.1 mt -46.49 112.62 0.52 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.107 -0.995 . . . . 0.0 109.868 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.615 ' HB2' HG21 ' A' ' 117' ' ' VAL . 1.1 t -95.92 103.64 15.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 110.205 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.16 -98.29 0.24 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.618 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -141.63 135.51 30.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -1.133 . . . . 0.0 110.614 -179.502 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 100' ' ' SER . 37.3 p -78.69 -64.91 1.07 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 110.11 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.52 ' N ' ' OG ' ' A' ' 99' ' ' SER . 15.8 p -74.86 140.28 43.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.087 -1.008 . . . . 0.0 110.065 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.595 ' HB2' ' CE2' ' A' ' 87' ' ' PHE . 3.8 m -151.16 148.35 28.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -0.934 . . . . 0.0 110.659 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.672 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -125.48 145.25 50.17 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.564 -0.71 . . . . 0.0 109.769 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.583 ' O ' ' CA ' ' A' ' 81' ' ' TYR . 7.6 t -69.4 78.93 0.39 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.104 -0.998 . . . . 0.0 109.946 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.445 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.4 OUTLIER -47.3 171.15 0.08 OUTLIER Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.286 -0.884 . . . . 0.0 112.197 -179.397 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.929 ' CB ' HD12 ' A' ' 38' ' ' ILE . 47.9 Cg_endo -78.08 21.84 0.65 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 124.731 1.911 . . . . 0.0 112.569 -178.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -114.69 7.61 22.14 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.53 ' O ' HG23 ' A' ' 108' ' ' THR . 0.8 OUTLIER 76.91 61.83 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.835 -0.803 . . . . 0.0 109.572 -179.761 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.571 ' O ' ' HA ' ' A' ' 103' ' ' CYS . 0.0 OUTLIER -171.41 -170.62 0.84 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.277 -179.426 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.746 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 19.4 m95 -118.22 86.45 2.53 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.631 -0.668 . . . . 0.0 110.133 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.543 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 2.7 mmmt -92.1 152.33 42.59 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.407 -0.808 . . . . 0.0 110.014 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.618 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 48.8 Cg_endo -72.23 -178.68 21.17 Favored 'Cis proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.071 -2.054 . . . . 0.0 111.025 -0.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 111' ' ' PRO . 3.4 mt-10 -37.11 118.5 0.61 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.334 0.588 . . . . 0.0 110.758 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.642 HD13 ' HB3' ' A' ' 109' ' ' TRP . 2.9 tp -47.39 141.65 6.55 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.365 -0.834 . . . . 0.0 110.562 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.878 ' HG2' HD12 ' A' ' 66' ' ' ILE . 41.1 Cg_endo -71.37 159.91 50.24 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.119 1.589 . . . . 0.0 110.289 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.565 ' O ' HG22 ' A' ' 117' ' ' VAL . 13.9 tttt -124.3 108.5 12.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 0.0 110.545 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.545 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 5.2 t -58.47 84.38 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.29 -0.881 . . . . 0.0 108.85 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.615 HG21 ' HB2' ' A' ' 96' ' ' SER . 4.0 m -103.45 -176.95 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.771 0.796 . . . . 0.0 111.113 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.572 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.765 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.309 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 1' ' ' VAL . 8.1 p . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -129.99 166.89 19.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.935 . . . . 0.0 110.149 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.542 ' HB3' ' O ' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -111.85 91.8 3.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.173 -0.954 . . . . 0.0 110.735 -179.629 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.476 ' O ' ' C ' ' A' ' 5' ' ' SER . 39.0 mt-30 -91.64 -177.17 4.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -0.943 . . . . 0.0 109.426 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.476 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.5 OUTLIER -36.9 131.76 0.7 Allowed Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.799 -0.563 . . . . 0.0 110.134 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.795 ' HG3' HG11 ' A' ' 27' ' ' VAL . 48.5 Cg_endo -68.87 157.35 62.19 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.998 1.525 . . . . 0.0 111.084 -178.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -75.58 170.74 19.61 Favored 'Trans proline' 0 C--N 1.302 -1.921 0 O-C-N 123.926 1.487 . . . . 0.0 109.608 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.6 p -70.33 175.49 4.64 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.145 -0.972 . . . . 0.0 109.874 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.683 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -140.33 -169.53 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -0.91 . . . . 0.0 110.804 179.556 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.2 OUTLIER -39.76 92.14 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.606 -179.262 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' A' ' 9' ' ' ILE . 3.9 m-80 42.08 41.26 1.94 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.276 -0.89 . . . . 0.0 110.113 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.449 ' O ' HG13 ' A' ' 9' ' ' ILE . . . -140.73 145.96 17.0 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -92.63 -166.81 1.61 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.268 -1.137 . . . . 0.0 110.605 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.612 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 14.9 p80 -153.9 126.14 7.94 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.157 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -145.62 112.31 5.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 110.311 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.439 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -111.05 19.43 25.13 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.457 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 0.3 OUTLIER 67.07 35.76 4.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.389 -1.065 . . . . 0.0 110.222 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.558 ' OE1' ' CE1' ' A' ' 21' ' ' TYR . 5.9 pt-20 176.88 -175.22 0.12 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 110.436 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -128.43 -3.8 5.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.377 -0.827 . . . . 0.0 110.056 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.588 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 0.9 OUTLIER -109.55 150.8 27.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 110.257 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.596 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 1.9 m-85 -167.43 42.31 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.54 -0.725 . . . . 0.0 109.746 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.518 ' HA ' ' HB2' ' A' ' 3' ' ' CYS . 21.1 p -52.79 99.15 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 122.042 0.925 . . . . 0.0 111.729 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.541 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 26.7 t70 50.54 163.45 0.0 OUTLIER 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 121.742 0.782 . . . . 0.0 112.037 178.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 48.32 26.83 5.15 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.629 ' O ' HG23 ' A' ' 26' ' ' VAL . 16.7 m -106.47 174.56 5.84 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.289 -1.124 . . . . 0.0 110.302 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 25' ' ' SER . 24.6 t -155.56 154.25 6.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.821 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.892 ' O ' HG23 ' A' ' 43' ' ' VAL . 39.2 t -143.81 124.17 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.837 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -74.55 104.52 5.28 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 118.483 -1.287 . . . . 0.0 107.534 177.538 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 1.083 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.2 m-30 -68.36 127.1 31.72 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.287 -0.883 . . . . 0.0 110.395 -178.081 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -84.8 156.4 21.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.817 . . . . 0.0 110.08 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.538 ' SG ' HD12 ' A' ' 37' ' ' LEU . 75.6 m -124.86 154.35 41.17 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -0.885 . . . . 0.0 110.155 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.484 ' O ' ' N ' ' A' ' 34' ' ' GLY . 7.8 m-20 -41.92 143.37 0.56 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.322 -0.861 . . . . 0.0 110.202 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 95.8 p -52.56 88.63 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.91 . . . . 0.0 110.503 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 32' ' ' ASN . . . 127.69 10.95 3.42 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.2 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.441 ' CD2' ' O ' ' A' ' 56' ' ' CYS . 1.7 m-30 -106.64 153.8 21.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.08 -1.247 . . . . 0.0 110.442 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.849 ' HB2' HD11 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -90.04 137.42 32.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.458 -0.776 . . . . 0.0 110.582 -179.473 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.558 HD13 ' O ' ' A' ' 29' ' ' TYR . 0.9 OUTLIER -98.92 98.54 9.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.189 -0.945 . . . . 0.0 109.484 178.909 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.849 HD11 ' HB2' ' A' ' 36' ' ' SER . 0.1 OUTLIER -95.86 141.86 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.902 . . . . 0.0 109.397 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.99 -120.21 3.88 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -125.01 137.14 54.24 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.362 -1.081 . . . . 0.0 109.93 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.531 ' O ' HG23 ' A' ' 28' ' ' THR . 73.0 p -71.86 55.86 0.29 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.229 -0.919 . . . . 0.0 109.77 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.445 ' HA2' ' C ' ' A' ' 27' ' ' VAL . . . 154.74 117.6 0.61 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.083 HG21 ' CE1' ' A' ' 29' ' ' TYR . 2.1 t -67.73 179.65 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.188 -1.183 . . . . 0.0 108.177 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.48 ' H ' HG12 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -139.72 104.04 4.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.955 -1.091 . . . . 0.0 110.638 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.599 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -81.93 111.05 17.76 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.161 -1.016 . . . . 0.0 109.262 178.675 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.58 103.2 7.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.584 -0.697 . . . . 0.0 110.488 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.61 36.21 8.08 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.462 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 64.89 31.38 80.75 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -147.78 105.42 3.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.176 -1.191 . . . . 0.0 110.549 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.74 ' CH2' HG23 ' A' ' 27' ' ' VAL . 77.6 m95 -58.5 140.06 54.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.155 -0.965 . . . . 0.0 109.514 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.2 m -143.51 170.64 15.43 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.952 -1.092 . . . . 0.0 111.059 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.516 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 20.0 t0 53.01 65.7 5.61 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.539 -0.726 . . . . 0.0 110.889 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.516 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.8 Cg_endo -91.23 139.15 2.4 Favored 'Trans proline' 0 C--N 1.3 -1.977 0 C-N-CA 121.9 1.733 . . . . 0.0 110.329 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.425 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 47.8 Cg_endo -83.52 -175.68 2.42 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.826 1.435 . . . . 0.0 110.052 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.554 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 7.4 p -124.63 143.65 50.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.38 -0.825 . . . . 0.0 111.569 -178.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 10' ' ' SER . 90.1 m -107.58 80.43 1.4 Allowed 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.464 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.9 OUTLIER -110.63 -150.43 0.46 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.712 -0.618 . . . . 0.0 110.162 -178.447 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.759 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -127.82 120.01 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.256 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.835 HG13 ' CB ' ' A' ' 36' ' ' SER . 26.9 m -115.13 52.66 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.018 -1.051 . . . . 0.0 111.824 -178.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.513 ' N ' ' OD1' ' A' ' 107' ' ' ASN . 9.0 mtpt -71.45 129.73 39.53 Favored 'General case' 0 C--N 1.283 -2.312 0 C-N-CA 118.262 -1.375 . . . . 0.0 108.232 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.5 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 5.8 m -95.01 172.2 5.72 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.928 -1.107 . . . . 0.0 112.371 -178.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 43.6 Cg_endo -84.94 -66.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.721 1.906 . . . . 0.0 110.287 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.456 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 167.98 129.29 0.04 OUTLIER Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -179.232 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.67 ' HG2' HD22 ' A' ' 71' ' ' LEU . 45.9 Cg_endo -74.0 65.23 5.11 Favored 'Trans proline' 0 C--N 1.296 -2.187 0 O-C-N 123.61 1.321 . . . . 0.0 109.868 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.705 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -85.49 170.39 12.7 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.739 -0.601 . . . . 0.0 110.446 -179.576 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.779 HG23 ' HA ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -169.31 164.09 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.126 -0.984 . . . . 0.0 110.277 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.565 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 73.2 m -66.47 75.27 0.1 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.535 -0.728 . . . . 0.0 111.978 -178.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.554 ' CB ' ' O ' ' A' ' 67' ' ' SER . 1.5 t-20 76.31 -24.72 0.21 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.285 -0.885 . . . . 0.0 112.473 178.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.573 ' CA ' ' HA ' ' A' ' 89' ' ' CYS . . . -86.32 38.6 3.08 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.779 ' HA ' HG23 ' A' ' 66' ' ' ILE . 11.9 p90 -41.61 159.75 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 123.032 1.396 . . . . 0.0 112.839 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.066 HD13 ' HB2' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -43.11 -81.39 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 113.922 -1.49 . . . . 0.0 109.699 178.269 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.597 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER 79.05 13.89 1.17 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.606 -0.684 . . . . 0.0 110.427 179.668 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.479 ' HB3' ' HB2' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -156.73 53.27 0.52 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.124 -0.985 . . . . 0.0 110.507 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.747 ' O ' HG12 ' A' ' 85' ' ' VAL . . . 122.38 113.09 2.17 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 1.066 ' HB2' HD13 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -172.25 160.44 5.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -1.14 . . . . 0.0 110.18 -179.823 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.511 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -152.29 169.46 22.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.455 -0.778 . . . . 0.0 109.949 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -58.92 -32.94 70.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.096 -1.003 . . . . 0.0 109.784 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.51 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -142.18 167.66 21.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.465 -0.772 . . . . 0.0 110.328 179.867 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.623 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 3.2 m-85 -141.83 -151.29 0.35 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.237 -0.915 . . . . 0.0 110.121 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.668 ' C ' HG23 ' A' ' 59' ' ' VAL . 85.2 p -160.54 -99.24 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.041 -1.037 . . . . 0.0 111.239 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.675 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -120.66 23.52 10.74 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.487 -1.383 . . . . 0.0 110.931 -178.281 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.693 ' C ' HG22 ' A' ' 102' ' ' THR . 17.5 t-20 -165.02 -109.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.769 -1.207 . . . . 0.0 110.541 178.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 48.52 75.71 0.14 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.706 -1.246 . . . . 0.0 109.114 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.683 ' CA ' HG23 ' A' ' 102' ' ' THR . 1.8 t-20 -69.79 125.89 28.07 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.51 -0.744 . . . . 0.0 110.942 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.747 HG12 ' O ' ' A' ' 74' ' ' GLY . 13.3 m -108.53 125.08 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.214 -0.929 . . . . 0.0 109.418 178.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.577 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -80.82 123.93 28.66 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.989 -1.07 . . . . 0.0 108.882 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.761 ' CD1' HG21 ' A' ' 66' ' ' ILE . 9.7 m-85 -87.96 124.07 33.34 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.459 1.123 . . . . 0.0 112.302 -178.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.511 ' HB2' ' OG ' ' A' ' 72' ' ' SER . 0.0 OUTLIER -106.88 96.72 6.64 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.594 -178.899 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.573 ' HA ' ' CA ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -46.65 137.46 6.87 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.002 -1.061 . . . . 0.0 109.719 179.494 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.457 ' HD3' ' ND2' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -64.42 57.08 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.255 -0.903 . . . . 0.0 111.351 -179.377 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.581 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER 58.68 137.65 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.353 -0.842 . . . . 0.0 112.689 178.465 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.624 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 57.0 55.47 30.13 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 178.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.624 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 34.3 m-85 -162.05 165.05 27.79 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.312 -1.11 . . . . 0.0 110.396 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.542 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 1.2 ttmm -123.2 104.03 8.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.296 -0.878 . . . . 0.0 109.629 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.556 HD23 HD11 ' A' ' 66' ' ' ILE . 4.6 mt -46.66 93.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.965 . . . . 0.0 110.451 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -71.7 84.91 0.9 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.337 -0.852 . . . . 0.0 109.671 179.514 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 157.86 -88.75 0.11 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.598 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.2 OUTLIER -160.92 128.36 4.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.153 -1.204 . . . . 0.0 110.716 -179.547 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.505 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 0.4 OUTLIER -69.38 -76.91 0.09 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.289 -0.882 . . . . 0.0 110.612 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 40.4 p -74.55 106.02 5.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.284 -0.885 . . . . 0.0 110.725 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.496 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 58.3 m -113.66 164.38 13.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.354 -0.841 . . . . 0.0 110.068 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.693 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -136.2 142.01 44.06 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.274 -0.891 . . . . 0.0 111.066 -179.721 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.621 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 0.5 OUTLIER -71.93 87.02 1.01 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.246 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.489 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -62.28 178.39 0.33 Allowed Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.202 -0.936 . . . . 0.0 112.619 -178.225 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.759 ' CB ' HD12 ' A' ' 38' ' ' ILE . 44.3 Cg_endo -79.02 42.84 1.36 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 124.813 1.954 . . . . 0.0 112.207 -178.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -140.64 16.76 2.86 Favored Glycine 0 C--N 1.292 -1.884 0 N-CA-C 108.2 -1.96 . . . . 0.0 108.2 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.583 ' O ' HG23 ' A' ' 108' ' ' THR . 22.3 m-80 62.98 57.0 1.72 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.666 -0.903 . . . . 0.0 109.725 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.583 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.2 OUTLIER -160.37 -159.5 0.7 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.309 -0.869 . . . . 0.0 110.452 -179.585 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.621 ' CZ3' ' N ' ' A' ' 103' ' ' CYS . 37.0 m95 -136.6 91.28 2.64 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.372 -0.83 . . . . 0.0 110.442 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.571 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 15.2 mmtt -100.4 148.99 35.68 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.562 -0.711 . . . . 0.0 110.078 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.598 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 47.2 Cg_endo -71.01 174.36 45.2 Favored 'Cis proline' 0 C--N 1.312 -1.342 0 C-N-CA 121.999 -2.084 . . . . 0.0 111.014 -0.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -33.17 131.14 0.2 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.458 0.647 . . . . 0.0 111.838 -179.0 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.597 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.9 OUTLIER -53.38 137.59 50.18 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.56 -0.712 . . . . 0.0 109.812 179.298 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.688 ' HG2' HD12 ' A' ' 66' ' ' ILE . 40.4 Cg_endo -69.19 147.69 67.09 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 O-C-N 124.139 1.599 . . . . 0.0 111.066 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.574 ' O ' HG22 ' A' ' 117' ' ' VAL . 3.6 ttpp -115.9 92.47 3.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.43 -0.794 . . . . 0.0 110.301 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.587 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.1 t -47.67 105.97 0.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.919 . . . . 0.0 110.088 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 115' ' ' LYS . 0.7 OUTLIER -122.55 177.08 4.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.427 -0.796 . . . . 0.0 110.511 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 21.3 ptt85 . . . . . 0 C--N 1.297 -1.674 0 C-N-CA 118.805 -1.158 . . . . 0.0 110.384 179.64 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 51.6 t . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.293 0.568 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.4 ptpt -137.57 178.3 7.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 0.0 110.456 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.546 ' O ' ' N ' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -161.27 93.12 0.93 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.607 -0.683 . . . . 0.0 109.514 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 9.5 mt-30 -72.84 176.96 5.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.072 -1.017 . . . . 0.0 110.428 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.9 140.93 29.13 Favored Pre-proline 0 C--N 1.301 -1.532 0 O-C-N 121.569 -0.707 . . . . 0.0 109.95 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.833 ' HG2' ' CD2' ' A' ' 14' ' ' HIS . 53.4 Cg_endo -70.91 153.21 63.76 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 124.019 1.536 . . . . 0.0 110.861 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -74.98 170.63 19.99 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.959 1.505 . . . . 0.0 109.947 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 92.4 p -69.51 178.25 2.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.174 -0.954 . . . . 0.0 110.191 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.629 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -142.39 -170.17 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 122.125 0.964 . . . . 0.0 111.273 179.81 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 54.7 m -38.22 93.61 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.068 -179.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER 43.92 30.47 0.4 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.243 -0.911 . . . . 0.0 110.502 179.689 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.64 162.31 25.15 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.134 -1.587 . . . . 0.0 109.134 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 30' ' ' SER . 5.2 ptt180 -118.45 -173.0 2.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.079 -1.248 . . . . 0.0 110.778 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.833 ' CD2' ' HG2' ' A' ' 6' ' ' PRO . 47.2 p-80 -131.95 153.53 50.21 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.306 0.574 . . . . 0.0 110.66 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -170.63 -156.57 0.13 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.283 -0.885 . . . . 0.0 110.072 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.441 ' C ' ' CD2' ' A' ' 17' ' ' TYR . . . 124.27 24.98 1.71 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.441 ' CD2' ' C ' ' A' ' 16' ' ' GLY . 24.5 m-85 58.66 65.86 1.17 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.175 -1.191 . . . . 0.0 110.284 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 19' ' ' ASP . 1.6 pp20? -141.21 -174.37 4.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.91 . . . . 0.0 109.874 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.449 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 31.9 m-20 -158.3 -33.38 0.07 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.11 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.577 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 5.6 p90 -160.74 70.7 0.4 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.851 -1.156 . . . . 0.0 110.782 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.616 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 30.5 m-85 -46.95 175.4 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.469 -0.77 . . . . 0.0 110.318 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.526 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 21.2 m -132.64 -54.57 0.95 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.058 -1.026 . . . . 0.0 110.738 -179.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.424 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 3.9 t70 -171.95 148.12 2.25 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.394 -0.816 . . . . 0.0 109.44 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 65.88 11.83 55.5 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 -178.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.616 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 66.2 m -86.5 175.0 8.59 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.407 -1.055 . . . . 0.0 110.167 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.717 HG13 ' O ' ' A' ' 43' ' ' VAL . 26.1 t -151.34 154.75 7.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.514 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.684 HG11 ' HB2' ' A' ' 14' ' ' HIS . 24.5 t -135.02 117.47 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.147 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.28 104.22 2.6 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.302 -1.359 . . . . 0.0 107.746 178.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.687 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.2 m-30 -68.25 133.18 48.4 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.325 -178.092 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -92.87 153.55 18.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.309 -0.869 . . . . 0.0 109.973 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 57.2 m -119.49 154.41 33.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 110.025 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' A' ' 35' ' ' TYR . 1.6 t-20 -46.81 140.28 4.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.935 . . . . 0.0 110.141 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -45.2 108.68 0.13 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.141 -0.975 . . . . 0.0 110.45 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.81 9.84 27.72 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.5 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 2.7 m-30 -108.5 146.76 32.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.104 -1.233 . . . . 0.0 110.327 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.888 ' HB2' HG22 ' A' ' 59' ' ' VAL . 48.2 t -89.33 137.71 32.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.395 -0.816 . . . . 0.0 110.878 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.656 HD13 ' O ' ' A' ' 29' ' ' TYR . 4.3 tp -94.12 110.04 21.78 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 177.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.71 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -107.56 147.46 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.069 -1.019 . . . . 0.0 109.839 -179.225 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.9 -163.55 12.96 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -65.08 130.81 44.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.219 -1.165 . . . . 0.0 109.773 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.9 p -74.11 53.37 0.49 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.209 -0.932 . . . . 0.0 110.22 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.654 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 150.62 105.59 0.32 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.717 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -48.09 177.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.222 -1.164 . . . . 0.0 108.601 179.377 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.5 ' HA ' ' O ' ' A' ' 25' ' ' SER . 2.5 tp -139.5 105.68 5.24 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.361 -0.837 . . . . 0.0 109.829 178.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.628 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 1.0 OUTLIER -86.05 106.87 17.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.093 -1.004 . . . . 0.0 109.969 179.58 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.7 m -124.38 104.0 8.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.492 -0.755 . . . . 0.0 109.856 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.77 53.97 3.82 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 48.49 46.94 29.5 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -156.83 99.14 1.83 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -1.153 . . . . 0.0 110.897 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.628 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 90.8 m95 -68.18 137.97 55.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.2 -0.938 . . . . 0.0 109.063 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.8 p -140.24 169.77 17.06 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.833 -1.167 . . . . 0.0 111.519 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.508 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.5 OUTLIER 51.8 65.86 5.88 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.734 -0.604 . . . . 0.0 111.457 179.627 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.508 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 46.7 Cg_endo -90.65 130.39 1.54 Allowed 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 121.874 1.716 . . . . 0.0 110.057 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.541 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 53.5 Cg_endo -77.76 176.37 10.1 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.811 1.427 . . . . 0.0 110.705 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.524 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 12.2 p -108.97 156.46 19.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.464 -0.772 . . . . 0.0 110.776 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 10' ' ' SER . 22.2 m -122.67 80.14 1.71 Allowed 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.507 ' O ' ' N ' ' A' ' 36' ' ' SER . 5.8 mm100 -109.98 -145.07 0.39 Allowed 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.428 0.632 . . . . 0.0 110.609 -178.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.592 HD12 ' N ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -137.32 114.16 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.952 HG21 ' HB3' ' A' ' 81' ' ' TYR . 19.6 m -111.87 60.66 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.161 -0.962 . . . . 0.0 112.182 -178.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 107' ' ' ASN . 8.5 mttt -69.73 159.35 33.69 Favored 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 117.852 -1.539 . . . . 0.0 107.245 178.142 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.488 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -118.95 168.82 9.03 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 120.391 -1.443 . . . . 0.0 114.304 -176.974 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -89.9 -81.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.739 2.293 . . . . 0.0 110.972 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 177.37 125.62 0.18 Allowed Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 121.711 -0.618 . . . . 0.0 109.521 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.595 ' N ' ' NE1' ' A' ' 109' ' ' TRP . 49.0 Cg_endo -75.86 67.32 6.65 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 123.714 1.376 . . . . 0.0 109.673 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.55 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -81.7 175.32 10.56 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.57 -0.707 . . . . 0.0 110.471 -179.451 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.697 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -172.46 163.48 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.295 -0.878 . . . . 0.0 110.341 179.665 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 96.4 p -72.86 100.13 2.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.522 -0.736 . . . . 0.0 110.645 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.469 ' O ' ' SG ' ' A' ' 116' ' ' CYS . 7.4 m-20 44.51 45.17 7.6 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.362 -0.837 . . . . 0.0 110.573 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.697 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -152.71 31.02 0.83 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.572 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 6.9 p90 -44.68 -176.08 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 122.663 1.22 . . . . 0.0 112.644 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.681 HD13 ' H ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -110.49 162.99 14.14 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.558 179.22 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.508 ' HB2' ' HD3' ' A' ' 88' ' ' LYS . 2.5 t -144.49 14.89 1.61 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.003 -1.061 . . . . 0.0 110.178 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.67 -69.79 0.74 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.216 -0.927 . . . . 0.0 110.909 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.452 ' O ' HG12 ' A' ' 85' ' ' VAL . . . -136.82 81.47 0.28 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.594 ' CE2' ' OH ' ' A' ' 79' ' ' TYR . 1.9 t80 -105.94 160.02 15.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.43 -1.041 . . . . 0.0 109.977 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.481 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 25.3 tttt -158.4 148.14 19.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.897 . . . . 0.0 110.446 -179.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' A' ' 76' ' ' LYS . 2.2 mtp85 -44.71 -34.58 2.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.177 -0.952 . . . . 0.0 109.702 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.448 ' O ' ' HD3' ' A' ' 76' ' ' LYS . 0.5 OUTLIER -143.63 153.48 42.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.406 -0.808 . . . . 0.0 109.917 179.725 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.594 ' OH ' ' CE2' ' A' ' 75' ' ' PHE . 8.3 m-85 -125.41 -148.12 0.38 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.161 -0.962 . . . . 0.0 110.462 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.525 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 81.6 p -158.62 -124.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.3 -0.875 . . . . 0.0 110.3 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.952 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -99.93 29.9 3.98 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.037 -1.039 . . . . 0.0 111.068 -178.295 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.67 ' C ' HG22 ' A' ' 102' ' ' THR . 48.7 t30 -173.93 -114.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.93 -1.107 . . . . 0.0 110.462 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 49.43 75.39 0.16 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.696 -1.252 . . . . 0.0 109.244 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.616 ' CA ' HG23 ' A' ' 102' ' ' THR . 10.3 p30 -69.27 125.46 26.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.381 -0.824 . . . . 0.0 110.826 -179.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.597 HG23 ' CE1' ' A' ' 87' ' ' PHE . 26.4 m -107.2 118.03 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.166 -0.959 . . . . 0.0 110.235 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.547 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -78.77 137.7 37.86 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.738 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.665 ' CZ ' HD12 ' A' ' 113' ' ' LEU . 70.0 m-85 -95.58 137.83 34.1 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.872 -1.142 . . . . 0.0 112.52 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.508 ' HD3' ' HB2' ' A' ' 72' ' ' SER . 0.7 OUTLIER -111.1 93.84 4.69 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.744 -179.923 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.578 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -44.15 131.97 5.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.053 -1.029 . . . . 0.0 110.302 -179.663 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 11.6 mmtt -42.27 -78.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.295 -0.878 . . . . 0.0 110.258 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.573 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -162.3 136.78 6.73 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.321 -0.862 . . . . 0.0 110.492 -179.892 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.592 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 52.98 66.08 2.94 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.592 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 14.6 m-85 -162.49 172.43 15.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.42 -1.047 . . . . 0.0 110.096 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.592 ' O ' HG22 ' A' ' 117' ' ' VAL . 4.4 mtmt -131.2 107.65 9.15 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.321 -0.862 . . . . 0.0 109.957 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.578 HD11 ' H ' ' A' ' 89' ' ' CYS . 1.1 mt -49.54 93.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.099 -1.001 . . . . 0.0 110.425 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.468 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -77.44 109.33 11.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -0.937 . . . . 0.0 110.184 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 135.03 -85.13 0.26 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.565 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.2 OUTLIER -158.77 112.46 2.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.293 -1.122 . . . . 0.0 110.546 -179.61 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.422 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 28.4 t -72.82 -0.1 12.47 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.279 -0.888 . . . . 0.0 110.326 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.5 p -141.5 117.92 10.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.143 -0.973 . . . . 0.0 109.547 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.49 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 40.1 m -134.33 151.42 51.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.149 -0.969 . . . . 0.0 111.122 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.67 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -120.36 151.95 38.55 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.61 0.719 . . . . 0.0 110.049 179.608 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.594 ' SG ' ' CZ2' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -83.8 77.96 9.79 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.683 -0.635 . . . . 0.0 110.554 -179.348 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.501 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.5 OUTLIER -48.37 175.78 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.348 -0.845 . . . . 0.0 111.675 -179.641 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.71 ' CB ' HD12 ' A' ' 38' ' ' ILE . 47.3 Cg_endo -77.53 43.18 1.28 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.656 1.872 . . . . 0.0 111.968 -178.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -139.57 12.04 3.21 Favored Glycine 0 C--N 1.292 -1.903 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 2.0 m120 64.2 63.83 0.76 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.718 -0.872 . . . . 0.0 109.836 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -159.8 -160.52 0.82 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.319 -0.863 . . . . 0.0 111.035 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.638 ' HB3' HD11 ' A' ' 113' ' ' LEU . 26.4 m95 -137.43 82.0 1.9 Allowed 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.64 0.733 . . . . 0.0 110.293 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.567 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.8 OUTLIER -99.27 136.5 20.45 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.72 -0.612 . . . . 0.0 110.161 -179.819 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.567 ' C ' ' HA ' ' A' ' 110' ' ' LYS . 42.7 Cg_endo -69.53 164.94 77.26 Favored 'Cis proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.084 -2.048 . . . . 0.0 111.001 -0.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -41.24 149.39 0.1 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.563 -0.711 . . . . 0.0 110.555 -179.303 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.733 HD22 ' H ' ' A' ' 113' ' ' LEU . 1.1 mm? -57.19 145.64 65.25 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.422 -0.798 . . . . 0.0 109.982 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.662 ' HG2' HD12 ' A' ' 66' ' ' ILE . 37.4 Cg_endo -69.0 169.47 17.87 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 O-C-N 124.31 1.689 . . . . 0.0 110.951 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.719 ' HG2' HG13 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -128.34 106.32 8.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 0.0 110.528 -179.549 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.545 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.4 t -63.31 87.13 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.184 -0.947 . . . . 0.0 108.912 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.719 HG13 ' HG2' ' A' ' 115' ' ' LYS . 2.3 m -103.3 177.58 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.612 0.72 . . . . 0.0 111.007 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.582 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.709 0 C-N-CA 118.971 -1.092 . . . . 0.0 110.327 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 1' ' ' VAL . 5.0 p . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.2 0.524 . . . . 0.0 110.052 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.75 177.54 7.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.393 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.576 ' CB ' ' N ' ' A' ' 22' ' ' THR . 1.4 t -159.4 104.13 1.63 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.434 -0.791 . . . . 0.0 110.486 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.424 ' C ' ' O ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -81.25 176.58 9.63 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.73 -1.232 . . . . 0.0 109.325 179.023 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 19' ' ' ASP . 0.1 OUTLIER -54.57 146.68 33.37 Favored Pre-proline 0 C--N 1.294 -1.812 0 O-C-N 121.379 -0.825 . . . . 0.0 109.666 179.882 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.84 ' HG2' ' CD2' ' A' ' 14' ' ' HIS . 51.7 Cg_endo -70.11 154.2 66.56 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.93 1.489 . . . . 0.0 111.404 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -76.21 172.88 15.44 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.014 1.534 . . . . 0.0 110.281 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 m -69.7 179.47 2.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.161 -0.962 . . . . 0.0 110.007 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.633 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -145.24 -170.16 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 122.335 1.064 . . . . 0.0 111.905 -179.786 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.496 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 14.1 t -46.17 105.75 0.07 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.313 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 10' ' ' SER . 6.6 m120 40.96 26.43 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.352 -0.842 . . . . 0.0 110.763 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -141.38 169.86 24.92 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 30' ' ' SER . 2.5 ptt180 -133.91 -178.55 5.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -1.142 . . . . 0.0 110.332 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.84 ' CD2' ' HG2' ' A' ' 6' ' ' PRO . 39.6 p-80 -120.22 156.23 31.58 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.545 -0.722 . . . . 0.0 110.095 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -173.84 50.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.141 -0.974 . . . . 0.0 110.587 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 17' ' ' TYR . . . -53.92 -78.76 0.1 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.469 ' HB3' ' OE2' ' A' ' 18' ' ' GLU . 0.2 OUTLIER 174.98 35.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.355 -1.085 . . . . 0.0 110.248 179.515 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.469 ' OE2' ' HB3' ' A' ' 17' ' ' TYR . 0.6 OUTLIER 176.81 -178.38 0.16 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 110.428 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 5' ' ' SER . 8.1 t70 -117.49 -43.62 2.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.428 -0.795 . . . . 0.0 109.955 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 3' ' ' CYS . 14.2 m-85 -84.31 130.3 34.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.334 -0.854 . . . . 0.0 109.859 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.607 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.5 OUTLIER -132.42 -6.02 3.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.344 -0.847 . . . . 0.0 110.889 -179.39 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.576 ' N ' ' CB ' ' A' ' 3' ' ' CYS . 66.7 p 45.91 -96.71 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.516 -0.74 . . . . 0.0 111.841 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.402 ' HB2' ' H ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER -150.13 150.89 32.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.843 -1.161 . . . . 0.0 110.661 -178.442 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 79.42 15.49 79.81 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.607 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 20.5 m -97.25 172.77 7.59 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.459 -1.024 . . . . 0.0 110.281 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.706 HG13 ' O ' ' A' ' 43' ' ' VAL . 33.4 t -151.49 151.94 11.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.382 -0.824 . . . . 0.0 110.066 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.636 HG11 ' HB2' ' A' ' 14' ' ' HIS . 34.6 t -134.66 119.89 30.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.223 -0.923 . . . . 0.0 111.583 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.764 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -72.3 103.6 3.45 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.399 -1.321 . . . . 0.0 107.489 177.736 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.669 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 2.2 m-30 -67.55 121.4 15.77 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.338 -0.851 . . . . 0.0 110.074 -178.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -74.76 150.3 39.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.206 -0.934 . . . . 0.0 109.617 179.352 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.479 ' SG ' HD12 ' A' ' 37' ' ' LEU . 60.3 m -118.2 159.51 23.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.176 -0.952 . . . . 0.0 110.306 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 33' ' ' SER . 4.4 t-20 -53.72 134.89 41.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 110.236 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 32' ' ' ASN . 0.5 OUTLIER -44.39 102.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.245 -0.909 . . . . 0.0 110.305 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.73 -11.31 12.17 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -93.84 139.74 30.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.236 -1.155 . . . . 0.0 110.062 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.634 ' HB3' HD11 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -84.62 142.05 30.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.172 -0.955 . . . . 0.0 110.879 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.693 HD21 ' HA ' ' A' ' 41' ' ' SER . 3.2 tp -92.81 97.04 10.51 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.458 -0.776 . . . . 0.0 109.231 179.018 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.904 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -88.42 157.0 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.409 -0.807 . . . . 0.0 109.05 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 91.07 178.22 43.31 Favored Glycine 0 N--CA 1.488 2.11 0 C-N-CA 119.417 -1.373 . . . . 0.0 109.988 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.459 ' O ' ' HG3' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -54.71 124.65 17.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.311 -1.111 . . . . 0.0 109.85 179.729 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.764 ' O ' HG23 ' A' ' 28' ' ' THR . 0.1 OUTLIER -72.45 55.14 0.34 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.206 -0.934 . . . . 0.0 109.956 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.644 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 161.39 96.98 0.11 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.706 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -45.3 173.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.365 -1.079 . . . . 0.0 108.345 179.336 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.477 ' HB3' ' OD2' ' A' ' 52' ' ' ASP . 7.3 tp -134.08 103.37 5.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.984 -1.073 . . . . 0.0 110.371 178.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.549 ' HB2' ' CE2' ' A' ' 50' ' ' TRP . 0.6 OUTLIER -77.23 115.28 16.88 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.367 -0.833 . . . . 0.0 109.45 179.168 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.86 101.74 5.37 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.113 -0.992 . . . . 0.0 110.171 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.402 ' H ' ' HB2' ' A' ' 23' ' ' ASP . . . 77.96 41.15 19.18 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.41 30.76 78.75 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.79 102.09 4.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -1.142 . . . . 0.0 110.552 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.549 ' CE2' ' HB2' ' A' ' 45' ' ' CYS . 89.7 m95 -73.59 123.0 23.14 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.127 -0.983 . . . . 0.0 109.551 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.418 ' O ' ' CG ' ' A' ' 52' ' ' ASP . 22.4 m -129.22 -176.38 3.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.062 -1.024 . . . . 0.0 111.399 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.52 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 1.6 p30 37.56 65.64 2.56 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.851 -0.53 . . . . 0.0 111.191 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.1 Cg_endo -91.09 131.73 1.48 Allowed 'Trans proline' 0 C--N 1.301 -1.946 0 C-N-CA 121.95 1.767 . . . . 0.0 110.03 178.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.541 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 53.8 Cg_endo -76.27 172.67 15.82 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.596 1.314 . . . . 0.0 110.205 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.615 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 37.9 p -114.22 143.16 45.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.08 -1.013 . . . . 0.0 111.291 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 10' ' ' SER . 69.4 m -107.57 78.89 1.24 Allowed 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -113.84 -159.33 0.69 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.481 0.658 . . . . 0.0 110.56 -178.299 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.635 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -110.49 142.8 21.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.426 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.726 HG21 ' CB ' ' A' ' 81' ' ' TYR . 21.3 m -133.44 44.96 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.988 -1.07 . . . . 0.0 110.992 -178.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.629 ' HD2' HG22 ' A' ' 58' ' ' ILE . 2.9 mttp -81.34 102.45 10.45 Favored 'General case' 0 C--N 1.281 -2.377 0 C-N-CA 118.858 -1.137 . . . . 0.0 109.343 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.512 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 53.2 m -72.94 164.0 64.11 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.372 -0.83 . . . . 0.0 111.298 -178.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.544 ' HD2' ' HA ' ' A' ' 108' ' ' THR . 42.5 Cg_endo -69.54 -89.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 124.306 1.687 . . . . 0.0 110.666 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.477 ' HB3' ' CG2' ' A' ' 65' ' ' THR . 0.2 OUTLIER -159.68 133.36 4.97 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.776 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.694 ' HA ' HD21 ' A' ' 113' ' ' LEU . 56.7 Cg_endo -77.93 65.86 8.24 Favored 'Trans proline' 0 C--N 1.296 -2.22 0 O-C-N 123.604 1.318 . . . . 0.0 109.671 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.716 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.7 OUTLIER -87.27 -175.37 5.26 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.533 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.716 HG22 ' C ' ' A' ' 65' ' ' THR . 0.2 OUTLIER 179.7 169.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 C-N-CA 118.756 -1.178 . . . . 0.0 110.721 179.438 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.511 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 4.0 t -69.71 90.89 0.59 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.46 -0.775 . . . . 0.0 110.915 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 1.9 m-80 51.17 34.72 11.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.336 -0.852 . . . . 0.0 110.902 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.666 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -139.15 30.07 2.48 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.57 ' O ' ' N ' ' A' ' 88' ' ' LYS . 4.7 p90 -43.12 -174.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 122.707 1.241 . . . . 0.0 112.789 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.749 HD22 ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -113.73 158.0 21.49 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.056 179.088 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.8 19.44 2.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.094 -1.004 . . . . 0.0 110.086 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.8 t -99.25 -85.14 0.4 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.918 . . . . 0.0 110.844 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -98.62 -86.24 1.86 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.59 ' CE2' ' OH ' ' A' ' 79' ' ' TYR . 17.5 t80 57.3 106.84 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.418 -1.048 . . . . 0.0 110.207 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.61 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -114.96 123.35 48.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.253 -0.905 . . . . 0.0 108.918 179.309 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.526 ' C ' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -28.79 -39.54 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.353 0.597 . . . . 0.0 111.204 -179.073 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -123.52 105.81 10.07 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.379 -0.825 . . . . 0.0 109.739 179.192 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.61 ' CE1' ' O ' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -91.73 175.23 6.97 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.128 -0.982 . . . . 0.0 109.849 -179.517 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.555 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -170.27 107.09 0.33 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.149 -0.97 . . . . 0.0 111.128 179.821 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.726 ' CB ' HG21 ' A' ' 59' ' ' VAL . 10.2 t80 46.77 18.44 0.07 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.091 -1.006 . . . . 0.0 111.809 178.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.661 ' C ' HG22 ' A' ' 102' ' ' THR . 28.5 p30 -172.49 -128.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.186 -1.571 . . . . 0.0 110.841 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.462 ' OD2' ' HA ' ' A' ' 79' ' ' TYR . 11.0 m-20 52.78 72.51 0.41 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.858 -1.151 . . . . 0.0 108.831 -178.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.761 ' CA ' HG23 ' A' ' 102' ' ' THR . 15.5 p30 -68.5 138.41 55.18 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.473 -0.767 . . . . 0.0 110.169 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.608 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 5.2 m -124.54 119.49 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.181 -0.949 . . . . 0.0 110.746 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.537 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 5.2 t0 -81.39 132.56 35.33 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.655 ' CE1' HD12 ' A' ' 71' ' ' LEU . 69.6 m-85 -92.01 120.94 33.12 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 122.326 1.06 . . . . 0.0 112.464 -177.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -92.7 90.68 7.17 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.763 179.594 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.517 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -44.07 131.02 6.02 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.157 -0.965 . . . . 0.0 109.774 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -37.65 -70.9 0.09 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.647 -0.658 . . . . 0.0 110.74 -179.434 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.574 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 49.1 t80 -175.11 145.65 0.81 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.276 -0.89 . . . . 0.0 110.366 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.58 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 46.18 42.21 12.27 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 12.1 m-85 -145.37 150.7 37.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.526 -0.985 . . . . 0.0 109.934 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.531 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 6.8 mtmp? -107.42 138.96 42.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.291 -0.881 . . . . 0.0 109.903 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.63 HD23 ' HB2' ' A' ' 114' ' ' PRO . 0.5 OUTLIER -78.49 100.17 6.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.025 -1.047 . . . . 0.0 110.725 -179.545 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.454 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -78.49 105.91 10.08 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.423 -0.798 . . . . 0.0 109.436 179.273 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 138.62 -88.61 0.2 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.586 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -158.07 112.94 2.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.296 -1.12 . . . . 0.0 110.549 -179.614 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 82.8 p -65.0 -22.11 66.95 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.191 -0.943 . . . . 0.0 110.765 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.6 p -125.65 126.26 44.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.813 -1.179 . . . . 0.0 109.877 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.535 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 4.5 m -135.11 172.57 12.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 0.0 110.429 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.761 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -148.03 140.46 24.42 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.506 -0.746 . . . . 0.0 110.456 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.574 ' O ' ' CA ' ' A' ' 81' ' ' TYR . 7.8 t -59.97 88.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.43 -0.794 . . . . 0.0 109.43 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.465 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.2 OUTLIER -61.53 173.23 0.82 Allowed Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.037 -1.039 . . . . 0.0 111.768 -178.844 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.904 ' CB ' HD12 ' A' ' 38' ' ' ILE . 50.5 Cg_endo -75.37 13.91 1.03 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 124.554 1.818 . . . . 0.0 111.937 -178.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.486 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -112.35 23.14 16.42 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.699 ' O ' HG23 ' A' ' 108' ' ' THR . 39.5 m-80 60.47 48.53 7.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.808 -0.819 . . . . 0.0 110.636 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.699 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.6 OUTLIER -160.98 -179.39 7.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.03 -1.044 . . . . 0.0 111.387 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.691 ' HB3' HD13 ' A' ' 113' ' ' LEU . 42.2 m95 -104.15 99.01 8.74 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.556 0.693 . . . . 0.0 110.845 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.536 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 8.8 mttt -110.19 141.01 22.96 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.503 -0.748 . . . . 0.0 109.59 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.586 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.4 Cg_endo -71.04 168.68 71.45 Favored 'Cis proline' 0 C--N 1.313 -1.312 0 C-N-CA 122.109 -2.038 . . . . 0.0 110.981 -0.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 111' ' ' PRO . 4.3 tt0 -38.97 130.79 1.46 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.502 -0.749 . . . . 0.0 111.106 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.694 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -42.32 146.88 0.63 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.47 -0.769 . . . . 0.0 110.117 179.178 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.675 ' HG2' HD12 ' A' ' 66' ' ' ILE . 41.9 Cg_endo -74.14 173.51 14.0 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 O-C-N 124.382 1.727 . . . . 0.0 110.658 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.542 ' O ' HG22 ' A' ' 117' ' ' VAL . 24.6 ttmt -135.12 111.67 9.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 110.565 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.535 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.8 t -66.15 100.19 0.58 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.344 -0.847 . . . . 0.0 108.809 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -110.57 -177.63 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-O 121.798 0.809 . . . . 0.0 110.825 -179.12 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.296 -1.75 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.472 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.224 0.535 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.6 172.76 6.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.158 -0.964 . . . . 0.0 110.601 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.565 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -124.76 83.73 2.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.441 -0.787 . . . . 0.0 109.829 179.853 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.562 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 9.3 mt-30 -60.11 174.54 0.5 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.291 -0.88 . . . . 0.0 110.417 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 19' ' ' ASP . 1.0 OUTLIER -47.09 144.48 4.0 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.423 -0.798 . . . . 0.0 110.204 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.67 ' HG3' HG11 ' A' ' 27' ' ' VAL . 53.3 Cg_endo -71.52 157.72 55.53 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.988 1.52 . . . . 0.0 110.871 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -76.72 171.96 17.06 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.992 1.522 . . . . 0.0 110.286 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.61 175.96 6.64 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.221 -0.924 . . . . 0.0 109.895 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.604 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -141.14 -170.57 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 122.281 1.039 . . . . 0.0 111.587 179.581 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.4 OUTLIER -44.93 105.13 0.05 Allowed 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.157 -178.998 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.453 ' C ' ' O ' ' A' ' 10' ' ' SER . 0.9 OUTLIER 39.05 27.95 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.315 -0.866 . . . . 0.0 110.583 179.604 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -135.99 160.42 24.61 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -123.2 178.22 5.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -1.131 . . . . 0.0 110.321 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.638 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 11.3 p80 -123.31 135.98 54.46 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.572 -0.705 . . . . 0.0 110.355 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -137.43 64.68 1.52 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.413 -0.804 . . . . 0.0 110.077 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -59.09 -173.59 0.55 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.06 31.61 1.63 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.322 -1.105 . . . . 0.0 110.229 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.568 ' OE2' ' CD1' ' A' ' 21' ' ' TYR . 6.7 pt-20 179.09 -171.81 0.14 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 110.371 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 5' ' ' SER . 29.4 t0 -92.03 -52.54 4.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 110.014 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.573 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 52.0 p90 -104.03 -155.17 0.52 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.177 -0.952 . . . . 0.0 109.983 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.618 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 1.8 m-85 -170.0 -31.62 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.157 -0.964 . . . . 0.0 110.883 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.565 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 3.0 m 78.42 -83.03 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.659 -0.65 . . . . 0.0 111.904 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 47' ' ' GLY . 2.1 t70 -161.93 157.13 23.33 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.745 -1.222 . . . . 0.0 110.14 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.29 14.86 60.25 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.618 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 20.1 m -94.01 176.77 6.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.476 -1.014 . . . . 0.0 110.179 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.664 HG13 ' O ' ' A' ' 43' ' ' VAL . 25.2 t -154.29 158.29 3.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 119.549 -0.861 . . . . 0.0 110.379 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.67 HG11 ' HG3' ' A' ' 6' ' ' PRO . 10.0 t -141.82 113.31 3.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 118.933 -1.107 . . . . 0.0 111.915 -179.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.905 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -69.8 105.21 2.69 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.127 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.645 ' CE1' HG21 ' A' ' 43' ' ' VAL . 3.1 m-30 -67.73 -176.44 0.65 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 110.21 -178.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.464 ' O ' ' CA ' ' A' ' 12' ' ' GLY . 0.6 OUTLIER -142.25 146.94 35.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.434 -0.791 . . . . 0.0 109.626 179.455 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.613 ' SG ' HD12 ' A' ' 37' ' ' LEU . 35.2 m -123.3 137.19 54.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 110.245 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 31' ' ' CYS . 2.5 m-20 -44.04 148.2 0.43 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 110.141 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -47.98 131.06 15.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.0 110.138 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.05 -12.7 52.55 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.513 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 1.9 m-30 -110.17 125.94 53.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.266 -1.138 . . . . 0.0 110.42 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.619 ' HB3' HD11 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -79.86 144.85 33.09 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.322 -0.861 . . . . 0.0 110.977 -179.689 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.656 ' C ' HD13 ' A' ' 38' ' ' ILE . 2.3 tp -95.48 105.11 17.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.347 -0.845 . . . . 0.0 109.935 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.869 HD12 ' HB3' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -97.2 149.56 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.247 -0.908 . . . . 0.0 109.466 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 130.89 -158.71 22.74 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.487 ' O ' ' C ' ' A' ' 41' ' ' SER . 8.5 t-20 -97.89 51.7 1.05 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.107 -1.231 . . . . 0.0 109.897 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.905 ' O ' HG23 ' A' ' 28' ' ' THR . 79.5 p 28.65 45.45 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.499 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.494 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 157.33 126.04 0.89 Allowed Glycine 0 N--CA 1.49 2.299 0 C-N-CA 119.378 -1.392 . . . . 0.0 110.44 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.664 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.7 t -65.01 178.27 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.182 -1.187 . . . . 0.0 107.864 178.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.55 ' C ' ' CD2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -140.41 94.31 2.72 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.057 178.452 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.588 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -81.88 107.75 14.85 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.114 178.566 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.526 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -132.37 121.13 23.0 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.317 -179.479 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.539 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 90.96 8.88 64.5 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.04 27.86 19.84 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -154.22 125.57 7.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.223 -1.163 . . . . 0.0 110.19 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.588 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 92.2 m95 -72.06 137.32 47.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.713 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.93 166.49 25.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.127 -0.983 . . . . 0.0 111.077 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.52 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 87.8 m-20 48.34 65.37 7.16 Favored Pre-proline 0 N--CA 1.492 1.629 0 CA-C-O 121.216 0.532 . . . . 0.0 111.204 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.4 Cg_endo -91.02 151.41 3.87 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 O-C-N 124.433 1.754 . . . . 0.0 110.045 179.096 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.557 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 48.8 Cg_endo -78.72 175.95 10.42 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 123.852 1.448 . . . . 0.0 110.41 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.627 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 17.7 p -119.03 177.55 4.82 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.28 -0.887 . . . . 0.0 110.876 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 10' ' ' SER . 65.4 m -132.93 71.8 1.48 Allowed 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -113.72 171.95 7.27 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.144 -178.713 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -87.66 144.13 9.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 119.349 -0.94 . . . . 0.0 108.577 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.634 HG23 ' CA ' ' A' ' 80' ' ' SER . 34.1 m -130.42 44.9 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.549 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 2.6 mmtt -53.91 179.79 0.02 OUTLIER 'General case' 0 C--N 1.278 -2.507 0 C-N-CA 118.035 -1.466 . . . . 0.0 108.381 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -145.36 165.28 22.25 Favored Pre-proline 0 N--CA 1.492 1.667 0 C-N-CA 118.402 -1.319 . . . . 0.0 112.887 -178.587 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.426 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 45.4 Cg_endo -88.2 -78.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.877 1.988 . . . . 0.0 110.401 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.426 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 170.93 129.26 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.653 -0.654 . . . . 0.0 109.352 -179.365 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.613 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 52.8 Cg_endo -80.97 65.83 8.89 Favored 'Trans proline' 0 C--N 1.298 -2.091 0 O-C-N 123.723 1.38 . . . . 0.0 110.074 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.605 ' O ' HD23 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -84.19 169.0 15.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.468 -0.77 . . . . 0.0 109.9 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.828 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -169.17 161.78 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.035 -1.041 . . . . 0.0 110.638 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.492 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 0.6 OUTLIER -66.28 105.84 1.53 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.544 -0.723 . . . . 0.0 111.025 -179.18 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.459 ' O ' ' CG ' ' A' ' 90' ' ' LYS . 7.4 m-80 38.74 38.64 0.28 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.532 -0.73 . . . . 0.0 110.803 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.828 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -147.38 32.67 1.36 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.584 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 3.6 p90 -46.46 -170.77 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 122.72 1.248 . . . . 0.0 112.515 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.742 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -114.07 168.48 9.78 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.007 179.554 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.3 t -149.67 15.87 0.87 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.848 -1.158 . . . . 0.0 110.644 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.505 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 41.9 t -92.49 -77.1 0.44 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.921 . . . . 0.0 110.515 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -130.87 77.98 0.38 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.62 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -103.85 163.74 12.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.354 -1.086 . . . . 0.0 109.548 179.538 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.62 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 17.0 ttmm -165.2 158.89 16.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 109.941 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.469 ' N ' ' HG2' ' A' ' 76' ' ' LYS . 26.2 mtt180 -54.1 -25.21 20.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.072 -1.017 . . . . 0.0 109.861 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.474 ' O ' ' HD2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -145.14 160.41 41.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.452 -0.78 . . . . 0.0 110.203 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.591 ' OH ' ' CE2' ' A' ' 75' ' ' PHE . 16.2 m-85 -135.75 -150.14 0.36 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.308 -0.87 . . . . 0.0 109.818 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.634 ' CA ' HG23 ' A' ' 59' ' ' VAL . 83.3 p -162.5 -104.96 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.807 -1.183 . . . . 0.0 111.388 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.596 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -114.47 15.87 17.8 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.481 -1.387 . . . . 0.0 110.431 -178.741 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.683 ' O ' HG22 ' A' ' 102' ' ' THR . 7.7 p30 -160.51 -107.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.925 -1.109 . . . . 0.0 110.443 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 82' ' ' ASN . 0.3 OUTLIER 46.34 74.24 0.15 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.806 -1.184 . . . . 0.0 108.734 -179.1 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.952 ' CA ' HG23 ' A' ' 102' ' ' THR . 20.8 t-20 -68.52 122.64 18.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.468 -0.77 . . . . 0.0 110.338 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.533 HG11 ' HG3' ' A' ' 64' ' ' PRO . 23.4 m -104.96 120.04 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 0.0 110.608 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' A' ' 73' ' ' SER . 62.8 t0 -83.72 127.77 34.03 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.742 ' CE1' HD12 ' A' ' 71' ' ' LEU . 35.1 m-85 -85.15 122.52 29.46 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.412 1.101 . . . . 0.0 111.876 -178.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -101.26 88.55 3.51 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.94 -179.778 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.549 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -42.52 129.24 4.03 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.31 -0.869 . . . . 0.0 109.814 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.459 ' CG ' ' O ' ' A' ' 68' ' ' ASN . 2.1 mmmt -38.48 -89.67 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.551 -0.718 . . . . 0.0 110.841 -179.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.573 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 1.9 t80 -153.37 131.13 11.59 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.102 -0.999 . . . . 0.0 110.341 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.584 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 60.11 52.66 51.41 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 26.4 m-85 -158.08 145.79 18.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.54 -0.976 . . . . 0.0 109.764 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.55 ' O ' ' N ' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -103.29 153.18 20.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.529 179.735 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.657 HD23 HD11 ' A' ' 66' ' ' ILE . 2.7 mt -91.32 97.55 11.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.754 -1.216 . . . . 0.0 110.086 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.828 ' HB2' HG21 ' A' ' 117' ' ' VAL . 16.8 t -80.65 107.83 13.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 110.241 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 98' ' ' SER . . . 129.85 -32.42 3.16 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.635 -1.269 . . . . 0.0 110.561 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.513 ' O ' ' HB3' ' A' ' 114' ' ' PRO . 12.7 p 177.18 -168.48 0.06 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.999 -1.295 . . . . 0.0 111.154 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.3 p -160.24 -35.09 0.05 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.247 0.546 . . . . 0.0 109.836 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 82.7 p -130.59 82.82 2.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 0.0 109.556 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.497 ' O ' ' N ' ' A' ' 85' ' ' VAL . 7.1 m -91.0 176.15 6.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.396 -0.815 . . . . 0.0 110.993 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.952 HG23 ' CA ' ' A' ' 84' ' ' ASN . 1.6 m -151.06 142.98 23.91 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.601 -0.687 . . . . 0.0 110.317 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' A' ' 79' ' ' TYR . 8.2 t -75.23 78.02 2.35 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.494 -0.754 . . . . 0.0 109.635 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.514 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -64.43 177.29 0.58 Allowed Pre-proline 0 C--N 1.299 -1.595 0 O-C-N 121.324 -0.86 . . . . 0.0 110.465 -179.664 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.869 ' HB3' HD12 ' A' ' 38' ' ' ILE . 42.0 Cg_endo -69.8 131.73 21.8 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 124.332 1.701 . . . . 0.0 110.142 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 121.9 -10.91 9.5 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 108.679 -1.769 . . . . 0.0 108.679 -179.062 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.591 ' O ' HG23 ' A' ' 108' ' ' THR . 10.4 m-20 79.64 92.25 0.05 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.893 -0.769 . . . . 0.0 110.807 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.591 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -177.51 -162.56 0.07 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.581 179.597 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.613 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 20.5 m95 -147.88 82.78 1.51 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.389 0.614 . . . . 0.0 109.897 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.509 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 9.2 mmtt -91.81 146.51 33.13 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.393 -0.817 . . . . 0.0 109.972 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 110' ' ' LYS . 46.7 Cg_endo -75.42 176.35 43.98 Favored 'Cis proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.654 -2.228 . . . . 0.0 110.481 -0.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.2 OUTLIER -37.17 124.63 0.95 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.685 -0.634 . . . . 0.0 110.741 -179.524 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.609 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.5 OUTLIER -42.57 137.36 2.36 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.873 . . . . 0.0 109.859 179.811 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.742 ' HG2' HD12 ' A' ' 66' ' ' ILE . 49.0 Cg_endo -74.67 165.1 32.32 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 O-C-N 124.258 1.662 . . . . 0.0 111.614 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.887 ' HG2' HG13 ' A' ' 117' ' ' VAL . 12.6 ttmt -126.71 105.19 8.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.538 -0.726 . . . . 0.0 109.924 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.531 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.6 t -55.38 86.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.16 -0.963 . . . . 0.0 109.846 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.887 HG13 ' HG2' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -98.62 -172.16 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 121.822 0.82 . . . . 0.0 110.528 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.2 mtm180 . . . . . 0 C--N 1.294 -1.83 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.497 -179.991 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.366 0.603 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.51 177.39 6.38 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.385 -0.822 . . . . 0.0 110.305 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.547 ' HB2' ' CA ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -125.41 75.35 1.46 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.421 -0.799 . . . . 0.0 110.106 -179.889 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.444 ' O ' ' C ' ' A' ' 5' ' ' SER . 3.0 mp0 -54.17 172.02 0.1 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.041 -1.037 . . . . 0.0 109.725 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.2 p -42.41 144.82 0.89 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 109.94 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.858 ' HG3' HG11 ' A' ' 27' ' ' VAL . 53.9 Cg_endo -70.62 160.45 49.43 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.046 1.551 . . . . 0.0 110.79 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -76.26 170.21 20.46 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 O-C-N 124.014 1.534 . . . . 0.0 109.945 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.55 176.18 6.38 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.141 -0.975 . . . . 0.0 110.27 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.499 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -144.26 -170.33 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 122.24 1.019 . . . . 0.0 111.746 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.484 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.3 OUTLIER -50.27 105.19 0.09 Allowed 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.287 -178.91 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 10' ' ' SER . 65.0 m-20 37.27 47.12 0.65 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.516 -0.74 . . . . 0.0 111.274 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.53 152.85 24.3 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 30' ' ' SER . 1.6 ptt180 -113.04 -172.5 2.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.104 -1.233 . . . . 0.0 111.192 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.623 ' CG ' ' HG2' ' A' ' 6' ' ' PRO . 20.3 p80 -143.99 111.6 6.04 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.294 0.568 . . . . 0.0 109.469 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 14' ' ' HIS . 2.6 t-20 -177.87 174.22 1.46 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.601 -1.312 . . . . 0.0 110.87 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 17' ' ' TYR . . . 145.62 -39.74 1.14 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.468 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.8 OUTLIER 178.17 46.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.513 -0.992 . . . . 0.0 109.568 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.644 ' OE2' HG13 ' A' ' 27' ' ' VAL . 0.9 OUTLIER -134.19 -94.16 0.3 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.225 -0.922 . . . . 0.0 110.491 -179.495 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 9.2 m-20 66.26 6.45 4.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.279 -0.888 . . . . 0.0 110.387 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -170.42 116.48 0.5 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 110.621 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.62 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 18.3 m-85 -132.83 173.47 11.35 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.364 -0.835 . . . . 0.0 109.294 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.547 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 1.9 p -130.59 -68.9 0.67 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.779 -1.2 . . . . 0.0 110.75 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.417 ' C ' ' OD1' ' A' ' 23' ' ' ASP . 14.7 t0 -162.04 132.4 4.85 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.392 -0.818 . . . . 0.0 109.684 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.54 16.19 71.64 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.618 -1.793 . . . . 0.0 108.618 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.62 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.5 OUTLIER -97.73 -179.25 4.38 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.46 -1.023 . . . . 0.0 110.506 -179.808 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 43' ' ' VAL . 11.8 t -149.58 162.26 4.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.041 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.858 HG11 ' HG3' ' A' ' 6' ' ' PRO . 16.4 t -143.07 118.56 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 119.698 -0.801 . . . . 0.0 111.681 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.885 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -75.3 102.41 5.05 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 118.636 -1.225 . . . . 0.0 107.884 177.831 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.725 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.3 m-30 -67.94 127.55 33.25 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.441 -0.787 . . . . 0.0 109.915 -178.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -82.14 142.34 32.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.059 -1.026 . . . . 0.0 109.728 179.404 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.54 ' SG ' HD12 ' A' ' 37' ' ' LEU . 64.3 m -112.56 142.87 44.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.17 -0.956 . . . . 0.0 110.075 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.479 ' O ' ' HB2' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -46.59 167.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 110.141 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 p -64.72 138.81 58.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.108 -0.995 . . . . 0.0 110.425 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.37 6.11 89.5 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.572 ' CD2' ' O ' ' A' ' 56' ' ' CYS . 1.0 OUTLIER -111.63 120.88 43.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.172 -1.193 . . . . 0.0 110.274 -179.881 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.639 ' HB3' HD11 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -79.79 130.45 35.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.394 -0.816 . . . . 0.0 110.942 -179.663 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.701 HD13 ' O ' ' A' ' 29' ' ' TYR . 1.9 tp -81.05 100.15 8.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.377 -0.827 . . . . 0.0 109.131 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.831 HD12 ' HB3' ' A' ' 105' ' ' PRO . 1.0 OUTLIER -89.12 151.05 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.495 -179.716 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.7 -176.66 26.37 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.413 ' OD1' ' O ' ' A' ' 40' ' ' ASN . 12.0 p30 -59.21 143.12 49.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -1.168 . . . . 0.0 109.72 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.885 ' O ' HG23 ' A' ' 28' ' ' THR . 0.4 OUTLIER -76.09 53.27 0.78 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.158 -0.964 . . . . 0.0 110.125 -179.908 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.504 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 160.56 131.07 1.18 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 27' ' ' VAL . 2.2 t -69.58 -175.28 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.113 -1.228 . . . . 0.0 108.364 178.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.635 ' H ' HG12 ' A' ' 43' ' ' VAL . 6.1 tp -143.84 98.54 3.25 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.479 178.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.608 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.8 OUTLIER -84.3 112.47 20.34 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.231 178.895 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 t -124.77 145.94 49.47 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.332 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 54.28 32.09 50.9 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.44 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 69.19 40.01 82.42 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 1.5 mt-10 -151.42 128.04 10.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.298 -1.119 . . . . 0.0 110.502 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.608 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 74.8 m95 -81.95 134.36 35.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.25 -0.907 . . . . 0.0 110.107 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 25.9 t -151.29 163.38 39.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.115 -0.991 . . . . 0.0 110.742 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.52 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 2.4 m-20 64.3 65.5 1.1 Allowed Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.633 -0.667 . . . . 0.0 110.944 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 52.1 Cg_endo -91.77 132.92 1.34 Allowed 'Trans proline' 0 C--N 1.299 -2.053 0 C-N-CA 121.89 1.727 . . . . 0.0 110.173 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.459 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.2 Cg_endo -76.61 172.05 16.92 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.689 1.363 . . . . 0.0 109.488 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.611 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 52.8 p -109.86 148.91 30.67 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.812 -1.18 . . . . 0.0 111.919 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.572 ' O ' ' CD2' ' A' ' 35' ' ' TYR . 86.5 m -111.44 77.62 1.05 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 36' ' ' SER . 1.0 OUTLIER -115.25 -163.72 0.9 Allowed 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.547 0.689 . . . . 0.0 110.502 -178.115 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.634 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -107.7 137.62 38.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.376 -0.828 . . . . 0.0 108.888 179.505 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.688 HG23 ' HA ' ' A' ' 80' ' ' SER . 30.2 m -123.08 41.1 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.034 -1.041 . . . . 0.0 111.229 -178.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.443 ' CD ' HG22 ' A' ' 58' ' ' ILE . 7.8 mtpp -75.49 98.63 3.99 Favored 'General case' 0 C--N 1.284 -2.267 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.443 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 107' ' ' ASN . 64.0 m -70.01 161.96 71.93 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.438 -0.789 . . . . 0.0 111.842 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 44.7 Cg_endo -72.57 -88.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.546 1.814 . . . . 0.0 111.008 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.457 ' CD2' ' HE1' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -172.49 132.12 0.68 Allowed Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.527 -0.733 . . . . 0.0 109.225 -179.321 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.628 ' HA ' HD21 ' A' ' 113' ' ' LEU . 58.2 Cg_endo -85.35 69.85 5.3 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 O-C-N 123.398 1.21 . . . . 0.0 109.886 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.711 ' O ' HG23 ' A' ' 66' ' ' ILE . 3.2 p -87.19 -40.6 14.44 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.464 1.126 . . . . 0.0 109.999 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.775 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER 52.59 160.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.355 -178.894 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.479 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 0.5 OUTLIER -58.64 91.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.474 -0.766 . . . . 0.0 111.576 -178.826 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 47.94 60.27 3.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.378 -0.826 . . . . 0.0 111.471 178.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.576 ' O ' ' CG ' ' A' ' 70' ' ' TYR . . . -143.58 -36.98 0.07 OUTLIER Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.17 -1.491 . . . . 0.0 110.226 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.611 ' CE1' ' HB3' ' A' ' 88' ' ' LYS . 40.2 p90 42.44 -175.34 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 122.097 0.951 . . . . 0.0 110.932 -178.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.988 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -122.75 -32.13 3.59 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.694 -178.549 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.833 ' H ' HD22 ' A' ' 71' ' ' LEU . 0.5 OUTLIER 57.09 15.15 2.27 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.635 -1.291 . . . . 0.0 110.78 177.587 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.421 ' HB2' ' H ' ' A' ' 86' ' ' ASP . 66.2 m -119.49 10.02 11.71 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.524 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 133.91 87.38 0.29 Allowed Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.358 -1.401 . . . . 0.0 110.047 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.585 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -127.36 150.82 49.44 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.31 -1.112 . . . . 0.0 109.55 179.429 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.441 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 2.0 tttp -135.39 170.41 15.99 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.423 -0.798 . . . . 0.0 109.723 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 30.0 mtt85 -67.45 -26.08 66.21 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.307 -0.871 . . . . 0.0 109.855 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.94 150.87 36.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 110.481 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.585 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 13.8 m-85 -128.82 -170.62 2.3 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.292 -0.88 . . . . 0.0 110.332 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.688 ' HA ' HG23 ' A' ' 59' ' ' VAL . 1.2 t -169.83 90.33 0.19 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.227 -0.921 . . . . 0.0 110.136 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.571 ' CB ' HG21 ' A' ' 59' ' ' VAL . 6.6 t80 55.72 134.2 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.158 -0.964 . . . . 0.0 110.042 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.75 ' O ' HG22 ' A' ' 102' ' ' THR . 6.7 t-20 71.66 -129.82 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.822 -1.174 . . . . 0.0 110.578 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.551 ' HB3' ' HB3' ' A' ' 103' ' ' CYS . 5.1 t0 51.62 74.54 0.25 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.653 -1.279 . . . . 0.0 108.921 -178.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.549 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 21.3 t-20 -75.69 141.84 42.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.437 -0.79 . . . . 0.0 111.608 -178.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.805 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -125.9 146.88 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.4 -0.812 . . . . 0.0 109.679 178.834 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.554 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -109.57 108.29 18.69 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.027 -1.046 . . . . 0.0 108.95 179.473 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.988 ' CE1' HD12 ' A' ' 71' ' ' LEU . 35.5 m-85 -66.84 134.93 53.09 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.382 1.087 . . . . 0.0 113.715 -177.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.611 ' HB3' ' CE1' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -123.3 84.37 2.26 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.664 -179.816 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.773 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -32.75 133.7 0.12 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.762 -0.586 . . . . 0.0 111.489 -179.518 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -40.51 -87.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.496 -0.753 . . . . 0.0 110.331 179.584 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -161.94 143.37 10.98 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.173 -0.955 . . . . 0.0 110.03 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.572 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 59.05 24.95 59.07 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.572 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 18.1 m-85 -138.99 144.56 38.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.566 -0.961 . . . . 0.0 109.901 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 117' ' ' VAL . 9.6 ttpt -105.36 153.65 21.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.261 -0.899 . . . . 0.0 109.493 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.773 HD11 ' H ' ' A' ' 89' ' ' CYS . 3.4 mt -88.57 114.14 24.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.708 -1.245 . . . . 0.0 110.445 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.453 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 1.3 t -89.21 97.48 11.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.334 -0.854 . . . . 0.0 109.721 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.26 -111.38 0.64 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.615 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 5.7 t -129.51 127.22 40.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.27 -1.135 . . . . 0.0 110.557 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.487 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 0.8 OUTLIER -74.07 -44.38 54.33 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.388 -0.82 . . . . 0.0 110.37 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 32.2 p -101.21 123.39 45.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.122 -0.986 . . . . 0.0 110.154 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.535 ' C ' ' HG1' ' A' ' 102' ' ' THR . 57.9 m -129.99 -168.14 1.92 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 110.298 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.75 HG22 ' O ' ' A' ' 82' ' ' ASN . 14.6 m -162.72 134.14 5.08 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.252 -0.979 . . . . 0.0 111.134 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.603 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 1.6 t -57.41 95.42 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.677 -0.64 . . . . 0.0 109.48 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.4 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -83.12 173.94 6.77 Favored Pre-proline 0 C--N 1.299 -1.587 0 O-C-N 120.974 -1.079 . . . . 0.0 110.789 -179.609 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.831 ' HB3' HD12 ' A' ' 38' ' ' ILE . 43.9 Cg_endo -76.26 132.16 13.53 Favored 'Trans proline' 0 C--N 1.299 -2.051 0 O-C-N 124.467 1.772 . . . . 0.0 110.703 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.548 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 121.69 -4.04 10.9 Favored Glycine 0 N--CA 1.482 1.748 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.824 ' O ' HG23 ' A' ' 108' ' ' THR . 7.2 m120 80.25 81.28 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.91 -0.759 . . . . 0.0 110.499 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.824 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 177.48 -177.26 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.222 -0.924 . . . . 0.0 111.467 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.805 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 44.6 m95 -124.54 101.77 7.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.624 -0.673 . . . . 0.0 110.515 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.531 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 4.6 mttt -102.59 148.91 36.19 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.25 -0.906 . . . . 0.0 109.871 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.615 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 52.3 Cg_endo -73.28 -175.19 14.18 Favored 'Cis proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.144 -2.023 . . . . 0.0 111.007 -0.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.7 mt-10 -38.37 123.84 1.21 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.339 0.59 . . . . 0.0 110.437 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.661 HD13 ' HB3' ' A' ' 109' ' ' TRP . 2.9 tp -53.9 143.11 42.72 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 110.448 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.775 ' HG2' HD12 ' A' ' 66' ' ' ILE . 41.2 Cg_endo -72.1 155.66 56.6 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.024 1.539 . . . . 0.0 110.594 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.709 ' HG2' HG13 ' A' ' 117' ' ' VAL . 0.4 OUTLIER -120.91 110.87 16.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.327 -0.858 . . . . 0.0 110.508 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 1.3 t -60.48 96.91 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.186 -0.946 . . . . 0.0 109.342 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.709 HG13 ' HG2' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -107.04 -175.35 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 121.798 0.809 . . . . 0.0 111.019 -179.447 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.296 -1.735 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.176 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 62.7 t . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.192 0.52 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.54 149.82 52.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.194 -0.941 . . . . 0.0 110.275 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.528 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.6 m -80.64 138.74 36.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.422 -0.799 . . . . 0.0 110.611 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.446 ' O ' ' C ' ' A' ' 5' ' ' SER . 21.0 mt-30 -119.5 174.28 6.48 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.439 -0.788 . . . . 0.0 109.286 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 19' ' ' ASP . 1.1 p -42.64 133.76 2.83 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 0.0 109.776 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.736 ' HG3' HG11 ' A' ' 27' ' ' VAL . 51.7 Cg_endo -70.2 155.76 63.76 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.944 1.497 . . . . 0.0 111.357 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -76.73 170.67 19.43 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.041 1.548 . . . . 0.0 110.04 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.13 176.2 4.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.168 -0.958 . . . . 0.0 109.689 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.661 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -142.52 -170.32 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 122.178 0.99 . . . . 0.0 111.81 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.531 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 13.2 t -37.69 94.37 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.204 -179.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 9' ' ' ILE . 11.8 m-20 42.9 25.45 0.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.068 -1.02 . . . . 0.0 110.648 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -121.01 -166.56 13.03 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.53 ' HG3' ' CB ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -151.71 178.8 8.99 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.193 -1.181 . . . . 0.0 110.145 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.632 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 9.2 p80 -135.6 141.33 45.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.403 -0.811 . . . . 0.0 110.462 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -171.22 65.54 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.895 . . . . 0.0 110.267 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.41 ' O ' ' CD2' ' A' ' 17' ' ' TYR . . . -60.23 -81.59 0.08 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -177.38 29.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -1.156 . . . . 0.0 110.298 179.876 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.415 ' HG3' ' CE1' ' A' ' 21' ' ' TYR . 0.9 OUTLIER -165.59 -165.92 0.9 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.921 . . . . 0.0 110.212 179.81 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 20' ' ' PHE . 25.1 p-10 -123.27 -41.82 2.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.896 . . . . 0.0 109.947 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.506 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 2.0 m-85 -96.14 149.74 21.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.387 -0.821 . . . . 0.0 110.338 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.688 ' CD2' ' HB3' ' A' ' 25' ' ' SER . 1.6 m-85 -130.91 -2.41 4.1 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.217 -0.927 . . . . 0.0 110.833 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.528 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 15.6 p 42.8 -99.3 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.353 -0.842 . . . . 0.0 111.264 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.534 ' OD1' ' HA ' ' A' ' 46' ' ' SER . 3.6 t0 -156.82 137.53 13.26 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.059 -1.026 . . . . 0.0 110.179 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 86.87 23.75 40.75 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.688 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 58.2 m -116.61 154.41 30.55 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -1.079 . . . . 0.0 109.563 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.909 HG13 ' O ' ' A' ' 43' ' ' VAL . 38.1 t -126.1 149.33 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.884 -1.135 . . . . 0.0 112.556 -177.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.74 ' O ' HG23 ' A' ' 43' ' ' VAL . 45.8 t -121.44 120.77 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.587 -0.696 . . . . 0.0 111.32 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -73.81 103.12 4.24 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 177.443 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 1.026 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.0 m-30 -67.63 121.11 15.18 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.244 -177.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.53 ' CB ' ' HG3' ' A' ' 13' ' ' ARG . 2.3 m -70.81 -163.89 0.08 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.979 -1.075 . . . . 0.0 108.966 179.127 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.53 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 5.5 t -164.38 160.47 20.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.896 -1.127 . . . . 0.0 110.702 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 34' ' ' GLY . 9.7 t-20 -55.56 144.3 26.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.343 -0.848 . . . . 0.0 109.679 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.54 79.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.255 -0.903 . . . . 0.0 110.428 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 32' ' ' ASN . . . 153.7 -28.9 0.75 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.434 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 6.4 m-85 -87.25 134.97 33.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.155 -1.203 . . . . 0.0 110.184 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.733 ' CB ' HG13 ' A' ' 59' ' ' VAL . 1.2 t -80.28 142.49 34.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.278 -0.889 . . . . 0.0 110.527 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.854 HD13 ' O ' ' A' ' 29' ' ' TYR . 2.1 tp -93.81 111.18 22.83 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.375 -0.828 . . . . 0.0 109.21 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.654 ' N ' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -103.53 156.9 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.137 -0.977 . . . . 0.0 109.62 -179.661 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.23 -146.53 16.48 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.535 ' O ' ' C ' ' A' ' 41' ' ' SER . 0.7 OUTLIER -106.16 54.97 0.68 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.107 -1.231 . . . . 0.0 110.021 179.829 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.571 ' O ' HG23 ' A' ' 28' ' ' THR . 7.3 p 14.44 56.62 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.167 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.581 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 155.58 118.83 0.63 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.026 HG21 ' CE1' ' A' ' 29' ' ' TYR . 1.9 t -70.42 -178.77 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.084 -1.244 . . . . 0.0 108.005 178.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.488 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.2 tp -144.15 97.52 3.06 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.715 -1.241 . . . . 0.0 110.531 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.589 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.9 OUTLIER -83.92 111.98 19.74 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.304 178.951 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.534 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 0.4 OUTLIER -123.2 93.22 3.88 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.299 -179.681 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.28 61.52 1.64 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 49.55 27.06 8.08 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -136.47 108.85 7.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.207 -1.172 . . . . 0.0 110.442 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.589 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 70.8 m95 -74.76 135.29 41.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 109.711 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -144.14 157.62 44.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.085 -1.009 . . . . 0.0 111.092 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.534 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 4.4 t70 63.56 64.41 1.38 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.691 -0.631 . . . . 0.0 110.965 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.534 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 53.3 Cg_endo -92.14 133.44 1.28 Allowed 'Trans proline' 0 C--N 1.298 -2.098 0 O-C-N 124.406 1.74 . . . . 0.0 109.674 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.534 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 49.4 Cg_endo -75.93 176.81 9.54 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 O-C-N 123.688 1.362 . . . . 0.0 109.819 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.54 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 6.7 p -111.09 -175.75 2.78 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.995 0.902 . . . . 0.0 111.271 -178.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 10' ' ' SER . 0.8 OUTLIER -144.64 75.08 1.44 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.109 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.522 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.3 OUTLIER -112.85 -158.86 0.66 Allowed 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.913 -178.908 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.637 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -113.78 130.42 67.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 108.603 179.415 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.733 HG13 ' CB ' ' A' ' 36' ' ' SER . 19.2 m -118.49 46.43 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.994 -1.067 . . . . 0.0 112.067 -178.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.499 ' HE3' HG22 ' A' ' 58' ' ' ILE . 1.6 mttt -58.13 -175.11 0.02 OUTLIER 'General case' 0 C--N 1.281 -2.384 0 C-N-CA 117.763 -1.575 . . . . 0.0 107.541 178.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.524 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 1.2 m -141.54 167.38 17.21 Favored Pre-proline 0 C--N 1.293 -1.857 0 C-N-CA 117.811 -1.555 . . . . 0.0 113.814 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.494 ' O ' ' CG ' ' A' ' 63' ' ' HIS . 48.9 Cg_endo -90.08 -69.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 125.026 2.066 . . . . 0.0 110.368 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.494 ' CG ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 165.4 124.24 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.299 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.72 ' HG2' HD21 ' A' ' 71' ' ' LEU . 45.9 Cg_endo -76.47 80.22 2.8 Favored 'Trans proline' 0 C--N 1.301 -1.953 0 O-C-N 123.467 1.246 . . . . 0.0 109.329 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.512 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -102.91 173.79 6.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.872 . . . . 0.0 109.791 -179.33 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.821 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -169.99 166.35 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.334 -0.947 . . . . 0.0 110.305 179.558 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.472 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 16.4 t -75.73 107.04 7.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.488 -0.757 . . . . 0.0 110.652 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.529 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 3.3 m-80 38.89 55.87 2.0 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.567 -0.708 . . . . 0.0 110.643 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.77 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -168.66 32.04 0.18 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.63 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 16.9 p90 -45.25 -174.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 123.463 1.601 . . . . 0.0 112.862 -179.073 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.968 HD11 ' HB2' ' A' ' 75' ' ' PHE . 2.8 pp -100.89 126.79 47.54 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 113.308 -1.769 . . . . 0.0 109.887 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.509 ' HB3' ' HB2' ' A' ' 88' ' ' LYS . 0.2 OUTLIER -96.35 2.48 52.78 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.28 -0.888 . . . . 0.0 109.515 179.767 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.7 t -73.09 -73.91 0.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.38 -0.825 . . . . 0.0 110.572 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.9 97.62 0.12 Allowed Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.626 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.968 ' HB2' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -94.17 145.13 24.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.358 -1.083 . . . . 0.0 109.18 179.053 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.486 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -132.38 160.72 35.53 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.158 -0.964 . . . . 0.0 110.242 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -52.45 -33.99 46.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.225 -0.922 . . . . 0.0 110.394 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.406 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -142.02 165.62 26.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.333 -0.855 . . . . 0.0 110.361 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.582 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 22.3 m-85 -138.06 -138.63 0.14 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.373 -0.83 . . . . 0.0 109.956 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 21.2 p -170.05 -132.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 0.0 109.629 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.646 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 1.6 t80 -101.87 38.23 1.68 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.002 -1.061 . . . . 0.0 109.459 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.676 ' C ' HG22 ' A' ' 102' ' ' THR . 9.4 p30 -169.36 -114.37 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.73 -1.231 . . . . 0.0 110.498 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 82' ' ' ASN . 81.5 m-20 44.83 77.19 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.78 -1.2 . . . . 0.0 109.374 -179.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.823 ' CA ' HG23 ' A' ' 102' ' ' THR . 5.6 p-10 -75.11 113.5 12.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.285 -0.885 . . . . 0.0 110.93 -178.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.578 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 15.7 m -101.56 120.86 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.773 -1.204 . . . . 0.0 110.364 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.537 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 25.8 t0 -76.65 126.3 30.75 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.169 -0.957 . . . . 0.0 109.161 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.634 ' CZ ' HD12 ' A' ' 113' ' ' LEU . 23.4 m-85 -86.97 126.02 34.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.052 -1.03 . . . . 0.0 111.357 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -104.31 110.94 23.37 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.53 -179.377 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.441 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -58.56 133.11 55.55 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.038 -1.039 . . . . 0.0 109.551 179.314 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -42.63 -67.49 0.27 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.12 -179.644 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.521 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.3 OUTLIER -176.66 137.16 0.26 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.413 -0.804 . . . . 0.0 110.345 179.935 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.597 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 54.03 58.22 13.55 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.597 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 12.7 m-85 -162.21 155.84 20.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.534 -0.98 . . . . 0.0 109.819 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.609 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -110.2 124.18 51.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.142 -0.973 . . . . 0.0 110.323 -179.856 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.568 HD23 HD11 ' A' ' 66' ' ' ILE . 1.7 mt -63.7 87.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.373 -0.83 . . . . 0.0 110.033 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.453 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -69.47 104.81 2.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 110.07 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 141.58 -81.53 0.24 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.581 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -169.72 124.73 0.81 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.257 -1.143 . . . . 0.0 110.534 -179.827 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 73.8 p -68.56 -72.19 0.19 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.349 -0.845 . . . . 0.0 110.867 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.537 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 58.6 p -78.19 118.33 20.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.153 -0.967 . . . . 0.0 110.329 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 85' ' ' VAL . 59.9 m -125.25 158.47 34.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.55 -0.719 . . . . 0.0 110.611 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.823 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -135.08 142.26 46.25 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.395 179.694 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.585 ' SG ' ' CZ2' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -67.9 105.41 1.98 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.614 -0.679 . . . . 0.0 110.278 -179.769 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.532 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -76.88 -175.15 0.47 Allowed Pre-proline 0 C--N 1.295 -1.779 0 O-C-N 121.231 -0.918 . . . . 0.0 111.315 -179.411 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.644 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 41.4 Cg_endo -87.78 126.42 2.14 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 124.4 1.737 . . . . 0.0 110.597 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 117.53 2.86 17.15 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.88 ' O ' HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER 79.16 105.61 0.07 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.649 -0.912 . . . . 0.0 110.426 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.88 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER 166.03 -163.39 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.867 0.841 . . . . 0.0 111.271 179.443 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.703 ' HB3' HD11 ' A' ' 113' ' ' LEU . 32.8 m95 -144.91 88.02 1.87 Allowed 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.698 0.761 . . . . 0.0 109.651 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.578 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 14.4 mmmt -98.54 137.08 20.62 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.764 -0.585 . . . . 0.0 110.186 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.581 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 42.8 Cg_endo -69.69 166.25 74.34 Favored 'Cis proline' 0 N--CA 1.49 1.298 0 C-N-CA 122.056 -2.06 . . . . 0.0 110.983 -0.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -38.52 153.23 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.578 -0.702 . . . . 0.0 111.081 -179.168 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.703 HD11 ' HB3' ' A' ' 109' ' ' TRP . 1.2 mm? -64.68 141.61 98.32 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.43 -0.793 . . . . 0.0 109.716 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.821 ' HG2' HD12 ' A' ' 66' ' ' ILE . 42.5 Cg_endo -72.1 165.12 33.56 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 O-C-N 124.189 1.626 . . . . 0.0 110.548 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.728 ' HG2' HG13 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -129.28 107.44 9.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.339 -0.851 . . . . 0.0 109.918 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.538 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 3.0 t -61.17 83.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.276 -0.89 . . . . 0.0 109.466 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.728 HG13 ' HG2' ' A' ' 115' ' ' LYS . 3.3 m -101.86 -169.68 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-O 121.945 0.879 . . . . 0.0 110.89 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.467 ' HG2' ' CE1' ' A' ' 93' ' ' TYR . 6.7 mtm-85 . . . . . 0 C--N 1.291 -1.953 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.211 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.8 p . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.27 0.557 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -119.78 174.73 6.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.412 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.553 ' O ' ' N ' ' A' ' 21' ' ' TYR . 1.1 m -113.54 89.75 3.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.35 -0.844 . . . . 0.0 110.56 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.41 ' O ' ' C ' ' A' ' 5' ' ' SER . 62.3 mt-30 -69.68 172.11 7.99 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.021 -1.05 . . . . 0.0 109.844 179.6 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 19' ' ' ASP . 1.1 p -42.12 141.95 1.28 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 110.138 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.82 ' HG3' HG11 ' A' ' 27' ' ' VAL . 51.1 Cg_endo -71.8 154.89 58.8 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.029 1.542 . . . . 0.0 111.019 -179.494 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -74.74 172.48 16.17 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.868 1.457 . . . . 0.0 110.005 179.458 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.7 p -70.98 174.91 5.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.107 -0.996 . . . . 0.0 110.017 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.728 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -142.8 -170.3 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 122.156 0.979 . . . . 0.0 111.543 179.719 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.523 ' O ' ' CB ' ' A' ' 56' ' ' CYS . 1.2 m -43.54 90.83 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.673 -179.302 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.8 OUTLIER 43.7 53.08 6.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.114 -0.991 . . . . 0.0 110.581 179.827 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.31 147.22 16.15 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.483 ' O ' ' N ' ' A' ' 30' ' ' SER . 1.3 mtp180 -92.98 -167.99 1.85 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.246 -1.149 . . . . 0.0 110.647 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.61 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 17.6 p80 -156.33 -159.19 0.86 Allowed 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.283 0.564 . . . . 0.0 110.543 -179.501 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 13.5 t-20 72.89 141.36 0.06 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.514 -0.741 . . . . 0.0 110.572 179.625 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.54 -57.92 0.19 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -163.63 29.27 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -1.134 . . . . 0.0 110.111 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.72 -178.26 7.19 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.194 -0.941 . . . . 0.0 110.444 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 5' ' ' SER . 24.0 m-20 -124.06 -44.15 2.06 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.417 -0.802 . . . . 0.0 109.976 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -94.92 139.94 30.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 109.94 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.628 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.3 OUTLIER -128.43 -4.67 5.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.254 -0.904 . . . . 0.0 110.625 -179.633 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.53 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 32.2 p 45.86 -97.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.92 . . . . 0.0 111.91 179.768 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.524 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -153.2 158.57 41.93 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.91 -1.119 . . . . 0.0 110.594 -178.51 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.53 25.65 75.36 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 179.733 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.628 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -114.43 171.21 7.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.416 -1.049 . . . . 0.0 110.2 -179.763 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.874 HG13 ' O ' ' A' ' 43' ' ' VAL . 40.6 t -143.08 153.93 16.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.518 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.939 ' O ' HG23 ' A' ' 43' ' ' VAL . 18.8 t -132.86 123.7 49.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.62 -179.262 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.796 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -76.31 103.04 6.13 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.937 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 1.014 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.4 m-30 -68.12 127.27 32.29 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.412 -0.805 . . . . 0.0 110.349 -178.13 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -71.53 158.21 36.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.561 179.451 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.419 ' SG ' HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -133.6 156.82 47.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.113 -0.992 . . . . 0.0 110.337 -179.808 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.36 129.24 37.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.269 -0.894 . . . . 0.0 110.067 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 t -46.57 122.71 4.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 0.0 110.592 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.25 -40.85 1.89 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.478 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.444 ' CE1' HG13 ' A' ' 58' ' ' ILE . 7.9 m-85 -90.86 155.45 18.75 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -1.155 . . . . 0.0 110.786 -179.504 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.693 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -91.45 141.45 28.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.404 -0.81 . . . . 0.0 110.205 179.541 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.536 ' HA ' ' O ' ' A' ' 55' ' ' THR . 0.6 OUTLIER -92.9 97.4 10.72 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.275 -0.89 . . . . 0.0 109.531 179.207 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.822 HG23 ' CB ' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -85.81 142.79 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.421 -0.799 . . . . 0.0 108.985 179.847 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.57 -154.11 21.94 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 42' ' ' GLY . 15.6 p-10 -110.73 51.86 0.75 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.168 -1.195 . . . . 0.0 110.541 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.796 ' O ' HG23 ' A' ' 28' ' ' THR . 75.4 p 28.0 38.6 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.904 179.657 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.53 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 169.09 125.99 0.82 Allowed Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.452 -1.356 . . . . 0.0 110.125 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.014 HG21 ' CE1' ' A' ' 29' ' ' TYR . 2.0 t -71.94 -178.1 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -1.113 . . . . 0.0 108.092 179.026 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.516 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.5 tp -144.59 99.48 3.36 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.251 -0.979 . . . . 0.0 110.225 179.05 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.587 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -87.15 110.17 19.95 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.055 -1.058 . . . . 0.0 109.438 178.686 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.7 p -128.64 123.19 32.59 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.032 -179.774 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.524 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 76.24 35.85 41.76 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.876 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.19 40.88 97.05 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 1.8 mt-10 -157.95 128.94 6.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.379 -1.071 . . . . 0.0 110.292 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.604 ' CH2' HG23 ' A' ' 27' ' ' VAL . 84.2 m95 -82.46 138.53 34.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.792 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -143.73 157.89 44.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.163 -0.961 . . . . 0.0 111.011 -179.574 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.504 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER 63.2 65.46 1.31 Allowed Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.631 -0.668 . . . . 0.0 111.0 179.606 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.504 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.5 Cg_endo -90.64 140.95 3.12 Favored 'Trans proline' 0 C--N 1.301 -1.967 0 C-N-CA 121.851 1.701 . . . . 0.0 109.972 179.158 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.525 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 46.9 Cg_endo -78.71 175.56 10.87 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.729 1.383 . . . . 0.0 110.233 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.568 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 11.1 p -124.38 158.82 31.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.207 -0.933 . . . . 0.0 111.438 -178.914 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.523 ' CB ' ' O ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -116.06 78.37 1.18 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.177 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.455 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -117.2 -158.51 0.7 Allowed 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.875 -178.922 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.584 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -116.06 142.71 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.92 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.713 HG21 ' CB ' ' A' ' 81' ' ' TYR . 12.7 m -127.88 43.05 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.825 -1.172 . . . . 0.0 111.559 -178.663 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -80.91 95.23 6.68 Favored 'General case' 0 C--N 1.281 -2.384 0 C-N-CA 119.071 -1.052 . . . . 0.0 108.593 179.014 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.47 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 32.3 m -69.28 162.33 66.81 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.356 -0.84 . . . . 0.0 111.153 -178.481 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.511 ' HD2' ' HA ' ' A' ' 108' ' ' THR . 49.6 Cg_endo -72.97 -92.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 124.471 1.774 . . . . 0.0 110.349 -179.521 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.465 ' C ' ' CD1' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -155.82 137.45 9.65 Favored Pre-proline 0 C--N 1.299 -1.611 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.62 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.931 ' HG2' HD21 ' A' ' 71' ' ' LEU . 52.2 Cg_endo -77.82 62.61 7.91 Favored 'Trans proline' 0 C--N 1.294 -2.336 0 O-C-N 123.525 1.277 . . . . 0.0 109.072 -179.161 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.474 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.8 OUTLIER -75.66 166.82 22.98 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.098 -179.634 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.967 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -165.87 164.74 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 C-N-CA 118.75 -1.18 . . . . 0.0 110.716 179.81 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.432 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -71.06 95.49 1.21 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.483 -0.761 . . . . 0.0 110.482 -179.534 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.452 ' O ' ' SG ' ' A' ' 116' ' ' CYS . 3.8 m-20 45.67 51.41 10.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 110.593 179.572 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.967 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -162.12 38.9 0.38 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.771 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.582 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 50.2 p90 -49.54 -152.53 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.898 1.333 . . . . 0.0 112.958 -179.393 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.026 HD23 ' CE2' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -141.07 120.56 13.2 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.031 -176.383 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.2 t -100.78 17.9 20.82 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.615 -0.678 . . . . 0.0 109.414 -179.851 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.9 t -77.98 -79.2 0.12 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.582 -0.699 . . . . 0.0 111.255 -179.166 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -122.76 -66.16 0.22 Allowed Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.632 -178.954 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.574 ' HB2' ' CD1' ' A' ' 71' ' ' LEU . 52.1 t80 58.71 167.0 0.05 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.571 -0.958 . . . . 0.0 110.255 -179.144 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.583 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 17.7 tttm -178.14 145.3 0.36 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.408 -0.807 . . . . 0.0 109.748 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -41.79 -32.43 0.4 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.17 -0.956 . . . . 0.0 110.244 -179.824 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.9 m -147.33 166.97 25.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.481 -0.762 . . . . 0.0 110.297 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.583 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 8.7 m-85 -140.5 -172.15 3.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.244 -0.91 . . . . 0.0 110.031 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.584 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 6.6 t -170.24 109.63 0.38 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.935 -1.103 . . . . 0.0 111.161 179.734 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.713 ' CB ' HG21 ' A' ' 59' ' ' VAL . 14.1 t80 32.75 32.64 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.307 -0.871 . . . . 0.0 111.663 179.164 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.545 ' HA ' HG22 ' A' ' 102' ' ' THR . 49.9 t30 -176.63 -134.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.642 -1.286 . . . . 0.0 110.522 179.342 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 50.65 69.66 0.61 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.056 -1.027 . . . . 0.0 109.019 -178.695 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.615 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 0.4 OUTLIER -69.75 131.88 45.24 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.486 -0.759 . . . . 0.0 110.09 -179.204 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.593 ' CG2' HD22 ' A' ' 71' ' ' LEU . 16.2 m -119.27 122.25 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.054 -1.029 . . . . 0.0 111.018 -179.723 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -79.73 138.76 37.4 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.481 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 1.026 ' CE2' HD23 ' A' ' 71' ' ' LEU . 72.5 m-85 -93.59 146.6 23.69 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.918 -1.114 . . . . 0.0 112.215 -178.07 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -118.82 89.93 3.23 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.65 -179.765 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.597 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -42.08 131.16 3.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 0.0 110.249 -179.653 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 89' ' ' CYS . 0.1 OUTLIER -38.99 -66.06 0.31 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.527 -0.733 . . . . 0.0 110.624 -179.535 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.585 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER 176.69 141.74 0.07 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.401 -0.812 . . . . 0.0 110.025 179.978 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.583 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 53.35 46.2 64.36 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.946 -1.661 . . . . 0.0 108.946 -179.605 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.585 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 16.3 m-85 -155.59 152.13 28.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.556 -0.967 . . . . 0.0 109.64 -179.48 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.559 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -112.63 128.18 56.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 110.191 -179.998 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.597 HD11 ' H ' ' A' ' 89' ' ' CYS . 0.7 OUTLIER -64.39 97.05 0.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -0.91 . . . . 0.0 110.422 -179.879 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.456 ' HB2' HG21 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -78.67 101.1 7.32 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.315 -0.866 . . . . 0.0 109.54 179.469 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.22 -85.37 0.18 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.739 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.577 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 2.4 m -158.41 111.69 2.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.329 -1.101 . . . . 0.0 110.641 -179.353 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.8 t -71.65 -5.56 34.57 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.246 -0.909 . . . . 0.0 110.666 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.3 p -138.46 120.02 15.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.115 -0.99 . . . . 0.0 110.185 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.541 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 20.9 m -133.65 172.11 13.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.347 -0.845 . . . . 0.0 110.745 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.58 HG23 ' N ' ' A' ' 84' ' ' ASN . 17.1 m -147.51 136.24 21.96 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.385 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.575 ' O ' ' CA ' ' A' ' 81' ' ' TYR . 4.8 t -48.95 96.2 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.145 179.577 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.472 ' CB ' ' HG3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -64.63 174.22 1.32 Allowed Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.082 -1.011 . . . . 0.0 111.902 -178.935 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.822 ' CB ' HG23 ' A' ' 38' ' ' ILE . 49.7 Cg_endo -82.04 16.47 1.74 Allowed 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 124.613 1.849 . . . . 0.0 111.559 -178.585 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -119.53 25.81 7.54 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 179.307 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.687 ' O ' HG23 ' A' ' 108' ' ' THR . 2.4 m120 61.24 51.63 4.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.746 -0.855 . . . . 0.0 109.932 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.687 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.5 OUTLIER -161.91 -176.72 5.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 0.0 110.977 -179.849 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.623 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 51.0 m95 -109.06 102.03 11.05 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.483 -0.76 . . . . 0.0 110.553 -179.727 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.515 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -107.06 140.53 21.5 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.45 -0.781 . . . . 0.0 110.209 -179.746 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.577 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.1 Cg_endo -73.18 172.44 60.46 Favored 'Cis proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.964 -2.098 . . . . 0.0 110.363 -0.355 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.9 OUTLIER -40.25 137.07 1.1 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.393 -0.817 . . . . 0.0 110.966 -179.278 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.646 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -47.83 146.57 3.86 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.448 -0.782 . . . . 0.0 110.162 179.547 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.787 ' HG2' HD12 ' A' ' 66' ' ' ILE . 39.3 Cg_endo -72.9 167.68 26.67 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 124.38 1.726 . . . . 0.0 111.063 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.513 ' O ' HG22 ' A' ' 117' ' ' VAL . 3.3 ttpt -127.32 109.68 12.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.386 -0.821 . . . . 0.0 110.801 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.531 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.9 t -66.35 90.16 0.15 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.1 -1.0 . . . . 0.0 109.172 179.225 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 94' ' ' LYS . 1.7 m -105.69 -176.26 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 121.73 0.776 . . . . 0.0 110.925 -179.386 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.5 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.762 0 C-N-CA 118.927 -1.109 . . . . 0.0 110.616 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.436 ' H3 ' HG22 ' A' ' 1' ' ' VAL . 16.6 m . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.101 0.477 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.42 166.58 20.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.132 -0.98 . . . . 0.0 110.471 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.506 ' N ' ' O ' ' A' ' 21' ' ' TYR . 0.9 OUTLIER -135.23 83.63 2.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.418 -0.801 . . . . 0.0 109.805 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.84 172.27 0.11 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.05 -1.031 . . . . 0.0 110.229 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 p -52.45 144.02 25.13 Favored Pre-proline 0 C--N 1.301 -1.525 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.071 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.654 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 54.6 Cg_endo -72.35 151.88 54.54 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 123.798 1.42 . . . . 0.0 110.644 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.64 171.49 18.11 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 O-C-N 123.884 1.465 . . . . 0.0 109.722 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.04 177.82 2.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.069 -1.02 . . . . 0.0 109.675 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.615 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -140.93 -170.47 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 122.155 0.979 . . . . 0.0 111.543 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 48.4 t -37.87 95.66 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.998 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.5 OUTLIER 42.33 27.24 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.304 -0.873 . . . . 0.0 110.41 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -126.93 -176.34 14.44 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.53 ' HG3' ' CB ' ' A' ' 30' ' ' SER . 0.5 OUTLIER -138.24 177.64 7.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.258 -1.142 . . . . 0.0 110.578 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.654 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 10.8 p80 -130.19 132.76 46.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.504 -0.748 . . . . 0.0 110.209 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -154.11 80.04 1.12 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.203 -0.936 . . . . 0.0 110.568 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.99 -117.36 0.24 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.97 27.02 1.83 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -1.156 . . . . 0.0 110.392 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.621 ' CG ' ' CZ ' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -163.37 -179.29 6.44 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.18 -0.95 . . . . 0.0 109.998 179.593 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -135.23 19.25 3.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -0.95 . . . . 0.0 110.302 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.05 49.31 0.85 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 110.433 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.621 ' CZ ' ' CG ' ' A' ' 18' ' ' GLU . 13.1 m-85 -50.42 165.69 0.09 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.066 -1.021 . . . . 0.0 109.443 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.503 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 10.1 p -131.78 -70.25 0.58 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.016 -1.053 . . . . 0.0 110.837 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.423 ' OD1' ' HA ' ' A' ' 46' ' ' SER . 4.9 t0 -159.56 137.46 10.15 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.332 -0.855 . . . . 0.0 109.663 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 79.35 13.92 82.15 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.614 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -96.65 171.81 8.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.518 -0.99 . . . . 0.0 109.828 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.834 HG13 ' O ' ' A' ' 43' ' ' VAL . 39.5 t -146.76 154.91 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.121 -0.987 . . . . 0.0 110.796 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.642 ' O ' HG23 ' A' ' 43' ' ' VAL . 20.9 t -133.19 117.09 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.613 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.683 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -72.43 102.5 3.2 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 118.45 -1.3 . . . . 0.0 108.032 177.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.663 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.3 m-30 -68.04 174.5 3.76 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.422 -0.799 . . . . 0.0 109.959 -178.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.53 ' CB ' ' HG3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -135.36 148.17 49.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.913 . . . . 0.0 109.606 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.404 ' O ' ' C ' ' A' ' 32' ' ' ASN . 57.7 m -118.62 147.95 43.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.168 -0.958 . . . . 0.0 110.311 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 31' ' ' CYS . 1.8 t-20 -44.27 150.95 0.27 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.217 -0.927 . . . . 0.0 109.944 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 88.2 p -55.35 99.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 0.0 110.31 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 134.68 -20.09 3.92 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -98.76 131.59 44.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.252 -1.146 . . . . 0.0 110.288 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.721 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -79.57 144.24 34.05 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.336 -0.852 . . . . 0.0 111.123 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.625 HD21 ' HA ' ' A' ' 41' ' ' SER . 0.6 OUTLIER -91.99 102.09 14.64 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.475 -0.766 . . . . 0.0 109.205 178.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.79 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -90.9 142.68 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.077 -1.015 . . . . 0.0 109.734 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 132.35 -158.94 23.2 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.493 ' O ' ' C ' ' A' ' 41' ' ' SER . 0.3 OUTLIER -98.31 49.34 0.99 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.842 -1.387 . . . . 0.0 109.65 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.683 ' O ' HG23 ' A' ' 28' ' ' THR . 0.4 OUTLIER 27.89 57.29 0.1 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.331 179.654 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.581 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 155.63 117.23 0.57 Allowed Glycine 0 N--CA 1.488 2.166 0 C-N-CA 119.465 -1.35 . . . . 0.0 110.023 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.834 ' O ' HG13 ' A' ' 26' ' ' VAL . 2.0 t -62.71 -178.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.991 -1.3 . . . . 0.0 108.013 178.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.555 ' H ' HG12 ' A' ' 43' ' ' VAL . 4.3 tp -144.45 95.11 2.66 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.014 -1.074 . . . . 0.0 110.508 178.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.574 ' SG ' ' CD2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -80.92 110.3 16.31 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.379 178.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.423 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 8.0 t -126.57 111.04 13.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.592 -0.692 . . . . 0.0 110.643 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.07 22.5 38.17 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.454 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 81.01 19.86 66.43 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -140.64 113.64 8.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.099 -1.236 . . . . 0.0 110.526 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.574 ' CD2' ' SG ' ' A' ' 45' ' ' CYS . 87.8 m95 -62.58 138.11 58.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.317 -0.864 . . . . 0.0 109.73 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 52' ' ' ASP . 3.5 m -141.84 171.61 13.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.102 -0.999 . . . . 0.0 111.417 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.465 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER 37.29 67.65 1.82 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.912 -0.493 . . . . 0.0 111.593 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.465 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.0 Cg_endo -90.66 144.03 3.65 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 O-C-N 124.327 1.698 . . . . 0.0 109.592 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.518 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 45.9 Cg_endo -74.68 171.26 18.55 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.618 1.325 . . . . 0.0 110.35 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.582 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 15.7 p -114.18 169.16 9.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.163 -0.961 . . . . 0.0 111.468 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 10' ' ' SER . 37.8 m -126.73 79.32 1.86 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -114.82 -170.8 1.81 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 120.161 -0.615 . . . . 0.0 110.135 -178.746 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.606 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -107.92 112.87 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.192 -0.943 . . . . 0.0 108.504 179.221 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.84 ' O ' HG23 ' A' ' 59' ' ' VAL . 6.0 m -95.92 83.14 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.051 -1.031 . . . . 0.0 111.612 -178.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.2 mtmt -120.31 96.36 5.11 Favored 'General case' 0 C--N 1.289 -2.059 0 O-C-N 120.417 -1.427 . . . . 0.0 108.657 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 79' ' ' TYR . 4.5 p -68.06 162.52 59.03 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.412 -0.805 . . . . 0.0 111.659 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.515 ' HD2' ' HA ' ' A' ' 108' ' ' THR . 42.9 Cg_endo -70.47 -89.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.832 0 O-C-N 124.696 1.892 . . . . 0.0 110.286 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.421 ' O ' HG23 ' A' ' 65' ' ' THR . 0.3 OUTLIER -160.51 130.54 3.45 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.612 ' HG3' HG11 ' A' ' 85' ' ' VAL . 50.9 Cg_endo -77.32 70.85 6.61 Favored 'Trans proline' 0 C--N 1.294 -2.322 0 O-C-N 123.787 1.414 . . . . 0.0 109.818 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.669 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.5 OUTLIER -93.45 -175.78 3.91 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.121 -0.987 . . . . 0.0 109.512 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.669 HG22 ' C ' ' A' ' 65' ' ' THR . 0.4 OUTLIER 177.88 167.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.059 -1.026 . . . . 0.0 110.573 178.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.552 ' O ' ' CB ' ' A' ' 68' ' ' ASN . 2.9 m -64.19 73.15 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.568 -0.708 . . . . 0.0 111.323 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 67' ' ' SER . 0.5 OUTLIER 75.2 -16.72 0.55 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.432 -0.793 . . . . 0.0 111.933 179.093 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.604 ' HA2' ' HA ' ' A' ' 89' ' ' CYS . . . -86.32 35.52 3.3 Favored Glycine 0 N--CA 1.491 2.354 0 O-C-N 120.733 -1.23 . . . . 0.0 110.425 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.573 ' O ' ' O ' ' A' ' 69' ' ' GLY . 2.2 p90 -43.15 -173.49 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 122.712 1.244 . . . . 0.0 112.526 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.724 ' H ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -113.31 161.49 17.18 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.272 178.795 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.8 t -146.97 22.07 1.23 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.173 -0.954 . . . . 0.0 109.917 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.39 -51.37 2.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 0.0 110.898 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.616 ' O ' HG12 ' A' ' 85' ' ' VAL . . . -153.44 88.67 0.13 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.58 ' CE2' ' OH ' ' A' ' 79' ' ' TYR . 1.8 t80 -126.3 117.27 22.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -1.133 . . . . 0.0 110.177 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.62 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 28.2 tttt -113.79 148.06 37.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.201 -0.937 . . . . 0.0 109.656 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.462 ' C ' ' O ' ' A' ' 76' ' ' LYS . 1.3 ttm-85 -42.0 -27.41 0.12 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.968 -1.082 . . . . 0.0 109.873 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 76' ' ' LYS . 40.5 m -140.94 147.12 38.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.525 -0.734 . . . . 0.0 110.283 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.672 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -144.03 178.92 7.53 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.218 -0.926 . . . . 0.0 109.583 179.553 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.57 ' O ' ' O ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -170.43 137.85 1.47 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.067 -1.021 . . . . 0.0 110.315 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.833 ' CB ' HG21 ' A' ' 59' ' ' VAL . 6.6 t80 25.49 105.44 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 120.988 0.423 . . . . 0.0 111.982 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.789 ' O ' HG22 ' A' ' 102' ' ' THR . 10.6 m-20 96.4 -134.86 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 123.373 0.669 . . . . 0.0 109.699 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 52.91 67.65 0.96 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.735 -1.228 . . . . 0.0 108.93 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.645 ' N ' HG23 ' A' ' 102' ' ' THR . 8.1 p30 -69.69 113.04 6.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.556 -0.715 . . . . 0.0 110.969 -178.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.616 HG12 ' O ' ' A' ' 74' ' ' GLY . 30.0 m -94.16 117.58 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.115 -0.991 . . . . 0.0 110.102 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -79.61 131.8 36.09 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.019 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.612 ' CE1' HD12 ' A' ' 71' ' ' LEU . 54.6 m-85 -92.37 116.5 29.03 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.962 -1.087 . . . . 0.0 112.154 -178.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -88.38 94.82 9.97 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.389 179.143 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.604 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 1.7 t -48.17 119.26 2.83 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.036 -1.04 . . . . 0.0 110.466 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.51 ' CG ' ' O ' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -57.17 125.05 20.95 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.227 -0.921 . . . . 0.0 109.96 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.489 ' HB2' ' O ' ' A' ' 90' ' ' LYS . 2.3 m-85 62.44 -174.5 0.14 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.171 -0.956 . . . . 0.0 111.351 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.46 54.73 0.9 Allowed Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.543 ' CB ' ' SG ' ' A' ' 116' ' ' CYS . 5.5 m-85 -106.34 158.08 17.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.325 -1.103 . . . . 0.0 109.448 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.593 ' O ' HG22 ' A' ' 117' ' ' VAL . 9.6 mtmm -99.9 141.6 32.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.073 -1.017 . . . . 0.0 109.655 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.54 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 1.2 mt -87.2 94.11 9.57 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.581 -1.325 . . . . 0.0 110.057 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.565 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -69.61 101.14 1.57 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.233 -0.917 . . . . 0.0 109.127 179.38 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.13 -96.75 0.21 Allowed Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.202 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.596 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 3.3 m -150.19 116.59 5.75 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.165 -1.197 . . . . 0.0 110.577 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.411 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 42.8 p -77.17 10.3 2.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.235 -0.915 . . . . 0.0 111.293 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 77.0 p -154.42 99.4 2.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.849 -1.157 . . . . 0.0 110.48 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 3.5 m -111.57 -174.43 2.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.367 -0.833 . . . . 0.0 110.056 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.789 HG22 ' O ' ' A' ' 82' ' ' ASN . 5.8 m -155.88 144.19 20.03 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.481 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.616 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 42.7 t -65.07 86.15 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.672 -0.642 . . . . 0.0 109.386 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.456 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -62.56 176.57 0.49 Allowed Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.194 -0.941 . . . . 0.0 112.731 -178.148 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.79 ' CB ' HD12 ' A' ' 38' ' ' ILE . 46.5 Cg_endo -80.37 12.5 2.52 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 124.848 1.973 . . . . 0.0 111.777 -178.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -118.46 18.22 11.04 Favored Glycine 0 C--N 1.294 -1.757 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.718 ' O ' HG23 ' A' ' 108' ' ' THR . 1.2 m120 65.22 66.99 0.53 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.696 -0.885 . . . . 0.0 109.796 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.718 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -168.59 -172.84 1.75 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.227 -0.989 . . . . 0.0 111.497 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.616 ' CZ3' ' N ' ' A' ' 103' ' ' CYS . 41.2 m95 -123.3 95.68 4.69 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.571 0.7 . . . . 0.0 110.132 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.552 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -108.33 146.09 32.87 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.537 -0.727 . . . . 0.0 110.249 -179.537 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.596 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 44.3 Cg_endo -72.65 173.37 54.31 Favored 'Cis proline' 0 C--N 1.315 -1.235 0 C-N-CA 121.697 -2.21 . . . . 0.0 110.534 -0.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.3 mm-40 -36.93 131.05 0.76 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.657 -0.652 . . . . 0.0 111.551 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.57 HD23 ' O ' ' A' ' 65' ' ' THR . 0.2 OUTLIER -43.93 154.5 0.37 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.482 -0.761 . . . . 0.0 109.749 179.003 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.574 ' O ' HD12 ' A' ' 66' ' ' ILE . 41.4 Cg_endo -83.59 171.67 10.77 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 O-C-N 124.092 1.575 . . . . 0.0 111.433 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.565 ' HB3' ' CB ' ' A' ' 96' ' ' SER . 3.3 ttpt -129.82 109.65 11.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.366 -0.834 . . . . 0.0 110.2 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.543 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.0 OUTLIER -69.12 108.54 3.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.153 -0.967 . . . . 0.0 109.257 179.715 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -118.95 -174.54 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.635 0.731 . . . . 0.0 110.195 -179.274 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.409 ' HG2' ' CZ ' ' A' ' 93' ' ' TYR . 26.4 mtm180 . . . . . 0 C--N 1.292 -1.9 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.221 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 53.8 t . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.247 0.546 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.624 ' HA ' HG22 ' A' ' 22' ' ' THR . 0.1 OUTLIER -136.17 100.2 4.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.329 -0.857 . . . . 0.0 110.387 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.559 ' O ' ' N ' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -69.72 88.22 0.52 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.213 -0.929 . . . . 0.0 109.779 179.566 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.469 ' O ' ' C ' ' A' ' 5' ' ' SER . 1.1 pt20 -85.43 -174.02 4.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.04 -1.037 . . . . 0.0 110.064 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.469 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.3 OUTLIER -38.3 127.39 1.07 Allowed Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 120.306 -0.557 . . . . 0.0 109.569 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.652 ' HG3' HG11 ' A' ' 27' ' ' VAL . 45.6 Cg_endo -66.31 154.76 72.96 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.902 1.475 . . . . 0.0 111.509 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -75.49 171.52 18.07 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.115 1.587 . . . . 0.0 110.487 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.69 176.0 3.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 110.014 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.639 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -141.57 -170.28 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-O 122.143 0.973 . . . . 0.0 111.463 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.8 OUTLIER -40.78 95.26 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.26 -179.468 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.49 ' N ' ' O ' ' A' ' 9' ' ' ILE . 2.4 m-20 43.08 41.39 2.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 110.352 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' A' ' 30' ' ' SER . . . -146.11 158.23 27.62 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.521 ' HG3' ' CB ' ' A' ' 30' ' ' SER . 4.5 ptt180 -113.82 -179.85 3.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.233 -1.157 . . . . 0.0 110.325 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.623 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 11.5 p80 -128.98 133.42 47.78 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.629 -0.669 . . . . 0.0 110.049 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -136.62 96.36 3.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.052 -1.03 . . . . 0.0 110.877 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.22 179.59 30.99 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -105.91 46.16 0.94 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.078 -1.248 . . . . 0.0 110.245 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.602 ' CG ' ' CZ ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -175.82 -159.7 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.924 . . . . 0.0 110.392 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.5 -27.41 1.05 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.434 -0.791 . . . . 0.0 110.81 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.416 ' C ' ' OE2' ' A' ' 18' ' ' GLU . 25.8 m-85 -109.74 101.98 10.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.02 -1.05 . . . . 0.0 110.849 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.634 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 2.5 m-85 -102.4 44.9 0.99 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.57 -0.706 . . . . 0.0 109.604 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.624 HG22 ' HA ' ' A' ' 2' ' ' LYS . 24.9 p -53.98 99.8 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.1 0.952 . . . . 0.0 111.718 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.533 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 9.8 t70 50.15 165.28 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 121.794 0.807 . . . . 0.0 111.905 178.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.501 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 46.32 26.15 2.24 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.634 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 35.5 m -109.6 154.88 22.15 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.387 -1.066 . . . . 0.0 110.263 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.877 HG13 ' O ' ' A' ' 43' ' ' VAL . 50.5 t -139.14 153.91 25.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.411 -0.915 . . . . 0.0 110.608 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 1.004 ' O ' HG23 ' A' ' 43' ' ' VAL . 28.7 t -141.55 117.39 6.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.384 -0.927 . . . . 0.0 111.245 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.617 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -69.34 102.97 1.86 Allowed 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 118.469 -1.292 . . . . 0.0 107.669 178.256 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 1.039 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.5 m-30 -67.89 177.99 1.93 Allowed 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.749 -0.781 . . . . 0.0 109.979 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.521 ' CB ' ' HG3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -140.77 151.2 44.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 109.708 179.727 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.418 ' O ' ' C ' ' A' ' 32' ' ' ASN . 87.6 m -122.67 149.66 43.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.159 -0.963 . . . . 0.0 110.693 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.418 ' C ' ' O ' ' A' ' 31' ' ' CYS . 5.4 p-10 -42.48 145.55 0.41 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.46 -0.775 . . . . 0.0 110.175 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.4 129.17 31.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.187 -0.946 . . . . 0.0 110.486 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.87 -27.79 15.17 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 -89.39 162.81 15.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.103 -1.233 . . . . 0.0 110.349 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.848 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.9 OUTLIER -103.29 147.33 27.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.406 -0.809 . . . . 0.0 110.964 -179.158 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.663 ' O ' HD23 ' A' ' 37' ' ' LEU . 6.3 tt -100.99 96.35 7.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.307 -0.871 . . . . 0.0 109.688 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.842 HD11 ' HB2' ' A' ' 36' ' ' SER . 0.3 OUTLIER -93.13 139.64 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 109.09 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 150.91 -126.97 2.23 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.506 ' O ' ' C ' ' A' ' 41' ' ' SER . 4.6 m120 -135.16 50.15 2.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -1.164 . . . . 0.0 109.54 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.617 ' O ' HG23 ' A' ' 28' ' ' THR . 2.1 p 25.46 54.84 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.345 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.501 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 150.86 113.42 0.6 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.039 HG21 ' CE1' ' A' ' 29' ' ' TYR . 1.9 t -64.65 -177.99 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.161 -1.2 . . . . 0.0 107.821 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.531 ' HA ' ' O ' ' A' ' 25' ' ' SER . 2.3 tp -146.65 97.89 2.98 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.286 -0.966 . . . . 0.0 110.702 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.595 ' SG ' ' CD2' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -75.08 114.1 13.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.081 -1.012 . . . . 0.0 109.165 178.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 85.1 p -129.73 92.74 3.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.57 -0.706 . . . . 0.0 110.219 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.99 39.42 2.68 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.04 11.92 53.11 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -133.3 120.16 20.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -1.183 . . . . 0.0 110.316 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.616 ' CH2' HG23 ' A' ' 27' ' ' VAL . 73.7 m95 -62.93 137.97 58.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.284 -0.885 . . . . 0.0 109.829 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.2 m -136.63 163.99 29.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.153 -0.967 . . . . 0.0 111.032 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.481 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 3.8 m-20 53.45 66.13 4.94 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.615 -0.678 . . . . 0.0 111.198 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.481 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.7 Cg_endo -90.37 135.85 2.23 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 O-C-N 124.288 1.678 . . . . 0.0 109.643 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.574 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 42.3 Cg_endo -71.54 178.61 5.46 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.591 1.311 . . . . 0.0 110.378 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 5.3 p -121.99 163.13 19.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.372 -0.83 . . . . 0.0 112.028 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 10' ' ' SER . 86.9 m -116.57 85.59 2.34 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -120.32 -141.23 0.34 Allowed 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.45 0.643 . . . . 0.0 110.405 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.714 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -136.32 127.13 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.297 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.848 HG13 ' CB ' ' A' ' 36' ' ' SER . 34.0 m -123.08 49.28 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.031 -1.043 . . . . 0.0 111.61 -178.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 15.0 mtmt -55.99 -179.17 0.02 OUTLIER 'General case' 0 C--N 1.28 -2.431 0 C-N-CA 117.988 -1.485 . . . . 0.0 107.978 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.554 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -145.38 163.39 32.33 Favored Pre-proline 0 C--N 1.297 -1.705 0 C-N-CA 118.707 -1.197 . . . . 0.0 112.297 -179.048 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 42.8 Cg_endo -83.66 -71.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.748 1.92 . . . . 0.0 109.639 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.551 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 162.02 129.46 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.57 ' N ' ' NE1' ' A' ' 109' ' ' TRP . 49.7 Cg_endo -77.12 69.43 7.07 Favored 'Trans proline' 0 C--N 1.299 -2.065 0 O-C-N 123.721 1.38 . . . . 0.0 110.178 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.883 ' O ' HD23 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -99.38 139.31 35.22 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.884 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -131.71 159.29 43.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 C-N-CA 118.594 -1.243 . . . . 0.0 111.057 -178.712 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.472 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 0.1 OUTLIER -58.66 111.85 1.41 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.752 -0.592 . . . . 0.0 111.239 -179.339 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.408 ' O ' ' HG3' ' A' ' 90' ' ' LYS . 1.2 m-20 51.32 25.04 2.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.298 -0.876 . . . . 0.0 109.756 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.55 ' C ' HG23 ' A' ' 66' ' ' ILE . . . -132.45 -177.41 14.9 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.59 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 37.1 p90 -178.54 -172.59 0.29 Allowed 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.541 -0.976 . . . . 0.0 109.388 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.764 HD22 ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -126.44 151.49 47.67 Favored 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.709 178.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.2 t -113.65 -6.72 13.35 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.943 -1.098 . . . . 0.0 109.927 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.93 -80.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.378 -0.826 . . . . 0.0 110.259 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -169.79 93.03 0.1 Allowed Glycine 0 N--CA 1.488 2.162 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.167 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.598 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -86.22 174.95 8.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.359 -1.083 . . . . 0.0 109.171 179.219 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.566 ' N ' ' CG ' ' A' ' 75' ' ' PHE . 4.7 tttt -159.68 159.5 33.05 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.317 -0.864 . . . . 0.0 110.256 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.67 -39.63 17.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.898 . . . . 0.0 109.867 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.58 136.66 18.49 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.507 -0.746 . . . . 0.0 110.099 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.598 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 43.6 m-85 -99.29 -162.17 0.93 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.916 . . . . 0.0 109.774 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.627 ' CA ' HG23 ' A' ' 59' ' ' VAL . 85.6 p -146.59 -104.45 0.1 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -0.895 . . . . 0.0 109.083 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.609 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -111.91 145.14 40.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.818 -1.177 . . . . 0.0 107.904 178.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.897 ' C ' HG22 ' A' ' 102' ' ' THR . 1.6 m120 61.32 -99.43 0.09 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.375 -0.828 . . . . 0.0 110.153 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.476 ' HB2' ' HB3' ' A' ' 103' ' ' CYS . 10.3 m-20 41.14 79.48 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.995 -1.066 . . . . 0.0 109.238 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.765 ' CA ' HG23 ' A' ' 102' ' ' THR . 21.5 t-20 -75.39 143.85 42.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.389 -0.819 . . . . 0.0 112.286 -177.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.84 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 4.5 m -132.37 115.07 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.437 -0.789 . . . . 0.0 109.44 177.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.553 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 2.7 t70 -75.54 134.64 40.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.315 -0.866 . . . . 0.0 108.992 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.68 ' CE1' HD12 ' A' ' 71' ' ' LEU . 45.0 m-85 -94.63 142.47 27.4 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 118.682 -1.207 . . . . 0.0 112.253 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.564 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -120.12 98.71 6.2 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.581 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.686 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -46.92 129.49 11.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.133 -0.979 . . . . 0.0 110.457 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.435 ' O ' ' O ' ' A' ' 89' ' ' CYS . 6.8 mmtp -44.37 -92.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.29 -0.881 . . . . 0.0 110.173 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.556 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 1.9 t80 -152.73 158.81 42.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.211 -0.931 . . . . 0.0 110.049 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.588 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 45.31 25.85 1.32 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.588 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 18.0 m-85 -141.45 147.39 37.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.401 -1.058 . . . . 0.0 110.395 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.1 ptmm? -117.83 129.96 55.98 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.294 -0.879 . . . . 0.0 109.897 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.686 HD11 ' H ' ' A' ' 89' ' ' CYS . 1.2 mt -57.12 103.0 0.1 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.186 -0.946 . . . . 0.0 110.8 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.697 ' HB2' HG21 ' A' ' 117' ' ' VAL . 3.0 t -85.96 91.36 8.35 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.22 -0.925 . . . . 0.0 109.053 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 152.2 -91.27 0.13 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.575 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -149.41 118.85 6.89 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.159 -1.2 . . . . 0.0 110.83 -179.432 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.541 ' HB3' HD13 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -80.88 13.71 2.54 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.25 -0.906 . . . . 0.0 110.918 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 60.2 p -152.91 113.41 4.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.123 -0.985 . . . . 0.0 109.72 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.517 ' HG ' ' HE2' ' A' ' 87' ' ' PHE . 13.0 m -124.6 -177.36 3.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 110.971 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.897 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -153.49 128.2 9.43 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.685 0.755 . . . . 0.0 110.21 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.587 ' N ' ' O ' ' A' ' 82' ' ' ASN . 4.7 t -66.09 81.5 0.08 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.476 ' HA ' ' H ' ' A' ' 82' ' ' ASN . 0.4 OUTLIER -64.38 173.75 1.41 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.342 -0.849 . . . . 0.0 110.988 -179.152 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.799 ' HG3' HG23 ' A' ' 38' ' ' ILE . 41.7 Cg_endo -73.18 120.49 6.6 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 O-C-N 124.586 1.835 . . . . 0.0 110.859 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.557 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 131.51 -6.06 5.57 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.824 ' O ' HG23 ' A' ' 108' ' ' THR . 1.6 m-20 81.0 93.61 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.916 -0.755 . . . . 0.0 111.361 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.824 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 175.02 -168.34 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.475 -0.766 . . . . 0.0 111.198 179.024 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.84 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 36.9 m95 -142.14 94.08 2.62 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.579 -0.7 . . . . 0.0 110.03 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.562 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 14.7 mmtt -103.61 147.17 33.82 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.367 -0.833 . . . . 0.0 110.086 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.575 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.1 Cg_endo -71.98 175.27 43.53 Favored 'Cis proline' 0 N--CA 1.49 1.28 0 C-N-CA 121.956 -2.102 . . . . 0.0 110.956 0.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 113' ' ' LEU . 12.7 pt-20 -37.68 122.39 0.95 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.684 -0.635 . . . . 0.0 110.986 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.883 HD23 ' O ' ' A' ' 65' ' ' THR . 0.9 OUTLIER -41.24 141.14 1.1 Allowed Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.517 -0.739 . . . . 0.0 110.174 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.884 ' HG2' HD12 ' A' ' 66' ' ' ILE . 40.4 Cg_endo -69.8 159.42 53.43 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 124.206 1.635 . . . . 0.0 110.851 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.565 ' HG2' HG13 ' A' ' 117' ' ' VAL . 3.2 ttpm? -119.43 101.34 7.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.919 . . . . 0.0 110.281 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.534 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 4.6 t -61.77 82.3 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.052 -1.03 . . . . 0.0 108.894 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.697 HG21 ' HB2' ' A' ' 96' ' ' SER . 4.5 m -96.48 -171.61 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-O 121.942 0.877 . . . . 0.0 111.37 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.413 ' HG2' ' CE1' ' A' ' 93' ' ' TYR . 9.0 mtm180 . . . . . 0 C--N 1.293 -1.877 0 C-N-CA 119.152 -1.019 . . . . 0.0 110.446 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.642 HG22 ' HA3' ' A' ' 48' ' ' GLY . 4.7 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.227 0.537 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -141.51 176.67 8.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.197 -0.939 . . . . 0.0 110.388 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.536 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.1 m -130.13 87.74 2.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.406 -0.809 . . . . 0.0 110.37 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -70.86 175.4 5.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.815 -1.178 . . . . 0.0 109.926 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -44.09 141.41 2.47 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.31 -0.868 . . . . 0.0 109.977 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.744 ' HG3' HG11 ' A' ' 27' ' ' VAL . 53.2 Cg_endo -70.71 156.38 60.98 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 124.015 1.534 . . . . 0.0 110.845 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -75.23 174.92 11.97 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.955 1.503 . . . . 0.0 110.093 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.38 -179.92 1.81 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.186 -0.946 . . . . 0.0 110.389 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.679 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -145.11 -170.23 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 122.206 1.003 . . . . 0.0 111.45 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.2 OUTLIER -45.1 92.75 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.387 -179.597 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.506 ' N ' ' O ' ' A' ' 9' ' ' ILE . 27.6 m-20 42.62 53.19 4.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.271 -0.893 . . . . 0.0 110.205 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.14 163.66 32.01 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 30' ' ' SER . 10.1 ptp180 -114.92 -178.38 3.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -1.148 . . . . 0.0 110.438 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.62 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 18.1 p80 -136.67 124.21 22.22 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.67 -0.644 . . . . 0.0 110.107 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -133.74 96.12 3.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 110.53 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.25 16.72 58.84 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.426 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 5.7 m-85 53.36 56.46 7.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.356 -1.084 . . . . 0.0 110.162 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.473 ' CD ' ' CE2' ' A' ' 21' ' ' TYR . 0.3 OUTLIER 179.93 -165.25 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.341 -0.849 . . . . 0.0 110.096 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -138.48 -39.98 0.51 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 109.815 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -110.64 136.03 50.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.406 -0.809 . . . . 0.0 109.721 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.645 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.4 OUTLIER -122.27 -7.01 8.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.921 . . . . 0.0 110.605 -179.541 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.536 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 38.2 p 46.06 -95.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.6 -0.687 . . . . 0.0 111.824 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.413 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 1.0 OUTLIER -153.95 151.21 29.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.772 -1.205 . . . . 0.0 110.637 -178.732 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.57 29.92 54.35 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.645 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -121.79 169.7 10.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.356 -1.084 . . . . 0.0 110.552 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.788 HG13 ' O ' ' A' ' 43' ' ' VAL . 24.2 t -142.52 156.29 18.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.888 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.744 HG11 ' HG3' ' A' ' 6' ' ' PRO . 11.9 t -131.19 124.75 56.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.433 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.85 101.91 8.81 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 118.541 -1.264 . . . . 0.0 107.613 177.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.69 ' O ' HD13 ' A' ' 37' ' ' LEU . 1.8 m-30 -68.29 122.11 17.67 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.644 -0.823 . . . . 0.0 110.024 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -86.61 144.69 27.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -0.975 . . . . 0.0 109.574 179.423 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.498 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 33.9 m -102.48 171.43 7.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.152 -0.968 . . . . 0.0 110.563 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -72.03 163.87 27.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -0.894 . . . . 0.0 110.096 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.48 99.84 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 0.0 110.693 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.99 19.29 9.16 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.498 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 6.9 m-85 -117.17 124.47 49.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.049 -1.265 . . . . 0.0 110.185 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.632 ' OG ' HG21 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -74.88 140.5 43.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.35 -0.844 . . . . 0.0 111.261 -179.549 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.69 HD13 ' O ' ' A' ' 29' ' ' TYR . 2.7 tp -92.63 106.95 18.84 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.515 -0.741 . . . . 0.0 109.35 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.746 HD12 ' HB3' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -98.43 155.91 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.151 -0.968 . . . . 0.0 109.394 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.67 175.87 38.44 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.462 ' O ' ' HG3' ' A' ' 54' ' ' PRO . 2.5 m120 -50.82 143.69 9.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -1.152 . . . . 0.0 109.873 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 76.2 p -80.09 51.94 1.45 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -0.95 . . . . 0.0 110.161 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.554 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 161.23 122.87 0.64 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.788 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.4 t -65.62 177.45 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.108 -1.231 . . . . 0.0 108.423 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.534 HD22 ' C ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -141.34 93.4 2.57 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.416 179.308 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.617 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -81.51 110.65 17.1 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.935 -1.106 . . . . 0.0 109.122 178.695 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.33 97.15 3.22 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.568 -0.708 . . . . 0.0 110.034 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.413 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 108.8 39.58 1.7 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.642 ' HA3' HG22 ' A' ' 1' ' ' VAL . . . 60.84 27.7 67.18 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 48' ' ' GLY . 2.7 mt-10 -154.1 132.46 11.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.193 -1.181 . . . . 0.0 110.396 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.617 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 84.8 m95 -82.34 142.85 31.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.882 . . . . 0.0 109.546 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.7 166.1 25.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.902 -1.124 . . . . 0.0 111.499 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.502 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.4 OUTLIER 44.96 65.98 5.72 Favored Pre-proline 0 N--CA 1.496 1.829 0 CA-C-O 121.146 0.498 . . . . 0.0 111.554 179.439 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.502 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.9 Cg_endo -91.33 130.89 1.35 Allowed 'Trans proline' 0 C--N 1.299 -2.04 0 O-C-N 124.342 1.706 . . . . 0.0 109.713 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.479 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.3 Cg_endo -77.47 158.94 32.64 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 123.752 1.396 . . . . 0.0 110.183 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.611 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 38.8 p -99.43 164.18 12.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.246 -0.909 . . . . 0.0 111.184 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 10' ' ' SER . 13.9 m -129.15 74.44 1.58 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.542 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -110.32 -175.43 2.73 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.563 0.697 . . . . 0.0 110.711 -178.025 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.595 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -96.26 128.77 47.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.647 HG23 ' CA ' ' A' ' 80' ' ' SER . 30.7 m -118.55 41.64 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.065 -1.022 . . . . 0.0 111.229 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 0.9 OUTLIER -52.75 179.42 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.323 0 C-N-CA 118.369 -1.333 . . . . 0.0 108.293 179.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.473 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -141.73 169.64 10.8 Favored Pre-proline 0 C--N 1.298 -1.643 0 C-N-CA 118.272 -1.371 . . . . 0.0 113.654 -178.015 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.437 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 46.6 Cg_endo -90.27 -75.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.393 2.062 . . . . 0.0 110.688 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.437 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 170.26 125.31 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.689 -0.632 . . . . 0.0 109.453 -179.125 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.662 ' HA ' HD21 ' A' ' 113' ' ' LEU . 55.3 Cg_endo -77.94 65.73 8.26 Favored 'Trans proline' 0 C--N 1.299 -2.065 0 O-C-N 123.74 1.389 . . . . 0.0 110.171 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.699 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -83.89 -179.1 7.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.38 -0.825 . . . . 0.0 109.629 179.504 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.742 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -179.56 169.49 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.045 -1.035 . . . . 0.0 110.628 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.523 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -74.21 105.76 5.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.572 -0.705 . . . . 0.0 111.037 -179.621 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 33.0 m120 38.47 38.35 0.23 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.587 -0.696 . . . . 0.0 111.129 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.708 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -144.58 27.85 1.93 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.533 ' O ' ' O ' ' A' ' 69' ' ' GLY . 12.4 p90 -43.64 -175.58 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.653 1.216 . . . . 0.0 112.501 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.825 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -112.72 157.52 21.2 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.579 179.234 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.7 t -138.69 23.12 2.68 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.932 -1.105 . . . . 0.0 109.806 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -100.93 -79.03 0.51 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.389 -0.819 . . . . 0.0 111.024 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -131.26 78.41 0.37 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -102.46 169.96 8.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.406 -1.055 . . . . 0.0 109.65 179.525 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.603 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 4.8 tttm -169.39 159.09 8.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.307 -0.871 . . . . 0.0 110.234 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.49 -40.08 11.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.365 -0.834 . . . . 0.0 110.091 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.504 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 0.3 OUTLIER -141.59 172.31 12.86 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.477 -0.765 . . . . 0.0 110.049 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.597 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 6.5 m-85 -141.63 -156.18 0.66 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.328 -0.857 . . . . 0.0 109.949 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.647 ' CA ' HG23 ' A' ' 59' ' ' VAL . 5.4 m -150.72 -111.32 0.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.953 -1.092 . . . . 0.0 110.929 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.619 ' O ' ' CG ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -110.32 18.48 19.83 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.691 -1.256 . . . . 0.0 110.509 -179.145 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.659 ' C ' HG22 ' A' ' 102' ' ' THR . 17.7 p-10 -158.02 -114.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.797 -1.189 . . . . 0.0 110.357 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.9 t0 49.85 73.55 0.25 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.738 -1.226 . . . . 0.0 109.2 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.866 ' CA ' HG23 ' A' ' 102' ' ' THR . 9.4 p30 -69.35 120.69 15.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.306 -0.871 . . . . 0.0 110.252 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.577 HG11 ' HG3' ' A' ' 64' ' ' PRO . 16.1 m -101.34 120.28 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.06 -1.025 . . . . 0.0 110.511 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.417 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -83.22 125.98 32.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.235 -0.915 . . . . 0.0 108.534 179.112 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.825 ' CE1' HD12 ' A' ' 71' ' ' LEU . 72.8 m-85 -86.97 139.21 30.82 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 122.185 0.993 . . . . 0.0 111.827 -178.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -114.43 91.56 3.67 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.809 -179.383 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.531 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -43.35 127.24 4.52 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.259 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 3.3 mmtt -35.58 -77.19 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.682 -178.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.571 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.3 OUTLIER -167.42 135.5 2.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.364 -0.835 . . . . 0.0 110.168 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.583 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 60.27 47.77 89.43 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.583 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 24.3 m-85 -154.28 157.4 38.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.512 -0.993 . . . . 0.0 109.764 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.562 ' O ' HG22 ' A' ' 117' ' ' VAL . 36.6 mtpt -118.38 122.26 42.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 110.063 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.674 HD23 HD11 ' A' ' 66' ' ' ILE . 10.1 mt -60.26 104.61 0.33 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.153 -0.967 . . . . 0.0 110.429 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.624 ' HB2' HG21 ' A' ' 117' ' ' VAL . 12.7 t -92.66 101.98 14.4 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.357 -0.839 . . . . 0.0 109.842 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 98' ' ' SER . . . 146.76 -56.28 0.51 Allowed Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.78 -1.2 . . . . 0.0 110.224 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.563 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 58.8 p 179.49 99.06 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.285 -1.126 . . . . 0.0 110.913 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 53.1 m -65.36 -18.39 65.28 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.121 -0.987 . . . . 0.0 110.372 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.6 p -137.08 101.17 4.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.158 -0.964 . . . . 0.0 109.626 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 85' ' ' VAL . 3.2 m -113.29 168.22 9.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.361 -0.837 . . . . 0.0 111.059 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.866 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -139.74 142.29 36.82 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.58 0.705 . . . . 0.0 110.083 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.599 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -73.25 94.77 2.03 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.555 -0.716 . . . . 0.0 110.663 -179.511 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.536 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -69.4 -175.41 0.27 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.375 -0.828 . . . . 0.0 110.959 -179.739 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.746 ' HB3' HD12 ' A' ' 38' ' ' ILE . 43.2 Cg_endo -81.42 128.52 6.24 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.343 1.707 . . . . 0.0 110.753 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 123.56 -7.65 8.96 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.746 ' O ' HG23 ' A' ' 108' ' ' THR . 1.3 m120 80.92 96.01 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.642 0.734 . . . . 0.0 111.111 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.746 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 176.25 -159.2 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.485 -0.76 . . . . 0.0 110.654 179.341 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.744 ' HB3' HD13 ' A' ' 113' ' ' LEU . 22.6 m95 -145.84 89.95 1.94 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.39 -0.819 . . . . 0.0 110.172 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.517 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 13.6 mttm -100.62 142.77 25.27 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.562 -0.711 . . . . 0.0 110.531 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.563 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.4 Cg_endo -74.19 172.47 61.74 Favored 'Cis proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.68 -2.217 . . . . 0.0 110.266 -0.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.3 mp0 -37.6 127.41 1.13 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.466 -0.771 . . . . 0.0 111.439 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.744 HD13 ' HB3' ' A' ' 109' ' ' TRP . 0.2 OUTLIER -40.74 150.39 0.29 Allowed Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.492 -0.755 . . . . 0.0 110.192 179.116 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.742 ' HG2' HD12 ' A' ' 66' ' ' ILE . 39.6 Cg_endo -76.01 165.95 28.87 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 O-C-N 124.177 1.619 . . . . 0.0 110.937 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.539 ' O ' HG22 ' A' ' 117' ' ' VAL . 12.5 ttpt -129.84 101.8 6.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.268 -0.895 . . . . 0.0 110.034 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.529 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.2 t -55.59 91.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.098 -1.001 . . . . 0.0 109.377 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.624 HG21 ' HB2' ' A' ' 96' ' ' SER . 1.5 m -104.8 -177.79 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 121.714 0.768 . . . . 0.0 110.641 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.517 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 5.0 ptt-85 . . . . . 0 C--N 1.295 -1.776 0 C-N-CA 119.014 -1.075 . . . . 0.0 110.549 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 54.4 t . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.318 0.58 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.75 170.3 10.24 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.242 -0.911 . . . . 0.0 110.419 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.579 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.2 m -125.44 142.14 51.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.411 -0.806 . . . . 0.0 109.531 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 4.6 mp0 -113.0 175.86 5.26 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.015 -1.053 . . . . 0.0 109.807 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.57 140.87 56.55 Favored Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 121.298 -0.876 . . . . 0.0 109.734 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.815 ' HG3' HG11 ' A' ' 27' ' ' VAL . 49.2 Cg_endo -71.49 153.25 60.6 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 O-C-N 124.023 1.538 . . . . 0.0 110.717 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.61 173.01 14.59 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.863 1.454 . . . . 0.0 110.009 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.61 176.44 3.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.917 . . . . 0.0 109.935 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.68 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -143.43 -169.61 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 122.194 0.997 . . . . 0.0 111.336 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 11' ' ' ASN . 0.3 OUTLIER -46.61 93.56 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.683 -179.312 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.46 ' N ' ' O ' ' A' ' 9' ' ' ILE . 4.2 m-80 42.08 53.15 4.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.195 -0.941 . . . . 0.0 110.427 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.05 152.59 24.01 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.461 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -98.14 -167.76 1.56 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -1.147 . . . . 0.0 110.686 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.636 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 20.7 p80 -153.19 113.04 3.9 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.537 0.684 . . . . 0.0 110.191 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.414 ' O ' ' C ' ' A' ' 16' ' ' GLY . 0.9 OUTLIER -138.78 63.57 1.51 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.101 -0.999 . . . . 0.0 110.098 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 17' ' ' TYR . . . -44.01 -77.11 0.1 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.431 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 9.8 t80 -178.01 36.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -1.113 . . . . 0.0 110.197 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.566 ' OE2' ' CG ' ' A' ' 21' ' ' TYR . 2.0 pt-20 178.5 -161.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.89 . . . . 0.0 110.011 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -117.37 -36.84 3.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.227 -0.92 . . . . 0.0 110.286 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.535 ' O ' ' CG ' ' A' ' 20' ' ' PHE . 21.9 p90 -129.99 123.55 30.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.152 -0.967 . . . . 0.0 110.471 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.637 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 14.0 m-85 -92.08 -167.79 1.85 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.451 -0.78 . . . . 0.0 110.27 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.579 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 0.6 OUTLIER -141.84 -64.66 0.43 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.915 -1.116 . . . . 0.0 110.964 -179.483 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 7.8 t0 -169.07 144.37 3.23 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.466 -0.771 . . . . 0.0 109.492 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.449 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 68.47 13.79 65.91 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.637 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 16.2 m -88.94 177.71 6.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.527 -0.984 . . . . 0.0 110.094 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 43' ' ' VAL . 24.4 t -154.15 155.54 6.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.498 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.815 HG11 ' HG3' ' A' ' 6' ' ' PRO . 16.1 t -136.22 114.8 15.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 119.416 -0.914 . . . . 0.0 111.684 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.464 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -71.66 104.56 3.39 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.431 -1.308 . . . . 0.0 107.626 177.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.887 ' O ' HD13 ' A' ' 37' ' ' LEU . 2.1 m-30 -67.79 130.48 43.13 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.135 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 13' ' ' ARG . 1.0 OUTLIER -82.24 160.33 23.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 109.808 179.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 12.4 m -130.45 162.87 28.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.154 -0.966 . . . . 0.0 110.107 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -64.13 152.57 40.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 110.088 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.12 108.72 0.27 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 110.418 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 109.44 -6.76 31.95 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 3.2 m-30 -95.18 128.88 42.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.208 -1.172 . . . . 0.0 110.279 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.587 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -81.94 145.93 30.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.189 -0.945 . . . . 0.0 110.96 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.887 HD13 ' O ' ' A' ' 29' ' ' TYR . 4.5 tp -94.73 98.4 10.75 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.445 -0.784 . . . . 0.0 108.932 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.823 HD12 ' HB2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -91.28 160.51 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.252 -0.905 . . . . 0.0 109.476 -179.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 95.53 -179.33 35.88 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -53.78 142.13 24.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.162 -1.199 . . . . 0.0 109.714 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.464 ' O ' HG23 ' A' ' 28' ' ' THR . 9.6 p -73.62 53.8 0.44 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.935 . . . . 0.0 110.256 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.616 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 148.24 122.9 1.3 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.676 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.6 t -54.87 -179.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.162 -1.199 . . . . 0.0 107.926 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.492 ' H ' HG12 ' A' ' 43' ' ' VAL . 0.3 OUTLIER -143.42 96.75 2.96 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.237 178.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.596 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -81.36 104.86 12.1 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.112 178.604 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.7 p -129.49 102.78 6.54 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.478 -0.764 . . . . 0.0 110.229 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.64 26.13 8.78 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.57 21.66 78.73 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -141.26 110.49 6.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -1.203 . . . . 0.0 110.365 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.596 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 88.2 m95 -64.27 136.6 57.33 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.239 -0.913 . . . . 0.0 109.894 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.429 ' O ' ' HB3' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -143.97 158.79 43.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 110.837 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.488 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 20.7 t0 60.32 66.31 1.96 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.753 -0.592 . . . . 0.0 111.242 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 48.7 Cg_endo -90.71 131.13 1.57 Allowed 'Trans proline' 0 C--N 1.301 -1.973 0 O-C-N 124.342 1.707 . . . . 0.0 109.682 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.548 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.9 Cg_endo -77.0 170.53 19.6 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 O-C-N 123.809 1.426 . . . . 0.0 110.035 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.539 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 12.3 p -113.16 147.87 36.54 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.066 -1.021 . . . . 0.0 111.824 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 36' ' ' SER . 42.2 m -114.11 78.68 1.17 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -114.07 -156.81 0.61 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.324 0.583 . . . . 0.0 110.324 -178.564 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.657 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -109.27 139.7 31.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.341 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.711 ' HB ' ' HA ' ' A' ' 105' ' ' PRO . 34.1 m -130.31 52.67 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 120.889 -1.132 . . . . 0.0 111.525 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 2.9 mptt -81.55 171.01 15.18 Favored 'General case' 0 C--N 1.282 -2.353 0 C-N-CA 118.349 -1.34 . . . . 0.0 107.567 178.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.465 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 60.3 m -140.81 164.74 34.35 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 120.302 -1.499 . . . . 0.0 113.031 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 40.1 Cg_endo -69.55 -86.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 124.886 1.993 . . . . 0.0 110.569 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.463 ' CD2' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -176.02 136.72 0.48 Allowed Pre-proline 0 C--N 1.301 -1.53 0 O-C-N 121.517 -0.739 . . . . 0.0 109.531 -179.616 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.599 ' HG3' ' CZ2' ' A' ' 109' ' ' TRP . 57.6 Cg_endo -86.21 69.9 4.54 Favored 'Trans proline' 0 C--N 1.297 -2.14 0 O-C-N 123.756 1.398 . . . . 0.0 109.599 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.698 ' O ' HG23 ' A' ' 66' ' ' ILE . 3.2 p -84.77 -43.74 13.96 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 122.506 1.146 . . . . 0.0 109.78 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.698 HG23 ' O ' ' A' ' 65' ' ' THR . 0.0 OUTLIER 56.22 160.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.828 -178.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.517 ' N ' HG13 ' A' ' 66' ' ' ILE . 8.1 t -63.7 98.18 0.18 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.479 -0.763 . . . . 0.0 111.345 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.451 ' C ' ' HG3' ' A' ' 90' ' ' LYS . 3.6 m-20 44.72 52.21 7.94 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.4 -0.813 . . . . 0.0 111.255 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.593 ' O ' ' CD2' ' A' ' 70' ' ' TYR . . . -135.32 -39.47 0.17 Allowed Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.308 -1.425 . . . . 0.0 109.635 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 16.2 p90 41.36 -177.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 122.807 1.289 . . . . 0.0 112.222 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.893 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -130.69 153.13 49.3 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.138 -179.047 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.1 t -112.51 -9.47 13.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.65 -1.281 . . . . 0.0 110.781 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.512 ' HB2' ' HB2' ' A' ' 86' ' ' ASP . 11.0 t -55.8 -70.31 0.12 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.175 -0.953 . . . . 0.0 110.269 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.42 101.58 0.15 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.557 ' C ' ' CD1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -98.71 145.24 27.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.312 -1.11 . . . . 0.0 110.005 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.444 ' HG2' ' N ' ' A' ' 77' ' ' ARG . 10.4 tttm -126.16 165.74 18.34 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.438 -0.789 . . . . 0.0 109.419 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.444 ' N ' ' HG2' ' A' ' 76' ' ' LYS . 8.6 mtp180 -56.09 -56.0 26.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.062 -1.024 . . . . 0.0 110.023 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.6 171.28 8.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.467 -0.77 . . . . 0.0 109.948 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.572 ' CD1' ' CZ2' ' A' ' 109' ' ' TRP . 27.1 m-85 -145.03 -179.88 6.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 0.0 110.219 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.534 ' O ' ' HB3' ' A' ' 103' ' ' CYS . 1.5 m -158.49 176.07 12.89 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.156 -0.965 . . . . 0.0 110.981 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.598 ' H ' ' CG2' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -38.57 -24.94 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.83 -0.544 . . . . 0.0 111.546 -178.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.688 ' O ' HG22 ' A' ' 102' ' ' THR . 43.8 t-20 -116.67 -122.48 0.29 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.779 -1.201 . . . . 0.0 110.094 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 51.98 71.08 0.49 Allowed 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.761 -1.212 . . . . 0.0 108.979 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.567 ' N ' HG23 ' A' ' 102' ' ' THR . 9.3 p30 -72.18 152.32 42.33 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.894 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.795 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 0.3 OUTLIER -133.04 121.12 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.337 -0.852 . . . . 0.0 110.261 179.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.547 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 3.3 t0 -81.76 122.01 27.13 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.246 -0.909 . . . . 0.0 109.033 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.893 ' CE1' HD12 ' A' ' 71' ' ' LEU . 28.3 m-85 -80.48 132.52 35.71 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.275 1.035 . . . . 0.0 112.531 -177.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.598 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 4.2 tmtt? -116.41 87.59 2.72 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.046 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.558 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -36.5 131.21 0.68 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.434 -0.791 . . . . 0.0 111.315 -179.349 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.451 ' HG3' ' C ' ' A' ' 68' ' ' ASN . 0.3 OUTLIER -39.01 -93.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.542 -0.724 . . . . 0.0 110.966 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.569 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 77.3 t80 -152.95 120.27 5.89 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.101 -0.999 . . . . 0.0 110.311 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.578 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 72.06 54.74 7.75 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.578 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 63.0 m-85 -159.42 150.76 20.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.482 -1.011 . . . . 0.0 109.925 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.553 ' O ' HG22 ' A' ' 117' ' ' VAL . 7.9 mtmt -104.89 140.53 38.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.237 -0.914 . . . . 0.0 110.252 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.56 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 7.1 mt -80.8 99.79 8.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.89 -1.131 . . . . 0.0 110.267 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 3.7 t -82.39 93.73 7.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.185 -0.947 . . . . 0.0 109.962 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 114' ' ' PRO . . . 154.15 -97.2 0.17 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.615 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 15.3 t -150.79 122.03 7.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.191 -1.182 . . . . 0.0 110.276 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.414 ' O ' ' CD2' ' A' ' 87' ' ' PHE . 79.4 p -58.51 -58.94 6.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.246 -0.909 . . . . 0.0 110.426 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 51.5 p -91.75 138.67 31.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.407 -0.808 . . . . 0.0 110.197 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.547 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 70.7 m -144.58 169.93 17.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.393 -0.817 . . . . 0.0 109.974 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.688 HG22 ' O ' ' A' ' 82' ' ' ASN . 1.8 m -147.88 134.44 19.8 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.32 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 108' ' ' THR . 1.8 t -54.77 87.47 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.51 -0.744 . . . . 0.0 109.502 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -53.05 170.8 0.24 Allowed Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.033 -1.042 . . . . 0.0 112.417 -178.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.823 ' HB2' HD12 ' A' ' 38' ' ' ILE . 51.5 Cg_endo -81.88 15.58 1.92 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 125.012 2.059 . . . . 0.0 111.37 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.555 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -114.59 13.32 20.64 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.862 ' O ' HG23 ' A' ' 108' ' ' THR . 11.1 t30 77.69 62.33 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.892 -0.769 . . . . 0.0 110.351 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.862 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -177.68 178.0 1.05 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 118.818 -1.153 . . . . 0.0 111.891 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.795 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 25.2 m95 -104.2 89.65 3.33 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.233 0.54 . . . . 0.0 110.746 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.544 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 3.8 mmtm -98.01 154.63 37.68 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.222 -0.924 . . . . 0.0 109.502 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.615 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 51.5 Cg_endo -71.71 -174.43 11.48 Favored 'Cis proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.258 -1.976 . . . . 0.0 111.054 -0.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -36.87 120.69 0.73 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.347 0.594 . . . . 0.0 110.762 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.676 HD13 ' HB3' ' A' ' 109' ' ' TRP . 4.2 tp -54.01 138.97 54.64 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.339 -0.851 . . . . 0.0 110.096 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.585 ' HG3' ' CD2' ' A' ' 87' ' ' PHE . 40.6 Cg_endo -70.17 158.81 55.25 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 O-C-N 124.051 1.553 . . . . 0.0 110.565 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.641 ' HG2' HG13 ' A' ' 117' ' ' VAL . 61.5 tttt -126.7 94.05 3.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.665 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.554 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 1.6 t -45.16 96.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.222 -0.924 . . . . 0.0 109.113 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.641 HG13 ' HG2' ' A' ' 115' ' ' LYS . 0.7 OUTLIER -109.93 -173.24 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 121.83 0.824 . . . . 0.0 110.59 -179.262 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.421 ' CG ' ' CE1' ' A' ' 93' ' ' TYR . 11.7 mtp180 . . . . . 0 C--N 1.293 -1.887 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.555 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.169 0.509 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.04 178.46 6.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 110.51 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.591 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 9.2 t -141.26 132.79 26.97 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.457 ' O ' ' C ' ' A' ' 5' ' ' SER . 5.3 mt-30 -115.13 179.27 4.0 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.141 -0.974 . . . . 0.0 110.041 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.2 OUTLIER -40.22 141.04 0.88 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.701 -0.624 . . . . 0.0 109.986 -179.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.759 ' HG3' HG11 ' A' ' 27' ' ' VAL . 50.6 Cg_endo -70.3 154.87 65.24 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 123.993 1.523 . . . . 0.0 111.028 -178.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -75.01 173.57 14.28 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.049 1.552 . . . . 0.0 109.957 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.47 178.42 2.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.222 -0.924 . . . . 0.0 110.16 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.656 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -144.13 -170.09 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.208 1.004 . . . . 0.0 111.196 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 11' ' ' ASN . 21.7 m -44.1 92.56 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.455 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 9' ' ' ILE . 2.3 m-80 43.59 54.04 5.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 110.243 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.456 ' O ' HG13 ' A' ' 9' ' ' ILE . . . -157.71 146.98 14.36 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.55 ' HG2' ' CB ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -97.48 -176.9 3.63 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.331 -1.099 . . . . 0.0 110.335 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.626 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 19.3 p80 -140.15 158.89 43.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.64 -0.662 . . . . 0.0 110.334 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.559 ' HB2' HG13 ' A' ' 27' ' ' VAL . 10.8 m120 -47.71 162.77 0.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.924 . . . . 0.0 110.246 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -156.6 26.12 0.52 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -87.13 14.44 7.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.105 -1.232 . . . . 0.0 110.222 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.548 ' HG3' ' CE2' ' A' ' 21' ' ' TYR . 8.8 pm0 -135.05 -150.31 0.38 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.933 . . . . 0.0 109.994 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 4' ' ' GLN . 2.9 t70 -163.63 -36.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 110.209 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.575 ' CD2' ' O ' ' A' ' 20' ' ' PHE . 16.3 p90 -135.41 81.53 1.9 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.965 . . . . 0.0 109.97 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.614 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 1.6 m-85 -59.27 -23.88 62.75 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.556 -0.715 . . . . 0.0 110.872 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.563 ' N ' ' HB3' ' A' ' 3' ' ' CYS . 91.2 m 58.89 -95.53 0.06 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.377 -0.827 . . . . 0.0 111.424 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 4.3 t0 -147.56 150.28 34.17 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.987 -1.071 . . . . 0.0 110.331 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 77.1 18.9 78.0 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.614 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -103.4 160.2 14.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.571 -0.958 . . . . 0.0 110.563 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.789 HG13 ' O ' ' A' ' 43' ' ' VAL . 39.4 t -141.07 156.92 22.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.418 -0.801 . . . . 0.0 110.522 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.759 HG11 ' HG3' ' A' ' 6' ' ' PRO . 20.0 t -138.03 122.54 22.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 119.186 -1.006 . . . . 0.0 111.691 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.77 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -76.34 103.55 6.42 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.73 ' O ' HD13 ' A' ' 37' ' ' LEU . 2.6 m-30 -68.67 125.6 27.07 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.414 -178.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.55 ' CB ' ' HG2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -92.91 147.16 23.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.155 -0.965 . . . . 0.0 109.621 179.269 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 37' ' ' LEU . 34.0 m -106.63 159.83 15.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.115 -0.991 . . . . 0.0 110.681 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.461 ' O ' ' N ' ' A' ' 34' ' ' GLY . 5.0 t30 -52.06 160.76 0.69 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.361 -0.837 . . . . 0.0 110.007 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.23 79.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 110.537 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 32' ' ' ASN . . . 145.08 -10.42 1.8 Allowed Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.706 -1.235 . . . . 0.0 110.206 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -97.04 137.66 35.78 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.049 -1.265 . . . . 0.0 110.478 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.721 ' HB2' HG13 ' A' ' 59' ' ' VAL . 0.5 OUTLIER -82.68 145.41 29.64 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.394 -0.816 . . . . 0.0 110.914 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.73 HD13 ' O ' ' A' ' 29' ' ' TYR . 9.5 tp -98.41 106.42 18.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.473 -0.767 . . . . 0.0 109.687 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.784 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -101.31 163.31 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.923 . . . . 0.0 109.069 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.19 176.96 44.84 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -55.69 133.1 50.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.236 -1.155 . . . . 0.0 109.846 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.77 ' O ' HG23 ' A' ' 28' ' ' THR . 81.2 p -76.88 54.01 0.97 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -0.949 . . . . 0.0 110.158 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.539 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 167.38 109.56 0.22 Allowed Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.695 -1.241 . . . . 0.0 110.131 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.789 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -58.59 177.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.032 -1.275 . . . . 0.0 108.16 178.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.84 99.79 3.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.158 -0.964 . . . . 0.0 110.259 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.624 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 3.1 t -84.63 111.86 19.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.144 -0.972 . . . . 0.0 109.31 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.6 t -124.84 82.67 2.07 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.166 -0.959 . . . . 0.0 110.395 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.16 45.06 1.92 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.445 ' HA2' ' HB2' ' A' ' 3' ' ' CYS . . . 62.75 15.2 54.1 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -126.28 97.43 5.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.223 -1.163 . . . . 0.0 110.338 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.624 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 87.7 m95 -66.59 137.46 56.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -0.95 . . . . 0.0 109.822 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.31 162.88 34.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.149 -0.969 . . . . 0.0 111.189 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.524 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 33.3 m-20 56.41 65.13 4.32 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.852 -0.53 . . . . 0.0 111.445 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.3 Cg_endo -92.33 134.96 1.39 Allowed 'Trans proline' 0 C--N 1.299 -2.042 0 O-C-N 124.379 1.726 . . . . 0.0 109.521 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.512 ' HG2' ' HB2' ' A' ' 29' ' ' TYR . 47.4 Cg_endo -78.19 174.23 12.76 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 123.607 1.319 . . . . 0.0 109.758 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.556 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 17.1 p -113.15 144.97 41.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.045 -1.034 . . . . 0.0 112.219 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 11.0 m -113.63 77.13 1.03 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 36' ' ' SER . 4.5 mm-40 -111.77 -171.53 1.86 Allowed 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.531 0.682 . . . . 0.0 110.945 -177.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.594 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -101.58 128.25 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.301 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.721 HG13 ' HB2' ' A' ' 36' ' ' SER . 20.6 m -118.65 52.31 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.058 -1.026 . . . . 0.0 111.039 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.465 ' N ' ' OD1' ' A' ' 107' ' ' ASN . 1.6 mttp -83.97 110.42 18.41 Favored 'General case' 0 C--N 1.283 -2.318 0 C-N-CA 118.5 -1.28 . . . . 0.0 109.367 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.555 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 84.4 m -78.05 166.55 42.55 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.189 -0.945 . . . . 0.0 111.274 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.555 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 38.0 Cg_endo -71.89 -76.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.278 1.672 . . . . 0.0 110.47 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.4 ' CG ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 175.39 136.33 0.17 Allowed Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.652 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.608 ' HG3' ' CZ2' ' A' ' 109' ' ' TRP . 58.8 Cg_endo -84.95 87.75 1.0 Allowed 'Trans proline' 0 C--N 1.297 -2.178 0 O-C-N 123.733 1.386 . . . . 0.0 109.721 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.695 ' O ' HG23 ' A' ' 66' ' ' ILE . 2.6 p -112.29 -43.23 3.56 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 122.394 1.092 . . . . 0.0 110.144 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.698 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER 51.95 166.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.242 -179.16 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.507 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 12.9 t -65.15 97.43 0.25 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.521 -0.737 . . . . 0.0 111.265 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 6.2 m-80 45.95 55.64 6.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.448 -0.783 . . . . 0.0 111.905 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.57 ' O ' ' CG ' ' A' ' 70' ' ' TYR . . . -135.34 -42.31 0.12 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.629 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 18.7 p90 43.67 -179.31 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 122.891 1.329 . . . . 0.0 112.074 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.845 HD13 ' N ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -125.24 153.54 43.01 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.15 -179.856 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.484 ' HB3' ' HG3' ' A' ' 88' ' ' LYS . 0.3 OUTLIER -111.58 7.84 20.72 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.01 -1.056 . . . . 0.0 110.267 -178.486 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.85 -70.68 0.52 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.283 -0.886 . . . . 0.0 110.331 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -175.95 100.04 0.14 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.594 ' O ' ' CD2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -94.01 110.03 21.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.402 -1.058 . . . . 0.0 109.498 179.533 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.512 ' N ' ' OH ' ' A' ' 79' ' ' TYR . 9.4 mttp -86.08 151.96 23.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.913 . . . . 0.0 110.247 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.3 mtt180 -48.45 -32.91 8.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.283 -0.885 . . . . 0.0 110.085 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.4 p -141.38 159.05 43.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.399 -0.813 . . . . 0.0 110.307 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.584 ' OH ' ' CD1' ' A' ' 75' ' ' PHE . 79.5 m-85 -132.23 -171.26 2.59 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.281 -0.887 . . . . 0.0 110.05 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.67 ' C ' HG23 ' A' ' 59' ' ' VAL . 78.8 p -147.18 -103.67 0.09 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.873 -1.142 . . . . 0.0 111.495 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.612 ' O ' ' CG ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -114.29 22.35 13.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 119.77 -1.831 . . . . 0.0 110.96 -178.396 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.683 ' C ' HG22 ' A' ' 102' ' ' THR . 50.3 t30 -165.55 -110.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.869 -1.144 . . . . 0.0 110.72 178.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 82' ' ' ASN . 0.1 OUTLIER 46.99 79.03 0.06 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.686 -1.259 . . . . 0.0 108.923 -179.032 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.736 ' CA ' HG23 ' A' ' 102' ' ' THR . 2.1 p-10 -71.91 142.12 49.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.347 -0.846 . . . . 0.0 110.885 -178.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.778 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 5.4 m -129.42 117.55 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.909 . . . . 0.0 110.455 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.539 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 3.1 t0 -76.64 128.52 34.85 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.376 -0.828 . . . . 0.0 108.897 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.656 ' CD1' HG21 ' A' ' 66' ' ' ILE . 34.2 m-85 -88.09 142.59 27.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.033 -1.042 . . . . 0.0 112.629 -177.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -121.4 84.78 2.29 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.128 -179.434 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.683 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.8 OUTLIER -35.2 126.46 0.58 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.761 -0.587 . . . . 0.0 110.853 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.9 OUTLIER -34.18 -78.52 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.625 -0.672 . . . . 0.0 110.843 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.464 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -168.78 143.45 3.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.312 -0.868 . . . . 0.0 110.395 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 51.51 45.26 53.83 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.577 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 10.8 m-85 -148.22 154.78 40.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.406 -1.055 . . . . 0.0 110.217 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.705 ' O ' HG22 ' A' ' 117' ' ' VAL . 35.9 mtpt -109.94 131.12 55.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 109.967 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.683 HD11 ' H ' ' A' ' 89' ' ' CYS . 2.0 mt -73.12 93.12 1.77 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.904 . . . . 0.0 110.246 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.468 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -74.39 98.54 3.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.928 . . . . 0.0 109.766 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 147.32 -97.94 0.19 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.608 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -149.87 128.52 12.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.234 -1.156 . . . . 0.0 110.211 -179.655 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 87' ' ' PHE . 24.9 p -72.36 -45.44 59.84 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.125 -0.985 . . . . 0.0 110.59 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.6 p -102.89 116.3 32.29 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.115 -0.991 . . . . 0.0 110.248 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 16.4 m -120.83 178.96 4.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.421 -0.799 . . . . 0.0 110.297 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.736 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.5 OUTLIER -152.58 134.24 14.61 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.571 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.554 ' SG ' ' O ' ' A' ' 80' ' ' SER . 12.9 t -62.03 78.48 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.542 0.687 . . . . 0.0 109.547 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.499 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -56.43 176.9 0.19 Allowed Pre-proline 0 N--CA 1.498 1.935 0 CA-C-O 121.506 0.67 . . . . 0.0 112.753 -178.485 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.784 ' CB ' HD12 ' A' ' 38' ' ' ILE . 47.2 Cg_endo -79.08 25.45 0.57 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 124.779 1.936 . . . . 0.0 112.079 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -122.86 18.86 7.96 Favored Glycine 0 N--CA 1.482 1.757 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.691 ' O ' HG23 ' A' ' 108' ' ' THR . 16.3 m-80 62.63 53.05 2.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.894 -0.768 . . . . 0.0 110.066 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.2 OUTLIER -163.64 179.27 7.3 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.288 -0.883 . . . . 0.0 111.166 179.881 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.778 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 45.4 m95 -110.03 90.74 3.4 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.561 -0.712 . . . . 0.0 110.243 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.581 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 1.0 OUTLIER -100.33 154.91 36.94 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.322 -0.861 . . . . 0.0 109.596 179.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.608 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.3 Cg_endo -69.48 -179.92 19.96 Favored 'Cis proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.33 -1.946 . . . . 0.0 111.414 0.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.472 ' C ' ' O ' ' A' ' 111' ' ' PRO . 9.5 mt-10 -34.44 121.8 0.5 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.416 0.627 . . . . 0.0 111.097 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.609 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 3.0 tp -49.13 141.7 10.82 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.39 -0.819 . . . . 0.0 110.127 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.698 ' HG2' HD12 ' A' ' 66' ' ' ILE . 41.5 Cg_endo -70.26 158.5 56.1 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 124.073 1.564 . . . . 0.0 110.416 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.845 ' HG2' HG13 ' A' ' 117' ' ' VAL . 11.5 ttpt -124.11 107.17 10.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 110.37 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 2.6 t -63.01 78.28 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.17 -0.957 . . . . 0.0 109.168 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.845 HG13 ' HG2' ' A' ' 115' ' ' LYS . 2.5 m -92.92 -173.83 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.903 0.859 . . . . 0.0 111.264 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.461 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.6 OUTLIER . . . . . 0 C--N 1.296 -1.758 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.239 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 2' ' ' LYS . 59.1 t . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.162 0.505 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 32.4 mttt -93.53 164.79 13.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.248 -0.907 . . . . 0.0 110.285 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.571 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -131.37 83.74 2.12 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.165 -0.959 . . . . 0.0 110.343 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.423 ' O ' ' C ' ' A' ' 5' ' ' SER . 4.3 pm0 -63.52 179.57 0.45 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.12 -0.988 . . . . 0.0 109.928 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.3 p -44.99 144.52 1.93 Allowed Pre-proline 0 C--N 1.297 -1.684 0 C-N-CA 119.715 -0.794 . . . . 0.0 109.443 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.892 ' HG3' HG11 ' A' ' 27' ' ' VAL . 45.9 Cg_endo -70.16 159.86 51.63 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 124.028 1.541 . . . . 0.0 111.004 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.72 171.17 18.73 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.004 1.528 . . . . 0.0 110.216 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 77.4 p -73.58 179.18 4.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 0.0 110.17 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.639 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -145.14 -169.51 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 122.232 1.015 . . . . 0.0 111.78 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 3.6 t -50.27 100.23 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.2 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 10' ' ' SER . 5.5 m-20 36.72 55.49 1.16 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.658 -0.651 . . . . 0.0 111.335 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.414 ' HA3' ' SG ' ' A' ' 56' ' ' CYS . . . -150.28 -163.34 11.13 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.528 ' CG ' ' HB3' ' A' ' 30' ' ' SER . 0.0 OUTLIER -148.2 174.9 11.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.206 -1.173 . . . . 0.0 110.362 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.621 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 23.2 p80 -140.74 -155.32 0.58 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.551 -0.718 . . . . 0.0 110.023 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 0.1 OUTLIER 70.35 106.8 0.06 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.332 -0.855 . . . . 0.0 110.434 179.621 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.495 ' O ' ' CD2' ' A' ' 17' ' ' TYR . . . -166.35 46.89 0.27 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.495 ' CD2' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER 179.18 -33.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -1.175 . . . . 0.0 110.571 -179.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 8.8 pt-20 -179.71 -168.69 0.12 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.094 -1.004 . . . . 0.0 110.761 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -114.35 -41.69 3.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.461 -0.774 . . . . 0.0 109.635 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -95.64 130.13 42.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.395 -0.815 . . . . 0.0 109.733 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.647 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.4 OUTLIER -122.45 -6.48 8.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.144 -0.973 . . . . 0.0 110.626 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.571 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 72.6 p 46.69 -95.75 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.501 -0.75 . . . . 0.0 112.1 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 0.8 OUTLIER -154.62 144.86 21.97 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.887 -1.133 . . . . 0.0 110.577 -178.527 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.22 31.96 29.92 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.647 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -122.13 172.25 8.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.438 -1.037 . . . . 0.0 110.267 -179.742 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.91 HG13 ' O ' ' A' ' 43' ' ' VAL . 48.6 t -142.99 152.87 16.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.265 -0.897 . . . . 0.0 110.826 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.935 ' O ' HG23 ' A' ' 43' ' ' VAL . 11.9 t -129.81 122.11 53.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 C-N-CA 119.831 -0.747 . . . . 0.0 111.413 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.42 102.3 5.12 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 118.723 -1.191 . . . . 0.0 107.882 178.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.952 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.1 m-30 -68.34 120.65 14.81 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.263 -178.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.528 ' HB3' ' CG ' ' A' ' 13' ' ' ARG . 4.9 t -73.18 -177.65 2.59 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.945 -1.097 . . . . 0.0 109.2 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 30' ' ' SER . 71.0 m -151.56 163.89 38.06 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.344 -0.848 . . . . 0.0 109.975 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.34 145.58 26.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.182 -0.949 . . . . 0.0 109.701 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.432 ' O ' ' OG ' ' A' ' 33' ' ' SER . 1.6 p -52.64 110.9 0.56 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 110.499 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.04 -20.43 26.33 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -79.27 132.17 36.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.182 -1.187 . . . . 0.0 110.354 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.702 ' HB3' HD11 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -80.84 138.86 36.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.16 -0.962 . . . . 0.0 110.579 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.565 HD13 ' O ' ' A' ' 29' ' ' TYR . 0.8 OUTLIER -85.87 98.03 10.54 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.431 -0.793 . . . . 0.0 109.358 179.09 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.903 HD12 ' HB3' ' A' ' 105' ' ' PRO . 0.7 OUTLIER -89.17 148.86 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -0.884 . . . . 0.0 109.065 179.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.89 -150.43 16.91 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.05 137.43 32.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.358 -1.083 . . . . 0.0 110.371 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.415 ' HA ' HD21 ' A' ' 37' ' ' LEU . 54.8 p -76.69 55.29 1.04 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.933 . . . . 0.0 109.444 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.606 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 153.93 121.17 0.8 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.952 HG21 ' CE1' ' A' ' 29' ' ' TYR . 1.7 t -69.27 -178.29 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.173 -1.193 . . . . 0.0 108.263 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.498 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.3 tp -143.92 97.54 3.08 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.923 -1.11 . . . . 0.0 110.714 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.594 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 1.0 OUTLIER -86.04 114.7 23.13 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.081 -1.047 . . . . 0.0 109.132 178.569 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.07 91.91 3.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.501 -0.749 . . . . 0.0 110.225 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.526 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 78.49 63.49 2.12 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 46.7 53.15 10.35 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -157.31 73.37 0.73 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.346 -1.091 . . . . 0.0 110.569 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.594 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 76.1 m95 -55.7 137.73 48.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.087 -1.008 . . . . 0.0 109.354 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -146.87 163.8 34.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.001 -1.062 . . . . 0.0 111.342 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.51 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 1.5 m-20 62.11 65.77 1.56 Allowed Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.826 -0.546 . . . . 0.0 111.377 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.51 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 46.5 Cg_endo -91.47 129.23 1.2 Allowed 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 121.802 1.668 . . . . 0.0 110.17 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.573 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 49.7 Cg_endo -80.21 168.21 18.83 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.904 1.476 . . . . 0.0 110.086 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.615 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 65.7 p -107.83 148.01 30.12 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.979 -1.076 . . . . 0.0 111.347 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 10' ' ' SER . 88.9 m -109.25 77.91 1.1 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -113.81 -167.68 1.24 Allowed 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.394 0.616 . . . . 0.0 110.487 -178.305 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.654 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -104.69 134.69 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.246 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.634 HG21 ' CB ' ' A' ' 81' ' ' TYR . 19.8 m -122.7 43.75 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.063 -1.023 . . . . 0.0 111.099 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -82.93 96.69 8.37 Favored 'General case' 0 C--N 1.286 -2.179 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.956 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 107' ' ' ASN . 29.2 m -69.69 162.09 69.97 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.397 -0.814 . . . . 0.0 111.423 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.459 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 44.3 Cg_endo -72.88 -90.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.559 1.82 . . . . 0.0 110.578 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.402 ' CD2' ' HE1' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -161.69 132.77 3.79 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.802 ' HA ' HD21 ' A' ' 113' ' ' LEU . 55.7 Cg_endo -78.7 65.71 8.67 Favored 'Trans proline' 0 C--N 1.295 -2.267 0 O-C-N 123.665 1.35 . . . . 0.0 109.454 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.646 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -82.98 176.03 9.58 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.579 -0.701 . . . . 0.0 110.287 -179.652 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.646 HG22 ' C ' ' A' ' 65' ' ' THR . 0.2 OUTLIER -176.7 163.39 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.227 -0.92 . . . . 0.0 110.625 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.46 ' N ' HG13 ' A' ' 66' ' ' ILE . 1.8 m -75.9 107.61 8.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.509 -0.744 . . . . 0.0 110.831 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 8.6 m-20 43.37 37.89 1.53 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.457 -0.777 . . . . 0.0 110.432 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.597 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -145.1 26.72 1.88 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.551 ' O ' ' N ' ' A' ' 88' ' ' LYS . 23.4 p90 -43.91 -178.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.409 1.1 . . . . 0.0 111.833 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.69 ' H ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -109.63 156.29 20.4 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 121.913 0.864 . . . . 0.0 110.858 179.083 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.08 11.77 4.25 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.778 -1.201 . . . . 0.0 110.033 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.22 -79.68 0.23 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.347 -0.845 . . . . 0.0 110.917 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -141.42 84.08 0.21 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.537 ' C ' ' CD1' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -98.95 160.92 13.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.467 -1.019 . . . . 0.0 109.911 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.584 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 24.4 ttmt -153.44 156.81 38.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.264 -0.897 . . . . 0.0 110.531 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 26.5 mtp85 -53.37 -30.16 38.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.897 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.418 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -141.77 171.56 13.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.484 -0.76 . . . . 0.0 110.21 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.584 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 31.2 m-85 -144.08 177.66 8.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.214 -0.929 . . . . 0.0 110.408 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.575 ' HA ' HG23 ' A' ' 59' ' ' VAL . 7.7 p -162.85 92.36 0.77 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.177 -0.952 . . . . 0.0 110.238 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.634 ' CB ' HG21 ' A' ' 59' ' ' VAL . 13.3 t80 56.83 136.31 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.092 -1.005 . . . . 0.0 110.247 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.733 ' O ' HG22 ' A' ' 102' ' ' THR . 14.4 t-20 63.57 -125.05 0.55 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.849 -1.157 . . . . 0.0 110.521 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.498 ' HB3' ' HB3' ' A' ' 103' ' ' CYS . 0.5 OUTLIER 54.13 71.2 0.53 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.617 -1.302 . . . . 0.0 109.014 -178.526 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.539 ' N ' HG23 ' A' ' 102' ' ' THR . 5.4 t30 -73.53 136.69 44.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.515 -0.741 . . . . 0.0 111.332 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.586 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 12.5 m -124.0 117.21 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.246 -0.909 . . . . 0.0 109.877 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 48.6 t0 -78.4 136.04 37.56 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.682 ' CE1' HD12 ' A' ' 71' ' ' LEU . 60.6 m-85 -94.24 129.68 40.78 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.99 -1.069 . . . . 0.0 112.158 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 70' ' ' TYR . 9.1 tptt -99.52 90.05 4.37 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.631 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.518 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -44.35 128.77 6.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.004 -1.06 . . . . 0.0 109.861 -179.668 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 2.9 mmtt -38.93 -78.0 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.595 -0.691 . . . . 0.0 110.472 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.589 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -168.27 141.53 3.14 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.358 -0.839 . . . . 0.0 110.366 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.582 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 49.79 53.78 20.47 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.589 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 11.6 m-85 -158.28 151.23 22.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.469 -1.019 . . . . 0.0 109.624 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.565 ' O ' HG22 ' A' ' 117' ' ' VAL . 13.1 mtmm -109.18 134.64 51.47 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.113 -0.992 . . . . 0.0 110.161 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' A' ' 114' ' ' PRO . 1.8 mt -72.13 103.51 3.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.259 -0.9 . . . . 0.0 110.571 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.488 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -84.87 112.83 20.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.151 -0.968 . . . . 0.0 109.751 179.379 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 132.08 -77.74 0.38 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.538 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -167.73 112.05 0.67 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.358 -1.084 . . . . 0.0 110.44 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 43.9 t -69.97 -7.07 37.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.211 -0.931 . . . . 0.0 110.306 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.0 p -139.65 98.8 3.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.182 -0.949 . . . . 0.0 110.04 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.604 ' HG ' ' HE2' ' A' ' 87' ' ' PHE . 7.0 m -106.47 -174.69 2.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.192 -0.943 . . . . 0.0 110.565 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.733 HG22 ' O ' ' A' ' 82' ' ' ASN . 19.8 m -157.93 134.9 9.97 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.251 -0.98 . . . . 0.0 111.301 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.602 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 1.8 t -62.2 87.4 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.479 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -78.57 177.05 3.06 Favored Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.133 -0.98 . . . . 0.0 110.859 -179.387 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.903 ' HB3' HD12 ' A' ' 38' ' ' ILE . 41.9 Cg_endo -73.55 138.28 26.6 Favored 'Trans proline' 0 C--N 1.302 -1.91 0 O-C-N 124.436 1.756 . . . . 0.0 110.499 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.554 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 116.92 -10.05 15.72 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.554 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 1.4 m-20 81.12 77.72 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.943 -0.74 . . . . 0.0 110.065 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -173.73 -175.05 1.03 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.626 -0.83 . . . . 0.0 110.969 -179.697 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.606 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 38.9 m95 -124.35 89.03 3.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.546 -0.721 . . . . 0.0 109.723 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.592 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -101.86 136.05 19.6 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.491 -0.755 . . . . 0.0 110.652 -179.109 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.592 ' C ' ' HA ' ' A' ' 110' ' ' LYS . 40.9 Cg_endo -68.52 163.73 77.28 Favored 'Cis proline' 0 N--CA 1.489 1.224 0 C-N-CA 122.101 -2.041 . . . . 0.0 111.029 -0.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 111' ' ' PRO . 28.5 tt0 -40.06 155.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.457 0.646 . . . . 0.0 110.689 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.802 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -62.99 146.29 95.78 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.494 -0.754 . . . . 0.0 110.043 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.576 ' HG3' ' CD2' ' A' ' 87' ' ' PHE . 41.1 Cg_endo -72.45 175.4 10.15 Favored 'Trans proline' 0 C--N 1.299 -2.057 0 O-C-N 124.365 1.718 . . . . 0.0 111.136 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.643 ' HG2' HG13 ' A' ' 117' ' ' VAL . 6.4 tttp -133.79 114.39 13.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.493 -0.755 . . . . 0.0 109.907 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.52 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 3.5 t -72.96 71.19 1.06 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.082 -1.011 . . . . 0.0 109.505 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.643 HG13 ' HG2' ' A' ' 115' ' ' LYS . 5.9 m -86.91 -170.37 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-O 122.057 0.932 . . . . 0.0 110.924 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.477 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.294 -1.844 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.281 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.593 HG23 ' HA3' ' A' ' 48' ' ' GLY . 9.1 m . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.301 0.572 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.77 178.96 6.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.296 -0.878 . . . . 0.0 110.512 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.524 ' O ' ' N ' ' A' ' 21' ' ' TYR . 1.2 m -117.99 136.38 53.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.493 -0.754 . . . . 0.0 110.131 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 5' ' ' SER . 5.7 pt20 -110.61 172.94 6.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.046 -1.034 . . . . 0.0 109.647 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.503 ' HB2' ' HA ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -46.65 132.86 8.21 Favored Pre-proline 0 C--N 1.298 -1.637 0 C-N-CA 119.369 -0.933 . . . . 0.0 109.36 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.592 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 43.8 Cg_endo -69.81 166.03 29.03 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.939 1.494 . . . . 0.0 110.325 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.02 166.47 27.81 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 O-C-N 123.942 1.496 . . . . 0.0 110.306 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.74 175.37 9.45 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.376 -0.827 . . . . 0.0 109.949 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 11' ' ' ASN . 0.3 OUTLIER -141.44 -170.33 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-O 122.227 1.013 . . . . 0.0 111.331 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.5 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 1.3 m -46.44 91.54 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.92 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.506 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER 42.03 51.09 4.33 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.147 -0.97 . . . . 0.0 110.376 179.643 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -150.53 151.79 23.76 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -111.15 -179.05 3.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.34 -1.094 . . . . 0.0 110.265 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.614 ' N ' ' CD2' ' A' ' 14' ' ' HIS . 8.4 m170 -66.06 -139.42 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.279 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -85.28 -97.76 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.935 . . . . 0.0 110.212 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.32 -71.2 0.69 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -164.61 84.75 0.42 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -1.173 . . . . 0.0 110.254 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.441 ' N ' ' CD ' ' A' ' 18' ' ' GLU . 5.9 mp0 -109.49 -54.01 2.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.84 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.503 ' HA ' ' HB2' ' A' ' 5' ' ' SER . 2.1 m-20 59.04 18.38 6.28 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.5 -0.75 . . . . 0.0 110.232 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.563 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 0.2 OUTLIER -163.27 149.13 11.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 110.618 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.6 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 9.0 m-85 -163.98 174.75 11.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.509 -0.744 . . . . 0.0 109.649 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.501 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 22.6 p -136.03 -69.83 0.48 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.779 -1.201 . . . . 0.0 111.099 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -161.49 145.4 12.88 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.514 -0.742 . . . . 0.0 109.384 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.17 12.31 57.59 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.38 -1.888 . . . . 0.0 108.38 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.6 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -82.63 174.3 11.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.507 -0.996 . . . . 0.0 109.816 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.719 HG13 ' O ' ' A' ' 43' ' ' VAL . 28.2 t -153.85 156.65 5.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.856 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.682 ' O ' HG23 ' A' ' 43' ' ' VAL . 4.0 t -137.16 114.22 12.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 C-N-CA 119.631 -0.827 . . . . 0.0 111.546 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.881 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -70.45 102.76 2.27 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 118.543 -1.263 . . . . 0.0 108.015 178.366 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.639 ' O ' HD13 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -68.22 97.49 0.72 Allowed 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.205 -0.998 . . . . 0.0 109.592 -178.589 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.493 ' OG ' ' O ' ' A' ' 14' ' ' HIS . 0.1 OUTLIER -70.08 139.43 52.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.78 -1.2 . . . . 0.0 109.8 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 56' ' ' CYS . 12.4 m -108.27 153.11 23.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.372 -0.83 . . . . 0.0 109.679 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 31' ' ' CYS . 0.7 OUTLIER -44.05 140.92 1.87 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.163 -0.961 . . . . 0.0 109.841 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 83.2 p -52.42 98.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 110.084 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 134.33 -1.74 4.13 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' A' ' 56' ' ' CYS . 0.6 OUTLIER -106.15 161.03 14.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.067 -1.255 . . . . 0.0 110.421 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.98 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.7 OUTLIER -102.58 129.99 49.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.359 -0.838 . . . . 0.0 110.963 -179.405 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.809 HD21 ' HA ' ' A' ' 41' ' ' SER . 4.6 tp -89.05 120.67 30.67 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.329 -0.857 . . . . 0.0 109.294 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.789 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -118.37 141.74 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.138 -0.976 . . . . 0.0 109.881 -179.501 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.506 ' O ' ' CB ' ' A' ' 40' ' ' ASN . . . 101.58 44.22 2.0 Favored Glycine 0 N--CA 1.488 2.154 0 C-N-CA 119.393 -1.384 . . . . 0.0 109.687 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 3.1 t30 72.11 169.45 0.32 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.491 -1.005 . . . . 0.0 109.775 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.881 ' O ' HG23 ' A' ' 28' ' ' THR . 0.8 OUTLIER -112.36 63.15 0.63 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 110.457 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.541 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 160.12 113.89 0.34 Allowed Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.635 -1.269 . . . . 0.0 110.306 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.719 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.1 t -60.84 -179.06 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.05 -1.265 . . . . 0.0 108.066 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.458 ' HA ' ' O ' ' A' ' 25' ' ' SER . 0.8 OUTLIER -143.78 102.55 3.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.994 -1.066 . . . . 0.0 110.533 178.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.591 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.6 OUTLIER -85.48 113.84 22.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.317 -0.864 . . . . 0.0 109.276 178.654 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 87.7 p -129.64 137.52 50.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 0.0 110.531 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.01 9.12 45.93 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.593 ' HA3' HG23 ' A' ' 1' ' ' VAL . . . 93.36 29.08 10.54 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -146.08 135.18 22.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.366 -1.079 . . . . 0.0 110.097 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.591 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 89.1 m95 -80.71 138.36 36.34 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.217 -0.927 . . . . 0.0 109.909 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -141.81 165.46 27.4 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.119 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.529 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 1.3 t70 43.11 64.87 5.99 Favored Pre-proline 0 N--CA 1.491 1.614 0 CA-C-O 121.141 0.496 . . . . 0.0 111.819 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 47.0 Cg_endo -91.8 125.56 0.86 Allowed 'Trans proline' 0 C--N 1.3 -1.996 0 O-C-N 124.341 1.706 . . . . 0.0 109.261 178.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.517 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 45.1 Cg_endo -70.79 -178.44 2.74 Favored 'Trans proline' 0 C--N 1.297 -2.15 0 O-C-N 123.808 1.425 . . . . 0.0 110.759 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.571 ' N ' ' O ' ' A' ' 38' ' ' ILE . 6.0 p -119.82 -169.09 1.71 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.851 0.834 . . . . 0.0 111.255 -178.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 10' ' ' SER . 96.4 m -151.92 86.65 1.32 Allowed 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -111.11 -139.5 0.38 Allowed 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.055 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.781 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -142.82 74.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 179.391 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.98 HG13 ' CB ' ' A' ' 36' ' ' SER . 4.6 m -68.72 126.49 28.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 122.55 1.167 . . . . 0.0 110.679 -177.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 107' ' ' ASN . 24.6 mtpt -147.22 93.67 2.28 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.499 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 27.4 m -69.1 162.78 62.84 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.513 -0.742 . . . . 0.0 111.732 -177.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 46.1 Cg_endo -72.82 -90.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.612 1.848 . . . . 0.0 110.615 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.458 ' HB3' ' CG2' ' A' ' 65' ' ' THR . 0.0 OUTLIER -164.98 129.34 1.81 Allowed Pre-proline 0 C--N 1.302 -1.462 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.615 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 54.7 Cg_endo -77.33 65.68 7.94 Favored 'Trans proline' 0 C--N 1.298 -2.114 0 O-C-N 123.608 1.32 . . . . 0.0 109.617 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.724 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.8 OUTLIER -83.95 178.81 7.72 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.266 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.786 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -175.02 158.39 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.077 179.388 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.501 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 0.7 OUTLIER -64.35 101.82 0.47 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.496 -0.753 . . . . 0.0 110.5 -179.57 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.463 ' O ' ' SG ' ' A' ' 116' ' ' CYS . 45.0 m-20 39.66 50.74 2.26 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.438 -0.789 . . . . 0.0 110.607 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.786 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -158.54 32.07 0.48 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.562 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 4.9 p90 -45.17 -172.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.798 1.285 . . . . 0.0 112.684 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.706 ' H ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -109.96 167.91 9.82 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.601 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.46 ' O ' ' OG ' ' A' ' 72' ' ' SER . 0.3 OUTLIER -144.97 24.91 1.45 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.044 -1.035 . . . . 0.0 110.155 -179.611 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.3 t -104.24 -89.02 0.41 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.032 -1.042 . . . . 0.0 110.824 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -118.92 72.86 0.31 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 2.9 t80 -98.2 164.82 12.16 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.446 -1.032 . . . . 0.0 110.19 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.63 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 2.4 tttp -168.93 159.13 9.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.367 -0.833 . . . . 0.0 109.95 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -52.6 -27.79 18.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.128 -0.983 . . . . 0.0 109.981 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.462 ' C ' ' CG ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -141.31 173.87 11.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.366 -0.834 . . . . 0.0 110.556 -179.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.575 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 43.3 m-85 -148.82 -168.15 3.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.519 -0.738 . . . . 0.0 109.486 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.608 ' CA ' HG23 ' A' ' 59' ' ' VAL . 88.1 p -141.47 -102.12 0.14 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.741 -1.225 . . . . 0.0 111.355 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.686 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -119.27 19.36 12.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.608 -1.307 . . . . 0.0 111.24 -178.696 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.791 ' O ' HG22 ' A' ' 102' ' ' THR . 29.0 t-20 -159.86 -101.59 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.875 -1.14 . . . . 0.0 110.118 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 82' ' ' ASN . 2.9 m-20 44.94 72.79 0.18 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.87 -1.144 . . . . 0.0 109.277 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.887 ' CA ' HG23 ' A' ' 102' ' ' THR . 8.7 p30 -68.74 113.91 6.63 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.386 -0.821 . . . . 0.0 110.172 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.529 ' N ' ' O ' ' A' ' 101' ' ' SER . 33.1 m -99.28 121.88 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.249 -0.907 . . . . 0.0 111.073 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.522 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 28.8 t70 -83.27 134.6 34.93 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.645 ' CE1' HD12 ' A' ' 71' ' ' LEU . 29.3 m-85 -91.46 132.82 35.98 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.825 -1.172 . . . . 0.0 112.046 -178.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.2 OUTLIER -111.2 92.0 3.87 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.181 -179.39 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.477 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -44.49 128.37 6.37 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.043 -1.036 . . . . 0.0 109.907 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 2.4 mmmp? -41.19 -85.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.32 -0.862 . . . . 0.0 110.375 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.581 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -159.09 142.2 14.52 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.273 -0.892 . . . . 0.0 110.418 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.594 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 54.7 54.94 29.95 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.594 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 18.2 m-85 -160.27 167.41 27.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.469 -1.018 . . . . 0.0 109.729 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.481 ' N ' ' O ' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -132.22 114.37 14.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.24 -0.913 . . . . 0.0 109.911 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.753 HD23 HD11 ' A' ' 66' ' ' ILE . 10.2 mt -46.39 107.49 0.11 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.11 -0.994 . . . . 0.0 110.479 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.705 ' HB2' HG21 ' A' ' 117' ' ' VAL . 1.2 t -90.1 97.04 10.96 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.432 -0.792 . . . . 0.0 109.685 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.62 -40.33 1.38 Allowed Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.404 -1.379 . . . . 0.0 110.546 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.581 ' O ' ' HB3' ' A' ' 114' ' ' PRO . 0.0 OUTLIER 177.58 -164.45 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.889 -1.359 . . . . 0.0 111.524 -179.191 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.529 ' N ' ' OG ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -149.21 -53.42 0.17 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.713 -0.617 . . . . 0.0 110.2 -179.833 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 91.1 p -110.48 105.51 14.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.23 -0.919 . . . . 0.0 110.644 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.529 ' O ' ' N ' ' A' ' 85' ' ' VAL . 50.6 m -113.73 164.27 13.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.329 -0.857 . . . . 0.0 110.118 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.887 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -133.39 143.39 48.9 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.345 -0.847 . . . . 0.0 110.885 -179.687 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.628 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -72.95 98.27 2.45 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.33 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.565 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -67.98 176.27 1.41 Allowed Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.182 -0.949 . . . . 0.0 112.333 -178.52 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.789 ' CB ' HD12 ' A' ' 38' ' ' ILE . 41.0 Cg_endo -70.03 -33.36 15.72 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 124.689 1.889 . . . . 0.0 111.728 -177.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.56 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -75.5 4.64 41.42 Favored Glycine 0 N--CA 1.486 2.001 0 C-N-CA 119.267 -1.444 . . . . 0.0 110.799 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.719 ' O ' HG23 ' A' ' 108' ' ' THR . 0.9 OUTLIER 78.13 89.4 0.07 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.445 -1.033 . . . . 0.0 110.929 179.245 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.719 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -178.45 -161.7 0.05 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.857 . . . . 0.0 110.906 179.354 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.727 ' HB3' HD13 ' A' ' 113' ' ' LEU . 22.7 m95 -142.71 97.94 3.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 111.305 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.525 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 2.5 mtpp -106.75 145.83 31.85 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.411 -0.806 . . . . 0.0 109.512 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.536 ' HG2' ' HB2' ' A' ' 98' ' ' SER . 47.3 Cg_endo -72.91 178.62 31.27 Favored 'Cis proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.088 -2.047 . . . . 0.0 111.089 -0.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.447 ' O ' ' C ' ' A' ' 113' ' ' LEU . 5.3 tt0 -40.74 121.16 1.42 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.606 -0.684 . . . . 0.0 110.352 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.727 HD13 ' HB3' ' A' ' 109' ' ' TRP . 0.6 OUTLIER -40.91 138.56 1.31 Allowed Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.416 -0.802 . . . . 0.0 110.001 179.701 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.731 ' HG2' HD12 ' A' ' 66' ' ' ILE . 42.8 Cg_endo -75.04 160.69 39.75 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 O-C-N 124.176 1.619 . . . . 0.0 111.758 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.75 ' HG2' HG13 ' A' ' 117' ' ' VAL . 5.6 ttpp -125.67 99.89 6.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.469 -0.769 . . . . 0.0 110.813 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.546 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.8 t -53.29 100.88 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.93 . . . . 0.0 109.468 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.75 HG13 ' HG2' ' A' ' 115' ' ' LYS . 2.0 m -118.92 179.18 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.664 0.745 . . . . 0.0 110.624 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.5 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.293 -1.858 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.371 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 53.8 t . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.213 0.53 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -81.13 170.32 16.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.256 -0.902 . . . . 0.0 110.319 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 21' ' ' TYR . 1.2 m -125.39 90.58 3.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 109.713 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.517 ' HA ' ' O ' ' A' ' 19' ' ' ASP . 37.6 tt0 -72.88 173.58 8.99 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.021 -1.049 . . . . 0.0 109.895 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.513 ' N ' ' CG ' ' A' ' 4' ' ' GLN . 0.7 OUTLIER -44.09 134.76 4.12 Favored Pre-proline 0 C--N 1.297 -1.706 0 O-C-N 121.501 -0.749 . . . . 0.0 109.642 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.647 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 51.6 Cg_endo -71.36 150.5 58.59 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.939 1.494 . . . . 0.0 110.525 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.34 172.23 15.36 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 O-C-N 124.007 1.53 . . . . 0.0 109.932 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.53 177.71 2.81 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.248 -0.907 . . . . 0.0 109.509 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.682 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -139.09 -170.41 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 122.172 0.987 . . . . 0.0 111.297 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 5.5 t -47.37 98.25 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.616 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.2 m120 44.35 47.85 8.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 0.0 110.415 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.467 ' O ' HG13 ' A' ' 9' ' ' ILE . . . -159.6 156.64 27.81 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.42 -169.71 1.51 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.117 -1.225 . . . . 0.0 111.071 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.657 ' HB2' HG11 ' A' ' 27' ' ' VAL . 13.8 p80 -137.85 126.0 22.97 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.353 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.669 ' O ' HG13 ' A' ' 27' ' ' VAL . 2.1 t30 -100.37 -175.33 2.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.308 -0.87 . . . . 0.0 110.263 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.485 ' HA3' ' OH ' ' A' ' 21' ' ' TYR . . . 154.22 -36.6 0.7 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.472 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER 67.44 35.88 4.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.395 -1.061 . . . . 0.0 110.482 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.595 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -142.48 -159.61 0.99 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.292 -0.88 . . . . 0.0 109.817 179.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.517 ' O ' ' HA ' ' A' ' 4' ' ' GLN . 1.5 m-20 -147.47 -35.2 0.24 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.171 -0.956 . . . . 0.0 110.59 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -121.03 79.05 1.46 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.191 -0.943 . . . . 0.0 110.14 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.603 ' CE2' ' CG2' ' A' ' 27' ' ' VAL . 0.9 OUTLIER -57.57 -24.7 57.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.07 -1.019 . . . . 0.0 110.339 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.448 ' C ' ' HB2' ' A' ' 3' ' ' CYS . 0.2 OUTLIER 66.43 -79.08 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.464 -0.772 . . . . 0.0 112.32 178.561 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.529 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER -168.3 160.84 11.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.891 -1.13 . . . . 0.0 109.865 -178.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 59.39 17.07 38.09 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.506 ' CB ' ' CD1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -92.89 160.11 15.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.566 -0.961 . . . . 0.0 109.725 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.674 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 57.4 t -133.75 150.23 31.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 118.977 -1.089 . . . . 0.0 110.907 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.861 ' O ' HG23 ' A' ' 43' ' ' VAL . 45.6 t -138.13 112.02 8.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.46 -0.775 . . . . 0.0 110.977 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -69.99 104.14 2.46 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.035 -1.466 . . . . 0.0 107.653 178.211 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 1.122 ' CE1' HG21 ' A' ' 43' ' ' VAL . 1.9 m-30 -67.62 130.67 43.75 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.956 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.71 152.64 23.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.122 -0.986 . . . . 0.0 109.906 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 1.024 ' SG ' HD12 ' A' ' 37' ' ' LEU . 98.1 m -129.71 143.81 50.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.154 -0.966 . . . . 0.0 110.354 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -55.17 127.95 31.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.267 -0.896 . . . . 0.0 110.285 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 71.1 p -44.88 139.73 2.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.298 -0.876 . . . . 0.0 110.332 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.5 -21.81 37.91 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.614 ' CE2' HG23 ' A' ' 58' ' ' ILE . 8.4 m-85 -108.94 141.22 41.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.12 -1.223 . . . . 0.0 110.3 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.792 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -79.03 136.36 37.16 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.349 -0.844 . . . . 0.0 110.995 -179.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 1.024 HD12 ' SG ' ' A' ' 31' ' ' CYS . 3.8 tt -92.54 94.23 8.95 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.833 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.9 OUTLIER -76.68 145.16 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.43 -0.793 . . . . 0.0 109.207 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 126.94 -160.26 21.2 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.514 ' O ' ' C ' ' A' ' 41' ' ' SER . 4.2 m-20 -115.8 52.01 0.92 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.113 -1.228 . . . . 0.0 109.798 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.675 ' O ' HG23 ' A' ' 28' ' ' THR . 18.3 p 24.88 67.78 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.715 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.87 116.08 0.42 Allowed Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.383 -1.389 . . . . 0.0 110.609 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.122 HG21 ' CE1' ' A' ' 29' ' ' TYR . 1.4 t -84.72 126.88 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.7 tp -97.29 106.88 19.29 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 120.201 -1.562 . . . . 0.0 111.423 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.602 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.8 OUTLIER -87.56 114.72 24.43 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.449 -0.901 . . . . 0.0 108.92 178.034 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.515 ' HA ' ' OD2' ' A' ' 23' ' ' ASP . 0.3 OUTLIER -132.43 128.67 38.0 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.404 -179.686 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.529 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 80.02 -5.48 62.38 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.449 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 109.79 6.76 28.24 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -126.54 116.49 21.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -1.18 . . . . 0.0 110.517 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.602 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 82.7 m95 -64.85 141.42 58.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.224 -0.922 . . . . 0.0 109.542 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 52' ' ' ASP . 2.4 t -140.98 -177.77 5.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.015 -1.053 . . . . 0.0 111.105 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.526 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER 36.26 65.4 2.14 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.746 -0.596 . . . . 0.0 111.207 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.526 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.8 Cg_endo -91.58 138.15 2.09 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 124.403 1.738 . . . . 0.0 109.666 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.536 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 51.3 Cg_endo -80.56 175.88 9.68 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.489 1.257 . . . . 0.0 110.321 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.618 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 20.0 p -130.12 138.58 50.75 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.171 -0.956 . . . . 0.0 111.0 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 10' ' ' SER . 14.2 m -97.52 76.48 2.54 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.494 ' HG3' HG12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -119.08 144.83 46.37 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.428 0.632 . . . . 0.0 110.219 -178.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.614 HG23 ' CE2' ' A' ' 35' ' ' TYR . 1.7 pt -69.46 120.54 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.792 HG13 ' CB ' ' A' ' 36' ' ' SER . 12.1 m -99.5 51.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.151 -0.968 . . . . 0.0 112.094 -178.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.425 ' HD3' HD12 ' A' ' 58' ' ' ILE . 3.0 mtpp -87.61 99.35 11.99 Favored 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 118.626 -1.229 . . . . 0.0 108.434 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.477 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 59.6 m -69.25 162.62 64.62 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.397 -0.814 . . . . 0.0 111.502 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 47.9 Cg_endo -72.0 -91.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.464 1.771 . . . . 0.0 110.587 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.469 ' HB3' ' CG2' ' A' ' 65' ' ' THR . 0.0 OUTLIER -158.27 132.27 5.04 Favored Pre-proline 0 C--N 1.302 -1.47 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.707 ' HA ' HD21 ' A' ' 113' ' ' LEU . 55.5 Cg_endo -77.77 67.89 7.83 Favored 'Trans proline' 0 C--N 1.293 -2.344 0 O-C-N 123.757 1.398 . . . . 0.0 109.528 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.657 ' O ' HD23 ' A' ' 113' ' ' LEU . 1.5 p -88.97 174.98 7.61 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.805 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -170.35 159.87 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 118.405 -1.318 . . . . 0.0 110.675 179.182 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.489 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 1.5 m -61.33 95.84 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.644 -0.66 . . . . 0.0 110.395 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.458 ' O ' ' SG ' ' A' ' 116' ' ' CYS . 8.6 m-20 44.57 45.07 7.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.426 -0.796 . . . . 0.0 110.597 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.805 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -151.85 33.4 0.88 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.567 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 3.7 p90 -45.89 -171.39 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 122.743 1.258 . . . . 0.0 112.628 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.798 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -113.85 162.93 15.73 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.194 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.7 t -149.88 28.93 0.75 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.993 -1.067 . . . . 0.0 109.944 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.64 -16.98 7.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 111.235 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -154.08 -87.86 0.06 OUTLIER Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.169 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.616 ' CD2' ' N ' ' A' ' 76' ' ' LYS . 58.5 t80 58.6 170.24 0.06 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.626 -0.926 . . . . 0.0 110.577 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.616 ' N ' ' CD2' ' A' ' 75' ' ' PHE . 4.1 tptt 174.83 134.3 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.403 -0.811 . . . . 0.0 109.842 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 76' ' ' LYS . 2.3 mtt-85 -40.1 -45.16 1.93 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.262 -0.899 . . . . 0.0 110.4 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.457 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 3.6 t -132.86 125.42 29.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.438 -0.789 . . . . 0.0 110.198 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.599 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 14.9 m-85 -101.49 -173.98 2.49 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.146 -0.971 . . . . 0.0 110.506 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -170.41 106.9 0.31 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.148 -0.97 . . . . 0.0 110.971 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.773 ' CB ' HG21 ' A' ' 59' ' ' VAL . 5.1 t80 35.04 32.51 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.107 -0.996 . . . . 0.0 112.118 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.567 ' N ' ' O ' ' A' ' 103' ' ' CYS . 15.5 t30 -177.37 -140.25 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.221 -1.549 . . . . 0.0 111.149 178.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.41 ' C ' HG23 ' A' ' 102' ' ' THR . 1.6 m-20 56.3 73.19 0.45 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.114 -0.991 . . . . 0.0 108.948 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.542 ' N ' HG23 ' A' ' 102' ' ' THR . 7.0 t30 -69.57 112.53 6.13 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.458 -0.776 . . . . 0.0 110.31 -179.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.606 ' O ' HG23 ' A' ' 85' ' ' VAL . 23.1 m -95.03 120.55 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 111.053 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 4.4 t0 -80.77 131.23 35.4 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.798 ' CE1' HD12 ' A' ' 71' ' ' LEU . 46.4 m-85 -91.14 136.9 32.77 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.881 -1.137 . . . . 0.0 111.945 -178.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -115.65 102.5 9.81 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.964 -179.587 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.517 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -49.44 131.31 20.66 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.098 -1.001 . . . . 0.0 110.081 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -39.96 -69.19 0.14 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.477 -0.764 . . . . 0.0 110.347 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.585 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 39.3 t80 -172.86 141.6 1.04 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -0.817 . . . . 0.0 110.21 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 50.99 56.92 12.14 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.585 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 13.2 m-85 -155.29 172.24 18.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.341 -1.093 . . . . 0.0 110.23 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 117' ' ' VAL . 0.7 OUTLIER -133.01 106.98 7.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.294 -0.879 . . . . 0.0 109.86 179.735 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.578 ' CD2' ' HB3' ' A' ' 87' ' ' PHE . 1.1 mt -46.83 99.38 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.194 -0.941 . . . . 0.0 110.675 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.453 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -78.99 101.4 7.76 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.358 -0.839 . . . . 0.0 109.441 179.226 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.86 -89.2 0.19 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.594 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.4 OUTLIER -154.35 116.94 4.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -1.173 . . . . 0.0 110.612 -179.404 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.536 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 2.0 m -83.42 29.83 0.49 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.308 -0.87 . . . . 0.0 110.832 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 65.4 p -170.5 102.56 0.26 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.16 -0.962 . . . . 0.0 109.531 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 85' ' ' VAL . 9.2 m -125.37 172.63 9.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.181 -0.949 . . . . 0.0 111.092 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.542 HG23 ' N ' ' A' ' 84' ' ' ASN . 19.9 m -143.52 142.47 31.14 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.458 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.567 ' O ' ' N ' ' A' ' 82' ' ' ASN . 6.8 t -54.57 100.51 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.399 -0.813 . . . . 0.0 109.124 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.45 ' OG ' ' HE3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -72.99 173.0 6.58 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 120.783 -1.198 . . . . 0.0 111.462 -178.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.833 ' CB ' HD12 ' A' ' 38' ' ' ILE . 47.2 Cg_endo -80.08 25.65 0.6 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.559 1.821 . . . . 0.0 112.451 -178.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -126.57 16.94 6.54 Favored Glycine 0 N--CA 1.484 1.851 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.595 ' O ' HG23 ' A' ' 108' ' ' THR . 0.9 OUTLIER 68.86 51.98 0.55 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.628 -0.925 . . . . 0.0 109.969 -179.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.595 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -160.78 -169.5 2.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.906 . . . . 0.0 111.109 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.688 ' HB3' HD13 ' A' ' 113' ' ' LEU . 36.4 m95 -117.48 99.95 7.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.382 -0.823 . . . . 0.0 110.336 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.52 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 2.8 mtmt -105.56 140.19 20.93 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.537 -0.727 . . . . 0.0 110.071 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.594 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 47.3 Cg_endo -73.54 171.71 64.79 Favored 'Cis proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.809 -2.163 . . . . 0.0 110.434 -0.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.0 OUTLIER -40.8 128.53 2.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.372 -0.83 . . . . 0.0 111.074 -179.419 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.707 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -41.46 147.58 0.47 Allowed Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.511 -0.743 . . . . 0.0 110.541 179.461 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.681 ' HG2' HD12 ' A' ' 66' ' ' ILE . 41.4 Cg_endo -75.53 169.91 21.36 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.342 1.707 . . . . 0.0 111.05 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.832 ' HG2' HG13 ' A' ' 117' ' ' VAL . 30.7 ttmt -128.79 110.62 12.32 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.24 -0.912 . . . . 0.0 110.503 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.554 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 3.2 t -65.95 93.55 0.2 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.012 -1.055 . . . . 0.0 109.351 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.832 HG13 ' HG2' ' A' ' 115' ' ' LYS . 2.3 m -113.21 -174.54 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 121.859 0.838 . . . . 0.0 111.176 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.529 ' HG2' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.792 0 CA-C-O 117.951 -1.024 . . . . 0.0 110.348 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.536 HG22 ' N ' ' A' ' 2' ' ' LYS . 7.0 p . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.248 0.547 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.536 ' N ' HG22 ' A' ' 1' ' ' VAL . 10.5 ptmt -159.84 -177.74 6.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 110.385 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.535 ' O ' ' HB2' ' A' ' 21' ' ' TYR . 1.1 m -133.54 81.16 1.91 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.606 -0.684 . . . . 0.0 109.818 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.631 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 58.4 mt-30 -63.46 178.57 0.54 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.827 -1.171 . . . . 0.0 110.456 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.8 p -46.35 143.83 3.58 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.45 -0.782 . . . . 0.0 109.896 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.889 ' HG3' HG11 ' A' ' 27' ' ' VAL . 48.7 Cg_endo -73.97 151.63 45.25 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.076 1.566 . . . . 0.0 111.204 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.61 171.31 18.03 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.789 1.415 . . . . 0.0 109.956 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.2 p -69.65 175.86 3.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.118 -0.989 . . . . 0.0 110.001 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.744 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -142.25 -170.16 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 122.239 1.019 . . . . 0.0 111.296 179.757 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 3.2 t -51.48 99.47 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.852 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 10' ' ' SER . 1.3 m120 41.66 57.58 3.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.236 -0.915 . . . . 0.0 110.656 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -163.82 148.72 15.25 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.455 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -98.12 -176.85 3.54 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.298 -1.119 . . . . 0.0 110.12 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.623 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 23.8 p80 -143.92 138.65 28.69 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.697 -0.627 . . . . 0.0 109.814 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -166.93 -141.13 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.102 -0.999 . . . . 0.0 110.432 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.72 36.93 1.21 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 53.44 47.21 24.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.394 -1.063 . . . . 0.0 110.235 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.639 ' CB ' ' CE2' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -110.44 -159.74 0.69 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.248 -0.908 . . . . 0.0 109.913 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.421 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 0.4 OUTLIER 174.73 -28.05 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.342 -0.849 . . . . 0.0 110.458 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.631 ' HA ' ' HA ' ' A' ' 4' ' ' GLN . 3.2 p90 -165.45 55.01 0.11 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.143 -0.973 . . . . 0.0 110.722 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.639 ' CE2' ' CB ' ' A' ' 18' ' ' GLU . 19.5 m-85 -43.51 159.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.148 -0.97 . . . . 0.0 110.255 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.471 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -125.35 -59.98 1.36 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.933 -1.104 . . . . 0.0 110.58 -179.218 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.444 ' OD1' ' HA ' ' A' ' 46' ' ' SER . 3.6 t0 -166.37 140.62 4.26 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.472 -0.768 . . . . 0.0 109.618 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 74.36 17.27 79.71 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.584 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 3.1 m -97.54 168.04 10.61 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.474 -1.015 . . . . 0.0 109.936 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.702 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 74.5 t -137.27 158.43 35.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.032 -1.067 . . . . 0.0 111.1 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.896 ' O ' HG23 ' A' ' 43' ' ' VAL . 39.0 t -143.67 107.61 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.426 -0.796 . . . . 0.0 110.957 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.81 105.65 2.41 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 117.974 -1.491 . . . . 0.0 107.722 178.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 1.06 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.0 m-30 -67.78 119.53 12.63 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.613 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -69.64 152.0 45.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.169 -0.957 . . . . 0.0 109.958 -179.86 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.511 ' SG ' HD12 ' A' ' 37' ' ' LEU . 78.6 m -121.81 163.92 18.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 110.424 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 33' ' ' SER . 3.3 m-20 -58.79 138.99 56.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.308 -0.87 . . . . 0.0 110.059 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 32' ' ' ASN . 1.5 m -43.2 104.9 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 110.22 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.51 -32.63 5.14 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -72.66 130.29 40.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.288 -1.125 . . . . 0.0 110.423 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.601 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -78.55 149.39 33.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.328 -0.858 . . . . 0.0 110.897 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.588 ' C ' HD13 ' A' ' 38' ' ' ILE . 2.5 tp -95.09 113.45 25.14 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.414 -0.804 . . . . 0.0 108.858 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.629 HD13 ' N ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -108.7 150.5 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.921 . . . . 0.0 109.298 -179.653 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 125.61 -139.41 11.51 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.35 -1.405 . . . . 0.0 109.697 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.504 ' O ' ' C ' ' A' ' 41' ' ' SER . 0.6 OUTLIER -110.0 51.43 0.76 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.196 -1.179 . . . . 0.0 109.989 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.513 ' HA ' HD21 ' A' ' 37' ' ' LEU . 13.5 p 22.68 50.64 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.345 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.465 ' HA3' ' CG1' ' A' ' 26' ' ' VAL . . . 152.37 131.58 1.71 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.331 -1.414 . . . . 0.0 110.408 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.06 HG21 ' CE1' ' A' ' 29' ' ' TYR . 1.2 t -81.67 121.38 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 178.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.491 ' HA ' ' O ' ' A' ' 25' ' ' SER . 11.6 tp -95.13 103.48 15.33 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 120.277 -1.514 . . . . 0.0 111.385 -178.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.607 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.7 OUTLIER -80.99 121.43 26.04 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.061 178.491 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.444 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 4.7 m -135.14 123.95 23.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.438 -0.789 . . . . 0.0 110.863 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.4 16.08 80.06 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.462 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 87.03 25.9 32.96 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -141.33 103.43 4.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.169 -1.195 . . . . 0.0 110.318 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.607 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 77.9 m95 -56.25 137.31 52.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.913 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 52' ' ' ASP . 10.1 m -140.73 179.45 6.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.93 . . . . 0.0 111.009 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.516 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER 39.25 65.36 3.44 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.666 -0.646 . . . . 0.0 111.177 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.516 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 46.3 Cg_endo -90.14 127.64 1.48 Allowed 'Trans proline' 0 C--N 1.298 -2.122 0 O-C-N 124.356 1.714 . . . . 0.0 109.689 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.527 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 50.8 Cg_endo -76.62 176.78 9.66 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 O-C-N 123.821 1.432 . . . . 0.0 110.746 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.529 ' OG1' ' CG1' ' A' ' 38' ' ' ILE . 9.6 p -119.98 153.37 36.08 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.476 -0.765 . . . . 0.0 111.125 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 10' ' ' SER . 94.6 m -114.11 78.84 1.18 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -115.09 -178.24 3.32 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.3 0.572 . . . . 0.0 110.366 -178.511 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.596 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -95.6 130.1 44.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.305 -0.872 . . . . 0.0 109.299 179.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.601 ' CG1' ' CB ' ' A' ' 36' ' ' SER . 23.4 m -117.3 49.91 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 110.787 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 1.1 mttm -64.83 -163.27 0.02 OUTLIER 'General case' 0 C--N 1.281 -2.393 0 C-N-CA 118.797 -1.161 . . . . 0.0 109.167 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.497 ' SG ' ' HD2' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -151.0 154.56 34.36 Favored Pre-proline 0 C--N 1.291 -1.94 0 C-N-CA 119.167 -1.013 . . . . 0.0 112.179 -179.219 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.561 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 43.2 Cg_endo -81.03 -59.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.54 1.81 . . . . 0.0 108.539 177.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.561 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.2 OUTLIER 157.45 127.2 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.588 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.861 ' HG2' HD21 ' A' ' 71' ' ' LEU . 55.7 Cg_endo -79.91 67.14 8.7 Favored 'Trans proline' 0 C--N 1.296 -2.213 0 O-C-N 123.767 1.404 . . . . 0.0 109.771 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.718 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -92.96 177.04 6.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.334 -0.854 . . . . 0.0 109.363 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.876 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -174.82 162.87 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 119.155 -1.018 . . . . 0.0 110.303 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 68' ' ' ASN . 3.0 t -67.32 108.08 2.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.514 -0.741 . . . . 0.0 111.054 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 31.2 m-80 38.69 34.93 0.09 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.593 -0.692 . . . . 0.0 110.853 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.876 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -145.92 35.98 1.35 Allowed Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.359 -1.4 . . . . 0.0 110.001 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.671 ' HA ' HG23 ' A' ' 66' ' ' ILE . 5.1 p90 -48.28 -163.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 123.169 1.461 . . . . 0.0 112.287 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.032 HD11 ' HB2' ' A' ' 75' ' ' PHE . 1.9 pp -117.66 124.6 48.95 Favored 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 114.341 -1.3 . . . . 0.0 110.11 -178.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.512 ' HB3' ' HB2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -92.61 9.99 32.36 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.479 -0.763 . . . . 0.0 109.534 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.28 -71.73 0.43 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.382 -0.824 . . . . 0.0 110.652 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -172.55 98.5 0.13 Allowed Glycine 0 N--CA 1.489 2.197 0 C-N-CA 119.781 -1.2 . . . . 0.0 110.121 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 1.032 ' HB2' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -98.78 174.9 6.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.427 -1.043 . . . . 0.0 109.576 179.529 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.561 ' N ' ' CG ' ' A' ' 75' ' ' PHE . 3.3 ttmt -166.54 168.39 14.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.339 -0.85 . . . . 0.0 109.873 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.55 -31.03 61.8 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.754 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.462 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 0.5 OUTLIER -155.26 163.3 40.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.14 -0.975 . . . . 0.0 110.447 -179.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.608 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 10.2 m-85 -133.83 -164.97 1.57 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.262 -0.899 . . . . 0.0 110.401 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.553 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 40.9 p -143.22 -149.25 0.26 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.394 -0.817 . . . . 0.0 109.383 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.596 ' CB ' HG21 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -70.67 144.74 50.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.632 -1.293 . . . . 0.0 108.508 179.052 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.759 ' C ' HG22 ' A' ' 102' ' ' THR . 34.8 t-20 65.45 -111.85 0.23 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.328 -0.857 . . . . 0.0 110.704 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 1.0 OUTLIER 46.43 84.42 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.617 -1.302 . . . . 0.0 108.207 -178.31 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.0 OUTLIER -85.5 135.01 34.01 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.464 -0.772 . . . . 0.0 112.143 -177.595 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.738 ' HB ' HD22 ' A' ' 71' ' ' LEU . 6.3 m -119.94 118.95 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.312 -0.867 . . . . 0.0 109.435 177.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 20.0 t0 -73.61 134.56 43.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.092 -1.005 . . . . 0.0 109.16 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.684 ' CD1' HG21 ' A' ' 66' ' ' ILE . 28.2 m-85 -94.25 129.35 40.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.071 -1.018 . . . . 0.0 111.144 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.571 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -106.67 96.11 6.21 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.806 -179.124 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.435 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -47.56 133.63 13.03 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.904 -1.122 . . . . 0.0 109.217 179.199 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -40.43 -85.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.272 -0.892 . . . . 0.0 110.269 -179.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.472 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 1.0 OUTLIER -163.65 135.01 4.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.458 -0.776 . . . . 0.0 109.922 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.72 48.94 62.58 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.081 -1.607 . . . . 0.0 109.081 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.536 ' CB ' ' SG ' ' A' ' 116' ' ' CYS . 36.2 m-85 -153.04 170.01 21.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.442 -1.034 . . . . 0.0 110.131 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.537 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 1.0 OUTLIER -131.17 107.46 9.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.271 -0.893 . . . . 0.0 109.656 179.432 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.776 HD22 ' HB2' ' A' ' 114' ' ' PRO . 43.0 mt -46.87 102.76 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.187 -0.945 . . . . 0.0 110.623 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.473 ' HB2' HG21 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -81.15 98.13 7.91 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.39 -0.819 . . . . 0.0 109.29 179.067 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.87 -86.3 0.17 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.585 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -160.4 124.51 3.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.157 -1.202 . . . . 0.0 110.734 -179.489 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.46 ' OG ' ' N ' ' A' ' 100' ' ' SER . 13.3 p -70.03 -55.99 8.11 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.101 -0.999 . . . . 0.0 110.574 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.46 ' N ' ' OG ' ' A' ' 99' ' ' SER . 54.7 p -94.75 121.5 36.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.286 -0.884 . . . . 0.0 110.127 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 29.6 m -121.42 -174.64 2.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.892 . . . . 0.0 110.119 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.759 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -157.28 128.5 6.79 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.324 -0.86 . . . . 0.0 110.735 179.658 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.555 ' N ' ' O ' ' A' ' 82' ' ' ASN . 46.9 t -65.52 91.93 0.13 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.746 -0.596 . . . . 0.0 109.613 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.465 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -71.58 -179.89 0.84 Allowed Pre-proline 0 C--N 1.298 -1.644 0 O-C-N 121.403 -0.811 . . . . 0.0 110.863 -179.339 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.597 ' HG3' HG23 ' A' ' 38' ' ' ILE . 42.7 Cg_endo -80.55 121.61 4.27 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 O-C-N 124.467 1.772 . . . . 0.0 110.424 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.577 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 132.21 -3.6 5.19 Favored Glycine 0 N--CA 1.481 1.638 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.853 ' O ' HG23 ' A' ' 108' ' ' THR . 1.0 OUTLIER 80.71 88.08 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.777 -0.837 . . . . 0.0 111.264 179.431 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.853 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 176.66 -164.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 111.523 179.15 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.661 ' HB3' HD13 ' A' ' 113' ' ' LEU . 28.6 m95 -139.68 90.02 2.37 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.412 0.625 . . . . 0.0 110.13 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.544 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 1.5 mmtp -99.3 141.25 22.51 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.408 -0.808 . . . . 0.0 110.15 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.585 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.0 Cg_endo -72.0 173.33 52.56 Favored 'Cis proline' 0 C--N 1.312 -1.348 0 C-N-CA 122.034 -2.069 . . . . 0.0 110.811 -0.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 111' ' ' PRO . 10.2 pt-20 -40.81 137.83 1.13 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.398 -0.814 . . . . 0.0 110.801 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.7 HD23 ' O ' ' A' ' 65' ' ' THR . 0.3 OUTLIER -53.09 144.55 27.75 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.416 -0.802 . . . . 0.0 110.342 179.639 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.776 ' HB2' HD22 ' A' ' 95' ' ' LEU . 43.4 Cg_endo -72.22 163.62 38.13 Favored 'Trans proline' 0 C--N 1.302 -1.885 0 O-C-N 124.224 1.644 . . . . 0.0 111.12 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.55 ' HG2' HG13 ' A' ' 117' ' ' VAL . 9.4 tttt -127.84 115.39 18.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.456 -0.778 . . . . 0.0 109.848 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.536 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 0.8 OUTLIER -66.29 100.94 0.67 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.034 -1.041 . . . . 0.0 109.651 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.55 HG13 ' HG2' ' A' ' 115' ' ' LYS . 0.7 OUTLIER -118.22 -177.19 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 121.625 0.726 . . . . 0.0 110.931 -179.538 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.7 mtp-105 . . . . . 0 C--N 1.295 -1.797 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.53 179.937 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 1' ' ' VAL . 7.7 p . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 121.24 0.543 . . . . 0.0 110.115 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -135.13 103.89 5.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 110.332 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.612 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 37.3 t -68.98 155.87 39.58 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.669 -0.644 . . . . 0.0 110.486 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.423 ' O ' ' C ' ' A' ' 5' ' ' SER . 69.6 mt-30 -140.08 -177.09 4.84 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.356 -0.84 . . . . 0.0 109.644 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.2 OUTLIER -42.05 133.02 2.51 Favored Pre-proline 0 C--N 1.297 -1.683 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.123 -179.666 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.781 ' HG3' HG11 ' A' ' 27' ' ' VAL . 51.8 Cg_endo -70.14 157.41 59.74 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.12 1.589 . . . . 0.0 111.112 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -75.66 172.23 16.71 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.969 1.51 . . . . 0.0 110.109 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.46 175.26 4.9 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.208 -0.932 . . . . 0.0 109.94 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.65 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -139.58 -170.36 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 122.241 1.02 . . . . 0.0 111.412 179.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 11' ' ' ASN . 39.2 m -45.38 97.26 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.484 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 9' ' ' ILE . 2.5 m-20 43.14 47.26 5.26 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.294 -0.879 . . . . 0.0 110.511 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -152.4 155.67 26.26 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.466 ' N ' ' O ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -104.58 -166.42 1.24 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.347 -1.09 . . . . 0.0 110.659 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.583 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 14.6 p80 -151.74 121.79 7.14 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.104 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -119.32 123.11 43.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.202 -0.936 . . . . 0.0 110.33 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.71 -5.44 6.42 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.41 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 0.5 OUTLIER 55.49 55.99 6.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -1.149 . . . . 0.0 110.075 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.555 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 2.6 pp20? -178.59 -162.67 0.06 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.3 -0.875 . . . . 0.0 110.223 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.414 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 1.1 t0 -136.4 -42.62 0.62 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.358 -0.839 . . . . 0.0 109.844 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.431 ' CD1' ' C ' ' A' ' 20' ' ' PHE . 21.2 p90 -111.53 140.65 45.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.332 -0.855 . . . . 0.0 109.844 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.644 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.5 OUTLIER -122.65 -12.06 8.16 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.28 -0.888 . . . . 0.0 110.432 -179.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.564 HG22 ' N ' ' A' ' 23' ' ' ASP . 82.8 m 52.61 -99.15 0.08 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.458 -0.776 . . . . 0.0 111.173 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.564 ' N ' HG22 ' A' ' 22' ' ' THR . 0.4 OUTLIER -151.63 157.45 42.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.19 -0.943 . . . . 0.0 109.995 -179.248 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.59 16.0 80.31 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.644 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 30.4 m -99.34 173.99 6.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.434 -1.039 . . . . 0.0 110.316 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.797 HG13 ' O ' ' A' ' 43' ' ' VAL . 28.2 t -151.66 154.75 7.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.318 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.781 HG11 ' HG3' ' A' ' 6' ' ' PRO . 17.4 t -136.52 114.32 14.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 119.349 -0.941 . . . . 0.0 111.459 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -69.29 104.09 2.14 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 118.397 -1.321 . . . . 0.0 107.77 178.12 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.65 ' CE2' HG21 ' A' ' 9' ' ' ILE . 2.1 m-30 -68.09 144.87 54.88 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.431 -0.793 . . . . 0.0 110.287 -178.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -100.08 153.16 19.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.389 -0.819 . . . . 0.0 109.591 179.214 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.567 ' SG ' HD12 ' A' ' 37' ' ' LEU . 57.1 m -125.0 160.46 28.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.149 -0.969 . . . . 0.0 110.515 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -49.55 157.61 0.52 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.445 -0.785 . . . . 0.0 110.102 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.29 99.71 0.74 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.221 -0.924 . . . . 0.0 110.261 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.25 10.44 5.6 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 -107.99 166.35 10.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -1.15 . . . . 0.0 110.295 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 1.008 ' HB3' HG22 ' A' ' 59' ' ' VAL . 4.8 p -108.27 133.57 52.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.433 -0.792 . . . . 0.0 110.649 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.567 HD12 ' SG ' ' A' ' 31' ' ' CYS . 0.6 OUTLIER -95.1 109.82 21.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -0.955 . . . . 0.0 109.697 179.178 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.767 HG23 ' HG3' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -105.19 140.09 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.252 -0.905 . . . . 0.0 108.962 179.556 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.95 -156.81 24.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.488 ' O ' ' C ' ' A' ' 41' ' ' SER . 4.7 m-20 -99.5 51.19 0.93 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -1.153 . . . . 0.0 109.848 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.493 ' O ' HG23 ' A' ' 28' ' ' THR . 59.2 p 27.22 57.41 0.08 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.803 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.619 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 144.06 114.88 0.99 Allowed Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.158 -1.496 . . . . 0.0 110.73 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.797 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -55.06 -177.65 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.081 -1.247 . . . . 0.0 107.636 178.426 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.524 ' HA ' ' O ' ' A' ' 25' ' ' SER . 5.0 tp -145.87 93.02 2.28 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.313 -0.867 . . . . 0.0 110.106 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.609 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.8 OUTLIER -74.19 118.9 17.67 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.173 -0.955 . . . . 0.0 109.455 179.379 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.2 t -129.73 76.12 1.7 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.114 -0.991 . . . . 0.0 110.804 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.74 53.43 0.71 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 58.13 26.17 58.15 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -145.75 119.12 8.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -1.181 . . . . 0.0 109.917 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.612 ' CE2' ' SG ' ' A' ' 3' ' ' CYS . 91.7 m95 -81.68 133.36 35.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.881 . . . . 0.0 110.358 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.31 165.28 26.14 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.196 -0.94 . . . . 0.0 110.72 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.538 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 1.1 t0 55.1 64.54 5.67 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.559 -0.713 . . . . 0.0 111.0 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.538 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.5 Cg_endo -91.8 136.14 1.71 Allowed 'Trans proline' 0 C--N 1.3 -2.007 0 O-C-N 124.347 1.709 . . . . 0.0 109.491 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 43.4 Cg_endo -75.09 175.26 11.48 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 O-C-N 123.58 1.305 . . . . 0.0 110.397 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 6.3 p -121.98 145.39 48.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.32 -0.863 . . . . 0.0 111.656 -178.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.441 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 77.4 m -105.93 83.01 1.85 Allowed 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.493 ' OE1' HG13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -110.46 -145.54 0.4 Allowed 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.735 -0.603 . . . . 0.0 110.193 -178.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.605 ' N ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -137.05 100.15 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.158 -0.963 . . . . 0.0 108.909 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 1.059 HG21 ' HB3' ' A' ' 81' ' ' TYR . 31.8 m -102.09 64.28 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.255 -0.903 . . . . 0.0 112.213 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 2.0 mptp? -66.97 176.51 2.05 Favored 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 117.541 -1.663 . . . . 0.0 107.306 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.529 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 1.1 m -130.63 166.59 26.02 Favored Pre-proline 0 N--CA 1.494 1.73 0 C-N-CA 117.996 -1.482 . . . . 0.0 113.904 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.588 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 44.5 Cg_endo -88.88 -76.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 125.01 2.058 . . . . 0.0 110.735 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.588 ' CD2' ' O ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER 169.9 124.12 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.263 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.613 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 48.1 Cg_endo -76.09 71.1 5.8 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 123.58 1.305 . . . . 0.0 109.661 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.689 ' C ' HG22 ' A' ' 66' ' ' ILE . 1.1 p -89.39 -174.62 4.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.394 -0.816 . . . . 0.0 109.826 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.806 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -179.95 167.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.181 179.248 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.492 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 31.8 t -72.31 95.45 1.72 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.566 -0.709 . . . . 0.0 110.827 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 80.0 m-20 46.58 43.62 12.61 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.358 -0.839 . . . . 0.0 110.894 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.806 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -151.61 32.81 0.91 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.577 ' O ' ' N ' ' A' ' 88' ' ' LYS . 1.9 p90 -44.9 -174.99 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 122.697 1.237 . . . . 0.0 112.522 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.678 ' H ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -108.0 168.16 9.48 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.442 179.4 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.8 14.91 0.84 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.943 -1.098 . . . . 0.0 110.009 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.488 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -95.21 -55.46 3.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.312 -0.867 . . . . 0.0 110.557 -179.708 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.606 ' O ' HG12 ' A' ' 85' ' ' VAL . . . -153.09 88.8 0.13 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.615 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -109.44 162.79 14.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.288 -1.125 . . . . 0.0 109.717 179.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.615 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -159.51 155.53 26.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.134 -0.979 . . . . 0.0 110.458 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.0 mtp180 -56.62 -40.08 74.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.224 -0.922 . . . . 0.0 110.027 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.2 t -136.89 127.36 26.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.425 -0.797 . . . . 0.0 110.11 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.585 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 14.5 m-85 -102.35 -146.96 0.37 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.138 -0.977 . . . . 0.0 110.217 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 60.0 p -160.03 -119.85 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.371 -0.83 . . . . 0.0 109.773 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 1.059 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -109.13 35.39 3.28 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.829 -1.169 . . . . 0.0 110.536 -179.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.698 ' C ' HG22 ' A' ' 102' ' ' THR . 0.1 OUTLIER -169.76 -109.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.159 -0.963 . . . . 0.0 110.296 179.425 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.449 ' OD2' ' ND2' ' A' ' 82' ' ' ASN . 8.1 m-20 42.99 75.47 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.96 -1.088 . . . . 0.0 109.761 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.817 ' CA ' HG23 ' A' ' 102' ' ' THR . 9.4 p30 -69.53 120.37 15.21 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.259 -0.9 . . . . 0.0 110.206 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.844 HG23 ' CE1' ' A' ' 87' ' ' PHE . 33.8 m -108.14 118.35 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.86 -1.15 . . . . 0.0 111.029 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.538 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 9.0 t0 -76.91 134.49 38.94 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.844 ' CE1' HG23 ' A' ' 85' ' ' VAL . 48.8 m-85 -93.87 127.4 39.61 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.009 -1.057 . . . . 0.0 112.42 -177.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.577 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -102.69 110.08 21.9 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.091 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.453 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -56.64 132.5 51.99 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.004 -1.06 . . . . 0.0 109.855 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 89' ' ' CYS . 0.3 OUTLIER -39.93 -69.95 0.12 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.483 -0.761 . . . . 0.0 110.33 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.537 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.3 OUTLIER -171.77 136.86 0.96 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.324 -0.86 . . . . 0.0 110.277 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.584 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 50.6 58.77 8.65 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.116 -1.593 . . . . 0.0 109.116 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 9.9 m-85 -160.66 152.48 19.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.432 -1.04 . . . . 0.0 110.162 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -105.74 142.55 35.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -0.846 . . . . 0.0 109.596 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.615 HD23 ' HB2' ' A' ' 114' ' ' PRO . 0.7 OUTLIER -84.05 93.66 8.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.08 -1.013 . . . . 0.0 110.423 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.459 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -70.4 102.45 2.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.267 -0.895 . . . . 0.0 109.671 179.554 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.52 -93.1 0.19 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.586 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.2 OUTLIER -152.47 118.74 5.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.158 -1.201 . . . . 0.0 110.491 -179.523 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.16 5.07 1.8 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.285 -0.884 . . . . 0.0 111.641 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.492 ' OG ' ' HA ' ' A' ' 86' ' ' ASP . 0.6 OUTLIER -161.87 119.77 2.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.702 -1.249 . . . . 0.0 109.896 179.409 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.467 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 3.1 m -129.63 168.2 16.81 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.408 -0.808 . . . . 0.0 110.482 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.817 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -130.71 140.67 50.36 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.298 179.764 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.559 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -72.56 84.98 1.15 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.761 -0.587 . . . . 0.0 110.564 -179.53 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.475 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -62.7 174.22 0.86 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.285 -0.885 . . . . 0.0 111.197 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.82 ' CB ' HG11 ' A' ' 59' ' ' VAL . 40.8 Cg_endo -72.68 125.45 10.57 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 O-C-N 124.551 1.816 . . . . 0.0 110.626 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.574 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 129.77 -11.54 5.97 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.633 ' O ' HG23 ' A' ' 108' ' ' THR . 0.6 OUTLIER 82.5 90.25 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 122.014 -0.698 . . . . 0.0 110.366 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.633 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -179.86 -166.35 0.08 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.492 -0.755 . . . . 0.0 110.407 179.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.74 ' HB3' HD11 ' A' ' 113' ' ' LEU . 38.8 m95 -141.66 92.7 2.48 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.46 -0.775 . . . . 0.0 110.379 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.532 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 6.2 mttt -104.5 139.86 20.52 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.57 -0.706 . . . . 0.0 109.69 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.586 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 46.3 Cg_endo -71.63 166.59 78.21 Favored 'Cis proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.033 -2.069 . . . . 0.0 111.207 -0.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 111' ' ' PRO . 2.9 tt0 -38.31 133.94 0.91 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.684 -0.635 . . . . 0.0 110.976 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.777 HD22 ' H ' ' A' ' 113' ' ' LEU . 0.9 OUTLIER -45.67 148.24 1.35 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.902 . . . . 0.0 109.684 179.412 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.736 ' HG2' HD12 ' A' ' 66' ' ' ILE . 42.2 Cg_endo -74.35 170.92 19.13 Favored 'Trans proline' 0 C--N 1.299 -2.067 0 O-C-N 124.253 1.659 . . . . 0.0 110.851 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.67 ' HG2' HG13 ' A' ' 117' ' ' VAL . 35.7 tttt -128.93 111.44 13.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.161 -0.962 . . . . 0.0 110.449 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.544 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 3.8 t -67.29 81.79 0.14 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.797 0.808 . . . . 0.0 109.83 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.67 HG13 ' HG2' ' A' ' 115' ' ' LYS . 1.4 m -97.4 -169.29 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.904 0.859 . . . . 0.0 110.717 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.469 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.293 -1.876 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.505 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.427 HG21 ' C ' ' A' ' 47' ' ' GLY . 3.4 m . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.285 0.564 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.8 mttm -94.4 169.86 9.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.218 -0.926 . . . . 0.0 110.549 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.617 ' CB ' ' N ' ' A' ' 22' ' ' THR . 0.7 OUTLIER -129.14 146.68 51.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.302 -0.874 . . . . 0.0 110.401 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 19' ' ' ASP . 0.5 OUTLIER -128.92 177.42 7.12 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.506 -0.746 . . . . 0.0 109.578 179.496 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.02 136.45 14.2 Favored Pre-proline 0 C--N 1.298 -1.656 0 O-C-N 121.26 -0.9 . . . . 0.0 109.706 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.657 ' HG3' HG11 ' A' ' 27' ' ' VAL . 48.5 Cg_endo -69.37 163.51 37.67 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.052 1.554 . . . . 0.0 111.08 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.95 170.25 20.21 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.896 1.472 . . . . 0.0 109.618 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.482 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -87.17 105.47 17.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.106 -0.996 . . . . 0.0 109.973 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.755 HD12 ' OD1' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -47.34 -179.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-O 121.861 0.839 . . . . 0.0 111.059 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 11' ' ' ASN . 0.4 OUTLIER -103.55 69.28 0.98 Allowed 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.975 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.755 ' OD1' HD12 ' A' ' 9' ' ' ILE . 3.1 p30 164.4 -24.23 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.595 -0.69 . . . . 0.0 109.786 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.402 ' HA3' ' SG ' ' A' ' 56' ' ' CYS . . . -145.91 -160.61 8.76 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -126.77 -175.7 3.48 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.476 -1.014 . . . . 0.0 109.358 179.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.612 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 10.2 p80 -137.23 160.89 37.72 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.308 -0.87 . . . . 0.0 110.768 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 14' ' ' HIS . 26.7 p-10 -38.54 146.81 0.06 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.541 -0.724 . . . . 0.0 110.985 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -137.83 18.34 3.38 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.76 -26.46 9.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.296 -1.12 . . . . 0.0 110.258 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -81.64 -147.53 0.07 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.939 . . . . 0.0 109.827 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 20' ' ' PHE . 3.7 p30 178.53 -34.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.597 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.508 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 9.5 m-85 -124.58 133.78 53.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -0.929 . . . . 0.0 109.9 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.67 ' CD2' ' HB3' ' A' ' 25' ' ' SER . 2.8 m-85 -127.82 -9.87 5.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.068 -1.02 . . . . 0.0 111.132 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.617 ' N ' ' CB ' ' A' ' 3' ' ' CYS . 69.6 p 37.82 -98.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.507 -0.745 . . . . 0.0 111.424 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.486 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 23.0 t0 -150.65 138.88 20.27 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.991 -1.068 . . . . 0.0 110.488 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.43 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 91.09 22.7 31.84 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.67 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 50.8 m -118.27 163.82 16.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.306 -1.114 . . . . 0.0 110.073 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.87 HG13 ' O ' ' A' ' 43' ' ' VAL . 19.6 t -139.58 149.85 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.029 -1.044 . . . . 0.0 112.289 -178.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.657 HG11 ' HG3' ' A' ' 6' ' ' PRO . 18.1 t -122.26 114.13 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-O 121.356 0.598 . . . . 0.0 112.007 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.794 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -71.51 105.63 3.68 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.437 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.888 ' O ' HD13 ' A' ' 37' ' ' LEU . 2.8 m-30 -67.82 136.1 53.61 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.729 -178.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 13' ' ' ARG . 6.3 m -73.46 -173.64 1.46 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.99 -1.069 . . . . 0.0 109.301 179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -154.74 137.12 14.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.974 -1.079 . . . . 0.0 110.803 -179.642 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -44.84 159.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.342 -0.849 . . . . 0.0 109.775 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.99 97.63 0.69 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.215 -0.928 . . . . 0.0 110.401 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 129.22 -20.85 5.26 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.511 ' CD2' ' O ' ' A' ' 56' ' ' CYS . 2.5 m-30 -92.33 139.31 30.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.197 -1.178 . . . . 0.0 110.627 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.659 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -91.03 144.4 25.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.294 -0.879 . . . . 0.0 110.73 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.888 HD13 ' O ' ' A' ' 29' ' ' TYR . 2.4 tp -91.36 113.75 26.09 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.415 -0.803 . . . . 0.0 109.798 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.854 HG23 ' HG3' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -107.21 149.89 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.223 -0.923 . . . . 0.0 109.748 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 129.32 -153.39 19.86 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.507 ' O ' ' C ' ' A' ' 41' ' ' SER . 1.2 t30 -92.4 50.72 1.65 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.079 -1.248 . . . . 0.0 109.765 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.794 ' O ' HG23 ' A' ' 28' ' ' THR . 13.7 p 26.44 43.03 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.708 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.713 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 152.7 123.21 0.97 Allowed Glycine 0 N--CA 1.49 2.27 0 C-N-CA 119.229 -1.463 . . . . 0.0 110.694 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.87 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.6 t -58.15 -178.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.563 HD12 HG23 ' A' ' 26' ' ' VAL . 10.8 tp -147.81 97.99 2.89 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.722 -1.191 . . . . 0.0 110.684 178.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.483 ' HB2' ' CD2' ' A' ' 50' ' ' TRP . 14.6 t -78.39 115.54 18.18 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.41 179.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.47 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 4.7 m -124.48 81.82 1.98 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.551 -0.718 . . . . 0.0 110.272 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.486 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 93.64 56.85 1.39 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.67 23.15 9.55 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -126.04 82.04 2.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.284 -1.127 . . . . 0.0 110.681 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.538 ' HH2' ' CD2' ' A' ' 21' ' ' TYR . 67.0 m95 -54.33 128.52 31.84 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.15 -0.969 . . . . 0.0 109.148 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.407 ' O ' ' CB ' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -148.07 157.06 43.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.935 -1.103 . . . . 0.0 111.474 -179.328 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.503 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 4.8 t0 66.66 65.79 0.73 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.796 -0.565 . . . . 0.0 111.348 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.503 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.9 Cg_endo -91.45 141.49 2.75 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 O-C-N 124.37 1.721 . . . . 0.0 109.986 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.547 ' HG2' ' HB2' ' A' ' 29' ' ' TYR . 51.8 Cg_endo -80.11 -179.31 5.15 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 O-C-N 123.891 1.469 . . . . 0.0 110.308 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.567 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 8.6 p -117.91 -172.28 2.22 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.971 0.891 . . . . 0.0 111.104 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.511 ' O ' ' CD2' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -147.8 79.62 1.48 Allowed 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.778 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -113.42 -152.27 0.5 Allowed 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.004 -178.605 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.737 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -118.76 128.53 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.169 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.67 HG21 ' HB3' ' A' ' 81' ' ' TYR . 26.0 m -120.39 48.17 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.896 -1.127 . . . . 0.0 112.346 -178.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -60.94 164.07 5.25 Favored 'General case' 0 C--N 1.278 -2.519 0 C-N-CA 117.581 -1.648 . . . . 0.0 107.558 178.788 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 79' ' ' TYR . 35.5 m -131.98 161.33 63.31 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 120.603 -1.311 . . . . 0.0 111.749 -178.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 43.5 Cg_endo -75.79 -84.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.832 0 O-C-N 124.565 1.824 . . . . 0.0 110.251 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -179.84 128.43 0.24 Allowed Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 121.552 -0.717 . . . . 0.0 109.167 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.664 ' CB ' HG21 ' A' ' 85' ' ' VAL . 54.2 Cg_endo -77.97 67.14 8.13 Favored 'Trans proline' 0 C--N 1.298 -2.081 0 O-C-N 123.773 1.407 . . . . 0.0 109.744 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.509 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -87.11 175.27 8.17 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.383 -0.823 . . . . 0.0 110.199 -179.691 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.803 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -170.21 165.49 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 110.211 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.449 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 17.5 m -74.6 106.14 6.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.451 -0.781 . . . . 0.0 110.724 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.435 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 5.1 m120 41.54 41.13 1.53 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.344 -0.848 . . . . 0.0 110.718 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.803 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -150.61 32.52 1.0 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.573 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 5.5 p90 -44.13 -173.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 122.826 1.298 . . . . 0.0 112.657 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.704 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -111.04 162.23 15.08 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.392 179.42 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.06 20.03 1.42 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.961 -1.087 . . . . 0.0 110.103 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.3 t -103.03 -67.82 0.86 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.254 -0.904 . . . . 0.0 110.693 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.406 ' O ' HG12 ' A' ' 85' ' ' VAL . . . -137.85 82.9 0.26 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.631 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 2.5 t80 -110.3 163.86 13.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.358 -1.083 . . . . 0.0 110.238 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.631 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 19.7 tttm -164.17 153.3 13.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.883 . . . . 0.0 110.007 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -51.72 -28.33 14.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 0.0 109.822 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.5 m -144.54 158.18 43.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.417 -0.802 . . . . 0.0 110.436 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.569 ' OH ' ' CE2' ' A' ' 75' ' ' PHE . 10.9 m-85 -131.27 -149.55 0.39 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.401 -0.812 . . . . 0.0 109.572 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.638 ' CA ' HG23 ' A' ' 59' ' ' VAL . 94.8 p -157.46 -108.84 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.73 -1.231 . . . . 0.0 110.984 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.67 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -108.16 23.36 14.6 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.286 -1.509 . . . . 0.0 110.467 -179.525 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.743 ' C ' HG22 ' A' ' 102' ' ' THR . 47.6 t30 -171.31 -97.01 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.152 -0.968 . . . . 0.0 110.424 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 82' ' ' ASN . 5.0 m-20 42.05 72.48 0.17 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 109.546 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.813 ' CA ' HG23 ' A' ' 102' ' ' THR . 0.4 OUTLIER -68.62 137.5 54.28 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.345 -179.065 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.664 HG21 ' CB ' ' A' ' 64' ' ' PRO . 16.0 m -117.79 120.19 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.143 -0.973 . . . . 0.0 110.552 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -78.07 128.12 33.35 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.57 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.708 ' CD1' HG21 ' A' ' 66' ' ' ILE . 32.6 m-85 -89.17 125.14 34.93 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.031 -1.043 . . . . 0.0 112.087 -178.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.565 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -100.11 93.05 5.52 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.922 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.495 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -44.3 133.81 5.29 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.014 -1.054 . . . . 0.0 109.923 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -39.5 -72.47 0.06 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.515 -0.741 . . . . 0.0 110.345 -179.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.454 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 5.5 t80 -175.92 144.68 0.62 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.299 -0.876 . . . . 0.0 110.018 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.548 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 52.55 31.91 37.69 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.548 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 13.9 m-85 -141.67 146.96 36.75 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.514 -0.992 . . . . 0.0 110.097 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 116' ' ' CYS . 19.0 mttt -104.0 155.6 18.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.355 -0.84 . . . . 0.0 109.27 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.576 ' CD2' ' HB3' ' A' ' 87' ' ' PHE . 0.8 OUTLIER -91.93 100.86 13.45 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.736 -1.227 . . . . 0.0 110.5 -179.587 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.62 100.78 7.14 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.442 -0.786 . . . . 0.0 109.559 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.2 -81.02 0.22 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.586 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -167.16 114.8 0.8 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.228 -1.16 . . . . 0.0 110.774 -179.32 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -61.49 -48.5 80.79 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.203 -0.935 . . . . 0.0 110.74 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.2 p -101.24 130.63 47.39 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.191 -0.943 . . . . 0.0 109.87 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 11.6 m -140.89 158.71 43.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.156 -0.965 . . . . 0.0 110.743 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.813 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -134.88 140.31 45.69 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.515 -0.741 . . . . 0.0 109.652 179.625 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.609 ' O ' ' CB ' ' A' ' 104' ' ' SER . 0.7 OUTLIER -59.08 -59.18 5.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.241 -0.912 . . . . 0.0 111.057 -178.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.609 ' CB ' ' O ' ' A' ' 103' ' ' CYS . 0.2 OUTLIER 82.92 161.93 0.12 Allowed Pre-proline 0 C--N 1.292 -1.934 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -178.76 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.854 ' HG3' HG23 ' A' ' 38' ' ' ILE . 38.3 Cg_endo -67.1 120.28 7.35 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.767 1.404 . . . . 0.0 111.2 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 130.99 -9.09 5.72 Favored Glycine 0 N--CA 1.481 1.665 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.927 ' O ' HG23 ' A' ' 108' ' ' THR . 0.1 OUTLIER 77.66 105.34 0.07 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.592 -0.946 . . . . 0.0 111.103 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.927 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER 171.67 -148.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.426 -0.796 . . . . 0.0 110.711 179.345 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.678 ' HB3' HD11 ' A' ' 113' ' ' LEU . 22.3 m95 -163.32 66.31 0.18 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.345 -0.847 . . . . 0.0 109.617 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.527 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.2 OUTLIER -83.81 140.27 40.6 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.508 -0.745 . . . . 0.0 110.238 -179.625 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.586 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 44.8 Cg_endo -72.48 165.44 83.13 Favored 'Cis proline' 0 C--N 1.313 -1.336 0 C-N-CA 121.901 -2.125 . . . . 0.0 110.682 -0.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.5 pm0 -37.5 140.75 0.2 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.675 -0.641 . . . . 0.0 110.888 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.767 HD22 ' H ' ' A' ' 113' ' ' LEU . 1.2 mm? -50.68 146.3 9.92 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.361 -0.837 . . . . 0.0 109.696 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.744 ' HG2' HD12 ' A' ' 66' ' ' ILE . 37.6 Cg_endo -71.02 168.51 22.98 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 124.181 1.621 . . . . 0.0 111.268 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.574 ' HG2' HG13 ' A' ' 117' ' ' VAL . 5.0 ttpt -128.12 111.97 14.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.342 -0.849 . . . . 0.0 110.355 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.54 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.1 t -68.0 100.14 0.94 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 109.33 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.574 HG13 ' HG2' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -113.78 -178.58 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.483 0.659 . . . . 0.0 110.367 -179.487 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.533 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 6.5 ptt180 . . . . . 0 C--N 1.295 -1.784 0 C-N-CA 118.871 -1.131 . . . . 0.0 110.51 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.6 m . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.327 0.584 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.547 ' HG2' HG22 ' A' ' 22' ' ' THR . 0.0 OUTLIER -112.97 166.61 11.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.324 -0.86 . . . . 0.0 109.971 179.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.464 ' O ' ' O ' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -96.68 83.23 3.42 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.054 -1.029 . . . . 0.0 109.784 179.81 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.536 ' HA ' ' O ' ' A' ' 19' ' ' ASP . 0.6 OUTLIER -47.53 173.12 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.89 -1.131 . . . . 0.0 109.601 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.473 ' N ' ' O ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -42.84 135.59 2.78 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.256 -0.902 . . . . 0.0 109.974 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.774 ' CG ' HG11 ' A' ' 27' ' ' VAL . 51.6 Cg_endo -70.75 151.35 63.34 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.855 1.45 . . . . 0.0 110.754 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.61 170.46 20.18 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 123.938 1.494 . . . . 0.0 110.469 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.71 174.64 4.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.339 -0.851 . . . . 0.0 109.961 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.615 HD11 ' HB3' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -144.84 -170.0 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 122.198 0.999 . . . . 0.0 111.401 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' A' ' 56' ' ' CYS . 7.1 m -40.32 99.34 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.998 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 32' ' ' ASN . 1.6 m-80 40.91 28.13 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.374 -0.828 . . . . 0.0 110.565 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -132.13 157.23 22.37 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -112.35 -165.85 1.03 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.47 -1.018 . . . . 0.0 110.586 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.643 ' HB2' HG11 ' A' ' 27' ' ' VAL . 10.3 p80 -148.76 122.84 9.47 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.105 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -113.53 -167.0 1.14 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.172 -0.955 . . . . 0.0 110.446 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 145.49 -15.31 1.83 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 61.13 59.13 2.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.424 -1.045 . . . . 0.0 110.408 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.539 ' OE1' ' CD2' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -174.17 -174.63 0.92 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.176 -0.953 . . . . 0.0 110.449 179.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.536 ' O ' ' HA ' ' A' ' 4' ' ' GLN . 7.8 t70 -131.73 -41.57 1.05 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.405 -0.809 . . . . 0.0 109.71 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 m-30 -106.43 143.55 34.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.446 -0.784 . . . . 0.0 110.04 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.655 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.4 OUTLIER -127.17 -8.22 5.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.262 -0.899 . . . . 0.0 110.691 -179.743 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.553 ' HG1' ' C ' ' A' ' 21' ' ' TYR . 30.2 p 50.89 -93.39 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.721 -0.612 . . . . 0.0 112.37 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 33.6 t0 -158.34 143.31 16.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.02 -1.05 . . . . 0.0 110.404 -178.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.539 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 87.3 20.68 51.63 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.655 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -115.7 166.6 11.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.371 -1.076 . . . . 0.0 110.489 -179.723 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.8 HG13 ' O ' ' A' ' 43' ' ' VAL . 20.8 t -142.19 156.55 19.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.433 -0.792 . . . . 0.0 110.649 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.774 HG11 ' CG ' ' A' ' 6' ' ' PRO . 10.8 t -130.71 111.6 20.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.224 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.441 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -66.67 103.61 1.12 Allowed 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 118.56 -1.256 . . . . 0.0 108.327 178.607 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.641 ' CE1' HG21 ' A' ' 43' ' ' VAL . 1.7 m-30 -68.73 121.79 17.21 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.595 -0.691 . . . . 0.0 110.384 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -69.87 158.85 34.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -0.985 . . . . 0.0 109.415 179.23 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.9 154.2 46.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.951 -1.093 . . . . 0.0 110.704 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 11' ' ' ASN . 3.8 t-20 -64.45 152.75 40.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.402 -0.811 . . . . 0.0 110.01 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.71 120.69 15.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.2 -0.937 . . . . 0.0 110.278 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.16 -5.67 30.36 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.588 ' CD2' ' O ' ' A' ' 56' ' ' CYS . 0.8 OUTLIER -116.06 146.91 41.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.189 -1.183 . . . . 0.0 110.518 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.732 ' HB3' HD11 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -89.05 142.01 28.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.395 -0.816 . . . . 0.0 111.205 -179.693 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.568 ' C ' HD13 ' A' ' 38' ' ' ILE . 0.7 OUTLIER -94.54 104.55 16.5 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.46 -0.775 . . . . 0.0 109.079 178.802 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.868 HG23 ' HG3' ' A' ' 105' ' ' PRO . 0.8 OUTLIER -94.96 141.89 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.305 -0.872 . . . . 0.0 109.677 -179.361 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.48 -160.29 23.05 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.519 ' O ' ' C ' ' A' ' 41' ' ' SER . 0.7 OUTLIER -99.54 50.4 0.93 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.1 -1.235 . . . . 0.0 109.974 179.824 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.526 ' HA ' HD21 ' A' ' 37' ' ' LEU . 0.3 OUTLIER 22.06 63.52 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.864 179.585 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.473 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 146.34 120.75 1.29 Allowed Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.416 -1.373 . . . . 0.0 110.184 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.8 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -68.43 179.65 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.452 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.413 ' HA ' HG22 ' A' ' 26' ' ' VAL . 25.3 tp -136.24 104.69 5.73 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.602 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.531 ' HB2' ' CH2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -75.32 103.83 5.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.394 -0.816 . . . . 0.0 109.236 179.379 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.504 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 12.2 t -132.59 103.62 6.24 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.31 -0.869 . . . . 0.0 110.304 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.88 41.36 5.97 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.443 ' HA2' ' C ' ' A' ' 2' ' ' LYS . . . 60.33 18.1 48.76 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.12 153.94 49.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -1.128 . . . . 0.0 110.147 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.531 ' CH2' ' HB2' ' A' ' 45' ' ' CYS . 83.0 m95 -105.46 130.82 53.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.749 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 11.8 t -136.87 156.16 48.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.972 . . . . 0.0 111.173 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.531 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.1 OUTLIER 65.2 64.96 0.98 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.819 -0.551 . . . . 0.0 111.436 179.477 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.0 Cg_endo -91.93 137.86 1.91 Allowed 'Trans proline' 0 C--N 1.3 -2.02 0 O-C-N 124.39 1.732 . . . . 0.0 109.695 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.583 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 47.8 Cg_endo -81.75 164.19 18.33 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.728 1.383 . . . . 0.0 110.453 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.608 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 33.9 p -107.37 -174.97 2.66 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.226 -0.921 . . . . 0.0 111.185 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.588 ' O ' ' CD2' ' A' ' 35' ' ' TYR . 1.0 OUTLIER -140.71 76.14 1.54 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.336 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.538 ' HG3' ' CG1' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -115.82 174.05 6.23 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.129 -178.729 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.563 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -90.28 124.26 42.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.278 -0.889 . . . . 0.0 108.683 179.389 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.699 ' HB ' ' HA ' ' A' ' 105' ' ' PRO . 29.5 m -112.37 48.43 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.098 -1.001 . . . . 0.0 111.752 -178.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.474 ' O ' ' OD1' ' A' ' 107' ' ' ASN . 11.4 mttm -55.48 170.49 0.24 Allowed 'General case' 0 C--N 1.28 -2.448 0 C-N-CA 117.624 -1.63 . . . . 0.0 108.043 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.534 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -131.53 168.36 17.79 Favored Pre-proline 0 N--CA 1.491 1.602 0 C-N-CA 118.532 -1.267 . . . . 0.0 112.999 -178.1 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.502 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 47.2 Cg_endo -89.98 -73.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 124.896 1.998 . . . . 0.0 110.421 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.502 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 164.24 126.12 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.285 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.903 ' HA ' HD21 ' A' ' 113' ' ' LEU . 55.5 Cg_endo -80.53 60.63 7.93 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 123.544 1.286 . . . . 0.0 110.211 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.601 ' O ' HD23 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -76.17 170.64 15.93 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.535 -0.728 . . . . 0.0 109.478 179.444 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.98 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -168.05 164.88 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.015 -1.053 . . . . 0.0 110.525 -179.6 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.424 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 2.5 t -70.22 98.81 1.41 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.514 -0.741 . . . . 0.0 110.675 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 51.0 m-80 43.19 48.98 5.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.368 -0.832 . . . . 0.0 110.841 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.98 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -160.18 38.74 0.45 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.587 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 53.1 p90 -49.23 -151.89 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 122.886 1.327 . . . . 0.0 113.134 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.009 HD23 ' CE2' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -144.72 122.04 11.59 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.765 -176.445 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.9 t -98.88 14.0 30.5 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.342 -0.848 . . . . 0.0 110.127 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.511 ' OG ' ' N ' ' A' ' 86' ' ' ASP . 1.3 p -74.82 -101.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.312 -0.867 . . . . 0.0 110.712 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -120.28 74.92 0.32 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.615 ' HD2' HD11 ' A' ' 71' ' ' LEU . 1.9 t80 -91.53 161.5 14.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.495 -1.003 . . . . 0.0 110.396 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.587 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 23.8 tttt -162.35 156.15 21.02 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.451 -0.78 . . . . 0.0 109.862 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -47.14 -32.65 4.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -0.883 . . . . 0.0 110.146 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.524 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 3.3 t -144.04 167.82 21.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.385 -0.822 . . . . 0.0 110.366 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 9.3 m-85 -138.02 -149.87 0.32 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.292 -0.88 . . . . 0.0 109.844 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.649 ' CA ' HG23 ' A' ' 59' ' ' VAL . 2.7 p -156.33 -100.41 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.597 -1.315 . . . . 0.0 111.877 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.628 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -123.04 14.2 9.82 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.733 -1.229 . . . . 0.0 110.311 -178.466 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.774 ' O ' HG22 ' A' ' 102' ' ' THR . 8.0 p30 -155.74 -108.3 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.02 -1.05 . . . . 0.0 110.398 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 82' ' ' ASN . 5.3 t0 46.22 71.99 0.26 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.817 -1.177 . . . . 0.0 109.539 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.894 ' CA ' HG23 ' A' ' 102' ' ' THR . 14.0 p-10 -68.65 106.47 2.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.314 -0.866 . . . . 0.0 109.491 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.586 ' CG2' HD22 ' A' ' 71' ' ' LEU . 35.8 m -92.03 121.48 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.11 -0.993 . . . . 0.0 111.523 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.529 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.6 OUTLIER -82.66 135.36 35.05 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.25 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 1.009 ' CE2' HD23 ' A' ' 71' ' ' LEU . 38.3 m-85 -90.94 144.39 25.73 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.805 -1.184 . . . . 0.0 112.252 -177.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -116.1 91.95 3.75 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.669 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.548 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -44.76 132.52 6.49 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.068 -1.02 . . . . 0.0 110.054 -179.741 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -40.82 -74.17 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.41 -0.806 . . . . 0.0 110.639 -179.683 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.576 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 31.5 t80 -169.62 144.11 2.86 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.225 -0.922 . . . . 0.0 110.674 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.578 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 46.38 41.11 11.63 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.607 ' CE1' ' HB3' ' A' ' 118' ' ' ARG . 12.2 m-85 -145.93 147.5 31.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.517 -0.99 . . . . 0.0 109.947 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 117' ' ' VAL . 6.7 ttpt -102.57 152.48 21.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.196 -0.94 . . . . 0.0 109.959 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.612 HD23 ' HB2' ' A' ' 114' ' ' PRO . 0.6 OUTLIER -92.99 89.44 6.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.056 -1.027 . . . . 0.0 110.446 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.739 ' HB2' HG21 ' A' ' 117' ' ' VAL . 18.6 t -70.55 108.1 4.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.9 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 138.69 -65.34 0.54 Allowed Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.844 -1.17 . . . . 0.0 110.236 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.576 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.1 OUTLIER 174.84 114.43 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.277 -1.131 . . . . 0.0 110.705 -179.383 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.485 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 0.9 OUTLIER -80.86 20.92 0.72 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.106 -0.996 . . . . 0.0 111.258 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.409 ' O ' ' OG ' ' A' ' 100' ' ' SER . 16.4 p -161.28 103.84 1.26 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.957 -1.09 . . . . 0.0 109.905 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.498 ' O ' ' N ' ' A' ' 85' ' ' VAL . 70.2 m -123.13 171.13 9.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.933 . . . . 0.0 110.611 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.894 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -136.78 145.39 44.5 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.223 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 79' ' ' TYR . 7.0 t -74.96 88.76 2.37 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.466 -0.772 . . . . 0.0 109.912 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.452 ' OG ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -66.03 174.5 1.62 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.258 -0.901 . . . . 0.0 111.327 -179.44 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.868 ' HG3' HG23 ' A' ' 38' ' ' ILE . 41.7 Cg_endo -74.16 126.94 10.86 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.401 1.738 . . . . 0.0 110.73 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 120.48 -6.64 11.57 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.577 ' O ' HG23 ' A' ' 108' ' ' THR . 0.5 OUTLIER 82.13 96.06 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 O-C-N 122.107 -0.643 . . . . 0.0 110.699 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -178.51 -162.34 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.356 -0.84 . . . . 0.0 111.175 179.516 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.619 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 31.1 m95 -150.34 87.51 1.46 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.59 -0.694 . . . . 0.0 110.11 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.516 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 58.4 mttt -98.85 140.27 21.64 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.475 -0.765 . . . . 0.0 110.098 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.576 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 47.7 Cg_endo -72.7 174.55 48.53 Favored 'Cis proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.992 -2.087 . . . . 0.0 110.686 -0.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 112' ' ' GLU . 0.0 OUTLIER -43.82 135.27 4.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.402 -0.811 . . . . 0.0 110.988 -179.558 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.903 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -45.76 146.8 1.78 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.445 -0.785 . . . . 0.0 110.287 179.426 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.723 ' HG2' HD12 ' A' ' 66' ' ' ILE . 42.7 Cg_endo -76.53 169.57 21.6 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 O-C-N 124.341 1.706 . . . . 0.0 111.182 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.593 ' HG2' HG13 ' A' ' 117' ' ' VAL . 2.6 ttpt -130.16 109.71 11.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.24 -0.912 . . . . 0.0 110.208 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 2.0 t -63.9 80.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -0.913 . . . . 0.0 109.341 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.739 HG21 ' HB2' ' A' ' 96' ' ' SER . 0.3 OUTLIER -88.54 -176.82 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.749 0.785 . . . . 0.0 110.645 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.607 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--N 1.295 -1.792 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.504 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.401 ' C ' ' HD3' ' A' ' 2' ' ' LYS . 4.8 m . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.302 0.572 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.401 ' HD3' ' C ' ' A' ' 1' ' ' VAL . 0.0 OUTLIER -122.81 176.84 5.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.934 . . . . 0.0 110.313 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.57 ' HB3' ' N ' ' A' ' 22' ' ' THR . 2.8 t -136.63 95.55 3.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.344 -0.848 . . . . 0.0 110.828 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 5' ' ' SER . 0.0 OUTLIER -74.33 176.45 6.7 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 118.766 -1.174 . . . . 0.0 108.972 178.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -46.76 145.46 3.08 Favored Pre-proline 0 C--N 1.293 -1.861 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.278 179.794 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.825 ' HG3' HG11 ' A' ' 27' ' ' VAL . 48.8 Cg_endo -71.01 153.91 63.0 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.835 1.44 . . . . 0.0 110.78 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -74.84 171.61 17.93 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 O-C-N 123.911 1.48 . . . . 0.0 109.787 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.64 177.09 3.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.14 -0.975 . . . . 0.0 109.758 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.713 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -142.54 -170.57 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 122.178 0.989 . . . . 0.0 111.642 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 14.2 t -40.85 93.28 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.698 -179.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 9' ' ' ILE . 3.5 m-80 42.17 44.16 3.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 110.25 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -140.82 178.05 20.39 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.527 ' CB ' ' HB3' ' A' ' 30' ' ' SER . 0.0 OUTLIER -125.0 -168.27 1.8 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.178 -1.189 . . . . 0.0 110.578 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.625 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 13.9 p80 -156.46 123.94 5.43 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.958 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -147.5 128.11 14.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.166 -0.959 . . . . 0.0 110.53 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.49 -115.73 2.14 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -166.84 37.27 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -1.131 . . . . 0.0 110.052 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.592 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 1.4 pp20? -150.04 -155.61 0.64 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 0.0 110.09 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -140.7 -42.44 0.4 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.367 -0.833 . . . . 0.0 110.068 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.402 ' C ' ' OE1' ' A' ' 18' ' ' GLU . 17.6 m-85 -119.52 100.98 7.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 109.526 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.655 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.8 OUTLIER -77.53 -11.04 59.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.44 -0.787 . . . . 0.0 111.395 -179.226 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.57 ' N ' ' HB3' ' A' ' 3' ' ' CYS . 56.4 p 46.71 -95.78 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.209 -0.932 . . . . 0.0 111.636 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.539 ' H ' ' HG1' ' A' ' 22' ' ' THR . 1.3 t70 -152.77 146.92 25.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.842 -1.161 . . . . 0.0 110.948 -178.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 82.45 23.88 55.38 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.655 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.9 OUTLIER -116.9 169.84 9.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.395 -1.061 . . . . 0.0 110.207 -179.799 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.848 HG13 ' O ' ' A' ' 43' ' ' VAL . 23.7 t -139.26 156.15 26.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 119.29 -0.964 . . . . 0.0 111.033 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.9 ' O ' HG23 ' A' ' 43' ' ' VAL . 24.0 t -133.25 124.25 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 119.846 -0.741 . . . . 0.0 111.066 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.849 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -73.86 100.9 3.61 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 118.347 -1.341 . . . . 0.0 108.432 178.412 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 1.076 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.1 m-30 -68.56 127.93 34.8 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.144 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.527 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 12.5 t -80.12 -170.43 2.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.026 -1.046 . . . . 0.0 109.687 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.623 ' SG ' HD12 ' A' ' 37' ' ' LEU . 67.4 m -150.83 160.94 43.54 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.147 -0.971 . . . . 0.0 110.161 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.523 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 14.8 t-20 -48.43 171.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.0 110.059 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.68 107.45 5.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 110.181 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.79 11.46 40.4 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.523 ' CG ' ' HB3' ' A' ' 32' ' ' ASN . 2.9 m-30 -106.84 128.33 54.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -1.136 . . . . 0.0 110.238 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.624 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.5 OUTLIER -74.23 138.99 44.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.306 -0.871 . . . . 0.0 110.808 -179.885 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.778 HD13 ' O ' ' A' ' 29' ' ' TYR . 2.8 tp -91.24 104.51 17.05 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.445 -0.784 . . . . 0.0 109.421 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.799 HG23 ' HG3' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -97.48 154.04 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.279 -0.888 . . . . 0.0 109.37 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.478 ' O ' ' CB ' ' A' ' 40' ' ' ASN . . . 94.56 39.54 4.68 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.7 OUTLIER 68.52 174.5 0.28 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.353 -1.087 . . . . 0.0 110.116 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.849 ' O ' HG23 ' A' ' 28' ' ' THR . 0.3 OUTLIER -119.79 71.5 0.89 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 110.318 -179.859 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.501 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 163.36 119.35 0.48 Allowed Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.75 -1.215 . . . . 0.0 110.173 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.076 HG21 ' CE1' ' A' ' 29' ' ' TYR . 2.0 t -76.31 -175.23 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.147 -1.208 . . . . 0.0 108.506 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.563 ' H ' HG12 ' A' ' 43' ' ' VAL . 0.9 OUTLIER -144.05 102.28 3.86 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.215 178.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.543 ' HB2' ' CD2' ' A' ' 50' ' ' TRP . 13.5 t -83.96 124.61 31.2 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.362 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.428 ' C ' ' OD2' ' A' ' 23' ' ' ASP . 84.5 p -132.22 80.22 1.9 Allowed 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.283 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.444 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 92.8 46.75 3.33 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.59 23.22 62.6 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 50' ' ' TRP . 3.3 mt-10 -126.4 68.78 1.22 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.206 -1.173 . . . . 0.0 110.374 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.594 ' CH2' HG23 ' A' ' 27' ' ' VAL . 72.7 m95 -43.58 135.63 3.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.485 -0.759 . . . . 0.0 109.632 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.2 t -146.73 169.87 18.16 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.962 -1.086 . . . . 0.0 111.069 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.534 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER 59.52 65.02 2.72 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.671 -0.643 . . . . 0.0 110.981 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.534 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.0 Cg_endo -91.22 127.95 1.18 Allowed 'Trans proline' 0 C--N 1.301 -1.928 0 O-C-N 124.393 1.733 . . . . 0.0 110.305 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.523 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 51.4 Cg_endo -77.09 173.18 14.84 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 O-C-N 123.897 1.472 . . . . 0.0 110.096 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.584 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 21.0 p -107.09 164.6 12.01 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.92 . . . . 0.0 111.272 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 10' ' ' SER . 97.3 m -128.37 76.11 1.68 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 177.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -111.82 -158.93 0.66 Allowed 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.28 0.562 . . . . 0.0 110.162 -178.831 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.21 147.13 15.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.624 HG13 ' CB ' ' A' ' 36' ' ' SER . 33.7 m -132.49 49.25 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 O-C-N 121.044 -1.035 . . . . 0.0 111.267 -178.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 5.3 mttm -64.19 -169.5 0.03 OUTLIER 'General case' 0 C--N 1.281 -2.404 0 C-N-CA 118.225 -1.39 . . . . 0.0 107.9 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.545 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -144.52 170.75 7.69 Favored Pre-proline 0 C--N 1.293 -1.848 0 C-N-CA 118.347 -1.341 . . . . 0.0 113.22 -178.824 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.557 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 45.1 Cg_endo -92.47 -70.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.421 2.081 . . . . 0.0 109.139 178.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.557 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 159.34 129.44 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 122.04 -0.413 . . . . 0.0 110.068 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.574 ' HG3' ' CZ2' ' A' ' 109' ' ' TRP . 55.3 Cg_endo -85.18 94.31 0.66 Allowed 'Trans proline' 0 C--N 1.299 -2.044 0 O-C-N 123.802 1.422 . . . . 0.0 109.346 178.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.726 ' O ' HG23 ' A' ' 66' ' ' ILE . 3.5 p -111.57 -43.15 3.7 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 122.342 1.068 . . . . 0.0 110.452 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.73 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER 53.27 170.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.017 -178.71 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.506 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -68.37 101.66 1.26 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.472 -0.767 . . . . 0.0 111.331 -179.088 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 60.7 m-20 42.36 51.95 4.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.507 -0.746 . . . . 0.0 111.684 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.594 ' O ' ' CD1' ' A' ' 70' ' ' TYR . . . -133.05 -38.49 0.23 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.631 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 2.0 p90 38.2 -171.58 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 122.965 1.364 . . . . 0.0 112.645 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.661 HD22 ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -139.17 159.76 41.39 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.724 -178.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.59 27.73 3.04 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.755 -1.215 . . . . 0.0 110.152 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.74 -78.65 0.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.193 -0.942 . . . . 0.0 111.111 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -135.4 82.15 0.29 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.624 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -108.93 170.65 7.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.5 -1.0 . . . . 0.0 109.934 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.624 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 10.5 ttmt -171.23 170.1 6.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.353 -0.842 . . . . 0.0 109.974 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.402 ' N ' ' CG ' ' A' ' 76' ' ' LYS . 29.3 mtm180 -60.67 -37.39 81.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.971 -1.081 . . . . 0.0 110.517 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.4 m -134.09 159.0 42.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.286 -0.883 . . . . 0.0 110.322 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.623 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 3.7 m-85 -133.72 -146.44 0.27 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.312 -0.868 . . . . 0.0 110.058 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.574 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 21.6 p -160.02 -128.52 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.907 -1.121 . . . . 0.0 110.94 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.609 ' O ' ' CG ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -93.8 14.24 19.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.375 -1.453 . . . . 0.0 110.603 -179.292 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.689 ' C ' HG22 ' A' ' 102' ' ' THR . 50.6 t30 -160.73 -104.05 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.743 -1.223 . . . . 0.0 110.706 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 82' ' ' ASN . 0.7 OUTLIER 45.68 79.48 0.05 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.877 -1.14 . . . . 0.0 108.801 -178.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.716 ' CA ' HG23 ' A' ' 102' ' ' THR . 30.2 p-10 -69.36 150.29 47.48 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.415 -0.803 . . . . 0.0 110.853 -178.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.507 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 17.0 m -133.5 118.67 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.419 -0.8 . . . . 0.0 110.049 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.541 ' O ' ' HB2' ' A' ' 71' ' ' LEU . 8.8 t0 -82.55 127.46 33.36 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.206 -0.934 . . . . 0.0 108.613 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.698 ' CD1' HG21 ' A' ' 66' ' ' ILE . 53.5 m-85 -84.26 136.96 33.72 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.369 1.081 . . . . 0.0 113.339 -177.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.631 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -111.8 85.62 2.18 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.149 179.792 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.547 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -37.3 130.06 0.93 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.52 -0.737 . . . . 0.0 111.198 -179.029 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.8 OUTLIER -41.35 -88.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.489 -0.757 . . . . 0.0 110.697 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.557 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 3.8 t80 -152.68 144.93 23.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.227 -0.92 . . . . 0.0 110.543 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.549 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 46.87 53.85 9.89 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.569 ' CD1' ' HB3' ' A' ' 118' ' ' ARG . 9.3 m-85 -151.28 167.87 26.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.253 -1.145 . . . . 0.0 110.27 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 117' ' ' VAL . 1.9 ttpt -132.23 112.23 12.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.361 -0.837 . . . . 0.0 109.812 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.567 HD23 ' CD1' ' A' ' 66' ' ' ILE . 6.2 mt -47.65 109.56 0.23 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.261 -0.899 . . . . 0.0 110.348 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.433 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -90.61 99.32 12.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.392 -0.817 . . . . 0.0 109.88 179.614 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 141.09 -76.62 0.31 Allowed Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.119 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.615 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 1.2 m -163.4 117.35 1.59 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.372 -1.075 . . . . 0.0 110.594 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.404 ' HB2' HD13 ' A' ' 95' ' ' LEU . 9.8 p -76.63 6.27 6.18 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.276 -0.89 . . . . 0.0 110.967 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 59.8 p -147.42 113.11 5.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.114 -0.991 . . . . 0.0 109.761 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.442 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 13.1 m -128.25 168.9 14.83 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.242 -0.912 . . . . 0.0 110.776 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.716 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.5 OUTLIER -136.44 146.66 46.61 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.51 -0.744 . . . . 0.0 110.461 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 80' ' ' SER . 41.9 t -76.41 84.91 3.15 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.611 -0.681 . . . . 0.0 110.439 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.516 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -65.59 -179.12 0.32 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 110.279 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.799 ' HG3' HG23 ' A' ' 38' ' ' ILE . 46.1 Cg_endo -76.47 131.27 12.48 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 O-C-N 124.23 1.647 . . . . 0.0 110.878 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 121.91 -11.33 9.43 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.587 ' O ' HG23 ' A' ' 108' ' ' THR . 1.0 OUTLIER 82.8 92.9 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 O-C-N 122.015 -0.697 . . . . 0.0 110.956 179.668 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -179.1 -160.02 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.556 -0.715 . . . . 0.0 110.725 179.437 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.674 ' HB3' HD13 ' A' ' 113' ' ' LEU . 24.0 m95 -148.9 87.92 1.58 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.513 -0.742 . . . . 0.0 110.538 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.548 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -95.2 154.68 39.46 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.382 -0.824 . . . . 0.0 109.777 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.615 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 48.5 Cg_endo -71.65 -177.51 17.41 Favored 'Cis proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.163 -2.016 . . . . 0.0 110.514 -0.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.474 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.9 OUTLIER -37.54 111.74 0.17 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.802 -0.561 . . . . 0.0 110.236 -179.759 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.674 HD13 ' HB3' ' A' ' 109' ' ' TRP . 3.9 tp -37.61 141.86 0.45 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.66 -0.65 . . . . 0.0 110.446 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.73 ' HG2' HD12 ' A' ' 66' ' ' ILE . 40.6 Cg_endo -69.89 161.79 44.6 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 124.11 1.584 . . . . 0.0 110.47 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.517 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.8 OUTLIER -125.1 100.21 6.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 110.497 179.704 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.547 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.9 t -56.19 91.84 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.019 -1.051 . . . . 0.0 109.272 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 3.7 m -110.95 179.11 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.628 0.728 . . . . 0.0 110.941 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.569 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.688 0 C-N-CA 118.997 -1.081 . . . . 0.0 110.239 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.513 ' CG1' ' HA3' ' A' ' 48' ' ' GLY . 69.2 t . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 121.231 0.539 . . . . 0.0 110.275 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.474 ' N ' HG12 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -119.87 179.69 4.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.901 . . . . 0.0 110.294 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.549 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.3 m -131.61 137.28 48.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.546 -0.721 . . . . 0.0 110.008 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.567 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 3.8 mt-30 -114.2 168.49 9.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.767 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -45.21 131.89 5.72 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.112 -0.992 . . . . 0.0 109.446 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.681 ' HG3' HG11 ' A' ' 27' ' ' VAL . 45.6 Cg_endo -66.99 153.16 78.8 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 124.011 1.532 . . . . 0.0 112.209 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.64 175.29 11.49 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 124.097 1.578 . . . . 0.0 110.304 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.44 173.63 5.7 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.276 -0.89 . . . . 0.0 110.254 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.432 HG12 ' CG ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -143.46 -172.96 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-O 122.038 0.923 . . . . 0.0 111.085 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.3 OUTLIER -39.73 100.51 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.215 -179.214 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.415 ' C ' ' O ' ' A' ' 10' ' ' SER . 1.2 m120 39.21 45.59 1.14 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.434 -0.791 . . . . 0.0 111.09 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.452 ' HA3' ' CB ' ' A' ' 56' ' ' CYS . . . -158.21 161.45 31.62 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.435 ' HG3' ' HB2' ' A' ' 30' ' ' SER . 0.8 OUTLIER -119.41 -175.22 2.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -1.146 . . . . 0.0 110.713 -179.613 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.635 ' HB2' HG11 ' A' ' 27' ' ' VAL . 7.5 p80 -126.91 163.3 23.95 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.196 0.522 . . . . 0.0 110.063 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.491 ' ND2' ' OG ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -170.5 -159.07 0.17 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.093 -1.004 . . . . 0.0 110.322 -179.819 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.44 -126.36 2.37 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.535 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 11.4 p90 -149.19 33.87 0.73 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -1.129 . . . . 0.0 110.068 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.488 ' HG3' ' CZ ' ' A' ' 21' ' ' TYR . 0.9 OUTLIER -147.1 -177.43 5.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.933 . . . . 0.0 109.912 179.854 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -124.03 -41.33 2.22 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.207 -0.933 . . . . 0.0 110.253 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.621 ' O ' ' CG ' ' A' ' 20' ' ' PHE . 21.0 p90 -128.34 98.81 5.19 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.11 -0.994 . . . . 0.0 110.516 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.618 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 11.6 m-85 -61.95 -165.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.984 -1.073 . . . . 0.0 110.054 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.549 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 0.3 OUTLIER -151.42 -65.57 0.18 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.026 -1.046 . . . . 0.0 110.778 -179.731 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -167.15 147.33 5.47 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.444 -0.785 . . . . 0.0 109.658 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 65.61 14.58 60.53 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.618 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -94.54 172.41 8.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.387 -1.067 . . . . 0.0 109.938 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 43' ' ' VAL . 24.4 t -148.75 154.71 9.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.224 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.681 HG11 ' HG3' ' A' ' 6' ' ' PRO . 24.4 t -134.04 113.81 18.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.596 -0.69 . . . . 0.0 110.922 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -69.39 104.08 2.18 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 118.052 -1.459 . . . . 0.0 107.597 178.187 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.653 ' O ' HD13 ' A' ' 37' ' ' LEU . 1.3 m-30 -67.4 111.87 4.3 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.366 -178.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.491 ' OG ' ' ND2' ' A' ' 15' ' ' ASN . 0.7 OUTLIER -70.69 154.98 41.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.114 -0.991 . . . . 0.0 110.278 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.7 m -123.97 157.27 34.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.319 -0.863 . . . . 0.0 109.662 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.52 168.51 1.57 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.107 -0.996 . . . . 0.0 110.241 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.21 100.61 0.81 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.26 -0.9 . . . . 0.0 110.124 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.482 ' O ' HG22 ' A' ' 58' ' ' ILE . . . 120.92 -6.99 11.0 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.693 ' CD2' HG23 ' A' ' 58' ' ' ILE . 27.7 m-85 -96.61 133.63 40.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -1.136 . . . . 0.0 110.2 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.723 ' HB2' HG22 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -89.25 144.34 26.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 0.0 110.797 -179.783 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.653 HD13 ' O ' ' A' ' 29' ' ' TYR . 1.9 tp -92.09 98.15 11.37 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.376 -0.827 . . . . 0.0 109.237 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.929 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -87.99 144.02 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.31 -0.869 . . . . 0.0 109.051 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.59 -174.6 22.87 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.475 ' ND2' ' OD1' ' A' ' 52' ' ' ASP . 2.4 m-80 -55.33 145.93 20.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.343 -1.092 . . . . 0.0 110.092 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.608 ' O ' HG23 ' A' ' 28' ' ' THR . 87.4 p -80.52 49.53 1.17 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.173 -0.954 . . . . 0.0 110.076 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.657 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 152.19 109.83 0.43 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.665 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -46.49 172.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.244 -1.151 . . . . 0.0 108.244 179.276 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 25' ' ' SER . 0.4 OUTLIER -138.26 97.08 3.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.046 -1.034 . . . . 0.0 110.183 179.01 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.608 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.2 OUTLIER -76.48 107.78 9.0 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.091 -1.005 . . . . 0.0 109.266 178.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.66 107.05 8.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.545 -0.722 . . . . 0.0 110.238 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.03 5.08 55.15 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.513 ' HA3' ' CG1' ' A' ' 1' ' ' VAL . . . 94.49 15.79 45.54 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -141.42 113.73 8.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.348 -1.09 . . . . 0.0 110.261 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.608 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 96.3 m95 -58.34 134.75 56.86 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.189 -0.944 . . . . 0.0 109.975 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.7 t -135.3 149.84 49.87 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.184 -0.948 . . . . 0.0 110.95 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.51 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 1.1 t70 62.81 65.47 1.41 Allowed Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.716 -0.615 . . . . 0.0 111.372 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.51 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.6 Cg_endo -91.58 124.44 0.82 Allowed 'Trans proline' 0 C--N 1.3 -2.021 0 O-C-N 124.337 1.704 . . . . 0.0 109.841 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.494 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.0 Cg_endo -71.67 175.14 9.99 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 O-C-N 123.88 1.463 . . . . 0.0 109.979 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.601 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 23.6 p -118.37 141.81 48.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.194 -0.941 . . . . 0.0 111.187 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 10' ' ' SER . 35.1 m -103.58 76.06 1.37 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.479 ' OE1' ' CB ' ' A' ' 55' ' ' THR . 0.0 OUTLIER -113.46 147.24 38.21 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.406 0.622 . . . . 0.0 110.214 -178.73 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.693 HG23 ' CD2' ' A' ' 35' ' ' TYR . 1.7 pt -70.74 112.55 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.435 -0.79 . . . . 0.0 109.161 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.894 HG21 ' CB ' ' A' ' 81' ' ' TYR . 18.8 m -99.54 53.01 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.309 -0.869 . . . . 0.0 111.751 -178.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 23.2 mtpp -71.62 -174.12 1.07 Allowed 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 118.065 -1.454 . . . . 0.0 107.2 177.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.516 ' SG ' ' HB2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -143.42 163.61 35.88 Favored Pre-proline 0 C--N 1.29 -2.018 0 C-N-CA 118.014 -1.474 . . . . 0.0 111.98 -178.499 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.528 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 41.3 Cg_endo -80.57 -68.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.866 0 O-C-N 124.787 1.941 . . . . 0.0 109.609 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.528 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 161.13 135.06 0.01 OUTLIER Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.881 ' HG2' HD21 ' A' ' 71' ' ' LEU . 56.9 Cg_endo -82.95 66.76 7.9 Favored 'Trans proline' 0 C--N 1.289 -2.555 0 O-C-N 123.952 1.501 . . . . 0.0 109.47 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.73 ' O ' HG23 ' A' ' 66' ' ' ILE . 3.1 p -81.88 -41.92 20.29 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 122.43 1.109 . . . . 0.0 110.455 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.878 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER 54.54 162.15 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.53 -179.037 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.449 ' N ' HG13 ' A' ' 66' ' ' ILE . 12.8 t -65.95 101.1 0.63 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.573 -0.705 . . . . 0.0 111.78 -178.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 2.2 m-20 41.68 31.91 0.22 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.499 -0.751 . . . . 0.0 111.743 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.559 ' C ' ' CD1' ' A' ' 70' ' ' TYR . . . -124.11 -27.0 1.43 Allowed Glycine 0 N--CA 1.491 2.358 0 C-N-CA 118.732 -1.699 . . . . 0.0 109.938 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.559 ' CD1' ' C ' ' A' ' 69' ' ' GLY . 37.9 p90 33.4 -160.59 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 122.762 1.268 . . . . 0.0 112.016 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.895 HD23 ' HE1' ' A' ' 87' ' ' PHE . 0.7 OUTLIER -135.56 149.08 49.33 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 114.154 -1.384 . . . . 0.0 109.691 -176.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' A' ' 72' ' ' SER . 0.1 OUTLIER -116.03 24.38 11.49 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.866 -1.146 . . . . 0.0 109.883 -179.662 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.51 ' OG ' ' CB ' ' A' ' 86' ' ' ASP . 8.5 m -101.62 -99.87 0.27 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.065 -1.022 . . . . 0.0 111.836 -178.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.489 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -109.81 -73.96 0.77 Allowed Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.739 -1.22 . . . . 0.0 111.144 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.5 OUTLIER 60.62 174.54 0.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.409 -1.053 . . . . 0.0 109.609 -178.768 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.627 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 28.6 ttmt 179.65 159.07 0.71 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.302 -0.874 . . . . 0.0 109.641 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.526 ' N ' ' HG2' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -43.01 -31.17 0.49 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.292 -0.88 . . . . 0.0 110.635 -179.843 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.446 ' C ' ' CG ' ' A' ' 79' ' ' TYR . 2.8 p -154.43 169.93 22.58 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.132 -0.98 . . . . 0.0 111.161 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.656 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -150.62 -168.53 3.13 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.443 -0.786 . . . . 0.0 108.897 179.762 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 82' ' ' ASN . 0.1 OUTLIER -170.75 120.52 0.56 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.667 -1.27 . . . . 0.0 111.424 179.783 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.894 ' CB ' HG21 ' A' ' 59' ' ' VAL . 4.1 t80 38.37 22.85 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.995 -1.066 . . . . 0.0 112.074 178.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.672 ' C ' HG22 ' A' ' 102' ' ' THR . 26.2 p30 -178.49 -134.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.025 -1.672 . . . . 0.0 110.882 178.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.524 ' CB ' ' HB3' ' A' ' 79' ' ' TYR . 0.4 OUTLIER 57.27 72.14 0.53 Allowed 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.006 -1.059 . . . . 0.0 108.519 -178.46 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.649 ' CA ' HG23 ' A' ' 102' ' ' THR . 6.8 p30 -68.44 143.23 55.11 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.453 -0.78 . . . . 0.0 110.331 -178.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.746 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 3.6 m -134.47 121.36 36.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.228 -0.92 . . . . 0.0 110.221 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.548 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 1.1 t70 -69.95 141.96 52.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.09 -1.006 . . . . 0.0 108.479 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.895 ' HE1' HD23 ' A' ' 71' ' ' LEU . 7.1 m-85 -104.89 143.38 33.23 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.672 -1.267 . . . . 0.0 112.5 -178.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.509 ' O ' HD21 ' A' ' 95' ' ' LEU . 3.7 tptt -116.4 -173.34 2.35 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.163 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.503 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -132.11 127.96 37.12 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.241 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.49 ' C ' ' O ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -33.57 -70.72 0.07 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.404 0.621 . . . . 0.0 110.733 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.518 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -177.25 145.42 0.45 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.371 -0.831 . . . . 0.0 109.927 179.708 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.442 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 51.86 43.13 54.46 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.572 ' CE1' ' HB3' ' A' ' 118' ' ' ARG . 11.6 m-85 -146.61 162.7 37.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.34 -1.094 . . . . 0.0 110.32 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 117' ' ' VAL . 23.1 tptt -127.5 113.26 15.92 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.391 -0.818 . . . . 0.0 109.877 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.631 HD23 ' HB2' ' A' ' 114' ' ' PRO . 2.1 mt -46.49 112.62 0.52 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.107 -0.995 . . . . 0.0 109.868 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.615 ' HB2' HG21 ' A' ' 117' ' ' VAL . 1.1 t -95.92 103.64 15.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 110.205 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.16 -98.29 0.24 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.618 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -141.63 135.51 30.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -1.133 . . . . 0.0 110.614 -179.502 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 100' ' ' SER . 37.3 p -78.69 -64.91 1.07 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 110.11 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.52 ' N ' ' OG ' ' A' ' 99' ' ' SER . 15.8 p -74.86 140.28 43.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.087 -1.008 . . . . 0.0 110.065 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.595 ' HB2' ' CE2' ' A' ' 87' ' ' PHE . 3.8 m -151.16 148.35 28.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -0.934 . . . . 0.0 110.659 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.672 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -125.48 145.25 50.17 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.564 -0.71 . . . . 0.0 109.769 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.583 ' O ' ' CA ' ' A' ' 81' ' ' TYR . 7.6 t -69.4 78.93 0.39 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.104 -0.998 . . . . 0.0 109.946 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.445 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.4 OUTLIER -47.3 171.15 0.08 OUTLIER Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.286 -0.884 . . . . 0.0 112.197 -179.397 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.929 ' CB ' HD12 ' A' ' 38' ' ' ILE . 47.9 Cg_endo -78.08 21.84 0.65 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 124.731 1.911 . . . . 0.0 112.569 -178.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -114.69 7.61 22.14 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.53 ' O ' HG23 ' A' ' 108' ' ' THR . 0.8 OUTLIER 76.91 61.83 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.835 -0.803 . . . . 0.0 109.572 -179.761 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.571 ' O ' ' HA ' ' A' ' 103' ' ' CYS . 0.0 OUTLIER -171.41 -170.62 0.84 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.277 -179.426 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.746 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 19.4 m95 -118.22 86.45 2.53 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.631 -0.668 . . . . 0.0 110.133 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.543 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 2.7 mmmt -92.1 152.33 42.59 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.407 -0.808 . . . . 0.0 110.014 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.618 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 48.8 Cg_endo -72.23 -178.68 21.17 Favored 'Cis proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.071 -2.054 . . . . 0.0 111.025 -0.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 111' ' ' PRO . 3.4 mt-10 -37.11 118.5 0.61 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.334 0.588 . . . . 0.0 110.758 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.642 HD13 ' HB3' ' A' ' 109' ' ' TRP . 2.9 tp -47.39 141.65 6.55 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.365 -0.834 . . . . 0.0 110.562 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.878 ' HG2' HD12 ' A' ' 66' ' ' ILE . 41.1 Cg_endo -71.37 159.91 50.24 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.119 1.589 . . . . 0.0 110.289 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.565 ' O ' HG22 ' A' ' 117' ' ' VAL . 13.9 tttt -124.3 108.5 12.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 0.0 110.545 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.545 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 5.2 t -58.47 84.38 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.29 -0.881 . . . . 0.0 108.85 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.615 HG21 ' HB2' ' A' ' 96' ' ' SER . 4.0 m -103.45 -176.95 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.771 0.796 . . . . 0.0 111.113 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.572 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.765 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.309 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 1' ' ' VAL . 8.1 p . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -129.99 166.89 19.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.935 . . . . 0.0 110.149 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.542 ' HB3' ' O ' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -111.85 91.8 3.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.173 -0.954 . . . . 0.0 110.735 -179.629 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.476 ' O ' ' C ' ' A' ' 5' ' ' SER . 39.0 mt-30 -91.64 -177.17 4.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -0.943 . . . . 0.0 109.426 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.476 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.5 OUTLIER -36.9 131.76 0.7 Allowed Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.799 -0.563 . . . . 0.0 110.134 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.795 ' HG3' HG11 ' A' ' 27' ' ' VAL . 48.5 Cg_endo -68.87 157.35 62.19 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.998 1.525 . . . . 0.0 111.084 -178.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -75.58 170.74 19.61 Favored 'Trans proline' 0 C--N 1.302 -1.921 0 O-C-N 123.926 1.487 . . . . 0.0 109.608 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.6 p -70.33 175.49 4.64 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.145 -0.972 . . . . 0.0 109.874 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.683 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -140.33 -169.53 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -0.91 . . . . 0.0 110.804 179.556 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.2 OUTLIER -39.76 92.14 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.606 -179.262 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' A' ' 9' ' ' ILE . 3.9 m-80 42.08 41.26 1.94 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.276 -0.89 . . . . 0.0 110.113 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.449 ' O ' HG13 ' A' ' 9' ' ' ILE . . . -140.73 145.96 17.0 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -92.63 -166.81 1.61 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.268 -1.137 . . . . 0.0 110.605 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.612 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 14.9 p80 -153.9 126.14 7.94 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.157 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -145.62 112.31 5.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 110.311 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.439 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -111.05 19.43 25.13 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.457 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 0.3 OUTLIER 67.07 35.76 4.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.389 -1.065 . . . . 0.0 110.222 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.558 ' OE1' ' CE1' ' A' ' 21' ' ' TYR . 5.9 pt-20 176.88 -175.22 0.12 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 110.436 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -128.43 -3.8 5.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.377 -0.827 . . . . 0.0 110.056 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.588 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 0.9 OUTLIER -109.55 150.8 27.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 110.257 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.596 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 1.9 m-85 -167.43 42.31 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.54 -0.725 . . . . 0.0 109.746 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.518 ' HA ' ' HB2' ' A' ' 3' ' ' CYS . 21.1 p -52.79 99.15 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 122.042 0.925 . . . . 0.0 111.729 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.541 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 26.7 t70 50.54 163.45 0.0 OUTLIER 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 121.742 0.782 . . . . 0.0 112.037 178.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 48.32 26.83 5.15 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.629 ' O ' HG23 ' A' ' 26' ' ' VAL . 16.7 m -106.47 174.56 5.84 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.289 -1.124 . . . . 0.0 110.302 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 25' ' ' SER . 24.6 t -155.56 154.25 6.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.821 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.892 ' O ' HG23 ' A' ' 43' ' ' VAL . 39.2 t -143.81 124.17 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.837 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -74.55 104.52 5.28 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 118.483 -1.287 . . . . 0.0 107.534 177.538 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 1.083 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.2 m-30 -68.36 127.1 31.72 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.287 -0.883 . . . . 0.0 110.395 -178.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -84.8 156.4 21.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.817 . . . . 0.0 110.08 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.538 ' SG ' HD12 ' A' ' 37' ' ' LEU . 75.6 m -124.86 154.35 41.17 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -0.885 . . . . 0.0 110.155 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.484 ' O ' ' N ' ' A' ' 34' ' ' GLY . 7.8 m-20 -41.92 143.37 0.56 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.322 -0.861 . . . . 0.0 110.202 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 95.8 p -52.56 88.63 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.91 . . . . 0.0 110.503 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 32' ' ' ASN . . . 127.69 10.95 3.42 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.2 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.441 ' CD2' ' O ' ' A' ' 56' ' ' CYS . 1.7 m-30 -106.64 153.8 21.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.08 -1.247 . . . . 0.0 110.442 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.849 ' HB2' HD11 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -90.04 137.42 32.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.458 -0.776 . . . . 0.0 110.582 -179.473 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.558 HD13 ' O ' ' A' ' 29' ' ' TYR . 0.9 OUTLIER -98.92 98.54 9.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.189 -0.945 . . . . 0.0 109.484 178.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.849 HD11 ' HB2' ' A' ' 36' ' ' SER . 0.1 OUTLIER -95.86 141.86 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.902 . . . . 0.0 109.397 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.99 -120.21 3.88 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -125.01 137.14 54.24 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.362 -1.081 . . . . 0.0 109.93 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.531 ' O ' HG23 ' A' ' 28' ' ' THR . 73.0 p -71.86 55.86 0.29 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.229 -0.919 . . . . 0.0 109.77 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.445 ' HA2' ' C ' ' A' ' 27' ' ' VAL . . . 154.74 117.6 0.61 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.083 HG21 ' CE1' ' A' ' 29' ' ' TYR . 2.1 t -67.73 179.65 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.188 -1.183 . . . . 0.0 108.177 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.48 ' H ' HG12 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -139.72 104.04 4.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.955 -1.091 . . . . 0.0 110.638 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.599 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -81.93 111.05 17.76 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.161 -1.016 . . . . 0.0 109.262 178.675 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.58 103.2 7.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.584 -0.697 . . . . 0.0 110.488 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.61 36.21 8.08 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.462 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 64.89 31.38 80.75 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -147.78 105.42 3.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.176 -1.191 . . . . 0.0 110.549 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.74 ' CH2' HG23 ' A' ' 27' ' ' VAL . 77.6 m95 -58.5 140.06 54.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.155 -0.965 . . . . 0.0 109.514 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.2 m -143.51 170.64 15.43 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.952 -1.092 . . . . 0.0 111.059 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.516 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 20.0 t0 53.01 65.7 5.61 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.539 -0.726 . . . . 0.0 110.889 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.516 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.8 Cg_endo -91.23 139.15 2.4 Favored 'Trans proline' 0 C--N 1.3 -1.977 0 C-N-CA 121.9 1.733 . . . . 0.0 110.329 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.425 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 47.8 Cg_endo -83.52 -175.68 2.42 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.826 1.435 . . . . 0.0 110.052 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.554 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 7.4 p -124.63 143.65 50.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.38 -0.825 . . . . 0.0 111.569 -178.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 10' ' ' SER . 90.1 m -107.58 80.43 1.4 Allowed 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.464 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.9 OUTLIER -110.63 -150.43 0.46 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.712 -0.618 . . . . 0.0 110.162 -178.447 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.759 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -127.82 120.01 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.256 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.835 HG13 ' CB ' ' A' ' 36' ' ' SER . 26.9 m -115.13 52.66 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.018 -1.051 . . . . 0.0 111.824 -178.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.513 ' N ' ' OD1' ' A' ' 107' ' ' ASN . 9.0 mtpt -71.45 129.73 39.53 Favored 'General case' 0 C--N 1.283 -2.312 0 C-N-CA 118.262 -1.375 . . . . 0.0 108.232 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.5 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 5.8 m -95.01 172.2 5.72 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.928 -1.107 . . . . 0.0 112.371 -178.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 43.6 Cg_endo -84.94 -66.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.721 1.906 . . . . 0.0 110.287 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.456 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 167.98 129.29 0.04 OUTLIER Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -179.232 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.67 ' HG2' HD22 ' A' ' 71' ' ' LEU . 45.9 Cg_endo -74.0 65.23 5.11 Favored 'Trans proline' 0 C--N 1.296 -2.187 0 O-C-N 123.61 1.321 . . . . 0.0 109.868 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.705 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -85.49 170.39 12.7 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.739 -0.601 . . . . 0.0 110.446 -179.576 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.779 HG23 ' HA ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -169.31 164.09 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.126 -0.984 . . . . 0.0 110.277 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.565 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 73.2 m -66.47 75.27 0.1 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.535 -0.728 . . . . 0.0 111.978 -178.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.554 ' CB ' ' O ' ' A' ' 67' ' ' SER . 1.5 t-20 76.31 -24.72 0.21 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.285 -0.885 . . . . 0.0 112.473 178.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.573 ' CA ' ' HA ' ' A' ' 89' ' ' CYS . . . -86.32 38.6 3.08 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.779 ' HA ' HG23 ' A' ' 66' ' ' ILE . 11.9 p90 -41.61 159.75 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 123.032 1.396 . . . . 0.0 112.839 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.066 HD13 ' HB2' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -43.11 -81.39 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 113.922 -1.49 . . . . 0.0 109.699 178.269 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.597 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER 79.05 13.89 1.17 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.606 -0.684 . . . . 0.0 110.427 179.668 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.479 ' HB3' ' HB2' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -156.73 53.27 0.52 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.124 -0.985 . . . . 0.0 110.507 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.747 ' O ' HG12 ' A' ' 85' ' ' VAL . . . 122.38 113.09 2.17 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 1.066 ' HB2' HD13 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -172.25 160.44 5.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -1.14 . . . . 0.0 110.18 -179.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.511 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -152.29 169.46 22.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.455 -0.778 . . . . 0.0 109.949 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -58.92 -32.94 70.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.096 -1.003 . . . . 0.0 109.784 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.51 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -142.18 167.66 21.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.465 -0.772 . . . . 0.0 110.328 179.867 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.623 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 3.2 m-85 -141.83 -151.29 0.35 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.237 -0.915 . . . . 0.0 110.121 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.668 ' C ' HG23 ' A' ' 59' ' ' VAL . 85.2 p -160.54 -99.24 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.041 -1.037 . . . . 0.0 111.239 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.675 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -120.66 23.52 10.74 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.487 -1.383 . . . . 0.0 110.931 -178.281 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.693 ' C ' HG22 ' A' ' 102' ' ' THR . 17.5 t-20 -165.02 -109.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.769 -1.207 . . . . 0.0 110.541 178.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 48.52 75.71 0.14 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.706 -1.246 . . . . 0.0 109.114 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.683 ' CA ' HG23 ' A' ' 102' ' ' THR . 24.4 t30 -69.79 125.89 28.07 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.51 -0.744 . . . . 0.0 110.942 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.747 HG12 ' O ' ' A' ' 74' ' ' GLY . 13.3 m -108.53 125.08 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.214 -0.929 . . . . 0.0 109.418 178.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.577 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -80.82 123.93 28.66 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.989 -1.07 . . . . 0.0 108.882 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.761 ' CD1' HG21 ' A' ' 66' ' ' ILE . 9.7 m-85 -87.96 124.07 33.34 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.459 1.123 . . . . 0.0 112.302 -178.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.511 ' HB2' ' OG ' ' A' ' 72' ' ' SER . 0.0 OUTLIER -106.88 96.72 6.64 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.594 -178.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.573 ' HA ' ' CA ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -46.65 137.46 6.87 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.002 -1.061 . . . . 0.0 109.719 179.494 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.457 ' HD3' ' ND2' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -64.42 57.08 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.255 -0.903 . . . . 0.0 111.351 -179.377 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.581 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER 58.68 137.65 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.353 -0.842 . . . . 0.0 112.689 178.465 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.624 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 57.0 55.47 30.13 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 178.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.624 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 34.3 m-85 -162.05 165.05 27.79 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.312 -1.11 . . . . 0.0 110.396 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.542 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 1.2 ttmm -123.2 104.03 8.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.296 -0.878 . . . . 0.0 109.629 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.556 HD23 HD11 ' A' ' 66' ' ' ILE . 4.6 mt -46.66 93.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.965 . . . . 0.0 110.451 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -71.7 84.91 0.9 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.337 -0.852 . . . . 0.0 109.671 179.514 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 157.86 -88.75 0.11 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.598 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.2 OUTLIER -160.92 128.36 4.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.153 -1.204 . . . . 0.0 110.716 -179.547 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.505 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 0.4 OUTLIER -69.38 -76.91 0.09 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.289 -0.882 . . . . 0.0 110.612 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 40.4 p -74.55 106.02 5.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.284 -0.885 . . . . 0.0 110.725 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.491 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 58.3 m -113.66 164.38 13.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.354 -0.841 . . . . 0.0 110.068 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.693 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -136.2 142.01 44.06 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.274 -0.891 . . . . 0.0 111.066 -179.721 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.621 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 0.5 OUTLIER -71.93 87.02 1.01 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.246 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.489 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -62.28 178.39 0.33 Allowed Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.202 -0.936 . . . . 0.0 112.619 -178.225 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.759 ' CB ' HD12 ' A' ' 38' ' ' ILE . 44.3 Cg_endo -79.02 42.84 1.36 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 124.813 1.954 . . . . 0.0 112.207 -178.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -140.64 16.76 2.86 Favored Glycine 0 C--N 1.292 -1.884 0 N-CA-C 108.2 -1.96 . . . . 0.0 108.2 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.583 ' O ' HG23 ' A' ' 108' ' ' THR . 22.3 m-80 62.98 57.0 1.72 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.666 -0.903 . . . . 0.0 109.725 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.583 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.2 OUTLIER -160.37 -159.5 0.7 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.309 -0.869 . . . . 0.0 110.452 -179.585 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.621 ' CZ3' ' N ' ' A' ' 103' ' ' CYS . 37.0 m95 -136.6 91.28 2.64 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.372 -0.83 . . . . 0.0 110.442 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.571 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 15.2 mmtt -100.4 148.99 35.68 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.562 -0.711 . . . . 0.0 110.078 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.598 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 47.2 Cg_endo -71.01 174.36 45.2 Favored 'Cis proline' 0 C--N 1.312 -1.342 0 C-N-CA 121.999 -2.084 . . . . 0.0 111.014 -0.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -33.17 131.14 0.2 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.458 0.647 . . . . 0.0 111.838 -179.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.597 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.9 OUTLIER -53.38 137.59 50.18 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.56 -0.712 . . . . 0.0 109.812 179.298 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.688 ' HG2' HD12 ' A' ' 66' ' ' ILE . 40.4 Cg_endo -69.19 147.69 67.09 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 O-C-N 124.139 1.599 . . . . 0.0 111.066 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.574 ' O ' HG22 ' A' ' 117' ' ' VAL . 3.6 ttpp -115.9 92.47 3.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.43 -0.794 . . . . 0.0 110.301 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.587 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.1 t -47.67 105.97 0.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.919 . . . . 0.0 110.088 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 115' ' ' LYS . 0.7 OUTLIER -122.55 177.08 4.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.427 -0.796 . . . . 0.0 110.511 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 21.3 ptt85 . . . . . 0 C--N 1.297 -1.674 0 C-N-CA 118.805 -1.158 . . . . 0.0 110.384 179.64 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 51.6 t . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.293 0.568 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.4 ptpt -137.57 178.3 7.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 0.0 110.456 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.546 ' O ' ' N ' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -161.27 93.12 0.93 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.607 -0.683 . . . . 0.0 109.514 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 9.5 mt-30 -72.84 176.96 5.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.072 -1.017 . . . . 0.0 110.428 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.9 140.93 29.13 Favored Pre-proline 0 C--N 1.301 -1.532 0 O-C-N 121.569 -0.707 . . . . 0.0 109.95 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.681 ' HG3' HG21 ' A' ' 27' ' ' VAL . 53.4 Cg_endo -70.91 153.21 63.76 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 124.019 1.536 . . . . 0.0 110.861 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -74.98 170.63 19.99 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.959 1.505 . . . . 0.0 109.947 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 92.4 p -69.51 178.25 2.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.174 -0.954 . . . . 0.0 110.191 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.629 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -142.39 -170.17 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 122.125 0.964 . . . . 0.0 111.273 179.81 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 54.7 m -38.22 93.61 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.068 -179.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER 43.92 30.47 0.4 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.243 -0.911 . . . . 0.0 110.502 179.689 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.64 162.31 25.15 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.134 -1.587 . . . . 0.0 109.134 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 30' ' ' SER . 5.2 ptt180 -118.45 -173.0 2.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.079 -1.248 . . . . 0.0 110.778 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.684 ' HB2' HG11 ' A' ' 27' ' ' VAL . 11.9 p80 -131.95 153.53 50.21 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.306 0.574 . . . . 0.0 110.66 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -170.63 -156.57 0.13 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.283 -0.885 . . . . 0.0 110.072 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.441 ' C ' ' CD2' ' A' ' 17' ' ' TYR . . . 124.27 24.98 1.71 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.441 ' CD2' ' C ' ' A' ' 16' ' ' GLY . 24.5 m-85 58.66 65.86 1.17 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.175 -1.191 . . . . 0.0 110.284 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 19' ' ' ASP . 1.6 pp20? -141.21 -174.37 4.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.91 . . . . 0.0 109.874 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.449 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 31.9 m-20 -158.3 -33.38 0.07 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.11 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.577 ' O ' ' CG ' ' A' ' 20' ' ' PHE . 5.6 p90 -160.74 70.7 0.4 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.851 -1.156 . . . . 0.0 110.782 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.616 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 30.5 m-85 -46.95 175.4 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.469 -0.77 . . . . 0.0 110.318 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.526 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 21.2 m -132.64 -54.57 0.95 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.058 -1.026 . . . . 0.0 110.738 -179.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.424 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 3.9 t70 -171.95 148.12 2.25 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.394 -0.816 . . . . 0.0 109.44 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 65.88 11.83 55.5 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 -178.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.616 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 66.2 m -86.5 175.0 8.59 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.407 -1.055 . . . . 0.0 110.167 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.717 HG13 ' O ' ' A' ' 43' ' ' VAL . 26.1 t -151.34 154.75 7.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.514 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.684 HG11 ' HB2' ' A' ' 14' ' ' HIS . 24.5 t -135.02 117.47 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.147 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.28 104.22 2.6 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.302 -1.359 . . . . 0.0 107.746 178.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.687 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.2 m-30 -68.25 133.18 48.4 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.325 -178.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -92.87 153.55 18.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.309 -0.869 . . . . 0.0 109.973 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 57.2 m -119.49 154.41 33.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 110.025 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' A' ' 35' ' ' TYR . 1.6 t-20 -46.81 140.28 4.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.935 . . . . 0.0 110.141 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -45.2 108.68 0.13 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.141 -0.975 . . . . 0.0 110.45 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.81 9.84 27.72 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.5 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 2.7 m-30 -108.5 146.76 32.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.104 -1.233 . . . . 0.0 110.327 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.888 ' HB2' HG22 ' A' ' 59' ' ' VAL . 48.2 t -89.33 137.71 32.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.395 -0.816 . . . . 0.0 110.878 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.656 HD13 ' O ' ' A' ' 29' ' ' TYR . 4.3 tp -94.12 110.04 21.78 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 177.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.71 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -107.56 147.46 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.069 -1.019 . . . . 0.0 109.839 -179.225 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.9 -163.55 12.96 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -65.08 130.81 44.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.219 -1.165 . . . . 0.0 109.773 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.9 p -74.11 53.37 0.49 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.209 -0.932 . . . . 0.0 110.22 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.654 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 150.62 105.59 0.32 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.717 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -48.09 177.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.222 -1.164 . . . . 0.0 108.601 179.377 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.5 ' HA ' ' O ' ' A' ' 25' ' ' SER . 2.5 tp -139.5 105.68 5.24 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.361 -0.837 . . . . 0.0 109.829 178.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.628 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 1.0 OUTLIER -86.05 106.87 17.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.093 -1.004 . . . . 0.0 109.969 179.58 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.7 m -124.38 104.0 8.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.492 -0.755 . . . . 0.0 109.856 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.77 53.97 3.82 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 48.49 46.94 29.5 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -156.83 99.14 1.83 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -1.153 . . . . 0.0 110.897 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.628 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 90.8 m95 -68.18 137.97 55.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.2 -0.938 . . . . 0.0 109.063 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.8 p -140.24 169.77 17.06 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.833 -1.167 . . . . 0.0 111.519 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.508 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.5 OUTLIER 51.8 65.86 5.88 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.734 -0.604 . . . . 0.0 111.457 179.627 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.508 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 46.7 Cg_endo -90.65 130.39 1.54 Allowed 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 121.874 1.716 . . . . 0.0 110.057 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.541 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 53.5 Cg_endo -77.76 176.37 10.1 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.811 1.427 . . . . 0.0 110.705 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.524 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 12.2 p -108.97 156.46 19.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.464 -0.772 . . . . 0.0 110.776 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 10' ' ' SER . 22.2 m -122.67 80.14 1.71 Allowed 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.507 ' O ' ' N ' ' A' ' 36' ' ' SER . 5.8 mm100 -109.98 -145.07 0.39 Allowed 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.428 0.632 . . . . 0.0 110.609 -178.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.592 ' N ' HD12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -137.32 114.16 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.952 HG21 ' HB3' ' A' ' 81' ' ' TYR . 19.6 m -111.87 60.66 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.161 -0.962 . . . . 0.0 112.182 -178.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 107' ' ' ASN . 8.5 mttt -69.73 159.35 33.69 Favored 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 117.852 -1.539 . . . . 0.0 107.245 178.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.488 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -118.95 168.82 9.03 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 120.391 -1.443 . . . . 0.0 114.304 -176.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -89.9 -81.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.739 2.293 . . . . 0.0 110.972 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 177.37 125.62 0.18 Allowed Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 121.711 -0.618 . . . . 0.0 109.521 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.595 ' N ' ' NE1' ' A' ' 109' ' ' TRP . 49.0 Cg_endo -75.86 67.32 6.65 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 123.714 1.376 . . . . 0.0 109.673 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.55 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -81.7 175.32 10.56 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.57 -0.707 . . . . 0.0 110.471 -179.451 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.697 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -172.46 163.48 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.295 -0.878 . . . . 0.0 110.341 179.665 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 96.4 p -72.86 100.13 2.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.522 -0.736 . . . . 0.0 110.645 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.469 ' O ' ' SG ' ' A' ' 116' ' ' CYS . 7.4 m-20 44.51 45.17 7.6 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.362 -0.837 . . . . 0.0 110.573 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.697 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -152.71 31.02 0.83 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.572 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 6.9 p90 -44.68 -176.08 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 122.663 1.22 . . . . 0.0 112.644 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.681 ' H ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -110.49 162.99 14.14 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.558 179.22 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.508 ' HB2' ' HD3' ' A' ' 88' ' ' LYS . 2.5 t -144.49 14.89 1.61 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.003 -1.061 . . . . 0.0 110.178 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.67 -69.79 0.74 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.216 -0.927 . . . . 0.0 110.909 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.452 ' O ' HG12 ' A' ' 85' ' ' VAL . . . -136.82 81.47 0.28 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.594 ' CE2' ' OH ' ' A' ' 79' ' ' TYR . 1.9 t80 -105.94 160.02 15.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.43 -1.041 . . . . 0.0 109.977 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.481 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 25.3 tttt -158.4 148.14 19.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.897 . . . . 0.0 110.446 -179.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' A' ' 76' ' ' LYS . 2.2 mtp85 -44.71 -34.58 2.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.177 -0.952 . . . . 0.0 109.702 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.448 ' O ' ' HD3' ' A' ' 76' ' ' LYS . 0.5 OUTLIER -143.63 153.48 42.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.406 -0.808 . . . . 0.0 109.917 179.725 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.594 ' OH ' ' CE2' ' A' ' 75' ' ' PHE . 8.3 m-85 -125.41 -148.12 0.38 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.161 -0.962 . . . . 0.0 110.462 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.525 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 81.6 p -158.62 -124.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.3 -0.875 . . . . 0.0 110.3 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.952 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -99.93 29.9 3.98 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.037 -1.039 . . . . 0.0 111.068 -178.295 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.67 ' C ' HG22 ' A' ' 102' ' ' THR . 48.7 t30 -173.93 -114.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.93 -1.107 . . . . 0.0 110.462 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 49.43 75.39 0.16 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.696 -1.252 . . . . 0.0 109.244 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.616 ' CA ' HG23 ' A' ' 102' ' ' THR . 10.3 p30 -69.27 125.46 26.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.381 -0.824 . . . . 0.0 110.826 -179.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.597 HG23 ' CE1' ' A' ' 87' ' ' PHE . 26.4 m -107.2 118.03 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.166 -0.959 . . . . 0.0 110.235 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.547 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -78.77 137.7 37.86 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.738 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.665 ' CZ ' HD12 ' A' ' 113' ' ' LEU . 70.0 m-85 -95.58 137.83 34.1 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.872 -1.142 . . . . 0.0 112.52 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.508 ' HD3' ' HB2' ' A' ' 72' ' ' SER . 0.7 OUTLIER -111.1 93.84 4.69 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.744 -179.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.578 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -44.15 131.97 5.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.053 -1.029 . . . . 0.0 110.302 -179.663 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 11.6 mmtt -42.27 -78.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.295 -0.878 . . . . 0.0 110.258 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.573 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -162.3 136.78 6.73 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.321 -0.862 . . . . 0.0 110.492 -179.892 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.592 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 52.98 66.08 2.94 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.592 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 14.6 m-85 -162.49 172.43 15.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.42 -1.047 . . . . 0.0 110.096 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.592 ' O ' HG22 ' A' ' 117' ' ' VAL . 4.4 mtmt -131.2 107.65 9.15 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.321 -0.862 . . . . 0.0 109.957 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.578 HD11 ' H ' ' A' ' 89' ' ' CYS . 1.1 mt -49.54 93.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.099 -1.001 . . . . 0.0 110.425 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.468 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -77.44 109.33 11.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -0.937 . . . . 0.0 110.184 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 135.03 -85.13 0.26 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.565 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.2 OUTLIER -158.77 112.46 2.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.293 -1.122 . . . . 0.0 110.546 -179.61 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.422 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 28.4 t -72.82 -0.1 12.47 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.279 -0.888 . . . . 0.0 110.326 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.5 p -141.5 117.92 10.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.143 -0.973 . . . . 0.0 109.547 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.49 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 40.1 m -134.33 151.42 51.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.149 -0.969 . . . . 0.0 111.122 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.67 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -120.36 151.95 38.55 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.61 0.719 . . . . 0.0 110.049 179.608 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.594 ' SG ' ' CZ2' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -83.8 77.96 9.79 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.683 -0.635 . . . . 0.0 110.554 -179.348 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.501 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.5 OUTLIER -48.37 175.78 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.348 -0.845 . . . . 0.0 111.675 -179.641 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.71 ' CB ' HD12 ' A' ' 38' ' ' ILE . 47.3 Cg_endo -77.53 43.18 1.28 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.656 1.872 . . . . 0.0 111.968 -178.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -139.57 12.04 3.21 Favored Glycine 0 C--N 1.292 -1.903 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 2.0 m120 64.2 63.83 0.76 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.718 -0.872 . . . . 0.0 109.836 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -159.8 -160.52 0.82 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.319 -0.863 . . . . 0.0 111.035 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.638 ' HB3' HD11 ' A' ' 113' ' ' LEU . 26.4 m95 -137.43 82.0 1.9 Allowed 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.64 0.733 . . . . 0.0 110.293 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.567 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.8 OUTLIER -99.27 136.5 20.45 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.72 -0.612 . . . . 0.0 110.161 -179.819 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.567 ' C ' ' HA ' ' A' ' 110' ' ' LYS . 42.7 Cg_endo -69.53 164.94 77.26 Favored 'Cis proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.084 -2.048 . . . . 0.0 111.001 -0.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -41.24 149.39 0.1 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.563 -0.711 . . . . 0.0 110.555 -179.303 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.733 HD22 ' H ' ' A' ' 113' ' ' LEU . 1.1 mm? -57.19 145.64 65.25 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.422 -0.798 . . . . 0.0 109.982 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.662 ' HG2' HD12 ' A' ' 66' ' ' ILE . 37.4 Cg_endo -69.0 169.47 17.87 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 O-C-N 124.31 1.689 . . . . 0.0 110.951 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.719 ' HG2' HG13 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -128.34 106.32 8.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 0.0 110.528 -179.549 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.545 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.4 t -63.31 87.13 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.184 -0.947 . . . . 0.0 108.912 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.719 HG13 ' HG2' ' A' ' 115' ' ' LYS . 2.3 m -103.3 177.58 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.612 0.72 . . . . 0.0 111.007 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.582 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.709 0 C-N-CA 118.971 -1.092 . . . . 0.0 110.327 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 1' ' ' VAL . 5.0 p . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.2 0.524 . . . . 0.0 110.052 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.75 177.54 7.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.393 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.576 ' CB ' ' N ' ' A' ' 22' ' ' THR . 1.4 t -159.4 104.13 1.63 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.434 -0.791 . . . . 0.0 110.486 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.424 ' C ' ' O ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -81.25 176.58 9.63 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.73 -1.232 . . . . 0.0 109.325 179.023 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 19' ' ' ASP . 0.1 OUTLIER -54.57 146.68 33.37 Favored Pre-proline 0 C--N 1.294 -1.812 0 O-C-N 121.379 -0.825 . . . . 0.0 109.666 179.882 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.64 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 51.7 Cg_endo -70.11 154.2 66.56 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.93 1.489 . . . . 0.0 111.404 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -76.21 172.88 15.44 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.014 1.534 . . . . 0.0 110.281 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 m -69.7 179.47 2.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.161 -0.962 . . . . 0.0 110.007 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.633 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -145.24 -170.16 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 122.335 1.064 . . . . 0.0 111.905 -179.786 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.496 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 14.1 t -46.17 105.75 0.07 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.313 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 10' ' ' SER . 6.6 m120 40.96 26.43 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.352 -0.842 . . . . 0.0 110.763 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -141.38 169.86 24.92 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 30' ' ' SER . 2.5 ptt180 -133.91 -178.55 5.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -1.142 . . . . 0.0 110.332 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.64 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 7.0 p80 -120.22 156.23 31.58 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.545 -0.722 . . . . 0.0 110.095 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -173.84 50.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.141 -0.974 . . . . 0.0 110.587 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 17' ' ' TYR . . . -53.92 -78.76 0.1 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.469 ' HB3' ' OE2' ' A' ' 18' ' ' GLU . 0.2 OUTLIER 174.98 35.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.355 -1.085 . . . . 0.0 110.248 179.515 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.469 ' OE2' ' HB3' ' A' ' 17' ' ' TYR . 0.6 OUTLIER 176.81 -178.38 0.16 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 110.428 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 5' ' ' SER . 8.1 t70 -117.49 -43.62 2.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.428 -0.795 . . . . 0.0 109.955 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 3' ' ' CYS . 14.2 m-85 -84.31 130.3 34.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.334 -0.854 . . . . 0.0 109.859 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.607 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.5 OUTLIER -132.42 -6.02 3.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.344 -0.847 . . . . 0.0 110.889 -179.39 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.576 ' N ' ' CB ' ' A' ' 3' ' ' CYS . 66.7 p 45.91 -96.71 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.516 -0.74 . . . . 0.0 111.841 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.402 ' HB2' ' H ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER -150.13 150.89 32.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.843 -1.161 . . . . 0.0 110.661 -178.442 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 79.42 15.49 79.81 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.607 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 20.5 m -97.25 172.77 7.59 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.459 -1.024 . . . . 0.0 110.281 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.706 HG13 ' O ' ' A' ' 43' ' ' VAL . 33.4 t -151.49 151.94 11.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.382 -0.824 . . . . 0.0 110.066 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.636 HG11 ' HB2' ' A' ' 14' ' ' HIS . 34.6 t -134.66 119.89 30.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.223 -0.923 . . . . 0.0 111.583 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.764 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -72.3 103.6 3.45 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.399 -1.321 . . . . 0.0 107.489 177.736 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.669 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 2.2 m-30 -67.55 121.4 15.77 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.338 -0.851 . . . . 0.0 110.074 -178.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -74.76 150.3 39.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.206 -0.934 . . . . 0.0 109.617 179.352 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.479 ' SG ' HD12 ' A' ' 37' ' ' LEU . 60.3 m -118.2 159.51 23.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.176 -0.952 . . . . 0.0 110.306 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 33' ' ' SER . 4.4 t-20 -53.72 134.89 41.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 110.236 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 32' ' ' ASN . 0.5 OUTLIER -44.39 102.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.245 -0.909 . . . . 0.0 110.305 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.73 -11.31 12.17 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -93.84 139.74 30.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.236 -1.155 . . . . 0.0 110.062 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.634 ' HB3' HD11 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -84.62 142.05 30.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.172 -0.955 . . . . 0.0 110.879 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.693 HD21 ' HA ' ' A' ' 41' ' ' SER . 3.2 tp -92.81 97.04 10.51 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.458 -0.776 . . . . 0.0 109.231 179.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.904 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -88.42 157.0 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.409 -0.807 . . . . 0.0 109.05 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 91.07 178.22 43.31 Favored Glycine 0 N--CA 1.488 2.11 0 C-N-CA 119.417 -1.373 . . . . 0.0 109.988 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.459 ' O ' ' HG3' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -54.71 124.65 17.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.311 -1.111 . . . . 0.0 109.85 179.729 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.764 ' O ' HG23 ' A' ' 28' ' ' THR . 0.1 OUTLIER -72.45 55.14 0.34 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.206 -0.934 . . . . 0.0 109.956 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.644 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 161.39 96.98 0.11 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.706 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -45.3 173.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.365 -1.079 . . . . 0.0 108.345 179.336 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.477 ' HB3' ' OD2' ' A' ' 52' ' ' ASP . 7.3 tp -134.08 103.37 5.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.984 -1.073 . . . . 0.0 110.371 178.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.549 ' HB2' ' CE2' ' A' ' 50' ' ' TRP . 0.6 OUTLIER -77.23 115.28 16.88 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.367 -0.833 . . . . 0.0 109.45 179.168 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.86 101.74 5.37 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.113 -0.992 . . . . 0.0 110.171 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.402 ' H ' ' HB2' ' A' ' 23' ' ' ASP . . . 77.96 41.15 19.18 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.41 30.76 78.75 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.79 102.09 4.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -1.142 . . . . 0.0 110.552 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.549 ' CE2' ' HB2' ' A' ' 45' ' ' CYS . 89.7 m95 -73.59 123.0 23.14 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.127 -0.983 . . . . 0.0 109.551 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.418 ' O ' ' CG ' ' A' ' 52' ' ' ASP . 22.4 m -129.22 -176.38 3.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.062 -1.024 . . . . 0.0 111.399 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.52 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 1.6 p30 37.56 65.64 2.56 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.851 -0.53 . . . . 0.0 111.191 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.1 Cg_endo -91.09 131.73 1.48 Allowed 'Trans proline' 0 C--N 1.301 -1.946 0 C-N-CA 121.95 1.767 . . . . 0.0 110.03 178.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.541 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 53.8 Cg_endo -76.27 172.67 15.82 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.596 1.314 . . . . 0.0 110.205 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.615 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 37.9 p -114.22 143.16 45.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.08 -1.013 . . . . 0.0 111.291 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 10' ' ' SER . 69.4 m -107.57 78.89 1.24 Allowed 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -113.84 -159.33 0.69 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.481 0.658 . . . . 0.0 110.56 -178.299 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.635 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -110.49 142.8 21.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.426 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.726 HG21 ' CB ' ' A' ' 81' ' ' TYR . 21.3 m -133.44 44.96 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.988 -1.07 . . . . 0.0 110.992 -178.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.629 ' HD2' HG22 ' A' ' 58' ' ' ILE . 2.9 mttp -81.34 102.45 10.45 Favored 'General case' 0 C--N 1.281 -2.377 0 C-N-CA 118.858 -1.137 . . . . 0.0 109.343 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.512 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 53.2 m -72.94 164.0 64.11 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.372 -0.83 . . . . 0.0 111.298 -178.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.544 ' HD2' ' HA ' ' A' ' 108' ' ' THR . 42.5 Cg_endo -69.54 -89.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 124.306 1.687 . . . . 0.0 110.666 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.477 ' HB3' ' CG2' ' A' ' 65' ' ' THR . 0.0 OUTLIER -159.68 133.36 4.97 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.776 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.694 ' HA ' HD21 ' A' ' 113' ' ' LEU . 56.7 Cg_endo -77.93 65.86 8.24 Favored 'Trans proline' 0 C--N 1.296 -2.22 0 O-C-N 123.604 1.318 . . . . 0.0 109.671 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.716 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.7 OUTLIER -87.27 -175.37 5.26 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.533 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.716 HG22 ' C ' ' A' ' 65' ' ' THR . 0.2 OUTLIER 179.7 169.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 C-N-CA 118.756 -1.178 . . . . 0.0 110.721 179.438 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.511 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 4.0 t -69.71 90.89 0.59 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.46 -0.775 . . . . 0.0 110.915 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 1.9 m-80 51.17 34.72 11.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.336 -0.852 . . . . 0.0 110.902 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.666 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -139.15 30.07 2.48 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.57 ' O ' ' N ' ' A' ' 88' ' ' LYS . 4.7 p90 -43.12 -174.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 122.707 1.241 . . . . 0.0 112.789 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.749 HD22 ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -113.73 158.0 21.49 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.056 179.088 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.8 19.44 2.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.094 -1.004 . . . . 0.0 110.086 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.8 t -99.25 -85.14 0.4 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.918 . . . . 0.0 110.844 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -98.62 -86.24 1.86 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.59 ' CE2' ' OH ' ' A' ' 79' ' ' TYR . 17.5 t80 57.3 106.84 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.418 -1.048 . . . . 0.0 110.207 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.61 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -114.96 123.35 48.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.253 -0.905 . . . . 0.0 108.918 179.309 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.526 ' C ' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -28.79 -39.54 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.353 0.597 . . . . 0.0 111.204 -179.073 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -123.52 105.81 10.07 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.379 -0.825 . . . . 0.0 109.739 179.192 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.61 ' CE1' ' O ' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -91.73 175.23 6.97 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.128 -0.982 . . . . 0.0 109.849 -179.517 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.555 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -170.27 107.09 0.33 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.149 -0.97 . . . . 0.0 111.128 179.821 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.726 ' CB ' HG21 ' A' ' 59' ' ' VAL . 10.2 t80 46.77 18.44 0.07 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.091 -1.006 . . . . 0.0 111.809 178.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.661 ' C ' HG22 ' A' ' 102' ' ' THR . 28.5 p30 -172.49 -128.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.186 -1.571 . . . . 0.0 110.841 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.462 ' OD2' ' HA ' ' A' ' 79' ' ' TYR . 11.0 m-20 52.78 72.51 0.41 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.858 -1.151 . . . . 0.0 108.831 -178.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.761 ' CA ' HG23 ' A' ' 102' ' ' THR . 15.5 p30 -68.5 138.41 55.18 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.473 -0.767 . . . . 0.0 110.169 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.608 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 5.2 m -124.54 119.49 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.181 -0.949 . . . . 0.0 110.746 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.537 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 5.2 t0 -81.39 132.56 35.33 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.655 ' CE1' HD12 ' A' ' 71' ' ' LEU . 69.6 m-85 -92.01 120.94 33.12 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 122.326 1.06 . . . . 0.0 112.464 -177.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -92.7 90.68 7.17 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.763 179.594 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.517 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -44.07 131.02 6.02 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.157 -0.965 . . . . 0.0 109.774 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -37.65 -70.9 0.09 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.647 -0.658 . . . . 0.0 110.74 -179.434 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.574 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 49.1 t80 -175.11 145.65 0.81 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.276 -0.89 . . . . 0.0 110.366 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.58 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 46.18 42.21 12.27 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 12.1 m-85 -145.37 150.7 37.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.526 -0.985 . . . . 0.0 109.934 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.531 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 6.8 mtmp? -107.42 138.96 42.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.291 -0.881 . . . . 0.0 109.903 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.63 HD23 ' HB2' ' A' ' 114' ' ' PRO . 0.5 OUTLIER -78.49 100.17 6.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.025 -1.047 . . . . 0.0 110.725 -179.545 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.454 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -78.49 105.91 10.08 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.423 -0.798 . . . . 0.0 109.436 179.273 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 138.62 -88.61 0.2 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.586 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -158.07 112.94 2.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.296 -1.12 . . . . 0.0 110.549 -179.614 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 82.8 p -65.0 -22.11 66.95 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.191 -0.943 . . . . 0.0 110.765 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.6 p -125.65 126.26 44.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.813 -1.179 . . . . 0.0 109.877 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.535 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 4.5 m -135.11 172.57 12.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 0.0 110.429 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.761 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -148.03 140.46 24.42 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.506 -0.746 . . . . 0.0 110.456 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.574 ' O ' ' CA ' ' A' ' 81' ' ' TYR . 7.8 t -59.97 88.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.43 -0.794 . . . . 0.0 109.43 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.465 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.2 OUTLIER -61.53 173.23 0.82 Allowed Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.037 -1.039 . . . . 0.0 111.768 -178.844 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.904 ' CB ' HD12 ' A' ' 38' ' ' ILE . 50.5 Cg_endo -75.37 13.91 1.03 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 124.554 1.818 . . . . 0.0 111.937 -178.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.486 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -112.35 23.14 16.42 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.699 ' O ' HG23 ' A' ' 108' ' ' THR . 39.5 m-80 60.47 48.53 7.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.808 -0.819 . . . . 0.0 110.636 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.699 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.6 OUTLIER -160.98 -179.39 7.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.03 -1.044 . . . . 0.0 111.387 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.691 ' HB3' HD13 ' A' ' 113' ' ' LEU . 42.2 m95 -104.15 99.01 8.74 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.556 0.693 . . . . 0.0 110.845 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.536 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 8.8 mttt -110.19 141.01 22.96 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.503 -0.748 . . . . 0.0 109.59 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.586 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.4 Cg_endo -71.04 168.68 71.45 Favored 'Cis proline' 0 C--N 1.313 -1.312 0 C-N-CA 122.109 -2.038 . . . . 0.0 110.981 -0.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 111' ' ' PRO . 4.3 tt0 -38.97 130.79 1.46 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.502 -0.749 . . . . 0.0 111.106 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.694 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -42.32 146.88 0.63 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.47 -0.769 . . . . 0.0 110.117 179.178 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.675 ' HG2' HD12 ' A' ' 66' ' ' ILE . 41.9 Cg_endo -74.14 173.51 14.0 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 O-C-N 124.382 1.727 . . . . 0.0 110.658 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.542 ' O ' HG22 ' A' ' 117' ' ' VAL . 24.6 ttmt -135.12 111.67 9.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 110.565 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.535 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.8 t -66.15 100.19 0.58 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.344 -0.847 . . . . 0.0 108.809 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -110.57 -177.63 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-O 121.798 0.809 . . . . 0.0 110.825 -179.12 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.296 -1.75 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.472 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.224 0.535 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.6 172.76 6.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.158 -0.964 . . . . 0.0 110.601 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.565 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -124.76 83.73 2.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.441 -0.787 . . . . 0.0 109.829 179.853 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.562 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 3.0 mt-30 -60.11 174.54 0.5 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.291 -0.88 . . . . 0.0 110.417 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 19' ' ' ASP . 1.0 OUTLIER -47.09 144.48 4.0 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.423 -0.798 . . . . 0.0 110.204 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.67 ' HG3' HG11 ' A' ' 27' ' ' VAL . 53.3 Cg_endo -71.52 157.72 55.53 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.988 1.52 . . . . 0.0 110.871 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -76.72 171.96 17.06 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.992 1.522 . . . . 0.0 110.286 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.61 175.96 6.64 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.221 -0.924 . . . . 0.0 109.895 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.604 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -141.14 -170.57 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 122.281 1.039 . . . . 0.0 111.587 179.581 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.4 OUTLIER -44.93 105.13 0.05 Allowed 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.157 -178.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.453 ' C ' ' O ' ' A' ' 10' ' ' SER . 0.9 OUTLIER 39.05 27.95 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.315 -0.866 . . . . 0.0 110.583 179.604 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -135.99 160.42 24.61 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -123.2 178.22 5.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -1.131 . . . . 0.0 110.321 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.638 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 11.3 p80 -123.31 135.98 54.46 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.572 -0.705 . . . . 0.0 110.355 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -137.43 64.68 1.52 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.413 -0.804 . . . . 0.0 110.077 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -59.09 -173.59 0.55 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.06 31.61 1.63 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.322 -1.105 . . . . 0.0 110.229 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.568 ' OE2' ' CD1' ' A' ' 21' ' ' TYR . 6.7 pt-20 179.09 -171.81 0.14 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 110.371 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 5' ' ' SER . 29.4 t0 -92.03 -52.54 4.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 110.014 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.573 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 52.0 p90 -104.03 -155.17 0.52 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.177 -0.952 . . . . 0.0 109.983 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.618 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 1.8 m-85 -170.0 -31.62 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.157 -0.964 . . . . 0.0 110.883 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.565 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 3.0 m 78.42 -83.03 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.659 -0.65 . . . . 0.0 111.904 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 47' ' ' GLY . 2.1 t70 -161.93 157.13 23.33 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.745 -1.222 . . . . 0.0 110.14 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.29 14.86 60.25 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.618 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 20.1 m -94.01 176.77 6.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.476 -1.014 . . . . 0.0 110.179 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.664 HG13 ' O ' ' A' ' 43' ' ' VAL . 25.2 t -154.29 158.29 3.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 119.549 -0.861 . . . . 0.0 110.379 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.67 HG11 ' HG3' ' A' ' 6' ' ' PRO . 10.0 t -141.82 113.31 3.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 118.933 -1.107 . . . . 0.0 111.915 -179.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.905 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -69.8 105.21 2.69 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.127 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.645 ' CE1' HG21 ' A' ' 43' ' ' VAL . 3.1 m-30 -67.73 -176.44 0.65 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 110.21 -178.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.464 ' O ' ' CA ' ' A' ' 12' ' ' GLY . 0.6 OUTLIER -142.25 146.94 35.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.434 -0.791 . . . . 0.0 109.626 179.455 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.613 ' SG ' HD12 ' A' ' 37' ' ' LEU . 35.2 m -123.3 137.19 54.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 110.245 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 31' ' ' CYS . 2.5 m-20 -44.04 148.2 0.43 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 110.141 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -47.98 131.06 15.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.0 110.138 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.05 -12.7 52.55 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.513 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 1.9 m-30 -110.17 125.94 53.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.266 -1.138 . . . . 0.0 110.42 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.619 ' HB3' HD11 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -79.86 144.85 33.09 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.322 -0.861 . . . . 0.0 110.977 -179.689 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.656 ' C ' HD13 ' A' ' 38' ' ' ILE . 2.3 tp -95.48 105.11 17.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.347 -0.845 . . . . 0.0 109.935 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.869 HD12 ' HB3' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -97.2 149.56 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.247 -0.908 . . . . 0.0 109.466 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 130.89 -158.71 22.74 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.487 ' O ' ' C ' ' A' ' 41' ' ' SER . 8.5 t-20 -97.89 51.7 1.05 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.107 -1.231 . . . . 0.0 109.897 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.905 ' O ' HG23 ' A' ' 28' ' ' THR . 79.5 p 28.65 45.45 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.499 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.494 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 157.33 126.04 0.89 Allowed Glycine 0 N--CA 1.49 2.299 0 C-N-CA 119.378 -1.392 . . . . 0.0 110.44 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.664 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.7 t -65.01 178.27 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.182 -1.187 . . . . 0.0 107.864 178.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.55 ' C ' ' CD2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -140.41 94.31 2.72 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.057 178.452 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.588 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -81.88 107.75 14.85 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.114 178.566 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.526 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -132.37 121.13 23.0 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.317 -179.479 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.539 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 90.96 8.88 64.5 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.04 27.86 19.84 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -154.22 125.57 7.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.223 -1.163 . . . . 0.0 110.19 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.588 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 92.2 m95 -72.06 137.32 47.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.713 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.93 166.49 25.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.127 -0.983 . . . . 0.0 111.077 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.52 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 87.8 m-20 48.34 65.37 7.16 Favored Pre-proline 0 N--CA 1.492 1.629 0 CA-C-O 121.216 0.532 . . . . 0.0 111.204 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.4 Cg_endo -91.02 151.41 3.87 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 O-C-N 124.433 1.754 . . . . 0.0 110.045 179.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.557 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 48.8 Cg_endo -78.72 175.95 10.42 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 123.852 1.448 . . . . 0.0 110.41 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.627 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 17.7 p -119.03 177.55 4.82 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.28 -0.887 . . . . 0.0 110.876 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 10' ' ' SER . 65.4 m -132.93 71.8 1.48 Allowed 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -113.72 171.95 7.27 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.144 -178.713 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -87.66 144.13 9.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 119.349 -0.94 . . . . 0.0 108.577 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.634 HG23 ' CA ' ' A' ' 80' ' ' SER . 34.1 m -130.42 44.9 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.549 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 2.6 mmtt -53.91 179.79 0.02 OUTLIER 'General case' 0 C--N 1.278 -2.507 0 C-N-CA 118.035 -1.466 . . . . 0.0 108.381 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -145.36 165.28 22.25 Favored Pre-proline 0 N--CA 1.492 1.667 0 C-N-CA 118.402 -1.319 . . . . 0.0 112.887 -178.587 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.426 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 45.4 Cg_endo -88.2 -78.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.877 1.988 . . . . 0.0 110.401 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.426 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 170.93 129.26 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.653 -0.654 . . . . 0.0 109.352 -179.365 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.613 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 52.8 Cg_endo -80.97 65.83 8.89 Favored 'Trans proline' 0 C--N 1.298 -2.091 0 O-C-N 123.723 1.38 . . . . 0.0 110.074 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.605 ' O ' HD23 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -84.19 169.0 15.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.468 -0.77 . . . . 0.0 109.9 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.828 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -169.17 161.78 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.035 -1.041 . . . . 0.0 110.638 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.492 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 0.6 OUTLIER -66.28 105.84 1.53 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.544 -0.723 . . . . 0.0 111.025 -179.18 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.459 ' O ' ' CG ' ' A' ' 90' ' ' LYS . 7.4 m-80 38.74 38.64 0.28 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.532 -0.73 . . . . 0.0 110.803 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.828 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -147.38 32.67 1.36 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.584 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 3.6 p90 -46.46 -170.77 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 122.72 1.248 . . . . 0.0 112.515 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.742 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -114.07 168.48 9.78 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.007 179.554 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.3 t -149.67 15.87 0.87 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.848 -1.158 . . . . 0.0 110.644 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.505 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 41.9 t -92.49 -77.1 0.44 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.921 . . . . 0.0 110.515 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -130.87 77.98 0.38 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.62 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -103.85 163.74 12.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.354 -1.086 . . . . 0.0 109.548 179.538 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.62 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 17.0 ttmm -165.2 158.89 16.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 109.941 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.469 ' N ' ' HG2' ' A' ' 76' ' ' LYS . 26.2 mtt180 -54.1 -25.21 20.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.072 -1.017 . . . . 0.0 109.861 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.474 ' O ' ' HD2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -145.14 160.41 41.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.452 -0.78 . . . . 0.0 110.203 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.591 ' OH ' ' CE2' ' A' ' 75' ' ' PHE . 16.2 m-85 -135.75 -150.14 0.36 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.308 -0.87 . . . . 0.0 109.818 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.634 ' CA ' HG23 ' A' ' 59' ' ' VAL . 83.3 p -162.5 -104.96 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.807 -1.183 . . . . 0.0 111.388 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.596 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -114.47 15.87 17.8 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.481 -1.387 . . . . 0.0 110.431 -178.741 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.683 ' O ' HG22 ' A' ' 102' ' ' THR . 7.7 p30 -160.51 -107.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.925 -1.109 . . . . 0.0 110.443 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 82' ' ' ASN . 0.3 OUTLIER 46.34 74.24 0.15 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.806 -1.184 . . . . 0.0 108.734 -179.1 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.952 ' CA ' HG23 ' A' ' 102' ' ' THR . 20.8 t-20 -68.52 122.64 18.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.468 -0.77 . . . . 0.0 110.338 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.533 HG11 ' HG3' ' A' ' 64' ' ' PRO . 23.4 m -104.96 120.04 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 0.0 110.608 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' A' ' 73' ' ' SER . 62.8 t0 -83.72 127.77 34.03 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.742 ' CE1' HD12 ' A' ' 71' ' ' LEU . 35.1 m-85 -85.15 122.52 29.46 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.412 1.101 . . . . 0.0 111.876 -178.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -101.26 88.55 3.51 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.94 -179.778 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.549 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -42.52 129.24 4.03 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.31 -0.869 . . . . 0.0 109.814 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.459 ' CG ' ' O ' ' A' ' 68' ' ' ASN . 2.1 mmmt -38.48 -89.67 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.551 -0.718 . . . . 0.0 110.841 -179.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.573 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 1.9 t80 -153.37 131.13 11.59 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.102 -0.999 . . . . 0.0 110.341 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.584 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 60.11 52.66 51.41 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 26.4 m-85 -158.08 145.79 18.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.54 -0.976 . . . . 0.0 109.764 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.55 ' O ' ' N ' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -103.29 153.18 20.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.529 179.735 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.657 HD23 HD11 ' A' ' 66' ' ' ILE . 2.7 mt -91.32 97.55 11.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.754 -1.216 . . . . 0.0 110.086 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.828 ' HB2' HG21 ' A' ' 117' ' ' VAL . 16.8 t -80.65 107.83 13.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 110.241 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 98' ' ' SER . . . 129.85 -32.42 3.16 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.635 -1.269 . . . . 0.0 110.561 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.513 ' O ' ' HB3' ' A' ' 114' ' ' PRO . 12.7 p 177.18 -168.48 0.06 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.999 -1.295 . . . . 0.0 111.154 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.3 p -160.24 -35.09 0.05 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.247 0.546 . . . . 0.0 109.836 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 82.7 p -130.59 82.82 2.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 0.0 109.556 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.497 ' O ' ' N ' ' A' ' 85' ' ' VAL . 7.1 m -91.0 176.15 6.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.396 -0.815 . . . . 0.0 110.993 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.952 HG23 ' CA ' ' A' ' 84' ' ' ASN . 1.6 m -151.06 142.98 23.91 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.601 -0.687 . . . . 0.0 110.317 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' A' ' 79' ' ' TYR . 8.2 t -75.23 78.02 2.35 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.494 -0.754 . . . . 0.0 109.635 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.514 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -64.43 177.29 0.58 Allowed Pre-proline 0 C--N 1.299 -1.595 0 O-C-N 121.324 -0.86 . . . . 0.0 110.465 -179.664 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.869 ' HB3' HD12 ' A' ' 38' ' ' ILE . 42.0 Cg_endo -69.8 131.73 21.8 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 124.332 1.701 . . . . 0.0 110.142 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 121.9 -10.91 9.5 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 108.679 -1.769 . . . . 0.0 108.679 -179.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.591 ' O ' HG23 ' A' ' 108' ' ' THR . 10.4 m-20 79.64 92.25 0.05 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.893 -0.769 . . . . 0.0 110.807 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.591 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -177.51 -162.56 0.07 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.581 179.597 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.613 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 20.5 m95 -147.88 82.78 1.51 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.389 0.614 . . . . 0.0 109.897 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.509 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 9.2 mmtt -91.81 146.51 33.13 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.393 -0.817 . . . . 0.0 109.972 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 110' ' ' LYS . 46.7 Cg_endo -75.42 176.35 43.98 Favored 'Cis proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.654 -2.228 . . . . 0.0 110.481 -0.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.2 OUTLIER -37.17 124.63 0.95 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.685 -0.634 . . . . 0.0 110.741 -179.524 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.609 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.5 OUTLIER -42.57 137.36 2.36 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.873 . . . . 0.0 109.859 179.811 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.742 ' HG2' HD12 ' A' ' 66' ' ' ILE . 49.0 Cg_endo -74.67 165.1 32.32 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 O-C-N 124.258 1.662 . . . . 0.0 111.614 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.887 ' HG2' HG13 ' A' ' 117' ' ' VAL . 12.6 ttmt -126.71 105.19 8.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.538 -0.726 . . . . 0.0 109.924 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.531 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.6 t -55.38 86.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.16 -0.963 . . . . 0.0 109.846 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.887 HG13 ' HG2' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -98.62 -172.16 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 121.822 0.82 . . . . 0.0 110.528 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.2 mtm180 . . . . . 0 C--N 1.294 -1.83 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.497 -179.991 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.366 0.603 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.51 177.39 6.38 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.385 -0.822 . . . . 0.0 110.305 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.547 ' HB2' ' CA ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -125.41 75.35 1.46 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.421 -0.799 . . . . 0.0 110.106 -179.889 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.444 ' O ' ' C ' ' A' ' 5' ' ' SER . 3.0 mp0 -54.17 172.02 0.1 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.041 -1.037 . . . . 0.0 109.725 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.2 p -42.41 144.82 0.89 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 109.94 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.858 ' HG3' HG11 ' A' ' 27' ' ' VAL . 53.9 Cg_endo -70.62 160.45 49.43 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.046 1.551 . . . . 0.0 110.79 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -76.26 170.21 20.46 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 O-C-N 124.014 1.534 . . . . 0.0 109.945 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.55 176.18 6.38 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.141 -0.975 . . . . 0.0 110.27 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.499 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -144.26 -170.33 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 122.24 1.019 . . . . 0.0 111.746 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.484 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.3 OUTLIER -50.27 105.19 0.09 Allowed 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.287 -178.91 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 10' ' ' SER . 65.0 m-20 37.27 47.12 0.65 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.516 -0.74 . . . . 0.0 111.274 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.53 152.85 24.3 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 30' ' ' SER . 1.6 ptt180 -113.04 -172.5 2.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.104 -1.233 . . . . 0.0 111.192 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.623 ' CG ' ' HG2' ' A' ' 6' ' ' PRO . 20.3 p80 -143.99 111.6 6.04 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.294 0.568 . . . . 0.0 109.469 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 14' ' ' HIS . 2.6 t-20 -177.87 174.22 1.46 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.601 -1.312 . . . . 0.0 110.87 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 17' ' ' TYR . . . 145.62 -39.74 1.14 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.468 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.8 OUTLIER 178.17 46.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.513 -0.992 . . . . 0.0 109.568 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.644 ' OE2' HG13 ' A' ' 27' ' ' VAL . 0.9 OUTLIER -134.19 -94.16 0.3 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.225 -0.922 . . . . 0.0 110.491 -179.495 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 9.2 m-20 66.26 6.45 4.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.279 -0.888 . . . . 0.0 110.387 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -170.42 116.48 0.5 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 110.621 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.62 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 18.3 m-85 -132.83 173.47 11.35 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.364 -0.835 . . . . 0.0 109.294 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.547 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 1.9 p -130.59 -68.9 0.67 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.779 -1.2 . . . . 0.0 110.75 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.417 ' OD1' ' C ' ' A' ' 23' ' ' ASP . 14.7 t0 -162.04 132.4 4.85 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.392 -0.818 . . . . 0.0 109.684 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.54 16.19 71.64 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.618 -1.793 . . . . 0.0 108.618 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.62 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.5 OUTLIER -97.73 -179.25 4.38 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.46 -1.023 . . . . 0.0 110.506 -179.808 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 43' ' ' VAL . 11.8 t -149.58 162.26 4.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.041 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.858 HG11 ' HG3' ' A' ' 6' ' ' PRO . 16.4 t -143.07 118.56 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 119.698 -0.801 . . . . 0.0 111.681 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.885 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -75.3 102.41 5.05 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 118.636 -1.225 . . . . 0.0 107.884 177.831 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.725 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.3 m-30 -67.94 127.55 33.25 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.441 -0.787 . . . . 0.0 109.915 -178.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -82.14 142.34 32.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.059 -1.026 . . . . 0.0 109.728 179.404 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.54 ' SG ' HD12 ' A' ' 37' ' ' LEU . 64.3 m -112.56 142.87 44.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.17 -0.956 . . . . 0.0 110.075 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.479 ' O ' ' HB2' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -46.59 167.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 110.141 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 p -64.72 138.81 58.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.108 -0.995 . . . . 0.0 110.425 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.37 6.11 89.5 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.572 ' CD2' ' O ' ' A' ' 56' ' ' CYS . 1.0 OUTLIER -111.63 120.88 43.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.172 -1.193 . . . . 0.0 110.274 -179.881 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.639 ' HB3' HD11 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -79.79 130.45 35.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.394 -0.816 . . . . 0.0 110.942 -179.663 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.701 HD13 ' O ' ' A' ' 29' ' ' TYR . 1.9 tp -81.05 100.15 8.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.377 -0.827 . . . . 0.0 109.131 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.831 HD12 ' HB3' ' A' ' 105' ' ' PRO . 1.0 OUTLIER -89.12 151.05 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.495 -179.716 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.7 -176.66 26.37 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.413 ' OD1' ' O ' ' A' ' 40' ' ' ASN . 12.0 p30 -59.21 143.12 49.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -1.168 . . . . 0.0 109.72 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.885 ' O ' HG23 ' A' ' 28' ' ' THR . 0.4 OUTLIER -76.09 53.27 0.78 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.158 -0.964 . . . . 0.0 110.125 -179.908 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.504 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 160.56 131.07 1.18 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 27' ' ' VAL . 2.2 t -69.58 -175.28 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.113 -1.228 . . . . 0.0 108.364 178.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.635 ' H ' HG12 ' A' ' 43' ' ' VAL . 6.1 tp -143.84 98.54 3.25 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.479 178.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.608 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.8 OUTLIER -84.3 112.47 20.34 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.231 178.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 t -124.77 145.94 49.47 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.332 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 54.28 32.09 50.9 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.44 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 69.19 40.01 82.42 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 1.5 mt-10 -151.42 128.04 10.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.298 -1.119 . . . . 0.0 110.502 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.608 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 74.8 m95 -81.95 134.36 35.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.25 -0.907 . . . . 0.0 110.107 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 25.9 t -151.29 163.38 39.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.115 -0.991 . . . . 0.0 110.742 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.52 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 2.4 m-20 64.3 65.5 1.1 Allowed Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.633 -0.667 . . . . 0.0 110.944 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 52.1 Cg_endo -91.77 132.92 1.34 Allowed 'Trans proline' 0 C--N 1.299 -2.053 0 C-N-CA 121.89 1.727 . . . . 0.0 110.173 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.459 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.2 Cg_endo -76.61 172.05 16.92 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.689 1.363 . . . . 0.0 109.488 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.611 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 52.8 p -109.86 148.91 30.67 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.812 -1.18 . . . . 0.0 111.919 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.572 ' O ' ' CD2' ' A' ' 35' ' ' TYR . 86.5 m -111.44 77.62 1.05 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 36' ' ' SER . 1.0 OUTLIER -115.25 -163.72 0.9 Allowed 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.547 0.689 . . . . 0.0 110.502 -178.115 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.634 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -107.7 137.62 38.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.376 -0.828 . . . . 0.0 108.888 179.505 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.688 HG23 ' HA ' ' A' ' 80' ' ' SER . 30.2 m -123.08 41.1 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.034 -1.041 . . . . 0.0 111.229 -178.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.443 ' CD ' HG22 ' A' ' 58' ' ' ILE . 7.8 mtpp -75.49 98.63 3.99 Favored 'General case' 0 C--N 1.284 -2.267 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.443 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 107' ' ' ASN . 64.0 m -70.01 161.96 71.93 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.438 -0.789 . . . . 0.0 111.842 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 44.7 Cg_endo -72.57 -88.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.546 1.814 . . . . 0.0 111.008 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.457 ' CD2' ' HE1' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -172.49 132.12 0.68 Allowed Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.527 -0.733 . . . . 0.0 109.225 -179.321 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.628 ' HA ' HD21 ' A' ' 113' ' ' LEU . 58.2 Cg_endo -85.35 69.85 5.3 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 O-C-N 123.398 1.21 . . . . 0.0 109.886 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.711 ' O ' HG23 ' A' ' 66' ' ' ILE . 3.2 p -87.19 -40.6 14.44 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.464 1.126 . . . . 0.0 109.999 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.775 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER 52.59 160.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.355 -178.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.479 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 0.5 OUTLIER -58.64 91.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.474 -0.766 . . . . 0.0 111.576 -178.826 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 47.94 60.27 3.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.378 -0.826 . . . . 0.0 111.471 178.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.576 ' O ' ' CG ' ' A' ' 70' ' ' TYR . . . -143.58 -36.98 0.07 OUTLIER Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.17 -1.491 . . . . 0.0 110.226 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.611 ' CE1' ' HB3' ' A' ' 88' ' ' LYS . 40.2 p90 42.44 -175.34 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 122.097 0.951 . . . . 0.0 110.932 -178.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.988 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -122.75 -32.13 3.59 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.694 -178.549 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.833 ' H ' HD22 ' A' ' 71' ' ' LEU . 0.5 OUTLIER 57.09 15.15 2.27 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.635 -1.291 . . . . 0.0 110.78 177.587 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.421 ' HB2' ' H ' ' A' ' 86' ' ' ASP . 66.2 m -119.49 10.02 11.71 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.524 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 133.91 87.38 0.29 Allowed Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.358 -1.401 . . . . 0.0 110.047 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.585 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -127.36 150.82 49.44 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.31 -1.112 . . . . 0.0 109.55 179.429 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.441 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 2.0 tttp -135.39 170.41 15.99 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.423 -0.798 . . . . 0.0 109.723 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 30.0 mtt85 -67.45 -26.08 66.21 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.307 -0.871 . . . . 0.0 109.855 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.94 150.87 36.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 110.481 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.585 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 13.8 m-85 -128.82 -170.62 2.3 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.292 -0.88 . . . . 0.0 110.332 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.688 ' HA ' HG23 ' A' ' 59' ' ' VAL . 1.2 t -169.83 90.33 0.19 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.227 -0.921 . . . . 0.0 110.136 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.571 ' CB ' HG21 ' A' ' 59' ' ' VAL . 6.6 t80 55.72 134.2 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.158 -0.964 . . . . 0.0 110.042 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.75 ' O ' HG22 ' A' ' 102' ' ' THR . 22.7 t30 71.66 -129.82 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.822 -1.174 . . . . 0.0 110.578 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.551 ' HB3' ' HB3' ' A' ' 103' ' ' CYS . 5.1 t0 51.62 74.54 0.25 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.653 -1.279 . . . . 0.0 108.921 -178.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.549 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 21.3 t-20 -75.69 141.84 42.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.437 -0.79 . . . . 0.0 111.608 -178.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.805 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -125.9 146.88 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.4 -0.812 . . . . 0.0 109.679 178.834 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.554 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -109.57 108.29 18.69 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.027 -1.046 . . . . 0.0 108.95 179.473 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.988 ' CE1' HD12 ' A' ' 71' ' ' LEU . 35.5 m-85 -66.84 134.93 53.09 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.382 1.087 . . . . 0.0 113.715 -177.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.611 ' HB3' ' CE1' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -123.3 84.37 2.26 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.664 -179.816 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.773 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -32.75 133.7 0.12 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.762 -0.586 . . . . 0.0 111.489 -179.518 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -40.51 -87.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.496 -0.753 . . . . 0.0 110.331 179.584 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -161.94 143.37 10.98 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.173 -0.955 . . . . 0.0 110.03 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.572 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 59.05 24.95 59.07 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.572 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 18.1 m-85 -138.99 144.56 38.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.566 -0.961 . . . . 0.0 109.901 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 117' ' ' VAL . 9.6 ttpt -105.36 153.65 21.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.261 -0.899 . . . . 0.0 109.493 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.773 HD11 ' H ' ' A' ' 89' ' ' CYS . 3.4 mt -88.57 114.14 24.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.708 -1.245 . . . . 0.0 110.445 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.453 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 1.3 t -89.21 97.48 11.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.334 -0.854 . . . . 0.0 109.721 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.26 -111.38 0.64 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.615 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 5.7 t -129.51 127.22 40.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.27 -1.135 . . . . 0.0 110.557 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.487 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 0.8 OUTLIER -74.07 -44.38 54.33 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.388 -0.82 . . . . 0.0 110.37 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 32.2 p -101.21 123.39 45.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.122 -0.986 . . . . 0.0 110.154 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.535 ' C ' ' HG1' ' A' ' 102' ' ' THR . 57.9 m -129.99 -168.14 1.92 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 110.298 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.75 HG22 ' O ' ' A' ' 82' ' ' ASN . 14.6 m -162.72 134.14 5.08 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.252 -0.979 . . . . 0.0 111.134 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.603 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 1.6 t -57.41 95.42 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.677 -0.64 . . . . 0.0 109.48 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.4 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -83.12 173.94 6.77 Favored Pre-proline 0 C--N 1.299 -1.587 0 O-C-N 120.974 -1.079 . . . . 0.0 110.789 -179.609 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.831 ' HB3' HD12 ' A' ' 38' ' ' ILE . 43.9 Cg_endo -76.26 132.16 13.53 Favored 'Trans proline' 0 C--N 1.299 -2.051 0 O-C-N 124.467 1.772 . . . . 0.0 110.703 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.548 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 121.69 -4.04 10.9 Favored Glycine 0 N--CA 1.482 1.748 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.824 ' O ' HG23 ' A' ' 108' ' ' THR . 8.2 m-80 80.25 81.28 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.91 -0.759 . . . . 0.0 110.499 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.824 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 177.48 -177.26 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.222 -0.924 . . . . 0.0 111.467 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.805 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 44.6 m95 -124.54 101.77 7.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.624 -0.673 . . . . 0.0 110.515 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.531 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 4.6 mttt -102.59 148.91 36.19 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.25 -0.906 . . . . 0.0 109.871 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.615 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 52.3 Cg_endo -73.28 -175.19 14.18 Favored 'Cis proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.144 -2.023 . . . . 0.0 111.007 -0.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.7 mt-10 -38.37 123.84 1.21 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.339 0.59 . . . . 0.0 110.437 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.661 HD13 ' HB3' ' A' ' 109' ' ' TRP . 2.9 tp -53.9 143.11 42.72 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 110.448 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.775 ' HG2' HD12 ' A' ' 66' ' ' ILE . 41.2 Cg_endo -72.1 155.66 56.6 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.024 1.539 . . . . 0.0 110.594 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.709 ' HG2' HG13 ' A' ' 117' ' ' VAL . 0.4 OUTLIER -120.91 110.87 16.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.327 -0.858 . . . . 0.0 110.508 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 1.3 t -60.48 96.91 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.186 -0.946 . . . . 0.0 109.342 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.709 HG13 ' HG2' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -107.04 -175.35 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 121.798 0.809 . . . . 0.0 111.019 -179.447 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.296 -1.735 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.176 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 62.7 t . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.192 0.52 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.54 149.82 52.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.194 -0.941 . . . . 0.0 110.275 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.528 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.6 m -80.64 138.74 36.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.422 -0.799 . . . . 0.0 110.611 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.446 ' O ' ' C ' ' A' ' 5' ' ' SER . 21.0 mt-30 -119.5 174.28 6.48 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.439 -0.788 . . . . 0.0 109.286 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 19' ' ' ASP . 1.1 p -42.64 133.76 2.83 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 0.0 109.776 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.736 ' HG3' HG11 ' A' ' 27' ' ' VAL . 51.7 Cg_endo -70.2 155.76 63.76 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.944 1.497 . . . . 0.0 111.357 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -76.73 170.67 19.43 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.041 1.548 . . . . 0.0 110.04 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.13 176.2 4.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.168 -0.958 . . . . 0.0 109.689 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.661 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -142.52 -170.32 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 122.178 0.99 . . . . 0.0 111.81 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.531 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 13.2 t -37.69 94.37 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.204 -179.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 9' ' ' ILE . 11.8 m-20 42.9 25.45 0.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.068 -1.02 . . . . 0.0 110.648 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -121.01 -166.56 13.03 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.53 ' HG3' ' CB ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -151.71 178.8 8.99 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.193 -1.181 . . . . 0.0 110.145 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.632 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 9.2 p80 -135.6 141.33 45.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.403 -0.811 . . . . 0.0 110.462 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -171.22 65.54 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.895 . . . . 0.0 110.267 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.41 ' O ' ' CD2' ' A' ' 17' ' ' TYR . . . -60.23 -81.59 0.08 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -177.38 29.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -1.156 . . . . 0.0 110.298 179.876 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.415 ' HG3' ' CE1' ' A' ' 21' ' ' TYR . 0.9 OUTLIER -165.59 -165.92 0.9 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.921 . . . . 0.0 110.212 179.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 20' ' ' PHE . 25.1 p-10 -123.27 -41.82 2.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.896 . . . . 0.0 109.947 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.506 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 2.0 m-85 -96.14 149.74 21.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.387 -0.821 . . . . 0.0 110.338 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.688 ' CD2' ' HB3' ' A' ' 25' ' ' SER . 1.6 m-85 -130.91 -2.41 4.1 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.217 -0.927 . . . . 0.0 110.833 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.528 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 15.6 p 42.8 -99.3 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.353 -0.842 . . . . 0.0 111.264 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.534 ' OD1' ' HA ' ' A' ' 46' ' ' SER . 3.6 t0 -156.82 137.53 13.26 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.059 -1.026 . . . . 0.0 110.179 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 86.87 23.75 40.75 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.688 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 58.2 m -116.61 154.41 30.55 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -1.079 . . . . 0.0 109.563 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.909 HG13 ' O ' ' A' ' 43' ' ' VAL . 38.1 t -126.1 149.33 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.884 -1.135 . . . . 0.0 112.556 -177.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.74 ' O ' HG23 ' A' ' 43' ' ' VAL . 45.8 t -121.44 120.77 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.587 -0.696 . . . . 0.0 111.32 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -73.81 103.12 4.24 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 177.443 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 1.026 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.0 m-30 -67.63 121.11 15.18 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.244 -177.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.53 ' CB ' ' HG3' ' A' ' 13' ' ' ARG . 2.3 m -70.81 -163.89 0.08 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.979 -1.075 . . . . 0.0 108.966 179.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.53 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 5.5 t -164.38 160.47 20.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.896 -1.127 . . . . 0.0 110.702 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 34' ' ' GLY . 9.7 t-20 -55.56 144.3 26.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.343 -0.848 . . . . 0.0 109.679 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.54 79.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.255 -0.903 . . . . 0.0 110.428 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 32' ' ' ASN . . . 153.7 -28.9 0.75 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.434 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 6.4 m-85 -87.25 134.97 33.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.155 -1.203 . . . . 0.0 110.184 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.733 ' CB ' HG13 ' A' ' 59' ' ' VAL . 1.2 t -80.28 142.49 34.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.278 -0.889 . . . . 0.0 110.527 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.854 HD13 ' O ' ' A' ' 29' ' ' TYR . 2.1 tp -93.81 111.18 22.83 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.375 -0.828 . . . . 0.0 109.21 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.654 HD13 ' N ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -103.53 156.9 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.137 -0.977 . . . . 0.0 109.62 -179.661 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.23 -146.53 16.48 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.535 ' O ' ' C ' ' A' ' 41' ' ' SER . 0.7 OUTLIER -106.16 54.97 0.68 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.107 -1.231 . . . . 0.0 110.021 179.829 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.571 ' O ' HG23 ' A' ' 28' ' ' THR . 7.3 p 14.44 56.62 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.167 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.581 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 155.58 118.83 0.63 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.026 HG21 ' CE1' ' A' ' 29' ' ' TYR . 1.9 t -70.42 -178.77 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.084 -1.244 . . . . 0.0 108.005 178.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.488 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.2 tp -144.15 97.52 3.06 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.715 -1.241 . . . . 0.0 110.531 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.589 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.9 OUTLIER -83.92 111.98 19.74 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.304 178.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.534 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 0.4 OUTLIER -123.2 93.22 3.88 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.299 -179.681 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.28 61.52 1.64 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 49.55 27.06 8.08 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -136.47 108.85 7.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.207 -1.172 . . . . 0.0 110.442 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.589 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 70.8 m95 -74.76 135.29 41.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 109.711 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -144.14 157.62 44.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.085 -1.009 . . . . 0.0 111.092 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.534 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 4.4 t70 63.56 64.41 1.38 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.691 -0.631 . . . . 0.0 110.965 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.534 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 53.3 Cg_endo -92.14 133.44 1.28 Allowed 'Trans proline' 0 C--N 1.298 -2.098 0 O-C-N 124.406 1.74 . . . . 0.0 109.674 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.534 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 49.4 Cg_endo -75.93 176.81 9.54 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 O-C-N 123.688 1.362 . . . . 0.0 109.819 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.54 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 6.7 p -111.09 -175.75 2.78 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.995 0.902 . . . . 0.0 111.271 -178.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 10' ' ' SER . 0.8 OUTLIER -144.64 75.08 1.44 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.109 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.522 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.3 OUTLIER -112.85 -158.86 0.66 Allowed 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.913 -178.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.637 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -113.78 130.42 67.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 108.603 179.415 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.733 HG13 ' CB ' ' A' ' 36' ' ' SER . 19.2 m -118.49 46.43 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.994 -1.067 . . . . 0.0 112.067 -178.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.499 ' HE3' HG22 ' A' ' 58' ' ' ILE . 1.6 mttt -58.13 -175.11 0.02 OUTLIER 'General case' 0 C--N 1.281 -2.384 0 C-N-CA 117.763 -1.575 . . . . 0.0 107.541 178.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.524 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 1.2 m -141.54 167.38 17.21 Favored Pre-proline 0 C--N 1.293 -1.857 0 C-N-CA 117.811 -1.555 . . . . 0.0 113.814 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.553 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 48.9 Cg_endo -90.08 -69.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 125.026 2.066 . . . . 0.0 110.368 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.553 ' CD2' ' O ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER 165.4 124.24 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.299 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.72 ' HG2' HD21 ' A' ' 71' ' ' LEU . 45.9 Cg_endo -76.47 80.22 2.8 Favored 'Trans proline' 0 C--N 1.301 -1.953 0 O-C-N 123.467 1.246 . . . . 0.0 109.329 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.512 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -102.91 173.79 6.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.872 . . . . 0.0 109.791 -179.33 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.821 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -169.99 166.35 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.334 -0.947 . . . . 0.0 110.305 179.558 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.472 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 16.4 t -75.73 107.04 7.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.488 -0.757 . . . . 0.0 110.652 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.529 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 3.3 m-80 38.89 55.87 2.0 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.567 -0.708 . . . . 0.0 110.643 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.77 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -168.66 32.04 0.18 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.63 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 16.9 p90 -45.25 -174.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 123.463 1.601 . . . . 0.0 112.862 -179.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.968 HD11 ' HB2' ' A' ' 75' ' ' PHE . 2.8 pp -100.89 126.79 47.54 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 113.308 -1.769 . . . . 0.0 109.887 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.509 ' HB3' ' HB2' ' A' ' 88' ' ' LYS . 0.2 OUTLIER -96.35 2.48 52.78 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.28 -0.888 . . . . 0.0 109.515 179.767 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.7 t -73.09 -73.91 0.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.38 -0.825 . . . . 0.0 110.572 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.9 97.62 0.12 Allowed Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.626 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.968 ' HB2' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -94.17 145.13 24.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.358 -1.083 . . . . 0.0 109.18 179.053 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.486 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -132.38 160.72 35.53 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.158 -0.964 . . . . 0.0 110.242 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -52.45 -33.99 46.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.225 -0.922 . . . . 0.0 110.394 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.406 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -142.02 165.62 26.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.333 -0.855 . . . . 0.0 110.361 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.582 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 22.3 m-85 -138.06 -138.63 0.14 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.373 -0.83 . . . . 0.0 109.956 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 21.2 p -170.05 -132.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 0.0 109.629 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.646 ' O ' ' CG ' ' A' ' 81' ' ' TYR . 1.6 t80 -101.87 38.23 1.68 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.002 -1.061 . . . . 0.0 109.459 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.676 ' C ' HG22 ' A' ' 102' ' ' THR . 9.4 p30 -169.36 -114.37 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.73 -1.231 . . . . 0.0 110.498 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 82' ' ' ASN . 81.5 m-20 44.83 77.19 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.78 -1.2 . . . . 0.0 109.374 -179.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.823 ' CA ' HG23 ' A' ' 102' ' ' THR . 5.6 p-10 -75.11 113.5 12.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.285 -0.885 . . . . 0.0 110.93 -178.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.578 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 15.7 m -101.56 120.86 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.773 -1.204 . . . . 0.0 110.364 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.537 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 25.8 t0 -76.65 126.3 30.75 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.169 -0.957 . . . . 0.0 109.161 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.634 ' CZ ' HD12 ' A' ' 113' ' ' LEU . 23.4 m-85 -86.97 126.02 34.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.052 -1.03 . . . . 0.0 111.357 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -104.31 110.94 23.37 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.53 -179.377 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.441 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -58.56 133.11 55.55 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.038 -1.039 . . . . 0.0 109.551 179.314 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -42.63 -67.49 0.27 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.12 -179.644 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.521 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.3 OUTLIER -176.66 137.16 0.26 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.413 -0.804 . . . . 0.0 110.345 179.935 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.597 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 54.03 58.22 13.55 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.597 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 12.7 m-85 -162.21 155.84 20.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.534 -0.98 . . . . 0.0 109.819 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.609 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -110.2 124.18 51.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.142 -0.973 . . . . 0.0 110.323 -179.856 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.568 HD23 HD11 ' A' ' 66' ' ' ILE . 1.7 mt -63.7 87.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.373 -0.83 . . . . 0.0 110.033 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.453 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -69.47 104.81 2.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 110.07 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 141.58 -81.53 0.24 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.581 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -169.72 124.73 0.81 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.257 -1.143 . . . . 0.0 110.534 -179.827 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 73.8 p -68.56 -72.19 0.19 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.349 -0.845 . . . . 0.0 110.867 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.537 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 58.6 p -78.19 118.33 20.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.153 -0.967 . . . . 0.0 110.329 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 85' ' ' VAL . 59.9 m -125.25 158.47 34.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.55 -0.719 . . . . 0.0 110.611 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.823 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -135.08 142.26 46.25 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.395 179.694 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.585 ' SG ' ' CZ2' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -67.9 105.41 1.98 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.614 -0.679 . . . . 0.0 110.278 -179.769 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.532 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -76.88 -175.15 0.47 Allowed Pre-proline 0 C--N 1.295 -1.779 0 O-C-N 121.231 -0.918 . . . . 0.0 111.315 -179.411 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.644 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 41.4 Cg_endo -87.78 126.42 2.14 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 124.4 1.737 . . . . 0.0 110.597 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 117.53 2.86 17.15 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.88 ' O ' HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER 79.16 105.61 0.07 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.649 -0.912 . . . . 0.0 110.426 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.88 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER 166.03 -163.39 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.867 0.841 . . . . 0.0 111.271 179.443 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.703 ' HB3' HD11 ' A' ' 113' ' ' LEU . 32.8 m95 -144.91 88.02 1.87 Allowed 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.698 0.761 . . . . 0.0 109.651 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.578 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 14.4 mmmt -98.54 137.08 20.62 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.764 -0.585 . . . . 0.0 110.186 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.581 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 42.8 Cg_endo -69.69 166.25 74.34 Favored 'Cis proline' 0 N--CA 1.49 1.298 0 C-N-CA 122.056 -2.06 . . . . 0.0 110.983 -0.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -38.52 153.23 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.578 -0.702 . . . . 0.0 111.081 -179.168 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.703 HD11 ' HB3' ' A' ' 109' ' ' TRP . 1.2 mm? -64.68 141.61 98.32 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.43 -0.793 . . . . 0.0 109.716 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.821 ' HG2' HD12 ' A' ' 66' ' ' ILE . 42.5 Cg_endo -72.1 165.12 33.56 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 O-C-N 124.189 1.626 . . . . 0.0 110.548 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.728 ' HG2' HG13 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -129.28 107.44 9.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.339 -0.851 . . . . 0.0 109.918 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.538 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 3.0 t -61.17 83.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.276 -0.89 . . . . 0.0 109.466 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.728 HG13 ' HG2' ' A' ' 115' ' ' LYS . 3.3 m -101.86 -169.68 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-O 121.945 0.879 . . . . 0.0 110.89 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.467 ' HG2' ' CE1' ' A' ' 93' ' ' TYR . 6.7 mtm-85 . . . . . 0 C--N 1.291 -1.953 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.211 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.8 p . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.27 0.557 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -119.78 174.73 6.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.412 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.553 ' O ' ' N ' ' A' ' 21' ' ' TYR . 1.1 m -113.54 89.75 3.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.35 -0.844 . . . . 0.0 110.56 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.41 ' O ' ' C ' ' A' ' 5' ' ' SER . 18.7 mt-30 -69.68 172.11 7.99 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.021 -1.05 . . . . 0.0 109.844 179.6 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 19' ' ' ASP . 1.1 p -42.12 141.95 1.28 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 110.138 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.82 ' HG3' HG11 ' A' ' 27' ' ' VAL . 51.1 Cg_endo -71.8 154.89 58.8 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.029 1.542 . . . . 0.0 111.019 -179.494 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -74.74 172.48 16.17 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.868 1.457 . . . . 0.0 110.005 179.458 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.7 p -70.98 174.91 5.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.107 -0.996 . . . . 0.0 110.017 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.728 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -142.8 -170.3 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 122.156 0.979 . . . . 0.0 111.543 179.719 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.523 ' O ' ' CB ' ' A' ' 56' ' ' CYS . 1.2 m -43.54 90.83 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.673 -179.302 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.8 OUTLIER 43.7 53.08 6.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.114 -0.991 . . . . 0.0 110.581 179.827 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.31 147.22 16.15 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.483 ' O ' ' N ' ' A' ' 30' ' ' SER . 1.3 mtp180 -92.98 -167.99 1.85 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.246 -1.149 . . . . 0.0 110.647 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.61 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 17.6 p80 -156.33 -159.19 0.86 Allowed 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.283 0.564 . . . . 0.0 110.543 -179.501 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 13.5 t-20 72.89 141.36 0.06 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.514 -0.741 . . . . 0.0 110.572 179.625 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.54 -57.92 0.19 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -163.63 29.27 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -1.134 . . . . 0.0 110.111 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.72 -178.26 7.19 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.194 -0.941 . . . . 0.0 110.444 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 5' ' ' SER . 24.0 m-20 -124.06 -44.15 2.06 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.417 -0.802 . . . . 0.0 109.976 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -94.92 139.94 30.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 109.94 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.628 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.3 OUTLIER -128.43 -4.67 5.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.254 -0.904 . . . . 0.0 110.625 -179.633 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.53 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 32.2 p 45.86 -97.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.92 . . . . 0.0 111.91 179.768 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.524 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -153.2 158.57 41.93 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.91 -1.119 . . . . 0.0 110.594 -178.51 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.53 25.65 75.36 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 179.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.628 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -114.43 171.21 7.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.416 -1.049 . . . . 0.0 110.2 -179.763 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.874 HG13 ' O ' ' A' ' 43' ' ' VAL . 40.6 t -143.08 153.93 16.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.518 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.939 ' O ' HG23 ' A' ' 43' ' ' VAL . 18.8 t -132.86 123.7 49.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.62 -179.262 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.796 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -76.31 103.04 6.13 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.937 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 1.014 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.4 m-30 -68.12 127.27 32.29 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.412 -0.805 . . . . 0.0 110.349 -178.13 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -71.53 158.21 36.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.561 179.451 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.419 ' SG ' HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -133.6 156.82 47.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.113 -0.992 . . . . 0.0 110.337 -179.808 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.36 129.24 37.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.269 -0.894 . . . . 0.0 110.067 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 t -46.57 122.71 4.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 0.0 110.592 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.25 -40.85 1.89 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.478 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.444 ' CE1' HG13 ' A' ' 58' ' ' ILE . 7.9 m-85 -90.86 155.45 18.75 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -1.155 . . . . 0.0 110.786 -179.504 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.693 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -91.45 141.45 28.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.404 -0.81 . . . . 0.0 110.205 179.541 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.536 ' HA ' ' O ' ' A' ' 55' ' ' THR . 0.6 OUTLIER -92.9 97.4 10.72 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.275 -0.89 . . . . 0.0 109.531 179.207 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.822 HG23 ' CB ' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -85.81 142.79 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.421 -0.799 . . . . 0.0 108.985 179.847 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.57 -154.11 21.94 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 42' ' ' GLY . 15.6 p-10 -110.73 51.86 0.75 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.168 -1.195 . . . . 0.0 110.541 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.796 ' O ' HG23 ' A' ' 28' ' ' THR . 75.4 p 28.0 38.6 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.904 179.657 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.53 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 169.09 125.99 0.82 Allowed Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.452 -1.356 . . . . 0.0 110.125 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.014 HG21 ' CE1' ' A' ' 29' ' ' TYR . 2.0 t -71.94 -178.1 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -1.113 . . . . 0.0 108.092 179.026 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.516 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.5 tp -144.59 99.48 3.36 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.251 -0.979 . . . . 0.0 110.225 179.05 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.587 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -87.15 110.17 19.95 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.055 -1.058 . . . . 0.0 109.438 178.686 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.7 p -128.64 123.19 32.59 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.032 -179.774 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.524 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 76.24 35.85 41.76 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.876 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.19 40.88 97.05 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 1.8 mt-10 -157.95 128.94 6.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.379 -1.071 . . . . 0.0 110.292 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.604 ' CH2' HG23 ' A' ' 27' ' ' VAL . 84.2 m95 -82.46 138.53 34.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.792 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -143.73 157.89 44.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.163 -0.961 . . . . 0.0 111.011 -179.574 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.504 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER 63.2 65.46 1.31 Allowed Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.631 -0.668 . . . . 0.0 111.0 179.606 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.504 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.5 Cg_endo -90.64 140.95 3.12 Favored 'Trans proline' 0 C--N 1.301 -1.967 0 C-N-CA 121.851 1.701 . . . . 0.0 109.972 179.158 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.525 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 46.9 Cg_endo -78.71 175.56 10.87 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.729 1.383 . . . . 0.0 110.233 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.568 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 11.1 p -124.38 158.82 31.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.207 -0.933 . . . . 0.0 111.438 -178.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.523 ' CB ' ' O ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -116.06 78.37 1.18 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.177 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.455 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -117.2 -158.51 0.7 Allowed 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.875 -178.922 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.584 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -116.06 142.71 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.92 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.713 HG21 ' CB ' ' A' ' 81' ' ' TYR . 12.7 m -127.88 43.05 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.825 -1.172 . . . . 0.0 111.559 -178.663 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -80.91 95.23 6.68 Favored 'General case' 0 C--N 1.281 -2.384 0 C-N-CA 119.071 -1.052 . . . . 0.0 108.593 179.014 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.47 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 32.3 m -69.28 162.33 66.81 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.356 -0.84 . . . . 0.0 111.153 -178.481 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.511 ' HD2' ' HA ' ' A' ' 108' ' ' THR . 49.6 Cg_endo -72.97 -92.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 124.471 1.774 . . . . 0.0 110.349 -179.521 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.465 ' C ' ' CD1' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -155.82 137.45 9.65 Favored Pre-proline 0 C--N 1.299 -1.611 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.62 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.931 ' HG2' HD21 ' A' ' 71' ' ' LEU . 52.2 Cg_endo -77.82 62.61 7.91 Favored 'Trans proline' 0 C--N 1.294 -2.336 0 O-C-N 123.525 1.277 . . . . 0.0 109.072 -179.161 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.474 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.8 OUTLIER -75.66 166.82 22.98 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.098 -179.634 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.967 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -165.87 164.74 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 C-N-CA 118.75 -1.18 . . . . 0.0 110.716 179.81 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.432 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -71.06 95.49 1.21 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.483 -0.761 . . . . 0.0 110.482 -179.534 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.452 ' O ' ' SG ' ' A' ' 116' ' ' CYS . 3.8 m-20 45.67 51.41 10.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 110.593 179.572 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.967 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -162.12 38.9 0.38 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.582 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 50.2 p90 -49.54 -152.53 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.898 1.333 . . . . 0.0 112.958 -179.393 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.026 HD23 ' CE2' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -141.07 120.56 13.2 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.031 -176.383 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.2 t -100.78 17.9 20.82 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.615 -0.678 . . . . 0.0 109.414 -179.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.9 t -77.98 -79.2 0.12 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.582 -0.699 . . . . 0.0 111.255 -179.166 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -122.76 -66.16 0.22 Allowed Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.632 -178.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.574 ' HB2' ' CD1' ' A' ' 71' ' ' LEU . 52.1 t80 58.71 167.0 0.05 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.571 -0.958 . . . . 0.0 110.255 -179.144 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.583 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 17.7 tttm -178.14 145.3 0.36 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.408 -0.807 . . . . 0.0 109.748 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -41.79 -32.43 0.4 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.17 -0.956 . . . . 0.0 110.244 -179.824 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.9 m -147.33 166.97 25.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.481 -0.762 . . . . 0.0 110.297 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.583 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 8.7 m-85 -140.5 -172.15 3.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.244 -0.91 . . . . 0.0 110.031 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.584 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 6.6 t -170.24 109.63 0.38 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.935 -1.103 . . . . 0.0 111.161 179.734 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.713 ' CB ' HG21 ' A' ' 59' ' ' VAL . 14.1 t80 32.75 32.64 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.307 -0.871 . . . . 0.0 111.663 179.164 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.545 ' HA ' HG22 ' A' ' 102' ' ' THR . 49.9 t30 -176.63 -134.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.642 -1.286 . . . . 0.0 110.522 179.342 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 50.65 69.66 0.61 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.056 -1.027 . . . . 0.0 109.019 -178.695 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.58 ' N ' HG23 ' A' ' 102' ' ' THR . 16.2 p30 -69.75 131.88 45.24 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.486 -0.759 . . . . 0.0 110.09 -179.204 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.593 ' CG2' HD22 ' A' ' 71' ' ' LEU . 16.2 m -119.27 122.25 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.054 -1.029 . . . . 0.0 111.018 -179.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -79.73 138.76 37.4 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.481 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 1.026 ' CE2' HD23 ' A' ' 71' ' ' LEU . 72.5 m-85 -93.59 146.6 23.69 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.918 -1.114 . . . . 0.0 112.215 -178.07 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -118.82 89.93 3.23 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.65 -179.765 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.597 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -42.08 131.16 3.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 0.0 110.249 -179.653 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 89' ' ' CYS . 0.1 OUTLIER -38.99 -66.06 0.31 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.527 -0.733 . . . . 0.0 110.624 -179.535 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.585 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER 176.69 141.74 0.07 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.401 -0.812 . . . . 0.0 110.025 179.978 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.583 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 53.35 46.2 64.36 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.946 -1.661 . . . . 0.0 108.946 -179.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.585 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 16.3 m-85 -155.59 152.13 28.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.556 -0.967 . . . . 0.0 109.64 -179.48 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.559 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -112.63 128.18 56.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 110.191 -179.998 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.597 HD11 ' H ' ' A' ' 89' ' ' CYS . 0.7 OUTLIER -64.39 97.05 0.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -0.91 . . . . 0.0 110.422 -179.879 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.456 ' HB2' HG21 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -78.67 101.1 7.32 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.315 -0.866 . . . . 0.0 109.54 179.469 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.22 -85.37 0.18 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.577 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 2.4 m -158.41 111.69 2.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.329 -1.101 . . . . 0.0 110.641 -179.353 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.8 t -71.65 -5.56 34.57 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.246 -0.909 . . . . 0.0 110.666 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.3 p -138.46 120.02 15.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.115 -0.99 . . . . 0.0 110.185 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.541 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 20.9 m -133.65 172.11 13.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.347 -0.845 . . . . 0.0 110.745 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.58 HG23 ' N ' ' A' ' 84' ' ' ASN . 17.1 m -147.51 136.24 21.96 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.385 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.575 ' O ' ' CA ' ' A' ' 81' ' ' TYR . 4.8 t -48.95 96.2 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.145 179.577 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.472 ' CB ' ' HG3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -64.63 174.22 1.32 Allowed Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.082 -1.011 . . . . 0.0 111.902 -178.935 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.822 ' CB ' HG23 ' A' ' 38' ' ' ILE . 49.7 Cg_endo -82.04 16.47 1.74 Allowed 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 124.613 1.849 . . . . 0.0 111.559 -178.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -119.53 25.81 7.54 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 179.307 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.687 ' O ' HG23 ' A' ' 108' ' ' THR . 1.9 m-80 61.24 51.63 4.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.746 -0.855 . . . . 0.0 109.932 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.687 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.5 OUTLIER -161.91 -176.72 5.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 0.0 110.977 -179.849 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.623 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 51.0 m95 -109.06 102.03 11.05 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.483 -0.76 . . . . 0.0 110.553 -179.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.515 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -107.06 140.53 21.5 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.45 -0.781 . . . . 0.0 110.209 -179.746 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.577 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.1 Cg_endo -73.18 172.44 60.46 Favored 'Cis proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.964 -2.098 . . . . 0.0 110.363 -0.355 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.9 OUTLIER -40.25 137.07 1.1 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.393 -0.817 . . . . 0.0 110.966 -179.278 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.646 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -47.83 146.57 3.86 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.448 -0.782 . . . . 0.0 110.162 179.547 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.787 ' HG2' HD12 ' A' ' 66' ' ' ILE . 39.3 Cg_endo -72.9 167.68 26.67 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 124.38 1.726 . . . . 0.0 111.063 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.513 ' O ' HG22 ' A' ' 117' ' ' VAL . 3.3 ttpt -127.32 109.68 12.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.386 -0.821 . . . . 0.0 110.801 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.531 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.9 t -66.35 90.16 0.15 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.1 -1.0 . . . . 0.0 109.172 179.225 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 94' ' ' LYS . 1.7 m -105.69 -176.26 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 121.73 0.776 . . . . 0.0 110.925 -179.386 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.5 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.762 0 C-N-CA 118.927 -1.109 . . . . 0.0 110.616 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.436 ' H3 ' HG22 ' A' ' 1' ' ' VAL . 16.6 m . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.101 0.477 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.42 166.58 20.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.132 -0.98 . . . . 0.0 110.471 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.506 ' N ' ' O ' ' A' ' 21' ' ' TYR . 0.9 OUTLIER -135.23 83.63 2.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.418 -0.801 . . . . 0.0 109.805 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.84 172.27 0.11 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.05 -1.031 . . . . 0.0 110.229 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 p -52.45 144.02 25.13 Favored Pre-proline 0 C--N 1.301 -1.525 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.071 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.654 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 54.6 Cg_endo -72.35 151.88 54.54 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 123.798 1.42 . . . . 0.0 110.644 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.64 171.49 18.11 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 O-C-N 123.884 1.465 . . . . 0.0 109.722 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.04 177.82 2.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.069 -1.02 . . . . 0.0 109.675 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.615 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -140.93 -170.47 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 122.155 0.979 . . . . 0.0 111.543 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 48.4 t -37.87 95.66 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.998 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.5 OUTLIER 42.33 27.24 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.304 -0.873 . . . . 0.0 110.41 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -126.93 -176.34 14.44 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.53 ' HG3' ' CB ' ' A' ' 30' ' ' SER . 0.5 OUTLIER -138.24 177.64 7.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.258 -1.142 . . . . 0.0 110.578 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.654 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 10.8 p80 -130.19 132.76 46.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.504 -0.748 . . . . 0.0 110.209 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -154.11 80.04 1.12 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.203 -0.936 . . . . 0.0 110.568 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.99 -117.36 0.24 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.97 27.02 1.83 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -1.156 . . . . 0.0 110.392 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.621 ' CG ' ' CZ ' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -163.37 -179.29 6.44 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.18 -0.95 . . . . 0.0 109.998 179.593 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -135.23 19.25 3.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -0.95 . . . . 0.0 110.302 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.05 49.31 0.85 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 110.433 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.621 ' CZ ' ' CG ' ' A' ' 18' ' ' GLU . 13.1 m-85 -50.42 165.69 0.09 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.066 -1.021 . . . . 0.0 109.443 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.503 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 10.1 p -131.78 -70.25 0.58 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.016 -1.053 . . . . 0.0 110.837 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.423 ' OD1' ' HA ' ' A' ' 46' ' ' SER . 4.9 t0 -159.56 137.46 10.15 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.332 -0.855 . . . . 0.0 109.663 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 79.35 13.92 82.15 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.614 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -96.65 171.81 8.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.518 -0.99 . . . . 0.0 109.828 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.834 HG13 ' O ' ' A' ' 43' ' ' VAL . 39.5 t -146.76 154.91 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.121 -0.987 . . . . 0.0 110.796 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.642 ' O ' HG23 ' A' ' 43' ' ' VAL . 20.9 t -133.19 117.09 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.613 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.683 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -72.43 102.5 3.2 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 118.45 -1.3 . . . . 0.0 108.032 177.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.663 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.3 m-30 -68.04 174.5 3.76 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.422 -0.799 . . . . 0.0 109.959 -178.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.53 ' CB ' ' HG3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -135.36 148.17 49.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.913 . . . . 0.0 109.606 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.404 ' O ' ' C ' ' A' ' 32' ' ' ASN . 57.7 m -118.62 147.95 43.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.168 -0.958 . . . . 0.0 110.311 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 31' ' ' CYS . 1.8 t-20 -44.27 150.95 0.27 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.217 -0.927 . . . . 0.0 109.944 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 88.2 p -55.35 99.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 0.0 110.31 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 134.68 -20.09 3.92 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -98.76 131.59 44.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.252 -1.146 . . . . 0.0 110.288 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.721 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -79.57 144.24 34.05 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.336 -0.852 . . . . 0.0 111.123 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.625 HD21 ' HA ' ' A' ' 41' ' ' SER . 0.6 OUTLIER -91.99 102.09 14.64 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.475 -0.766 . . . . 0.0 109.205 178.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.79 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -90.9 142.68 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.077 -1.015 . . . . 0.0 109.734 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 132.35 -158.94 23.2 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.493 ' O ' ' C ' ' A' ' 41' ' ' SER . 0.3 OUTLIER -98.31 49.34 0.99 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.842 -1.387 . . . . 0.0 109.65 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.683 ' O ' HG23 ' A' ' 28' ' ' THR . 0.4 OUTLIER 27.89 57.29 0.1 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.331 179.654 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.581 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 155.63 117.23 0.57 Allowed Glycine 0 N--CA 1.488 2.166 0 C-N-CA 119.465 -1.35 . . . . 0.0 110.023 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.834 ' O ' HG13 ' A' ' 26' ' ' VAL . 2.0 t -62.71 -178.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.991 -1.3 . . . . 0.0 108.013 178.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.555 ' H ' HG12 ' A' ' 43' ' ' VAL . 4.3 tp -144.45 95.11 2.66 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.014 -1.074 . . . . 0.0 110.508 178.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.574 ' SG ' ' CD2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -80.92 110.3 16.31 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.379 178.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.423 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 8.0 t -126.57 111.04 13.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.592 -0.692 . . . . 0.0 110.643 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.07 22.5 38.17 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.454 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 81.01 19.86 66.43 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -140.64 113.64 8.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.099 -1.236 . . . . 0.0 110.526 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.574 ' CD2' ' SG ' ' A' ' 45' ' ' CYS . 87.8 m95 -62.58 138.11 58.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.317 -0.864 . . . . 0.0 109.73 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 52' ' ' ASP . 3.5 m -141.84 171.61 13.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.102 -0.999 . . . . 0.0 111.417 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.465 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER 37.29 67.65 1.82 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.912 -0.493 . . . . 0.0 111.593 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.465 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.0 Cg_endo -90.66 144.03 3.65 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 O-C-N 124.327 1.698 . . . . 0.0 109.592 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.518 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 45.9 Cg_endo -74.68 171.26 18.55 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.618 1.325 . . . . 0.0 110.35 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.582 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 15.7 p -114.18 169.16 9.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.163 -0.961 . . . . 0.0 111.468 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 10' ' ' SER . 37.8 m -126.73 79.32 1.86 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -114.82 -170.8 1.81 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 120.161 -0.615 . . . . 0.0 110.135 -178.746 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.606 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -107.92 112.87 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.192 -0.943 . . . . 0.0 108.504 179.221 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.84 ' O ' HG23 ' A' ' 59' ' ' VAL . 6.0 m -95.92 83.14 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.051 -1.031 . . . . 0.0 111.612 -178.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.2 mtmt -120.31 96.36 5.11 Favored 'General case' 0 C--N 1.289 -2.059 0 O-C-N 120.417 -1.427 . . . . 0.0 108.657 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 79' ' ' TYR . 4.5 p -68.06 162.52 59.03 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.412 -0.805 . . . . 0.0 111.659 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.515 ' HD2' ' HA ' ' A' ' 108' ' ' THR . 42.9 Cg_endo -70.47 -89.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.832 0 O-C-N 124.696 1.892 . . . . 0.0 110.286 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.421 ' O ' HG23 ' A' ' 65' ' ' THR . 0.3 OUTLIER -160.51 130.54 3.45 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.612 ' HG3' HG11 ' A' ' 85' ' ' VAL . 50.9 Cg_endo -77.32 70.85 6.61 Favored 'Trans proline' 0 C--N 1.294 -2.322 0 O-C-N 123.787 1.414 . . . . 0.0 109.818 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.669 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.5 OUTLIER -93.45 -175.78 3.91 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.121 -0.987 . . . . 0.0 109.512 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.669 HG22 ' C ' ' A' ' 65' ' ' THR . 0.4 OUTLIER 177.88 167.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.059 -1.026 . . . . 0.0 110.573 178.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.552 ' O ' ' CB ' ' A' ' 68' ' ' ASN . 2.9 m -64.19 73.15 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.568 -0.708 . . . . 0.0 111.323 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 67' ' ' SER . 0.5 OUTLIER 75.2 -16.72 0.55 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.432 -0.793 . . . . 0.0 111.933 179.093 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.604 ' HA2' ' HA ' ' A' ' 89' ' ' CYS . . . -86.32 35.52 3.3 Favored Glycine 0 N--CA 1.491 2.354 0 O-C-N 120.733 -1.23 . . . . 0.0 110.425 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.573 ' O ' ' O ' ' A' ' 69' ' ' GLY . 2.2 p90 -43.15 -173.49 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 122.712 1.244 . . . . 0.0 112.526 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.724 ' H ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -113.31 161.49 17.18 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.272 178.795 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.8 t -146.97 22.07 1.23 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.173 -0.954 . . . . 0.0 109.917 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.39 -51.37 2.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 0.0 110.898 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.616 ' O ' HG12 ' A' ' 85' ' ' VAL . . . -153.44 88.67 0.13 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.58 ' CE2' ' OH ' ' A' ' 79' ' ' TYR . 1.8 t80 -126.3 117.27 22.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -1.133 . . . . 0.0 110.177 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.62 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 28.2 tttt -113.79 148.06 37.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.201 -0.937 . . . . 0.0 109.656 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.462 ' C ' ' O ' ' A' ' 76' ' ' LYS . 1.3 ttm-85 -42.0 -27.41 0.12 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.968 -1.082 . . . . 0.0 109.873 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 76' ' ' LYS . 40.5 m -140.94 147.12 38.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.525 -0.734 . . . . 0.0 110.283 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.672 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -144.03 178.92 7.53 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.218 -0.926 . . . . 0.0 109.583 179.553 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.57 ' O ' ' O ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -170.43 137.85 1.47 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.067 -1.021 . . . . 0.0 110.315 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.833 ' CB ' HG21 ' A' ' 59' ' ' VAL . 6.6 t80 25.49 105.44 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 120.988 0.423 . . . . 0.0 111.982 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.789 ' O ' HG22 ' A' ' 102' ' ' THR . 10.6 m-20 96.4 -134.86 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 123.373 0.669 . . . . 0.0 109.699 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 52.91 67.65 0.96 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.735 -1.228 . . . . 0.0 108.93 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.645 ' N ' HG23 ' A' ' 102' ' ' THR . 8.1 p30 -69.69 113.04 6.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.556 -0.715 . . . . 0.0 110.969 -178.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.616 HG12 ' O ' ' A' ' 74' ' ' GLY . 30.0 m -94.16 117.58 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.115 -0.991 . . . . 0.0 110.102 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -79.61 131.8 36.09 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.019 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.612 ' CE1' HD12 ' A' ' 71' ' ' LEU . 54.6 m-85 -92.37 116.5 29.03 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.962 -1.087 . . . . 0.0 112.154 -178.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -88.38 94.82 9.97 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.389 179.143 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.604 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 1.7 t -48.17 119.26 2.83 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.036 -1.04 . . . . 0.0 110.466 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.51 ' CG ' ' O ' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -57.17 125.05 20.95 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.227 -0.921 . . . . 0.0 109.96 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.489 ' HB2' ' O ' ' A' ' 90' ' ' LYS . 2.3 m-85 62.44 -174.5 0.14 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.171 -0.956 . . . . 0.0 111.351 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.46 54.73 0.9 Allowed Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.543 ' CB ' ' SG ' ' A' ' 116' ' ' CYS . 5.5 m-85 -106.34 158.08 17.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.325 -1.103 . . . . 0.0 109.448 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.593 ' O ' HG22 ' A' ' 117' ' ' VAL . 9.6 mtmm -99.9 141.6 32.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.073 -1.017 . . . . 0.0 109.655 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.54 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 1.2 mt -87.2 94.11 9.57 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.581 -1.325 . . . . 0.0 110.057 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.565 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -69.61 101.14 1.57 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.233 -0.917 . . . . 0.0 109.127 179.38 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.13 -96.75 0.21 Allowed Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.202 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.596 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 3.3 m -150.19 116.59 5.75 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.165 -1.197 . . . . 0.0 110.577 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.411 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 42.8 p -77.17 10.3 2.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.235 -0.915 . . . . 0.0 111.293 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 77.0 p -154.42 99.4 2.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.849 -1.157 . . . . 0.0 110.48 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 3.5 m -111.57 -174.43 2.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.367 -0.833 . . . . 0.0 110.056 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.789 HG22 ' O ' ' A' ' 82' ' ' ASN . 5.8 m -155.88 144.19 20.03 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.481 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.616 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 42.7 t -65.07 86.15 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.672 -0.642 . . . . 0.0 109.386 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.456 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -62.56 176.57 0.49 Allowed Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.194 -0.941 . . . . 0.0 112.731 -178.148 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.79 ' CB ' HD12 ' A' ' 38' ' ' ILE . 46.5 Cg_endo -80.37 12.5 2.52 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 124.848 1.973 . . . . 0.0 111.777 -178.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -118.46 18.22 11.04 Favored Glycine 0 C--N 1.294 -1.757 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.718 ' O ' HG23 ' A' ' 108' ' ' THR . 1.2 m120 65.22 66.99 0.53 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.696 -0.885 . . . . 0.0 109.796 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.718 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -168.59 -172.84 1.75 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.227 -0.989 . . . . 0.0 111.497 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.616 ' CZ3' ' N ' ' A' ' 103' ' ' CYS . 41.2 m95 -123.3 95.68 4.69 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.571 0.7 . . . . 0.0 110.132 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.552 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -108.33 146.09 32.87 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.537 -0.727 . . . . 0.0 110.249 -179.537 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.596 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 44.3 Cg_endo -72.65 173.37 54.31 Favored 'Cis proline' 0 C--N 1.315 -1.235 0 C-N-CA 121.697 -2.21 . . . . 0.0 110.534 -0.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.3 mm-40 -36.93 131.05 0.76 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.657 -0.652 . . . . 0.0 111.551 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.57 HD23 ' O ' ' A' ' 65' ' ' THR . 0.2 OUTLIER -43.93 154.5 0.37 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.482 -0.761 . . . . 0.0 109.749 179.003 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.574 ' O ' HD12 ' A' ' 66' ' ' ILE . 41.4 Cg_endo -83.59 171.67 10.77 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 O-C-N 124.092 1.575 . . . . 0.0 111.433 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.565 ' HB3' ' CB ' ' A' ' 96' ' ' SER . 3.3 ttpt -129.82 109.65 11.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.366 -0.834 . . . . 0.0 110.2 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.543 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.0 OUTLIER -69.12 108.54 3.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.153 -0.967 . . . . 0.0 109.257 179.715 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -118.95 -174.54 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.635 0.731 . . . . 0.0 110.195 -179.274 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.409 ' HG2' ' CZ ' ' A' ' 93' ' ' TYR . 26.4 mtm180 . . . . . 0 C--N 1.292 -1.9 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.221 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 53.8 t . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.247 0.546 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.624 ' HA ' HG22 ' A' ' 22' ' ' THR . 0.1 OUTLIER -136.17 100.2 4.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.329 -0.857 . . . . 0.0 110.387 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.559 ' O ' ' N ' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -69.72 88.22 0.52 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.213 -0.929 . . . . 0.0 109.779 179.566 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.469 ' O ' ' C ' ' A' ' 5' ' ' SER . 1.1 pt20 -85.43 -174.02 4.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.04 -1.037 . . . . 0.0 110.064 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.469 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.3 OUTLIER -38.3 127.39 1.07 Allowed Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 120.306 -0.557 . . . . 0.0 109.569 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.652 ' HG3' HG11 ' A' ' 27' ' ' VAL . 45.6 Cg_endo -66.31 154.76 72.96 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.902 1.475 . . . . 0.0 111.509 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -75.49 171.52 18.07 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.115 1.587 . . . . 0.0 110.487 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.69 176.0 3.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 110.014 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.639 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -141.57 -170.28 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-O 122.143 0.973 . . . . 0.0 111.463 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.8 OUTLIER -40.78 95.26 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.26 -179.468 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.49 ' N ' ' O ' ' A' ' 9' ' ' ILE . 2.4 m-20 43.08 41.39 2.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 110.352 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' A' ' 30' ' ' SER . . . -146.11 158.23 27.62 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.521 ' HG3' ' CB ' ' A' ' 30' ' ' SER . 4.5 ptt180 -113.82 -179.85 3.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.233 -1.157 . . . . 0.0 110.325 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.623 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 11.5 p80 -128.98 133.42 47.78 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.629 -0.669 . . . . 0.0 110.049 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -136.62 96.36 3.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.052 -1.03 . . . . 0.0 110.877 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.22 179.59 30.99 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -105.91 46.16 0.94 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.078 -1.248 . . . . 0.0 110.245 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.602 ' CG ' ' CZ ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -175.82 -159.7 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.924 . . . . 0.0 110.392 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.5 -27.41 1.05 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.434 -0.791 . . . . 0.0 110.81 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.416 ' C ' ' OE2' ' A' ' 18' ' ' GLU . 25.8 m-85 -109.74 101.98 10.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.02 -1.05 . . . . 0.0 110.849 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.634 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 2.5 m-85 -102.4 44.9 0.99 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.57 -0.706 . . . . 0.0 109.604 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.624 HG22 ' HA ' ' A' ' 2' ' ' LYS . 24.9 p -53.98 99.8 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.1 0.952 . . . . 0.0 111.718 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.533 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 9.8 t70 50.15 165.28 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 121.794 0.807 . . . . 0.0 111.905 178.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.501 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 46.32 26.15 2.24 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.634 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 35.5 m -109.6 154.88 22.15 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.387 -1.066 . . . . 0.0 110.263 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.877 HG13 ' O ' ' A' ' 43' ' ' VAL . 50.5 t -139.14 153.91 25.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.411 -0.915 . . . . 0.0 110.608 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 1.004 ' O ' HG23 ' A' ' 43' ' ' VAL . 28.7 t -141.55 117.39 6.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.384 -0.927 . . . . 0.0 111.245 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.617 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -69.34 102.97 1.86 Allowed 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 118.469 -1.292 . . . . 0.0 107.669 178.256 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 1.039 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.5 m-30 -67.89 177.99 1.93 Allowed 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.749 -0.781 . . . . 0.0 109.979 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.521 ' CB ' ' HG3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -140.77 151.2 44.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 109.708 179.727 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.418 ' O ' ' C ' ' A' ' 32' ' ' ASN . 87.6 m -122.67 149.66 43.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.159 -0.963 . . . . 0.0 110.693 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.418 ' C ' ' O ' ' A' ' 31' ' ' CYS . 5.4 p-10 -42.48 145.55 0.41 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.46 -0.775 . . . . 0.0 110.175 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.4 129.17 31.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.187 -0.946 . . . . 0.0 110.486 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.87 -27.79 15.17 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 -89.39 162.81 15.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.103 -1.233 . . . . 0.0 110.349 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.848 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.9 OUTLIER -103.29 147.33 27.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.406 -0.809 . . . . 0.0 110.964 -179.158 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.663 ' O ' HD23 ' A' ' 37' ' ' LEU . 6.3 tt -100.99 96.35 7.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.307 -0.871 . . . . 0.0 109.688 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.842 HD11 ' HB2' ' A' ' 36' ' ' SER . 0.3 OUTLIER -93.13 139.64 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 109.09 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 150.91 -126.97 2.23 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.506 ' O ' ' C ' ' A' ' 41' ' ' SER . 4.6 m120 -135.16 50.15 2.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -1.164 . . . . 0.0 109.54 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.617 ' O ' HG23 ' A' ' 28' ' ' THR . 2.1 p 25.46 54.84 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.345 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.501 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 150.86 113.42 0.6 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.039 HG21 ' CE1' ' A' ' 29' ' ' TYR . 1.9 t -64.65 -177.99 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.161 -1.2 . . . . 0.0 107.821 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.531 ' HA ' ' O ' ' A' ' 25' ' ' SER . 2.3 tp -146.65 97.89 2.98 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.286 -0.966 . . . . 0.0 110.702 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.595 ' SG ' ' CD2' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -75.08 114.1 13.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.081 -1.012 . . . . 0.0 109.165 178.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 85.1 p -129.73 92.74 3.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.57 -0.706 . . . . 0.0 110.219 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.99 39.42 2.68 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.04 11.92 53.11 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -133.3 120.16 20.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -1.183 . . . . 0.0 110.316 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.616 ' CH2' HG23 ' A' ' 27' ' ' VAL . 73.7 m95 -62.93 137.97 58.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.284 -0.885 . . . . 0.0 109.829 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.2 m -136.63 163.99 29.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.153 -0.967 . . . . 0.0 111.032 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.481 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 3.8 m-20 53.45 66.13 4.94 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.615 -0.678 . . . . 0.0 111.198 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.481 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.7 Cg_endo -90.37 135.85 2.23 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 O-C-N 124.288 1.678 . . . . 0.0 109.643 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.574 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 42.3 Cg_endo -71.54 178.61 5.46 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.591 1.311 . . . . 0.0 110.378 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 5.3 p -121.99 163.13 19.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.372 -0.83 . . . . 0.0 112.028 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 10' ' ' SER . 86.9 m -116.57 85.59 2.34 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -120.32 -141.23 0.34 Allowed 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.45 0.643 . . . . 0.0 110.405 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.714 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -136.32 127.13 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.297 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.848 HG13 ' CB ' ' A' ' 36' ' ' SER . 34.0 m -123.08 49.28 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.031 -1.043 . . . . 0.0 111.61 -178.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 15.0 mtmt -55.99 -179.17 0.02 OUTLIER 'General case' 0 C--N 1.28 -2.431 0 C-N-CA 117.988 -1.485 . . . . 0.0 107.978 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.554 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -145.38 163.39 32.33 Favored Pre-proline 0 C--N 1.297 -1.705 0 C-N-CA 118.707 -1.197 . . . . 0.0 112.297 -179.048 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 42.8 Cg_endo -83.66 -71.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.748 1.92 . . . . 0.0 109.639 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.551 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 162.02 129.46 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.57 ' N ' ' NE1' ' A' ' 109' ' ' TRP . 49.7 Cg_endo -77.12 69.43 7.07 Favored 'Trans proline' 0 C--N 1.299 -2.065 0 O-C-N 123.721 1.38 . . . . 0.0 110.178 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.883 ' O ' HD23 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -99.38 139.31 35.22 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.884 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -131.71 159.29 43.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 C-N-CA 118.594 -1.243 . . . . 0.0 111.057 -178.712 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.472 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 0.1 OUTLIER -58.66 111.85 1.41 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.752 -0.592 . . . . 0.0 111.239 -179.339 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.408 ' O ' ' HG3' ' A' ' 90' ' ' LYS . 1.2 m-20 51.32 25.04 2.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.298 -0.876 . . . . 0.0 109.756 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.55 ' C ' HG23 ' A' ' 66' ' ' ILE . . . -132.45 -177.41 14.9 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.59 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 37.1 p90 -178.54 -172.59 0.29 Allowed 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.541 -0.976 . . . . 0.0 109.388 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.764 HD22 ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -126.44 151.49 47.67 Favored 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.709 178.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.2 t -113.65 -6.72 13.35 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.943 -1.098 . . . . 0.0 109.927 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.93 -80.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.378 -0.826 . . . . 0.0 110.259 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -169.79 93.03 0.1 Allowed Glycine 0 N--CA 1.488 2.162 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.167 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.598 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -86.22 174.95 8.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.359 -1.083 . . . . 0.0 109.171 179.219 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.566 ' N ' ' CG ' ' A' ' 75' ' ' PHE . 4.7 tttt -159.68 159.5 33.05 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.317 -0.864 . . . . 0.0 110.256 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.67 -39.63 17.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.898 . . . . 0.0 109.867 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.58 136.66 18.49 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.507 -0.746 . . . . 0.0 110.099 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.598 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 43.6 m-85 -99.29 -162.17 0.93 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.916 . . . . 0.0 109.774 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.627 ' CA ' HG23 ' A' ' 59' ' ' VAL . 85.6 p -146.59 -104.45 0.1 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -0.895 . . . . 0.0 109.083 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.609 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -111.91 145.14 40.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.818 -1.177 . . . . 0.0 107.904 178.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.897 ' C ' HG22 ' A' ' 102' ' ' THR . 1.6 m120 61.32 -99.43 0.09 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.375 -0.828 . . . . 0.0 110.153 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.476 ' HB2' ' HB3' ' A' ' 103' ' ' CYS . 10.3 m-20 41.14 79.48 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.995 -1.066 . . . . 0.0 109.238 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.765 ' CA ' HG23 ' A' ' 102' ' ' THR . 21.5 t-20 -75.39 143.85 42.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.389 -0.819 . . . . 0.0 112.286 -177.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.84 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 4.5 m -132.37 115.07 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.437 -0.789 . . . . 0.0 109.44 177.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.553 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 2.7 t70 -75.54 134.64 40.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.315 -0.866 . . . . 0.0 108.992 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.68 ' CE1' HD12 ' A' ' 71' ' ' LEU . 45.0 m-85 -94.63 142.47 27.4 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 118.682 -1.207 . . . . 0.0 112.253 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.564 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -120.12 98.71 6.2 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.581 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.686 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -46.92 129.49 11.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.133 -0.979 . . . . 0.0 110.457 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.435 ' O ' ' O ' ' A' ' 89' ' ' CYS . 6.8 mmtp -44.37 -92.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.29 -0.881 . . . . 0.0 110.173 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.556 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 1.9 t80 -152.73 158.81 42.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.211 -0.931 . . . . 0.0 110.049 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.588 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 45.31 25.85 1.32 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.588 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 18.0 m-85 -141.45 147.39 37.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.401 -1.058 . . . . 0.0 110.395 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.1 ptmm? -117.83 129.96 55.98 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.294 -0.879 . . . . 0.0 109.897 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.686 HD11 ' H ' ' A' ' 89' ' ' CYS . 1.2 mt -57.12 103.0 0.1 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.186 -0.946 . . . . 0.0 110.8 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.697 ' HB2' HG21 ' A' ' 117' ' ' VAL . 3.0 t -85.96 91.36 8.35 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.22 -0.925 . . . . 0.0 109.053 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 152.2 -91.27 0.13 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.575 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -149.41 118.85 6.89 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.159 -1.2 . . . . 0.0 110.83 -179.432 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.541 ' HB3' HD13 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -80.88 13.71 2.54 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.25 -0.906 . . . . 0.0 110.918 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 60.2 p -152.91 113.41 4.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.123 -0.985 . . . . 0.0 109.72 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.517 ' HG ' ' HE2' ' A' ' 87' ' ' PHE . 13.0 m -124.6 -177.36 3.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 110.971 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.897 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -153.49 128.2 9.43 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.685 0.755 . . . . 0.0 110.21 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.587 ' N ' ' O ' ' A' ' 82' ' ' ASN . 4.7 t -66.09 81.5 0.08 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.476 ' HA ' ' H ' ' A' ' 82' ' ' ASN . 0.4 OUTLIER -64.38 173.75 1.41 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.342 -0.849 . . . . 0.0 110.988 -179.152 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.799 ' HG3' HG23 ' A' ' 38' ' ' ILE . 41.7 Cg_endo -73.18 120.49 6.6 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 O-C-N 124.586 1.835 . . . . 0.0 110.859 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.557 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 131.51 -6.06 5.57 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.824 ' O ' HG23 ' A' ' 108' ' ' THR . 1.6 m-20 81.0 93.61 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.916 -0.755 . . . . 0.0 111.361 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.824 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 175.02 -168.34 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.475 -0.766 . . . . 0.0 111.198 179.024 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.84 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 36.9 m95 -142.14 94.08 2.62 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.579 -0.7 . . . . 0.0 110.03 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.562 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 14.7 mmtt -103.61 147.17 33.82 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.367 -0.833 . . . . 0.0 110.086 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.575 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.1 Cg_endo -71.98 175.27 43.53 Favored 'Cis proline' 0 N--CA 1.49 1.28 0 C-N-CA 121.956 -2.102 . . . . 0.0 110.956 0.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 113' ' ' LEU . 12.7 pt-20 -37.68 122.39 0.95 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.684 -0.635 . . . . 0.0 110.986 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.883 HD23 ' O ' ' A' ' 65' ' ' THR . 0.9 OUTLIER -41.24 141.14 1.1 Allowed Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.517 -0.739 . . . . 0.0 110.174 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.884 ' HG2' HD12 ' A' ' 66' ' ' ILE . 40.4 Cg_endo -69.8 159.42 53.43 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 124.206 1.635 . . . . 0.0 110.851 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.565 ' HG2' HG13 ' A' ' 117' ' ' VAL . 3.2 ttpm? -119.43 101.34 7.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.919 . . . . 0.0 110.281 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.534 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 4.6 t -61.77 82.3 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.052 -1.03 . . . . 0.0 108.894 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.697 HG21 ' HB2' ' A' ' 96' ' ' SER . 4.5 m -96.48 -171.61 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-O 121.942 0.877 . . . . 0.0 111.37 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.413 ' HG2' ' CE1' ' A' ' 93' ' ' TYR . 9.0 mtm180 . . . . . 0 C--N 1.293 -1.877 0 C-N-CA 119.152 -1.019 . . . . 0.0 110.446 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.642 HG22 ' HA3' ' A' ' 48' ' ' GLY . 4.7 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.227 0.537 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -141.51 176.67 8.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.197 -0.939 . . . . 0.0 110.388 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.536 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.1 m -130.13 87.74 2.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.406 -0.809 . . . . 0.0 110.37 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -70.86 175.4 5.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.815 -1.178 . . . . 0.0 109.926 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -44.09 141.41 2.47 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.31 -0.868 . . . . 0.0 109.977 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.744 ' HG3' HG11 ' A' ' 27' ' ' VAL . 53.2 Cg_endo -70.71 156.38 60.98 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 124.015 1.534 . . . . 0.0 110.845 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -75.23 174.92 11.97 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.955 1.503 . . . . 0.0 110.093 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.38 -179.92 1.81 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.186 -0.946 . . . . 0.0 110.389 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.679 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -145.11 -170.23 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 122.206 1.003 . . . . 0.0 111.45 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.2 OUTLIER -45.1 92.75 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.387 -179.597 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.506 ' N ' ' O ' ' A' ' 9' ' ' ILE . 27.6 m-20 42.62 53.19 4.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.271 -0.893 . . . . 0.0 110.205 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.14 163.66 32.01 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 30' ' ' SER . 10.1 ptp180 -114.92 -178.38 3.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -1.148 . . . . 0.0 110.438 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.62 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 18.1 p80 -136.67 124.21 22.22 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.67 -0.644 . . . . 0.0 110.107 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -133.74 96.12 3.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 110.53 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.25 16.72 58.84 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.426 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 5.7 m-85 53.36 56.46 7.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.356 -1.084 . . . . 0.0 110.162 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.473 ' CD ' ' CE2' ' A' ' 21' ' ' TYR . 0.3 OUTLIER 179.93 -165.25 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.341 -0.849 . . . . 0.0 110.096 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -138.48 -39.98 0.51 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 109.815 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -110.64 136.03 50.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.406 -0.809 . . . . 0.0 109.721 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.645 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.4 OUTLIER -122.27 -7.01 8.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.921 . . . . 0.0 110.605 -179.541 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.536 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 38.2 p 46.06 -95.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.6 -0.687 . . . . 0.0 111.824 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.413 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 1.0 OUTLIER -153.95 151.21 29.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.772 -1.205 . . . . 0.0 110.637 -178.732 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.57 29.92 54.35 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.645 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -121.79 169.7 10.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.356 -1.084 . . . . 0.0 110.552 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.788 HG13 ' O ' ' A' ' 43' ' ' VAL . 24.2 t -142.52 156.29 18.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.888 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.744 HG11 ' HG3' ' A' ' 6' ' ' PRO . 11.9 t -131.19 124.75 56.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.433 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.85 101.91 8.81 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 118.541 -1.264 . . . . 0.0 107.613 177.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.69 ' O ' HD13 ' A' ' 37' ' ' LEU . 1.8 m-30 -68.29 122.11 17.67 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.644 -0.823 . . . . 0.0 110.024 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -86.61 144.69 27.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -0.975 . . . . 0.0 109.574 179.423 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.498 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 33.9 m -102.48 171.43 7.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.152 -0.968 . . . . 0.0 110.563 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -72.03 163.87 27.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -0.894 . . . . 0.0 110.096 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.48 99.84 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 0.0 110.693 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.99 19.29 9.16 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.498 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 6.9 m-85 -117.17 124.47 49.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.049 -1.265 . . . . 0.0 110.185 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.632 ' OG ' HG21 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -74.88 140.5 43.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.35 -0.844 . . . . 0.0 111.261 -179.549 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.69 HD13 ' O ' ' A' ' 29' ' ' TYR . 2.7 tp -92.63 106.95 18.84 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.515 -0.741 . . . . 0.0 109.35 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.746 HD12 ' HB3' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -98.43 155.91 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.151 -0.968 . . . . 0.0 109.394 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.67 175.87 38.44 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.462 ' O ' ' HG3' ' A' ' 54' ' ' PRO . 2.5 m120 -50.82 143.69 9.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -1.152 . . . . 0.0 109.873 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 76.2 p -80.09 51.94 1.45 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -0.95 . . . . 0.0 110.161 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.554 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 161.23 122.87 0.64 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.788 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.4 t -65.62 177.45 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.108 -1.231 . . . . 0.0 108.423 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.534 HD22 ' C ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -141.34 93.4 2.57 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.416 179.308 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.617 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -81.51 110.65 17.1 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.935 -1.106 . . . . 0.0 109.122 178.695 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.33 97.15 3.22 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.568 -0.708 . . . . 0.0 110.034 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.413 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 108.8 39.58 1.7 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.642 ' HA3' HG22 ' A' ' 1' ' ' VAL . . . 60.84 27.7 67.18 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 48' ' ' GLY . 2.7 mt-10 -154.1 132.46 11.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.193 -1.181 . . . . 0.0 110.396 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.617 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 84.8 m95 -82.34 142.85 31.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.882 . . . . 0.0 109.546 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.7 166.1 25.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.902 -1.124 . . . . 0.0 111.499 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.502 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.4 OUTLIER 44.96 65.98 5.72 Favored Pre-proline 0 N--CA 1.496 1.829 0 CA-C-O 121.146 0.498 . . . . 0.0 111.554 179.439 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.502 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.9 Cg_endo -91.33 130.89 1.35 Allowed 'Trans proline' 0 C--N 1.299 -2.04 0 O-C-N 124.342 1.706 . . . . 0.0 109.713 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.479 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.3 Cg_endo -77.47 158.94 32.64 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 123.752 1.396 . . . . 0.0 110.183 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.611 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 38.8 p -99.43 164.18 12.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.246 -0.909 . . . . 0.0 111.184 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 10' ' ' SER . 13.9 m -129.15 74.44 1.58 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.542 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -110.32 -175.43 2.73 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.563 0.697 . . . . 0.0 110.711 -178.025 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.595 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -96.26 128.77 47.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.647 HG23 ' CA ' ' A' ' 80' ' ' SER . 30.7 m -118.55 41.64 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.065 -1.022 . . . . 0.0 111.229 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 0.9 OUTLIER -52.75 179.42 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.323 0 C-N-CA 118.369 -1.333 . . . . 0.0 108.293 179.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.473 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -141.73 169.64 10.8 Favored Pre-proline 0 C--N 1.298 -1.643 0 C-N-CA 118.272 -1.371 . . . . 0.0 113.654 -178.015 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.437 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 46.6 Cg_endo -90.27 -75.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.393 2.062 . . . . 0.0 110.688 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.437 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 170.26 125.31 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.689 -0.632 . . . . 0.0 109.453 -179.125 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.662 ' HA ' HD21 ' A' ' 113' ' ' LEU . 55.3 Cg_endo -77.94 65.73 8.26 Favored 'Trans proline' 0 C--N 1.299 -2.065 0 O-C-N 123.74 1.389 . . . . 0.0 110.171 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.699 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -83.89 -179.1 7.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.38 -0.825 . . . . 0.0 109.629 179.504 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.742 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -179.56 169.49 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.045 -1.035 . . . . 0.0 110.628 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.523 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -74.21 105.76 5.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.572 -0.705 . . . . 0.0 111.037 -179.621 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 33.0 m120 38.47 38.35 0.23 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.587 -0.696 . . . . 0.0 111.129 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.708 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -144.58 27.85 1.93 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.533 ' O ' ' O ' ' A' ' 69' ' ' GLY . 12.4 p90 -43.64 -175.58 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.653 1.216 . . . . 0.0 112.501 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.825 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -112.72 157.52 21.2 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.579 179.234 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.7 t -138.69 23.12 2.68 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.932 -1.105 . . . . 0.0 109.806 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -100.93 -79.03 0.51 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.389 -0.819 . . . . 0.0 111.024 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -131.26 78.41 0.37 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -102.46 169.96 8.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.406 -1.055 . . . . 0.0 109.65 179.525 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.603 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 4.8 tttm -169.39 159.09 8.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.307 -0.871 . . . . 0.0 110.234 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.49 -40.08 11.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.365 -0.834 . . . . 0.0 110.091 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.504 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 0.3 OUTLIER -141.59 172.31 12.86 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.477 -0.765 . . . . 0.0 110.049 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.597 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 6.5 m-85 -141.63 -156.18 0.66 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.328 -0.857 . . . . 0.0 109.949 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.647 ' CA ' HG23 ' A' ' 59' ' ' VAL . 5.4 m -150.72 -111.32 0.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.953 -1.092 . . . . 0.0 110.929 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.619 ' O ' ' CG ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -110.32 18.48 19.83 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.691 -1.256 . . . . 0.0 110.509 -179.145 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.659 ' C ' HG22 ' A' ' 102' ' ' THR . 17.7 p-10 -158.02 -114.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.797 -1.189 . . . . 0.0 110.357 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.9 t0 49.85 73.55 0.25 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.738 -1.226 . . . . 0.0 109.2 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.866 ' CA ' HG23 ' A' ' 102' ' ' THR . 9.4 p30 -69.35 120.69 15.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.306 -0.871 . . . . 0.0 110.252 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.577 HG11 ' HG3' ' A' ' 64' ' ' PRO . 16.1 m -101.34 120.28 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.06 -1.025 . . . . 0.0 110.511 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.417 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -83.22 125.98 32.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.235 -0.915 . . . . 0.0 108.534 179.112 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.825 ' CE1' HD12 ' A' ' 71' ' ' LEU . 72.8 m-85 -86.97 139.21 30.82 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 122.185 0.993 . . . . 0.0 111.827 -178.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -114.43 91.56 3.67 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.809 -179.383 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.531 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -43.35 127.24 4.52 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.259 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 3.3 mmtt -35.58 -77.19 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.682 -178.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.571 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.3 OUTLIER -167.42 135.5 2.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.364 -0.835 . . . . 0.0 110.168 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.583 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 60.27 47.77 89.43 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.583 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 24.3 m-85 -154.28 157.4 38.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.512 -0.993 . . . . 0.0 109.764 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.562 ' O ' HG22 ' A' ' 117' ' ' VAL . 36.6 mtpt -118.38 122.26 42.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 110.063 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.674 HD23 HD11 ' A' ' 66' ' ' ILE . 10.1 mt -60.26 104.61 0.33 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.153 -0.967 . . . . 0.0 110.429 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.624 ' HB2' HG21 ' A' ' 117' ' ' VAL . 12.7 t -92.66 101.98 14.4 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.357 -0.839 . . . . 0.0 109.842 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 98' ' ' SER . . . 146.76 -56.28 0.51 Allowed Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.78 -1.2 . . . . 0.0 110.224 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.563 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 58.8 p 179.49 99.06 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.285 -1.126 . . . . 0.0 110.913 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 53.1 m -65.36 -18.39 65.28 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.121 -0.987 . . . . 0.0 110.372 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.6 p -137.08 101.17 4.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.158 -0.964 . . . . 0.0 109.626 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 85' ' ' VAL . 3.2 m -113.29 168.22 9.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.361 -0.837 . . . . 0.0 111.059 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.866 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -139.74 142.29 36.82 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.58 0.705 . . . . 0.0 110.083 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.599 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -73.25 94.77 2.03 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.555 -0.716 . . . . 0.0 110.663 -179.511 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.536 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -69.4 -175.41 0.27 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.375 -0.828 . . . . 0.0 110.959 -179.739 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.746 ' HB3' HD12 ' A' ' 38' ' ' ILE . 43.2 Cg_endo -81.42 128.52 6.24 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.343 1.707 . . . . 0.0 110.753 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 123.56 -7.65 8.96 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.746 ' O ' HG23 ' A' ' 108' ' ' THR . 1.3 m120 80.92 96.01 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.642 0.734 . . . . 0.0 111.111 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.746 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 176.25 -159.2 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.485 -0.76 . . . . 0.0 110.654 179.341 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.744 ' HB3' HD13 ' A' ' 113' ' ' LEU . 22.6 m95 -145.84 89.95 1.94 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.39 -0.819 . . . . 0.0 110.172 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.517 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 13.6 mttm -100.62 142.77 25.27 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.562 -0.711 . . . . 0.0 110.531 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.563 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.4 Cg_endo -74.19 172.47 61.74 Favored 'Cis proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.68 -2.217 . . . . 0.0 110.266 -0.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.3 mp0 -37.6 127.41 1.13 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.466 -0.771 . . . . 0.0 111.439 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.744 HD13 ' HB3' ' A' ' 109' ' ' TRP . 0.2 OUTLIER -40.74 150.39 0.29 Allowed Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.492 -0.755 . . . . 0.0 110.192 179.116 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.742 ' HG2' HD12 ' A' ' 66' ' ' ILE . 39.6 Cg_endo -76.01 165.95 28.87 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 O-C-N 124.177 1.619 . . . . 0.0 110.937 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.539 ' O ' HG22 ' A' ' 117' ' ' VAL . 12.5 ttpt -129.84 101.8 6.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.268 -0.895 . . . . 0.0 110.034 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.529 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.2 t -55.59 91.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.098 -1.001 . . . . 0.0 109.377 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.624 HG21 ' HB2' ' A' ' 96' ' ' SER . 1.5 m -104.8 -177.79 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 121.714 0.768 . . . . 0.0 110.641 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.517 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 5.0 ptt-85 . . . . . 0 C--N 1.295 -1.776 0 C-N-CA 119.014 -1.075 . . . . 0.0 110.549 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 54.4 t . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.318 0.58 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.75 170.3 10.24 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.242 -0.911 . . . . 0.0 110.419 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.579 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.2 m -125.44 142.14 51.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.411 -0.806 . . . . 0.0 109.531 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 4.6 mp0 -113.0 175.86 5.26 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.015 -1.053 . . . . 0.0 109.807 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.57 140.87 56.55 Favored Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 121.298 -0.876 . . . . 0.0 109.734 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.815 ' HG3' HG11 ' A' ' 27' ' ' VAL . 49.2 Cg_endo -71.49 153.25 60.6 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 O-C-N 124.023 1.538 . . . . 0.0 110.717 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.61 173.01 14.59 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.863 1.454 . . . . 0.0 110.009 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.61 176.44 3.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.917 . . . . 0.0 109.935 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.68 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -143.43 -169.61 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 122.194 0.997 . . . . 0.0 111.336 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 11' ' ' ASN . 0.3 OUTLIER -46.61 93.56 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.683 -179.312 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.46 ' N ' ' O ' ' A' ' 9' ' ' ILE . 4.2 m-80 42.08 53.15 4.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.195 -0.941 . . . . 0.0 110.427 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.05 152.59 24.01 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.461 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -98.14 -167.76 1.56 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -1.147 . . . . 0.0 110.686 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.636 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 20.7 p80 -153.19 113.04 3.9 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.537 0.684 . . . . 0.0 110.191 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.414 ' O ' ' C ' ' A' ' 16' ' ' GLY . 0.9 OUTLIER -138.78 63.57 1.51 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.101 -0.999 . . . . 0.0 110.098 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 17' ' ' TYR . . . -44.01 -77.11 0.1 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.431 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 9.8 t80 -178.01 36.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -1.113 . . . . 0.0 110.197 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.566 ' OE2' ' CG ' ' A' ' 21' ' ' TYR . 2.0 pt-20 178.5 -161.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.89 . . . . 0.0 110.011 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -117.37 -36.84 3.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.227 -0.92 . . . . 0.0 110.286 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.535 ' O ' ' CG ' ' A' ' 20' ' ' PHE . 21.9 p90 -129.99 123.55 30.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.152 -0.967 . . . . 0.0 110.471 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.637 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 14.0 m-85 -92.08 -167.79 1.85 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.451 -0.78 . . . . 0.0 110.27 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.579 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 0.6 OUTLIER -141.84 -64.66 0.43 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.915 -1.116 . . . . 0.0 110.964 -179.483 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 7.8 t0 -169.07 144.37 3.23 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.466 -0.771 . . . . 0.0 109.492 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.449 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 68.47 13.79 65.91 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.637 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 16.2 m -88.94 177.71 6.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.527 -0.984 . . . . 0.0 110.094 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 43' ' ' VAL . 24.4 t -154.15 155.54 6.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.498 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.815 HG11 ' HG3' ' A' ' 6' ' ' PRO . 16.1 t -136.22 114.8 15.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 119.416 -0.914 . . . . 0.0 111.684 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.464 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -71.66 104.56 3.39 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.431 -1.308 . . . . 0.0 107.626 177.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.887 ' O ' HD13 ' A' ' 37' ' ' LEU . 2.1 m-30 -67.79 130.48 43.13 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.135 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 13' ' ' ARG . 1.0 OUTLIER -82.24 160.33 23.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 109.808 179.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 12.4 m -130.45 162.87 28.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.154 -0.966 . . . . 0.0 110.107 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -64.13 152.57 40.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 110.088 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.12 108.72 0.27 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 110.418 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 109.44 -6.76 31.95 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 3.2 m-30 -95.18 128.88 42.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.208 -1.172 . . . . 0.0 110.279 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.587 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -81.94 145.93 30.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.189 -0.945 . . . . 0.0 110.96 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.887 HD13 ' O ' ' A' ' 29' ' ' TYR . 4.5 tp -94.73 98.4 10.75 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.445 -0.784 . . . . 0.0 108.932 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.823 HD12 ' HB2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -91.28 160.51 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.252 -0.905 . . . . 0.0 109.476 -179.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 95.53 -179.33 35.88 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -53.78 142.13 24.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.162 -1.199 . . . . 0.0 109.714 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.464 ' O ' HG23 ' A' ' 28' ' ' THR . 9.6 p -73.62 53.8 0.44 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.935 . . . . 0.0 110.256 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.616 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 148.24 122.9 1.3 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.676 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.6 t -54.87 -179.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.162 -1.199 . . . . 0.0 107.926 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.492 ' H ' HG12 ' A' ' 43' ' ' VAL . 0.3 OUTLIER -143.42 96.75 2.96 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.237 178.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.596 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -81.36 104.86 12.1 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.112 178.604 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.7 p -129.49 102.78 6.54 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.478 -0.764 . . . . 0.0 110.229 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.64 26.13 8.78 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.57 21.66 78.73 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -141.26 110.49 6.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -1.203 . . . . 0.0 110.365 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.596 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 88.2 m95 -64.27 136.6 57.33 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.239 -0.913 . . . . 0.0 109.894 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.429 ' O ' ' HB3' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -143.97 158.79 43.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 110.837 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.488 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 20.7 t0 60.32 66.31 1.96 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.753 -0.592 . . . . 0.0 111.242 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 48.7 Cg_endo -90.71 131.13 1.57 Allowed 'Trans proline' 0 C--N 1.301 -1.973 0 O-C-N 124.342 1.707 . . . . 0.0 109.682 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.548 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.9 Cg_endo -77.0 170.53 19.6 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 O-C-N 123.809 1.426 . . . . 0.0 110.035 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.539 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 12.3 p -113.16 147.87 36.54 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.066 -1.021 . . . . 0.0 111.824 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 36' ' ' SER . 42.2 m -114.11 78.68 1.17 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -114.07 -156.81 0.61 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.324 0.583 . . . . 0.0 110.324 -178.564 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.657 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -109.27 139.7 31.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.341 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.711 ' HB ' ' HA ' ' A' ' 105' ' ' PRO . 34.1 m -130.31 52.67 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 120.889 -1.132 . . . . 0.0 111.525 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 2.9 mptt -81.55 171.01 15.18 Favored 'General case' 0 C--N 1.282 -2.353 0 C-N-CA 118.349 -1.34 . . . . 0.0 107.567 178.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.465 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 60.3 m -140.81 164.74 34.35 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 120.302 -1.499 . . . . 0.0 113.031 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 40.1 Cg_endo -69.55 -86.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 124.886 1.993 . . . . 0.0 110.569 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.463 ' CD2' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -176.02 136.72 0.48 Allowed Pre-proline 0 C--N 1.301 -1.53 0 O-C-N 121.517 -0.739 . . . . 0.0 109.531 -179.616 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.599 ' HG3' ' CZ2' ' A' ' 109' ' ' TRP . 57.6 Cg_endo -86.21 69.9 4.54 Favored 'Trans proline' 0 C--N 1.297 -2.14 0 O-C-N 123.756 1.398 . . . . 0.0 109.599 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.698 ' O ' HG23 ' A' ' 66' ' ' ILE . 3.2 p -84.77 -43.74 13.96 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 122.506 1.146 . . . . 0.0 109.78 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.698 HG23 ' O ' ' A' ' 65' ' ' THR . 0.0 OUTLIER 56.22 160.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.828 -178.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.517 ' N ' HG13 ' A' ' 66' ' ' ILE . 8.1 t -63.7 98.18 0.18 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.479 -0.763 . . . . 0.0 111.345 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.451 ' C ' ' HG3' ' A' ' 90' ' ' LYS . 3.6 m-20 44.72 52.21 7.94 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.4 -0.813 . . . . 0.0 111.255 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.593 ' O ' ' CD2' ' A' ' 70' ' ' TYR . . . -135.32 -39.47 0.17 Allowed Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.308 -1.425 . . . . 0.0 109.635 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 16.2 p90 41.36 -177.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 122.807 1.289 . . . . 0.0 112.222 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.893 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -130.69 153.13 49.3 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.138 -179.047 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.1 t -112.51 -9.47 13.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.65 -1.281 . . . . 0.0 110.781 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.512 ' HB2' ' HB2' ' A' ' 86' ' ' ASP . 11.0 t -55.8 -70.31 0.12 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.175 -0.953 . . . . 0.0 110.269 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.42 101.58 0.15 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.557 ' C ' ' CD1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -98.71 145.24 27.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.312 -1.11 . . . . 0.0 110.005 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.444 ' HG2' ' N ' ' A' ' 77' ' ' ARG . 10.4 tttm -126.16 165.74 18.34 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.438 -0.789 . . . . 0.0 109.419 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.444 ' N ' ' HG2' ' A' ' 76' ' ' LYS . 8.6 mtp180 -56.09 -56.0 26.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.062 -1.024 . . . . 0.0 110.023 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.6 171.28 8.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.467 -0.77 . . . . 0.0 109.948 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.572 ' CD1' ' CZ2' ' A' ' 109' ' ' TRP . 27.1 m-85 -145.03 -179.88 6.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 0.0 110.219 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.534 ' O ' ' HB3' ' A' ' 103' ' ' CYS . 1.5 m -158.49 176.07 12.89 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.156 -0.965 . . . . 0.0 110.981 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.598 ' H ' ' CG2' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -38.57 -24.94 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.83 -0.544 . . . . 0.0 111.546 -178.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.688 ' O ' HG22 ' A' ' 102' ' ' THR . 43.8 t-20 -116.67 -122.48 0.29 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.779 -1.201 . . . . 0.0 110.094 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 51.98 71.08 0.49 Allowed 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.761 -1.212 . . . . 0.0 108.979 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.567 ' N ' HG23 ' A' ' 102' ' ' THR . 9.3 p30 -72.18 152.32 42.33 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.894 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.795 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 0.3 OUTLIER -133.04 121.12 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.337 -0.852 . . . . 0.0 110.261 179.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.547 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 3.3 t0 -81.76 122.01 27.13 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.246 -0.909 . . . . 0.0 109.033 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.893 ' CE1' HD12 ' A' ' 71' ' ' LEU . 28.3 m-85 -80.48 132.52 35.71 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.275 1.035 . . . . 0.0 112.531 -177.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.598 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 4.2 tmtt? -116.41 87.59 2.72 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.046 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.558 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -36.5 131.21 0.68 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.434 -0.791 . . . . 0.0 111.315 -179.349 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.451 ' HG3' ' C ' ' A' ' 68' ' ' ASN . 0.3 OUTLIER -39.01 -93.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.542 -0.724 . . . . 0.0 110.966 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.569 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 77.3 t80 -152.95 120.27 5.89 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.101 -0.999 . . . . 0.0 110.311 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.578 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 72.06 54.74 7.75 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.578 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 63.0 m-85 -159.42 150.76 20.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.482 -1.011 . . . . 0.0 109.925 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.553 ' O ' HG22 ' A' ' 117' ' ' VAL . 7.9 mtmt -104.89 140.53 38.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.237 -0.914 . . . . 0.0 110.252 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.56 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 7.1 mt -80.8 99.79 8.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.89 -1.131 . . . . 0.0 110.267 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 3.7 t -82.39 93.73 7.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.185 -0.947 . . . . 0.0 109.962 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 114' ' ' PRO . . . 154.15 -97.2 0.17 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.615 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 15.3 t -150.79 122.03 7.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.191 -1.182 . . . . 0.0 110.276 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.414 ' O ' ' CD2' ' A' ' 87' ' ' PHE . 79.4 p -58.51 -58.94 6.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.246 -0.909 . . . . 0.0 110.426 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 51.5 p -91.75 138.67 31.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.407 -0.808 . . . . 0.0 110.197 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.547 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 70.7 m -144.58 169.93 17.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.393 -0.817 . . . . 0.0 109.974 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.688 HG22 ' O ' ' A' ' 82' ' ' ASN . 1.8 m -147.88 134.44 19.8 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.32 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 108' ' ' THR . 1.8 t -54.77 87.47 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.51 -0.744 . . . . 0.0 109.502 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -53.05 170.8 0.24 Allowed Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.033 -1.042 . . . . 0.0 112.417 -178.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.823 ' HB2' HD12 ' A' ' 38' ' ' ILE . 51.5 Cg_endo -81.88 15.58 1.92 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 125.012 2.059 . . . . 0.0 111.37 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.555 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -114.59 13.32 20.64 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.862 ' O ' HG23 ' A' ' 108' ' ' THR . 11.1 t30 77.69 62.33 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.892 -0.769 . . . . 0.0 110.351 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.862 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -177.68 178.0 1.05 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 118.818 -1.153 . . . . 0.0 111.891 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.795 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 25.2 m95 -104.2 89.65 3.33 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.233 0.54 . . . . 0.0 110.746 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.544 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 3.8 mmtm -98.01 154.63 37.68 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.222 -0.924 . . . . 0.0 109.502 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.615 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 51.5 Cg_endo -71.71 -174.43 11.48 Favored 'Cis proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.258 -1.976 . . . . 0.0 111.054 -0.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -36.87 120.69 0.73 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.347 0.594 . . . . 0.0 110.762 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.676 HD13 ' HB3' ' A' ' 109' ' ' TRP . 4.2 tp -54.01 138.97 54.64 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.339 -0.851 . . . . 0.0 110.096 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.585 ' HG3' ' CD2' ' A' ' 87' ' ' PHE . 40.6 Cg_endo -70.17 158.81 55.25 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 O-C-N 124.051 1.553 . . . . 0.0 110.565 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.641 ' HG2' HG13 ' A' ' 117' ' ' VAL . 61.5 tttt -126.7 94.05 3.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.665 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.554 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 1.6 t -45.16 96.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.222 -0.924 . . . . 0.0 109.113 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.641 HG13 ' HG2' ' A' ' 115' ' ' LYS . 0.7 OUTLIER -109.93 -173.24 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 121.83 0.824 . . . . 0.0 110.59 -179.262 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.421 ' CG ' ' CE1' ' A' ' 93' ' ' TYR . 11.7 mtp180 . . . . . 0 C--N 1.293 -1.887 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.555 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.169 0.509 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.04 178.46 6.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 110.51 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.591 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 9.2 t -141.26 132.79 26.97 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.457 ' O ' ' C ' ' A' ' 5' ' ' SER . 5.3 mt-30 -115.13 179.27 4.0 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.141 -0.974 . . . . 0.0 110.041 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.2 OUTLIER -40.22 141.04 0.88 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.701 -0.624 . . . . 0.0 109.986 -179.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.759 ' HG3' HG11 ' A' ' 27' ' ' VAL . 50.6 Cg_endo -70.3 154.87 65.24 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 123.993 1.523 . . . . 0.0 111.028 -178.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -75.01 173.57 14.28 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.049 1.552 . . . . 0.0 109.957 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.47 178.42 2.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.222 -0.924 . . . . 0.0 110.16 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.656 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -144.13 -170.09 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.208 1.004 . . . . 0.0 111.196 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 11' ' ' ASN . 21.7 m -44.1 92.56 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.455 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 9' ' ' ILE . 2.3 m-80 43.59 54.04 5.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 110.243 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.456 ' O ' HG13 ' A' ' 9' ' ' ILE . . . -157.71 146.98 14.36 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.55 ' HG2' ' CB ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -97.48 -176.9 3.63 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.331 -1.099 . . . . 0.0 110.335 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.626 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 19.3 p80 -140.15 158.89 43.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.64 -0.662 . . . . 0.0 110.334 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.559 ' HB2' HG13 ' A' ' 27' ' ' VAL . 10.8 m120 -47.71 162.77 0.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.924 . . . . 0.0 110.246 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -156.6 26.12 0.52 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -87.13 14.44 7.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.105 -1.232 . . . . 0.0 110.222 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.548 ' HG3' ' CE2' ' A' ' 21' ' ' TYR . 8.8 pm0 -135.05 -150.31 0.38 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.933 . . . . 0.0 109.994 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 4' ' ' GLN . 2.9 t70 -163.63 -36.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 110.209 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.575 ' CD2' ' O ' ' A' ' 20' ' ' PHE . 16.3 p90 -135.41 81.53 1.9 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.965 . . . . 0.0 109.97 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.614 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 1.6 m-85 -59.27 -23.88 62.75 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.556 -0.715 . . . . 0.0 110.872 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.563 ' N ' ' HB3' ' A' ' 3' ' ' CYS . 91.2 m 58.89 -95.53 0.06 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.377 -0.827 . . . . 0.0 111.424 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 4.3 t0 -147.56 150.28 34.17 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.987 -1.071 . . . . 0.0 110.331 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 77.1 18.9 78.0 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.614 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -103.4 160.2 14.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.571 -0.958 . . . . 0.0 110.563 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.789 HG13 ' O ' ' A' ' 43' ' ' VAL . 39.4 t -141.07 156.92 22.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.418 -0.801 . . . . 0.0 110.522 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.759 HG11 ' HG3' ' A' ' 6' ' ' PRO . 20.0 t -138.03 122.54 22.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 119.186 -1.006 . . . . 0.0 111.691 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.77 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -76.34 103.55 6.42 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.73 ' O ' HD13 ' A' ' 37' ' ' LEU . 2.6 m-30 -68.67 125.6 27.07 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.414 -178.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.55 ' CB ' ' HG2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -92.91 147.16 23.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.155 -0.965 . . . . 0.0 109.621 179.269 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 37' ' ' LEU . 34.0 m -106.63 159.83 15.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.115 -0.991 . . . . 0.0 110.681 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.461 ' O ' ' N ' ' A' ' 34' ' ' GLY . 5.0 t30 -52.06 160.76 0.69 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.361 -0.837 . . . . 0.0 110.007 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.23 79.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 110.537 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 32' ' ' ASN . . . 145.08 -10.42 1.8 Allowed Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.706 -1.235 . . . . 0.0 110.206 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -97.04 137.66 35.78 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.049 -1.265 . . . . 0.0 110.478 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.721 ' HB2' HG13 ' A' ' 59' ' ' VAL . 0.5 OUTLIER -82.68 145.41 29.64 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.394 -0.816 . . . . 0.0 110.914 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.73 HD13 ' O ' ' A' ' 29' ' ' TYR . 9.5 tp -98.41 106.42 18.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.473 -0.767 . . . . 0.0 109.687 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.784 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -101.31 163.31 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.923 . . . . 0.0 109.069 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.19 176.96 44.84 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -55.69 133.1 50.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.236 -1.155 . . . . 0.0 109.846 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.77 ' O ' HG23 ' A' ' 28' ' ' THR . 81.2 p -76.88 54.01 0.97 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -0.949 . . . . 0.0 110.158 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.539 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 167.38 109.56 0.22 Allowed Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.695 -1.241 . . . . 0.0 110.131 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.789 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -58.59 177.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.032 -1.275 . . . . 0.0 108.16 178.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.84 99.79 3.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.158 -0.964 . . . . 0.0 110.259 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.624 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 3.1 t -84.63 111.86 19.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.144 -0.972 . . . . 0.0 109.31 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.6 t -124.84 82.67 2.07 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.166 -0.959 . . . . 0.0 110.395 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.16 45.06 1.92 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.445 ' HA2' ' HB2' ' A' ' 3' ' ' CYS . . . 62.75 15.2 54.1 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -126.28 97.43 5.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.223 -1.163 . . . . 0.0 110.338 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.624 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 87.7 m95 -66.59 137.46 56.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -0.95 . . . . 0.0 109.822 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.31 162.88 34.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.149 -0.969 . . . . 0.0 111.189 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.524 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 33.3 m-20 56.41 65.13 4.32 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.852 -0.53 . . . . 0.0 111.445 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.3 Cg_endo -92.33 134.96 1.39 Allowed 'Trans proline' 0 C--N 1.299 -2.042 0 O-C-N 124.379 1.726 . . . . 0.0 109.521 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.512 ' HG2' ' HB2' ' A' ' 29' ' ' TYR . 47.4 Cg_endo -78.19 174.23 12.76 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 123.607 1.319 . . . . 0.0 109.758 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.556 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 17.1 p -113.15 144.97 41.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.045 -1.034 . . . . 0.0 112.219 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 11.0 m -113.63 77.13 1.03 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 36' ' ' SER . 4.5 mm-40 -111.77 -171.53 1.86 Allowed 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.531 0.682 . . . . 0.0 110.945 -177.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.594 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -101.58 128.25 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.301 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.721 HG13 ' HB2' ' A' ' 36' ' ' SER . 20.6 m -118.65 52.31 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.058 -1.026 . . . . 0.0 111.039 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.465 ' N ' ' OD1' ' A' ' 107' ' ' ASN . 1.6 mttp -83.97 110.42 18.41 Favored 'General case' 0 C--N 1.283 -2.318 0 C-N-CA 118.5 -1.28 . . . . 0.0 109.367 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.555 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 84.4 m -78.05 166.55 42.55 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.189 -0.945 . . . . 0.0 111.274 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.555 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 38.0 Cg_endo -71.89 -76.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.278 1.672 . . . . 0.0 110.47 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.4 ' CG ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 175.39 136.33 0.17 Allowed Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.652 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.608 ' HG3' ' CZ2' ' A' ' 109' ' ' TRP . 58.8 Cg_endo -84.95 87.75 1.0 Allowed 'Trans proline' 0 C--N 1.297 -2.178 0 O-C-N 123.733 1.386 . . . . 0.0 109.721 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.695 ' O ' HG23 ' A' ' 66' ' ' ILE . 2.6 p -112.29 -43.23 3.56 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 122.394 1.092 . . . . 0.0 110.144 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.698 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER 51.95 166.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.242 -179.16 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.507 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 12.9 t -65.15 97.43 0.25 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.521 -0.737 . . . . 0.0 111.265 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 6.2 m-80 45.95 55.64 6.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.448 -0.783 . . . . 0.0 111.905 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.57 ' O ' ' CG ' ' A' ' 70' ' ' TYR . . . -135.34 -42.31 0.12 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.629 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 18.7 p90 43.67 -179.31 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 122.891 1.329 . . . . 0.0 112.074 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.845 HD13 ' N ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -125.24 153.54 43.01 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.15 -179.856 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.484 ' HB3' ' HG3' ' A' ' 88' ' ' LYS . 0.3 OUTLIER -111.58 7.84 20.72 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.01 -1.056 . . . . 0.0 110.267 -178.486 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.85 -70.68 0.52 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.283 -0.886 . . . . 0.0 110.331 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -175.95 100.04 0.14 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.594 ' O ' ' CD2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -94.01 110.03 21.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.402 -1.058 . . . . 0.0 109.498 179.533 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.512 ' N ' ' OH ' ' A' ' 79' ' ' TYR . 9.4 mttp -86.08 151.96 23.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.913 . . . . 0.0 110.247 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.3 mtt180 -48.45 -32.91 8.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.283 -0.885 . . . . 0.0 110.085 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.4 p -141.38 159.05 43.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.399 -0.813 . . . . 0.0 110.307 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.584 ' OH ' ' CD1' ' A' ' 75' ' ' PHE . 79.5 m-85 -132.23 -171.26 2.59 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.281 -0.887 . . . . 0.0 110.05 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.67 ' C ' HG23 ' A' ' 59' ' ' VAL . 78.8 p -147.18 -103.67 0.09 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.873 -1.142 . . . . 0.0 111.495 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.612 ' O ' ' CG ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -114.29 22.35 13.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 119.77 -1.831 . . . . 0.0 110.96 -178.396 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.683 ' C ' HG22 ' A' ' 102' ' ' THR . 50.3 t30 -165.55 -110.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.869 -1.144 . . . . 0.0 110.72 178.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 82' ' ' ASN . 0.1 OUTLIER 46.99 79.03 0.06 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.686 -1.259 . . . . 0.0 108.923 -179.032 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.736 ' CA ' HG23 ' A' ' 102' ' ' THR . 2.1 p-10 -71.91 142.12 49.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.347 -0.846 . . . . 0.0 110.885 -178.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.778 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 5.4 m -129.42 117.55 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.909 . . . . 0.0 110.455 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.539 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 3.1 t0 -76.64 128.52 34.85 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.376 -0.828 . . . . 0.0 108.897 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.656 ' CD1' HG21 ' A' ' 66' ' ' ILE . 34.2 m-85 -88.09 142.59 27.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.033 -1.042 . . . . 0.0 112.629 -177.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -121.4 84.78 2.29 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.128 -179.434 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.683 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.8 OUTLIER -35.2 126.46 0.58 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.761 -0.587 . . . . 0.0 110.853 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.9 OUTLIER -34.18 -78.52 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.625 -0.672 . . . . 0.0 110.843 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.464 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -168.78 143.45 3.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.312 -0.868 . . . . 0.0 110.395 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 51.51 45.26 53.83 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.577 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 10.8 m-85 -148.22 154.78 40.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.406 -1.055 . . . . 0.0 110.217 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.705 ' O ' HG22 ' A' ' 117' ' ' VAL . 35.9 mtpt -109.94 131.12 55.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 109.967 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.683 HD11 ' H ' ' A' ' 89' ' ' CYS . 2.0 mt -73.12 93.12 1.77 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.904 . . . . 0.0 110.246 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.468 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -74.39 98.54 3.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.928 . . . . 0.0 109.766 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 147.32 -97.94 0.19 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.608 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -149.87 128.52 12.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.234 -1.156 . . . . 0.0 110.211 -179.655 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 87' ' ' PHE . 24.9 p -72.36 -45.44 59.84 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.125 -0.985 . . . . 0.0 110.59 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.6 p -102.89 116.3 32.29 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.115 -0.991 . . . . 0.0 110.248 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 16.4 m -120.83 178.96 4.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.421 -0.799 . . . . 0.0 110.297 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.736 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.5 OUTLIER -152.58 134.24 14.61 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.571 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.554 ' SG ' ' O ' ' A' ' 80' ' ' SER . 12.9 t -62.03 78.48 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.542 0.687 . . . . 0.0 109.547 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.499 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -56.43 176.9 0.19 Allowed Pre-proline 0 N--CA 1.498 1.935 0 CA-C-O 121.506 0.67 . . . . 0.0 112.753 -178.485 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.784 ' CB ' HD12 ' A' ' 38' ' ' ILE . 47.2 Cg_endo -79.08 25.45 0.57 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 124.779 1.936 . . . . 0.0 112.079 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -122.86 18.86 7.96 Favored Glycine 0 N--CA 1.482 1.757 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.691 ' O ' HG23 ' A' ' 108' ' ' THR . 16.3 m-80 62.63 53.05 2.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.894 -0.768 . . . . 0.0 110.066 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.2 OUTLIER -163.64 179.27 7.3 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.288 -0.883 . . . . 0.0 111.166 179.881 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.778 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 45.4 m95 -110.03 90.74 3.4 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.561 -0.712 . . . . 0.0 110.243 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.581 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 1.0 OUTLIER -100.33 154.91 36.94 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.322 -0.861 . . . . 0.0 109.596 179.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.608 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.3 Cg_endo -69.48 -179.92 19.96 Favored 'Cis proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.33 -1.946 . . . . 0.0 111.414 0.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.472 ' C ' ' O ' ' A' ' 111' ' ' PRO . 9.5 mt-10 -34.44 121.8 0.5 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.416 0.627 . . . . 0.0 111.097 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.609 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 3.0 tp -49.13 141.7 10.82 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.39 -0.819 . . . . 0.0 110.127 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.698 ' HG2' HD12 ' A' ' 66' ' ' ILE . 41.5 Cg_endo -70.26 158.5 56.1 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 124.073 1.564 . . . . 0.0 110.416 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.845 ' HG2' HG13 ' A' ' 117' ' ' VAL . 11.5 ttpt -124.11 107.17 10.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 110.37 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 2.6 t -63.01 78.28 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.17 -0.957 . . . . 0.0 109.168 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.845 HG13 ' HG2' ' A' ' 115' ' ' LYS . 2.5 m -92.92 -173.83 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.903 0.859 . . . . 0.0 111.264 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.461 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.6 OUTLIER . . . . . 0 C--N 1.296 -1.758 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.239 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 2' ' ' LYS . 59.1 t . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.162 0.505 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 32.4 mttt -93.53 164.79 13.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.248 -0.907 . . . . 0.0 110.285 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.571 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -131.37 83.74 2.12 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.165 -0.959 . . . . 0.0 110.343 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.423 ' O ' ' C ' ' A' ' 5' ' ' SER . 4.3 pm0 -63.52 179.57 0.45 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.12 -0.988 . . . . 0.0 109.928 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.3 p -44.99 144.52 1.93 Allowed Pre-proline 0 C--N 1.297 -1.684 0 C-N-CA 119.715 -0.794 . . . . 0.0 109.443 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.892 ' HG3' HG11 ' A' ' 27' ' ' VAL . 45.9 Cg_endo -70.16 159.86 51.63 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 124.028 1.541 . . . . 0.0 111.004 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.72 171.17 18.73 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.004 1.528 . . . . 0.0 110.216 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 77.4 p -73.58 179.18 4.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 0.0 110.17 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.639 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -145.14 -169.51 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 122.232 1.015 . . . . 0.0 111.78 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 3.6 t -50.27 100.23 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.2 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 10' ' ' SER . 5.5 m-20 36.72 55.49 1.16 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.658 -0.651 . . . . 0.0 111.335 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.414 ' HA3' ' SG ' ' A' ' 56' ' ' CYS . . . -150.28 -163.34 11.13 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.528 ' CG ' ' HB3' ' A' ' 30' ' ' SER . 0.0 OUTLIER -148.2 174.9 11.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.206 -1.173 . . . . 0.0 110.362 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.621 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 23.2 p80 -140.74 -155.32 0.58 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.551 -0.718 . . . . 0.0 110.023 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 0.1 OUTLIER 70.35 106.8 0.06 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.332 -0.855 . . . . 0.0 110.434 179.621 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.495 ' O ' ' CD2' ' A' ' 17' ' ' TYR . . . -166.35 46.89 0.27 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.495 ' CD2' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER 179.18 -33.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -1.175 . . . . 0.0 110.571 -179.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 8.8 pt-20 -179.71 -168.69 0.12 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.094 -1.004 . . . . 0.0 110.761 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -114.35 -41.69 3.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.461 -0.774 . . . . 0.0 109.635 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -95.64 130.13 42.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.395 -0.815 . . . . 0.0 109.733 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.647 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.4 OUTLIER -122.45 -6.48 8.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.144 -0.973 . . . . 0.0 110.626 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.571 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 72.6 p 46.69 -95.75 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.501 -0.75 . . . . 0.0 112.1 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 0.8 OUTLIER -154.62 144.86 21.97 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.887 -1.133 . . . . 0.0 110.577 -178.527 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.22 31.96 29.92 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.647 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -122.13 172.25 8.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.438 -1.037 . . . . 0.0 110.267 -179.742 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.91 HG13 ' O ' ' A' ' 43' ' ' VAL . 48.6 t -142.99 152.87 16.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.265 -0.897 . . . . 0.0 110.826 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.935 ' O ' HG23 ' A' ' 43' ' ' VAL . 11.9 t -129.81 122.11 53.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 C-N-CA 119.831 -0.747 . . . . 0.0 111.413 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.42 102.3 5.12 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 118.723 -1.191 . . . . 0.0 107.882 178.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.952 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.1 m-30 -68.34 120.65 14.81 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.263 -178.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.528 ' HB3' ' CG ' ' A' ' 13' ' ' ARG . 4.9 t -73.18 -177.65 2.59 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.945 -1.097 . . . . 0.0 109.2 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 30' ' ' SER . 71.0 m -151.56 163.89 38.06 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.344 -0.848 . . . . 0.0 109.975 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.34 145.58 26.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.182 -0.949 . . . . 0.0 109.701 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.432 ' O ' ' OG ' ' A' ' 33' ' ' SER . 1.6 p -52.64 110.9 0.56 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 110.499 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.04 -20.43 26.33 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -79.27 132.17 36.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.182 -1.187 . . . . 0.0 110.354 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.702 ' HB3' HD11 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -80.84 138.86 36.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.16 -0.962 . . . . 0.0 110.579 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.565 HD13 ' O ' ' A' ' 29' ' ' TYR . 0.8 OUTLIER -85.87 98.03 10.54 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.431 -0.793 . . . . 0.0 109.358 179.09 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.903 HD12 ' HB3' ' A' ' 105' ' ' PRO . 0.7 OUTLIER -89.17 148.86 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -0.884 . . . . 0.0 109.065 179.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.89 -150.43 16.91 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.05 137.43 32.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.358 -1.083 . . . . 0.0 110.371 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.415 ' HA ' HD21 ' A' ' 37' ' ' LEU . 54.8 p -76.69 55.29 1.04 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.933 . . . . 0.0 109.444 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.606 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 153.93 121.17 0.8 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.952 HG21 ' CE1' ' A' ' 29' ' ' TYR . 1.7 t -69.27 -178.29 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.173 -1.193 . . . . 0.0 108.263 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.498 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.3 tp -143.92 97.54 3.08 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.923 -1.11 . . . . 0.0 110.714 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.594 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 1.0 OUTLIER -86.04 114.7 23.13 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.081 -1.047 . . . . 0.0 109.132 178.569 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.07 91.91 3.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.501 -0.749 . . . . 0.0 110.225 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.526 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 78.49 63.49 2.12 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 46.7 53.15 10.35 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -157.31 73.37 0.73 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.346 -1.091 . . . . 0.0 110.569 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.594 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 76.1 m95 -55.7 137.73 48.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.087 -1.008 . . . . 0.0 109.354 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -146.87 163.8 34.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.001 -1.062 . . . . 0.0 111.342 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.51 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 1.5 m-20 62.11 65.77 1.56 Allowed Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.826 -0.546 . . . . 0.0 111.377 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.51 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 46.5 Cg_endo -91.47 129.23 1.2 Allowed 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 121.802 1.668 . . . . 0.0 110.17 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.573 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 49.7 Cg_endo -80.21 168.21 18.83 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.904 1.476 . . . . 0.0 110.086 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.615 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 65.7 p -107.83 148.01 30.12 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.979 -1.076 . . . . 0.0 111.347 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 10' ' ' SER . 88.9 m -109.25 77.91 1.1 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -113.81 -167.68 1.24 Allowed 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.394 0.616 . . . . 0.0 110.487 -178.305 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.654 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -104.69 134.69 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.246 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.634 HG21 ' CB ' ' A' ' 81' ' ' TYR . 19.8 m -122.7 43.75 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.063 -1.023 . . . . 0.0 111.099 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -82.93 96.69 8.37 Favored 'General case' 0 C--N 1.286 -2.179 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.956 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 107' ' ' ASN . 29.2 m -69.69 162.09 69.97 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.397 -0.814 . . . . 0.0 111.423 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.459 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 44.3 Cg_endo -72.88 -90.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.559 1.82 . . . . 0.0 110.578 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.402 ' CD2' ' HE1' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -161.69 132.77 3.79 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.802 ' HA ' HD21 ' A' ' 113' ' ' LEU . 55.7 Cg_endo -78.7 65.71 8.67 Favored 'Trans proline' 0 C--N 1.295 -2.267 0 O-C-N 123.665 1.35 . . . . 0.0 109.454 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.646 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -82.98 176.03 9.58 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.579 -0.701 . . . . 0.0 110.287 -179.652 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.646 HG22 ' C ' ' A' ' 65' ' ' THR . 0.2 OUTLIER -176.7 163.39 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.227 -0.92 . . . . 0.0 110.625 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.46 ' N ' HG13 ' A' ' 66' ' ' ILE . 1.8 m -75.9 107.61 8.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.509 -0.744 . . . . 0.0 110.831 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 8.6 m-20 43.37 37.89 1.53 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.457 -0.777 . . . . 0.0 110.432 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.597 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -145.1 26.72 1.88 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.551 ' O ' ' N ' ' A' ' 88' ' ' LYS . 23.4 p90 -43.91 -178.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.409 1.1 . . . . 0.0 111.833 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.69 ' H ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -109.63 156.29 20.4 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 121.913 0.864 . . . . 0.0 110.858 179.083 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.08 11.77 4.25 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.778 -1.201 . . . . 0.0 110.033 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.22 -79.68 0.23 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.347 -0.845 . . . . 0.0 110.917 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -141.42 84.08 0.21 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.537 ' C ' ' CD1' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -98.95 160.92 13.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.467 -1.019 . . . . 0.0 109.911 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.584 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 24.4 ttmt -153.44 156.81 38.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.264 -0.897 . . . . 0.0 110.531 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 26.5 mtp85 -53.37 -30.16 38.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.897 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.418 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -141.77 171.56 13.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.484 -0.76 . . . . 0.0 110.21 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.584 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 31.2 m-85 -144.08 177.66 8.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.214 -0.929 . . . . 0.0 110.408 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.575 ' HA ' HG23 ' A' ' 59' ' ' VAL . 7.7 p -162.85 92.36 0.77 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.177 -0.952 . . . . 0.0 110.238 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.634 ' CB ' HG21 ' A' ' 59' ' ' VAL . 13.3 t80 56.83 136.31 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.092 -1.005 . . . . 0.0 110.247 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.733 ' O ' HG22 ' A' ' 102' ' ' THR . 14.4 t-20 63.57 -125.05 0.55 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.849 -1.157 . . . . 0.0 110.521 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.498 ' HB3' ' HB3' ' A' ' 103' ' ' CYS . 0.5 OUTLIER 54.13 71.2 0.53 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.617 -1.302 . . . . 0.0 109.014 -178.526 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.539 ' N ' HG23 ' A' ' 102' ' ' THR . 5.4 t30 -73.53 136.69 44.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.515 -0.741 . . . . 0.0 111.332 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.586 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 12.5 m -124.0 117.21 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.246 -0.909 . . . . 0.0 109.877 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 48.6 t0 -78.4 136.04 37.56 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.682 ' CE1' HD12 ' A' ' 71' ' ' LEU . 60.6 m-85 -94.24 129.68 40.78 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.99 -1.069 . . . . 0.0 112.158 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 70' ' ' TYR . 9.1 tptt -99.52 90.05 4.37 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.631 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.518 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -44.35 128.77 6.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.004 -1.06 . . . . 0.0 109.861 -179.668 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 2.9 mmtt -38.93 -78.0 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.595 -0.691 . . . . 0.0 110.472 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.589 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -168.27 141.53 3.14 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.358 -0.839 . . . . 0.0 110.366 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.582 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 49.79 53.78 20.47 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.589 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 11.6 m-85 -158.28 151.23 22.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.469 -1.019 . . . . 0.0 109.624 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.565 ' O ' HG22 ' A' ' 117' ' ' VAL . 13.1 mtmm -109.18 134.64 51.47 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.113 -0.992 . . . . 0.0 110.161 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' A' ' 114' ' ' PRO . 1.8 mt -72.13 103.51 3.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.259 -0.9 . . . . 0.0 110.571 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.488 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -84.87 112.83 20.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.151 -0.968 . . . . 0.0 109.751 179.379 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 132.08 -77.74 0.38 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.538 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -167.73 112.05 0.67 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.358 -1.084 . . . . 0.0 110.44 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 43.9 t -69.97 -7.07 37.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.211 -0.931 . . . . 0.0 110.306 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.0 p -139.65 98.8 3.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.182 -0.949 . . . . 0.0 110.04 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.604 ' HG ' ' HE2' ' A' ' 87' ' ' PHE . 7.0 m -106.47 -174.69 2.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.192 -0.943 . . . . 0.0 110.565 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.733 HG22 ' O ' ' A' ' 82' ' ' ASN . 19.8 m -157.93 134.9 9.97 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.251 -0.98 . . . . 0.0 111.301 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.602 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 1.8 t -62.2 87.4 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.479 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -78.57 177.05 3.06 Favored Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.133 -0.98 . . . . 0.0 110.859 -179.387 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.903 ' HB3' HD12 ' A' ' 38' ' ' ILE . 41.9 Cg_endo -73.55 138.28 26.6 Favored 'Trans proline' 0 C--N 1.302 -1.91 0 O-C-N 124.436 1.756 . . . . 0.0 110.499 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.554 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 116.92 -10.05 15.72 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.554 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 1.4 m-20 81.12 77.72 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.943 -0.74 . . . . 0.0 110.065 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -173.73 -175.05 1.03 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.626 -0.83 . . . . 0.0 110.969 -179.697 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.606 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 38.9 m95 -124.35 89.03 3.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.546 -0.721 . . . . 0.0 109.723 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.592 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -101.86 136.05 19.6 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.491 -0.755 . . . . 0.0 110.652 -179.109 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.592 ' C ' ' HA ' ' A' ' 110' ' ' LYS . 40.9 Cg_endo -68.52 163.73 77.28 Favored 'Cis proline' 0 N--CA 1.489 1.224 0 C-N-CA 122.101 -2.041 . . . . 0.0 111.029 -0.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 111' ' ' PRO . 28.5 tt0 -40.06 155.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.457 0.646 . . . . 0.0 110.689 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.802 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -62.99 146.29 95.78 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.494 -0.754 . . . . 0.0 110.043 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.576 ' HG3' ' CD2' ' A' ' 87' ' ' PHE . 41.1 Cg_endo -72.45 175.4 10.15 Favored 'Trans proline' 0 C--N 1.299 -2.057 0 O-C-N 124.365 1.718 . . . . 0.0 111.136 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.643 ' HG2' HG13 ' A' ' 117' ' ' VAL . 6.4 tttp -133.79 114.39 13.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.493 -0.755 . . . . 0.0 109.907 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.52 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 3.5 t -72.96 71.19 1.06 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.082 -1.011 . . . . 0.0 109.505 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.643 HG13 ' HG2' ' A' ' 115' ' ' LYS . 5.9 m -86.91 -170.37 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-O 122.057 0.932 . . . . 0.0 110.924 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.477 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.294 -1.844 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.281 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.593 HG23 ' HA3' ' A' ' 48' ' ' GLY . 9.1 m . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.301 0.572 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.77 178.96 6.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.296 -0.878 . . . . 0.0 110.512 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.524 ' O ' ' N ' ' A' ' 21' ' ' TYR . 1.2 m -117.99 136.38 53.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.493 -0.754 . . . . 0.0 110.131 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 5' ' ' SER . 5.7 pt20 -110.61 172.94 6.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.046 -1.034 . . . . 0.0 109.647 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.503 ' HB2' ' HA ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -46.65 132.86 8.21 Favored Pre-proline 0 C--N 1.298 -1.637 0 C-N-CA 119.369 -0.933 . . . . 0.0 109.36 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.592 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 43.8 Cg_endo -69.81 166.03 29.03 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.939 1.494 . . . . 0.0 110.325 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.02 166.47 27.81 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 O-C-N 123.942 1.496 . . . . 0.0 110.306 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.74 175.37 9.45 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.376 -0.827 . . . . 0.0 109.949 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 11' ' ' ASN . 0.3 OUTLIER -141.44 -170.33 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-O 122.227 1.013 . . . . 0.0 111.331 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.5 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 1.3 m -46.44 91.54 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.92 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.506 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER 42.03 51.09 4.33 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.147 -0.97 . . . . 0.0 110.376 179.643 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -150.53 151.79 23.76 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -111.15 -179.05 3.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.34 -1.094 . . . . 0.0 110.265 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.614 ' N ' ' CD2' ' A' ' 14' ' ' HIS . 8.4 m170 -66.06 -139.42 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.279 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -85.28 -97.76 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.935 . . . . 0.0 110.212 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.32 -71.2 0.69 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -164.61 84.75 0.42 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -1.173 . . . . 0.0 110.254 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.441 ' N ' ' CD ' ' A' ' 18' ' ' GLU . 5.9 mp0 -109.49 -54.01 2.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.84 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.503 ' HA ' ' HB2' ' A' ' 5' ' ' SER . 2.1 m-20 59.04 18.38 6.28 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.5 -0.75 . . . . 0.0 110.232 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.563 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 0.2 OUTLIER -163.27 149.13 11.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 110.618 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.6 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 9.0 m-85 -163.98 174.75 11.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.509 -0.744 . . . . 0.0 109.649 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.501 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 22.6 p -136.03 -69.83 0.48 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.779 -1.201 . . . . 0.0 111.099 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -161.49 145.4 12.88 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.514 -0.742 . . . . 0.0 109.384 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.17 12.31 57.59 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.38 -1.888 . . . . 0.0 108.38 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.6 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -82.63 174.3 11.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.507 -0.996 . . . . 0.0 109.816 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.719 HG13 ' O ' ' A' ' 43' ' ' VAL . 28.2 t -153.85 156.65 5.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.856 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.682 ' O ' HG23 ' A' ' 43' ' ' VAL . 4.0 t -137.16 114.22 12.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 C-N-CA 119.631 -0.827 . . . . 0.0 111.546 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.881 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -70.45 102.76 2.27 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 118.543 -1.263 . . . . 0.0 108.015 178.366 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.639 ' O ' HD13 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -68.22 97.49 0.72 Allowed 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.205 -0.998 . . . . 0.0 109.592 -178.589 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.493 ' OG ' ' O ' ' A' ' 14' ' ' HIS . 0.1 OUTLIER -70.08 139.43 52.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.78 -1.2 . . . . 0.0 109.8 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 56' ' ' CYS . 12.4 m -108.27 153.11 23.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.372 -0.83 . . . . 0.0 109.679 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 31' ' ' CYS . 0.7 OUTLIER -44.05 140.92 1.87 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.163 -0.961 . . . . 0.0 109.841 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 83.2 p -52.42 98.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 110.084 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 134.33 -1.74 4.13 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' A' ' 56' ' ' CYS . 0.6 OUTLIER -106.15 161.03 14.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.067 -1.255 . . . . 0.0 110.421 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.98 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.7 OUTLIER -102.58 129.99 49.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.359 -0.838 . . . . 0.0 110.963 -179.405 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.809 HD21 ' HA ' ' A' ' 41' ' ' SER . 4.6 tp -89.05 120.67 30.67 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.329 -0.857 . . . . 0.0 109.294 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.789 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -118.37 141.74 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.138 -0.976 . . . . 0.0 109.881 -179.501 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.506 ' O ' ' CB ' ' A' ' 40' ' ' ASN . . . 101.58 44.22 2.0 Favored Glycine 0 N--CA 1.488 2.154 0 C-N-CA 119.393 -1.384 . . . . 0.0 109.687 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 3.1 t30 72.11 169.45 0.32 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.491 -1.005 . . . . 0.0 109.775 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.881 ' O ' HG23 ' A' ' 28' ' ' THR . 0.8 OUTLIER -112.36 63.15 0.63 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 110.457 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.541 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 160.12 113.89 0.34 Allowed Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.635 -1.269 . . . . 0.0 110.306 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.719 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.1 t -60.84 -179.06 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.05 -1.265 . . . . 0.0 108.066 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.458 ' HA ' ' O ' ' A' ' 25' ' ' SER . 0.8 OUTLIER -143.78 102.55 3.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.994 -1.066 . . . . 0.0 110.533 178.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.591 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.6 OUTLIER -85.48 113.84 22.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.317 -0.864 . . . . 0.0 109.276 178.654 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 87.7 p -129.64 137.52 50.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 0.0 110.531 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.01 9.12 45.93 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.593 ' HA3' HG23 ' A' ' 1' ' ' VAL . . . 93.36 29.08 10.54 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -146.08 135.18 22.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.366 -1.079 . . . . 0.0 110.097 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.591 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 89.1 m95 -80.71 138.36 36.34 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.217 -0.927 . . . . 0.0 109.909 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -141.81 165.46 27.4 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.119 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.529 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 1.3 t70 43.11 64.87 5.99 Favored Pre-proline 0 N--CA 1.491 1.614 0 CA-C-O 121.141 0.496 . . . . 0.0 111.819 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 47.0 Cg_endo -91.8 125.56 0.86 Allowed 'Trans proline' 0 C--N 1.3 -1.996 0 O-C-N 124.341 1.706 . . . . 0.0 109.261 178.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.517 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 45.1 Cg_endo -70.79 -178.44 2.74 Favored 'Trans proline' 0 C--N 1.297 -2.15 0 O-C-N 123.808 1.425 . . . . 0.0 110.759 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.571 ' N ' ' O ' ' A' ' 38' ' ' ILE . 6.0 p -119.82 -169.09 1.71 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.851 0.834 . . . . 0.0 111.255 -178.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 10' ' ' SER . 96.4 m -151.92 86.65 1.32 Allowed 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -111.11 -139.5 0.38 Allowed 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.055 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.781 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -142.82 74.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 179.391 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.98 HG13 ' CB ' ' A' ' 36' ' ' SER . 4.6 m -68.72 126.49 28.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 122.55 1.167 . . . . 0.0 110.679 -177.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 107' ' ' ASN . 24.6 mtpt -147.22 93.67 2.28 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.499 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 27.4 m -69.1 162.78 62.84 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.513 -0.742 . . . . 0.0 111.732 -177.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 46.1 Cg_endo -72.82 -90.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.612 1.848 . . . . 0.0 110.615 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.458 ' HB3' ' CG2' ' A' ' 65' ' ' THR . 0.0 OUTLIER -164.98 129.34 1.81 Allowed Pre-proline 0 C--N 1.302 -1.462 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.615 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 54.7 Cg_endo -77.33 65.68 7.94 Favored 'Trans proline' 0 C--N 1.298 -2.114 0 O-C-N 123.608 1.32 . . . . 0.0 109.617 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.724 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.8 OUTLIER -83.95 178.81 7.72 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.266 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.786 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -175.02 158.39 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.077 179.388 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.501 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 0.7 OUTLIER -64.35 101.82 0.47 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.496 -0.753 . . . . 0.0 110.5 -179.57 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.463 ' O ' ' SG ' ' A' ' 116' ' ' CYS . 45.0 m-20 39.66 50.74 2.26 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.438 -0.789 . . . . 0.0 110.607 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.786 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -158.54 32.07 0.48 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.562 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 4.9 p90 -45.17 -172.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.798 1.285 . . . . 0.0 112.684 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.706 ' H ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -109.96 167.91 9.82 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.601 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.46 ' O ' ' OG ' ' A' ' 72' ' ' SER . 0.3 OUTLIER -144.97 24.91 1.45 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.044 -1.035 . . . . 0.0 110.155 -179.611 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.3 t -104.24 -89.02 0.41 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.032 -1.042 . . . . 0.0 110.824 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -118.92 72.86 0.31 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 2.9 t80 -98.2 164.82 12.16 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.446 -1.032 . . . . 0.0 110.19 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.63 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 2.4 tttp -168.93 159.13 9.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.367 -0.833 . . . . 0.0 109.95 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -52.6 -27.79 18.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.128 -0.983 . . . . 0.0 109.981 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.462 ' C ' ' CG ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -141.31 173.87 11.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.366 -0.834 . . . . 0.0 110.556 -179.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.575 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 43.3 m-85 -148.82 -168.15 3.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.519 -0.738 . . . . 0.0 109.486 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.608 ' CA ' HG23 ' A' ' 59' ' ' VAL . 88.1 p -141.47 -102.12 0.14 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.741 -1.225 . . . . 0.0 111.355 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.686 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -119.27 19.36 12.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.608 -1.307 . . . . 0.0 111.24 -178.696 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.791 ' O ' HG22 ' A' ' 102' ' ' THR . 29.0 t-20 -159.86 -101.59 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.875 -1.14 . . . . 0.0 110.118 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 82' ' ' ASN . 2.9 m-20 44.94 72.79 0.18 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.87 -1.144 . . . . 0.0 109.277 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.887 ' CA ' HG23 ' A' ' 102' ' ' THR . 8.7 p30 -68.74 113.91 6.63 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.386 -0.821 . . . . 0.0 110.172 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.529 ' N ' ' O ' ' A' ' 101' ' ' SER . 33.1 m -99.28 121.88 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.249 -0.907 . . . . 0.0 111.073 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.522 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 28.8 t70 -83.27 134.6 34.93 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.645 ' CE1' HD12 ' A' ' 71' ' ' LEU . 29.3 m-85 -91.46 132.82 35.98 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.825 -1.172 . . . . 0.0 112.046 -178.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.2 OUTLIER -111.2 92.0 3.87 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.181 -179.39 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.477 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -44.49 128.37 6.37 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.043 -1.036 . . . . 0.0 109.907 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 2.4 mmmp? -41.19 -85.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.32 -0.862 . . . . 0.0 110.375 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.581 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -159.09 142.2 14.52 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.273 -0.892 . . . . 0.0 110.418 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.594 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 54.7 54.94 29.95 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.594 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 18.2 m-85 -160.27 167.41 27.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.469 -1.018 . . . . 0.0 109.729 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.481 ' N ' ' O ' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -132.22 114.37 14.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.24 -0.913 . . . . 0.0 109.911 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.753 HD23 HD11 ' A' ' 66' ' ' ILE . 10.2 mt -46.39 107.49 0.11 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.11 -0.994 . . . . 0.0 110.479 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.705 ' HB2' HG21 ' A' ' 117' ' ' VAL . 1.2 t -90.1 97.04 10.96 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.432 -0.792 . . . . 0.0 109.685 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.62 -40.33 1.38 Allowed Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.404 -1.379 . . . . 0.0 110.546 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.581 ' O ' ' HB3' ' A' ' 114' ' ' PRO . 0.0 OUTLIER 177.58 -164.45 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.889 -1.359 . . . . 0.0 111.524 -179.191 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.529 ' N ' ' OG ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -149.21 -53.42 0.17 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.713 -0.617 . . . . 0.0 110.2 -179.833 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 91.1 p -110.48 105.51 14.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.23 -0.919 . . . . 0.0 110.644 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.529 ' O ' ' N ' ' A' ' 85' ' ' VAL . 50.6 m -113.73 164.27 13.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.329 -0.857 . . . . 0.0 110.118 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.887 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -133.39 143.39 48.9 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.345 -0.847 . . . . 0.0 110.885 -179.687 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.628 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -72.95 98.27 2.45 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.33 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.565 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -67.98 176.27 1.41 Allowed Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.182 -0.949 . . . . 0.0 112.333 -178.52 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.789 ' CB ' HD12 ' A' ' 38' ' ' ILE . 41.0 Cg_endo -70.03 -33.36 15.72 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 124.689 1.889 . . . . 0.0 111.728 -177.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.56 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -75.5 4.64 41.42 Favored Glycine 0 N--CA 1.486 2.001 0 C-N-CA 119.267 -1.444 . . . . 0.0 110.799 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.719 ' O ' HG23 ' A' ' 108' ' ' THR . 0.9 OUTLIER 78.13 89.4 0.07 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.445 -1.033 . . . . 0.0 110.929 179.245 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.719 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -178.45 -161.7 0.05 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.857 . . . . 0.0 110.906 179.354 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.727 ' HB3' HD13 ' A' ' 113' ' ' LEU . 22.7 m95 -142.71 97.94 3.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 111.305 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.525 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 2.5 mtpp -106.75 145.83 31.85 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.411 -0.806 . . . . 0.0 109.512 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.536 ' HG2' ' HB2' ' A' ' 98' ' ' SER . 47.3 Cg_endo -72.91 178.62 31.27 Favored 'Cis proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.088 -2.047 . . . . 0.0 111.089 -0.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.447 ' O ' ' C ' ' A' ' 113' ' ' LEU . 5.3 tt0 -40.74 121.16 1.42 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.606 -0.684 . . . . 0.0 110.352 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.727 HD13 ' HB3' ' A' ' 109' ' ' TRP . 0.6 OUTLIER -40.91 138.56 1.31 Allowed Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.416 -0.802 . . . . 0.0 110.001 179.701 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.731 ' HG2' HD12 ' A' ' 66' ' ' ILE . 42.8 Cg_endo -75.04 160.69 39.75 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 O-C-N 124.176 1.619 . . . . 0.0 111.758 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.75 ' HG2' HG13 ' A' ' 117' ' ' VAL . 5.6 ttpp -125.67 99.89 6.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.469 -0.769 . . . . 0.0 110.813 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.546 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.8 t -53.29 100.88 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.93 . . . . 0.0 109.468 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.75 HG13 ' HG2' ' A' ' 115' ' ' LYS . 2.0 m -118.92 179.18 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.664 0.745 . . . . 0.0 110.624 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.5 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.293 -1.858 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.371 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 53.8 t . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.213 0.53 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -81.13 170.32 16.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.256 -0.902 . . . . 0.0 110.319 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 21' ' ' TYR . 1.2 m -125.39 90.58 3.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 109.713 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.517 ' HA ' ' O ' ' A' ' 19' ' ' ASP . 37.6 tt0 -72.88 173.58 8.99 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.021 -1.049 . . . . 0.0 109.895 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.513 ' N ' ' CG ' ' A' ' 4' ' ' GLN . 0.7 OUTLIER -44.09 134.76 4.12 Favored Pre-proline 0 C--N 1.297 -1.706 0 O-C-N 121.501 -0.749 . . . . 0.0 109.642 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.647 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 51.6 Cg_endo -71.36 150.5 58.59 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.939 1.494 . . . . 0.0 110.525 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.34 172.23 15.36 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 O-C-N 124.007 1.53 . . . . 0.0 109.932 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.53 177.71 2.81 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.248 -0.907 . . . . 0.0 109.509 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.682 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -139.09 -170.41 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 122.172 0.987 . . . . 0.0 111.297 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 5.5 t -47.37 98.25 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.616 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.2 m120 44.35 47.85 8.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 0.0 110.415 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.467 ' O ' HG13 ' A' ' 9' ' ' ILE . . . -159.6 156.64 27.81 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.42 -169.71 1.51 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.117 -1.225 . . . . 0.0 111.071 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.657 ' HB2' HG11 ' A' ' 27' ' ' VAL . 13.8 p80 -137.85 126.0 22.97 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.353 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.669 ' O ' HG13 ' A' ' 27' ' ' VAL . 2.1 t30 -100.37 -175.33 2.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.308 -0.87 . . . . 0.0 110.263 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.485 ' HA3' ' OH ' ' A' ' 21' ' ' TYR . . . 154.22 -36.6 0.7 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.472 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER 67.44 35.88 4.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.395 -1.061 . . . . 0.0 110.482 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.595 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -142.48 -159.61 0.99 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.292 -0.88 . . . . 0.0 109.817 179.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.517 ' O ' ' HA ' ' A' ' 4' ' ' GLN . 1.5 m-20 -147.47 -35.2 0.24 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.171 -0.956 . . . . 0.0 110.59 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -121.03 79.05 1.46 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.191 -0.943 . . . . 0.0 110.14 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.603 ' CE2' ' CG2' ' A' ' 27' ' ' VAL . 0.9 OUTLIER -57.57 -24.7 57.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.07 -1.019 . . . . 0.0 110.339 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.448 ' C ' ' HB2' ' A' ' 3' ' ' CYS . 0.2 OUTLIER 66.43 -79.08 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.464 -0.772 . . . . 0.0 112.32 178.561 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.529 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER -168.3 160.84 11.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.891 -1.13 . . . . 0.0 109.865 -178.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 59.39 17.07 38.09 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.506 ' CB ' ' CD1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -92.89 160.11 15.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.566 -0.961 . . . . 0.0 109.725 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.674 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 57.4 t -133.75 150.23 31.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 118.977 -1.089 . . . . 0.0 110.907 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.861 ' O ' HG23 ' A' ' 43' ' ' VAL . 45.6 t -138.13 112.02 8.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.46 -0.775 . . . . 0.0 110.977 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -69.99 104.14 2.46 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.035 -1.466 . . . . 0.0 107.653 178.211 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 1.122 ' CE1' HG21 ' A' ' 43' ' ' VAL . 1.9 m-30 -67.62 130.67 43.75 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.956 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.71 152.64 23.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.122 -0.986 . . . . 0.0 109.906 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 1.024 ' SG ' HD12 ' A' ' 37' ' ' LEU . 98.1 m -129.71 143.81 50.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.154 -0.966 . . . . 0.0 110.354 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -55.17 127.95 31.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.267 -0.896 . . . . 0.0 110.285 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 71.1 p -44.88 139.73 2.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.298 -0.876 . . . . 0.0 110.332 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.5 -21.81 37.91 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.614 ' CE2' HG23 ' A' ' 58' ' ' ILE . 8.4 m-85 -108.94 141.22 41.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.12 -1.223 . . . . 0.0 110.3 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.792 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -79.03 136.36 37.16 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.349 -0.844 . . . . 0.0 110.995 -179.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 1.024 HD12 ' SG ' ' A' ' 31' ' ' CYS . 3.8 tt -92.54 94.23 8.95 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.833 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.9 OUTLIER -76.68 145.16 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.43 -0.793 . . . . 0.0 109.207 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 126.94 -160.26 21.2 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.514 ' O ' ' C ' ' A' ' 41' ' ' SER . 4.2 m-20 -115.8 52.01 0.92 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.113 -1.228 . . . . 0.0 109.798 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.675 ' O ' HG23 ' A' ' 28' ' ' THR . 18.3 p 24.88 67.78 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.715 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.87 116.08 0.42 Allowed Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.383 -1.389 . . . . 0.0 110.609 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.122 HG21 ' CE1' ' A' ' 29' ' ' TYR . 1.4 t -84.72 126.88 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.7 tp -97.29 106.88 19.29 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 120.201 -1.562 . . . . 0.0 111.423 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.602 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.8 OUTLIER -87.56 114.72 24.43 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.449 -0.901 . . . . 0.0 108.92 178.034 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.515 ' HA ' ' OD2' ' A' ' 23' ' ' ASP . 0.3 OUTLIER -132.43 128.67 38.0 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.404 -179.686 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.529 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 80.02 -5.48 62.38 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.449 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 109.79 6.76 28.24 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -126.54 116.49 21.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -1.18 . . . . 0.0 110.517 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.602 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 82.7 m95 -64.85 141.42 58.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.224 -0.922 . . . . 0.0 109.542 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 52' ' ' ASP . 2.4 t -140.98 -177.77 5.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.015 -1.053 . . . . 0.0 111.105 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.526 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER 36.26 65.4 2.14 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.746 -0.596 . . . . 0.0 111.207 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.526 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.8 Cg_endo -91.58 138.15 2.09 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 124.403 1.738 . . . . 0.0 109.666 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.536 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 51.3 Cg_endo -80.56 175.88 9.68 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.489 1.257 . . . . 0.0 110.321 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.618 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 20.0 p -130.12 138.58 50.75 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.171 -0.956 . . . . 0.0 111.0 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 10' ' ' SER . 14.2 m -97.52 76.48 2.54 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.494 ' HG3' HG12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -119.08 144.83 46.37 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.428 0.632 . . . . 0.0 110.219 -178.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.614 HG23 ' CE2' ' A' ' 35' ' ' TYR . 1.7 pt -69.46 120.54 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.792 HG13 ' CB ' ' A' ' 36' ' ' SER . 12.1 m -99.5 51.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.151 -0.968 . . . . 0.0 112.094 -178.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.425 ' HD3' HD12 ' A' ' 58' ' ' ILE . 3.0 mtpp -87.61 99.35 11.99 Favored 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 118.626 -1.229 . . . . 0.0 108.434 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.477 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 59.6 m -69.25 162.62 64.62 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.397 -0.814 . . . . 0.0 111.502 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 47.9 Cg_endo -72.0 -91.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.464 1.771 . . . . 0.0 110.587 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.469 ' HB3' ' CG2' ' A' ' 65' ' ' THR . 0.0 OUTLIER -158.27 132.27 5.04 Favored Pre-proline 0 C--N 1.302 -1.47 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.707 ' HA ' HD21 ' A' ' 113' ' ' LEU . 55.5 Cg_endo -77.77 67.89 7.83 Favored 'Trans proline' 0 C--N 1.293 -2.344 0 O-C-N 123.757 1.398 . . . . 0.0 109.528 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.657 ' O ' HD23 ' A' ' 113' ' ' LEU . 1.5 p -88.97 174.98 7.61 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.805 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -170.35 159.87 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 118.405 -1.318 . . . . 0.0 110.675 179.182 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.489 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 1.5 m -61.33 95.84 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.644 -0.66 . . . . 0.0 110.395 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.458 ' O ' ' SG ' ' A' ' 116' ' ' CYS . 8.6 m-20 44.57 45.07 7.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.426 -0.796 . . . . 0.0 110.597 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.805 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -151.85 33.4 0.88 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.567 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 3.7 p90 -45.89 -171.39 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 122.743 1.258 . . . . 0.0 112.628 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.798 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -113.85 162.93 15.73 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.194 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.7 t -149.88 28.93 0.75 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.993 -1.067 . . . . 0.0 109.944 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.64 -16.98 7.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 111.235 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -154.08 -87.86 0.06 OUTLIER Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.169 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.616 ' CD2' ' N ' ' A' ' 76' ' ' LYS . 58.5 t80 58.6 170.24 0.06 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.626 -0.926 . . . . 0.0 110.577 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.616 ' N ' ' CD2' ' A' ' 75' ' ' PHE . 4.1 tptt 174.83 134.3 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.403 -0.811 . . . . 0.0 109.842 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 76' ' ' LYS . 2.3 mtt-85 -40.1 -45.16 1.93 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.262 -0.899 . . . . 0.0 110.4 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.457 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 3.6 t -132.86 125.42 29.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.438 -0.789 . . . . 0.0 110.198 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.599 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 14.9 m-85 -101.49 -173.98 2.49 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.146 -0.971 . . . . 0.0 110.506 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -170.41 106.9 0.31 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.148 -0.97 . . . . 0.0 110.971 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.773 ' CB ' HG21 ' A' ' 59' ' ' VAL . 5.1 t80 35.04 32.51 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.107 -0.996 . . . . 0.0 112.118 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.567 ' N ' ' O ' ' A' ' 103' ' ' CYS . 15.5 t30 -177.37 -140.25 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.221 -1.549 . . . . 0.0 111.149 178.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.41 ' C ' HG23 ' A' ' 102' ' ' THR . 1.6 m-20 56.3 73.19 0.45 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.114 -0.991 . . . . 0.0 108.948 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.542 ' N ' HG23 ' A' ' 102' ' ' THR . 7.0 t30 -69.57 112.53 6.13 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.458 -0.776 . . . . 0.0 110.31 -179.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.606 ' O ' HG23 ' A' ' 85' ' ' VAL . 23.1 m -95.03 120.55 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 111.053 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 4.4 t0 -80.77 131.23 35.4 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.798 ' CE1' HD12 ' A' ' 71' ' ' LEU . 46.4 m-85 -91.14 136.9 32.77 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.881 -1.137 . . . . 0.0 111.945 -178.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -115.65 102.5 9.81 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.964 -179.587 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.517 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -49.44 131.31 20.66 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.098 -1.001 . . . . 0.0 110.081 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -39.96 -69.19 0.14 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.477 -0.764 . . . . 0.0 110.347 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.585 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 39.3 t80 -172.86 141.6 1.04 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -0.817 . . . . 0.0 110.21 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 50.99 56.92 12.14 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.585 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 13.2 m-85 -155.29 172.24 18.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.341 -1.093 . . . . 0.0 110.23 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 117' ' ' VAL . 0.7 OUTLIER -133.01 106.98 7.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.294 -0.879 . . . . 0.0 109.86 179.735 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.578 ' CD2' ' HB3' ' A' ' 87' ' ' PHE . 1.1 mt -46.83 99.38 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.194 -0.941 . . . . 0.0 110.675 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.453 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -78.99 101.4 7.76 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.358 -0.839 . . . . 0.0 109.441 179.226 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.86 -89.2 0.19 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.594 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.4 OUTLIER -154.35 116.94 4.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -1.173 . . . . 0.0 110.612 -179.404 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.536 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 2.0 m -83.42 29.83 0.49 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.308 -0.87 . . . . 0.0 110.832 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 65.4 p -170.5 102.56 0.26 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.16 -0.962 . . . . 0.0 109.531 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 85' ' ' VAL . 9.2 m -125.37 172.63 9.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.181 -0.949 . . . . 0.0 111.092 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.542 HG23 ' N ' ' A' ' 84' ' ' ASN . 19.9 m -143.52 142.47 31.14 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.458 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.567 ' O ' ' N ' ' A' ' 82' ' ' ASN . 6.8 t -54.57 100.51 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.399 -0.813 . . . . 0.0 109.124 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.45 ' OG ' ' HE3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -72.99 173.0 6.58 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 120.783 -1.198 . . . . 0.0 111.462 -178.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.833 ' CB ' HD12 ' A' ' 38' ' ' ILE . 47.2 Cg_endo -80.08 25.65 0.6 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.559 1.821 . . . . 0.0 112.451 -178.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -126.57 16.94 6.54 Favored Glycine 0 N--CA 1.484 1.851 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.595 ' O ' HG23 ' A' ' 108' ' ' THR . 0.9 OUTLIER 68.86 51.98 0.55 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.628 -0.925 . . . . 0.0 109.969 -179.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.595 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -160.78 -169.5 2.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.906 . . . . 0.0 111.109 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.688 ' HB3' HD13 ' A' ' 113' ' ' LEU . 36.4 m95 -117.48 99.95 7.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.382 -0.823 . . . . 0.0 110.336 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.52 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 2.8 mtmt -105.56 140.19 20.93 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.537 -0.727 . . . . 0.0 110.071 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.594 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 47.3 Cg_endo -73.54 171.71 64.79 Favored 'Cis proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.809 -2.163 . . . . 0.0 110.434 -0.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.0 OUTLIER -40.8 128.53 2.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.372 -0.83 . . . . 0.0 111.074 -179.419 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.707 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -41.46 147.58 0.47 Allowed Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.511 -0.743 . . . . 0.0 110.541 179.461 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.681 ' HG2' HD12 ' A' ' 66' ' ' ILE . 41.4 Cg_endo -75.53 169.91 21.36 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.342 1.707 . . . . 0.0 111.05 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.832 ' HG2' HG13 ' A' ' 117' ' ' VAL . 30.7 ttmt -128.79 110.62 12.32 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.24 -0.912 . . . . 0.0 110.503 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.554 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 3.2 t -65.95 93.55 0.2 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.012 -1.055 . . . . 0.0 109.351 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.832 HG13 ' HG2' ' A' ' 115' ' ' LYS . 2.3 m -113.21 -174.54 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 121.859 0.838 . . . . 0.0 111.176 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.529 ' HG2' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.792 0 CA-C-O 117.951 -1.024 . . . . 0.0 110.348 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.536 HG22 ' N ' ' A' ' 2' ' ' LYS . 7.0 p . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.248 0.547 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.536 ' N ' HG22 ' A' ' 1' ' ' VAL . 10.5 ptmt -159.84 -177.74 6.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 110.385 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.535 ' O ' ' HB2' ' A' ' 21' ' ' TYR . 1.1 m -133.54 81.16 1.91 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.606 -0.684 . . . . 0.0 109.818 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.631 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 58.4 mt-30 -63.46 178.57 0.54 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.827 -1.171 . . . . 0.0 110.456 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.8 p -46.35 143.83 3.58 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.45 -0.782 . . . . 0.0 109.896 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.889 ' HG3' HG11 ' A' ' 27' ' ' VAL . 48.7 Cg_endo -73.97 151.63 45.25 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.076 1.566 . . . . 0.0 111.204 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.61 171.31 18.03 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.789 1.415 . . . . 0.0 109.956 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.2 p -69.65 175.86 3.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.118 -0.989 . . . . 0.0 110.001 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.744 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -142.25 -170.16 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 122.239 1.019 . . . . 0.0 111.296 179.757 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 3.2 t -51.48 99.47 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.852 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 10' ' ' SER . 1.3 m120 41.66 57.58 3.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.236 -0.915 . . . . 0.0 110.656 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -163.82 148.72 15.25 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.455 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -98.12 -176.85 3.54 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.298 -1.119 . . . . 0.0 110.12 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.623 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 23.8 p80 -143.92 138.65 28.69 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.697 -0.627 . . . . 0.0 109.814 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -166.93 -141.13 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.102 -0.999 . . . . 0.0 110.432 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.72 36.93 1.21 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 53.44 47.21 24.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.394 -1.063 . . . . 0.0 110.235 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.639 ' CB ' ' CE2' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -110.44 -159.74 0.69 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.248 -0.908 . . . . 0.0 109.913 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.421 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 0.4 OUTLIER 174.73 -28.05 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.342 -0.849 . . . . 0.0 110.458 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.631 ' HA ' ' HA ' ' A' ' 4' ' ' GLN . 3.2 p90 -165.45 55.01 0.11 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.143 -0.973 . . . . 0.0 110.722 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.639 ' CE2' ' CB ' ' A' ' 18' ' ' GLU . 19.5 m-85 -43.51 159.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.148 -0.97 . . . . 0.0 110.255 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.471 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -125.35 -59.98 1.36 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.933 -1.104 . . . . 0.0 110.58 -179.218 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.444 ' OD1' ' HA ' ' A' ' 46' ' ' SER . 3.6 t0 -166.37 140.62 4.26 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.472 -0.768 . . . . 0.0 109.618 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 74.36 17.27 79.71 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.584 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 3.1 m -97.54 168.04 10.61 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.474 -1.015 . . . . 0.0 109.936 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.702 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 74.5 t -137.27 158.43 35.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.032 -1.067 . . . . 0.0 111.1 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.896 ' O ' HG23 ' A' ' 43' ' ' VAL . 39.0 t -143.67 107.61 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.426 -0.796 . . . . 0.0 110.957 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.81 105.65 2.41 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 117.974 -1.491 . . . . 0.0 107.722 178.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 1.06 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.0 m-30 -67.78 119.53 12.63 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.613 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -69.64 152.0 45.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.169 -0.957 . . . . 0.0 109.958 -179.86 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.511 ' SG ' HD12 ' A' ' 37' ' ' LEU . 78.6 m -121.81 163.92 18.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 110.424 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 33' ' ' SER . 3.3 m-20 -58.79 138.99 56.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.308 -0.87 . . . . 0.0 110.059 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 32' ' ' ASN . 1.5 m -43.2 104.9 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 110.22 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.51 -32.63 5.14 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -72.66 130.29 40.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.288 -1.125 . . . . 0.0 110.423 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.601 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -78.55 149.39 33.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.328 -0.858 . . . . 0.0 110.897 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.588 ' C ' HD13 ' A' ' 38' ' ' ILE . 2.5 tp -95.09 113.45 25.14 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.414 -0.804 . . . . 0.0 108.858 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.629 HD13 ' N ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -108.7 150.5 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.921 . . . . 0.0 109.298 -179.653 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 125.61 -139.41 11.51 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.35 -1.405 . . . . 0.0 109.697 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.504 ' O ' ' C ' ' A' ' 41' ' ' SER . 0.6 OUTLIER -110.0 51.43 0.76 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.196 -1.179 . . . . 0.0 109.989 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.513 ' HA ' HD21 ' A' ' 37' ' ' LEU . 13.5 p 22.68 50.64 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.345 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.465 ' HA3' ' CG1' ' A' ' 26' ' ' VAL . . . 152.37 131.58 1.71 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.331 -1.414 . . . . 0.0 110.408 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.06 HG21 ' CE1' ' A' ' 29' ' ' TYR . 1.2 t -81.67 121.38 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 178.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.491 ' HA ' ' O ' ' A' ' 25' ' ' SER . 11.6 tp -95.13 103.48 15.33 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 120.277 -1.514 . . . . 0.0 111.385 -178.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.607 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.7 OUTLIER -80.99 121.43 26.04 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.061 178.491 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.444 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 4.7 m -135.14 123.95 23.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.438 -0.789 . . . . 0.0 110.863 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.4 16.08 80.06 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.462 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 87.03 25.9 32.96 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -141.33 103.43 4.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.169 -1.195 . . . . 0.0 110.318 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.607 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 77.9 m95 -56.25 137.31 52.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.913 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 52' ' ' ASP . 10.1 m -140.73 179.45 6.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.93 . . . . 0.0 111.009 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.516 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER 39.25 65.36 3.44 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.666 -0.646 . . . . 0.0 111.177 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.516 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 46.3 Cg_endo -90.14 127.64 1.48 Allowed 'Trans proline' 0 C--N 1.298 -2.122 0 O-C-N 124.356 1.714 . . . . 0.0 109.689 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.527 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 50.8 Cg_endo -76.62 176.78 9.66 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 O-C-N 123.821 1.432 . . . . 0.0 110.746 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.529 ' OG1' ' CG1' ' A' ' 38' ' ' ILE . 9.6 p -119.98 153.37 36.08 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.476 -0.765 . . . . 0.0 111.125 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 10' ' ' SER . 94.6 m -114.11 78.84 1.18 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -115.09 -178.24 3.32 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.3 0.572 . . . . 0.0 110.366 -178.511 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.596 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -95.6 130.1 44.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.305 -0.872 . . . . 0.0 109.299 179.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.601 ' CG1' ' CB ' ' A' ' 36' ' ' SER . 23.4 m -117.3 49.91 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 110.787 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 1.1 mttm -64.83 -163.27 0.02 OUTLIER 'General case' 0 C--N 1.281 -2.393 0 C-N-CA 118.797 -1.161 . . . . 0.0 109.167 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.497 ' SG ' ' HD2' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -151.0 154.56 34.36 Favored Pre-proline 0 C--N 1.291 -1.94 0 C-N-CA 119.167 -1.013 . . . . 0.0 112.179 -179.219 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.561 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 43.2 Cg_endo -81.03 -59.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.54 1.81 . . . . 0.0 108.539 177.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.561 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.2 OUTLIER 157.45 127.2 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.588 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.861 ' HG2' HD21 ' A' ' 71' ' ' LEU . 55.7 Cg_endo -79.91 67.14 8.7 Favored 'Trans proline' 0 C--N 1.296 -2.213 0 O-C-N 123.767 1.404 . . . . 0.0 109.771 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.718 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -92.96 177.04 6.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.334 -0.854 . . . . 0.0 109.363 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.876 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -174.82 162.87 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 119.155 -1.018 . . . . 0.0 110.303 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 68' ' ' ASN . 3.0 t -67.32 108.08 2.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.514 -0.741 . . . . 0.0 111.054 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 31.2 m-80 38.69 34.93 0.09 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.593 -0.692 . . . . 0.0 110.853 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.876 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -145.92 35.98 1.35 Allowed Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.359 -1.4 . . . . 0.0 110.001 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.671 ' HA ' HG23 ' A' ' 66' ' ' ILE . 5.1 p90 -48.28 -163.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 123.169 1.461 . . . . 0.0 112.287 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.032 HD11 ' HB2' ' A' ' 75' ' ' PHE . 1.9 pp -117.66 124.6 48.95 Favored 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 114.341 -1.3 . . . . 0.0 110.11 -178.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.512 ' HB3' ' HB2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -92.61 9.99 32.36 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.479 -0.763 . . . . 0.0 109.534 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.28 -71.73 0.43 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.382 -0.824 . . . . 0.0 110.652 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -172.55 98.5 0.13 Allowed Glycine 0 N--CA 1.489 2.197 0 C-N-CA 119.781 -1.2 . . . . 0.0 110.121 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 1.032 ' HB2' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -98.78 174.9 6.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.427 -1.043 . . . . 0.0 109.576 179.529 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.561 ' N ' ' CG ' ' A' ' 75' ' ' PHE . 3.3 ttmt -166.54 168.39 14.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.339 -0.85 . . . . 0.0 109.873 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.55 -31.03 61.8 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.754 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.462 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 0.5 OUTLIER -155.26 163.3 40.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.14 -0.975 . . . . 0.0 110.447 -179.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.608 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 10.2 m-85 -133.83 -164.97 1.57 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.262 -0.899 . . . . 0.0 110.401 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.553 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 40.9 p -143.22 -149.25 0.26 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.394 -0.817 . . . . 0.0 109.383 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.596 ' CB ' HG21 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -70.67 144.74 50.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.632 -1.293 . . . . 0.0 108.508 179.052 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.759 ' C ' HG22 ' A' ' 102' ' ' THR . 34.8 t-20 65.45 -111.85 0.23 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.328 -0.857 . . . . 0.0 110.704 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 1.0 OUTLIER 46.43 84.42 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.617 -1.302 . . . . 0.0 108.207 -178.31 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.0 OUTLIER -85.5 135.01 34.01 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.464 -0.772 . . . . 0.0 112.143 -177.595 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.738 ' HB ' HD22 ' A' ' 71' ' ' LEU . 6.3 m -119.94 118.95 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.312 -0.867 . . . . 0.0 109.435 177.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 20.0 t0 -73.61 134.56 43.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.092 -1.005 . . . . 0.0 109.16 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.684 ' CD1' HG21 ' A' ' 66' ' ' ILE . 28.2 m-85 -94.25 129.35 40.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.071 -1.018 . . . . 0.0 111.144 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.571 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -106.67 96.11 6.21 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.806 -179.124 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.435 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -47.56 133.63 13.03 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.904 -1.122 . . . . 0.0 109.217 179.199 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -40.43 -85.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.272 -0.892 . . . . 0.0 110.269 -179.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.472 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 1.0 OUTLIER -163.65 135.01 4.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.458 -0.776 . . . . 0.0 109.922 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.72 48.94 62.58 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.081 -1.607 . . . . 0.0 109.081 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.536 ' CB ' ' SG ' ' A' ' 116' ' ' CYS . 36.2 m-85 -153.04 170.01 21.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.442 -1.034 . . . . 0.0 110.131 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.537 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 1.0 OUTLIER -131.17 107.46 9.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.271 -0.893 . . . . 0.0 109.656 179.432 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.776 HD22 ' HB2' ' A' ' 114' ' ' PRO . 43.0 mt -46.87 102.76 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.187 -0.945 . . . . 0.0 110.623 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.473 ' HB2' HG21 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -81.15 98.13 7.91 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.39 -0.819 . . . . 0.0 109.29 179.067 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.87 -86.3 0.17 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.585 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -160.4 124.51 3.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.157 -1.202 . . . . 0.0 110.734 -179.489 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.46 ' OG ' ' N ' ' A' ' 100' ' ' SER . 13.3 p -70.03 -55.99 8.11 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.101 -0.999 . . . . 0.0 110.574 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.46 ' N ' ' OG ' ' A' ' 99' ' ' SER . 54.7 p -94.75 121.5 36.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.286 -0.884 . . . . 0.0 110.127 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 29.6 m -121.42 -174.64 2.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.892 . . . . 0.0 110.119 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.759 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -157.28 128.5 6.79 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.324 -0.86 . . . . 0.0 110.735 179.658 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.555 ' N ' ' O ' ' A' ' 82' ' ' ASN . 46.9 t -65.52 91.93 0.13 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.746 -0.596 . . . . 0.0 109.613 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.465 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -71.58 -179.89 0.84 Allowed Pre-proline 0 C--N 1.298 -1.644 0 O-C-N 121.403 -0.811 . . . . 0.0 110.863 -179.339 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.597 ' HG3' HG23 ' A' ' 38' ' ' ILE . 42.7 Cg_endo -80.55 121.61 4.27 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 O-C-N 124.467 1.772 . . . . 0.0 110.424 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.577 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 132.21 -3.6 5.19 Favored Glycine 0 N--CA 1.481 1.638 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.853 ' O ' HG23 ' A' ' 108' ' ' THR . 1.0 OUTLIER 80.71 88.08 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.777 -0.837 . . . . 0.0 111.264 179.431 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.853 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 176.66 -164.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 111.523 179.15 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.661 ' HB3' HD13 ' A' ' 113' ' ' LEU . 28.6 m95 -139.68 90.02 2.37 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.412 0.625 . . . . 0.0 110.13 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.544 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 1.5 mmtp -99.3 141.25 22.51 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.408 -0.808 . . . . 0.0 110.15 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.585 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.0 Cg_endo -72.0 173.33 52.56 Favored 'Cis proline' 0 C--N 1.312 -1.348 0 C-N-CA 122.034 -2.069 . . . . 0.0 110.811 -0.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 111' ' ' PRO . 10.2 pt-20 -40.81 137.83 1.13 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.398 -0.814 . . . . 0.0 110.801 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.7 HD23 ' O ' ' A' ' 65' ' ' THR . 0.3 OUTLIER -53.09 144.55 27.75 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.416 -0.802 . . . . 0.0 110.342 179.639 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.776 ' HB2' HD22 ' A' ' 95' ' ' LEU . 43.4 Cg_endo -72.22 163.62 38.13 Favored 'Trans proline' 0 C--N 1.302 -1.885 0 O-C-N 124.224 1.644 . . . . 0.0 111.12 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.55 ' HG2' HG13 ' A' ' 117' ' ' VAL . 9.4 tttt -127.84 115.39 18.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.456 -0.778 . . . . 0.0 109.848 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.536 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 0.8 OUTLIER -66.29 100.94 0.67 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.034 -1.041 . . . . 0.0 109.651 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.55 HG13 ' HG2' ' A' ' 115' ' ' LYS . 0.7 OUTLIER -118.22 -177.19 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 121.625 0.726 . . . . 0.0 110.931 -179.538 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.7 mtp-105 . . . . . 0 C--N 1.295 -1.797 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.53 179.937 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 1' ' ' VAL . 7.7 p . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 121.24 0.543 . . . . 0.0 110.115 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -135.13 103.89 5.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 110.332 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.612 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 37.3 t -68.98 155.87 39.58 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.669 -0.644 . . . . 0.0 110.486 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.423 ' O ' ' C ' ' A' ' 5' ' ' SER . 69.6 mt-30 -140.08 -177.09 4.84 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.356 -0.84 . . . . 0.0 109.644 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.2 OUTLIER -42.05 133.02 2.51 Favored Pre-proline 0 C--N 1.297 -1.683 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.123 -179.666 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.781 ' HG3' HG11 ' A' ' 27' ' ' VAL . 51.8 Cg_endo -70.14 157.41 59.74 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.12 1.589 . . . . 0.0 111.112 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -75.66 172.23 16.71 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.969 1.51 . . . . 0.0 110.109 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.46 175.26 4.9 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.208 -0.932 . . . . 0.0 109.94 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.65 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -139.58 -170.36 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 122.241 1.02 . . . . 0.0 111.412 179.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 11' ' ' ASN . 39.2 m -45.38 97.26 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.484 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 9' ' ' ILE . 2.5 m-20 43.14 47.26 5.26 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.294 -0.879 . . . . 0.0 110.511 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -152.4 155.67 26.26 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.466 ' N ' ' O ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -104.58 -166.42 1.24 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.347 -1.09 . . . . 0.0 110.659 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.583 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 14.6 p80 -151.74 121.79 7.14 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.104 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -119.32 123.11 43.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.202 -0.936 . . . . 0.0 110.33 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.71 -5.44 6.42 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.41 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 0.5 OUTLIER 55.49 55.99 6.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -1.149 . . . . 0.0 110.075 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.555 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 2.6 pp20? -178.59 -162.67 0.06 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.3 -0.875 . . . . 0.0 110.223 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.414 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 1.1 t0 -136.4 -42.62 0.62 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.358 -0.839 . . . . 0.0 109.844 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.431 ' CD1' ' C ' ' A' ' 20' ' ' PHE . 21.2 p90 -111.53 140.65 45.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.332 -0.855 . . . . 0.0 109.844 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.644 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.5 OUTLIER -122.65 -12.06 8.16 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.28 -0.888 . . . . 0.0 110.432 -179.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.564 HG22 ' N ' ' A' ' 23' ' ' ASP . 82.8 m 52.61 -99.15 0.08 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.458 -0.776 . . . . 0.0 111.173 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.564 ' N ' HG22 ' A' ' 22' ' ' THR . 0.4 OUTLIER -151.63 157.45 42.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.19 -0.943 . . . . 0.0 109.995 -179.248 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.59 16.0 80.31 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.644 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 30.4 m -99.34 173.99 6.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.434 -1.039 . . . . 0.0 110.316 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.797 HG13 ' O ' ' A' ' 43' ' ' VAL . 28.2 t -151.66 154.75 7.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.318 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.781 HG11 ' HG3' ' A' ' 6' ' ' PRO . 17.4 t -136.52 114.32 14.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 119.349 -0.941 . . . . 0.0 111.459 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -69.29 104.09 2.14 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 118.397 -1.321 . . . . 0.0 107.77 178.12 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.65 ' CE2' HG21 ' A' ' 9' ' ' ILE . 2.1 m-30 -68.09 144.87 54.88 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.431 -0.793 . . . . 0.0 110.287 -178.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -100.08 153.16 19.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.389 -0.819 . . . . 0.0 109.591 179.214 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.567 ' SG ' HD12 ' A' ' 37' ' ' LEU . 57.1 m -125.0 160.46 28.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.149 -0.969 . . . . 0.0 110.515 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -49.55 157.61 0.52 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.445 -0.785 . . . . 0.0 110.102 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.29 99.71 0.74 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.221 -0.924 . . . . 0.0 110.261 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.25 10.44 5.6 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 -107.99 166.35 10.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -1.15 . . . . 0.0 110.295 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 1.008 ' HB3' HG22 ' A' ' 59' ' ' VAL . 4.8 p -108.27 133.57 52.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.433 -0.792 . . . . 0.0 110.649 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.567 HD12 ' SG ' ' A' ' 31' ' ' CYS . 0.6 OUTLIER -95.1 109.82 21.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -0.955 . . . . 0.0 109.697 179.178 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.767 HG23 ' HG3' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -105.19 140.09 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.252 -0.905 . . . . 0.0 108.962 179.556 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.95 -156.81 24.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.488 ' O ' ' C ' ' A' ' 41' ' ' SER . 4.7 m-20 -99.5 51.19 0.93 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -1.153 . . . . 0.0 109.848 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.493 ' O ' HG23 ' A' ' 28' ' ' THR . 59.2 p 27.22 57.41 0.08 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.803 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.619 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 144.06 114.88 0.99 Allowed Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.158 -1.496 . . . . 0.0 110.73 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.797 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -55.06 -177.65 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.081 -1.247 . . . . 0.0 107.636 178.426 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.524 ' HA ' ' O ' ' A' ' 25' ' ' SER . 5.0 tp -145.87 93.02 2.28 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.313 -0.867 . . . . 0.0 110.106 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.609 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.8 OUTLIER -74.19 118.9 17.67 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.173 -0.955 . . . . 0.0 109.455 179.379 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.2 t -129.73 76.12 1.7 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.114 -0.991 . . . . 0.0 110.804 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.74 53.43 0.71 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 58.13 26.17 58.15 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -145.75 119.12 8.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -1.181 . . . . 0.0 109.917 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.612 ' CE2' ' SG ' ' A' ' 3' ' ' CYS . 91.7 m95 -81.68 133.36 35.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.881 . . . . 0.0 110.358 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.31 165.28 26.14 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.196 -0.94 . . . . 0.0 110.72 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.538 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 1.1 t0 55.1 64.54 5.67 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.559 -0.713 . . . . 0.0 111.0 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.538 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.5 Cg_endo -91.8 136.14 1.71 Allowed 'Trans proline' 0 C--N 1.3 -2.007 0 O-C-N 124.347 1.709 . . . . 0.0 109.491 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 43.4 Cg_endo -75.09 175.26 11.48 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 O-C-N 123.58 1.305 . . . . 0.0 110.397 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 6.3 p -121.98 145.39 48.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.32 -0.863 . . . . 0.0 111.656 -178.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.441 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 77.4 m -105.93 83.01 1.85 Allowed 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.493 ' OE1' HG13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -110.46 -145.54 0.4 Allowed 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.735 -0.603 . . . . 0.0 110.193 -178.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.605 ' N ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -137.05 100.15 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.158 -0.963 . . . . 0.0 108.909 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 1.059 HG21 ' HB3' ' A' ' 81' ' ' TYR . 31.8 m -102.09 64.28 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.255 -0.903 . . . . 0.0 112.213 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 2.0 mptp? -66.97 176.51 2.05 Favored 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 117.541 -1.663 . . . . 0.0 107.306 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.529 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 1.1 m -130.63 166.59 26.02 Favored Pre-proline 0 N--CA 1.494 1.73 0 C-N-CA 117.996 -1.482 . . . . 0.0 113.904 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.588 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 44.5 Cg_endo -88.88 -76.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 125.01 2.058 . . . . 0.0 110.735 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.588 ' CD2' ' O ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER 169.9 124.12 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.263 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.613 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 48.1 Cg_endo -76.09 71.1 5.8 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 123.58 1.305 . . . . 0.0 109.661 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.689 ' C ' HG22 ' A' ' 66' ' ' ILE . 1.1 p -89.39 -174.62 4.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.394 -0.816 . . . . 0.0 109.826 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.806 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -179.95 167.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.181 179.248 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.492 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 31.8 t -72.31 95.45 1.72 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.566 -0.709 . . . . 0.0 110.827 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 80.0 m-20 46.58 43.62 12.61 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.358 -0.839 . . . . 0.0 110.894 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.806 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -151.61 32.81 0.91 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.577 ' O ' ' N ' ' A' ' 88' ' ' LYS . 1.9 p90 -44.9 -174.99 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 122.697 1.237 . . . . 0.0 112.522 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.678 ' H ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -108.0 168.16 9.48 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.442 179.4 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.8 14.91 0.84 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.943 -1.098 . . . . 0.0 110.009 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.488 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -95.21 -55.46 3.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.312 -0.867 . . . . 0.0 110.557 -179.708 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.606 ' O ' HG12 ' A' ' 85' ' ' VAL . . . -153.09 88.8 0.13 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.615 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -109.44 162.79 14.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.288 -1.125 . . . . 0.0 109.717 179.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.615 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -159.51 155.53 26.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.134 -0.979 . . . . 0.0 110.458 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.0 mtp180 -56.62 -40.08 74.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.224 -0.922 . . . . 0.0 110.027 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.2 t -136.89 127.36 26.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.425 -0.797 . . . . 0.0 110.11 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.585 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 14.5 m-85 -102.35 -146.96 0.37 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.138 -0.977 . . . . 0.0 110.217 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 60.0 p -160.03 -119.85 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.371 -0.83 . . . . 0.0 109.773 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 1.059 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -109.13 35.39 3.28 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.829 -1.169 . . . . 0.0 110.536 -179.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.698 ' C ' HG22 ' A' ' 102' ' ' THR . 0.1 OUTLIER -169.76 -109.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.159 -0.963 . . . . 0.0 110.296 179.425 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.449 ' OD2' ' ND2' ' A' ' 82' ' ' ASN . 8.1 m-20 42.99 75.47 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.96 -1.088 . . . . 0.0 109.761 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.817 ' CA ' HG23 ' A' ' 102' ' ' THR . 9.4 p30 -69.53 120.37 15.21 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.259 -0.9 . . . . 0.0 110.206 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.844 HG23 ' CE1' ' A' ' 87' ' ' PHE . 33.8 m -108.14 118.35 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.86 -1.15 . . . . 0.0 111.029 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.538 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 9.0 t0 -76.91 134.49 38.94 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.844 ' CE1' HG23 ' A' ' 85' ' ' VAL . 48.8 m-85 -93.87 127.4 39.61 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.009 -1.057 . . . . 0.0 112.42 -177.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.577 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -102.69 110.08 21.9 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.091 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.453 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -56.64 132.5 51.99 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.004 -1.06 . . . . 0.0 109.855 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 89' ' ' CYS . 0.3 OUTLIER -39.93 -69.95 0.12 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.483 -0.761 . . . . 0.0 110.33 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.537 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.3 OUTLIER -171.77 136.86 0.96 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.324 -0.86 . . . . 0.0 110.277 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.584 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 50.6 58.77 8.65 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.116 -1.593 . . . . 0.0 109.116 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 9.9 m-85 -160.66 152.48 19.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.432 -1.04 . . . . 0.0 110.162 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -105.74 142.55 35.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -0.846 . . . . 0.0 109.596 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.615 HD23 ' HB2' ' A' ' 114' ' ' PRO . 0.7 OUTLIER -84.05 93.66 8.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.08 -1.013 . . . . 0.0 110.423 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.459 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -70.4 102.45 2.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.267 -0.895 . . . . 0.0 109.671 179.554 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.52 -93.1 0.19 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.586 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.2 OUTLIER -152.47 118.74 5.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.158 -1.201 . . . . 0.0 110.491 -179.523 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.16 5.07 1.8 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.285 -0.884 . . . . 0.0 111.641 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.492 ' OG ' ' HA ' ' A' ' 86' ' ' ASP . 0.6 OUTLIER -161.87 119.77 2.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.702 -1.249 . . . . 0.0 109.896 179.409 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.467 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 3.1 m -129.63 168.2 16.81 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.408 -0.808 . . . . 0.0 110.482 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.817 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -130.71 140.67 50.36 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.298 179.764 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.559 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -72.56 84.98 1.15 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.761 -0.587 . . . . 0.0 110.564 -179.53 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.475 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -62.7 174.22 0.86 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.285 -0.885 . . . . 0.0 111.197 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.82 ' CB ' HG11 ' A' ' 59' ' ' VAL . 40.8 Cg_endo -72.68 125.45 10.57 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 O-C-N 124.551 1.816 . . . . 0.0 110.626 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.574 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 129.77 -11.54 5.97 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.633 ' O ' HG23 ' A' ' 108' ' ' THR . 0.6 OUTLIER 82.5 90.25 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 122.014 -0.698 . . . . 0.0 110.366 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.633 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -179.86 -166.35 0.08 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.492 -0.755 . . . . 0.0 110.407 179.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.74 ' HB3' HD11 ' A' ' 113' ' ' LEU . 38.8 m95 -141.66 92.7 2.48 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.46 -0.775 . . . . 0.0 110.379 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.532 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 6.2 mttt -104.5 139.86 20.52 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.57 -0.706 . . . . 0.0 109.69 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.586 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 46.3 Cg_endo -71.63 166.59 78.21 Favored 'Cis proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.033 -2.069 . . . . 0.0 111.207 -0.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 111' ' ' PRO . 2.9 tt0 -38.31 133.94 0.91 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.684 -0.635 . . . . 0.0 110.976 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.777 HD22 ' H ' ' A' ' 113' ' ' LEU . 0.9 OUTLIER -45.67 148.24 1.35 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.902 . . . . 0.0 109.684 179.412 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.736 ' HG2' HD12 ' A' ' 66' ' ' ILE . 42.2 Cg_endo -74.35 170.92 19.13 Favored 'Trans proline' 0 C--N 1.299 -2.067 0 O-C-N 124.253 1.659 . . . . 0.0 110.851 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.67 ' HG2' HG13 ' A' ' 117' ' ' VAL . 35.7 tttt -128.93 111.44 13.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.161 -0.962 . . . . 0.0 110.449 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.544 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 3.8 t -67.29 81.79 0.14 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.797 0.808 . . . . 0.0 109.83 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.67 HG13 ' HG2' ' A' ' 115' ' ' LYS . 1.4 m -97.4 -169.29 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.904 0.859 . . . . 0.0 110.717 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.469 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.293 -1.876 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.505 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.427 HG21 ' C ' ' A' ' 47' ' ' GLY . 3.4 m . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.285 0.564 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.8 mttm -94.4 169.86 9.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.218 -0.926 . . . . 0.0 110.549 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.617 ' CB ' ' N ' ' A' ' 22' ' ' THR . 0.7 OUTLIER -129.14 146.68 51.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.302 -0.874 . . . . 0.0 110.401 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 19' ' ' ASP . 0.5 OUTLIER -128.92 177.42 7.12 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.506 -0.746 . . . . 0.0 109.578 179.496 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.02 136.45 14.2 Favored Pre-proline 0 C--N 1.298 -1.656 0 O-C-N 121.26 -0.9 . . . . 0.0 109.706 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.657 ' HG3' HG11 ' A' ' 27' ' ' VAL . 48.5 Cg_endo -69.37 163.51 37.67 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.052 1.554 . . . . 0.0 111.08 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.95 170.25 20.21 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.896 1.472 . . . . 0.0 109.618 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.482 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -87.17 105.47 17.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.106 -0.996 . . . . 0.0 109.973 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.755 HD12 ' OD1' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -47.34 -179.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-O 121.861 0.839 . . . . 0.0 111.059 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 11' ' ' ASN . 0.4 OUTLIER -103.55 69.28 0.98 Allowed 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.975 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.755 ' OD1' HD12 ' A' ' 9' ' ' ILE . 3.1 p30 164.4 -24.23 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.595 -0.69 . . . . 0.0 109.786 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.402 ' HA3' ' SG ' ' A' ' 56' ' ' CYS . . . -145.91 -160.61 8.76 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -126.77 -175.7 3.48 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.476 -1.014 . . . . 0.0 109.358 179.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.612 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 10.2 p80 -137.23 160.89 37.72 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.308 -0.87 . . . . 0.0 110.768 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 14' ' ' HIS . 26.7 p-10 -38.54 146.81 0.06 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.541 -0.724 . . . . 0.0 110.985 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -137.83 18.34 3.38 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.76 -26.46 9.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.296 -1.12 . . . . 0.0 110.258 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -81.64 -147.53 0.07 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.939 . . . . 0.0 109.827 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 20' ' ' PHE . 3.7 p30 178.53 -34.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.597 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.508 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 9.5 m-85 -124.58 133.78 53.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -0.929 . . . . 0.0 109.9 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.67 ' CD2' ' HB3' ' A' ' 25' ' ' SER . 2.8 m-85 -127.82 -9.87 5.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.068 -1.02 . . . . 0.0 111.132 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.617 ' N ' ' CB ' ' A' ' 3' ' ' CYS . 69.6 p 37.82 -98.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.507 -0.745 . . . . 0.0 111.424 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.486 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 23.0 t0 -150.65 138.88 20.27 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.991 -1.068 . . . . 0.0 110.488 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.43 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 91.09 22.7 31.84 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.67 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 50.8 m -118.27 163.82 16.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.306 -1.114 . . . . 0.0 110.073 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.87 HG13 ' O ' ' A' ' 43' ' ' VAL . 19.6 t -139.58 149.85 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.029 -1.044 . . . . 0.0 112.289 -178.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.657 HG11 ' HG3' ' A' ' 6' ' ' PRO . 18.1 t -122.26 114.13 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-O 121.356 0.598 . . . . 0.0 112.007 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.794 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -71.51 105.63 3.68 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.437 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.888 ' O ' HD13 ' A' ' 37' ' ' LEU . 2.8 m-30 -67.82 136.1 53.61 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.729 -178.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 13' ' ' ARG . 6.3 m -73.46 -173.64 1.46 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.99 -1.069 . . . . 0.0 109.301 179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -154.74 137.12 14.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.974 -1.079 . . . . 0.0 110.803 -179.642 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -44.84 159.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.342 -0.849 . . . . 0.0 109.775 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.99 97.63 0.69 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.215 -0.928 . . . . 0.0 110.401 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 129.22 -20.85 5.26 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.511 ' CD2' ' O ' ' A' ' 56' ' ' CYS . 2.5 m-30 -92.33 139.31 30.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.197 -1.178 . . . . 0.0 110.627 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.659 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -91.03 144.4 25.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.294 -0.879 . . . . 0.0 110.73 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.888 HD13 ' O ' ' A' ' 29' ' ' TYR . 2.4 tp -91.36 113.75 26.09 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.415 -0.803 . . . . 0.0 109.798 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.854 HG23 ' HG3' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -107.21 149.89 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.223 -0.923 . . . . 0.0 109.748 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 129.32 -153.39 19.86 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.507 ' O ' ' C ' ' A' ' 41' ' ' SER . 1.2 t30 -92.4 50.72 1.65 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.079 -1.248 . . . . 0.0 109.765 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.794 ' O ' HG23 ' A' ' 28' ' ' THR . 13.7 p 26.44 43.03 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.708 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.713 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 152.7 123.21 0.97 Allowed Glycine 0 N--CA 1.49 2.27 0 C-N-CA 119.229 -1.463 . . . . 0.0 110.694 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.87 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.6 t -58.15 -178.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.563 HD12 HG23 ' A' ' 26' ' ' VAL . 10.8 tp -147.81 97.99 2.89 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.722 -1.191 . . . . 0.0 110.684 178.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.483 ' HB2' ' CD2' ' A' ' 50' ' ' TRP . 14.6 t -78.39 115.54 18.18 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.41 179.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.47 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 4.7 m -124.48 81.82 1.98 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.551 -0.718 . . . . 0.0 110.272 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.486 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 93.64 56.85 1.39 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.67 23.15 9.55 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -126.04 82.04 2.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.284 -1.127 . . . . 0.0 110.681 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.538 ' HH2' ' CD2' ' A' ' 21' ' ' TYR . 67.0 m95 -54.33 128.52 31.84 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.15 -0.969 . . . . 0.0 109.148 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.407 ' O ' ' CB ' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -148.07 157.06 43.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.935 -1.103 . . . . 0.0 111.474 -179.328 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.503 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 4.8 t0 66.66 65.79 0.73 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.796 -0.565 . . . . 0.0 111.348 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.503 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.9 Cg_endo -91.45 141.49 2.75 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 O-C-N 124.37 1.721 . . . . 0.0 109.986 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.547 ' HG2' ' HB2' ' A' ' 29' ' ' TYR . 51.8 Cg_endo -80.11 -179.31 5.15 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 O-C-N 123.891 1.469 . . . . 0.0 110.308 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.567 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 8.6 p -117.91 -172.28 2.22 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.971 0.891 . . . . 0.0 111.104 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.511 ' O ' ' CD2' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -147.8 79.62 1.48 Allowed 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.778 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -113.42 -152.27 0.5 Allowed 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.004 -178.605 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.737 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -118.76 128.53 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.169 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.67 HG21 ' HB3' ' A' ' 81' ' ' TYR . 26.0 m -120.39 48.17 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.896 -1.127 . . . . 0.0 112.346 -178.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -60.94 164.07 5.25 Favored 'General case' 0 C--N 1.278 -2.519 0 C-N-CA 117.581 -1.648 . . . . 0.0 107.558 178.788 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 79' ' ' TYR . 35.5 m -131.98 161.33 63.31 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 120.603 -1.311 . . . . 0.0 111.749 -178.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 43.5 Cg_endo -75.79 -84.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.832 0 O-C-N 124.565 1.824 . . . . 0.0 110.251 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -179.84 128.43 0.24 Allowed Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 121.552 -0.717 . . . . 0.0 109.167 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.664 ' CB ' HG21 ' A' ' 85' ' ' VAL . 54.2 Cg_endo -77.97 67.14 8.13 Favored 'Trans proline' 0 C--N 1.298 -2.081 0 O-C-N 123.773 1.407 . . . . 0.0 109.744 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.509 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -87.11 175.27 8.17 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.383 -0.823 . . . . 0.0 110.199 -179.691 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.803 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -170.21 165.49 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 110.211 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.449 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 17.5 m -74.6 106.14 6.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.451 -0.781 . . . . 0.0 110.724 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.435 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 5.1 m120 41.54 41.13 1.53 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.344 -0.848 . . . . 0.0 110.718 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.803 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -150.61 32.52 1.0 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.573 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 5.5 p90 -44.13 -173.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 122.826 1.298 . . . . 0.0 112.657 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.704 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -111.04 162.23 15.08 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.392 179.42 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.06 20.03 1.42 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.961 -1.087 . . . . 0.0 110.103 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.3 t -103.03 -67.82 0.86 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.254 -0.904 . . . . 0.0 110.693 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.406 ' O ' HG12 ' A' ' 85' ' ' VAL . . . -137.85 82.9 0.26 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.631 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 2.5 t80 -110.3 163.86 13.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.358 -1.083 . . . . 0.0 110.238 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.631 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 19.7 tttm -164.17 153.3 13.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.883 . . . . 0.0 110.007 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -51.72 -28.33 14.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 0.0 109.822 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.5 m -144.54 158.18 43.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.417 -0.802 . . . . 0.0 110.436 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.569 ' OH ' ' CE2' ' A' ' 75' ' ' PHE . 10.9 m-85 -131.27 -149.55 0.39 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.401 -0.812 . . . . 0.0 109.572 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.638 ' CA ' HG23 ' A' ' 59' ' ' VAL . 94.8 p -157.46 -108.84 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.73 -1.231 . . . . 0.0 110.984 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.67 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -108.16 23.36 14.6 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.286 -1.509 . . . . 0.0 110.467 -179.525 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.743 ' C ' HG22 ' A' ' 102' ' ' THR . 47.6 t30 -171.31 -97.01 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.152 -0.968 . . . . 0.0 110.424 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 82' ' ' ASN . 5.0 m-20 42.05 72.48 0.17 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 109.546 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.813 ' CA ' HG23 ' A' ' 102' ' ' THR . 0.4 OUTLIER -68.62 137.5 54.28 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.345 -179.065 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.664 HG21 ' CB ' ' A' ' 64' ' ' PRO . 16.0 m -117.79 120.19 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.143 -0.973 . . . . 0.0 110.552 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -78.07 128.12 33.35 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.57 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.708 ' CD1' HG21 ' A' ' 66' ' ' ILE . 32.6 m-85 -89.17 125.14 34.93 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.031 -1.043 . . . . 0.0 112.087 -178.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.565 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -100.11 93.05 5.52 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.922 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.495 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -44.3 133.81 5.29 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.014 -1.054 . . . . 0.0 109.923 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -39.5 -72.47 0.06 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.515 -0.741 . . . . 0.0 110.345 -179.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.454 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 5.5 t80 -175.92 144.68 0.62 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.299 -0.876 . . . . 0.0 110.018 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.548 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 52.55 31.91 37.69 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.548 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 13.9 m-85 -141.67 146.96 36.75 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.514 -0.992 . . . . 0.0 110.097 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 116' ' ' CYS . 19.0 mttt -104.0 155.6 18.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.355 -0.84 . . . . 0.0 109.27 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.576 ' CD2' ' HB3' ' A' ' 87' ' ' PHE . 0.8 OUTLIER -91.93 100.86 13.45 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.736 -1.227 . . . . 0.0 110.5 -179.587 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.62 100.78 7.14 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.442 -0.786 . . . . 0.0 109.559 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.2 -81.02 0.22 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.586 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -167.16 114.8 0.8 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.228 -1.16 . . . . 0.0 110.774 -179.32 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -61.49 -48.5 80.79 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.203 -0.935 . . . . 0.0 110.74 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.2 p -101.24 130.63 47.39 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.191 -0.943 . . . . 0.0 109.87 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 11.6 m -140.89 158.71 43.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.156 -0.965 . . . . 0.0 110.743 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.813 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -134.88 140.31 45.69 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.515 -0.741 . . . . 0.0 109.652 179.625 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.609 ' O ' ' CB ' ' A' ' 104' ' ' SER . 0.7 OUTLIER -59.08 -59.18 5.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.241 -0.912 . . . . 0.0 111.057 -178.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.609 ' CB ' ' O ' ' A' ' 103' ' ' CYS . 0.2 OUTLIER 82.92 161.93 0.12 Allowed Pre-proline 0 C--N 1.292 -1.934 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -178.76 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.854 ' HG3' HG23 ' A' ' 38' ' ' ILE . 38.3 Cg_endo -67.1 120.28 7.35 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.767 1.404 . . . . 0.0 111.2 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 130.99 -9.09 5.72 Favored Glycine 0 N--CA 1.481 1.665 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.927 ' O ' HG23 ' A' ' 108' ' ' THR . 0.1 OUTLIER 77.66 105.34 0.07 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.592 -0.946 . . . . 0.0 111.103 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.927 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER 171.67 -148.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.426 -0.796 . . . . 0.0 110.711 179.345 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.678 ' HB3' HD11 ' A' ' 113' ' ' LEU . 22.3 m95 -163.32 66.31 0.18 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.345 -0.847 . . . . 0.0 109.617 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.527 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.2 OUTLIER -83.81 140.27 40.6 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.508 -0.745 . . . . 0.0 110.238 -179.625 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.586 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 44.8 Cg_endo -72.48 165.44 83.13 Favored 'Cis proline' 0 C--N 1.313 -1.336 0 C-N-CA 121.901 -2.125 . . . . 0.0 110.682 -0.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.5 pm0 -37.5 140.75 0.2 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.675 -0.641 . . . . 0.0 110.888 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.767 HD22 ' H ' ' A' ' 113' ' ' LEU . 1.2 mm? -50.68 146.3 9.92 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.361 -0.837 . . . . 0.0 109.696 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.744 ' HG2' HD12 ' A' ' 66' ' ' ILE . 37.6 Cg_endo -71.02 168.51 22.98 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 124.181 1.621 . . . . 0.0 111.268 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.574 ' HG2' HG13 ' A' ' 117' ' ' VAL . 5.0 ttpt -128.12 111.97 14.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.342 -0.849 . . . . 0.0 110.355 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.54 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.1 t -68.0 100.14 0.94 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 109.33 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.574 HG13 ' HG2' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -113.78 -178.58 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.483 0.659 . . . . 0.0 110.367 -179.487 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.533 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 6.5 ptt180 . . . . . 0 C--N 1.295 -1.784 0 C-N-CA 118.871 -1.131 . . . . 0.0 110.51 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.6 m . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.327 0.584 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.547 ' HG2' HG22 ' A' ' 22' ' ' THR . 0.0 OUTLIER -112.97 166.61 11.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.324 -0.86 . . . . 0.0 109.971 179.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.464 ' O ' ' O ' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -96.68 83.23 3.42 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.054 -1.029 . . . . 0.0 109.784 179.81 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.536 ' HA ' ' O ' ' A' ' 19' ' ' ASP . 0.6 OUTLIER -47.53 173.12 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.89 -1.131 . . . . 0.0 109.601 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.473 ' N ' ' O ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -42.84 135.59 2.78 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.256 -0.902 . . . . 0.0 109.974 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.774 ' CG ' HG11 ' A' ' 27' ' ' VAL . 51.6 Cg_endo -70.75 151.35 63.34 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.855 1.45 . . . . 0.0 110.754 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.61 170.46 20.18 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 123.938 1.494 . . . . 0.0 110.469 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.71 174.64 4.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.339 -0.851 . . . . 0.0 109.961 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.615 HD11 ' HB3' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -144.84 -170.0 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 122.198 0.999 . . . . 0.0 111.401 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' A' ' 56' ' ' CYS . 7.1 m -40.32 99.34 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.998 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 32' ' ' ASN . 1.6 m-80 40.91 28.13 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.374 -0.828 . . . . 0.0 110.565 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -132.13 157.23 22.37 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -112.35 -165.85 1.03 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.47 -1.018 . . . . 0.0 110.586 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.643 ' HB2' HG11 ' A' ' 27' ' ' VAL . 10.3 p80 -148.76 122.84 9.47 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.105 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -113.53 -167.0 1.14 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.172 -0.955 . . . . 0.0 110.446 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 145.49 -15.31 1.83 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 61.13 59.13 2.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.424 -1.045 . . . . 0.0 110.408 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.539 ' OE1' ' CD2' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -174.17 -174.63 0.92 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.176 -0.953 . . . . 0.0 110.449 179.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.536 ' O ' ' HA ' ' A' ' 4' ' ' GLN . 7.8 t70 -131.73 -41.57 1.05 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.405 -0.809 . . . . 0.0 109.71 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 m-30 -106.43 143.55 34.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.446 -0.784 . . . . 0.0 110.04 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.655 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.4 OUTLIER -127.17 -8.22 5.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.262 -0.899 . . . . 0.0 110.691 -179.743 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.553 ' HG1' ' C ' ' A' ' 21' ' ' TYR . 30.2 p 50.89 -93.39 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.721 -0.612 . . . . 0.0 112.37 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 33.6 t0 -158.34 143.31 16.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.02 -1.05 . . . . 0.0 110.404 -178.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.539 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 87.3 20.68 51.63 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.655 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -115.7 166.6 11.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.371 -1.076 . . . . 0.0 110.489 -179.723 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.8 HG13 ' O ' ' A' ' 43' ' ' VAL . 20.8 t -142.19 156.55 19.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.433 -0.792 . . . . 0.0 110.649 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.774 HG11 ' CG ' ' A' ' 6' ' ' PRO . 10.8 t -130.71 111.6 20.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.224 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.441 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -66.67 103.61 1.12 Allowed 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 118.56 -1.256 . . . . 0.0 108.327 178.607 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.641 ' CE1' HG21 ' A' ' 43' ' ' VAL . 1.7 m-30 -68.73 121.79 17.21 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.595 -0.691 . . . . 0.0 110.384 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -69.87 158.85 34.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -0.985 . . . . 0.0 109.415 179.23 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.9 154.2 46.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.951 -1.093 . . . . 0.0 110.704 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 11' ' ' ASN . 3.8 t-20 -64.45 152.75 40.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.402 -0.811 . . . . 0.0 110.01 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.71 120.69 15.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.2 -0.937 . . . . 0.0 110.278 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.16 -5.67 30.36 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.588 ' CD2' ' O ' ' A' ' 56' ' ' CYS . 0.8 OUTLIER -116.06 146.91 41.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.189 -1.183 . . . . 0.0 110.518 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.732 ' HB3' HD11 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -89.05 142.01 28.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.395 -0.816 . . . . 0.0 111.205 -179.693 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.568 ' C ' HD13 ' A' ' 38' ' ' ILE . 0.7 OUTLIER -94.54 104.55 16.5 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.46 -0.775 . . . . 0.0 109.079 178.802 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.868 HG23 ' HG3' ' A' ' 105' ' ' PRO . 0.8 OUTLIER -94.96 141.89 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.305 -0.872 . . . . 0.0 109.677 -179.361 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.48 -160.29 23.05 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.519 ' O ' ' C ' ' A' ' 41' ' ' SER . 0.7 OUTLIER -99.54 50.4 0.93 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.1 -1.235 . . . . 0.0 109.974 179.824 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.526 ' HA ' HD21 ' A' ' 37' ' ' LEU . 0.3 OUTLIER 22.06 63.52 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.864 179.585 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.473 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 146.34 120.75 1.29 Allowed Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.416 -1.373 . . . . 0.0 110.184 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.8 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -68.43 179.65 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.452 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.413 ' HA ' HG22 ' A' ' 26' ' ' VAL . 25.3 tp -136.24 104.69 5.73 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.602 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.531 ' HB2' ' CH2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -75.32 103.83 5.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.394 -0.816 . . . . 0.0 109.236 179.379 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.504 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 12.2 t -132.59 103.62 6.24 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.31 -0.869 . . . . 0.0 110.304 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.88 41.36 5.97 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.443 ' HA2' ' C ' ' A' ' 2' ' ' LYS . . . 60.33 18.1 48.76 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.12 153.94 49.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -1.128 . . . . 0.0 110.147 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.531 ' CH2' ' HB2' ' A' ' 45' ' ' CYS . 83.0 m95 -105.46 130.82 53.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.749 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 11.8 t -136.87 156.16 48.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.972 . . . . 0.0 111.173 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.531 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.1 OUTLIER 65.2 64.96 0.98 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.819 -0.551 . . . . 0.0 111.436 179.477 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.0 Cg_endo -91.93 137.86 1.91 Allowed 'Trans proline' 0 C--N 1.3 -2.02 0 O-C-N 124.39 1.732 . . . . 0.0 109.695 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.583 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 47.8 Cg_endo -81.75 164.19 18.33 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.728 1.383 . . . . 0.0 110.453 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.608 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 33.9 p -107.37 -174.97 2.66 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.226 -0.921 . . . . 0.0 111.185 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.588 ' O ' ' CD2' ' A' ' 35' ' ' TYR . 1.0 OUTLIER -140.71 76.14 1.54 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.336 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.538 ' HG3' ' CG1' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -115.82 174.05 6.23 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.129 -178.729 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.563 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -90.28 124.26 42.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.278 -0.889 . . . . 0.0 108.683 179.389 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.699 ' HB ' ' HA ' ' A' ' 105' ' ' PRO . 29.5 m -112.37 48.43 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.098 -1.001 . . . . 0.0 111.752 -178.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.474 ' O ' ' OD1' ' A' ' 107' ' ' ASN . 11.4 mttm -55.48 170.49 0.24 Allowed 'General case' 0 C--N 1.28 -2.448 0 C-N-CA 117.624 -1.63 . . . . 0.0 108.043 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.534 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -131.53 168.36 17.79 Favored Pre-proline 0 N--CA 1.491 1.602 0 C-N-CA 118.532 -1.267 . . . . 0.0 112.999 -178.1 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.502 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 47.2 Cg_endo -89.98 -73.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 124.896 1.998 . . . . 0.0 110.421 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.502 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 164.24 126.12 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.285 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.903 ' HA ' HD21 ' A' ' 113' ' ' LEU . 55.5 Cg_endo -80.53 60.63 7.93 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 123.544 1.286 . . . . 0.0 110.211 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.601 ' O ' HD23 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -76.17 170.64 15.93 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.535 -0.728 . . . . 0.0 109.478 179.444 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.98 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -168.05 164.88 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.015 -1.053 . . . . 0.0 110.525 -179.6 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.424 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 2.5 t -70.22 98.81 1.41 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.514 -0.741 . . . . 0.0 110.675 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 51.0 m-80 43.19 48.98 5.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.368 -0.832 . . . . 0.0 110.841 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.98 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -160.18 38.74 0.45 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.587 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 53.1 p90 -49.23 -151.89 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 122.886 1.327 . . . . 0.0 113.134 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.009 HD23 ' CE2' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -144.72 122.04 11.59 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.765 -176.445 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.9 t -98.88 14.0 30.5 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.342 -0.848 . . . . 0.0 110.127 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.511 ' OG ' ' N ' ' A' ' 86' ' ' ASP . 1.3 p -74.82 -101.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.312 -0.867 . . . . 0.0 110.712 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -120.28 74.92 0.32 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.615 ' HD2' HD11 ' A' ' 71' ' ' LEU . 1.9 t80 -91.53 161.5 14.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.495 -1.003 . . . . 0.0 110.396 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.587 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 23.8 tttt -162.35 156.15 21.02 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.451 -0.78 . . . . 0.0 109.862 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -47.14 -32.65 4.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -0.883 . . . . 0.0 110.146 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.524 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 3.3 t -144.04 167.82 21.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.385 -0.822 . . . . 0.0 110.366 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 9.3 m-85 -138.02 -149.87 0.32 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.292 -0.88 . . . . 0.0 109.844 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.649 ' CA ' HG23 ' A' ' 59' ' ' VAL . 2.7 p -156.33 -100.41 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.597 -1.315 . . . . 0.0 111.877 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.628 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -123.04 14.2 9.82 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.733 -1.229 . . . . 0.0 110.311 -178.466 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.774 ' O ' HG22 ' A' ' 102' ' ' THR . 8.0 p30 -155.74 -108.3 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.02 -1.05 . . . . 0.0 110.398 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 82' ' ' ASN . 5.3 t0 46.22 71.99 0.26 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.817 -1.177 . . . . 0.0 109.539 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.894 ' CA ' HG23 ' A' ' 102' ' ' THR . 14.0 p-10 -68.65 106.47 2.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.314 -0.866 . . . . 0.0 109.491 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.586 ' CG2' HD22 ' A' ' 71' ' ' LEU . 35.8 m -92.03 121.48 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.11 -0.993 . . . . 0.0 111.523 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.529 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.6 OUTLIER -82.66 135.36 35.05 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.25 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 1.009 ' CE2' HD23 ' A' ' 71' ' ' LEU . 38.3 m-85 -90.94 144.39 25.73 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.805 -1.184 . . . . 0.0 112.252 -177.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -116.1 91.95 3.75 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.669 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.548 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -44.76 132.52 6.49 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.068 -1.02 . . . . 0.0 110.054 -179.741 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -40.82 -74.17 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.41 -0.806 . . . . 0.0 110.639 -179.683 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.576 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 31.5 t80 -169.62 144.11 2.86 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.225 -0.922 . . . . 0.0 110.674 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.578 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 46.38 41.11 11.63 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.607 ' CE1' ' HB3' ' A' ' 118' ' ' ARG . 12.2 m-85 -145.93 147.5 31.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.517 -0.99 . . . . 0.0 109.947 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 117' ' ' VAL . 6.7 ttpt -102.57 152.48 21.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.196 -0.94 . . . . 0.0 109.959 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.612 HD23 ' HB2' ' A' ' 114' ' ' PRO . 0.6 OUTLIER -92.99 89.44 6.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.056 -1.027 . . . . 0.0 110.446 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.739 ' HB2' HG21 ' A' ' 117' ' ' VAL . 18.6 t -70.55 108.1 4.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.9 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 138.69 -65.34 0.54 Allowed Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.844 -1.17 . . . . 0.0 110.236 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.576 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.1 OUTLIER 174.84 114.43 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.277 -1.131 . . . . 0.0 110.705 -179.383 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.485 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 0.9 OUTLIER -80.86 20.92 0.72 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.106 -0.996 . . . . 0.0 111.258 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.409 ' O ' ' OG ' ' A' ' 100' ' ' SER . 16.4 p -161.28 103.84 1.26 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.957 -1.09 . . . . 0.0 109.905 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.498 ' O ' ' N ' ' A' ' 85' ' ' VAL . 70.2 m -123.13 171.13 9.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.933 . . . . 0.0 110.611 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.894 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -136.78 145.39 44.5 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.223 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 79' ' ' TYR . 7.0 t -74.96 88.76 2.37 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.466 -0.772 . . . . 0.0 109.912 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.452 ' OG ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -66.03 174.5 1.62 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.258 -0.901 . . . . 0.0 111.327 -179.44 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.868 ' HG3' HG23 ' A' ' 38' ' ' ILE . 41.7 Cg_endo -74.16 126.94 10.86 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.401 1.738 . . . . 0.0 110.73 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 120.48 -6.64 11.57 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.577 ' O ' HG23 ' A' ' 108' ' ' THR . 0.5 OUTLIER 82.13 96.06 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 O-C-N 122.107 -0.643 . . . . 0.0 110.699 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -178.51 -162.34 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.356 -0.84 . . . . 0.0 111.175 179.516 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.619 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 31.1 m95 -150.34 87.51 1.46 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.59 -0.694 . . . . 0.0 110.11 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.516 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 58.4 mttt -98.85 140.27 21.64 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.475 -0.765 . . . . 0.0 110.098 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.576 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 47.7 Cg_endo -72.7 174.55 48.53 Favored 'Cis proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.992 -2.087 . . . . 0.0 110.686 -0.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 112' ' ' GLU . 0.0 OUTLIER -43.82 135.27 4.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.402 -0.811 . . . . 0.0 110.988 -179.558 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.903 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -45.76 146.8 1.78 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.445 -0.785 . . . . 0.0 110.287 179.426 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.723 ' HG2' HD12 ' A' ' 66' ' ' ILE . 42.7 Cg_endo -76.53 169.57 21.6 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 O-C-N 124.341 1.706 . . . . 0.0 111.182 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.593 ' HG2' HG13 ' A' ' 117' ' ' VAL . 2.6 ttpt -130.16 109.71 11.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.24 -0.912 . . . . 0.0 110.208 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 2.0 t -63.9 80.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -0.913 . . . . 0.0 109.341 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.739 HG21 ' HB2' ' A' ' 96' ' ' SER . 0.3 OUTLIER -88.54 -176.82 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.749 0.785 . . . . 0.0 110.645 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.607 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--N 1.295 -1.792 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.504 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.401 ' C ' ' HD3' ' A' ' 2' ' ' LYS . 4.8 m . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.302 0.572 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.401 ' HD3' ' C ' ' A' ' 1' ' ' VAL . 0.0 OUTLIER -122.81 176.84 5.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.934 . . . . 0.0 110.313 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.57 ' HB3' ' N ' ' A' ' 22' ' ' THR . 2.8 t -136.63 95.55 3.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.344 -0.848 . . . . 0.0 110.828 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 5' ' ' SER . 0.0 OUTLIER -74.33 176.45 6.7 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 118.766 -1.174 . . . . 0.0 108.972 178.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -46.76 145.46 3.08 Favored Pre-proline 0 C--N 1.293 -1.861 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.278 179.794 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.825 ' HG3' HG11 ' A' ' 27' ' ' VAL . 48.8 Cg_endo -71.01 153.91 63.0 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.835 1.44 . . . . 0.0 110.78 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -74.84 171.61 17.93 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 O-C-N 123.911 1.48 . . . . 0.0 109.787 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.64 177.09 3.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.14 -0.975 . . . . 0.0 109.758 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.713 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -142.54 -170.57 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 122.178 0.989 . . . . 0.0 111.642 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 14.2 t -40.85 93.28 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.698 -179.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 9' ' ' ILE . 3.5 m-80 42.17 44.16 3.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 110.25 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -140.82 178.05 20.39 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.527 ' CB ' ' HB3' ' A' ' 30' ' ' SER . 0.0 OUTLIER -125.0 -168.27 1.8 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.178 -1.189 . . . . 0.0 110.578 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.625 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 13.9 p80 -156.46 123.94 5.43 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.958 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -147.5 128.11 14.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.166 -0.959 . . . . 0.0 110.53 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.49 -115.73 2.14 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -166.84 37.27 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -1.131 . . . . 0.0 110.052 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.592 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 1.4 pp20? -150.04 -155.61 0.64 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 0.0 110.09 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -140.7 -42.44 0.4 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.367 -0.833 . . . . 0.0 110.068 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.402 ' C ' ' OE1' ' A' ' 18' ' ' GLU . 17.6 m-85 -119.52 100.98 7.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 109.526 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.655 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.8 OUTLIER -77.53 -11.04 59.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.44 -0.787 . . . . 0.0 111.395 -179.226 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.57 ' N ' ' HB3' ' A' ' 3' ' ' CYS . 56.4 p 46.71 -95.78 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.209 -0.932 . . . . 0.0 111.636 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.539 ' H ' ' HG1' ' A' ' 22' ' ' THR . 1.3 t70 -152.77 146.92 25.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.842 -1.161 . . . . 0.0 110.948 -178.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 82.45 23.88 55.38 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.655 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.9 OUTLIER -116.9 169.84 9.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.395 -1.061 . . . . 0.0 110.207 -179.799 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.848 HG13 ' O ' ' A' ' 43' ' ' VAL . 23.7 t -139.26 156.15 26.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 119.29 -0.964 . . . . 0.0 111.033 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.9 ' O ' HG23 ' A' ' 43' ' ' VAL . 24.0 t -133.25 124.25 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 119.846 -0.741 . . . . 0.0 111.066 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.849 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -73.86 100.9 3.61 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 118.347 -1.341 . . . . 0.0 108.432 178.412 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 1.076 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.1 m-30 -68.56 127.93 34.8 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.144 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.527 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 12.5 t -80.12 -170.43 2.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.026 -1.046 . . . . 0.0 109.687 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.623 ' SG ' HD12 ' A' ' 37' ' ' LEU . 67.4 m -150.83 160.94 43.54 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.147 -0.971 . . . . 0.0 110.161 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.523 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 14.8 t-20 -48.43 171.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.0 110.059 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.68 107.45 5.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 110.181 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.79 11.46 40.4 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.523 ' CG ' ' HB3' ' A' ' 32' ' ' ASN . 2.9 m-30 -106.84 128.33 54.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -1.136 . . . . 0.0 110.238 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.624 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.5 OUTLIER -74.23 138.99 44.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.306 -0.871 . . . . 0.0 110.808 -179.885 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.778 HD13 ' O ' ' A' ' 29' ' ' TYR . 2.8 tp -91.24 104.51 17.05 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.445 -0.784 . . . . 0.0 109.421 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.799 HG23 ' HG3' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -97.48 154.04 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.279 -0.888 . . . . 0.0 109.37 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.478 ' O ' ' CB ' ' A' ' 40' ' ' ASN . . . 94.56 39.54 4.68 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.7 OUTLIER 68.52 174.5 0.28 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.353 -1.087 . . . . 0.0 110.116 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.849 ' O ' HG23 ' A' ' 28' ' ' THR . 0.3 OUTLIER -119.79 71.5 0.89 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 110.318 -179.859 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.501 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 163.36 119.35 0.48 Allowed Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.75 -1.215 . . . . 0.0 110.173 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.076 HG21 ' CE1' ' A' ' 29' ' ' TYR . 2.0 t -76.31 -175.23 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.147 -1.208 . . . . 0.0 108.506 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.563 ' H ' HG12 ' A' ' 43' ' ' VAL . 0.9 OUTLIER -144.05 102.28 3.86 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.215 178.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.543 ' HB2' ' CD2' ' A' ' 50' ' ' TRP . 13.5 t -83.96 124.61 31.2 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.362 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.428 ' C ' ' OD2' ' A' ' 23' ' ' ASP . 84.5 p -132.22 80.22 1.9 Allowed 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.283 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.444 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 92.8 46.75 3.33 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.59 23.22 62.6 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 50' ' ' TRP . 3.3 mt-10 -126.4 68.78 1.22 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.206 -1.173 . . . . 0.0 110.374 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.594 ' CH2' HG23 ' A' ' 27' ' ' VAL . 72.7 m95 -43.58 135.63 3.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.485 -0.759 . . . . 0.0 109.632 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.2 t -146.73 169.87 18.16 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.962 -1.086 . . . . 0.0 111.069 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.534 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER 59.52 65.02 2.72 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.671 -0.643 . . . . 0.0 110.981 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.534 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.0 Cg_endo -91.22 127.95 1.18 Allowed 'Trans proline' 0 C--N 1.301 -1.928 0 O-C-N 124.393 1.733 . . . . 0.0 110.305 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.523 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 51.4 Cg_endo -77.09 173.18 14.84 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 O-C-N 123.897 1.472 . . . . 0.0 110.096 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.584 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 21.0 p -107.09 164.6 12.01 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.92 . . . . 0.0 111.272 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 10' ' ' SER . 97.3 m -128.37 76.11 1.68 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 177.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -111.82 -158.93 0.66 Allowed 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.28 0.562 . . . . 0.0 110.162 -178.831 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.21 147.13 15.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.624 HG13 ' CB ' ' A' ' 36' ' ' SER . 33.7 m -132.49 49.25 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 O-C-N 121.044 -1.035 . . . . 0.0 111.267 -178.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 5.3 mttm -64.19 -169.5 0.03 OUTLIER 'General case' 0 C--N 1.281 -2.404 0 C-N-CA 118.225 -1.39 . . . . 0.0 107.9 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.545 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -144.52 170.75 7.69 Favored Pre-proline 0 C--N 1.293 -1.848 0 C-N-CA 118.347 -1.341 . . . . 0.0 113.22 -178.824 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.557 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 45.1 Cg_endo -92.47 -70.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.421 2.081 . . . . 0.0 109.139 178.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.557 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 159.34 129.44 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 122.04 -0.413 . . . . 0.0 110.068 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.574 ' HG3' ' CZ2' ' A' ' 109' ' ' TRP . 55.3 Cg_endo -85.18 94.31 0.66 Allowed 'Trans proline' 0 C--N 1.299 -2.044 0 O-C-N 123.802 1.422 . . . . 0.0 109.346 178.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.726 ' O ' HG23 ' A' ' 66' ' ' ILE . 3.5 p -111.57 -43.15 3.7 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 122.342 1.068 . . . . 0.0 110.452 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.73 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER 53.27 170.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.017 -178.71 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.506 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -68.37 101.66 1.26 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.472 -0.767 . . . . 0.0 111.331 -179.088 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 60.7 m-20 42.36 51.95 4.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.507 -0.746 . . . . 0.0 111.684 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.594 ' O ' ' CD1' ' A' ' 70' ' ' TYR . . . -133.05 -38.49 0.23 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.631 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 2.0 p90 38.2 -171.58 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 122.965 1.364 . . . . 0.0 112.645 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.661 HD22 ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -139.17 159.76 41.39 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.724 -178.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.59 27.73 3.04 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.755 -1.215 . . . . 0.0 110.152 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.74 -78.65 0.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.193 -0.942 . . . . 0.0 111.111 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -135.4 82.15 0.29 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.624 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -108.93 170.65 7.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.5 -1.0 . . . . 0.0 109.934 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.624 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 10.5 ttmt -171.23 170.1 6.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.353 -0.842 . . . . 0.0 109.974 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.402 ' N ' ' CG ' ' A' ' 76' ' ' LYS . 29.3 mtm180 -60.67 -37.39 81.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.971 -1.081 . . . . 0.0 110.517 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.4 m -134.09 159.0 42.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.286 -0.883 . . . . 0.0 110.322 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.623 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 3.7 m-85 -133.72 -146.44 0.27 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.312 -0.868 . . . . 0.0 110.058 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.574 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 21.6 p -160.02 -128.52 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.907 -1.121 . . . . 0.0 110.94 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.609 ' O ' ' CG ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -93.8 14.24 19.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.375 -1.453 . . . . 0.0 110.603 -179.292 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.689 ' C ' HG22 ' A' ' 102' ' ' THR . 50.6 t30 -160.73 -104.05 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.743 -1.223 . . . . 0.0 110.706 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 82' ' ' ASN . 0.7 OUTLIER 45.68 79.48 0.05 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.877 -1.14 . . . . 0.0 108.801 -178.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.716 ' CA ' HG23 ' A' ' 102' ' ' THR . 30.2 p-10 -69.36 150.29 47.48 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.415 -0.803 . . . . 0.0 110.853 -178.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.507 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 17.0 m -133.5 118.67 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.419 -0.8 . . . . 0.0 110.049 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.541 ' O ' ' HB2' ' A' ' 71' ' ' LEU . 8.8 t0 -82.55 127.46 33.36 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.206 -0.934 . . . . 0.0 108.613 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.698 ' CD1' HG21 ' A' ' 66' ' ' ILE . 53.5 m-85 -84.26 136.96 33.72 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.369 1.081 . . . . 0.0 113.339 -177.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.631 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -111.8 85.62 2.18 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.149 179.792 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.547 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -37.3 130.06 0.93 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.52 -0.737 . . . . 0.0 111.198 -179.029 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.8 OUTLIER -41.35 -88.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.489 -0.757 . . . . 0.0 110.697 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.557 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 3.8 t80 -152.68 144.93 23.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.227 -0.92 . . . . 0.0 110.543 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.549 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 46.87 53.85 9.89 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.569 ' CD1' ' HB3' ' A' ' 118' ' ' ARG . 9.3 m-85 -151.28 167.87 26.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.253 -1.145 . . . . 0.0 110.27 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 117' ' ' VAL . 1.9 ttpt -132.23 112.23 12.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.361 -0.837 . . . . 0.0 109.812 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.567 HD23 ' CD1' ' A' ' 66' ' ' ILE . 6.2 mt -47.65 109.56 0.23 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.261 -0.899 . . . . 0.0 110.348 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.433 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -90.61 99.32 12.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.392 -0.817 . . . . 0.0 109.88 179.614 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 141.09 -76.62 0.31 Allowed Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.119 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.615 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 1.2 m -163.4 117.35 1.59 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.372 -1.075 . . . . 0.0 110.594 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.404 ' HB2' HD13 ' A' ' 95' ' ' LEU . 9.8 p -76.63 6.27 6.18 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.276 -0.89 . . . . 0.0 110.967 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 59.8 p -147.42 113.11 5.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.114 -0.991 . . . . 0.0 109.761 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.442 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 13.1 m -128.25 168.9 14.83 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.242 -0.912 . . . . 0.0 110.776 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.716 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.5 OUTLIER -136.44 146.66 46.61 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.51 -0.744 . . . . 0.0 110.461 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 80' ' ' SER . 41.9 t -76.41 84.91 3.15 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.611 -0.681 . . . . 0.0 110.439 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.516 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -65.59 -179.12 0.32 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 110.279 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.799 ' HG3' HG23 ' A' ' 38' ' ' ILE . 46.1 Cg_endo -76.47 131.27 12.48 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 O-C-N 124.23 1.647 . . . . 0.0 110.878 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 121.91 -11.33 9.43 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.587 ' O ' HG23 ' A' ' 108' ' ' THR . 1.0 OUTLIER 82.8 92.9 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 O-C-N 122.015 -0.697 . . . . 0.0 110.956 179.668 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -179.1 -160.02 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.556 -0.715 . . . . 0.0 110.725 179.437 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.674 ' HB3' HD13 ' A' ' 113' ' ' LEU . 24.0 m95 -148.9 87.92 1.58 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.513 -0.742 . . . . 0.0 110.538 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.548 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -95.2 154.68 39.46 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.382 -0.824 . . . . 0.0 109.777 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.615 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 48.5 Cg_endo -71.65 -177.51 17.41 Favored 'Cis proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.163 -2.016 . . . . 0.0 110.514 -0.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.474 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.9 OUTLIER -37.54 111.74 0.17 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.802 -0.561 . . . . 0.0 110.236 -179.759 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.674 HD13 ' HB3' ' A' ' 109' ' ' TRP . 3.9 tp -37.61 141.86 0.45 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.66 -0.65 . . . . 0.0 110.446 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.73 ' HG2' HD12 ' A' ' 66' ' ' ILE . 40.6 Cg_endo -69.89 161.79 44.6 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 124.11 1.584 . . . . 0.0 110.47 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.517 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.8 OUTLIER -125.1 100.21 6.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 110.497 179.704 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.547 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.9 t -56.19 91.84 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.019 -1.051 . . . . 0.0 109.272 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 3.7 m -110.95 179.11 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.628 0.728 . . . . 0.0 110.941 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.569 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.688 0 C-N-CA 118.997 -1.081 . . . . 0.0 110.239 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.513 ' CG1' ' HA3' ' A' ' 48' ' ' GLY . 69.2 t . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 121.231 0.539 . . . . 0.0 110.275 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.474 ' N ' HG12 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -119.87 179.69 4.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.901 . . . . 0.0 110.294 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.549 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.3 m -131.61 137.28 48.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.546 -0.721 . . . . 0.0 110.008 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.567 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 3.8 mt-30 -114.2 168.49 9.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.767 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -45.21 131.89 5.72 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.112 -0.992 . . . . 0.0 109.446 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.681 ' HG3' HG11 ' A' ' 27' ' ' VAL . 45.6 Cg_endo -66.99 153.16 78.8 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 124.011 1.532 . . . . 0.0 112.209 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.64 175.29 11.49 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 124.097 1.578 . . . . 0.0 110.304 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.44 173.63 5.7 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.276 -0.89 . . . . 0.0 110.254 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.432 HG12 ' CG ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -143.46 -172.96 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-O 122.038 0.923 . . . . 0.0 111.085 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.3 OUTLIER -39.73 100.51 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.215 -179.214 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.415 ' C ' ' O ' ' A' ' 10' ' ' SER . 1.2 m120 39.21 45.59 1.14 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.434 -0.791 . . . . 0.0 111.09 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.452 ' HA3' ' CB ' ' A' ' 56' ' ' CYS . . . -158.21 161.45 31.62 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.435 ' HG3' ' HB2' ' A' ' 30' ' ' SER . 0.8 OUTLIER -119.41 -175.22 2.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -1.146 . . . . 0.0 110.713 -179.613 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.635 ' HB2' HG11 ' A' ' 27' ' ' VAL . 7.5 p80 -126.91 163.3 23.95 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.196 0.522 . . . . 0.0 110.063 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.491 ' ND2' ' OG ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -170.5 -159.07 0.17 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.093 -1.004 . . . . 0.0 110.322 -179.819 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.44 -126.36 2.37 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.535 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 11.4 p90 -149.19 33.87 0.73 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -1.129 . . . . 0.0 110.068 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.488 ' HG3' ' CZ ' ' A' ' 21' ' ' TYR . 0.9 OUTLIER -147.1 -177.43 5.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.933 . . . . 0.0 109.912 179.854 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -124.03 -41.33 2.22 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.207 -0.933 . . . . 0.0 110.253 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.621 ' O ' ' CG ' ' A' ' 20' ' ' PHE . 21.0 p90 -128.34 98.81 5.19 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.11 -0.994 . . . . 0.0 110.516 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.618 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 11.6 m-85 -61.95 -165.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.984 -1.073 . . . . 0.0 110.054 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.549 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 0.3 OUTLIER -151.42 -65.57 0.18 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.026 -1.046 . . . . 0.0 110.778 -179.731 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -167.15 147.33 5.47 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.444 -0.785 . . . . 0.0 109.658 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 65.61 14.58 60.53 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.618 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -94.54 172.41 8.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.387 -1.067 . . . . 0.0 109.938 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 43' ' ' VAL . 24.4 t -148.75 154.71 9.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.224 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.681 HG11 ' HG3' ' A' ' 6' ' ' PRO . 24.4 t -134.04 113.81 18.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.596 -0.69 . . . . 0.0 110.922 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -69.39 104.08 2.18 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 118.052 -1.459 . . . . 0.0 107.597 178.187 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.653 ' O ' HD13 ' A' ' 37' ' ' LEU . 1.3 m-30 -67.4 111.87 4.3 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.366 -178.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.491 ' OG ' ' ND2' ' A' ' 15' ' ' ASN . 0.7 OUTLIER -70.69 154.98 41.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.114 -0.991 . . . . 0.0 110.278 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.7 m -123.97 157.27 34.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.319 -0.863 . . . . 0.0 109.662 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.52 168.51 1.57 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.107 -0.996 . . . . 0.0 110.241 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.21 100.61 0.81 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.26 -0.9 . . . . 0.0 110.124 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.482 ' O ' HG22 ' A' ' 58' ' ' ILE . . . 120.92 -6.99 11.0 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.693 ' CD2' HG23 ' A' ' 58' ' ' ILE . 27.7 m-85 -96.61 133.63 40.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -1.136 . . . . 0.0 110.2 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.723 ' HB2' HG22 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -89.25 144.34 26.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 0.0 110.797 -179.783 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.653 HD13 ' O ' ' A' ' 29' ' ' TYR . 1.9 tp -92.09 98.15 11.37 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.376 -0.827 . . . . 0.0 109.237 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.929 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -87.99 144.02 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.31 -0.869 . . . . 0.0 109.051 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.59 -174.6 22.87 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.475 ' ND2' ' OD1' ' A' ' 52' ' ' ASP . 2.4 m-80 -55.33 145.93 20.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.343 -1.092 . . . . 0.0 110.092 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.608 ' O ' HG23 ' A' ' 28' ' ' THR . 87.4 p -80.52 49.53 1.17 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.173 -0.954 . . . . 0.0 110.076 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.657 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 152.19 109.83 0.43 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.665 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -46.49 172.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.244 -1.151 . . . . 0.0 108.244 179.276 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 25' ' ' SER . 0.4 OUTLIER -138.26 97.08 3.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.046 -1.034 . . . . 0.0 110.183 179.01 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.608 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.2 OUTLIER -76.48 107.78 9.0 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.091 -1.005 . . . . 0.0 109.266 178.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.66 107.05 8.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.545 -0.722 . . . . 0.0 110.238 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.03 5.08 55.15 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.513 ' HA3' ' CG1' ' A' ' 1' ' ' VAL . . . 94.49 15.79 45.54 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -141.42 113.73 8.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.348 -1.09 . . . . 0.0 110.261 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.608 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 96.3 m95 -58.34 134.75 56.86 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.189 -0.944 . . . . 0.0 109.975 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.7 t -135.3 149.84 49.87 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.184 -0.948 . . . . 0.0 110.95 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.51 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 1.1 t70 62.81 65.47 1.41 Allowed Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.716 -0.615 . . . . 0.0 111.372 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.51 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.6 Cg_endo -91.58 124.44 0.82 Allowed 'Trans proline' 0 C--N 1.3 -2.021 0 O-C-N 124.337 1.704 . . . . 0.0 109.841 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.494 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.0 Cg_endo -71.67 175.14 9.99 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 O-C-N 123.88 1.463 . . . . 0.0 109.979 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.601 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 23.6 p -118.37 141.81 48.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.194 -0.941 . . . . 0.0 111.187 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 10' ' ' SER . 35.1 m -103.58 76.06 1.37 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.479 ' OE1' ' CB ' ' A' ' 55' ' ' THR . 0.0 OUTLIER -113.46 147.24 38.21 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.406 0.622 . . . . 0.0 110.214 -178.73 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.693 HG23 ' CD2' ' A' ' 35' ' ' TYR . 1.7 pt -70.74 112.55 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.435 -0.79 . . . . 0.0 109.161 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.894 HG21 ' CB ' ' A' ' 81' ' ' TYR . 18.8 m -99.54 53.01 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.309 -0.869 . . . . 0.0 111.751 -178.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 23.2 mtpp -71.62 -174.12 1.07 Allowed 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 118.065 -1.454 . . . . 0.0 107.2 177.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.516 ' SG ' ' HB2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -143.42 163.61 35.88 Favored Pre-proline 0 C--N 1.29 -2.018 0 C-N-CA 118.014 -1.474 . . . . 0.0 111.98 -178.499 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.528 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 41.3 Cg_endo -80.57 -68.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.866 0 O-C-N 124.787 1.941 . . . . 0.0 109.609 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.528 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 161.13 135.06 0.01 OUTLIER Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.881 ' HG2' HD21 ' A' ' 71' ' ' LEU . 56.9 Cg_endo -82.95 66.76 7.9 Favored 'Trans proline' 0 C--N 1.289 -2.555 0 O-C-N 123.952 1.501 . . . . 0.0 109.47 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.73 ' O ' HG23 ' A' ' 66' ' ' ILE . 3.1 p -81.88 -41.92 20.29 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 122.43 1.109 . . . . 0.0 110.455 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.878 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER 54.54 162.15 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.53 -179.037 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.449 ' N ' HG13 ' A' ' 66' ' ' ILE . 12.8 t -65.95 101.1 0.63 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.573 -0.705 . . . . 0.0 111.78 -178.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 2.2 m-20 41.68 31.91 0.22 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.499 -0.751 . . . . 0.0 111.743 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.559 ' C ' ' CD1' ' A' ' 70' ' ' TYR . . . -124.11 -27.0 1.43 Allowed Glycine 0 N--CA 1.491 2.358 0 C-N-CA 118.732 -1.699 . . . . 0.0 109.938 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.559 ' CD1' ' C ' ' A' ' 69' ' ' GLY . 37.9 p90 33.4 -160.59 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 122.762 1.268 . . . . 0.0 112.016 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.895 HD23 ' HE1' ' A' ' 87' ' ' PHE . 0.7 OUTLIER -135.56 149.08 49.33 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 114.154 -1.384 . . . . 0.0 109.691 -176.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' A' ' 72' ' ' SER . 0.1 OUTLIER -116.03 24.38 11.49 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.866 -1.146 . . . . 0.0 109.883 -179.662 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.51 ' OG ' ' CB ' ' A' ' 86' ' ' ASP . 8.5 m -101.62 -99.87 0.27 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.065 -1.022 . . . . 0.0 111.836 -178.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.489 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -109.81 -73.96 0.77 Allowed Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.739 -1.22 . . . . 0.0 111.144 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.5 OUTLIER 60.62 174.54 0.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.409 -1.053 . . . . 0.0 109.609 -178.768 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.627 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 28.6 ttmt 179.65 159.07 0.71 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.302 -0.874 . . . . 0.0 109.641 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.526 ' N ' ' HG2' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -43.01 -31.17 0.49 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.292 -0.88 . . . . 0.0 110.635 -179.843 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.446 ' C ' ' CG ' ' A' ' 79' ' ' TYR . 2.8 p -154.43 169.93 22.58 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.132 -0.98 . . . . 0.0 111.161 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.656 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -150.62 -168.53 3.13 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.443 -0.786 . . . . 0.0 108.897 179.762 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 82' ' ' ASN . 0.1 OUTLIER -170.75 120.52 0.56 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.667 -1.27 . . . . 0.0 111.424 179.783 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.894 ' CB ' HG21 ' A' ' 59' ' ' VAL . 4.1 t80 38.37 22.85 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.995 -1.066 . . . . 0.0 112.074 178.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.672 ' C ' HG22 ' A' ' 102' ' ' THR . 26.2 p30 -178.49 -134.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.025 -1.672 . . . . 0.0 110.882 178.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.524 ' CB ' ' HB3' ' A' ' 79' ' ' TYR . 0.4 OUTLIER 57.27 72.14 0.53 Allowed 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.006 -1.059 . . . . 0.0 108.519 -178.46 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.649 ' CA ' HG23 ' A' ' 102' ' ' THR . 6.8 p30 -68.44 143.23 55.11 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.453 -0.78 . . . . 0.0 110.331 -178.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.746 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 3.6 m -134.47 121.36 36.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.228 -0.92 . . . . 0.0 110.221 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.548 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 1.1 t70 -69.95 141.96 52.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.09 -1.006 . . . . 0.0 108.479 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.895 ' HE1' HD23 ' A' ' 71' ' ' LEU . 7.1 m-85 -104.89 143.38 33.23 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.672 -1.267 . . . . 0.0 112.5 -178.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.509 ' O ' HD21 ' A' ' 95' ' ' LEU . 3.7 tptt -116.4 -173.34 2.35 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.163 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.503 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -132.11 127.96 37.12 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.241 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.49 ' C ' ' O ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -33.57 -70.72 0.07 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.404 0.621 . . . . 0.0 110.733 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.518 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -177.25 145.42 0.45 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.371 -0.831 . . . . 0.0 109.927 179.708 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.442 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 51.86 43.13 54.46 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.572 ' CE1' ' HB3' ' A' ' 118' ' ' ARG . 11.6 m-85 -146.61 162.7 37.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.34 -1.094 . . . . 0.0 110.32 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 117' ' ' VAL . 23.1 tptt -127.5 113.26 15.92 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.391 -0.818 . . . . 0.0 109.877 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.631 HD23 ' HB2' ' A' ' 114' ' ' PRO . 2.1 mt -46.49 112.62 0.52 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.107 -0.995 . . . . 0.0 109.868 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.615 ' HB2' HG21 ' A' ' 117' ' ' VAL . 1.1 t -95.92 103.64 15.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 110.205 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.16 -98.29 0.24 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.618 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -141.63 135.51 30.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -1.133 . . . . 0.0 110.614 -179.502 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 100' ' ' SER . 37.3 p -78.69 -64.91 1.07 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 110.11 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.52 ' N ' ' OG ' ' A' ' 99' ' ' SER . 15.8 p -74.86 140.28 43.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.087 -1.008 . . . . 0.0 110.065 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.595 ' HB2' ' CE2' ' A' ' 87' ' ' PHE . 3.8 m -151.16 148.35 28.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -0.934 . . . . 0.0 110.659 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.672 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -125.48 145.25 50.17 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.564 -0.71 . . . . 0.0 109.769 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.583 ' O ' ' CA ' ' A' ' 81' ' ' TYR . 7.6 t -69.4 78.93 0.39 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.104 -0.998 . . . . 0.0 109.946 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.445 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.4 OUTLIER -47.3 171.15 0.08 OUTLIER Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.286 -0.884 . . . . 0.0 112.197 -179.397 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.929 ' CB ' HD12 ' A' ' 38' ' ' ILE . 47.9 Cg_endo -78.08 21.84 0.65 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 124.731 1.911 . . . . 0.0 112.569 -178.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -114.69 7.61 22.14 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.53 ' O ' HG23 ' A' ' 108' ' ' THR . 0.8 OUTLIER 76.91 61.83 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.835 -0.803 . . . . 0.0 109.572 -179.761 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.571 ' O ' ' HA ' ' A' ' 103' ' ' CYS . 0.0 OUTLIER -171.41 -170.62 0.84 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.277 -179.426 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.746 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 19.4 m95 -118.22 86.45 2.53 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.631 -0.668 . . . . 0.0 110.133 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.543 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 2.7 mmmt -92.1 152.33 42.59 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.407 -0.808 . . . . 0.0 110.014 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.618 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 48.8 Cg_endo -72.23 -178.68 21.17 Favored 'Cis proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.071 -2.054 . . . . 0.0 111.025 -0.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 111' ' ' PRO . 3.4 mt-10 -37.11 118.5 0.61 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.334 0.588 . . . . 0.0 110.758 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.642 HD13 ' HB3' ' A' ' 109' ' ' TRP . 2.9 tp -47.39 141.65 6.55 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.365 -0.834 . . . . 0.0 110.562 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.878 ' HG2' HD12 ' A' ' 66' ' ' ILE . 41.1 Cg_endo -71.37 159.91 50.24 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.119 1.589 . . . . 0.0 110.289 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.565 ' O ' HG22 ' A' ' 117' ' ' VAL . 13.9 tttt -124.3 108.5 12.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 0.0 110.545 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.545 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 5.2 t -58.47 84.38 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.29 -0.881 . . . . 0.0 108.85 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.615 HG21 ' HB2' ' A' ' 96' ' ' SER . 4.0 m -103.45 -176.95 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.771 0.796 . . . . 0.0 111.113 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.572 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.765 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.309 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 1' ' ' VAL . 8.1 p . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 121.246 0.546 . . . . 0.0 110.135 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -129.99 166.89 19.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.935 . . . . 0.0 110.149 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.542 ' HB3' ' O ' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -111.85 91.8 3.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.173 -0.954 . . . . 0.0 110.735 -179.629 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.476 ' O ' ' C ' ' A' ' 5' ' ' SER . 39.0 mt-30 -91.64 -177.17 4.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -0.943 . . . . 0.0 109.426 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.476 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.5 OUTLIER -36.9 131.76 0.7 Allowed Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.799 -0.563 . . . . 0.0 110.134 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.795 ' HG3' HG11 ' A' ' 27' ' ' VAL . 48.5 Cg_endo -68.87 157.35 62.19 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.998 1.525 . . . . 0.0 111.084 -178.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -75.58 170.74 19.61 Favored 'Trans proline' 0 C--N 1.302 -1.921 0 O-C-N 123.926 1.487 . . . . 0.0 109.608 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.6 p -70.33 175.49 4.64 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.145 -0.972 . . . . 0.0 109.874 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.683 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -140.33 -169.53 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -0.91 . . . . 0.0 110.804 179.556 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.2 OUTLIER -39.76 92.14 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.606 -179.262 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' A' ' 9' ' ' ILE . 3.9 m-80 42.08 41.26 1.94 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.276 -0.89 . . . . 0.0 110.113 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.449 ' O ' HG13 ' A' ' 9' ' ' ILE . . . -140.73 145.96 17.0 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -92.63 -166.81 1.61 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.268 -1.137 . . . . 0.0 110.605 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.612 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 14.9 p80 -153.9 126.14 7.94 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.157 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -145.62 112.31 5.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 110.311 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.439 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -111.05 19.43 25.13 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.457 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 0.3 OUTLIER 67.07 35.76 4.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.389 -1.065 . . . . 0.0 110.222 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.558 ' OE1' ' CE1' ' A' ' 21' ' ' TYR . 5.9 pt-20 176.88 -175.22 0.12 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 110.436 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -128.43 -3.8 5.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.377 -0.827 . . . . 0.0 110.056 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.588 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 0.9 OUTLIER -109.55 150.8 27.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 110.257 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.596 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 1.9 m-85 -167.43 42.31 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.54 -0.725 . . . . 0.0 109.746 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.518 ' HA ' ' HB2' ' A' ' 3' ' ' CYS . 21.1 p -52.79 99.15 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 122.042 0.925 . . . . 0.0 111.729 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.541 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 26.7 t70 50.54 163.45 0.0 OUTLIER 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 121.742 0.782 . . . . 0.0 112.037 178.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 48.32 26.83 5.15 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.629 ' O ' HG23 ' A' ' 26' ' ' VAL . 16.7 m -106.47 174.56 5.84 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.289 -1.124 . . . . 0.0 110.302 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 25' ' ' SER . 24.6 t -155.56 154.25 6.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.821 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.892 ' O ' HG23 ' A' ' 43' ' ' VAL . 39.2 t -143.81 124.17 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.837 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -74.55 104.52 5.28 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 118.483 -1.287 . . . . 0.0 107.534 177.538 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 1.083 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.2 m-30 -68.36 127.1 31.72 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.287 -0.883 . . . . 0.0 110.395 -178.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -84.8 156.4 21.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.817 . . . . 0.0 110.08 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.538 ' SG ' HD12 ' A' ' 37' ' ' LEU . 75.6 m -124.86 154.35 41.17 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -0.885 . . . . 0.0 110.155 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.484 ' O ' ' N ' ' A' ' 34' ' ' GLY . 7.8 m-20 -41.92 143.37 0.56 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.322 -0.861 . . . . 0.0 110.202 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 95.8 p -52.56 88.63 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.91 . . . . 0.0 110.503 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 32' ' ' ASN . . . 127.69 10.95 3.42 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.2 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.441 ' CD2' ' O ' ' A' ' 56' ' ' CYS . 1.7 m-30 -106.64 153.8 21.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.08 -1.247 . . . . 0.0 110.442 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.849 ' HB2' HD11 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -90.04 137.42 32.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.458 -0.776 . . . . 0.0 110.582 -179.473 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.558 HD13 ' O ' ' A' ' 29' ' ' TYR . 0.9 OUTLIER -98.92 98.54 9.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.189 -0.945 . . . . 0.0 109.484 178.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.849 HD11 ' HB2' ' A' ' 36' ' ' SER . 0.1 OUTLIER -95.86 141.86 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.902 . . . . 0.0 109.397 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.99 -120.21 3.88 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -125.01 137.14 54.24 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.362 -1.081 . . . . 0.0 109.93 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.531 ' O ' HG23 ' A' ' 28' ' ' THR . 73.0 p -71.86 55.86 0.29 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.229 -0.919 . . . . 0.0 109.77 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.445 ' HA2' ' C ' ' A' ' 27' ' ' VAL . . . 154.74 117.6 0.61 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.083 HG21 ' CE1' ' A' ' 29' ' ' TYR . 2.1 t -67.73 179.65 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.188 -1.183 . . . . 0.0 108.177 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.48 ' H ' HG12 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -139.72 104.04 4.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.955 -1.091 . . . . 0.0 110.638 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.599 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -81.93 111.05 17.76 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.161 -1.016 . . . . 0.0 109.262 178.675 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.58 103.2 7.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.584 -0.697 . . . . 0.0 110.488 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.61 36.21 8.08 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.462 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 64.89 31.38 80.75 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -147.78 105.42 3.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.176 -1.191 . . . . 0.0 110.549 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.74 ' CH2' HG23 ' A' ' 27' ' ' VAL . 77.6 m95 -58.5 140.06 54.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.155 -0.965 . . . . 0.0 109.514 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.2 m -143.51 170.64 15.43 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.952 -1.092 . . . . 0.0 111.059 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.516 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 20.0 t0 53.01 65.7 5.61 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.539 -0.726 . . . . 0.0 110.889 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.516 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.8 Cg_endo -91.23 139.15 2.4 Favored 'Trans proline' 0 C--N 1.3 -1.977 0 C-N-CA 121.9 1.733 . . . . 0.0 110.329 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.425 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 47.8 Cg_endo -83.52 -175.68 2.42 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.826 1.435 . . . . 0.0 110.052 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.554 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 7.4 p -124.63 143.65 50.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.38 -0.825 . . . . 0.0 111.569 -178.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 10' ' ' SER . 90.1 m -107.58 80.43 1.4 Allowed 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.464 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.9 OUTLIER -110.63 -150.43 0.46 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.712 -0.618 . . . . 0.0 110.162 -178.447 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.759 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -127.82 120.01 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.256 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.835 HG13 ' CB ' ' A' ' 36' ' ' SER . 26.9 m -115.13 52.66 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.018 -1.051 . . . . 0.0 111.824 -178.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.513 ' N ' ' OD1' ' A' ' 107' ' ' ASN . 9.0 mtpt -71.45 129.73 39.53 Favored 'General case' 0 C--N 1.283 -2.312 0 C-N-CA 118.262 -1.375 . . . . 0.0 108.232 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.5 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 5.8 m -95.01 172.2 5.72 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.928 -1.107 . . . . 0.0 112.371 -178.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 43.6 Cg_endo -84.94 -66.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.721 1.906 . . . . 0.0 110.287 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.456 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 167.98 129.29 0.04 OUTLIER Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -179.232 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.67 ' HG2' HD22 ' A' ' 71' ' ' LEU . 45.9 Cg_endo -74.0 65.23 5.11 Favored 'Trans proline' 0 C--N 1.296 -2.187 0 O-C-N 123.61 1.321 . . . . 0.0 109.868 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.705 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -85.49 170.39 12.7 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.739 -0.601 . . . . 0.0 110.446 -179.576 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.779 HG23 ' HA ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -169.31 164.09 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.126 -0.984 . . . . 0.0 110.277 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.565 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 73.2 m -66.47 75.27 0.1 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.535 -0.728 . . . . 0.0 111.978 -178.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.554 ' CB ' ' O ' ' A' ' 67' ' ' SER . 1.5 t-20 76.31 -24.72 0.21 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.285 -0.885 . . . . 0.0 112.473 178.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.573 ' CA ' ' HA ' ' A' ' 89' ' ' CYS . . . -86.32 38.6 3.08 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.779 ' HA ' HG23 ' A' ' 66' ' ' ILE . 11.9 p90 -41.61 159.75 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 123.032 1.396 . . . . 0.0 112.839 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.066 HD13 ' HB2' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -43.11 -81.39 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 113.922 -1.49 . . . . 0.0 109.699 178.269 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.597 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER 79.05 13.89 1.17 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.606 -0.684 . . . . 0.0 110.427 179.668 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.479 ' HB3' ' HB2' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -156.73 53.27 0.52 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.124 -0.985 . . . . 0.0 110.507 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.747 ' O ' HG12 ' A' ' 85' ' ' VAL . . . 122.38 113.09 2.17 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 1.066 ' HB2' HD13 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -172.25 160.44 5.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -1.14 . . . . 0.0 110.18 -179.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.511 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -152.29 169.46 22.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.455 -0.778 . . . . 0.0 109.949 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -58.92 -32.94 70.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.096 -1.003 . . . . 0.0 109.784 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.51 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -142.18 167.66 21.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.465 -0.772 . . . . 0.0 110.328 179.867 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.623 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 3.2 m-85 -141.83 -151.29 0.35 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.237 -0.915 . . . . 0.0 110.121 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.668 ' C ' HG23 ' A' ' 59' ' ' VAL . 85.2 p -160.54 -99.24 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.041 -1.037 . . . . 0.0 111.239 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.675 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -120.66 23.52 10.74 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.487 -1.383 . . . . 0.0 110.931 -178.281 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.693 ' C ' HG22 ' A' ' 102' ' ' THR . 17.5 t-20 -165.02 -109.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.769 -1.207 . . . . 0.0 110.541 178.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 48.52 75.71 0.14 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.706 -1.246 . . . . 0.0 109.114 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.683 ' CA ' HG23 ' A' ' 102' ' ' THR . 24.4 t30 -69.79 125.89 28.07 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.51 -0.744 . . . . 0.0 110.942 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.747 HG12 ' O ' ' A' ' 74' ' ' GLY . 13.3 m -108.53 125.08 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.214 -0.929 . . . . 0.0 109.418 178.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.577 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -80.82 123.93 28.66 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.989 -1.07 . . . . 0.0 108.882 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.761 ' CD1' HG21 ' A' ' 66' ' ' ILE . 9.7 m-85 -87.96 124.07 33.34 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.459 1.123 . . . . 0.0 112.302 -178.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.511 ' HB2' ' OG ' ' A' ' 72' ' ' SER . 0.0 OUTLIER -106.88 96.72 6.64 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.594 -178.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.573 ' HA ' ' CA ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -46.65 137.46 6.87 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.002 -1.061 . . . . 0.0 109.719 179.494 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.457 ' HD3' ' ND2' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -64.42 57.08 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.255 -0.903 . . . . 0.0 111.351 -179.377 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.581 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER 58.68 137.65 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.353 -0.842 . . . . 0.0 112.689 178.465 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.624 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 57.0 55.47 30.13 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 178.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.624 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 34.3 m-85 -162.05 165.05 27.79 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.312 -1.11 . . . . 0.0 110.396 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.542 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 1.2 ttmm -123.2 104.03 8.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.296 -0.878 . . . . 0.0 109.629 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.556 HD23 HD11 ' A' ' 66' ' ' ILE . 4.6 mt -46.66 93.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.965 . . . . 0.0 110.451 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -71.7 84.91 0.9 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.337 -0.852 . . . . 0.0 109.671 179.514 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 157.86 -88.75 0.11 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.598 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.2 OUTLIER -160.92 128.36 4.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.153 -1.204 . . . . 0.0 110.716 -179.547 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.505 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 0.4 OUTLIER -69.38 -76.91 0.09 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.289 -0.882 . . . . 0.0 110.612 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 40.4 p -74.55 106.02 5.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.284 -0.885 . . . . 0.0 110.725 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.491 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 58.3 m -113.66 164.38 13.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.354 -0.841 . . . . 0.0 110.068 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.693 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -136.2 142.01 44.06 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.274 -0.891 . . . . 0.0 111.066 -179.721 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.621 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 0.5 OUTLIER -71.93 87.02 1.01 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.246 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.489 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -62.28 178.39 0.33 Allowed Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.202 -0.936 . . . . 0.0 112.619 -178.225 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.759 ' CB ' HD12 ' A' ' 38' ' ' ILE . 44.3 Cg_endo -79.02 42.84 1.36 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 124.813 1.954 . . . . 0.0 112.207 -178.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -140.64 16.76 2.86 Favored Glycine 0 C--N 1.292 -1.884 0 N-CA-C 108.2 -1.96 . . . . 0.0 108.2 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.583 ' O ' HG23 ' A' ' 108' ' ' THR . 22.3 m-80 62.98 57.0 1.72 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.666 -0.903 . . . . 0.0 109.725 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.583 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.2 OUTLIER -160.37 -159.5 0.7 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.309 -0.869 . . . . 0.0 110.452 -179.585 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.621 ' CZ3' ' N ' ' A' ' 103' ' ' CYS . 37.0 m95 -136.6 91.28 2.64 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.372 -0.83 . . . . 0.0 110.442 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.571 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 15.2 mmtt -100.4 148.99 35.68 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.562 -0.711 . . . . 0.0 110.078 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.598 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 47.2 Cg_endo -71.01 174.36 45.2 Favored 'Cis proline' 0 C--N 1.312 -1.342 0 C-N-CA 121.999 -2.084 . . . . 0.0 111.014 -0.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -33.17 131.14 0.2 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.458 0.647 . . . . 0.0 111.838 -179.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.597 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.9 OUTLIER -53.38 137.59 50.18 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.56 -0.712 . . . . 0.0 109.812 179.298 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.688 ' HG2' HD12 ' A' ' 66' ' ' ILE . 40.4 Cg_endo -69.19 147.69 67.09 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 O-C-N 124.139 1.599 . . . . 0.0 111.066 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.574 ' O ' HG22 ' A' ' 117' ' ' VAL . 3.6 ttpp -115.9 92.47 3.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.43 -0.794 . . . . 0.0 110.301 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.587 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.1 t -47.67 105.97 0.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.919 . . . . 0.0 110.088 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 115' ' ' LYS . 0.7 OUTLIER -122.55 177.08 4.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.427 -0.796 . . . . 0.0 110.511 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 21.3 ptt85 . . . . . 0 C--N 1.297 -1.674 0 C-N-CA 118.805 -1.158 . . . . 0.0 110.384 179.64 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 51.6 t . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.293 0.568 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.4 ptpt -137.57 178.3 7.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 0.0 110.456 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.546 ' O ' ' N ' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -161.27 93.12 0.93 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.607 -0.683 . . . . 0.0 109.514 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 9.5 mt-30 -72.84 176.96 5.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.072 -1.017 . . . . 0.0 110.428 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.9 140.93 29.13 Favored Pre-proline 0 C--N 1.301 -1.532 0 O-C-N 121.569 -0.707 . . . . 0.0 109.95 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.681 ' HG3' HG21 ' A' ' 27' ' ' VAL . 53.4 Cg_endo -70.91 153.21 63.76 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 124.019 1.536 . . . . 0.0 110.861 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -74.98 170.63 19.99 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.959 1.505 . . . . 0.0 109.947 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 92.4 p -69.51 178.25 2.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.174 -0.954 . . . . 0.0 110.191 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.629 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -142.39 -170.17 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 122.125 0.964 . . . . 0.0 111.273 179.81 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 54.7 m -38.22 93.61 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.068 -179.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER 43.92 30.47 0.4 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.243 -0.911 . . . . 0.0 110.502 179.689 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.64 162.31 25.15 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.134 -1.587 . . . . 0.0 109.134 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 30' ' ' SER . 5.2 ptt180 -118.45 -173.0 2.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.079 -1.248 . . . . 0.0 110.778 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.684 ' HB2' HG11 ' A' ' 27' ' ' VAL . 11.9 p80 -131.95 153.53 50.21 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.306 0.574 . . . . 0.0 110.66 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -170.63 -156.57 0.13 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.283 -0.885 . . . . 0.0 110.072 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.441 ' C ' ' CD2' ' A' ' 17' ' ' TYR . . . 124.27 24.98 1.71 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.441 ' CD2' ' C ' ' A' ' 16' ' ' GLY . 24.5 m-85 58.66 65.86 1.17 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.175 -1.191 . . . . 0.0 110.284 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 19' ' ' ASP . 1.6 pp20? -141.21 -174.37 4.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.91 . . . . 0.0 109.874 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.449 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 31.9 m-20 -158.3 -33.38 0.07 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.11 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.577 ' O ' ' CG ' ' A' ' 20' ' ' PHE . 5.6 p90 -160.74 70.7 0.4 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.851 -1.156 . . . . 0.0 110.782 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.616 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 30.5 m-85 -46.95 175.4 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.469 -0.77 . . . . 0.0 110.318 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.526 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 21.2 m -132.64 -54.57 0.95 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.058 -1.026 . . . . 0.0 110.738 -179.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.424 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 3.9 t70 -171.95 148.12 2.25 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.394 -0.816 . . . . 0.0 109.44 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 65.88 11.83 55.5 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 -178.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.616 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 66.2 m -86.5 175.0 8.59 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.407 -1.055 . . . . 0.0 110.167 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.717 HG13 ' O ' ' A' ' 43' ' ' VAL . 26.1 t -151.34 154.75 7.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.514 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.684 HG11 ' HB2' ' A' ' 14' ' ' HIS . 24.5 t -135.02 117.47 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.147 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.28 104.22 2.6 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.302 -1.359 . . . . 0.0 107.746 178.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.687 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.2 m-30 -68.25 133.18 48.4 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.325 -178.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -92.87 153.55 18.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.309 -0.869 . . . . 0.0 109.973 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 57.2 m -119.49 154.41 33.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 110.025 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' A' ' 35' ' ' TYR . 1.6 t-20 -46.81 140.28 4.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.935 . . . . 0.0 110.141 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -45.2 108.68 0.13 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.141 -0.975 . . . . 0.0 110.45 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.81 9.84 27.72 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.5 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 2.7 m-30 -108.5 146.76 32.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.104 -1.233 . . . . 0.0 110.327 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.888 ' HB2' HG22 ' A' ' 59' ' ' VAL . 48.2 t -89.33 137.71 32.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.395 -0.816 . . . . 0.0 110.878 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.656 HD13 ' O ' ' A' ' 29' ' ' TYR . 4.3 tp -94.12 110.04 21.78 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 177.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.71 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -107.56 147.46 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.069 -1.019 . . . . 0.0 109.839 -179.225 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.9 -163.55 12.96 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -65.08 130.81 44.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.219 -1.165 . . . . 0.0 109.773 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.9 p -74.11 53.37 0.49 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.209 -0.932 . . . . 0.0 110.22 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.654 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 150.62 105.59 0.32 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.717 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -48.09 177.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.222 -1.164 . . . . 0.0 108.601 179.377 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.5 ' HA ' ' O ' ' A' ' 25' ' ' SER . 2.5 tp -139.5 105.68 5.24 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.361 -0.837 . . . . 0.0 109.829 178.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.628 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 1.0 OUTLIER -86.05 106.87 17.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.093 -1.004 . . . . 0.0 109.969 179.58 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.7 m -124.38 104.0 8.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.492 -0.755 . . . . 0.0 109.856 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.77 53.97 3.82 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 48.49 46.94 29.5 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -156.83 99.14 1.83 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -1.153 . . . . 0.0 110.897 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.628 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 90.8 m95 -68.18 137.97 55.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.2 -0.938 . . . . 0.0 109.063 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.8 p -140.24 169.77 17.06 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.833 -1.167 . . . . 0.0 111.519 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.508 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.5 OUTLIER 51.8 65.86 5.88 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.734 -0.604 . . . . 0.0 111.457 179.627 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.508 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 46.7 Cg_endo -90.65 130.39 1.54 Allowed 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 121.874 1.716 . . . . 0.0 110.057 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.541 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 53.5 Cg_endo -77.76 176.37 10.1 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.811 1.427 . . . . 0.0 110.705 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.524 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 12.2 p -108.97 156.46 19.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.464 -0.772 . . . . 0.0 110.776 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 10' ' ' SER . 22.2 m -122.67 80.14 1.71 Allowed 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.507 ' O ' ' N ' ' A' ' 36' ' ' SER . 5.8 mm100 -109.98 -145.07 0.39 Allowed 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.428 0.632 . . . . 0.0 110.609 -178.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.592 ' N ' HD12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -137.32 114.16 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.952 HG21 ' HB3' ' A' ' 81' ' ' TYR . 19.6 m -111.87 60.66 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.161 -0.962 . . . . 0.0 112.182 -178.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 107' ' ' ASN . 8.5 mttt -69.73 159.35 33.69 Favored 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 117.852 -1.539 . . . . 0.0 107.245 178.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.488 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -118.95 168.82 9.03 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 120.391 -1.443 . . . . 0.0 114.304 -176.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -89.9 -81.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.739 2.293 . . . . 0.0 110.972 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 177.37 125.62 0.18 Allowed Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 121.711 -0.618 . . . . 0.0 109.521 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.595 ' N ' ' NE1' ' A' ' 109' ' ' TRP . 49.0 Cg_endo -75.86 67.32 6.65 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 123.714 1.376 . . . . 0.0 109.673 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.55 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -81.7 175.32 10.56 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.57 -0.707 . . . . 0.0 110.471 -179.451 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.697 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -172.46 163.48 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.295 -0.878 . . . . 0.0 110.341 179.665 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 96.4 p -72.86 100.13 2.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.522 -0.736 . . . . 0.0 110.645 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.469 ' O ' ' SG ' ' A' ' 116' ' ' CYS . 7.4 m-20 44.51 45.17 7.6 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.362 -0.837 . . . . 0.0 110.573 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.697 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -152.71 31.02 0.83 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.572 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 6.9 p90 -44.68 -176.08 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 122.663 1.22 . . . . 0.0 112.644 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.681 ' H ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -110.49 162.99 14.14 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.558 179.22 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.508 ' HB2' ' HD3' ' A' ' 88' ' ' LYS . 2.5 t -144.49 14.89 1.61 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.003 -1.061 . . . . 0.0 110.178 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.67 -69.79 0.74 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.216 -0.927 . . . . 0.0 110.909 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.452 ' O ' HG12 ' A' ' 85' ' ' VAL . . . -136.82 81.47 0.28 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.594 ' CE2' ' OH ' ' A' ' 79' ' ' TYR . 1.9 t80 -105.94 160.02 15.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.43 -1.041 . . . . 0.0 109.977 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.481 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 25.3 tttt -158.4 148.14 19.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.897 . . . . 0.0 110.446 -179.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' A' ' 76' ' ' LYS . 2.2 mtp85 -44.71 -34.58 2.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.177 -0.952 . . . . 0.0 109.702 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.448 ' O ' ' HD3' ' A' ' 76' ' ' LYS . 0.5 OUTLIER -143.63 153.48 42.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.406 -0.808 . . . . 0.0 109.917 179.725 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.594 ' OH ' ' CE2' ' A' ' 75' ' ' PHE . 8.3 m-85 -125.41 -148.12 0.38 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.161 -0.962 . . . . 0.0 110.462 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.525 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 81.6 p -158.62 -124.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.3 -0.875 . . . . 0.0 110.3 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.952 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -99.93 29.9 3.98 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.037 -1.039 . . . . 0.0 111.068 -178.295 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.67 ' C ' HG22 ' A' ' 102' ' ' THR . 48.7 t30 -173.93 -114.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.93 -1.107 . . . . 0.0 110.462 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 49.43 75.39 0.16 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.696 -1.252 . . . . 0.0 109.244 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.616 ' CA ' HG23 ' A' ' 102' ' ' THR . 10.3 p30 -69.27 125.46 26.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.381 -0.824 . . . . 0.0 110.826 -179.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.597 HG23 ' CE1' ' A' ' 87' ' ' PHE . 26.4 m -107.2 118.03 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.166 -0.959 . . . . 0.0 110.235 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.547 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -78.77 137.7 37.86 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.738 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.665 ' CZ ' HD12 ' A' ' 113' ' ' LEU . 70.0 m-85 -95.58 137.83 34.1 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.872 -1.142 . . . . 0.0 112.52 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.508 ' HD3' ' HB2' ' A' ' 72' ' ' SER . 0.7 OUTLIER -111.1 93.84 4.69 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.744 -179.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.578 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -44.15 131.97 5.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.053 -1.029 . . . . 0.0 110.302 -179.663 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 11.6 mmtt -42.27 -78.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.295 -0.878 . . . . 0.0 110.258 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.573 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -162.3 136.78 6.73 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.321 -0.862 . . . . 0.0 110.492 -179.892 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.592 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 52.98 66.08 2.94 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.592 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 14.6 m-85 -162.49 172.43 15.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.42 -1.047 . . . . 0.0 110.096 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.592 ' O ' HG22 ' A' ' 117' ' ' VAL . 4.4 mtmt -131.2 107.65 9.15 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.321 -0.862 . . . . 0.0 109.957 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.578 HD11 ' H ' ' A' ' 89' ' ' CYS . 1.1 mt -49.54 93.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.099 -1.001 . . . . 0.0 110.425 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.468 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -77.44 109.33 11.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -0.937 . . . . 0.0 110.184 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 135.03 -85.13 0.26 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.565 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.2 OUTLIER -158.77 112.46 2.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.293 -1.122 . . . . 0.0 110.546 -179.61 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.422 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 28.4 t -72.82 -0.1 12.47 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.279 -0.888 . . . . 0.0 110.326 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.5 p -141.5 117.92 10.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.143 -0.973 . . . . 0.0 109.547 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.49 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 40.1 m -134.33 151.42 51.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.149 -0.969 . . . . 0.0 111.122 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.67 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -120.36 151.95 38.55 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.61 0.719 . . . . 0.0 110.049 179.608 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.594 ' SG ' ' CZ2' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -83.8 77.96 9.79 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.683 -0.635 . . . . 0.0 110.554 -179.348 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.501 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.5 OUTLIER -48.37 175.78 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.348 -0.845 . . . . 0.0 111.675 -179.641 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.71 ' CB ' HD12 ' A' ' 38' ' ' ILE . 47.3 Cg_endo -77.53 43.18 1.28 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.656 1.872 . . . . 0.0 111.968 -178.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -139.57 12.04 3.21 Favored Glycine 0 C--N 1.292 -1.903 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 2.0 m120 64.2 63.83 0.76 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.718 -0.872 . . . . 0.0 109.836 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -159.8 -160.52 0.82 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.319 -0.863 . . . . 0.0 111.035 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.638 ' HB3' HD11 ' A' ' 113' ' ' LEU . 26.4 m95 -137.43 82.0 1.9 Allowed 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.64 0.733 . . . . 0.0 110.293 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.567 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.8 OUTLIER -99.27 136.5 20.45 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.72 -0.612 . . . . 0.0 110.161 -179.819 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.567 ' C ' ' HA ' ' A' ' 110' ' ' LYS . 42.7 Cg_endo -69.53 164.94 77.26 Favored 'Cis proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.084 -2.048 . . . . 0.0 111.001 -0.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -41.24 149.39 0.1 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.563 -0.711 . . . . 0.0 110.555 -179.303 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.733 HD22 ' H ' ' A' ' 113' ' ' LEU . 1.1 mm? -57.19 145.64 65.25 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.422 -0.798 . . . . 0.0 109.982 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.662 ' HG2' HD12 ' A' ' 66' ' ' ILE . 37.4 Cg_endo -69.0 169.47 17.87 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 O-C-N 124.31 1.689 . . . . 0.0 110.951 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.719 ' HG2' HG13 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -128.34 106.32 8.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 0.0 110.528 -179.549 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.545 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.4 t -63.31 87.13 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.184 -0.947 . . . . 0.0 108.912 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.719 HG13 ' HG2' ' A' ' 115' ' ' LYS . 2.3 m -103.3 177.58 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.612 0.72 . . . . 0.0 111.007 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.582 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.709 0 C-N-CA 118.971 -1.092 . . . . 0.0 110.327 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 1' ' ' VAL . 5.0 p . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.2 0.524 . . . . 0.0 110.052 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.75 177.54 7.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.393 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.576 ' CB ' ' N ' ' A' ' 22' ' ' THR . 1.4 t -159.4 104.13 1.63 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.434 -0.791 . . . . 0.0 110.486 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.424 ' C ' ' O ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -81.25 176.58 9.63 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.73 -1.232 . . . . 0.0 109.325 179.023 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 19' ' ' ASP . 0.1 OUTLIER -54.57 146.68 33.37 Favored Pre-proline 0 C--N 1.294 -1.812 0 O-C-N 121.379 -0.825 . . . . 0.0 109.666 179.882 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.64 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 51.7 Cg_endo -70.11 154.2 66.56 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.93 1.489 . . . . 0.0 111.404 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -76.21 172.88 15.44 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.014 1.534 . . . . 0.0 110.281 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 m -69.7 179.47 2.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.161 -0.962 . . . . 0.0 110.007 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.633 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -145.24 -170.16 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 122.335 1.064 . . . . 0.0 111.905 -179.786 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.496 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 14.1 t -46.17 105.75 0.07 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.313 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 10' ' ' SER . 6.6 m120 40.96 26.43 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.352 -0.842 . . . . 0.0 110.763 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -141.38 169.86 24.92 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 30' ' ' SER . 2.5 ptt180 -133.91 -178.55 5.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -1.142 . . . . 0.0 110.332 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.64 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 7.0 p80 -120.22 156.23 31.58 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.545 -0.722 . . . . 0.0 110.095 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -173.84 50.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.141 -0.974 . . . . 0.0 110.587 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 17' ' ' TYR . . . -53.92 -78.76 0.1 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.469 ' HB3' ' OE2' ' A' ' 18' ' ' GLU . 0.2 OUTLIER 174.98 35.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.355 -1.085 . . . . 0.0 110.248 179.515 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.469 ' OE2' ' HB3' ' A' ' 17' ' ' TYR . 0.6 OUTLIER 176.81 -178.38 0.16 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 110.428 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 5' ' ' SER . 8.1 t70 -117.49 -43.62 2.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.428 -0.795 . . . . 0.0 109.955 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 3' ' ' CYS . 14.2 m-85 -84.31 130.3 34.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.334 -0.854 . . . . 0.0 109.859 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.607 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.5 OUTLIER -132.42 -6.02 3.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.344 -0.847 . . . . 0.0 110.889 -179.39 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.576 ' N ' ' CB ' ' A' ' 3' ' ' CYS . 66.7 p 45.91 -96.71 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.516 -0.74 . . . . 0.0 111.841 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.402 ' HB2' ' H ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER -150.13 150.89 32.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.843 -1.161 . . . . 0.0 110.661 -178.442 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 79.42 15.49 79.81 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.607 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 20.5 m -97.25 172.77 7.59 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.459 -1.024 . . . . 0.0 110.281 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.706 HG13 ' O ' ' A' ' 43' ' ' VAL . 33.4 t -151.49 151.94 11.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.382 -0.824 . . . . 0.0 110.066 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.636 HG11 ' HB2' ' A' ' 14' ' ' HIS . 34.6 t -134.66 119.89 30.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.223 -0.923 . . . . 0.0 111.583 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.764 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -72.3 103.6 3.45 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.399 -1.321 . . . . 0.0 107.489 177.736 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.669 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 2.2 m-30 -67.55 121.4 15.77 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.338 -0.851 . . . . 0.0 110.074 -178.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -74.76 150.3 39.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.206 -0.934 . . . . 0.0 109.617 179.352 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.479 ' SG ' HD12 ' A' ' 37' ' ' LEU . 60.3 m -118.2 159.51 23.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.176 -0.952 . . . . 0.0 110.306 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 33' ' ' SER . 4.4 t-20 -53.72 134.89 41.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 110.236 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 32' ' ' ASN . 0.5 OUTLIER -44.39 102.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.245 -0.909 . . . . 0.0 110.305 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.73 -11.31 12.17 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -93.84 139.74 30.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.236 -1.155 . . . . 0.0 110.062 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.634 ' HB3' HD11 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -84.62 142.05 30.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.172 -0.955 . . . . 0.0 110.879 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.693 HD21 ' HA ' ' A' ' 41' ' ' SER . 3.2 tp -92.81 97.04 10.51 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.458 -0.776 . . . . 0.0 109.231 179.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.904 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -88.42 157.0 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.409 -0.807 . . . . 0.0 109.05 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 91.07 178.22 43.31 Favored Glycine 0 N--CA 1.488 2.11 0 C-N-CA 119.417 -1.373 . . . . 0.0 109.988 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.459 ' O ' ' HG3' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -54.71 124.65 17.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.311 -1.111 . . . . 0.0 109.85 179.729 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.764 ' O ' HG23 ' A' ' 28' ' ' THR . 0.1 OUTLIER -72.45 55.14 0.34 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.206 -0.934 . . . . 0.0 109.956 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.644 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 161.39 96.98 0.11 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.706 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -45.3 173.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.365 -1.079 . . . . 0.0 108.345 179.336 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.477 ' HB3' ' OD2' ' A' ' 52' ' ' ASP . 7.3 tp -134.08 103.37 5.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.984 -1.073 . . . . 0.0 110.371 178.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.549 ' HB2' ' CE2' ' A' ' 50' ' ' TRP . 0.6 OUTLIER -77.23 115.28 16.88 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.367 -0.833 . . . . 0.0 109.45 179.168 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.86 101.74 5.37 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.113 -0.992 . . . . 0.0 110.171 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.402 ' H ' ' HB2' ' A' ' 23' ' ' ASP . . . 77.96 41.15 19.18 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.41 30.76 78.75 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.79 102.09 4.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -1.142 . . . . 0.0 110.552 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.549 ' CE2' ' HB2' ' A' ' 45' ' ' CYS . 89.7 m95 -73.59 123.0 23.14 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.127 -0.983 . . . . 0.0 109.551 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.418 ' O ' ' CG ' ' A' ' 52' ' ' ASP . 22.4 m -129.22 -176.38 3.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.062 -1.024 . . . . 0.0 111.399 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.52 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 1.6 p30 37.56 65.64 2.56 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.851 -0.53 . . . . 0.0 111.191 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.1 Cg_endo -91.09 131.73 1.48 Allowed 'Trans proline' 0 C--N 1.301 -1.946 0 C-N-CA 121.95 1.767 . . . . 0.0 110.03 178.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.541 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 53.8 Cg_endo -76.27 172.67 15.82 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.596 1.314 . . . . 0.0 110.205 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.615 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 37.9 p -114.22 143.16 45.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.08 -1.013 . . . . 0.0 111.291 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 10' ' ' SER . 69.4 m -107.57 78.89 1.24 Allowed 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -113.84 -159.33 0.69 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.481 0.658 . . . . 0.0 110.56 -178.299 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.635 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -110.49 142.8 21.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.426 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.726 HG21 ' CB ' ' A' ' 81' ' ' TYR . 21.3 m -133.44 44.96 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.988 -1.07 . . . . 0.0 110.992 -178.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.629 ' HD2' HG22 ' A' ' 58' ' ' ILE . 2.9 mttp -81.34 102.45 10.45 Favored 'General case' 0 C--N 1.281 -2.377 0 C-N-CA 118.858 -1.137 . . . . 0.0 109.343 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.512 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 53.2 m -72.94 164.0 64.11 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.372 -0.83 . . . . 0.0 111.298 -178.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.544 ' HD2' ' HA ' ' A' ' 108' ' ' THR . 42.5 Cg_endo -69.54 -89.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 124.306 1.687 . . . . 0.0 110.666 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.477 ' HB3' ' CG2' ' A' ' 65' ' ' THR . 0.0 OUTLIER -159.68 133.36 4.97 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.776 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.694 ' HA ' HD21 ' A' ' 113' ' ' LEU . 56.7 Cg_endo -77.93 65.86 8.24 Favored 'Trans proline' 0 C--N 1.296 -2.22 0 O-C-N 123.604 1.318 . . . . 0.0 109.671 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.716 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.7 OUTLIER -87.27 -175.37 5.26 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.533 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.716 HG22 ' C ' ' A' ' 65' ' ' THR . 0.2 OUTLIER 179.7 169.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 C-N-CA 118.756 -1.178 . . . . 0.0 110.721 179.438 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.511 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 4.0 t -69.71 90.89 0.59 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.46 -0.775 . . . . 0.0 110.915 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 1.9 m-80 51.17 34.72 11.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.336 -0.852 . . . . 0.0 110.902 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.666 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -139.15 30.07 2.48 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.57 ' O ' ' N ' ' A' ' 88' ' ' LYS . 4.7 p90 -43.12 -174.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 122.707 1.241 . . . . 0.0 112.789 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.749 HD22 ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -113.73 158.0 21.49 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.056 179.088 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.8 19.44 2.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.094 -1.004 . . . . 0.0 110.086 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.8 t -99.25 -85.14 0.4 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.918 . . . . 0.0 110.844 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -98.62 -86.24 1.86 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.59 ' CE2' ' OH ' ' A' ' 79' ' ' TYR . 17.5 t80 57.3 106.84 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.418 -1.048 . . . . 0.0 110.207 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.61 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -114.96 123.35 48.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.253 -0.905 . . . . 0.0 108.918 179.309 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.526 ' C ' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -28.79 -39.54 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.353 0.597 . . . . 0.0 111.204 -179.073 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -123.52 105.81 10.07 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.379 -0.825 . . . . 0.0 109.739 179.192 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.61 ' CE1' ' O ' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -91.73 175.23 6.97 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.128 -0.982 . . . . 0.0 109.849 -179.517 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.555 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -170.27 107.09 0.33 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.149 -0.97 . . . . 0.0 111.128 179.821 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.726 ' CB ' HG21 ' A' ' 59' ' ' VAL . 10.2 t80 46.77 18.44 0.07 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.091 -1.006 . . . . 0.0 111.809 178.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.661 ' C ' HG22 ' A' ' 102' ' ' THR . 28.5 p30 -172.49 -128.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.186 -1.571 . . . . 0.0 110.841 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.462 ' OD2' ' HA ' ' A' ' 79' ' ' TYR . 11.0 m-20 52.78 72.51 0.41 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.858 -1.151 . . . . 0.0 108.831 -178.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.761 ' CA ' HG23 ' A' ' 102' ' ' THR . 15.5 p30 -68.5 138.41 55.18 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.473 -0.767 . . . . 0.0 110.169 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.608 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 5.2 m -124.54 119.49 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.181 -0.949 . . . . 0.0 110.746 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.537 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 5.2 t0 -81.39 132.56 35.33 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.655 ' CE1' HD12 ' A' ' 71' ' ' LEU . 69.6 m-85 -92.01 120.94 33.12 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 122.326 1.06 . . . . 0.0 112.464 -177.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -92.7 90.68 7.17 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.763 179.594 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.517 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -44.07 131.02 6.02 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.157 -0.965 . . . . 0.0 109.774 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -37.65 -70.9 0.09 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.647 -0.658 . . . . 0.0 110.74 -179.434 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.574 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 49.1 t80 -175.11 145.65 0.81 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.276 -0.89 . . . . 0.0 110.366 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.58 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 46.18 42.21 12.27 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 12.1 m-85 -145.37 150.7 37.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.526 -0.985 . . . . 0.0 109.934 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.531 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 6.8 mtmp? -107.42 138.96 42.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.291 -0.881 . . . . 0.0 109.903 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.63 HD23 ' HB2' ' A' ' 114' ' ' PRO . 0.5 OUTLIER -78.49 100.17 6.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.025 -1.047 . . . . 0.0 110.725 -179.545 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.454 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -78.49 105.91 10.08 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.423 -0.798 . . . . 0.0 109.436 179.273 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 138.62 -88.61 0.2 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.586 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -158.07 112.94 2.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.296 -1.12 . . . . 0.0 110.549 -179.614 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 82.8 p -65.0 -22.11 66.95 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.191 -0.943 . . . . 0.0 110.765 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.6 p -125.65 126.26 44.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.813 -1.179 . . . . 0.0 109.877 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.535 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 4.5 m -135.11 172.57 12.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 0.0 110.429 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.761 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -148.03 140.46 24.42 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.506 -0.746 . . . . 0.0 110.456 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.574 ' O ' ' CA ' ' A' ' 81' ' ' TYR . 7.8 t -59.97 88.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.43 -0.794 . . . . 0.0 109.43 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.465 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.2 OUTLIER -61.53 173.23 0.82 Allowed Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.037 -1.039 . . . . 0.0 111.768 -178.844 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.904 ' CB ' HD12 ' A' ' 38' ' ' ILE . 50.5 Cg_endo -75.37 13.91 1.03 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 124.554 1.818 . . . . 0.0 111.937 -178.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.486 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -112.35 23.14 16.42 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.699 ' O ' HG23 ' A' ' 108' ' ' THR . 39.5 m-80 60.47 48.53 7.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.808 -0.819 . . . . 0.0 110.636 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.699 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.6 OUTLIER -160.98 -179.39 7.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.03 -1.044 . . . . 0.0 111.387 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.691 ' HB3' HD13 ' A' ' 113' ' ' LEU . 42.2 m95 -104.15 99.01 8.74 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.556 0.693 . . . . 0.0 110.845 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.536 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 8.8 mttt -110.19 141.01 22.96 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.503 -0.748 . . . . 0.0 109.59 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.586 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.4 Cg_endo -71.04 168.68 71.45 Favored 'Cis proline' 0 C--N 1.313 -1.312 0 C-N-CA 122.109 -2.038 . . . . 0.0 110.981 -0.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 111' ' ' PRO . 4.3 tt0 -38.97 130.79 1.46 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.502 -0.749 . . . . 0.0 111.106 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.694 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -42.32 146.88 0.63 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.47 -0.769 . . . . 0.0 110.117 179.178 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.675 ' HG2' HD12 ' A' ' 66' ' ' ILE . 41.9 Cg_endo -74.14 173.51 14.0 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 O-C-N 124.382 1.727 . . . . 0.0 110.658 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.542 ' O ' HG22 ' A' ' 117' ' ' VAL . 24.6 ttmt -135.12 111.67 9.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 110.565 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.535 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.8 t -66.15 100.19 0.58 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.344 -0.847 . . . . 0.0 108.809 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -110.57 -177.63 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-O 121.798 0.809 . . . . 0.0 110.825 -179.12 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.296 -1.75 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.472 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.224 0.535 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.6 172.76 6.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.158 -0.964 . . . . 0.0 110.601 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.565 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -124.76 83.73 2.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.441 -0.787 . . . . 0.0 109.829 179.853 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.562 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 3.0 mt-30 -60.11 174.54 0.5 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.291 -0.88 . . . . 0.0 110.417 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 19' ' ' ASP . 1.0 OUTLIER -47.09 144.48 4.0 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.423 -0.798 . . . . 0.0 110.204 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.67 ' HG3' HG11 ' A' ' 27' ' ' VAL . 53.3 Cg_endo -71.52 157.72 55.53 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.988 1.52 . . . . 0.0 110.871 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -76.72 171.96 17.06 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.992 1.522 . . . . 0.0 110.286 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.61 175.96 6.64 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.221 -0.924 . . . . 0.0 109.895 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.604 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -141.14 -170.57 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 122.281 1.039 . . . . 0.0 111.587 179.581 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.4 OUTLIER -44.93 105.13 0.05 Allowed 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.157 -178.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.453 ' C ' ' O ' ' A' ' 10' ' ' SER . 0.9 OUTLIER 39.05 27.95 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.315 -0.866 . . . . 0.0 110.583 179.604 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -135.99 160.42 24.61 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -123.2 178.22 5.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -1.131 . . . . 0.0 110.321 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.638 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 11.3 p80 -123.31 135.98 54.46 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.572 -0.705 . . . . 0.0 110.355 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -137.43 64.68 1.52 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.413 -0.804 . . . . 0.0 110.077 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -59.09 -173.59 0.55 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.06 31.61 1.63 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.322 -1.105 . . . . 0.0 110.229 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.568 ' OE2' ' CD1' ' A' ' 21' ' ' TYR . 6.7 pt-20 179.09 -171.81 0.14 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 110.371 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 5' ' ' SER . 29.4 t0 -92.03 -52.54 4.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 110.014 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.573 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 52.0 p90 -104.03 -155.17 0.52 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.177 -0.952 . . . . 0.0 109.983 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.618 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 1.8 m-85 -170.0 -31.62 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.157 -0.964 . . . . 0.0 110.883 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.565 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 3.0 m 78.42 -83.03 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.659 -0.65 . . . . 0.0 111.904 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 47' ' ' GLY . 2.1 t70 -161.93 157.13 23.33 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.745 -1.222 . . . . 0.0 110.14 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.29 14.86 60.25 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.618 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 20.1 m -94.01 176.77 6.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.476 -1.014 . . . . 0.0 110.179 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.664 HG13 ' O ' ' A' ' 43' ' ' VAL . 25.2 t -154.29 158.29 3.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 119.549 -0.861 . . . . 0.0 110.379 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.67 HG11 ' HG3' ' A' ' 6' ' ' PRO . 10.0 t -141.82 113.31 3.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 118.933 -1.107 . . . . 0.0 111.915 -179.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.905 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -69.8 105.21 2.69 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.127 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.645 ' CE1' HG21 ' A' ' 43' ' ' VAL . 3.1 m-30 -67.73 -176.44 0.65 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 110.21 -178.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.464 ' O ' ' CA ' ' A' ' 12' ' ' GLY . 0.6 OUTLIER -142.25 146.94 35.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.434 -0.791 . . . . 0.0 109.626 179.455 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.613 ' SG ' HD12 ' A' ' 37' ' ' LEU . 35.2 m -123.3 137.19 54.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 110.245 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 31' ' ' CYS . 2.5 m-20 -44.04 148.2 0.43 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 110.141 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -47.98 131.06 15.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.0 110.138 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.05 -12.7 52.55 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.513 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 1.9 m-30 -110.17 125.94 53.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.266 -1.138 . . . . 0.0 110.42 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.619 ' HB3' HD11 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -79.86 144.85 33.09 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.322 -0.861 . . . . 0.0 110.977 -179.689 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.656 ' C ' HD13 ' A' ' 38' ' ' ILE . 2.3 tp -95.48 105.11 17.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.347 -0.845 . . . . 0.0 109.935 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.869 HD12 ' HB3' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -97.2 149.56 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.247 -0.908 . . . . 0.0 109.466 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 130.89 -158.71 22.74 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.487 ' O ' ' C ' ' A' ' 41' ' ' SER . 8.5 t-20 -97.89 51.7 1.05 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.107 -1.231 . . . . 0.0 109.897 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.905 ' O ' HG23 ' A' ' 28' ' ' THR . 79.5 p 28.65 45.45 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.499 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.494 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 157.33 126.04 0.89 Allowed Glycine 0 N--CA 1.49 2.299 0 C-N-CA 119.378 -1.392 . . . . 0.0 110.44 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.664 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.7 t -65.01 178.27 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.182 -1.187 . . . . 0.0 107.864 178.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.55 ' C ' ' CD2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -140.41 94.31 2.72 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.057 178.452 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.588 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -81.88 107.75 14.85 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.114 178.566 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.526 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -132.37 121.13 23.0 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.317 -179.479 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.539 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 90.96 8.88 64.5 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.04 27.86 19.84 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -154.22 125.57 7.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.223 -1.163 . . . . 0.0 110.19 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.588 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 92.2 m95 -72.06 137.32 47.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.713 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.93 166.49 25.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.127 -0.983 . . . . 0.0 111.077 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.52 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 87.8 m-20 48.34 65.37 7.16 Favored Pre-proline 0 N--CA 1.492 1.629 0 CA-C-O 121.216 0.532 . . . . 0.0 111.204 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.4 Cg_endo -91.02 151.41 3.87 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 O-C-N 124.433 1.754 . . . . 0.0 110.045 179.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.557 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 48.8 Cg_endo -78.72 175.95 10.42 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 123.852 1.448 . . . . 0.0 110.41 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.627 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 17.7 p -119.03 177.55 4.82 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.28 -0.887 . . . . 0.0 110.876 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 10' ' ' SER . 65.4 m -132.93 71.8 1.48 Allowed 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -113.72 171.95 7.27 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.144 -178.713 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -87.66 144.13 9.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 119.349 -0.94 . . . . 0.0 108.577 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.634 HG23 ' CA ' ' A' ' 80' ' ' SER . 34.1 m -130.42 44.9 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.549 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 2.6 mmtt -53.91 179.79 0.02 OUTLIER 'General case' 0 C--N 1.278 -2.507 0 C-N-CA 118.035 -1.466 . . . . 0.0 108.381 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -145.36 165.28 22.25 Favored Pre-proline 0 N--CA 1.492 1.667 0 C-N-CA 118.402 -1.319 . . . . 0.0 112.887 -178.587 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.426 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 45.4 Cg_endo -88.2 -78.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.877 1.988 . . . . 0.0 110.401 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.426 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 170.93 129.26 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.653 -0.654 . . . . 0.0 109.352 -179.365 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.613 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 52.8 Cg_endo -80.97 65.83 8.89 Favored 'Trans proline' 0 C--N 1.298 -2.091 0 O-C-N 123.723 1.38 . . . . 0.0 110.074 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.605 ' O ' HD23 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -84.19 169.0 15.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.468 -0.77 . . . . 0.0 109.9 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.828 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -169.17 161.78 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.035 -1.041 . . . . 0.0 110.638 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.492 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 0.6 OUTLIER -66.28 105.84 1.53 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.544 -0.723 . . . . 0.0 111.025 -179.18 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.459 ' O ' ' CG ' ' A' ' 90' ' ' LYS . 7.4 m-80 38.74 38.64 0.28 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.532 -0.73 . . . . 0.0 110.803 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.828 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -147.38 32.67 1.36 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.584 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 3.6 p90 -46.46 -170.77 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 122.72 1.248 . . . . 0.0 112.515 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.742 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -114.07 168.48 9.78 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.007 179.554 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.3 t -149.67 15.87 0.87 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.848 -1.158 . . . . 0.0 110.644 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.505 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 41.9 t -92.49 -77.1 0.44 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.921 . . . . 0.0 110.515 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -130.87 77.98 0.38 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.62 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -103.85 163.74 12.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.354 -1.086 . . . . 0.0 109.548 179.538 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.62 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 17.0 ttmm -165.2 158.89 16.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 109.941 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.469 ' N ' ' HG2' ' A' ' 76' ' ' LYS . 26.2 mtt180 -54.1 -25.21 20.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.072 -1.017 . . . . 0.0 109.861 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.474 ' O ' ' HD2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -145.14 160.41 41.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.452 -0.78 . . . . 0.0 110.203 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.591 ' OH ' ' CE2' ' A' ' 75' ' ' PHE . 16.2 m-85 -135.75 -150.14 0.36 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.308 -0.87 . . . . 0.0 109.818 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.634 ' CA ' HG23 ' A' ' 59' ' ' VAL . 83.3 p -162.5 -104.96 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.807 -1.183 . . . . 0.0 111.388 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.596 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -114.47 15.87 17.8 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.481 -1.387 . . . . 0.0 110.431 -178.741 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.683 ' O ' HG22 ' A' ' 102' ' ' THR . 7.7 p30 -160.51 -107.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.925 -1.109 . . . . 0.0 110.443 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 82' ' ' ASN . 0.3 OUTLIER 46.34 74.24 0.15 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.806 -1.184 . . . . 0.0 108.734 -179.1 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.952 ' CA ' HG23 ' A' ' 102' ' ' THR . 20.8 t-20 -68.52 122.64 18.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.468 -0.77 . . . . 0.0 110.338 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.533 HG11 ' HG3' ' A' ' 64' ' ' PRO . 23.4 m -104.96 120.04 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 0.0 110.608 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' A' ' 73' ' ' SER . 62.8 t0 -83.72 127.77 34.03 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.742 ' CE1' HD12 ' A' ' 71' ' ' LEU . 35.1 m-85 -85.15 122.52 29.46 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.412 1.101 . . . . 0.0 111.876 -178.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -101.26 88.55 3.51 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.94 -179.778 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.549 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -42.52 129.24 4.03 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.31 -0.869 . . . . 0.0 109.814 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.459 ' CG ' ' O ' ' A' ' 68' ' ' ASN . 2.1 mmmt -38.48 -89.67 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.551 -0.718 . . . . 0.0 110.841 -179.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.573 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 1.9 t80 -153.37 131.13 11.59 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.102 -0.999 . . . . 0.0 110.341 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.584 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 60.11 52.66 51.41 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 26.4 m-85 -158.08 145.79 18.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.54 -0.976 . . . . 0.0 109.764 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.55 ' O ' ' N ' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -103.29 153.18 20.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.529 179.735 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.657 HD23 HD11 ' A' ' 66' ' ' ILE . 2.7 mt -91.32 97.55 11.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.754 -1.216 . . . . 0.0 110.086 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.828 ' HB2' HG21 ' A' ' 117' ' ' VAL . 16.8 t -80.65 107.83 13.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 110.241 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 98' ' ' SER . . . 129.85 -32.42 3.16 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.635 -1.269 . . . . 0.0 110.561 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.513 ' O ' ' HB3' ' A' ' 114' ' ' PRO . 12.7 p 177.18 -168.48 0.06 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.999 -1.295 . . . . 0.0 111.154 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.3 p -160.24 -35.09 0.05 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.247 0.546 . . . . 0.0 109.836 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 82.7 p -130.59 82.82 2.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 0.0 109.556 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.497 ' O ' ' N ' ' A' ' 85' ' ' VAL . 7.1 m -91.0 176.15 6.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.396 -0.815 . . . . 0.0 110.993 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.952 HG23 ' CA ' ' A' ' 84' ' ' ASN . 1.6 m -151.06 142.98 23.91 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.601 -0.687 . . . . 0.0 110.317 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' A' ' 79' ' ' TYR . 8.2 t -75.23 78.02 2.35 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.494 -0.754 . . . . 0.0 109.635 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.514 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -64.43 177.29 0.58 Allowed Pre-proline 0 C--N 1.299 -1.595 0 O-C-N 121.324 -0.86 . . . . 0.0 110.465 -179.664 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.869 ' HB3' HD12 ' A' ' 38' ' ' ILE . 42.0 Cg_endo -69.8 131.73 21.8 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 124.332 1.701 . . . . 0.0 110.142 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 121.9 -10.91 9.5 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 108.679 -1.769 . . . . 0.0 108.679 -179.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.591 ' O ' HG23 ' A' ' 108' ' ' THR . 10.4 m-20 79.64 92.25 0.05 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.893 -0.769 . . . . 0.0 110.807 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.591 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -177.51 -162.56 0.07 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.581 179.597 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.613 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 20.5 m95 -147.88 82.78 1.51 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.389 0.614 . . . . 0.0 109.897 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.509 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 9.2 mmtt -91.81 146.51 33.13 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.393 -0.817 . . . . 0.0 109.972 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 110' ' ' LYS . 46.7 Cg_endo -75.42 176.35 43.98 Favored 'Cis proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.654 -2.228 . . . . 0.0 110.481 -0.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.2 OUTLIER -37.17 124.63 0.95 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.685 -0.634 . . . . 0.0 110.741 -179.524 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.609 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.5 OUTLIER -42.57 137.36 2.36 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.873 . . . . 0.0 109.859 179.811 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.742 ' HG2' HD12 ' A' ' 66' ' ' ILE . 49.0 Cg_endo -74.67 165.1 32.32 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 O-C-N 124.258 1.662 . . . . 0.0 111.614 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.887 ' HG2' HG13 ' A' ' 117' ' ' VAL . 12.6 ttmt -126.71 105.19 8.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.538 -0.726 . . . . 0.0 109.924 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.531 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.6 t -55.38 86.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.16 -0.963 . . . . 0.0 109.846 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.887 HG13 ' HG2' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -98.62 -172.16 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 121.822 0.82 . . . . 0.0 110.528 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.2 mtm180 . . . . . 0 C--N 1.294 -1.83 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.497 -179.991 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.366 0.603 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.51 177.39 6.38 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.385 -0.822 . . . . 0.0 110.305 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.547 ' HB2' ' CA ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -125.41 75.35 1.46 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.421 -0.799 . . . . 0.0 110.106 -179.889 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.444 ' O ' ' C ' ' A' ' 5' ' ' SER . 3.0 mp0 -54.17 172.02 0.1 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.041 -1.037 . . . . 0.0 109.725 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.2 p -42.41 144.82 0.89 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 109.94 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.858 ' HG3' HG11 ' A' ' 27' ' ' VAL . 53.9 Cg_endo -70.62 160.45 49.43 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.046 1.551 . . . . 0.0 110.79 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -76.26 170.21 20.46 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 O-C-N 124.014 1.534 . . . . 0.0 109.945 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.55 176.18 6.38 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.141 -0.975 . . . . 0.0 110.27 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.499 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -144.26 -170.33 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 122.24 1.019 . . . . 0.0 111.746 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.484 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.3 OUTLIER -50.27 105.19 0.09 Allowed 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.287 -178.91 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 10' ' ' SER . 65.0 m-20 37.27 47.12 0.65 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.516 -0.74 . . . . 0.0 111.274 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.53 152.85 24.3 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 30' ' ' SER . 1.6 ptt180 -113.04 -172.5 2.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.104 -1.233 . . . . 0.0 111.192 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.623 ' CG ' ' HG2' ' A' ' 6' ' ' PRO . 20.3 p80 -143.99 111.6 6.04 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.294 0.568 . . . . 0.0 109.469 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 14' ' ' HIS . 2.6 t-20 -177.87 174.22 1.46 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.601 -1.312 . . . . 0.0 110.87 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 17' ' ' TYR . . . 145.62 -39.74 1.14 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.468 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.8 OUTLIER 178.17 46.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.513 -0.992 . . . . 0.0 109.568 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.644 ' OE2' HG13 ' A' ' 27' ' ' VAL . 0.9 OUTLIER -134.19 -94.16 0.3 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.225 -0.922 . . . . 0.0 110.491 -179.495 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 9.2 m-20 66.26 6.45 4.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.279 -0.888 . . . . 0.0 110.387 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -170.42 116.48 0.5 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 110.621 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.62 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 18.3 m-85 -132.83 173.47 11.35 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.364 -0.835 . . . . 0.0 109.294 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.547 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 1.9 p -130.59 -68.9 0.67 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.779 -1.2 . . . . 0.0 110.75 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.417 ' OD1' ' C ' ' A' ' 23' ' ' ASP . 14.7 t0 -162.04 132.4 4.85 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.392 -0.818 . . . . 0.0 109.684 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.54 16.19 71.64 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.618 -1.793 . . . . 0.0 108.618 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.62 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.5 OUTLIER -97.73 -179.25 4.38 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.46 -1.023 . . . . 0.0 110.506 -179.808 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 43' ' ' VAL . 11.8 t -149.58 162.26 4.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.041 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.858 HG11 ' HG3' ' A' ' 6' ' ' PRO . 16.4 t -143.07 118.56 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 119.698 -0.801 . . . . 0.0 111.681 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.885 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -75.3 102.41 5.05 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 118.636 -1.225 . . . . 0.0 107.884 177.831 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.725 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.3 m-30 -67.94 127.55 33.25 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.441 -0.787 . . . . 0.0 109.915 -178.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -82.14 142.34 32.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.059 -1.026 . . . . 0.0 109.728 179.404 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.54 ' SG ' HD12 ' A' ' 37' ' ' LEU . 64.3 m -112.56 142.87 44.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.17 -0.956 . . . . 0.0 110.075 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.479 ' O ' ' HB2' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -46.59 167.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 110.141 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 p -64.72 138.81 58.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.108 -0.995 . . . . 0.0 110.425 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.37 6.11 89.5 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.572 ' CD2' ' O ' ' A' ' 56' ' ' CYS . 1.0 OUTLIER -111.63 120.88 43.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.172 -1.193 . . . . 0.0 110.274 -179.881 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.639 ' HB3' HD11 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -79.79 130.45 35.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.394 -0.816 . . . . 0.0 110.942 -179.663 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.701 HD13 ' O ' ' A' ' 29' ' ' TYR . 1.9 tp -81.05 100.15 8.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.377 -0.827 . . . . 0.0 109.131 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.831 HD12 ' HB3' ' A' ' 105' ' ' PRO . 1.0 OUTLIER -89.12 151.05 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.495 -179.716 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.7 -176.66 26.37 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.413 ' OD1' ' O ' ' A' ' 40' ' ' ASN . 12.0 p30 -59.21 143.12 49.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -1.168 . . . . 0.0 109.72 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.885 ' O ' HG23 ' A' ' 28' ' ' THR . 0.4 OUTLIER -76.09 53.27 0.78 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.158 -0.964 . . . . 0.0 110.125 -179.908 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.504 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 160.56 131.07 1.18 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 27' ' ' VAL . 2.2 t -69.58 -175.28 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.113 -1.228 . . . . 0.0 108.364 178.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.635 ' H ' HG12 ' A' ' 43' ' ' VAL . 6.1 tp -143.84 98.54 3.25 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.479 178.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.608 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.8 OUTLIER -84.3 112.47 20.34 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.231 178.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 t -124.77 145.94 49.47 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.332 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 54.28 32.09 50.9 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.44 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 69.19 40.01 82.42 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 1.5 mt-10 -151.42 128.04 10.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.298 -1.119 . . . . 0.0 110.502 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.608 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 74.8 m95 -81.95 134.36 35.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.25 -0.907 . . . . 0.0 110.107 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 25.9 t -151.29 163.38 39.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.115 -0.991 . . . . 0.0 110.742 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.52 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 2.4 m-20 64.3 65.5 1.1 Allowed Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.633 -0.667 . . . . 0.0 110.944 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 52.1 Cg_endo -91.77 132.92 1.34 Allowed 'Trans proline' 0 C--N 1.299 -2.053 0 C-N-CA 121.89 1.727 . . . . 0.0 110.173 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.459 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.2 Cg_endo -76.61 172.05 16.92 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.689 1.363 . . . . 0.0 109.488 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.611 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 52.8 p -109.86 148.91 30.67 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.812 -1.18 . . . . 0.0 111.919 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.572 ' O ' ' CD2' ' A' ' 35' ' ' TYR . 86.5 m -111.44 77.62 1.05 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 36' ' ' SER . 1.0 OUTLIER -115.25 -163.72 0.9 Allowed 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.547 0.689 . . . . 0.0 110.502 -178.115 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.634 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -107.7 137.62 38.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.376 -0.828 . . . . 0.0 108.888 179.505 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.688 HG23 ' HA ' ' A' ' 80' ' ' SER . 30.2 m -123.08 41.1 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.034 -1.041 . . . . 0.0 111.229 -178.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.443 ' CD ' HG22 ' A' ' 58' ' ' ILE . 7.8 mtpp -75.49 98.63 3.99 Favored 'General case' 0 C--N 1.284 -2.267 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.443 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 107' ' ' ASN . 64.0 m -70.01 161.96 71.93 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.438 -0.789 . . . . 0.0 111.842 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 44.7 Cg_endo -72.57 -88.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.546 1.814 . . . . 0.0 111.008 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.457 ' CD2' ' HE1' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -172.49 132.12 0.68 Allowed Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.527 -0.733 . . . . 0.0 109.225 -179.321 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.628 ' HA ' HD21 ' A' ' 113' ' ' LEU . 58.2 Cg_endo -85.35 69.85 5.3 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 O-C-N 123.398 1.21 . . . . 0.0 109.886 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.711 ' O ' HG23 ' A' ' 66' ' ' ILE . 3.2 p -87.19 -40.6 14.44 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.464 1.126 . . . . 0.0 109.999 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.775 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER 52.59 160.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.355 -178.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.479 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 0.5 OUTLIER -58.64 91.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.474 -0.766 . . . . 0.0 111.576 -178.826 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 47.94 60.27 3.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.378 -0.826 . . . . 0.0 111.471 178.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.576 ' O ' ' CG ' ' A' ' 70' ' ' TYR . . . -143.58 -36.98 0.07 OUTLIER Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.17 -1.491 . . . . 0.0 110.226 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.611 ' CE1' ' HB3' ' A' ' 88' ' ' LYS . 40.2 p90 42.44 -175.34 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 122.097 0.951 . . . . 0.0 110.932 -178.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.988 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -122.75 -32.13 3.59 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.694 -178.549 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.833 ' H ' HD22 ' A' ' 71' ' ' LEU . 0.5 OUTLIER 57.09 15.15 2.27 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.635 -1.291 . . . . 0.0 110.78 177.587 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.421 ' HB2' ' H ' ' A' ' 86' ' ' ASP . 66.2 m -119.49 10.02 11.71 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.524 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 133.91 87.38 0.29 Allowed Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.358 -1.401 . . . . 0.0 110.047 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.585 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -127.36 150.82 49.44 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.31 -1.112 . . . . 0.0 109.55 179.429 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.441 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 2.0 tttp -135.39 170.41 15.99 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.423 -0.798 . . . . 0.0 109.723 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 30.0 mtt85 -67.45 -26.08 66.21 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.307 -0.871 . . . . 0.0 109.855 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.94 150.87 36.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 110.481 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.585 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 13.8 m-85 -128.82 -170.62 2.3 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.292 -0.88 . . . . 0.0 110.332 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.688 ' HA ' HG23 ' A' ' 59' ' ' VAL . 1.2 t -169.83 90.33 0.19 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.227 -0.921 . . . . 0.0 110.136 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.571 ' CB ' HG21 ' A' ' 59' ' ' VAL . 6.6 t80 55.72 134.2 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.158 -0.964 . . . . 0.0 110.042 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.75 ' O ' HG22 ' A' ' 102' ' ' THR . 22.7 t30 71.66 -129.82 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.822 -1.174 . . . . 0.0 110.578 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.551 ' HB3' ' HB3' ' A' ' 103' ' ' CYS . 5.1 t0 51.62 74.54 0.25 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.653 -1.279 . . . . 0.0 108.921 -178.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.549 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 21.3 t-20 -75.69 141.84 42.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.437 -0.79 . . . . 0.0 111.608 -178.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.805 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -125.9 146.88 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.4 -0.812 . . . . 0.0 109.679 178.834 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.554 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -109.57 108.29 18.69 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.027 -1.046 . . . . 0.0 108.95 179.473 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.988 ' CE1' HD12 ' A' ' 71' ' ' LEU . 35.5 m-85 -66.84 134.93 53.09 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.382 1.087 . . . . 0.0 113.715 -177.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.611 ' HB3' ' CE1' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -123.3 84.37 2.26 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.664 -179.816 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.773 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -32.75 133.7 0.12 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.762 -0.586 . . . . 0.0 111.489 -179.518 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -40.51 -87.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.496 -0.753 . . . . 0.0 110.331 179.584 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -161.94 143.37 10.98 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.173 -0.955 . . . . 0.0 110.03 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.572 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 59.05 24.95 59.07 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.572 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 18.1 m-85 -138.99 144.56 38.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.566 -0.961 . . . . 0.0 109.901 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 117' ' ' VAL . 9.6 ttpt -105.36 153.65 21.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.261 -0.899 . . . . 0.0 109.493 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.773 HD11 ' H ' ' A' ' 89' ' ' CYS . 3.4 mt -88.57 114.14 24.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.708 -1.245 . . . . 0.0 110.445 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.453 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 1.3 t -89.21 97.48 11.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.334 -0.854 . . . . 0.0 109.721 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.26 -111.38 0.64 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.615 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 5.7 t -129.51 127.22 40.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.27 -1.135 . . . . 0.0 110.557 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.487 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 0.8 OUTLIER -74.07 -44.38 54.33 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.388 -0.82 . . . . 0.0 110.37 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 32.2 p -101.21 123.39 45.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.122 -0.986 . . . . 0.0 110.154 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.535 ' C ' ' HG1' ' A' ' 102' ' ' THR . 57.9 m -129.99 -168.14 1.92 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 110.298 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.75 HG22 ' O ' ' A' ' 82' ' ' ASN . 14.6 m -162.72 134.14 5.08 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.252 -0.979 . . . . 0.0 111.134 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.603 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 1.6 t -57.41 95.42 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.677 -0.64 . . . . 0.0 109.48 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.4 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -83.12 173.94 6.77 Favored Pre-proline 0 C--N 1.299 -1.587 0 O-C-N 120.974 -1.079 . . . . 0.0 110.789 -179.609 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.831 ' HB3' HD12 ' A' ' 38' ' ' ILE . 43.9 Cg_endo -76.26 132.16 13.53 Favored 'Trans proline' 0 C--N 1.299 -2.051 0 O-C-N 124.467 1.772 . . . . 0.0 110.703 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.548 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 121.69 -4.04 10.9 Favored Glycine 0 N--CA 1.482 1.748 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.824 ' O ' HG23 ' A' ' 108' ' ' THR . 8.2 m-80 80.25 81.28 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.91 -0.759 . . . . 0.0 110.499 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.824 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 177.48 -177.26 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.222 -0.924 . . . . 0.0 111.467 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.805 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 44.6 m95 -124.54 101.77 7.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.624 -0.673 . . . . 0.0 110.515 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.531 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 4.6 mttt -102.59 148.91 36.19 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.25 -0.906 . . . . 0.0 109.871 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.615 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 52.3 Cg_endo -73.28 -175.19 14.18 Favored 'Cis proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.144 -2.023 . . . . 0.0 111.007 -0.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.7 mt-10 -38.37 123.84 1.21 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.339 0.59 . . . . 0.0 110.437 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.661 HD13 ' HB3' ' A' ' 109' ' ' TRP . 2.9 tp -53.9 143.11 42.72 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 110.448 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.775 ' HG2' HD12 ' A' ' 66' ' ' ILE . 41.2 Cg_endo -72.1 155.66 56.6 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.024 1.539 . . . . 0.0 110.594 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.709 ' HG2' HG13 ' A' ' 117' ' ' VAL . 0.4 OUTLIER -120.91 110.87 16.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.327 -0.858 . . . . 0.0 110.508 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 1.3 t -60.48 96.91 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.186 -0.946 . . . . 0.0 109.342 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.709 HG13 ' HG2' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -107.04 -175.35 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 121.798 0.809 . . . . 0.0 111.019 -179.447 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.296 -1.735 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.176 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 62.7 t . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.192 0.52 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.54 149.82 52.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.194 -0.941 . . . . 0.0 110.275 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.528 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.6 m -80.64 138.74 36.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.422 -0.799 . . . . 0.0 110.611 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.446 ' O ' ' C ' ' A' ' 5' ' ' SER . 21.0 mt-30 -119.5 174.28 6.48 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.439 -0.788 . . . . 0.0 109.286 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 19' ' ' ASP . 1.1 p -42.64 133.76 2.83 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 0.0 109.776 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.736 ' HG3' HG11 ' A' ' 27' ' ' VAL . 51.7 Cg_endo -70.2 155.76 63.76 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.944 1.497 . . . . 0.0 111.357 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -76.73 170.67 19.43 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.041 1.548 . . . . 0.0 110.04 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.13 176.2 4.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.168 -0.958 . . . . 0.0 109.689 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.661 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -142.52 -170.32 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 122.178 0.99 . . . . 0.0 111.81 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.531 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 13.2 t -37.69 94.37 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.204 -179.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 9' ' ' ILE . 11.8 m-20 42.9 25.45 0.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.068 -1.02 . . . . 0.0 110.648 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -121.01 -166.56 13.03 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.53 ' HG3' ' CB ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -151.71 178.8 8.99 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.193 -1.181 . . . . 0.0 110.145 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.632 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 9.2 p80 -135.6 141.33 45.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.403 -0.811 . . . . 0.0 110.462 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -171.22 65.54 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.895 . . . . 0.0 110.267 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.41 ' O ' ' CD2' ' A' ' 17' ' ' TYR . . . -60.23 -81.59 0.08 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -177.38 29.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -1.156 . . . . 0.0 110.298 179.876 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.415 ' HG3' ' CE1' ' A' ' 21' ' ' TYR . 0.9 OUTLIER -165.59 -165.92 0.9 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.921 . . . . 0.0 110.212 179.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 20' ' ' PHE . 25.1 p-10 -123.27 -41.82 2.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.896 . . . . 0.0 109.947 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.506 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 2.0 m-85 -96.14 149.74 21.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.387 -0.821 . . . . 0.0 110.338 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.688 ' CD2' ' HB3' ' A' ' 25' ' ' SER . 1.6 m-85 -130.91 -2.41 4.1 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.217 -0.927 . . . . 0.0 110.833 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.528 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 15.6 p 42.8 -99.3 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.353 -0.842 . . . . 0.0 111.264 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.534 ' OD1' ' HA ' ' A' ' 46' ' ' SER . 3.6 t0 -156.82 137.53 13.26 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.059 -1.026 . . . . 0.0 110.179 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 86.87 23.75 40.75 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.688 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 58.2 m -116.61 154.41 30.55 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -1.079 . . . . 0.0 109.563 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.909 HG13 ' O ' ' A' ' 43' ' ' VAL . 38.1 t -126.1 149.33 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.884 -1.135 . . . . 0.0 112.556 -177.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.74 ' O ' HG23 ' A' ' 43' ' ' VAL . 45.8 t -121.44 120.77 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.587 -0.696 . . . . 0.0 111.32 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -73.81 103.12 4.24 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 177.443 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 1.026 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.0 m-30 -67.63 121.11 15.18 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.244 -177.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.53 ' CB ' ' HG3' ' A' ' 13' ' ' ARG . 2.3 m -70.81 -163.89 0.08 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.979 -1.075 . . . . 0.0 108.966 179.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.53 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 5.5 t -164.38 160.47 20.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.896 -1.127 . . . . 0.0 110.702 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 34' ' ' GLY . 9.7 t-20 -55.56 144.3 26.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.343 -0.848 . . . . 0.0 109.679 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.54 79.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.255 -0.903 . . . . 0.0 110.428 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 32' ' ' ASN . . . 153.7 -28.9 0.75 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.434 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 6.4 m-85 -87.25 134.97 33.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.155 -1.203 . . . . 0.0 110.184 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.733 ' CB ' HG13 ' A' ' 59' ' ' VAL . 1.2 t -80.28 142.49 34.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.278 -0.889 . . . . 0.0 110.527 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.854 HD13 ' O ' ' A' ' 29' ' ' TYR . 2.1 tp -93.81 111.18 22.83 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.375 -0.828 . . . . 0.0 109.21 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.654 HD13 ' N ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -103.53 156.9 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.137 -0.977 . . . . 0.0 109.62 -179.661 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.23 -146.53 16.48 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.535 ' O ' ' C ' ' A' ' 41' ' ' SER . 0.7 OUTLIER -106.16 54.97 0.68 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.107 -1.231 . . . . 0.0 110.021 179.829 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.571 ' O ' HG23 ' A' ' 28' ' ' THR . 7.3 p 14.44 56.62 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.167 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.581 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 155.58 118.83 0.63 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.026 HG21 ' CE1' ' A' ' 29' ' ' TYR . 1.9 t -70.42 -178.77 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.084 -1.244 . . . . 0.0 108.005 178.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.488 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.2 tp -144.15 97.52 3.06 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.715 -1.241 . . . . 0.0 110.531 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.589 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.9 OUTLIER -83.92 111.98 19.74 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.304 178.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.534 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 0.4 OUTLIER -123.2 93.22 3.88 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.299 -179.681 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.28 61.52 1.64 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 49.55 27.06 8.08 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -136.47 108.85 7.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.207 -1.172 . . . . 0.0 110.442 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.589 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 70.8 m95 -74.76 135.29 41.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 109.711 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -144.14 157.62 44.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.085 -1.009 . . . . 0.0 111.092 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.534 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 4.4 t70 63.56 64.41 1.38 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.691 -0.631 . . . . 0.0 110.965 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.534 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 53.3 Cg_endo -92.14 133.44 1.28 Allowed 'Trans proline' 0 C--N 1.298 -2.098 0 O-C-N 124.406 1.74 . . . . 0.0 109.674 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.534 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 49.4 Cg_endo -75.93 176.81 9.54 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 O-C-N 123.688 1.362 . . . . 0.0 109.819 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.54 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 6.7 p -111.09 -175.75 2.78 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.995 0.902 . . . . 0.0 111.271 -178.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 10' ' ' SER . 0.8 OUTLIER -144.64 75.08 1.44 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.109 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.522 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.3 OUTLIER -112.85 -158.86 0.66 Allowed 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.913 -178.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.637 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -113.78 130.42 67.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 108.603 179.415 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.733 HG13 ' CB ' ' A' ' 36' ' ' SER . 19.2 m -118.49 46.43 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.994 -1.067 . . . . 0.0 112.067 -178.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.499 ' HE3' HG22 ' A' ' 58' ' ' ILE . 1.6 mttt -58.13 -175.11 0.02 OUTLIER 'General case' 0 C--N 1.281 -2.384 0 C-N-CA 117.763 -1.575 . . . . 0.0 107.541 178.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.524 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 1.2 m -141.54 167.38 17.21 Favored Pre-proline 0 C--N 1.293 -1.857 0 C-N-CA 117.811 -1.555 . . . . 0.0 113.814 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.553 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 48.9 Cg_endo -90.08 -69.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 125.026 2.066 . . . . 0.0 110.368 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.553 ' CD2' ' O ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER 165.4 124.24 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.299 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.72 ' HG2' HD21 ' A' ' 71' ' ' LEU . 45.9 Cg_endo -76.47 80.22 2.8 Favored 'Trans proline' 0 C--N 1.301 -1.953 0 O-C-N 123.467 1.246 . . . . 0.0 109.329 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.512 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -102.91 173.79 6.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.872 . . . . 0.0 109.791 -179.33 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.821 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -169.99 166.35 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.334 -0.947 . . . . 0.0 110.305 179.558 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.472 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 16.4 t -75.73 107.04 7.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.488 -0.757 . . . . 0.0 110.652 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.529 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 3.3 m-80 38.89 55.87 2.0 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.567 -0.708 . . . . 0.0 110.643 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.77 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -168.66 32.04 0.18 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.63 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 16.9 p90 -45.25 -174.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 123.463 1.601 . . . . 0.0 112.862 -179.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.968 HD11 ' HB2' ' A' ' 75' ' ' PHE . 2.8 pp -100.89 126.79 47.54 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 113.308 -1.769 . . . . 0.0 109.887 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.509 ' HB3' ' HB2' ' A' ' 88' ' ' LYS . 0.2 OUTLIER -96.35 2.48 52.78 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.28 -0.888 . . . . 0.0 109.515 179.767 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.7 t -73.09 -73.91 0.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.38 -0.825 . . . . 0.0 110.572 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.9 97.62 0.12 Allowed Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.626 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.968 ' HB2' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -94.17 145.13 24.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.358 -1.083 . . . . 0.0 109.18 179.053 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.486 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -132.38 160.72 35.53 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.158 -0.964 . . . . 0.0 110.242 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -52.45 -33.99 46.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.225 -0.922 . . . . 0.0 110.394 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.406 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -142.02 165.62 26.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.333 -0.855 . . . . 0.0 110.361 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.582 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 22.3 m-85 -138.06 -138.63 0.14 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.373 -0.83 . . . . 0.0 109.956 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 21.2 p -170.05 -132.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 0.0 109.629 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.646 ' O ' ' CG ' ' A' ' 81' ' ' TYR . 1.6 t80 -101.87 38.23 1.68 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.002 -1.061 . . . . 0.0 109.459 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.676 ' C ' HG22 ' A' ' 102' ' ' THR . 9.4 p30 -169.36 -114.37 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.73 -1.231 . . . . 0.0 110.498 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 82' ' ' ASN . 81.5 m-20 44.83 77.19 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.78 -1.2 . . . . 0.0 109.374 -179.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.823 ' CA ' HG23 ' A' ' 102' ' ' THR . 5.6 p-10 -75.11 113.5 12.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.285 -0.885 . . . . 0.0 110.93 -178.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.578 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 15.7 m -101.56 120.86 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.773 -1.204 . . . . 0.0 110.364 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.537 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 25.8 t0 -76.65 126.3 30.75 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.169 -0.957 . . . . 0.0 109.161 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.634 ' CZ ' HD12 ' A' ' 113' ' ' LEU . 23.4 m-85 -86.97 126.02 34.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.052 -1.03 . . . . 0.0 111.357 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -104.31 110.94 23.37 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.53 -179.377 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.441 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -58.56 133.11 55.55 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.038 -1.039 . . . . 0.0 109.551 179.314 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -42.63 -67.49 0.27 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.12 -179.644 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.521 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.3 OUTLIER -176.66 137.16 0.26 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.413 -0.804 . . . . 0.0 110.345 179.935 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.597 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 54.03 58.22 13.55 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.597 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 12.7 m-85 -162.21 155.84 20.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.534 -0.98 . . . . 0.0 109.819 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.609 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -110.2 124.18 51.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.142 -0.973 . . . . 0.0 110.323 -179.856 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.568 HD23 HD11 ' A' ' 66' ' ' ILE . 1.7 mt -63.7 87.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.373 -0.83 . . . . 0.0 110.033 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.453 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -69.47 104.81 2.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 110.07 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 141.58 -81.53 0.24 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.581 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -169.72 124.73 0.81 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.257 -1.143 . . . . 0.0 110.534 -179.827 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 73.8 p -68.56 -72.19 0.19 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.349 -0.845 . . . . 0.0 110.867 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.537 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 58.6 p -78.19 118.33 20.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.153 -0.967 . . . . 0.0 110.329 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 85' ' ' VAL . 59.9 m -125.25 158.47 34.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.55 -0.719 . . . . 0.0 110.611 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.823 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -135.08 142.26 46.25 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.395 179.694 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.585 ' SG ' ' CZ2' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -67.9 105.41 1.98 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.614 -0.679 . . . . 0.0 110.278 -179.769 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.532 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -76.88 -175.15 0.47 Allowed Pre-proline 0 C--N 1.295 -1.779 0 O-C-N 121.231 -0.918 . . . . 0.0 111.315 -179.411 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.644 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 41.4 Cg_endo -87.78 126.42 2.14 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 124.4 1.737 . . . . 0.0 110.597 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 117.53 2.86 17.15 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.88 ' O ' HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER 79.16 105.61 0.07 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.649 -0.912 . . . . 0.0 110.426 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.88 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER 166.03 -163.39 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.867 0.841 . . . . 0.0 111.271 179.443 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.703 ' HB3' HD11 ' A' ' 113' ' ' LEU . 32.8 m95 -144.91 88.02 1.87 Allowed 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.698 0.761 . . . . 0.0 109.651 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.578 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 14.4 mmmt -98.54 137.08 20.62 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.764 -0.585 . . . . 0.0 110.186 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.581 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 42.8 Cg_endo -69.69 166.25 74.34 Favored 'Cis proline' 0 N--CA 1.49 1.298 0 C-N-CA 122.056 -2.06 . . . . 0.0 110.983 -0.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -38.52 153.23 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.578 -0.702 . . . . 0.0 111.081 -179.168 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.703 HD11 ' HB3' ' A' ' 109' ' ' TRP . 1.2 mm? -64.68 141.61 98.32 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.43 -0.793 . . . . 0.0 109.716 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.821 ' HG2' HD12 ' A' ' 66' ' ' ILE . 42.5 Cg_endo -72.1 165.12 33.56 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 O-C-N 124.189 1.626 . . . . 0.0 110.548 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.728 ' HG2' HG13 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -129.28 107.44 9.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.339 -0.851 . . . . 0.0 109.918 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.538 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 3.0 t -61.17 83.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.276 -0.89 . . . . 0.0 109.466 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.728 HG13 ' HG2' ' A' ' 115' ' ' LYS . 3.3 m -101.86 -169.68 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-O 121.945 0.879 . . . . 0.0 110.89 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.467 ' HG2' ' CE1' ' A' ' 93' ' ' TYR . 6.7 mtm-85 . . . . . 0 C--N 1.291 -1.953 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.211 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.8 p . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.27 0.557 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -119.78 174.73 6.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.412 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.553 ' O ' ' N ' ' A' ' 21' ' ' TYR . 1.1 m -113.54 89.75 3.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.35 -0.844 . . . . 0.0 110.56 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.41 ' O ' ' C ' ' A' ' 5' ' ' SER . 18.7 mt-30 -69.68 172.11 7.99 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.021 -1.05 . . . . 0.0 109.844 179.6 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 19' ' ' ASP . 1.1 p -42.12 141.95 1.28 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 110.138 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.82 ' HG3' HG11 ' A' ' 27' ' ' VAL . 51.1 Cg_endo -71.8 154.89 58.8 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.029 1.542 . . . . 0.0 111.019 -179.494 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -74.74 172.48 16.17 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.868 1.457 . . . . 0.0 110.005 179.458 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.7 p -70.98 174.91 5.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.107 -0.996 . . . . 0.0 110.017 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.728 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -142.8 -170.3 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 122.156 0.979 . . . . 0.0 111.543 179.719 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.523 ' O ' ' CB ' ' A' ' 56' ' ' CYS . 1.2 m -43.54 90.83 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.673 -179.302 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.8 OUTLIER 43.7 53.08 6.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.114 -0.991 . . . . 0.0 110.581 179.827 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.31 147.22 16.15 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.483 ' O ' ' N ' ' A' ' 30' ' ' SER . 1.3 mtp180 -92.98 -167.99 1.85 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.246 -1.149 . . . . 0.0 110.647 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.61 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 17.6 p80 -156.33 -159.19 0.86 Allowed 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.283 0.564 . . . . 0.0 110.543 -179.501 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 13.5 t-20 72.89 141.36 0.06 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.514 -0.741 . . . . 0.0 110.572 179.625 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.54 -57.92 0.19 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -163.63 29.27 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -1.134 . . . . 0.0 110.111 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.72 -178.26 7.19 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.194 -0.941 . . . . 0.0 110.444 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 5' ' ' SER . 24.0 m-20 -124.06 -44.15 2.06 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.417 -0.802 . . . . 0.0 109.976 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -94.92 139.94 30.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 109.94 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.628 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.3 OUTLIER -128.43 -4.67 5.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.254 -0.904 . . . . 0.0 110.625 -179.633 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.53 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 32.2 p 45.86 -97.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.92 . . . . 0.0 111.91 179.768 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.524 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -153.2 158.57 41.93 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.91 -1.119 . . . . 0.0 110.594 -178.51 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.53 25.65 75.36 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 179.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.628 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -114.43 171.21 7.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.416 -1.049 . . . . 0.0 110.2 -179.763 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.874 HG13 ' O ' ' A' ' 43' ' ' VAL . 40.6 t -143.08 153.93 16.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.518 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.939 ' O ' HG23 ' A' ' 43' ' ' VAL . 18.8 t -132.86 123.7 49.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.62 -179.262 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.796 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -76.31 103.04 6.13 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.937 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 1.014 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.4 m-30 -68.12 127.27 32.29 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.412 -0.805 . . . . 0.0 110.349 -178.13 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -71.53 158.21 36.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.561 179.451 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.419 ' SG ' HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -133.6 156.82 47.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.113 -0.992 . . . . 0.0 110.337 -179.808 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.36 129.24 37.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.269 -0.894 . . . . 0.0 110.067 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 t -46.57 122.71 4.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 0.0 110.592 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.25 -40.85 1.89 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.478 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.444 ' CE1' HG13 ' A' ' 58' ' ' ILE . 7.9 m-85 -90.86 155.45 18.75 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -1.155 . . . . 0.0 110.786 -179.504 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.693 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -91.45 141.45 28.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.404 -0.81 . . . . 0.0 110.205 179.541 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.536 ' HA ' ' O ' ' A' ' 55' ' ' THR . 0.6 OUTLIER -92.9 97.4 10.72 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.275 -0.89 . . . . 0.0 109.531 179.207 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.822 HG23 ' CB ' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -85.81 142.79 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.421 -0.799 . . . . 0.0 108.985 179.847 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.57 -154.11 21.94 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 42' ' ' GLY . 15.6 p-10 -110.73 51.86 0.75 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.168 -1.195 . . . . 0.0 110.541 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.796 ' O ' HG23 ' A' ' 28' ' ' THR . 75.4 p 28.0 38.6 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.904 179.657 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.53 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 169.09 125.99 0.82 Allowed Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.452 -1.356 . . . . 0.0 110.125 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.014 HG21 ' CE1' ' A' ' 29' ' ' TYR . 2.0 t -71.94 -178.1 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -1.113 . . . . 0.0 108.092 179.026 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.516 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.5 tp -144.59 99.48 3.36 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.251 -0.979 . . . . 0.0 110.225 179.05 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.587 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -87.15 110.17 19.95 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.055 -1.058 . . . . 0.0 109.438 178.686 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.7 p -128.64 123.19 32.59 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.032 -179.774 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.524 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 76.24 35.85 41.76 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.876 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.19 40.88 97.05 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 1.8 mt-10 -157.95 128.94 6.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.379 -1.071 . . . . 0.0 110.292 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.604 ' CH2' HG23 ' A' ' 27' ' ' VAL . 84.2 m95 -82.46 138.53 34.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.792 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -143.73 157.89 44.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.163 -0.961 . . . . 0.0 111.011 -179.574 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.504 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER 63.2 65.46 1.31 Allowed Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.631 -0.668 . . . . 0.0 111.0 179.606 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.504 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.5 Cg_endo -90.64 140.95 3.12 Favored 'Trans proline' 0 C--N 1.301 -1.967 0 C-N-CA 121.851 1.701 . . . . 0.0 109.972 179.158 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.525 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 46.9 Cg_endo -78.71 175.56 10.87 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.729 1.383 . . . . 0.0 110.233 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.568 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 11.1 p -124.38 158.82 31.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.207 -0.933 . . . . 0.0 111.438 -178.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.523 ' CB ' ' O ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -116.06 78.37 1.18 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.177 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.455 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -117.2 -158.51 0.7 Allowed 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.875 -178.922 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.584 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -116.06 142.71 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.92 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.713 HG21 ' CB ' ' A' ' 81' ' ' TYR . 12.7 m -127.88 43.05 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.825 -1.172 . . . . 0.0 111.559 -178.663 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -80.91 95.23 6.68 Favored 'General case' 0 C--N 1.281 -2.384 0 C-N-CA 119.071 -1.052 . . . . 0.0 108.593 179.014 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.47 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 32.3 m -69.28 162.33 66.81 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.356 -0.84 . . . . 0.0 111.153 -178.481 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.511 ' HD2' ' HA ' ' A' ' 108' ' ' THR . 49.6 Cg_endo -72.97 -92.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 124.471 1.774 . . . . 0.0 110.349 -179.521 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.465 ' C ' ' CD1' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -155.82 137.45 9.65 Favored Pre-proline 0 C--N 1.299 -1.611 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.62 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.931 ' HG2' HD21 ' A' ' 71' ' ' LEU . 52.2 Cg_endo -77.82 62.61 7.91 Favored 'Trans proline' 0 C--N 1.294 -2.336 0 O-C-N 123.525 1.277 . . . . 0.0 109.072 -179.161 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.474 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.8 OUTLIER -75.66 166.82 22.98 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.098 -179.634 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.967 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -165.87 164.74 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 C-N-CA 118.75 -1.18 . . . . 0.0 110.716 179.81 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.432 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -71.06 95.49 1.21 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.483 -0.761 . . . . 0.0 110.482 -179.534 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.452 ' O ' ' SG ' ' A' ' 116' ' ' CYS . 3.8 m-20 45.67 51.41 10.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 110.593 179.572 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.967 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -162.12 38.9 0.38 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.582 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 50.2 p90 -49.54 -152.53 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.898 1.333 . . . . 0.0 112.958 -179.393 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.026 HD23 ' CE2' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -141.07 120.56 13.2 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.031 -176.383 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.2 t -100.78 17.9 20.82 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.615 -0.678 . . . . 0.0 109.414 -179.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.9 t -77.98 -79.2 0.12 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.582 -0.699 . . . . 0.0 111.255 -179.166 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -122.76 -66.16 0.22 Allowed Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.632 -178.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.574 ' HB2' ' CD1' ' A' ' 71' ' ' LEU . 52.1 t80 58.71 167.0 0.05 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.571 -0.958 . . . . 0.0 110.255 -179.144 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.583 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 17.7 tttm -178.14 145.3 0.36 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.408 -0.807 . . . . 0.0 109.748 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -41.79 -32.43 0.4 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.17 -0.956 . . . . 0.0 110.244 -179.824 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.9 m -147.33 166.97 25.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.481 -0.762 . . . . 0.0 110.297 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.583 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 8.7 m-85 -140.5 -172.15 3.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.244 -0.91 . . . . 0.0 110.031 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.584 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 6.6 t -170.24 109.63 0.38 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.935 -1.103 . . . . 0.0 111.161 179.734 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.713 ' CB ' HG21 ' A' ' 59' ' ' VAL . 14.1 t80 32.75 32.64 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.307 -0.871 . . . . 0.0 111.663 179.164 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.545 ' HA ' HG22 ' A' ' 102' ' ' THR . 49.9 t30 -176.63 -134.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.642 -1.286 . . . . 0.0 110.522 179.342 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 50.65 69.66 0.61 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.056 -1.027 . . . . 0.0 109.019 -178.695 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.58 ' N ' HG23 ' A' ' 102' ' ' THR . 16.2 p30 -69.75 131.88 45.24 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.486 -0.759 . . . . 0.0 110.09 -179.204 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.593 ' CG2' HD22 ' A' ' 71' ' ' LEU . 16.2 m -119.27 122.25 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.054 -1.029 . . . . 0.0 111.018 -179.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -79.73 138.76 37.4 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.481 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 1.026 ' CE2' HD23 ' A' ' 71' ' ' LEU . 72.5 m-85 -93.59 146.6 23.69 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.918 -1.114 . . . . 0.0 112.215 -178.07 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -118.82 89.93 3.23 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.65 -179.765 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.597 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -42.08 131.16 3.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 0.0 110.249 -179.653 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 89' ' ' CYS . 0.1 OUTLIER -38.99 -66.06 0.31 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.527 -0.733 . . . . 0.0 110.624 -179.535 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.585 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER 176.69 141.74 0.07 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.401 -0.812 . . . . 0.0 110.025 179.978 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.583 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 53.35 46.2 64.36 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.946 -1.661 . . . . 0.0 108.946 -179.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.585 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 16.3 m-85 -155.59 152.13 28.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.556 -0.967 . . . . 0.0 109.64 -179.48 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.559 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -112.63 128.18 56.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 110.191 -179.998 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.597 HD11 ' H ' ' A' ' 89' ' ' CYS . 0.7 OUTLIER -64.39 97.05 0.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -0.91 . . . . 0.0 110.422 -179.879 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.456 ' HB2' HG21 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -78.67 101.1 7.32 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.315 -0.866 . . . . 0.0 109.54 179.469 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.22 -85.37 0.18 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.577 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 2.4 m -158.41 111.69 2.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.329 -1.101 . . . . 0.0 110.641 -179.353 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.8 t -71.65 -5.56 34.57 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.246 -0.909 . . . . 0.0 110.666 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.3 p -138.46 120.02 15.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.115 -0.99 . . . . 0.0 110.185 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.541 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 20.9 m -133.65 172.11 13.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.347 -0.845 . . . . 0.0 110.745 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.58 HG23 ' N ' ' A' ' 84' ' ' ASN . 17.1 m -147.51 136.24 21.96 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.385 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.575 ' O ' ' CA ' ' A' ' 81' ' ' TYR . 4.8 t -48.95 96.2 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.145 179.577 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.472 ' CB ' ' HG3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -64.63 174.22 1.32 Allowed Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.082 -1.011 . . . . 0.0 111.902 -178.935 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.822 ' CB ' HG23 ' A' ' 38' ' ' ILE . 49.7 Cg_endo -82.04 16.47 1.74 Allowed 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 124.613 1.849 . . . . 0.0 111.559 -178.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -119.53 25.81 7.54 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 179.307 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.687 ' O ' HG23 ' A' ' 108' ' ' THR . 1.9 m-80 61.24 51.63 4.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.746 -0.855 . . . . 0.0 109.932 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.687 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.5 OUTLIER -161.91 -176.72 5.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 0.0 110.977 -179.849 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.623 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 51.0 m95 -109.06 102.03 11.05 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.483 -0.76 . . . . 0.0 110.553 -179.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.515 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -107.06 140.53 21.5 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.45 -0.781 . . . . 0.0 110.209 -179.746 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.577 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.1 Cg_endo -73.18 172.44 60.46 Favored 'Cis proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.964 -2.098 . . . . 0.0 110.363 -0.355 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.9 OUTLIER -40.25 137.07 1.1 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.393 -0.817 . . . . 0.0 110.966 -179.278 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.646 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -47.83 146.57 3.86 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.448 -0.782 . . . . 0.0 110.162 179.547 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.787 ' HG2' HD12 ' A' ' 66' ' ' ILE . 39.3 Cg_endo -72.9 167.68 26.67 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 124.38 1.726 . . . . 0.0 111.063 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.513 ' O ' HG22 ' A' ' 117' ' ' VAL . 3.3 ttpt -127.32 109.68 12.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.386 -0.821 . . . . 0.0 110.801 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.531 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.9 t -66.35 90.16 0.15 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.1 -1.0 . . . . 0.0 109.172 179.225 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 94' ' ' LYS . 1.7 m -105.69 -176.26 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 121.73 0.776 . . . . 0.0 110.925 -179.386 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.5 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.762 0 C-N-CA 118.927 -1.109 . . . . 0.0 110.616 179.472 . . . . . . . . 2 2 . 1 stop_ save_